Citrus Sinensis ID: 035691

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640
Protein Sequence
NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGISELKLPPCTPSESKKRQKSNGFKLMIPLLSGLVGLVLVMSLLIIDRLRRKRTVTSSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN
Secondary Structure (PSIPRED)
cccccccccccccccEEcccHHccccccccccccccccccccccccccccccccccccccccccccEEEEcccccccccccccccEEEEccEEEEcccHHccccccccEEEccccEEEEcccccccccccccEEEcccccccccccccccccccccccccccEEEccccccccccccccccccccEEEccccEEEEEcccccccccccccEEcccccccccccccccccccccccccccccccccccHHHHccccccccccccHHHHccccccEEEcccccccccccHHHHccccccccccccccccccccHHHHccccccEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEEcccccEEEEEEEcccccccccHHHHHHHHHHcccccccccEEEEcccccccccEEEEEEEcccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEccccccccccccccEEEcccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccEEEEcccccccccccHHHcccccccEEEcccccccccccHHHccccccEEEEEcccccccccccccccHHHHHHcccccEEEcccccccccccHHHcccccccEEEEccccccccccHHHcccccccEEEEccccccccccccccccHHHcccccccEEEEcccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEEccccccccccHHHcccccccEEEcccccccccccHHEEEcccccccccccHHHccccccEEEEEccccccccccHHHcccccccEEEcccccccccccHHHccccccEEEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccHHHHHHHHccccHHcEEEccccEEEEEEEEcccccEEEEEEccccccccccHHHHHHHHHHHcHHHHHHHEEEEEccccccccccEEEEEEccccccHHHHHcccccccccccccccccHHHHHHHHHHHHHHHHHHHcccHccEEcccccHHHEEEcccccEEEccccccHEEcccccccccccEEEEcccccccccccEEEEEccc
Coil and Loop (DISEMBL)
NLTFLMLINLQqnnfsgniphEIGRLFQLRYIIFnsntlqgqipvnlthcselRTLDLVLNKLEenqlvgelppyigftlpniripllagnqffgniphsisnasklewLDFANNSltasipedlgrlrnltrlnfarndlgtrkvndLRFLDSLVNCTYLEIVSLNVNSlrsipisvgylpklqVLSLFEnnisgeipsslgnftfltelnlrgnsirgsipsalgnchqlqsldlsktiflgqypvrwldlshnhltgpiplavgnlksiphldlsknklsgeipsslgscvgleylnlsinsfhgpihpglsslkslegldLFQNTFqaksqngdvprkgifknasaisvagneklcggiselklppctpseskkrqksngfklMIPLLSGLVGLVLVMSLLIIDRLrrkrtvtssesssrkDLLLNVSYESLLKatggfssanligtgsfgsvykgildpdqTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITAcsssdfqgnDFKALVYEFMHHgsleswlhpesasddlnyspsILSFLQRLNIAINVASALEYLHHHCKkqivhcdlkpsnvlldndmiahvgdfgltrfipevissnqcssvglkgtvgyaapeygmgsqvstn
Flexible Loop (DISEMBL)
NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTasipedlgrlrnltrlnfarndlgtrkvndlRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAksqngdvprkGIFKNASAISVAGNEKLCGGISELKLPPCTPSESKKRQKSNGFKLMIPLLSGLVGLVLVMSLLIidrlrrkrtvtssesssrkdllLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGyaapeygmgsqvstn
Low Complexity Region (SEG)
NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGISELKLPPCTPSESKKRQKSNGFKLMIPllsglvglvlvmsllIIDRLRRKRTVTSSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN
Disordered region (IsUnstruct)
**TFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTF************GIFKNASAISVAGNEKLCGGIS*******************GFKLMIPLLSGLVGLVLVMSLLIIDRLRR**************LLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA************
Disordered Region (DISOPRED)
NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGISE*********************LMIPLLSGLVGLVLVMSLLIID********************LNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESA****NYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP**********VGLKGTVGYAAPEYGMGS*V***
Disordered Region (DISEMBL)
NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGISELKLPPC**********SNGFKLMIPLLSGLVGLVLVMSLLIIDRLR*************KDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN
Disordered Region (DISPRO)
*LTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGISELKLPPCTPS**KKRQKSNGFKLMIPLLSGLVGLVLVMSLLIIDRLRRK*****SESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASD*****PSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS**
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGISELKLPPCTPSESKKRQKSNGFKLMIPLLSGLVGLVLVMSLLIIDRLRRKRTVTSSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	640	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.992	0.628	0.404	1e-132
C0LGT6	1031	LRR receptor-like serine/	no	no	0.982	0.610	0.399	1e-126
Q9SD62	1025	Putative receptor-like pr	no	no	0.982	0.613	0.408	1e-122
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.953	0.622	0.352	1e-91
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.953	0.488	0.332	2e-80
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.934	0.501	0.329	7e-80
Q9FL28	1173	LRR receptor-like serine/	no	no	0.956	0.521	0.333	1e-79
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.954	0.554	0.324	1e-78
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.95	0.485	0.322	1e-76
Q9M0G7	1013	Leucine-rich repeat recep	no	no	0.925	0.584	0.318	1e-73

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  474 bits (1220), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 301/745 (40%), Positives = 411/745 (55%), Gaps = 110/745 (14%)

Query: 2   LTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLN 61
           LT L+ +NL  NN  G +P  +G L  L  +  + N L+G+IP ++   +++ +L LV N
Sbjct: 161 LTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVAN 220

Query: 62  KLE-------------------ENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSIS 102
                                  N   G L P +G  LPN+    + GN F G+IP ++S
Sbjct: 221 NFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLS 280

Query: 103 NASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLE 162
           N S LE L    N+LT SIP   G + NL  L    N LG+    DL FL SL NCT LE
Sbjct: 281 NISTLERLGMNENNLTGSIPT-FGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLE 339

Query: 163 IVSLNVNSLRS------------------------------------------------- 173
            + +  N L                                                   
Sbjct: 340 TLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSG 399

Query: 174 -IPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQL 232
            +P S+G L  L+ LSLF N +SG IP+ +GN T L  L+L  N   G +P++LGNC  L
Sbjct: 400 PLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHL 459

Query: 233 QSLDLSKTIFLGQYPVRW--------LDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSG 284
             L +      G  P+          LD+S N L G +P  +G L+++  L L  NKLSG
Sbjct: 460 LELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSG 519

Query: 285 EIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNT--------FQAKSQ- 335
           ++P +LG+C+ +E L L  N F+G I P L  L  ++ +DL  N         F + S+ 
Sbjct: 520 KLPQTLGNCLTMESLFLEGNLFYGDI-PDLKGLVGVKEVDLSNNDLSGSIPEYFASFSKL 578

Query: 336 ----------NGDVPRKGIFKNASAISVAGNEKLCGGISELKLPPC---TPSESKKRQKS 382
                      G VP KGIF+NA+ +S+ GN  LCGGI   +L PC    PS  KK   S
Sbjct: 579 EYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKK-HSS 637

Query: 383 NGFKLMIPLLSGLVGLVLVMS---LLIIDRLRRKRTVTSSESSSRKDLL-LNVSYESLLK 438
              K++I +  G+  L+L+      LI  R R+K   T++ + S  ++L   +SY  L  
Sbjct: 638 RLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRN 697

Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHR 498
           AT GFSS+N++G+GSFG+VYK +L  ++ VVAVKVL + +RGA+KSFMAECE+L++IRHR
Sbjct: 698 ATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHR 757

Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           NLVK++TACSS DFQGN+F+AL+YEFM +GSL+ WLHPE   ++++     L+ L+RLNI
Sbjct: 758 NLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEV-EEIHRPSRTLTLLERLNI 816

Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI---PEVISSNQC 615
           AI+VAS L+YLH HC + I HCDLKPSNVLLD+D+ AHV DFGL R +    E    NQ 
Sbjct: 817 AIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQL 876

Query: 616 SSVGLKGTVGYAAPEYGMGSQVSTN 640
           SS G++GT+GYAAPEYG+G Q S N
Sbjct: 877 SSAGVRGTIGYAAPEYGVGGQPSIN 901

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  451 bits (1160), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 291/728 (39%), Positives = 398/728 (54%), Gaps = 99/728 (13%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           NLT L  ++   N   G IP E+ RL Q+ +     N+  G  P  L + S L +L L  
Sbjct: 191 NLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLA- 249

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
               +N   G L    G+ LPN+R  LL  NQF G IP +++N S LE  D ++N L+ S
Sbjct: 250 ----DNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGS 305

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLR-------- 172
           IP   G+LRNL  L    N LG    + L F+ ++ NCT LE + +  N L         
Sbjct: 306 IPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIA 365

Query: 173 ------------------------------------------SIPISVGYLPKLQVLSLF 190
                                                      +P+S G L  LQV+ L+
Sbjct: 366 NLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLY 425

Query: 191 ENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYP--- 247
            N ISGEIPS  GN T L +L+L  NS  G IP +LG C  L  L +      G  P   
Sbjct: 426 SNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEI 485

Query: 248 -----VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLS 302
                + ++DLS+N LTG  P  VG L+ +  L  S NKLSG++P ++G C+ +E+L + 
Sbjct: 486 LQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQ 545

Query: 303 INSFHGPIHPGLSSLKSLEGLDLFQNTFQAK----------------SQN---GDVPRKG 343
            NSF G I P +S L SL+ +D   N    +                S N   G VP  G
Sbjct: 546 GNSFDGAI-PDISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTG 604

Query: 344 IFKNASAISVAGNEKLCGGISELKLPPCTPSESKKRQKSNGFKLMIPLLSGL-VGLVLVM 402
           +F+NA+A+SV GN  +CGG+ E++L PC    S +++K     +   ++SG+ +G+  ++
Sbjct: 605 VFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKP--LSVRKKVVSGICIGIASLL 662

Query: 403 SLLIIDRL----RRKRTVTSSESSSRKDLLL-----NVSYESLLKATGGFSSANLIGTGS 453
            ++I+  L    +RK+   +S+ +      L      VSYE L  AT  FSS NLIG+G+
Sbjct: 663 LIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGN 722

Query: 454 FGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQ 513
           FG+V+KG+L P+  +VAVKVL L + GA KSFMAECE  + IRHRNLVK+IT CSS D +
Sbjct: 723 FGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSE 782

Query: 514 GNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHC 573
           GNDF+ALVYEFM  GSL+ WL  E      ++S S L+  ++LNIAI+VASALEYLH HC
Sbjct: 783 GNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRS-LTPAEKLNIAIDVASALEYLHVHC 841

Query: 574 KKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISS---NQCSSVGLKGTVGYAAPE 630
              + HCD+KPSN+LLD+D+ AHV DFGL + + +       NQ SS G++GT+GYAAPE
Sbjct: 842 HDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPE 901

Query: 631 YGMGSQVS 638
           YGMG Q S
Sbjct: 902 YGMGGQPS 909

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  440 bits (1131), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 297/727 (40%), Positives = 393/727 (54%), Gaps = 98/727 (13%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           NLT L +++   N   G IP +I RL Q+ +     N   G  P  + + S L  L +  
Sbjct: 199 NLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSIT- 257

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
                N   G L P  G  LPN++I  +  N F G IP ++SN S L  LD  +N LT  
Sbjct: 258 ----GNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGK 313

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLR-------- 172
           IP   GRL+NL  L    N LG     DL FL +L NC+ L+ +++  N L         
Sbjct: 314 IPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIA 373

Query: 173 ------------------SIPISVGYLPKLQVLSL------------------------F 190
                             SIP  +G L  LQ L L                        +
Sbjct: 374 NLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLY 433

Query: 191 ENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRW 250
            N +SGEIPSSLGN + LT L L  NS  GSIPS+LG+C  L  L+L      G  P   
Sbjct: 434 SNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHEL 493

Query: 251 LDL--------SHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLS 302
           ++L        S N L GP+   +G LK +  LD+S NKLSG+IP +L +C+ LE+L L 
Sbjct: 494 MELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQ 553

Query: 303 INSFHGPIHPGLSSLKSLEGLDLFQNTFQAK-------------------SQNGDVPRKG 343
            NSF GPI P +  L  L  LDL +N                        + +G VP +G
Sbjct: 554 GNSFVGPI-PDIRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEG 612

Query: 344 IFKNASAISVAGNEKLCGGISELKLPPCTPSESKKRQKSNGFKLMIPLLSGLVGLVLVMS 403
           +F+N SA+SV GN  LCGGI  L+L PC  S    R+ S+  K++   +S ++  +L++ 
Sbjct: 613 VFRNTSAMSVFGNINLCGGIPSLQLQPC--SVELPRRHSSVRKIITICVSAVMAALLLLC 670

Query: 404 LLIID----RLRRKRTVTSSESSSR-----KDLLLNVSYESLLKATGGFSSANLIGTGSF 454
           L ++     +LR K    ++  + R     K     +SY+ L K TGGFSS+NLIG+G+F
Sbjct: 671 LCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNF 730

Query: 455 GSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQG 514
           G+V+KG L      VA+KVL L +RGA KSF+AECEAL  IRHRNLVK++T CSSSDF+G
Sbjct: 731 GAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEG 790

Query: 515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCK 574
           NDF+ALVYEFM +G+L+ WLHP+   +  N S + L    RLNIAI+VASAL YLH +C 
Sbjct: 791 NDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRT-LGLFARLNIAIDVASALVYLHTYCH 849

Query: 575 KQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN---QCSSVGLKGTVGYAAPEY 631
             I HCD+KPSN+LLD D+ AHV DFGL + + +        Q SS G++GT+GYAAPEY
Sbjct: 850 NPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEY 909

Query: 632 GMGSQVS 638
           GMG   S
Sbjct: 910 GMGGHPS 916

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  337 bits (865), Expect = 1e-91,   Method: Compositional matrix adjust.
 Identities = 252/714 (35%), Positives = 365/714 (51%), Gaps = 104/714 (14%)

Query: 5   LMLINLQQNNFSGNIPHEIG-RLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKL 63
           L  I+L  N+ +G IP      L +LR+++  SN L G +P +L++ + L+ +DL     
Sbjct: 168 LQYIDLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDL----- 222

Query: 64  EENQLVGELPPYIGFTLPNIRIPLLAGNQFFGN--------IPHSISNASKLEWLDFANN 115
           E N L GELP  +   +P ++   L+ N F  +           S++N+S L+ L+ A N
Sbjct: 223 ESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGN 282

Query: 116 SLTASIPEDLGRLR-NLTRLNFARNDLGTRKVNDLRFLD------------------SLV 156
           SL   I   +  L  NL +++  +N +      ++  L                    L 
Sbjct: 283 SLGGEITSSVRHLSVNLVQIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELC 342

Query: 157 NCTYLEIVSLNVNSLR-SIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRG 215
             + LE V L+ N L   IP+ +G +P+L +L +  NN+SG IP S GN + L  L L G
Sbjct: 343 KLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYG 402

Query: 216 NSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVR----------WLDLSHNHLTGPIPLA 265
           N + G++P +LG C  L+ LDLS     G  PV           +L+LS NHL+GPIPL 
Sbjct: 403 NHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLE 462

Query: 266 VGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDL 325
           +  +  +  +DLS N+LSG+IP  LGSC+ LE+LNLS N F   +   L  L  L+ LD+
Sbjct: 463 LSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDV 522

Query: 326 ------------FQNTFQAKSQN-------GDVPRKGIFKNASAISVAGNEKLCGGISEL 366
                       FQ +   K  N       G+V  KG F   +  S  G+  LCG I  +
Sbjct: 523 SFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGM 582

Query: 367 KLPPCTPSESKKRQKSNGFKLMIPLLSGLVGLVLVMSLLIIDRLR--------RKRTVTS 418
           +         KK+ K     L + L      ++ V    ++ R R         K  V  
Sbjct: 583 Q-------ACKKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVED 635

Query: 419 SESSSRKD-LLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH 477
            E  ++ D     +SY+ L+ ATGGF++++LIG+G FG VYKG+L  + T VAVKV  L 
Sbjct: 636 EEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLR-NNTKVAVKV--LD 692

Query: 478 QRGALK---SFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWL 534
            + AL+   SF  EC+ L+  RHRNL++IIT CS   F      ALV   M +GSLE  L
Sbjct: 693 PKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFN-----ALVLPLMPNGSLERHL 747

Query: 535 HPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI 594
           +P        YS   L  +Q +NI  +VA  + YLHH+   ++VHCDLKPSN+LLD++M 
Sbjct: 748 YPGE------YSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMT 801

Query: 595 AHVGDFGLTRF---IPEVISSNQCSSVG-----LKGTVGYAAPEYGMGSQVSTN 640
           A V DFG++R    + E +S++   S G     L G+VGY APEYGMG + ST+
Sbjct: 802 ALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTH 855

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  300 bits (769), Expect = 2e-80,   Method: Compositional matrix adjust.
 Identities = 234/704 (33%), Positives = 332/704 (47%), Gaps = 94/704 (13%)

Query: 1    NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
            N T L +I++  N+F G IP  IGRL +L  +    N L G +P +L +C +L  LDL  
Sbjct: 454  NCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLA- 512

Query: 61   NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIP---------------------- 98
                +NQL G +P   GF L  +   +L  N   GN+P                      
Sbjct: 513  ----DNQLSGSIPSSFGF-LKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGT 567

Query: 99   -HSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTR------KVNDLRF 151
             H +  +S     D  NN     IP +LG  +NL RL   +N L  +      K+ +L  
Sbjct: 568  IHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSL 627

Query: 152  LD------------SLVNCTYLEIVSLNVNSLRS-IPISVGYLPKLQVLSLFENNISGEI 198
            LD             LV C  L  + LN N L   IP  +G L +L  L L  N     +
Sbjct: 628  LDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESL 687

Query: 199  PSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYP--------VRW 250
            P+ L N T L  L+L GNS+ GSIP  +GN   L  L+L K  F G  P        +  
Sbjct: 688  PTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYE 747

Query: 251  LDLSHNHLTGPIPLAVGNLKSIPH-LDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGP 309
            L LS N LTG IP+ +G L+ +   LDLS N  +G+IPS++G+   LE L+LS N   G 
Sbjct: 748  LRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGE 807

Query: 310  IHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGISELKLP 369
            +   +  +KSL  L++  N    K        K  F    A S  GN  LCG      L 
Sbjct: 808  VPGSVGDMKSLGYLNVSFNNLGGK-------LKKQFSRWPADSFLGNTGLCGS----PLS 856

Query: 370  PCTPSESKKRQKSNGFK--LMIPLLSGLVG---LVLVMSLLIIDRLRRKRTVTSSESS-- 422
             C    S  +Q+    +  ++I  +S L     ++LV++L    R    + V    ++  
Sbjct: 857  RCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYT 916

Query: 423  --------SRKDLLLN------VSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTV 468
                    + K L  N      + +E +++AT   S   +IG+G  G VYK  L+  +TV
Sbjct: 917  SSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETV 976

Query: 469  VAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHG 528
               K+L+     + KSF  E + L  IRHR+LVK++  CSS   +      L+YE+M +G
Sbjct: 977  AVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSS---KSEGLNLLIYEYMKNG 1033

Query: 529  SLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVL 588
            S+  WLH +     L     +L +  RL IA+ +A  +EYLHH C   IVH D+K SNVL
Sbjct: 1034 SIWDWLHEDKPV--LEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVL 1091

Query: 589  LDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYG 632
            LD++M AH+GDFGL + + E   +N  S+     + GY APEY 
Sbjct: 1092 LDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYA 1135

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  298 bits (764), Expect = 7e-80,   Method: Compositional matrix adjust.
 Identities = 234/710 (32%), Positives = 345/710 (48%), Gaps = 112/710 (15%)

Query: 5    LMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLE 64
            LM ++L  NNF+G IP  + +   L     + N L+G +P  + + + L+ L      L 
Sbjct: 426  LMALDLDSNNFTGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRL-----VLS 480

Query: 65   ENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPED 124
            +NQL GE+P  IG  L ++ +  L  N F G IP  + + + L  LD  +N+L   IP+ 
Sbjct: 481  DNQLTGEIPREIG-KLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDK 539

Query: 125  LGRLRNLTRLNFARNDLGTR------------KVNDLRFLDSLVNCTYLEIVSLNVNSLR 172
            +  L  L  L  + N+L               ++ DL FL       +  I  L+ N L 
Sbjct: 540  ITALAQLQCLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQ------HHGIFDLSYNRLS 593

Query: 173  S-IPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQ 231
              IP  +G    L  +SL  N++SGEIP+SL   T LT L+L GN++ GSIP  +GN  +
Sbjct: 594  GPIPEELGECLVLVEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLK 653

Query: 232  LQSLDLSKTIFLGQYPVRW--------LDLSHNHLTGPIPLAVGNLKSIPHLDLS----- 278
            LQ L+L+     G  P  +        L+L+ N L GP+P ++GNLK + H+DLS     
Sbjct: 654  LQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLS 713

Query: 279  -------------------KNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKS 319
                               +NK +GEIPS LG+   LEYL++S N   G I   +  L +
Sbjct: 714  GELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPN 773

Query: 320  LEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGISELKLPPCTPSESKKR 379
            LE L+L +N  +     G+VP  G+ ++ S   ++GN++LCG +       C    +K R
Sbjct: 774  LEFLNLAKNNLR-----GEVPSDGVCQDPSKALLSGNKELCGRVVG---SDCKIEGTKLR 825

Query: 380  QKSNGFKLMIPLLSGLVGLVLVMSL---LIIDRLRRKRTVTSSESS-------------- 422
                   LM+     ++  V V SL    +  R++++      E S              
Sbjct: 826  SAWGIAGLMLGFT--IIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLS 883

Query: 423  ---SRKDL----------LLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVV 469
               SR+ L          LL V    +++AT  FS  N+IG G FG+VYK  L P +  V
Sbjct: 884  GSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACL-PGEKTV 942

Query: 470  AVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGS 529
            AVK L   +    + FMAE E L  ++H NLV ++  CS S     + K LVYE+M +GS
Sbjct: 943  AVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFS-----EEKLLVYEYMVNGS 997

Query: 530  LESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL 589
            L+ WL  ++   +      +L + +RL IA+  A  L +LHH     I+H D+K SN+LL
Sbjct: 998  LDHWLRNQTGMLE------VLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILL 1051

Query: 590  DNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST 639
            D D    V DFGL R I    S    S+V + GT GY  PEYG  ++ +T
Sbjct: 1052 DGDFEPKVADFGLARLISACES--HVSTV-IAGTFGYIPPEYGQSARATT 1098

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  298 bits (762), Expect = 1e-79,   Method: Compositional matrix adjust.
 Identities = 242/726 (33%), Positives = 357/726 (49%), Gaps = 114/726 (15%)

Query: 1    NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
            NL  L ++ +  NN SG +P ++G L  LR +  + N L G IP ++++C+ L+ LDL  
Sbjct: 358  NLRNLTVLTVGFNNISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDL-- 415

Query: 61   NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
                 NQ+ GE+P   GF   N+    +  N F G IP  I N S LE L  A+N+LT +
Sbjct: 416  ---SHNQMTGEIPR--GFGRMNLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGT 470

Query: 121  IPEDLGRLRNLTRLNFARNDLG---TRKVNDLRFLDSLV---------------NCTYLE 162
            +   +G+L+ L  L  + N L     R++ +L+ L+ L                N T L+
Sbjct: 471  LKPLIGKLQKLRILQVSYNSLTGPIPREIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQ 530

Query: 163  IVSLNVNSLRS-IPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGS 221
             + +  N L   IP  +  +  L VL L  N  SG+IP+       LT L+L+GN   GS
Sbjct: 531  GLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGS 590

Query: 222  IPSALGNCHQLQSLDLSKTIFLGQYPVR----------WLDLSHNHLTGPIPLAVGNLKS 271
            IP++L +   L + D+S  +  G  P            +L+ S+N LTG IP  +G L+ 
Sbjct: 591  IPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEM 650

Query: 272  IPHLDLSKNKLSGEIPSSLGSCV----------------------GLEY---LNLSINSF 306
            +  +DLS N  SG IP SL +C                       G++    LNLS NSF
Sbjct: 651  VQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSF 710

Query: 307  HGPIHPGLSSLKSLEGLDLFQNTFQAK-----------------SQN--GDVPRKGIFKN 347
             G I     ++  L  LDL  N    +                 S N  G VP  G+FKN
Sbjct: 711  SGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKN 770

Query: 348  ASAISVAGNEKLCGGISELKLPPCTPSESKKRQKSNGFKLMIPLLSGLVGLVLVMSLLII 407
             +A  + GN  LCG    LK  PCT      +QKS+ F     ++  ++G    + L+++
Sbjct: 771  INASDLMGNTDLCGSKKPLK--PCT-----IKQKSSHFSKRTRVILIILGSAAALLLVLL 823

Query: 408  DRLRRK------RTVTSSESSSRKDL-----LLNVSYESLLKATGGFSSANLIGTGSFGS 456
              L         + + +S  SS  DL     L     + L +AT  F+SAN+IG+ S  +
Sbjct: 824  LVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLST 883

Query: 457  VYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITACSSSDFQG 514
            VYKG L+ D TV+AVKVL L +  A   K F  E + L  ++HRNLVKI+       ++ 
Sbjct: 884  VYKGQLE-DGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFA----WES 938

Query: 515  NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCK 574
               KALV  FM +G+LE  +H  +A         I S L+++++ +++AS ++YLH    
Sbjct: 939  GKTKALVLPFMENGNLEDTIHGSAAP--------IGSLLEKIDLCVHIASGIDYLHSGYG 990

Query: 575  KQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP-EVISSNQCSSVGLKGTVGYAAPEYGM 633
              IVHCDLKP+N+LLD+D +AHV DFG  R +      S   S+   +GT+GY APE+  
Sbjct: 991  FPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAY 1050

Query: 634  GSQVST 639
              +V+T
Sbjct: 1051 MRKVTT 1056

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  294 bits (752), Expect = 1e-78,   Method: Compositional matrix adjust.
 Identities = 228/703 (32%), Positives = 340/703 (48%), Gaps = 92/703 (13%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           NL++ + I+  +N  +G IP E+G +  L  +    N L G IPV L+    L  LDL +
Sbjct: 311 NLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSI 370

Query: 61  NKLE-------------------ENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSI 101
           N L                    +N L G +PP +G+   ++ +  ++ N   G IP  +
Sbjct: 371 NALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGW-YSDLWVLDMSDNHLSGRIPSYL 429

Query: 102 SNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYL 161
              S +  L+   N+L+ +IP  +   + L +L  ARN+L  R      F  +L     +
Sbjct: 430 CLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGR------FPSNLCKQVNV 483

Query: 162 EIVSLNVNSLR-SIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRG 220
             + L  N  R SIP  VG    LQ L L +N  +GE+P  +G  + L  LN+  N + G
Sbjct: 484 TAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTG 543

Query: 221 SIPSALGNCHQLQSLDLSKTIFLGQYP--------VRWLDLSHNHLTGPIPLAVGNLKSI 272
            +PS + NC  LQ LD+    F G  P        +  L LS+N+L+G IP+A+GNL  +
Sbjct: 544 EVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRL 603

Query: 273 PHLDLSKNKLSGEIPSSLGSCVGLEY-LNLSINSFHGPIHPGLSSLKSLEGL-------- 323
             L +  N  +G IP  LGS  GL+  LNLS N   G I P LS+L  LE L        
Sbjct: 604 TELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLS 663

Query: 324 -----------DLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGI--SELKLPP 370
                       L    F   S  G +P   + +N S  S  GNE LCG      ++  P
Sbjct: 664 GEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISMSSFIGNEGLCGPPLNQCIQTQP 720

Query: 371 CTPSESKKRQKSNGFKLMIPLLSGLVGLVLVMSLLIIDRLRRK--RTVTSSESSSR-KDL 427
             PS+S  +        +I + + ++G V +M + +I  L R+  RTV SS    +  ++
Sbjct: 721 FAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEM 780

Query: 428 LLNV--------SYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR 479
            L++        +++ L+ AT  F  + ++G G+ G+VYK +L    T+   K+   H+ 
Sbjct: 781 SLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEG 840

Query: 480 G----ALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH 535
           G       SF AE   L NIRHRN+VK+   C   + QG++   L+YE+M  GSL   LH
Sbjct: 841 GNNNNVDNSFRAEILTLGNIRHRNIVKLHGFC---NHQGSNL--LLYEYMPKGSLGEILH 895

Query: 536 PESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA 595
             S +         L + +R  IA+  A  L YLHH CK +I H D+K +N+LLD+   A
Sbjct: 896 DPSCN---------LDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEA 946

Query: 596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS 638
           HVGDFGL + I ++  S   S++   G+ GY APEY    +V+
Sbjct: 947 HVGDFGLAKVI-DMPHSKSMSAIA--GSYGYIAPEYAYTMKVT 986

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  288 bits (736), Expect = 1e-76,   Method: Compositional matrix adjust.
 Identities = 226/700 (32%), Positives = 338/700 (48%), Gaps = 92/700 (13%)

Query: 1    NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
            N T L  I+   N  SG IP  IGRL  L  +    N L G IP +L +C ++  +DL  
Sbjct: 455  NCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLA- 513

Query: 61   NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
                +NQL G +P   GF L  + + ++  N   GN+P S+ N   L  ++F++N    S
Sbjct: 514  ----DNQLSGSIPSSFGF-LTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGS 568

Query: 121  I-----------------------PEDLGRLRNLTRLNFARNDLGTR------KVNDLRF 151
            I                       P +LG+  NL RL   +N    R      K+++L  
Sbjct: 569  ISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSL 628

Query: 152  LDSLVN------------CTYLEIVSLNVNSLRS-IPISVGYLPKLQVLSLFENNISGEI 198
            LD   N            C  L  + LN N L   IP  +G LP L  L L  N   G +
Sbjct: 629  LDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSL 688

Query: 199  PSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYP--------VRW 250
            P+ + + T +  L L GNS+ GSIP  +GN   L +L+L +    G  P        +  
Sbjct: 689  PTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFE 748

Query: 251  LDLSHNHLTGPIPLAVGNLKSIPH-LDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGP 309
            L LS N LTG IP+ +G L+ +   LDLS N  +G IPS++ +   LE L+LS N   G 
Sbjct: 749  LRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGE 808

Query: 310  IHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGISELKLP 369
            +   +  +KSL  L+L  N  + K        K  F    A +  GN  LCG      L 
Sbjct: 809  VPGQIGDMKSLGYLNLSYNNLEGK-------LKKQFSRWQADAFVGNAGLCGS----PLS 857

Query: 370  PCTPSESK-KRQKSNGFKLMIPLLSGLVGLVLVMSLLII------DRLRRKR----TVTS 418
             C  + SK +R  S    ++I  +S L  + L++ ++I+      D  ++ R      +S
Sbjct: 858  HCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSS 917

Query: 419  SESSSRKDLLLN------VSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVK 472
            + SSS+  L  N      + ++ +++AT   +   +IG+G  G VYK  L   +T+   K
Sbjct: 918  NSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKK 977

Query: 473  VLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLES 532
            +L+     + KSF  E + L  IRHR+LVK++  CSS   + +    L+YE+M +GS+  
Sbjct: 978  ILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSS---KADGLNLLIYEYMANGSVWD 1034

Query: 533  WLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND 592
            WLH    +++      +L +  RL IA+ +A  +EYLH+ C   IVH D+K SNVLLD++
Sbjct: 1035 WLH----ANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSN 1090

Query: 593  MIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYG 632
            + AH+GDFGL + +     +N  S+    G+ GY APEY 
Sbjct: 1091 IEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYA 1130

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1

 Score =  278 bits (710), Expect = 1e-73,   Method: Compositional matrix adjust.
 Identities = 208/653 (31%), Positives = 329/653 (50%), Gaps = 61/653 (9%)

Query: 10  LQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLV 69
           L +NNF+G IP EIG +  L+ + F+ N L G+IP+ +T    L+ L+L+ NKL      
Sbjct: 267 LYENNFTGTIPREIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRNKLS----- 321

Query: 70  GELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLR 129
           G +PP I  +L  +++  L  N   G +P  +   S L+WLD ++NS +  IP  L    
Sbjct: 322 GSIPPAIS-SLAQLQVLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCNKG 380

Query: 130 NLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLR-SIPISVGYLPKLQVLS 188
           NLT+L    N    +         +L  C  L  V +  N L  SIPI  G L KLQ L 
Sbjct: 381 NLTKLILFNNTFTGQ------IPATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLE 434

Query: 189 LFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPV 248
           L  N +SG IP  + +   L+ ++   N IR S+PS + + H LQ+  ++     G+ P 
Sbjct: 435 LAGNRLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPD 494

Query: 249 RW--------LDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLN 300
           ++        LDLS N LTG IP ++ + + +  L+L  N L+GEIP  + +   L  L+
Sbjct: 495 QFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLD 554

Query: 301 LSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLC 360
           LS NS  G +   + +  +LE L++  N        G VP  G  K  +   + GN  LC
Sbjct: 555 LSNNSLTGVLPESIGTSPALELLNVSYNKL-----TGPVPINGFLKTINPDDLRGNSGLC 609

Query: 361 GGISELKLPPCTPSESKKRQKSN--GFKLMIPLLSGLVGLVLVMSLLIIDRLRRKRTVTS 418
           GG+    LPPC+  +      S+  G +++   L G+  ++ +  L I+ R   K+  ++
Sbjct: 610 GGV----LPPCSKFQRATSSHSSLHGKRIVAGWLIGIASVLALGILTIVTRTLYKKWYSN 665

Query: 419 ----SESSSRKDLLLNVSYESLLKATGG-----FSSANLIGTGSFGSVYKGILDPDQTVV 469
                E++S+ +    +     L  T          +N+IG G+ G VYK  +    TV+
Sbjct: 666 GFCGDETASKGEWPWRLMAFHRLGFTASDILACIKESNMIGMGATGIVYKAEMSRSSTVL 725

Query: 470 AVKVLFLH----QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL-VYEF 524
           AVK L+      + G    F+ E   L  +RHRN+V+++       F  ND   + VYEF
Sbjct: 726 AVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLL------GFLYNDKNMMIVYEF 779

Query: 525 MHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKP 584
           M +G+L   +H ++A+  L     ++ ++ R NIA+ VA  L YLHH C   ++H D+K 
Sbjct: 780 MLNGNLGDAIHGKNAAGRL-----LVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKS 834

Query: 585 SNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV 637
           +N+LLD ++ A + DFGL R    +++  + +   + G+ GY APEYG   +V
Sbjct: 835 NNILLDANLDARIADFGLAR----MMARKKETVSMVAGSYGYIAPEYGYTLKV 883

Involved in the regulation of procambium maintenance and polarity during vascular-tissue development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	640
359482058	1040	PREDICTED: probable LRR receptor-like se	0.990	0.609	0.485	1e-173
147853780	1904	hypothetical protein VITISV_030954 [Viti	0.990	0.332	0.484	1e-171
224090977	1034	predicted protein [Populus trichocarpa]	0.971	0.601	0.498	1e-167
255585471	963	serine-threonine protein kinase, plant-t	0.975	0.647	0.472	1e-160
357505893	1003	Receptor kinase-like protein [Medicago t	0.973	0.621	0.459	1e-158
359486510	965	PREDICTED: probable LRR receptor-like se	0.987	0.654	0.465	1e-157
356566660	1020	PREDICTED: probable LRR receptor-like se	0.965	0.605	0.470	1e-155
255577438	1028	receptor-kinase, putative [Ricinus commu	0.979	0.609	0.461	1e-155
224113117	1006	predicted protein [Populus trichocarpa]	0.985	0.627	0.463	1e-151
224097750	1023	predicted protein [Populus trichocarpa]	0.984	0.615	0.460	1e-148

>gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  613 bits (1582), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 349/719 (48%), Positives = 439/719 (61%), Gaps = 85/719 (11%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           NLT +  ++   N+  G+IP  +G+L  L ++    N   G IP ++ + S L    L  
Sbjct: 199 NLTSIKSLSFAVNHLEGSIPQALGQLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPY 258

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
           NKL      G LP  + FTLPN+++  +  N F G++P S+SNAS L   D   ++ T  
Sbjct: 259 NKL-----YGSLPWDLAFTLPNLQVLNIGNNDFTGSLPSSLSNASNLLEFDITMSNFTGK 313

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSL-------------- 166
           +  D G + NL  L  A N LG  + +DL FL+SL+ C  L+++ L              
Sbjct: 314 VSIDFGGMPNLWGLFLASNPLGKGEADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSIA 373

Query: 167 ------------------------------------NVNSLRSIPISVGYLPKLQVLSLF 190
                                               N +   SIP+ +G L  L  + L 
Sbjct: 374 NLSTQLMKLKLDNNQLSGTIPPGIGNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLS 433

Query: 191 ENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRW 250
            N +SG IPSSLGN T L  L+L+ N + G IPS+ GN   LQ LDLS     G  P + 
Sbjct: 434 RNQLSGHIPSSLGNITRLYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKV 493

Query: 251 LDL---------SHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNL 301
           +DL         + N LTG +P  V  LK++ HLD+S+NKLSGEIP  LGSC+ LE+L++
Sbjct: 494 MDLVSLTISLNLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHM 553

Query: 302 SINSFHGPIHPGLSSLKSLEGLDLFQNTFQAK------------------SQNGDVPRKG 343
             N F G I P   SL+ L  LDL +N    +                  +  G +P KG
Sbjct: 554 EGNFFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLSLSNLNLSFNNFEGQLPTKG 613

Query: 344 IFKNASAISVAGNEKLCGGISELKLPPCTPSESKKRQKSNGFKLMIPLLSGLVGLVLVMS 403
           +F NA++ SVAGN KLCGGI EL LP C  ++ K  +   G KLMI LL+G +GLVL+MS
Sbjct: 614 VFNNATSTSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLIMS 673

Query: 404 LLIIDRLRRKRTVTSSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILD 463
           LL+I+RLRR +   S  S+S KDL+LNVSY+ L KATGGFSSANLIGTG FGSVYKGIL 
Sbjct: 674 LLVINRLRRVKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGILG 733

Query: 464 PDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYE 523
            D+TVVAVKV+ LHQRGA+KSF AECEALRNIRHRNLVK++T CSS D+QGNDFKALVYE
Sbjct: 734 QDETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYE 793

Query: 524 FMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLK 583
           FM +GSLE+WLHP    D++N    ILS  QRLNIAI+VASAL+YLHHHC K IVHCDLK
Sbjct: 794 FMPNGSLENWLHPVPTPDEINDVLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLK 853

Query: 584 PSNVLLDNDMIAHVGDFGLTRFIPEVISS---NQCSSVGLKGTVGYAAPEYGMGSQVST 639
           PSN+LLDNDM AHVGDFGL RFIPE       +Q SS+GLKGT+GYAAPEYGMG++VS 
Sbjct: 854 PSNILLDNDMTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSA 912

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera]

 Score =  609 bits (1570), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 348/719 (48%), Positives = 437/719 (60%), Gaps = 85/719 (11%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           NLT +  ++   N+  G+IP  +G+L  L ++    N   G IP ++ + S L    L  
Sbjct: 230 NLTSIKSLSFAVNHLEGSIPQALGQLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSLPY 289

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
           NKL      G LP  + FTLPN+++  +  N F G +P S+SNAS L   D   ++ T  
Sbjct: 290 NKL-----YGSLPWDLAFTLPNLQVLNIGNNDFTGPLPSSLSNASNLLEFDITMSNFTGK 344

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSL-------------- 166
           +  D G + NL  L  A N LG  + +DL FL+SL+ C  L+++ L              
Sbjct: 345 VSIDFGGMPNLWGLFLASNPLGKGEADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSIA 404

Query: 167 ------------------------------------NVNSLRSIPISVGYLPKLQVLSLF 190
                                               N +   SIP+ +G L  L  + L 
Sbjct: 405 NLSTQLMKLKLDNNQLSGTIPPGIGNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLS 464

Query: 191 ENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRW 250
            N +SG IPSSLGN T L  L+L+ N + G IPS+ GN   LQ LDLS     G  P + 
Sbjct: 465 RNQLSGHIPSSLGNITRLYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKV 524

Query: 251 LDL---------SHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNL 301
           +DL         + N LTG +P  V  LK++ HLD+S+NKLSGEIP  LGSC+ LE+L++
Sbjct: 525 MDLVSLTISLNLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHM 584

Query: 302 SINSFHGPIHPGLSSLKSLEGLDLFQNTFQAK------------------SQNGDVPRKG 343
             N F G I P   SL+ L  LDL +N    +                  +  G +P KG
Sbjct: 585 EGNFFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLSLSNLNLSFNNFEGQLPTKG 644

Query: 344 IFKNASAISVAGNEKLCGGISELKLPPCTPSESKKRQKSNGFKLMIPLLSGLVGLVLVMS 403
           +F NA++ SVAGN KLCGGI EL LP C  ++ K  +   G KLMI LL+G +GLVL+MS
Sbjct: 645 VFNNATSTSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLIMS 704

Query: 404 LLIIDRLRRKRTVTSSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILD 463
           LL+I+RLRR +   S  S+S KDL+LNVSY+ L KATGGFSSANLIGTG FGSVYKG L 
Sbjct: 705 LLVINRLRRVKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGXLG 764

Query: 464 PDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYE 523
            D+TVVAVKV+ LHQRGA+KSF AECEALRNIRHRNLVK++T CSS D+QGNDFKALVYE
Sbjct: 765 QDETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYE 824

Query: 524 FMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLK 583
           FM +GSLE+WLHP    D++N    ILS  QRLNIAI+VASAL+YLHHHC K IVHCDLK
Sbjct: 825 FMPNGSLENWLHPVPTPDEINDVLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLK 884

Query: 584 PSNVLLDNDMIAHVGDFGLTRFIPEVISS---NQCSSVGLKGTVGYAAPEYGMGSQVST 639
           PSN+LLDNDM AHVGDFGL RFIPE       +Q SS+GLKGT+GYAAPEYGMG++VS 
Sbjct: 885 PSNILLDNDMTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKVSA 943

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224090977|ref|XP_002309132.1| predicted protein [Populus trichocarpa] gi|222855108|gb|EEE92655.1| predicted protein [Populus trichocarpa]

 Score =  593 bits (1530), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 354/710 (49%), Positives = 442/710 (62%), Gaps = 88/710 (12%)

Query: 13  NNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGEL 72
           NNF G+IP  +GRL  L ++    N L G IP  + + S L     ++  L  NQL G L
Sbjct: 209 NNFEGSIPDALGRLKTLNFLGLGLNNLSGMIPPTIFNLSSL-----IVFTLPYNQLHGTL 263

Query: 73  PPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLT 132
           P  +G TLPN+++  +  N F G +P SISNAS L  LD   ++ T  +  D G L NL 
Sbjct: 264 PSDLGLTLPNLQVLNIGHNFFSGPLPVSISNASNLLELDIDTSNFT-KVTIDFGGLPNLW 322

Query: 133 RLNFARNDLGTRKVNDLRFLDSLVNC-------------------------TYLEIVSLN 167
            L  + N LG  + +DL F+DSL  C                         T L ++ L 
Sbjct: 323 SLALSSNPLGKGEADDLSFIDSLTKCRNLRLLDLSNSHFGGVIPDSIGNLSTQLFLLKLR 382

Query: 168 VNSLR-------------------------SIPISVGYLPKLQVLSLFENNISGEIPSSL 202
            N L                          SIP  +G L  LQ L L EN +SG IPSSL
Sbjct: 383 GNQLSGSIPTVIENLLNLAELTVEKNYLSGSIPSVLGNLKMLQRLDLSENKLSGLIPSSL 442

Query: 203 GNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRW---------LDL 253
           GN T L E +L+ N I GSIPS+ GN   LQ+LDLS+ +  G  P            L+L
Sbjct: 443 GNITQLFEFHLQKNQIMGSIPSSFGNLKYLQNLDLSQNLLSGTIPKEVMGLSSLTISLNL 502

Query: 254 SHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPG 313
           + N LTGP+P    NL ++ +LD+S+NKL G+IPSSLGSCV LE L++  N F G I P 
Sbjct: 503 AQNQLTGPLPPEAQNLMNLGYLDVSENKLYGQIPSSLGSCVTLEKLHMQGNFFEGAIPPS 562

Query: 314 LSSLKSLEGLDLFQNTFQAKSQN------------------GDVPRKGIFKNASAISVAG 355
            SSL+ L  +DL +N    +                     G+VPR+G F NA+AIS++G
Sbjct: 563 FSSLRGLRDMDLSRNNLSGQIPQFLKRLALISLNLSFNHFEGEVPREGAFLNATAISLSG 622

Query: 356 NEKLCGGISELKLPPCTPSESKKRQKSNGFKLMIPLLSGLVGLVLVMSLLIIDRLRRK-- 413
           N++LCGGI +LKLP C  + SK  + S   KLMI +L+ L+ LV VMS+L+I+RLR+K  
Sbjct: 623 NKRLCGGIPQLKLPRCVVNRSKNGKTSRRVKLMIAILTPLLVLVFVMSILVINRLRKKNR 682

Query: 414 RTVTSSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKV 473
           ++  +S  SS+++LLL VSY +L KAT GFSSANLIG GSFGSVY+GILDP++TVVAVKV
Sbjct: 683 QSSLASSLSSKQELLLKVSYRNLHKATAGFSSANLIGAGSFGSVYRGILDPNETVVAVKV 742

Query: 474 LFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESW 533
           LF+ QR  LKSFMAECE L+NIRHRNLVKI+TACSS DFQGNDFKALVYEFM +G+LESW
Sbjct: 743 LFMRQRKTLKSFMAECEILKNIRHRNLVKILTACSSVDFQGNDFKALVYEFMPNGTLESW 802

Query: 534 LHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM 593
           LH    ++ +N    ILSF QRLNIAI+VA+AL YLH+ C K +VHCDLKPSNVLLDNDM
Sbjct: 803 LHSFPRTNGINEDLKILSFHQRLNIAIDVAAALNYLHYQCHKPVVHCDLKPSNVLLDNDM 862

Query: 594 IAHVGDFGLTRFIPEVIS---SNQCSSVGLKGTVGYAAPEYGMGSQVSTN 640
            AHVGDFGL RFI E I+    N+ SSVGLKGTVGYAAPEYGMGS+ S N
Sbjct: 863 TAHVGDFGLARFIEEAINPSHRNESSSVGLKGTVGYAAPEYGMGSKPSMN 912

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255585471|ref|XP_002533428.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526716|gb|EEF28948.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  571 bits (1471), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 331/700 (47%), Positives = 431/700 (61%), Gaps = 76/700 (10%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           NL+ L  ++L +N   G +P+ +G L  L ++   SN L G IP +L + S +R LD+  
Sbjct: 199 NLSQLQRLSLAENRMVGEVPNSLGWLRNLTFLSLRSNRLSGTIPSSLFNLSSIRNLDI-- 256

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
               EN   G LP  IGF LPNIR   ++ N+F G IP S+SNA+ LE L    N+LT  
Sbjct: 257 ---GENNFHGNLPSDIGFLLPNIRWFAISSNEFTGKIPVSLSNATNLESLLLLQNNLTGE 313

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRS------- 173
           +P  L +L  L   +   N+LGT K +DL FL SL N T LE + +N N+          
Sbjct: 314 VPS-LAKLDRLRVFSLTSNNLGTGKADDLSFLHSLTNTTALEELGVNGNNFGGMLPDSIA 372

Query: 174 -------------------------------------------IPISVGYLPKLQVLSLF 190
                                                      IP S+G L  L VL+L 
Sbjct: 373 NLSTTLRILLLDNNRIIGSIPSGIENLVSLEDFEVWNNQLSGFIPDSIGKLQNLVVLALN 432

Query: 191 ENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVR- 249
            N +SG IPSSLGN T L +L +  N++ G IPS LG C  +  L LS+  F G  P   
Sbjct: 433 SNMLSGHIPSSLGNLTNLIQLLVEDNNLSGRIPSDLGRCQNMLGLSLSQNNFSGSIPPEV 492

Query: 250 --------WLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNL 301
                   +LDLS N+LTG +P+ VGNLKS+   D+S NKLSGEIP +LGSC+ LE LN+
Sbjct: 493 ISISSLSIYLDLSQNNLTGTLPMEVGNLKSLSEFDVSGNKLSGEIPRTLGSCISLEILNM 552

Query: 302 SINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCG 361
           + N+F G I   LSSL++L+ LDL  N       +G VP KGIFKNASA SV GN  LCG
Sbjct: 553 AGNNFQGLIPSSLSSLRALQILDLSNNHL-----SGMVPSKGIFKNASATSVEGNNMLCG 607

Query: 362 GISELKLPPCTPSESKKRQKSNGFKLMIPLLSGLVGLVLVMSLLIIDRLRRKRTVTSSES 421
           GI E +LP C  +  KK + +   K +I  +SG+  L+L++ L    +  +K   T+++ 
Sbjct: 608 GIPEFQLPVCNSARHKKNRLTPVLKTVISAISGMAFLILMLYLFWFRQ--KKVNETTADF 665

Query: 422 SSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA 481
           S +K  ++ +SY++L KAT GFSSAN+IG GSFGSVYKG LD + T++AVKV  L +RG 
Sbjct: 666 SEKK--IMELSYQNLHKATDGFSSANIIGMGSFGSVYKGRLDREGTLIAVKVFNLMRRGG 723

Query: 482 LKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASD 541
            KSF+AECEALRNIRHRNL+K++TACSS D+ GNDFKALVYEFM +GSLE WLHP  A++
Sbjct: 724 FKSFLAECEALRNIRHRNLLKVLTACSSLDYHGNDFKALVYEFMVNGSLEEWLHPPVATN 783

Query: 542 DLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG 601
           +       L+FLQRLNIAI+VASAL YLHHHC+ QIVHCDLKPSN+LLD ++  HVGDFG
Sbjct: 784 EAELETRKLNFLQRLNIAIDVASALYYLHHHCEPQIVHCDLKPSNILLDEELTGHVGDFG 843

Query: 602 LTRFIPEVISSN--QCSSVGLKGTVGYAAPEYGMGSQVST 639
           L RF+ +   ++  Q SS+G++GTVGYA PEYGM S+VST
Sbjct: 844 LARFLLDATQNHYTQSSSIGVRGTVGYAPPEYGMSSEVST 883

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357505893|ref|XP_003623235.1| Receptor kinase-like protein [Medicago truncatula] gi|355498250|gb|AES79453.1| Receptor kinase-like protein [Medicago truncatula]

 Score =  565 bits (1455), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 331/720 (45%), Positives = 433/720 (60%), Gaps = 97/720 (13%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           N + L L+NL  NN  G IP+E+G+L +L     N N L G IP+++ + S L  L    
Sbjct: 178 NFSSLSLLNLAVNNLHGTIPNEVGKLSRLTLFALNGNHLYGTIPLSVFNISSLSFL---- 233

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
               +N L G LP  +GFTLPN+       N F G IP S+SNAS+LE LDFA N+L  +
Sbjct: 234 -TFSQNNLHGNLPYDVGFTLPNLETFAGGVNDFTGTIPESLSNASRLEILDFAENNLIGT 292

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIV---------------- 164
           +P+++GRL  L RLNF  N LG  +  +L FL SL+NCT LE++                
Sbjct: 293 LPKNIGRLTLLKRLNFDTNRLGNGEDGELNFLTSLINCTALEVLGLAENQFGGKLPSSIG 352

Query: 165 --SLNVNSLR--------SIPI------------------------SVGYLPKLQVLSLF 190
             S+N+N+L         SIPI                        ++G L KL  L L+
Sbjct: 353 NLSINLNALDLGENAIYGSIPIGISNLVNLTSLGMEKNNLSGFVPDTIGMLQKLVDLELY 412

Query: 191 ENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVR- 249
            N  SG IPSS+GN T LT+L +  N+  GSIP++L NC +L  L+LS  +  G  P + 
Sbjct: 413 SNKFSGVIPSSIGNLTRLTKLLIADNNFEGSIPTSLENCQRLLMLNLSHNMLNGSIPRQV 472

Query: 250 --------WLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNL 301
                   +LDLSHN LTG +P  +G L ++ +LDLSKNKLSG IPSS+GSCV LE+L++
Sbjct: 473 FALSSLSIYLDLSHNSLTGSLPFEIGKLVNLANLDLSKNKLSGMIPSSIGSCVSLEWLHM 532

Query: 302 SINSFHGPIHPGLSSLKSLEGLDLFQNTFQAK-------------------SQNGDVPRK 342
             N F G I   + +L+ ++ +DL  N    K                   + +G++P  
Sbjct: 533 QGNFFEGNIPSTIQNLRGIQHIDLSCNNLSGKIPEFLGEIKGLMHLNLSYNNLDGELPMN 592

Query: 343 GIFKNASAISVAGNEKLCGGISELKLPPCTPSESKKRQKSNGFKLMIPLLSGLVGLVLVM 402
           GIFKNA++ S+ GN KLCGG+ EL LP CT     K++K +  K++IP+ S L+ L+ + 
Sbjct: 593 GIFKNATSFSINGNIKLCGGVPELNLPACT----IKKEKFHSLKVIIPIASALIFLLFLS 648

Query: 403 SLLIIDRLRRKRTVTSSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGIL 462
             LII  ++R R  TS E+++ +DL LN+SY  ++K TGGFS+ NLIG+GSFGSVYKG L
Sbjct: 649 GFLIIIVIKRSRKKTSRETTTIEDLELNISYSEIVKCTGGFSNDNLIGSGSFGSVYKGTL 708

Query: 463 DPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVY 522
             D T +A+KVL L QRGA KSF+ EC AL+ IRHRNL+KIITA SS D QG DFKALVY
Sbjct: 709 SSDGTTIAIKVLNLEQRGASKSFIDECNALKVIRHRNLLKIITAISSIDHQGKDFKALVY 768

Query: 523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDL 582
           EFM +GSLE WLHP +           L+F+QRLNIAI+VA ALEYLHH C+  IVHCD+
Sbjct: 769 EFMSNGSLEDWLHPINQK-------KTLTFVQRLNIAIDVACALEYLHHFCETPIVHCDI 821

Query: 583 KPSNVLLDNDMIAHVGDFGLTRFIPEVISS---NQCSSVGLKGTVGYAAPEYGMGSQVST 639
           KPSNVLLDNDM+A VGDFGL  F+ E       +   S  LKG+VGY  PEYGMG   S 
Sbjct: 822 KPSNVLLDNDMVARVGDFGLATFLFEESCDSPKHSTMSASLKGSVGYIPPEYGMGGHPSA 881

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359486510|ref|XP_002271317.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like, partial [Vitis vinifera]

 Score =  560 bits (1444), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 335/720 (46%), Positives = 435/720 (60%), Gaps = 88/720 (12%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           NL+ L  ++  QNN  G IP  + +L  L ++  N+N L G IP +L++ S      L+ 
Sbjct: 127 NLSSLERLSATQNNIVGTIPASLFQLITLTHVALNANGLSGTIPPSLSNLS-----SLIF 181

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
             +  N L G LP  +G TLPN++   L+GN+F G+IP S+SNAS LE+     N+LT  
Sbjct: 182 FAVSFNHLHGNLPSNLGITLPNLQDLSLSGNRFTGSIPVSLSNASNLEYFSCNGNNLTGK 241

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLR-------- 172
           +P  L +L+ L   +   N+LG  ++ DL FL SL N + LE+++LNVN+          
Sbjct: 242 VP-SLEKLQRLHFFSVTSNNLGNGEIEDLGFLSSLTNVSNLEVLALNVNNFGGVLPESIG 300

Query: 173 ------------------------------------------SIPISVGYLPKLQVLSLF 190
                                                     SIP+ +G L  L+VL L 
Sbjct: 301 NWSTKLATLLLDGNKIGGSIPAGIGNLVSLERLEMWENQLSGSIPVDIGKLQNLRVLMLI 360

Query: 191 ENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRW 250
           +N +SG +PSSLGN   L +L L  N  +G IPS+LG C  L  LDLS     G  P + 
Sbjct: 361 KNKLSGILPSSLGNLENLIQLVLGRNYFQGKIPSSLGKCQNLLFLDLSLNNLSGTIPPQV 420

Query: 251 LDLSH---------NHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNL 301
           + LS          N LTG +P+ VGNLK++  LD+S N LSG IPSS+GSC  LEYL++
Sbjct: 421 VSLSSLSISLDISDNRLTGALPIEVGNLKNLGVLDVSNNMLSGGIPSSVGSCTSLEYLSM 480

Query: 302 SINSFHGPIHPGLSSLKSLEGLDLFQNTFQAK---------------SQN---GDVPRKG 343
             N F G I    SSL+ +  LDL  N    K               S N   G +P +G
Sbjct: 481 KGNFFQGSIPSSFSSLRGIRILDLSHNNLSGKIPEFLQDIHFQLVNLSYNDFEGILPTEG 540

Query: 344 IFKNASAISVAGNEKLCGGISELKLPPCTPSESKKRQKSNGFKLMIPLLSGLVGLVLVMS 403
           +FKN SA S+ GN KLCGGI E +LP C   E KKR  S   K++I  +SGL+ +  V+S
Sbjct: 541 VFKNVSATSIMGNSKLCGGIPEFQLPKCNLQEPKKRGLSLALKIIIATVSGLLAITCVLS 600

Query: 404 LLIIDRLRRKRTVTSSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILD 463
            LI   LR+K+   +S SS +  L   VSY+SLL+AT GFSS+NLIG GSFGSVYKGILD
Sbjct: 601 FLIFLWLRKKKGEPASSSSEKSLLK--VSYQSLLRATDGFSSSNLIGVGSFGSVYKGILD 658

Query: 464 PDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYE 523
            D T +AVKVL L ++GA KSF+AECEALRNIRHRNLVK++TACS  D+QGNDFKA+VYE
Sbjct: 659 HDGTAIAVKVLNLLRKGASKSFIAECEALRNIRHRNLVKVLTACSGVDYQGNDFKAVVYE 718

Query: 524 FMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLK 583
           FM +GSLE WLHP   + + +  P  L+FLQRLNIAI+VA AL+YLHH C+  IVHCDLK
Sbjct: 719 FMVNGSLEQWLHPTPTTAEASAPPRKLNFLQRLNIAIDVACALDYLHHQCQTPIVHCDLK 778

Query: 584 PSNVLLDNDMIAHVGDFGLTRFIPEV---ISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN 640
           PSNVLLD +M  HVGDFG+ +F+PE    +   Q SS+G++GT+GYAAPEYGMGS+VST+
Sbjct: 779 PSNVLLDTEMTGHVGDFGIAKFLPEAATRVPEIQSSSIGIRGTIGYAAPEYGMGSEVSTS 838

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356566660|ref|XP_003551548.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Glycine max]

 Score =  555 bits (1431), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 333/708 (47%), Positives = 419/708 (59%), Gaps = 90/708 (12%)

Query: 13  NNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGEL 72
           NN  GNIP+EIG+L +L  +  N N L G IP  + + S L         + +N L G +
Sbjct: 195 NNLHGNIPNEIGQLSRLTLLALNGNYLSGTIPGTIFNISSL-----FFFTVSQNHLHGNI 249

Query: 73  PPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLT 132
           P  +G+T PN+       N F G IP S+SNAS+LE LDFA N LT ++P+++GRL  L 
Sbjct: 250 PADVGYTFPNLETFAGGVNSFTGTIPESLSNASRLEILDFAENGLTGTLPKNIGRLPLLK 309

Query: 133 RLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLR-------------------- 172
           RLNF  N LGT K  DL FL SLVNCT L+++ L+ NS                      
Sbjct: 310 RLNFDDNRLGTGKAGDLNFLASLVNCTALKVLGLSDNSFGGELPSTIANLSTQLTSLTLG 369

Query: 173 ------SIPISVGYLPKLQVLSLFENNISG------------------------EIPSSL 202
                 S+PI +  L  L  L L ENN+SG                         IPSS+
Sbjct: 370 GNGIHGSVPIGIRNLVNLTFLGLEENNLSGFVPHTIGMLRLLNGLDLNGNNFSGVIPSSI 429

Query: 203 GNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVR---------WLDL 253
           GN T LT L +  N+  GSIP+ LG C  L  L+LS  +  G  P +         +LDL
Sbjct: 430 GNLTRLTRLQMEENNFEGSIPANLGKCQSLLMLNLSHNMLNGTIPRQVLTLSSLSIYLDL 489

Query: 254 SHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPG 313
           SHN LTGP+   VG L ++  LDLS+NKLSG IPSSLGSC+GLE+++L  N F G I   
Sbjct: 490 SHNALTGPVLAEVGKLVNLAQLDLSENKLSGMIPSSLGSCIGLEWIHLQGNFFEGNIPST 549

Query: 314 LSSLKSLEGLDLFQNTFQAK----------------SQN---GDVPRKGIFKNASAISVA 354
           +  L+ L+ +DL  N F  K                S N   G +P  GIFKNA++ SV 
Sbjct: 550 MRYLRGLQDIDLSCNNFSGKIPEFLGEFKVLEHLNLSYNDFSGKLPMNGIFKNATSYSVY 609

Query: 355 GNEKLCGGISELKLPPCTPSESKKRQKSNGFKLMIPLLSGLVGLVLVMSLLIIDRLRRKR 414
           GN KLCGG  EL LP CT  ++   +K +  K++I ++  LV ++L+   L I  ++R R
Sbjct: 610 GNSKLCGGAPELDLPACTIKKASSFRKFHDPKVVISVIVALVFVLLLFCFLAISMVKRAR 669

Query: 415 TVTSSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVL 474
              +S S++ KDL L +SY  + K TGGFS  NL+G+GSFGSVYKG L  D + VAVKVL
Sbjct: 670 K-KASRSTTTKDLDLQISYSEIAKCTGGFSPDNLVGSGSFGSVYKGTLSSDGSSVAVKVL 728

Query: 475 FLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWL 534
            L QRGA KSF+ EC+ LR+IRHRNL+KIITA SS D QGNDFKALV+EFM +GSLE WL
Sbjct: 729 NLEQRGASKSFIDECQVLRSIRHRNLLKIITAISSVDHQGNDFKALVFEFMPNGSLEDWL 788

Query: 535 HPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI 594
           HP    D+       LSF+QRLNIAI+VA ALEYLHH C   IVHCD+KPSNVLLDNDM+
Sbjct: 789 HP---VDNQQKQTKTLSFIQRLNIAIDVACALEYLHHFCHTPIVHCDIKPSNVLLDNDMV 845

Query: 595 AHVGDFGLTRFIPEVIS-SNQCSSVG--LKGTVGYAAPEYGMGSQVST 639
           AHVGDFGL  F+ E  S S Q S++   LKG++GY  PEYGMG   S 
Sbjct: 846 AHVGDFGLATFLFEESSGSPQQSTMSGVLKGSIGYIPPEYGMGGHPSA 893

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255577438|ref|XP_002529598.1| receptor-kinase, putative [Ricinus communis] gi|223530931|gb|EEF32790.1| receptor-kinase, putative [Ricinus communis]

 Score =  554 bits (1427), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 334/723 (46%), Positives = 440/723 (60%), Gaps = 96/723 (13%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           NL+ L +I   +NNF G IP+ IG+L  L+      +   G IP ++ + S L  L + +
Sbjct: 194 NLSSLEIIYGTRNNFHGEIPNSIGQLKSLQTFSLGGSNFSGVIPPSIFNLSSLTILSVPI 253

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
           N     QL G LPP +G +LP + +  L  N+F G+IP +ISNAS L  LD + N+ T  
Sbjct: 254 N-----QLHGNLPPDLGQSLPKLEVLRLYANKFSGSIPPTISNASNLVALDVSQNNFTGK 308

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLR-------- 172
           +P  L RL NL+ +   +N+LG  + +DL FL +L N T LEI+++  N+L         
Sbjct: 309 VPS-LARLHNLSYIGIHKNNLGNGEDDDLSFLYTLANNTNLEILAITENNLGGVLPEMLS 367

Query: 173 ------------------------------------------SIPISVGYLPKLQVLSLF 190
                                                     SIP S+G L  L  L L 
Sbjct: 368 NFSTKLVHMAFGRNKIRGRIPSEIDNLIRLEALGFERNELTGSIPSSLGKLKNLIKLYLN 427

Query: 191 ENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRW 250
           +NNISG IPSSLGN T L+ ++L+ N++ GSIPS+LGNC Q+  +DLS+    G  P   
Sbjct: 428 DNNISGSIPSSLGNITSLSTISLKVNNLEGSIPSSLGNCQQMLLMDLSRNNLSGTIPKEL 487

Query: 251 ---------LDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNL 301
                    LDLS N  TG +P+ VG L ++ +LD+SKNKLSGEIP SLGSC  LE L L
Sbjct: 488 ISIPSLSISLDLSENQFTGSLPMEVGGLVNLGYLDVSKNKLSGEIPKSLGSCTRLETLYL 547

Query: 302 SINSFHGPIHPGLSSL------------------------KSLEGLDLFQNTFQAKSQNG 337
             N+F G I   LSSL                        KSLE LDL  N F+     G
Sbjct: 548 QGNAFQGTIPVSLSSLRGINDLNLSHNNLTGQIPNFFAEFKSLEKLDLSYNDFE-----G 602

Query: 338 DVPRKGIFKNASAISVAGNEKLCGGISELKLPPCTPSESKKRQKSNGFKLMIPLLSGLVG 397
           +VP +G+FKNASA S++GN+ LCGGI E+ LP CT ++S K + S+  +L+I +    V 
Sbjct: 603 EVPAEGVFKNASAFSISGNKNLCGGIPEINLPRCTLNKSMKPKTSHKLRLIIVVACCGVV 662

Query: 398 LVLVMSLLIIDRLRRKRTVTSSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSV 457
            VL+++  ++    + R    +  SS       VSY++LLKAT GFSSANLIG GSFGSV
Sbjct: 663 GVLLLTSALLFCCLKMRKNKEASGSSLDIFFQKVSYQNLLKATDGFSSANLIGAGSFGSV 722

Query: 458 YKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF 517
           YKGIL PD+T++AVKVL L  +GA +SFM EC+AL N+RHRNLVK++TACSSSDF+ NDF
Sbjct: 723 YKGILAPDETIIAVKVLNLQHKGASRSFMTECQALANVRHRNLVKVLTACSSSDFEENDF 782

Query: 518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQI 577
           KALVYE+M +GSLE WLHP + + D +  P ILS ++RL+I+I+VASAL+YLH+ C+  +
Sbjct: 783 KALVYEYMVNGSLEEWLHP-TQNPDQDQPPRILSLIERLSISIDVASALDYLHNQCQVPV 841

Query: 578 VHCDLKPSNVLLDNDMIAHVGDFGLTRF-IPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ 636
           VHCDLKPSN+LLD+DM AHVGDFGL RF I     S+  SS+G++GTVGYAAPEYGMGS 
Sbjct: 842 VHCDLKPSNILLDSDMTAHVGDFGLARFLIAAPHHSSPSSSIGIRGTVGYAAPEYGMGSD 901

Query: 637 VST 639
           VST
Sbjct: 902 VST 904

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224113117|ref|XP_002316396.1| predicted protein [Populus trichocarpa] gi|222865436|gb|EEF02567.1| predicted protein [Populus trichocarpa]

 Score =  543 bits (1398), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 334/720 (46%), Positives = 429/720 (59%), Gaps = 89/720 (12%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           NL+ + +I +  N+  G+IP+ IG+L +LR +    N L G IP ++ + S L    + +
Sbjct: 175 NLSSVEIIGVGDNHLQGSIPYGIGKLKRLRKLSVPLNNLSGTIPPSIYNLSSLTLFSVAI 234

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
           N     Q  G LP  +G  LP++ + +   N+F G IP +ISNAS L  +DF NNS T  
Sbjct: 235 N-----QFHGSLPSDLGQKLPSLEVLVFYANRFNGPIPVTISNASTLSVIDFGNNSFTGK 289

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLE------------------ 162
           +P     L NL  L    N+LG  +  DL FL SL N T LE                  
Sbjct: 290 VPP-FANLPNLQYLGIDSNELGNGEEGDLSFLQSLANYTNLEELGMSDNNLGGMFPEIIS 348

Query: 163 -------IVSLNVNSLRS-------------------------IPISVGYLPKLQVLSLF 190
                   +S+  N +R                          IP S+G L  L  L+L 
Sbjct: 349 NFSSQFTTLSMGRNQVRGSIPVDIGNLISLDTLMLETNQLTGVIPTSIGKLKNLHGLTLV 408

Query: 191 ENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRW 250
           EN ISG IPSSLGN T L EL L  N+++G IPS+L NC  L SL L++    G    + 
Sbjct: 409 ENKISGNIPSSLGNVTSLVELYLSANNLQGGIPSSLANCQNLMSLKLAQNNLSGPLTKQV 468

Query: 251 ---------LDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNL 301
                    LDLSHN L GP+P  VG L ++ +LD+S N+LSGEIP SLGSC+ LEYL+L
Sbjct: 469 IGMASLSVSLDLSHNQLIGPLPSEVGRLVNLGYLDVSHNRLSGEIPGSLGSCIMLEYLHL 528

Query: 302 SINSFHGPIHPGLSSLKSLEGLDLFQNT-------FQAKSQ------------NGDVPRK 342
             N   G I   LSSL++L+ L+L  N        F A  Q             G++P +
Sbjct: 529 EGNFLQGSIPELLSSLRALQYLNLSYNNLTGQIPRFLADFQLLQRLDLSFNHLEGEMPTQ 588

Query: 343 GIFKNASAISVAGNEKLCGGISELKLPPCTPSESKKRQKSNGFKLMIPLLSGLVGLVLVM 402
            +F N SA+SV GN+KLCGGIS+L L  CT +E +K + S   KL+I +  G +  +L++
Sbjct: 589 RVFGNVSAVSVLGNDKLCGGISQLNLSRCTSNELRKPKFSTKLKLVISIPCGFIIALLLI 648

Query: 403 SLLIIDRLRRKRTVTSSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGIL 462
           S L+I   R+ +   +S +S        V+YE L +ATGGFSS+N IG GSFGSVYK IL
Sbjct: 649 SSLLIHSWRKTKNEPASGASWEVSFR-RVTYEELYQATGGFSSSNFIGGGSFGSVYKAIL 707

Query: 463 DPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVY 522
            PD  +VAVKV  L ++GA KS+MAEC AL NIRHRNLVKI+TACSS DF+GNDFKALVY
Sbjct: 708 APDGMIVAVKVFNLLRKGASKSYMAECAALINIRHRNLVKILTACSSLDFRGNDFKALVY 767

Query: 523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDL 582
           EFM +GSLE WLHP   SD+       L+ +QRLN+AI+VASAL+YLH+HC+  +VHCDL
Sbjct: 768 EFMVNGSLEEWLHPVHTSDE-EREQGNLNLIQRLNVAIDVASALDYLHYHCQMAVVHCDL 826

Query: 583 KPSNVLLDNDMIAHVGDFGLTRFIPEV---ISSNQCSSVGLKGTVGYAAPEYGMGSQVST 639
           KPSNVLLD DM AHVGDFGL RF PE    +SSNQ SS+GLKGTVGYAAPEYG+G++VST
Sbjct: 827 KPSNVLLDGDMTAHVGDFGLARFRPEASVQLSSNQNSSIGLKGTVGYAAPEYGIGNEVST 886

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224097750|ref|XP_002311066.1| predicted protein [Populus trichocarpa] gi|222850886|gb|EEE88433.1| predicted protein [Populus trichocarpa]

 Score =  533 bits (1373), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 331/719 (46%), Positives = 420/719 (58%), Gaps = 89/719 (12%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           NL+ L +I   +NN  G IP  IG+L +L    F  N+L G IP ++ + S L      L
Sbjct: 192 NLSELQIIRGVRNNLQGGIPDSIGQLKRLADFTFGVNSLSGTIPSSIYNMSSLVRFSAPL 251

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
           N     QL G LPP +G TLPN+    +  NQF G IP ++SNASK+  L   NNS T  
Sbjct: 252 N-----QLYGILPPELGLTLPNLDTFNILSNQFRGLIPSTLSNASKISDLQLRNNSFTGK 306

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLN------------- 167
           +P  L  L NL RL    N+LG  + +DL FL  L N T LEI+++N             
Sbjct: 307 VP-SLAGLHNLQRLVLNFNNLGNNEDDDLGFLYPLANTTSLEILAINHNNFGGVLPEIVC 365

Query: 168 ------------VNSLRS-------------------------IPISVGYLPKLQVLSLF 190
                        N+LR                          IP S+G L +L V ++ 
Sbjct: 366 NFSTKLRIMIIGENNLRGSIPTEIGKLIGLDTLGLELNQLTGIIPSSIGKLQRLGVFNIN 425

Query: 191 ENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVR- 249
            N ISG IPSSLGN T L E+    N+++G IPS+LGNC  L  L L +    G  P   
Sbjct: 426 GNKISGNIPSSLGNITSLLEVYFFANNLQGRIPSSLGNCQNLLMLRLDQNNLSGSIPKEV 485

Query: 250 --------WLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNL 301
                   +LDL+ N L GP+P  VG L  +  L++ KN+LSGEIP  L SCV LE+LNL
Sbjct: 486 LGISSLSMYLDLAENQLIGPLPSEVGKLVHLGGLNVYKNRLSGEIPGILSSCVSLEHLNL 545

Query: 302 SINSFHGPIHPGLSSLKSLEGLDLFQNTFQAK-------------------SQNGDVPRK 342
             N F G I   LSSL++L+ L+L  N    K                   +  G+VP +
Sbjct: 546 GPNFFQGSIPESLSSLRALQILNLSHNNLSGKIPKFLAEFKLLTSLDLSFNNLEGEVPVQ 605

Query: 343 GIFKNASAISVAGNEKLCGGISELKLPPCTPSESKKRQKSNGFKLMIPLLSGLVGLVLVM 402
           G+F  AS  S+ GN+KLCGG  +L L  CT  +S+K + S   KL+I +  G VG++L++
Sbjct: 606 GVFARASGFSMLGNKKLCGGRPQLNLSRCTSKKSRKLKSSTKMKLIIAIPCGFVGIILLV 665

Query: 403 SLLIIDRLRRKRTVTSSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGIL 462
           S ++   L+ K++  +S  S  +     V+YE LL+AT GFS ANLIG GSFGSVYKGIL
Sbjct: 666 SYMLFFLLKEKKSRPAS-GSPWESTFQRVAYEDLLQATKGFSPANLIGAGSFGSVYKGIL 724

Query: 463 DPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVY 522
             D   VAVKV  L + GA KSFMAEC AL NIRHRNLVK++TACS  DFQGNDFKALVY
Sbjct: 725 RSDGAAVAVKVFNLLREGASKSFMAECAALINIRHRNLVKVLTACSGIDFQGNDFKALVY 784

Query: 523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDL 582
           EFM +GSLE WLHP   SD+ +     LS LQRLNIAI+VASAL+YLH+HC+  + HCDL
Sbjct: 785 EFMVNGSLEEWLHPVQISDEAHVRRD-LSLLQRLNIAIDVASALDYLHNHCQIAVAHCDL 843

Query: 583 KPSNVLLDNDMIAHVGDFGLTRFIPEV---ISSNQCSSVGLKGTVGYAAPEYGMGSQVS 638
           KPSNVLLD DM AHVGDFGL R +P+    +  +Q SS+GLKGT+GYAAPEYG+GS+VS
Sbjct: 844 KPSNVLLDGDMTAHVGDFGLARLLPQASHQLCLDQTSSIGLKGTIGYAAPEYGLGSEVS 902

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	640
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.970	0.614	0.407	2e-111
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.959	0.599	0.408	1.9e-106
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.957	0.594	0.395	4.1e-104
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.959	0.607	0.386	1.1e-103
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.962	0.600	0.410	3e-101
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.964	0.611	0.374	2.7e-100
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.953	0.520	0.344	6.9e-80
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.929	0.607	0.348	5.4e-79
UNIPROTKB|O24435	813	O24435 "Receptor kinase-like p	0.817	0.643	0.368	2.7e-77
TAIR|locus:2175703	502	AT5G39390 [Arabidopsis thalian	0.503	0.641	0.484	7.1e-77

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 1100 (392.3 bits), Expect = 2.0e-111, P = 2.0e-111
 Identities = 267/656 (40%), Positives = 371/656 (56%)

Query:     5 LMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLE 64
             L+  N+  N F+G+IP  +  +  L  +  N N L G IP    +   L+ L L  N L 
Sbjct:   261 LLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPT-FGNVPNLKLLFLHTNSLG 319

Query:    65 ENQLVGELPPYIGFT-LPNIRIPLLAGNQFFGNIPHSISNAS-KLEWLDFANNSLTASIP 122
              +    +L      T    +    +  N+  G++P SI+N S KL  LD     ++ SIP
Sbjct:   320 SDSS-RDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIP 378

Query:   123 EDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLP 182
              D+G L NL +L   +N L       L     L+N  YL + S  ++    IP  +G + 
Sbjct:   379 YDIGNLINLQKLILDQNMLSGPLPTSL---GKLLNLRYLSLFSNRLSG--GIPAFIGNMT 433

Query:   183 KLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIF 242
              L+ L L  N   G +P+SLGN + L EL +  N + G+IP  +    QL  LD+S    
Sbjct:   434 MLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSL 493

Query:   243 LGQYP--------VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCV 294
             +G  P        +  L L  N L+G +P  +GN  ++  L L  N   G+IP   G  V
Sbjct:   494 IGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-LV 552

Query:   295 GLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVA 354
             G++ ++LS N   G I    +S   LE L+L  N  + K     VP KGIF+NA+ +S+ 
Sbjct:   553 GVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGK-----VPVKGIFENATTVSIV 607

Query:   355 GNEKLCGGISELKLPPC---TPSESKKRQKSNGFKLMIPXXXXXXXXXXXXXXXIID--- 408
             GN  LCGGI   +L PC    PS  KK   S   K++I                +     
Sbjct:   608 GNNDLCGGIMGFQLKPCLSQAPSVVKKHS-SRLKKVVIGVSVGITLLLLLFMASVTLIWL 666

Query:   409 RLRRKRTVTSSESSSRKDLLLN-VSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQT 467
             R R+K   T++ + S  ++L   +SY  L  AT GFSS+N++G+GSFG+VYK +L  ++ 
Sbjct:   667 RKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKK 726

Query:   468 VVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHH 527
             VVAVKVL + +RGA+KSFMAECE+L++IRHRNLVK++TACSS DFQGN+F+AL+YEFM +
Sbjct:   727 VVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPN 786

Query:   528 GSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNV 587
             GSL+ WLHPE   ++++     L+ L+RLNIAI+VAS L+YLH HC + I HCDLKPSNV
Sbjct:   787 GSLDMWLHPEEV-EEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNV 845

Query:   588 LLDNDMIAHVGDFGLTRFI---PEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN 640
             LLD+D+ AHV DFGL R +    E    NQ SS G++GT+GYAAPEYG+G Q S N
Sbjct:   846 LLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSIN 901

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1053 (375.7 bits), Expect = 1.9e-106, P = 1.9e-106
 Identities = 270/661 (40%), Positives = 370/661 (55%)

Query:     5 LMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLE 64
             L ++ +  N+F+G IP  +  +  LR +   SN L G+IP++      L  L L  N L 
Sbjct:   276 LQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLG 335

Query:    65 ENQLVGELPPYIGFTLPNI-RIPLL-AG-NQFFGNIPHSISNAS-KLEWLDFANNSLTAS 120
              N   G+L  ++G  L N  ++  L  G N+  G +P  I+N S +L  L    N ++ S
Sbjct:   336 -NYSSGDLD-FLG-ALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGS 392

Query:   121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRS-IPISVG 179
             IP  +G L +L  L+   N L T K+       SL   + L  V L  N L   IP S+G
Sbjct:   393 IPHGIGNLVSLQTLDLGENLL-TGKLPP-----SLGELSELRKVLLYSNGLSGEIPSSLG 446

Query:   180 YLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSK 239
              +  L  L L  N+  G IPSSLG+ ++L +LNL  N + GSIP  L     L  L++S 
Sbjct:   447 NISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSF 506

Query:   240 TIFLGQYPVRW----------LDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSS 289
              + +G  P+R           LD+S+N L+G IP  + N  S+  L L  N   G IP  
Sbjct:   507 NLLVG--PLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDI 564

Query:   290 LGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNAS 349
              G   GL +L+LS N+  G I   +++   L+ L+L  N F     +G VP +G+F+N S
Sbjct:   565 RG-LTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNF-----DGAVPTEGVFRNTS 618

Query:   350 AISVAGNEKLCGGISELKLPPCTPSESKKRQKSNGFKLMIPXXXXXXXXXXXXXXXIID- 408
             A+SV GN  LCGGI  L+L PC  S    R+ S+  K++                 ++  
Sbjct:   619 AMSVFGNINLCGGIPSLQLQPC--SVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYL 676

Query:   409 ---RLRRKRTVTSSESSSR-----KDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKG 460
                +LR K    ++  + R     K     +SY+ L K TGGFSS+NLIG+G+FG+V+KG
Sbjct:   677 CWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKG 736

Query:   461 ILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL 520
              L      VA+KVL L +RGA KSF+AECEAL  IRHRNLVK++T CSSSDF+GNDF+AL
Sbjct:   737 FLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRAL 796

Query:   521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHC 580
             VYEFM +G+L+ WLHP+   +  N S + L    RLNIAI+VASAL YLH +C   I HC
Sbjct:   797 VYEFMPNGNLDMWLHPDEIEETGNPSRT-LGLFARLNIAIDVASALVYLHTYCHNPIAHC 855

Query:   581 DLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN---QCSSVGLKGTVGYAAPEYGMGSQV 637
             D+KPSN+LLD D+ AHV DFGL + + +        Q SS G++GT+GYAAPEYGMG   
Sbjct:   856 DIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHP 915

Query:   638 S 638
             S
Sbjct:   916 S 916

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 1031 (368.0 bits), Expect = 4.1e-104, P = 4.1e-104
 Identities = 258/653 (39%), Positives = 359/653 (54%)

Query:    10 LQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLV 69
             L  N F+G IP  +  +  L     +SN L G IP++      L  L +  N L  N   
Sbjct:   273 LGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSS 332

Query:    70 GELPPYIGFTLPNIRIPLL-AG-NQFFGNIPHSISNASK-LEWLDFANNSLTASIPEDLG 126
             G    +IG      ++  L  G N+  G +P SI+N S  L  L    N ++ +IP D+G
Sbjct:   333 GL--EFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIG 390

Query:   127 RLRNLTRLNFARNDL-GTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRS-IPISVGYLPKL 184
              L +L  L+   N L G   V+       L+N   L++V L  N++   IP   G + +L
Sbjct:   391 NLVSLQELSLETNMLSGELPVS----FGKLLN---LQVVDLYSNAISGEIPSYFGNMTRL 443

Query:   185 QVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLG 244
             Q L L  N+  G IP SLG   +L +L +  N + G+IP  +     L  +DLS     G
Sbjct:   444 QKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTG 503

Query:   245 QYP--VRWLDL------SHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGL 296
              +P  V  L+L      S+N L+G +P A+G   S+  L +  N   G IP  +   V L
Sbjct:   504 HFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSL 562

Query:   297 EYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGN 356
             + ++ S N+  G I   L+SL SL  L+L  N F+     G VP  G+F+NA+A+SV GN
Sbjct:   563 KNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFE-----GRVPTTGVFRNATAVSVFGN 617

Query:   357 EKLCGGISELKLPPCTPSESKKRQKSNGFKLMIPXXXXXXXXXXXXXXXIIDR---LRRK 413
               +CGG+ E++L PC    S +++K    +  +                +      ++RK
Sbjct:   618 TNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRK 677

Query:   414 RTVTSSESSSRKDLLLN-----VSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTV 468
             +   +S+ +      L      VSYE L  AT  FSS NLIG+G+FG+V+KG+L P+  +
Sbjct:   678 KKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKL 737

Query:   469 VAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHG 528
             VAVKVL L + GA KSFMAECE  + IRHRNLVK+IT CSS D +GNDF+ALVYEFM  G
Sbjct:   738 VAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKG 797

Query:   529 SLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVL 588
             SL+ WL  E      ++S S L+  ++LNIAI+VASALEYLH HC   + HCD+KPSN+L
Sbjct:   798 SLDMWLQLEDLERVNDHSRS-LTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNIL 856

Query:   589 LDNDMIAHVGDFGLTRFIPEVISS---NQCSSVGLKGTVGYAAPEYGMGSQVS 638
             LD+D+ AHV DFGL + + +       NQ SS G++GT+GYAAPEYGMG Q S
Sbjct:   857 LDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPS 909

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 1027 (366.6 bits), Expect = 1.1e-103, P = 1.1e-103
 Identities = 253/654 (38%), Positives = 367/654 (56%)

Query:     8 INLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQ 67
             +NL +N+  G IP  +  +  L+    N N + G I  N      L+ LDL  N L  + 
Sbjct:   264 LNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLDLSENPLG-SY 322

Query:    68 LVGELPPYIGFTLPNI-RIPLLA-G-NQFFGNIPHSISNAS-KLEWLDFANNSLTASIPE 123
               G+L  +I  +L N   + LL+ G  +  G +P SI+N S +L  L+   N    SIP+
Sbjct:   323 TFGDLE-FID-SLTNCTHLQLLSVGYTRLGGALPTSIANMSTELISLNLIGNHFFGSIPQ 380

Query:   124 DLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRS-IPISVGYLP 182
             D+G L  L RL   +N L       L    SL     L ++SL  N +   IP  +G L 
Sbjct:   381 DIGNLIGLQRLQLGKNML----TGPLP--TSLGKLLRLGLLSLYSNRMSGEIPSFIGNLT 434

Query:   183 KLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIF 242
             +L++L L  N+  G +P SLG  + + +L +  N + G+IP  +     L +L +     
Sbjct:   435 QLEILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSL 494

Query:   243 LGQYP---------VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSC 293
              G  P         V+ L L +N  +G +P  +GN  ++  L L  N   G IP+  G  
Sbjct:   495 SGSLPNDIGSLQNLVK-LSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIPNIRG-L 552

Query:   294 VGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISV 353
             +G+  ++LS N   G I    ++   LE L+L  N F      G VP KG F+N++ + V
Sbjct:   553 MGVRRVDLSNNDLSGSIPEYFANFSKLEYLNLSINNF-----TGKVPSKGNFQNSTIVFV 607

Query:   354 AGNEKLCGGISELKLPPCTPSESKKRQKSNGF--KLMIPXXXXXXXXXXXXXXXII---D 408
              GN+ LCGGI +LKL PC   E     K +    K+ I                ++    
Sbjct:   608 FGNKNLCGGIKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIASMVLCWF 667

Query:   409 RLRRKRTVTSSESSSRKDLLLN-VSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQT 467
             R RRK   T++   S+ ++    +SY  L  AT GFSS+N++G+GSFG+V+K +L  +  
Sbjct:   668 RKRRKNQQTNNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESK 727

Query:   468 VVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHH 527
             +VAVKVL + +RGA+KSFMAECE+L++ RHRNLVK++TAC+S+DFQGN+F+AL+YE++ +
Sbjct:   728 IVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPN 787

Query:   528 GSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNV 587
             GS++ WLHPE   +++   P  L+ L+RLNI I+VAS L+YLH HC + I HCDLKPSNV
Sbjct:   788 GSVDMWLHPEEV-EEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNV 846

Query:   588 LLDNDMIAHVGDFGLTRFIPEVISS---NQCSSVGLKGTVGYAAPEYGMGSQVS 638
             LL++D+ AHV DFGL R + +       NQ SS G++GT+GYAAPEYGMG Q S
Sbjct:   847 LLEDDLTAHVSDFGLARLLLKFDKESFLNQLSSAGVRGTIGYAAPEYGMGGQPS 900

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1004 (358.5 bits), Expect = 3.0e-101, P = 3.0e-101
 Identities = 269/655 (41%), Positives = 356/655 (54%)

Query:     2 LTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLN 61
             L  L +I++  N F G IP  +     L  I    N   G I         L  L L  N
Sbjct:   272 LHLLEVIDMGTNRFHGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLWRN 331

Query:    62 KLE--ENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNAS-KLEWLDFANNSLT 118
               +  E    G +      +   ++   L  N   G +P+S SN S  L +L    N +T
Sbjct:   332 LFQTREQDDWGFISDLTNCS--KLQTLNLGENNLGGVLPNSFSNLSTSLSFLALELNKIT 389

Query:   119 ASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISV 178
              SIP+D+G L  L  L    N+      + L     L N   L     N++   SIP+++
Sbjct:   390 GSIPKDIGNLIGLQHLYLCNNNFRGSLPSSL---GRLKNLGILLAYENNLSG--SIPLAI 444

Query:   179 GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQ-SLDL 237
             G L +L +L L  N  SG IP +L N T L  L L  N++ G IPS L N   L   +++
Sbjct:   445 GNLTELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINV 504

Query:   238 SKTIFLGQYP-----VRWLDLSH---NHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSS 289
             SK    G  P     ++ L   H   N L+G IP  +G+ + + +L L  N LSG IPS+
Sbjct:   505 SKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSA 564

Query:   290 LGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNAS 349
             LG   GLE L+LS N+  G I   L+ +  L  L+L  N+F      G+VP  G F  AS
Sbjct:   565 LGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFV-----GEVPTIGAFAAAS 619

Query:   350 AISVAGNEKLCGGISELKLPPCTPS-ESKKRQKSNGFKLMIPXXXXXXXXXXXXXXXIID 408
              IS+ GN KLCGGI +L LP C P  E++K      F ++ P                + 
Sbjct:   620 GISIQGNAKLCGGIPDLHLPRCCPLLENRKH-----FPVL-PISVSLAAALAILSSLYLL 673

Query:   409 RLRRKRTVTSSES-SSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQT 467
                 KRT   + S +S K   L VSY  L+KAT GF+  NL+G+GSFGSVYKG L+  Q 
Sbjct:   674 ITWHKRTKKGAPSRTSMKGHPL-VSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNI-QD 731

Query:   468 VVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHH 527
              VAVKVL L    ALKSF AECEALRN+RHRNLVKI+T CSS D +GNDFKA+VY+FM +
Sbjct:   732 HVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPN 791

Query:   528 GSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNV 587
             GSLE W+HPE+ +D  +     L+  +R+ I ++VA AL+YLH H  + +VHCD+K SNV
Sbjct:   792 GSLEDWIHPET-NDQADQRH--LNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNV 848

Query:   588 LLDNDMIAHVGDFGLTRFIPEVISSNQ--CSSVGLKGTVGYAAPEYGMGSQVSTN 640
             LLD+DM+AHVGDFGL R + +  S  Q   SS+G  GT+GYAAPEYG+G   ST+
Sbjct:   849 LLDSDMVAHVGDFGLARILVDGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTH 903

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 995 (355.3 bits), Expect = 2.7e-100, P = 2.7e-100
 Identities = 243/649 (37%), Positives = 354/649 (54%)

Query:     8 INLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQ 67
             ++L  N  +G IP  +  +  L       N + G I  N      L  L+L  N L    
Sbjct:   264 LSLHGNFLTGAIPTTLANISTLEMFGIGKNRMTGSISPNFGKLENLHYLELANNSLGSYS 323

Query:    68 LVGELPPYIGFT-LPNIRIPLLAGNQFFGNIPHSISNAS-KLEWLDFANNSLTASIPEDL 125
               G+L      T   ++    ++ N+  G +P SI N S +L  L+   N +  SIP D+
Sbjct:   324 F-GDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKGNLIYGSIPHDI 382

Query:   126 GRLRNLTRLNFARNDL-GTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKL 184
             G L  L  L  A N L G    +    L +LV    L + S   +    IP  +G L +L
Sbjct:   383 GNLIGLQSLLLADNLLTGPLPTS----LGNLVGLGELILFSNRFSG--EIPSFIGNLTQL 436

Query:   185 QVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLG 244
               L L  N+  G +P SLG+ + + +L +  N + G+IP  +     L  L++      G
Sbjct:   437 VKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNMESNSLSG 496

Query:   245 QYP--VRWLD------LSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGL 296
               P  +  L       L +N+L+G +P  +G   S+  + L +N   G IP   G  +G+
Sbjct:   497 SLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPDIKG-LMGV 555

Query:   297 EYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGN 356
             + ++LS N+  G I     +   LE L+L  N F+     G VP +GIF+NA+ +SV GN
Sbjct:   556 KNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFE-----GRVPTEGIFQNATLVSVFGN 610

Query:   357 EKLCGGISELKLPPCT----PSESKKRQKSNGFKLMIPXXXXXXXXXXXXXXXIIDRLRR 412
             + LCG I ELKL PC     P E++         + +                   + + 
Sbjct:   611 KNLCGSIKELKLKPCIAQAPPVETRHPSLLKKVAIGVSVGIALLLLLFIVSLSWFKKRKN 670

Query:   413 KRTVTSSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVK 472
              + + +S   + +     +SY  L  AT GFSS+N++G+GSFG+V+K +L  +  +VAVK
Sbjct:   671 NQKINNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVK 730

Query:   473 VLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLES 532
             VL + +RGA+KSFMAECE+L++IRHRNLVK++TAC+S DFQGN+F+AL+YEFM +GSL+ 
Sbjct:   731 VLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDK 790

Query:   533 WLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND 592
             WLHPE   ++++     L+ L+RLNIAI+VAS L+YLH HC + I HCDLKPSN+LLD+D
Sbjct:   791 WLHPEEV-EEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDD 849

Query:   593 MIAHVGDFGLTRFIPEVISS---NQCSSVGLKGTVGYAAPEYGMGSQVS 638
             + AHV DFGL R + +       NQ SS G++GT+GYAAPEYGMG Q S
Sbjct:   850 LTAHVSDFGLARLLLKFDQESFFNQLSSAGVRGTIGYAAPEYGMGGQPS 898

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 806 (288.8 bits), Expect = 6.9e-80, P = 6.9e-80
 Identities = 234/680 (34%), Positives = 341/680 (50%)

Query:     1 NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDL-- 58
             N T L L++L  N  +G IP   GR+  L +I    N   G+IP ++ +CS L TL +  
Sbjct:   406 NCTGLKLLDLSHNQMTGEIPRGFGRM-NLTFISIGRNHFTGEIPDDIFNCSNLETLSVAD 464

Query:    59 ---------VLNKLEE--------NQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSI 101
                      ++ KL++        N L G +P  IG  L ++ I  L  N F G IP  +
Sbjct:   465 NNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPREIG-NLKDLNILYLHSNGFTGRIPREM 523

Query:   102 SNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYL 161
             SN + L+ L   +N L   IPE++  ++ L+ L+ + N    +       L+SL   TYL
Sbjct:   524 SNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESL---TYL 580

Query:   162 EIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIP----SSLGNFTFLTELNLRGNS 217
              +     N   SIP S+  L  L    + +N ++G IP    +SL N      LN   N 
Sbjct:   581 SLQGNKFNG--SIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQLY--LNFSNNL 636

Query:   218 IRGSIPSALGNCHQLQSLDLSKTIFLGQYP--------VRWLDLSHNHLTGPIPLAV-GN 268
             + G+IP  LG    +Q +DLS  +F G  P        V  LD S N+L+G IP  V   
Sbjct:   637 LTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQG 696

Query:   269 LKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
             +  I  L+LS+N  SGEIP S G+   L  L+LS N+  G I   L++L +L+ L L  N
Sbjct:   697 MDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASN 756

Query:   329 TFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGISELKLPPCTPSESKKRQKSNGFKLM 388
               +     G VP  G+FKN +A  + GN  LCG    LK  PCT  +           ++
Sbjct:   757 NLK-----GHVPESGVFKNINASDLMGNTDLCGSKKPLK--PCTIKQKSSHFSKRTRVIL 809

Query:   389 IPXXXXXXXXXXXXXXXIIDRLRRK-RTVTSSESSSRKDL-----LLNVSYESLLKATGG 442
             I                I+   ++K + + +S  SS  DL     L     + L +AT  
Sbjct:   810 IILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDS 869

Query:   443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNL 500
             F+SAN+IG+ S  +VYKG L+ D TV+AVKVL L +  A   K F  E + L  ++HRNL
Sbjct:   870 FNSANIIGSSSLSTVYKGQLE-DGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNL 928

Query:   501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
             VKI+       ++    KALV  FM +G+LE  +H  +A       P I S L+++++ +
Sbjct:   929 VKILGFA----WESGKTKALVLPFMENGNLEDTIHGSAA-------P-IGSLLEKIDLCV 976

Query:   561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP-EVISSNQCSSVG 619
             ++AS ++YLH      IVHCDLKP+N+LLD+D +AHV DFG  R +      S   S+  
Sbjct:   977 HIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSA 1036

Query:   620 LKGTVGYAAPEYGMGSQVST 639
              +GT+GY APE+    +V+T
Sbjct:  1037 FEGTIGYLAPEFAYMRKVTT 1056

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 794 (284.6 bits), Expect = 5.4e-79, P = 5.4e-79
 Identities = 240/688 (34%), Positives = 354/688 (51%)

Query:     1 NLTFLMLINLQQNNFSGNIPHE-IGRLFQLRYIIF--------NSNTLQGQIPVNLTHCS 51
             N T L  ++L+ N  SG +P + I ++ QL+++          N+NT       +L + S
Sbjct:   213 NSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSS 272

Query:    52 ELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLD 111
             +L+ L+L       N L GE+   +     N+    L  N+  G+IP  ISN   L  L+
Sbjct:   273 DLQELELA-----GNSLGGEITSSVRHLSVNLVQIHLDQNRIHGSIPPEISNLLNLTLLN 327

Query:   112 FANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSL 171
              ++N L+  IP +L +L  L R+  + N L T ++     L  +     L++   N++  
Sbjct:   328 LSSNLLSGPIPRELCKLSKLERVYLSNNHL-TGEIP--MELGDIPRLGLLDVSRNNLSG- 383

Query:   172 RSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQ 231
              SIP S G L +L+ L L+ N++SG +P SLG    L  L+L  N++ G+IP  + +   
Sbjct:   384 -SIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVS--N 440

Query:   232 LQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLG 291
             L++L L            +L+LS NHL+GPIPL +  +  +  +DLS N+LSG+IP  LG
Sbjct:   441 LRNLKL------------YLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLG 488

Query:   292 SCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN--------TFQAKSQ-------- 335
             SC+ LE+LNLS N F   +   L  L  L+ LD+  N        +FQ  S         
Sbjct:   489 SCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSF 548

Query:   336 ---NGDVPRKGIFKNASAISVAGNEKLCGGISELKLPPCTPSESKKRQKSNGFKLMIPXX 392
                +G+V  KG F   +  S  G+  LCG I  ++   C     KK+ K     L +   
Sbjct:   549 NLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQA--C-----KKKHKYPSVLLPVLLS 601

Query:   393 XXXXXXXXXXXXXIIDRLR--------RKRTVTSSESSSRKDLLL-NVSYESLLKATGGF 443
                          ++ R R         K  V   E  ++ D     +SY+ L+ ATGGF
Sbjct:   602 LIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGF 661

Query:   444 SSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALK---SFMAECEALRNIRHRNL 500
             ++++LIG+G FG VYKG+L  + T VAVKVL    + AL+   SF  EC+ L+  RHRNL
Sbjct:   662 NASSLIGSGRFGHVYKGVLR-NNTKVAVKVL--DPKTALEFSGSFKRECQILKRTRHRNL 718

Query:   501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
             ++IIT CS   F      ALV   M +GSLE  L+P        YS   L  +Q +NI  
Sbjct:   719 IRIITTCSKPGFN-----ALVLPLMPNGSLERHLYPGE------YSSKNLDLIQLVNICS 767

Query:   561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP---EVISSNQCSS 617
             +VA  + YLHH+   ++VHCDLKPSN+LLD++M A V DFG++R +    E +S++   S
Sbjct:   768 DVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVS 827

Query:   618 VG-----LKGTVGYAAPEYGMGSQVSTN 640
              G     L G+VGY APEYGMG + ST+
Sbjct:   828 FGSTDGLLCGSVGYIAPEYGMGKRASTH 855

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 778 (278.9 bits), Expect = 2.7e-77, P = 2.7e-77
 Identities = 204/554 (36%), Positives = 291/554 (52%)

Query:     1 NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
             NL  L  + +  N F G IP  IG    +       N+  G +P  +     L+ L+L  
Sbjct:   245 NLPSLQEVYMYYNQFHGRIPASIGNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELP- 303

Query:    61 NKLEENQLVGELPPYIGFT-LPNIRIPLLAGNQFFGNIPHSISN-ASKLEWLDFANNSLT 118
               L E +   +       T   N++   L G +F G +P S+SN +S L  L   +N ++
Sbjct:   304 ETLSEAEETNDWKFMTALTNCSNLQEVELGGCKFGGVLPDSVSNLSSSLVSLSIRDNKIS 363

Query:   119 ASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISV 178
              S+P D+G L NL  L+ A N L     +    L +L   T    V  N   + S+P+++
Sbjct:   364 GSLPRDIGNLVNLQYLSLANNSLTGSLPSSFSKLKNLRRLT----VDNN-KLIGSLPLTI 418

Query:   179 GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQS-LDL 237
             G L +L  + +  N   G IPS+LGN T L ++NL  N+  G IP  + +   L   LD+
Sbjct:   419 GNLTQLTNMEVQFNAFGGTIPSTLGNLTKLFQINLGHNNFIGQIPIEIFSIPALSEILDV 478

Query:   238 SKTIFLGQYPVRWLDLSH--------NHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSS 289
             S     G  P     L +        N L+G  P  +G  + + HL L  N L+G IP +
Sbjct:   479 SHNNLEGSIPKEIGKLKNIVEFHADSNKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIA 538

Query:   290 LGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNAS 349
             L    GL+ L+LS N+  G I   L  +  L  L+L  N+F     +G+VP  G+F NAS
Sbjct:   539 LTQLKGLDTLDLSGNNLSGQIPMSLGDMPLLHSLNLSFNSF-----HGEVPTNGVFANAS 593

Query:   350 AISVAGNEKLCGGISELKLPPCTPSESKKRQKSNGFKLMIPXXXXXXXXXXXXXXXIID- 408
              I + GN  +CGGI EL LP C+  +S+K++K     L++                ++  
Sbjct:   594 EIYIQGNAHICGGIPELHLPTCS-LKSRKKKKHQILLLVVVICLVSTLAVFSLLYMLLTC 652

Query:   409 RLRRKRTVTSSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQ-- 466
               RRK+ V ++ S     +   ++Y+ L+KAT GFSS++L+G+GSFGSVYKG  D     
Sbjct:   653 HKRRKKEVPATTSMQGHPM---ITYKQLVKATDGFSSSHLLGSGSFGSVYKGEFDSQDGE 709

Query:   467 --TVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEF 524
               ++VAV+VL L    ALKSF AECE LRN RHRNLVKI+T CSS D +GNDFKA+VY+F
Sbjct:   710 ITSLVAVRVLKLETPKALKSFTAECETLRNTRHRNLVKIVTICSSIDNRGNDFKAIVYDF 769

Query:   525 MHHGSLESWLHPES 538
             M +GSLE WLHPE+
Sbjct:   770 MPNGSLEDWLHPET 783

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0016567 "protein ubiquitination" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)]

 Score = 774 (277.5 bits), Expect = 7.1e-77, P = 7.1e-77
 Identities = 168/347 (48%), Positives = 221/347 (63%)

Query:   300 NLSINSFH--GPIHPGLSSLKSLEGLDLFQNTFQA---KSQNGDVPRKGIFKNASAISVA 354
             +L +  F   G I P + +L  L  L+L  N+FQ+   +   G VP KG+F+N + +SV 
Sbjct:    77 SLDLGGFKLSGSISPSIGNLSFLRSLNLGDNSFQSNIPQEFEGSVPTKGVFQNGTTVSVF 136

Query:   355 GNEKLCGGISELKLPPCTPSESKKRQKSNGFKLMIPXXXXXXXXXXXXXXXIIDRLRRKR 414
             GNE LCGG+ E++L PC  S  +K+  S G K+ +                I+  L    
Sbjct:   137 GNENLCGGVIEMQLKPCIESPRQKKPFSLGEKVAV-----GVGVALLFLFIIVASL---- 187

Query:   415 TVTSSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVL 474
                 S    + D    +SYE L  AT GFSS+NLIG+G+F  V+KG+L  ++ +VAVKVL
Sbjct:   188 ----SWFKKKND---KISYEELYNATSGFSSSNLIGSGNFSDVFKGLLGLEEKLVAVKVL 240

Query:   475 FLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWL 534
              L + GA KSF+AECE+ + IRHRNL K+IT CSS D QGNDF+ALVYEFM  GSL+ WL
Sbjct:   241 NLLKHGATKSFIAECESFKGIRHRNLAKLITVCSSLDSQGNDFRALVYEFMPKGSLDMWL 300

Query:   535 HPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI 594
              PE      N+S S L+F +++NIAI+VASALEYLH +C   + HCD+KPSNVLLD+D+ 
Sbjct:   301 QPEDLESANNHSRS-LTFAEKVNIAIDVASALEYLHVYCHDPVAHCDIKPSNVLLDDDLT 359

Query:   595 AHVGDFGLTRFI---PEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS 638
             AHV DFGL R +    E    NQ SS G++GT+GYAAPEYGMGS+ S
Sbjct:   360 AHVSDFGLARLLYNFDEKTFLNQFSSAGVRGTIGYAAPEYGMGSKPS 406

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh4_pg.C_LG_VI000800 hypothetical protein (1034 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	640
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-64
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-44
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-44
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-35
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-34
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-33
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-32
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-32
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-31
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-31
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-31
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-31
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-26
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	7e-23
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-22
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-21
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-21
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-20
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-19
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-19
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-19
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-18
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-18
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-18
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-18
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-17
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-17
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-17
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-17
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-16
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-16
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-16
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-16
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-16
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-16
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-16
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-16
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-15
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-15
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-15
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-15
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-15
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-14
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-14
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-14
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-14
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-14
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-14
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-14
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-14
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	9e-14
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-14
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-13
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-13
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-13
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-13
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-13
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-13
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-13
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-13
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-13
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	8e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	9e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	9e-13
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-12
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-12
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-12
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-12
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-12
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	8e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-11
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-11
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-11
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-11
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-11
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-11
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-11
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-11
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	9e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-10
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-10
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-10
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-10
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-10
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-10
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-10
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	8e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-09
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-09
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-09
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	5e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-09
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	8e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-09
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-09
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-08
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-08
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-08
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-08
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-08
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-08
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-08
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-08
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-08
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-08
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-08
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-08
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	9e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	9e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	9e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-07
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-07
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-07
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-07
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-07
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-07
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-07
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-07
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	7e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	7e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-07
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	8e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-06
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-06
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-06
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-06
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-06
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-06
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-06
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-06
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-06
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-05
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-05
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-05
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-05
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-05
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-05
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	3e-05
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-05
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-05
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-05
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-05
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-05
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-05
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	9e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-04
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-04
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-04
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-04
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-04
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-04
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-04
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-04
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-04
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-04
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-04
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-04
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-04
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-04
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-04
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-04
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-04
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-04
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	5e-04
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-04
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-04
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-04
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	7e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-04
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-04
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	9e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	0.001
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	0.001
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	0.001
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	0.001
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	0.001
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	0.001
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	0.002
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	0.002
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	0.002
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	0.002
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	0.002
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	0.002
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	0.002
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	0.003
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	0.003
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	0.003
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	0.004
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  227 bits (579), Expect = 9e-64
 Identities = 189/639 (29%), Positives = 285/639 (44%), Gaps = 88/639 (13%)

Query: 5   LMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKL- 63
           L  I L  NN SG IP+EIG L  L ++    N L G IP +L +   L+ L L  NKL 
Sbjct: 214 LKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLS 273

Query: 64  ------------------EENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNAS 105
                              +N L GE+P  +   L N+ I  L  N F G IP ++++  
Sbjct: 274 GPIPPSIFSLQKLISLDLSDNSLSGEIPELV-IQLQNLEILHLFSNNFTGKIPVALTSLP 332

Query: 106 KLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVS 165
           +L+ L   +N  +  IP++LG+  NLT L+ + N+L           + L +   L  + 
Sbjct: 333 RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGE------IPEGLCSSGNLFKLI 386

Query: 166 LNVNSLRS-IPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPS 224
           L  NSL   IP S+G    L+ + L +N+ SGE+PS       +  L++  N+++G I S
Sbjct: 387 LFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINS 446

Query: 225 ALGNCHQLQSLDLSKTIFLGQYP-------VRWLDLSHNHLTGPIPLAVGNLKSIPHLDL 277
              +   LQ L L++  F G  P       +  LDLS N  +G +P  +G+L  +  L L
Sbjct: 447 RKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKL 506

Query: 278 SKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAK---- 333
           S+NKLSGEIP  L SC  L  L+LS N   G I    S +  L  LDL QN    +    
Sbjct: 507 SENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKN 566

Query: 334 ------------SQN---GDVPRKGIFKNASAISVAGNEKLCGGISELKLPPCTPSESKK 378
                       S N   G +P  G F   +A +VAGN  LCGG +   LPPC     K+
Sbjct: 567 LGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPC-----KR 621

Query: 379 RQKSNGFKLMIP-LLSGLVGLVLVMSLLIIDRLRRKRTV--TSSESSSRKDLLLNVSYES 435
            +K+  +   I   L   + L LV    +  R R    +    +E  + +    +     
Sbjct: 622 VRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSK 681

Query: 436 LLKATGGFSS---ANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-KSFMAECEA 491
            +      SS    N+I  G  G+ YKG    +     VK   ++   ++  S +A+   
Sbjct: 682 SITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKE--INDVNSIPSSEIAD--- 736

Query: 492 LRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILS 551
           +  ++H N+VK+I  C S          L++E++   +L   L               LS
Sbjct: 737 MGKLQHPNIVKLIGLCRS-----EKGAYLIHEYIEGKNLSEVL-------------RNLS 778

Query: 552 FLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD 590
           + +R  IAI +A AL +LH  C   +V  +L P  +++D
Sbjct: 779 WERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID 817

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  170 bits (432), Expect = 2e-44
 Identities = 121/341 (35%), Positives = 175/341 (51%), Gaps = 35/341 (10%)

Query: 2   LTFLMLINLQQNNFSGNIPHEIGRL-FQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           L ++  INL  N  SG IP +I      LRY+  ++N   G IP        L TLDL  
Sbjct: 92  LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPN--LETLDL-- 147

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
                N L GE+P  IG    ++++  L GN   G IP+S++N + LE+L  A+N L   
Sbjct: 148 ---SNNMLSGEIPNDIGS-FSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQ 203

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGY 180
           IP +LG++++L  +    N+L      ++  L SL    +L++V  N+     IP S+G 
Sbjct: 204 IPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSL---NHLDLVYNNLTG--PIPSSLGN 258

Query: 181 LPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKT 240
           L  LQ L L++N +SG IP S+ +   L  L+L  NS+ G IP  +    QLQ+L++   
Sbjct: 259 LKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI---QLQNLEI--- 312

Query: 241 IFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLN 300
                     L L  N+ TG IP+A+ +L  +  L L  NK SGEIP +LG    L  L+
Sbjct: 313 ----------LHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLD 362

Query: 301 LSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPR 341
           LS N+  G I  GL S  +L  L LF N     S  G++P+
Sbjct: 363 LSTNNLTGEIPEGLCSSGNLFKLILFSN-----SLEGEIPK 398

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  169 bits (430), Expect = 3e-44
 Identities = 117/350 (33%), Positives = 164/350 (46%), Gaps = 49/350 (14%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           NLT L  + L  N   G IP E+G++  L++I    N L G+IP  +   + L  LDLV 
Sbjct: 186 NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVY 245

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
                N L G +P  +G  L N++   L  N+  G IP SI +  KL  LD ++NSL+  
Sbjct: 246 -----NNLTGPIPSSLG-NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGE 299

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGY 180
           IPE + +L+NL  L+   N+   +                             IP+++  
Sbjct: 300 IPELVIQLQNLEILHLFSNNFTGK-----------------------------IPVALTS 330

Query: 181 LPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKT 240
           LP+LQVL L+ N  SGEIP +LG    LT L+L  N++ G IP  L +   L  L L   
Sbjct: 331 LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSN 390

Query: 241 IFLGQYP--------VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGS 292
              G+ P        +R + L  N  +G +P     L  +  LD+S N L G I S    
Sbjct: 391 SLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWD 450

Query: 293 CVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRK 342
              L+ L+L+ N F G + P     K LE LDL +N F     +G VPRK
Sbjct: 451 MPSLQMLSLARNKFFGGL-PDSFGSKRLENLDLSRNQF-----SGAVPRK 494

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  131 bits (332), Expect = 5e-35
 Identities = 55/184 (29%), Positives = 84/184 (45%), Gaps = 23/184 (12%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALK-SFMAECEALRNIRHRNLVKIITAC 507
           +G G FG+VY          VA+K++      +L    + E E L+ + H N+VK+    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLY--- 57

Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F+  +   LV E+   GSL+  L               LS  + L I + +   LE
Sbjct: 58  --GVFEDENHLYLVMEYCEGGSLKDLLKEN---------EGKLSEDEILRILLQILEGLE 106

Query: 568 YLHHHCKKQIVHCDLKPSNVLLDND-MIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
           YLH +    I+H DLKP N+LLD+D     + DFGL++ +      +   ++   GT  Y
Sbjct: 107 YLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTS--DKSLLKTIV--GTPAY 159

Query: 627 AAPE 630
            APE
Sbjct: 160 MAPE 163

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  130 bits (329), Expect = 3e-34
 Identities = 58/185 (31%), Positives = 80/185 (43%), Gaps = 24/185 (12%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVKIIT 505
             +G GSFG VY         +VA+KV+     +   +  + E + L+ ++H N+V++  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
                 F+  D   LV E+   G L   L               LS  +       + SA
Sbjct: 65  V-----FEDEDKLYLVMEYCEGGDLFDLLK----------KRGRLSEDEARFYLRQILSA 109

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG 625
           LEYLH    K IVH DLKP N+LLD D    + DFGL R +         + V   GT  
Sbjct: 110 LEYLH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFV---GTPE 161

Query: 626 YAAPE 630
           Y APE
Sbjct: 162 YMAPE 166

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  126 bits (320), Expect = 6e-33
 Identities = 56/197 (28%), Positives = 85/197 (43%), Gaps = 37/197 (18%)

Query: 447 NLIGTGSFGSVYKGILDPDQ---TVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVK 502
             +G G+FG VYKG L       T VAVK L         K F+ E   ++ + H N+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 503 IITACSSSD--FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           ++  C+  +  +       LV E+M  G L  +L  +S     +   S LS    L+ AI
Sbjct: 61  LLGVCTEEEPLY-------LVLEYMEGGDLLDYLR-KSRPVFPSPEKSTLSLKDLLSFAI 112

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI-------------- 606
            +A  +EYL     K+ VH DL   N L+  D++  + DFGL+R +              
Sbjct: 113 QIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKL 169

Query: 607 ------PEVISSNQCSS 617
                 PE +     +S
Sbjct: 170 PIRWMAPESLKDGIFTS 186

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  124 bits (313), Expect = 7e-32
 Identities = 60/184 (32%), Positives = 86/184 (46%), Gaps = 24/184 (13%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--GALKSFMAECEALRNIRHRNLVKIITA 506
           +G+GSFG+VYK        +VAVK+L          ++   E   LR + H N+V++I A
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
                F+  D   LV E+   G L  +L               LS  +   IA+ +   L
Sbjct: 67  -----FEDKDHLYLVMEYCEGGDLFDYLSRGG----------PLSEDEAKKIALQILRGL 111

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
           EYLH +    I+H DLKP N+LLD + +  + DFGL + + +  SS         GT  Y
Sbjct: 112 EYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLT----TFVGTPWY 164

Query: 627 AAPE 630
            APE
Sbjct: 165 MAPE 168

Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  131 bits (331), Expect = 9e-32
 Identities = 100/266 (37%), Positives = 139/266 (52%), Gaps = 27/266 (10%)

Query: 70  GELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISN-ASKLEWLDFANNSLTASIPEDLGRL 128
           G++   I F LP I+   L+ NQ  G IP  I   +S L +L+ +NN+ T SIP   G +
Sbjct: 83  GKISSAI-FRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSI 139

Query: 129 RNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRS-IPISVGYLPKLQVL 187
            NL  L+ + N L     ND+    S      L+++ L  N L   IP S+  L  L+ L
Sbjct: 140 PNLETLDLSNNMLSGEIPNDIGSFSS------LKVLDLGGNVLVGKIPNSLTNLTSLEFL 193

Query: 188 SLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYP 247
           +L  N + G+IP  LG    L  + L  N++ G IP  +G    L SL+           
Sbjct: 194 TLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIG---GLTSLN----------- 239

Query: 248 VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFH 307
              LDL +N+LTGPIP ++GNLK++ +L L +NKLSG IP S+ S   L  L+LS NS  
Sbjct: 240 --HLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLS 297

Query: 308 GPIHPGLSSLKSLEGLDLFQNTFQAK 333
           G I   +  L++LE L LF N F  K
Sbjct: 298 GEIPELVIQLQNLEILHLFSNNFTGK 323

Length = 968

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  122 bits (309), Expect = 2e-31
 Identities = 51/193 (26%), Positives = 82/193 (42%), Gaps = 40/193 (20%)

Query: 449 IGTGSFGSVYKGILDPD----QTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVKI 503
           +G G+FG VYKG L       +  VAVK L        ++ F+ E   +R + H N+VK+
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
           +  C+  +        +V E+M  G L  +L            P  LS    L+ A+ +A
Sbjct: 67  LGVCTEEEPL-----MIVMEYMPGGDLLDYLR--------KNRPKELSLSDLLSFALQIA 113

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI----------------- 606
             +EYL     K  +H DL   N L+  +++  + DFGL+R +                 
Sbjct: 114 RGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRW 170

Query: 607 --PEVISSNQCSS 617
             PE +   + +S
Sbjct: 171 MAPESLKEGKFTS 183

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  129 bits (325), Expect = 5e-31
 Identities = 85/247 (34%), Positives = 135/247 (54%), Gaps = 19/247 (7%)

Query: 102 SNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYL 161
           +N+S++  +D +  +++  I   + RL  +  +N + N L     +D+         + L
Sbjct: 66  NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTT-----SSSL 120

Query: 162 EIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGS 221
             ++L+ N+  +  I  G +P L+ L L  N +SGEIP+ +G+F+ L  L+L GN + G 
Sbjct: 121 RYLNLSNNNF-TGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK 179

Query: 222 IPSALGNCHQLQSLDLSKTIFLGQYPV--------RWLDLSHNHLTGPIPLAVGNLKSIP 273
           IP++L N   L+ L L+    +GQ P         +W+ L +N+L+G IP  +G L S+ 
Sbjct: 180 IPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLN 239

Query: 274 HLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAK 333
           HLDL  N L+G IPSSLG+   L+YL L  N   GPI P + SL+ L  LDL  N     
Sbjct: 240 HLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDN----- 294

Query: 334 SQNGDVP 340
           S +G++P
Sbjct: 295 SLSGEIP 301

Length = 968

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  121 bits (306), Expect = 5e-31
 Identities = 53/187 (28%), Positives = 85/187 (45%), Gaps = 25/187 (13%)

Query: 449 IGTGSFGSVYKGILDPD----QTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVKI 503
           +G G+FG VYKG L       +  VAVK L        ++ F+ E   +R + H N+VK+
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
           +  C+  +        +V E+M  G L S+L           +   LS    L+ A+ +A
Sbjct: 67  LGVCTEEEPL-----YIVMEYMEGGDLLSYLR---------KNRPKLSLSDLLSFALQIA 112

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
             +EYL     K  +H DL   N L+  +++  + DFGL+R +      +     G K  
Sbjct: 113 RGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLY---DDDYYRKRGGKLP 166

Query: 624 VGYAAPE 630
           + + APE
Sbjct: 167 IRWMAPE 173

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  121 bits (305), Expect = 7e-31
 Identities = 54/187 (28%), Positives = 84/187 (44%), Gaps = 24/187 (12%)

Query: 449 IGTGSFGSVYKGILDPD----QTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKI 503
           +G G+FG VYKG L  D    +T VAVK L         + F+ E   ++ + H N+V++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
           +  C+  +        +V E+M  G L  +L               L+    L +A+ +A
Sbjct: 67  LGVCTQGEPL-----YIVTEYMPGGDLLDFLRKHGEK---------LTLKDLLQMALQIA 112

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
             +EYL     K  VH DL   N L+  +++  + DFGL+R I E          G K  
Sbjct: 113 KGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYE--DDYYRKRGGGKLP 167

Query: 624 VGYAAPE 630
           + + APE
Sbjct: 168 IKWMAPE 174

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  108 bits (271), Expect = 3e-26
 Identities = 51/189 (26%), Positives = 86/189 (45%), Gaps = 26/189 (13%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA--LKSFMAECEALRNIRHRNLVKII 504
            L+G GSFGSVY  +      ++AVK + L       L++   E   L +++H N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESA-SDDL--NYSPSILSFLQRLNIAIN 561
            +    +    +   +  E++  GSL S L       + +   Y+  IL           
Sbjct: 66  GSERDEE---KNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE---------- 112

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
               L YLH      IVH D+K +N+L+D+D +  + DFG  + + ++ +     SV  +
Sbjct: 113 ---GLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSV--R 164

Query: 622 GTVGYAAPE 630
           GT  + APE
Sbjct: 165 GTPYWMAPE 173

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 97.9 bits (244), Expect = 7e-23
 Identities = 60/183 (32%), Positives = 88/183 (48%), Gaps = 26/183 (14%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITAC 507
            IG G FG V  G     +  VAVK L      A ++F+AE   +  +RH NLV+++   
Sbjct: 13  TIGKGEFGDVMLGDYRGQK--VAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVV 69

Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
                QGN    +V E+M  GSL  +L     +        +++  Q+L  A++V   +E
Sbjct: 70  ----LQGNPL-YIVTEYMAKGSLVDYLRSRGRA--------VITLAQQLGFALDVCEGME 116

Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYA 627
           YL    +K  VH DL   NVL+  D++A V DFGL +       ++Q    G K  V + 
Sbjct: 117 YLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK------EASQGQDSG-KLPVKWT 166

Query: 628 APE 630
           APE
Sbjct: 167 APE 169

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 53/195 (27%), Positives = 77/195 (39%), Gaps = 36/195 (18%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F     IG G FG VYK         VA+KV+ L  +   +  + E + L+  +H N+VK
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLN----- 557
              +     +   D   +V EF   GSL+  L                S  Q L      
Sbjct: 62  YYGS-----YLKKDELWIVMEFCSGGSLKDLLK---------------STNQTLTESQIA 101

Query: 558 -IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL-TRFIPEVISSNQC 615
            +   +   LEYLH      I+H D+K +N+LL +D    + DFGL  +       +   
Sbjct: 102 YVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV 158

Query: 616 SSVGLKGTVGYAAPE 630
                 GT  + APE
Sbjct: 159 ------GTPYWMAPE 167

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 58/166 (34%), Positives = 84/166 (50%), Gaps = 18/166 (10%)

Query: 449 IGTGSFGSVYKG---ILDPDQ--TVVAVKVLF-LHQRGALKSFMAECEALRNIRHRNLVK 502
           +G G+FG V+ G    L+P+    +VAVK L       A K F  E E L N +H N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLH---PESASDDLNYSPSI-LSFLQRLNI 558
               C+  D        +V+E+M HG L  +L    P++A      SP   L+  Q L I
Sbjct: 73  FYGVCTEGDPP-----IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
           A+ +AS + YL     +  VH DL   N L+  D++  +GDFG++R
Sbjct: 128 AVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 93.0 bits (232), Expect = 4e-21
 Identities = 52/184 (28%), Positives = 89/184 (48%), Gaps = 24/184 (13%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVKIITAC 507
           +G GS G VYK    P   + A+K +         K  + E + LR+     +VK    C
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64

Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
             + ++  +  ++V E+M  GSL   L              +L++     IA  +   L+
Sbjct: 65  YGAFYKEGEI-SIVLEYMDGGSLADLL-----KKVGKIPEPVLAY-----IARQILKGLD 113

Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS-VGLKGTVGY 626
           YLH   K+ I+H D+KPSN+L+++     + DFG+++ +    + +QC++ V   GTV Y
Sbjct: 114 YLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN--TLDQCNTFV---GTVTY 166

Query: 627 AAPE 630
            +PE
Sbjct: 167 MSPE 170

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 24/199 (12%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNL 500
           +   +LIG G+FG VYKG+       VA+K + L   +  ALKS M E + L+N++H N+
Sbjct: 2   YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61

Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK I +      + +D   ++ E+  +GSL   +           S   +   Q      
Sbjct: 62  VKYIGS-----IETSDSLYIILEYAENGSLRQIIKK---FGPFPESLVAVYVYQ------ 107

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            V   L YLH   ++ ++H D+K +N+L   D +  + DFG+   + +V S +  S V  
Sbjct: 108 -VLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV-SKDDASVV-- 160

Query: 621 KGTVGYAAPEYGMGSQVST 639
            GT  + APE    S  ST
Sbjct: 161 -GTPYWMAPEVIEMSGAST 178

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 91.3 bits (227), Expect = 3e-20
 Identities = 48/167 (28%), Positives = 74/167 (44%), Gaps = 20/167 (11%)

Query: 447 NLIGTGSFGSVYKGILDP--DQT--VVAVKVLFLHQRGALKS-FMAECEALRNIRHRNLV 501
             +G G FG V     DP  D T   VAVK L        +S F  E E LR + H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           K    C      G     L+ E++  GSL  +L       +L     +L F      +  
Sbjct: 70  KYKGVCEK---PGGRSLRLIMEYLPSGSLRDYLQRHRDQINL---KRLLLF------SSQ 117

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           +   ++YL     ++ +H DL   N+L++++ +  + DFGL + +PE
Sbjct: 118 ICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 87.8 bits (218), Expect = 3e-19
 Identities = 50/184 (27%), Positives = 84/184 (45%), Gaps = 25/184 (13%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALK--SFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VAVK L   + G +   +F+ E + ++ +RH  LV++   
Sbjct: 14  LGAGQFGEVWMGTWN-GTTKVAVKTL---KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
           CS    +      +V E+M  GSL  +L               L   Q +++A  +A  +
Sbjct: 70  CS----EEEPI-YIVTEYMSKGSLLDFLKSGEGKK--------LRLPQLVDMAAQIAEGM 116

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            YL     +  +H DL   N+L+  +++  + DFGL R I +       +  G K  + +
Sbjct: 117 AYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE---YTAREGAKFPIKW 170

Query: 627 AAPE 630
            APE
Sbjct: 171 TAPE 174

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 87.2 bits (216), Expect = 4e-19
 Identities = 52/185 (28%), Positives = 88/185 (47%), Gaps = 22/185 (11%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITA 506
           + +G G +G VY+G+       VAVK L       ++ F+ E   ++ I+H NLV+++  
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 507 CS-SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
           C+    F       ++ EFM +G+L  +L      +    +  +L     L +A  ++SA
Sbjct: 71  CTREPPFY------IITEFMTYGNLLDYLR---ECNRQEVNAVVL-----LYMATQISSA 116

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG 625
           +EYL    KK  +H DL   N L+  + +  V DFGL+R +     +      G K  + 
Sbjct: 117 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH---AGAKFPIK 170

Query: 626 YAAPE 630
           + APE
Sbjct: 171 WTAPE 175

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 86.7 bits (215), Expect = 6e-19
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 32/203 (15%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F+    +G+G FG V++G L  ++  VA+K+L        + F  E +AL+ +RH++L+ 
Sbjct: 8   FTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66

Query: 503 IITACSSSDFQGNDFKALVY---EFMHHGSLESWLH-PESASDDLNYSPSILSFLQRLNI 558
           +   CS  +         VY   E M  GSL ++L  PE     +    S++      ++
Sbjct: 67  LFAVCSVGE--------PVYIITELMEKGSLLAFLRSPEGQVLPV---ASLI------DM 109

Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
           A  VA  + YL    ++  +H DL   N+L+  D++  V DFGL R I E +  +    +
Sbjct: 110 ACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI 166

Query: 619 GLKGTVGYAAPE---YGMGSQVS 638
             K T    APE   +G  S  S
Sbjct: 167 PYKWT----APEAASHGTFSTKS 185

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 58/193 (30%), Positives = 93/193 (48%), Gaps = 25/193 (12%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V++G+ + + T VAVK L   + G +  K F+AE + ++ +RH  L+++   
Sbjct: 14  LGAGQFGEVWEGLWN-NTTPVAVKTL---KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
           C+       +   +V E M +GSL  +L   +           L   Q +++A  VAS +
Sbjct: 70  CTL-----EEPIYIVTELMKYGSLLEYLQGGAGRA--------LKLPQLIDMAAQVASGM 116

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            YL        +H DL   NVL+  + I  V DFGL R I E I     +  G K  + +
Sbjct: 117 AYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE---AREGAKFPIKW 170

Query: 627 AAPEYGMGSQVST 639
            APE  + ++ S 
Sbjct: 171 TAPEAALYNRFSI 183

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 85.9 bits (213), Expect = 1e-18
 Identities = 46/170 (27%), Positives = 77/170 (45%), Gaps = 22/170 (12%)

Query: 449 IGTGSFGSVYKGILD---PDQ--TVVAVKVLF----LHQRGALKSFMAECEALRNIRHRN 499
           +G GSFG VY+G+       +  T VA+K +     + +R     F+ E   ++     +
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER---IEFLNEASVMKEFNCHH 70

Query: 500 LVKIITACSSSDFQGNDFKALV-YEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           +V+++   S     G     LV  E M  G L+S+L       + N      +  + + +
Sbjct: 71  VVRLLGVVS----TGQ--PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124

Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           A  +A  + YL     K+ VH DL   N ++  D+   +GDFG+TR I E
Sbjct: 125 AAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE 171

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 87.9 bits (216), Expect = 1e-18
 Identities = 66/195 (33%), Positives = 93/195 (47%), Gaps = 25/195 (12%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRH-RNLVKI 503
            +G GSFG VY      D+ +VA+KVL      +   ++ F+ E + L ++ H  N+VK+
Sbjct: 7   KLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
                   FQ      LV E++  GSLE  L               LS  + L I   + 
Sbjct: 64  YDF-----FQDEGSLYLVMEYVDGGSLEDLLKK-------IGRKGPLSESEALFILAQIL 111

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLD-NDMIAHVGDFGLTRFIPE--VISSNQCSSVGL 620
           SALEYLH    K I+H D+KP N+LLD +  +  + DFGL + +P+    SS        
Sbjct: 112 SALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTS 168

Query: 621 KGTVGYAAPEYGMGS 635
            GT GY APE  +G 
Sbjct: 169 VGTPGYMAPEVLLGL 183

Length = 384

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 83.2 bits (206), Expect = 9e-18
 Identities = 58/198 (29%), Positives = 84/198 (42%), Gaps = 44/198 (22%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKII 504
           N IG G+FG VY  +      ++AVK + +       +K    E + L  ++H NLVK  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK-- 63

Query: 505 TACSSSDFQGNDFKALVYEFMHH---GSLESWLHPESASDDLN----YSPSILSFLQRLN 557
                 +         VY FM +   G+LE  L       D +    Y+  +L       
Sbjct: 64  --YYGVEVHREK----VYIFMEYCSGGTLEELLE-HGRILDEHVIRVYTLQLLE------ 110

Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
                   L YLH H    IVH D+KP+N+ LD++ +  +GDFG       V   N  ++
Sbjct: 111 -------GLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCA-----VKLKNNTTT 155

Query: 618 VG-----LKGTVGYAAPE 630
           +G     L GT  Y APE
Sbjct: 156 MGEEVQSLAGTPAYMAPE 173

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 82.9 bits (206), Expect = 1e-17
 Identities = 47/186 (25%), Positives = 84/186 (45%), Gaps = 20/186 (10%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA--LKSFMAECEALRNIRHRNLVKII 504
             IG GSFG VY      D  +  +K + L        +  + E + L+ + H N++K  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
                  F+      +V E+   G L   +  +   +   +        Q L+  + +  
Sbjct: 66  -----ESFEEKGKLCIVMEYADGGDLSQKIK-KQKKEGKPFPEE-----QILDWFVQLCL 114

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
           AL+YLH    ++I+H D+KP N+ L ++ +  +GDFG+++    V+SS    +  + GT 
Sbjct: 115 ALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISK----VLSSTVDLAKTVVGTP 167

Query: 625 GYAAPE 630
            Y +PE
Sbjct: 168 YYLSPE 173

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 52/170 (30%), Positives = 80/170 (47%), Gaps = 13/170 (7%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTV---VAVKVLFL--HQRGALKSFMAECEALRNIRH 497
                ++G G FGSV +G L  D      VAVK + L  H    ++ F++E   +++  H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 498 RNLVKIITAC-SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
            N++K+I  C  +S  Q      ++  FM HG L S+L        L   P  L     L
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFL----LYSRLGGLPEKLPLQTLL 116

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
              +++A  +EYL +   +  +H DL   N +L  DM   V DFGL++ I
Sbjct: 117 KFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKI 163

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 83.0 bits (206), Expect = 1e-17
 Identities = 47/161 (29%), Positives = 84/161 (52%), Gaps = 20/161 (12%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--GALKSFMAECEALRNIRHRNLVKIITA 506
           IG G++G VYK        +VA+K + +     G   + + E + L+ +RH N+V++   
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPS-ILSFLQRLNIAINVASA 565
            +S   +G+ +  +V+E+M H  L   L     S ++ ++ S I  ++++L         
Sbjct: 67  VTSKG-KGSIY--MVFEYMDH-DLTGLLD----SPEVKFTESQIKCYMKQL------LEG 112

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           L+YLH      I+H D+K SN+L++ND +  + DFGL R  
Sbjct: 113 LQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPY 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 81.4 bits (202), Expect = 3e-17
 Identities = 60/193 (31%), Positives = 83/193 (43%), Gaps = 33/193 (17%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKIIT 505
           +G GSFG V          + A+KVL    + +R  ++  + E   L  I H  +VK+  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ---RLNIAINV 562
           A     FQ  +   LV E+   G L S L  E              F +   R   A  +
Sbjct: 61  A-----FQTEEKLYLVLEYAPGGELFSHLSKE------------GRFSEERARFYAA-EI 102

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQ-CSSVGLK 621
             ALEYLH      I++ DLKP N+LLD D    + DFGL +   E+ S     ++    
Sbjct: 103 VLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAK---ELSSEGSRTNTF--C 154

Query: 622 GTVGYAAPEYGMG 634
           GT  Y APE  +G
Sbjct: 155 GTPEYLAPEVLLG 167

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 80.3 bits (199), Expect = 1e-16
 Identities = 54/203 (26%), Positives = 77/203 (37%), Gaps = 38/203 (18%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEAL-RNIRHRNLVKI 503
           +IG GSF +V            A+K+L    L +   +K    E E L R   H  ++K+
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
                   FQ  +    V E+  +G L  ++    +          L        A  + 
Sbjct: 68  Y-----YTFQDEENLYFVLEYAPNGELLQYIRKYGS----------LDEKCTRFYAAEIL 112

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEV-------ISSNQCS 616
            ALEYLH    K I+H DLKP N+LLD DM   + DFG  + +            +    
Sbjct: 113 LALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169

Query: 617 SVGLK---------GTVGYAAPE 630
           S   K         GT  Y +PE
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPE 192

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 57/197 (28%), Positives = 92/197 (46%), Gaps = 34/197 (17%)

Query: 449 IGTGSFGSV----YKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVK 502
           +G+G FG V    ++G +D     VA+K++   + GA+    F+ E + +  + H NLV+
Sbjct: 12  LGSGQFGVVHLGKWRGKID-----VAIKMI---REGAMSEDDFIEEAKVMMKLSHPNLVQ 63

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +   C+    Q   F  +V E+M +G L ++L               L     L++  +V
Sbjct: 64  LYGVCTK---QRPIF--IVTEYMANGCLLNYLRER---------KGKLGTEWLLDMCSDV 109

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
             A+EYL  +     +H DL   N L+  D +  V DFGL R+   V+     SS G K 
Sbjct: 110 CEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARY---VLDDQYTSSQGTKF 163

Query: 623 TVGYAAPEYGMGSQVST 639
            V +A PE    S+ S+
Sbjct: 164 PVKWAPPEVFDYSRFSS 180

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 81.4 bits (201), Expect = 1e-16
 Identities = 59/186 (31%), Positives = 94/186 (50%), Gaps = 29/186 (15%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLF-LHQRGALKSFMAECEALRNIRHRNLVKIIT 505
           N IG+G+ G+VYK I  P   + A+KV++  H+    +    E E LR++ H N+VK   
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK--- 136

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
            C        + + L+ EFM  GSLE                 I       ++A  + S 
Sbjct: 137 -CHDMFDHNGEIQVLL-EFMDGGSLEG--------------THIADEQFLADVARQILSG 180

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC-SSVGLKGTV 624
           + YLH   ++ IVH D+KPSN+L+++     + DFG++R + + +  + C SSV   GT+
Sbjct: 181 IAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DPCNSSV---GTI 232

Query: 625 GYAAPE 630
            Y +PE
Sbjct: 233 AYMSPE 238

Length = 353

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 79.5 bits (197), Expect = 2e-16
 Identities = 58/191 (30%), Positives = 77/191 (40%), Gaps = 40/191 (20%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIRHRNLVKIIT 505
           +GTGSFG V            A+K+L   +   LK     + E   L++IRH  LV +  
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI------A 559
           +     FQ +    LV E++  G L S L                    R         A
Sbjct: 69  S-----FQDDSNLYLVMEYVPGGELFSHLRKS----------------GRFPEPVARFYA 107

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             V  ALEYLH      IV+ DLKP N+LLD+D    + DFG  + +     +       
Sbjct: 108 AQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT------- 157

Query: 620 LKGTVGYAAPE 630
           L GT  Y APE
Sbjct: 158 LCGTPEYLAPE 168

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 78.8 bits (194), Expect = 3e-16
 Identities = 53/184 (28%), Positives = 85/184 (46%), Gaps = 26/184 (14%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           IG+G FG V+ G        VA+K +   + GA+  + F+ E + +  + H  LV++   
Sbjct: 12  IGSGQFGLVWLGYWLEK-RKVAIKTI---REGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
           C+           LV+EFM HG L  +L  +       +S   L     L + ++V   +
Sbjct: 68  CTE-----RSPICLVFEFMEHGCLSDYLRAQRGK----FSQETL-----LGMCLDVCEGM 113

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            YL       ++H DL   N L+  + +  V DFG+TRF   V+     SS G K  V +
Sbjct: 114 AYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRF---VLDDQYTSSTGTKFPVKW 167

Query: 627 AAPE 630
           ++PE
Sbjct: 168 SSPE 171

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 79.2 bits (195), Expect = 3e-16
 Identities = 55/165 (33%), Positives = 74/165 (44%), Gaps = 22/165 (13%)

Query: 449 IGTGSFGSVYKGILDP--DQT--VVAVKVLFLHQRGALKS-FMAECEALRNIRHRNLVKI 503
           +G G FG V     DP  D T  +VAVK L         S +  E   L+ + H N+VK 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
              CS    QG     L+ E++  GSL  +L               L+  Q L  A  + 
Sbjct: 72  KGCCSE---QGGKGLQLIMEYVPLGSLRDYLPKHK-----------LNLAQLLLFAQQIC 117

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
             + YLH    +  +H DL   NVLLDND +  +GDFGL + +PE
Sbjct: 118 EGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 23/164 (14%)

Query: 449 IGTGSFGSVYKGILDPD----QTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKI 503
           +G+G+FG+VYKG+  P+    +  VA+KVL       A K  + E   + ++ H ++V++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
           +  C SS  Q      L+ + M  G L  ++     +         +     LN  + +A
Sbjct: 75  LGICLSSQVQ------LITQLMPLGCLLDYVRNHKDN---------IGSQYLLNWCVQIA 119

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP 607
             + YL    +K++VH DL   NVL+       + DFGL + + 
Sbjct: 120 KGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 79.1 bits (196), Expect = 3e-16
 Identities = 52/198 (26%), Positives = 87/198 (43%), Gaps = 40/198 (20%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--GALKSFMAECEALRNIRHRNLVKIITA 506
           +G G++G VYK        +VA+K + L     G   + + E   L+ ++H N+VK++  
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
             +          LV+E+     L+ +L       D    P   + ++   I   +   L
Sbjct: 67  IHTERKL-----YLVFEYCDM-DLKKYL-------DKRPGPLSPNLIKS--IMYQLLRGL 111

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR--------FIPEVISSNQCSSV 618
            Y H H   +I+H DLKP N+L++ D +  + DFGL R        +  EV+        
Sbjct: 112 AYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-------- 160

Query: 619 GLKGTVGYAAPEYGMGSQ 636
               T+ Y APE  +GS+
Sbjct: 161 ----TLWYRAPEILLGSK 174

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 78.5 bits (193), Expect = 5e-16
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 18/168 (10%)

Query: 449 IGTGSFGSVYKG-----ILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKI 503
           +G G+FG V+       + + D+ +VAVK L      A + F  E E L  ++H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDL-----NYSPSILSFLQRLNI 558
              C+           +V+E+M HG L  +L        +     + +P  L+  Q L I
Sbjct: 73  YGVCTEGRPL-----LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           A  +AS + YL        VH DL   N L+   ++  +GDFG++R I
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI 172

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 78.3 bits (193), Expect = 6e-16
 Identities = 51/170 (30%), Positives = 83/170 (48%), Gaps = 20/170 (11%)

Query: 449 IGTGSFGSVYKG-ILDPDQ----TVVAVKVLFLHQRGALKS-FMAECEALRNIRHRNLVK 502
           +G G+FG VYKG +  P++    T VA+K L  +    ++  F  E E + +++H N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSP------SILSFLQRL 556
           ++  C+           +++E++ HG L  +L   S   D+          S L     L
Sbjct: 73  LLGVCTKEQPT-----CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           +IAI +A+ +EYL  H     VH DL   N L+   +   + DFGL+R I
Sbjct: 128 HIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDI 174

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 45/188 (23%), Positives = 83/188 (44%), Gaps = 23/188 (12%)

Query: 447 NLIGTGSFGSVYKGILD-PDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG V +G L  P +  + V +  L           F+ E   +    H N+++
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +    + S         ++ E+M +GSL+ +L                +  Q + +   +
Sbjct: 70  LEGVVTKSRPV-----MIITEYMENGSLDKFLRENDGK---------FTVGQLVGMLRGI 115

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
           AS ++YL        VH DL   N+L++++++  V DFGL+R + +  S    ++ G K 
Sbjct: 116 ASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED--SEATYTTKGGKI 170

Query: 623 TVGYAAPE 630
            + + APE
Sbjct: 171 PIRWTAPE 178

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 50/165 (30%), Positives = 86/165 (52%), Gaps = 16/165 (9%)

Query: 449 IGTGSFGSVYKGILDPDQTV--VAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKII 504
           +G G FGSV +G L+ D ++  VAVK + +    R  ++ F++E   ++   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 505 TAC-SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPS--ILSFLQRLNIAIN 561
             C  + + +G     ++  FM HG L S+L      D   Y P+  ++ F+       +
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT------D 120

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           +AS +EYL     K  +H DL   N +L+ +M   V DFGL++ I
Sbjct: 121 IASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI 162

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 52/164 (31%), Positives = 81/164 (49%), Gaps = 16/164 (9%)

Query: 449 IGTGSFGSV-----YKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKI 503
           +G G+FG V     Y    + D+ +VAVK L      A K F  E E L N++H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLH---PESASDDLNYSPSILSFLQRLNIAI 560
              C   D        +V+E+M HG L  +L    P++        P+ L+  Q L+IA 
Sbjct: 73  YGVCVEGDPL-----IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
            +A+ + YL     +  VH DL   N L+  +++  +GDFG++R
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 55/167 (32%), Positives = 81/167 (48%), Gaps = 19/167 (11%)

Query: 449 IGTGSFGSVYKGI---LDP--DQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKI 503
           +G G+FG V+      L P  D+ +VAVK L      A K F  E E L N++H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWL--HPESASDDLNYSP----SILSFLQRLN 557
              C   D        +V+E+M HG L  +L  H   A   ++  P      L   Q L+
Sbjct: 73  YGVCGDGDPL-----IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127

Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
           IA  +AS + YL     +  VH DL   N L+  +++  +GDFG++R
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 75.7 bits (187), Expect = 3e-15
 Identities = 49/192 (25%), Positives = 84/192 (43%), Gaps = 31/192 (16%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKIIT 505
           I  G++G V+         + A+KV+    + ++  +   + E + L   +   +VK+  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDD---LNYSPSILSFLQRLNIAINV 562
           +     FQG     LV E++  G L S L    + D+     Y   I+            
Sbjct: 61  S-----FQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVL----------- 104

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI----PEVISSNQCSSV 618
             ALEYLH +    I+H DLKP N+L+D++    + DFGL++         ++ ++    
Sbjct: 105 --ALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK 159

Query: 619 GLKGTVGYAAPE 630
            + GT  Y APE
Sbjct: 160 RIVGTPDYIAPE 171

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 75.3 bits (185), Expect = 4e-15
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 44/202 (21%)

Query: 449 IGTGSFGSV----YKGILDPDQTVVAVKVLFLHQRGALKS--FMAECEALRNIRHRNLVK 502
           +GTG FG V    ++G  D     VA+K++   + G++    F+ E + +  + H  LV+
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-----VAIKMI---KEGSMSEDEFIEEAKVMMKLSHEKLVQ 63

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWL-----HPESASDDLNYSPSILSFLQRLN 557
           +   C+    Q   +  +V E+M +G L ++L       + +              Q L 
Sbjct: 64  LYGVCTK---QRPIY--IVTEYMSNGCLLNYLREHGKRFQPS--------------QLLE 104

Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
           +  +V   + YL     KQ +H DL   N L+D+     V DFGL+R+   V+     SS
Sbjct: 105 MCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRY---VLDDEYTSS 158

Query: 618 VGLKGTVGYAAPEYGMGSQVST 639
           VG K  V ++ PE  + S+ S+
Sbjct: 159 VGSKFPVRWSPPEVLLYSKFSS 180

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 74.7 bits (183), Expect = 7e-15
 Identities = 51/187 (27%), Positives = 89/187 (47%), Gaps = 26/187 (13%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VA+K L   + G +  ++F+ E + ++ +RH  LV++   
Sbjct: 14  LGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S           +V E+M  GSL  +L  E            L   Q +++A  +AS +
Sbjct: 70  VSEEPIY------IVTEYMSKGSLLDFLKGEMGK--------YLRLPQLVDMAAQIASGM 115

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            Y+    +   VH DL+ +N+L+  +++  V DFGL R I +   +   +  G K  + +
Sbjct: 116 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKW 169

Query: 627 AAPEYGM 633
            APE  +
Sbjct: 170 TAPEAAL 176

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 56/163 (34%), Positives = 79/163 (48%), Gaps = 20/163 (12%)

Query: 449 IGTGSFGSVYKGILDP--DQT--VVAVKVLFLHQRGA-LKSFMAECEALRNIRHRNLVKI 503
           +G G FG V     DP  D T   VAVK L     G  +     E E LRN+ H N+VK 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
              C+  +  GN  K L+ EF+  GSL+ +L       +L          Q+L  A+ + 
Sbjct: 72  KGICT--EDGGNGIK-LIMEFLPSGSLKEYLPRNKNKINLK---------QQLKYAVQIC 119

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
             ++YL     +Q VH DL   NVL++++    +GDFGLT+ I
Sbjct: 120 KGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 52/192 (27%), Positives = 82/192 (42%), Gaps = 26/192 (13%)

Query: 442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNIRHR 498
            F    +IG G+FG V        + + A+K +      ++G++++ + E   L+ + H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
            LV +     S  FQ  +   LV + +  G L   L     S  + +S   + F      
Sbjct: 61  FLVNL---WYS--FQDEENMYLVVDLLLGGDLRYHL-----SQKVKFSEEQVKF-----W 105

Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
              +  ALEYLH    K I+H D+KP N+LLD     H+ DF +   +          + 
Sbjct: 106 ICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP-----DTLTT 157

Query: 619 GLKGTVGYAAPE 630
              GT GY APE
Sbjct: 158 STSGTPGYMAPE 169

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 52/192 (27%), Positives = 84/192 (43%), Gaps = 36/192 (18%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-----RGALKSFMAECEALRNIRHRNLVK 502
           L+G+GSFGSVY+G+   D    AVK + L       + A+K    E   L  ++H N+V+
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 503 IITACSSSDFQGNDFKALVY-EFMHHGSLESWLHPESASDD---LNYSPSILSFLQRLNI 558
            +      D         ++ E +  GSL   L    +  +     Y+  IL        
Sbjct: 67  YLGTEREED------NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL-------- 112

Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
                  LEYLH    +  VH D+K +N+L+D + +  + DFG+ + + E   +      
Sbjct: 113 -----LGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF--- 161

Query: 619 GLKGTVGYAAPE 630
             KG+  + APE
Sbjct: 162 --KGSPYWMAPE 171

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 50/203 (24%), Positives = 81/203 (39%), Gaps = 51/203 (25%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFL-----HQRGALKSFMAECEALRNIRHRNLVK- 502
           IG GSFG+V K     D  ++  K +        ++  L   ++E   LR ++H N+V+ 
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQL---VSEVNILRELKHPNIVRY 64

Query: 503 ---IITACSSSDFQGNDFKALVYEFMHHGSLESWLH---------PESASDDLNYSPSIL 550
              II   + + +       +V E+   G L   +           E           I 
Sbjct: 65  YDRIIDRSNQTLY-------IVMEYCEGGDLAQLIQKCKKERKYIEEEF---------IW 108

Query: 551 SFLQRLNIAINVASALEYLHH--HCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
             L +L        AL   H+       ++H DLKP+N+ LD +    +GDFGL + +  
Sbjct: 109 RILTQL------LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162

Query: 609 VISSNQCSS-VGLKGTVGYAAPE 630
              S+   + V   GT  Y +PE
Sbjct: 163 --DSSFAKTYV---GTPYYMSPE 180

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 50/186 (26%), Positives = 76/186 (40%), Gaps = 22/186 (11%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA-LKSFMAECEALRNIRHRNLVKIITAC 507
           IG G+   VY  I  P+   VA+K + L +    +     E +A+    H N+VK  T+ 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS- 67

Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F   D   LV  ++  GSL   +   S          I + L+       V   LE
Sbjct: 68  ----FVVGDELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLK------EVLKGLE 116

Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG-- 625
           YLH +     +H D+K  N+LL  D    + DFG++  + +       +    K  VG  
Sbjct: 117 YLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLAD---GGDRTRKVRKTFVGTP 170

Query: 626 -YAAPE 630
            + APE
Sbjct: 171 CWMAPE 176

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 73.4 bits (181), Expect = 3e-14
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 45/203 (22%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALK---SFMA--ECEALRNIRHRNLV 501
             +G G++  VYK        +VA+K + L +R   K   +F A  E + L+ ++H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPS-ILSFLQRLNIAI 560
            ++       F       LV+EFM    LE  +  +S    +  +P+ I S++       
Sbjct: 66  GLLDV-----FGHKSNINLVFEFME-TDLEKVIKDKS----IVLTPADIKSYMLMT---- 111

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI--------PEVISS 612
                LEYLH +    I+H DLKP+N+L+ +D +  + DFGL R           +V+  
Sbjct: 112 --LRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-- 164

Query: 613 NQCSSVGLKGTVGYAAPEYGMGS 635
                     T  Y APE   G+
Sbjct: 165 ----------TRWYRAPELLFGA 177

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 58/182 (31%), Positives = 84/182 (46%), Gaps = 26/182 (14%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG G FG V  G  D     VAVK +        ++F+AE   +  +RH NLV+++    
Sbjct: 14  IGKGEFGDVMLG--DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 69

Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
               +G  +  +V E+M  GSL  +L     S        +L     L  +++V  A+EY
Sbjct: 70  EE--KGGLY--IVTEYMAKGSLVDYLRSRGRS--------VLGGDCLLKFSLDVCEAMEY 117

Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           L  +     VH DL   NVL+  D +A V DFGLT+   E  S+     + +K T    A
Sbjct: 118 LEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT----A 167

Query: 629 PE 630
           PE
Sbjct: 168 PE 169

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 72.4 bits (178), Expect = 4e-14
 Identities = 50/162 (30%), Positives = 65/162 (40%), Gaps = 27/162 (16%)

Query: 449 IGTGSFGSVYKGI-LDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKII 504
           +G G+FGSV KG+ L      V V V  L Q       K F+ E   +  + H  +V++I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWL--HPESASDDLNYSPSILSFLQRLNIAINV 562
             C            LV E    G L  +L    E    DL              +A  V
Sbjct: 63  GVCKGEPLM------LVMELAPLGPLLKYLKKRREIPVSDL------------KELAHQV 104

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
           A  + YL     K  VH DL   NVLL N   A + DFG++R
Sbjct: 105 AMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSR 143

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 72.5 bits (178), Expect = 6e-14
 Identities = 55/165 (33%), Positives = 82/165 (49%), Gaps = 19/165 (11%)

Query: 448 LIGTGSFGSVYKGILDP--DQT--VVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKI 503
            +G G+FGSV     DP  D T  VVAVK L       L+ F  E E L++++H N+VK 
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
              C S+   G     LV E++ +GSL  +L       D      +L +      A  + 
Sbjct: 71  KGVCYSA---GRRNLRLVMEYLPYGSLRDYLQKHRERLD---HRKLLLY------ASQIC 118

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
             +EYL     K+ VH DL   N+L++++    +GDFGLT+ +P+
Sbjct: 119 KGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 72.2 bits (177), Expect = 6e-14
 Identities = 51/179 (28%), Positives = 82/179 (45%), Gaps = 32/179 (17%)

Query: 449 IGTGSFGSVYK----GIL-DPDQTVVAVKVLFLHQRGA----LKSFMAECEALRNIRHRN 499
           IG G+FG V++    G+L     T+VAVK+L   +  A       F  E   +    H N
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAALMAEFDHPN 69

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH-------PESASDDLNYS-----P 547
           +VK++  C+           L++E+M +G L  +L           +    +       P
Sbjct: 70  IVKLLGVCAVGKPM-----CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 548 SILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
             LS  ++L IA  VA+ + YL    +++ VH DL   N L+  +M+  + DFGL+R I
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 180

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 72.2 bits (177), Expect = 6e-14
 Identities = 56/175 (32%), Positives = 84/175 (48%), Gaps = 29/175 (16%)

Query: 447 NLIGTGSFGSVYKG----ILDP--DQTVVAVKVLFLHQRGAL----KSFMAECEALRNIR 496
           N +G+G+FG VY+G    IL P      VAVK L   ++GA     K F+ E   + N  
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFN 57

Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H N+VK++  C       N+ + ++ E M  G L S+L          + P +L+  + L
Sbjct: 58  HPNIVKLLGVCLL-----NEPQYIIMELMEGGDLLSYLRDARVE---RFGPPLLTLKELL 109

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLL-----DNDMIAHVGDFGLTRFI 606
           +I ++VA    YL    +   +H DL   N L+     D D +  +GDFGL R I
Sbjct: 110 DICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI 161

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 71.4 bits (175), Expect = 9e-14
 Identities = 52/194 (26%), Positives = 94/194 (48%), Gaps = 34/194 (17%)

Query: 448 LIGTGSFGSVYKGILDP---DQTVVAVKVLFL----HQRGALKSFMAECEALRNIRHRNL 500
           +IG G FG V +G L      +  VA+K L       QR   + F++E   +    H N+
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR---RDFLSEASIMGQFDHPNI 67

Query: 501 VK---IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLN 557
           +    ++T              ++ EFM +G+L+S+L      +D  ++      +Q + 
Sbjct: 68  IHLEGVVTKSRPV--------MIITEFMENGALDSFLR----QNDGQFTV-----IQLVG 110

Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISS-NQCS 616
           +   +A+ ++YL    +   VH DL   N+L++++++  V DFGL+RF+ +  S     S
Sbjct: 111 MLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTS 167

Query: 617 SVGLKGTVGYAAPE 630
           S+G K  + + APE
Sbjct: 168 SLGGKIPIRWTAPE 181

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 72.1 bits (177), Expect = 9e-14
 Identities = 52/173 (30%), Positives = 88/173 (50%), Gaps = 23/173 (13%)

Query: 448 LIGTGSFGSV----YKGILDPDQTV-VAVKVLFL--HQRGALKSFMAECEALRNI-RHRN 499
            +G G+FG V      G+ +P++T  VAVK+L     ++  L   ++E E ++ I +H+N
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGKHKN 77

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH-----PESASDDLNYSPS-ILSFL 553
           ++ ++  C+    +G  +  +V E+  HG+L  +L       E AS D    P   L+  
Sbjct: 78  IINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132

Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
             ++ A  VA  +E+L     K+ +H DL   NVL+  D +  + DFGL R I
Sbjct: 133 DLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 18/161 (11%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMA--ECEALRNIRHRNLVKIITA 506
           IG G+FG V+K      + +VA+K + +          A  E + L+ ++H N+V +I  
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 507 CSSSDFQGNDFKA---LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
           C +     N +K    LV+EF  H  L   L  ++    L     I   ++ L       
Sbjct: 80  CRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTL---SEIKKVMKML------L 129

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
           + L Y+H   + +I+H D+K +N+L+  D I  + DFGL R
Sbjct: 130 NGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 51/193 (26%), Positives = 92/193 (47%), Gaps = 30/193 (15%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFL----------HQRGALKSFMAECEALRNIRH 497
           LIG G++G VY  +      ++AVK + L           Q+  +K+  +E E L+++ H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 498 RNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLN 557
            N+V+ +           ++ ++  E++  GS+ S L          +   ++ F     
Sbjct: 68  LNIVQYL-GFE----TTEEYLSIFLEYVPGGSIGSCLRTYG-----RFEEQLVRFFTE-- 115

Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
               V   L YLH    K I+H DLK  N+L+D D I  + DFG+++   ++  ++Q  S
Sbjct: 116 ---QVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS 169

Query: 618 VGLKGTVGYAAPE 630
             ++G+V + APE
Sbjct: 170 --MQGSVFWMAPE 180

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 48/161 (29%), Positives = 76/161 (47%), Gaps = 25/161 (15%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKV----LFLHQRGALKSFMAECEALRNIRHRNLVKI 503
            IG G+FG VYKG+L    T VAVK     L    +   + F+ E E L+   H N+VK+
Sbjct: 2   KIGKGNFGDVYKGVLK-GNTEVAVKTCRSTLPPDLK---RKFLQEAEILKQYDHPNIVKL 57

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
           I  C            +V E +  GSL ++L  +            L+  + L ++++ A
Sbjct: 58  IGVCVQKQPI-----YIVMELVPGGSLLTFLRKKKNR---------LTVKKLLQMSLDAA 103

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
           + +EYL     K  +H DL   N L+  + +  + DFG++R
Sbjct: 104 AGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 52/193 (26%), Positives = 81/193 (41%), Gaps = 29/193 (15%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--GALKSFMAECEALRNIRHRNLVKIITA 506
           IG G+ G V+K         VA+K + L +   G     + E +AL+  +H  +VK++  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
                  G+ F  LV E+M          P   S+ L      L   Q  +    +   +
Sbjct: 68  FP----HGSGF-VLVMEYM----------PSDLSEVLRDEERPLPEAQVKSYMRMLLKGV 112

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI---PEVISSNQCSSVGLKGT 623
            Y+H      I+H DLKP+N+L+  D +  + DFGL R        + S+Q        T
Sbjct: 113 AYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV------AT 163

Query: 624 VGYAAPEYGMGSQ 636
             Y APE   G++
Sbjct: 164 RWYRAPELLYGAR 176

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 54/189 (28%), Positives = 85/189 (44%), Gaps = 35/189 (18%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-KSFMAECEALRNIRHRNLVKIITAC 507
           +G G+ G V K +  P   ++AVK + L    A+ K  + E + L       +V    A 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLH------PESASDDLNYSPSILSFLQRLNIAIN 561
               +   D  ++  E+M  GSL+  L       PE           IL       IA+ 
Sbjct: 69  ----YNNGDI-SICMEYMDGGSLDKILKEVQGRIPER----------ILGK-----IAVA 108

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           V   L YLH   K +I+H D+KPSN+L+++     + DFG++    ++++S   + V   
Sbjct: 109 VLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG---QLVNSLAKTFV--- 160

Query: 622 GTVGYAAPE 630
           GT  Y APE
Sbjct: 161 GTSSYMAPE 169

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 56/194 (28%), Positives = 88/194 (45%), Gaps = 21/194 (10%)

Query: 440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIR 496
            G F     IG G F  VYK I   D  VVA+K + + +    K+    + E + L+ + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H N++K + +     F  N+   +V E    G L   +        L    +I  +    
Sbjct: 61  HPNVIKYLAS-----FIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF--- 112

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
              + + SALE++H    K+I+H D+KP+NV +    +  +GD GL RF     SS   +
Sbjct: 113 ---VQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTA 162

Query: 617 SVGLKGTVGYAAPE 630
           +  L GT  Y +PE
Sbjct: 163 AHSLVGTPYYMSPE 176

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 69.7 bits (171), Expect = 4e-13
 Identities = 43/165 (26%), Positives = 70/165 (42%), Gaps = 21/165 (12%)

Query: 448 LIGTGSFGSVYKGI-LDPDQTV--VAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKI 503
            +G GSFG V +G        V  VAVK L   +    +  F+ E   + ++ H NL+++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
                +          +V E    GSL   L  ++                  + A+ +A
Sbjct: 62  YGVVLTHPLM------MVTELAPLGSLLDRLRKDA--------LGHFLISTLCDYAVQIA 107

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           + + YL     K+ +H DL   N+LL +D    +GDFGL R +P+
Sbjct: 108 NGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 53/187 (28%), Positives = 88/187 (47%), Gaps = 25/187 (13%)

Query: 448 LIGTGSFGSVYKGI---LDPDQTVVAVKVLFLHQRGALKS-FMAECEALRNIRHRNLVKI 503
            IG G FG VY+G+    + ++  VAVK        +++  F+ E   +R   H ++VK+
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
           I   + +         +V E    G L S+L  +     L+ +  IL   Q       ++
Sbjct: 73  IGVITENPVW------IVMELAPLGELRSYL--QVNKYSLDLASLILYSYQ-------LS 117

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
           +AL YL     K+ VH D+   NVL+ +     +GDFGL+R++ +   S   +S G K  
Sbjct: 118 TALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED--ESYYKASKG-KLP 171

Query: 624 VGYAAPE 630
           + + APE
Sbjct: 172 IKWMAPE 178

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 69.6 bits (170), Expect = 5e-13
 Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 27/167 (16%)

Query: 448 LIGTGSFGSVYKGILDPD----QTVVAVKVLFLHQRGALKSFMAECE---ALRNIRHRNL 500
           L+G+G FG+V+KGI  P+    +  VA+K +    R   ++F    +   A+ ++ H  +
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI--QDRSGRQTFQEITDHMLAMGSLDHAYI 71

Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           V+++  C  +  Q      LV +    GSL    H     D L+  P  L     LN  +
Sbjct: 72  VRLLGICPGASLQ------LVTQLSPLGSLLD--HVRQHRDSLD--PQRL-----LNWCV 116

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP 607
            +A  + YL  H    +VH +L   N+LL +D I  + DFG+   + 
Sbjct: 117 QIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 70.3 bits (173), Expect = 5e-13
 Identities = 46/172 (26%), Positives = 75/172 (43%), Gaps = 36/172 (20%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLF------LHQRGALKSFMAECEALRNIRHRNL 500
             IG+G++G V   +       VA+K +       +  +  L+    E + LR++RH N+
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61

Query: 501 VK---IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLN---YSPSILSFLQ 554
           +    I+   S  DF  ND   +V E M                DL+    SP  L+   
Sbjct: 62  IGLLDILRPPSPEDF--NDV-YIVTELMET--------------DLHKVIKSPQPLTDDH 104

Query: 555 RLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                  +   L+YLH      ++H DLKPSN+L++++    + DFGL R +
Sbjct: 105 IQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 68.8 bits (168), Expect = 6e-13
 Identities = 51/182 (28%), Positives = 86/182 (47%), Gaps = 28/182 (15%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG G FG+V +G     +  VAVK +        ++F+ E   +  + H+NLV+++    
Sbjct: 14  IGEGEFGAVLQGEYTGQK--VAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
            +         +V E M  G+L ++L     +        ++S +Q L  +++VA  +EY
Sbjct: 70  HNGLY------IVMELMSKGNLVNFLRTRGRA--------LVSVIQLLQFSLDVAEGMEY 115

Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           L     K++VH DL   N+L+  D +A V DFGL R     + ++       K  V + A
Sbjct: 116 LE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNS-------KLPVKWTA 165

Query: 629 PE 630
           PE
Sbjct: 166 PE 167

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 69.3 bits (170), Expect = 7e-13
 Identities = 49/186 (26%), Positives = 76/186 (40%), Gaps = 25/186 (13%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA---LKSFMAECEALRNIRHRNLVKII 504
           ++G G++G V K        +VA+K  F          K+ + E + LR +RH N+V + 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKK-FKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
            A       G  +  LV+E++    LE           L  SP  L      +    +  
Sbjct: 67  EAFRRK---GRLY--LVFEYVERTLLE----------LLEASPGGLPPDAVRSYIWQLLQ 111

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
           A+ Y H      I+H D+KP N+L+    +  + DFG  R +    +S     V    T 
Sbjct: 112 AIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV---ATR 165

Query: 625 GYAAPE 630
            Y APE
Sbjct: 166 WYRAPE 171

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 68.5 bits (167), Expect = 8e-13
 Identities = 49/184 (26%), Positives = 86/184 (46%), Gaps = 26/184 (14%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VAVK L   + G +  +SF+ E + ++ +RH  LV++   
Sbjct: 14  LGNGQFGEVWMGTWN-GNTKVAVKTL---KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV 69

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S           +V E+M  GSL  +L               L     +++A  VA+ +
Sbjct: 70  VSEEPIY------IVTEYMSKGSLLDFLKDGEGRA--------LKLPNLVDMAAQVAAGM 115

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            Y+    +   +H DL+ +N+L+ + ++  + DFGL R I +   +   +  G K  + +
Sbjct: 116 AYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIED---NEYTARQGAKFPIKW 169

Query: 627 AAPE 630
            APE
Sbjct: 170 TAPE 173

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 69.4 bits (170), Expect = 9e-13
 Identities = 61/186 (32%), Positives = 84/186 (45%), Gaps = 26/186 (13%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEAL-RNIRHRNLVKII 504
           IG GSFG V       D    AVKVL    + ++   K  MAE   L +N++H  LV + 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
                  FQ  D    V ++++ G L   L  E      ++      F      A  +AS
Sbjct: 62  ----HYSFQTADKLYFVLDYVNGGELFFHLQRER-----SFPEPRARFY-----AAEIAS 107

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
           AL YLH      I++ DLKP N+LLD+     + DFGL +   E I  ++ +S    GT 
Sbjct: 108 ALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTST-FCGTP 160

Query: 625 GYAAPE 630
            Y APE
Sbjct: 161 EYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 68.8 bits (168), Expect = 9e-13
 Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 13/170 (7%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTV---VAVKVLF--LHQRGALKSFMAECEALRNIRH 497
           F+   ++G G FGSV +  L  +      VAVK+L   +     ++ F+ E   ++   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 498 RNLVKIITACSSSDFQGN-DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
            N++K+I     S  +G      ++  FM HG L ++L      ++    P  L     +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEE----PFTLPLQTLV 116

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
              I++AS +EYL     K  +H DL   N +L+ +M   V DFGL++ I
Sbjct: 117 RFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKI 163

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 68.6 bits (167), Expect = 1e-12
 Identities = 50/164 (30%), Positives = 84/164 (51%), Gaps = 23/164 (14%)

Query: 448 LIGTGSFGSVYKGILDPD-QTV-VAVKVLFLHQRGALKS---FMAECEALRNIRHRNLVK 502
           ++G+G+FG+VYKGI  P+ +TV + V +  L++    K+   FM E   + ++ H +LV+
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++  C S   Q      LV + M HG L  ++H        N    +L     LN  + +
Sbjct: 74  LLGVCLSPTIQ------LVTQLMPHGCLLDYVHEHKD----NIGSQLL-----LNWCVQI 118

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           A  + YL    ++++VH DL   NVL+ +     + DFGL R +
Sbjct: 119 AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 46/161 (28%), Positives = 72/161 (44%), Gaps = 26/161 (16%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVK--VLFLHQRGALKSFMAECEALRNIRHRNLVKIITA 506
           IG G++G VYK        +VA+K   L     G  K+ + E + L+ + H N++K++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNY---SPSILSFLQRLNIAINVA 563
                F+      LV+EFM    L   +       D         I S+L +L       
Sbjct: 67  -----FRHKGDLYLVFEFMDT-DLYKLI------KDRQRGLPESLIKSYLYQL------L 108

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
             L + H H    I+H DLKP N+L++ + +  + DFGL R
Sbjct: 109 QGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLAR 146

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 52/194 (26%), Positives = 83/194 (42%), Gaps = 22/194 (11%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVK-VLF-LHQRGALKSFMAECEALRNIR---HRNLV 501
             IG G++G+VYK         VA+K V   L + G   S + E   L+ +    H N+V
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +++  C            LV+E +    L ++L               L      ++   
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLS--------KCPKPGLPPETIKDLMRQ 115

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           +   +++LH H    IVH DLKP N+L+ +D    + DFGL R     I S + +   + 
Sbjct: 116 LLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR-----IYSFEMALTSVV 167

Query: 622 GTVGYAAPEYGMGS 635
            T+ Y APE  + S
Sbjct: 168 VTLWYRAPEVLLQS 181

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 49/185 (26%), Positives = 90/185 (48%), Gaps = 27/185 (14%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  + + T VAVK L   + G +  ++F+ E   ++ ++H  LV++   
Sbjct: 14  LGAGQFGEVWMGYYN-NSTKVAVKTL---KPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 69

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +  +        ++ E+M  GSL  +L  +     L   P ++ F      +  +A  +
Sbjct: 70  VTKEEP-----IYIITEYMAKGSLLDFLKSDEGGKVL--LPKLIDF------SAQIAEGM 116

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS-VGLKGTVG 625
            Y+    +K  +H DL+ +NVL+   ++  + DFGL R    VI  N+ ++  G K  + 
Sbjct: 117 AYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLAR----VIEDNEYTAREGAKFPIK 169

Query: 626 YAAPE 630
           + APE
Sbjct: 170 WTAPE 174

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 50/183 (27%), Positives = 71/183 (38%), Gaps = 35/183 (19%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG+G++G VYK        +VA+KV+ L      +    E   L+  RH N+V    +  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS-- 68

Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
              +   D   +V E+   GSL          D    +   LS LQ   +       L Y
Sbjct: 69  ---YLRRDKLWIVMEYCGGGSL---------QDIYQVTRGPLSELQIAYVCRETLKGLAY 116

Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG----LTR-------FI-------PEVI 610
           LH       +H D+K +N+LL  D    + DFG    LT        FI       PEV 
Sbjct: 117 LHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA 173

Query: 611 SSN 613
           +  
Sbjct: 174 AVE 176

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 66.7 bits (163), Expect = 5e-12
 Identities = 48/162 (29%), Positives = 71/162 (43%), Gaps = 22/162 (13%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKII 504
           L+G GS+G V K        +VA+K  FL     +   K  M E   L+ +RH NLV +I
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKK-FLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
                  F+      LV+EF+ H  L          DDL   P+ L   +       +  
Sbjct: 67  EV-----FRRKKRLYLVFEFVDHTVL----------DDLEKYPNGLDESRVRKYLFQILR 111

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
            +E+ H H    I+H D+KP N+L+    +  + DFG  R +
Sbjct: 112 GIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 65.8 bits (160), Expect = 8e-12
 Identities = 50/187 (26%), Positives = 89/187 (47%), Gaps = 26/187 (13%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VA+K L   + G +  ++F+ E + ++ +RH  LV +   
Sbjct: 14  LGQGCFGEVWMGTWN-GTTKVAIKTL---KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S           +V EFM  GSL  +L       D  Y    L   Q +++A  +A  +
Sbjct: 70  VSEEPIY------IVTEFMGKGSLLDFLK----EGDGKY----LKLPQLVDMAAQIADGM 115

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            Y+    +   +H DL+ +N+L+ ++++  + DFGL R I +   +   +  G K  + +
Sbjct: 116 AYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIED---NEYTARQGAKFPIKW 169

Query: 627 AAPEYGM 633
            APE  +
Sbjct: 170 TAPEAAL 176

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 65.9 bits (161), Expect = 8e-12
 Identities = 42/168 (25%), Positives = 82/168 (48%), Gaps = 14/168 (8%)

Query: 442 GFSSANLIGTGSFGSVYKGIL-DPDQTV---VAVKVLFLH-QRGALKSFMAECEALRNIR 496
             + ++L+  G+FG ++ GIL D        V VK +  H     +   + E   L  + 
Sbjct: 7   RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS 66

Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H+N++ I+  C     +  +   ++Y +M+ G+L+ +L      +  N  P  LS  Q +
Sbjct: 67  HQNILPILHVC----IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANN--PQALSTQQLV 120

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
           ++AI +A  + YLH   K+ ++H D+   N ++D ++   + D  L+R
Sbjct: 121 HMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSR 165

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 61/196 (31%), Positives = 91/196 (46%), Gaps = 27/196 (13%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALK-SFMAECEALRNIRHRNLVKIITA 506
           L+G G+FG V+KG L  D+T VAVK         LK  F++E   L+   H N+VK+I  
Sbjct: 2   LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
           C+           +V E +  G   S+L  +   D+L          Q +  A++ A+ +
Sbjct: 61  CTQ-----RQPIYIVMELVPGGDFLSFLRKKK--DELKTK-------QLVKFALDAAAGM 106

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT-VG 625
            YL     K  +H DL   N L+  + +  + DFG++R   + I     SS GLK   + 
Sbjct: 107 AYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY----SSSGLKQIPIK 159

Query: 626 YAAPE---YGMGSQVS 638
           + APE   YG  S  S
Sbjct: 160 WTAPEALNYGRYSSES 175

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 65.6 bits (161), Expect = 1e-11
 Identities = 46/170 (27%), Positives = 71/170 (41%), Gaps = 43/170 (25%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR-------HRNLV 501
           +G G+FGSVY         +VA+K +    +    S+  EC  LR ++       H N+V
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKM----KKKFYSW-EECMNLREVKSLRKLNEHPNIV 61

Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSL-------ESWLHPESASDDLNYSPSILSFLQ 554
           K+        F+ ND    V+E+M  G+L       +     ES          I S + 
Sbjct: 62  KLKEV-----FRENDELYFVFEYM-EGNLYQLMKDRKGKPFSES---------VIRSIIY 106

Query: 555 RLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
           +      +   L ++H H      H DLKP N+L+    +  + DFGL R
Sbjct: 107 Q------ILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 53/186 (28%), Positives = 85/186 (45%), Gaps = 30/186 (16%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G+G FG V+ G     Q  VA+K +     GA+  + F+ E + +  + H  LV++   
Sbjct: 12  LGSGQFGVVHLGKWRA-QIKVAIKAI---NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 507 CSSSDFQGNDFKAL--VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
           C+         K L  V EFM +G L ++L           S  +L     L++  +V  
Sbjct: 68  CTQQ-------KPLYIVTEFMENGCLLNYLRQRQG----KLSKDML-----LSMCQDVCE 111

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            +EYL    +   +H DL   N L+ +  +  V DFG+TR+   V+     SS G K  V
Sbjct: 112 GMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRY---VLDDEYTSSSGAKFPV 165

Query: 625 GYAAPE 630
            ++ PE
Sbjct: 166 KWSPPE 171

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 52/191 (27%), Positives = 82/191 (42%), Gaps = 39/191 (20%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITAC 507
            +G GS+GSVYK I      VVA+KV+ +     L+  + E   L+      +VK     
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK----- 62

Query: 508 SSSDFQGNDFKA----LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
               + G+ FK     +V E+   GS+         SD +  +   L+  +   I     
Sbjct: 63  ----YYGSYFKNTDLWIVMEYCGAGSV---------SDIMKITNKTLTEEEIAAILYQTL 109

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
             LEYLH     + +H D+K  N+LL+ +  A + DFG        +S     ++  + T
Sbjct: 110 KGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFG--------VSGQLTDTMAKRNT 158

Query: 624 V-G---YAAPE 630
           V G   + APE
Sbjct: 159 VIGTPFWMAPE 169

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 49/172 (28%), Positives = 85/172 (49%), Gaps = 26/172 (15%)

Query: 449 IGTGSFGSVYKGIL------DPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIRHRN 499
           +G GSFG VY+G        + + T VAVK +  ++  +L+    F+ E   ++     +
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAE-TRVAVKTV--NESASLRERIEFLNEASVMKGFTCHH 70

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH---PESASDDLNYSPSILSFLQRL 556
           +V+++   S           +V E M HG L+S+L    PE+ ++     P++   +Q  
Sbjct: 71  VVRLLGVVSKGQP-----TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ-- 123

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
            +A  +A  + YL+    K+ VH DL   N ++ +D    +GDFG+TR I E
Sbjct: 124 -MAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 171

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 44/170 (25%), Positives = 83/170 (48%), Gaps = 22/170 (12%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA---LKSFMAECEALRNI-RHRNLVK 502
           ++IG G+FG V + ++  D   +   +  L +  +    + F  E E L  +  H N++ 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLH--------PESASDDLNYSPSILSFLQ 554
           ++ AC     +   +  +  E+  +G+L  +L         P  A +  + + S L+  Q
Sbjct: 68  LLGAC-----ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKE--HGTASTLTSQQ 120

Query: 555 RLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
            L  A +VA+ ++YL    +KQ +H DL   NVL+  ++ + + DFGL+R
Sbjct: 121 LLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 57/203 (28%), Positives = 85/203 (41%), Gaps = 30/203 (14%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVK-VLFLHQRGALK-SFMAECEALRNIRHRNL 500
           F   N IG G++G VY+        +VA+K V   ++R  +  S + E   L N+RH N+
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68

Query: 501 VKIITACSSSDFQGNDFKA--LVYEFMHH--GSLESWLHPESASDDLNYSPSILSFLQRL 556
           V++          G    +  LV E+      SL            L+  P+  S  Q  
Sbjct: 69  VELKEVV-----VGKHLDSIFLVMEYCEQDLASL------------LDNMPTPFSESQVK 111

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
            + + +   L+YLH +    I+H DLK SN+LL +     + DFGL R            
Sbjct: 112 CLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK 168

Query: 617 SVGLKGTVGYAAPEYGMGSQVST 639
            V    T+ Y APE  +G    T
Sbjct: 169 VV----TLWYRAPELLLGCTTYT 187

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 67.1 bits (164), Expect = 1e-11
 Identities = 34/93 (36%), Positives = 49/93 (52%), Gaps = 8/93 (8%)

Query: 207 FLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRW--------LDLSHNHL 258
           F+  L L    +RG IP+ +     LQS++LS     G  P           LDLS+N  
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 259 TGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLG 291
            G IP ++G L S+  L+L+ N LSG +P++LG
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 67.1 bits (164), Expect = 1e-11
 Identities = 42/119 (35%), Positives = 57/119 (47%), Gaps = 31/119 (26%)

Query: 110 LDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVN 169
           L   N  L   IP D+ +LR+L  +N                              L+ N
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSIN------------------------------LSGN 452

Query: 170 SLR-SIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALG 227
           S+R +IP S+G +  L+VL L  N+ +G IP SLG  T L  LNL GNS+ G +P+ALG
Sbjct: 453 SIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 44/184 (23%), Positives = 89/184 (48%), Gaps = 26/184 (14%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VA+K L   ++G++  ++F+AE   ++ ++H  LV++   
Sbjct: 14  LGAGQFGEVWMGYYN-GHTKVAIKSL---KQGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +           ++ E+M +GSL  +L               L+  + +++A  +A  +
Sbjct: 70  VTQEPIY------IITEYMENGSLVDFLKTPEGIK--------LTINKLIDMAAQIAEGM 115

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            ++    +K  +H DL+ +N+L+   +   + DFGL R I +   +   +  G K  + +
Sbjct: 116 AFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIED---NEYTAREGAKFPIKW 169

Query: 627 AAPE 630
            APE
Sbjct: 170 TAPE 173

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 51/192 (26%), Positives = 91/192 (47%), Gaps = 32/192 (16%)

Query: 448 LIGTGSFGSVYKGILD-PDQTVVAVKVLFLH------QRGALKSFMAECEALRNIRHRNL 500
           +IG G FG V++GIL  P +  VAV +  L       QR   + F++E   +    H N+
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR---QDFLSEASIMGQFSHHNI 68

Query: 501 VKIITACSSSDFQGNDFK--ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           +++    +        FK   ++ E+M +G+L+ +L       D  +S       Q + +
Sbjct: 69  IRLEGVVTK-------FKPAMIITEYMENGALDKYLR----DHDGEFSS-----YQLVGM 112

Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
              +A+ ++YL        VH DL   N+L+++++   V DFGL+R + +       +S 
Sbjct: 113 LRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSG 169

Query: 619 GLKGTVGYAAPE 630
           G K  + + APE
Sbjct: 170 G-KIPIRWTAPE 180

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 66.0 bits (161), Expect = 3e-11
 Identities = 42/105 (40%), Positives = 56/105 (53%), Gaps = 17/105 (16%)

Query: 164 VSLNVNSLRS-IPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSI 222
           + L+   LR  IP  +  L  LQ ++L  N+I G IP SLG+ T L  L+L  NS  GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 223 PSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVG 267
           P +LG   QL SL             R L+L+ N L+G +P A+G
Sbjct: 483 PESLG---QLTSL-------------RILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 58/196 (29%), Positives = 88/196 (44%), Gaps = 27/196 (13%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKS-FMAECEALRNIRHRNLVKIITAC 507
           IG G+FG V+ G L  D T VAVK         LK+ F+ E   L+   H N+V++I  C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
           +    Q      +V E +  G   ++L  E            L   + + +  N A+ +E
Sbjct: 63  T----QKQPI-YIVMELVQGGDFLTFLRTEGPR---------LKVKELIQMVENAAAGME 108

Query: 568 YLH-HHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT-VG 625
           YL   HC    +H DL   N L+    +  + DFG++R   + + +   S+ G+K   V 
Sbjct: 109 YLESKHC----IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA---STGGMKQIPVK 161

Query: 626 YAAPE---YGMGSQVS 638
           + APE   YG  S  S
Sbjct: 162 WTAPEALNYGRYSSES 177

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 64.6 bits (158), Expect = 3e-11
 Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 18/161 (11%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKII-T 505
           +G G+FG VYK        VVA+K + +H  + G   + + E + L+ ++H N+V +I  
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 506 ACSSSDFQGNDFKA--LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
           A    D       +  +V  +M H  L   L   S    +  + S     Q     + + 
Sbjct: 76  AVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPS----VKLTES-----QIKCYMLQLL 125

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
             + YLH   +  I+H D+K +N+L+DN  I  + DFGL R
Sbjct: 126 EGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLAR 163

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 51/186 (27%), Positives = 91/186 (48%), Gaps = 24/186 (12%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIIT 505
           ++G G+FG V+      DQ +V +K + + Q  +    +   EC+ L+ + H N+++   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY- 65

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
                +F  +    +V E+   G+L  ++     S  L    +IL F  ++ +A      
Sbjct: 66  ----ENFLEDKALMIVMEYAPGGTLAEYIQKRCNS--LLDEDTILHFFVQILLA------ 113

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLD-NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
              LHH   K I+H DLK  N+LLD + M+  +GDFG+++    + S ++  +V   GT 
Sbjct: 114 ---LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISK---ILSSKSKAYTV--VGTP 165

Query: 625 GYAAPE 630
            Y +PE
Sbjct: 166 CYISPE 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 52/194 (26%), Positives = 96/194 (49%), Gaps = 29/194 (14%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFL---------HQRGALKSFMAECEALRNIRHR 498
           LIG+GSFGSVY G+      ++AVK + L          +R  L +   E   L+ ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           N+V+ +   S      N F     E++  GS+ + L+   A ++      + +F+++   
Sbjct: 67  NIVQYL-GSSLDADHLNIF----LEYVPGGSVAALLNNYGAFEE----TLVRNFVRQ--- 114

Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE--VISSNQCS 616
              +   L YLH+   + I+H D+K +N+L+DN     + DFG+++ +    + +    +
Sbjct: 115 ---ILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA 168

Query: 617 SVGLKGTVGYAAPE 630
              L+G+V + APE
Sbjct: 169 RPSLQGSVFWMAPE 182

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 58/178 (32%), Positives = 83/178 (46%), Gaps = 36/178 (20%)

Query: 443 FSSANLIGTGSFGSVYKGI-LDPDQTVVAVKVLFLHQR-GALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK    D  + V   KV   +++ G   + + E + LR + HRN+
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68

Query: 501 VK---IITACSSSDFQGNDFKA------LVYEFMHH---GSLESWLHPESASDDLNYSPS 548
           V    I+T          DFK       LV+E+M H   G LES L        +++S  
Sbjct: 69  VNLKEIVT----DKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL--------VHFSED 116

Query: 549 -ILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF 605
            I SF+++L         L Y H   KK  +H D+K SN+LL+N     + DFGL R 
Sbjct: 117 HIKSFMKQL------LEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 63.9 bits (155), Expect = 6e-11
 Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 18/168 (10%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL---KSFMAECEALRNI-RHRNLVK 502
           ++IG G+FG V K  +  D   +   +  + +  +    + F  E E L  +  H N++ 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWL------HPESASDDLNYSPSILSFLQRL 556
           ++ AC     +   +  L  E+  HG+L  +L        + A    N + S LS  Q L
Sbjct: 73  LLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
           + A +VA  ++YL    +KQ +H DL   N+L+  + +A + DFGL+R
Sbjct: 128 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 62.7 bits (152), Expect = 9e-11
 Identities = 49/171 (28%), Positives = 85/171 (49%), Gaps = 24/171 (14%)

Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIRHRNL 500
           +G GSFG VY+GI      D  +T VA+K +  ++  +++    F+ E   ++     ++
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEFNCHHV 71

Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH---PESASDDLNYSPSILSFLQRLN 557
           V+++   S    QG     ++ E M  G L+S+L    PE  ++ +   PS+   +Q   
Sbjct: 72  VRLLGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ--- 123

Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           +A  +A  + YL+     + VH DL   N ++  D    +GDFG+TR I E
Sbjct: 124 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 171

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 62.8 bits (153), Expect = 9e-11
 Identities = 46/169 (27%), Positives = 73/169 (43%), Gaps = 20/169 (11%)

Query: 447 NLIGTGSFGSVYKGIL-----DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNL 500
             +G G+FG VY+G+      D  +  VAVK L           F+ E   +    H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           V++I       F+    + ++ E M  G L+S+L       +    PS L+    L  A 
Sbjct: 72  VRLIGVS----FERLP-RFILLELMAGGDLKSFLRENRPRPE---RPSSLTMKDLLFCAR 123

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDN---DMIAHVGDFGLTRFI 606
           +VA   +YL    +   +H D+   N LL       +A + DFG+ R I
Sbjct: 124 DVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI 169

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 62.6 bits (152), Expect = 9e-11
 Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 16/158 (10%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIRHRNLVKIIT 505
           IG G FG V  G ++   T   V V  L    +++    F+ E +  R+++H NL++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
            C+           LV EF   G L+ +L     ++ +   P+ L   QR+  A  +A  
Sbjct: 63  QCTEVTPY-----LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTL---QRM--ACEIALG 112

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT 603
           L +LH +     +H DL   N LL  D+   +GD+GL+
Sbjct: 113 LLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 50/191 (26%), Positives = 83/191 (43%), Gaps = 21/191 (10%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVK---VLFLHQRGALKSFMAECEALRNIRHRN 499
           F     IG G F  VY+     D   VA+K   +  L    A    + E + L+ + H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           ++K      +S  + N+   +V E    G L   +        L    ++  +       
Sbjct: 64  VIKY----YASFIEDNELN-IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYF------ 112

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
           + + SALE++H    ++++H D+KP+NV +    +  +GD GL RF     SS   ++  
Sbjct: 113 VQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHS 165

Query: 620 LKGTVGYAAPE 630
           L GT  Y +PE
Sbjct: 166 LVGTPYYMSPE 176

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 56/196 (28%), Positives = 90/196 (45%), Gaps = 32/196 (16%)

Query: 448 LIGTGSFGSVYK-GILDPDQTVVAVKVLFLH-------QRGALKSF---MAECEALR-NI 495
            +G+G+FG VYK    +  Q ++A+K + +H       +R   KS    ++E   ++  +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N+V+         F  ND   +V + +    L    H  S  +            +R
Sbjct: 67  RHPNIVRYYKT-----FLENDRLYIVMDLIEGAPLGE--HFNSLKEKKQRFTE-----ER 114

Query: 556 L-NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQ 614
           + NI + +  AL YLH   +K+IVH DL P+N++L  D    + DFGL +       S  
Sbjct: 115 IWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP--ESKL 170

Query: 615 CSSVGLKGTVGYAAPE 630
            S V   GT+ Y+ PE
Sbjct: 171 TSVV---GTILYSCPE 183

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.7 bits (155), Expect = 2e-10
 Identities = 52/161 (32%), Positives = 74/161 (45%), Gaps = 17/161 (10%)

Query: 244 GQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSI 303
           G++ +  L L +  L G IP  +  L+ +  ++LS N + G IP SLGS   LE L+LS 
Sbjct: 416 GKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSY 475

Query: 304 NSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRK--GIFKNASAISVAGNEKLCG 361
           NSF+G I   L  L SL  L+L  N     S +G VP    G   + ++ +   N  LCG
Sbjct: 476 NSFNGSIPESLGQLTSLRILNLNGN-----SLSGRVPAALGGRLLHRASFNFTDNAGLCG 530

Query: 362 GISELKLPPCTPSESKKRQKSNGFKLMIPLLSGLVGLVLVM 402
                 L  C P        S G K+ I      V  + ++
Sbjct: 531 IPG---LRACGP------HLSVGAKIGIA-FGVSVAFLFLV 561

Length = 623

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 34/183 (18%)

Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQRGA----LKSFMAECEALRNIRHRN 499
           +G G FG V K            T VAVK+L   +  A    L+  ++E   L+ + H +
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKML---KENASSSELRDLLSEFNLLKQVNHPH 64

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH--------------PESASDDLNY 545
           ++K+  ACS           L+ E+  +GSL S+L                 ++S   N 
Sbjct: 65  VIKLYGACSQDGPL-----LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119

Query: 546 SPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF 605
               L+    ++ A  ++  ++YL    + ++VH DL   NVL+       + DFGL+R 
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176

Query: 606 IPE 608
           + E
Sbjct: 177 VYE 179

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 59/197 (29%), Positives = 94/197 (47%), Gaps = 25/197 (12%)

Query: 449 IGTGSFGSVYK----GI--LDPDQTV-VAVKVLFLHQRGA-LKSFMAECEALRNI-RHRN 499
           +G G FG V +    GI    PDQTV VAVK+L  +     L   ++E E ++ I +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH------PESASDDLNYSPSILSFL 553
           ++ ++  C+    Q      +V E+   G+L  +L       P+   D        LSF 
Sbjct: 80  IINLLGVCT----QEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134

Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
             ++ A  VA  +EYL     ++ +H DL   NVL+  D +  + DFGL R + ++    
Sbjct: 135 DLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191

Query: 614 QCSSVGLKGTVGYAAPE 630
           + S+  L   V + APE
Sbjct: 192 KTSNGRLP--VKWMAPE 206

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 47/199 (23%), Positives = 86/199 (43%), Gaps = 23/199 (11%)

Query: 443 FSSANL-----IGTGSFGSVY----KGILDPD-QTVVAVKVL-FLHQRGALKSFMAECEA 491
           F  +NL     +G G FG V+    KGI +   +T+V VK L           F  E + 
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 492 LRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILS 551
            R + H+N+V+++  C  ++        ++ E+   G L+ +L    + D+    P  LS
Sbjct: 62  FRKLSHKNVVRLLGLCREAEPH-----YMILEYTDLGDLKQFLRATKSKDEKLKPPP-LS 115

Query: 552 FLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVIS 611
             Q++ +   +A  +++L +    + VH DL   N L+ +     V    L++   +V +
Sbjct: 116 TKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK---DVYN 169

Query: 612 SNQCSSVGLKGTVGYAAPE 630
           S           + + APE
Sbjct: 170 SEYYKLRNALIPLRWLAPE 188

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 42/203 (20%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITA 506
           IG G++G VYK        +VA+K + L     G   + + E   L+ + H N+V+++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLL-- 64

Query: 507 CSSSDFQGNDFKA-LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
               D   ++ K  LV+EF+    L+ ++  +S+       P I S+L +L         
Sbjct: 65  ----DVVHSENKLYLVFEFLDL-DLKKYM--DSSPLTGLDPPLIKSYLYQL------LQG 111

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR-F-IP------EVISSNQCSS 617
           + Y H H   +++H DLKP N+L+D +    + DFGL R F +P      EV+       
Sbjct: 112 IAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV------- 161

Query: 618 VGLKGTVGYAAPEYGMGS-QVST 639
                T+ Y APE  +GS Q ST
Sbjct: 162 -----TLWYRAPEILLGSRQYST 179

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 54/189 (28%), Positives = 84/189 (44%), Gaps = 34/189 (17%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIRHRNLVKII 504
            +GTG+FG V+       +   A+KV+ + +   LK       E   L+ + H  ++++ 
Sbjct: 8   TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPE---SASDDLNYSPSILSFLQRLNIAIN 561
              +  D     F  ++ E++  G L S+L      S S  L Y+  I+           
Sbjct: 68  --WTEHD---QRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVC---------- 112

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
              ALEYLH    K+IV+ DLKP N+LLD +    + DFG   F  ++       +  L 
Sbjct: 113 ---ALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFG---FAKKLRD----RTWTLC 159

Query: 622 GTVGYAAPE 630
           GT  Y APE
Sbjct: 160 GTPEYLAPE 168

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 50/187 (26%), Positives = 83/187 (44%), Gaps = 26/187 (13%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITAC 507
           ++G G++G VY       Q  +A+K +       ++    E      ++HRN+V+ + + 
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 508 SSSDFQGNDFKALVYEFMHH---GSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
           S + F    FK     FM     GSL + L   S    L  +   + F  +      +  
Sbjct: 75  SENGF----FKI----FMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTK-----QILE 119

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDN-DMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
            L+YLH     QIVH D+K  NVL++    +  + DFG ++ +  +   N C+     GT
Sbjct: 120 GLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI---NPCTET-FTGT 172

Query: 624 VGYAAPE 630
           + Y APE
Sbjct: 173 LQYMAPE 179

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 52/194 (26%), Positives = 83/194 (42%), Gaps = 25/194 (12%)

Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-KSFMAECEALRNIRHRN 499
                 + +G G+ GSV K  L     + A+K +       L K  + E E  ++ +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 500 LVKIITAC---SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           +VK   A    SSS         +  E+   GSL+S ++ +           +L      
Sbjct: 61  IVKYYGAFLDESSSSI------GIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVL-----G 108

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
            IA +V   L YLH    ++I+H D+KPSN+LL       + DFG++    E+++S   +
Sbjct: 109 KIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS---GELVNSLAGT 162

Query: 617 SVGLKGTVGYAAPE 630
                GT  Y APE
Sbjct: 163 FT---GTSFYMAPE 173

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 20/162 (12%)

Query: 447 NLIGTGSFGSVYKGIL---DPDQTVVAVKVLF-LHQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG VY G L   D  +   AVK L  +     ++ F+ E   +++  H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++  C  S+        +V  +M HG L +++  E+      ++P++   +      + V
Sbjct: 61  LLGICLPSE----GSPLVVLPYMKHGDLRNFIRSET------HNPTVKDLI---GFGLQV 107

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
           A  +EYL     K+ VH DL   N +LD      V DFGL R
Sbjct: 108 AKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 61.4 bits (149), Expect = 4e-10
 Identities = 55/191 (28%), Positives = 77/191 (40%), Gaps = 28/191 (14%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIRHRN 499
           F     +GTGSFG V            A+K L   +   +K       E   L  + H  
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           +V ++  CS   FQ  +    + EF+  G L +  H   A     +   +  F       
Sbjct: 80  IVNMM--CS---FQDENRVYFLLEFVVGGELFT--HLRKAG---RFPNDVAKFYH----- 124

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             +  A EYLH    K I++ DLKP N+LLDN     V DFG  + +P+        +  
Sbjct: 125 AELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-------RTFT 174

Query: 620 LKGTVGYAAPE 630
           L GT  Y APE
Sbjct: 175 LCGTPEYLAPE 185

Length = 329

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 60.3 bits (147), Expect = 5e-10
 Identities = 40/153 (26%), Positives = 67/153 (43%), Gaps = 18/153 (11%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG G+ G VYK         VA+K + L ++   +  + E   +++ +H N+V       
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRL-RKQNKELIINEILIMKDCKHPNIVDYY---- 81

Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
              +   D   +V E+M  GSL         +D +  +   ++  Q   +   V   LEY
Sbjct: 82  -DSYLVGDELWVVMEYMDGGSL---------TDIITQNFVRMNEPQIAYVCREVLQGLEY 131

Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG 601
           LH    + ++H D+K  N+LL  D    + DFG
Sbjct: 132 LH---SQNVIHRDIKSDNILLSKDGSVKLADFG 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 59.7 bits (144), Expect = 8e-10
 Identities = 45/184 (24%), Positives = 89/184 (48%), Gaps = 26/184 (14%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+    +   T VAVK +   + G++  ++F+AE   ++ ++H  LVK+   
Sbjct: 14  LGAGQFGEVWMATYN-KHTKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +           ++ EFM  GSL  +L     SD+ +  P      + ++ +  +A  +
Sbjct: 70  VTKEPIY------IITEFMAKGSLLDFLK----SDEGSKQP----LPKLIDFSAQIAEGM 115

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            ++    ++  +H DL+ +N+L+   ++  + DFGL R I +   +   +  G K  + +
Sbjct: 116 AFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIED---NEYTAREGAKFPIKW 169

Query: 627 AAPE 630
            APE
Sbjct: 170 TAPE 173

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 62/191 (32%), Positives = 84/191 (43%), Gaps = 34/191 (17%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKS-----FMAECEAL-RNIRHRNLV 501
           +IG GSFG V       D +  AVKVL   ++  LK       MAE   L +N++H  LV
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVL--QKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
            +        FQ  +    V ++++ G L   L  E       +      F      A  
Sbjct: 60  GL-----HYSFQTAEKLYFVLDYVNGGELFFHLQRERC-----FLEPRARFY-----AAE 104

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR--FIPEVISSNQCSSVG 619
           VASA+ YLH      I++ DLKP N+LLD+     + DFGL +    PE  +S  C    
Sbjct: 105 VASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC---- 157

Query: 620 LKGTVGYAAPE 630
             GT  Y APE
Sbjct: 158 --GTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 48/170 (28%), Positives = 81/170 (47%), Gaps = 22/170 (12%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA---LKSFMAECEALRNI-RHRNLVK 502
           ++IG G+FG V K  +  D   +   +  + +  +    + F  E E L  +  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLH--------PESASDDLNYSPSILSFLQ 554
           ++ AC     +   +  L  E+  HG+L  +L         P  A    N + S LS  Q
Sbjct: 61  LLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA--NSTASTLSSQQ 113

Query: 555 RLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
            L+ A +VA  ++YL    +KQ +H DL   N+L+  + +A + DFGL+R
Sbjct: 114 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 46/185 (24%), Positives = 84/185 (45%), Gaps = 21/185 (11%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVK---VLFLHQRGALKSFMAECEALRNIRHRNLVKIIT 505
           IG G F  VY+     D+  VA+K   +  +    A +  + E + L+ + H N++K + 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
           +     F  ++   +V E    G L   +        L    ++  +       + + SA
Sbjct: 70  S-----FIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYF------VQLCSA 118

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG 625
           +E++H    ++++H D+KP+NV +    +  +GD GL RF     SS   ++  L GT  
Sbjct: 119 VEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGTPY 171

Query: 626 YAAPE 630
           Y +PE
Sbjct: 172 YMSPE 176

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 59.5 bits (145), Expect = 2e-09
 Identities = 52/173 (30%), Positives = 79/173 (45%), Gaps = 49/173 (28%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR----------HR 498
           +G G++G V+K I    + VVA+K +F     A   F    +A R  R          H 
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIF----DA---FRNATDAQRTFREIMFLQELGDHP 67

Query: 499 NLVKIITACSSSDFQGNDFKA-------LVYEFMHHGSLESWLHPESASDDLNYSPSILS 551
           N+VK++          N  KA       LV+E+M     E+ LH    ++       IL 
Sbjct: 68  NIVKLL----------NVIKAENDKDIYLVFEYM-----ETDLHAVIRAN-------ILE 105

Query: 552 FLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
            + +  I   +  AL+Y+H      ++H DLKPSN+LL++D    + DFGL R
Sbjct: 106 DVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLAR 155

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 57/197 (28%), Positives = 92/197 (46%), Gaps = 25/197 (12%)

Query: 449 IGTGSFGSVYKGI---LDPDQ----TVVAVKVLFLH-QRGALKSFMAECEALRNI-RHRN 499
           +G G FG V       LD ++    T VAVK+L        L   ++E E ++ I +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASD-DLNYSPS-----ILSFL 553
           ++ ++ AC+    Q      +V E+   G+L  +L        +  Y+P+      LSF 
Sbjct: 86  IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
             ++ A  VA  +EYL     K+ +H DL   NVL+  D +  + DFGL R I  +    
Sbjct: 141 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197

Query: 614 QCSSVGLKGTVGYAAPE 630
           + ++  L   V + APE
Sbjct: 198 KTTNGRLP--VKWMAPE 212

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 22/185 (11%)

Query: 449 IGTGSFGSVYKGI--LDPDQTVVAVKVLFLHQRGALK-SFMAECEALRNIRHRNLVKIIT 505
           +G+G+FG V KG+  +   Q  VA+KVL      +++   M E E +  + +  +V++I 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
            C +          LV E    G L  +L   S   D     +++  + +      V+  
Sbjct: 63  VCEAEALM------LVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQ------VSMG 107

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG 625
           ++YL     K  VH DL   NVLL N   A + DFGL++ +    S  +  S G K  + 
Sbjct: 108 MKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG-KWPLK 163

Query: 626 YAAPE 630
           + APE
Sbjct: 164 WYAPE 168

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 50/187 (26%), Positives = 87/187 (46%), Gaps = 23/187 (12%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALK---SFMAECEALRNIRHRNLVKIIT 505
           IG G FG V    +  D  V  V V  L    + K    F+ + +  R ++H N+++ + 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
            C     +   +  LV+E+   G L+S+L    + +  +   S L  LQR+  A  +A+ 
Sbjct: 63  QC----VEAIPY-LLVFEYCELGDLKSYL----SQEQWHRRNSQLLLLQRM--ACEIAAG 111

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL--TRFIPEVISSNQCSSVGLKGT 623
           + ++H H     +H DL   N  L +D+   VGD+G+  +R+  + I +     V L+  
Sbjct: 112 VTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR-- 166

Query: 624 VGYAAPE 630
             + APE
Sbjct: 167 --WLAPE 171

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 58.4 bits (142), Expect = 2e-09
 Identities = 49/190 (25%), Positives = 76/190 (40%), Gaps = 36/190 (18%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIIT 505
           +G G FG V    +       A+K +      + G  +   +E E L    H  +VK+  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
                 F+   +  ++ E+   G L + L      D+         +  R  IA  V  A
Sbjct: 61  T-----FKDKKYIYMLMEYCLGGELWTILRDRGLFDE---------YTARFYIA-CVVLA 105

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK---- 621
            EYLH+   + I++ DLKP N+LLD++    + DFG  + +            G K    
Sbjct: 106 FEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL----------KSGQKTWTF 152

Query: 622 -GTVGYAAPE 630
            GT  Y APE
Sbjct: 153 CGTPEYVAPE 162

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 2e-09
 Identities = 49/167 (29%), Positives = 71/167 (42%), Gaps = 25/167 (14%)

Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRH 497
             F    +IG G+FG V+         V A+KVL    + +R  +    AE + L +   
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 498 RNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLN 557
             +VK+  +     FQ  +   LV E+M  G L + L      D             R  
Sbjct: 61  PWIVKLYYS-----FQDEEHLYLVMEYMPGGDLMNLL---IRKDVFPEE------TARFY 106

Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV--GDFGL 602
           IA  V  AL+ +H   K   +H D+KP N+L+D D   H+   DFGL
Sbjct: 107 IAELVL-ALDSVH---KLGFIHRDIKPDNILIDAD--GHIKLADFGL 147

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 41/205 (20%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 501 VKIITACSSSDFQGNDFKA-LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           VK++      D    + K  LV+EF+H   L+ ++  +++       P I S+L +L   
Sbjct: 62  VKLL------DVIHTENKLYLVFEFLHQ-DLKKFM--DASPLSGIPLPLIKSYLFQL--- 109

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR--------FIPEVIS 611
                 L + H H   +++H DLKP N+L++ +    + DFGL R        +  EV+ 
Sbjct: 110 ---LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV- 162

Query: 612 SNQCSSVGLKGTVGYAAPEYGMGSQ 636
                      T+ Y APE  +G +
Sbjct: 163 -----------TLWYRAPEILLGCK 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 62/187 (33%), Positives = 84/187 (44%), Gaps = 26/187 (13%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEAL-RNIRHRNLVKI 503
           +IG GSFG V       D    AVKVL    +  R   K  MAE   L +N++H  LV +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
                   FQ  +    V +F++ G L   L  E +  +            R   A  +A
Sbjct: 62  -----HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPR---------ARFYAA-EIA 106

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
           SAL YLH      IV+ DLKP N+LLD+     + DFGL +   E I+ +  ++    GT
Sbjct: 107 SALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTT-FCGT 159

Query: 624 VGYAAPE 630
             Y APE
Sbjct: 160 PEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 58.0 bits (140), Expect = 3e-09
 Identities = 48/193 (24%), Positives = 86/193 (44%), Gaps = 34/193 (17%)

Query: 448 LIGTGSFGSVYKGILD---PDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVK- 502
           +IG G FG V  G L      +  VA+K L   +     + F++E   +    H N++  
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 503 --IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
             ++T              +V E+M +GSL+++L                + +Q + +  
Sbjct: 71  EGVVTKSKPV--------MIVTEYMENGSLDAFLRKHDGQ---------FTVIQLVGMLR 113

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI---PEVISSNQCSS 617
            +AS ++YL        VH DL   N+L++++++  V DFGL+R +   PE   + +   
Sbjct: 114 GIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR--- 167

Query: 618 VGLKGTVGYAAPE 630
            G K  + + APE
Sbjct: 168 -GGKIPIRWTAPE 179

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 58.4 bits (141), Expect = 3e-09
 Identities = 43/173 (24%), Positives = 81/173 (46%), Gaps = 25/173 (14%)

Query: 449 IGTGSFGSVY----KGILD------PDQT----VVAVKVLFLH-QRGALKSFMAECEALR 493
           +G G FG V+    +G+ +      P+      +VAVK+L     + A   F+ E + + 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 494 NIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSI--LS 551
            +++ N+++++  C S D        ++ E+M +G L  +L          ++ +I  +S
Sbjct: 73  RLKNPNIIRLLGVCVSDDPL-----CMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127

Query: 552 FLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
               L +A+ +AS ++YL        VH DL   N L+ N     + DFG++R
Sbjct: 128 IANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 58.3 bits (141), Expect = 4e-09
 Identities = 51/189 (26%), Positives = 84/189 (44%), Gaps = 25/189 (13%)

Query: 449 IGTGSFGSVYKGI---LDPDQTV--VAVKVLFLHQRGALK-SFMAECEALRNI-RHRNLV 501
           +G G+FG V +     L     V  VAVK+L      + + + M+E + + ++  H N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
            ++ AC+     G     ++ E+  +G L ++L  +  S         L+    L+ +  
Sbjct: 103 NLLGACTIG---GPIL--VITEYCCYGDLLNFLRRKRES--------FLTLEDLLSFSYQ 149

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           VA  + +L     K  +H DL   NVLL +  I  + DFGL R I     SN       +
Sbjct: 150 VAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN--DSNYVVKGNAR 204

Query: 622 GTVGYAAPE 630
             V + APE
Sbjct: 205 LPVKWMAPE 213

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 57.9 bits (140), Expect = 4e-09
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 44/201 (21%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--GALKSFMAECEALRNIRHRNLVKIITA 506
           IG G++G VYK         +A+K + L Q   G   + + E   L+ ++H N+V++   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL--- 66

Query: 507 CSSSDFQGNDFKA-LVYEFMHHGSLESWLHPESASDDLNYSPSIL-SFLQRLNIAINVAS 564
               D   ++ +  LV+E++    L+   H +S S D   +P ++ ++L +      +  
Sbjct: 67  ---QDVVHSEKRLYLVFEYL---DLDLKKHMDS-SPDFAKNPRLIKTYLYQ------ILR 113

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA-HVGDFGLTR--------FIPEVISSNQC 615
            + Y H H   +++H DLKP N+L+D    A  + DFGL R        F  EV+     
Sbjct: 114 GIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----- 165

Query: 616 SSVGLKGTVGYAAPEYGMGSQ 636
                  T+ Y APE  +GS+
Sbjct: 166 -------TLWYRAPEILLGSR 179

Length = 294

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 58.4 bits (141), Expect = 5e-09
 Identities = 77/239 (32%), Positives = 113/239 (47%), Gaps = 21/239 (8%)

Query: 100 SISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCT 159
           ++ N   L  LD   N L ++I E L  L NLT L     DL    + D+  L  L+   
Sbjct: 88  NLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSL-----DLDNNNITDIPPLIGLLKSN 141

Query: 160 YLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIR 219
            L+ + L+ N + S+P  +  LP L+ L L  N++S ++P  L N + L  L+L GN I 
Sbjct: 142 -LKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS 199

Query: 220 GSIPSALGNCHQLQSLDLSK-------TIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSI 272
             +P  +     L+ LDLS        +       +  L+LS+N L   +P ++GNL ++
Sbjct: 200 -DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNL 257

Query: 273 PHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSF--HGPIHPGLSSLKSLEGLDLFQNT 329
             LDLS N++S    SSLGS   L  L+LS NS     P+   L  L  L    L    
Sbjct: 258 ETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLK 314

Length = 394

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 57.3 bits (138), Expect = 7e-09
 Identities = 45/180 (25%), Positives = 82/180 (45%), Gaps = 32/180 (17%)

Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPD----QTVVAVKVLFLHQRGAL-----KSFM 486
           +LK T  F    ++G+G+FG+VYKG+  P+    +  VA+K L    R A      K  +
Sbjct: 3   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL----REATSPKANKEIL 57

Query: 487 AECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYS 546
            E   + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y 
Sbjct: 58  DEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQY- 110

Query: 547 PSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                    LN  + +A  + YL    ++++VH DL   NVL+       + DFGL + +
Sbjct: 111 --------LLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 57.3 bits (138), Expect = 7e-09
 Identities = 64/190 (33%), Positives = 85/190 (44%), Gaps = 32/190 (16%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL------KSFMAECEAL-RNIRHRNL 500
           +IG GSFG V       ++   AVKVL   Q+ A+      K  M+E   L +N++H  L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVL---QKKAILKKKEEKHIMSERNVLLKNVKHPFL 58

Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           V +        FQ  D    V ++++ G L   L  E            L    R   A 
Sbjct: 59  VGL-----HFSFQTADKLYFVLDYINGGELFYHLQRERC---------FLEPRARF-YAA 103

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +ASAL YLH      IV+ DLKP N+LLD+     + DFGL +   E I  N  +S   
Sbjct: 104 EIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTST-F 156

Query: 621 KGTVGYAAPE 630
            GT  Y APE
Sbjct: 157 CGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 57.7 bits (140), Expect = 7e-09
 Identities = 52/206 (25%), Positives = 84/206 (40%), Gaps = 55/206 (26%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF------LHQRGALKSFMAECEALRNIR 496
           + + + +G+G++G V           VA+K L       +H +   +    E   L+++ 
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR----ELRLLKHMD 72

Query: 497 HRNLVKII----TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSF 552
           H N++ ++     A S  DFQ  D   LV   M  G+            DLN   +I+  
Sbjct: 73  HENVIGLLDVFTPASSLEDFQ--DV-YLVTHLM--GA------------DLN---NIVKC 112

Query: 553 LQRLN------IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
            Q+L+      +   +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R  
Sbjct: 113 -QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR-- 166

Query: 607 PEVISSNQCSS--VGLKGTVGYAAPE 630
                         G   T  Y APE
Sbjct: 167 -------HTDDEMTGYVATRWYRAPE 185

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 57.1 bits (138), Expect = 8e-09
 Identities = 59/191 (30%), Positives = 91/191 (47%), Gaps = 33/191 (17%)

Query: 448 LIGTGSFGSVY--KGILDPDQ-TVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLV 501
           ++G GSFG V+  + I  PD   + A+KVL    L  R  +++ M E + L  + H  +V
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFIV 61

Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPES--ASDDLNYSPSILSFLQRLNIA 559
           K+  A     FQ      L+ +F+  G L + L  E     +D+ +  + L         
Sbjct: 62  KLHYA-----FQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL--------- 107

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
              A AL++LH      I++ DLKP N+LLD +    + DFGL++   E I   +  +  
Sbjct: 108 ---ALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEK-KAYS 157

Query: 620 LKGTVGYAAPE 630
             GTV Y APE
Sbjct: 158 FCGTVEYMAPE 168

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 57.0 bits (138), Expect = 8e-09
 Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 40/199 (20%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITA 506
           IG G++G VYKG       +VA+K + L   + G   + + E   L+ ++H N+V +   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL-SFLQRLNIAINVASA 565
                 Q +    L++EF+   S++   + +S          ++ S+L +      +   
Sbjct: 68  L----MQESRL-YLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQ------ILQG 113

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF--IP------EVISSNQCSS 617
           + + H     +++H DLKP N+L+DN  +  + DFGL R   IP      EV+       
Sbjct: 114 ILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV------- 163

Query: 618 VGLKGTVGYAAPEYGMGSQ 636
                T+ Y APE  +GS 
Sbjct: 164 -----TLWYRAPEVLLGSP 177

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 56.7 bits (137), Expect = 8e-09
 Identities = 50/189 (26%), Positives = 76/189 (40%), Gaps = 24/189 (12%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKIIT 505
           +G G FG V    +     + A K L    L +R   +  + E + L  +  R +V    
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIV---- 56

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
              +  F+  D   LV   M+ G L+  ++        N         + +  A  +   
Sbjct: 57  -SLAYAFETKDDLCLVMTLMNGGDLKYHIY--------NVGEPGFPEARAIFYAAQIICG 107

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG 625
           LE+LH   +++IV+ DLKP NVLLD+     + D GL   +            G  GT G
Sbjct: 108 LEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-----GKKIKGRAGTPG 159

Query: 626 YAAPEYGMG 634
           Y APE   G
Sbjct: 160 YMAPEVLQG 168

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 56.5 bits (137), Expect = 1e-08
 Identities = 53/208 (25%), Positives = 80/208 (38%), Gaps = 48/208 (23%)

Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALK-SFMAECEALRN 494
           L   TG F    +IG G++G VYK        +VA+K+  +      +     E   LR 
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKI--MDIIEDEEEEIKEEYNILRK 58

Query: 495 I-RHRNLVKIITACSSSDFQGNDFKA-LVYEFMHHGSLESWLHPESASDDLNYSPSILSF 552
              H N+     A    +  GND +  LV E    G         S +D +     +   
Sbjct: 59  YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGG---------SVTDLVK---GLRKK 106

Query: 553 LQRLN------IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG--DFGLTR 604
            +RL       I       L YLH +   +++H D+K  N+LL  +  A V   DFG++ 
Sbjct: 107 GKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKN--AEVKLVDFGVSA 161

Query: 605 -----------FI-------PEVISSNQ 614
                      FI       PEVI+ ++
Sbjct: 162 QLDSTLGRRNTFIGTPYWMAPEVIACDE 189

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 56.7 bits (137), Expect = 1e-08
 Identities = 51/197 (25%), Positives = 94/197 (47%), Gaps = 31/197 (15%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITAC 507
           +G G++ +VYKG       +VA+K + L  + G   + + E   ++ ++H N+V++    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL---- 63

Query: 508 SSSDFQGNDFK-ALVYEFMHHGSLESWL--HPESASDDLNYSPSILSFLQRLNIAINVAS 564
              D    + K  LV+E+M    L+ ++  H    + D N   ++ SF  +L        
Sbjct: 64  --HDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPN---TVKSFTYQL------LK 111

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF--IPEVISSNQCSSVGLKG 622
            + + H +   +++H DLKP N+L++      + DFGL R   IP    SN+        
Sbjct: 112 GIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV------ 162

Query: 623 TVGYAAPEYGMGSQVST 639
           T+ Y AP+  +GS+  +
Sbjct: 163 TLWYRAPDVLLGSRTYS 179

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 55/197 (27%), Positives = 94/197 (47%), Gaps = 24/197 (12%)

Query: 449 IGTGSFGSVYKGILDPDQ-TVVAVKVLFL--HQRGALKSFMAECEALRNIR---HRNLVK 502
           IG G++G+VYK   DP     VA+K + +  ++ G   S + E   L+ +    H N+V+
Sbjct: 8   IGVGAYGTVYKA-RDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++  C++S         LV+E +    L ++L  +        + +I   +++       
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYL--DKVPPPGLPAETIKDLMRQF------ 117

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
              L++LH +C   IVH DLKP N+L+ +     + DFGL R     I S Q +   +  
Sbjct: 118 LRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR-----IYSCQMALTPVVV 169

Query: 623 TVGYAAPEYGMGSQVST 639
           T+ Y APE  + S  +T
Sbjct: 170 TLWYRAPEVLLQSTYAT 186

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 48/190 (25%), Positives = 77/190 (40%), Gaps = 22/190 (11%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMA--ECEALRNIRHRNL 500
           F   N IG GSFG V+K +   D+ V A+K + L +    +   A  E   L  +    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           ++   +     F       +V E+  +G L   L               L   Q     I
Sbjct: 62  IRYYES-----FLDKGKLNIVMEYAENGDLHKLLK--------MQRGRPLPEDQVWRFFI 108

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L +LH    K+I+H D+K  N+ LD      +GD G+ +    ++S N   +  +
Sbjct: 109 QILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAK----LLSDNTNFANTI 161

Query: 621 KGTVGYAAPE 630
            GT  Y +PE
Sbjct: 162 VGTPYYLSPE 171

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 54/195 (27%), Positives = 87/195 (44%), Gaps = 36/195 (18%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F+    IG GSFG VYKGI +  + VVA+K++ L +        AE E + +I+    + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--------AEDE-IEDIQQE--IT 54

Query: 503 IITACSS---SDFQGNDFKA----LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           +++ C S   + + G+  K     ++ E++  GS    L P    +   Y  +IL     
Sbjct: 55  VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEE--TYIATILR---- 108

Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
                 +   L+YLH   K   +H D+K +NVLL       + DFG    +   ++  Q 
Sbjct: 109 -----EILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFG----VAGQLTDTQI 156

Query: 616 SSVGLKGTVGYAAPE 630
                 GT  + APE
Sbjct: 157 KRNTFVGTPFWMAPE 171

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 47/167 (28%), Positives = 77/167 (46%), Gaps = 29/167 (17%)

Query: 448 LIGTGSFGSVYKGILDPD----QTVVAVKVLFLHQR-GALKSFMAECEALRNIRHRNLVK 502
           ++G+G+FG+VYKGI  PD    +  VA+KVL  +    A K  + E   +  +    + +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPES---ASDDLNYSPSILSFLQRLNIA 559
           ++  C +S  Q      LV + M +G L  ++        S DL            LN  
Sbjct: 74  LLGICLTSTVQ------LVTQLMPYGCLLDYVRENKDRIGSQDL------------LNWC 115

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           + +A  + YL    + ++VH DL   NVL+ +     + DFGL R +
Sbjct: 116 VQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 41/145 (28%), Positives = 64/145 (44%), Gaps = 20/145 (13%)

Query: 467 TVVAVKVLFLHQR-----GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALV 521
            +VAVKVL    R      A + F+ E + L  +   N+ +++  C+           ++
Sbjct: 47  VLVAVKVL----RPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPL-----CMI 97

Query: 522 YEFMHHGSLESWL--HPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVH 579
            E+M +G L  +L  H    S     S S LSF   L +A  +AS + YL        VH
Sbjct: 98  MEYMENGDLNQFLQKHVAETSGLACNSKS-LSFSTLLYMATQIASGMRYLESL---NFVH 153

Query: 580 CDLKPSNVLLDNDMIAHVGDFGLTR 604
            DL   N L+  +    + DFG++R
Sbjct: 154 RDLATRNCLVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 51/199 (25%), Positives = 93/199 (46%), Gaps = 33/199 (16%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL------KSFMAECEALRNIR 496
           ++   ++G G++G+VY G+ +  Q ++AVK + L     L      +    E + L++++
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQ-LIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60

Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDL---NYSPSILSFL 553
           H N+V+ +  C       N   ++  EF+  GS+ S L+      +     Y+  IL   
Sbjct: 61  HVNIVQYLGTC----LDDNTI-SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD-- 113

Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
                       + YLH++C   +VH D+K +NV+L  + I  + DFG  R +  V    
Sbjct: 114 -----------GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159

Query: 614 QCSSV--GLKGTVGYAAPE 630
             S++   + GT  + APE
Sbjct: 160 THSNMLKSMHGTPYWMAPE 178

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 47/171 (27%), Positives = 76/171 (44%), Gaps = 23/171 (13%)

Query: 449 IGTGSFGSVYKGI---LDPDQT--VVAVKVLFLHQRGA---LKSFMAECEALRNI-RHRN 499
           +G G FG V       +D D+    V V V  L        L   ++E E ++ I +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHP------ESASDDLNYSPSILSFL 553
           ++ ++ AC+    Q      LV E+   G+L  +L        + + D        L+F 
Sbjct: 80  IINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134

Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
             ++ A  VA  +EYL     ++ +H DL   NVL+  D +  + DFGL R
Sbjct: 135 DLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 55.7 bits (135), Expect = 2e-08
 Identities = 50/193 (25%), Positives = 82/193 (42%), Gaps = 36/193 (18%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG------ALKSFMAECEALRNIRHRNL 500
           N I  G++G VY+        +VA+K L + +        +L+    E   L  ++H N+
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR----EINILLKLQHPNI 66

Query: 501 VKIITACSSSDFQGNDFKALVYEFMHH---GSLESWLHPESASDDLNYSPSILSFLQRLN 557
           V +      S+    D   +V E++ H     +E+   P   S+       +   + +L 
Sbjct: 67  VTVKEVVVGSNL---DKIYMVMEYVEHDLKSLMETMKQPFLQSE-------VKCLMLQL- 115

Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
                 S + +LH +    I+H DLK SN+LL+N  I  + DFGL R     +       
Sbjct: 116 -----LSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLV 167

Query: 618 VGLKGTVGYAAPE 630
           V    T+ Y APE
Sbjct: 168 V----TLWYRAPE 176

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 54/195 (27%), Positives = 85/195 (43%), Gaps = 36/195 (18%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F+    IG GSFG V+KGI +  Q VVA+K++ L +        AE E + +I+    + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AEDE-IEDIQQE--IT 54

Query: 503 IITACSSS---DFQGNDFKA----LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           +++ C S     + G+  K     ++ E++  G         SA D L   P      Q 
Sbjct: 55  VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGG---------SALDLLRAGP--FDEFQI 103

Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
             +   +   L+YLH   K   +H D+K +NVLL       + DFG    +   ++  Q 
Sbjct: 104 ATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFG----VAGQLTDTQI 156

Query: 616 SSVGLKGTVGYAAPE 630
                 GT  + APE
Sbjct: 157 KRNTFVGTPFWMAPE 171

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 50/187 (26%), Positives = 76/187 (40%), Gaps = 22/187 (11%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALK---SFMAECEALRNIRHRNLVKIIT 505
           IG G FG V  G      +   V V  L           F+ E +  R + H N+++ + 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
            C  S         LV EF   G L+++L              +L   QR+  A  VAS 
Sbjct: 63  QCIESIPY-----LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVL---QRM--ACEVASG 112

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL--TRFIPEVISSNQCSSVGLKGT 623
           L +LH   +   +H DL   N  L  D+   +GD+GL   ++  +   +  C +V L+  
Sbjct: 113 LLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR-- 167

Query: 624 VGYAAPE 630
             + APE
Sbjct: 168 --WLAPE 172

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 47/171 (27%), Positives = 71/171 (41%), Gaps = 39/171 (22%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSF---MAECEALRNIRHRN 499
           F+    IG GSFG+VY         VVA+K +    + + + +   + E   L+ +RH N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPE----SASD--DLNYSPSILSFL 553
            +              ++K   Y   H     +WL  E    SASD  +++  P     L
Sbjct: 77  TI--------------EYKG-CYLREH----TAWLVMEYCLGSASDILEVHKKP-----L 112

Query: 554 QRLNIAI---NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG 601
           Q + IA         L YLH H +   +H D+K  N+LL       + DFG
Sbjct: 113 QEVEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFG 160

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 55.5 bits (134), Expect = 3e-08
 Identities = 40/160 (25%), Positives = 66/160 (41%), Gaps = 20/160 (12%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           IG GS+G V+K        +VA+K     +   +  K  + E   L+ ++H NLV +I  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
                F+      LV+E+  H  L          ++L  +P  +       I      A+
Sbjct: 69  -----FRRKRKLHLVFEYCDHTVL----------NELEKNPRGVPEHLIKKIIWQTLQAV 113

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
            + H H     +H D+KP N+L+       + DFG  R +
Sbjct: 114 NFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARIL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 51/191 (26%), Positives = 90/191 (47%), Gaps = 29/191 (15%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVKIITAC 507
           +G G++ +V+KG     + +VA+K + L H+ GA  + + E   L+N++H N+V +    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTL---- 68

Query: 508 SSSDFQGNDFK-ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
              D    +    LV+E++              SD   Y  +  + +   N+ I +   L
Sbjct: 69  --HDIIHTERCLTLVFEYLD-------------SDLKQYLDNCGNLMSMHNVKIFMFQLL 113

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF--IPEVISSNQCSSVGLKGTV 624
             L +  K++I+H DLKP N+L++      + DFGL R   +P    SN+        T+
Sbjct: 114 RGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV------TL 167

Query: 625 GYAAPEYGMGS 635
            Y  P+  +GS
Sbjct: 168 WYRPPDVLLGS 178

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 27/199 (13%)

Query: 449 IGTGSFGSVYKGI-LDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIR---HRNLVK 502
           IG G++G V+K   L      VA+K + +   + G   S + E   LR++    H N+V+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLH--PESASDDLNYSPSILSFLQRLNIAI 560
           +   C+ S         LV+E +    L ++L   PE           +   L+      
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLR------ 121

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L++LH H   ++VH DLKP N+L+ +     + DFGL R     I S Q +   +
Sbjct: 122 ----GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR-----IYSFQMALTSV 169

Query: 621 KGTVGYAAPEYGMGSQVST 639
             T+ Y APE  + S  +T
Sbjct: 170 VVTLWYRAPEVLLQSSYAT 188

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 45/163 (27%), Positives = 74/163 (45%), Gaps = 15/163 (9%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G GS G V+  +       VAVK + L    ++K  + E + +R + H N+VK+     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDL----NYSPSILSFLQRLNIAINVAS 564
            S   G+D    V       S+  ++  E    DL       P +     RL     +  
Sbjct: 73  PS---GSDLTEDVGSLTELNSV--YIVQEYMETDLANVLEQGP-LSEEHARL-FMYQLLR 125

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLD-NDMIAHVGDFGLTRFI 606
            L+Y+H      ++H DLKP+NV ++  D++  +GDFGL R +
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIV 165

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 54.7 bits (131), Expect = 4e-08
 Identities = 54/195 (27%), Positives = 85/195 (43%), Gaps = 36/195 (18%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F+    IG GSFG V+KGI +  Q VVA+K++ L +        AE E + +I+    + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--------AEDE-IEDIQQE--IT 54

Query: 503 IITACSS---SDFQGNDFKA----LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           +++ C S   + + G+  K     ++ E++  GS    L P             L   Q 
Sbjct: 55  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----------LDETQI 103

Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
             I   +   L+YLH   K   +H D+K +NVLL       + DFG    +   ++  Q 
Sbjct: 104 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFG----VAGQLTDTQI 156

Query: 616 SSVGLKGTVGYAAPE 630
                 GT  + APE
Sbjct: 157 KRNTFVGTPFWMAPE 171

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 54.4 bits (131), Expect = 5e-08
 Identities = 46/191 (24%), Positives = 88/191 (46%), Gaps = 30/191 (15%)

Query: 448 LIGTGSFGSVYKGI-LDPDQTVVAVKVLF----LHQRGALKSFMAECEALRNIRHRNLVK 502
           L+G G+FG VY    +D  + +   +V F       +  + +   E + L+N++H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESA-SDDL--NYSPSILSFLQRLNIA 559
                     + ++  ++  E+M  GS++  L    A ++ +   Y+  IL         
Sbjct: 69  YYGC-----LRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE-------- 115

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
                 +EYLH +    IVH D+K +N+L D+     +GDFG ++ + + I S+      
Sbjct: 116 -----GVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICSSGTGMKS 166

Query: 620 LKGTVGYAAPE 630
           + GT  + +PE
Sbjct: 167 VTGTPYWMSPE 177

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 55.0 bits (133), Expect = 5e-08
 Identities = 54/196 (27%), Positives = 85/196 (43%), Gaps = 31/196 (15%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNL 500
           + + + IG G++G V      P    VA+K +  F HQ    ++ + E + LR  +H N+
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHENI 65

Query: 501 VKIITACSSSDFQGNDFKA--LVYEFMHHGSLESWLHPESASDDLNYSPSILSFL-QRLN 557
           + I+       F+   F    +V E M     E+ L+    +  L+    I  FL Q L 
Sbjct: 66  IGILDIIRPPSFE--SFNDVYIVQELM-----ETDLYKLIKTQHLSND-HIQYFLYQILR 117

Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
                   L+Y+H      ++H DLKPSN+LL+ +    + DFGL R    +       +
Sbjct: 118 -------GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLAR----IADPEHDHT 163

Query: 618 VGLKGTVG---YAAPE 630
             L   V    Y APE
Sbjct: 164 GFLTEYVATRWYRAPE 179

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 49/178 (27%), Positives = 83/178 (46%), Gaps = 25/178 (14%)

Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVLF-LHQRGALKSFMAECEALRNIRHRNLVK 502
           +G  +FG +YKG L     D  Q +VA+K L  ++       F  E   +  + H N+V 
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQ-LVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWL---HPES----ASDDLNYSPSILSFLQR 555
           ++   +           +++E+++ G L  +L    P S    +SD+     S L     
Sbjct: 72  LLGVVTQEQPV-----CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126

Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
           L+IAI +A+ +EYL  H     VH DL   N+L+   +   + D GL+R   E+ S++
Sbjct: 127 LHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSR---EIYSAD 178

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 54.5 bits (131), Expect = 5e-08
 Identities = 52/191 (27%), Positives = 78/191 (40%), Gaps = 21/191 (10%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKIIT 505
           +G G FG V    +     + A K L    L +R   +  M E   L  +  R +V +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
           A     FQ      LV   M+ G L   ++      +++         +       + S 
Sbjct: 61  A-----FQTKTDLCLVMTIMNGGDLRYHIY------NVDEENPGFPEPRACFYTAQIISG 109

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG 625
           LE+LH     +I++ DLKP NVLLDND    + D GL   + +     Q  + G  GT G
Sbjct: 110 LEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKD----GQSKTKGYAGTPG 162

Query: 626 YAAPEYGMGSQ 636
           + APE   G +
Sbjct: 163 FMAPELLQGEE 173

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 54.1 bits (130), Expect = 6e-08
 Identities = 56/192 (29%), Positives = 85/192 (44%), Gaps = 31/192 (16%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-KSFMAECEALRNIRHRNLVKIITAC 507
           +G G+ G+VYK      + ++AVKV+ L     L K  M+E E L       ++    A 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA- 67

Query: 508 SSSDFQGNDFKALVYEFMHHGSLES-WLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
               F   +  ++  EFM  GSL+     PE               L R  IA+ V   L
Sbjct: 68  ----FFVENRISICTEFMDGGSLDVYRKIPEHV-------------LGR--IAVAVVKGL 108

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            YL      +I+H D+KPSN+L++      + DFG++    ++++S   + V   GT  Y
Sbjct: 109 TYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYV---GTNAY 159

Query: 627 AAPEYGMGSQVS 638
            APE   G Q  
Sbjct: 160 MAPERISGEQYG 171

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 54.1 bits (130), Expect = 6e-08
 Identities = 44/176 (25%), Positives = 83/176 (47%), Gaps = 30/176 (17%)

Query: 449 IGTGSFGSVY----KGILD-----------PDQTV-VAVKVLFLH-QRGALKSFMAECEA 491
           +G G FG V+    +G+              +Q V VAVK+L     + A   F+ E + 
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 492 LRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWL---HPESASDDLNYSPS 548
           +  ++  N+++++  C +SD        ++ E+M +G L  +L    P+ A++  +   +
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPL-----CMITEYMENGDLNQFLSRHEPQEAAEKAD-VVT 126

Query: 549 ILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
           I S+   + +A  +AS ++YL        VH DL   N L+  +    + DFG++R
Sbjct: 127 I-SYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 53.6 bits (129), Expect = 9e-08
 Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 19/156 (12%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G+FG VYK          A K++ +     L+ FM E + L   +H N+V +  A  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 509 SSDFQGNDFKALVY-EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
                  + K  +  EF   G+L+S +       +L      L+  Q   +   +  AL 
Sbjct: 73  ------YENKLWILIEFCDGGALDSIM------LELE---RGLTEPQIRYVCRQMLEALN 117

Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT 603
           +LH H   +++H DLK  N+LL  D    + DFG++
Sbjct: 118 FLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 53.4 bits (128), Expect = 9e-08
 Identities = 56/186 (30%), Positives = 77/186 (41%), Gaps = 25/186 (13%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEA--LRNIRHRNLVKIITA 506
           +G GS+G V       D     +K L L      +   AE EA  L  ++H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY--- 64

Query: 507 CSSSDFQGND-FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
                ++G D    +V  F   G L   L  +           +L   Q +   + +A A
Sbjct: 65  --RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGK--------LLPENQVVEWFVQIAMA 114

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG-LKGTV 624
           L+YLH   +K I+H DLK  NV L    I  VGD G+ R +      NQC     L GT 
Sbjct: 115 LQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL-----ENQCDMASTLIGTP 166

Query: 625 GYAAPE 630
            Y +PE
Sbjct: 167 YYMSPE 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 54.1 bits (130), Expect = 9e-08
 Identities = 56/186 (30%), Positives = 82/186 (44%), Gaps = 24/186 (12%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKII 504
           ++G GSFG V    L     + AVKVL    + Q   ++  M E   L   R+   +  +
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C    FQ  D    V EF++ G L    H + +     +  +   F      A  + S
Sbjct: 62  YCC----FQTPDRLFFVMEFVNGGDL--MFHIQKSR---RFDEARARFY-----AAEITS 107

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
           AL +LH    K I++ DLK  NVLLD++    + DFG+ +   E I  N  ++    GT 
Sbjct: 108 ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGI-FNGKTTSTFCGTP 160

Query: 625 GYAAPE 630
            Y APE
Sbjct: 161 DYIAPE 166

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 53.8 bits (129), Expect = 9e-08
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 43/198 (21%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLV---KII 504
           +G GS+ +VYKGI   +  +VA+KV+ +  + G   + + E   L+ ++H N+V    II
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWL--HPESASDDLNYSPSILSFLQRLNIAINV 562
               +  F        V+E+MH   L  ++  HP        +  ++  F+ +L      
Sbjct: 73  HTKETLTF--------VFEYMH-TDLAQYMIQHPGGL-----HPYNVRLFMFQL------ 112

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG-----DFGLTRFIPEVISSNQCSS 617
              L Y+H    + I+H DLKP N+L     I+++G     DFGL R   + I S   SS
Sbjct: 113 LRGLAYIHG---QHILHRDLKPQNLL-----ISYLGELKLADFGLAR--AKSIPSQTYSS 162

Query: 618 VGLKGTVGYAAPEYGMGS 635
             +  T+ Y  P+  +G+
Sbjct: 163 EVV--TLWYRPPDVLLGA 178

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 45/169 (26%), Positives = 74/169 (43%), Gaps = 22/169 (13%)

Query: 449 IGTGSFGSVYKGIL------DPDQTVVAVKVLFLHQRGALKS-FMAECEALRNIRHRNLV 501
           +G   FG VYKG L      +  Q V A+K L     G L+  F  E      ++H N+V
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAV-AIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWL---HPES---ASDDLNYSPSILSFLQR 555
            ++   +          ++++ +  H  L  +L    P S   ++DD     S L     
Sbjct: 72  CLLGVVTK-----EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF 126

Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
           ++I   +A+ +E+L  H    +VH DL   NVL+ + +   + D GL R
Sbjct: 127 VHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 53.4 bits (129), Expect = 1e-07
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 52/203 (25%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F+    IG GSFG VYK I      VVA+KV+ L +        AE + + +I+    ++
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--------AE-DEIEDIQQE--IQ 51

Query: 503 IITACSSS---DFQG---NDFK-ALVYEFMHHGSLESWLHPESASDDLNYSP---SILSF 552
            ++ C S     + G      K  ++ E+   G         S  D L       + ++F
Sbjct: 52  FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGG---------SCLDLLKPGKLDETYIAF 102

Query: 553 LQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISS 612
           + R      V   LEYLH   ++  +H D+K +N+LL  +    + DFG+         S
Sbjct: 103 ILR-----EVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGV---------S 145

Query: 613 NQCSSVGLK-----GTVGYAAPE 630
            Q +S   K     GT  + APE
Sbjct: 146 GQLTSTMSKRNTFVGTPFWMAPE 168

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 51/196 (26%), Positives = 85/196 (43%), Gaps = 39/196 (19%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLV---KII 504
           +G GS+ +VYKG       +VA+K + L H+ GA  + + E   L++++H N+V    II
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI---N 561
               +          LV+E++              +D   Y       L   N+ +    
Sbjct: 73  HTKKT--------LTLVFEYLD-------------TDLKQYMDDCGGGLSMHNVRLFLFQ 111

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF--IPEVISSNQCSSVG 619
           +   L Y H    ++++H DLKP N+L+       + DFGL R   +P    SN+     
Sbjct: 112 LLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--- 165

Query: 620 LKGTVGYAAPEYGMGS 635
              T+ Y  P+  +GS
Sbjct: 166 ---TLWYRPPDVLLGS 178

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 41/209 (19%)

Query: 432 SYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR-GALKSFMAECE 490
           SYE L K          +G GS+ +VYKG    +  +VA+KV+ L +  G   + + E  
Sbjct: 6   SYEKLEK----------LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREAS 55

Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWL--HPESASDDLNYSPS 548
            L+ ++H N+V +            +   LV+E++H   L  ++  HP     +     +
Sbjct: 56  LLKGLKHANIVLL-----HDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPE-----N 104

Query: 549 ILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF--I 606
           +  FL +L         L Y+H   ++ I+H DLKP N+L+ +     + DFGL R   +
Sbjct: 105 VKLFLFQL------LRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSV 155

Query: 607 PEVISSNQCSSVGLKGTVGYAAPEYGMGS 635
           P    SN+        T+ Y  P+  +GS
Sbjct: 156 PSHTYSNEVV------TLWYRPPDVLLGS 178

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 51/191 (26%), Positives = 80/191 (41%), Gaps = 24/191 (12%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           F    ++G G FG V    +     + A K L    + +R      + E + L  +  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           +V +  A     ++  D   LV   M+ G L+  ++      +  +      F      A
Sbjct: 62  VVSLAYA-----YETKDALCLVLTLMNGGDLKFHIY---HMGEAGFEEGRAVFY-----A 108

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             +   LE LH   +++IV+ DLKP N+LLD+     + D GL   +PE  +       G
Sbjct: 109 AEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK-----G 160

Query: 620 LKGTVGYAAPE 630
             GTVGY APE
Sbjct: 161 RVGTVGYMAPE 171

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 27/57 (47%), Positives = 34/57 (59%)

Query: 88  LAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTR 144
           L+GN   GNIP S+ + + LE LD + NS   SIPE LG+L +L  LN   N L  R
Sbjct: 449 LSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGR 505

Length = 623

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 29/221 (13%)

Query: 46  NLTHCSELRTLDLVLNKLEENQL-----------------VGELPPYIGFTLPNIRIPLL 88
           NL +   L +LDL LN+L  N                   + ++PP IG    N++   L
Sbjct: 88  NLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDL 147

Query: 89  AGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVND 148
           + N+   ++P  + N   L+ LD + N L+  +P+ L  L NL  L+ + N +    +  
Sbjct: 148 SDNKI-ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI--SDLPP 203

Query: 149 LRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFL 208
              L S      LE + L+ NS+  +  S+  L  L  L L  N +  ++P S+GN + L
Sbjct: 204 EIELLSA-----LEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNL 257

Query: 209 TELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVR 249
             L+L  N I  S  S+LG+   L+ LDLS        P+ 
Sbjct: 258 ETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLSNALPLI 296

Length = 394

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 50/191 (26%), Positives = 91/191 (47%), Gaps = 29/191 (15%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVKIITAC 507
           +G G++ +V+KG     + +VA+K + L H+ GA  + + E   L++++H N+V +    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL---- 69

Query: 508 SSSDFQGNDFK-ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
              D    D    LV+E++    L+ ++      DD     +I+S          +   L
Sbjct: 70  --HDIVHTDKSLTLVFEYLDK-DLKQYM------DDCG---NIMSMHNVKIFLYQILRGL 117

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF--IPEVISSNQCSSVGLKGTV 624
            Y H   +++++H DLKP N+L++      + DFGL R   +P    SN+        T+
Sbjct: 118 AYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV------TL 168

Query: 625 GYAAPEYGMGS 635
            Y  P+  +GS
Sbjct: 169 WYRPPDVLLGS 179

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 51/206 (24%), Positives = 86/206 (41%), Gaps = 37/206 (17%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVK-VLFLH-----QRGALKSFMAECEALRNIRHRNLV 501
            +GTG+F S Y+       T++AVK V ++      Q   +++   E   +  + H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 502 KIITA-CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA- 559
           +++ A C  S F       L  E+M  GS+   L          Y      F + + I  
Sbjct: 67  RMLGATCEDSHFN------LFVEWMAGGSVSHLLS--------KYGA----FKEAVIINY 108

Query: 560 -INVASALEYLHHHCKKQIVHCDLKPSNVLLDND-MIAHVGDFGLTRFIPEVISSNQCSS 617
              +   L YLH   + QI+H D+K +N+L+D+      + DFG    +    +      
Sbjct: 109 TEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQ 165

Query: 618 VGLKGTVGYAAPE------YGMGSQV 637
             L GT+ + APE      YG    V
Sbjct: 166 GQLLGTIAFMAPEVLRGEQYGRSCDV 191

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 51/190 (26%), Positives = 88/190 (46%), Gaps = 27/190 (14%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVKIITAC 507
           +G G++ +VYKG       +VA+K + L H+ GA  + + E   L++++H N+V +    
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL---- 69

Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
                       LV+E++    L+ +L  +   + +N     L   Q L         L 
Sbjct: 70  -HDIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNSINMHNVKLFLFQLLR-------GLN 118

Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF--IPEVISSNQCSSVGLKGTVG 625
           Y H   +++++H DLKP N+L++      + DFGL R   IP    SN+        T+ 
Sbjct: 119 YCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV------TLW 169

Query: 626 YAAPEYGMGS 635
           Y  P+  +GS
Sbjct: 170 YRPPDILLGS 179

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 25/197 (12%)

Query: 449 IGTGSFGSVYK----GI-LDPDQTVVAVKVLFLHQRGA---LKSFMAECEALRNI-RHRN 499
           +G G FG V      GI  D  +  V V V  L        L   ++E E ++ I +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESA-----SDDLNYSP-SILSFL 553
           ++ ++ AC+    Q      +V E+   G+L  +L          S D+   P   ++F 
Sbjct: 83  IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137

Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
             ++    VA  +EYL     ++ +H DL   NVL+  + +  + DFGL R +  +    
Sbjct: 138 DLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYK 194

Query: 614 QCSSVGLKGTVGYAAPE 630
           + ++  L   V + APE
Sbjct: 195 KTTNGRLP--VKWMAPE 209

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 49/215 (22%), Positives = 78/215 (36%), Gaps = 60/215 (27%)

Query: 449 IGTGSFGSVYKGILD--PDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKI 503
           IG G++G VYK       D    A+K          G  +S   E   LR ++H N+V  
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS- 66

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDL-----NYSPSILSFLQRL-- 556
                           LV  F+ H     +L  + A  DL      +  +    +     
Sbjct: 67  ----------------LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMV 110

Query: 557 -NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH----VGDFGLTRFI----- 606
            ++   + + + YLH      ++H DLKP+N+L+  +        +GD GL R       
Sbjct: 111 KSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167

Query: 607 ------PEVISSNQCSSVGLKGTVGYAAPEYGMGS 635
                 P V+            T+ Y APE  +G+
Sbjct: 168 PLADLDPVVV------------TIWYRAPELLLGA 190

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 57/189 (30%), Positives = 78/189 (41%), Gaps = 31/189 (16%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKII 504
           L+G G+FG V            A+K+L    +  +  +   + E   L+N RH      +
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRH----PFL 57

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESA-SDDLN--YSPSILSFLQRLNIAIN 561
           TA   S FQ +D    V E+ + G L   L  E   S+D    Y   I+S          
Sbjct: 58  TALKYS-FQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS---------- 106

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
              AL YLH      +V+ DLK  N++LD D    + DFGL +   E IS          
Sbjct: 107 ---ALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKT-FC 156

Query: 622 GTVGYAAPE 630
           GT  Y APE
Sbjct: 157 GTPEYLAPE 165

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 54/165 (32%), Positives = 75/165 (45%), Gaps = 28/165 (16%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKI- 503
           +IG GS+G V   I       VA+K +   F H   A +  + E + LR +RH ++V+I 
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR-ILREIKLLRLLRHPDIVEIK 65

Query: 504 -ITACSSSDFQGNDFKAL--VYEFMHHGSLESWLHPE-SASDDLNYSPSILSFLQRLNIA 559
            I    S      +FK +  V+E M     ES LH    A+DDL          Q L   
Sbjct: 66  HIMLPPSR----REFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLR-- 114

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
                AL+Y+H      + H DLKP N+L + D    + DFGL R
Sbjct: 115 -----ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 45/162 (27%), Positives = 64/162 (39%), Gaps = 31/162 (19%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G+FG VYK        + A KV+       L+ +M E E L    H  +VK++ A  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA-- 77

Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLH----PESASDDLNYSPSILSF---LQRLNIAIN 561
                          F   G L  W+     P  A D +     +L     L    I + 
Sbjct: 78  ---------------FYWDGKL--WIMIEFCPGGAVDAI-----MLELDRGLTEPQIQVI 115

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT 603
               LE L +    +I+H DLK  NVLL  D    + DFG++
Sbjct: 116 CRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVS 157

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 51.9 bits (124), Expect = 4e-07
 Identities = 52/191 (27%), Positives = 78/191 (40%), Gaps = 24/191 (12%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           F    ++G G FG V    +     + A K L    + +R      + E + L  +  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           +V +  A     ++  D   LV   M+ G L+  ++        N         + L  A
Sbjct: 62  VVNLAYA-----YETKDALCLVLTIMNGGDLKFHIY--------NMGNPGFEEERALFYA 108

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             +   LE LH   ++  V+ DLKP N+LLD+     + D GL   IPE  S       G
Sbjct: 109 AEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR-----G 160

Query: 620 LKGTVGYAAPE 630
             GTVGY APE
Sbjct: 161 RVGTVGYMAPE 171

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 51.2 bits (122), Expect = 6e-07
 Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 19/156 (12%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G+FG VYK        + A KV+       L+ +M E + L +  H N+VK++ A  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF- 71

Query: 509 SSDFQGNDFKALVYEFMHHGSLES-WLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
              +  N+   L+ EF   G++++  L  E            L+  Q   +      AL 
Sbjct: 72  ---YYENNLWILI-EFCAGGAVDAVMLELERP----------LTEPQIRVVCKQTLEALN 117

Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT 603
           YLH   + +I+H DLK  N+L   D    + DFG++
Sbjct: 118 YLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 50.9 bits (122), Expect = 6e-07
 Identities = 51/194 (26%), Positives = 75/194 (38%), Gaps = 38/194 (19%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           I  G+FGSVY           A+KVL        KS M     + N++    + +I   S
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVL-------KKSDMIAKNQVTNVKAERAIMMIQGES 56

Query: 509 SS------DFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
                    FQ  D+  LV E+++ G   S +        L   P   +          V
Sbjct: 57  PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKT------LGGLPEDWA----KQYIAEV 106

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR--FIPEVISSNQCSSVGL 620
              +E LH   ++ I+H D+KP N+L+D      + DFGL+R     +            
Sbjct: 107 VLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV--------- 154

Query: 621 KGTVGYAAPEYGMG 634
            GT  Y APE  +G
Sbjct: 155 -GTPDYLAPETILG 167

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 50.9 bits (122), Expect = 7e-07
 Identities = 49/198 (24%), Positives = 80/198 (40%), Gaps = 37/198 (18%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLH---------QRGALKSFMAECEALRNIRHR 498
           LIG G++G+VY+G   P   VVA+K++ L          QR        E   L  +R  
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQR--------EVALLSQLRQS 59

Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
                IT    S  +G     ++ E+   GS+ + +       +   S  I   L     
Sbjct: 60  Q-PPNITKYYGSYLKGPRL-WIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLV---- 112

Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
                 AL+Y+H   K  ++H D+K +N+L+ N     + DFG    +  +++ N     
Sbjct: 113 ------ALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFG----VAALLNQNSSKRS 159

Query: 619 GLKGTVGYAAPEYGMGSQ 636
              GT  + APE     +
Sbjct: 160 TFVGTPYWMAPEVITEGK 177

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 51.2 bits (122), Expect = 7e-07
 Identities = 55/189 (29%), Positives = 83/189 (43%), Gaps = 31/189 (16%)

Query: 448 LIGTGSFGSVYKGILDPDQTV---VAVKVL---FLHQRGALKSFMAECEALRNIRHRNLV 501
           L+G G+FG V   IL  ++      A+K+L    +  +  +   + E   L+N RH  L 
Sbjct: 2   LLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58

Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
            +  A     FQ +D    V E+ + G L   L  E       ++     F         
Sbjct: 59  ALKYA-----FQTHDRLCFVMEYANGGELFFHLSRERV-----FTEERARFY-----GAE 103

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           + SALEYLH    + +V+ D+K  N++LD D    + DFGL +   E I S+  +     
Sbjct: 104 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGI-SDGATMKTFC 156

Query: 622 GTVGYAAPE 630
           GT  Y APE
Sbjct: 157 GTPEYLAPE 165

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 51.2 bits (123), Expect = 7e-07
 Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 31/165 (18%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVK-------VLFLHQRGALKSFMAECEALRNIRHRNLV 501
           IG+G++G V   I       VA+K       V  L +R      + E + LR+ +H N++
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRT-----LRELKILRHFKHDNII 67

Query: 502 KIITACSSSDFQGNDFKA--LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
            I          G DFK   +V + M     ES LH    SD       I  FL +L   
Sbjct: 68  AIRDILRPP---GADFKDVYVVMDLM-----ESDLHHIIHSDQPLTEEHIRYFLYQL--- 116

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
                 L+Y+H      ++H DLKPSN+L++ D    +GDFG+ R
Sbjct: 117 ---LRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 50.8 bits (122), Expect = 8e-07
 Identities = 54/205 (26%), Positives = 80/205 (39%), Gaps = 45/205 (21%)

Query: 443 FSSANL-----IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG-ALKSFMAECEALRNIR 496
           F++ +L     IG G+FG+V K +  P  T++AVK +         K  + + + +  +R
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV--MR 58

Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPE--SASDDLNYSPSILSFLQ 554
             +   I+       F G  F          G  + W+  E    S D  Y         
Sbjct: 59  SSDCPYIVK------FYGALF--------REG--DCWICMELMDISLDKFYKYVYEVLKS 102

Query: 555 RLN------IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
            +       IA+    AL YL    K  I+H D+KPSN+LLD +    + DFG       
Sbjct: 103 VIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFG------- 153

Query: 609 VISSNQCSSVGLKGTVG---YAAPE 630
            IS     S+      G   Y APE
Sbjct: 154 -ISGQLVDSIAKTRDAGCRPYMAPE 177

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 52.1 bits (125), Expect = 8e-07
 Identities = 58/222 (26%), Positives = 87/222 (39%), Gaps = 52/222 (23%)

Query: 448 LIGTGSFGSVYKGILDPD-QTVVAVKVL--------FLHQRGALKSFMAECEALRNIRHR 498
           LIG G  G VY    DP     VA+K +         L +R     F+ E +   ++ H 
Sbjct: 9   LIGKGGMGEVYLA-YDPVCSRRVALKKIREDLSENPLLKKR-----FLREAKIAADLIHP 62

Query: 499 NLVKIITACSSSD--------FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            +V + + CS  D         +G   K+L         L+S    ES S +L    S+ 
Sbjct: 63  GIVPVYSICSDGDPVYYTMPYIEGYTLKSL---------LKSVWQKESLSKELAEKTSVG 113

Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI---- 606
           +FL    I   + + +EY+H    K ++H DLKP N+LL       + D+G   F     
Sbjct: 114 AFLS---IFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEE 167

Query: 607 ----------PEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS 638
                       +  S+      + GT  Y APE  +G   S
Sbjct: 168 EDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS 209

Length = 932

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 50.7 bits (121), Expect = 8e-07
 Identities = 51/190 (26%), Positives = 87/190 (45%), Gaps = 30/190 (15%)

Query: 448 LIGTGSFGSVYKGILD-PDQTVVAVKVLFLHQRGALK---SFMAECEALRNIRHRNLVK- 502
           ++GTG FG + +G L  P +  + V +  L    + K    F+AE   L    H N+V+ 
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 503 --IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
             +IT       +GN    +V E+M +G+L+S+L               L   Q + +  
Sbjct: 72  EGVIT-------RGNTM-MIVTEYMSNGALDSFLRKHEGQ---------LVAGQLMGMLP 114

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +AS ++YL    +   VH  L    VL+++D++  +  F   R + E  S    +++  
Sbjct: 115 GLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSEAIYTTMSG 168

Query: 621 KGTVGYAAPE 630
           K  V +AAPE
Sbjct: 169 KSPVLWAAPE 178

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 48/196 (24%), Positives = 89/196 (45%), Gaps = 25/196 (12%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIRHRNL 500
           F    ++G G++G V K      + +VA+K     +      ++ + E + LR ++  N+
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62

Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWL-HPESASDDLNYSPSILSFLQRLNIA 559
           V++  A     F+      LV+E++    LE     P     +      + S++ +L  A
Sbjct: 63  VELKEA-----FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE-----KVRSYIYQLIKA 112

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
           I+      + H   K  IVH D+KP N+L+ ++ +  + DFG  R + E  ++N    V 
Sbjct: 113 IH------WCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV- 162

Query: 620 LKGTVGYAAPEYGMGS 635
              T  Y +PE  +G+
Sbjct: 163 --ATRWYRSPELLLGA 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 51/195 (26%), Positives = 86/195 (44%), Gaps = 34/195 (17%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           ++S   +G+G++GSV   I       VA+K L   F  +  A +++  E   L++++H N
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHEN 75

Query: 500 LVKII----TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           ++ ++    +A S  +FQ  DF  LV  +M    L+  +    + D + Y          
Sbjct: 76  VIGLLDVFTSAVSGDEFQ--DF-YLVMPYMQ-TDLQKIMGHPLSEDKVQY---------- 121

Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
             +   +   L+Y+H      I+H DLKP N+ ++ D    + DFGL R           
Sbjct: 122 --LVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------HADA 169

Query: 616 SSVGLKGTVGYAAPE 630
              G   T  Y APE
Sbjct: 170 EMTGYVVTRWYRAPE 184

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 51/219 (23%), Positives = 88/219 (40%), Gaps = 37/219 (16%)

Query: 417 TSSESSSRKDLLLNVSYESLLKATG--GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVL 474
           ++SES    D  L  + +   +     G++    +  GS G V+          V +K+ 
Sbjct: 40  SASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKI- 98

Query: 475 FLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWL 534
              Q+G     + E   L+N+ H +++++                LV      G++   +
Sbjct: 99  --GQKGTT---LIEAMLLQNVNHPSVIRMK-------------DTLVS-----GAITCMV 135

Query: 535 HPESASDDLNY---SPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN 591
            P  +SD   Y       L   Q L I   +   L YLH     +I+H D+K  N+ +++
Sbjct: 136 LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFIND 192

Query: 592 DMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPE 630
                +GD G  +F   V++      +GL GTV   APE
Sbjct: 193 VDQVCIGDLGAAQF--PVVAPA---FLGLAGTVETNAPE 226

Length = 357

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 48/192 (25%), Positives = 82/192 (42%), Gaps = 24/192 (12%)

Query: 442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHR 498
            F     +G GS+GSVYK     D    A+K +    + Q+    + + E   L ++ H 
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDA-VNEIRILASVNHP 59

Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           N++        +   GN    +V E+   G L   +        L     I        I
Sbjct: 60  NIISY----KEAFLDGNKL-CIVMEYAPFGDLSKAISKRKKKRKLIPEQEI------WRI 108

Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
            I +   L+ LH   +++I+H DLK +N+LL  + +  +GD G+++ + + ++  Q    
Sbjct: 109 FIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI--- 162

Query: 619 GLKGTVGYAAPE 630
              GT  Y APE
Sbjct: 163 ---GTPHYMAPE 171

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 48/186 (25%), Positives = 81/186 (43%), Gaps = 24/186 (12%)

Query: 449 IGTGSFGSVYKGILDPDQT--VVAVKVLFLHQRG-ALK-SFMAECEALRNIRHRNLVKII 504
           +G+G+FG+V KG+    ++   VAVK+L       ALK   + E   ++ + +  +V++I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C +  +       LV E    G L  +L       + N +           +   V+ 
Sbjct: 63  GICEAESWM------LVMELAELGPLNKFLQKNKHVTEKNIT----------ELVHQVSM 106

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            ++YL        VH DL   NVLL     A + DFGL++ +    +  +  + G K  V
Sbjct: 107 GMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG-KWPV 162

Query: 625 GYAAPE 630
            + APE
Sbjct: 163 KWYAPE 168

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 50.1 bits (120), Expect = 2e-06
 Identities = 47/160 (29%), Positives = 68/160 (42%), Gaps = 25/160 (15%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAE---CEALRNIRHRNLVK 502
           +G G FG V          + A+K L    +  R  ++S M E    E   + RH  LV 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +  AC    FQ  D    V E+   G L   +H +           + S  + +  A  V
Sbjct: 67  LF-AC----FQTEDHVCFVMEYAAGGDLMMHIHTD-----------VFSEPRAVFYAACV 110

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL 602
              L+YLH +   +IV+ DLK  N+LLD +    + DFGL
Sbjct: 111 VLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL 147

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 54/193 (27%), Positives = 88/193 (45%), Gaps = 28/193 (14%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-KSFMAECEALRNIRHRNLVKIITAC 507
           +G G+ GSV K    P  TV+A KV+ +  + ++ K  + E + +   R   +V    A 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA- 71

Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F   +   +  EFM  GSL+               P  +  L +  IA+ V   L 
Sbjct: 72  ----FLNENNICMCMEFMDCGSLDRIYK--------KGGPIPVEILGK--IAVAVVEGLT 117

Query: 568 YLH--HHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG 625
           YL+  H     I+H D+KPSN+L+++     + DFG++    E+I+S   + V   GT  
Sbjct: 118 YLYNVHR----IMHRDIKPSNILVNSRGQIKLCDFGVS---GELINSIADTFV---GTST 167

Query: 626 YAAPEYGMGSQVS 638
           Y +PE   G + +
Sbjct: 168 YMSPERIQGGKYT 180

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 51/182 (28%), Positives = 80/182 (43%), Gaps = 23/182 (12%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG G+ G+VY  I       VA+K + L Q+   +  + E   +R  +H N+V  +    
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYL---- 82

Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
            S   G++   +V E++  GSL   +  E+  D+   +      LQ          ALE+
Sbjct: 83  DSYLVGDEL-WVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQ----------ALEF 130

Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           LH     Q++H D+K  N+LL  D    + DFG        I+  Q     + GT  + A
Sbjct: 131 LH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSTMVGTPYWMA 183

Query: 629 PE 630
           PE
Sbjct: 184 PE 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 59/210 (28%), Positives = 86/210 (40%), Gaps = 39/210 (18%)

Query: 434 ESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALR 493
           ESL   T  +     IG G++G VYK     D ++ AVK+L       +     E EA  
Sbjct: 15  ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL-----DPISDVDEEIEAEY 69

Query: 494 NI-----RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPS 548
           NI      H N+VK       +D        LV E  + GS+   +              
Sbjct: 70  NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVK------------G 117

Query: 549 ILSFLQRLN---IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF 605
           +L   QRL+   I+  +  AL  L H    +I+H D+K +N+LL  +    + DFG+   
Sbjct: 118 LLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV--- 174

Query: 606 IPEVISSNQCSSVGLK-----GTVGYAAPE 630
                 S Q +S  L+     GT  + APE
Sbjct: 175 ------SAQLTSTRLRRNTSVGTPFWMAPE 198

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 37/148 (25%), Positives = 66/148 (44%), Gaps = 24/148 (16%)

Query: 449 IGTGSFGSVYKGI-------LDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLV 501
           +G G+F  ++KGI        +  +T V +KVL    R   +SF      +  + H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
                C        D   +V E++  GSL+++L             ++++   +L +A  
Sbjct: 63  LNYGVC-----VCGDESIMVQEYVKFGSLDTYLKKNK---------NLINISWKLEVAKQ 108

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLL 589
           +A AL +L     K + H ++   NVLL
Sbjct: 109 LAWALHFLE---DKGLTHGNVCAKNVLL 133

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 50.2 bits (120), Expect = 3e-06
 Identities = 31/106 (29%), Positives = 57/106 (53%), Gaps = 7/106 (6%)

Query: 35  NSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFF 94
           ++  L+G IP +++    L++++L       N + G +PP +G ++ ++ +  L+ N F 
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINL-----SGNSIRGNIPPSLG-SITSLEVLDLSYNSFN 479

Query: 95  GNIPHSISNASKLEWLDFANNSLTASIPEDLG-RLRNLTRLNFARN 139
           G+IP S+   + L  L+   NSL+  +P  LG RL +    NF  N
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525

Length = 623

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 49.3 bits (118), Expect = 3e-06
 Identities = 52/189 (27%), Positives = 81/189 (42%), Gaps = 30/189 (15%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNI-RHRNLVKI 503
           ++G GSFG V    L     + AVKVL    + Q   ++  M E   L    +H  L ++
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
             +C    FQ  D    V E+++ G L   +          +      F      A  + 
Sbjct: 62  H-SC----FQTKDRLFFVMEYVNGGDLMFHIQ-----RSGRFDEPRARFY-----AAEIV 106

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR--FIPEVISSNQCSSVGLK 621
             L++LH   ++ I++ DLK  NVLLD++    + DFG+ +   +  V +S  C      
Sbjct: 107 LGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC------ 157

Query: 622 GTVGYAAPE 630
           GT  Y APE
Sbjct: 158 GTPDYIAPE 166

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 56/191 (29%), Positives = 84/191 (43%), Gaps = 34/191 (17%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG G+FG VY+      + + A+KVL      + K  +A+ E    I  RN++ + T   
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERNIL-VRTLLD 53

Query: 509 SS--------DFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
            S         FQ +    LV ++M  G L   L  E    +            R    I
Sbjct: 54  ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE-----------DRAKFYI 102

Query: 561 -NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             +  ALE+LH +    IV+ DLKP N+LLD      + DFGL++     ++ N+ ++  
Sbjct: 103 AELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK---ANLTDNKTTNT- 155

Query: 620 LKGTVGYAAPE 630
             GT  Y APE
Sbjct: 156 FCGTTEYLAPE 166

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 49.1 bits (117), Expect = 3e-06
 Identities = 30/72 (41%), Positives = 39/72 (54%), Gaps = 8/72 (11%)

Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
           A  +   LE LH   +++IV+ DLKP N+LLD+     + D GL   IPE     +    
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE----GETIR- 159

Query: 619 GLKGTVGYAAPE 630
           G  GTVGY APE
Sbjct: 160 GRVGTVGYMAPE 171

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 49.9 bits (119), Expect = 4e-06
 Identities = 49/167 (29%), Positives = 74/167 (44%), Gaps = 37/167 (22%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNIRHRNLVKIIT 505
           I  G+FG VY G    +  + AVKV+    +  +  +    AE +AL             
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDAL------------- 58

Query: 506 ACSSSDF--------QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLN 557
           A S S F        Q  +   LV E++  G ++S LH     D+       + ++    
Sbjct: 59  ALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE----EMAVKYISE-- 112

Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
               VA AL+YLH H    I+H DLKP N+L+ N+    + DFGL++
Sbjct: 113 ----VALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 49.0 bits (117), Expect = 4e-06
 Identities = 45/213 (21%), Positives = 80/213 (37%), Gaps = 43/213 (20%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ----RGALKSFMAEC----------EAL 492
             +G G++G V K        +VA+K + + +        +  +  C          + +
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 493 RNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSF 552
             I+H N++ ++       +   DF  LV + M    L+  +               L+ 
Sbjct: 75  NEIKHENIMGLVDV-----YVEGDFINLVMDIMA-SDLKKVVD----------RKIRLTE 118

Query: 553 LQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISS 612
            Q   I + + + L  LH   K   +H DL P+N+ +++  I  + DFGL R       S
Sbjct: 119 SQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175

Query: 613 NQCSSVGLKG----------TVGYAAPEYGMGS 635
           +  S                T+ Y APE  MG+
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGA 208

Length = 335

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 48.6 bits (116), Expect = 4e-06
 Identities = 42/158 (26%), Positives = 77/158 (48%), Gaps = 20/158 (12%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITA 506
           IG G++G+V+K        +VA+K + L     G   S + E   L+ ++H+N+V++   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
             S     +    LV+E+     L+ +   +S + D++    + SF+ +L         L
Sbjct: 68  LHS-----DKKLTLVFEYCDQ-DLKKYF--DSCNGDID-PEIVKSFMFQL------LKGL 112

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
            + H H    ++H DLKP N+L++ +    + DFGL R
Sbjct: 113 AFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 48.5 bits (115), Expect = 5e-06
 Identities = 53/186 (28%), Positives = 78/186 (41%), Gaps = 25/186 (13%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKII 504
           L+G G+FG V            A+K+L    +  +  +   + E   L+N RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
                  FQ  D    V E+++ G L   L  E       +S     F         + S
Sbjct: 61  ----KYSFQTKDRLCFVMEYVNGGELFFHLSRERV-----FSEDRTRFY-----GAEIVS 106

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
           AL+YLH     +IV+ DLK  N++LD D    + DFGL +   E I ++  +     GT 
Sbjct: 107 ALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK---EGI-TDAATMKTFCGTP 159

Query: 625 GYAAPE 630
            Y APE
Sbjct: 160 EYLAPE 165

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 48.5 bits (115), Expect = 5e-06
 Identities = 57/189 (30%), Positives = 84/189 (44%), Gaps = 30/189 (15%)

Query: 448 LIGTGSFGSVYKGILDPDQTV---VAVKVL---FLHQRGALKSFMAECEALRNIRHRNLV 501
           L+G G+FG V   IL  ++      A+K+L    +  +  +   + E   L+N RH    
Sbjct: 2   LLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH---- 54

Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
             +TA   S FQ +D    V E+ + G L  + H    S +  +S     F         
Sbjct: 55  PFLTALKYS-FQTHDRLCFVMEYANGGEL--FFH---LSRERVFSEDRARFY-----GAE 103

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           + SAL+YLH   +K +V+ DLK  N++LD D    + DFGL +   E I           
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKT-FC 157

Query: 622 GTVGYAAPE 630
           GT  Y APE
Sbjct: 158 GTPEYLAPE 166

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 48.3 bits (115), Expect = 6e-06
 Identities = 50/200 (25%), Positives = 85/200 (42%), Gaps = 35/200 (17%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVK--VLFLHQRGALKSFMAECEALRNIRHRN-LVKIIT 505
           IG G++G VYK        +VA+K   L + + G   + + E   L+ +     +V+++ 
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNY--------SPSILSFLQRLN 557
                +  G     LV+E++    L+ ++       D N         + +I SF+ +L 
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDS-DLKKFM-------DSNGRGPGRPLPAKTIKSFMYQLL 120

Query: 558 IAINVASALEYLHHHCKKQ-IVHCDLKPSNVLLDND-MIAHVGDFGLTRFIPEVISSNQC 615
             +           HC K  ++H DLKP N+L+D    +  + D GL R     + S   
Sbjct: 121 KGV----------AHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH 170

Query: 616 SSVGLKGTVGYAAPEYGMGS 635
             V    T+ Y APE  +GS
Sbjct: 171 EIV----TLWYRAPEVLLGS 186

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 29/72 (40%), Positives = 38/72 (52%), Gaps = 8/72 (11%)

Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
           A  +   LE L    +++IV+ DLKP N+LLD+     + D GL   IPE  +       
Sbjct: 108 AAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR----- 159

Query: 619 GLKGTVGYAAPE 630
           G  GTVGY APE
Sbjct: 160 GRVGTVGYMAPE 171

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 47.9 bits (114), Expect = 9e-06
 Identities = 47/181 (25%), Positives = 74/181 (40%), Gaps = 28/181 (15%)

Query: 452 GSFGSVYKGIL--DPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSS 509
           GS G V+      D  +  V VK +     G  K+   E + L+ I HR ++ +I A   
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAV---TGG--KTPGREIDILKTISHRAIINLIHAYR- 156

Query: 510 SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYL 569
                  +K+ V   M     + + + + +          L   Q + I   +  AL YL
Sbjct: 157 -------WKSTVCMVMPKYKCDLFTYVDRSGP--------LPLEQAITIQRRLLEALAYL 201

Query: 570 HHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAP 629
           H    + I+H D+K  N+ LD    A +GDFG    +     + QC   G  GT+   +P
Sbjct: 202 H---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC--YGWSGTLETNSP 256

Query: 630 E 630
           E
Sbjct: 257 E 257

Length = 392

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 46/182 (25%), Positives = 77/182 (42%), Gaps = 22/182 (12%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG+G++G VYK        + A+KV+ L           E   +++ +H N+V    +  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS-- 74

Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
              +   D   +  EF   GSL+          D+ +    LS  Q   ++      L Y
Sbjct: 75  ---YLRRDKLWICMEFCGGGSLQ----------DIYHVTGPLSESQIAYVSRETLQGLYY 121

Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           LH   K   +H D+K +N+LL ++    + DFG++  I   I+  +       GT  + A
Sbjct: 122 LHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK----SFIGTPYWMA 174

Query: 629 PE 630
           PE
Sbjct: 175 PE 176

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 50/191 (26%), Positives = 84/191 (43%), Gaps = 32/191 (16%)

Query: 449 IGTGSFGSVYKGILDPDQTVVA---VKVLFLHQRGALK---SFMAECEA--LRNIRHRNL 500
           +G GSFG+VY   L  D+  VA   +KVL     G L    +  A  EA  L  + H  +
Sbjct: 8   LGKGSFGTVY---LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64

Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK       + F   D   ++ E+     L+  L     +        +  +  +L + +
Sbjct: 65  VKF-----HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV 119

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS-SVG 619
           +      Y+H   +++I+H DLK  N+ L N+++  +GDFG++R +        C  +  
Sbjct: 120 H------YMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLL-----MGSCDLATT 164

Query: 620 LKGTVGYAAPE 630
             GT  Y +PE
Sbjct: 165 FTGTPYYMSPE 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 52/188 (27%), Positives = 75/188 (39%), Gaps = 28/188 (14%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKII 504
           ++G GSFG V    L     V A+KVL    + Q   +   M E   L           +
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKH---PFL 58

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
           TA     FQ  D    V E+++ G L   +      D+         F      A  V  
Sbjct: 59  TALHCC-FQTKDRLFFVMEYVNGGDLMFQIQRSRKFDE-----PRSRFY-----AAEVTL 107

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR--FIPEVISSNQCSSVGLKG 622
           AL +LH H    +++ DLK  N+LLD +    + DFG+ +   +  V ++  C      G
Sbjct: 108 ALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC------G 158

Query: 623 TVGYAAPE 630
           T  Y APE
Sbjct: 159 TPDYIAPE 166

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 49/166 (29%), Positives = 77/166 (46%), Gaps = 32/166 (19%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVK--- 502
           IG G++G V           VA+K +   F ++  A ++ + E + LR++ H N++    
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT-LREIKLLRHLDHENVIAIKD 71

Query: 503 IITACSSSDFQGNDFKALVYEFMH---HGSLESWLHPESASDD-LNYSPSILSFLQRLNI 558
           I+       F  ND   +VYE M    H  + S    ++ SDD   Y      FL +L  
Sbjct: 72  IMPPPHREAF--NDV-YIVYELMDTDLHQIIRS---SQTLSDDHCQY------FLYQL-- 117

Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
                  L+Y+H      ++H DLKPSN+LL+ +    + DFGL R
Sbjct: 118 ----LRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 34/147 (23%), Positives = 68/147 (46%), Gaps = 18/147 (12%)

Query: 468 VVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMH 526
           +VAVK+L     + A   F+ E + L  ++  N+++++  C   D        ++ E+M 
Sbjct: 48  LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPL-----CMITEYME 102

Query: 527 HGSLESWLH---------PESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQI 577
           +G L  +L            + +    +    +S+   L++A+ +AS ++YL        
Sbjct: 103 NGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNF 159

Query: 578 VHCDLKPSNVLLDNDMIAHVGDFGLTR 604
           VH DL   N L+  ++   + DFG++R
Sbjct: 160 VHRDLATRNCLVGENLTIKIADFGMSR 186

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 48/205 (23%), Positives = 85/205 (41%), Gaps = 18/205 (8%)

Query: 428 LLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMA 487
           L ++   +L    G F    ++G G++G VYKG       + A+KV+ + +    +    
Sbjct: 3   LDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKL 61

Query: 488 ECEALRNI-RHRNLVKIITACSSSDFQGNDFKA-LVYEFMHHGSLESWLHPESASDDLNY 545
           E   L+    HRN+     A       G+D +  LV EF   GS+   +     +     
Sbjct: 62  EINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN---AL 118

Query: 546 SPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF 605
               ++++ R      +   L +LH H   +++H D+K  NVLL  +    + DFG++  
Sbjct: 119 KEDWIAYICR-----EILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170

Query: 606 IPEVISSNQCSSVGLKGTVGYAAPE 630
           +   +           GT  + APE
Sbjct: 171 LDRTVGRRNT----FIGTPYWMAPE 191

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 47.0 bits (111), Expect = 2e-05
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 33/198 (16%)

Query: 447 NLIGTGSFGSVYKGI-LDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIIT 505
           N+IG GSFG VY+ I +D  + V   KVL   Q    K+   E   ++N+ H N++ +  
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVL---QDPQYKN--RELLIMKNLNHINIIFLKD 126

Query: 506 ACSSSDFQGND---FKALVYEFMHHGSLESWLHPESASDDLNY----SPSILSFLQRLNI 558
              +  F+ N+   F  +V EF+          P++    + +    + ++  FL +L  
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFI----------PQTVHKYMKHYARNNHALPLFLVKL-Y 175

Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLD-NDMIAHVGDFGLTRFIPEVISSNQCSS 617
           +  +  AL Y+H    K I H DLKP N+L+D N     + DFG  +    +++  +  S
Sbjct: 176 SYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK---NLLAGQR--S 227

Query: 618 VGLKGTVGYAAPEYGMGS 635
           V    +  Y APE  +G+
Sbjct: 228 VSYICSRFYRAPELMLGA 245

Length = 440

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 40/151 (26%), Positives = 70/151 (46%), Gaps = 29/151 (19%)

Query: 449 IGTGSFGSVYKGILDPD----------QTVVAVKVLFLHQRGALKSFMAECEALRNIRHR 498
           +G G+F ++YKG+L             +  V +KVL    R +L +F      +  + H+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLSHK 61

Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           +LVK+   C   +        +V E++  G L+ +LH E        + S+   L    +
Sbjct: 62  HLVKLYGVCVRDENI------MVEEYVKFGPLDVFLHREKN------NVSLHWKLD---V 106

Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLL 589
           A  +ASAL YL     K++VH ++   N+L+
Sbjct: 107 AKQLASALHYLE---DKKLVHGNVCGKNILV 134

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 46.2 bits (110), Expect = 3e-05
 Identities = 41/157 (26%), Positives = 63/157 (40%), Gaps = 20/157 (12%)

Query: 448 LIGTGSFG--SVYKGILDPDQTVVAVKVLFLHQRGA--LKSFMAECEALRNIRHRNLVKI 503
           LIG        V+     P  T+VAVK + L       LK    E    R ++H N++  
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
           +T+     F  +    +V   M +GS E  L          + P  L  L    I  +V 
Sbjct: 65  VTS-----FIVDSELYVVSPLMAYGSCEDLLK--------THFPEGLPELAIAFILKDVL 111

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF 600
           +AL+Y+H    K  +H  +K S++LL  D    +   
Sbjct: 112 NALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 45.7 bits (108), Expect = 3e-05
 Identities = 48/188 (25%), Positives = 85/188 (45%), Gaps = 29/188 (15%)

Query: 449 IGTGSFGSVY--KGILDPDQTVV---AVKVLFLHQRGALKSFMAECEALRNIRHRNLVKI 503
           IG GSFG +Y  K   D +  V+    +  + + ++ A K    E   L  ++H N+V  
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPNIVTF 64

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
                 + FQ N    +V E+   G L   ++ +           + S  Q L+  + ++
Sbjct: 65  F-----ASFQENGRLFIVMEYCDGGDLMKRINRQRGV--------LFSEDQILSWFVQIS 111

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLD-NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
             L+++H    ++I+H D+K  N+ L  N M+A +GDFG+ R + + +           G
Sbjct: 112 LGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV----G 164

Query: 623 TVGYAAPE 630
           T  Y +PE
Sbjct: 165 TPYYLSPE 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 47.1 bits (112), Expect = 3e-05
 Identities = 48/184 (26%), Positives = 71/184 (38%), Gaps = 32/184 (17%)

Query: 469 VAVKVLF------LHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVY 522
           VA+K+L        HQR   +   A C  L    H N+V ++     S          V+
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLY---HPNIVALL----DSGEAPPGLLFAVF 58

Query: 523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDL 582
           E++   +L   L  + A          L   +   + + V  AL   H    + IVH DL
Sbjct: 59  EYVPGRTLREVLAADGA----------LPAGETGRLMLQVLDALACAH---NQGIVHRDL 105

Query: 583 KPSNVLL---DNDMIAHVGDFGLTRFIPEV--ISSNQCSSVG-LKGTVGYAAPEYGMGSQ 636
           KP N+++        A V DFG+   +P V        +    + GT  Y APE   G  
Sbjct: 106 KPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP 165

Query: 637 VSTN 640
           V+ N
Sbjct: 166 VTPN 169

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 46.2 bits (110), Expect = 3e-05
 Identities = 50/184 (27%), Positives = 68/184 (36%), Gaps = 34/184 (18%)

Query: 181 LPKLQVLSLFENNISGE----IPSSLGNFTFLTELNLRGN------SIRGSIPSALGNCH 230
           L  LQVL L  N +  E    + S+L     L EL L  N          S+   L    
Sbjct: 22  LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81

Query: 231 QLQSLDLSKTIFLGQYPVRW-----------LDLSHNHL-TGPIPLAVGNLKSIPH---- 274
            LQ LDLS                       L L++N L    + L    LK +P     
Sbjct: 82  GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEK 141

Query: 275 LDLSKNKLSGE----IPSSLGSCVGLEYLNLSINSFHGP----IHPGLSSLKSLEGLDLF 326
           L L +N+L G     +  +L +   L+ LNL+ N         +  GL +  +LE LDL 
Sbjct: 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLN 201

Query: 327 QNTF 330
            N  
Sbjct: 202 NNGL 205

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 46.1 bits (109), Expect = 3e-05
 Identities = 56/226 (24%), Positives = 88/226 (38%), Gaps = 39/226 (17%)

Query: 409 RLRRKRTVTSSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSV----YKGILDP 464
           +L +K+   S++   RK+    + YE        F+    +GTGSFG V    YK    P
Sbjct: 8   QLHKKKDSDSTKEPKRKN---KMKYED-------FNFIRTLGTGSFGRVILATYKNEDFP 57

Query: 465 DQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEF 524
              +   +   + ++  +    +E + L  I H   V +        F+   +  LV EF
Sbjct: 58  PVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNL-----YGSFKDESYLYLVLEF 112

Query: 525 MHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKP 584
           +  G   ++L          +   +  F      A  +    EYL       IV+ DLKP
Sbjct: 113 VIGGEFFTFLRRNK-----RFPNDVGCFY-----AAQIVLIFEYLQ---SLNIVYRDLKP 159

Query: 585 SNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPE 630
            N+LLD D    + DFG  + +          +  L GT  Y APE
Sbjct: 160 ENLLLDKDGFIKMTDFGFAKVV-------DTRTYTLCGTPEYIAPE 198

Length = 340

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 46.1 bits (109), Expect = 3e-05
 Identities = 42/161 (26%), Positives = 73/161 (45%), Gaps = 22/161 (13%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRN---LVKI 503
           +G+G++G+V   +       VA+K L+   +  L  K    E   L++++H N   L+ +
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
            T   S D + +DF  LV  FM     +   H + + D + +            +   + 
Sbjct: 83  FTPDLSLD-RFHDF-YLVMPFMGTDLGKLMKHEKLSEDRIQF------------LVYQML 128

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
             L+Y+H      I+H DLKP N+ ++ D    + DFGL R
Sbjct: 129 KGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 45.9 bits (108), Expect = 3e-05
 Identities = 47/182 (25%), Positives = 80/182 (43%), Gaps = 23/182 (12%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG G+ G+VY  +       VA++ + L Q+   +  + E   +R  ++ N+V  + +  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 85

Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
              +   D   +V E++  GSL   +  E+  D+   +      LQ          ALE+
Sbjct: 86  ---YLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQ----------ALEF 131

Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           LH +   Q++H D+K  N+LL  D    + DFG        I+  Q     + GT  + A
Sbjct: 132 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSTMVGTPYWMA 184

Query: 629 PE 630
           PE
Sbjct: 185 PE 186

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 45.5 bits (107), Expect = 4e-05
 Identities = 48/182 (26%), Positives = 80/182 (43%), Gaps = 23/182 (12%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG G+ G+VY  I       VA+K + L Q+   +  + E   +R  ++ N+V  + +  
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 84

Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
              +   D   +V E++  GSL   +  E+  D+   +      LQ          AL++
Sbjct: 85  ---YLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQ----------ALDF 130

Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           LH +   Q++H D+K  N+LL  D    + DFG        I+  Q     + GT  + A
Sbjct: 131 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSTMVGTPYWMA 183

Query: 629 PE 630
           PE
Sbjct: 184 PE 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 44/166 (26%), Positives = 67/166 (40%), Gaps = 29/166 (17%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA---LKSFMAECEALRNIRHRN 499
           FS    IG GSFG+VY      +  VVA+K +    + +    +  + E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPE----SASDDLNYSPSILSFLQR 555
            ++                   Y   +     +WL  E    SASD L      L  ++ 
Sbjct: 77  TIQ-------------------YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI 117

Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG 601
             +       L YLH H    ++H D+K  N+LL    +  +GDFG
Sbjct: 118 AAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 160

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 51/189 (26%), Positives = 72/189 (38%), Gaps = 37/189 (19%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA---LKSFMAECEALRNIRHRNLVKIIT 505
           IG GSFG+VY         VVAVK +    +      +  + E + L+ ++H N ++   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE--- 85

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPE----SASDDLNYSPSILSFLQRLNIAIN 561
                           Y+  +     +WL  E    SASD L      L  ++   I   
Sbjct: 86  ----------------YKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHG 129

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
               L YLH H     +H D+K  N+LL       + DFG         SS   S V   
Sbjct: 130 ALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSAS-----KSSPANSFV--- 178

Query: 622 GTVGYAAPE 630
           GT  + APE
Sbjct: 179 GTPYWMAPE 187

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 45.4 bits (107), Expect = 5e-05
 Identities = 49/194 (25%), Positives = 83/194 (42%), Gaps = 43/194 (22%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV        +  VAVK L       +H R   +    E   L++++H N++ 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR----ELRLLKHMKHENVIG 78

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLN----- 557
           ++   + +     +F             E +L       DLN   +I+   Q+L+     
Sbjct: 79  LLDVFTPAT-SIENFN------------EVYLVTNLMGADLN---NIVKC-QKLSDEHVQ 121

Query: 558 -IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
            +   +   L+Y+H      I+H DLKPSNV ++ D    + DFGL R   + ++     
Sbjct: 122 FLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT----- 173

Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 174 --GYVATRWYRAPE 185

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 45.4 bits (108), Expect = 5e-05
 Identities = 47/160 (29%), Positives = 66/160 (41%), Gaps = 23/160 (14%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKII 504
           L+G G  G V+   L     + A+KVL    + +R  +K  + E E L  + H  L  + 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
                + FQ   +  LV ++   G L   L  +        S  +  F      A  V  
Sbjct: 68  -----ASFQTETYLCLVMDYCPGGELFRLLQRQPGK---CLSEEVARFY-----AAEVLL 114

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV--GDFGL 602
           ALEYLH      IV+ DLKP N+LL      H+   DF L
Sbjct: 115 ALEYLH---LLGIVYRDLKPENILLHES--GHIMLSDFDL 149

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 45.1 bits (107), Expect = 7e-05
 Identities = 56/203 (27%), Positives = 85/203 (41%), Gaps = 37/203 (18%)

Query: 449 IGTGSFGSVYKGILDP-DQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNLVKIIT 505
           IG G+FG V+  + DP D   VA+K +        + K    E + L   +H N++  + 
Sbjct: 8   IGYGAFGVVW-SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALD 66

Query: 506 ACSSSDFQGNDFKALVY---EFMHHGSLESWLH-----PESASDDLNYSPSILSFLQRLN 557
                     D    +Y   E M      S LH     P+  S D      +  FL +  
Sbjct: 67  ILQPPHI---DPFEEIYVVTELMQ-----SDLHKIIVSPQPLSSD-----HVKVFLYQ-- 111

Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
               +   L+YLH      I+H D+KP N+L++++ +  + DFGL R      S +    
Sbjct: 112 ----ILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQE 164

Query: 618 VGLKGTVGYAAPEYGMGSQVSTN 640
           V    T  Y APE  MGS+  T+
Sbjct: 165 V---VTQYYRAPEILMGSRHYTS 184

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 44.7 bits (106), Expect = 7e-05
 Identities = 28/76 (36%), Positives = 38/76 (50%), Gaps = 13/76 (17%)

Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
           IA+++  ALEYLH      ++H D+KPSNVL++ +    + DFG        IS     S
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFG--------ISGYLVDS 157

Query: 618 VGLKGTVG---YAAPE 630
           V      G   Y APE
Sbjct: 158 VAKTIDAGCKPYMAPE 173

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 44.2 bits (104), Expect = 9e-05
 Identities = 39/158 (24%), Positives = 68/158 (43%), Gaps = 29/158 (18%)

Query: 449 IGTGSFGSVYKGILDP------------DQTVVAVKVLFLHQRGALKSFMAECEALRNIR 496
           +G G+   +Y GIL+              +  V +KVL    R    +F      +R + 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H+++V +   C       N    +V EF+  G L+ ++H +S          +L+   + 
Sbjct: 63  HKHIVLLYGVCVRD--VEN---IMVEEFVEFGPLDLFMHRKS---------DVLTTPWKF 108

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI 594
            +A  +ASAL YL     K +VH ++   N+LL  + I
Sbjct: 109 KVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGI 143

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 44.8 bits (106), Expect = 1e-04
 Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 6/98 (6%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           +L+ LM + L +N  SG IP E+    +L  +  + N L GQIP + +    L  LD   
Sbjct: 497 SLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLD--- 553

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIP 98
             L +NQL GE+P  +G     +++  ++ N   G++P
Sbjct: 554 --LSQNQLSGEIPKNLGNVESLVQVN-ISHNHLHGSLP 588

Length = 968

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 44.7 bits (105), Expect = 1e-04
 Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 24/197 (12%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKS-FMAECEALRNIRHRNLV 501
           F   + +G G+ G V K    P   ++A K++ L  + A+++  + E + L       +V
Sbjct: 7   FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
               A     F  +   ++  E M  GSL+  L      +       IL       ++I 
Sbjct: 67  GFYGA-----FYSDGEISICMEHMDGGSLDQVL-----KEAKRIPEEILG-----KVSIA 111

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           V   L YL    K QI+H D+KPSN+L+++     + DFG++    ++I S   S V   
Sbjct: 112 VLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFV--- 163

Query: 622 GTVGYAAPEYGMGSQVS 638
           GT  Y +PE   G+  S
Sbjct: 164 GTRSYMSPERLQGTHYS 180

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 44.4 bits (105), Expect = 1e-04
 Identities = 26/66 (39%), Positives = 36/66 (54%), Gaps = 7/66 (10%)

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
           ALE+LH   ++ I++ DLKP N+LLD      + DFGL +   E I     +     GT+
Sbjct: 112 ALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCK---ESIHEGTVTHT-FCGTI 164

Query: 625 GYAAPE 630
            Y APE
Sbjct: 165 EYMAPE 170

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 52/197 (26%), Positives = 88/197 (44%), Gaps = 24/197 (12%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKS-FMAECEALRNIRHRNLV 501
           F   + +G G+ G V+K    P   ++A K++ L  + A+++  + E + L       +V
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
               A     F  +   ++  E M  GSL+  L       +      IL       ++I 
Sbjct: 67  GFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAGRIPE-----QILG-----KVSIA 111

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           V   L YL    K +I+H D+KPSN+L+++     + DFG++    ++I S   S V   
Sbjct: 112 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFV--- 163

Query: 622 GTVGYAAPEYGMGSQVS 638
           GT  Y +PE   G+  S
Sbjct: 164 GTRSYMSPERLQGTHYS 180

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 20/84 (23%), Positives = 35/84 (41%), Gaps = 8/84 (9%)

Query: 526 HHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPS 585
               L  W+  E+  +        +S  ++ +IA  +A  L  LH      + H DL P 
Sbjct: 67  WSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPG 118

Query: 586 NVLLDNDMIAHVGDFGLTRFIPEV 609
           N+L+D+  I  + D+    + P  
Sbjct: 119 NILVDDGKILGIIDWEYAGYGPPA 142

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 44/182 (24%), Positives = 75/182 (41%), Gaps = 22/182 (12%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G+G++G VYK        + AVK++ L           E   ++  +H N+V    +  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS-- 74

Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
              +   +   +  E+   GSL+          D+ +    LS LQ   +       L Y
Sbjct: 75  ---YLSREKLWICMEYCGGGSLQ----------DIYHVTGPLSELQIAYVCRETLQGLAY 121

Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           LH   K   +H D+K +N+LL ++    + DFG+   I   I+  +       GT  + A
Sbjct: 122 LHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK----SFIGTPYWMA 174

Query: 629 PE 630
           PE
Sbjct: 175 PE 176

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 23/66 (34%), Positives = 31/66 (46%), Gaps = 3/66 (4%)

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            L+Y+H      ++H DLKP N+L++ D    + DFGL R   E    N         T 
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 625 GYAAPE 630
            Y APE
Sbjct: 174 WYRAPE 179

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 48/197 (24%), Positives = 80/197 (40%), Gaps = 18/197 (9%)

Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI 495
           L    G F    L+G G++G VYKG       + A+KV+ +      +    E   L+  
Sbjct: 1   LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKY 59

Query: 496 -RHRNLVKIITACSSSDFQGNDFKA-LVYEFMHHGSLESWLHPESASDDLNYSPSILSFL 553
             HRN+     A    +  G D +  LV EF   GS+   +     +         ++++
Sbjct: 60  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN---TLKEEWIAYI 116

Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
            R      +   L +LH H   +++H D+K  NVLL  +    + DFG++  +   +   
Sbjct: 117 CR-----EILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 168

Query: 614 QCSSVGLKGTVGYAAPE 630
                   GT  + APE
Sbjct: 169 NT----FIGTPYWMAPE 181

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 35/190 (18%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITAC 507
           +G G++GSVYK +  P    +A+K + L          + E + L    H+ +   I   
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HKAVSPYIV-- 62

Query: 508 SSSDFQGNDF-KALVY---EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
              DF G  F +  VY   E+M  GSL+  L+    + +      +L       I   V 
Sbjct: 63  ---DFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPED-VLRR-----ITYAVV 112

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
             L++L    +  I+H D+KP+NVL++ +    + DFG        +S N  +S+  K  
Sbjct: 113 KGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFG--------VSGNLVASLA-KTN 161

Query: 624 VG---YAAPE 630
           +G   Y APE
Sbjct: 162 IGCQSYMAPE 171

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 43.3 bits (103), Expect = 2e-04
 Identities = 24/79 (30%), Positives = 33/79 (41%), Gaps = 20/79 (25%)

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI-AHVGDFGLTRFIPEVISSNQC 615
            I   +  AL  LH   K  I+H D+K  NVL D      ++ D+GL            C
Sbjct: 113 KIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGL------------C 157

Query: 616 SSVGLK----GTVGYAAPE 630
             +G      GT+ Y +PE
Sbjct: 158 KIIGTPSCYDGTLDYFSPE 176

Length = 267

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 53/188 (28%), Positives = 78/188 (41%), Gaps = 28/188 (14%)

Query: 448 LIGTGSFGSVYKGILDPDQ-TVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKI--- 503
           +IG G FG VY G    D   + A+K L    +  +K    E  AL      +LV     
Sbjct: 1   IIGRGGFGEVY-GCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSLVSTGDC 56

Query: 504 -ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
               C S  F   D  + + + M+ G L   L          +S + + F      A  +
Sbjct: 57  PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-----FSEAEMRFY-----AAEI 106

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
              LE++H+   + +V+ DLKP+N+LLD      + D GL     +       +SV   G
Sbjct: 107 ILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASV---G 157

Query: 623 TVGYAAPE 630
           T GY APE
Sbjct: 158 THGYMAPE 165

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 80

Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 81  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 125

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 126 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----- 175

Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 176 --GYVATRWYRAPE 187

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 25/73 (34%), Positives = 37/73 (50%), Gaps = 7/73 (9%)

Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
           + + +  AL YL    K  ++H D+KPSN+LLD      + DFG++  +  V S  +  S
Sbjct: 119 MTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAKTRS 174

Query: 618 VGLKGTVGYAAPE 630
               G   Y APE
Sbjct: 175 ---AGCAAYMAPE 184

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 44/185 (23%), Positives = 81/185 (43%), Gaps = 28/185 (15%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKIIT 505
           +G G +G V+         +VA+K +    L +   ++  + E + L   +   LVK++ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
           A     FQ +++  L  E++  G   + L+      + +++        R  +A     A
Sbjct: 69  A-----FQDDEYLYLAMEYVPGGDFRTLLNNLGVLSE-DHA--------RFYMAEMFE-A 113

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG 625
           ++ LH   +   +H DLKP N L+D      + DFGL++ I    +S       + G+  
Sbjct: 114 VDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-------VVGSPD 163

Query: 626 YAAPE 630
           Y APE
Sbjct: 164 YMAPE 168

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 46/202 (22%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G+ G V K +  P   ++A K++ L  +           A+RN   R L K++  C+
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHLEIK----------PAIRNQIIREL-KVLHECN 57

Query: 509 S-------SDFQGNDFKALVYEFMHHGSLESWLH-----PESASDDLNYSPSILSFLQRL 556
           S         F  +   ++  E M  GSL+  L      PE+              L ++
Sbjct: 58  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEN-------------ILGKI 104

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
           +IA  V   L YL    K +I+H D+KPSN+L+++     + DFG++    ++I S   S
Sbjct: 105 SIA--VLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANS 157

Query: 617 SVGLKGTVGYAAPEYGMGSQVS 638
            V   GT  Y +PE   G+  +
Sbjct: 158 FV---GTRSYMSPERLQGTHYT 176

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 45/182 (24%), Positives = 80/182 (43%), Gaps = 23/182 (12%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG GS G V           VAVK + L ++   +    E   +R+  H N+V +     
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMY---- 85

Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
           +S   G++   +V EF+  G+L   +     +++           Q   + ++V  AL Y
Sbjct: 86  NSYLVGDEL-WVVMEFLEGGALTDIVTHTRMNEE-----------QIATVCLSVLRALSY 133

Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           LH+   + ++H D+K  ++LL +D    + DFG    + + +   +     L GT  + A
Sbjct: 134 LHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK----SLVGTPYWMA 186

Query: 629 PE 630
           PE
Sbjct: 187 PE 188

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 42.8 bits (101), Expect = 3e-04
 Identities = 49/176 (27%), Positives = 76/176 (43%), Gaps = 43/176 (24%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F +  LI  G++G+VY            V+     QR A+K    +   LRN   +  V+
Sbjct: 3   FETIKLISNGAYGAVY-----------LVRHKETRQRFAMKKINKQNLILRNQIQQVFVE 51

Query: 503 --IITA----------CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
             I+T           CS   F+      +V E++  G   + L         N     +
Sbjct: 52  RDILTFAENPFVVSMFCS---FETKRHLCMVMEYVEGGDCATLLK--------NIGALPV 100

Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG--DFGLTR 604
             + R+  A  V  ALEYLH++    IVH DLKP N+L+ +  + H+   DFGL++
Sbjct: 101 D-MARMYFAETVL-ALEYLHNY---GIVHRDLKPDNLLITS--MGHIKLTDFGLSK 149

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 26/66 (39%), Positives = 39/66 (59%), Gaps = 6/66 (9%)

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
           ALE+LH   K  IV+ D+K  N+LLD++    + DFGL++   E +S  +  +    GT+
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSK---EFLSEEKERTYSFCGTI 170

Query: 625 GYAAPE 630
            Y APE
Sbjct: 171 EYMAPE 176

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 44/182 (24%), Positives = 81/182 (44%), Gaps = 23/182 (12%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG GS G V    +     +VAVK + L ++   +    E   +R+ +H N+V++     
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMY---- 83

Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
           +S   G++   +V EF+  G+L   +     +++           Q   + + V  AL  
Sbjct: 84  NSYLVGDEL-WVVMEFLEGGALTDIVTHTRMNEE-----------QIAAVCLAVLKALSV 131

Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           LH    + ++H D+K  ++LL +D    + DFG    + + +   +     L GT  + A
Sbjct: 132 LH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK----SLVGTPYWMA 184

Query: 629 PE 630
           PE
Sbjct: 185 PE 186

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 42.4 bits (99), Expect = 4e-04
 Identities = 48/192 (25%), Positives = 82/192 (42%), Gaps = 30/192 (15%)

Query: 448 LIGTGSFGSVYKGI-LDPDQTVVAVKVLF----LHQRGALKSFMAECEALRNIRHRNLVK 502
           L+G G+FG VY    +D  + + A +V F          + +   E + L+N++H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESA---SDDLNYSPSILSFLQRLNIA 559
                     +      +  E+M  GS++  L    A   S    Y+  IL         
Sbjct: 69  YYGCLRD---RAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE-------- 117

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEV-ISSNQCSSV 618
                 + YLH +    IVH D+K +N+L D+     +GDFG ++ +  + +S     SV
Sbjct: 118 -----GMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV 169

Query: 619 GLKGTVGYAAPE 630
              GT  + +PE
Sbjct: 170 --TGTPYWMSPE 179

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 42.4 bits (100), Expect = 4e-04
 Identities = 22/77 (28%), Positives = 39/77 (50%), Gaps = 7/77 (9%)

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             + SA+ Y+H   K  I+H D+K  N+ L    +  +GDFG+++    ++ S    +  
Sbjct: 108 FQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISK----ILGSEYSMAET 160

Query: 620 LKGTVGYAAPEYGMGSQ 636
           + GT  Y +PE   G +
Sbjct: 161 VVGTPYYMSPELCQGVK 177

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 42.5 bits (100), Expect = 4e-04
 Identities = 35/119 (29%), Positives = 54/119 (45%), Gaps = 17/119 (14%)

Query: 512 FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHH 571
           FQ  +    V E+++ G L    H +S+     +  +   F      A  +   L++LH 
Sbjct: 65  FQTKEHLFFVMEYLNGGDL--MFHIQSS---GRFDEARARFY-----AAEIICGLQFLH- 113

Query: 572 HCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPE 630
             KK I++ DLK  NVLLD D    + DFG+ +    +    + S+    GT  Y APE
Sbjct: 114 --KKGIIYRDLKLDNVLLDKDGHIKIADFGMCK--ENMNGEGKAST--FCGTPDYIAPE 166

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 42.4 bits (99), Expect = 5e-04
 Identities = 48/182 (26%), Positives = 80/182 (43%), Gaps = 23/182 (12%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG G+ G+V+  I       VA+K + L ++   +  + E   ++ +++ N+V  + +  
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS-- 84

Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
              F   D   +V E++  GSL   +  E+  D+   +      LQ          ALE+
Sbjct: 85  ---FLVGDELFVVMEYLAGGSLTDVV-TETCMDEAQIAAVCRECLQ----------ALEF 130

Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           LH     Q++H D+K  NVLL  D    + DFG        I+  Q     + GT  + A
Sbjct: 131 LH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFC----AQITPEQSKRSTMVGTPYWMA 183

Query: 629 PE 630
           PE
Sbjct: 184 PE 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 42.4 bits (100), Expect = 5e-04
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 54/207 (26%)

Query: 449 IGTGSFGSV---YKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVK 502
           IG+G+ G V   Y  +   +   VA+K L   F +   A +++  E   ++ + H+N++ 
Sbjct: 24  IGSGAQGIVCAAYDTVTGQN---VAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIG 79

Query: 503 IITAC----SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           ++       S  +FQ  D   LV E M   +L   +  +   + ++Y       L ++  
Sbjct: 80  LLNVFTPQKSLEEFQ--DV-YLVMELMDA-NLCQVIQMDLDHERMSY------LLYQMLC 129

Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR-------FIPEVIS 611
            I      ++LH      I+H DLKPSN+++ +D    + DFGL R         P V+ 
Sbjct: 130 GI------KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV- 179

Query: 612 SNQCSSVGLKGTVGYAAPE--YGMGSQ 636
                      T  Y APE   GMG +
Sbjct: 180 -----------TRYYRAPEVILGMGYK 195

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 34/194 (17%)

Query: 448 LIGTGSFGSVYKGI-LDPDQTVVAVKVLFL--HQRGALKSFMAECEA--LRNIRHRNLVK 502
           L+G G+FG VY     D  + +   +V F    Q  + +    ECE   L+N+RH  +V+
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDD---LNYSPSILSFLQRLNIA 559
               C   D +       V E+M  GS++  L    A  +     Y+  IL         
Sbjct: 69  YY-GCLR-DPEEKKLSIFV-EYMPGGSIKDQLKAYGALTENVTRRYTRQILQ-------- 117

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
                 + YLH +    IVH D+K +N+L D+     +GDFG ++ I  +      S  G
Sbjct: 118 -----GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC----MSGTG 165

Query: 620 LKGTVG---YAAPE 630
           +K   G   + +PE
Sbjct: 166 IKSVTGTPYWMSPE 179

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 42.6 bits (100), Expect = 5e-04
 Identities = 31/98 (31%), Positives = 45/98 (45%), Gaps = 8/98 (8%)

Query: 536 PESASDDLNY---SPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND 592
           P+  SD   Y       L   Q   +A  + SA++Y+H    + I+H D+K  NVL++  
Sbjct: 240 PKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGP 296

Query: 593 MIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPE 630
               +GDFG   F     S+      G+ GTV   APE
Sbjct: 297 EDICLGDFGAACFARGSWSTP--FHYGIAGTVDTNAPE 332

Length = 461

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 42.5 bits (100), Expect = 6e-04
 Identities = 26/76 (34%), Positives = 37/76 (48%), Gaps = 5/76 (6%)

Query: 2   LTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLN 61
           L  L  INL  N+  GNIP  +G +  L  +  + N+  G IP +L   + LR L+    
Sbjct: 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILN---- 496

Query: 62  KLEENQLVGELPPYIG 77
            L  N L G +P  +G
Sbjct: 497 -LNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 42.1 bits (99), Expect = 6e-04
 Identities = 48/196 (24%), Positives = 91/196 (46%), Gaps = 29/196 (14%)

Query: 443 FSSANLIGTGSFGSVY--KGILDPDQ-TVVAVKVL----FLHQRGALKSFMAECEALRNI 495
           F    ++GTG++G V+  + +   D   + A+KVL     + +    +    E + L  +
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 496 RHRN-LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ 554
           R    LV +  A     FQ +    L+ ++++ G L + L+      +            
Sbjct: 62  RRCPFLVTLHYA-----FQTDTKLHLILDYVNGGELFTHLYQREHFTESEV--------- 107

Query: 555 RLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQ 614
           R+ IA  +  AL++LH   +  I++ D+K  N+LLD++    + DFGL++   E ++  +
Sbjct: 108 RVYIA-EIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSK---EFLAEEE 160

Query: 615 CSSVGLKGTVGYAAPE 630
             +    GT+ Y APE
Sbjct: 161 ERAYSFCGTIEYMAPE 176

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 42.5 bits (100), Expect = 6e-04
 Identities = 22/64 (34%), Positives = 36/64 (56%), Gaps = 6/64 (9%)

Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG--LKGTVGY 626
           +HH   K ++H D+K +N+LL ++ +  +GDFG ++     +S +    VG    GT  Y
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDD----VGRTFCGTPYY 211

Query: 627 AAPE 630
            APE
Sbjct: 212 VAPE 215

Length = 496

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 41.9 bits (98), Expect = 6e-04
 Identities = 50/187 (26%), Positives = 74/187 (39%), Gaps = 26/187 (13%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKI---- 503
           +IG G FG VY         + A+K L    +  +K    E  AL      +LV      
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSLVSTGDCP 57

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
              C +  F   D    + + M+ G L   L          +S   + F      A  + 
Sbjct: 58  FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV-----FSEKEMRFY-----ATEII 107

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
             LE++H+   + +V+ DLKP+N+LLD      + D GL     +       +SV   GT
Sbjct: 108 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASV---GT 158

Query: 624 VGYAAPE 630
            GY APE
Sbjct: 159 HGYMAPE 165

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 42.0 bits (98), Expect = 7e-04
 Identities = 46/166 (27%), Positives = 69/166 (41%), Gaps = 29/166 (17%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSF---MAECEALRNIRHRN 499
           F+    IG GSFG+VY         VVA+K +    + + + +   + E + L+ I+H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPE----SASDDLNYSPSILSFLQR 555
                    S +++G       Y   H     +WL  E    SASD L      L  ++ 
Sbjct: 87  ---------SIEYKG------CYLREH----TAWLVMEYCLGSASDLLEVHKKPLQEVEI 127

Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG 601
             I       L YLH H    ++H D+K  N+LL       + DFG
Sbjct: 128 AAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFG 170

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.1 bits (99), Expect = 7e-04
 Identities = 47/171 (27%), Positives = 77/171 (45%), Gaps = 35/171 (20%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR-HRNLV 501
           F +  +IG G+FG V          + A+K L       LKS M + + L +++  R+++
Sbjct: 3   FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL-------LKSEMFKKDQLAHVKAERDVL 55

Query: 502 KIITACSSS--------DFQGNDFKALVYEFMHHGSLESWL-HPESASDDLNYSPSILSF 552
               A S S         FQ   +  L+ EF+  G L + L   ++ S+D+         
Sbjct: 56  ----AESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVT-------- 103

Query: 553 LQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT 603
             R  +A  V  A+E +H   K   +H D+KP N+L+D      + DFGL+
Sbjct: 104 --RFYMAECVL-AIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 41.9 bits (98), Expect = 8e-04
 Identities = 41/155 (26%), Positives = 68/155 (43%), Gaps = 29/155 (18%)

Query: 478 QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPE 537
           QRG   +   E   LR I H +++++        F  N F  L+              P 
Sbjct: 126 QRGGTAT---EAHILRAINHPSIIQLK-----GTFTYNKFTCLIL-------------PR 164

Query: 538 SASDDLNY--SPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA 595
             +D   Y  +   ++    L I  +V  A++YLH +   +I+H D+K  N+ +++    
Sbjct: 165 YKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDV 221

Query: 596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPE 630
            +GDFG   F P  I++N+    G  GT+   APE
Sbjct: 222 CLGDFGAACF-PVDINANK--YYGWAGTIATNAPE 253

Length = 391

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 41.5 bits (97), Expect = 8e-04
 Identities = 54/202 (26%), Positives = 84/202 (41%), Gaps = 36/202 (17%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRN------IRHRNLV 501
           ++G GSFG V+   L       A+K L   +   L     EC  +          H  L 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKAL--KKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASD-DLNYSPSILSFLQRLNIAI 560
            +   C+   FQ  +    V E+++ G L    H +S    DL  +    +F      A 
Sbjct: 60  HLY--CT---FQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRA----TFY-----AA 103

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR--FIPEVISSNQCSSV 618
            +   L++LH    K IV+ DLK  N+LLD D    + DFG+ +   + +  +   C   
Sbjct: 104 EIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC--- 157

Query: 619 GLKGTVGYAAPEYGMGSQVSTN 640
              GT  Y APE  +G + +T+
Sbjct: 158 ---GTPDYIAPEILLGQKYNTS 176

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 41.5 bits (97), Expect = 9e-04
 Identities = 24/62 (38%), Positives = 32/62 (51%), Gaps = 6/62 (9%)

Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           LH H    IV+ D+KP NVLLD+     + D GL   + +  +  Q +     GT GY A
Sbjct: 109 LHLHSMD-IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA-----GTNGYMA 162

Query: 629 PE 630
           PE
Sbjct: 163 PE 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 41.6 bits (97), Expect = 0.001
 Identities = 52/191 (27%), Positives = 80/191 (41%), Gaps = 23/191 (12%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNIRHRN 499
           F    +IG G+FG V    L     V A+K+L    + +R     F  E + L N  ++ 
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           +  +  A     FQ  +   LV ++   G L + L   S  +D         +L  + IA
Sbjct: 63  ITTLHYA-----FQDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVIA 114

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
           I+    L Y+H          D+KP N+L+D +    + DFG    + E       SSV 
Sbjct: 115 IDSVHQLHYVHR---------DIKPDNILMDMNGHIRLADFGSCLKLME--DGTVQSSVA 163

Query: 620 LKGTVGYAAPE 630
           + GT  Y +PE
Sbjct: 164 V-GTPDYISPE 173

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 37/130 (28%), Positives = 55/130 (42%), Gaps = 19/130 (14%)

Query: 510 SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI-AINVASALEY 568
             FQ  +    V EF++ G L   +  +   D           L R    A  +   L++
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFD-----------LYRATFYAAEIVCGLQF 111

Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           LH    K I++ DLK  NV+LD D    + DFG+ +    V   N+ S+    GT  Y A
Sbjct: 112 LH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRAST--FCGTPDYIA 164

Query: 629 PEYGMGSQVS 638
           PE   G + +
Sbjct: 165 PEILQGLKYT 174

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 44/163 (26%), Positives = 74/163 (45%), Gaps = 27/163 (16%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKIIT 505
           IG+G+ G V           VAVK L   F +Q  A +++  E   L+ + H+N++ ++ 
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 87

Query: 506 AC----SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
                 S  +FQ      LV E M   +L   +H E   + ++Y            +   
Sbjct: 88  VFTPQKSLEEFQD---VYLVMELMD-ANLCQVIHMELDHERMSY------------LLYQ 131

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
           +   +++LH      I+H DLKPSN+++ +D    + DFGL R
Sbjct: 132 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 40.9 bits (96), Expect = 0.001
 Identities = 48/196 (24%), Positives = 75/196 (38%), Gaps = 34/196 (17%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           F+   ++G GSFG V          + A+K+L    + Q   ++  M E   L       
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFL---QRL 556
            +  + +C    FQ  D    V E+++ G             DL Y    +        +
Sbjct: 62  FLTQLHSC----FQTMDRLYFVMEYVNGG-------------DLMYHIQQVGKFKEPHAV 104

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR--FIPEVISSNQ 614
             A  +A  L +LH    K I++ DLK  NV+LD +    + DFG+ +        +   
Sbjct: 105 FYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTF 161

Query: 615 CSSVGLKGTVGYAAPE 630
           C      GT  Y APE
Sbjct: 162 C------GTPDYIAPE 171

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 40.8 bits (96), Expect = 0.001
 Identities = 46/170 (27%), Positives = 73/170 (42%), Gaps = 35/170 (20%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR-HRNL- 500
           F S  +IG G+FG V          + A+K L        KS M E E + ++R  R++ 
Sbjct: 3   FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKL-------RKSEMLEKEQVAHVRAERDIL 55

Query: 501 --------VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSF 552
                   VK+    S   FQ  ++  L+ E++  G + + L  +   D      +    
Sbjct: 56  AEADNPWVVKLY--YS---FQDENYLYLIMEYLPGGDMMTLLMKK---DTFTEEET---- 103

Query: 553 LQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL 602
             R  IA  +  A++ +H   K   +H D+KP N+LLD      + DFGL
Sbjct: 104 --RFYIAETIL-AIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 48/182 (26%), Positives = 80/182 (43%), Gaps = 23/182 (12%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG GS G V           VAVK++ L ++   +    E   +R+ +H+N+V++     
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY---- 84

Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
            S   G +   L+ EF+  G+L   +           S + L+  Q   +  +V  AL Y
Sbjct: 85  KSYLVGEELWVLM-EFLQGGALTDIV-----------SQTRLNEEQIATVCESVLQALCY 132

Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           LH    + ++H D+K  ++LL  D    + DFG    I + +   +     L GT  + A
Sbjct: 133 LH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK----SLVGTPYWMA 185

Query: 629 PE 630
           PE
Sbjct: 186 PE 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 18/47 (38%), Positives = 32/47 (68%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNL 47
           ++T L +++L  N+F+G+IP  +G+L  LR +  N N+L G++P  L
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 52/195 (26%), Positives = 79/195 (40%), Gaps = 39/195 (20%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-----RHRNLVKI 503
           IG G++G V+K +   + +  AVK+L       +     E EA  NI      H N+VK 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKIL-----DPIHDIDEEIEAEYNILKALSDHPNVVKF 80

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLN---IAI 560
                  D +  D   LV E  + GS+             +     L   +R+    IA 
Sbjct: 81  YGMYYKKDVKNGDQLWLVLELCNGGSVT------------DLVKGFLKRGERMEEPIIAY 128

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +  AL  L H    + +H D+K +N+LL  +    + DFG+         S Q +S  L
Sbjct: 129 ILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV---------SAQLTSTRL 179

Query: 621 K-----GTVGYAAPE 630
           +     GT  + APE
Sbjct: 180 RRNTSVGTPFWMAPE 194

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 52/190 (27%), Positives = 76/190 (40%), Gaps = 21/190 (11%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQT--VVAVKVLFLHQRGALKSFMAECEALRNIRHRNL 500
           F   +L+G G FG V   ++    T  + A+KV+      A +  ++  E  R+I   + 
Sbjct: 3   FDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLA-QETVSFFEEERDILSISN 59

Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
              I     + FQ  D   LV E+   G L S L   +  +D         +L  L +AI
Sbjct: 60  SPWIPQLQYA-FQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLAI 115

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
           +    + Y         VH D+KP NVL+D      + DFG    +      N    V  
Sbjct: 116 HSVHQMGY---------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-- 164

Query: 621 KGTVGYAAPE 630
            GT  Y APE
Sbjct: 165 -GTPDYIAPE 173

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 23/66 (34%), Positives = 36/66 (54%), Gaps = 6/66 (9%)

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
           ALE+LH   K  I++ D+K  N+LLD++    + DFGL++   E        +    GT+
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK---EFHEDEVERAYSFCGTI 170

Query: 625 GYAAPE 630
            Y AP+
Sbjct: 171 EYMAPD 176

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 40.2 bits (94), Expect = 0.002
 Identities = 47/187 (25%), Positives = 79/187 (42%), Gaps = 28/187 (14%)

Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKI 503
           IG GSFG   K IL     D  Q V+    +        +    E   L N++H N+V+ 
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
                   F+ N    +V ++   G L   ++ +           +    Q L+  + + 
Sbjct: 65  -----QESFEENGNLYIVMDYCEGGDLYKKINAQRGV--------LFPEDQILDWFVQIC 111

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
            AL+++H    ++I+H D+K  N+ L  D    +GDFG+ R    V++S    +    GT
Sbjct: 112 LALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIAR----VLNSTVELARTCIGT 164

Query: 624 VGYAAPE 630
             Y +PE
Sbjct: 165 PYYLSPE 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 45/168 (26%), Positives = 73/168 (43%), Gaps = 17/168 (10%)

Query: 463 DPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVY 522
           DP + VVA  V+   +R A  +  +E   L    H  +VK        DF+ +D   L+ 
Sbjct: 91  DPKEKVVAKFVMLNDERQAAYA-RSELHCLAACDHFGIVK-----HFDDFKSDDKLLLIM 144

Query: 523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDL 582
           E+   G L   +  +   + L +    +  L        +  AL+ +H      ++H DL
Sbjct: 145 EYGSGGDLNKQIK-QRLKEHLPFQEYEVGLL-----FYQIVLALDEVHSRK---MMHRDL 195

Query: 583 KPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPE 630
           K +N+ L    I  +GDFG ++   + +S +  SS    GT  Y APE
Sbjct: 196 KSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS--FCGTPYYLAPE 241

Length = 478

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 40.5 bits (94), Expect = 0.002
 Identities = 39/163 (23%), Positives = 75/163 (46%), Gaps = 27/163 (16%)

Query: 449 IGTGSFGSV---YKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIIT 505
           IG+G+ G V   Y  +LD +  +  +   F +Q  A +++  E   ++ + H+N++ ++ 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 83

Query: 506 ACSSS----DFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
             +      +FQ      LV E M   +L   +  E   + ++Y            +   
Sbjct: 84  VFTPQKSLEEFQD---VYLVMELMD-ANLCQVIQMELDHERMSY------------LLYQ 127

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
           +   +++LH      I+H DLKPSN+++ +D    + DFGL R
Sbjct: 128 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 39.7 bits (93), Expect = 0.003
 Identities = 47/184 (25%), Positives = 77/184 (41%), Gaps = 27/184 (14%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNLVKIITA 506
           IG GS G V           VAVK + L   QR  L     E   +R+ +H N+V++   
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL--LFNEVVIMRDYQHPNIVEMY-- 82

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
              S +   D   +V EF+  G+L   +     +++           Q   + + V  AL
Sbjct: 83  ---SSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----------QIATVCLAVLKAL 128

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            +LH      ++H D+K  ++LL +D    + DFG    + + +   +     L GT  +
Sbjct: 129 SFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK----SLVGTPYW 181

Query: 627 AAPE 630
            APE
Sbjct: 182 MAPE 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 57/207 (27%), Positives = 87/207 (42%), Gaps = 41/207 (19%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNIRHRN 499
           F    +IG G+FG V    +   + + A+K+L    + +R     F  E    RN+    
Sbjct: 3   FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREE----RNVLVNG 58

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILS--FLQRLN 557
             + IT    + FQ  ++  LV ++   G L + L      D L   P  ++  ++  + 
Sbjct: 59  DCQWITTLHYA-FQDENYLYLVMDYYVGGDLLTLL--SKFEDRL---PEDMARFYIAEMV 112

Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQ--- 614
           +AI+    L Y         VH D+KP NVLLD +    + DFG        +  NQ   
Sbjct: 113 LAIHSIHQLHY---------VHRDIKPDNVLLDMNGHIRLADFG------SCLKMNQDGT 157

Query: 615 -CSSVGLKGTVGYAAPEY------GMG 634
             SSV + GT  Y +PE       GMG
Sbjct: 158 VQSSVAV-GTPDYISPEILQAMEDGMG 183

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 40.2 bits (94), Expect = 0.003
 Identities = 50/205 (24%), Positives = 81/205 (39%), Gaps = 42/205 (20%)

Query: 435 SLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEA 491
           ++ + T  +     +G G+FG V           VA+K +   F     A +++  E + 
Sbjct: 4   TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKL 62

Query: 492 LRNIRHRNLVKI--ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNY---- 545
           L+++RH N++ +  I      D         V E +                DL+     
Sbjct: 63  LKHLRHENIISLSDIFISPLEDIY------FVTELL--------------GTDLHRLLTS 102

Query: 546 SPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF 605
            P    F+Q       +   L+Y+H      +VH DLKPSN+L++ +    + DFGL R 
Sbjct: 103 RPLEKQFIQYF--LYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR- 156

Query: 606 IPEVISSNQCSSVGLKGTVGYAAPE 630
               I   Q +  G   T  Y APE
Sbjct: 157 ----IQDPQMT--GYVSTRYYRAPE 175

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 39.4 bits (92), Expect = 0.004
 Identities = 55/195 (28%), Positives = 81/195 (41%), Gaps = 31/195 (15%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNIRHRN 499
           F    +IG G+FG V    +     V A+K+L    + +R     F  E + L N   R 
Sbjct: 3   FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSF-LQRLNI 558
           +  +  A     FQ  +   LV ++   G L + L   S  +D      +  F L  + +
Sbjct: 63  ITNLHYA-----FQDENNLYLVMDYYVGGDLLTLL---SKFED-RLPEDMARFYLAEMVL 113

Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV--GDFG-LTRFIPEVISSNQC 615
           AI+    L Y         VH D+KP NVLL  D   H+   DFG   R + +       
Sbjct: 114 AIDSVHQLGY---------VHRDIKPDNVLL--DKNGHIRLADFGSCLRLLAD---GTVQ 159

Query: 616 SSVGLKGTVGYAAPE 630
           S+V + GT  Y +PE
Sbjct: 160 SNVAV-GTPDYISPE 173

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 39.2 bits (91), Expect = 0.004
 Identities = 48/196 (24%), Positives = 80/196 (40%), Gaps = 34/196 (17%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           F+   ++G GSFG V          + A+K+L    + Q   ++  M E   L       
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFL---QRL 556
            +  + +C    FQ  D    V E+++ G             DL Y    +      Q +
Sbjct: 62  FLTQLHSC----FQTVDRLYFVMEYVNGG-------------DLMYHIQQVGKFKEPQAV 104

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR--FIPEVISSNQ 614
             A  ++  L +LH   ++ I++ DLK  NV+LD++    + DFG+ +   +  V +   
Sbjct: 105 FYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTF 161

Query: 615 CSSVGLKGTVGYAAPE 630
           C      GT  Y APE
Sbjct: 162 C------GTPDYIAPE 171

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	640
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.98
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.98
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.98
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.97
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
KOG0605	550	consensus NDR and related serine/threonine kinases	99.97
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.97
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.97
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.97
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.97
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.97
KOG0578	550	consensus p21-activated serine/threonine protein k	99.97
KOG0198	313	consensus MEKK and related serine/threonine protei	99.97
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.97
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.97
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.97
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.97
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.97
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.96
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.96
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.96
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.96
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.96
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.96
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.96
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.96
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.96
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.96
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.96
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.96
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.96
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.96
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.96
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.96
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.96
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.96
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.96
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.96
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.96
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.96
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.96
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.96
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.96
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.96
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.95
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.95
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.95
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.95
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.95
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.95
KOG0589	426	consensus Serine/threonine protein kinase [General	99.95
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.95
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.95
KOG0610	459	consensus Putative serine/threonine protein kinase	99.95
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.95
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.95
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.95
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.95
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.95
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.95
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.95
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.95
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.95
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.95
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.95
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.95
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.95
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.95
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.95
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.95
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.95
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.95
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.95
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.95
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.95
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.95
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.95
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.95
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.95
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.95
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.95
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.95
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.95
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.95
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.95
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.95
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.95
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.95
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.95
PHA03212	391	serine/threonine kinase US3; Provisional	99.95
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.94
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.94
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.94
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.94
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.94
PTZ00267	478	NIMA-related protein kinase; Provisional	99.94
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.94
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.94
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.94
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.94
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.94
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.94
KOG0586	596	consensus Serine/threonine protein kinase [General	99.94
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.94
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.94
KOG0584	632	consensus Serine/threonine protein kinase [General	99.94
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.94
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.94
PTZ00283	496	serine/threonine protein kinase; Provisional	99.94
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.94
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.94
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.94
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.94
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.94
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.94
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.94
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.94
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.94
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.94
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.94
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.94
PTZ00036	440	glycogen synthase kinase; Provisional	99.94
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.94
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.94
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.94
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.93
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.93
PHA03211	461	serine/threonine kinase US3; Provisional	99.93
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.93
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.93
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.93
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.93
PHA02988	283	hypothetical protein; Provisional	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.93
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.93
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.93
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.93
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.93
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.93
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.93
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.93
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.93
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.93
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.93
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.93
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.93
PHA03209	357	serine/threonine kinase US3; Provisional	99.93
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.93
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.93
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.93
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.93
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.93
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.93
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.93
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.93
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.93
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.93
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.93
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.93
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.93
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.93
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.93
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.93
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.93
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.93
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.93
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.93
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.93
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.93
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.93
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.93
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.93
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.93
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.93
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.93
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.93
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.93
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.93
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.93
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.93
PTZ00284	467	protein kinase; Provisional	99.93
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.93
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.93
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.93
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.93
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.93
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.93
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.93
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.93
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.92
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.92
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.92
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.92
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.92
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.92
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.92
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.92
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.92
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.92
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.92
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.92
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.92
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.92
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.92
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.92
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.92
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.92
PHA03207	392	serine/threonine kinase US3; Provisional	99.92
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.92
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.92
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.92
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.92
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.92
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.92
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.92
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.92
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.92
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.92
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.92
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.92
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.92
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.92
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.92
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.92
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.92
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.92
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.92
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.92
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.92
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.92
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.92
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.92
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.92
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.92
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.92
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.92
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.92
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.92
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.92
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.92
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.92
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.92
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.92
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.92
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.92
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.92
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.92
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.92
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.92
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.92
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.92
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.92
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.92
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.92
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.92
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.92
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.92
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.92
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.92
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.92
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.92
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.92
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.92
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.92
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.92
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.92
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.92
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.91
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.91
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.91
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.91
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.91
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.91
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.91
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.91
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.91
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.91
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.91
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.91
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.91
KOG1152	772	consensus Signal transduction serine/threonine kin	99.91
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.91
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.91
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.91
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.91
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.91
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.91
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.91
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.91
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.91
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.91
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.91
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.91
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.91
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.91
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.91
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.91
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.91
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.91
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.91
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.91
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.91
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.91
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.91
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.91
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.91
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.91
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.91
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.91
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.91
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.91
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.91
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.91
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.91
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.91
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.91
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.91
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.9
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.9
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.9
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.9
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.9
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.9
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.9
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.9
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.9
PHA03210	501	serine/threonine kinase US3; Provisional	99.9
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.9
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.9
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.9
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.9
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.9
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.9
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.9
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.9
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.9
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.9
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.9
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.9
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.9
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.9
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.9
PLN00009	294	cyclin-dependent kinase A; Provisional	99.9
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.9
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.9
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.9
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.9
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.9
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.9
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.9
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.9
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.9
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.9
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.9
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.9
PHA02882	294	putative serine/threonine kinase; Provisional	99.9
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.89
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.89
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.89
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.89
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.89
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.89
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.89
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.89
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.89
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.89
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.89
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.89
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.89
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.89
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.89
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.89
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.89
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.88
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.88
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.88
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.88
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.88
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.88
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.88
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.88
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.88
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.88
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.88
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.88
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.87
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.87
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.86
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.85
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.83
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.83
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.83
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.83
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.83
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.82
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.82
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.82
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.81
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.81
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.81
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.8
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.8
PRK10345	210	hypothetical protein; Provisional	99.79
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.78
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.78
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.78
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.78
smart00090	237	RIO RIO-like kinase.	99.77
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.71
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.71
PRK12274	218	serine/threonine protein kinase; Provisional	99.7
PRK14879	211	serine/threonine protein kinase; Provisional	99.69
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.69
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.67
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.67
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.64
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.6
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.59
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.58
PLN00181	793	protein SPA1-RELATED; Provisional	99.58
PLN03150	623	hypothetical protein; Provisional	99.56
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.56
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.55
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.53
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.53
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.52
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.46
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.43
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.36
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.35
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.35
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.34
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.32
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.31
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.3
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.27
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.26
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.25
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.24
PLN03150	623	hypothetical protein; Provisional	99.24
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.24
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.23
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.21
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.21
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.18
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.17
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.14
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.12
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.08
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.08
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.07
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.05
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.97
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	98.97
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.96
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.93
KOG3087	229	consensus Serine/threonine protein kinase [General	98.84
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.82
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.81
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.8
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.77
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.76
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.75
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.73
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.65
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.62
KOG1243	690	consensus Protein kinase [General function predict	98.59
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.56
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.49
KOG1644	233	consensus U2-associated snRNP A' protein [RNA proc	98.48
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.47
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.45
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.44
PRK09902	216	hypothetical protein; Provisional	98.4
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.38
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.34

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.8e-73  Score=671.88  Aligned_cols=589  Identities=31%  Similarity=0.464  Sum_probs=367.3

Q ss_pred             CCCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCC----------------
Q 035691            2 LTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEE----------------   65 (640)
Q Consensus         2 l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~----------------   65 (640)
                      +++|+.|+|++|++++.+|..|+++++|++|++++|.+++..|..|.++++|++|+|++|++..                
T Consensus       211 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~  290 (968)
T PLN00113        211 MKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLD  290 (968)
T ss_pred             cCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEE
Confidence            5667777777777777777777777777777777777776677777777777777777665532                


Q ss_pred             ---ccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCC
Q 035691           66 ---NQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLG  142 (640)
Q Consensus        66 ---~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  142 (640)
                         |.+.+.+|..+ ..+++|+.|++++|.+.+..|..+..+++|+.|+|++|.+++..|..++.+++|+.|+|++|+++
T Consensus       291 Ls~n~l~~~~p~~~-~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~  369 (968)
T PLN00113        291 LSDNSLSGEIPELV-IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLT  369 (968)
T ss_pred             CcCCeeccCCChhH-cCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeE
Confidence               11112222222 22444444444444444444444444444444444444444444444444444444444444443


Q ss_pred             CCCCCcccccccccCCCCcceEecCCCCCCC-cCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCC
Q 035691          143 TRKVNDLRFLDSLVNCTYLEIVSLNVNSLRS-IPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGS  221 (640)
Q Consensus       143 ~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  221 (640)
                      +.      .++.+..+++|+.|++++|.+.. +|..+..+++|+.|++++|.+++..|..|..+++|+.|++++|.+++.
T Consensus       370 ~~------~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  443 (968)
T PLN00113        370 GE------IPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGR  443 (968)
T ss_pred             ee------CChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCc
Confidence            32      12223333334444444444433 333444445555555555555555555555555555555555555544


Q ss_pred             CCccccCCCC-----------------------ccEEeccCccccCC--------CCCceEEccCCcCCCCCCccCCCCC
Q 035691          222 IPSALGNCHQ-----------------------LQSLDLSKTIFLGQ--------YPVRWLDLSHNHLTGPIPLAVGNLK  270 (640)
Q Consensus       222 ~~~~~~~l~~-----------------------L~~L~ls~n~~~~~--------~~l~~L~Ls~N~l~~~~~~~~~~l~  270 (640)
                      +|..+..+++                       |+.|++++|.+.+.        ..|+.|+|++|++++.+|..|.+++
T Consensus       444 ~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  523 (968)
T PLN00113        444 INSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCK  523 (968)
T ss_pred             cChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCcc
Confidence            4444444444                       44455554444322        2356677777777777777777777


Q ss_pred             CCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCcccCCCCCCCCCcc
Q 035691          271 SIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASA  350 (640)
Q Consensus       271 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~p~~~~~~~~~~  350 (640)
                      +|+.|+|++|.+++.+|..|..+++|+.|+|++|++++.+|..+..+++|+.|++++|++.     +.+|..+.+.++..
T Consensus       524 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~-----~~~p~~~~~~~~~~  598 (968)
T PLN00113        524 KLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLH-----GSLPSTGAFLAINA  598 (968)
T ss_pred             CCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcce-----eeCCCcchhcccCh
Confidence            7777777777777777777777777777777777777777777777777777777777777     67887777888888


Q ss_pred             ccccCCCCCcCCCcCCCCCCCCCCccccccccCCeeeehhhhhhHHHHHHHHHhhhheeecccccccCCC-cccccc---
Q 035691          351 ISVAGNEKLCGGISELKLPPCTPSESKKRQKSNGFKLMIPLLSGLVGLVLVMSLLIIDRLRRKRTVTSSE-SSSRKD---  426 (640)
Q Consensus       351 ~~~~~n~~~c~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~rr~~~~~~~~-~~~~~~---  426 (640)
                      ..+.||+.+|++.+....|+|...   .... ..+.++++++++++++++++.+++++|+|++.+....+ ....+.   
T Consensus       599 ~~~~~n~~lc~~~~~~~~~~c~~~---~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  674 (968)
T PLN00113        599 SAVAGNIDLCGGDTTSGLPPCKRV---RKTP-SWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQF  674 (968)
T ss_pred             hhhcCCccccCCccccCCCCCccc---cccc-eeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccc
Confidence            889999999997765556666321   1111 11222222222223223333223333322221111111 111111   


Q ss_pred             ----cccccCHHHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcc
Q 035691          427 ----LLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK  502 (640)
Q Consensus       427 ----~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~  502 (640)
                          ....++++++.   ..|...++||+|+||.||+|++..++..||||+++.....    ...|++++++++|||||+
T Consensus       675 ~~~~~~~~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~  747 (968)
T PLN00113        675 FDSKVSKSITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVK  747 (968)
T ss_pred             cccccchhhhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcce
Confidence                11123334433   4567778999999999999999889999999998543321    235688999999999999


Q ss_pred             eeEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCC
Q 035691          503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDL  582 (640)
Q Consensus       503 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdl  582 (640)
                      ++++|...     +..++|||||++|+|.++++.             ++|..+.+|+.|++.||+|||+.+.++|+|||+
T Consensus       748 ~~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~~-------------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dl  809 (968)
T PLN00113        748 LIGLCRSE-----KGAYLIHEYIEGKNLSEVLRN-------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNL  809 (968)
T ss_pred             EEEEEEcC-----CCCEEEEeCCCCCcHHHHHhc-------------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCC
Confidence            99997543     467899999999999999841             678899999999999999999765689999999


Q ss_pred             CCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          583 KPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       583 kp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ||+||+++.++.+++. ||.+.....        .....||+.|||||++.+..+++|
T Consensus       810 kp~Nil~~~~~~~~~~-~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~  858 (968)
T PLN00113        810 SPEKIIIDGKDEPHLR-LSLPGLLCT--------DTKCFISSAYVAPETRETKDITEK  858 (968)
T ss_pred             CHHhEEECCCCceEEE-ecccccccc--------CCCccccccccCcccccCCCCCcc
Confidence            9999999999988875 666543211        112358899999999998888764

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1e-41  Score=402.16  Aligned_cols=352  Identities=35%  Similarity=0.527  Sum_probs=266.0

Q ss_pred             CCCCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCC
Q 035691            1 NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTL   80 (640)
Q Consensus         1 nl~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l   80 (640)
                      ++++|++|+|++|++++.+|..|+.+++|++|+|++|.+++.+|..|.++++|++|+|++|.+..     .+|..+ ..+
T Consensus       186 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~-----~~p~~l-~~l  259 (968)
T PLN00113        186 NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTG-----PIPSSL-GNL  259 (968)
T ss_pred             hCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceecc-----ccChhH-hCC
Confidence            47899999999999999999999999999999999999999999999999999999999887753     344433 346


Q ss_pred             CCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcc-----------
Q 035691           81 PNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDL-----------  149 (640)
Q Consensus        81 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----------  149 (640)
                      ++|+.|+|++|++++..|..+.++++|++|+|++|.+++.+|..+.++++|++|++++|.+++..+..+           
T Consensus       260 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L  339 (968)
T PLN00113        260 KNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQL  339 (968)
T ss_pred             CCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEEC
Confidence            666666666666666666666666666666666666666566666666666666666665554311000           


Q ss_pred             -------cccccccCCCCcceEecCCCCCCC-cCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCC
Q 035691          150 -------RFLDSLVNCTYLEIVSLNVNSLRS-IPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGS  221 (640)
Q Consensus       150 -------~~~~~l~~l~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  221 (640)
                             ..+..+..+++|+.|++++|+++. +|..+..+++|+.|++++|.+.+.+|..+..+++|+.|+|++|++++.
T Consensus       340 ~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~  419 (968)
T PLN00113        340 WSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGE  419 (968)
T ss_pred             cCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeE
Confidence                   023344445555555555555554 455555555666666666666666666677777888888888888878


Q ss_pred             CCccccCCCCccEEeccCccccCCC-------------------------------CCceEEccCCcCCCCCCccCCCCC
Q 035691          222 IPSALGNCHQLQSLDLSKTIFLGQY-------------------------------PVRWLDLSHNHLTGPIPLAVGNLK  270 (640)
Q Consensus       222 ~~~~~~~l~~L~~L~ls~n~~~~~~-------------------------------~l~~L~Ls~N~l~~~~~~~~~~l~  270 (640)
                      .|..|..+++|+.|++++|.+.+..                               .|+.|++++|++++..|..|.+++
T Consensus       420 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~  499 (968)
T PLN00113        420 LPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLS  499 (968)
T ss_pred             CChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhh
Confidence            8888888888888888887664321                               256788888888888888899999


Q ss_pred             CCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCcccCCC-CCCCCCc
Q 035691          271 SIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRK-GIFKNAS  349 (640)
Q Consensus       271 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~p~~-~~~~~~~  349 (640)
                      +|+.|+|++|++++.+|..+.++++|++|+|++|.+++.+|..|..+++|+.|||++|+++     +.+|.. ..+..+.
T Consensus       500 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-----~~~p~~l~~l~~L~  574 (968)
T PLN00113        500 ELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLS-----GEIPKNLGNVESLV  574 (968)
T ss_pred             ccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCccc-----ccCChhHhcCcccC
Confidence            9999999999999999999999999999999999999999999999999999999999998     666654 5567889


Q ss_pred             cccccCCCCCcCCC
Q 035691          350 AISVAGNEKLCGGI  363 (640)
Q Consensus       350 ~~~~~~n~~~c~~~  363 (640)
                      .+++++|+..+.-|
T Consensus       575 ~l~ls~N~l~~~~p  588 (968)
T PLN00113        575 QVNISHNHLHGSLP  588 (968)
T ss_pred             EEeccCCcceeeCC
Confidence            99999998766444

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-42  Score=343.91  Aligned_cols=347  Identities=24%  Similarity=0.211  Sum_probs=211.8

Q ss_pred             CcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCC
Q 035691            5 LMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIR   84 (640)
Q Consensus         5 L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~   84 (640)
                      -+.||+++|.|+..-+..|.++++|+++++.+|.++ .+|..-....+|+.|+|.+|.|++      +...-..-++.|+
T Consensus        80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~s------v~se~L~~l~alr  152 (873)
T KOG4194|consen   80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISS------VTSEELSALPALR  152 (873)
T ss_pred             eeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeecccccc------ccHHHHHhHhhhh
Confidence            356899999998888888899999999999999888 677755555568888888888765      3333333356666


Q ss_pred             eeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCccc--------------
Q 035691           85 IPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLR--------------  150 (640)
Q Consensus        85 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--------------  150 (640)
                      .||||.|.|+.+.-.+|..-.++++|+|++|+|+.+-.+.|.++.+|..|.|++|+|+.+|...|+              
T Consensus       153 slDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~  232 (873)
T KOG4194|consen  153 SLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNR  232 (873)
T ss_pred             hhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccc
Confidence            666666666655555565555666666666666665556666666666666666666665432111              


Q ss_pred             ----ccccccCCCCcceEecCCCCCCCcCc-CCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCcc
Q 035691          151 ----FLDSLVNCTYLEIVSLNVNSLRSIPI-SVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSA  225 (640)
Q Consensus       151 ----~~~~l~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~  225 (640)
                          ..-.|.++++|+.|.|..|.++.+.+ .|..+.++++|+|+.|+++..-.+++.+++.|+.|+||+|.|..+.++.
T Consensus       233 irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~  312 (873)
T KOG4194|consen  233 IRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDS  312 (873)
T ss_pred             eeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecch
Confidence                11234444444445555555544433 2333555555555555555555555555666666666666665555555


Q ss_pred             ccCCCCccEEeccCccccCCCC--------CceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCC---ccccCCC
Q 035691          226 LGNCHQLQSLDLSKTIFLGQYP--------VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIP---SSLGSCV  294 (640)
Q Consensus       226 ~~~l~~L~~L~ls~n~~~~~~~--------l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~  294 (640)
                      +..+++|+.||||.|.+..+.+        |+.|+|++|.|+.+-..+|.++++|++|||++|.|+..+.   ..|.+|+
T Consensus       313 WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~  392 (873)
T KOG4194|consen  313 WSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLP  392 (873)
T ss_pred             hhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccch
Confidence            5555666666666655544332        5556666666665555566666666666666666665443   2456666


Q ss_pred             CCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCcccCCCCCCCCCccccccCCCCCcCCC
Q 035691          295 GLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGI  363 (640)
Q Consensus       295 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~p~~~~~~~~~~~~~~~n~~~c~~~  363 (640)
                      +|+.|+|.+|+|..+.-.+|.+++.|++|||.+|.+.....+++.|.     .++.+-+.....+|.+.
T Consensus       393 ~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-----~Lk~Lv~nSssflCDCq  456 (873)
T KOG4194|consen  393 SLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-----ELKELVMNSSSFLCDCQ  456 (873)
T ss_pred             hhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-----hhhhhhhcccceEEecc
Confidence            77777777777766556677777777777777777765554444432     34444445555566655

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-41  Score=343.77  Aligned_cols=334  Identities=24%  Similarity=0.225  Sum_probs=246.9

Q ss_pred             CCCCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCC
Q 035691            1 NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTL   80 (640)
Q Consensus         1 nl~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l   80 (640)
                      ||++|+.+++..|.++ .+|.......+|+.|+|.+|.|+.+..++++.++.|++||||.|.|++      +|...|-.-
T Consensus       100 nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~------i~~~sfp~~  172 (873)
T KOG4194|consen  100 NLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISE------IPKPSFPAK  172 (873)
T ss_pred             cCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhc------ccCCCCCCC
Confidence            4555555555555555 455444444445555555555555555555555555555555555543      444444333


Q ss_pred             CCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCccc----------
Q 035691           81 PNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLR----------  150 (640)
Q Consensus        81 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~----------  150 (640)
                      .+++.|+|++|.|+.+..+.|.++.+|.+|.|+.|+|+.+++..|+.|++|+.|+|..|+|.-+..-.|.          
T Consensus       173 ~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlkl  252 (873)
T KOG4194|consen  173 VNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKL  252 (873)
T ss_pred             CCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhh
Confidence            4455555555555544445555555555555555555544444455455555555555544332111111          


Q ss_pred             --------ccccccCCCCcceEecCCCCCCCcCc-CCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCC
Q 035691          151 --------FLDSLVNCTYLEIVSLNVNSLRSIPI-SVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGS  221 (640)
Q Consensus       151 --------~~~~l~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  221 (640)
                              -...|..|.++++|+|+.|+++.+.. ++.++++|+.|+||+|.|..+.++.+.-.++|++|+|++|+|+..
T Consensus       253 qrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l  332 (873)
T KOG4194|consen  253 QRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRL  332 (873)
T ss_pred             hhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccC
Confidence                    22467789999999999999999765 678899999999999999999999999999999999999999999


Q ss_pred             CCccccCCCCccEEeccCcc--------ccCCCCCceEEccCCcCCCCCC---ccCCCCCCCCEEECCCCcccCcCCccc
Q 035691          222 IPSALGNCHQLQSLDLSKTI--------FLGQYPVRWLDLSHNHLTGPIP---LAVGNLKSIPHLDLSKNKLSGEIPSSL  290 (640)
Q Consensus       222 ~~~~~~~l~~L~~L~ls~n~--------~~~~~~l~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~p~~~  290 (640)
                      .++.|..+..|+.|.|++|.        |.++.+|+.|||++|.|+..+.   ..|.+|++|+.|+|.+|+|..+.-.+|
T Consensus       333 ~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAf  412 (873)
T KOG4194|consen  333 DEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAF  412 (873)
T ss_pred             ChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhh
Confidence            99999999999999999985        5677889999999999987664   468999999999999999997777899


Q ss_pred             cCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCcccCCC
Q 035691          291 GSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRK  342 (640)
Q Consensus       291 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~p~~  342 (640)
                      .++.+|++|||.+|.|..+.|.+|..+ .|++|-+..-.|-|+|+-.|+++|
T Consensus       413 sgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCql~Wl~qW  463 (873)
T KOG4194|consen  413 SGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQLKWLAQW  463 (873)
T ss_pred             ccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEEeccHHHHHHH
Confidence            999999999999999999999999999 999999999999999998888876

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=315.97  Aligned_cols=178  Identities=31%  Similarity=0.543  Sum_probs=157.3

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      .++|...+.||+|+||+||+|+++.++..||||.+...  .++..+....|+.+|++++|||||++++++..     .++
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-----~~~   83 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED-----DDF   83 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec-----CCe
Confidence            46788888899999999999999999999999999655  55667889999999999999999999999644     458


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC-----
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND-----  592 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~-----  592 (640)
                      +|+|||||.||||.+|++..+.          +++.++..++.|+|.||++||+   ++||||||||.|||++..     
T Consensus        84 i~lVMEyC~gGDLs~yi~~~~~----------l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~  150 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRRRGR----------LPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDT  150 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCC
Confidence            9999999999999999987653          8899999999999999999999   799999999999999764     


Q ss_pred             -CcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          593 -MIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       593 -~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                       -.+||+|||+||.+.+     .....+.+|+|.|||||+++..+|+.|
T Consensus       151 ~~~LKIADFGfAR~L~~-----~~~a~tlcGSplYMAPEV~~~~~YdAK  194 (429)
T KOG0595|consen  151 SPVLKIADFGFARFLQP-----GSMAETLCGSPLYMAPEVIMSQQYDAK  194 (429)
T ss_pred             CceEEecccchhhhCCc-----hhHHHHhhCCccccCHHHHHhccccch
Confidence             4689999999998853     223345789999999999999999876

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=318.21  Aligned_cols=198  Identities=44%  Similarity=0.730  Sum_probs=168.5

Q ss_pred             cccccCHHHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEe
Q 035691          427 LLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITA  506 (640)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~  506 (640)
                      ....++++++.++|++|+..+.||+|+||.||+|... +|+.||||++........++|.+|+.++.+++|||+|+++||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            5667999999999999999999999999999999997 569999998865443313569999999999999999999999


Q ss_pred             eccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCC
Q 035691          507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSN  586 (640)
Q Consensus       507 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~N  586 (640)
                      |.+.+    +..++|+|||++|+|.++|+.....        .++|.++++||.++|+||+|||+.+.++|+||||||+|
T Consensus       140 C~e~~----~~~~LVYEym~nGsL~d~L~~~~~~--------~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssN  207 (361)
T KOG1187|consen  140 CLEGG----EHRLLVYEYMPNGSLEDHLHGKKGE--------PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSN  207 (361)
T ss_pred             EecCC----ceEEEEEEccCCCCHHHHhCCCCCC--------CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHH
Confidence            96543    2589999999999999999865431        48999999999999999999999988899999999999


Q ss_pred             eeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          587 VLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       587 iLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ||+|+++.+||+|||+|+..+.. .......  ..||.+|+|||++..+..|+|
T Consensus       208 ILLD~~~~aKlsDFGLa~~~~~~-~~~~~~~--~~gt~gY~~PEy~~~g~lt~K  258 (361)
T KOG1187|consen  208 ILLDEDFNAKLSDFGLAKLGPEG-DTSVSTT--VMGTFGYLAPEYASTGKLTEK  258 (361)
T ss_pred             eeECCCCCEEccCccCcccCCcc-ccceeee--cCCCCccCChhhhccCCcCcc
Confidence            99999999999999999866531 1111111  059999999999998888875

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-36  Score=290.70  Aligned_cols=178  Identities=31%  Similarity=0.416  Sum_probs=157.0

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      .++|++.++||+|+||+||.++.+++++.||+|++++.   ..+..+...+|..+|.+++||.||+++..     |++.+
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~~   98 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTEE   98 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccCC
Confidence            46789999999999999999999999999999999644   23456788999999999999999999877     78888


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..|+|+||+.||+|..+|++.+.          +++..+..++.+|+.||+|||+   .+||||||||+|||+|.+|+++
T Consensus        99 kLylVld~~~GGeLf~hL~~eg~----------F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~  165 (357)
T KOG0598|consen   99 KLYLVLDYLNGGELFYHLQREGR----------FSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIK  165 (357)
T ss_pred             eEEEEEeccCCccHHHHHHhcCC----------cchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEE
Confidence            99999999999999999976543          8888899999999999999999   7999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|||+++.-..    ....+.+++||+.|||||++++..|+.
T Consensus       166 LtDFgL~k~~~~----~~~~t~tfcGT~eYmAPEil~~~gy~~  204 (357)
T KOG0598|consen  166 LTDFGLCKEDLK----DGDATRTFCGTPEYMAPEILLGKGYDK  204 (357)
T ss_pred             Eeccccchhccc----CCCccccccCCccccChHHHhcCCCCc
Confidence            999999995322    122344589999999999999988875

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=287.05  Aligned_cols=175  Identities=29%  Similarity=0.425  Sum_probs=151.5

Q ss_pred             cccCcccccccceEEEEEECCCCeEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          444 SSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       444 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      +..+.||+|..|+||+++++.+++.+|+|++... +....+++.+|+++++..+||+||++||+|+...    ....++|
T Consensus        82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~----~~isI~m  157 (364)
T KOG0581|consen   82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG----EEISICM  157 (364)
T ss_pred             hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC----ceEEeeh
Confidence            3458899999999999999999999999999443 3445578999999999999999999999964322    1589999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      |||++|+|..++...+          .+++...-+|+.+|++||.|||+.  ++||||||||+|||++.+|++||+|||.
T Consensus       158 EYMDgGSLd~~~k~~g----------~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGV  225 (364)
T KOG0581|consen  158 EYMDGGSLDDILKRVG----------RIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGV  225 (364)
T ss_pred             hhcCCCCHHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccc
Confidence            9999999999987542          288899999999999999999974  7999999999999999999999999999


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ++.+...      ...+++||..|||||.+.|..|+.+
T Consensus       226 S~~lvnS------~a~tfvGT~~YMsPERi~g~~Ys~~  257 (364)
T KOG0581|consen  226 SGILVNS------IANTFVGTSAYMSPERISGESYSVK  257 (364)
T ss_pred             cHHhhhh------hcccccccccccChhhhcCCcCCcc
Confidence            9976532      3345789999999999999998864

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-36  Score=279.25  Aligned_cols=186  Identities=25%  Similarity=0.378  Sum_probs=156.1

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +|++.++||+|+||.||++++..+|..||.|.+...  +.+.++....|+.+|++++|||||+++++..   .......+
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f---~~~~evln   96 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF---IEDNEVLN   96 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh---hccchhhH
Confidence            356779999999999999999999999999998533  4556688999999999999999999987532   22233488


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeeCCCCCCCeeeCCCCcEEEc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKK-QIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~-~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      +|||||++|||..+++..+...      ..+++..+|++..|++.||..+|+..++ -|+||||||.||+++.+|.+|++
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qk------r~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLG  170 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQK------RLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLG  170 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhcc------ccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeec
Confidence            9999999999999997544322      4589999999999999999999985433 28999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |||++|.+...    .....+.+|||+||+||.+.+..|+.|
T Consensus       171 DfGL~r~l~s~----~tfA~S~VGTPyYMSPE~i~~~~Y~~k  208 (375)
T KOG0591|consen  171 DFGLGRFLSSK----TTFAHSLVGTPYYMSPERIHESGYNFK  208 (375)
T ss_pred             cchhHhHhcch----hHHHHhhcCCCcccCHHHHhcCCCCcc
Confidence            99999987542    233455789999999999999999875

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-34  Score=281.68  Aligned_cols=175  Identities=27%  Similarity=0.373  Sum_probs=146.3

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc------h-hHHHHHHHHHHHHhcCCCCCcceeEeeccCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR------G-ALKSFMAECEALRNIRHRNLVKIITACSSSDF  512 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  512 (640)
                      .+.|.+.+.||+|+||.|-+|..+.+|+.||||++....-      . ......+|+++|+++.|||||++++++     
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f-----  245 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF-----  245 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee-----
Confidence            3456778999999999999999999999999999954321      1 112356999999999999999999994     


Q ss_pred             CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC
Q 035691          513 QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND  592 (640)
Q Consensus       513 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~  592 (640)
                      ...++.|||||||+||+|.+++-..+.          +.+.....+++|++.|+.|||+   +||+||||||+|||+..+
T Consensus       246 ~~~ds~YmVlE~v~GGeLfd~vv~nk~----------l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~  312 (475)
T KOG0615|consen  246 EVPDSSYMVLEYVEGGELFDKVVANKY----------LREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSND  312 (475)
T ss_pred             ecCCceEEEEEEecCccHHHHHHhccc----------cccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccC
Confidence            455578999999999999999876654          4555667899999999999999   799999999999999766


Q ss_pred             ---CcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCC
Q 035691          593 ---MIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV  637 (640)
Q Consensus       593 ---~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  637 (640)
                         ..+||+|||+|+...+     ...+.+.||||.|.|||++.+.-.
T Consensus       313 ~e~~llKItDFGlAK~~g~-----~sfm~TlCGTpsYvAPEVl~~kg~  355 (475)
T KOG0615|consen  313 AEDCLLKITDFGLAKVSGE-----GSFMKTLCGTPSYVAPEVLASKGV  355 (475)
T ss_pred             CcceEEEecccchhhcccc-----ceehhhhcCCccccChhheecCCe
Confidence               7899999999997642     334567899999999999976543

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=7.1e-37  Score=310.57  Aligned_cols=339  Identities=28%  Similarity=0.426  Sum_probs=232.0

Q ss_pred             CCCCcEEeCCCCccc-cCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCC
Q 035691            2 LTFLMLINLQQNNFS-GNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTL   80 (640)
Q Consensus         2 l~~L~~L~L~~n~i~-~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l   80 (640)
                      |+..+-.|+++|.++ +..|.....++++++|.|.+.++. .+|..++.|.+|++|.+++|+|..  +.|++.     .|
T Consensus         6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~--vhGELs-----~L   77 (1255)
T KOG0444|consen    6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLIS--VHGELS-----DL   77 (1255)
T ss_pred             cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHh--hhhhhc-----cc
Confidence            345566777777777 456677777777777777777776 666777777777777777776643  222221     24


Q ss_pred             CCCCeeeccCCccc-ccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCC
Q 035691           81 PNIRIPLLAGNQFF-GNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCT  159 (640)
Q Consensus        81 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~  159 (640)
                      +.|+.+++.+|++. .-+|..+-.+..|++||||+|+++ ..|..+..-+++-.|+||+|+|.++|.      .-|.+++
T Consensus        78 p~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn------~lfinLt  150 (1255)
T KOG0444|consen   78 PRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPN------SLFINLT  150 (1255)
T ss_pred             hhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCc------hHHHhhH
Confidence            44444555555443 123333334445555555555554 344444444445555555555544432      2233444


Q ss_pred             CcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCc-------------------------ccCCcCccCCCCCCEEEcc
Q 035691          160 YLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNIS-------------------------GEIPSSLGNFTFLTELNLR  214 (640)
Q Consensus       160 ~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~-------------------------~~~p~~~~~l~~L~~L~L~  214 (640)
                      .|-.||||+|++..+|+.+..+..|++|+|++|.+.                         .-+|.++..+.+|..+|||
T Consensus       151 DLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS  230 (1255)
T KOG0444|consen  151 DLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLS  230 (1255)
T ss_pred             hHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhcccc
Confidence            444445555554444444444444444444444332                         3467788889999999999


Q ss_pred             CCCCCCCCCccccCCCCccEEeccCccccCCC-------CCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccC-cC
Q 035691          215 GNSIRGSIPSALGNCHQLQSLDLSKTIFLGQY-------PVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSG-EI  286 (640)
Q Consensus       215 ~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~-------~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~  286 (640)
                      .|.+. ..|+.+-++++|+.|+||+|.++.+.       .++.|+||+|+++ .+|.+++.+++|+.|++.+|+++- -+
T Consensus       231 ~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGi  308 (1255)
T KOG0444|consen  231 ENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGI  308 (1255)
T ss_pred             ccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCC
Confidence            99998 88999999999999999999987653       4889999999999 899999999999999999999983 47


Q ss_pred             CccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCcccCCCCCCCCCccccccCCCCCcCCC
Q 035691          287 PSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGI  363 (640)
Q Consensus       287 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~p~~~~~~~~~~~~~~~n~~~c~~~  363 (640)
                      |+.++.+.+|+.+..++|.+. ..|..++.+..|+.|.|++|.+..++..-     -.++.++.+++..||.+.-+|
T Consensus       309 PSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaI-----HlL~~l~vLDlreNpnLVMPP  379 (1255)
T KOG0444|consen  309 PSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAI-----HLLPDLKVLDLRENPNLVMPP  379 (1255)
T ss_pred             ccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeechhhh-----hhcCCcceeeccCCcCccCCC
Confidence            889999999999999999997 78999999999999999999998654321     235567888888888765444

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-34  Score=285.57  Aligned_cols=175  Identities=29%  Similarity=0.433  Sum_probs=149.7

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      |+..++||+|.||.||+|++..+|+.||+|++....  ++......+||.+|++++|||||++.+......   ...+|+
T Consensus       119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~---~~siYl  195 (560)
T KOG0600|consen  119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL---SGSIYL  195 (560)
T ss_pred             HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC---CceEEE
Confidence            455688999999999999999999999999997654  556677889999999999999999999976542   457899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      |+|||++ ||.-++.....         .+++.++..++.|++.||+|+|+   ++|+|||||.+|||||.+|.+||+||
T Consensus       196 VFeYMdh-DL~GLl~~p~v---------kft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDF  262 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPGV---------KFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADF  262 (560)
T ss_pred             EEecccc-hhhhhhcCCCc---------ccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccc
Confidence            9999988 78777754332         38889999999999999999999   79999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      |+|+++......   ..+..+-|.||+|||.++|..
T Consensus       263 GLAr~y~~~~~~---~~T~rVvTLWYRpPELLLG~t  295 (560)
T KOG0600|consen  263 GLARFYTPSGSA---PYTSRVVTLWYRPPELLLGAT  295 (560)
T ss_pred             cceeeccCCCCc---ccccceEEeeccChHHhcCCc
Confidence            999988653322   133456799999999999975

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=288.96  Aligned_cols=176  Identities=36%  Similarity=0.505  Sum_probs=145.8

Q ss_pred             cccCcccccccceEEEEEECCCCeE-EEEEEeecccch--hHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          444 SSANLIGTGSFGSVYKGILDPDQTV-VAVKVLFLHQRG--ALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       444 ~~~~~lg~G~~g~Vy~~~~~~~~~~-vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      ...+.+|+|+||+||+|.++  |+. ||||++.....+  ..+.|.+|+.+|.+++|||||+++|+|.....    ..++
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~~i  117 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SLCI  117 (362)
T ss_pred             hhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ceEE
Confidence            34466999999999999996  555 999999654322  25699999999999999999999999865431    5789


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eeeCCCCCCCeeeCCCC-cEEEc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQ-IVHCDLKPSNVLLDNDM-IAHVG  598 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~-ivHrdlkp~NiLl~~~~-~~kl~  598 (640)
                      |||||++|+|.++++....        ..+++..++.|+.|||+||.|||+.   + ||||||||+|||++.++ ++||+
T Consensus       118 VtEy~~~GsL~~~l~~~~~--------~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~  186 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHKKRK--------RKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIA  186 (362)
T ss_pred             EEEeCCCCcHHHHHhhccc--------CCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEEC
Confidence            9999999999999976411        3489999999999999999999994   5 99999999999999997 99999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCC--CCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGM--GSQVSTN  640 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~k  640 (640)
                      |||+++......    ...+...||+.|||||++.  +.+|+.|
T Consensus       187 DFGlsr~~~~~~----~~~~~~~GT~~wMAPEv~~~~~~~~~~K  226 (362)
T KOG0192|consen  187 DFGLSREKVISK----TSMTSVAGTYRWMAPEVLRGEKSPYTEK  226 (362)
T ss_pred             CCccceeecccc----ccccCCCCCccccChhhhcCCCCcCCcc
Confidence            999998653211    1222357999999999999  5588765

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.4e-34  Score=269.71  Aligned_cols=173  Identities=24%  Similarity=0.379  Sum_probs=144.5

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .|+...++|+|+||.||+|+++++|+.||||++..+.+  .-.+-.++|+++|++++|||+|.++++     |..+..++
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEV-----Frrkrklh   77 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEV-----FRRKRKLH   77 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHH-----HHhcceeE
Confidence            46677899999999999999999999999999954332  233568899999999999999999999     56667899


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +|+|||+.--|.+ |....         ..++...+.+++.|++.|+.|+|+   .+++||||||+|||++.+|.+|+||
T Consensus        78 LVFE~~dhTvL~e-Le~~p---------~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCD  144 (396)
T KOG0593|consen   78 LVFEYCDHTVLHE-LERYP---------NGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCD  144 (396)
T ss_pred             EEeeecchHHHHH-HHhcc---------CCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEecc
Confidence            9999998844444 33322         348888999999999999999999   5999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      ||+||.+.++..    ..+.++.|.||+|||.+.|..
T Consensus       145 FGFAR~L~~pgd----~YTDYVATRWYRaPELLvGDt  177 (396)
T KOG0593|consen  145 FGFARTLSAPGD----NYTDYVATRWYRAPELLVGDT  177 (396)
T ss_pred             chhhHhhcCCcc----hhhhhhhhhhccChhhhcccC
Confidence            999998754221    223457899999999999944

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=263.19  Aligned_cols=173  Identities=31%  Similarity=0.382  Sum_probs=152.6

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|+....||.|+||+|..++.+.+|..+|+|+++..+   .++.+...+|..+|+.+.||.++++++.     +.+...
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t-----~~d~~~  118 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGT-----FKDNSN  118 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEe-----eccCCe
Confidence            34677799999999999999999999999999996543   3456788899999999999999999988     455668


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||++||.|..+++..+.          +++..+..+|+||+.|++|||+   ..|++||+||+|||+|.+|.+||
T Consensus       119 lymvmeyv~GGElFS~Lrk~~r----------F~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKi  185 (355)
T KOG0616|consen  119 LYMVMEYVPGGELFSYLRKSGR----------FSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKI  185 (355)
T ss_pred             EEEEEeccCCccHHHHHHhcCC----------CCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEE
Confidence            9999999999999999976543          7888899999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      +|||+|+...+       .+.+.||||.|+|||++.+..+.
T Consensus       186 tDFGFAK~v~~-------rT~TlCGTPeYLAPEii~sk~yn  219 (355)
T KOG0616|consen  186 TDFGFAKRVSG-------RTWTLCGTPEYLAPEIIQSKGYN  219 (355)
T ss_pred             EeccceEEecC-------cEEEecCCccccChHHhhcCCCC
Confidence            99999997643       23457899999999999887764

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.9e-33  Score=284.05  Aligned_cols=176  Identities=29%  Similarity=0.398  Sum_probs=155.4

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      .+|...++||+|||++||++++..+|+.||+|++...   ....++...+|+++.+.++|||||+++++     |++.++
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecCCc
Confidence            4688899999999999999999889999999999642   45567889999999999999999999999     677789


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      +|+|.|+|+.|+|.++++..+.          +++..+..+.+||+.||.|||+   .+|+|||||..|++++++.++||
T Consensus        93 VYivLELC~~~sL~el~Krrk~----------ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKI  159 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKRRKP----------LTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKI  159 (592)
T ss_pred             eEEEEEecCCccHHHHHHhcCC----------CCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEe
Confidence            9999999999999999985433          8889999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      +|||+|..+..+    ...-.+.||||-|.|||++...-++
T Consensus       160 gDFGLAt~le~~----~Erk~TlCGTPNYIAPEVl~k~gHs  196 (592)
T KOG0575|consen  160 GDFGLATQLEYD----GERKKTLCGTPNYIAPEVLNKSGHS  196 (592)
T ss_pred             cccceeeeecCc----ccccceecCCCcccChhHhccCCCC
Confidence            999999977532    2334567999999999999865544

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=2.4e-35  Score=299.48  Aligned_cols=318  Identities=26%  Similarity=0.349  Sum_probs=234.5

Q ss_pred             CCCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCC
Q 035691            2 LTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLP   81 (640)
Q Consensus         2 l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~   81 (640)
                      +++++.|.|.+.++. .+|++++.+.+|++|.+++|++. .+-+.++.|+.|+.+++.+|+|..    ..+|+.+|. +.
T Consensus        31 Mt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKn----sGiP~diF~-l~  103 (1255)
T KOG0444|consen   31 MTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKN----SGIPTDIFR-LK  103 (1255)
T ss_pred             hhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhcccccc----CCCCchhcc-cc
Confidence            455666666666666 56667777777777777777666 344456666666666666666653    126666664 66


Q ss_pred             CCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCccc-----------
Q 035691           82 NIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLR-----------  150 (640)
Q Consensus        82 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----------  150 (640)
                      .|++||||+|+++ ..|..+...+++.+|+||+|+|..++-..|.+|+.|-.||||+|++..+|++.-+           
T Consensus       104 dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~  182 (1255)
T KOG0444|consen  104 DLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSN  182 (1255)
T ss_pred             cceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCC
Confidence            6666666666665 4455565666666666666666654445555666666666666666555432110           


Q ss_pred             ------ccccccCCCCcceEecCCCCCC--CcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCC
Q 035691          151 ------FLDSLVNCTYLEIVSLNVNSLR--SIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSI  222 (640)
Q Consensus       151 ------~~~~l~~l~~L~~L~L~~N~l~--~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  222 (640)
                            -...+..+++|+.|.+++.+=+  .+|.++..+.+|..+|||.|.+. +.|+.+.++.+|+.|+||+|+|+ ..
T Consensus       183 NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL  260 (1255)
T KOG0444|consen  183 NPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-EL  260 (1255)
T ss_pred             ChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-ee
Confidence                  1123445566666666666544  37888888889999999999999 88999999999999999999998 44


Q ss_pred             CccccCCCCccEEeccCccccCCC-------CCceEEccCCcCC-CCCCccCCCCCCCCEEECCCCcccCcCCccccCCC
Q 035691          223 PSALGNCHQLQSLDLSKTIFLGQY-------PVRWLDLSHNHLT-GPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCV  294 (640)
Q Consensus       223 ~~~~~~l~~L~~L~ls~n~~~~~~-------~l~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  294 (640)
                      ........+|+.|+||.|+++.++       .|+.|++.+|+++ .-+|..++.+.+|+.+..++|++. ..|..++.|.
T Consensus       261 ~~~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~  339 (1255)
T KOG0444|consen  261 NMTEGEWENLETLNLSRNQLTVLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCV  339 (1255)
T ss_pred             eccHHHHhhhhhhccccchhccchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhH
Confidence            555667788999999999887654       4788999999987 346899999999999999999998 9999999999


Q ss_pred             CCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccc
Q 035691          295 GLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQ  331 (640)
Q Consensus       295 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  331 (640)
                      .|+.|.|+.|++- ..|+++.-|+.|+.||+..|+--
T Consensus       340 kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL  375 (1255)
T KOG0444|consen  340 KLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL  375 (1255)
T ss_pred             HHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence            9999999999997 68999999999999999999854

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.98  E-value=6.5e-36  Score=289.79  Aligned_cols=335  Identities=32%  Similarity=0.483  Sum_probs=261.0

Q ss_pred             CCCCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCC---------------
Q 035691            1 NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEE---------------   65 (640)
Q Consensus         1 nl~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~---------------   65 (640)
                      ||..|++|++++|+++ ..|++++.+..++.|+.++|+++ .+|.++..+.+|..||.++|++.+               
T Consensus        66 nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~el~~~i~~~~~l~dl~  143 (565)
T KOG0472|consen   66 NLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELKELPDSIGRLLDLEDLD  143 (565)
T ss_pred             cccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccccceeecCchHHHHhhhhhhh
Confidence            5677888899999888 67778888888888888888888 788888888888888888887754               


Q ss_pred             --ccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCC
Q 035691           66 --NQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGT  143 (640)
Q Consensus        66 --~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  143 (640)
                        ++-..++|++++. +.++..+++.+|.+....|+.+. ++.|+.||...|-++ .+|+.++++.+|..|+|.+|+|..
T Consensus       144 ~~~N~i~slp~~~~~-~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~  220 (565)
T KOG0472|consen  144 ATNNQISSLPEDMVN-LSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRF  220 (565)
T ss_pred             ccccccccCchHHHH-HHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhccccc
Confidence              1111235555553 56666666666666655554444 777777787777777 577778888888888888888876


Q ss_pred             CCCCcccccccccCCCCcceEecCCCCCCCcCcCCC-CCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCC
Q 035691          144 RKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVG-YLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSI  222 (640)
Q Consensus       144 ~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  222 (640)
                      +        .+|.+|+.|++|+++.|+|+.+|.+.. +++++.+|||.+|+++ ..|+.++-+.+|+.||+|+|.|+ ..
T Consensus       221 l--------Pef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~L  290 (565)
T KOG0472|consen  221 L--------PEFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SL  290 (565)
T ss_pred             C--------CCCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cC
Confidence            4        468899999999999999999998775 7999999999999999 78999999999999999999999 66


Q ss_pred             CccccCCCCccEEeccCcccc-------------------------CC-------------C------------------
Q 035691          223 PSALGNCHQLQSLDLSKTIFL-------------------------GQ-------------Y------------------  246 (640)
Q Consensus       223 ~~~~~~l~~L~~L~ls~n~~~-------------------------~~-------------~------------------  246 (640)
                      |..++++ .|+.|.+.+|.+.                         |.             .                  
T Consensus       291 p~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~  369 (565)
T KOG0472|consen  291 PYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDV  369 (565)
T ss_pred             Ccccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcc
Confidence            7789999 8999988877421                         00             0                  


Q ss_pred             --------C-----------Cce------------------------EEccCCcCCCCCCccCCCCCCCCEEECCCCccc
Q 035691          247 --------P-----------VRW------------------------LDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLS  283 (640)
Q Consensus       247 --------~-----------l~~------------------------L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  283 (640)
                              |           .+.                        +++++|.++ .+|..++.+++|..|+|++|.+.
T Consensus       370 s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln  448 (565)
T KOG0472|consen  370 SDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN  448 (565)
T ss_pred             cccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh
Confidence                    0           112                        334444443 56777788889999999999887


Q ss_pred             CcCCccccCCCCCCeEEecCCccC-----------------------CCCCccCCCCCCCCeEeCcCCccccccCCcccC
Q 035691          284 GEIPSSLGSCVGLEYLNLSINSFH-----------------------GPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVP  340 (640)
Q Consensus       284 ~~~p~~~~~l~~L~~L~L~~N~l~-----------------------~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~p  340 (640)
                       .+|..++.+..|+.||+|.|+|.                       .+.|+.+.++.+|..|||.+|.++.      +|
T Consensus       449 -~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~------IP  521 (565)
T KOG0472|consen  449 -DLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQ------IP  521 (565)
T ss_pred             -hcchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhh------CC
Confidence             78888888888999999888774                       3344458889999999999999983      44


Q ss_pred             C-CCCCCCCccccccCCCCC
Q 035691          341 R-KGIFKNASAISVAGNEKL  359 (640)
Q Consensus       341 ~-~~~~~~~~~~~~~~n~~~  359 (640)
                      . .+.+.++..+.+.|||+.
T Consensus       522 p~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  522 PILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             hhhccccceeEEEecCCccC
Confidence            4 488999999999999864

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.98  E-value=1.6e-32  Score=253.26  Aligned_cols=174  Identities=30%  Similarity=0.452  Sum_probs=149.1

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +|...+++|+|.||.||+|++.++|+.||||+++....  +-.....+|++.|++++|+||+.++++     |.......
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~-----F~~~~~l~   77 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV-----FPHKSNLS   77 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh-----ccCCCceE
Confidence            56677899999999999999999999999999976543  234578899999999999999999999     66667889


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +|+|||+- ||...++...         ..+....+..++.++.+|++|+|.   ..|+|||+||.|+|++.+|.+||+|
T Consensus        78 lVfEfm~t-dLe~vIkd~~---------i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiAD  144 (318)
T KOG0659|consen   78 LVFEFMPT-DLEVVIKDKN---------IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIAD  144 (318)
T ss_pred             EEEEeccc-cHHHHhcccc---------cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeec
Confidence            99999976 8998887554         347888999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV  637 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  637 (640)
                      ||+|+.+.........    .+-|.||+|||.+.|++.
T Consensus       145 FGLAr~f~~p~~~~~~----~V~TRWYRAPELLfGsr~  178 (318)
T KOG0659|consen  145 FGLARFFGSPNRIQTH----QVVTRWYRAPELLFGSRQ  178 (318)
T ss_pred             ccchhccCCCCccccc----ceeeeeccChHHhccchh
Confidence            9999988654322211    257999999999998764

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.98  E-value=1.4e-32  Score=261.14  Aligned_cols=176  Identities=28%  Similarity=0.396  Sum_probs=149.6

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .|+..+.|++|+||.||+|+++.+++.||+|+++...  .+..-..++||.++.+++|||||.+-++..+..   -+.+|
T Consensus        77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~d~iy  153 (419)
T KOG0663|consen   77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---MDKIY  153 (419)
T ss_pred             HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---cceee
Confidence            3566789999999999999999999999999997554  333456789999999999999999999976654   34589


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +|||||++ ||+..+...+         ..+...++.-++.|++.|++|||.   ..|+||||||+|+|+.+.|.+||+|
T Consensus       154 ~VMe~~Eh-DLksl~d~m~---------q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaD  220 (419)
T KOG0663|consen  154 IVMEYVEH-DLKSLMETMK---------QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIAD  220 (419)
T ss_pred             eeHHHHHh-hHHHHHHhcc---------CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecc
Confidence            99999987 9999887654         237788899999999999999999   6899999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV  637 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  637 (640)
                      ||+||.+..+...    .+..+-|.||+|||.++|.+-
T Consensus       221 FGLAR~ygsp~k~----~T~lVVTLWYRaPELLLG~~t  254 (419)
T KOG0663|consen  221 FGLAREYGSPLKP----YTPLVVTLWYRAPELLLGAKT  254 (419)
T ss_pred             cchhhhhcCCccc----CcceEEEeeecCHHHhcCCcc
Confidence            9999988765332    223457999999999999763

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.97  E-value=1.5e-32  Score=276.91  Aligned_cols=176  Identities=33%  Similarity=0.474  Sum_probs=156.0

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ++|.+.+.||+|+||.||||+.+.+.+.||+|.+.+..  +++.+...+|++++++++|||||.++++     |++..+.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSAHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccceE
Confidence            46778899999999999999999999999999996543  3456789999999999999999999998     6777899


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      |+|.||+.| +|+.++.....          +++.++..++.++..||.|||+   .+|+|||+||.|||++..|++|++
T Consensus        77 ~vVte~a~g-~L~~il~~d~~----------lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~Klc  142 (808)
T KOG0597|consen   77 WVVTEYAVG-DLFTILEQDGK----------LPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLC  142 (808)
T ss_pred             EEEehhhhh-hHHHHHHhccC----------CCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeec
Confidence            999999987 99999976544          8999999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |||+||.+..    .........|||.|||||.+.+.+|+.
T Consensus       143 dFg~Ar~m~~----~t~vltsikGtPlYmAPElv~e~pyd~  179 (808)
T KOG0597|consen  143 DFGLARAMST----NTSVLTSIKGTPLYMAPELVEEQPYDH  179 (808)
T ss_pred             hhhhhhhccc----CceeeeeccCcccccCHHHHcCCCccc
Confidence            9999997754    233334567999999999999998874

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.97  E-value=3.2e-32  Score=289.85  Aligned_cols=193  Identities=30%  Similarity=0.456  Sum_probs=155.4

Q ss_pred             HHhcCCCcccCcccccccceEEEEEEC-----CCCeEEEEEEeecccch-hHHHHHHHHHHHHhcCCCCCcceeEeeccC
Q 035691          437 LKATGGFSSANLIGTGSFGSVYKGILD-----PDQTVVAVKVLFLHQRG-ALKSFMAECEALRNIRHRNLVKIITACSSS  510 (640)
Q Consensus       437 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~  510 (640)
                      +..+.+....+.||+|+||+||+|+..     ++...||||.++..... .+++|.+|++++..++|||||+++|+|...
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~  561 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG  561 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence            334455667789999999999999863     34567999999765554 678999999999999999999999998644


Q ss_pred             CcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCC
Q 035691          511 DFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYS----PSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSN  586 (640)
Q Consensus       511 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~----~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~N  586 (640)
                           +..++|+|||..|||.+||............    +..++..+.+.||.|||.||+||-+   ..+|||||.++|
T Consensus       562 -----~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRN  633 (774)
T KOG1026|consen  562 -----DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRN  633 (774)
T ss_pred             -----CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhh
Confidence                 4789999999999999999865544322211    3448889999999999999999998   699999999999


Q ss_pred             eeeCCCCcEEEccccccccCCCccCCCceeec-cccccccccCcccCCCCCCCCC
Q 035691          587 VLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV-GLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       587 iLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +||.++..|||+|||++|.....   +.+... ...-..+|||||.++.++||++
T Consensus       634 CLVge~l~VKIsDfGLsRdiYss---DYYk~~~~t~lPIRWMppEsIly~kFTte  685 (774)
T KOG1026|consen  634 CLVGENLVVKISDFGLSRDIYSS---DYYKVRGNTLLPIRWMPPESILYGKFTTE  685 (774)
T ss_pred             ceeccceEEEecccccchhhhhh---hhhcccCCceeeeecCCHHHhhcCcccch
Confidence            99999999999999999954321   222111 1112569999999999999975

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-32  Score=269.34  Aligned_cols=176  Identities=34%  Similarity=0.443  Sum_probs=144.7

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHh--cCCCCCcceeEeeccCCcCCCcee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRN--IRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ...+..+++|+|.||.||||++  +++.||||++...+   .+.|.+|-++.+.  ++|+||++++++-...... ....
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~ey  283 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEY  283 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccce
Confidence            3445668899999999999998  47999999996444   3678888888875  5899999999884332211 3467


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCCeeeCCCCCCCeeeCCC
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHH------CKKQIVHCDLKPSNVLLDND  592 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~------~~~~ivHrdlkp~NiLl~~~  592 (640)
                      ++|+||.+.|+|.+||+.+           ..+|....+|+..+++||+|||+.      .+++|+|||||++|||+..|
T Consensus       284 wLVt~fh~kGsL~dyL~~n-----------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D  352 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKAN-----------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND  352 (534)
T ss_pred             eEEeeeccCCcHHHHHHhc-----------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC
Confidence            8999999999999999754           378999999999999999999975      46789999999999999999


Q ss_pred             CcEEEccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          593 MIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       593 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      +++-|+|||+|..+....  ......+-+||.+|||||++.|.
T Consensus       353 lTccIaDFGLAl~~~p~~--~~~d~~~qVGT~RYMAPEvLEga  393 (534)
T KOG3653|consen  353 LTCCIADFGLALRLEPGK--PQGDTHGQVGTRRYMAPEVLEGA  393 (534)
T ss_pred             CcEEeeccceeEEecCCC--CCcchhhhhhhhhhcCHHHHhhh
Confidence            999999999999875322  22333446799999999999875

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.97  E-value=1.1e-31  Score=271.05  Aligned_cols=151  Identities=24%  Similarity=0.359  Sum_probs=137.3

Q ss_pred             HHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcC
Q 035691          437 LKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQ  513 (640)
Q Consensus       437 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  513 (640)
                      ....++|+.+.+||+|+||.||.|+-+.+|..+|+|+++++.   .++.+....|-.+|...++|.||+++..     |+
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQ  211 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQ  211 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ec
Confidence            335578999999999999999999999999999999997553   5567888999999999999999999988     78


Q ss_pred             CCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC
Q 035691          514 GNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM  593 (640)
Q Consensus       514 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~  593 (640)
                      +.++.|+||||++|||+..+|...+.          +++..+..++.+++.|++.+|.   .|+|||||||+|+|||..|
T Consensus       212 D~~~LYLiMEylPGGD~mTLL~~~~~----------L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~G  278 (550)
T KOG0605|consen  212 DKEYLYLIMEYLPGGDMMTLLMRKDT----------LTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKG  278 (550)
T ss_pred             CCCeeEEEEEecCCccHHHHHHhcCc----------CchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCC
Confidence            88899999999999999999976543          8888899999999999999999   6999999999999999999


Q ss_pred             cEEEcccccccc
Q 035691          594 IAHVGDFGLTRF  605 (640)
Q Consensus       594 ~~kl~DfGla~~  605 (640)
                      ++|++|||++..
T Consensus       279 HiKLSDFGLs~g  290 (550)
T KOG0605|consen  279 HIKLSDFGLSTG  290 (550)
T ss_pred             CEeeccccccch
Confidence            999999999863

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.97  E-value=7.1e-32  Score=271.98  Aligned_cols=185  Identities=30%  Similarity=0.415  Sum_probs=156.4

Q ss_pred             HHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCc
Q 035691          437 LKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNI-RHRNLVKIITACSSSDF  512 (640)
Q Consensus       437 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  512 (640)
                      .+...+|.+++.||+|+|++||+|+.+.+++.||||++.+.   .+...+-...|-.+|.++ .||.||+++..     |
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----F  143 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----F  143 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----e
Confidence            34456789999999999999999999999999999999543   223335567888899999 89999999988     7


Q ss_pred             CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC
Q 035691          513 QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND  592 (640)
Q Consensus       513 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~  592 (640)
                      +++...|+|+||+++|+|.++++..+.          +++.-...++.||+.|++|||+   .|||||||||+|||+|.+
T Consensus       144 QD~~sLYFvLe~A~nGdll~~i~K~Gs----------fde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~d  210 (604)
T KOG0592|consen  144 QDEESLYFVLEYAPNGDLLDLIKKYGS----------FDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKD  210 (604)
T ss_pred             ecccceEEEEEecCCCcHHHHHHHhCc----------chHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCC
Confidence            777899999999999999999986643          7788889999999999999999   699999999999999999


Q ss_pred             CcEEEccccccccCCCccCC-------Cceee--ccccccccccCcccCCCCCCCC
Q 035691          593 MIAHVGDFGLTRFIPEVISS-------NQCSS--VGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       593 ~~~kl~DfGla~~~~~~~~~-------~~~~~--~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |++||.|||-|+.+.+....       .....  ..++||..|.+||++..+..+.
T Consensus       211 mhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~  266 (604)
T KOG0592|consen  211 GHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGP  266 (604)
T ss_pred             CcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCc
Confidence            99999999999988543222       11122  4589999999999998877654

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.4e-31  Score=272.29  Aligned_cols=180  Identities=27%  Similarity=0.375  Sum_probs=152.6

Q ss_pred             HhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc----cc-hhHHHHHHHHHHHHhcC-CCCCcceeEeeccCC
Q 035691          438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH----QR-GALKSFMAECEALRNIR-HRNLVKIITACSSSD  511 (640)
Q Consensus       438 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~  511 (640)
                      ...+.|...+.||+|+||+|+.|++..++..||+|+++..    .. ...+...+|+.+++.++ ||||+++++++    
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~----   89 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF----   89 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE----
Confidence            4456889999999999999999999999999999977543    11 22355668999999998 99999999994    


Q ss_pred             cCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC
Q 035691          512 FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN  591 (640)
Q Consensus       512 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~  591 (640)
                       ......++||||+.||+|.+++....          .+.+..+..++.|++.|++|+|+   ++|+||||||+|||+|.
T Consensus        90 -~t~~~~~ivmEy~~gGdL~~~i~~~g----------~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~  155 (370)
T KOG0583|consen   90 -ATPTKIYIVMEYCSGGDLFDYIVNKG----------RLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDG  155 (370)
T ss_pred             -ecCCeEEEEEEecCCccHHHHHHHcC----------CCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecC
Confidence             45557999999999999999997633          27778899999999999999999   79999999999999999


Q ss_pred             C-CcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCC-CCC
Q 035691          592 D-MIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ-VST  639 (640)
Q Consensus       592 ~-~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~  639 (640)
                      + +.+||+|||++....    .......+.+||+.|+|||++.+.. |+.
T Consensus       156 ~~~~~Kl~DFG~s~~~~----~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g  201 (370)
T KOG0583|consen  156 NEGNLKLSDFGLSAISP----GEDGLLKTFCGSPAYAAPEVLSGKGTYSG  201 (370)
T ss_pred             CCCCEEEeccccccccC----CCCCcccCCCCCcccCCHHHhCCCCCcCC
Confidence            9 999999999999763    1122344578999999999999977 764

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.2e-32  Score=269.48  Aligned_cols=174  Identities=26%  Similarity=0.386  Sum_probs=146.5

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhH-HHHHHHHHHHHhcC-CCCCcceeEeeccCCcCCCc-e
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-KSFMAECEALRNIR-HRNLVKIITACSSSDFQGND-F  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~-~  517 (640)
                      ++|...+.||.|.||.||+|+..++|..||||.++..-.... ..=++|++.|+++. |||||++.+++.     +.+ .
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~-----d~~~~   84 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIR-----DNDRI   84 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhh-----ccCce
Confidence            457888999999999999999999999999999965433322 23468999999998 999999999953     334 8


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++|||||+. +|+++++.++         ..+++..+..|+.||.+||+|+|.   .|+.|||+||+|||+.....+||
T Consensus        85 L~fVfE~Md~-NLYqLmK~R~---------r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKi  151 (538)
T KOG0661|consen   85 LYFVFEFMDC-NLYQLMKDRN---------RLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKI  151 (538)
T ss_pred             EeeeHHhhhh-hHHHHHhhcC---------CcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEe
Confidence            9999999976 9999997653         349999999999999999999999   59999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV  637 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  637 (640)
                      +|||+||.+....   .+  +.++.|.||+|||+++...+
T Consensus       152 aDFGLARev~Skp---PY--TeYVSTRWYRAPEvLLrs~~  186 (538)
T KOG0661|consen  152 ADFGLAREVRSKP---PY--TEYVSTRWYRAPEVLLRSGY  186 (538)
T ss_pred             cccccccccccCC---Cc--chhhhcccccchHHhhhccc
Confidence            9999999764322   22  34578999999999976544

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-31  Score=269.92  Aligned_cols=176  Identities=31%  Similarity=0.511  Sum_probs=145.9

Q ss_pred             cccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEee
Q 035691          444 SSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYE  523 (640)
Q Consensus       444 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e  523 (640)
                      ...+.||+|.||.||.|++. ....||+|.++... ...++|.+|+++|++++|++||+++|+|...+     .++||||
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piyIVtE  281 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIYIVTE  281 (468)
T ss_pred             HHHHHhcCCccceEEEEEEc-CCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceEEEEE
Confidence            45578999999999999996 45589999996543 33478999999999999999999999985432     6899999


Q ss_pred             ccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccccc
Q 035691          524 FMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT  603 (640)
Q Consensus       524 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla  603 (640)
                      ||+.|+|.+||+....        ..+...+.+.++.|||+||+||.+   +++|||||.++||||+++..+||+|||+|
T Consensus       282 ~m~~GsLl~yLr~~~~--------~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLA  350 (468)
T KOG0197|consen  282 YMPKGSLLDYLRTREG--------GLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLA  350 (468)
T ss_pred             ecccCcHHHHhhhcCC--------CccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccc
Confidence            9999999999986332        347788899999999999999999   79999999999999999999999999999


Q ss_pred             ccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          604 RFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       604 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |...+..   .....+..-...|.|||.+..++||.|
T Consensus       351 r~~~d~~---Y~~~~~~kfPIkWtAPEa~~~~~FS~k  384 (468)
T KOG0197|consen  351 RLIGDDE---YTASEGGKFPIKWTAPEALNYGKFSSK  384 (468)
T ss_pred             cccCCCc---eeecCCCCCCceecCHHHHhhCCcccc
Confidence            9443221   111222234568999999999999875

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=9.8e-32  Score=260.67  Aligned_cols=175  Identities=25%  Similarity=0.399  Sum_probs=155.3

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeec---ccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL---HQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      .+|++.+.||+|.||+|-+|+....|+.||||.++.   .++...-.+.+|+++|..++||||+.++++     |+..+.
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENkdK  127 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENKDK  127 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCCce
Confidence            357778999999999999999988999999999953   345566788999999999999999999999     677789


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      ..+||||..+|.|++|+.+.+.          +++....++++||..|+.|+|.   .+++|||||.+|||+|+++.+||
T Consensus       128 IvivMEYaS~GeLYDYiSer~~----------LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKI  194 (668)
T KOG0611|consen  128 IVIVMEYASGGELYDYISERGS----------LSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKI  194 (668)
T ss_pred             EEEEEEecCCccHHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeee
Confidence            9999999999999999976643          8899999999999999999998   59999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      +|||++-.+..     .....++||+|-|.+||++.|.+|.
T Consensus       195 ADFGLSNly~~-----~kfLqTFCGSPLYASPEIvNG~PY~  230 (668)
T KOG0611|consen  195 ADFGLSNLYAD-----KKFLQTFCGSPLYASPEIVNGTPYK  230 (668)
T ss_pred             eccchhhhhcc-----ccHHHHhcCCcccCCccccCCCCCC
Confidence            99999986632     2234568999999999999998875

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=270.64  Aligned_cols=177  Identities=25%  Similarity=0.349  Sum_probs=154.8

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      ..|..-..||+|+.|.||.|+...+++.||||++........+-+.+|+.+|+..+|+|||++++.+     ..++..|+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sy-----lv~deLWV  347 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSY-----LVGDELWV  347 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHh-----cccceeEE
Confidence            3466668899999999999999999999999999887777777899999999999999999999884     33468999


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      |||||+||+|.+.+...           .+++.++..|++++++||+|||.   ++|+|||||.+|||++.+|.+||+||
T Consensus       348 VMEym~ggsLTDvVt~~-----------~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDF  413 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTKT-----------RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDF  413 (550)
T ss_pred             EEeecCCCchhhhhhcc-----------cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeee
Confidence            99999999999988543           27888999999999999999999   79999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |++..+.+..    ....+++|||+|||||++....|.+|
T Consensus       414 GFcaqi~~~~----~KR~TmVGTPYWMAPEVvtrk~YG~K  449 (550)
T KOG0578|consen  414 GFCAQISEEQ----SKRSTMVGTPYWMAPEVVTRKPYGPK  449 (550)
T ss_pred             eeeecccccc----CccccccCCCCccchhhhhhcccCcc
Confidence            9998775432    23445789999999999988777665

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=258.27  Aligned_cols=179  Identities=31%  Similarity=0.464  Sum_probs=149.1

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      .+|...+.||+|+||.||.+...++|...|||.+...+....+.+.+|+.+|.+++|||||+.+|.....+   ....++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~---~~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE---NDEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc---CeeeEe
Confidence            45677899999999999999999889999999997664333677899999999999999999999732221   136789


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC-CCcEEEcc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN-DMIAHVGD  599 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~-~~~~kl~D  599 (640)
                      .|||+++|+|.+++...+.         .+++..+..+.+||++||+|||+   ++||||||||+|||++. ++.+||+|
T Consensus        94 ~mEy~~~GsL~~~~~~~g~---------~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaD  161 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGG---------KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLAD  161 (313)
T ss_pred             eeeccCCCcHHHHHHHcCC---------CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEecc
Confidence            9999999999999976542         28999999999999999999998   79999999999999999 79999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      ||+++..... .........+.||+.|||||++..+
T Consensus       162 FG~a~~~~~~-~~~~~~~~~~~Gtp~~maPEvi~~g  196 (313)
T KOG0198|consen  162 FGLAKKLESK-GTKSDSELSVQGTPNYMAPEVIRNG  196 (313)
T ss_pred             Cccccccccc-cccccccccccCCccccCchhhcCC
Confidence            9999876531 1111223346799999999999843

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.6e-31  Score=273.09  Aligned_cols=178  Identities=29%  Similarity=0.380  Sum_probs=155.0

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~  515 (640)
                      -++|....+||+|+||+|+.+..+.+++.||||++++.   .+++.+..+.|.+|+... +||.+++++..     |++.
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQT~  441 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQTK  441 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----cccC
Confidence            45788999999999999999999999999999999755   355678889999999887 59999999988     8889


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      +++|+||||+.|||+..+.+.           ..+++..+..+++.|+.||+|||+   .+|||||||.+|||+|.+|++
T Consensus       442 ~~l~fvmey~~Ggdm~~~~~~-----------~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~  507 (694)
T KOG0694|consen  442 EHLFFVMEYVAGGDLMHHIHT-----------DVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHV  507 (694)
T ss_pred             CeEEEEEEecCCCcEEEEEec-----------ccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcE
Confidence            999999999999996555442           238888999999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ||+|||+++.-..    ....+.+++|||.|||||++.+..|+..
T Consensus       508 kiADFGlcKe~m~----~g~~TsTfCGTpey~aPEil~e~~Yt~a  548 (694)
T KOG0694|consen  508 KIADFGLCKEGMG----QGDRTSTFCGTPEFLAPEVLTEQSYTRA  548 (694)
T ss_pred             EecccccccccCC----CCCccccccCChhhcChhhhccCcccch
Confidence            9999999995431    2234567899999999999999999863

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.97  E-value=1.2e-30  Score=253.23  Aligned_cols=180  Identities=26%  Similarity=0.410  Sum_probs=147.8

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCC-CcceeEeeccCC-cCCCcee
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--GALKSFMAECEALRNIRHRN-LVKIITACSSSD-FQGNDFK  518 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~-~~~~~~~  518 (640)
                      |...+.||+|+||+||+|+.+.+|+.||+|++....+  +......+|+.+++.++|+| ||.+++++.... +......
T Consensus        13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l   92 (323)
T KOG0594|consen   13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL   92 (323)
T ss_pred             HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence            5556789999999999999999999999999976543  45567899999999999999 999999975443 2223368


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++|+||++. +|..++.......      ..++...+..++.|++.||+|||+   .+|+||||||.|||++++|.+||+
T Consensus        93 ~lvfe~~d~-DL~~ymd~~~~~~------~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKla  162 (323)
T KOG0594|consen   93 YLVFEFLDR-DLKKYMDSLPKKP------QGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLA  162 (323)
T ss_pred             EEEEEeecc-cHHHHHHhccccc------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeee
Confidence            899999976 9999987654321      236667899999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      |||+|+.+.-+..    ..+..++|.+|+|||+++|.+
T Consensus       163 DFGlAra~~ip~~----~yt~evvTlWYRaPEvLlGs~  196 (323)
T KOG0594|consen  163 DFGLARAFSIPMR----TYTPEVVTLWYRAPEVLLGST  196 (323)
T ss_pred             ccchHHHhcCCcc----cccccEEEeeccCHHHhcCCC
Confidence            9999996542211    123346899999999999984

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-30  Score=256.25  Aligned_cols=179  Identities=27%  Similarity=0.348  Sum_probs=153.3

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccch-hHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG-ALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      .+.|++.++||.|.-+.||+|+...+++.||||++...+.. ..+.+.+|+..|+.++||||++.+..     |..+...
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~s-----Fvv~~~L   99 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCS-----FVVDSEL   99 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEE-----EEeccee
Confidence            45688889999999999999999999999999999766543 35889999999999999999999877     5556689


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      |+||.||.+|++.+.++..-.        ..+.+..+..|.++++.||.|||.   .|.||||||+.|||||++|.+||+
T Consensus       100 WvVmpfMa~GS~ldIik~~~~--------~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLa  168 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYYP--------DGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLA  168 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHcc--------ccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEc
Confidence            999999999999999865433        458999999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      |||.+..+-...........+++||++|||||+++.
T Consensus       169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q  204 (516)
T KOG0582|consen  169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQ  204 (516)
T ss_pred             CceeeeeecccCceeeEeeccccCcccccChHHhhh
Confidence            999988765443322222256789999999999644

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.97  E-value=4.8e-31  Score=255.37  Aligned_cols=176  Identities=28%  Similarity=0.437  Sum_probs=140.5

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEE
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALV  521 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv  521 (640)
                      .|+..+++|+|+||.||+|...++++.||||++....+.    --+|+++|+.++|||||++..++....-.+.-+..+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            356678999999999999999999999999998433321    1378999999999999999988765542223466799


Q ss_pred             eeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC-CcEEEccc
Q 035691          522 YEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND-MIAHVGDF  600 (640)
Q Consensus       522 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~-~~~kl~Df  600 (640)
                      ||||+. +|.++++.....      ...++...+.-+..|+.+|+.|||+   .+|+||||||.|+|+|.+ |.+|||||
T Consensus       101 leymP~-tL~~~~r~~~~~------~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDF  170 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRA------NQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDF  170 (364)
T ss_pred             HHhchH-HHHHHHHHHhhc------CCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccC
Confidence            999987 898888642111      1236667788899999999999999   699999999999999977 89999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      |.|+.+....     ...+..+|.+|+|||.+.|..
T Consensus       171 GSAK~L~~~e-----pniSYicSRyYRaPELifga~  201 (364)
T KOG0658|consen  171 GSAKVLVKGE-----PNISYICSRYYRAPELIFGAT  201 (364)
T ss_pred             CcceeeccCC-----CceeEEEeccccCHHHHcCcc
Confidence            9999874321     122356899999999999875

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.97  E-value=1.6e-33  Score=273.30  Aligned_cols=314  Identities=26%  Similarity=0.376  Sum_probs=252.6

Q ss_pred             CCCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCC
Q 035691            2 LTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLP   81 (640)
Q Consensus         2 l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~   81 (640)
                      ++.|+.||..+|-+. .+|++++.+.+|..|+|.+|+|. ..| +|.+++.|++|+++.|+|+-      +|......++
T Consensus       182 m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~------lpae~~~~L~  252 (565)
T KOG0472|consen  182 MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEM------LPAEHLKHLN  252 (565)
T ss_pred             HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHh------hHHHHhcccc
Confidence            456777888888777 77778888888888888888887 666 68888888888888887764      9999998899


Q ss_pred             CCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcc------------
Q 035691           82 NIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDL------------  149 (640)
Q Consensus        82 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~------------  149 (640)
                      ++..|||++|+++ ..|+.+.-+.+|++||+|+|.|++ .|.+++++ .|+.|-+.+|.+.++....+            
T Consensus       253 ~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~-Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLr  329 (565)
T KOG0472|consen  253 SLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS-LPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLR  329 (565)
T ss_pred             cceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc-CCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHH
Confidence            9999999999999 678889999999999999999995 78889999 89999999998765311000            


Q ss_pred             -------------------c----ccccccCCCCcceEecCCCCCCCcCcCCCCCCC---CCEEEccCCcCcccCCcCcc
Q 035691          150 -------------------R----FLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPK---LQVLSLFENNISGEIPSSLG  203 (640)
Q Consensus       150 -------------------~----~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~---L~~L~L~~N~l~~~~p~~~~  203 (640)
                                         .    .........+.++|+++.-+++.+|++++.-.+   ....+++.|++. ++|..+.
T Consensus       330 s~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~  408 (565)
T KOG0472|consen  330 SKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLV  408 (565)
T ss_pred             HhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhH
Confidence                               0    000112345678899999999999987655444   788899999998 6787777


Q ss_pred             CCCCCCE-EEccCCCCCCCCCccccCCCCccEEeccCccccCC-------CCCceEEccCCcCCCCCCccCCCCCCCCEE
Q 035691          204 NFTFLTE-LNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQ-------YPVRWLDLSHNHLTGPIPLAVGNLKSIPHL  275 (640)
Q Consensus       204 ~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~-------~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L  275 (640)
                      .++.+.+ +.+++|.+. .+|..++.+++|..|+|++|.+..+       ..|+.||+|+|++. .+|...-.+..|+.+
T Consensus       409 ~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtl  486 (565)
T KOG0472|consen  409 ELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLNDLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETL  486 (565)
T ss_pred             HHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhhhcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHH
Confidence            7766544 455555554 7888888899999999998866543       34888999999988 788888888888888


Q ss_pred             ECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccc
Q 035691          276 DLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQ  331 (640)
Q Consensus       276 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  331 (640)
                      -.++|++....|+.+.+|.+|..|||.+|.+. .+|+.++++++|++|++++|+|.
T Consensus       487 las~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  487 LASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             HhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            88889999777777999999999999999998 78889999999999999999998

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=8.4e-30  Score=252.79  Aligned_cols=183  Identities=28%  Similarity=0.388  Sum_probs=147.0

Q ss_pred             HHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc--------------hhHHHHHHHHHHHHhcCCCCCcc
Q 035691          437 LKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--------------GALKSFMAECEALRNIRHRNLVK  502 (640)
Q Consensus       437 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~  502 (640)
                      .+..+.|++...||+|.||+|-+|+...+++.||||++.+...              ...+...+||.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            4456789999999999999999999999999999999953311              12257889999999999999999


Q ss_pred             eeEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCC
Q 035691          503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDL  582 (640)
Q Consensus       503 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdl  582 (640)
                      ++++-.+..   .+..|||+|||..|.+...-. ..         ..+++.++++++.++..||+|||.   ++|+||||
T Consensus       173 LiEvLDDP~---s~~~YlVley~s~G~v~w~p~-d~---------~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDI  236 (576)
T KOG0585|consen  173 LIEVLDDPE---SDKLYLVLEYCSKGEVKWCPP-DK---------PELSEQQARKYLRDVVLGLEYLHY---QGIIHRDI  236 (576)
T ss_pred             EEEeecCcc---cCceEEEEEeccCCccccCCC-Cc---------ccccHHHHHHHHHHHHHHHHHHHh---cCeecccc
Confidence            999975543   567999999999887753221 11         127889999999999999999999   69999999


Q ss_pred             CCCCeeeCCCCcEEEccccccccCCCccC-CCceeeccccccccccCcccCCCC
Q 035691          583 KPSNVLLDNDMIAHVGDFGLTRFIPEVIS-SNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       583 kp~NiLl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      ||+|+|++++|++||+|||.+-....... .........+|||.|||||...++
T Consensus       237 KPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~  290 (576)
T KOG0585|consen  237 KPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGG  290 (576)
T ss_pred             chhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCC
Confidence            99999999999999999999876532211 111112235799999999999874

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-30  Score=265.66  Aligned_cols=179  Identities=30%  Similarity=0.481  Sum_probs=146.3

Q ss_pred             HHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCC
Q 035691          434 ESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSD  511 (640)
Q Consensus       434 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  511 (640)
                      +++++..+.+.+.+.||+|+||+||+|+|-.   .||||+++...  ....++|.+|+.++++-||.||+-++|||..+.
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            4555555556777999999999999999843   49999997654  346689999999999999999999999985443


Q ss_pred             cCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC
Q 035691          512 FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN  591 (640)
Q Consensus       512 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~  591 (640)
                            ..||+.+|+|-+|+.+++..+.         .+...+...||.||++||.|||.   ++|||||||..||++.+
T Consensus       462 ------~AIiTqwCeGsSLY~hlHv~et---------kfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~  523 (678)
T KOG0193|consen  462 ------LAIITQWCEGSSLYTHLHVQET---------KFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHE  523 (678)
T ss_pred             ------eeeeehhccCchhhhhccchhh---------hhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEcc
Confidence                  3899999999999999986542         38889999999999999999999   89999999999999999


Q ss_pred             CCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          592 DMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       592 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      +++|||+|||++..-.-.....+  .....|...|||||+++..
T Consensus       524 ~~kVkIgDFGLatvk~~w~g~~q--~~qp~gsilwmAPEvIRmq  565 (678)
T KOG0193|consen  524 DLKVKIGDFGLATVKTRWSGEQQ--LEQPHGSLLWMAPEVIRMQ  565 (678)
T ss_pred             CCcEEEecccceeeeeeeccccc--cCCCccchhhhcHHHHhhc
Confidence            99999999999874322211111  1123478899999999753

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.96  E-value=7e-30  Score=258.47  Aligned_cols=180  Identities=24%  Similarity=0.365  Sum_probs=146.3

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecccch-hHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG-ALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      ...+.++||+|.||.|..|... .+..||||.++..... .+.+|..|+++|.+++|||||+++|+|...     +..++
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-----ePicm  612 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-----DPLCM  612 (807)
T ss_pred             heehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-----CchHH
Confidence            3456789999999999999875 4799999999755443 458999999999999999999999999543     36899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      |+|||++|+|..|+..+....        ..-....+||.||+.||+||.+   .++||||+.++|+|+|.++++||+||
T Consensus       613 I~EYmEnGDLnqFl~aheapt--------~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadf  681 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPT--------AETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADF  681 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcc--------cccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCc
Confidence            999999999999998764421        2223456799999999999999   59999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |++|.+.......  .....+-..+|||||.++-++||+|
T Consensus       682 gmsR~lysg~yy~--vqgr~vlpiRwmawEsillgkFtta  719 (807)
T KOG1094|consen  682 GMSRNLYSGDYYR--VQGRAVLPIRWMAWESILLGKFTTA  719 (807)
T ss_pred             ccccccccCCcee--eecceeeeeeehhHHHHHhccccch
Confidence            9999553221111  1111234679999999999999975

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.1e-29  Score=247.11  Aligned_cols=175  Identities=29%  Similarity=0.393  Sum_probs=143.0

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHh--cCCCCCcceeEeeccCCcCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRN--IRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ..++.+.||+|.||.||+|.++  |+.||||++...++   +.+.+|.++.+.  ++|+||..++++-... -..-...|
T Consensus       212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~-~gs~TQLw  285 (513)
T KOG2052|consen  212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKD-NGSWTQLW  285 (513)
T ss_pred             eeEEEEEecCccccceeecccc--CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccC-CCceEEEE
Confidence            3567789999999999999996  88999999965544   567789998887  4999999998873211 11223589


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeeeCCCCCCCeeeCCCCc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHH-----CKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~-----~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                      +|.||-+.|+|+|||....           ++....++++..+|.||++||..     .++.|+|||||+.|||+..++.
T Consensus       286 LvTdYHe~GSL~DyL~r~t-----------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~  354 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNRNT-----------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  354 (513)
T ss_pred             EeeecccCCcHHHHHhhcc-----------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence            9999999999999997633           67788999999999999999964     5778999999999999999999


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGM  633 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  633 (640)
                      +-|+|+|+|-...+....-.......+||.+|||||++-
T Consensus       355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLd  393 (513)
T KOG2052|consen  355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLD  393 (513)
T ss_pred             EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhh
Confidence            999999999866554333334445678999999999973

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.96  E-value=4.2e-30  Score=268.28  Aligned_cols=181  Identities=25%  Similarity=0.448  Sum_probs=152.7

Q ss_pred             CCcccCcccccccceEEEEEECCCC---eEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQ---TVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ...+.++||.|.||.||+|+++..|   ..||||.++.. .++++.+|+.|+.||.+++||||+++.|+.     .....
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV-----Tks~P  704 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV-----TKSKP  704 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE-----ecCce
Confidence            3456789999999999999997555   56999999755 356778999999999999999999999995     44457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      ++||.|||++|+|..||+.+..         .+.+.+...|.++||.||.||-+   .++|||||.++|||++.+..+||
T Consensus       705 vMIiTEyMENGsLDsFLR~~DG---------qftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKV  772 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQNDG---------QFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKV  772 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhcCC---------ceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEe
Confidence            8999999999999999987653         27888999999999999999998   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||++|.+++... ..+++.+-.-..+|.|||.+...+||.+
T Consensus       773 sDFGLSRvledd~~-~~ytt~GGKIPiRWTAPEAIa~RKFTsA  814 (996)
T KOG0196|consen  773 SDFGLSRVLEDDPE-AAYTTLGGKIPIRWTAPEAIAYRKFTSA  814 (996)
T ss_pred             ccccceeecccCCC-ccccccCCccceeecChhHhhhcccCch
Confidence            99999998865542 2233333233579999999999998853

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=3.4e-30  Score=234.58  Aligned_cols=179  Identities=27%  Similarity=0.399  Sum_probs=152.8

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      ..++|.+++.||+|.||.||.|+.++++-.||+|++.++.   .+-.+.+.+|+++-..++||||.+++++     |.+.
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~-----fhd~   94 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY-----FHDS   94 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh-----eecc
Confidence            3467888999999999999999999999999999995443   2334678999999999999999999999     5556


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      ...|+++||.+.|+++..|+..+..        .+++.....++.|+|.|+.|+|.   ++|+||||||+|+|++.++..
T Consensus        95 ~riyLilEya~~gel~k~L~~~~~~--------~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~l  163 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGRMK--------RFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGEL  163 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhcccc--------cccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCe
Confidence            6899999999999999999855442        36667788899999999999999   799999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+|||.+-.-+.      ....+.+||..|.|||++.+..++.
T Consensus       164 kiAdfGwsV~~p~------~kR~tlcgt~dyl~pEmv~~~~hd~  201 (281)
T KOG0580|consen  164 KIADFGWSVHAPS------NKRKTLCGTLDYLPPEMVEGRGHDK  201 (281)
T ss_pred             eccCCCceeecCC------CCceeeecccccCCHhhcCCCCccc
Confidence            9999999864321      1234578999999999999988764

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.96  E-value=3.3e-29  Score=262.78  Aligned_cols=182  Identities=25%  Similarity=0.305  Sum_probs=150.0

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|+..+.||+|+||+||+|+...+++.||+|++....   ......+.+|+.++.+++||+|+++++++     .+...
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence            46888999999999999999999899999999996432   22345788899999999999999999984     44568


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~----------~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL  142 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMKKD----------TLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKL  142 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEE
Confidence            899999999999999986432          27888999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCC-------------------------------ceeeccccccccccCcccCCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSN-------------------------------QCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||+++.+.......                               .......+||+.|+|||++.+..++.+
T Consensus       143 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~  216 (363)
T cd05628         143 SDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL  216 (363)
T ss_pred             eeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc
Confidence            9999998643211000                               000123579999999999988877653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.4e-29  Score=260.71  Aligned_cols=177  Identities=23%  Similarity=0.318  Sum_probs=154.6

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      .+.|..++.||+|+-|.|-.|++..||+.+|||++....   ......+.+|+.+|+-+.|||+++++++     +..+.
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV-----we~~~   85 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV-----WENKQ   85 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee-----eccCc
Confidence            467889999999999999999999999999999995442   2334678999999999999999999999     66677


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      +.|+|.||+++|.|.+++..++.          +++..+.+++.||+.|+.|+|+   -+|+|||+||+|+|+|.++.+|
T Consensus        86 ~lylvlEyv~gGELFdylv~kG~----------l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIK  152 (786)
T KOG0588|consen   86 HLYLVLEYVPGGELFDYLVRKGP----------LPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIK  152 (786)
T ss_pred             eEEEEEEecCCchhHHHHHhhCC----------CCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEe
Confidence            99999999999999999976654          7888899999999999999999   5999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|||+|....+.     ....+.||+|.|+|||+++|.+|..
T Consensus       153 IADFGMAsLe~~g-----klLeTSCGSPHYA~PEIV~G~pYdG  190 (786)
T KOG0588|consen  153 IADFGMASLEVPG-----KLLETSCGSPHYAAPEIVSGRPYDG  190 (786)
T ss_pred             eeccceeecccCC-----ccccccCCCcccCCchhhcCCCCCC
Confidence            9999999865432     1223458999999999999999864

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-29  Score=260.60  Aligned_cols=190  Identities=27%  Similarity=0.413  Sum_probs=153.4

Q ss_pred             ccCHHHHHHhcCCCcccCcccccccceEEEEEECCCCe---E-EEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcc
Q 035691          430 NVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQT---V-VAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVK  502 (640)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~  502 (640)
                      .+....++...++....++||+|+||.||+|.++..+.   . ||||..+..   .+....+|++|+++|++++|||||+
T Consensus       146 PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr  225 (474)
T KOG0194|consen  146 PIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVR  225 (474)
T ss_pred             cccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence            33444455556666777999999999999999874422   3 899998742   3556789999999999999999999


Q ss_pred             eeEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCC
Q 035691          503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDL  582 (640)
Q Consensus       503 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdl  582 (640)
                      ++|++..     +...++|||+|.||+|.++|+..+.         .++..+...++.+.|.||+|||+   .+++||||
T Consensus       226 ~yGVa~~-----~~Pl~ivmEl~~gGsL~~~L~k~~~---------~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDI  288 (474)
T KOG0194|consen  226 FYGVAVL-----EEPLMLVMELCNGGSLDDYLKKNKK---------SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDI  288 (474)
T ss_pred             EEEEEcC-----CCccEEEEEecCCCcHHHHHHhCCC---------CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhH
Confidence            9999643     4478999999999999999987653         38889999999999999999999   79999999


Q ss_pred             CCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          583 KPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       583 kp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      .++|+|++.++.+||+|||+++.........    ..-.-...|+|||.+..+.||.|
T Consensus       289 AARNcL~~~~~~vKISDFGLs~~~~~~~~~~----~~~klPirWLAPEtl~~~~~s~k  342 (474)
T KOG0194|consen  289 AARNCLYSKKGVVKISDFGLSRAGSQYVMKK----FLKKLPIRWLAPETLNTGIFSFK  342 (474)
T ss_pred             hHHHheecCCCeEEeCccccccCCcceeecc----ccccCcceecChhhhccCccccc
Confidence            9999999999999999999998543111100    00123568999999999988865

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.1e-30  Score=254.30  Aligned_cols=178  Identities=26%  Similarity=0.377  Sum_probs=152.6

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ..|+..+.||+|+||.||+|.+..+++.||+|+++... +...+...+|+.++..++++||.+.|+.     +..+...|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygs-----yl~g~~Lw   87 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGS-----YLKGTKLW   87 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhh-----eeecccHH
Confidence            34677799999999999999999999999999997654 4556789999999999999999999998     45556889


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      ++||||.||++.+.++....          +.+..+.-|.+++..|+.|+|+   .+.+|||||+.||++..+|.+|++|
T Consensus        88 iiMey~~gGsv~~lL~~~~~----------~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~D  154 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKSGNI----------LDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLAD  154 (467)
T ss_pred             HHHHHhcCcchhhhhccCCC----------CccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEe
Confidence            99999999999999976543          3445566789999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ||.+..++...    ....+++|||+|||||++.+..|+.|
T Consensus       155 fgVa~ql~~~~----~rr~tfvGTPfwMAPEVI~~~~Y~~K  191 (467)
T KOG0201|consen  155 FGVAGQLTNTV----KRRKTFVGTPFWMAPEVIKQSGYDTK  191 (467)
T ss_pred             cceeeeeechh----hccccccccccccchhhhccccccch
Confidence            99998765432    22356889999999999998888765

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.96  E-value=7.7e-29  Score=261.72  Aligned_cols=147  Identities=24%  Similarity=0.332  Sum_probs=129.2

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      .|+..+.||+|+||+||+|++..+++.||+|++....   ....+.+.+|++++++++|||||++++++     .+.+..
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence            5788899999999999999999999999999996432   33446789999999999999999999995     345589


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~----------~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~  143 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRME----------VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLT  143 (381)
T ss_pred             EEEEecCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEe
Confidence            99999999999999986432          27788888999999999999999   699999999999999999999999


Q ss_pred             cccccccC
Q 035691          599 DFGLTRFI  606 (640)
Q Consensus       599 DfGla~~~  606 (640)
                      |||+++.+
T Consensus       144 DFGl~~~~  151 (381)
T cd05626         144 DFGLCTGF  151 (381)
T ss_pred             eCcCCccc
Confidence            99998643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=6.2e-29  Score=261.16  Aligned_cols=182  Identities=23%  Similarity=0.320  Sum_probs=149.8

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||.||+|++..+|+.||||++....   ......+.+|+++++.++||||+++++++     .....
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence            46888999999999999999999999999999996432   23446688999999999999999999984     44568


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||
T Consensus        76 ~~lv~E~~~~g~L~~~l~~~~----------~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl  142 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMKKD----------TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKL  142 (364)
T ss_pred             EEEEECCCCCcHHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEE
Confidence            999999999999999986432          27888999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCC----------------------------------ceeeccccccccccCcccCCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSN----------------------------------QCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||+++.+.......                                  .......+||+.|+|||++.+..++.+
T Consensus       143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  219 (364)
T cd05599         143 SDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE  219 (364)
T ss_pred             eecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCe
Confidence            9999987543211000                                  001112469999999999988777653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.8e-29  Score=241.82  Aligned_cols=182  Identities=25%  Similarity=0.373  Sum_probs=152.6

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEee--cccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF--LHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ....|...+.||+|+||.|+.|.++.+|+.||+|++.  ....-..++..+|+++++.++|+||+.+.++........-.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3445666789999999999999999999999999995  44555668899999999999999999999998764444456


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      .+|+|+|+| +-||...++....          +.......+..|+++|+.|+|+   .+|+|||+||+|++++.+...|
T Consensus       100 DvYiV~elM-etDL~~iik~~~~----------L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lK  165 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQQD----------LTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLK  165 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcCcc----------ccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEE
Confidence            789999999 4589988875432          6777888999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      |+|||+||.....  ......++.+.|.||+|||+++...
T Consensus       166 I~DFGLAR~~~~~--~~~~~mTeYVaTRWYRAPElll~~~  203 (359)
T KOG0660|consen  166 ICDFGLARYLDKF--FEDGFMTEYVATRWYRAPELLLNSS  203 (359)
T ss_pred             eccccceeecccc--CcccchhcceeeeeecCHHHHhccc
Confidence            9999999987543  2333445678899999999986543

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.96  E-value=1.2e-28  Score=254.32  Aligned_cols=172  Identities=28%  Similarity=0.322  Sum_probs=143.9

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEee
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYE  523 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e  523 (640)
                      +.||+|+||.||+|+...+|+.||+|+++...   ......+.+|++++++++||||+++++++     ...+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence            46899999999999999999999999996432   33446788999999999999999999984     44568899999


Q ss_pred             ccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccccc
Q 035691          524 FMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT  603 (640)
Q Consensus       524 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla  603 (640)
                      |+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||++
T Consensus        76 ~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a  142 (323)
T cd05571          76 YANGGELFFHLSRER----------VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLC  142 (323)
T ss_pred             CCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCC
Confidence            999999999886432          27888899999999999999999   69999999999999999999999999999


Q ss_pred             ccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          604 RFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       604 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +.....    .......+||+.|+|||++.+..++.+
T Consensus       143 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~  175 (323)
T cd05571         143 KEGISD----GATMKTFCGTPEYLAPEVLEDNDYGRA  175 (323)
T ss_pred             cccccC----CCcccceecCccccChhhhcCCCCCcc
Confidence            853221    111223569999999999988777653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.96  E-value=8.5e-29  Score=261.67  Aligned_cols=146  Identities=25%  Similarity=0.328  Sum_probs=128.6

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      .|+..+.||+|+||.||+|+...+++.||+|++....   ....+.+.+|++++++++|||||++++++     .+++..
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCEE
Confidence            5788899999999999999999999999999996432   23446788999999999999999999995     445689


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++|||||++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~----------~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~  143 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRMG----------IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLT  143 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEe
Confidence            99999999999999886432          26778888999999999999999   699999999999999999999999


Q ss_pred             ccccccc
Q 035691          599 DFGLTRF  605 (640)
Q Consensus       599 DfGla~~  605 (640)
                      |||+|+.
T Consensus       144 DFGla~~  150 (382)
T cd05625         144 DFGLCTG  150 (382)
T ss_pred             ECCCCcc
Confidence            9999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-29  Score=255.18  Aligned_cols=173  Identities=25%  Similarity=0.483  Sum_probs=146.5

Q ss_pred             cccCHHHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeec
Q 035691          429 LNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS  508 (640)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~  508 (640)
                      ..+.++++.       .++-||+|+.|.||+|+++  ++.||||+++.-.       +.+|+-|++++||||+.|.|+|.
T Consensus       119 WeiPFe~Is-------ELeWlGSGaQGAVF~Grl~--netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCt  182 (904)
T KOG4721|consen  119 WEIPFEEIS-------ELEWLGSGAQGAVFLGRLH--NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCT  182 (904)
T ss_pred             ccCCHHHhh-------hhhhhccCcccceeeeecc--CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeec
Confidence            345566553       3478999999999999984  7889999884222       36789999999999999999996


Q ss_pred             cCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCee
Q 035691          509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVL  588 (640)
Q Consensus       509 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiL  588 (640)
                      ...     ++|||||||+.|-|++.|+..+.          +.......|..+||.||.|||.   ..|||||||.-|||
T Consensus       183 qsP-----cyCIiMEfCa~GqL~~VLka~~~----------itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiL  244 (904)
T KOG4721|consen  183 QSP-----CYCIIMEFCAQGQLYEVLKAGRP----------ITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNIL  244 (904)
T ss_pred             CCc-----eeEEeeeccccccHHHHHhccCc----------cCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceE
Confidence            554     78999999999999999986654          5556778899999999999999   48999999999999


Q ss_pred             eCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          589 LDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       589 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |..+-.+||+|||.++...+     ..+.+.++||..|||||++...+.++|
T Consensus       245 Is~~d~VKIsDFGTS~e~~~-----~STkMSFaGTVaWMAPEvIrnePcsEK  291 (904)
T KOG4721|consen  245 ISYDDVVKISDFGTSKELSD-----KSTKMSFAGTVAWMAPEVIRNEPCSEK  291 (904)
T ss_pred             eeccceEEeccccchHhhhh-----hhhhhhhhhhHhhhCHHHhhcCCcccc
Confidence            99999999999999986533     244567899999999999999998876

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.1e-28  Score=260.21  Aligned_cols=147  Identities=25%  Similarity=0.344  Sum_probs=129.3

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||.||+|+...+++.||||++....   ....+.+.+|+++++.++|||||++++++     .+...
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQY   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCe
Confidence            36888899999999999999999999999999985432   23446788999999999999999999985     44568


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .|+||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~----------~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl  142 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIKYD----------TFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKL  142 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEE
Confidence            999999999999999986432          26788888999999999999999   69999999999999999999999


Q ss_pred             cccccccc
Q 035691          598 GDFGLTRF  605 (640)
Q Consensus       598 ~DfGla~~  605 (640)
                      +|||+++.
T Consensus       143 ~DfGla~~  150 (377)
T cd05629         143 SDFGLSTG  150 (377)
T ss_pred             eecccccc
Confidence            99999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-29  Score=256.37  Aligned_cols=166  Identities=27%  Similarity=0.380  Sum_probs=140.4

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeecccc---hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR---GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      |+..+.||.|+||.||-|++..+.+.||||.+..+.+   ..+++++.|+..|.+++|||+|.+-|+|     -.+...|
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCy-----Lre~TaW  102 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCY-----LREHTAW  102 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCccccccee-----eccchHH
Confidence            6667889999999999999999999999999954433   3357899999999999999999999984     3444679


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +|||||-| +-.+++.-.+.         .+.+..+..|+.+.+.||+|||+   .+.||||||+.|||+++.|.||++|
T Consensus       103 LVMEYClG-SAsDlleVhkK---------plqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaD  169 (948)
T KOG0577|consen  103 LVMEYCLG-SASDLLEVHKK---------PLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLAD  169 (948)
T ss_pred             HHHHHHhc-cHHHHHHHHhc---------cchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeecc
Confidence            99999964 77777654432         26777889999999999999999   4899999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      ||.|..+.        ...+++|||+|||||+++.
T Consensus       170 FGSAsi~~--------PAnsFvGTPywMAPEVILA  196 (948)
T KOG0577|consen  170 FGSASIMA--------PANSFVGTPYWMAPEVILA  196 (948)
T ss_pred             ccchhhcC--------chhcccCCccccchhHhee
Confidence            99997543        2345789999999999975

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.4e-28  Score=255.09  Aligned_cols=175  Identities=25%  Similarity=0.359  Sum_probs=149.5

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||.||+|++..+++.||||+++...   ....+.+..|++++..++||||+++++++     ...+.
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence            46888999999999999999999899999999996432   23446788999999999999999999985     44558


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~----------~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL  142 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNNLG----------VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKL  142 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEE
Confidence            899999999999999986432          26788899999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||+++....       ......||+.|+|||++.+..++.+
T Consensus       143 ~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~  178 (333)
T cd05600         143 TDFGLSKGIVT-------YANSVVGSPDYMAPEVLRGKGYDFT  178 (333)
T ss_pred             EeCcCCccccc-------ccCCcccCccccChhHhcCCCCCCc
Confidence            99999986532       1223468999999999988877653

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.96  E-value=1.1e-28  Score=255.09  Aligned_cols=175  Identities=28%  Similarity=0.362  Sum_probs=148.9

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++....   ....+.+.+|+.++++++||||+++++++     ..++.
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   92 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDENR   92 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCCE
Confidence            56888899999999999999999999999999996432   23446788999999999999999999985     44558


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||
T Consensus        93 ~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl  159 (329)
T PTZ00263         93 VYFLLEFVVGGELFTHLRKAG----------RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKV  159 (329)
T ss_pred             EEEEEcCCCCChHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEE
Confidence            899999999999999886432          26778888999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||+++......       ....||+.|+|||++.+..++.+
T Consensus       160 ~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~  195 (329)
T PTZ00263        160 TDFGFAKKVPDRT-------FTLCGTPEYLAPEVIQSKGHGKA  195 (329)
T ss_pred             eeccCceEcCCCc-------ceecCChhhcCHHHHcCCCCCCc
Confidence            9999998653211       12468999999999988776643

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.96  E-value=1.4e-28  Score=259.51  Aligned_cols=182  Identities=25%  Similarity=0.305  Sum_probs=148.5

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||.||+|+...+++.||||++....   ....+.+.+|++++++++||||+++++++     ..++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~   75 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDN   75 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCE
Confidence            36889999999999999999999999999999985432   23346788999999999999999999984     45568


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++....          .+++..+..++.||+.||+|||+   .+|+||||||+||+++.++.+||
T Consensus        76 ~~lv~E~~~~g~L~~~i~~~~----------~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL  142 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIRLG----------IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKL  142 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEE
Confidence            999999999999999986532          26778888999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccC---------------------------------------CCceeeccccccccccCcccCCCCCCC
Q 035691          598 GDFGLTRFIPEVIS---------------------------------------SNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       598 ~DfGla~~~~~~~~---------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      +|||+|..+.....                                       ...+.....+||+.|||||++.+..++
T Consensus       143 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  222 (376)
T cd05598         143 TDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT  222 (376)
T ss_pred             EeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC
Confidence            99999853310000                                       000111235799999999999887776


Q ss_pred             CC
Q 035691          639 TN  640 (640)
Q Consensus       639 ~k  640 (640)
                      .+
T Consensus       223 ~~  224 (376)
T cd05598         223 QL  224 (376)
T ss_pred             cc
Confidence            53

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.96  E-value=2.7e-30  Score=241.70  Aligned_cols=172  Identities=25%  Similarity=0.350  Sum_probs=147.3

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      |.+.++||+|+||.||+|.++++|..+|+|.+...  ...+++..|+.+|++++.|++|++||.|     ......|+||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSY-----FK~sDLWIVM  107 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSY-----FKHSDLWIVM  107 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhh-----ccCCceEeeh
Confidence            55678999999999999999999999999998644  3457899999999999999999999984     3344689999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      |||..|+..+.++.++.         .+.+..+..+.+..+.||+|||.   ..-+|||||+.|||+..+|.+|++|||.
T Consensus       108 EYCGAGSiSDI~R~R~K---------~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGV  175 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARRK---------PLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGV  175 (502)
T ss_pred             hhcCCCcHHHHHHHhcC---------CccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccc
Confidence            99999999999876543         38888999999999999999998   5789999999999999999999999999


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCCCCCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV  637 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  637 (640)
                      |..+.+.    .....++.|||.|||||++..--|
T Consensus       176 AGQLTDT----MAKRNTVIGTPFWMAPEVI~EIGY  206 (502)
T KOG0574|consen  176 AGQLTDT----MAKRNTVIGTPFWMAPEVIEEIGY  206 (502)
T ss_pred             cchhhhh----HHhhCccccCcccccHHHHHHhcc
Confidence            9866432    223345789999999999865443

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.1e-28  Score=250.81  Aligned_cols=174  Identities=28%  Similarity=0.378  Sum_probs=148.0

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++....   ....+.+.+|+.++++++||||++++++     +.++..
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-----~~~~~~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWT-----EHDQRF   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhh-----hccCCe
Confidence            36888899999999999999999899999999996432   2334678899999999999999999987     444568


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++...+          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl  142 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRNSG----------RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKL  142 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEE
Confidence            899999999999999986443          27788889999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|||+++.....       .....||+.|+|||++.+..++.
T Consensus       143 ~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~  177 (291)
T cd05612         143 TDFGFAKKLRDR-------TWTLCGTPEYLAPEVIQSKGHNK  177 (291)
T ss_pred             EecCcchhccCC-------cccccCChhhcCHHHHcCCCCCc
Confidence            999999865321       11246899999999998877664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.96  E-value=2.3e-28  Score=247.76  Aligned_cols=177  Identities=28%  Similarity=0.358  Sum_probs=147.5

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      |+..+.||+|+||.||+|.+..+|+.||||++....   ......+.+|+++++.++|++|+++++++     ...+..+
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~~   76 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDALC   76 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeEE
Confidence            677889999999999999999899999999985432   22335678999999999999999999885     3445789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++|+|.+++.....        ..+++..+..++.|++.|++|||+   .+|+||||||+||++++++.+||+|
T Consensus        77 lv~e~~~~g~L~~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~D  145 (285)
T cd05631          77 LVLTIMNGGDLKFHIYNMGN--------PGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISD  145 (285)
T ss_pred             EEEEecCCCcHHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEee
Confidence            99999999999887754322        237888999999999999999999   7999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ||+++......     ......||+.|+|||++.+..++.+
T Consensus       146 fg~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~  181 (285)
T cd05631         146 LGLAVQIPEGE-----TVRGRVGTVGYMAPEVINNEKYTFS  181 (285)
T ss_pred             CCCcEEcCCCC-----eecCCCCCCCccCHhhhcCCCCCcc
Confidence            99998653211     1123468999999999998887754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-30  Score=237.31  Aligned_cols=178  Identities=25%  Similarity=0.386  Sum_probs=148.9

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      .++.|++.+.||+|+|+.||++.++.+|+.+|+|++...  .....+.+.+|+++.+.++|||||++.+.     +....
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t-----i~~~~   83 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEES   83 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh-----hcccc
Confidence            345677889999999999999999999999999998532  23356889999999999999999999987     55566


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC---CC
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN---DM  593 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~---~~  593 (640)
                      +.|+|+|+|.||+|..-+-..          ...++..+.+.+.||++|+.|+|.   .+|||||+||+|+++..   ..
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~R----------~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A  150 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVAR----------EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGA  150 (355)
T ss_pred             eeEEEEecccchHHHHHHHHH----------HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCC
Confidence            899999999999997655322          226778889999999999999999   79999999999999953   34


Q ss_pred             cEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          594 IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       594 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      .+|++|||+|..+.     ......+++|||.|||||++...+|+.
T Consensus       151 ~vKL~~FGvAi~l~-----~g~~~~G~~GtP~fmaPEvvrkdpy~k  191 (355)
T KOG0033|consen  151 AVKLADFGLAIEVN-----DGEAWHGFAGTPGYLSPEVLKKDPYSK  191 (355)
T ss_pred             ceeecccceEEEeC-----CccccccccCCCcccCHHHhhcCCCCC
Confidence            68999999998664     223445688999999999999888763

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.96  E-value=2.7e-28  Score=251.59  Aligned_cols=172  Identities=28%  Similarity=0.342  Sum_probs=143.4

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEee
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYE  523 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e  523 (640)
                      +.||+|+||.||+|+...+|+.||+|++...   .......+.+|+++++.++||||+++++++     ...+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence            4689999999999999989999999999643   233446778899999999999999999885     44557899999


Q ss_pred             ccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccccc
Q 035691          524 FMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT  603 (640)
Q Consensus       524 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla  603 (640)
                      |+++|+|..++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||++
T Consensus        76 ~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~  142 (323)
T cd05595          76 YANGGELFFHLSRER----------VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLC  142 (323)
T ss_pred             CCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHh
Confidence            999999998885432          27888999999999999999999   69999999999999999999999999998


Q ss_pred             ccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          604 RFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       604 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +.....    ........||+.|+|||++.+..++.+
T Consensus       143 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~  175 (323)
T cd05595         143 KEGISD----GATMKTFCGTPEYLAPEVLEDNDYGRA  175 (323)
T ss_pred             ccccCC----CCccccccCCcCcCCcccccCCCCCch
Confidence            753221    111223569999999999988877653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.95  E-value=3.6e-28  Score=251.14  Aligned_cols=172  Identities=28%  Similarity=0.347  Sum_probs=143.8

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEee
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYE  523 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e  523 (640)
                      +.||+|+||.||+|+...+|+.||+|++...   .......+.+|+++++.++||||+++++++     ...+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence            3689999999999999999999999999643   233446788999999999999999999884     44568899999


Q ss_pred             ccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccccc
Q 035691          524 FMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT  603 (640)
Q Consensus       524 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla  603 (640)
                      |+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||++
T Consensus        76 y~~~g~L~~~l~~~~----------~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~  142 (328)
T cd05593          76 YVNGGELFFHLSRER----------VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLC  142 (328)
T ss_pred             CCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCC
Confidence            999999998885432          27888999999999999999999   69999999999999999999999999999


Q ss_pred             ccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          604 RFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       604 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +.....    .......+||+.|+|||++.+..++.+
T Consensus       143 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~  175 (328)
T cd05593         143 KEGITD----AATMKTFCGTPEYLAPEVLEDNDYGRA  175 (328)
T ss_pred             ccCCCc----ccccccccCCcCccChhhhcCCCCCcc
Confidence            854221    111223569999999999988777653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.95  E-value=1.5e-28  Score=257.71  Aligned_cols=178  Identities=25%  Similarity=0.300  Sum_probs=148.0

Q ss_pred             HHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc
Q 035691          436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDF  512 (640)
Q Consensus       436 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  512 (640)
                      +....++|++.+.||+|+||.||+|++..+++.||+|++...   .....+.+.+|+.+++.++||||+++++++     
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----  112 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----  112 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----
Confidence            344457799999999999999999999999999999998542   222345688999999999999999999984     


Q ss_pred             CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC
Q 035691          513 QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND  592 (640)
Q Consensus       513 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~  592 (640)
                      .++...++||||+++|+|.+++...           .+++..+..++.|++.||+|||+   .+|+||||||+|||++.+
T Consensus       113 ~~~~~~~lv~Ey~~gg~L~~~l~~~-----------~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~  178 (370)
T cd05621         113 QDDKYLYMVMEYMPGGDLVNLMSNY-----------DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKH  178 (370)
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCC
Confidence            4556899999999999999988532           26777889999999999999999   699999999999999999


Q ss_pred             CcEEEccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          593 MIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       593 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      +.+||+|||+|+......   .......+||+.|||||++.+.
T Consensus       179 ~~~kL~DFG~a~~~~~~~---~~~~~~~~gt~~Y~aPE~~~~~  218 (370)
T cd05621         179 GHLKLADFGTCMKMDETG---MVRCDTAVGTPDYISPEVLKSQ  218 (370)
T ss_pred             CCEEEEecccceecccCC---ceecccCCCCcccCCHHHHhcc
Confidence            999999999998653221   1122345699999999998654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.95  E-value=2e-28  Score=253.91  Aligned_cols=174  Identities=27%  Similarity=0.377  Sum_probs=146.3

Q ss_pred             CCCcccCcccccccceEEEEEECCCC-eEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQ-TVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ++|++.+.||+|+||.||+|+++.++ ..||+|++...   .....+.+.+|+.+++.++|||||++++++     .+..
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~  104 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KDES  104 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----EeCC
Confidence            46888899999999999999876554 68999998543   233446788999999999999999999995     3455


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++|+|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+|
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~~----------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ik  171 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRNK----------RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIK  171 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEE
Confidence            7899999999999999986443          27888899999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|||+++.....       .....||+.|||||++.+..++.
T Consensus       172 L~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~  207 (340)
T PTZ00426        172 MTDFGFAKVVDTR-------TYTLCGTPEYIAPEILLNVGHGK  207 (340)
T ss_pred             EecCCCCeecCCC-------cceecCChhhcCHHHHhCCCCCc
Confidence            9999999865321       12346999999999998876654

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.95  E-value=5.4e-28  Score=249.74  Aligned_cols=173  Identities=28%  Similarity=0.328  Sum_probs=143.2

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEee
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYE  523 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e  523 (640)
                      +.||+|+||.||+|++..+|+.||+|+++...   ......+..|+++++.++||||+++++++     ......++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence            46899999999999999899999999996432   23446778899999999999999999884     44558899999


Q ss_pred             ccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccccc
Q 035691          524 FMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT  603 (640)
Q Consensus       524 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla  603 (640)
                      |+++|+|..++....          .+++..+..++.|++.||+|||+.  .+|+||||||+||+++.++.+||+|||++
T Consensus        76 ~~~~~~L~~~l~~~~----------~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~  143 (325)
T cd05594          76 YANGGELFFHLSRER----------VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLC  143 (325)
T ss_pred             CCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCC
Confidence            999999998885432          278889999999999999999963  58999999999999999999999999998


Q ss_pred             ccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          604 RFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       604 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +......    .......||+.|+|||++.+..++.+
T Consensus       144 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~  176 (325)
T cd05594         144 KEGIKDG----ATMKTFCGTPEYLAPEVLEDNDYGRA  176 (325)
T ss_pred             eecCCCC----cccccccCCcccCCHHHHccCCCCCc
Confidence            7532211    11223469999999999988877653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.95  E-value=3.1e-28  Score=255.26  Aligned_cols=182  Identities=25%  Similarity=0.307  Sum_probs=149.7

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|+..+.||+|+||.||+|+...+++.||+|++....   ......+.+|+.++..++||+|+++++++     .+...
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence            36888899999999999999999999999999996432   23346788899999999999999999984     45568


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~----------~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL  142 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKKD----------TLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKL  142 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEE
Confidence            999999999999999986432          27788899999999999999999   79999999999999999999999


Q ss_pred             ccccccccCCCccCC-------------------------------CceeeccccccccccCcccCCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISS-------------------------------NQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       598 ~DfGla~~~~~~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||+++.+......                               ........+||+.|+|||++.+..++.+
T Consensus       143 ~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~  216 (360)
T cd05627         143 SDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL  216 (360)
T ss_pred             eeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCc
Confidence            999998754321100                               0001123579999999999988877653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=3.6e-28  Score=249.60  Aligned_cols=170  Identities=28%  Similarity=0.336  Sum_probs=142.8

Q ss_pred             ccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEeecc
Q 035691          449 IGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFM  525 (640)
Q Consensus       449 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~  525 (640)
                      ||+|+||.||+|++..+++.||+|+++..   .......+.+|+.++++++||||+++++++     ...+..++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence            69999999999999989999999998643   233456788999999999999999999885     3455789999999


Q ss_pred             CCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccccccc
Q 035691          526 HHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF  605 (640)
Q Consensus       526 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~  605 (640)
                      ++|+|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++.
T Consensus        76 ~~g~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~  142 (312)
T cd05585          76 NGGELFHHLQREG----------RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKL  142 (312)
T ss_pred             CCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECccccc
Confidence            9999999986432          27788899999999999999999   6999999999999999999999999999985


Q ss_pred             CCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          606 IPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       606 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      .....    ......+||+.|+|||++.+..++.+
T Consensus       143 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~  173 (312)
T cd05585         143 NMKDD----DKTNTFCGTPEYLAPELLLGHGYTKA  173 (312)
T ss_pred             CccCC----CccccccCCcccCCHHHHcCCCCCCc
Confidence            42211    11223569999999999988877653

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=5.8e-29  Score=252.17  Aligned_cols=180  Identities=22%  Similarity=0.366  Sum_probs=155.5

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce-
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF-  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~-  517 (640)
                      +.|...+++|+|+||.++.++++.++..||+|.+....  ...++....|+.++++++|||||.+.+.+     ..++. 
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~-----~~~~~~   78 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSF-----EEDGQL   78 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccch-----hcCCce
Confidence            45778899999999999999999999999999996554  34456789999999999999999999984     33444 


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .+|||+||+||++.+.+...+.        ..+++..+++|+.|++.|+.|||+   .+|+|||||+.||++..++.+||
T Consensus        79 l~Ivm~Y~eGg~l~~~i~~~k~--------~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkL  147 (426)
T KOG0589|consen   79 LCIVMEYCEGGDLAQLIKEQKG--------VLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKL  147 (426)
T ss_pred             EEEEEeecCCCCHHHHHHHHhh--------ccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceee
Confidence            9999999999999999976553        348999999999999999999997   79999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||+|+.+....    ....+++||+.||.||.+.+-+|..|
T Consensus       148 gDfGlaK~l~~~~----~~a~tvvGTp~YmcPEil~d~pYn~K  186 (426)
T KOG0589|consen  148 GDFGLAKILNPED----SLASTVVGTPYYMCPEILSDIPYNEK  186 (426)
T ss_pred             cchhhhhhcCCch----hhhheecCCCcccCHHHhCCCCCCcc
Confidence            9999999876432    13345689999999999999888765

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.4e-29  Score=245.41  Aligned_cols=178  Identities=29%  Similarity=0.366  Sum_probs=153.4

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      -+.|+.-++||+|+||.||-|+.+.+|+.||+|.+++.   .++.....++|-.+++++..+.||.+-.+     |++.+
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-----feTkd  258 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-----FETKD  258 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-----ecCCC
Confidence            35677889999999999999999999999999998433   22333567899999999999999998777     67778


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..|+||..|.||||.-++.....        ..+++..+..++.+|+.||++||.   .+||+||+||+|||+|+.|+++
T Consensus       259 ~LClVLtlMNGGDLkfHiyn~g~--------~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvR  327 (591)
T KOG0986|consen  259 ALCLVLTLMNGGDLKFHIYNHGN--------PGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVR  327 (591)
T ss_pred             ceEEEEEeecCCceeEEeeccCC--------CCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeE
Confidence            99999999999999998876653        358999999999999999999999   7999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      |+|.|+|-.+.+..     ...+.+||.+|||||++..+.|+
T Consensus       328 ISDLGLAvei~~g~-----~~~~rvGT~GYMAPEvl~ne~Y~  364 (591)
T KOG0986|consen  328 ISDLGLAVEIPEGK-----PIRGRVGTVGYMAPEVLQNEVYD  364 (591)
T ss_pred             eeccceEEecCCCC-----ccccccCcccccCHHHHcCCccc
Confidence            99999998775422     12335799999999999998876

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.95  E-value=4.7e-29  Score=230.61  Aligned_cols=175  Identities=28%  Similarity=0.416  Sum_probs=148.7

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc--------hhHHHHHHHHHHHHhc-CCCCCcceeEeeccC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--------GALKSFMAECEALRNI-RHRNLVKIITACSSS  510 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  510 (640)
                      -..|...+.+|.|..+.|-+|.++++|..+|+|++.....        .-+++-..|+.+++++ .||+|+++.++    
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~----   91 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV----   91 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee----
Confidence            3456778899999999999999999999999999964321        1235677899999998 79999999999    


Q ss_pred             CcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC
Q 035691          511 DFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD  590 (640)
Q Consensus       511 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~  590 (640)
                       |+.....++|+|.|+.|.|.++|...          -.+++....+|++|+.+|+.|||.   +.|||||+||+|||+|
T Consensus        92 -yes~sF~FlVFdl~prGELFDyLts~----------VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILld  157 (411)
T KOG0599|consen   92 -YESDAFVFLVFDLMPRGELFDYLTSK----------VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLD  157 (411)
T ss_pred             -ccCcchhhhhhhhcccchHHHHhhhh----------eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeec
Confidence             55566889999999999999999643          238888999999999999999999   7999999999999999


Q ss_pred             CCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCC
Q 035691          591 NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV  637 (640)
Q Consensus       591 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  637 (640)
                      ++..+||+|||+|..+++.     ......||||+|.|||.+.+.-+
T Consensus       158 dn~~i~isDFGFa~~l~~G-----ekLrelCGTPgYLAPEtikC~m~  199 (411)
T KOG0599|consen  158 DNMNIKISDFGFACQLEPG-----EKLRELCGTPGYLAPETIKCSMY  199 (411)
T ss_pred             cccceEEeccceeeccCCc-----hhHHHhcCCCcccChhheeeecc
Confidence            9999999999999977542     22345789999999999976543

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=3.3e-28  Score=238.17  Aligned_cols=148  Identities=31%  Similarity=0.380  Sum_probs=131.1

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      +|+..+.||.|.-|+||.|..+.++..+|+|++++..   ++...+...|.+||+.++||.++.+|+.     ++.+++.
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-----fet~~~~  152 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-----FETDKYS  152 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-----eecccee
Confidence            3556688999999999999999999999999996543   3444677889999999999999999998     6777799


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      |+|||||+||+|....+....        ..+++..+..++.+|+.||+|||.   .|||+|||||+||||.++|++-++
T Consensus       153 cl~meyCpGGdL~~LrqkQp~--------~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLs  221 (459)
T KOG0610|consen  153 CLVMEYCPGGDLHSLRQKQPG--------KRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLS  221 (459)
T ss_pred             EEEEecCCCccHHHHHhhCCC--------CccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEee
Confidence            999999999999998876544        458999999999999999999999   699999999999999999999999


Q ss_pred             ccccccc
Q 035691          599 DFGLTRF  605 (640)
Q Consensus       599 DfGla~~  605 (640)
                      ||.++..
T Consensus       222 DFDLS~~  228 (459)
T KOG0610|consen  222 DFDLSLR  228 (459)
T ss_pred             ecccccc
Confidence            9998753

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.95  E-value=4.5e-28  Score=251.93  Aligned_cols=192  Identities=25%  Similarity=0.360  Sum_probs=147.4

Q ss_pred             cCCCcccCcccccccceEEEEEE-----CCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRNLVKIITACSSSDF  512 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  512 (640)
                      .++|++.+.||+|+||.||+|.+     +.+++.||||+++... ....+.+.+|+.++..+ +|||||+++++|..   
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~---   82 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK---   82 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC---
Confidence            45688899999999999999975     2345789999986432 23346789999999999 89999999998743   


Q ss_pred             CCCceeeEEeeccCCCChhhhcCCCCCCCC--------------------------------------------------
Q 035691          513 QGNDFKALVYEFMHHGSLESWLHPESASDD--------------------------------------------------  542 (640)
Q Consensus       513 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--------------------------------------------------  542 (640)
                       .+...++||||+++|+|.+++........                                                  
T Consensus        83 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          83 -PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             -CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence             23467899999999999998864321000                                                  


Q ss_pred             --CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccccccCCCccCCCceeeccc
Q 035691          543 --LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL  620 (640)
Q Consensus       543 --~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~  620 (640)
                        .......+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+|||+++........  ......
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~  236 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--VRKGSA  236 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcch--hcccCC
Confidence              00001347788889999999999999999   79999999999999999999999999999865332111  111123


Q ss_pred             cccccccCcccCCCCCCCCC
Q 035691          621 KGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       621 ~gt~~y~aPE~~~~~~~s~k  640 (640)
                      .+++.|+|||++.+..++.|
T Consensus       237 ~~~~~y~aPE~~~~~~~~~~  256 (338)
T cd05102         237 RLPLKWMAPESIFDKVYTTQ  256 (338)
T ss_pred             CCCccccCcHHhhcCCCCcc
Confidence            46788999999988877654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-28  Score=255.27  Aligned_cols=182  Identities=29%  Similarity=0.372  Sum_probs=147.9

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCC-cCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSD-FQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~~~~~  519 (640)
                      .|...+.||+|+||.||+|+++++|+.||||.++.. ....++...+|+++|++++|+|||+++++=.... .--.....
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            355668899999999999999999999999999643 3456688999999999999999999988721111 00133567


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC--CCC--cE
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD--NDM--IA  595 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~--~~~--~~  595 (640)
                      +|||||.+|||+..+......       ..+++.+.+.+..++..||.|||+   .+|+||||||.||++-  .+|  ..
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~-------~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~Iy  163 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENA-------YGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIY  163 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccc-------cCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEE
Confidence            999999999999999766554       469999999999999999999998   5999999999999983  323  57


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCC-CCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG-SQVS  638 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s  638 (640)
                      ||+|||.||.+++..     .-..++||+.|.|||.+.. ..|+
T Consensus       164 KLtDfG~Arel~d~s-----~~~S~vGT~~YLhPel~E~q~~y~  202 (732)
T KOG4250|consen  164 KLTDFGAARELDDNS-----LFTSLVGTEEYLHPELYERQKKYT  202 (732)
T ss_pred             eeecccccccCCCCC-----eeeeecCchhhcChHHHhhccCcC
Confidence            999999999875422     3345789999999999984 4443

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.9e-28  Score=270.55  Aligned_cols=186  Identities=30%  Similarity=0.459  Sum_probs=150.6

Q ss_pred             CCCcccCcccccccceEEEEEECCC-C----eEEEEEEee-cccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPD-Q----TVVAVKVLF-LHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~----~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  514 (640)
                      ...+..+.||+|+||.||+|...+- |    ..||||.++ ..+.+...+|.+|..+|++++|||||+++|+|...    
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~----  767 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS----  767 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC----
Confidence            3455678999999999999997532 2    348999885 34566778999999999999999999999998543    


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                       ...++++|||++|||..||+..+....   .+..+.....+.++.|||+|+.||++   +++|||||.++|+|++....
T Consensus       768 -~~~~i~leyM~gGDL~sflr~~r~~~~---~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~  840 (1025)
T KOG1095|consen  768 -GPPLILLEYMEGGDLLSFLRESRPAPF---QPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRV  840 (1025)
T ss_pred             -CCcEEEehhcccCcHHHHHHhcccccC---CCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCc
Confidence             367899999999999999987655332   24568888999999999999999999   79999999999999999999


Q ss_pred             EEEccccccccCCCccCCCceeeccc-cccccccCcccCCCCCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGL-KGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +||+|||+||.+...   +.+...+. .-..+|||||.++.+.||.|
T Consensus       841 VKIaDFGlArDiy~~---~yyr~~~~a~lPvkWm~PEsl~d~iFtsk  884 (1025)
T KOG1095|consen  841 VKIADFGLARDIYDK---DYYRKHGEAMLPVKWMPPESLKDGIFTSK  884 (1025)
T ss_pred             EEEcccchhHhhhhc---hheeccCccccceecCCHHHHhhcccccc
Confidence            999999999943221   11111111 12368999999999999876

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.95  E-value=5.5e-28  Score=253.76  Aligned_cols=181  Identities=23%  Similarity=0.275  Sum_probs=149.7

Q ss_pred             HHHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeecc
Q 035691          433 YESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSS  509 (640)
Q Consensus       433 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  509 (640)
                      ..++....++|++.+.||+|+||.||+|+++.+++.||+|++....   ....+.+.+|+.+++.++||||+++++++  
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~--  112 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF--  112 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE--
Confidence            3445555678999999999999999999999999999999985422   23345678999999999999999999984  


Q ss_pred             CCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee
Q 035691          510 SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL  589 (640)
Q Consensus       510 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl  589 (640)
                         ..+...++||||+++|+|.+++...           .+++..+..++.|++.||+|||+   .+|+||||||+||++
T Consensus       113 ---~~~~~~~lv~Ey~~gg~L~~~~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll  175 (371)
T cd05622         113 ---QDDRYLYMVMEYMPGGDLVNLMSNY-----------DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLL  175 (371)
T ss_pred             ---EcCCEEEEEEcCCCCCcHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEE
Confidence               4456899999999999999988532           26677888999999999999999   799999999999999


Q ss_pred             CCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          590 DNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       590 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      +.++.+||+|||+++......   .......+||+.|||||++.+.
T Consensus       176 ~~~~~ikL~DfG~a~~~~~~~---~~~~~~~~gt~~y~aPE~l~~~  218 (371)
T cd05622         176 DKSGHLKLADFGTCMKMNKEG---MVRCDTAVGTPDYISPEVLKSQ  218 (371)
T ss_pred             CCCCCEEEEeCCceeEcCcCC---cccccCcccCccccCHHHHhcc
Confidence            999999999999998653221   1112245699999999998754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-28  Score=233.16  Aligned_cols=177  Identities=29%  Similarity=0.351  Sum_probs=152.8

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|...++||+|.||+|-.|+.+.+|+.||+|++++.   .+.....-+.|-++|+..+||.+..+-..     |++.+.
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~dr  242 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQDR  242 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccCce
Confidence            5678889999999999999999999999999999644   34556677889999999999998877544     788899


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .|+||||+.||.|.-+|...+.          +++.....+...|..||.|||+   ++||+||+|.+|.++|.+|++||
T Consensus       243 lCFVMeyanGGeLf~HLsrer~----------FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKi  309 (516)
T KOG0690|consen  243 LCFVMEYANGGELFFHLSRERV----------FSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKI  309 (516)
T ss_pred             EEEEEEEccCceEeeehhhhhc----------ccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEe
Confidence            9999999999999988876543          6777777899999999999999   79999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|||+++.-.    .......++||||.|.|||++....|..
T Consensus       310 tDFGLCKE~I----~~g~t~kTFCGTPEYLAPEVleDnDYgr  347 (516)
T KOG0690|consen  310 TDFGLCKEEI----KYGDTTKTFCGTPEYLAPEVLEDNDYGR  347 (516)
T ss_pred             eecccchhcc----cccceeccccCChhhcCchhhccccccc
Confidence            9999998421    1234566799999999999999887764

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.8e-29  Score=255.61  Aligned_cols=175  Identities=27%  Similarity=0.379  Sum_probs=150.6

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      |.+...||.|+||+||+|..++++...|.|++........+.|+.||++|..++||+||+++++|     ..++..|+..
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ay-----y~enkLwili  108 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAY-----YFENKLWILI  108 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHH-----hccCceEEEE
Confidence            55667899999999999999988988999999887778889999999999999999999999984     4456789999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      |||+||-....+-.-.         ..+.+.++..++.|++.||.|||+   .+|||||||+.|||+.-+|.++++|||.
T Consensus       109 EFC~GGAVDaimlEL~---------r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGV  176 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLELG---------RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGV  176 (1187)
T ss_pred             eecCCchHhHHHHHhc---------cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccc
Confidence            9999999887665433         348889999999999999999999   7999999999999999999999999999


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      +....    ........+.|||+|||||++++..+-
T Consensus       177 SAKn~----~t~qkRDsFIGTPYWMAPEVvmCET~K  208 (1187)
T KOG0579|consen  177 SAKNK----STRQKRDSFIGTPYWMAPEVVMCETFK  208 (1187)
T ss_pred             cccch----hHHhhhccccCCcccccchheeecccc
Confidence            86432    122233467899999999999987654

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.95  E-value=1e-27  Score=247.06  Aligned_cols=177  Identities=29%  Similarity=0.364  Sum_probs=151.5

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc---hhHHHHHHHHHHHHhcC-CCCCcceeEeeccCCcCC
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR---GALKSFMAECEALRNIR-HRNLVKIITACSSSDFQG  514 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~  514 (640)
                      ....|++.+.||+|.||.||+|+.+.+|+.+|+|++.....   ...+...+|+.+|+++. |||||.++++     +.+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~-----~e~  107 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA-----FED  107 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE-----EEc
Confidence            34567888999999999999999999999999999965433   23468999999999998 9999999999     455


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC--
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND--  592 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~--  592 (640)
                      ....++|||++.||.|.+.+...           .+++..+..++.|++.|+.|||+   .+|+|||+||+|+|+...  
T Consensus       108 ~~~~~lvmEL~~GGeLfd~i~~~-----------~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~  173 (382)
T KOG0032|consen  108 PDSVYLVMELCEGGELFDRIVKK-----------HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDE  173 (382)
T ss_pred             CCeEEEEEEecCCchHHHHHHHc-----------cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccC
Confidence            56899999999999999988654           17888999999999999999999   799999999999999643  


Q ss_pred             --CcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          593 --MIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       593 --~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                        +.+|++|||+|.....     .....+.+||++|+|||++.+..++.
T Consensus       174 ~~~~ik~~DFGla~~~~~-----~~~~~~~~Gtp~y~APEvl~~~~y~~  217 (382)
T KOG0032|consen  174 GSGRIKLIDFGLAKFIKP-----GERLHTIVGTPEYVAPEVLGGRPYGD  217 (382)
T ss_pred             CCCcEEEeeCCCceEccC-----CceEeeecCCccccCchhhcCCCCCc
Confidence              5799999999997754     22344578999999999999877764

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.95  E-value=8.4e-28  Score=240.38  Aligned_cols=171  Identities=33%  Similarity=0.441  Sum_probs=139.8

Q ss_pred             cCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEee
Q 035691          446 ANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYE  523 (640)
Q Consensus       446 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e  523 (640)
                      .++||+|.||+||-|.++.+|+.||||++++-.  .+....+.+|+++|+.++||.||.+.-.     +++.+.+++|||
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M-----~ET~ervFVVME  643 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECM-----FETPERVFVVME  643 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEe-----ecCCceEEEEeh
Confidence            478999999999999999999999999995432  2334778999999999999999999877     556678999999


Q ss_pred             ccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC---CcEEEccc
Q 035691          524 FMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND---MIAHVGDF  600 (640)
Q Consensus       524 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~---~~~kl~Df  600 (640)
                      -+.|.-|...|....         ..+++.....++.||+.||.|||.   ++|+|+||||+|||+.+.   -.+||+||
T Consensus       644 Kl~GDMLEMILSsEk---------gRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDF  711 (888)
T KOG4236|consen  644 KLHGDMLEMILSSEK---------GRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDF  711 (888)
T ss_pred             hhcchHHHHHHHhhc---------ccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccc
Confidence            996544444443322         238888888999999999999999   799999999999999643   47999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      |+||.+++..     ....++|||.|.|||+++..-|.
T Consensus       712 GfARiIgEks-----FRrsVVGTPAYLaPEVLrnkGyN  744 (888)
T KOG4236|consen  712 GFARIIGEKS-----FRRSVVGTPAYLAPEVLRNKGYN  744 (888)
T ss_pred             cceeecchhh-----hhhhhcCCccccCHHHHhhcccc
Confidence            9999987532     22346899999999999765543

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.95  E-value=1.5e-27  Score=246.38  Aligned_cols=177  Identities=25%  Similarity=0.269  Sum_probs=144.7

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCC-CCcceeEeeccCCcCCCce
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHR-NLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~~~~  517 (640)
                      +|++.+.||+|+||.||+|+...+++.||||++...   .....+.+..|++++..++|+ +|+++++++     ...+.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence            477889999999999999999989999999999643   233456788999999999765 577777774     44557


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~----------~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL  142 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQVG----------KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKI  142 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEE
Confidence            899999999999999886432          26788899999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||+++.....    .......+||+.|+|||++.+..++.+
T Consensus       143 ~Dfg~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~  181 (324)
T cd05587         143 ADFGMCKENIFG----GKTTRTFCGTPDYIAPEIIAYQPYGKS  181 (324)
T ss_pred             eecCcceecCCC----CCceeeecCCccccChhhhcCCCCCcc
Confidence            999998743211    111223569999999999998877653

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.95  E-value=6.3e-28  Score=253.35  Aligned_cols=175  Identities=24%  Similarity=0.293  Sum_probs=145.2

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++     .++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~  115 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD  115 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence            3457888999999999999999999999999999996432   22335678999999999999999999884     445


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      ...++||||+++|+|.+++...           .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~-----------~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~  181 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSNY-----------DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHL  181 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCE
Confidence            6899999999999999988532           25677888899999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      ||+|||+++.......   ......+||+.|+|||++.+.
T Consensus       182 kL~DfG~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~  218 (370)
T cd05596         182 KLADFGTCMKMDANGM---VRCDTAVGTPDYISPEVLKSQ  218 (370)
T ss_pred             EEEeccceeeccCCCc---ccCCCCCCCcCeECHHHhccC
Confidence            9999999986532211   111235699999999998654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.95  E-value=1.9e-27  Score=243.52  Aligned_cols=190  Identities=23%  Similarity=0.369  Sum_probs=147.1

Q ss_pred             CCCcccCcccccccceEEEEEECC----------------CCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDP----------------DQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKI  503 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l  503 (640)
                      ++|.+.+.||+|+||.||+|++..                ++..||+|++.... ......|.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            468888999999999999998642                34579999986543 3345679999999999999999999


Q ss_pred             eEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 035691          504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDL---------NYSPSILSFLQRLNIAINVASALEYLHHHCK  574 (640)
Q Consensus       504 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~---------~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~  574 (640)
                      ++++..     .+..++||||+++|+|.+++.........         ......+++..+..++.|++.||.|||+   
T Consensus        85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---  156 (304)
T cd05096          85 LGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---  156 (304)
T ss_pred             EEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---
Confidence            999643     34689999999999999988543221110         1112347888899999999999999999   


Q ss_pred             CCeeeCCCCCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          575 KQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       575 ~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      .+|+||||||+||+++.++.+||+|||+++.......  ........++..|+|||++.++.++.|
T Consensus       157 ~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~  220 (304)
T cd05096         157 LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY--YRIQGRAVLPIRWMAWECILMGKFTTA  220 (304)
T ss_pred             CCccccCcchhheEEcCCccEEECCCccceecccCce--eEecCcCCCCccccCHHHHhcCCCCch
Confidence            6999999999999999999999999999986532211  111122345788999999988777653

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=9.1e-28  Score=251.00  Aligned_cols=182  Identities=26%  Similarity=0.363  Sum_probs=151.2

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||.||+|++..+|+.||||++....   ......+.+|++++..++||||+++++++     ..++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence            46888999999999999999999899999999996432   23456788999999999999999999884     45568


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL  142 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIRKD----------VFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKL  142 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEe
Confidence            999999999999999986542          27888899999999999999999   79999999999999999999999


Q ss_pred             ccccccccCCCccC-------------------------CCceeeccccccccccCcccCCCCCCCCC
Q 035691          598 GDFGLTRFIPEVIS-------------------------SNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       598 ~DfGla~~~~~~~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||+++.+.....                         ..........||+.|+|||++.+..++.+
T Consensus       143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  210 (350)
T cd05573         143 ADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE  210 (350)
T ss_pred             ecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCc
Confidence            99999986543220                         00011223569999999999988877653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.95  E-value=1.9e-27  Score=246.03  Aligned_cols=172  Identities=24%  Similarity=0.291  Sum_probs=142.8

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      ++||+|+||.||+|++..+++.||||+++...   ....+.+..|..++..+ +||||+++++++     ......++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence            46899999999999999999999999996432   23345688899999988 799999999985     4455789999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      ||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~g~L~~~~~~~~----------~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~  142 (329)
T cd05588          76 EFVSGGDLMFHMQRQR----------KLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGM  142 (329)
T ss_pred             eCCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCcc
Confidence            9999999998875432          27889999999999999999999   6999999999999999999999999999


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ++.....    .......+||+.|+|||++.+..++.+
T Consensus       143 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~  176 (329)
T cd05588         143 CKEGIRP----GDTTSTFCGTPNYIAPEILRGEDYGFS  176 (329)
T ss_pred             ccccccC----CCccccccCCccccCHHHHcCCCCCCc
Confidence            9743211    111223569999999999998877653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.4e-27  Score=247.18  Aligned_cols=174  Identities=26%  Similarity=0.283  Sum_probs=145.0

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||.||+|+...+++.||+|++...   .....+.+.+|+.++..++|+||+++++++     ..+..
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence            4688899999999999999999999999999999642   223446688999999999999999999985     44568


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++....         ..+++..+..++.|++.||+|||+   ++|+||||||+||+++.++.+||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl  143 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKFE---------DRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRL  143 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEE
Confidence            899999999999999986432         237888899999999999999999   79999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      +|||+++.+.....   .......||+.|||||++.+
T Consensus       144 ~Dfg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~  177 (331)
T cd05597         144 ADFGSCLRLLADGT---VQSNVAVGTPDYISPEILQA  177 (331)
T ss_pred             EECCceeecCCCCC---ccccceeccccccCHHHHhh
Confidence            99999876533211   11122458999999999863

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.95  E-value=1.4e-27  Score=247.30  Aligned_cols=174  Identities=25%  Similarity=0.290  Sum_probs=145.3

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||.||+|++..+++.||+|++...   .......+.+|+.++..++|++|+++++++     ...+.
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence            4688899999999999999999999999999998542   223345688899999999999999999984     44568


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~~---------~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl  143 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKFE---------DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRL  143 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEE
Confidence            899999999999999986532         127788889999999999999999   79999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      +|||+++.+....   ........||+.|+|||++.+
T Consensus       144 ~DfG~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~  177 (331)
T cd05624         144 ADFGSCLKMNQDG---TVQSSVAVGTPDYISPEILQA  177 (331)
T ss_pred             EeccceeeccCCC---ceeeccccCCcccCCHHHHhc
Confidence            9999998654321   111223469999999999865

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.95  E-value=3.6e-28  Score=211.33  Aligned_cols=173  Identities=25%  Similarity=0.453  Sum_probs=144.5

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      |...++||+|.||+||+|+.+++++.||+|.++..  +++-.....+|+.++++++|.|||+++++.     ..+...-+
T Consensus         4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkkltl   78 (292)
T KOG0662|consen    4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLTL   78 (292)
T ss_pred             hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeEE
Confidence            45568899999999999999999999999999654  345567889999999999999999999984     34457889


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      |+|||.. +|..+......         .++...+..++.|+.+|+.|+|+   .++.|||+||.|.++..+|+.|++||
T Consensus        79 vfe~cdq-dlkkyfdslng---------~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladf  145 (292)
T KOG0662|consen   79 VFEFCDQ-DLKKYFDSLNG---------DLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADF  145 (292)
T ss_pred             eHHHhhH-HHHHHHHhcCC---------cCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEeccc
Confidence            9999965 88877754332         26777888999999999999999   59999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV  637 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  637 (640)
                      |+|+.++-+.   .|-+. .+-|.+|++|.++.|++.
T Consensus       146 glarafgipv---rcysa-evvtlwyrppdvlfgakl  178 (292)
T KOG0662|consen  146 GLARAFGIPV---RCYSA-EVVTLWYRPPDVLFGAKL  178 (292)
T ss_pred             chhhhcCCce---Eeeec-eeeeeeccCcceeeeeeh
Confidence            9999775432   23333 346999999999988764

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.95  E-value=1.9e-27  Score=244.58  Aligned_cols=172  Identities=26%  Similarity=0.346  Sum_probs=140.3

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      +.||+|+||.||+|++..+++.||||+++...   ....+.+..|..++... +||||+++++++     ..+...++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            36899999999999999899999999996432   23345566777777654 899999999884     4455789999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      ||+++|+|..++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~gg~L~~~~~~~~----------~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~  142 (316)
T cd05592          76 EYLNGGDLMFHIQSSG----------RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGM  142 (316)
T ss_pred             cCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcC
Confidence            9999999998886432          27788889999999999999999   6999999999999999999999999999


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ++......    ......+||+.|+|||++.+..++.+
T Consensus       143 a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~  176 (316)
T cd05592         143 CKENMNGE----GKASTFCGTPDYIAPEILKGQKYNES  176 (316)
T ss_pred             CeECCCCC----CccccccCCccccCHHHHcCCCCCCc
Confidence            98542211    11223568999999999988877653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.95  E-value=1.6e-27  Score=241.93  Aligned_cols=173  Identities=25%  Similarity=0.438  Sum_probs=142.8

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ++|+..+.||+|+||.||+|+.+.+++.||+|+++... ......+.+|+++++.++||||+++++++     ..+...+
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~   79 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCLT   79 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeEE
Confidence            56888999999999999999999999999999986443 23345678999999999999999999984     4455789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++ +|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+|
T Consensus        80 lv~e~~~~-~l~~~l~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~D  146 (288)
T cd07871          80 LVFEYLDS-DLKQYLDNCG---------NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLAD  146 (288)
T ss_pred             EEEeCCCc-CHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECc
Confidence            99999985 8988875432         236788899999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      ||+++......    .......||+.|+|||++.+.
T Consensus       147 fG~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~  178 (288)
T cd07871         147 FGLARAKSVPT----KTYSNEVVTLWYRPPDVLLGS  178 (288)
T ss_pred             CcceeeccCCC----ccccCceecccccChHHhcCC
Confidence            99997543211    111224589999999998763

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.95  E-value=3e-27  Score=244.78  Aligned_cols=178  Identities=25%  Similarity=0.347  Sum_probs=150.4

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      .++|+..+.||+|+||.||+|++..+|..||+|++.... ....+.+.+|++++++++||||+++++++.     .++..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   78 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI   78 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCEE
Confidence            467889999999999999999999999999999996543 234467999999999999999999999954     34578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||+++|+|.+++....          .+++..+..++.|++.|+.|||+.  .+|+||||||+||+++.++.+||+
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~  146 (331)
T cd06649          79 SICMEHMDGGSLDQVLKEAK----------RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLC  146 (331)
T ss_pred             EEEeecCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEc
Confidence            99999999999999986432          277888999999999999999983  369999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |||+++......      .....||+.|+|||++.+..++.+
T Consensus       147 Dfg~~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~  182 (331)
T cd06649         147 DFGVSGQLIDSM------ANSFVGTRSYMSPERLQGTHYSVQ  182 (331)
T ss_pred             cCcccccccccc------cccCCCCcCcCCHhHhcCCCCCch
Confidence            999998653221      123468999999999998877653

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.95  E-value=1.3e-28  Score=231.76  Aligned_cols=186  Identities=25%  Similarity=0.370  Sum_probs=151.7

Q ss_pred             CCCcccCcccccccceEEEEEECCCC----eEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQ----TVVAVKVLFLHQR--GALKSFMAECEALRNIRHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  514 (640)
                      ..|+....||+|.||.||+|..+.+.    ..+|+|.++.+..  +-.....+|+..+++++|||+|.+..++...    
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~----   99 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH----   99 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence            34778889999999999999765443    2789999965432  3446788999999999999999999986332    


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC--
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND--  592 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~--  592 (640)
                      +..+++++||.+. ||.+.++..+....     ..++...+..|..||+.|+.|||+   .=|+||||||.||++..+  
T Consensus       100 d~~v~l~fdYAEh-DL~~II~fHr~~~~-----~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgp  170 (438)
T KOG0666|consen  100 DKKVWLLFDYAEH-DLWHIIKFHRASKA-----KQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGP  170 (438)
T ss_pred             CceEEEEehhhhh-hHHHHHHHhccchh-----ccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCC
Confidence            5679999999987 99998876654322     468888999999999999999999   468999999999999776  


Q ss_pred             --CcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          593 --MIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       593 --~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                        |.+||+|||+||.+..+.. ..+....++-|.||+|||.++|++..++
T Consensus       171 erG~VKIaDlGlaR~~~~plk-pl~s~d~VVVTiWYRAPELLLGa~hYT~  219 (438)
T KOG0666|consen  171 ERGRVKIADLGLARLFNNPLK-PLASLDPVVVTIWYRAPELLLGARHYTK  219 (438)
T ss_pred             ccCeeEeecccHHHHhhcccc-ccccCCceEEEEEecChHHhcccccccc
Confidence              8999999999998865543 2334456778999999999999987653

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.95  E-value=2.1e-27  Score=245.57  Aligned_cols=172  Identities=24%  Similarity=0.295  Sum_probs=142.2

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      +.||+|+||.||+|++..+++.||+|+++..   .....+.+..|+.++.++ +||||+++++++     ......++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence            4689999999999999999999999999643   223445678899888876 899999999984     4456889999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      ||+++|+|..++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+
T Consensus        76 E~~~~~~L~~~~~~~~----------~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~  142 (329)
T cd05618          76 EYVNGGDLMFHMQRQR----------KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGM  142 (329)
T ss_pred             eCCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCc
Confidence            9999999998875432          27888999999999999999999   6999999999999999999999999999


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ++......    .......||+.|+|||++.+..++.+
T Consensus       143 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~  176 (329)
T cd05618         143 CKEGLRPG----DTTSTFCGTPNYIAPEILRGEDYGFS  176 (329)
T ss_pred             cccccCCC----CccccccCCccccCHHHHcCCCCCCc
Confidence            97532111    11223568999999999998877653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.95  E-value=2.2e-27  Score=245.88  Aligned_cols=174  Identities=25%  Similarity=0.251  Sum_probs=145.9

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||.||+|+...+|+.||+|+++...   ....+.+.+|+.+++.++||||+++++++     .....
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence            36888999999999999999999999999999996432   23446788999999999999999999884     34557


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++....         ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~---------~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL  143 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRYE---------DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKL  143 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEe
Confidence            899999999999999986542         237888899999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      +|||+++.+.....   .......||+.|+|||++.+
T Consensus       144 ~Dfg~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~  177 (330)
T cd05601         144 ADFGSAARLTANKM---VNSKLPVGTPDYIAPEVLTT  177 (330)
T ss_pred             ccCCCCeECCCCCc---eeeecccCCccccCHHHhcc
Confidence            99999986543211   12223468999999999873

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.95  E-value=1.8e-27  Score=245.15  Aligned_cols=171  Identities=29%  Similarity=0.323  Sum_probs=141.6

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      +.||+|+||.||+|+++.+++.||||++...   .....+.+..|..++... +||||+++++++     ...+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence            4689999999999999989999999998643   233446778888888876 699999999984     4456789999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      ||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+
T Consensus        76 Ey~~~g~L~~~i~~~~----------~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~  142 (320)
T cd05590          76 EFVNGGDLMFHIQKSR----------RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGM  142 (320)
T ss_pred             cCCCCchHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCC
Confidence            9999999998886432          27788899999999999999999   6999999999999999999999999999


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ++.....    ........||+.|+|||++.+..++.
T Consensus       143 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~  175 (320)
T cd05590         143 CKEGIFN----GKTTSTFCGTPDYIAPEILQEMLYGP  175 (320)
T ss_pred             CeecCcC----CCcccccccCccccCHHHHcCCCCCC
Confidence            8753211    11223356999999999998877664

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.95  E-value=1.8e-27  Score=247.45  Aligned_cols=182  Identities=25%  Similarity=0.315  Sum_probs=146.3

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +|++.+.||+|+||.||+|++..+|+.||||++...  .......+.+|+++++.++||||+++++++...........+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            477889999999999999999999999999998532  223345788999999999999999999987654434445689


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +|||||+ ++|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|
T Consensus        81 lv~e~~~-~~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~D  146 (338)
T cd07859          81 VVFELME-SDLHQVIKAND----------DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICD  146 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc----------cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEcc
Confidence            9999995 68988885432          27888999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCC--CCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG--SQVS  638 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s  638 (640)
                      ||+++......... .......||+.|+|||++.+  ..++
T Consensus       147 fg~~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~  186 (338)
T cd07859         147 FGLARVAFNDTPTA-IFWTDYVATRWYRAPELCGSFFSKYT  186 (338)
T ss_pred             CccccccccccCcc-ccccCCCCCCCcCCHHHHhccccccC
Confidence            99998643221111 11123468999999999865  4444

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.95  E-value=2.8e-27  Score=244.16  Aligned_cols=172  Identities=33%  Similarity=0.380  Sum_probs=139.1

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHH-HHHhcCCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECE-ALRNIRHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      +.||+|+||+||+|++..+|+.||+|++....   ......+..|.. +++.++||||+++++++     ...+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence            36899999999999999999999999996432   222344555554 56789999999999884     4455789999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      ||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~  142 (323)
T cd05575          76 DYVNGGELFFHLQRER----------SFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGL  142 (323)
T ss_pred             cCCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCC
Confidence            9999999999886432          27788889999999999999999   6999999999999999999999999999


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ++......    .......||+.|+|||++.+..++.+
T Consensus       143 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~  176 (323)
T cd05575         143 CKEGIEHS----KTTSTFCGTPEYLAPEVLRKQPYDRT  176 (323)
T ss_pred             CcccccCC----CccccccCChhhcChhhhcCCCCCcc
Confidence            87532211    11223568999999999988877653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.95  E-value=2.7e-27  Score=244.57  Aligned_cols=172  Identities=34%  Similarity=0.377  Sum_probs=139.5

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHH-HHHhcCCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECE-ALRNIRHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      +.||+|+||+||+|+...+|+.||+|++....   ......+..|.. +++.++||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence            46899999999999999999999999996432   223345566655 46778999999999884     4455789999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      ||+++|+|..++....          .+++..+..++.||+.||+|||+   .+|+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~  142 (325)
T cd05604          76 DFVNGGELFFHLQRER----------SFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGL  142 (325)
T ss_pred             cCCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCC
Confidence            9999999998875432          27888999999999999999999   6999999999999999999999999999


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ++.....    .......+||+.|+|||++.+..++.+
T Consensus       143 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~  176 (325)
T cd05604         143 CKEGIAQ----SDTTTTFCGTPEYLAPEVIRKQPYDNT  176 (325)
T ss_pred             cccCCCC----CCCcccccCChhhCCHHHHcCCCCCCc
Confidence            8753211    111233569999999999988877653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.95  E-value=2.2e-27  Score=244.70  Aligned_cols=172  Identities=27%  Similarity=0.307  Sum_probs=141.8

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      ++||+|+||.||+|++..+++.||+|++...   .....+.+..|.+++..+ +||+|+++++++     ......++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence            4689999999999999989999999999643   233446678899998876 799999999985     4455789999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      ||+++|+|..++....          .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+
T Consensus        76 E~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~  142 (321)
T cd05591          76 EYVNGGDLMFQIQRSR----------KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGM  142 (321)
T ss_pred             eCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeeccc
Confidence            9999999998886432          27788889999999999999999   6999999999999999999999999999


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ++......    .......||+.|+|||++.+..++.+
T Consensus       143 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~  176 (321)
T cd05591         143 CKEGILNG----VTTTTFCGTPDYIAPEILQELEYGPS  176 (321)
T ss_pred             ceecccCC----ccccccccCccccCHHHHcCCCCCCc
Confidence            87542211    11223568999999999988777653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.95  E-value=2.4e-27  Score=244.68  Aligned_cols=177  Identities=24%  Similarity=0.271  Sum_probs=145.0

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCce
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      +|.+.+.||+|+||.||+|++..+++.||+|++....   ....+.+..|..++... +|++|+++++++     ...+.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence            4778899999999999999999899999999986432   22345677788888877 588899998884     34557


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~----------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL  142 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQVG----------RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKI  142 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEE
Confidence            899999999999998885432          27788899999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||+++.....    ........||+.|+|||++.+..++.+
T Consensus       143 ~DfG~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~  181 (323)
T cd05616         143 ADFGMCKENMWD----GVTTKTFCGTPDYIAPEIIAYQPYGKS  181 (323)
T ss_pred             ccCCCceecCCC----CCccccCCCChhhcCHHHhcCCCCCCc
Confidence            999999754211    111223569999999999998887654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.95  E-value=2.8e-27  Score=243.27  Aligned_cols=172  Identities=26%  Similarity=0.337  Sum_probs=141.2

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      +.||+|+||.||+|+++.+|+.||+|+++...   ....+.+..|..++... +||+|+++++++     ...+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence            46899999999999999999999999996432   23345677788888764 899999999984     4456899999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      ||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+
T Consensus        76 E~~~~g~L~~~i~~~~----------~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~  142 (316)
T cd05620          76 EFLNGGDLMFHIQDKG----------RFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGM  142 (316)
T ss_pred             CCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCC
Confidence            9999999998886432          26788889999999999999999   6999999999999999999999999999


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ++.....    .......+||+.|+|||++.+..++.+
T Consensus       143 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~  176 (316)
T cd05620         143 CKENVFG----DNRASTFCGTPDYIAPEILQGLKYTFS  176 (316)
T ss_pred             CeecccC----CCceeccCCCcCccCHHHHcCCCCCcc
Confidence            8743211    111233569999999999998877653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.95  E-value=2.8e-27  Score=244.29  Aligned_cols=174  Identities=28%  Similarity=0.386  Sum_probs=142.2

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHH---HhcCCCCCcceeEeeccCCcCCCc
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEAL---RNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      |++.+.||+|+||.||+|.+..+++.||||+++...   ....+.+..|++++   +.++||||+++++++     ...+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence            567789999999999999999899999999996432   23345666776655   456899999999984     4456


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++|+|..++...           .+++..+..++.|++.|++|||+   .+|+||||||+||+++.++.+|
T Consensus        76 ~~~lv~E~~~~~~L~~~~~~~-----------~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~k  141 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIHTD-----------VFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVK  141 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEE
Confidence            889999999999998887532           27888999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|||+++......    ......+||+.|+|||++.+..++.
T Consensus       142 L~Dfg~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~  180 (324)
T cd05589         142 IADFGLCKEGMGFG----DRTSTFCGTPEFLAPEVLTETSYTR  180 (324)
T ss_pred             eCcccCCccCCCCC----CcccccccCccccCHhHhcCCCCCc
Confidence            99999987532211    1122356999999999998877764

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.95  E-value=3.4e-27  Score=243.41  Aligned_cols=172  Identities=32%  Similarity=0.369  Sum_probs=138.7

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHH-HHHhcCCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECE-ALRNIRHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      ++||+|+||.||+|++..+++.||+|++....   ......+..|.. +++.++||||+++++++     .+.+..++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence            46899999999999999899999999985432   223345555654 57889999999999884     3455789999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      ||+++|+|..++....          .+++..+..++.||+.||+|||+   .+|+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  142 (321)
T cd05603          76 DYVNGGELFFHLQRER----------CFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGL  142 (321)
T ss_pred             cCCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCC
Confidence            9999999988875432          26778888999999999999998   6999999999999999999999999999


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ++......    .......||+.|+|||++.+..++.+
T Consensus       143 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~  176 (321)
T cd05603         143 CKEGVEPE----ETTSTFCGTPEYLAPEVLRKEPYDRT  176 (321)
T ss_pred             CccCCCCC----CccccccCCcccCCHHHhcCCCCCCc
Confidence            87532211    11223568999999999988777653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.95  E-value=3.6e-27  Score=238.35  Aligned_cols=174  Identities=29%  Similarity=0.367  Sum_probs=142.6

Q ss_pred             ccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEeecc
Q 035691          449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFM  525 (640)
Q Consensus       449 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~  525 (640)
                      ||+|+||+||+|.++.+++.||+|++....   ....+.+..|+++++.++||||+++.+++     ..+...++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence            699999999999999999999999985432   22335678899999999999999999884     3445789999999


Q ss_pred             CCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccccccc
Q 035691          526 HHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF  605 (640)
Q Consensus       526 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~  605 (640)
                      ++|+|.+++......      ...+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+|||+++.
T Consensus        76 ~~g~L~~~~~~~~~~------~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  146 (280)
T cd05608          76 NGGDLRYHIYNVDEE------NPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVE  146 (280)
T ss_pred             CCCCHHHHHHhcccc------CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcccee
Confidence            999998877432211      1347889999999999999999999   6999999999999999999999999999986


Q ss_pred             CCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          606 IPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       606 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +.....    ......||+.|+|||++.+..++.+
T Consensus       147 ~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~  177 (280)
T cd05608         147 LKDGQS----KTKGYAGTPGFMAPELLQGEEYDFS  177 (280)
T ss_pred             cCCCCc----cccccCCCcCccCHHHhcCCCCCcc
Confidence            543211    1223468999999999998887653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.95  E-value=2.8e-27  Score=244.08  Aligned_cols=177  Identities=24%  Similarity=0.270  Sum_probs=144.3

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcC-CCCCcceeEeeccCCcCCCce
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIR-HRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~  517 (640)
                      +|+..+.||+|+||.||+|+++.+|+.||+|++....   ....+.+..|..++..+. |++|+++++++     ...+.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence            3677789999999999999999999999999986432   233466788999998886 56777788773     44557


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++....          .+++.++..++.|++.||+|||+   .+|+||||||+||+++.++.+||
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~~~----------~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL  142 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQVG----------KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKI  142 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEE
Confidence            899999999999999885432          27888999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||+++......    .......||+.|+|||++.+..++.+
T Consensus       143 ~Dfg~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~  181 (323)
T cd05615         143 ADFGMCKEHMVDG----VTTRTFCGTPDYIAPEIIAYQPYGKS  181 (323)
T ss_pred             eccccccccCCCC----ccccCccCCccccCHHHHcCCCCCCc
Confidence            9999998542211    11223468999999999988777653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.95  E-value=3.9e-27  Score=243.03  Aligned_cols=171  Identities=29%  Similarity=0.337  Sum_probs=139.8

Q ss_pred             CcccccccceEEEEEEC---CCCeEEEEEEeeccc----chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          447 NLIGTGSFGSVYKGILD---PDQTVVAVKVLFLHQ----RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +.||+|+||.||+|+..   .+++.||||+++...    ......+.+|+.+++.++||||+++++++     ..+...+
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeEE
Confidence            67999999999999863   478899999996432    23345678999999999999999999985     3445789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|
T Consensus        77 lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~D  143 (323)
T cd05584          77 LILEYLSGGELFMHLEREG----------IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTD  143 (323)
T ss_pred             EEEeCCCCchHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEee
Confidence            9999999999999886432          26677888899999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+++......    .......||+.|+|||++.+..++.
T Consensus       144 fg~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~  179 (323)
T cd05584         144 FGLCKESIHEG----TVTHTFCGTIEYMAPEILMRSGHGK  179 (323)
T ss_pred             CcCCeecccCC----CcccccCCCccccChhhccCCCCCC
Confidence            99987532211    1122346899999999998876654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.95  E-value=4e-27  Score=242.07  Aligned_cols=172  Identities=27%  Similarity=0.372  Sum_probs=140.7

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      +.||+|+||+||+|++..+++.||||+++...   ....+.+..|..++... +||||+++++++     .+.+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence            36899999999999999899999999996432   23345677788888764 999999999985     3455789999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      ||+++|+|.+++....          .+++.++..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+
T Consensus        76 ey~~~g~L~~~l~~~~----------~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~  142 (316)
T cd05619          76 EYLNGGDLMFHIQSCH----------KFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGM  142 (316)
T ss_pred             eCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCc
Confidence            9999999999886432          26788889999999999999999   6999999999999999999999999999


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ++.....    ........||+.|+|||++.+..++.+
T Consensus       143 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~  176 (316)
T cd05619         143 CKENMLG----DAKTCTFCGTPDYIAPEILLGQKYNTS  176 (316)
T ss_pred             ceECCCC----CCceeeecCCccccCHHHHcCCCCCch
Confidence            8743211    111223468999999999988877653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=3.4e-27  Score=248.84  Aligned_cols=172  Identities=24%  Similarity=0.354  Sum_probs=144.1

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .++|++.+.||+|+||.||+|++..+++.||+|...      ...+.+|++++++++|||||++++++.     .....+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~  159 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFT-----YNKFTC  159 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCeeE
Confidence            457999999999999999999999999999999753      245678999999999999999999853     345789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +|||++. ++|.+++....          .+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.+||+|
T Consensus       160 lv~e~~~-~~L~~~l~~~~----------~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~D  225 (391)
T PHA03212        160 LILPRYK-TDLYCYLAAKR----------NIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGD  225 (391)
T ss_pred             EEEecCC-CCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEe
Confidence            9999985 68888875432          27788899999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+|+.......   ......+||+.|+|||++.+..++.
T Consensus       226 FG~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~  262 (391)
T PHA03212        226 FGAACFPVDINA---NKYYGWAGTIATNAPELLARDPYGP  262 (391)
T ss_pred             CCcccccccccc---cccccccCccCCCChhhhcCCCCCc
Confidence            999975432111   1122356999999999998887765

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.94  E-value=4.9e-27  Score=242.60  Aligned_cols=172  Identities=33%  Similarity=0.378  Sum_probs=137.8

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHH-HHHhcCCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECE-ALRNIRHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      +.||+|+||.||+|++..+++.||+|++....   ......+..|.. +++.++||||+++++++     ...+..++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence            36899999999999999899999999996432   122234444544 56778999999999884     4455789999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      ||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~  142 (325)
T cd05602          76 DYINGGELFYHLQRER----------CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGL  142 (325)
T ss_pred             eCCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCC
Confidence            9999999999886432          26677888899999999999999   6999999999999999999999999999


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ++......    ......+||+.|+|||++.+..++.+
T Consensus       143 a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~  176 (325)
T cd05602         143 CKENIEHN----GTTSTFCGTPEYLAPEVLHKQPYDRT  176 (325)
T ss_pred             CcccccCC----CCcccccCCccccCHHHHcCCCCCCc
Confidence            97542211    11233569999999999988877653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.94  E-value=5.7e-27  Score=242.77  Aligned_cols=177  Identities=24%  Similarity=0.363  Sum_probs=149.0

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      .++|++.+.||+|+||.||+|++..++..||+|++.... ....+.+.+|+++++.++||||++++++|.     .+...
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   78 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI   78 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE-----ECCEE
Confidence            467889999999999999999999999999999986542 233467899999999999999999999964     34578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||+++|+|.+++....          .+++..+..++.|++.|+.|||+.  .+|+||||||+||+++.++.+||+
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~  146 (333)
T cd06650          79 SICMEHMDGGSLDQVLKKAG----------RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLC  146 (333)
T ss_pred             EEEEecCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEe
Confidence            99999999999999986432          267788899999999999999973  479999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |||+++.+....      .....||+.|+|||++.+..++.
T Consensus       147 Dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~  181 (333)
T cd06650         147 DFGVSGQLIDSM------ANSFVGTRSYMSPERLQGTHYSV  181 (333)
T ss_pred             eCCcchhhhhhc------cccCCCCccccCHHHhcCCCCCc
Confidence            999997553211      12245899999999998877664

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.94  E-value=3.9e-27  Score=239.07  Aligned_cols=179  Identities=22%  Similarity=0.354  Sum_probs=146.9

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ++|++.+.||+|+||.||+|+++.+++.||||++....  ....+.+.+|+++++.++||||+++++++     ..++..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL   75 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence            46888999999999999999999999999999986432  23346788999999999999999999885     345578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||++++.+..+....          ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+
T Consensus        76 ~lv~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~  142 (287)
T cd07848          76 YLVFEYVEKNMLELLEEMP----------NGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLC  142 (287)
T ss_pred             EEEEecCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEe
Confidence            9999999988776554321          237888899999999999999998   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |||+++.......   .......||+.|+|||++.+..++.+
T Consensus       143 Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~  181 (287)
T cd07848         143 DFGFARNLSEGSN---ANYTEYVATRWYRSPELLLGAPYGKA  181 (287)
T ss_pred             eccCccccccccc---ccccccccccccCCcHHHcCCCCCCc
Confidence            9999986533211   11123468999999999988877653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.94  E-value=7.4e-27  Score=237.38  Aligned_cols=182  Identities=26%  Similarity=0.403  Sum_probs=145.1

Q ss_pred             CCcccCcccccccceEEEEEECC-CCeEEEEEEeeccc--chhHHHHHHHHHHHHhc---CCCCCcceeEeeccCCcCCC
Q 035691          442 GFSSANLIGTGSFGSVYKGILDP-DQTVVAVKVLFLHQ--RGALKSFMAECEALRNI---RHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~~  515 (640)
                      +|++.+.||+|+||.||+|++.. +++.||+|+++...  .+....+.+|+.+++.+   +||||++++++|........
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            68888999999999999999854 57889999986432  22334566787777765   69999999999865444445


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      ...++||||++ ++|.+++.....        ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~--------~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~  149 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPE--------PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQI  149 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCC--------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCE
Confidence            67899999997 589888864322        237888999999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ||+|||+++.....     .......||+.|+|||++.+..++.+
T Consensus       150 kl~Dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~  189 (290)
T cd07862         150 KLADFGLARIYSFQ-----MALTSVVVTLWYRAPEVLLQSSYATP  189 (290)
T ss_pred             EEccccceEeccCC-----cccccccccccccChHHHhCCCCCCc
Confidence            99999999865322     11223468999999999988777653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.94  E-value=4.2e-27  Score=261.93  Aligned_cols=192  Identities=26%  Similarity=0.301  Sum_probs=151.1

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||.||+|++..+|+.||+|++....   ....+++.+|++++++++||||+++++++.     ..+.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence            57889999999999999999999899999999985432   233467999999999999999999999864     3457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDL-NYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      .++||||++||+|.+++......... .......++..++.++.|++.||+|||+   .+|+||||||+||+++.++.+|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEE
Confidence            89999999999999988642211100 0111336677889999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccC--------------CCceeeccccccccccCcccCCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVIS--------------SNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       597 l~DfGla~~~~~~~~--------------~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |+|||+++.......              .........+||+.|||||++.+..++.+
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~k  211 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES  211 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcH
Confidence            999999986521100              00011123569999999999998887653

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.94  E-value=3.4e-27  Score=255.81  Aligned_cols=182  Identities=21%  Similarity=0.283  Sum_probs=149.9

Q ss_pred             CcccCcccccccceEEEEEECCC-CeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEE
Q 035691          443 FSSANLIGTGSFGSVYKGILDPD-QTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALV  521 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv  521 (640)
                      |.+.+.||+|+||.||+|....+ ++.||+|.+..........+.+|+.+++.++|||||++++++.     ..+..++|
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~~lv  143 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKLLLI  143 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEEEEE
Confidence            78889999999999999998777 7889999876555555567889999999999999999999953     44588999


Q ss_pred             eeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccc
Q 035691          522 YEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG  601 (640)
Q Consensus       522 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfG  601 (640)
                      |||+++|+|.+++......      ...+++..+..++.|++.||.|+|+   ++|+||||||+||+++.++.+||+|||
T Consensus       144 ~E~~~gg~L~~~l~~~~~~------~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFg  214 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKE------HLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFG  214 (478)
T ss_pred             EECCCCCCHHHHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCc
Confidence            9999999999887532111      0237788899999999999999999   699999999999999999999999999


Q ss_pred             ccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          602 LTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       602 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +++.+.....  .......+||+.|+|||++.+..++.+
T Consensus       215 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~  251 (478)
T PTZ00267        215 FSKQYSDSVS--LDVASSFCGTPYYLAPELWERKRYSKK  251 (478)
T ss_pred             CceecCCccc--cccccccCCCccccCHhHhCCCCCCcH
Confidence            9986643211  112234569999999999988877653

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.94  E-value=6.2e-27  Score=239.49  Aligned_cols=174  Identities=26%  Similarity=0.423  Sum_probs=142.6

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR-GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      .++|++.+.||+|+||.||+|+...+++.||||++..... .....+.+|+.+++.++||||+++++++     ......
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKETL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCeE
Confidence            4678999999999999999999998999999999864432 2334678899999999999999999995     345578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||++ +++.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+
T Consensus        79 ~lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~  145 (303)
T cd07869          79 TLVFEYVH-TDLCQYMDKHP---------GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLA  145 (303)
T ss_pred             EEEEECCC-cCHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEC
Confidence            99999996 68877775432         226778889999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      |||+++......    .......||+.|+|||++.+.
T Consensus       146 Dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~  178 (303)
T cd07869         146 DFGLARAKSVPS----HTYSNEVVTLWYRPPDVLLGS  178 (303)
T ss_pred             CCCcceeccCCC----ccCCCCcccCCCCChHHHcCC
Confidence            999997543211    111234589999999998764

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.6e-28  Score=264.51  Aligned_cols=181  Identities=27%  Similarity=0.289  Sum_probs=157.3

Q ss_pred             HHHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeec---ccchhHHHHHHHHHHHHhcCCCCCcceeEeecc
Q 035691          433 YESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL---HQRGALKSFMAECEALRNIRHRNLVKIITACSS  509 (640)
Q Consensus       433 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  509 (640)
                      ..++.-..++|.+.++||+|+||.|..++++.+++.||+|++.+   -.+.....|..|-++|..-+.+-||.++.+   
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA---  143 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA---  143 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH---
Confidence            44556667789999999999999999999999999999999965   234556789999999999999999999877   


Q ss_pred             CCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee
Q 035691          510 SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL  589 (640)
Q Consensus       510 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl  589 (640)
                        |+++.+.|+|||||+||||-.++....          .+|+..+..++..|..|+.-+|+   .|+|||||||+|||+
T Consensus       144 --FQD~~~LYlVMdY~pGGDlltLlSk~~----------~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLl  208 (1317)
T KOG0612|consen  144 --FQDERYLYLVMDYMPGGDLLTLLSKFD----------RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLL  208 (1317)
T ss_pred             --hcCccceEEEEecccCchHHHHHhhcC----------CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEe
Confidence              888899999999999999999987554          28888899999999999999999   799999999999999


Q ss_pred             CCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          590 DNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       590 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      |..|++|++|||-+-.+......   .+...+|||.|.+||++..
T Consensus       209 d~~GHikLADFGsClkm~~dG~V---~s~~aVGTPDYISPEvLqs  250 (1317)
T KOG0612|consen  209 DKSGHIKLADFGSCLKMDADGTV---RSSVAVGTPDYISPEVLQS  250 (1317)
T ss_pred             cccCcEeeccchhHHhcCCCCcE---EeccccCCCCccCHHHHHh
Confidence            99999999999998877654332   2334579999999999853

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.94  E-value=8.6e-30  Score=271.03  Aligned_cols=334  Identities=25%  Similarity=0.314  Sum_probs=216.6

Q ss_pred             CCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCC-----------------
Q 035691            3 TFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEE-----------------   65 (640)
Q Consensus         3 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-----------------   65 (640)
                      .+|+.|+++.|.|. ..|.+...+.+|++|+|..|++. ..|..+..+.+|+.||+|.|++..                 
T Consensus        68 ~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~~~Pl~i~~lt~~~~~~~s  145 (1081)
T KOG0618|consen   68 SHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFGPIPLVIEVLTAEEELAAS  145 (1081)
T ss_pred             HHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccCCCchhHHhhhHHHHHhhh
Confidence            45666777777776 55666666677777777777666 566666667777777777666532                 


Q ss_pred             --------------------ccccccCCchhhcCCCCCCe-eeccCCcccccCCccCcC-----------------CCCC
Q 035691           66 --------------------NQLVGELPPYIGFTLPNIRI-PLLAGNQFFGNIPHSISN-----------------ASKL  107 (640)
Q Consensus        66 --------------------~~~~~~lp~~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~-----------------l~~L  107 (640)
                                          |.+.+.++.+    ...++. |+|++|.+...+-..+.+                 .++|
T Consensus       146 ~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~----i~~l~~~ldLr~N~~~~~dls~~~~l~~l~c~rn~ls~l~~~g~~l  221 (1081)
T KOG0618|consen  146 NNEKIQRLGQTSIKKLDLRLNVLGGSFLID----IYNLTHQLDLRYNEMEVLDLSNLANLEVLHCERNQLSELEISGPSL  221 (1081)
T ss_pred             cchhhhhhccccchhhhhhhhhcccchhcc----hhhhheeeecccchhhhhhhhhccchhhhhhhhcccceEEecCcch
Confidence                                1111111111    112222 555555554111111110                 1233


Q ss_pred             CEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcCCCCCCCCCEE
Q 035691          108 EWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVL  187 (640)
Q Consensus       108 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L  187 (640)
                      +.|+.++|.++... ..+ .-.+|+++++++|+++.+       |+.+..+.+|+.+...+|+|+.+|..+..+++|+.|
T Consensus       222 ~~L~a~~n~l~~~~-~~p-~p~nl~~~dis~n~l~~l-------p~wi~~~~nle~l~~n~N~l~~lp~ri~~~~~L~~l  292 (1081)
T KOG0618|consen  222 TALYADHNPLTTLD-VHP-VPLNLQYLDISHNNLSNL-------PEWIGACANLEALNANHNRLVALPLRISRITSLVSL  292 (1081)
T ss_pred             heeeeccCcceeec-ccc-ccccceeeecchhhhhcc-------hHHHHhcccceEecccchhHHhhHHHHhhhhhHHHH
Confidence            33333333333111 111 113567777777777664       355667777788888888877777777777777777


Q ss_pred             EccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCcccc-------------------------CCCCccEEeccCccc
Q 035691          188 SLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALG-------------------------NCHQLQSLDLSKTIF  242 (640)
Q Consensus       188 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-------------------------~l~~L~~L~ls~n~~  242 (640)
                      ++.+|.+. -+|....+++.|++|+|..|+|...++..|.                         .++.|+.|++.+|.+
T Consensus       293 ~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~L  371 (1081)
T KOG0618|consen  293 SAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHL  371 (1081)
T ss_pred             Hhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcc
Confidence            77777777 5666677777777777777777633322221                         233455666667755


Q ss_pred             c--------CCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccC
Q 035691          243 L--------GQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGL  314 (640)
Q Consensus       243 ~--------~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~  314 (640)
                      .        +...|+.|+|++|+|...+...+.++..|++|+||+|+|+ .+|..+..++.|+.|..-+|++. ..| .+
T Consensus       372 td~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~  448 (1081)
T KOG0618|consen  372 TDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-EL  448 (1081)
T ss_pred             cccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hh
Confidence            3        4455889999999998666677889999999999999998 78888999999999999999987 566 88


Q ss_pred             CCCCCCCeEeCcCCccccccCCcccCCCCCCCCCccccccCCCCC
Q 035691          315 SSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKL  359 (640)
Q Consensus       315 ~~l~~L~~L~l~~N~l~~~~~~~~~p~~~~~~~~~~~~~~~n~~~  359 (640)
                      ..+++|+.+|+|.|.++..-    +|...-+++++.++++||.|.
T Consensus       449 ~~l~qL~~lDlS~N~L~~~~----l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  449 AQLPQLKVLDLSCNNLSEVT----LPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             hhcCcceEEecccchhhhhh----hhhhCCCcccceeeccCCccc
Confidence            89999999999999998543    333323478889999999873

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.94  E-value=2.7e-27  Score=245.83  Aligned_cols=174  Identities=28%  Similarity=0.403  Sum_probs=148.2

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcC-C-----CCCcceeEeeccCCcCCC
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR-H-----RNLVKIITACSSSDFQGN  515 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~~~~~~~~~~~~  515 (640)
                      +|.+.++||+|+||.|-+|++.++++.||||+++... ....+...|+.+|..++ |     -|+|+++++     |...
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~-----F~fr  260 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY-----FYFR  260 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec-----cccc
Confidence            7889999999999999999999999999999996443 34456788999999996 4     399999999     6667


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC--C
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND--M  593 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~--~  593 (640)
                      ++.|||+|.++. +|+++++....        ..++...+..|+.||+.||.+||+   .+|||+||||+|||+-+.  .
T Consensus       261 ~HlciVfELL~~-NLYellK~n~f--------~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~  328 (586)
T KOG0667|consen  261 NHLCIVFELLST-NLYELLKNNKF--------RGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRS  328 (586)
T ss_pred             cceeeeehhhhh-hHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcC
Confidence            799999998854 99999987765        448899999999999999999998   699999999999999644  4


Q ss_pred             cEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          594 IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       594 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      .+||+|||.|.+....    .+   +.+.+.+|+|||+++|.+|+.+
T Consensus       329 ~vKVIDFGSSc~~~q~----vy---tYiQSRfYRAPEVILGlpY~~~  368 (586)
T KOG0667|consen  329 RIKVIDFGSSCFESQR----VY---TYIQSRFYRAPEVILGLPYDTA  368 (586)
T ss_pred             ceeEEecccccccCCc----ce---eeeeccccccchhhccCCCCCc
Confidence            7999999999865332    22   3457899999999999999874

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.94  E-value=5.8e-27  Score=242.12  Aligned_cols=172  Identities=25%  Similarity=0.284  Sum_probs=142.8

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      +.||+|+||+||+|+...+++.||+|+++...   ....+.+..|+.++.++ +||+|+++++++     ......++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence            46899999999999999999999999996432   23446688999999888 699999999984     4455789999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      ||+++|+|..++....          .+++..+..++.|++.|++|||+   .+|+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~~~L~~~~~~~~----------~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~  142 (327)
T cd05617          76 EYVNGGDLMFHMQRQR----------KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGM  142 (327)
T ss_pred             eCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEecccc
Confidence            9999999998875432          27888999999999999999999   6999999999999999999999999999


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ++......    ......+||+.|+|||++.+..++.+
T Consensus       143 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~  176 (327)
T cd05617         143 CKEGLGPG----DTTSTFCGTPNYIAPEILRGEEYGFS  176 (327)
T ss_pred             ceeccCCC----CceecccCCcccCCHHHHCCCCCCch
Confidence            97532111    11223569999999999988877653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.94  E-value=5e-27  Score=243.23  Aligned_cols=173  Identities=26%  Similarity=0.284  Sum_probs=143.8

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||.||+++++.+++.||+|++...   .......+.+|+.++..++|++|+++++++     .....
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence            3688899999999999999999989999999998532   222335688899999999999999999885     44557


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++.....         .+++..+..++.|++.|++|||+   .+|+||||||+||+++.++.+||
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~~---------~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL  143 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKFED---------RLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRL  143 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEE
Confidence            8999999999999999964321         27888889999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGM  633 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  633 (640)
                      +|||+++......   .......+||+.|+|||++.
T Consensus       144 ~DfG~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~  176 (332)
T cd05623         144 ADFGSCLKLMEDG---TVQSSVAVGTPDYISPEILQ  176 (332)
T ss_pred             eecchheecccCC---cceecccccCccccCHHHHh
Confidence            9999997543211   11122346999999999986

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.94  E-value=3.4e-27  Score=242.54  Aligned_cols=177  Identities=28%  Similarity=0.384  Sum_probs=153.0

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ..+.|.+...||+|.|++|..|++..++..||+|.++...  ...++.+.+|+++|+.++|||||+++++     .....
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v-----~~t~~  128 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSV-----IETEA  128 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeee-----eeecc
Confidence            3566888899999999999999999999999999996553  3334568999999999999999999999     55566


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..|+||||+.+|.+++++.....          ..+..+..++.|+..|++|+|+   +.|+|||||++||+++.+..+|
T Consensus       129 ~lylV~eya~~ge~~~yl~~~gr----------~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnik  195 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVKHGR----------MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIK  195 (596)
T ss_pred             eeEEEEEeccCchhHHHHHhccc----------chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhccccccccee
Confidence            89999999999999999986654          3346778899999999999999   7999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      |+|||++.++...     ....+.+|++.|.|||++.|.++.
T Consensus       196 IaDfgfS~~~~~~-----~~lqt~cgsppyAaPEl~~g~~y~  232 (596)
T KOG0586|consen  196 IADFGFSTFFDYG-----LMLQTFCGSPPYAAPELFNGKKYD  232 (596)
T ss_pred             eeccccceeeccc-----ccccccCCCCCccChHhhcCcccC
Confidence            9999999987532     223457899999999999998765

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=6.9e-27  Score=236.92  Aligned_cols=178  Identities=29%  Similarity=0.361  Sum_probs=147.0

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      .|+..+.||+|+||.||++.+..+++.||||++....   ......+.+|+.+++.++||||+++++++     ..++..
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence            3677889999999999999998899999999985432   22234678899999999999999999885     344578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||+++|+|.+++.....        ..+++..+..++.|++.|++|||+   .+++||||||+||++++++.++|+
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~  144 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNMGN--------PGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRIS  144 (285)
T ss_pred             EEEEeccCCCcHHHHHHhcCc--------CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEe
Confidence            999999999999988754321        237888999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |||+++......     ......|++.|+|||++.+..++.+
T Consensus       145 Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~  181 (285)
T cd05605         145 DLGLAVEIPEGE-----TIRGRVGTVGYMAPEVVKNERYTFS  181 (285)
T ss_pred             eCCCceecCCCC-----ccccccCCCCccCcHHhcCCCCCcc
Confidence            999998653211     1123468999999999988777653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-27  Score=255.15  Aligned_cols=183  Identities=24%  Similarity=0.281  Sum_probs=146.8

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcC-CCCCcceeEeeccCC-cCC-Cce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR-HRNLVKIITACSSSD-FQG-NDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~-~~~-~~~  517 (640)
                      .++++.++|.+|||+.||.|++...|..||+|++-..++...+...+|+++|+.++ |+|||.+++.+.... -.. ...
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            34567899999999999999999777999999997778888899999999999996 999999999432222 122 245


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      +++.||||.||.|-+++..+..        ..+.+..+++|+.|+++|+++||.. +++|||||||.+|||++.+|..||
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq--------~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KL  187 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQ--------TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKL  187 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHh--------ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEe
Confidence            7899999999999999965433        2388999999999999999999985 678999999999999999999999


Q ss_pred             ccccccccCCCccCCCce-----eeccccccccccCcccC
Q 035691          598 GDFGLTRFIPEVISSNQC-----SSVGLKGTVGYAAPEYG  632 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~  632 (640)
                      ||||-|...-........     .......|+.|+|||++
T Consensus       188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMI  227 (738)
T KOG1989|consen  188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMI  227 (738)
T ss_pred             CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHH
Confidence            999988643221111000     01123369999999987

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.94  E-value=6.5e-28  Score=248.03  Aligned_cols=173  Identities=21%  Similarity=0.388  Sum_probs=144.9

Q ss_pred             cccCcccccccceEEEEEECCCCeEEEEEEeec----ccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          444 SSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL----HQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       444 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ....+||+|+|-+||||.+..+|..||.-.++.    ......++|..|+.+|+.++|||||+++.+|.+..   ....-
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n~~in  119 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---NKTIN  119 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---Cceee
Confidence            345789999999999999999999999765532    23455689999999999999999999999976543   35578


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC-CCcEEEc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN-DMIAHVG  598 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~-~~~~kl~  598 (640)
                      +|+|.|..|+|+.|+++.+.          +....+..|++||+.||.|||++ .++|+|||||-+||+|+. .|.+||+
T Consensus       120 ~iTEL~TSGtLr~Y~kk~~~----------vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIG  188 (632)
T KOG0584|consen  120 FITELFTSGTLREYRKKHRR----------VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIG  188 (632)
T ss_pred             eeeecccCCcHHHHHHHhcc----------CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeec
Confidence            99999999999999987654          67778999999999999999996 569999999999999975 4899999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV  637 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  637 (640)
                      |.|+|.......      ...++|||.|||||++. ..|
T Consensus       189 DLGLAtl~r~s~------aksvIGTPEFMAPEmYE-E~Y  220 (632)
T KOG0584|consen  189 DLGLATLLRKSH------AKSVIGTPEFMAPEMYE-ENY  220 (632)
T ss_pred             chhHHHHhhccc------cceeccCccccChHHHh-hhc
Confidence            999999775422      22367999999999986 444

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.94  E-value=7.7e-27  Score=242.02  Aligned_cols=174  Identities=25%  Similarity=0.287  Sum_probs=142.1

Q ss_pred             CCcccCcccccccceEEEEEEC---CCCeEEEEEEeeccc----chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcC
Q 035691          442 GFSSANLIGTGSFGSVYKGILD---PDQTVVAVKVLFLHQ----RGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQ  513 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  513 (640)
                      +|++.+.||+|+||.||+|+..   .+++.||+|++....    ....+.+..|+.+++.+ +||+|+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence            4778899999999999998863   478899999985422    22345688899999999 599999999884     4


Q ss_pred             CCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC
Q 035691          514 GNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM  593 (640)
Q Consensus       514 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~  593 (640)
                      .....++||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~  142 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQRD----------NFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEG  142 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCC
Confidence            4567899999999999999886432          27788899999999999999999   6999999999999999999


Q ss_pred             cEEEccccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          594 IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       594 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      .+||+|||+++.+.....   ......+||+.|+|||++.+..
T Consensus       143 ~~kl~DfG~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~  182 (332)
T cd05614         143 HVVLTDFGLSKEFLSEEK---ERTYSFCGTIEYMAPEIIRGKG  182 (332)
T ss_pred             CEEEeeCcCCccccccCC---CccccccCCccccCHHHhcCCC
Confidence            999999999986532211   1122356999999999987643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.94  E-value=8e-27  Score=233.96  Aligned_cols=181  Identities=24%  Similarity=0.353  Sum_probs=146.1

Q ss_pred             cCCCcccCcccccccceEEEEEEC---CCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILD---PDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      .++|++.+.||+|+||.||+|++.   ..+..||+|.++... ......|.+|+.++++++||||+++++++.     .+
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~   78 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RG   78 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cC
Confidence            346788899999999999999874   456789999986543 233467999999999999999999999954     34


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      +..++||||+++|+|.+++....         ..+++.+++.++.|++.|++|||+   .+++||||||+||+++.++.+
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~---------~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~  146 (266)
T cd05064          79 NTMMIVTEYMSNGALDSFLRKHE---------GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVC  146 (266)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcE
Confidence            57899999999999999986432         237889999999999999999998   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |++|||.+.......   ........++..|+|||.+.+..++.+
T Consensus       147 ~l~dfg~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~  188 (266)
T cd05064         147 KISGFRRLQEDKSEA---IYTTMSGKSPVLWAAPEAIQYHHFSSA  188 (266)
T ss_pred             EECCCcccccccccc---hhcccCCCCceeecCHHHHhhCCccch
Confidence            999999876432111   111112335678999999988877653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=5.2e-27  Score=254.43  Aligned_cols=195  Identities=23%  Similarity=0.281  Sum_probs=155.2

Q ss_pred             HHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc
Q 035691          435 SLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDF  512 (640)
Q Consensus       435 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  512 (640)
                      +.....++|++.+.||+|+||+||+|++..+|+.||||++....  ......+.+|+..+..++|+||+++++.+...+.
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            34445678999999999999999999999899999999986542  3345678899999999999999998876533221


Q ss_pred             C---CCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee
Q 035691          513 Q---GNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL  589 (640)
Q Consensus       513 ~---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl  589 (640)
                      .   .....++||||+++|+|.+++......      ...+++..+..++.|++.||.|+|+   .+|+||||||+||++
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~------~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl  176 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKT------NRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILL  176 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhcc------CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEE
Confidence            1   112467999999999999998643221      1347888999999999999999999   699999999999999


Q ss_pred             CCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          590 DNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       590 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +.++.+||+|||+++.+......  .......||+.|+|||++.+..++.|
T Consensus       177 ~~~~~vkL~DFGls~~~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~k  225 (496)
T PTZ00283        177 CSNGLVKLGDFGFSKMYAATVSD--DVGRTFCGTPYYVAPEIWRRKPYSKK  225 (496)
T ss_pred             eCCCCEEEEecccCeeccccccc--cccccccCCcceeCHHHhCCCCCCcH
Confidence            99999999999999876432211  11233569999999999998887653

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.94  E-value=9.6e-27  Score=239.59  Aligned_cols=172  Identities=27%  Similarity=0.317  Sum_probs=142.6

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      +.||+|+||+||+|++..+++.||||+++..   .......+..|.+++..+ +||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            4689999999999999989999999999643   233446678899999887 799999999985     3455789999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      ||+++|+|..++....          .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~~~L~~~~~~~~----------~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~  142 (318)
T cd05570          76 EYVNGGDLMFHIQRSG----------RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGM  142 (318)
T ss_pred             cCCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCC
Confidence            9999999998875432          27889999999999999999999   6999999999999999999999999999


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ++......    ......+||+.|+|||++.+..++.+
T Consensus       143 ~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~  176 (318)
T cd05570         143 CKEGILGG----VTTSTFCGTPDYIAPEILSYQPYGPA  176 (318)
T ss_pred             CeecCcCC----CcccceecCccccCHHHhcCCCCCcc
Confidence            87532111    11223468999999999998887654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.94  E-value=1e-26  Score=239.53  Aligned_cols=171  Identities=28%  Similarity=0.314  Sum_probs=141.0

Q ss_pred             CcccccccceEEEEEE---CCCCeEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEE
Q 035691          447 NLIGTGSFGSVYKGIL---DPDQTVVAVKVLFLHQR--GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALV  521 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv  521 (640)
                      +.||+|+||.||+++.   +.+|+.||+|++.....  .....+..|++++++++||||+++++++     ......++|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence            5799999999999876   35789999999964332  2335678899999999999999999985     344578999


Q ss_pred             eeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccc
Q 035691          522 YEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG  601 (640)
Q Consensus       522 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfG  601 (640)
                      |||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+|||
T Consensus        77 ~e~~~~~~L~~~l~~~~----------~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg  143 (318)
T cd05582          77 LDFLRGGDLFTRLSKEV----------MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFG  143 (318)
T ss_pred             EcCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeecc
Confidence            99999999999885432          37888999999999999999999   699999999999999999999999999


Q ss_pred             ccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          602 LTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       602 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +++......    .......||+.|+|||++.+..++.
T Consensus       144 ~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~  177 (318)
T cd05582         144 LSKESIDHE----KKAYSFCGTVEYMAPEVVNRRGHTQ  177 (318)
T ss_pred             CCcccCCCC----CceecccCChhhcCHHHHcCCCCCC
Confidence            998643211    1122356899999999998776654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.94  E-value=9.3e-27  Score=244.72  Aligned_cols=190  Identities=24%  Similarity=0.347  Sum_probs=145.7

Q ss_pred             CCCcccCcccccccceEEEEEECC-----CCeEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDP-----DQTVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQ  513 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  513 (640)
                      ++|++.+.||+|+||.||+|++..     ++..||||+++... ....+.+.+|+++++.+ +|+|||+++++|.     
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~-----  112 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT-----  112 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec-----
Confidence            467888999999999999998643     33579999996443 33456788999999999 8999999999964     


Q ss_pred             CCceeeEEeeccCCCChhhhcCCCCCCC----------------------------------------------------
Q 035691          514 GNDFKALVYEFMHHGSLESWLHPESASD----------------------------------------------------  541 (640)
Q Consensus       514 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~----------------------------------------------------  541 (640)
                      .....++||||+++|+|.+++.......                                                    
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            3447899999999999999885321100                                                    


Q ss_pred             --------CCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccccccCCCccCCC
Q 035691          542 --------DLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN  613 (640)
Q Consensus       542 --------~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~  613 (640)
                              ........+++..+.+++.||+.||+|||+   ++|+||||||+||++++++.+||+|||+++.......  
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~--  267 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN--  267 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc--
Confidence                    000011347888899999999999999999   6999999999999999999999999999986533211  


Q ss_pred             ceeeccccccccccCcccCCCCCCCCC
Q 035691          614 QCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       614 ~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ........+++.|||||++.+..++.|
T Consensus       268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~  294 (374)
T cd05106         268 YVVKGNARLPVKWMAPESIFDCVYTVQ  294 (374)
T ss_pred             eeeccCCCCccceeCHHHhcCCCCCcc
Confidence            111112235678999999988777654

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.94  E-value=1.2e-26  Score=244.15  Aligned_cols=191  Identities=25%  Similarity=0.339  Sum_probs=146.8

Q ss_pred             cCCCcccCcccccccceEEEEEE-----CCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRNLVKIITACSSSDF  512 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  512 (640)
                      .++|++.+.||+|+||.||+|++     ..++..||||+++... ....+.+.+|++++..+ +|||||+++++|..   
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~---  110 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV---  110 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc---
Confidence            34678889999999999999974     3456789999986432 33456789999999999 89999999999643   


Q ss_pred             CCCceeeEEeeccCCCChhhhcCCCCCCCC--------------------------------------------------
Q 035691          513 QGNDFKALVYEFMHHGSLESWLHPESASDD--------------------------------------------------  542 (640)
Q Consensus       513 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--------------------------------------------------  542 (640)
                        ....++||||+++|+|.+++........                                                  
T Consensus       111 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         111 --GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             --CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence              4468999999999999999864321000                                                  


Q ss_pred             ---------------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccccccCC
Q 035691          543 ---------------LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP  607 (640)
Q Consensus       543 ---------------~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~  607 (640)
                                     .......+++..+..++.||+.||+|||+   .+|+||||||+||++++++.+||+|||+++...
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIR  265 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence                           00011247888999999999999999999   699999999999999999999999999998654


Q ss_pred             CccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          608 EVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       608 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      .....  .......++..|+|||++.+..++.+
T Consensus       266 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~  296 (375)
T cd05104         266 NDSNY--VVKGNARLPVKWMAPESIFNCVYTFE  296 (375)
T ss_pred             Ccccc--cccCCCCCCcceeChhHhcCCCCCCC
Confidence            32111  11111235678999999988877654

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.94  E-value=1.5e-26  Score=241.89  Aligned_cols=166  Identities=32%  Similarity=0.497  Sum_probs=136.9

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEE
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALV  521 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv  521 (640)
                      |+..+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+++++.++|+||+++++++     ......++|
T Consensus        76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv  150 (353)
T PLN00034         76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGEIQVL  150 (353)
T ss_pred             HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCeEEEE
Confidence            445688999999999999999899999999985443 23446789999999999999999999984     445578999


Q ss_pred             eeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccc
Q 035691          522 YEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG  601 (640)
Q Consensus       522 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfG  601 (640)
                      |||+++|+|....              ...+..+..++.||+.||+|||+   .+|+||||||+||++++++.+||+|||
T Consensus       151 ~e~~~~~~L~~~~--------------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG  213 (353)
T PLN00034        151 LEFMDGGSLEGTH--------------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFG  213 (353)
T ss_pred             EecCCCCcccccc--------------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccc
Confidence            9999999986432              14556778899999999999999   699999999999999999999999999


Q ss_pred             ccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          602 LTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       602 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      +++.+.....    ......||..|+|||++..
T Consensus       214 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~  242 (353)
T PLN00034        214 VSRILAQTMD----PCNSSVGTIAYMSPERINT  242 (353)
T ss_pred             cceecccccc----cccccccCccccCcccccc
Confidence            9986542211    1123468999999998743

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.94  E-value=2.3e-26  Score=236.69  Aligned_cols=180  Identities=24%  Similarity=0.411  Sum_probs=145.3

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeE----EEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTV----VAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      .+|+..+.||+|+||.||+|++..++..    ||+|+++... ....+.+.+|+.+++.++||||++++++|...     
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-----   81 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   81 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence            4588899999999999999998655553    8999986433 34456889999999999999999999997432     


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                       ..++|+||+++|+|.+++....         ..+++..++.++.||+.||+|||+   .+|+||||||+||++++++.+
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~  148 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHK---------DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHV  148 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhcc---------ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcE
Confidence             3579999999999999986543         237788899999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ||+|||+++.+.....  ........++..|+|||.+.+..++.|
T Consensus       149 kl~DfG~a~~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~  191 (316)
T cd05108         149 KITDFGLAKLLGADEK--EYHAEGGKVPIKWMALESILHRIYTHQ  191 (316)
T ss_pred             EEccccccccccCCCc--ceeccCCccceeecChHHhccCCCCch
Confidence            9999999987643221  111122235678999999988777643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=4.8e-27  Score=221.93  Aligned_cols=178  Identities=26%  Similarity=0.369  Sum_probs=147.5

Q ss_pred             CHHHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCCcceeEeeccC
Q 035691          432 SYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-RHRNLVKIITACSSS  510 (640)
Q Consensus       432 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  510 (640)
                      .++++.+-++     +.||+|+|+.|--|....+|..||||++++.....+.+..+|++++.+. .|+||+.++++    
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief----  144 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF----  144 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH----
Confidence            3677777664     7899999999999999899999999999877656678899999999998 69999999999    


Q ss_pred             CcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC
Q 035691          511 DFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD  590 (640)
Q Consensus       511 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~  590 (640)
                       |+++...|+|||-|.||.|..+++....          +.+..+.++.++|+.||.|||.   ++|.|||+||+|||..
T Consensus       145 -FEdd~~FYLVfEKm~GGplLshI~~~~~----------F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~  210 (463)
T KOG0607|consen  145 -FEDDTRFYLVFEKMRGGPLLSHIQKRKH----------FNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCE  210 (463)
T ss_pred             -hcccceEEEEEecccCchHHHHHHHhhh----------ccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeec
Confidence             6777799999999999999998876543          7888899999999999999999   8999999999999996


Q ss_pred             CCC---cEEEccccccccCCCccCC---CceeeccccccccccCcccC
Q 035691          591 NDM---IAHVGDFGLTRFIPEVISS---NQCSSVGLKGTVGYAAPEYG  632 (640)
Q Consensus       591 ~~~---~~kl~DfGla~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~  632 (640)
                      +..   -+||+||.++..+.....-   ..-...+.+|+..|||||++
T Consensus       211 ~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVV  258 (463)
T KOG0607|consen  211 SPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVV  258 (463)
T ss_pred             CCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHH
Confidence            443   5899999887644211111   11112346799999999987

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2.4e-26  Score=238.07  Aligned_cols=166  Identities=29%  Similarity=0.321  Sum_probs=134.4

Q ss_pred             ccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhc---CCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNI---RHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       449 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      ||+|+||+||+|++..+++.||||++....   ......+..|..++...   +||+|+++++++     ......++||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence            699999999999999899999999985432   22234456677777665   699999999884     4455789999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      ||+++|+|.+++....          .+++..+..++.||+.||+|||+   .+|+||||||+||+++.++.+||+|||+
T Consensus        76 e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~  142 (330)
T cd05586          76 DYMSGGELFWHLQKEG----------RFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGL  142 (330)
T ss_pred             cCCCCChHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCc
Confidence            9999999998886432          27888999999999999999999   6999999999999999999999999999


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      ++......    ......+||+.|+|||++.+..
T Consensus       143 a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~  172 (330)
T cd05586         143 SKANLTDN----KTTNTFCGTTEYLAPEVLLDEK  172 (330)
T ss_pred             CcCCCCCC----CCccCccCCccccCHHHHcCCC
Confidence            97532211    1122356999999999987643

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.94  E-value=3.3e-26  Score=230.86  Aligned_cols=171  Identities=25%  Similarity=0.315  Sum_probs=140.7

Q ss_pred             ccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEeecc
Q 035691          449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFM  525 (640)
Q Consensus       449 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~  525 (640)
                      ||+|+||.||+++.+.+|+.||+|++....   ......+..|++++++++||||+++++++     ..+...++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence            699999999999999899999999985322   22234566799999999999999999884     4456789999999


Q ss_pred             CCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccccccc
Q 035691          526 HHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF  605 (640)
Q Consensus       526 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~  605 (640)
                      ++|+|.+++.....        ..+++..+..++.|++.|++|||+   .+|+||||||+||++++++.+||+|||++..
T Consensus        76 ~g~~L~~~~~~~~~--------~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~  144 (277)
T cd05607          76 NGGDLKYHIYNVGE--------RGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVE  144 (277)
T ss_pred             CCCCHHHHHHhccc--------cCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeee
Confidence            99999988754322        237788889999999999999999   7999999999999999999999999999986


Q ss_pred             CCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          606 IPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       606 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      .....     ......||+.|+|||++.+..++.+
T Consensus       145 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~  174 (277)
T cd05607         145 LKDGK-----TITQRAGTNGYMAPEILKEEPYSYP  174 (277)
T ss_pred             cCCCc-----eeeccCCCCCccCHHHHccCCCCCc
Confidence            54321     1122458999999999988877653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.94  E-value=4e-26  Score=231.27  Aligned_cols=183  Identities=31%  Similarity=0.431  Sum_probs=147.8

Q ss_pred             CCCcccCcccccccceEEEEEE----CCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          441 GGFSSANLIGTGSFGSVYKGIL----DPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      .+|++.+.||+|+||.||+|..    ..++..||+|.+........+.+.+|++++++++||||+++++++...   +..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCC
Confidence            4678889999999999999984    356889999998766555667899999999999999999999987532   234


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++|+|.+++.....         .+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+|
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~---------~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~  148 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRE---------RLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVK  148 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCc---------CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEE
Confidence            67899999999999999864322         27888999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|||+++........... .....++..|+|||++.+..++.
T Consensus       149 l~dfg~~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~  190 (284)
T cd05081         149 IGDFGLTKVLPQDKEYYKV-REPGESPIFWYAPESLTESKFSV  190 (284)
T ss_pred             ECCCcccccccCCCcceee-cCCCCCceEeeCHHHhccCCcCh
Confidence            9999999876432211111 11122445699999998877654

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3.1e-27  Score=240.28  Aligned_cols=187  Identities=28%  Similarity=0.458  Sum_probs=157.4

Q ss_pred             HHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcC
Q 035691          434 ESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQ  513 (640)
Q Consensus       434 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  513 (640)
                      ++++-...++....+||.|.||.||.|.|++..-.||||.++ .+....++|+.|+.+|+.++|||+|+++|+|...   
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK-EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~E---  335 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE---  335 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhh-hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccC---
Confidence            455555666777899999999999999999889999999984 4556778999999999999999999999998643   


Q ss_pred             CCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC
Q 035691          514 GNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM  593 (640)
Q Consensus       514 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~  593 (640)
                        ...|||+|||.+|+|.+||++...        ..++....+.|+.||+.||+||..   +++|||||.++|+|+.++.
T Consensus       336 --pPFYIiTEfM~yGNLLdYLRecnr--------~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnh  402 (1157)
T KOG4278|consen  336 --PPFYIITEFMCYGNLLDYLRECNR--------SEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENH  402 (1157)
T ss_pred             --CCeEEEEecccCccHHHHHHHhch--------hhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccc
Confidence              368999999999999999987654        236666778999999999999998   7999999999999999999


Q ss_pred             cEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          594 IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       594 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      .+||+|||++|.+.++....+.   +..-...|.|||-+....||.|
T Consensus       403 iVKvADFGLsRlMtgDTYTAHA---GAKFPIKWTAPEsLAyNtFSiK  446 (1157)
T KOG4278|consen  403 IVKVADFGLSRLMTGDTYTAHA---GAKFPIKWTAPESLAYNTFSIK  446 (1157)
T ss_pred             eEEeeccchhhhhcCCceeccc---CccCcccccCcccccccccccc
Confidence            9999999999998654322111   1223568999999999998865

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.94  E-value=3.8e-26  Score=231.47  Aligned_cols=177  Identities=29%  Similarity=0.350  Sum_probs=146.6

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      |+..+.||+|+||+||+|.+..+++.||+|.+....   ......+.+|+++++.++|++|+.+.+++     ..++..+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~   76 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEEE
Confidence            566788999999999999999999999999985432   22335678899999999999999999884     4456789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++|+|.+++.....        ..+++..+..++.|++.||.|||+   .+|+||||||+||++++++.+||+|
T Consensus        77 lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~D  145 (285)
T cd05632          77 LVLTIMNGGDLKFHIYNMGN--------PGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISD  145 (285)
T ss_pred             EEEEeccCccHHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEec
Confidence            99999999999988754322        238899999999999999999998   7999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ||+++......     ......|++.|+|||++.+..++.+
T Consensus       146 fg~~~~~~~~~-----~~~~~~g~~~~~aPE~~~~~~~~~~  181 (285)
T cd05632         146 LGLAVKIPEGE-----SIRGRVGTVGYMAPEVLNNQRYTLS  181 (285)
T ss_pred             CCcceecCCCC-----cccCCCCCcCccChHHhcCCCCCcc
Confidence            99997553211     1123468999999999988777653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.94  E-value=1.9e-26  Score=247.11  Aligned_cols=182  Identities=27%  Similarity=0.404  Sum_probs=140.9

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc---CCC
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDF---QGN  515 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---~~~  515 (640)
                      ..++|++.+.||+|+||.||+|++..+++.||||++....    ....+|+.+++.++|||||++++++....+   ...
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3457999999999999999999999899999999884322    234579999999999999999988643322   122


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC-c
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-I  594 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~-~  594 (640)
                      .+.++||||+++ ++.+++......      ...+++..+..++.|++.||+|||+   .+|+||||||+||+++.++ .
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~------~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~  209 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARN------NHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHT  209 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhc------CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCc
Confidence            357799999985 676665422110      1347888999999999999999999   6999999999999999664 7


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCC-CCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS-QVST  639 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~  639 (640)
                      +||+|||+|+.+....     ......||+.|+|||++.+. .++.
T Consensus       210 vkL~DFGla~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~  250 (440)
T PTZ00036        210 LKLCDFGSAKNLLAGQ-----RSVSYICSRFYRAPELMLGATNYTT  250 (440)
T ss_pred             eeeeccccchhccCCC-----CcccCCCCcCccCHHHhcCCCCCCc
Confidence            9999999998654321     11234689999999998765 3543

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.94  E-value=4.6e-26  Score=231.29  Aligned_cols=182  Identities=27%  Similarity=0.414  Sum_probs=145.6

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhc---CCCCCcceeEeeccCCcCCCc
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNI---RHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~~~  516 (640)
                      +|++.+.||+|+||.||+|+++.+++.||+|.++...  .+....+.+|+++++.+   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778899999999999999999999999999986432  22234566777777665   799999999997654444455


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++ ++.+++.....        ..+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+|
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~k  148 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPP--------PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVK  148 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEE
Confidence            68999999984 88888754322        237888999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |+|||+++......     ......||+.|+|||++.+..++.+
T Consensus       149 l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~  187 (288)
T cd07863         149 LADFGLARIYSCQM-----ALTPVVVTLWYRAPEVLLQSTYATP  187 (288)
T ss_pred             ECccCccccccCcc-----cCCCccccccccCchHhhCCCCCCc
Confidence            99999998653221     1122458999999999988877653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.94  E-value=3.7e-26  Score=231.50  Aligned_cols=177  Identities=28%  Similarity=0.376  Sum_probs=146.5

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      |+..+.||+|+||.||+|.+..+++.||||.+....   ....+.+..|+.+++.++|++|+.+++.+.     .++..+
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~   76 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDALC   76 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCEEE
Confidence            667788999999999999999999999999985432   222346778999999999999999999853     345789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++|+|.+++.....        ..+++..+..++.|++.|+.|||+   .+|+||||||+||+++.++.++|+|
T Consensus        77 lv~e~~~g~~L~~~l~~~~~--------~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~D  145 (285)
T cd05630          77 LVLTLMNGGDLKFHIYHMGE--------AGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISD  145 (285)
T ss_pred             EEEEecCCCcHHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEee
Confidence            99999999999998854322        237888999999999999999998   7999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ||++.......     ......||+.|+|||++.+..++.+
T Consensus       146 fg~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~  181 (285)
T cd05630         146 LGLAVHVPEGQ-----TIKGRVGTVGYMAPEVVKNERYTFS  181 (285)
T ss_pred             ccceeecCCCc-----cccCCCCCccccChHHHcCCCCCCc
Confidence            99987553211     1122468999999999988877653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.94  E-value=4.6e-26  Score=239.91  Aligned_cols=178  Identities=26%  Similarity=0.295  Sum_probs=143.8

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +|+..+.||+|+||.||+|++..+|+.||||++...  +....+.+.+|+++++.++||||+++++++...........+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999999889999999998543  223446788999999999999999999997544322233689


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+. ++|.+++...          ..+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|
T Consensus        81 lv~e~~~-~~l~~~~~~~----------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~D  146 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP----------QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICD  146 (372)
T ss_pred             EEeeccc-cCHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEecc
Confidence            9999997 5787777432          237888999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      ||+++.......   .......+|+.|+|||++.+..
T Consensus       147 fg~a~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~  180 (372)
T cd07853         147 FGLARVEEPDES---KHMTQEVVTQYYRAPEILMGSR  180 (372)
T ss_pred             ccceeecccCcc---ccCCCCCcCCCcCCHHHHcCCC
Confidence            999986532211   1112345789999999998754

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.93  E-value=4.5e-26  Score=240.49  Aligned_cols=194  Identities=27%  Similarity=0.352  Sum_probs=148.9

Q ss_pred             HHhcCCCcccCcccccccceEEEEEECC-----CCeEEEEEEeeccc-chhHHHHHHHHHHHHhcC-CCCCcceeEeecc
Q 035691          437 LKATGGFSSANLIGTGSFGSVYKGILDP-----DQTVVAVKVLFLHQ-RGALKSFMAECEALRNIR-HRNLVKIITACSS  509 (640)
Q Consensus       437 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~  509 (640)
                      ....++|++.+.||+|+||.||+|++..     .+..||||+++... ....+.+.+|+++++++. |||||+++++|. 
T Consensus        33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~-  111 (400)
T cd05105          33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT-  111 (400)
T ss_pred             eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc-
Confidence            3445678899999999999999998642     23579999996433 334568999999999996 999999999964 


Q ss_pred             CCcCCCceeeEEeeccCCCChhhhcCCCCCCCC-----------------------------------------------
Q 035691          510 SDFQGNDFKALVYEFMHHGSLESWLHPESASDD-----------------------------------------------  542 (640)
Q Consensus       510 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-----------------------------------------------  542 (640)
                          .....++|||||++|+|.+++........                                               
T Consensus       112 ----~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (400)
T cd05105         112 ----KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ  187 (400)
T ss_pred             ----cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence                34578999999999999998854221000                                               


Q ss_pred             ---------------------------------------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCC
Q 035691          543 ---------------------------------------LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLK  583 (640)
Q Consensus       543 ---------------------------------------~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlk  583 (640)
                                                             .......+++..+..++.|++.|+.|||+   .+|+|||||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dik  264 (400)
T cd05105         188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLA  264 (400)
T ss_pred             cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCC
Confidence                                                   00001247888889999999999999999   699999999


Q ss_pred             CCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          584 PSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       584 p~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |+||++++++.+||+|||+++........  .......+++.|+|||++.+..++.|
T Consensus       265 p~Nill~~~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~  319 (400)
T cd05105         265 ARNVLLAQGKIVKICDFGLARDIMHDSNY--VSKGSTFLPVKWMAPESIFDNLYTTL  319 (400)
T ss_pred             hHhEEEeCCCEEEEEeCCcceeccccccc--cccCCcCCCcceEChhhhcCCCCCch
Confidence            99999999999999999999865332111  11122346788999999988877654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.93  E-value=6.5e-26  Score=249.52  Aligned_cols=256  Identities=25%  Similarity=0.306  Sum_probs=179.6

Q ss_pred             CcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCC
Q 035691            5 LMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIR   84 (640)
Q Consensus         5 L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~   84 (640)
                      -..|||+.|+|+ .+|+.+.  .+|+.|++++|+|+ .+|.   .+++|++|+|++|+|+.      +|..    .++|+
T Consensus       203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lts------LP~l----p~sL~  265 (788)
T PRK15387        203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS------LPVL----PPGLL  265 (788)
T ss_pred             CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccCc------ccCc----ccccc
Confidence            457899999998 6787775  47999999999998 4554   35789999999998885      6642    46888


Q ss_pred             eeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceE
Q 035691           85 IPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIV  164 (640)
Q Consensus        85 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L  164 (640)
                      .|+|++|.|+.+ |..+   ++|+.|+|++|+|+. +|.   .+++|+.|+|++|+|+.++.    .+      ..|+.|
T Consensus       266 ~L~Ls~N~L~~L-p~lp---~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~Lp~----lp------~~L~~L  327 (788)
T PRK15387        266 ELSIFSNPLTHL-PALP---SGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLASLPA----LP------SELCKL  327 (788)
T ss_pred             eeeccCCchhhh-hhch---hhcCEEECcCCcccc-ccc---cccccceeECCCCccccCCC----Cc------cccccc
Confidence            999999998853 4433   578889999999985 454   24679999999999987642    11      357788


Q ss_pred             ecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccC
Q 035691          165 SLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLG  244 (640)
Q Consensus       165 ~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~  244 (640)
                      ++++|+|+.+|..   ..+|++|+|++|+|++ +|..   ..+|+.|++++|+|.. +|..   ..+|+.|         
T Consensus       328 ~Ls~N~L~~LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~L---------  387 (788)
T PRK15387        328 WAYNNQLTSLPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKEL---------  387 (788)
T ss_pred             ccccCcccccccc---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceE---------
Confidence            8999999888852   2578999999999984 5543   3578888999999884 4542   2456666         


Q ss_pred             CCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEe
Q 035691          245 QYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLD  324 (640)
Q Consensus       245 ~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  324 (640)
                             ++++|+|++ +|..   .++|+.|++++|+|+ .+|..+   .+|+.|+|++|+|+ .+|..+.++++|+.|+
T Consensus       388 -------dLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~Ld  451 (788)
T PRK15387        388 -------IVSGNRLTS-LPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVN  451 (788)
T ss_pred             -------EecCCcccC-CCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEE
Confidence                   555555553 3322   245666666666666 344322   34566666666665 4566666666666666


Q ss_pred             CcCCccc
Q 035691          325 LFQNTFQ  331 (640)
Q Consensus       325 l~~N~l~  331 (640)
                      |++|+|+
T Consensus       452 Ls~N~Ls  458 (788)
T PRK15387        452 LEGNPLS  458 (788)
T ss_pred             CCCCCCC
Confidence            6666665

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=3.8e-26  Score=243.87  Aligned_cols=175  Identities=26%  Similarity=0.356  Sum_probs=144.9

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ..+|.+.+.||+|+||.||+|++..+++.||||...      ...+.+|++++++++|+|||++++++..     +...+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~  236 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTC  236 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEE
Confidence            457899999999999999999999999999999642      1345789999999999999999998543     44788


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +|||++. ++|.+++....         ..+++.+++.|+.|++.||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus       237 lv~e~~~-~~L~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~D  303 (461)
T PHA03211        237 LVLPKYR-SDLYTYLGARL---------RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGD  303 (461)
T ss_pred             EEEEccC-CCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcc
Confidence            9999995 68888875432         238899999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ||+++........  .......||+.|+|||++.+..++.|
T Consensus       304 FGla~~~~~~~~~--~~~~~~~GT~~Y~APE~~~~~~~~~~  342 (461)
T PHA03211        304 FGAACFARGSWST--PFHYGIAGTVDTNAPEVLAGDPYTPS  342 (461)
T ss_pred             cCCceeccccccc--ccccccCCCcCCcCHHHHcCCCCCch
Confidence            9999865432111  11223569999999999998887753

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.93  E-value=1.4e-26  Score=235.98  Aligned_cols=183  Identities=26%  Similarity=0.397  Sum_probs=150.3

Q ss_pred             HHhcCCCcccCcccccccceEEEEEECC--CC--eEEEEEEeec-ccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCC
Q 035691          437 LKATGGFSSANLIGTGSFGSVYKGILDP--DQ--TVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVKIITACSSSD  511 (640)
Q Consensus       437 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  511 (640)
                      +.+++.....+.||+|.||.||+|.+..  .|  .-||||..+. ......+.|+.|+-+|+.++|||||+++|+|... 
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-  463 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-  463 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence            3444455677899999999999998742  22  3588898865 3345578999999999999999999999998543 


Q ss_pred             cCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC
Q 035691          512 FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN  591 (640)
Q Consensus       512 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~  591 (640)
                           ..|+|||.++.|.|++||+.++.         .++..+...++.||..||+|||+   .++|||||.++|||+..
T Consensus       464 -----P~WivmEL~~~GELr~yLq~nk~---------sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsS  526 (974)
T KOG4257|consen  464 -----PMWIVMELAPLGELREYLQQNKD---------SLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSS  526 (974)
T ss_pred             -----ceeEEEecccchhHHHHHHhccc---------cchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecC
Confidence                 58999999999999999987654         38888999999999999999999   79999999999999999


Q ss_pred             CCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          592 DMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       592 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ..-+|++|||++|.+......   ......-...|||||.+...+||.+
T Consensus       527 p~CVKLaDFGLSR~~ed~~yY---kaS~~kLPIKWmaPESINfRrFTtA  572 (974)
T KOG4257|consen  527 PQCVKLADFGLSRYLEDDAYY---KASRGKLPIKWMAPESINFRRFTTA  572 (974)
T ss_pred             cceeeecccchhhhccccchh---hccccccceeecCccccchhcccch
Confidence            999999999999988653322   2222233568999999999988863

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.93  E-value=7.3e-26  Score=228.47  Aligned_cols=191  Identities=25%  Similarity=0.357  Sum_probs=147.5

Q ss_pred             hcCCCcccCcccccccceEEEEEEC-----CCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILD-----PDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDF  512 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  512 (640)
                      .+++|++.+.||+|+||.||+|.++     .++..||+|++.... .....++.+|+.+++.++||||+++++++.    
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~----   79 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS----   79 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence            4567889999999999999999864     245789999885332 234467899999999999999999999853    


Q ss_pred             CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC
Q 035691          513 QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND  592 (640)
Q Consensus       513 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~  592 (640)
                       .....++||||+++|+|.+++...............+++.++..++.|++.|+.|||+   .+++||||||+||+++++
T Consensus        80 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~  155 (277)
T cd05062          80 -QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAED  155 (277)
T ss_pred             -CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCC
Confidence             3446899999999999999986533211111112346788899999999999999999   699999999999999999


Q ss_pred             CcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          593 MIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       593 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +.+|++|||+++........  .......+++.|||||++.+..++.
T Consensus       156 ~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~  200 (277)
T cd05062         156 FTVKIGDFGMTRDIYETDYY--RKGGKGLLPVRWMSPESLKDGVFTT  200 (277)
T ss_pred             CCEEECCCCCccccCCccee--ecCCCCccCHhhcChhHhhcCCcCc
Confidence            99999999999865322111  1111224578899999998877765

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.93  E-value=8e-26  Score=226.84  Aligned_cols=171  Identities=26%  Similarity=0.362  Sum_probs=144.7

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      ++|++.+.||+|+||.||+|+...+++.||+|++..........+.+|+.++++++||||+++++++.     .+...++
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~~i   83 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKLWI   83 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEEEE
Confidence            46888999999999999999998899999999997555445567889999999999999999999853     3457899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||+++|+|.+++....          .+++..+..++.|++.|++|||+   .+|+|||+||+||++++++.+||+||
T Consensus        84 v~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~df  150 (267)
T cd06646          84 CMEYCGGGSLQDIYHVTG----------PLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADF  150 (267)
T ss_pred             EEeCCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcC
Confidence            999999999999885432          26788899999999999999999   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGM  633 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  633 (640)
                      |+++.......    ......|++.|+|||.+.
T Consensus       151 g~~~~~~~~~~----~~~~~~~~~~y~~PE~~~  179 (267)
T cd06646         151 GVAAKITATIA----KRKSFIGTPYWMAPEVAA  179 (267)
T ss_pred             ccceeeccccc----ccCccccCccccCHhHcc
Confidence            99986532211    112245889999999885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.93  E-value=1.1e-25  Score=230.84  Aligned_cols=176  Identities=24%  Similarity=0.353  Sum_probs=147.8

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ++|++.+.||+|+||.||+|.+..++..||+|.+.... ......+.+|++++++++||||+++++++.     .++..+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   75 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEIS   75 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEEE
Confidence            36888999999999999999999899999999986442 233467889999999999999999999953     445789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++|+|.+++....          .+++..+..++.|++.||.|||+.  .+++||||||+||+++.++.+||+|
T Consensus        76 lv~ey~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~d  143 (308)
T cd06615          76 ICMEHMDGGSLDQVLKKAG----------RIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCD  143 (308)
T ss_pred             EEeeccCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEcc
Confidence            9999999999999986432          267888999999999999999973  4899999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+++......      .....|++.|+|||.+.+..++.
T Consensus       144 fg~~~~~~~~~------~~~~~~~~~~~aPE~~~~~~~~~  177 (308)
T cd06615         144 FGVSGQLIDSM------ANSFVGTRSYMSPERLQGTHYTV  177 (308)
T ss_pred             CCCcccccccc------cccCCCCcCccChhHhcCCCCCc
Confidence            99987553211      12346899999999988776654

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PHA02988 hypothetical protein; Provisional

Probab=99.93  E-value=6.5e-26  Score=229.29  Aligned_cols=171  Identities=21%  Similarity=0.240  Sum_probs=140.1

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeecccchh---HHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEee
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA---LKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYE  523 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e  523 (640)
                      ..||+|++|.||+|.+  +|+.||||+++......   .+.|.+|+.+|++++|||||++++++.... .+....++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence            5799999999999998  68999999996543322   467889999999999999999999975421 22346789999


Q ss_pred             ccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccccc
Q 035691          524 FMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT  603 (640)
Q Consensus       524 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla  603 (640)
                      |+++|+|.+++....          .+++.....++.|++.|+.|||+.  .+++||||||+||++++++.+||+|||++
T Consensus       103 y~~~g~L~~~l~~~~----------~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~  170 (283)
T PHA02988        103 YCTRGYLREVLDKEK----------DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLE  170 (283)
T ss_pred             eCCCCcHHHHHhhCC----------CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchH
Confidence            999999999996542          267888999999999999999973  47889999999999999999999999999


Q ss_pred             ccCCCccCCCceeeccccccccccCcccCCC--CCCCC
Q 035691          604 RFIPEVISSNQCSSVGLKGTVGYAAPEYGMG--SQVST  639 (640)
Q Consensus       604 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~  639 (640)
                      +......       ....||+.|+|||++.+  ..++.
T Consensus       171 ~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~  201 (283)
T PHA02988        171 KILSSPP-------FKNVNFMVYFSYKMLNDIFSEYTI  201 (283)
T ss_pred             hhhcccc-------ccccCcccccCHHHhhhccccccc
Confidence            8653211       12358899999999976  45554

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-28  Score=239.36  Aligned_cols=233  Identities=21%  Similarity=0.210  Sum_probs=204.5

Q ss_pred             CcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccC-CCcCCccccccCCchhhcCCCCC
Q 035691            5 LMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL-NKLEENQLVGELPPYIGFTLPNI   83 (640)
Q Consensus         5 L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~lp~~~~~~l~~L   83 (640)
                      -+.++|..|+|+.+.|.+|+.+.+|++|+|++|.|+.+-|.+|.++.+|.+|-+-+ |+|++      +|.+.|.+|..|
T Consensus        69 tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~------l~k~~F~gL~sl  142 (498)
T KOG4237|consen   69 TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITD------LPKGAFGGLSSL  142 (498)
T ss_pred             ceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhh------hhhhHhhhHHHH
Confidence            46799999999988889999999999999999999999999999999988876655 99997      999999999999


Q ss_pred             CeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCC-------------------
Q 035691           84 RIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTR-------------------  144 (640)
Q Consensus        84 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-------------------  144 (640)
                      +.|.+.-|++..+..++|..+++|..|.|..|.+..+.-.+|..+.+++.+.+..|.+-..                   
T Consensus       143 qrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsg  222 (498)
T KOG4237|consen  143 QRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSG  222 (498)
T ss_pred             HHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhccc
Confidence            9999999999999999999999999999999999976666999999999999999983211                   


Q ss_pred             -----------------CCCccc--------------------ccccccCCCCcceEecCCCCCCCcCc-CCCCCCCCCE
Q 035691          145 -----------------KVNDLR--------------------FLDSLVNCTYLEIVSLNVNSLRSIPI-SVGYLPKLQV  186 (640)
Q Consensus       145 -----------------~~~~~~--------------------~~~~l~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~  186 (640)
                                       ....+.                    ..+.|..+++|+.|+|++|+|+.|.+ +|..+..+++
T Consensus       223 arc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~e  302 (498)
T KOG4237|consen  223 ARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQE  302 (498)
T ss_pred             ceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhh
Confidence                             000000                    01236678999999999999999654 6778999999


Q ss_pred             EEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCcccc
Q 035691          187 LSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFL  243 (640)
Q Consensus       187 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~  243 (640)
                      |+|..|+|..+....|.++.+|+.|+|.+|+|+...|.+|..+.+|..|.|-.|.|.
T Consensus       303 L~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~  359 (498)
T KOG4237|consen  303 LYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN  359 (498)
T ss_pred             hhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence            999999999888889999999999999999999999999999999999999888763

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.93  E-value=8.2e-26  Score=236.89  Aligned_cols=181  Identities=25%  Similarity=0.277  Sum_probs=145.5

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc-CCC
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDF-QGN  515 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~  515 (640)
                      ..++|+..+.||+|+||.||+|++..+|+.||||++...  .......+.+|+.+++.++||||+++++++..... ...
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            346799999999999999999999989999999998543  23344678899999999999999999998743321 222


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      ...++||||+++ ++...+..            .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~------------~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~  162 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM------------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTL  162 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc------------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCE
Confidence            357899999975 56555431            26677888999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ||+|||+++......     ......||+.|+|||++.+..++.+
T Consensus       163 kl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~  202 (359)
T cd07876         163 KILDFGLARTACTNF-----MMTPYVVTRYYRAPEVILGMGYKEN  202 (359)
T ss_pred             EEecCCCccccccCc-----cCCCCcccCCCCCchhccCCCCCcc
Confidence            999999998543211     1123458999999999998877654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.2e-26  Score=229.71  Aligned_cols=178  Identities=22%  Similarity=0.311  Sum_probs=152.7

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccch--hHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      .+-|...+.||+|.|..|-.|++.-+|+.||||++++..-+  ....+.+|++.|+.++|||||++|++     ..+...
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQTK   91 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQTK   91 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccce
Confidence            34577778999999999999999999999999999766433  34578899999999999999999999     666778


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee-CCCCcEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL-DNDMIAH  596 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl-~~~~~~k  596 (640)
                      .|+|+|.-++|+|++|+-.+..         .+.+....+++.||..|+.|+|.   ..+|||||||+|+.+ ..-|.+|
T Consensus        92 lyLiLELGD~GDl~DyImKHe~---------Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVK  159 (864)
T KOG4717|consen   92 LYLILELGDGGDLFDYIMKHEE---------GLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVK  159 (864)
T ss_pred             EEEEEEecCCchHHHHHHhhhc---------cccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceE
Confidence            9999999999999999966543         37888899999999999999999   699999999999976 5668999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +.|||++-.+.+..     ...+.+|+..|-|||+++|..|+.
T Consensus       160 LTDFGFSNkf~PG~-----kL~TsCGSLAYSAPEILLGDsYDA  197 (864)
T KOG4717|consen  160 LTDFGFSNKFQPGK-----KLTTSCGSLAYSAPEILLGDSYDA  197 (864)
T ss_pred             eeeccccccCCCcc-----hhhcccchhhccCchhhhcCccCC
Confidence            99999998764321     223468999999999999998864

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.93  E-value=1.6e-25  Score=226.26  Aligned_cols=180  Identities=24%  Similarity=0.371  Sum_probs=143.5

Q ss_pred             CCCcccCcccccccceEEEEEECCCCe----EEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQT----VVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      ++|+..+.||+|+||.||+|.+..+++    .||+|.+.... .....++..|+..+++++||||+++++++..      
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~------   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG------   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC------
Confidence            457788999999999999999876776    46777764322 2334678888889999999999999998632      


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      ...++++||+++|+|.+++.....         .+++..+..++.|++.||+|||+   ++++||||||+||++++++.+
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~  148 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHRD---------SLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIV  148 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhccc---------CCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcE
Confidence            246789999999999999864332         37888999999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ||+|||+++.......  ........++..|+|||++.++.++.+
T Consensus       149 kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~  191 (279)
T cd05111         149 QIADFGVADLLYPDDK--KYFYSEHKTPIKWMALESILFGRYTHQ  191 (279)
T ss_pred             EEcCCccceeccCCCc--ccccCCCCCcccccCHHHhccCCcCch
Confidence            9999999986543211  111223457788999999988877653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.93  E-value=1.8e-25  Score=222.26  Aligned_cols=174  Identities=28%  Similarity=0.424  Sum_probs=140.4

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEeecc
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFM  525 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~  525 (640)
                      +.||+|+||.||+|+++.+++.||+|.+.... ......+.+|++++++++||||++++++|..     ....++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCCeEEEEeec
Confidence            46899999999999998899999999875432 3344679999999999999999999999643     44689999999


Q ss_pred             CCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccccccc
Q 035691          526 HHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF  605 (640)
Q Consensus       526 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~  605 (640)
                      ++++|.+++....         ..+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+|++|||+++.
T Consensus        76 ~~~~L~~~~~~~~---------~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  143 (252)
T cd05084          76 QGGDFLTFLRTEG---------PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSRE  143 (252)
T ss_pred             cCCcHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcc
Confidence            9999999986432         237888999999999999999998   6999999999999999999999999999986


Q ss_pred             CCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          606 IPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       606 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      .........  .....++..|+|||.+.++.++.
T Consensus       144 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~  175 (252)
T cd05084         144 EEDGVYAST--GGMKQIPVKWTAPEALNYGRYSS  175 (252)
T ss_pred             ccccccccc--CCCCCCceeecCchhhcCCCCCh
Confidence            532111100  01112346799999998877654

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.93  E-value=1.2e-25  Score=225.06  Aligned_cols=179  Identities=28%  Similarity=0.475  Sum_probs=147.2

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      .+|++.+.||+|+||.||+|.++.+++.||+|++.... ...+.+.+|++++++++||||++++++|..     +...++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   79 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYI   79 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcC-----CCCcEE
Confidence            34777899999999999999999889999999986432 334678999999999999999999998643     346789


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||+++|+|.+++.....        ..+++..++.++.|++.|++|||+   .+++||||||+||++++++.+||+||
T Consensus        80 v~e~~~~~~L~~~~~~~~~--------~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df  148 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNR--------QEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADF  148 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCC--------CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCC
Confidence            9999999999999864332        237888999999999999999998   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+++........   ......++..|+|||.+.+..++.
T Consensus       149 ~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~  184 (263)
T cd05052         149 GLSRLMTGDTYT---AHAGAKFPIKWTAPESLAYNKFSI  184 (263)
T ss_pred             ccccccccceee---ccCCCCCccccCCHHHhccCCCCc
Confidence            999866432211   111123467899999998877765

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.93  E-value=1.4e-25  Score=223.52  Aligned_cols=177  Identities=28%  Similarity=0.417  Sum_probs=143.3

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      ++|++.+.||+|+||.||+|+++ ++..+|+|.+.... ...+.+.+|+.++++++||||++++++|..     ....++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~i   76 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-----QKPLYI   76 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEcc-----CCCEEE
Confidence            45778899999999999999886 56689999875332 234678899999999999999999999643     346899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||+++|+|.+++.....         .+++..+..++.|++.|++|||+   .+|+||||||+||++++++.+||+||
T Consensus        77 v~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~  144 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQG---------KLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDF  144 (256)
T ss_pred             EEEcCCCCcHHHHHHhCcc---------CCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCC
Confidence            9999999999998864321         27788999999999999999998   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |.++......   ........++..|+|||++.+..++.
T Consensus       145 g~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~  180 (256)
T cd05114         145 GMTRYVLDDE---YTSSSGAKFPVKWSPPEVFNFSKYSS  180 (256)
T ss_pred             CCccccCCCc---eeccCCCCCchhhCChhhcccCccch
Confidence            9998653211   11112234567899999998776654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.93  E-value=9e-26  Score=231.58  Aligned_cols=173  Identities=24%  Similarity=0.432  Sum_probs=141.6

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ++|...+.||+|+||.||+|+++.+++.||+|+++... ......+.+|++++++++||||+++++++.     .++..+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKSLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCeEE
Confidence            46888899999999999999999899999999986443 233356788999999999999999999954     345789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++ ++.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|
T Consensus        81 lv~e~~~~-~l~~~~~~~~---------~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~D  147 (309)
T cd07872          81 LVFEYLDK-DLKQYMDDCG---------NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLAD  147 (309)
T ss_pred             EEEeCCCC-CHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECc
Confidence            99999975 8888775432         236788889999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      ||+++.......    ......+|+.|+|||++.+.
T Consensus       148 fg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~  179 (309)
T cd07872         148 FGLARAKSVPTK----TYSNEVVTLWYRPPDVLLGS  179 (309)
T ss_pred             cccceecCCCcc----ccccccccccccCCHHHhCC
Confidence            999975432111    11223578999999998653

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.93  E-value=8.8e-26  Score=236.34  Aligned_cols=182  Identities=23%  Similarity=0.279  Sum_probs=146.8

Q ss_pred             HhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCC-cCC
Q 035691          438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSD-FQG  514 (640)
Q Consensus       438 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~  514 (640)
                      ...++|+..+.||+|+||.||+|++..+++.||||++...  .....+.+.+|+.+++.++||||+++++++.... ...
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            3457899999999999999999999889999999998543  2333467889999999999999999999875432 122


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                      ....++||||+++ ++.+++..            .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~------------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~  157 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM------------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCT  157 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh------------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCC
Confidence            3457899999975 56665531            26777888999999999999999   69999999999999999999


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +||+|||+++......     ......||+.|+|||++.+..++.+
T Consensus       158 ~kl~Dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~  198 (355)
T cd07874         158 LKILDFGLARTAGTSF-----MMTPYVVTRYYRAPEVILGMGYKEN  198 (355)
T ss_pred             EEEeeCcccccCCCcc-----ccCCccccCCccCHHHHcCCCCCch
Confidence            9999999998653221     1123468999999999988877653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.93  E-value=2.1e-25  Score=225.42  Aligned_cols=171  Identities=29%  Similarity=0.374  Sum_probs=143.5

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      +|+..++||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++..     .+..++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   76 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRISI   76 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEEE
Confidence            5778899999999999999998899999999986442 2334678999999999999999999999643     457789


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||+++|++..+.              .+++..+..++.|++.|++|||+   .+|+|+||||+||+++.++.+||+||
T Consensus        77 v~e~~~~~~l~~~~--------------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~df  139 (279)
T cd06619          77 CTEFMDGGSLDVYR--------------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDF  139 (279)
T ss_pred             EEecCCCCChHHhh--------------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeC
Confidence            99999999996542              15677888999999999999999   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |++.......      .....||..|+|||++.+..++.+
T Consensus       140 g~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~  173 (279)
T cd06619         140 GVSTQLVNSI------AKTYVGTNAYMAPERISGEQYGIH  173 (279)
T ss_pred             Ccceeccccc------ccCCCCChhhcCceeecCCCCCCc
Confidence            9998653221      122468999999999988777643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.93  E-value=7.8e-26  Score=226.93  Aligned_cols=171  Identities=27%  Similarity=0.375  Sum_probs=144.8

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++.........+.+|+.+++.++||||+++++++     ...+..++
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~-----~~~~~~~l   83 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY-----LRRDKLWI   83 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EeCCEEEE
Confidence            4577788999999999999999989999999999766555556788999999999999999999985     34457899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||+++++|.+++....          .+++.++..++.|++.|+.|||+   .+++||||||+||+++.++.+||+||
T Consensus        84 v~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~df  150 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTG----------PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADF  150 (267)
T ss_pred             EEeccCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcc
Confidence            999999999999885432          27888999999999999999999   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGM  633 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  633 (640)
                      |++.......    .......|++.|+|||++.
T Consensus       151 g~~~~~~~~~----~~~~~~~~~~~y~aPE~~~  179 (267)
T cd06645         151 GVSAQITATI----AKRKSFIGTPYWMAPEVAA  179 (267)
T ss_pred             eeeeEccCcc----cccccccCcccccChhhhc
Confidence            9987653211    1122346899999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.93  E-value=2e-25  Score=223.72  Aligned_cols=182  Identities=23%  Similarity=0.327  Sum_probs=147.1

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-----chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-----RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      .+|++.+.||+|+||.||+|++..++..||+|.+....     ....+.+.+|++++++++||||+++++++....   .
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~   78 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM---E   78 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC---C
Confidence            46888999999999999999999899999999885322     223467889999999999999999999854321   3


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      ...++||||+++|+|.+++....          .+++.....++.|++.||+|||+   .+++|+||||+||+++.++.+
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~  145 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKSYG----------ALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNV  145 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCE
Confidence            46789999999999999886432          25677888999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+|||+++........ ........|+..|+|||++.+..++.
T Consensus       146 ~l~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~  188 (265)
T cd06652         146 KLGDFGASKRLQTICLS-GTGMKSVTGTPYWMSPEVISGEGYGR  188 (265)
T ss_pred             EECcCcccccccccccc-ccccccCCCCccccChhhhcCCCCCc
Confidence            99999999865322111 11122345889999999998877654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.93  E-value=1.4e-25  Score=233.80  Aligned_cols=176  Identities=25%  Similarity=0.326  Sum_probs=143.9

Q ss_pred             HHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc-C
Q 035691          437 LKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDF-Q  513 (640)
Q Consensus       437 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~  513 (640)
                      ....++|+..+.||+|+||.||+|.+..+++.||||++....  ....+.+.+|+++++.++||||+++++++..... .
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            345678999999999999999999998899999999985432  2234567899999999999999999988643321 1


Q ss_pred             CCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC
Q 035691          514 GNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM  593 (640)
Q Consensus       514 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~  593 (640)
                      .....+++||++ +++|.+++...           .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~~-----------~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~  155 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKCQ-----------KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDC  155 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCC
Confidence            223578999988 77898877421           27888999999999999999999   6999999999999999999


Q ss_pred             cEEEccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          594 IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       594 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      .+||+|||+++.....       ..+..||+.|+|||++.+
T Consensus       156 ~~kl~Dfg~~~~~~~~-------~~~~~~t~~y~aPE~~~~  189 (343)
T cd07878         156 ELRILDFGLARQADDE-------MTGYVATRWYRAPEIMLN  189 (343)
T ss_pred             CEEEcCCccceecCCC-------cCCccccccccCchHhcC
Confidence            9999999999865321       123468999999999876

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=1.1e-25  Score=235.41  Aligned_cols=174  Identities=24%  Similarity=0.352  Sum_probs=143.4

Q ss_pred             HhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       438 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ....+|++.+.||+|+||.||+|+...+++.||+|+....      ....|+.++++++|||||++++++.     ....
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~  131 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLV-----SGAI  131 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEE-----eCCe
Confidence            3445799999999999999999999988999999975322      2356899999999999999999854     3457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+. |+|.+++....         ..+++..+..|+.|++.||.|||+   .+|+||||||+||+++.++.+||
T Consensus       132 ~~lv~e~~~-~~l~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl  198 (357)
T PHA03209        132 TCMVLPHYS-SDLYTYLTKRS---------RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCI  198 (357)
T ss_pred             eEEEEEccC-CcHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEE
Confidence            889999995 58888875432         237889999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||+++.....     ....+..||+.|+|||++.+..++.+
T Consensus       199 ~DfG~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~  236 (357)
T PHA03209        199 GDLGAAQFPVVA-----PAFLGLAGTVETNAPEVLARDKYNSK  236 (357)
T ss_pred             ecCccccccccC-----cccccccccccccCCeecCCCCCCch
Confidence            999999753221     11123468999999999998887754

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.93  E-value=2.2e-25  Score=223.47  Aligned_cols=180  Identities=24%  Similarity=0.418  Sum_probs=146.5

Q ss_pred             CCCcccCcccccccceEEEEEECCC---CeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPD---QTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ++|++.+.||+|+||.||+|++..+   ...||||.++... ......|.+|+.++++++||||+++++++.     ...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   78 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----KSR   78 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----cCC
Confidence            5688889999999999999998643   4579999986443 334567899999999999999999999853     345


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++|+|.+++.....         .+++..+..++.|++.|++|||+   .+|+||||||+||++++++.+|
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~  146 (266)
T cd05033          79 PVMIITEYMENGSLDKFLRENDG---------KFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCK  146 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEE
Confidence            68999999999999999865332         37889999999999999999999   7999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ++|||+++.......  ........+++.|+|||.+.+..++.
T Consensus       147 l~dfg~~~~~~~~~~--~~~~~~~~~~~~y~~Pe~~~~~~~~~  187 (266)
T cd05033         147 VSDFGLSRRLEDSEA--TYTTKGGKIPIRWTAPEAIAYRKFTS  187 (266)
T ss_pred             ECccchhhccccccc--ceeccCCCCCccccChhhhccCCCcc
Confidence            999999987642111  11112233567899999998877664

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.93  E-value=1.6e-28  Score=238.47  Aligned_cols=277  Identities=24%  Similarity=0.200  Sum_probs=179.9

Q ss_pred             CCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcC-CccCccCCccccCCCC
Q 035691           52 ELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFAN-NSLTASIPEDLGRLRN  130 (640)
Q Consensus        52 ~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~  130 (640)
                      +-+.++|..|+|+.      ||++.|..+++|+.||||+|+|+.+.|++|.++.+|..|-+.+ |+|+.+..++|++|..
T Consensus        68 ~tveirLdqN~I~~------iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~s  141 (498)
T KOG4237|consen   68 ETVEIRLDQNQISS------IPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSS  141 (498)
T ss_pred             cceEEEeccCCccc------CChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHH
Confidence            34455555555554      5555555555555555555555555555555555555444433 5555544555555555


Q ss_pred             CCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCc-CCCCCCCCCEEEccCCc------------Cccc
Q 035691          131 LTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPI-SVGYLPKLQVLSLFENN------------ISGE  197 (640)
Q Consensus       131 L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~L~~N~------------l~~~  197 (640)
                      |+.|.+.-|++..+      ..+.|..+++|..|.+..|.+..++. .+..+..++.+++..|.            +...
T Consensus       142 lqrLllNan~i~Ci------r~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~  215 (498)
T KOG4237|consen  142 LQRLLLNANHINCI------RQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAM  215 (498)
T ss_pred             HHHHhcChhhhcch------hHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhh
Confidence            55555555555554      23445555555555555555555554 44445555555555555            2223


Q ss_pred             CCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEE--eccCc----------cccCCCCCceEEccCCcCCCCCCcc
Q 035691          198 IPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSL--DLSKT----------IFLGQYPVRWLDLSHNHLTGPIPLA  265 (640)
Q Consensus       198 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L--~ls~n----------~~~~~~~l~~L~Ls~N~l~~~~~~~  265 (640)
                      .|..+++....+-..|.++++..+.+..|...  ++.+  .++.+          .|.+++.|+.|+|++|+|+++-+.+
T Consensus       216 ~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~--~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~a  293 (498)
T KOG4237|consen  216 NPIETSGARCVSPYRLYYKRINQEDARKFLCS--LESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGA  293 (498)
T ss_pred             chhhcccceecchHHHHHHHhcccchhhhhhh--HHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhh
Confidence            44455566666666666666665544444322  1111  01111          2455666677799999999999999


Q ss_pred             CCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCcccCCC
Q 035691          266 VGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRK  342 (640)
Q Consensus       266 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~p~~  342 (640)
                      |.++..+++|+|..|+|...-...|.++.+|+.|+|.+|+|+...|.+|..+.+|.+|+|-.|+|.|.|.-.|+..|
T Consensus       294 Fe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~W  370 (498)
T KOG4237|consen  294 FEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEW  370 (498)
T ss_pred             hcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHH
Confidence            99999999999999999988888999999999999999999999999999999999999999999999976655443

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.93  E-value=1.2e-25  Score=225.57  Aligned_cols=181  Identities=24%  Similarity=0.393  Sum_probs=148.3

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||.||+|+...+++.||||.+...   .......+.+|+++++.++||||+++++++.     ..+.
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI-----EDNE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE-----ECCe
Confidence            5688899999999999999999989999999988542   2334467899999999999999999999853     3457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++......      ...+++..+..++.|++.|++|||+   .+++||||||+||+++.++.++|
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l  147 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQ------KRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhc------cCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEE
Confidence            88999999999999888532221      1237888899999999999999998   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|||+++.+.....    ......|++.|+|||.+.+..++.
T Consensus       148 ~d~g~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~  185 (267)
T cd08228         148 GDLGLGRFFSSKTT----AAHSLVGTPYYMSPERIHENGYNF  185 (267)
T ss_pred             CccccceeccchhH----HHhcCCCCccccChhhhccCCCCc
Confidence            99999986543211    112345889999999998776654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=8.3e-26  Score=239.81  Aligned_cols=189  Identities=24%  Similarity=0.308  Sum_probs=160.3

Q ss_pred             CHHHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCCcceeEeeccC
Q 035691          432 SYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-RHRNLVKIITACSSS  510 (640)
Q Consensus       432 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  510 (640)
                      .++.+...++.|.+.++||.|.+|.||+++.+.+++.+|+|+.......+ ++++.|..+++.. .|||++.++|++.-.
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            34555666788999999999999999999999999999999986544333 6778899999877 799999999998766


Q ss_pred             CcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC
Q 035691          511 DFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD  590 (640)
Q Consensus       511 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~  590 (640)
                      +...++..|+|||||.+|+.-++++....        ..+.|..+.-|++.++.|+.+||.   ..++|||||-.|||++
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g--------~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT  157 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKG--------NRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLT  157 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhcc--------cchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEe
Confidence            66677889999999999999999976552        458899999999999999999999   5899999999999999


Q ss_pred             CCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          591 NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       591 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      +++.+|++|||++..++..    .....+.+|||.|||||++.+.+
T Consensus       158 ~e~~VKLvDFGvSaQldsT----~grRnT~iGtP~WMAPEViac~e  199 (953)
T KOG0587|consen  158 ENAEVKLVDFGVSAQLDST----VGRRNTFIGTPYWMAPEVIACDE  199 (953)
T ss_pred             ccCcEEEeeeeeeeeeecc----cccccCcCCCcccccceeeeccc
Confidence            9999999999999865432    22334567999999999997654

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.93  E-value=1.8e-25  Score=227.25  Aligned_cols=174  Identities=32%  Similarity=0.377  Sum_probs=147.9

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|++++++++||||+++++++     ..+..
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSN   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCe
Confidence            36888899999999999999999899999999985432   23456788999999999999999999985     34457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++....          .+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.+||
T Consensus        76 ~~~v~e~~~~~~L~~~~~~~~----------~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl  142 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRKSG----------RFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKI  142 (290)
T ss_pred             EEEEEecCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEE
Confidence            899999999999999986542          27888899999999999999999   79999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|||+++.....       .....|++.|+|||.+.+..++.
T Consensus       143 ~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~  177 (290)
T cd05580         143 TDFGFAKRVKGR-------TYTLCGTPEYLAPEIILSKGYGK  177 (290)
T ss_pred             eeCCCccccCCC-------CCCCCCCccccChhhhcCCCCCc
Confidence            999999865432       12345899999999998776554

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.93  E-value=2.2e-25  Score=222.10  Aligned_cols=179  Identities=25%  Similarity=0.371  Sum_probs=149.8

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +|+..+.||+|+||.||+|+...+++.||+|.+...  .....+.+.+|+++++.++||||+++++++     ......+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-----LDKGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-----ccCCEEE
Confidence            467788999999999999999989999999998643  234557899999999999999999999985     3445789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++++|.+++.....        ..+++..++.++.|++.|+.|||+   .+++||||||+||+++.++.+||+|
T Consensus        76 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~d  144 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQRG--------RPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGD  144 (256)
T ss_pred             EEEEeCCCCcHHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcc
Confidence            99999999999999865322        237888999999999999999998   7999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ||+++.+......    .....|++.|+|||+..+..++.+
T Consensus       145 f~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~  181 (256)
T cd08529         145 LGVAKLLSDNTNF----ANTIVGTPYYLSPELCEDKPYNEK  181 (256)
T ss_pred             cccceeccCccch----hhccccCccccCHHHhcCCCCCCc
Confidence            9999866432211    123458899999999988776653

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.93  E-value=2.4e-25  Score=226.07  Aligned_cols=190  Identities=28%  Similarity=0.434  Sum_probs=149.7

Q ss_pred             CCCcccCcccccccceEEEEEE-----CCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      .+|.+.+.||+|+||+||++..     ..++..||+|.+........+.+.+|++++++++||||+++++++.     ..
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence            4578889999999999999985     2355679999987655555678999999999999999999999964     34


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCC---CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDD---LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND  592 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~  592 (640)
                      +..++||||+++|+|.+++........   .......+++.+++.++.|++.||+|||+   .+++||||||+||+++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~  156 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGEN  156 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccC
Confidence            578999999999999999864432111   11122348999999999999999999998   699999999999999999


Q ss_pred             CcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          593 MIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       593 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +.+||+|||+++.......  ........+++.|+|||++.+..++.|
T Consensus       157 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~  202 (288)
T cd05093         157 LLVKIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTE  202 (288)
T ss_pred             CcEEeccCCccccccCCce--eecCCCCCccccccCHHHhccCCCCch
Confidence            9999999999986532211  111122335788999999988777653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.93  E-value=1.8e-25  Score=226.25  Aligned_cols=189  Identities=25%  Similarity=0.350  Sum_probs=146.1

Q ss_pred             CCCcccCcccccccceEEEEEE----CCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGIL----DPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      .+|++.+.||+|+||.||+|+.    ..++..||+|.+.... ......+.+|++++++++||||+++++++     ...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV-----TQE   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE-----ecC
Confidence            3577889999999999999985    3456789999986433 23346788999999999999999999985     334


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCee
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDD-------LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVL  588 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiL  588 (640)
                      ...++||||+++|+|.+++........       .......+++.++..++.|++.||+|||+   .+++||||||+||+
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nil  156 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNIL  156 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEE
Confidence            578999999999999999853321100       00112347888999999999999999999   69999999999999


Q ss_pred             eCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          589 LDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       589 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +++++.+||+|||+++........  .......++..|+|||++.+..++.
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~  205 (283)
T cd05090         157 IGEQLHVKISDLGLSREIYSADYY--RVQPKSLLPIRWMPPEAIMYGKFSS  205 (283)
T ss_pred             EcCCCcEEeccccccccccCCcce--ecccCCCccceecChHHhccCCCCc
Confidence            999999999999999865322111  1112234677899999998877665

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.93  E-value=2.8e-25  Score=223.54  Aligned_cols=187  Identities=29%  Similarity=0.445  Sum_probs=145.0

Q ss_pred             cccCcccccccceEEEEEECCCCe--EEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc-CCCcee
Q 035691          444 SSANLIGTGSFGSVYKGILDPDQT--VVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDF-QGNDFK  518 (640)
Q Consensus       444 ~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~~~~  518 (640)
                      .+.+.||+|+||.||+|++..++.  .||+|.++..  .....+.+..|+++++.++||||++++++|..... ......
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456889999999999999876665  6899988643  23445788999999999999999999998754321 122356


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||+++|+|.+++.......    ....+++..+..++.|++.|++|||+   .+|+||||||+||++++++.+||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~  154 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGD----CPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVA  154 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccC----CcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEEC
Confidence            89999999999998874332211    12347899999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |||+++.+......  .......+++.|+|||...+..++.
T Consensus       155 Dfg~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~  193 (272)
T cd05075         155 DFGLSKKIYNGDYY--RQGRIAKMPVKWIAIESLADRVYTT  193 (272)
T ss_pred             CCCcccccCcccce--ecCCcccCCcccCCHHHccCCCcCh
Confidence            99999876432111  1111223577899999998877665

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=7.7e-27  Score=256.39  Aligned_cols=182  Identities=28%  Similarity=0.379  Sum_probs=152.2

Q ss_pred             HHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCC
Q 035691          437 LKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       437 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  514 (640)
                      ...+-+|+...+||.|.||.||-|...++|+..|||.++.++  ....+.+.+|+.++..++|||+|+.+|+     -.+
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGV-----EvH 1305 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGV-----EVH 1305 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCce-----eec
Confidence            344556778889999999999999999999999999886543  3344678899999999999999999998     455


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                      .+..+|.||||++|+|.+.+...+.          .++.....+..|++.|+.|||+   .|||||||||.||+++.+|.
T Consensus      1306 Rekv~IFMEyC~~GsLa~ll~~gri----------~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~ 1372 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLLEHGRI----------EDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGL 1372 (1509)
T ss_pred             HHHHHHHHHHhccCcHHHHHHhcch----------hhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCc
Confidence            6678999999999999999875543          5566677889999999999999   59999999999999999999


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      +|.+|||.|..+...............||+-|||||++.|..
T Consensus      1373 iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~ 1414 (1509)
T KOG4645|consen 1373 IKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTK 1414 (1509)
T ss_pred             EEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccc
Confidence            999999999987554322222334577999999999998865

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.93  E-value=1e-25  Score=228.44  Aligned_cols=189  Identities=23%  Similarity=0.260  Sum_probs=153.0

Q ss_pred             CHHHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCCcceeEeeccC
Q 035691          432 SYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-RHRNLVKIITACSSS  510 (640)
Q Consensus       432 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  510 (640)
                      .++++....++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++.+ +||||++++++|...
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            345566778899999999999999999999998999999998854322 235678899999999 699999999998655


Q ss_pred             CcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC
Q 035691          511 DFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD  590 (640)
Q Consensus       511 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~  590 (640)
                      ....++..++||||+++|+|.+++......      ...+++..+..++.|++.|+.|||+   .+++||||||+||+++
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~  158 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKR------GERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLT  158 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhcc------CccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEEC
Confidence            445566789999999999999887532111      1237888899999999999999999   6999999999999999


Q ss_pred             CCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          591 NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       591 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      +++.+|++|||+++.+....    .......|++.|+|||++.+
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~  198 (286)
T cd06638         159 TEGGVKLVDFGVSAQLTSTR----LRRNTSVGTPFWMAPEVIAC  198 (286)
T ss_pred             CCCCEEEccCCceeecccCC----CccccccCCCcccChhhhch
Confidence            99999999999998653211    11122358999999998854

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.93  E-value=1.3e-25  Score=225.89  Aligned_cols=181  Identities=26%  Similarity=0.369  Sum_probs=148.3

Q ss_pred             HhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCC-C
Q 035691          438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQG-N  515 (640)
Q Consensus       438 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~-~  515 (640)
                      .+++.|+..+.||+|+||.||+|....+++.||+|++..... ....+..|+.++.++ +||||+++++++....... .
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            356778888999999999999999998999999999865433 335788999999998 7999999999976543221 3


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      ...++||||+++|+|.+++.....        ..+++..+..++.|++.|++|||+   .+|+||||||+||++++++.+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~--------~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~  150 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKG--------NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEV  150 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCE
Confidence            468899999999999999865322        237888899999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      ||+|||+++.......    ......|++.|+|||++.+
T Consensus       151 ~l~Dfg~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~  185 (272)
T cd06637         151 KLVDFGVSAQLDRTVG----RRNTFIGTPYWMAPEVIAC  185 (272)
T ss_pred             EEccCCCceecccccc----cCCcccccccccCHhHhcc
Confidence            9999999986532211    1223468999999999863

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.93  E-value=1.9e-28  Score=260.93  Aligned_cols=334  Identities=26%  Similarity=0.306  Sum_probs=216.2

Q ss_pred             CcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCC
Q 035691            5 LMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIR   84 (640)
Q Consensus         5 L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~   84 (640)
                      |+.|||++|+++ ..|..+..+.+|+.|+++.|.|. ..|.+..++.+|++|.|..|++..      +|..+.. +.+|+
T Consensus        47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~~------lP~~~~~-lknl~  117 (1081)
T KOG0618|consen   47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQS------LPASISE-LKNLQ  117 (1081)
T ss_pred             eEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhhc------CchhHHh-hhccc
Confidence            677778877777 66777777777888888888777 666777777778888887777764      6666553 77777


Q ss_pred             eeeccCCcccccCCccCcCCCCCCEEECcCC-------------------ccCccCCccccCCCCCCEEEcccCcCCCCC
Q 035691           85 IPLLAGNQFFGNIPHSISNASKLEWLDFANN-------------------SLTASIPEDLGRLRNLTRLNFARNDLGTRK  145 (640)
Q Consensus        85 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N-------------------~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  145 (640)
                      .|+++.|++. .+|..+..++.+++++.++|                   .+.+.++..+..+..  .|+|++|.+....
T Consensus       118 ~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~~d  194 (1081)
T KOG0618|consen  118 YLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEVLD  194 (1081)
T ss_pred             ccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhhhhh
Confidence            7777777776 44544444444444444444                   233333333333333  3666666665221


Q ss_pred             CCccccccc---------------------------------ccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEccCC
Q 035691          146 VNDLRFLDS---------------------------------LVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFEN  192 (640)
Q Consensus       146 ~~~~~~~~~---------------------------------l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N  192 (640)
                      ...+...+.                                 -.--.+|+++++++|+++.+|.++..+.+|+.++..+|
T Consensus       195 ls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~~lp~wi~~~~nle~l~~n~N  274 (1081)
T KOG0618|consen  195 LSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHPVPLNLQYLDISHNNLSNLPEWIGACANLEALNANHN  274 (1081)
T ss_pred             hhhccchhhhhhhhcccceEEecCcchheeeeccCcceeeccccccccceeeecchhhhhcchHHHHhcccceEecccch
Confidence            111100000                                 00112455556666666666655555566666666666


Q ss_pred             cCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCC-------------------------
Q 035691          193 NISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYP-------------------------  247 (640)
Q Consensus       193 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~-------------------------  247 (640)
                      .++ .+|..+..+++|+.|...+|.+. -+|.....++.|+.|||..|.+...+.                         
T Consensus       275 ~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~  352 (1081)
T KOG0618|consen  275 RLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPS  352 (1081)
T ss_pred             hHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccccccc
Confidence            664 45555555566666666666665 456666778888899988876543322                         


Q ss_pred             --------CceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCC
Q 035691          248 --------VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKS  319 (640)
Q Consensus       248 --------l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  319 (640)
                              |+.|++.+|.++...-..+.+++.|+.|+|++|+|.......+.++..|+.|+||+|+++ .+|..+.+++.
T Consensus       353 ~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~  431 (1081)
T KOG0618|consen  353 YEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGR  431 (1081)
T ss_pred             ccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhh
Confidence                    456788888888777777888888888888888888444456678888888888888887 56788888888


Q ss_pred             CCeEeCcCCccccccCCcccCCCCCCCCCccccccCCCCC
Q 035691          320 LEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKL  359 (640)
Q Consensus       320 L~~L~l~~N~l~~~~~~~~~p~~~~~~~~~~~~~~~n~~~  359 (640)
                      |+.|...+|++.+.+      ....++.++.++++.|..-
T Consensus       432 L~tL~ahsN~l~~fP------e~~~l~qL~~lDlS~N~L~  465 (1081)
T KOG0618|consen  432 LHTLRAHSNQLLSFP------ELAQLPQLKVLDLSCNNLS  465 (1081)
T ss_pred             hHHHhhcCCceeech------hhhhcCcceEEecccchhh
Confidence            888888888887544      3345667778888877543

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.93  E-value=2.5e-25  Score=225.33  Aligned_cols=189  Identities=29%  Similarity=0.445  Sum_probs=147.6

Q ss_pred             CCcccCcccccccceEEEEEECCCC-----eEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQ-----TVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      +|++.+.||+|+||.||+|.....+     ..||+|.+.... ....+.|.+|++++.+++||||+++++++.     ..
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~~   80 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----KE   80 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----CC
Confidence            5778899999999999999876444     679999986443 233467899999999999999999999954     34


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCC------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDL------NYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL  589 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl  589 (640)
                      ...+++|||+++|+|.+++.........      ......+++..++.++.|++.|+.|||+   .+++||||||+||++
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~  157 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLV  157 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEE
Confidence            4678999999999999998654321110      0111347888999999999999999999   699999999999999


Q ss_pred             CCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          590 DNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       590 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ++++.+||+|||+++.......  ........+++.|+|||.+.+..++.|
T Consensus       158 ~~~~~~~L~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~  206 (283)
T cd05048         158 GEGLTVKISDFGLSRDIYSADY--YRVQSKSLLPVRWMPPEAILYGKFTTE  206 (283)
T ss_pred             cCCCcEEECCCcceeecccccc--ccccCCCcccccccCHHHhccCcCchh
Confidence            9999999999999985432111  111222346889999999988777653

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.93  E-value=1.3e-25  Score=232.80  Aligned_cols=191  Identities=24%  Similarity=0.352  Sum_probs=147.0

Q ss_pred             CCCcccCcccccccceEEEEEEC-----CCCeEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILD-----PDQTVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQ  513 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  513 (640)
                      ++|++.+.||+|+||.||+|+..     .+++.||+|+++... ....+.+..|+.++.++ +|+||++++++|..    
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~----   82 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK----   82 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec----
Confidence            46888999999999999999753     345789999986432 23346788899999999 89999999998743    


Q ss_pred             CCceeeEEeeccCCCChhhhcCCCCCCCC---------------------------------------------------
Q 035691          514 GNDFKALVYEFMHHGSLESWLHPESASDD---------------------------------------------------  542 (640)
Q Consensus       514 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---------------------------------------------------  542 (640)
                      .+...+++|||+++|+|.+++........                                                   
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence            33568899999999999998854221000                                                   


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccc
Q 035691          543 LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG  622 (640)
Q Consensus       543 ~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~g  622 (640)
                      .......+++..+..++.||+.|++|||+   .+|+||||||+||++++++.+||+|||+++.+......  .......+
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~--~~~~~~~~  237 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--VRKGDARL  237 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch--hhccCCCC
Confidence            00001257899999999999999999998   69999999999999999999999999999876432211  11112346


Q ss_pred             cccccCcccCCCCCCCCC
Q 035691          623 TVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       623 t~~y~aPE~~~~~~~s~k  640 (640)
                      +..|+|||++.+..+++|
T Consensus       238 ~~~y~aPE~~~~~~~~~~  255 (337)
T cd05054         238 PLKWMAPESIFDKVYTTQ  255 (337)
T ss_pred             CccccCcHHhcCCCCCcc
Confidence            778999999988887764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.93  E-value=2.8e-25  Score=228.87  Aligned_cols=180  Identities=23%  Similarity=0.330  Sum_probs=137.6

Q ss_pred             cCcccccccceEEEEEEC--CCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEee
Q 035691          446 ANLIGTGSFGSVYKGILD--PDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYE  523 (640)
Q Consensus       446 ~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e  523 (640)
                      ...||+|+||.||+|+++  .+++.||+|.+....  ....+.+|++++++++||||+++++++...   .+...++|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEe
Confidence            468999999999999975  366889999985432  234578999999999999999999986432   2456899999


Q ss_pred             ccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee----CCCCcEEEcc
Q 035691          524 FMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL----DNDMIAHVGD  599 (640)
Q Consensus       524 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl----~~~~~~kl~D  599 (640)
                      |+. +++.+++........ ......+++..+..++.|++.||+|||+   .+|+||||||+|||+    +.++.+||+|
T Consensus        81 ~~~-~~l~~~~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07868          81 YAE-HDLWHIIKFHRASKA-NKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             ccC-CCHHHHHHhcccccc-cCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence            986 488887754322111 1112347888999999999999999999   699999999999999    4567999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      ||+|+.+...... ........||+.|+|||++.+..
T Consensus       156 fG~a~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~  191 (317)
T cd07868         156 MGFARLFNSPLKP-LADLDPVVVTFWYRAPELLLGAR  191 (317)
T ss_pred             cCceeccCCCCcc-ccccCCccccccccCCHHHcCCC
Confidence            9999876432211 11223456899999999998754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.93  E-value=1.4e-25  Score=235.50  Aligned_cols=181  Identities=23%  Similarity=0.276  Sum_probs=146.8

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCC-cCCC
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSD-FQGN  515 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~  515 (640)
                      ..++|+..+.||+|+||.||+|++..+++.||||++...  .....+.+.+|+.+++.++||||+++++++.... ....
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            346799999999999999999999989999999998543  2334467889999999999999999999864432 1233


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      ...++||||+++ ++.+++..            .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~------------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~  165 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM------------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTL  165 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh------------cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcE
Confidence            457999999975 67666632            26677888999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ||+|||+++......     ......||+.|+|||++.+..++.+
T Consensus       166 kL~DfG~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~  205 (364)
T cd07875         166 KILDFGLARTAGTSF-----MMTPYVVTRYYRAPEVILGMGYKEN  205 (364)
T ss_pred             EEEeCCCccccCCCC-----cccCCcccCCcCCHHHHhCCCCCch
Confidence            999999998653221     1123468999999999988877653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=1.2e-27  Score=219.08  Aligned_cols=184  Identities=26%  Similarity=0.406  Sum_probs=148.2

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEee--cccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCC---C
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF--LHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQG---N  515 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~---~  515 (640)
                      +.|....+||+|.||.||+|+.+.+|+.||+|++-  ...++......+|++++..++|+|++.+++.|......+   .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34555678999999999999999999999998773  344556677899999999999999999999996654322   2


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      ...|+||++|+. +|.-++.....         .++...+.+++.++..||.|+|.   ..|+|||+||+|+||+.+|.+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~v---------r~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgil  163 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKV---------RFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGIL  163 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccc---------cccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceE
Confidence            237899999987 88777754432         37888999999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV  637 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  637 (640)
                      ||+|||+||.+...........+..+-|.+|++||.++|.+-
T Consensus       164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~  205 (376)
T KOG0669|consen  164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDRE  205 (376)
T ss_pred             EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccc
Confidence            999999998664322221222234566999999999998653

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.93  E-value=9e-26  Score=225.64  Aligned_cols=179  Identities=30%  Similarity=0.514  Sum_probs=149.5

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ..+|++.+.||+|+||.||+|++.. +..||+|++..........+..|+.+++.++||||+++++++.     .....+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   78 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPVY   78 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCeE
Confidence            4467888999999999999999985 8899999997665555678999999999999999999999854     345789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++|+|.+++.....        ..+++.++..++.|++.|+.|||+   .+++||||||+||++++++.+||+|
T Consensus        79 lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d  147 (261)
T cd05148          79 IITELMEKGSLLAFLRSPEG--------QVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVAD  147 (261)
T ss_pred             EEEeecccCCHHHHHhcCCC--------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEcc
Confidence            99999999999999975432        237888999999999999999998   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||.+..+.....    ......++..|+|||++.+..++.
T Consensus       148 ~g~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~  183 (261)
T cd05148         148 FGLARLIKEDVY----LSSDKKIPYKWTAPEAASHGTFST  183 (261)
T ss_pred             ccchhhcCCccc----cccCCCCceEecCHHHHccCCCCc
Confidence            999986643211    111234677899999988777654

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.93  E-value=1.7e-25  Score=227.05  Aligned_cols=193  Identities=26%  Similarity=0.362  Sum_probs=146.8

Q ss_pred             HhcCCCcccCcccccccceEEEEEEC-----CCCeEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCCcceeEeeccCC
Q 035691          438 KATGGFSSANLIGTGSFGSVYKGILD-----PDQTVVAVKVLFLHQR-GALKSFMAECEALRNIRHRNLVKIITACSSSD  511 (640)
Q Consensus       438 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  511 (640)
                      ...++|++.+.||+|+||.||+|..+     ..+..||+|.+..... .....+.+|+.+++.++||||+++++++.   
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---   79 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS---   79 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc---
Confidence            34567899999999999999999764     2356899998854332 23356889999999999999999999853   


Q ss_pred             cCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC
Q 035691          512 FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN  591 (640)
Q Consensus       512 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~  591 (640)
                        .....++||||+++|+|.+++.................+..+..++.|++.|+.|||+   ++|+||||||+||++++
T Consensus        80 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~  154 (288)
T cd05061          80 --KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAH  154 (288)
T ss_pred             --CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcC
Confidence              3346799999999999999996533211111111335667888999999999999998   69999999999999999


Q ss_pred             CCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          592 DMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       592 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ++.+|++|||+++........  .......++..|+|||.+.+..++.|
T Consensus       155 ~~~~~L~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~  201 (288)
T cd05061         155 DFTVKIGDFGMTRDIYETDYY--RKGGKGLLPVRWMAPESLKDGVFTTS  201 (288)
T ss_pred             CCcEEECcCCccccccccccc--cccCCCcccccccCHHHhccCCCChH
Confidence            999999999999865322111  11111235678999999988777653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.93  E-value=2.3e-25  Score=223.51  Aligned_cols=182  Identities=25%  Similarity=0.430  Sum_probs=145.6

Q ss_pred             CCCcccCcccccccceEEEEEECCCC---eEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQ---TVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ++|++.+.||+|+||.||+|++..++   ..||+|.++... ....+.+..|+.++++++||||+++++++.     .++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   78 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSK   78 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCC
Confidence            45778899999999999999875443   479999886432 234568899999999999999999999953     345


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++|+|.+++.....         .+++.+++.++.|++.|++|||+   .+++||||||+||+++.++.+|
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~  146 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKHDG---------QFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCK  146 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEE
Confidence            78999999999999999864322         37888999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ++|||+++.+...... ........++..|+|||.+.+..++.+
T Consensus       147 l~dfg~~~~~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~  189 (267)
T cd05066         147 VSDFGLSRVLEDDPEA-AYTTRGGKIPIRWTAPEAIAYRKFTSA  189 (267)
T ss_pred             eCCCCcccccccccce-eeecCCCccceeecCHhHhccCccCch
Confidence            9999999876432211 111112234568999999988776653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.93  E-value=2.6e-25  Score=224.66  Aligned_cols=180  Identities=26%  Similarity=0.408  Sum_probs=144.9

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCe----EEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQT----VVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  514 (640)
                      ..+|+..+.||+|+||.||+|++..++.    .||+|+++... ....+.+.+|+.+++.++||||++++++|..     
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----   80 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-----   80 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence            3567888999999999999999876665    48999986433 3345678899999999999999999999743     


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                       ...+++|||+++|+|.+++....         ..+++..++.++.|++.||+|||+   .+|+||||||+||++++++.
T Consensus        81 -~~~~l~~~~~~~g~l~~~l~~~~---------~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~  147 (279)
T cd05109          81 -STVQLVTQLMPYGCLLDYVRENK---------DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNH  147 (279)
T ss_pred             -CCcEEEEEcCCCCCHHHHHhhcc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCc
Confidence             23579999999999999986532         237888999999999999999999   79999999999999999999


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +||+|||+++.+......  .......+++.|+|||...+..++.
T Consensus       148 ~kL~dfG~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~  190 (279)
T cd05109         148 VKITDFGLARLLDIDETE--YHADGGKVPIKWMALESILHRRFTH  190 (279)
T ss_pred             EEECCCCceeecccccce--eecCCCccchhhCCHHHhccCCCCc
Confidence            999999999876432111  1111223567899999998877764

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=3.3e-25  Score=221.75  Aligned_cols=180  Identities=24%  Similarity=0.384  Sum_probs=147.8

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-----chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-----RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      ++|...+.||+|+||.||+|....+++.||+|.+....     ....+.+.+|++++++++||||+++++++     ..+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDD   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccC
Confidence            46888999999999999999998899999999985432     12345788999999999999999999995     344


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      +..++||||+++++|.+++....          .+++..+..++.|++.|+.|||+   .+++||||+|+||++++++.+
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~~~~----------~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~  143 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLKAYG----------ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNV  143 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCE
Confidence            58899999999999999886432          26778889999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+|||+++........ ........|+..|+|||++.+..++.
T Consensus       144 ~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~  186 (263)
T cd06625         144 KLGDFGASKRLQTICSS-GTGMKSVTGTPYWMSPEVISGEGYGR  186 (263)
T ss_pred             EEeecccceeccccccc-cccccCCCcCccccCcceeccCCCCc
Confidence            99999999865432111 11112345788999999998877654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.93  E-value=2.2e-25  Score=231.98  Aligned_cols=191  Identities=23%  Similarity=0.356  Sum_probs=145.5

Q ss_pred             CCCcccCcccccccceEEEEEE-----CCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcC
Q 035691          441 GGFSSANLIGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQ  513 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  513 (640)
                      ++|++.+.||+|+||.||+|++     ..+++.||||+++... ......+.+|+.++.++ +||||++++++|..    
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----   82 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK----   82 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec----
Confidence            4688899999999999999984     2467899999996433 23346788999999999 68999999998743    


Q ss_pred             CCceeeEEeeccCCCChhhhcCCCCCCCC---------------------------------------------------
Q 035691          514 GNDFKALVYEFMHHGSLESWLHPESASDD---------------------------------------------------  542 (640)
Q Consensus       514 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---------------------------------------------------  542 (640)
                      .+...++||||+++|+|.+++........                                                   
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence            23467899999999999998864321000                                                   


Q ss_pred             ------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccccccCCCccCCCcee
Q 035691          543 ------LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS  616 (640)
Q Consensus       543 ------~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~  616 (640)
                            .......+++..+..++.|++.|++|||+   .+|+||||||+||+++.++.+||+|||+++........  ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~  237 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--VR  237 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcch--hh
Confidence                  00001246788889999999999999999   69999999999999999999999999999865322111  11


Q ss_pred             eccccccccccCcccCCCCCCCCC
Q 035691          617 SVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       617 ~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      .....+++.|+|||++.+..++.|
T Consensus       238 ~~~~~~~~~y~aPE~~~~~~~~~~  261 (343)
T cd05103         238 KGDARLPLKWMAPETIFDRVYTIQ  261 (343)
T ss_pred             cCCCCCCcceECcHHhcCCCCCch
Confidence            112235678999999988776643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.93  E-value=3.2e-25  Score=221.64  Aligned_cols=181  Identities=31%  Similarity=0.507  Sum_probs=146.3

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|.++.... ..+.+.+|+.++++++||||+++++++.     .....
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   76 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEPI   76 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCCe
Confidence            3456888899999999999999976 567899999864432 3467899999999999999999999853     34468


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||+++++|.+++.....        ..+++..+..++.|++.|+.|||+   .+++||||||+||++++++.+||+
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~  145 (261)
T cd05068          77 YIVTELMKYGSLLEYLQGGAG--------RALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVA  145 (261)
T ss_pred             eeeeecccCCcHHHHHhccCC--------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEEC
Confidence            999999999999999865431        247889999999999999999998   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |||+++.+......   ...+..++..|+|||++.+..++.+
T Consensus       146 dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~  184 (261)
T cd05068         146 DFGLARVIKEDIYE---AREGAKFPIKWTAPEAALYNRFSIK  184 (261)
T ss_pred             CcceEEEccCCccc---ccCCCcCceeccCccccccCCCCch
Confidence            99999876422111   1111223467999999988776643

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.93  E-value=2.1e-25  Score=227.37  Aligned_cols=176  Identities=26%  Similarity=0.329  Sum_probs=149.1

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      .+|+..+.||+|+||.||+|....+++.||+|.+........+.+.+|+.+++.++||||+++++++.     .....++
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~l   93 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV   93 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEEEE
Confidence            56888899999999999999998899999999997655555577899999999999999999999954     3457899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||+++++|.+++...           .+++.++..++.|++.|+.|||+   .+++||||||+||+++.++.+||+||
T Consensus        94 v~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Df  159 (297)
T cd06656          94 VMEYLAGGSLTDVVTET-----------CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDF  159 (297)
T ss_pred             eecccCCCCHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcC
Confidence            99999999999988532           26778899999999999999999   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |++........    ......|++.|+|||.+.+..++.
T Consensus       160 g~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~  194 (297)
T cd06656         160 GFCAQITPEQS----KRSTMVGTPYWMAPEVVTRKAYGP  194 (297)
T ss_pred             ccceEccCCcc----CcCcccCCccccCHHHHcCCCCCc
Confidence            99986543211    112235889999999998877654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.93  E-value=2.2e-25  Score=227.18  Aligned_cols=176  Identities=25%  Similarity=0.329  Sum_probs=148.5

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      .+|+..+.||+|+||.||+|+...+++.||+|.+........+.+.+|+.+++.++||||+++++.+.     .+...++
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~-----~~~~~~l   94 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV   94 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE-----eCCEEEE
Confidence            46888899999999999999998899999999997665555678899999999999999999999854     3457899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||+++|+|.+++...           .+++.++..++.|++.|++|||+   .+|+||||||+||+++.++.+||+||
T Consensus        95 v~e~~~~~~L~~~~~~~-----------~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~df  160 (296)
T cd06654          95 VMEYLAGGSLTDVVTET-----------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDF  160 (296)
T ss_pred             eecccCCCCHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECcc
Confidence            99999999999988532           26778899999999999999999   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+++.......    ......|++.|+|||.+.+..++.
T Consensus       161 g~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~  195 (296)
T cd06654         161 GFCAQITPEQS----KRSTMVGTPYWMAPEVVTRKAYGP  195 (296)
T ss_pred             ccchhcccccc----ccCcccCCccccCHHHHcCCCCCc
Confidence            99886532211    112235889999999998877654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.93  E-value=9.2e-26  Score=225.28  Aligned_cols=174  Identities=33%  Similarity=0.498  Sum_probs=144.4

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeecccchhH--HHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      |+..+.||+|+||+||+|+...+++.||+|++........  ....+|+.++++++||||+++++++.     .....++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQ-----DDNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEE-----ESSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccc-----ccccccc
Confidence            4567899999999999999999999999999976654332  23456999999999999999999953     3567889


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||+++++|.+++...          ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+||
T Consensus        76 v~~~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Df  142 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQKN----------KPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDF  142 (260)
T ss_dssp             EEEEETTEBHHHHHHHH----------SSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSG
T ss_pred             ccccccccccccccccc----------cccccccccccccccccccccccc---cccccccccccccccccccccccccc
Confidence            99999999999999722          237889999999999999999999   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCC-CCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGM-GSQVS  638 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s  638 (640)
                      |.+..+..    .........+|..|+|||++. +..++
T Consensus       143 g~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~  177 (260)
T PF00069_consen  143 GSSVKLSE----NNENFNPFVGTPEYMAPEVLQQGKKYT  177 (260)
T ss_dssp             TTTEESTS----TTSEBSSSSSSGGGSCHHHHTTTSSBS
T ss_pred             cccccccc----ccccccccccccccccccccccccccc
Confidence            99975411    112223456899999999987 55544

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.93  E-value=2e-25  Score=223.15  Aligned_cols=178  Identities=24%  Similarity=0.459  Sum_probs=145.4

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      ++|++.+.||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++.     .....++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   78 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT-----KEEPIYI   78 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCcEE
Confidence            46788899999999999999976 66789999885433 23478899999999999999999998853     3456899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||+++|+|.+++.....        ..+++.++..++.|++.|++|||+   .+++||||||+||+++.++.+||+||
T Consensus        79 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df  147 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDEG--------GKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADF  147 (261)
T ss_pred             EEecCCCCcHHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCC
Confidence            9999999999999864322        237788899999999999999998   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+++.......   .......++..|+|||++.+..++.
T Consensus       148 g~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~  183 (261)
T cd05072         148 GLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFTI  183 (261)
T ss_pred             ccceecCCCce---eccCCCccceecCCHHHhccCCCCh
Confidence            99986543211   1111234577899999998877764

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.93  E-value=3.8e-25  Score=224.06  Aligned_cols=183  Identities=30%  Similarity=0.428  Sum_probs=146.9

Q ss_pred             CCcccCcccccccceEEEEEE----CCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          442 GFSSANLIGTGSFGSVYKGIL----DPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      .|++.+.||+|+||.||+|.+    +.++..||+|.++... ......+.+|+++++.++||||+++++++...   +..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CCC
Confidence            367789999999999999985    3568899999986443 33446799999999999999999999987542   134


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++++|.+++....         ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+|
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~---------~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~  149 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNK---------NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVK  149 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEE
Confidence            6789999999999999985432         137888999999999999999999   7999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |+|||+++.+...... ........|+..|+|||++.+..++.+
T Consensus       150 l~dfg~~~~~~~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~  192 (284)
T cd05079         150 IGDFGLTKAIETDKEY-YTVKDDLDSPVFWYAPECLIQSKFYIA  192 (284)
T ss_pred             ECCCccccccccCccc-eeecCCCCCCccccCHHHhccCCCCcc
Confidence            9999999866432211 111123456778999999988776653

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.93  E-value=2e-26  Score=216.18  Aligned_cols=177  Identities=27%  Similarity=0.318  Sum_probs=144.9

Q ss_pred             cCCCcc-cCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCce
Q 035691          440 TGGFSS-ANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       440 ~~~~~~-~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      +++|++ .++||-|-.|+|-.|.++.+|+.+|+|++...     ....+|++..-.. .|||||.++++|... +.+..+
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~rkc  133 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENS-YQGRKC  133 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCcee
Confidence            445544 36899999999999999999999999998433     3346788766655 799999999997554 677778


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC---CCc
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN---DMI  594 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~---~~~  594 (640)
                      ..+|||.|+||.|...++..+.        ..+.+.++..|++||+.|++|||+   .+|+||||||+|+|...   +..
T Consensus       134 LLiVmE~meGGeLfsriq~~g~--------~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~  202 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGD--------QAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAP  202 (400)
T ss_pred             eEeeeecccchHHHHHHHHccc--------ccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcc
Confidence            8999999999999999976654        348889999999999999999999   69999999999999964   458


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      +|++|||+|+.-.+     .....+.+-||+|.|||++-..+|+
T Consensus       203 lKLtDfGFAK~t~~-----~~~L~TPc~TPyYvaPevlg~eKyd  241 (400)
T KOG0604|consen  203 LKLTDFGFAKETQE-----PGDLMTPCFTPYYVAPEVLGPEKYD  241 (400)
T ss_pred             eEecccccccccCC-----CccccCCcccccccCHHHhCchhcC
Confidence            99999999996532     2233445789999999999766654

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.93  E-value=6e-25  Score=221.12  Aligned_cols=188  Identities=29%  Similarity=0.437  Sum_probs=145.9

Q ss_pred             CcccCcccccccceEEEEEECCC---CeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc-CCCc
Q 035691          443 FSSANLIGTGSFGSVYKGILDPD---QTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDF-QGND  516 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~~  516 (640)
                      |++.+.||+|+||.||+|....+   +..||+|++....  ......+.+|++.++.++||||+++++++..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            46778999999999999997643   4789999986433  2334678999999999999999999998754432 2234


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++|+|..++.......    ....+++..+..++.|++.|++|||+   .+++||||||+||++++++.+|
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~----~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~k  153 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGG----LPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVC  153 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccC----CcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEE
Confidence            5789999999999999885432211    11348889999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|||+++.+.......  ......++..|+|||++.+..++.
T Consensus       154 l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~  194 (273)
T cd05035         154 VADFGLSKKIYSGDYYR--QGRIAKMPVKWIAIESLADRVYTS  194 (273)
T ss_pred             ECCccceeecccccccc--ccccccCCccccCHhhcccCCCCc
Confidence            99999998654321111  111123567899999988776654

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.93  E-value=4.6e-25  Score=223.24  Aligned_cols=170  Identities=28%  Similarity=0.377  Sum_probs=143.2

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      |++.+.||+|+||.||+|.+..++..+|+|.+........+.+.+|+++++.++||||+++++++.     .+...++||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~v~   81 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWILI   81 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEEEE
Confidence            456788999999999999999899999999996655556678999999999999999999999864     345789999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      ||+++|++..++....         ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+
T Consensus        82 e~~~~~~l~~~~~~~~---------~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~  149 (282)
T cd06643          82 EFCAGGAVDAVMLELE---------RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGV  149 (282)
T ss_pred             EecCCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccc
Confidence            9999999988775322         237888999999999999999999   6999999999999999999999999999


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGM  633 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  633 (640)
                      ++......    .......||+.|+|||++.
T Consensus       150 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~  176 (282)
T cd06643         150 SAKNTRTI----QRRDSFIGTPYWMAPEVVM  176 (282)
T ss_pred             cccccccc----cccccccccccccCHhhcc
Confidence            97653211    1122345899999999984

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.93  E-value=4.1e-25  Score=220.08  Aligned_cols=178  Identities=20%  Similarity=0.310  Sum_probs=147.9

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      +|++.+.||+|+||.||++++..+++.||+|.++.. .....+.+.+|+.+++.++||||+++++++     .++...++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence            477889999999999999999989999999998643 234456788999999999999999999984     44568899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||+++|++.+++.....        ..+++..+..++.|++.|+.|||+   .+|+|+||||+||++++++.++++||
T Consensus        76 v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~df  144 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQRG--------KLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDF  144 (255)
T ss_pred             EEeeCCCCcHHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEccc
Confidence            9999999999998854322        236788899999999999999998   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |.++.......    ......|++.|+|||++.+..++.
T Consensus       145 g~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~  179 (255)
T cd08219         145 GSARLLTSPGA----YACTYVGTPYYVPPEIWENMPYNN  179 (255)
T ss_pred             Ccceeeccccc----ccccccCCccccCHHHHccCCcCc
Confidence            99986543211    112245889999999998776654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PTZ00284 protein kinase; Provisional

Probab=99.93  E-value=1.7e-25  Score=242.39  Aligned_cols=182  Identities=23%  Similarity=0.304  Sum_probs=142.0

Q ss_pred             HHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCC------CCcceeEee
Q 035691          434 ESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHR------NLVKIITAC  507 (640)
Q Consensus       434 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~------niv~l~~~~  507 (640)
                      +++...+++|++.+.||+|+||+||+|++..+++.||||+++... .....+..|+++++.++|.      +++++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            344456788999999999999999999999899999999995432 2234556778777777554      578888875


Q ss_pred             ccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCe
Q 035691          508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNV  587 (640)
Q Consensus       508 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~Ni  587 (640)
                      ..    ...+.++|||++ +++|.+++....          .+++..+..|+.||+.||+|||+.  .+|+||||||+||
T Consensus       201 ~~----~~~~~~iv~~~~-g~~l~~~l~~~~----------~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NI  263 (467)
T PTZ00284        201 QN----ETGHMCIVMPKY-GPCLLDWIMKHG----------PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENI  263 (467)
T ss_pred             Ec----CCceEEEEEecc-CCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHE
Confidence            32    234688999988 678888875432          278889999999999999999972  4999999999999


Q ss_pred             eeCCCC----------------cEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          588 LLDNDM----------------IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       588 Ll~~~~----------------~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |++.++                .+||+|||.+.....       .....+||+.|||||++.+..++.+
T Consensus       264 Ll~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-------~~~~~~gt~~Y~APE~~~~~~~~~~  325 (467)
T PTZ00284        264 LMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-------SRTAIVSTRHYRSPEVVLGLGWMYS  325 (467)
T ss_pred             EEecCCcccccccccccCCCCceEEECCCCccccCcc-------ccccccCCccccCcHHhhcCCCCcH
Confidence            998765                499999998864321       1223569999999999999887753

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.93  E-value=3.1e-25  Score=222.64  Aligned_cols=180  Identities=24%  Similarity=0.346  Sum_probs=146.7

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc------chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ------RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      +|+..+.||+|+||.||+|....+++.||+|++....      ....+.+..|++++++++|+||+++++++     ...
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence            4777899999999999999998899999999986432      12346789999999999999999999995     344


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC-c
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-I  594 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~-~  594 (640)
                      +..++||||+++++|.+++....          .+++..+..++.|++.|+.|||+   .+++||||+|+||+++.++ .
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~  142 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSKYG----------AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQR  142 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCE
Confidence            57899999999999999986432          26788899999999999999999   6999999999999998776 6


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +||+|||.+..+...............||..|+|||.+.+..++.
T Consensus       143 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~  187 (268)
T cd06630         143 LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGR  187 (268)
T ss_pred             EEEcccccccccccccccCCccccccccccceeCHhHhccCCCCc
Confidence            999999999876433211111122345889999999988776654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.93  E-value=1.9e-25  Score=249.79  Aligned_cols=185  Identities=24%  Similarity=0.345  Sum_probs=147.5

Q ss_pred             HHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCC
Q 035691          437 LKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       437 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  514 (640)
                      ....++|.+.+.||+|+||.||+|++..++..||+|++...  .......+..|+.+++.++|||||++++++...   .
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---~   85 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---A   85 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---C
Confidence            34557899999999999999999999999999999998643  233456789999999999999999999986432   2


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCeeeCCCCCCCeeeC
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHC----KKQIVHCDLKPSNVLLD  590 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~----~~~ivHrdlkp~NiLl~  590 (640)
                      ....|+||||+++|+|.+++......      ...+++..++.|+.||+.||.|||+..    ..+|+||||||+|||++
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~------~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~  159 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKM------FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS  159 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence            45689999999999999988643211      123889999999999999999999842    14699999999999996


Q ss_pred             C-----------------CCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          591 N-----------------DMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       591 ~-----------------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      .                 .+.+||+|||+++.+....     ......||+.|+|||++.+.
T Consensus       160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-----~~~s~vGTp~YmAPEvL~ge  216 (1021)
T PTZ00266        160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES-----MAHSCVGTPYYWSPELLLHE  216 (1021)
T ss_pred             cCccccccccccccccCCCCceEEccCCccccccccc-----cccccCCCccccCHHHHhcc
Confidence            4                 3458999999998653221     11234689999999998653

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4.5e-26  Score=223.73  Aligned_cols=179  Identities=27%  Similarity=0.355  Sum_probs=146.9

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecc--c-----chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCC
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--Q-----RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  514 (640)
                      +|-...+||+|+|+.||+|.+-...+.||||+-...  .     +...+...+|.++.+.++||.||++|+++.    .+
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs----lD  539 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS----LD  539 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee----ec
Confidence            455678899999999999999888899999987321  1     123467889999999999999999999963    34


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC---C
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD---N  591 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~---~  591 (640)
                      .+..|-|+|||+|.+|.-||+..+.          +++..+..|+.||..||.||.+. +++|||-||||.|||+.   .
T Consensus       540 tdsFCTVLEYceGNDLDFYLKQhkl----------mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gta  608 (775)
T KOG1151|consen  540 TDSFCTVLEYCEGNDLDFYLKQHKL----------MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTA  608 (775)
T ss_pred             cccceeeeeecCCCchhHHHHhhhh----------hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcc
Confidence            4568899999999999999987654          78889999999999999999984 57999999999999995   4


Q ss_pred             CCcEEEccccccccCCCccCCC---ceeeccccccccccCcccCCCC
Q 035691          592 DMIAHVGDFGLTRFIPEVISSN---QCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       592 ~~~~kl~DfGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      .|.+||.|||+++.+++.....   ...+....||.||.+||.+.-+
T Consensus       609 cGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVg  655 (775)
T KOG1151|consen  609 CGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVG  655 (775)
T ss_pred             cceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecC
Confidence            5899999999999986543221   1223456799999999998655

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.93  E-value=4e-25  Score=223.41  Aligned_cols=190  Identities=30%  Similarity=0.461  Sum_probs=148.9

Q ss_pred             CCCcccCcccccccceEEEEEEC-----CCCeEEEEEEeecccch-hHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILD-----PDQTVVAVKVLFLHQRG-ALKSFMAECEALRNIRHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  514 (640)
                      ++|.+.+.||+|+||.||+|.+.     .+++.||||+++..... ..+.+.+|+++++.++||||+++++++..     
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----   79 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE-----   79 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec-----
Confidence            45778899999999999999874     34578999998654443 45789999999999999999999999643     


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCC----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDL----NYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD  590 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~  590 (640)
                      ....++||||+++|+|.+++.........    ......+++.++..++.|++.|++|||+   .+++||||||+||+++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~  156 (280)
T cd05049          80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVG  156 (280)
T ss_pred             CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEc
Confidence            35789999999999999999754321100    1112347888999999999999999998   6999999999999999


Q ss_pred             CCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          591 NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       591 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      .++.+||+|||+++.......  ........+++.|+|||++.+..++.+
T Consensus       157 ~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~  204 (280)
T cd05049         157 YDLVVKIGDFGMSRDVYTTDY--YRVGGHTMLPIRWMPPESIMYRKFTTE  204 (280)
T ss_pred             CCCeEEECCcccceecccCcc--eecCCCCcccceecChhhhccCCcchh
Confidence            999999999999975432111  011112235788999999988887653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=2.5e-25  Score=224.92  Aligned_cols=174  Identities=26%  Similarity=0.355  Sum_probs=147.1

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .++|++.+.||+|+||.||+|.+..++..||+|++........+.+..|++++++++||||+++++++.     .+...+
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   78 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLW   78 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEE
Confidence            346888899999999999999998889999999997666666678999999999999999999999953     345789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++|+|.+++....         ..+++..+..++.|++.|+.|||+   .+|+|+||||+||+++.++.+||+|
T Consensus        79 lv~e~~~~~~L~~~~~~~~---------~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d  146 (280)
T cd06611          79 ILIEFCDGGALDSIMLELE---------RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLAD  146 (280)
T ss_pred             EEeeccCCCcHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEcc
Confidence            9999999999999886432         237888999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      ||++........    ......|++.|+|||.+.+
T Consensus       147 ~g~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~  177 (280)
T cd06611         147 FGVSAKNKSTLQ----KRDTFIGTPYWMAPEVVAC  177 (280)
T ss_pred             Cccchhhccccc----ccceeecchhhcCHHHHhh
Confidence            999875432111    1122458999999999853

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.93  E-value=7.2e-25  Score=219.78  Aligned_cols=182  Identities=23%  Similarity=0.343  Sum_probs=147.5

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-----chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-----RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      .+|+..+.||+|+||.||+|....++..||+|++....     .+..+.+.+|+.+++.++||||+++++++...   ..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~   78 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE   78 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence            46888899999999999999998899999999885432     22345788999999999999999999986432   13


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      ...+++|||+++++|.+++....          .+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.+
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~~~----------~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~  145 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKAYG----------ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNV  145 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCE
Confidence            46789999999999999886432          26778888999999999999998   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+|||+++......... .......++..|+|||.+.+..++.
T Consensus       146 ~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~  188 (266)
T cd06651         146 KLGDFGASKRLQTICMSG-TGIRSVTGTPYWMSPEVISGEGYGR  188 (266)
T ss_pred             EEccCCCccccccccccC-CccccCCccccccCHHHhCCCCCCc
Confidence            999999998654321111 1112245889999999998877764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.93  E-value=3.6e-25  Score=220.64  Aligned_cols=176  Identities=29%  Similarity=0.425  Sum_probs=142.4

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEE
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALV  521 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv  521 (640)
                      +|++.+.||+|+||.||+|+++ ++..+|+|++.... .....+.+|+++++.++||||+++++++.     .....++|
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv   77 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCT-----KQRPIFIV   77 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEc-----CCCceEEE
Confidence            4678899999999999999986 56789999885332 23357889999999999999999999853     34468999


Q ss_pred             eeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccc
Q 035691          522 YEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG  601 (640)
Q Consensus       522 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfG  601 (640)
                      |||+++++|.+++.....         .+++..++.++.|++.|++|||+   .+++||||||+||++++++.+||+|||
T Consensus        78 ~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg  145 (256)
T cd05059          78 TEYMANGCLLNYLRERKG---------KLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFG  145 (256)
T ss_pred             EecCCCCCHHHHHHhccc---------CCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcc
Confidence            999999999999864322         37888999999999999999999   699999999999999999999999999


Q ss_pred             ccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          602 LTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       602 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +++...+...   .......++..|+|||.+.+..++.
T Consensus       146 ~~~~~~~~~~---~~~~~~~~~~~y~~Pe~~~~~~~~~  180 (256)
T cd05059         146 LARYVLDDQY---TSSQGTKFPVKWAPPEVFDYSRFSS  180 (256)
T ss_pred             cceecccccc---cccCCCCCCccccCHHHhccCCCCc
Confidence            9986532111   1111122456899999998877764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.93  E-value=5.4e-25  Score=220.13  Aligned_cols=177  Identities=29%  Similarity=0.449  Sum_probs=138.3

Q ss_pred             CcccccccceEEEEEECC---CCeEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          447 NLIGTGSFGSVYKGILDP---DQTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      +.||+|+||.||+|.+..   ++..||+|.+... .....+.+.+|+.+++.++||||++++++|...    +...++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEEE
Confidence            468999999999998643   3467999988533 334457888999999999999999999986432    34578999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      ||+.+|+|.+++.....         ..++..+..++.|++.|+.|||+   .+++||||||+||++++++.+||+|||+
T Consensus        77 e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~  144 (262)
T cd05058          77 PYMKHGDLRNFIRSETH---------NPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGL  144 (262)
T ss_pred             ecCCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccc
Confidence            99999999999864322         25667788999999999999998   6999999999999999999999999999


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ++.+...............++..|+|||.+.+..++.
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  181 (262)
T cd05058         145 ARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTT  181 (262)
T ss_pred             cccccCCcceeecccccCcCCccccChhHhccCccch
Confidence            9865332111111111234677899999998777664

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.92  E-value=3e-25  Score=221.24  Aligned_cols=177  Identities=29%  Similarity=0.438  Sum_probs=143.3

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      ++|++.+.||+|+||.||+|.+. .+..||+|.++... ...+.+.+|+.++++++||||++++++|..     ....++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   76 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-----QRPIYI   76 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-----CCCcEE
Confidence            35778899999999999999876 45569999886432 234678999999999999999999999643     346799


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||+.+|+|.+++.....         .+++.+++.++.|++.|++|||+   .+++|+||||+||++++++.+||+||
T Consensus        77 v~e~~~~~~l~~~i~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~  144 (256)
T cd05113          77 VTEYMSNGCLLNYLREHGK---------RFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDF  144 (256)
T ss_pred             EEEcCCCCcHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCC
Confidence            9999999999999864321         37888999999999999999998   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |.++......   ........++..|+|||.+.+..++.
T Consensus       145 g~~~~~~~~~---~~~~~~~~~~~~y~~pe~~~~~~~~~  180 (256)
T cd05113         145 GLSRYVLDDE---YTSSVGSKFPVRWSPPEVLLYSKFSS  180 (256)
T ss_pred             ccceecCCCc---eeecCCCccChhhCCHHHHhcCcccc
Confidence            9998653221   11112233567899999998776654

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.92  E-value=3.6e-25  Score=225.06  Aligned_cols=191  Identities=26%  Similarity=0.263  Sum_probs=154.1

Q ss_pred             cCHHHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCCcceeEeecc
Q 035691          431 VSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-RHRNLVKIITACSS  509 (640)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  509 (640)
                      ++.+++..++++|++.+.||+|+||.||+|....+++.||+|++..... ....+.+|+.++.++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            3446667778999999999999999999999998999999999854322 235678899999998 89999999999865


Q ss_pred             CCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee
Q 035691          510 SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL  589 (640)
Q Consensus       510 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl  589 (640)
                      .+.......++||||+++|+|.++++.....      ...+++..++.++.|++.|++|||+   .+++||||||+||++
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~------~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili  161 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLIC------GQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILL  161 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEE
Confidence            4433445689999999999999988542211      1237888999999999999999998   699999999999999


Q ss_pred             CCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          590 DNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       590 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      +.++.+||+|||+++.......    ......|+..|+|||++.+.
T Consensus       162 ~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~  203 (291)
T cd06639         162 TTEGGVKLVDFGVSAQLTSTRL----RRNTSVGTPFWMAPEVIACE  203 (291)
T ss_pred             cCCCCEEEeecccchhcccccc----cccCccCCccccChhhhcCC
Confidence            9999999999999986542111    11223588999999997654

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.92  E-value=5.2e-25  Score=224.35  Aligned_cols=190  Identities=22%  Similarity=0.331  Sum_probs=145.5

Q ss_pred             CCCcccCcccccccceEEEEEECCC--------------CeEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPD--------------QTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIIT  505 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~  505 (640)
                      ++|++.+.||+|+||.||+|+....              ...||+|.+... .......|.+|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            4688889999999999999987532              235899998543 2334467999999999999999999999


Q ss_pred             eeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCC--CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCC
Q 035691          506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDD--LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLK  583 (640)
Q Consensus       506 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlk  583 (640)
                      ++.     .....++||||+++++|.+++........  .......+++..++.++.|++.|++|||+   .+++|||||
T Consensus        85 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlk  156 (295)
T cd05097          85 VCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLA  156 (295)
T ss_pred             EEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccC
Confidence            964     34578999999999999999854321100  00111236788999999999999999999   699999999


Q ss_pred             CCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          584 PSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       584 p~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |+||++++++.+||+|||+++.......  ........++..|+|||++.++.++.+
T Consensus       157 p~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~  211 (295)
T cd05097         157 TRNCLVGNHYTIKIADFGMSRNLYSGDY--YRIQGRAVLPIRWMAWESILLGKFTTA  211 (295)
T ss_pred             hhhEEEcCCCcEEecccccccccccCcc--eeccCcCcCceeecChhhhccCCcCch
Confidence            9999999999999999999986532111  111112335778999999988777653

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=7.2e-26  Score=231.12  Aligned_cols=180  Identities=25%  Similarity=0.303  Sum_probs=149.5

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      .-|..++.||-|+||+|+.++-.++...||+|.+++.+   +.+......|.+||.+.+.+-||+++..     |++++.
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDkdn  703 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKDN  703 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccCCc
Confidence            44777888999999999999988889999999996554   3455677889999999999999999877     788889


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      +|+||||++|||+..+|-+.+          .+++..+..++.+++.|+++.|.   .|+|||||||+|||||.+|++|+
T Consensus       704 LYFVMdYIPGGDmMSLLIrmg----------IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKL  770 (1034)
T KOG0608|consen  704 LYFVMDYIPGGDMMSLLIRMG----------IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKL  770 (1034)
T ss_pred             eEEEEeccCCccHHHHHHHhc----------cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceee
Confidence            999999999999999886554          37888888999999999999998   79999999999999999999999


Q ss_pred             ccccccccCCCc---------cCC-----------------------------CceeeccccccccccCcccCCCCCCC
Q 035691          598 GDFGLTRFIPEV---------ISS-----------------------------NQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       598 ~DfGla~~~~~~---------~~~-----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      .|||++.-++-.         ...                             ..+.....+||+-|+|||++...-++
T Consensus       771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~  849 (1034)
T KOG0608|consen  771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT  849 (1034)
T ss_pred             eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc
Confidence            999998643110         000                             01122346799999999999776554

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=8.5e-25  Score=219.02  Aligned_cols=182  Identities=24%  Similarity=0.357  Sum_probs=147.8

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecc-----cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH-----QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      .+|++.+.||+|+||.||+|++..++..||+|++...     .......+.+|++++++++||||+++++++....   .
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~---~   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE---E   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC---C
Confidence            4688899999999999999999989999999987432     1233467889999999999999999999864322   3


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      ...++||||+++++|.+++....          .+++..+..++.|++.|+.|||+   .+++||||||+||+++.++.+
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~~~----------~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~  145 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKAYG----------ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNV  145 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCE
Confidence            45789999999999999885432          26778889999999999999998   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|+|||+++........ ........|+..|+|||.+.+..++.
T Consensus       146 ~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~  188 (264)
T cd06653         146 KLGDFGASKRIQTICMS-GTGIKSVTGTPYWMSPEVISGEGYGR  188 (264)
T ss_pred             EECcccccccccccccc-CccccccCCcccccCHhhhcCCCCCc
Confidence            99999999865321111 11112345899999999998877664

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.92  E-value=3.8e-25  Score=233.37  Aligned_cols=192  Identities=25%  Similarity=0.370  Sum_probs=146.9

Q ss_pred             HhcCCCcccCcccccccceEEEEEEC-----CCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcC-CCCCcceeEeeccC
Q 035691          438 KATGGFSSANLIGTGSFGSVYKGILD-----PDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIR-HRNLVKIITACSSS  510 (640)
Q Consensus       438 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~  510 (640)
                      ...++|.+.+.||+|+||.||+|++.     ..++.||+|+++... ....+.+..|++++.++. |||||+++++|.. 
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-  112 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK-  112 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc-
Confidence            33445677899999999999999864     345689999996443 233457899999999997 9999999999643 


Q ss_pred             CcCCCceeeEEeeccCCCChhhhcCCCCCCC-------------------------------------------------
Q 035691          511 DFQGNDFKALVYEFMHHGSLESWLHPESASD-------------------------------------------------  541 (640)
Q Consensus       511 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------------------------------------------------  541 (640)
                          ....++||||+++|+|.++++..+...                                                 
T Consensus       113 ----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (401)
T cd05107         113 ----GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD  188 (401)
T ss_pred             ----CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence                346899999999999999986432100                                                 


Q ss_pred             ---------------------------------------CCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCC
Q 035691          542 ---------------------------------------DLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDL  582 (640)
Q Consensus       542 ---------------------------------------~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdl  582 (640)
                                                             ........+++..+..++.|++.||+|||+   .+++||||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdl  265 (401)
T cd05107         189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDL  265 (401)
T ss_pred             ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccC
Confidence                                                   000011246778889999999999999998   79999999


Q ss_pred             CCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          583 KPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       583 kp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+||++++++.+|++|||+++.+......  .......+++.|+|||.+.+..++.
T Consensus       266 kp~NiLl~~~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~  320 (401)
T cd05107         266 AARNVLICEGKLVKICDFGLARDIMRDSNY--ISKGSTFLPLKWMAPESIFNNLYTT  320 (401)
T ss_pred             CcceEEEeCCCEEEEEecCcceeccccccc--ccCCCcCCCCceeChHHhcCCCCCc
Confidence            999999999999999999999865322111  1111234678999999998877765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.92  E-value=4.1e-25  Score=222.89  Aligned_cols=191  Identities=25%  Similarity=0.365  Sum_probs=148.3

Q ss_pred             cCCCcccCcccccccceEEEEEECC-----CCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDP-----DQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQ  513 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  513 (640)
                      .++|++.+.||+|+||.||+|....     ++..||+|.+.... ......+.+|+.+++.++||||+++++++.     
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----   79 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-----   79 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc-----
Confidence            3467888999999999999998864     34789999985432 234467889999999999999999999954     


Q ss_pred             CCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC
Q 035691          514 GNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM  593 (640)
Q Consensus       514 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~  593 (640)
                      .....++||||+++|+|.+++...............+++..++.++.|++.|+.|||+   .+++||||||+||+++.++
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~  156 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDL  156 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCC
Confidence            3457899999999999999986543221110111347888999999999999999998   6999999999999999999


Q ss_pred             cEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          594 IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       594 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      .+||+|||+++.+......  .......++..|+|||.+.++.++.+
T Consensus       157 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~  201 (277)
T cd05032         157 TVKIGDFGMTRDIYETDYY--RKGGKGLLPVRWMAPESLKDGVFTTK  201 (277)
T ss_pred             CEEECCcccchhhccCccc--ccCCCCCccccccCHHHHhcCCCCcc
Confidence            9999999999865332111  11122346789999999987776643

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.92  E-value=8.9e-25  Score=240.60  Aligned_cols=258  Identities=24%  Similarity=0.289  Sum_probs=189.3

Q ss_pred             CCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCC
Q 035691           27 FQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASK  106 (640)
Q Consensus        27 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  106 (640)
                      .+-..|+|++|.|+ .+|..+.  ++|+.|++++|+|+.      +|..    +++|+.|+|++|+|+.+ |..   .++
T Consensus       201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~------LP~l----p~~Lk~LdLs~N~LtsL-P~l---p~s  263 (788)
T PRK15387        201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS------LPAL----PPELRTLEVSGNQLTSL-PVL---PPG  263 (788)
T ss_pred             CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC------CCCC----CCCCcEEEecCCccCcc-cCc---ccc
Confidence            34667899999998 5676665  478999999888875      6642    57888899999988854 432   367


Q ss_pred             CCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcCCCCCCCCCE
Q 035691          107 LEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQV  186 (640)
Q Consensus       107 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~  186 (640)
                      |+.|+|++|.|+. +|..+   .+|+.|+|++|+|+.++.          ..++|+.|+|++|+|+.+|...   .+|+.
T Consensus       264 L~~L~Ls~N~L~~-Lp~lp---~~L~~L~Ls~N~Lt~LP~----------~p~~L~~LdLS~N~L~~Lp~lp---~~L~~  326 (788)
T PRK15387        264 LLELSIFSNPLTH-LPALP---SGLCKLWIFGNQLTSLPV----------LPPGLQELSVSDNQLASLPALP---SELCK  326 (788)
T ss_pred             cceeeccCCchhh-hhhch---hhcCEEECcCCccccccc----------cccccceeECCCCccccCCCCc---ccccc
Confidence            8888888888884 44432   568888888888887642          1357888888888888877532   46778


Q ss_pred             EEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCccC
Q 035691          187 LSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAV  266 (640)
Q Consensus       187 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~  266 (640)
                      |++++|.|++ +|..   ..+|+.|+|++|+|++ +|...   .+|+.|                ++++|+|++ +|.. 
T Consensus       327 L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~lp---~~L~~L----------------~Ls~N~L~~-LP~l-  380 (788)
T PRK15387        327 LWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTLP---SELYKL----------------WAYNNRLTS-LPAL-  380 (788)
T ss_pred             cccccCcccc-cccc---ccccceEecCCCccCC-CCCCC---ccccee----------------hhhcccccc-Cccc-
Confidence            8888888874 4532   2478888888888884 44322   345555                788888884 5543 


Q ss_pred             CCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCcccCCC-CCC
Q 035691          267 GNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRK-GIF  345 (640)
Q Consensus       267 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~p~~-~~~  345 (640)
                        ..+|+.|+|++|+|+ .+|...   ++|+.|++++|+|++ +|..   ..+|+.|++++|+++.      +|.. ..+
T Consensus       381 --~~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt~------LP~sl~~L  444 (788)
T PRK15387        381 --PSGLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLTR------LPESLIHL  444 (788)
T ss_pred             --ccccceEEecCCccc-CCCCcc---cCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCcccc------cChHHhhc
Confidence              357999999999999 466433   579999999999986 5654   3578899999999984      4432 456


Q ss_pred             CCCccccccCCCCCc
Q 035691          346 KNASAISVAGNEKLC  360 (640)
Q Consensus       346 ~~~~~~~~~~n~~~c  360 (640)
                      ..+..+++++|++-.
T Consensus       445 ~~L~~LdLs~N~Ls~  459 (788)
T PRK15387        445 SSETTVNLEGNPLSE  459 (788)
T ss_pred             cCCCeEECCCCCCCc
Confidence            788899999998643

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.92  E-value=5.3e-25  Score=221.14  Aligned_cols=182  Identities=26%  Similarity=0.467  Sum_probs=145.1

Q ss_pred             CCCcccCcccccccceEEEEEECCCCe---EEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQT---VVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ++|++.+.||+|+||.||+|.++.+++   .||||++... .....+.|..|+.+++.++||||+++++++     ..+.
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSR   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCC
Confidence            346788999999999999999876654   6999998644 334457899999999999999999999985     3445


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++|+|.+++.....         .+++.+++.++.|++.|++|||+   .+++||||||+||+++.++.+|
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~k  146 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQNDG---------QFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCK  146 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCCC---------CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEE
Confidence            78999999999999999865322         37888999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCcee-eccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCS-SVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ++|||+++............ ......+..|+|||++.+..++.
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~  190 (269)
T cd05065         147 VSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTS  190 (269)
T ss_pred             ECCCccccccccCccccccccccCCCcceeecCHhHhccCcccc
Confidence            99999998654322111111 11111245799999998877764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.92  E-value=6.2e-25  Score=220.23  Aligned_cols=181  Identities=28%  Similarity=0.430  Sum_probs=149.4

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||.||+|....+|+.||+|.++..   +....+.+.+|++++++++|++|+++++++.     ..+.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence            5788899999999999999999989999999988532   2334578999999999999999999999853     3457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++......      ...+++.++..++.|++.|+.|||+   .+++||||+|+||+++.++.++|
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l  147 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQ------KRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhccc------CCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEE
Confidence            89999999999999988543221      1337888999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|||+++.+.....    ......|++.|+|||.+.+..++.
T Consensus       148 ~d~~~~~~~~~~~~----~~~~~~~~~~y~apE~~~~~~~~~  185 (267)
T cd08224         148 GDLGLGRFFSSKTT----AAHSLVGTPYYMSPERIHENGYNF  185 (267)
T ss_pred             eccceeeeccCCCc----ccceecCCccccCHHHhccCCCCc
Confidence            99999986543211    112235889999999998877654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.92  E-value=5.1e-25  Score=221.13  Aligned_cols=182  Identities=24%  Similarity=0.324  Sum_probs=146.8

Q ss_pred             HHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       436 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      ++.+++.+.....||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++|+||+++++++.     .+
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~   77 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----EN   77 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cC
Confidence            3445666666678999999999999998899999999987665556678999999999999999999999954     34


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC-CCc
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN-DMI  594 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~-~~~  594 (640)
                      +..++||||+++++|.+++......       ...++..+..++.|++.|++|||+   .+|+||||||+||+++. ++.
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~  147 (268)
T cd06624          78 GFFKIFMEQVPGGSLSALLRSKWGP-------LKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGV  147 (268)
T ss_pred             CEEEEEEecCCCCCHHHHHHHhccc-------CCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCe
Confidence            5789999999999999998643211       113677888999999999999998   79999999999999976 679


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      +||+|||.+........    ......|++.|+|||++.+..
T Consensus       148 ~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~  185 (268)
T cd06624         148 VKISDFGTSKRLAGINP----CTETFTGTLQYMAPEVIDKGP  185 (268)
T ss_pred             EEEecchhheecccCCC----ccccCCCCccccChhhhcccc
Confidence            99999999976532111    111235789999999986543

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.92  E-value=7.3e-25  Score=222.94  Aligned_cols=173  Identities=28%  Similarity=0.348  Sum_probs=145.6

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      +.|++.+.||+|+||.||+|++..+++.||+|.+........+.+.+|+.+++.++||||+++++++.     .+...++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WDGKLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eCCeEEE
Confidence            55888899999999999999999899999999997666666678999999999999999999999853     3457899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||++++++..++....         ..+++..+..++.|++.|++|||+   .+++||||||+||+++.++.+||+||
T Consensus        87 v~e~~~~~~l~~~~~~~~---------~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~df  154 (292)
T cd06644          87 MIEFCPGGAVDAIMLELD---------RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADF  154 (292)
T ss_pred             EEecCCCCcHHHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccC
Confidence            999999999988775432         237888999999999999999998   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      |+++......    .......+++.|+|||++.+
T Consensus       155 g~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~  184 (292)
T cd06644         155 GVSAKNVKTL----QRRDSFIGTPYWMAPEVVMC  184 (292)
T ss_pred             ccceeccccc----cccceecCCccccCceeecc
Confidence            9987543211    11123458899999999864

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.92  E-value=3.3e-25  Score=222.34  Aligned_cols=181  Identities=24%  Similarity=0.387  Sum_probs=148.6

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||.||+|+...+++.||||.+...   .....+.+.+|+.+++.++||||+++++++.     ..+.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence            4577889999999999999999889999999988543   2334468899999999999999999999853     3457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++++|.+++......      ...+++.+++.++.|++.|+.|||+   .+++|+||||+||+++.++.+++
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l  147 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQ------KRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhcc------CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEE
Confidence            88999999999999988632211      1347889999999999999999998   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|||+++.+.....    ......|+..|+|||++.+..++.
T Consensus       148 ~dfg~~~~~~~~~~----~~~~~~~~~~~~ape~~~~~~~~~  185 (267)
T cd08229         148 GDLGLGRFFSSKTT----AAHSLVGTPYYMSPERIHENGYNF  185 (267)
T ss_pred             CcchhhhccccCCc----ccccccCCcCccCHHHhcCCCccc
Confidence            99999886643211    112245889999999998776654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.92  E-value=8.6e-25  Score=217.84  Aligned_cols=178  Identities=21%  Similarity=0.334  Sum_probs=149.5

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +|+..+.||+|+||.||.++...+++.||+|.+....  ....+.+.+|++++++++|+||+++++++.     ..+..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-----DDNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-----cCCeEE
Confidence            4778899999999999999999999999999986543  344567899999999999999999999953     345789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++|+|.+++.....        ..+++.++..++.|++.|+.|||+   .+++||||+|+||++++++.+||+|
T Consensus        76 ~~~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d  144 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQKG--------QLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGD  144 (256)
T ss_pred             EEEEecCCCcHHHHHHhccc--------cCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECc
Confidence            99999999999999865422        237888999999999999999998   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||.++.......    ......|++.|+|||.+.+..++.
T Consensus       145 ~~~~~~~~~~~~----~~~~~~~~~~y~ape~~~~~~~~~  180 (256)
T cd08221         145 FGISKILGSEYS----MAETVVGTPYYMSPELCQGVKYNF  180 (256)
T ss_pred             CcceEEcccccc----cccccCCCccccCHhhcCCCCCCC
Confidence            999986643221    122345899999999998776654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.92  E-value=9.1e-25  Score=217.85  Aligned_cols=173  Identities=28%  Similarity=0.406  Sum_probs=137.6

Q ss_pred             cccccccceEEEEEEC--CCCeEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEeec
Q 035691          448 LIGTGSFGSVYKGILD--PDQTVVAVKVLFLHQR-GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEF  524 (640)
Q Consensus       448 ~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~  524 (640)
                      .||+|+||.||+|.++  .++..||+|++..... ...+.+.+|+.++++++||||++++++|..      +..++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEEe
Confidence            3899999999999774  4566799999864432 334679999999999999999999998632      357899999


Q ss_pred             cCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccccc
Q 035691          525 MHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR  604 (640)
Q Consensus       525 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~  604 (640)
                      +++|+|.+++....         ..+++..++.++.|++.|+.|||+   .+++||||||+||+++.++.+||+|||+++
T Consensus        76 ~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  143 (257)
T cd05115          76 ASGGPLNKFLSGKK---------DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSK  143 (257)
T ss_pred             CCCCCHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccc
Confidence            99999999986432         237889999999999999999998   699999999999999999999999999998


Q ss_pred             cCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          605 FIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       605 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ......... .......+++.|+|||.+.+..++.
T Consensus       144 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~  177 (257)
T cd05115         144 ALGADDSYY-KARSAGKWPLKWYAPECINFRKFSS  177 (257)
T ss_pred             cccCCccce-eccCCCCCCcccCCHHHHccCCCCc
Confidence            654322111 1111122467899999988776654

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.92  E-value=5.9e-25  Score=223.94  Aligned_cols=176  Identities=25%  Similarity=0.343  Sum_probs=149.2

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      .+|+..+.||.|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++++.     ..+..++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceEEE
Confidence            35888899999999999999998899999999997655555678899999999999999999999853     3457899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      |+||+++|+|.+++...           .+++.++..++.|++.|+.|||+   .+++||||||+||+++.++.+||+||
T Consensus        94 v~e~~~~~~L~~~~~~~-----------~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~df  159 (296)
T cd06655          94 VMEYLAGGSLTDVVTET-----------CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDF  159 (296)
T ss_pred             EEEecCCCcHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccC
Confidence            99999999999988532           26788999999999999999999   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+++.......    ......|++.|+|||.+.+..++.
T Consensus       160 g~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~  194 (296)
T cd06655         160 GFCAQITPEQS----KRSTMVGTPYWMAPEVVTRKAYGP  194 (296)
T ss_pred             ccchhcccccc----cCCCcCCCccccCcchhcCCCCCc
Confidence            99886533211    112235889999999998877654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.92  E-value=8.4e-26  Score=206.92  Aligned_cols=191  Identities=21%  Similarity=0.263  Sum_probs=157.3

Q ss_pred             HhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       438 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ...++|++.+.+|+|||+.||.++.-.++..||+|++..+...+.+..++|++..++++|||++++++++....-.+...
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            44678999999999999999999988899999999998887777789999999999999999999999986655445667


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .|++++|...|+|.+.+.......      ..+++.++++|+.++++|+++||+.. ++++||||||.|||+.+.+.+++
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg------~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl  170 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKG------NFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVL  170 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcC------CccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEE
Confidence            999999999999999987654321      34899999999999999999999953 36999999999999999999999


Q ss_pred             ccccccccCCCccCCCc-----eeeccccccccccCcccCCCC
Q 035691          598 GDFGLTRFIPEVISSNQ-----CSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      .|||.+...+-......     .......+|..|+|||.+...
T Consensus       171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk  213 (302)
T KOG2345|consen  171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVK  213 (302)
T ss_pred             EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecc
Confidence            99999876532111100     011123478999999998543

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.92  E-value=8.7e-25  Score=217.91  Aligned_cols=180  Identities=28%  Similarity=0.391  Sum_probs=148.4

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +|++.+.||+|+||.||++..+.+++.||+|.+....  ....+.+.+|++++++++|+|++++++.+..    .+...+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG----EDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC----CCCEEE
Confidence            4788899999999999999999889999999986433  2344678899999999999999999887422    234678


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++++|.+++.....        ..+++.++..++.|++.|++|||+   .+++||||||+||+++.++.++|+|
T Consensus        77 lv~e~~~~~~l~~~l~~~~~--------~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~d  145 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQKG--------KLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGD  145 (257)
T ss_pred             EEecccCCCcHHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEec
Confidence            99999999999999864322        237889999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ||+++.+.....    ......|++.|+|||++.+..++.+
T Consensus       146 f~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~  182 (257)
T cd08223         146 LGIARVLENQCD----MASTLIGTPYYMSPELFSNKPYNYK  182 (257)
T ss_pred             ccceEEecccCC----ccccccCCcCccChhHhcCCCCCch
Confidence            999986643211    1123458899999999988877653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.92  E-value=3.8e-25  Score=234.27  Aligned_cols=175  Identities=24%  Similarity=0.305  Sum_probs=142.5

Q ss_pred             cCCCcccCcccccccceEEEEEEC--CCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILD--PDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ..+|.+.+.||+|+||.||+|...  .++..||+|.+...     ....+|++++++++|||||++++++     .....
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~  160 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAY-----RWKST  160 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeE-----eeCCE
Confidence            456899999999999999999764  34678999987532     2346899999999999999999984     44557


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+. +++.+++...          ..+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||
T Consensus       161 ~~lv~e~~~-~~l~~~l~~~----------~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l  226 (392)
T PHA03207        161 VCMVMPKYK-CDLFTYVDRS----------GPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVL  226 (392)
T ss_pred             EEEEehhcC-CCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEE
Confidence            899999996 6888887432          237889999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||+++........  .......||+.|+|||++.+..++.+
T Consensus       227 ~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~  267 (392)
T PHA03207        227 GDFGAACKLDAHPDT--PQCYGWSGTLETNSPELLALDPYCAK  267 (392)
T ss_pred             ccCccccccCccccc--ccccccccccCccCHhHhcCCCCCch
Confidence            999999865432211  11224569999999999998877653

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.92  E-value=6.8e-25  Score=219.45  Aligned_cols=178  Identities=28%  Similarity=0.488  Sum_probs=143.7

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .++|++.+.||+|+||.||+|++..+ ..||+|+++.... ..+.+.+|+++++.++||||+++++++.      ....+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~   76 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIY   76 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC------CCCcE
Confidence            35688999999999999999998744 5699999864332 3367899999999999999999998742      23468


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++|+|.+++.....        ..+++..+..++.|++.||+|+|+   .+++||||||+||++++++.+||+|
T Consensus        77 lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~d  145 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMG--------KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVAD  145 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccc--------cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEecc
Confidence            99999999999999964322        237888999999999999999999   7999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||.++.+.....   .......++..|+|||+..+..++.
T Consensus       146 fg~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~  182 (262)
T cd05071         146 FGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTI  182 (262)
T ss_pred             CCceeecccccc---ccccCCcccceecCHhHhccCCCCc
Confidence            999986543211   1111234677899999988776654

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.6e-25  Score=230.61  Aligned_cols=170  Identities=27%  Similarity=0.440  Sum_probs=143.3

Q ss_pred             cccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEeeccCC
Q 035691          448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHH  527 (640)
Q Consensus       448 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~  527 (640)
                      +||+|.||+||.|++..+...+|||.+...+....+-+.+|+...++++|.|||+++|.|.     .+.+.-+.||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~s-----enGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVS-----ENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccC-----CCCeEEEEeecCCC
Confidence            6999999999999999999999999997777777788999999999999999999999953     34477899999999


Q ss_pred             CChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC-CCCcEEEccccccccC
Q 035691          528 GSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD-NDMIAHVGDFGLTRFI  606 (640)
Q Consensus       528 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~-~~~~~kl~DfGla~~~  606 (640)
                      |+|.++++..       +.|-.-.+.++-.+.+||++||.|||+   ..|||||||-+|+|+. -.|.+||+|||.++.+
T Consensus       657 GSLSsLLrsk-------WGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRL  726 (1226)
T KOG4279|consen  657 GSLSSLLRSK-------WGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRL  726 (1226)
T ss_pred             CcHHHHHHhc-------cCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhh
Confidence            9999998642       122223667888899999999999999   6999999999999996 4689999999999976


Q ss_pred             CCccCCCceeeccccccccccCcccCCCCC
Q 035691          607 PEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       607 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      ...   +.++ .++.||..|||||++-.++
T Consensus       727 Agi---nP~T-ETFTGTLQYMAPEvIDqG~  752 (1226)
T KOG4279|consen  727 AGI---NPCT-ETFTGTLQYMAPEVIDQGP  752 (1226)
T ss_pred             ccC---Cccc-cccccchhhhChHhhccCC
Confidence            432   2232 3477999999999996654

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.92  E-value=9.2e-25  Score=222.65  Aligned_cols=191  Identities=25%  Similarity=0.342  Sum_probs=148.6

Q ss_pred             cCCCcccCcccccccceEEEEEECCCC----------------eEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQ----------------TVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVK  502 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~  502 (640)
                      .++|++.+.||+|+||.||+|.....+                ..||+|.+.... ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            357888999999999999999875433                568999986443 334578899999999999999999


Q ss_pred             eeEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCC
Q 035691          503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDL-NYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCD  581 (640)
Q Consensus       503 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrd  581 (640)
                      ++++|.     .+...++||||+++++|.+++......... ......+++..++.++.|++.|++|||+   .+++|||
T Consensus        84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~d  155 (296)
T cd05051          84 LLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRD  155 (296)
T ss_pred             EEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccc
Confidence            999964     335789999999999999998654321111 1112348899999999999999999998   6999999


Q ss_pred             CCCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          582 LKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       582 lkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |||+||+++.++.+||+|||+++........  .......+++.|+|||++.+..++.+
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~  212 (296)
T cd05051         156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYY--RVQGRAPLPIRWMAWESVLLGKFTTK  212 (296)
T ss_pred             cchhceeecCCCceEEccccceeecccCcce--eecCcCCCCceecCHHHhhcCCCCcc
Confidence            9999999999999999999999865322111  11122346788999999888766653

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.92  E-value=9.7e-25  Score=221.90  Aligned_cols=190  Identities=28%  Similarity=0.424  Sum_probs=149.1

Q ss_pred             CCCcccCcccccccceEEEEEEC-----CCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILD-----PDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      ++|.+.+.||+|+||.||+|...     .++..||+|.+........+.+.+|++++++++||||+++++++.     ..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----cC
Confidence            34777899999999999999853     345679999986555555578999999999999999999999964     34


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCC------CCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASD------DLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL  589 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl  589 (640)
                      +..++||||+++++|.+++.......      ........+++.+++.++.|++.|++|||+   .+|+||||||+||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~  156 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLV  156 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEE
Confidence            56899999999999999986543210      000112348899999999999999999998   799999999999999


Q ss_pred             CCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          590 DNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       590 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ++++.+||+|||+++.......  ........++..|+|||++.+..++.|
T Consensus       157 ~~~~~~~l~dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~  205 (291)
T cd05094         157 GANLLVKIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTE  205 (291)
T ss_pred             ccCCcEEECCCCcccccCCCce--eecCCCCCcceeecChHHhccCCCCch
Confidence            9999999999999986532211  111122346789999999988877653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.92  E-value=6.5e-25  Score=224.36  Aligned_cols=173  Identities=24%  Similarity=0.418  Sum_probs=142.2

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ++|+..+.||+|+||.||+|+++.+++.||+|.++... ......+.+|+.+++.++||||+++++++.     .....+
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~~~   80 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT   80 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCeEE
Confidence            46888899999999999999999899999999986443 333456788999999999999999999953     445789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||++ ++|.+++.....         .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|
T Consensus        81 lv~e~~~-~~l~~~l~~~~~---------~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~d  147 (301)
T cd07873          81 LVFEYLD-KDLKQYLDDCGN---------SINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLAD  147 (301)
T ss_pred             EEEeccc-cCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECc
Confidence            9999997 589888754322         36788899999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      ||+++.......    ......+++.|+|||++.+.
T Consensus       148 fg~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~  179 (301)
T cd07873         148 FGLARAKSIPTK----TYSNEVVTLWYRPPDILLGS  179 (301)
T ss_pred             CcchhccCCCCC----cccccceeecccCcHHHhCC
Confidence            999975432111    11123478999999998664

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=1e-24  Score=218.06  Aligned_cols=174  Identities=28%  Similarity=0.382  Sum_probs=148.1

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      ++|+..+.||+|+||.||+|....+++.+|+|++........+.+.+|++++++++||||+++++++     ......++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEEEE
Confidence            5688889999999999999999888999999999766555668899999999999999999999984     34557899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      +|||+++++|.+++....         ..+++..+..++.|++.|++|||+   .+++|+||+|+||++++++.+||+||
T Consensus        78 ~~e~~~~~~l~~~~~~~~---------~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~  145 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTR---------GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADF  145 (262)
T ss_pred             EEeCCCCCcHHHHHHhhc---------cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECcc
Confidence            999999999999886532         127788999999999999999998   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      |.+........    ......++..|+|||.+.+.
T Consensus       146 g~~~~~~~~~~----~~~~~~~~~~y~~Pe~~~~~  176 (262)
T cd06613         146 GVSAQLTATIA----KRKSFIGTPYWMAPEVAAVE  176 (262)
T ss_pred             ccchhhhhhhh----ccccccCCccccCchhhccc
Confidence            99986543211    11224588899999998766

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=9.6e-25  Score=224.74  Aligned_cols=182  Identities=29%  Similarity=0.341  Sum_probs=148.6

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecccc---hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR---GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      +|+..+.||+|+||.||+|....+++.||+|.+.....   ...+.+..|+++++.++||||+++++++     ......
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   76 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETYL   76 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCEE
Confidence            67888999999999999999998899999999965432   2446788999999999999999999985     345578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||+.+++|.+++.....        ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~--------~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~  145 (316)
T cd05574          77 CLVMDYCPGGELFRLLQRQPG--------KCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLS  145 (316)
T ss_pred             EEEEEecCCCCHHHHHHhCCC--------CccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEe
Confidence            999999999999999864322        247888999999999999999998   699999999999999999999999


Q ss_pred             cccccccCCCccCCC-------------------------ceeeccccccccccCcccCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSN-------------------------QCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       599 DfGla~~~~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |||++..........                         ........||..|+|||++.+..++.
T Consensus       146 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~  211 (316)
T cd05574         146 DFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGS  211 (316)
T ss_pred             ecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCc
Confidence            999987543211100                         00111346899999999998877664

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.92  E-value=7.8e-25  Score=223.88  Aligned_cols=186  Identities=28%  Similarity=0.416  Sum_probs=143.1

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeE--EEEEEeecc-cchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCc
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTV--VAVKVLFLH-QRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ++|++.+.||+|+||.||+|.++.++..  +|+|.++.. .......+.+|++++.++ +||||+++++++.     .+.
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~-----~~~   81 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG   81 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC-----CCC
Confidence            4678889999999999999998877754  567766432 233446788999999999 8999999999953     345


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCC------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDL------NYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD  590 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~  590 (640)
                      ..++||||+++|+|.+++.........      ......+++.+++.++.|++.|++|||+   .+++||||||+||+++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~  158 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVG  158 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEec
Confidence            789999999999999998654321100      0111347889999999999999999998   7999999999999999


Q ss_pred             CCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          591 NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       591 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      .++.+||+|||+++.......     .....++..|+|||++.+..++.
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~  202 (303)
T cd05088         159 ENYVAKIADFGLSRGQEVYVK-----KTMGRLPVRWMAIESLNYSVYTT  202 (303)
T ss_pred             CCCcEEeCccccCcccchhhh-----cccCCCcccccCHHHHhccCCcc
Confidence            999999999999874321110     11112466899999987776654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.92  E-value=8.8e-25  Score=219.24  Aligned_cols=180  Identities=27%  Similarity=0.431  Sum_probs=145.7

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecccch---------hHHHHHHHHHHHHhcCCCCCcceeEeeccCCc
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG---------ALKSFMAECEALRNIRHRNLVKIITACSSSDF  512 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  512 (640)
                      +|.+...||+|+||.||+|.+..+++.||+|.+......         ..+.+.+|+.++++++||||+++++++.    
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----   76 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL----   76 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE----
Confidence            367788999999999999999888999999988543211         2257889999999999999999999853    


Q ss_pred             CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC
Q 035691          513 QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND  592 (640)
Q Consensus       513 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~  592 (640)
                       .....++||||+++++|.+++....          .+++..+..++.|++.|++|||+   .+++||||+|+||+++++
T Consensus        77 -~~~~~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~  142 (267)
T cd06628          77 -DADHLNIFLEYVPGGSVAALLNNYG----------AFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNK  142 (267)
T ss_pred             -eCCccEEEEEecCCCCHHHHHHhcc----------CccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCC
Confidence             3457889999999999999986432          26778889999999999999998   699999999999999999


Q ss_pred             CcEEEccccccccCCCccCCC--ceeeccccccccccCcccCCCCCCCC
Q 035691          593 MIAHVGDFGLTRFIPEVISSN--QCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       593 ~~~kl~DfGla~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +.+||+|||.++.........  ........|+..|+|||.+.+..++.
T Consensus       143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~  191 (267)
T cd06628         143 GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTR  191 (267)
T ss_pred             CCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCc
Confidence            999999999998764221110  11111245889999999998877654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.92  E-value=7.1e-25  Score=224.03  Aligned_cols=181  Identities=26%  Similarity=0.386  Sum_probs=145.7

Q ss_pred             CCCcccCcccccccceEEEEEE-----CCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcC
Q 035691          441 GGFSSANLIGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQ  513 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  513 (640)
                      ++|.+.+.||+|+||.||+|.+     ..++..||||.++... ....+.+.+|+++++++ +||||++++++|..    
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----  110 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI----  110 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec----
Confidence            4588889999999999999975     3356689999986443 33446789999999999 79999999998643    


Q ss_pred             CCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC
Q 035691          514 GNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM  593 (640)
Q Consensus       514 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~  593 (640)
                       .+..++||||+++|+|.+++.....        ..+++.++..++.|++.|++|||+   .+|+|+||||+||++++++
T Consensus       111 -~~~~~lv~e~~~~~~L~~~i~~~~~--------~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~  178 (302)
T cd05055         111 -GGPILVITEYCCYGDLLNFLRRKRE--------SFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGK  178 (302)
T ss_pred             -CCceEEEEEcCCCCcHHHHHHhCCC--------CCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCC
Confidence             3468999999999999999864332        227889999999999999999999   6999999999999999999


Q ss_pred             cEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          594 IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       594 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      .+|++|||+++........  .......+++.|+|||.+.+..++.
T Consensus       179 ~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~  222 (302)
T cd05055         179 IVKICDFGLARDIMNDSNY--VVKGNARLPVKWMAPESIFNCVYTF  222 (302)
T ss_pred             eEEECCCcccccccCCCce--eecCCCCcccccCCHhhhccCCCCc
Confidence            9999999999865432211  1111234678899999998877664

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.92  E-value=7.9e-25  Score=219.72  Aligned_cols=181  Identities=24%  Similarity=0.449  Sum_probs=144.9

Q ss_pred             CCCcccCcccccccceEEEEEECCCCe---EEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQT---VVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ++|+..+.||+|+||.||+|+.+.++.   .||+|.++.. .....+.+..|++++++++||||+++.+++.     ..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   79 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KFK   79 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cCC
Confidence            467788999999999999999875554   7999998644 2334567899999999999999999999964     344


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++++|.+++.....         .+++.++..++.|++.|++|||+   .+++||||||+||++++++.+|
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~k  147 (268)
T cd05063          80 PAMIITEYMENGALDKYLRDHDG---------EFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECK  147 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEE
Confidence            68999999999999999864321         37888999999999999999998   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ++|||+++......... ........++.|+|||++.+..++.
T Consensus       148 l~dfg~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~  189 (268)
T cd05063         148 VSDFGLSRVLEDDPEGT-YTTSGGKIPIRWTAPEAIAYRKFTS  189 (268)
T ss_pred             ECCCccceecccccccc-eeccCCCcCceecCHHHhhcCCcCh
Confidence            99999998664322111 1111122356799999998877654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.92  E-value=8.3e-25  Score=221.84  Aligned_cols=175  Identities=23%  Similarity=0.340  Sum_probs=145.1

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      +|++.+.||+|+||.||+|.+..++..||+|.+... .......+.+|++++++++||||+++++++     ......++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~l   76 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF-----FIEGAVYM   76 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-----ecCCeEEE
Confidence            577889999999999999999989999999988643 233446789999999999999999999984     34557899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||+++++|.+++......       ..+++..+..++.|++.|+.|||+.  .+|+||||||+||+++.++.+||+||
T Consensus        77 v~e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~df  147 (286)
T cd06622          77 CMEYMDAGSLDKLYAGGVAT-------EGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDF  147 (286)
T ss_pred             EEeecCCCCHHHHHHhcccc-------CCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeec
Confidence            99999999999888653211       2478899999999999999999963  58999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      |+++.+....      .....|++.|+|||.+.+..
T Consensus       148 g~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~  177 (286)
T cd06622         148 GVSGNLVASL------AKTNIGCQSYMAPERIKSGG  177 (286)
T ss_pred             CCcccccCCc------cccCCCccCccCcchhcCCC
Confidence            9997653221      11235788999999986544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.92  E-value=6.2e-25  Score=221.20  Aligned_cols=162  Identities=25%  Similarity=0.374  Sum_probs=129.8

Q ss_pred             cccccccceEEEEEECCC------------------------CeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcce
Q 035691          448 LIGTGSFGSVYKGILDPD------------------------QTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKI  503 (640)
Q Consensus       448 ~lg~G~~g~Vy~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l  503 (640)
                      .||+|+||.||+|....+                        ...||+|++..........|.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            589999999999985321                        23588998865544445678899999999999999999


Q ss_pred             eEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCC
Q 035691          504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLK  583 (640)
Q Consensus       504 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlk  583 (640)
                      +++|..     ....++||||+++|+|..++....         ..+++..+..++.|++.||+|||+   ++|+|||||
T Consensus        82 ~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlk  144 (274)
T cd05076          82 HGVCVR-----GSENIMVEEFVEHGPLDVCLRKEK---------GRVPVAWKITVAQQLASALSYLED---KNLVHGNVC  144 (274)
T ss_pred             EEEEEe-----CCceEEEEecCCCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCC
Confidence            999743     346789999999999999886432         237788899999999999999998   799999999


Q ss_pred             CCCeeeCCCC-------cEEEccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          584 PSNVLLDNDM-------IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       584 p~NiLl~~~~-------~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      |+||+++..+       .+|++|||.+......        ....++..|+|||.+.+
T Consensus       145 p~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~--------~~~~~~~~~~aPe~~~~  194 (274)
T cd05076         145 AKNILLARLGLAEGTSPFIKLSDPGVSFTALSR--------EERVERIPWIAPECVPG  194 (274)
T ss_pred             cccEEEeccCcccCccceeeecCCccccccccc--------cccccCCcccCchhhcC
Confidence            9999997643       4899999998643211        11246788999998875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.92  E-value=1.4e-24  Score=219.33  Aligned_cols=179  Identities=26%  Similarity=0.418  Sum_probs=144.6

Q ss_pred             CCCcccCcccccccceEEEEEECCCCe----EEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQT----VVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      .+|++.+.||+|+||.||+|.++.+|.    .||+|...... ......+.+|+.++++++||||++++++|..      
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence            457888999999999999999876654    58999885443 3344678999999999999999999999743      


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      ...++||||+++|+|.+++.....         .+++..+..++.|++.|++|||+   .+++||||||+||++++++.+
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~  148 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKD---------NIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHV  148 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeE
Confidence            367899999999999999865432         27888999999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+|||.++........  .......++..|+|||.+.+..++.
T Consensus       149 kL~dfg~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~  190 (279)
T cd05057         149 KITDFGLAKLLDVDEKE--YHAEGGKVPIKWMALESILHRIYTH  190 (279)
T ss_pred             EECCCcccccccCcccc--eecCCCcccccccCHHHhhcCCcCc
Confidence            99999999876432111  1111222467899999987776654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.92  E-value=1.1e-24  Score=223.09  Aligned_cols=190  Identities=23%  Similarity=0.380  Sum_probs=146.8

Q ss_pred             cCCCcccCcccccccceEEEEEEC-------CCCeEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCCcceeEeeccC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILD-------PDQTVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRNLVKIITACSSS  510 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  510 (640)
                      .++|++.+.||+|+||.||+|++.       .++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++.  
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--   91 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--   91 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe--
Confidence            456778899999999999999752       244579999885432 33456789999999999 8999999999864  


Q ss_pred             CcCCCceeeEEeeccCCCChhhhcCCCCCCCCC------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCC
Q 035691          511 DFQGNDFKALVYEFMHHGSLESWLHPESASDDL------NYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKP  584 (640)
Q Consensus       511 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp  584 (640)
                         .....++||||+++|+|.+++.........      ......+++.++..++.|++.|++|||+   .+++||||||
T Consensus        92 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp  165 (304)
T cd05101          92 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAA  165 (304)
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeeccccc
Confidence               344789999999999999998654321100      0112357888999999999999999999   6999999999


Q ss_pred             CCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          585 SNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       585 ~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +||++++++.+||+|||+++.+......  .......+++.|+|||++.+..++.
T Consensus       166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~  218 (304)
T cd05101         166 RNVLVTENNVMKIADFGLARDVNNIDYY--KKTTNGRLPVKWMAPEALFDRVYTH  218 (304)
T ss_pred             ceEEEcCCCcEEECCCccceeccccccc--ccccCCCCCceeeCchhhccCCCCc
Confidence            9999999999999999999866432211  1111234577899999998877764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.92  E-value=1e-24  Score=221.01  Aligned_cols=175  Identities=26%  Similarity=0.417  Sum_probs=142.5

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +|++.+.||+|+||.||+|+.+.+++.||+|++....  ....+.+.+|+.++++++||||+++++++.     .+...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence            4778899999999999999999899999999986432  233467889999999999999999999953     445789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||++ +++.+++......       ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|
T Consensus        76 ~v~e~~~-~~l~~~~~~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~d  144 (285)
T cd07861          76 LIFEFLS-MDLKKYLDSLPKG-------QYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLAD  144 (285)
T ss_pred             EEEecCC-CCHHHHHhcCCCC-------CcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECc
Confidence            9999997 6888887543321       237888999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      ||+++.......    ......+++.|+|||++.+..
T Consensus       145 fg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~  177 (285)
T cd07861         145 FGLARAFGIPVR----VYTHEVVTLWYRAPEVLLGSP  177 (285)
T ss_pred             ccceeecCCCcc----cccCCcccccccChHHhcCCC
Confidence            999975532211    111234788999999987643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.92  E-value=1.3e-24  Score=222.53  Aligned_cols=182  Identities=24%  Similarity=0.327  Sum_probs=147.1

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|+..+.||+|+||.||+|.+..+++.||+|.+....   ....+.+.+|+++++.++||||+++++.+     ..+..
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH   75 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence            36788899999999999999999999999999986443   23346788999999999999999999885     34557


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++....          .+++..+..++.|++.|++|||+   .+++||||||+||+++.++.+|+
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l  142 (305)
T cd05609          76 LCMVMEYVEGGDCATLLKNIG----------ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKL  142 (305)
T ss_pred             EEEEEecCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEE
Confidence            899999999999999985432          26788889999999999999998   69999999999999999999999


Q ss_pred             ccccccccCCCccCC-----------CceeeccccccccccCcccCCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISS-----------NQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       598 ~DfGla~~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||+++........           .........|+..|+|||.+.+..++.+
T Consensus       143 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  196 (305)
T cd05609         143 TDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP  196 (305)
T ss_pred             eeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCch
Confidence            999998742110000           0011112457889999999987776653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.92  E-value=1.4e-24  Score=221.37  Aligned_cols=186  Identities=26%  Similarity=0.400  Sum_probs=144.1

Q ss_pred             CCCcccCcccccccceEEEEEECCCCe--EEEEEEeecc-cchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCc
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQT--VVAVKVLFLH-QRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ++|++.+.||+|+||.||+|+.+.++.  .+|+|.++.. .....+.+.+|++++.++ +||||+++++++.     ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE-----NRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-----cCC
Confidence            468888999999999999999876665  4688887532 233456789999999999 7999999999854     344


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCC------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDD------LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD  590 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~  590 (640)
                      ..++||||+++|+|.+++........      .......+++..+..++.|++.|++|||+   .+|+||||||+||+++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~  153 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVG  153 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEEC
Confidence            68999999999999999865332110      01112358889999999999999999998   6999999999999999


Q ss_pred             CCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          591 NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       591 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +++.+||+|||++.......     .......+..|+|||++.+..++.
T Consensus       154 ~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~  197 (297)
T cd05089         154 ENLASKIADFGLSRGEEVYV-----KKTMGRLPVRWMAIESLNYSVYTT  197 (297)
T ss_pred             CCCeEEECCcCCCcccccee-----ccCCCCcCccccCchhhccCCCCc
Confidence            99999999999987432111     111112356799999998877664

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.92  E-value=7.6e-25  Score=221.75  Aligned_cols=189  Identities=23%  Similarity=0.307  Sum_probs=145.0

Q ss_pred             CCcccCcccccccceEEEEEECC-----CCeEEEEEEeecccch-hHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          442 GFSSANLIGTGSFGSVYKGILDP-----DQTVVAVKVLFLHQRG-ALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      +|++.+.||+|+||.||+|++..     ++..||+|++...... ..+.+.+|+.++..++||||+++++++.     ..
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~   80 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-----KE   80 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC
Confidence            35667889999999999998743     3578999999644332 3467889999999999999999999964     33


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCC------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDD------LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL  589 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl  589 (640)
                      ...++++||+++++|.+++........      .......+++..+..++.|++.||+|+|+   .+|+||||||+||++
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~  157 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLV  157 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEe
Confidence            468899999999999999853221110      00112347888899999999999999998   699999999999999


Q ss_pred             CCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          590 DNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       590 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ++++.+||+|||+++.......  ........+++.|+|||.+.++.++.+
T Consensus       158 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~  206 (283)
T cd05091         158 FDKLNVKISDLGLFREVYAADY--YKLMGNSLLPIRWMSPEAIMYGKFSID  206 (283)
T ss_pred             cCCCceEecccccccccccchh--eeeccCccCCccccCHHHHhcCCCCcc
Confidence            9999999999999986533211  111122346789999999988777653

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.92  E-value=1.1e-24  Score=222.18  Aligned_cols=190  Identities=21%  Similarity=0.336  Sum_probs=146.4

Q ss_pred             CCCcccCcccccccceEEEEEEC----------------CCCeEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILD----------------PDQTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKI  503 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l  503 (640)
                      ++|++.+.||+|+||.||+|.+.                .++..||+|++... .....+.+.+|+++++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46888999999999999998643                23457999998643 23345689999999999999999999


Q ss_pred             eEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCC
Q 035691          504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDL-NYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDL  582 (640)
Q Consensus       504 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdl  582 (640)
                      ++++.     ..+..++||||+++|+|.+++......... ......+++.++..++.|++.|++|||+   .+++||||
T Consensus        85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl  156 (296)
T cd05095          85 LAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDL  156 (296)
T ss_pred             EEEEe-----cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccC
Confidence            99953     344689999999999999998654322111 1122347888999999999999999999   69999999


Q ss_pred             CCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          583 KPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       583 kp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ||+||+++.++.+|++|||+++.+.....  ........+++.|+|||+..++.++.+
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~  212 (296)
T cd05095         157 ATRNCLVGKNYTIKIADFGMSRNLYSGDY--YRIQGRAVLPIRWMSWESILLGKFTTA  212 (296)
T ss_pred             ChheEEEcCCCCEEeccCcccccccCCcc--eeccCcCcCccccCCHHHHhcCCccch
Confidence            99999999999999999999986532211  011111234678999999888777653

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=4.1e-26  Score=222.24  Aligned_cols=181  Identities=25%  Similarity=0.295  Sum_probs=150.9

Q ss_pred             HHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCc
Q 035691          437 LKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNI-RHRNLVKIITACSSSDF  512 (640)
Q Consensus       437 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  512 (640)
                      .....+|....+||+|+||+|..|..+.+.+.||||+++..   +....+.-+.|-++|+.- +.|.+++++.+     |
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-----F  419 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-----F  419 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-----h
Confidence            34456788899999999999999999999999999999543   334556677888888876 67888888877     6


Q ss_pred             CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC
Q 035691          513 QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND  592 (640)
Q Consensus       513 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~  592 (640)
                      ++-+..|+||||+.||+|.-.++..+.          +.+..+..+|.+||-||-|||+   ++|++||||.+||++|.+
T Consensus       420 QTmDRLyFVMEyvnGGDLMyhiQQ~Gk----------FKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~e  486 (683)
T KOG0696|consen  420 QTMDRLYFVMEYVNGGDLMYHIQQVGK----------FKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSE  486 (683)
T ss_pred             hhhhheeeEEEEecCchhhhHHHHhcc----------cCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccC
Confidence            777799999999999999888875543          5556778899999999999999   899999999999999999


Q ss_pred             CcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          593 MIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       593 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |++||+|||+++.-.    ....++.+++|||.|+|||++...+|+.
T Consensus       487 GHiKi~DFGmcKEni----~~~~TTkTFCGTPdYiAPEIi~YqPYgk  529 (683)
T KOG0696|consen  487 GHIKIADFGMCKENI----FDGVTTKTFCGTPDYIAPEIIAYQPYGK  529 (683)
T ss_pred             CceEeeecccccccc----cCCcceeeecCCCcccccceEEeccccc
Confidence            999999999998421    1233456789999999999998887753

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.92  E-value=1.2e-24  Score=217.59  Aligned_cols=167  Identities=26%  Similarity=0.435  Sum_probs=133.3

Q ss_pred             CcccccccceEEEEEECC------------CCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCC
Q 035691          447 NLIGTGSFGSVYKGILDP------------DQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  514 (640)
                      +.||+|+||.||+|+...            ....||+|++..........|.+|+.+++.++||||+++++++..     
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~-----   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR-----   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence            468999999999998542            223588998866555555788999999999999999999999643     


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                      +...++||||+++|+|..++.....         .+++..+..++.||+.||+|||+   ++|+||||||+||+++.++.
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~  143 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRKSD---------VLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGI  143 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCc
Confidence            3467899999999999988764322         27888899999999999999998   79999999999999987654


Q ss_pred             -------EEEccccccccCCCccCCCceeeccccccccccCcccCCC-CCCC
Q 035691          595 -------AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG-SQVS  638 (640)
Q Consensus       595 -------~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s  638 (640)
                             +|++|||++......        ....|+..|+|||.+.+ ..++
T Consensus       144 ~~~~~~~~~l~d~g~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~  187 (262)
T cd05077         144 DGECGPFIKLSDPGIPITVLSR--------QECVERIPWIAPECVEDSKNLS  187 (262)
T ss_pred             cCCCCceeEeCCCCCCccccCc--------ccccccccccChhhhcCCCCCC
Confidence                   899999998754211        12347889999998863 3343

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.92  E-value=1.2e-24  Score=224.07  Aligned_cols=179  Identities=24%  Similarity=0.351  Sum_probs=136.4

Q ss_pred             CcccccccceEEEEEECC--CCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEeec
Q 035691          447 NLIGTGSFGSVYKGILDP--DQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEF  524 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~  524 (640)
                      ..||+|+||.||+|+.+.  ++..||+|.+....  ....+.+|++++++++||||+++++++...   .+...++||||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~   81 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFDY   81 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEee
Confidence            579999999999999753  56789999885332  234678999999999999999999987432   24568999999


Q ss_pred             cCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee----CCCCcEEEccc
Q 035691          525 MHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL----DNDMIAHVGDF  600 (640)
Q Consensus       525 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl----~~~~~~kl~Df  600 (640)
                      +++ ++.+++........ ......+++..+..++.|++.||+|||+   .+|+||||||+||++    +.++.+||+||
T Consensus        82 ~~~-~l~~~~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          82 AEH-DLWHIIKFHRASKA-NKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eCC-cHHHHHHhhhcccc-CCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            875 77777653322111 1112347888999999999999999999   699999999999999    56689999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      |+++........ ........||+.|+|||++.+..
T Consensus       157 G~a~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~  191 (317)
T cd07867         157 GFARLFNSPLKP-LADLDPVVVTFWYRAPELLLGAR  191 (317)
T ss_pred             cceeccCCCccc-ccccCcceecccccCcHHhcCCC
Confidence            999876432211 11223356899999999987743

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.92  E-value=1.1e-24  Score=219.83  Aligned_cols=188  Identities=24%  Similarity=0.361  Sum_probs=146.9

Q ss_pred             cCCCcccCcccccccceEEEEEECC-----CCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDP-----DQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQ  513 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  513 (640)
                      +++|++.+.||+|+||.||+|.+..     ++..||+|.+.... ......|..|+.+++.++|+||+++++++..    
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----   80 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE----   80 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----
Confidence            4568888999999999999999976     67889999885433 3334678999999999999999999998543    


Q ss_pred             CCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC
Q 035691          514 GNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM  593 (640)
Q Consensus       514 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~  593 (640)
                       ....++||||+++|+|.+++...+....   ....+++..+..++.||+.|++|||+   .+++||||||+||+++.++
T Consensus        81 -~~~~~lv~e~~~g~~L~~~i~~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~  153 (277)
T cd05036          81 -RLPRFILLELMAGGDLKSFLRENRPRPE---RPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKG  153 (277)
T ss_pred             -CCCcEEEEecCCCCCHHHHHHHhCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccC
Confidence             3467899999999999999865542211   12348899999999999999999999   6999999999999998754


Q ss_pred             ---cEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          594 ---IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       594 ---~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                         .+|++|||+++.......  ........++..|+|||++.+..++.|
T Consensus       154 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~  201 (277)
T cd05036         154 PGRVAKIADFGMARDIYRASY--YRKGGRAMLPIKWMPPEAFLDGIFTSK  201 (277)
T ss_pred             CCcceEeccCccccccCCccc--eecCCCCCccHhhCCHHHHhcCCcCch
Confidence               699999999986532111  011111223568999999988877653

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.92  E-value=1.4e-24  Score=219.38  Aligned_cols=190  Identities=27%  Similarity=0.414  Sum_probs=148.6

Q ss_pred             CCCcccCcccccccceEEEEEEC-----CCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILD-----PDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      .+|+..+.||+|+||.||+|...     .++..||+|.+........+.+.+|+++++.++|+||+++++++.     ..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT-----EG   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe-----cC
Confidence            35677899999999999999742     356789999987665566678999999999999999999999854     34


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCC-----CCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASD-----DLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD  590 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~-----~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~  590 (640)
                      ...++||||+++|+|.+++.......     ........+++.+++.++.|++.|++|||+   .+++||||||+||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~  156 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVG  156 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEc
Confidence            46899999999999999986543210     011112347889999999999999999998   6999999999999999


Q ss_pred             CCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          591 NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       591 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +++.+||+|||+++.+.....  ........+++.|+|||++.+..++.|
T Consensus       157 ~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~  204 (280)
T cd05092         157 QGLVVKIGDFGMSRDIYSTDY--YRVGGRTMLPIRWMPPESILYRKFTTE  204 (280)
T ss_pred             CCCCEEECCCCceeEcCCCce--eecCCCccccccccCHHHhccCCcCch
Confidence            999999999999975532111  111112335788999999988877653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.92  E-value=1.1e-24  Score=220.54  Aligned_cols=187  Identities=25%  Similarity=0.345  Sum_probs=152.0

Q ss_pred             cCHHHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCCcceeEeecc
Q 035691          431 VSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-RHRNLVKIITACSS  509 (640)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  509 (640)
                      .++.++....+.|++.+.||+|+||.||+|++..+++.||+|++..... ....+..|+.+++++ +||||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            3566666778889999999999999999999998999999999865432 335688899999998 79999999998753


Q ss_pred             CCc-CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCee
Q 035691          510 SDF-QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVL  588 (640)
Q Consensus       510 ~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiL  588 (640)
                      ... ......++||||+++|+|.+++.....        ..+++..+..++.|++.|+.|||+   .+|+|||+||+||+
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nil  153 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--------NALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVL  153 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccC--------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEE
Confidence            321 234578999999999999998865332        236778889999999999999999   69999999999999


Q ss_pred             eCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCC
Q 035691          589 LDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGM  633 (640)
Q Consensus       589 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  633 (640)
                      +++++.+||+|||+++.......    ......|++.|+|||++.
T Consensus       154 i~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~l~  194 (282)
T cd06636         154 LTENAEVKLVDFGVSAQLDRTVG----RRNTFIGTPYWMAPEVIA  194 (282)
T ss_pred             ECCCCCEEEeeCcchhhhhcccc----CCCcccccccccCHhhcC
Confidence            99999999999999886532111    112345899999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.92  E-value=2.4e-25  Score=222.29  Aligned_cols=176  Identities=37%  Similarity=0.539  Sum_probs=138.5

Q ss_pred             ccCcccccccceEEEEEEC----CCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          445 SANLIGTGSFGSVYKGILD----PDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       445 ~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ..+.||+|+||.||+|.+.    ..+..|+||.++... ....+.|.+|++.+++++||||++++|+|..     ....+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-----~~~~~   77 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-----NEPLF   77 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-----SSSEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc-----ccccc
Confidence            4578999999999999987    446789999995433 3346889999999999999999999999862     23588


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++|+|.+++.....        ..+++.+++.|+.|++.||.|||+   .+++|+||+++||+++.++.+||+|
T Consensus        78 lv~e~~~~g~L~~~L~~~~~--------~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~  146 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNK--------EPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSD  146 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCT--------TTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEES
T ss_pred             cccccccccccccccccccc--------cccccccccccccccccccccccc---ccccccccccccccccccccccccc
Confidence            99999999999999976522        348899999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      ||+++.......  ........+...|+|||.+.+..++
T Consensus       147 f~~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~  183 (259)
T PF07714_consen  147 FGLSRPISEKSK--YKNDSSQQLPLRYLAPEVLKDGEYT  183 (259)
T ss_dssp             TTTGEETTTSSS--EEESTTSESGGGGS-HHHHHHSEES
T ss_pred             cccccccccccc--ccccccccccccccccccccccccc
Confidence            999986622111  1112223467899999998776554

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.92  E-value=1.1e-24  Score=221.85  Aligned_cols=193  Identities=25%  Similarity=0.392  Sum_probs=148.2

Q ss_pred             HhcCCCcccCcccccccceEEEEEECCC-----CeEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCCcceeEeeccC
Q 035691          438 KATGGFSSANLIGTGSFGSVYKGILDPD-----QTVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRNLVKIITACSSS  510 (640)
Q Consensus       438 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  510 (640)
                      ...++|+..+.||+|+||.||+|.....     ...||+|.+.... ......+.+|+++++++ +|+||++++++|.. 
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-   87 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-   87 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC-
Confidence            3445688889999999999999987633     3789999986432 23346788999999999 89999999999643 


Q ss_pred             CcCCCceeeEEeeccCCCChhhhcCCCCCCCC------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCC
Q 035691          511 DFQGNDFKALVYEFMHHGSLESWLHPESASDD------LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKP  584 (640)
Q Consensus       511 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp  584 (640)
                          +...++||||+++|+|.+++........      .......+++..++.++.|++.|+.|||+   .+|+||||||
T Consensus        88 ----~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp  160 (293)
T cd05053          88 ----EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAA  160 (293)
T ss_pred             ----CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccce
Confidence                3468999999999999999865321100      00122458899999999999999999998   6999999999


Q ss_pred             CCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          585 SNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       585 ~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +||++++++.+|++|||+++.+........  .....++..|+|||++.+..++.+
T Consensus       161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~  214 (293)
T cd05053         161 RNVLVTEDHVMKIADFGLARDIHHIDYYRK--TTNGRLPVKWMAPEALFDRVYTHQ  214 (293)
T ss_pred             eeEEEcCCCeEEeCccccccccccccceec--cCCCCCCccccCHHHhccCCcCcc
Confidence            999999999999999999986643211111  111235678999999887766643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.92  E-value=4.9e-25  Score=224.10  Aligned_cols=172  Identities=27%  Similarity=0.340  Sum_probs=144.0

Q ss_pred             ccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEeec
Q 035691          445 SANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEF  524 (640)
Q Consensus       445 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~  524 (640)
                      ....||+|+||.||++....++..||||.+........+.+.+|+.+++.++||||+++++.+.     ..+..++||||
T Consensus        26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~lv~e~  100 (292)
T cd06658          26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWVVMEF  100 (292)
T ss_pred             hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEEEEeC
Confidence            3467999999999999998889999999986655555677899999999999999999999853     44578999999


Q ss_pred             cCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccccc
Q 035691          525 MHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR  604 (640)
Q Consensus       525 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~  604 (640)
                      +++++|.+++...           .+++..+..++.|++.|++|||+   .+|+||||||+||++++++.+||+|||++.
T Consensus       101 ~~~~~L~~~~~~~-----------~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~  166 (292)
T cd06658         101 LEGGALTDIVTHT-----------RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCA  166 (292)
T ss_pred             CCCCcHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchh
Confidence            9999999987432           26778899999999999999999   699999999999999999999999999987


Q ss_pred             cCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          605 FIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       605 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      .......    ......|+..|+|||.+.+..++.
T Consensus       167 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~  197 (292)
T cd06658         167 QVSKEVP----KRKSLVGTPYWMAPEVISRLPYGT  197 (292)
T ss_pred             hcccccc----cCceeecCccccCHHHHccCCCCc
Confidence            6532211    112245899999999998776664

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.92  E-value=1.3e-24  Score=217.18  Aligned_cols=177  Identities=27%  Similarity=0.496  Sum_probs=143.3

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      ++|++.+.||+|+||.||+|... ++..||+|.+..... ..+.+.+|+.++++++|++++++++++.      ....++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~l   77 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS------EEPIYI   77 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC------CCCcEE
Confidence            46788899999999999999876 667799999864333 3467999999999999999999998852      234689


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||+++++|.+++.....        ..+++.++..++.|++.|++|||+   .+++||||||+||++++++.+||+||
T Consensus        78 v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~df  146 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGEG--------RALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADF  146 (260)
T ss_pred             EEEecCCCcHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCc
Confidence            9999999999999864322        237888999999999999999999   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |.++.+......   ......++..|+|||++.+.+++.
T Consensus       147 g~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~  182 (260)
T cd05070         147 GLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTI  182 (260)
T ss_pred             eeeeeccCcccc---cccCCCCCccccChHHHhcCCCcc
Confidence            999865432111   111223567899999988777664

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.92  E-value=1e-24  Score=226.50  Aligned_cols=179  Identities=25%  Similarity=0.361  Sum_probs=146.4

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      +++|++.+.||+|+||.||+|++..+|+.||+|++... .......+.+|+.++++++||||+++++++....+......
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46799999999999999999999989999999998543 23344678899999999999999999998766655555678


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||+++ ++..++...           .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+
T Consensus        84 ~lv~e~~~~-~l~~~~~~~-----------~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~  148 (336)
T cd07849          84 YIVQELMET-DLYKLIKTQ-----------HLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKIC  148 (336)
T ss_pred             EEEehhccc-CHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEC
Confidence            999999974 887776432           27888899999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      |||+++........ ........||+.|+|||.+.+
T Consensus       149 dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~  183 (336)
T cd07849         149 DFGLARIADPEHDH-TGFLTEYVATRWYRAPEIMLN  183 (336)
T ss_pred             cccceeeccccccc-cCCcCCcCcCCCccChHHhhC
Confidence            99999865332111 111223568999999998765

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.92  E-value=9.4e-25  Score=221.21  Aligned_cols=176  Identities=27%  Similarity=0.359  Sum_probs=146.9

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ++|++.+.||+|+||+||+|....+|+.||+|++.... ....+.+.+|+++++.++||||+++++++.     .....+
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   79 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENNIC   79 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCEEE
Confidence            45777899999999999999999899999999886443 334578899999999999999999999954     345789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++|+|.+++...+          .+++..+..++.|++.|+.|||+.  .+++||||||+||++++++.++|+|
T Consensus        80 lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d  147 (284)
T cd06620          80 MCMEFMDCGSLDRIYKKGG----------PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCD  147 (284)
T ss_pred             EEEecCCCCCHHHHHHhcc----------CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEcc
Confidence            9999999999999875432          278888999999999999999973  4899999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+++......      .....|+..|+|||++.+..++.
T Consensus       148 ~gl~~~~~~~~------~~~~~~~~~~~aPE~~~~~~~~~  181 (284)
T cd06620         148 FGVSGELINSI------ADTFVGTSTYMSPERIQGGKYTV  181 (284)
T ss_pred             CCcccchhhhc------cCccccCcccCCHHHHccCCCCc
Confidence            99987542211      11245899999999998877664

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.92  E-value=2.5e-24  Score=215.43  Aligned_cols=177  Identities=29%  Similarity=0.432  Sum_probs=146.7

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +|+..+.||+|+||.||+|....+++.||+|.++....  ...+.+.+|+.+++.++|+||+++++++     ...+..+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence            47788999999999999999988999999999965544  3567899999999999999999999984     3445789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +|+||+++++|.+++....          .+++..+..++.|++.|++|||+   .+++|+||+|+||++++++.+||+|
T Consensus        76 lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d  142 (264)
T cd06626          76 IFMEYCSGGTLEELLEHGR----------ILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGD  142 (264)
T ss_pred             EEEecCCCCcHHHHHhhcC----------CCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcc
Confidence            9999999999999986432          26677889999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      ||.+..................+++.|+|||++.+..
T Consensus       143 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~  179 (264)
T cd06626         143 FGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK  179 (264)
T ss_pred             cccccccCCCCCcccccccCCcCCcCccChhhccCCC
Confidence            9999876432221111012345788999999987765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.92  E-value=1.5e-24  Score=219.58  Aligned_cols=179  Identities=30%  Similarity=0.420  Sum_probs=143.0

Q ss_pred             cccCcccccccceEEEEEE----CCCCeEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          444 SSANLIGTGSFGSVYKGIL----DPDQTVVAVKVLFLHQR-GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       444 ~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      +..+.||+|+||+||++..    ..++..||+|.++.... .....+.+|++++++++||||++++++|...   .....
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~~   83 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ---GGKGL   83 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CCceE
Confidence            7789999999999987653    35678999999865432 3456788999999999999999999987432   23467


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||+++|+|.+++...           .+++.++..++.|++.|+.|||+   .+|+||||||+||++++++.+||+
T Consensus        84 ~lv~e~~~~~~l~~~~~~~-----------~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~  149 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH-----------KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIG  149 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc-----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEe
Confidence            8999999999999998532           27889999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |||+++.+........ ......++..|+|||.+.+..++.|
T Consensus       150 dfg~~~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~  190 (283)
T cd05080         150 DFGLAKAVPEGHEYYR-VREDGDSPVFWYAVECLKENKFSYA  190 (283)
T ss_pred             ecccccccCCcchhhc-cCCCCCCCceeeCHhHhcccCCCcc
Confidence            9999987643221110 1111235678999999987776643

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.92  E-value=1.8e-24  Score=215.53  Aligned_cols=173  Identities=32%  Similarity=0.437  Sum_probs=141.9

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      .+|++.+.||+|+||.||+|..+  |..||+|.++..  ...+.+.+|+.++++++|++++++++++.    ..+...++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~l   77 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYI   77 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEE----cCCCceEE
Confidence            35788899999999999999874  788999988533  23467899999999999999999999753    23456799


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||+++|+|.+++.....        ..+++..+..++.|++.|++|||+   .+++||||||+||++++++.+|++||
T Consensus        78 v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df  146 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGR--------SVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDF  146 (256)
T ss_pred             EEECCCCCcHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCC
Confidence            9999999999999865332        237888999999999999999998   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+++......       ....++..|+|||++.+..++.
T Consensus       147 g~~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~  178 (256)
T cd05082         147 GLTKEASSTQ-------DTGKLPVKWTAPEALREKKFST  178 (256)
T ss_pred             ccceeccccC-------CCCccceeecCHHHHccCCCCc
Confidence            9988543211       1123467899999998877664

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.92  E-value=2e-24  Score=215.21  Aligned_cols=174  Identities=33%  Similarity=0.494  Sum_probs=145.1

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .++|++.+.||+|+||.||+|...  |+.||+|.+..... ..+.+.+|+.++++++|+||+++++++..     ....+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   76 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLY   76 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeE
Confidence            346788899999999999999874  78899999965443 45789999999999999999999999543     45789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++++|.+++.....        ..+++..+..++.|++.|+.|||+   .+++||||||+||++++++.+||+|
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d  145 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGR--------AVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSD  145 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcc
Confidence            99999999999999865432        237889999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||.++.......       ...++..|+|||++.++.++.
T Consensus       146 ~g~~~~~~~~~~-------~~~~~~~~~ape~~~~~~~~~  178 (256)
T cd05039         146 FGLAKEASQGQD-------SGKLPVKWTAPEALREKKFST  178 (256)
T ss_pred             cccccccccccc-------cCCCcccccCchhhcCCcCCc
Confidence            999986532111       123466899999998777654

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.92  E-value=1.7e-24  Score=219.96  Aligned_cols=188  Identities=27%  Similarity=0.362  Sum_probs=143.8

Q ss_pred             CCcccCcccccccceEEEEEECC-----CCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          442 GFSSANLIGTGSFGSVYKGILDP-----DQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      +|++.+.||+|+||.||+|+...     ....+|+|.+.... ....+.+.+|+.+++.++||||+++++.|..     +
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ-----D   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----C
Confidence            46778999999999999998742     23578898885433 2334678999999999999999999998643     3


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCC--------------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCC
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDD--------------LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCD  581 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~--------------~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrd  581 (640)
                      +..++||||+++|+|.+++........              .......+++.+++.++.|++.|++|||+   .+++|||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~d  152 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRD  152 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhh
Confidence            467899999999999998864321100              00112347889999999999999999998   6999999


Q ss_pred             CCCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          582 LKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       582 lkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |||+||++++++.+||+|||+++........  .......++..|+|||.+.+..++.
T Consensus       153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~  208 (290)
T cd05045         153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSY--VKRSKGRIPVKWMAIESLFDHIYTT  208 (290)
T ss_pred             hhhheEEEcCCCcEEeccccccccccCccch--hcccCCCCCccccCHHHHccCCcch
Confidence            9999999999999999999999865322111  1111223567899999987776654

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.92  E-value=9.5e-25  Score=220.30  Aligned_cols=174  Identities=26%  Similarity=0.377  Sum_probs=145.1

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEE
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALV  521 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv  521 (640)
                      |+..+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|++++++++||||+++++++     ......++|
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv   80 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKLWII   80 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCceEEE
Confidence            556678999999999999998889999999986443 34456789999999999999999999985     345578999


Q ss_pred             eeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccc
Q 035691          522 YEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG  601 (640)
Q Consensus       522 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfG  601 (640)
                      |||+++++|.+++...           .+++..+..++.|++.|+.|||+   .+++|+||+|+||++++++.+|++|||
T Consensus        81 ~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg  146 (277)
T cd06642          81 MEYLGGGSALDLLKPG-----------PLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFG  146 (277)
T ss_pred             EEccCCCcHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEcccc
Confidence            9999999999988532           26778899999999999999998   699999999999999999999999999


Q ss_pred             ccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          602 LTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       602 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +++.+....    .......|+..|+|||++.+..++.
T Consensus       147 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~  180 (277)
T cd06642         147 VAGQLTDTQ----IKRNTFVGTPFWMAPEVIKQSAYDF  180 (277)
T ss_pred             ccccccCcc----hhhhcccCcccccCHHHhCcCCCch
Confidence            998654321    1112235788999999998877654

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.92  E-value=2.7e-24  Score=214.46  Aligned_cols=172  Identities=26%  Similarity=0.390  Sum_probs=137.6

Q ss_pred             cccccccceEEEEEE--CCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEee
Q 035691          448 LIGTGSFGSVYKGIL--DPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYE  523 (640)
Q Consensus       448 ~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e  523 (640)
                      .||+|+||.||+|.+  ..++..||+|+++...  ....+.+.+|+.+++.++||||+++++++.      .+..++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence            589999999999975  4567899999986443  234568999999999999999999999863      234689999


Q ss_pred             ccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccccc
Q 035691          524 FMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT  603 (640)
Q Consensus       524 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla  603 (640)
                      |+++|+|.+++....          .+++..+..++.|++.|++|+|+   ++|+||||||+||++++++.+||+|||++
T Consensus        76 ~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~  142 (257)
T cd05116          76 LAELGPLNKFLQKNK----------HVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLS  142 (257)
T ss_pred             cCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccc
Confidence            999999999985432          27788999999999999999998   69999999999999999999999999999


Q ss_pred             ccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          604 RFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       604 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +.+........ ......+++.|+|||.+.+..++.
T Consensus       143 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~  177 (257)
T cd05116         143 KALGADENYYK-AKTHGKWPVKWYAPECMNYYKFSS  177 (257)
T ss_pred             cccCCCCCeee-ecCCCCCCccccCHhHhccCCcCc
Confidence            86643221111 111223467899999987766554

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.92  E-value=1.5e-24  Score=216.39  Aligned_cols=162  Identities=28%  Similarity=0.461  Sum_probs=134.2

Q ss_pred             CcccccccceEEEEEECCCC----------eEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          447 NLIGTGSFGSVYKGILDPDQ----------TVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      +.||+|+||.||+|.+..++          ..||+|.+...... ...+.+|+.+++.++||||++++++|..      .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence            46899999999999997666          35788877544333 5789999999999999999999998743      2


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC---
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM---  593 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~---  593 (640)
                      ..++||||+++|+|.+++.....         .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++   
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~  141 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREKN---------NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNE  141 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCcccc
Confidence            46899999999999999865432         37888899999999999999998   6999999999999999887   


Q ss_pred             ----cEEEccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          594 ----IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       594 ----~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                          .+|++|||+++....        .....++..|+|||++.+.
T Consensus       142 ~~~~~~kl~Dfg~a~~~~~--------~~~~~~~~~y~aPE~~~~~  179 (259)
T cd05037         142 GYVPFIKLSDPGIPITVLS--------REERVERIPWIAPECIRNG  179 (259)
T ss_pred             CCceeEEeCCCCccccccc--------ccccccCCCccChhhhcCC
Confidence                799999999986532        1123467789999998776

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.92  E-value=1.7e-24  Score=219.39  Aligned_cols=173  Identities=24%  Similarity=0.347  Sum_probs=143.1

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ++|+....||+|+||.||+|+++.+|+.||+|++....  ....+.+.+|+.+++.++||||+++++++     ......
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~   75 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKL   75 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEE
Confidence            36788899999999999999999899999999985432  22335688999999999999999999985     344578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||++++.+..+....          ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+
T Consensus        76 ~~v~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~  142 (286)
T cd07847          76 HLVFEYCDHTVLNELEKNP----------RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLC  142 (286)
T ss_pred             EEEEeccCccHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEEC
Confidence            9999999999888776432          237889999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      |||++........    ......++..|+|||++.+.
T Consensus       143 dfg~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~  175 (286)
T cd07847         143 DFGFARILTGPGD----DYTDYVATRWYRAPELLVGD  175 (286)
T ss_pred             ccccceecCCCcc----cccCcccccccCCHHHHhCC
Confidence            9999986643221    11123478899999998763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.92  E-value=2.6e-24  Score=213.57  Aligned_cols=172  Identities=31%  Similarity=0.450  Sum_probs=138.5

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEeecc
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR-GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFM  525 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~  525 (640)
                      ++||+|+||.||+|... ++..||+|++..... .....+.+|++++++++||||++++++|..     ....++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEECC
Confidence            46899999999999876 788999999854432 233578899999999999999999999643     34679999999


Q ss_pred             CCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccccccc
Q 035691          526 HHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF  605 (640)
Q Consensus       526 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~  605 (640)
                      ++|+|.+++.....         .+++..+..++.|++.|+.|+|+   .+++||||||+||++++++.+|++|||+++.
T Consensus        75 ~~~~L~~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~  142 (250)
T cd05085          75 PGGDFLSFLRKKKD---------ELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQ  142 (250)
T ss_pred             CCCcHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCcccee
Confidence            99999998854322         26788999999999999999998   6999999999999999999999999999975


Q ss_pred             CCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          606 IPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       606 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      .......   ......+++.|+|||++.+..++.
T Consensus       143 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~  173 (250)
T cd05085         143 EDDGIYS---SSGLKQIPIKWTAPEALNYGRYSS  173 (250)
T ss_pred             ccccccc---cCCCCCCcccccCHHHhccCCCCc
Confidence            4321111   111123466799999998877664

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.92  E-value=5.7e-25  Score=219.48  Aligned_cols=164  Identities=25%  Similarity=0.392  Sum_probs=134.3

Q ss_pred             CcccccccceEEEEEECCCCe-------EEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          447 NLIGTGSFGSVYKGILDPDQT-------VVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +.||+|+||.||+|..+..+.       .||+|.+........+.+.+|+.+++.++||||+++++++..     ....+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-----GDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-----CCCcE
Confidence            468999999999999865443       488888865555555788999999999999999999999643     34678


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc-----
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI-----  594 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~-----  594 (640)
                      +||||+++|+|.+++.....         .+++..+..++.|++.|++|||+   .+|+||||||+||+++.++.     
T Consensus        76 lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~  143 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNKN---------LINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGN  143 (258)
T ss_pred             EEEecCCCCcHHHHHhcCCC---------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCC
Confidence            99999999999999875432         37888899999999999999999   79999999999999987765     


Q ss_pred             ---EEEccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          595 ---AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       595 ---~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                         +|++|||++.....        .....+++.|+|||++.+.
T Consensus       144 ~~~~~l~d~g~~~~~~~--------~~~~~~~~~y~aPE~~~~~  179 (258)
T cd05078         144 PPFIKLSDPGISITVLP--------KEILLERIPWVPPECIENP  179 (258)
T ss_pred             CceEEecccccccccCC--------chhccccCCccCchhccCC
Confidence               69999999875422        1123578899999999764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=1.8e-24  Score=217.88  Aligned_cols=177  Identities=28%  Similarity=0.351  Sum_probs=149.6

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ++|+..+.||.|+||.||+|.+..+++.||+|++.... ......+.+|+++++.++|+||+++++++.     ++...+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLW   75 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEE
Confidence            35778899999999999999999899999999986543 344567889999999999999999999853     345789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +|+||+++++|.+++...           .+++..+..++.|++.|+.|||+   .+++||||+|+||++++++.++++|
T Consensus        76 ~v~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d  141 (274)
T cd06609          76 IIMEYCGGGSCLDLLKPG-----------KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLAD  141 (274)
T ss_pred             EEEEeeCCCcHHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcc
Confidence            999999999999998643           27888999999999999999998   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ||+++.+.....    ......|++.|+|||++.+..++.|
T Consensus       142 ~g~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~  178 (274)
T cd06609         142 FGVSGQLTSTMS----KRNTFVGTPFWMAPEVIKQSGYDEK  178 (274)
T ss_pred             cccceeeccccc----ccccccCCccccChhhhccCCCCch
Confidence            999987643211    1123458889999999988777653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.92  E-value=2.5e-25  Score=243.40  Aligned_cols=185  Identities=25%  Similarity=0.346  Sum_probs=140.7

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCC----
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQG----  514 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~----  514 (640)
                      ..+|+..++||+||||.||+++.+-+|+.||||++... +......+.+|+.++++++|||||+++..|.......    
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            34677789999999999999999999999999999654 3334467889999999999999999986542211000    


Q ss_pred             --------------------------------------------------------------------------------
Q 035691          515 --------------------------------------------------------------------------------  514 (640)
Q Consensus       515 --------------------------------------------------------------------------------  514 (640)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             ----------------------C--------ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH
Q 035691          515 ----------------------N--------DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS  564 (640)
Q Consensus       515 ----------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~  564 (640)
                                            +        -..||=||||+.-.++++++.+...         -.....++++++|++
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---------~~~d~~wrLFreIlE  708 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---------SQRDEAWRLFREILE  708 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---------hhhHHHHHHHHHHHH
Confidence                                  0        2346777777776677666544321         023467899999999


Q ss_pred             HHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccccccCC--------------CccCCCceeeccccccccccCcc
Q 035691          565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP--------------EVISSNQCSSVGLKGTVGYAAPE  630 (640)
Q Consensus       565 al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~--------------~~~~~~~~~~~~~~gt~~y~aPE  630 (640)
                      ||.|+|+   ++||||||||.||++|++..+||+|||+|....              ..........++.+||.-|+|||
T Consensus       709 GLaYIH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE  785 (1351)
T KOG1035|consen  709 GLAYIHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE  785 (1351)
T ss_pred             HHHHHHh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence            9999999   699999999999999999999999999998621              00111222345678999999999


Q ss_pred             cCCCCC
Q 035691          631 YGMGSQ  636 (640)
Q Consensus       631 ~~~~~~  636 (640)
                      ++.+..
T Consensus       786 ll~~~~  791 (1351)
T KOG1035|consen  786 LLSDTS  791 (1351)
T ss_pred             Hhcccc
Confidence            997765

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.92  E-value=1.6e-24  Score=217.71  Aligned_cols=172  Identities=26%  Similarity=0.304  Sum_probs=132.7

Q ss_pred             cccccccceEEEEEECC--CCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEeec
Q 035691          448 LIGTGSFGSVYKGILDP--DQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEF  524 (640)
Q Consensus       448 ~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~  524 (640)
                      .||+|+||.||+|....  ....+|+|.+.... ......+.+|+++++.++||||++++++|.     .....++||||
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e~   76 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLEF   76 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEEe
Confidence            58999999999997532  34578888875433 233467889999999999999999999864     34568999999


Q ss_pred             cCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccccc
Q 035691          525 MHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR  604 (640)
Q Consensus       525 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~  604 (640)
                      +++|+|.+++.......     ....++.....++.|++.|++|||+   .+|+||||||+||++++++.+||+|||+++
T Consensus        77 ~~~g~L~~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~  148 (269)
T cd05042          77 CPLGDLKNYLRSNRGMV-----AQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLAL  148 (269)
T ss_pred             CCCCcHHHHHHhccccc-----cccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEecccccc
Confidence            99999999986543211     1224677888999999999999999   699999999999999999999999999987


Q ss_pred             cCCCccCCCceeeccccccccccCcccCCC
Q 035691          605 FIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       605 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      .......  ........+++.|+|||++..
T Consensus       149 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~  176 (269)
T cd05042         149 EQYPEDY--YITKDCHAVPLRWLAPELVEI  176 (269)
T ss_pred             ccccchh--eeccCCCCCcccccCHHHHhh
Confidence            5432111  011122346778999998743

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.92  E-value=1.9e-24  Score=221.12  Aligned_cols=179  Identities=28%  Similarity=0.453  Sum_probs=142.7

Q ss_pred             CCCcccCcccccccceEEEEEECCCCe----EEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQT----VVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      ++|+..+.||+|+||.||+|++..+|.    .||+|.+.... ......+.+|+.+++.++||||++++++|...     
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----   81 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-----   81 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-----
Confidence            457788999999999999999876665    46888875432 23335788999999999999999999997432     


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                       ..++++||+++|+|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+
T Consensus        82 -~~~~v~e~~~~g~l~~~~~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~  148 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVHEHK---------DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHV  148 (303)
T ss_pred             -CceeeehhcCCCCHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCce
Confidence             3568999999999999986432         237788899999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+|||+++.+......  .......++..|+|||.+.+..++.
T Consensus       149 kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~  190 (303)
T cd05110         149 KITDFGLARLLEGDEKE--YNADGGKMPIKWMALECIHYRKFTH  190 (303)
T ss_pred             EEccccccccccCcccc--cccCCCccccccCCHHHhccCCCCh
Confidence            99999999865432111  1112234577899999998877664

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.92  E-value=2.7e-24  Score=214.69  Aligned_cols=182  Identities=31%  Similarity=0.475  Sum_probs=145.7

Q ss_pred             CcccccccceEEEEEECCC---CeEEEEEEeecccch-hHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          447 NLIGTGSFGSVYKGILDPD---QTVVAVKVLFLHQRG-ALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      +.||+|+||.||+|.....   +..||+|++...... ..+.+.+|++++..++|+||+++++++.     .....++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec-----CCCceEEEE
Confidence            4689999999999999865   889999999654433 3578999999999999999999999854     355789999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      ||+++|+|.+++....... .......+++..++.++.|++.|+.|||+   .+++||||||+||+++.++.+||+|||.
T Consensus        76 e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~  151 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVF-PSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGL  151 (262)
T ss_pred             EeccCCcHHHHHhhccccc-cccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccc
Confidence            9999999999987642110 00011348999999999999999999999   7999999999999999999999999999


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ++.......  ........+++.|+|||.+.+..++.
T Consensus       152 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~  186 (262)
T cd00192         152 SRDVYDDDY--YRKKTGGKLPIRWMAPESLKDGIFTS  186 (262)
T ss_pred             ccccccccc--cccccCCCcCccccCHHHhccCCcch
Confidence            987643221  11122345788999999988766554

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.92  E-value=2.4e-24  Score=218.39  Aligned_cols=174  Identities=28%  Similarity=0.371  Sum_probs=145.1

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +|++.+.||+|+||.||+|++..+|+.||+|++....  ....+.+.+|+.++++++||||+++++++     ......+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence            4778899999999999999998899999999996543  33456899999999999999999999985     3455789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+ +++|.+++....         ..+++.++..++.|++.||+|||+   .+++|+||||+||+++.++.++++|
T Consensus        76 ~v~e~~-~~~L~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~d  142 (286)
T cd07832          76 LVMEYM-PSDLSEVLRDEE---------RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIAD  142 (286)
T ss_pred             EEeccc-CCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEee
Confidence            999999 999999886433         237888999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      ||+++.......   .......|+.+|+|||++.+..
T Consensus       143 fg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~  176 (286)
T cd07832         143 FGLARLFSEEEP---RLYSHQVATRWYRAPELLYGAR  176 (286)
T ss_pred             eeecccccCCCC---CccccccCcccccCceeeeccc
Confidence            999986643211   1112245899999999987644

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.92  E-value=1.6e-24  Score=220.34  Aligned_cols=173  Identities=25%  Similarity=0.417  Sum_probs=141.3

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR-GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ++|+..+.||+|+||.||+|+.+.+++.||+|.+..... .....+.+|+++++.++||||+++++++     ..++..+
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   79 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTLT   79 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeEE
Confidence            568888999999999999999988999999999864332 2234577899999999999999999995     3456889


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++ +|.+++.....         .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|
T Consensus        80 lv~e~~~~-~L~~~~~~~~~---------~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~d  146 (291)
T cd07844          80 LVFEYLDT-DLKQYMDDCGG---------GLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLAD  146 (291)
T ss_pred             EEEecCCC-CHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECc
Confidence            99999985 99988764321         37788899999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      ||+++.......    ......++..|+|||++.+.
T Consensus       147 fg~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~  178 (291)
T cd07844         147 FGLARAKSVPSK----TYSNEVVTLWYRPPDVLLGS  178 (291)
T ss_pred             cccccccCCCCc----cccccccccccCCcHHhhcC
Confidence            999875422111    11122468899999998763

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.92  E-value=9.6e-25  Score=222.50  Aligned_cols=171  Identities=26%  Similarity=0.327  Sum_probs=143.4

Q ss_pred             cCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEeecc
Q 035691          446 ANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFM  525 (640)
Q Consensus       446 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~  525 (640)
                      ...||+|+||.||+|....+++.||+|++........+.+.+|+.+++.++||||+++++++.     .++..++||||+
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~iv~e~~  100 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEELWVLMEFL  100 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCeEEEEEecC
Confidence            357999999999999998889999999996655555577889999999999999999999853     345789999999


Q ss_pred             CCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccccccc
Q 035691          526 HHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF  605 (640)
Q Consensus       526 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~  605 (640)
                      ++++|..++...           .+++..++.++.|++.|+.|||+   .+++||||||+||+++.++.+||+|||+++.
T Consensus       101 ~~~~L~~~~~~~-----------~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~  166 (297)
T cd06659         101 QGGALTDIVSQT-----------RLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQ  166 (297)
T ss_pred             CCCCHHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhh
Confidence            999999877431           26788899999999999999998   6999999999999999999999999999875


Q ss_pred             CCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          606 IPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       606 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +.....    ......|++.|+|||++.+..++.
T Consensus       167 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~  196 (297)
T cd06659         167 ISKDVP----KRKSLVGTPYWMAPEVISRTPYGT  196 (297)
T ss_pred             cccccc----cccceecCccccCHHHHccCCCCc
Confidence            532211    112345899999999998877654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.92  E-value=3e-25  Score=232.89  Aligned_cols=176  Identities=27%  Similarity=0.444  Sum_probs=145.7

Q ss_pred             ccCcccccccceEEEEEECCCCe----EEEEEEee-cccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          445 SANLIGTGSFGSVYKGILDPDQT----VVAVKVLF-LHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       445 ~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~-~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ..++||+|+||+||+|.+-..|+    +||+|++. ....+...++++|+-+|.+++|||+++++|+|..+.      ..
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------~q  773 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------LQ  773 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------HH
Confidence            34789999999999999865554    68999884 334455688999999999999999999999986543      67


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +|++||+.|.|.+|++.++.         .+.....+.|+.|||+||.|||.   ++++||||.++|+|+..-..+||.|
T Consensus       774 lvtq~mP~G~LlDyvr~hr~---------~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitd  841 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRD---------NIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITD  841 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhc---------cccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEe
Confidence            99999999999999987653         26667889999999999999998   7999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ||+|+.......  .+...+..-.+.|||-|.+.-.+|+.+
T Consensus       842 fgla~ll~~d~~--ey~~~~gK~pikwmale~i~~~~~thq  880 (1177)
T KOG1025|consen  842 FGLAKLLAPDEK--EYSAPGGKVPIKWMALESIRIRKYTHQ  880 (1177)
T ss_pred             cchhhccCcccc--cccccccccCcHHHHHHHhhccCCCch
Confidence            999998754332  223333334678999999998888753

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.92  E-value=2.4e-24  Score=217.76  Aligned_cols=190  Identities=23%  Similarity=0.407  Sum_probs=149.4

Q ss_pred             hcCCCcccCcccccccceEEEEEECC----CCeEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcC
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDP----DQTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQ  513 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  513 (640)
                      ..++|++.+.||+|+||.||+|.+..    ++..||+|++... .....+.+.+|+.++++++||||+++++++..    
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----   79 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE----   79 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence            34678889999999999999999874    2678999988543 23345678999999999999999999998743    


Q ss_pred             CCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC
Q 035691          514 GNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM  593 (640)
Q Consensus       514 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~  593 (640)
                      .....++++||+++|+|.+++........  .....+++.+++.++.|++.||+|||+   .+++||||||+||++++++
T Consensus        80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~  154 (280)
T cd05043          80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEA--NNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEEL  154 (280)
T ss_pred             CCCCCEEEEEcCCCCcHHHHHHhcccccc--ccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCC
Confidence            23467899999999999999865432110  112358899999999999999999998   6999999999999999999


Q ss_pred             cEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          594 IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       594 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      .+||+|||+++.+.....  ........++..|+|||++.+..++.
T Consensus       155 ~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~  198 (280)
T cd05043         155 QVKITDNALSRDLFPMDY--HCLGDNENRPVKWMALESLVNKEYSS  198 (280)
T ss_pred             cEEECCCCCcccccCCce--EEeCCCCCcchhccCHHHHhcCCCCc
Confidence            999999999986533211  11112234677899999998776654

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.92  E-value=1.7e-24  Score=220.20  Aligned_cols=176  Identities=27%  Similarity=0.342  Sum_probs=148.0

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      ++|.+.+.||+|+||.||+|....++..||+|.+........+.+.+|+.+++.++||||++++++|.     ..+..++
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~l   93 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGDELWV   93 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCcEEE
Confidence            56888899999999999999988889999999986655555678899999999999999999999853     3457899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      |+||+++|+|.+++...           .+++..+..++.|++.|+.|||+   .+++||||||+||+++.++.+||+||
T Consensus        94 v~e~~~~~~L~~~~~~~-----------~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~df  159 (293)
T cd06647          94 VMEYLAGGSLTDVVTET-----------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDF  159 (293)
T ss_pred             EEecCCCCcHHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccC
Confidence            99999999999998532           26778889999999999999998   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |++........    ......|++.|+|||.+.+..++.
T Consensus       160 g~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~  194 (293)
T cd06647         160 GFCAQITPEQS----KRSTMVGTPYWMAPEVVTRKAYGP  194 (293)
T ss_pred             cceeccccccc----ccccccCChhhcCchhhccCCCCc
Confidence            99876543211    112235889999999998776654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.92  E-value=1.8e-24  Score=218.04  Aligned_cols=187  Identities=22%  Similarity=0.360  Sum_probs=146.6

Q ss_pred             CCCcccCcccccccceEEEEEECC-----CCeEEEEEEeecccch-hHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDP-----DQTVVAVKVLFLHQRG-ALKSFMAECEALRNIRHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  514 (640)
                      ++|+....||+|+||.||+|+.+.     +.+.||+|.+...... ..+.+.+|++++++++||||+++++++..     
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE-----   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC-----
Confidence            467888999999999999999753     3467999988654433 45789999999999999999999998543     


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                      ....++||||+++|+|.+++........ ......+++..+..++.|++.|++|||+   .+|+||||||+||+++.++.
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~-~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~  155 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDE-KLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQRE  155 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccc-cccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCc
Confidence            3467999999999999999865442110 0111248899999999999999999998   69999999999999999999


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|++|||+++......   ........++..|+|||.+.+..++.
T Consensus       156 ~~l~~~~~~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~  197 (275)
T cd05046         156 VKVSLLSLSKDVYNSE---YYKLRNALIPLRWLAPEAVQEDDFST  197 (275)
T ss_pred             EEEcccccccccCccc---ccccCCceeEEeecChhhhccCCCCc
Confidence            9999999987543211   11122234677899999988766543

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.92  E-value=2.7e-24  Score=215.42  Aligned_cols=179  Identities=25%  Similarity=0.392  Sum_probs=144.4

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc------chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ------RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      +|+..+.||+|+||.||+|... +++.+|+|.++...      ....+.+.+|+++++.++|+||++++++|.     ..
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----DD   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----cC
Confidence            4778899999999999999875 78899999885432      122356889999999999999999999964     34


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      ...++||||+++|+|.+++....          .+++..+..++.|++.|++|||+   .+|+|+||+|+||++++++.+
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~  141 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNRFG----------PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGII  141 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeE
Confidence            57899999999999999986432          26788889999999999999998   699999999999999999999


Q ss_pred             EEccccccccCCCccCC--CceeeccccccccccCcccCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISS--NQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+|||+++........  .........|+..|+|||++.+..++.
T Consensus       142 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~  187 (265)
T cd06631         142 KLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGR  187 (265)
T ss_pred             EeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcc
Confidence            99999998864321110  111122345899999999998776654

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.92  E-value=2.2e-24  Score=219.38  Aligned_cols=175  Identities=26%  Similarity=0.411  Sum_probs=141.1

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++++|.+.+.||+|+||.||+|....+|+.||+|++.... .+....+.+|+++++.++|+||+++++++.     .+..
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~   77 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKET   77 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCe
Confidence            4578999999999999999999998899999999985433 233346788999999999999999999853     3457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+. +++.+++....         ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l  144 (291)
T cd07870          78 LTFVFEYMH-TDLAQYMIQHP---------GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKL  144 (291)
T ss_pred             EEEEEeccc-CCHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEE
Confidence            899999996 67776664322         125677888899999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      +|||+++.......    ......+++.|+|||++.+.
T Consensus       145 ~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~  178 (291)
T cd07870         145 ADFGLARAKSIPSQ----TYSSEVVTLWYRPPDVLLGA  178 (291)
T ss_pred             eccccccccCCCCC----CCCCccccccccCCceeecC
Confidence            99999985432111    11223478999999998764

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.92  E-value=9.2e-25  Score=221.24  Aligned_cols=173  Identities=23%  Similarity=0.408  Sum_probs=141.3

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +|+..+.||+|+||.||+|++..+|+.||+|+++...  ......+.+|++++++++||||+++++++     .+....+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence            3677889999999999999999999999999986432  22335678899999999999999999984     4556789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +|+||++ +++.+++....         ..+++..+..++.||++||.|||+   .+|+||||||+||+++.++.+||+|
T Consensus        76 lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d  142 (284)
T cd07839          76 LVFEYCD-QDLKKYFDSCN---------GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLAD  142 (284)
T ss_pred             EEEecCC-CCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECc
Confidence            9999997 57877765332         227889999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      ||+++.......    ......+++.|+|||++.+..
T Consensus       143 fg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~  175 (284)
T cd07839         143 FGLARAFGIPVR----CYSAEVVTLWYRPPDVLFGAK  175 (284)
T ss_pred             cchhhccCCCCC----CcCCCccccCCcChHHHhCCc
Confidence            999986532211    112235789999999987754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.92  E-value=2.1e-24  Score=215.60  Aligned_cols=179  Identities=24%  Similarity=0.452  Sum_probs=144.9

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ..++|++.+.||+|+||.||+|..+ +++.||+|.+..... ..+.+.+|+.++++++|+||+++++++.      ....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~   75 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT------QEPI   75 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCCc
Confidence            3456888999999999999999876 678899999864332 3467899999999999999999998742      2357


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||+++|+|.+++.....        ..+++.++..++.|++.|++|||+   .+++||||||+||++++++.++++
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~  144 (260)
T cd05067          76 YIITEYMENGSLVDFLKTPEG--------IKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIA  144 (260)
T ss_pred             EEEEEcCCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEc
Confidence            899999999999998864332        237888999999999999999998   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |||+++.......   .......++..|+|||++.+..++.
T Consensus       145 dfg~~~~~~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~  182 (260)
T cd05067         145 DFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTI  182 (260)
T ss_pred             cCcceeecCCCCc---ccccCCcccccccCHHHhccCCcCc
Confidence            9999986542111   1111234567899999988776654

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.92  E-value=3.2e-24  Score=213.88  Aligned_cols=172  Identities=28%  Similarity=0.417  Sum_probs=143.7

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-----chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-----RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      +|+..+.||+|+||.||+|....+++.||+|.+....     +...+.+.+|+++++.++|+||+++++++.     .+.
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-----EED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-----cCC
Confidence            3677789999999999999998889999999985433     224467899999999999999999999853     345


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++++|.+++....          .+++..+..++.|++.|+.|||+   .+++|+||+|+||+++.++.+|
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~k  142 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKYG----------SFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVK  142 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEE
Confidence            7899999999999999986432          26788889999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      |+|||.+.......     ......|++.|+|||.+....
T Consensus       143 l~d~~~~~~~~~~~-----~~~~~~~~~~y~~pe~~~~~~  177 (258)
T cd06632         143 LADFGMAKQVVEFS-----FAKSFKGSPYWMAPEVIAQQG  177 (258)
T ss_pred             EccCccceeccccc-----cccccCCCcceeCHHHhcCCC
Confidence            99999988653321     112345889999999986654

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=2.1e-24  Score=220.51  Aligned_cols=170  Identities=23%  Similarity=0.171  Sum_probs=130.1

Q ss_pred             HhcCCCcccCcccccccceEEEEEECC-CCeEEEEEEeecc-----cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCC
Q 035691          438 KATGGFSSANLIGTGSFGSVYKGILDP-DQTVVAVKVLFLH-----QRGALKSFMAECEALRNIRHRNLVKIITACSSSD  511 (640)
Q Consensus       438 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  511 (640)
                      ...++|...+.||+|+||+||+|+++. +++.||||++...     .....+.|.+|+++|++++|+|++..+..+    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            345679999999999999999999875 6788899987432     122356799999999999999998543221    


Q ss_pred             cCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCC-CCCCeeeC
Q 035691          512 FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDL-KPSNVLLD  590 (640)
Q Consensus       512 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdl-kp~NiLl~  590 (640)
                          ...++||||++|++|... ..  .           .   ...++.|+++||.|+|+   .+|+|||| ||+|||++
T Consensus        91 ----~~~~LVmE~~~G~~L~~~-~~--~-----------~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~  146 (365)
T PRK09188         91 ----GKDGLVRGWTEGVPLHLA-RP--H-----------G---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMG  146 (365)
T ss_pred             ----CCcEEEEEccCCCCHHHh-Cc--c-----------c---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEc
Confidence                236899999999999632 10  0           0   13578899999999999   69999999 99999999


Q ss_pred             CCCcEEEccccccccCCCccCCCc----eeeccccccccccCcccCCCC
Q 035691          591 NDMIAHVGDFGLTRFIPEVISSNQ----CSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       591 ~~~~~kl~DfGla~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      .++.+||+|||+|+.+........    ....+..+++.|+|||++.-.
T Consensus       147 ~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        147 PDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            999999999999997654321111    111356688999999998543

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.91  E-value=2.2e-24  Score=223.06  Aligned_cols=175  Identities=19%  Similarity=0.171  Sum_probs=138.3

Q ss_pred             ccCccccc--ccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          445 SANLIGTG--SFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       445 ~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      +.++||+|  +||+||+++.+.+|+.||+|+++...  ....+.+.+|+++++.++||||++++++|.     .++..++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence            45789999  78899999999999999999996542  233456778999999999999999999953     4457899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||+++|+|.+++.....        ..+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.++++||
T Consensus        77 v~e~~~~~~l~~~~~~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~  145 (327)
T cd08227          77 VTSFMAYGSAKDLICTHFM--------DGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGL  145 (327)
T ss_pred             EEeccCCCcHHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEccc
Confidence            9999999999999864322        237888999999999999999998   69999999999999999999999999


Q ss_pred             cccccCCCccCCC---ceeeccccccccccCcccCCCC
Q 035691          601 GLTRFIPEVISSN---QCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       601 Gla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      |.+..........   ........++..|+|||++.+.
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  183 (327)
T cd08227         146 RSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQN  183 (327)
T ss_pred             chhhccccccccccccccccccccceecccChHHhhcc
Confidence            8754332111000   0011123467889999999763

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.91  E-value=2.9e-24  Score=214.03  Aligned_cols=179  Identities=22%  Similarity=0.347  Sum_probs=148.6

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +|+..+.||+|+||.||+++...+|+.||+|.+....  ....+++.+|+.++++++||||+++++++     ......+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence            4778899999999999999999899999999986432  33446789999999999999999999984     4456889


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++++|.+++.....        ..+++.++..++.|++.|+.|||+   .+++|+||+|+||+++.++.++++|
T Consensus        76 lv~e~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d  144 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQRG--------VLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGD  144 (256)
T ss_pred             EEEecCCCCcHHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEee
Confidence            99999999999998864332        236888999999999999999998   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ||.+........    ......|++.|+|||+..+..++.|
T Consensus       145 ~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~  181 (256)
T cd08218         145 FGIARVLNSTVE----LARTCIGTPYYLSPEICENRPYNNK  181 (256)
T ss_pred             ccceeecCcchh----hhhhccCCccccCHHHhCCCCCCCc
Confidence            999986543211    1122357889999999988776643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.91  E-value=1.9e-24  Score=216.05  Aligned_cols=180  Identities=27%  Similarity=0.493  Sum_probs=146.8

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ..++|++.+.||+|+||.||+|... ++..||||.+..... ..+.+.+|+.++++++|+||+++++++.     .....
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   76 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEPI   76 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCce
Confidence            3467888999999999999999976 567899999864332 3467899999999999999999999853     34568


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||+++++|.+++.....        ..+++.++..++.|++.|+.|||+   .+++|+||||+||++++++.+|++
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~--------~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~  145 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEG--------KKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIA  145 (261)
T ss_pred             EEEEeccCCCCHHHHHhcccc--------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEEC
Confidence            999999999999999865432        247889999999999999999998   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |||.++.+....   ........++..|+|||.+.+..++.
T Consensus       146 d~g~~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~  183 (261)
T cd05034         146 DFGLARLIEDDE---YTAREGAKFPIKWTAPEAANYGRFTI  183 (261)
T ss_pred             ccccceeccchh---hhhhhccCCCccccCHHHhccCCcCc
Confidence            999998664311   11111223567899999998876664

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.91  E-value=2.8e-24  Score=214.09  Aligned_cols=176  Identities=27%  Similarity=0.375  Sum_probs=148.9

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      ++|+..+.||+|+||.||+|....+++.||+|.+.....  .+.+.+|++++++++||||+++++++.     .....++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l   75 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDLWI   75 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcEEE
Confidence            568888999999999999999998899999999864432  578999999999999999999999853     3457899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ++||+++++|.+++....         ..+++..+..++.|++.|+.|||+   .+++||||+|+||++++++.+||+||
T Consensus        76 ~~e~~~~~~L~~~l~~~~---------~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~df  143 (256)
T cd06612          76 VMEYCGAGSVSDIMKITN---------KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADF  143 (256)
T ss_pred             EEecCCCCcHHHHHHhCc---------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEccc
Confidence            999999999999985432         237889999999999999999998   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |++........    ......|+..|+|||++.+..++.
T Consensus       144 g~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~  178 (256)
T cd06612         144 GVSGQLTDTMA----KRNTVIGTPFWMAPEVIQEIGYNN  178 (256)
T ss_pred             ccchhcccCcc----ccccccCCccccCHHHHhcCCCCc
Confidence            99986643221    112234788999999998877664

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.91  E-value=2e-24  Score=219.35  Aligned_cols=191  Identities=28%  Similarity=0.418  Sum_probs=147.8

Q ss_pred             cCCCcccCcccccccceEEEEEEC-----CCCeEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILD-----PDQTVVAVKVLFLHQR-GALKSFMAECEALRNIRHRNLVKIITACSSSDFQ  513 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  513 (640)
                      .++|+..+.||+|+||.||+|.+.     .++..||+|++..... ...+.+.+|+.++++++||||++++++|..    
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~----   79 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV----   79 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC----
Confidence            457888999999999999999874     3578899999864432 334678999999999999999999998643    


Q ss_pred             CCceeeEEeeccCCCChhhhcCCCCCCCC------------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCC
Q 035691          514 GNDFKALVYEFMHHGSLESWLHPESASDD------------LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCD  581 (640)
Q Consensus       514 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------------~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrd  581 (640)
                       +...++||||+++|+|.+++........            .......+++..++.++.|++.|+.|||+   .+++|||
T Consensus        80 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~d  155 (288)
T cd05050          80 -GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRD  155 (288)
T ss_pred             -CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeeccc
Confidence             3467999999999999999864322110            01112347888999999999999999998   6999999


Q ss_pred             CCCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          582 LKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       582 lkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |||+||++++++.+||+|||+++.+......  .......++..|+|||.+.+..++.|
T Consensus       156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~  212 (288)
T cd05050         156 LATRNCLVGENMVVKIADFGLSRNIYSADYY--KASENDAIPIRWMPPESIFYNRYTTE  212 (288)
T ss_pred             ccHhheEecCCCceEECccccceecccCccc--cccCCCccChhhcCHHHHhcCCCCch
Confidence            9999999999999999999998754322110  01111234677999999988777653

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.91  E-value=3.4e-24  Score=215.40  Aligned_cols=178  Identities=26%  Similarity=0.401  Sum_probs=143.0

Q ss_pred             CCCcccCcccccccceEEEEEECCC---CeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPD---QTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ++|++.+.||+|+||.||+|.+...   ...||+|...... ....+.+.+|+.++++++||||++++++|..      .
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~   79 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------N   79 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------C
Confidence            4577889999999999999987533   3568999886443 3455789999999999999999999998642      2


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++|+|.+++....         ..+++.+++.++.|++.|++|||+   .+++||||||+||+++.++.+|
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~  147 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNK---------YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVK  147 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeE
Confidence            4679999999999999986432         237888999999999999999998   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ++|||+++.......   .......++..|+|||.+.+..++.
T Consensus       148 l~d~g~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~  187 (270)
T cd05056         148 LGDFGLSRYLEDESY---YKASKGKLPIKWMAPESINFRRFTS  187 (270)
T ss_pred             EccCceeeecccccc---eecCCCCccccccChhhhccCCCCc
Confidence            999999986543211   1111223456899999988776654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.91  E-value=4.5e-24  Score=212.88  Aligned_cols=174  Identities=29%  Similarity=0.396  Sum_probs=139.2

Q ss_pred             CcccccccceEEEEEECCCC---eEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          447 NLIGTGSFGSVYKGILDPDQ---TVVAVKVLFLHQR-GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      +.||+|+||.||+|.+...+   ..||+|.+..... ...+.+.+|+++++.++|||||++++++.      .+..++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence            46899999999999875444   7899999864433 34467899999999999999999999853      23468999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      ||+++|+|.+++....          .+++..+..++.|++.|++|||+   .+++||||||+||++++++.+||+|||+
T Consensus        75 e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~  141 (257)
T cd05060          75 ELAPLGPLLKYLKKRR----------EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGM  141 (257)
T ss_pred             EeCCCCcHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccc
Confidence            9999999999996543          27888999999999999999998   6999999999999999999999999999


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ++.+...... ........++..|+|||.+.+..++.+
T Consensus       142 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~  178 (257)
T cd05060         142 SRALGAGSDY-YRATTAGRWPLKWYAPECINYGKFSSK  178 (257)
T ss_pred             cceeecCCcc-cccccCccccccccCHHHhcCCCCCcc
Confidence            9866432211 111112224568999999988777653

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.91  E-value=2.5e-24  Score=241.57  Aligned_cols=173  Identities=28%  Similarity=0.377  Sum_probs=144.3

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|.+.+.||+|+||.||+|++..+++.||||+++...   ......+..|+.+++.++||||+++++++     .....
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~   78 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSANN   78 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECCE
Confidence            57888999999999999999999899999999996432   23346788999999999999999999884     34457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .|+||||+.+|+|.+++....          .+++..++.++.||+.||+|||.   .+|+||||||+|||++.++.+||
T Consensus        79 ~~lVmEy~~g~~L~~li~~~~----------~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL  145 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHIYG----------YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKL  145 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEE
Confidence            899999999999999986432          26778889999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      +|||+++......    .......+|+.|+|||.....
T Consensus       146 ~DFGls~~~~~~~----~~~~~~~~t~~~~~pe~~~~~  179 (669)
T cd05610         146 TDFGLSKVTLNRE----LNMMDILTTPSMAKPKNDYSR  179 (669)
T ss_pred             EeCCCCccccCCc----ccccccccCccccCccccccC
Confidence            9999998653211    112235689999999875543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.91  E-value=3.1e-24  Score=216.59  Aligned_cols=175  Identities=26%  Similarity=0.364  Sum_probs=146.3

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      .|+..+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|+++++.++||||+++++++.     +....++
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLWI   79 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEEE
Confidence            4667788999999999999998889999999986543 344578899999999999999999999954     3457899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||+++|+|.+++...           .+++.++..++.|++.|++|+|+   .+++|+||+|+||+++.++.++++||
T Consensus        80 v~e~~~~~~L~~~i~~~-----------~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~df  145 (277)
T cd06640          80 IMEYLGGGSALDLLRAG-----------PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADF  145 (277)
T ss_pred             EEecCCCCcHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEccc
Confidence            99999999999988532           26777888999999999999998   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |++........    ......++..|+|||++.+..++.
T Consensus       146 g~~~~~~~~~~----~~~~~~~~~~y~apE~~~~~~~~~  180 (277)
T cd06640         146 GVAGQLTDTQI----KRNTFVGTPFWMAPEVIQQSAYDS  180 (277)
T ss_pred             ccceeccCCcc----ccccccCcccccCHhHhccCCCcc
Confidence            99976543211    112235788999999998877664

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.91  E-value=3.2e-24  Score=214.64  Aligned_cols=185  Identities=24%  Similarity=0.325  Sum_probs=148.9

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +|++.+.||+|+||.||+|.+..+++.||+|++....  ....+.+..|++++++++||||+++++++...   .+...+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence            4777899999999999999999899999999986432  33456788999999999999999999876432   245678


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHC--KKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~--~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      ++|||+++++|.+++......      ...+++..++.++.|++.|+.|||..+  ..+++|+||||+||++++++.+|+
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~------~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl  151 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKE------RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKL  151 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhc------ccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEE
Confidence            999999999999998643211      134788899999999999999999321  269999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|||+++.......    ......|++.|+|||++.+..++.
T Consensus       152 ~d~g~~~~~~~~~~----~~~~~~~~~~~~~pE~~~~~~~~~  189 (265)
T cd08217         152 GDFGLAKILGHDSS----FAKTYVGTPYYMSPEQLNHMSYDE  189 (265)
T ss_pred             ecccccccccCCcc----cccccccCCCccChhhhcCCCCCc
Confidence            99999987643221    112245899999999998876654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.91  E-value=2.6e-24  Score=214.97  Aligned_cols=177  Identities=27%  Similarity=0.480  Sum_probs=142.0

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      ++|.+.+.||+|+||.||+|.+.. +..||+|.+.... ...+.+.+|++++++++|||++++++++.      ....++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~   77 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNG-TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYI   77 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcC-CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEE
Confidence            457888999999999999999864 4569999875433 23467889999999999999999998852      234689


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||+++|+|.+++.....        ..+++..+..++.|++.|+.|||+   .+++||||||+||++++++.+||+||
T Consensus        78 v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~df  146 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDG--------KYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADF  146 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCC--------CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCC
Confidence            9999999999999864322        237888999999999999999998   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |.++........   ......++..|+|||...+..++.
T Consensus       147 g~~~~~~~~~~~---~~~~~~~~~~y~~Pe~~~~~~~~~  182 (260)
T cd05069         147 GLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTI  182 (260)
T ss_pred             ccceEccCCccc---ccCCCccchhhCCHHHhccCCcCh
Confidence            999865322111   111233677899999988777654

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.91  E-value=2.3e-24  Score=220.99  Aligned_cols=190  Identities=26%  Similarity=0.399  Sum_probs=145.9

Q ss_pred             cCCCcccCcccccccceEEEEEECC-------CCeEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCCcceeEeeccC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDP-------DQTVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRNLVKIITACSSS  510 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  510 (640)
                      .++|.+.+.||+|+||.||+|++..       ++..||+|.++... ......+..|+.+++.+ +||||++++++|.. 
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-   95 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-   95 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence            3568889999999999999998642       23579999986432 23446788999999999 79999999999643 


Q ss_pred             CcCCCceeeEEeeccCCCChhhhcCCCCCCCC------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCC
Q 035691          511 DFQGNDFKALVYEFMHHGSLESWLHPESASDD------LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKP  584 (640)
Q Consensus       511 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp  584 (640)
                          ....++||||+++|+|.+++........      .......+++.+++.++.|++.|++|||+   .+++||||||
T Consensus        96 ----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp  168 (307)
T cd05098          96 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAA  168 (307)
T ss_pred             ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccH
Confidence                3468999999999999999965432110      00112348889999999999999999998   6999999999


Q ss_pred             CCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          585 SNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       585 ~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +||++++++.+||+|||.++.........  ......+++.|+|||++.+..++.
T Consensus       169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~  221 (307)
T cd05098         169 RNVLVTEDNVMKIADFGLARDIHHIDYYK--KTTNGRLPVKWMAPEALFDRIYTH  221 (307)
T ss_pred             HheEEcCCCcEEECCCcccccccccchhh--ccccCCCccceeChHHhccCCCCc
Confidence            99999999999999999998654221110  111122457899999998877664

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.91  E-value=5.1e-24  Score=214.12  Aligned_cols=180  Identities=29%  Similarity=0.438  Sum_probs=138.9

Q ss_pred             CcccccccceEEEEEECCCCe--EEEEEEeecc-cchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          447 NLIGTGSFGSVYKGILDPDQT--VVAVKVLFLH-QRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      +.||+|+||.||+|++.+++.  .+|+|.+... .....+.+.+|++++.++ +||||++++++|..     ....++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-----CCCceEEE
Confidence            468999999999999987775  4688887532 234456788999999999 89999999999643     34679999


Q ss_pred             eccCCCChhhhcCCCCCCCC------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          523 EFMHHGSLESWLHPESASDD------LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ||+++|+|.+++........      .......+++.++..++.|++.|++|||+   .+++||||||+||++++++.+|
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~k  152 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAK  152 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEE
Confidence            99999999999865432110      00112347889999999999999999998   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ++|||+++......     .......+..|+|||++.+..++.
T Consensus       153 l~dfgl~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~  190 (270)
T cd05047         153 IADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTT  190 (270)
T ss_pred             ECCCCCccccchhh-----hccCCCCccccCChHHHccCCCCc
Confidence            99999986432111     011112456799999988777664

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.91  E-value=6.4e-25  Score=222.55  Aligned_cols=178  Identities=24%  Similarity=0.366  Sum_probs=146.6

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--------chhHHHHHHHHHHHHhcC---CCCCcceeEee
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--------RGALKSFMAECEALRNIR---HRNLVKIITAC  507 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---H~niv~l~~~~  507 (640)
                      .-.+|+..+.+|+|+||.|+.|.+++....|+||.+.+..        .+..-..-.|+++|..++   |+||++++++ 
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf-  637 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF-  637 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe-
Confidence            3456888999999999999999999888899999884331        001112346999999997   9999999999 


Q ss_pred             ccCCcCCCceeeEEeeccC-CCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCC
Q 035691          508 SSSDFQGNDFKALVYEFMH-HGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSN  586 (640)
Q Consensus       508 ~~~~~~~~~~~~lv~e~~~-~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~N  586 (640)
                          |+++++.|++||--. +-+|.+++..+..          +++.....|++||+.|+++||+   .+|||||||-+|
T Consensus       638 ----FEddd~yyl~te~hg~gIDLFd~IE~kp~----------m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikden  700 (772)
T KOG1152|consen  638 ----FEDDDYYYLETEVHGEGIDLFDFIEFKPR----------MDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDEN  700 (772)
T ss_pred             ----eecCCeeEEEecCCCCCcchhhhhhccCc----------cchHHHHHHHHHHHhccccccc---cCceeccccccc
Confidence                677779999999654 4589999976543          7788899999999999999999   699999999999


Q ss_pred             eeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          587 VLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       587 iLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +.+|.+|-+|++|||.|.....      ..-..++||..|.|||++.|.+|-.|
T Consensus       701 vivd~~g~~klidfgsaa~~ks------gpfd~f~gtv~~aapevl~g~~y~gk  748 (772)
T KOG1152|consen  701 VIVDSNGFVKLIDFGSAAYTKS------GPFDVFVGTVDYAAPEVLGGEKYLGK  748 (772)
T ss_pred             EEEecCCeEEEeeccchhhhcC------CCcceeeeeccccchhhhCCCccCCC
Confidence            9999999999999999875422      12235789999999999999887543

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.91  E-value=3.7e-24  Score=215.00  Aligned_cols=173  Identities=26%  Similarity=0.351  Sum_probs=134.6

Q ss_pred             CcccccccceEEEEEEC--CCCeEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEee
Q 035691          447 NLIGTGSFGSVYKGILD--PDQTVVAVKVLFLHQR-GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYE  523 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e  523 (640)
                      +.||+|+||.||+|...  .++..+|+|.++.... .....+.+|+.++++++||||+++++++..     ....++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-----VTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCCcEEEEE
Confidence            35899999999999864  3456799998865432 233578899999999999999999998643     346789999


Q ss_pred             ccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccccc
Q 035691          524 FMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT  603 (640)
Q Consensus       524 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla  603 (640)
                      |+++|+|.+++.......     ....++..+..++.|++.|++|||+   .+++||||||+||+++.++.+|++|||++
T Consensus        76 ~~~~g~L~~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~  147 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAE-----LMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLS  147 (269)
T ss_pred             CCCCCcHHHHHHHhhhcc-----cccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCcccc
Confidence            999999999986433211     1235667788899999999999999   69999999999999999999999999999


Q ss_pred             ccCCCccCCCceeeccccccccccCcccCCC
Q 035691          604 RFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       604 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      +.......  ........|++.|+|||++.+
T Consensus       148 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~  176 (269)
T cd05087         148 HNKYKEDY--YVTPDQLWVPLRWIAPELVDE  176 (269)
T ss_pred             ccccCcce--eecCCCcCCcccccCHhHhcc
Confidence            75432111  111223457888999999854

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.91  E-value=4.1e-24  Score=213.13  Aligned_cols=175  Identities=27%  Similarity=0.410  Sum_probs=141.8

Q ss_pred             CcccccccceEEEEEECC-CC--eEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          447 NLIGTGSFGSVYKGILDP-DQ--TVVAVKVLFLHQR-GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      +.||+|+||.||+|.+.. .+  ..||+|.+..... ...+.+.+|+.++++++||||+++++++..      ...++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence            468999999999999864 33  3699999965544 556789999999999999999999998532      5689999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      ||+++|+|.+++.....        ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+
T Consensus        75 e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~  143 (257)
T cd05040          75 ELAPLGSLLDRLRKDAL--------GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGL  143 (257)
T ss_pred             EecCCCcHHHHHHhccc--------ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccc
Confidence            99999999999865431        237889999999999999999999   6999999999999999999999999999


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ++.+....... .......++..|+|||++.+..++.
T Consensus       144 ~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~  179 (257)
T cd05040         144 MRALPQNEDHY-VMEEHLKVPFAWCAPESLRTRTFSH  179 (257)
T ss_pred             cccccccccce-ecccCCCCCceecCHHHhcccCcCc
Confidence            98764322111 1111234778999999988766654

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.91  E-value=3.7e-24  Score=218.45  Aligned_cols=172  Identities=28%  Similarity=0.421  Sum_probs=141.9

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecccch-----hHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG-----ALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      +|+..+.||+|+||.||+|.+..+++.||||.++.....     ....+..|++++++++|+||+++++++.     +..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG-----HKS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee-----cCC
Confidence            367788999999999999999888999999999654322     2356778999999999999999999953     355


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+ +|+|.+++....         ..+++..+..++.|+++||+|||+   .+|+|+||||+||+++.++.+|
T Consensus        76 ~~~lv~e~~-~~~L~~~i~~~~---------~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~  142 (298)
T cd07841          76 NINLVFEFM-ETDLEKVIKDKS---------IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLK  142 (298)
T ss_pred             EEEEEEccc-CCCHHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEE
Confidence            789999999 899999986533         137888999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      |+|||+++.......    ......+++.|+|||.+.+.
T Consensus       143 l~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~  177 (298)
T cd07841         143 LADFGLARSFGSPNR----KMTHQVVTRWYRAPELLFGA  177 (298)
T ss_pred             EccceeeeeccCCCc----cccccccceeeeCHHHHhCC
Confidence            999999986643211    11122467889999988653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.91  E-value=3.2e-24  Score=222.57  Aligned_cols=189  Identities=24%  Similarity=0.394  Sum_probs=145.4

Q ss_pred             CCCcccCcccccccceEEEEEECC-------CCeEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDP-------DQTVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRNLVKIITACSSSD  511 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  511 (640)
                      .+|++.+.||+|+||.||+|++..       ++..||+|.++... ....+.+.+|+++++++ +||||++++++|..  
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--   89 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ--   89 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc--
Confidence            457888999999999999998632       23468999886432 23456889999999999 89999999999643  


Q ss_pred             cCCCceeeEEeeccCCCChhhhcCCCCCCC------CCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCC
Q 035691          512 FQGNDFKALVYEFMHHGSLESWLHPESASD------DLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPS  585 (640)
Q Consensus       512 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~  585 (640)
                         ....++||||+++|+|.+++.......      ........+++.++..++.|++.||.|||+   .+++||||||+
T Consensus        90 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~  163 (334)
T cd05100          90 ---DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAAR  163 (334)
T ss_pred             ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccc
Confidence               346899999999999999986532110      001122458889999999999999999999   69999999999


Q ss_pred             CeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          586 NVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       586 NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||++++++.+||+|||+++........  .......++..|+|||++.+..++.
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~  215 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYY--KKTTNGRLPVKWMAPEALFDRVYTH  215 (334)
T ss_pred             eEEEcCCCcEEECCcccceeccccccc--ccccCCCcCceEcCHHHhccCCcCc
Confidence            999999999999999999865432111  1111223457899999998877764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.91  E-value=3.2e-24  Score=220.55  Aligned_cols=190  Identities=24%  Similarity=0.402  Sum_probs=145.2

Q ss_pred             CCCcccCcccccccceEEEEEEC-------CCCeEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILD-------PDQTVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRNLVKIITACSSSD  511 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~  511 (640)
                      ++|.+.+.||+|+||.||+|+..       .....||+|.+.... ......+..|+++++.+ +||||++++++|..  
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--   89 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ--   89 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc--
Confidence            46778899999999999999753       234579999886432 23446788999999999 69999999998643  


Q ss_pred             cCCCceeeEEeeccCCCChhhhcCCCCCCC------CCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCC
Q 035691          512 FQGNDFKALVYEFMHHGSLESWLHPESASD------DLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPS  585 (640)
Q Consensus       512 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~  585 (640)
                         ....++||||+++|+|.+++.......      ........+++.++..++.|++.|++|||+   .+++||||||+
T Consensus        90 ---~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~  163 (314)
T cd05099          90 ---EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAAR  163 (314)
T ss_pred             ---CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccce
Confidence               346899999999999999986532110      001112348889999999999999999998   69999999999


Q ss_pred             CeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          586 NVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       586 NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ||++++++.+||+|||+++..........  .....++..|||||++.+..++.+
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~  216 (314)
T cd05099         164 NVLVTEDNVMKIADFGLARGVHDIDYYKK--TSNGRLPVKWMAPEALFDRVYTHQ  216 (314)
T ss_pred             eEEEcCCCcEEEccccccccccccccccc--cccCCCCccccCHHHHccCCcCcc
Confidence            99999999999999999986643211111  111224567999999988776643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.91  E-value=2.1e-24  Score=223.96  Aligned_cols=180  Identities=24%  Similarity=0.353  Sum_probs=145.5

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      .++|++.+.||+|+||.||+|....+|+.||+|++....  ....+.+.+|+.+++.++||||+++++++.... .....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence            367888899999999999999999999999999985432  233467788999999999999999998865433 33457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+. |+|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+||++++++.+||
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~~----------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl  148 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSDQ----------PLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRI  148 (334)
T ss_pred             EEEEEehhh-hhHHHHhccCC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEe
Confidence            899999996 68988875432          27888999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      +|||+++..............+..|+..|+|||++.+
T Consensus       149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  185 (334)
T cd07855         149 GDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLS  185 (334)
T ss_pred             cccccceeecccCcCCCcccccccccccccChHHhcC
Confidence            9999998654322111111223468999999999765

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.91  E-value=5.4e-24  Score=212.03  Aligned_cols=177  Identities=26%  Similarity=0.454  Sum_probs=146.7

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +|+..+.||+|+||.||+|....+++.||+|.+....  ....+.+.+|+++++.++||||+++++.+     ..++..+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence            4778899999999999999998899999999986442  23456889999999999999999999884     3455789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC-CcEEEc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND-MIAHVG  598 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~-~~~kl~  598 (640)
                      +||||+++++|.+++.....        ..+++..+..++.|++.|+.|||+   .+++|+||+|+||+++++ +.+|++
T Consensus        76 lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~  144 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRCN--------SLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIG  144 (256)
T ss_pred             EEEecCCCCCHHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEc
Confidence            99999999999999865432        237888999999999999999999   699999999999999855 568999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |||.++.......     .....|+..|+|||.+.+..++.
T Consensus       145 d~~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~  180 (256)
T cd08220         145 DFGISKILSSKSK-----AYTVVGTPCYISPELCEGKPYNQ  180 (256)
T ss_pred             cCCCceecCCCcc-----ccccccCCcccCchhccCCCCCc
Confidence            9999986643211     12245889999999998776654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.91  E-value=4.9e-24  Score=218.79  Aligned_cols=184  Identities=26%  Similarity=0.428  Sum_probs=144.7

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcC---C
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQ---G  514 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~---~  514 (640)
                      .++|+..+.||+|+||.||+|....+++.||||.+....  ......+.+|++++++++||||++++++|......   .
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            456889999999999999999999899999999985432  22234567899999999999999999998654321   2


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                      ....++||||+.+ ++.+++....         ..+++.+++.++.|++.||+|||+   .+++||||||+||+++.++.
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~---------~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~  157 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKN---------VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGI  157 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCc
Confidence            3456899999974 7877775432         137889999999999999999999   69999999999999999999


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      +||+|||++..+...............++..|+|||.+.+..
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  199 (310)
T cd07865         158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGER  199 (310)
T ss_pred             EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCc
Confidence            999999999866432211111112345788999999887653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.91  E-value=4.9e-24  Score=214.49  Aligned_cols=175  Identities=27%  Similarity=0.435  Sum_probs=142.3

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecccc----------hhHHHHHHHHHHHHhcCCCCCcceeEeeccCC
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR----------GALKSFMAECEALRNIRHRNLVKIITACSSSD  511 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  511 (640)
                      +|...+.||+|+||.||+|....+|+.||+|.++....          ...+.+..|+.+++.++||||+++++++.   
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---   78 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET---   78 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence            36677899999999999999988899999998853211          11346888999999999999999999854   


Q ss_pred             cCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC
Q 035691          512 FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN  591 (640)
Q Consensus       512 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~  591 (640)
                        ..+..++||||+++|+|.+++....          .+++..+..++.|++.|+.|||+   .+++||||+|+||+++.
T Consensus        79 --~~~~~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~  143 (272)
T cd06629          79 --TEEYLSIFLEYVPGGSIGSCLRTYG----------RFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDA  143 (272)
T ss_pred             --cCCceEEEEecCCCCcHHHHHhhcc----------CCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcC
Confidence              3457899999999999999986542          26778889999999999999999   69999999999999999


Q ss_pred             CCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          592 DMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       592 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      ++.+|++|||+++........  .......|+..|+|||.+.+..
T Consensus       144 ~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~  186 (272)
T cd06629         144 DGICKISDFGISKKSDDIYDN--DQNMSMQGSVFWMAPEVIHSYS  186 (272)
T ss_pred             CCeEEEeeccccccccccccc--cccccccCCccccCHHHhcccc
Confidence            999999999999865322111  1122345889999999987644

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.91  E-value=4.9e-24  Score=215.15  Aligned_cols=174  Identities=28%  Similarity=0.392  Sum_probs=144.9

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEE
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALV  521 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv  521 (640)
                      |+..+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.++++++||||+++++++.     .+...++|
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv   80 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLWII   80 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEEEE
Confidence            567788999999999999998889999999985433 334467889999999999999999999953     44578999


Q ss_pred             eeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccc
Q 035691          522 YEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG  601 (640)
Q Consensus       522 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfG  601 (640)
                      |||+++|+|.+++...           .+++..+..++.|++.|+.|||+   .+++|+||+|+||+++.++.++|+|||
T Consensus        81 ~e~~~~~~l~~~i~~~-----------~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg  146 (277)
T cd06641          81 MEYLGGGSALDLLEPG-----------PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFG  146 (277)
T ss_pred             EEeCCCCcHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecc
Confidence            9999999999988532           26788899999999999999998   799999999999999999999999999


Q ss_pred             ccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          602 LTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       602 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +++.+.....    ......|+..|+|||.+.+..++.
T Consensus       147 ~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~  180 (277)
T cd06641         147 VAGQLTDTQI----KRNTFVGTPFWMAPEVIKQSAYDS  180 (277)
T ss_pred             cceecccchh----hhccccCCccccChhhhccCCCCc
Confidence            9876533211    112235788999999998776654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.91  E-value=2.3e-24  Score=215.01  Aligned_cols=175  Identities=29%  Similarity=0.416  Sum_probs=147.0

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      +|++.+.||.|+||.||+|.+..+++.||+|++....   .+..+.+.+|++++++++||||++++++     +......
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS-----FQDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHh-----hcCCCeE
Confidence            4778899999999999999998899999999996432   2345789999999999999999999988     4455689


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||+.+++|.+++....          .+++..+..++.|+++|+.|||+   .+++|+||+|+||++++++.++|+
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~  142 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQKV----------KFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHIT  142 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhcC----------CcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEe
Confidence            99999999999999986442          27788899999999999999998   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |||.+.......     ......|+..|+|||++.+..++.
T Consensus       143 d~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~  178 (258)
T cd05578         143 DFNIATKVTPDT-----LTTSTSGTPGYMAPEVLCRQGYSV  178 (258)
T ss_pred             ecccccccCCCc-----cccccCCChhhcCHHHHcccCCCC
Confidence            999988654321     112345888999999987766544

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.91  E-value=2e-24  Score=218.91  Aligned_cols=173  Identities=27%  Similarity=0.408  Sum_probs=143.3

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ++|+..+.||+|+||.||+|.++.+++.||+|++....  ....+.+.+|+++++.++||||+++++++     ..+...
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL   75 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence            36788899999999999999998889999999885332  22346788999999999999999999985     445678


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||++++++.++....          ..+++..+..++.|++.|++|||+   .+++|||++|+||++++++.+||+
T Consensus        76 ~lv~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~  142 (286)
T cd07846          76 YLVFEFVDHTVLDDLEKYP----------NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLC  142 (286)
T ss_pred             EEEEecCCccHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEE
Confidence            9999999999998876432          127888999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      |||+++.......    ......++..|+|||++.+.
T Consensus       143 dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~  175 (286)
T cd07846         143 DFGFARTLAAPGE----VYTDYVATRWYRAPELLVGD  175 (286)
T ss_pred             eeeeeeeccCCcc----ccCcccceeeccCcHHhccc
Confidence            9999986533211    11224578999999998764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.91  E-value=7.3e-24  Score=211.21  Aligned_cols=178  Identities=29%  Similarity=0.503  Sum_probs=145.2

Q ss_pred             CcccCcccccccceEEEEEECCCC----eEEEEEEeecccch-hHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQ----TVVAVKVLFLHQRG-ALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      |++.+.||.|+||.||+|++...+    ..||+|++...... ..+.+..|+++++.++|+||+++++++..     ...
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-----EEP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-----CCe
Confidence            356688999999999999998665    88999999654433 56789999999999999999999998543     357


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .+++|||+++++|.+++.....        ..+++.++..++.|++.|++|||+   .+++||||||+||++++++.+|+
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l  144 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRP--------KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKI  144 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhh--------ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEE
Confidence            8999999999999999865332        117889999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|||+++........   ......+++.|+|||.+.+..++.
T Consensus       145 ~dfg~~~~~~~~~~~---~~~~~~~~~~y~~Pe~~~~~~~~~  183 (258)
T smart00219      145 SDFGLSRDLYDDDYY---KKKGGKLPIRWMAPESLKDGKFTS  183 (258)
T ss_pred             cccCCceeccccccc---ccccCCCcccccChHHhccCCCCc
Confidence            999999866432111   111123678999999987666554

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.91  E-value=7.7e-24  Score=214.35  Aligned_cols=183  Identities=26%  Similarity=0.410  Sum_probs=146.5

Q ss_pred             CCCcccCcccccccceEEEEEECC----CCeEEEEEEeecccch-hHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDP----DQTVVAVKVLFLHQRG-ALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      ..|+..+.||+|+||.||+|++..    ++..||||++...... ..+.|.+|+++++.++||||+++++++...   ..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP---GG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC---CC
Confidence            346777899999999999998643    4789999999655443 457899999999999999999999986432   24


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      ...++||||+++|+|.+++.....         .+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~---------~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~  148 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRD---------QINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLV  148 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCcc---------ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCE
Confidence            568899999999999999865432         37888999999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+|||.+........... ......++..|+|||...+..++.
T Consensus       149 ~l~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~  191 (284)
T cd05038         149 KISDFGLAKVLPEDKDYYY-VKEPGESPIFWYAPECLRTSKFSS  191 (284)
T ss_pred             EEcccccccccccCCccee-ccCCCCCcccccCcHHHccCCCCc
Confidence            9999999987642211111 111123566799999988776653

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.91  E-value=4.8e-24  Score=216.37  Aligned_cols=181  Identities=26%  Similarity=0.314  Sum_probs=147.7

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR-GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ++|...+.||.|++|.||+|.+..+++.||+|.+..... .....+.+|++++++++||||++++++|...   .....+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEE
Confidence            357788999999999999999988999999999864432 3446789999999999999999999987432   234678


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++++|.+++......      ...+++..+..++.|++.|+.|||+   .+++|+||+|+||++++++.++|+|
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d  148 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKR------GGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCD  148 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEee
Confidence            999999999999887532211      1337788899999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||++........      ....++..|+|||.+.+..++.
T Consensus       149 fg~~~~~~~~~~------~~~~~~~~y~~pE~~~~~~~~~  182 (287)
T cd06621         149 FGVSGELVNSLA------GTFTGTSFYMAPERIQGKPYSI  182 (287)
T ss_pred             cccccccccccc------ccccCCccccCHHHhcCCCCCc
Confidence            999875532111      1234788999999998877664

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.91  E-value=5.1e-24  Score=212.84  Aligned_cols=179  Identities=23%  Similarity=0.451  Sum_probs=144.2

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ..++|++.+.||+|+||.||+|.+. .+..||+|.+... ....+.+.+|+++++.++|+||+++++++..      ...
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~   75 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPI   75 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCe
Confidence            3467888999999999999999875 5667999988543 2344678999999999999999999988532      357


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      +++|||+++|+|.+++.....        ...++.++..++.|++.|++|||+   .+++||||||+||+++.++.+||+
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~  144 (260)
T cd05073          76 YIITEFMAKGSLLDFLKSDEG--------SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIA  144 (260)
T ss_pred             EEEEEeCCCCcHHHHHHhCCc--------cccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEEC
Confidence            899999999999999865332        236788899999999999999998   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |||.++........   ......++..|+|||++.+..++.
T Consensus       145 d~~~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~  182 (260)
T cd05073         145 DFGLARVIEDNEYT---AREGAKFPIKWTAPEAINFGSFTI  182 (260)
T ss_pred             CCcceeeccCCCcc---cccCCcccccccCHhHhccCCcCc
Confidence            99999865432111   111223567899999998776654

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.91  E-value=5.2e-24  Score=215.05  Aligned_cols=168  Identities=26%  Similarity=0.298  Sum_probs=131.7

Q ss_pred             cccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHh---cCCCCCcceeEeeccCCcCCCceeeEE
Q 035691          448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRN---IRHRNLVKIITACSSSDFQGNDFKALV  521 (640)
Q Consensus       448 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~---l~H~niv~l~~~~~~~~~~~~~~~~lv  521 (640)
                      +||+|+||.||+|....+++.||+|.+....   ......+.+|..++..   .+||+|+.+++++.     ..+..++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-----TPDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-----cCCeEEEE
Confidence            4899999999999998899999999885432   1122334455444433   47999999988853     34578999


Q ss_pred             eeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccc
Q 035691          522 YEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG  601 (640)
Q Consensus       522 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfG  601 (640)
                      |||+++|+|.+++....          .+++..+..++.|++.|++|||+   .+|+||||||+||++++++.+|++|||
T Consensus        76 ~e~~~~~~L~~~i~~~~----------~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg  142 (279)
T cd05633          76 LDLMNGGDLHYHLSQHG----------VFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLG  142 (279)
T ss_pred             EecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCC
Confidence            99999999999886432          37889999999999999999999   699999999999999999999999999


Q ss_pred             ccccCCCccCCCceeeccccccccccCcccCCC-CCCCC
Q 035691          602 LTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG-SQVST  639 (640)
Q Consensus       602 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~  639 (640)
                      ++.......      .....||+.|+|||.+.+ ..++.
T Consensus       143 ~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~  175 (279)
T cd05633         143 LACDFSKKK------PHASVGTHGYMAPEVLQKGTAYDS  175 (279)
T ss_pred             cceeccccC------ccCcCCCcCccCHHHhcCCCCCCc
Confidence            987543211      112358999999999864 33443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.91  E-value=4.7e-24  Score=219.58  Aligned_cols=181  Identities=23%  Similarity=0.386  Sum_probs=143.8

Q ss_pred             CCcccCcccccccceEEEEEECC--CCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          442 GFSSANLIGTGSFGSVYKGILDP--DQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      +|++.+.||+|+||.||+|....  +++.||+|.+....   .+..+.+.+|+.+++.++||||+++++++...   ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence            47778899999999999999987  78999999996532   44456788999999999999999999997543   135


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC----C
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN----D  592 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~----~  592 (640)
                      ..++||||+++ ++.+++.......     ...+++..++.++.|++.|+.|||+   .+|+||||||+||+++.    +
T Consensus        78 ~~~lv~e~~~~-~l~~~~~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~  148 (316)
T cd07842          78 SVYLLFDYAEH-DLWQIIKFHRQAK-----RVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPER  148 (316)
T ss_pred             eEEEEEeCCCc-CHHHHHHhhccCC-----CcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCcc
Confidence            78999999975 6766664322211     1247888999999999999999999   69999999999999999    9


Q ss_pred             CcEEEccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          593 MIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       593 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      +.+||+|||+++.+...... ........+|+.|+|||++.+.
T Consensus       149 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~  190 (316)
T cd07842         149 GVVKIGDLGLARLFNAPLKP-LADLDPVVVTIWYRAPELLLGA  190 (316)
T ss_pred             ceEEECCCccccccCCCccc-ccccCCccccccccCHHHHhCC
Confidence            99999999999876433221 1222345688999999988764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.91  E-value=6.5e-24  Score=212.77  Aligned_cols=180  Identities=26%  Similarity=0.338  Sum_probs=147.7

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ++|++.+.||+|+||.||+|....++..||+|++.... ....+.+.+|+++++.++|+||+++++.+     ...+..+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDELW   75 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEEE
Confidence            46888999999999999999998889999999985432 22457889999999999999999999885     3445789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++++|.+++......       ..+++..+..++.|++.|++|||+   .+++||||+|+||++++++.+||+|
T Consensus        76 iv~e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~d  145 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSSYPR-------GGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIAD  145 (267)
T ss_pred             EEEeccCCCcHHHHHHHhccc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcc
Confidence            999999999999998643221       237888999999999999999998   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      ||++..+...............|+..|+|||++...
T Consensus       146 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~  181 (267)
T cd06610         146 FGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV  181 (267)
T ss_pred             cchHHHhccCccccccccccccCChhhcChHHHccc
Confidence            999986643322111112334689999999998766

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=4.9e-24  Score=214.61  Aligned_cols=184  Identities=24%  Similarity=0.331  Sum_probs=149.7

Q ss_pred             HhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCc-CCC
Q 035691          438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-RHRNLVKIITACSSSDF-QGN  515 (640)
Q Consensus       438 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~-~~~  515 (640)
                      ..+++|++.+.||+|+||.||+|.++.+++.||+|++..... ..+.+.+|+.+++++ +|+||+++++++..... ...
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            356889999999999999999999988899999999865443 336789999999998 79999999999765432 335


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      ...++||||+++++|.+++......      ...+++..+..++.|++.|++|||+   .+++|+||+|+||++++++.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~  152 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKK------GKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEV  152 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhc------CCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeE
Confidence            5689999999999999988643211      1237888899999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      |++|||++........    ......|++.|+|||++.+.
T Consensus       153 ~l~d~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~  188 (275)
T cd06608         153 KLVDFGVSAQLDSTLG----RRNTFIGTPYWMAPEVIACD  188 (275)
T ss_pred             EECCCccceecccchh----hhcCccccccccCHhHhccc
Confidence            9999999876532211    11224588999999988653

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.91  E-value=3.8e-24  Score=217.17  Aligned_cols=178  Identities=24%  Similarity=0.355  Sum_probs=145.7

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ++|+..+.||+|+||.||+|.++.+++.||+|+++..  .....+.+.+|+++++.++|+||+++++++.     .++..
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~   75 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR-----RKGRL   75 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEE-----ECCEE
Confidence            3688889999999999999999989999999998543  2334478899999999999999999999964     34578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||++++.+..+....          ..+++..+..++.|++.|+.|||+   .+++|||++|+||++++++.+||+
T Consensus        76 ~iv~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~  142 (288)
T cd07833          76 YLVFEYVERTLLELLEASP----------GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLC  142 (288)
T ss_pred             EEEEecCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEE
Confidence            9999999987776655322          226788999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCC-CCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS-QVST  639 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~  639 (640)
                      |||+++.......   .......++..|+|||++.+. .++.
T Consensus       143 d~g~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~  181 (288)
T cd07833         143 DFGFARALRARPA---SPLTDYVATRWYRAPELLVGDTNYGK  181 (288)
T ss_pred             eeecccccCCCcc---ccccCcccccCCcCCchhcCCCCcCc
Confidence            9999987643221   011234578999999999887 5543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.91  E-value=5.5e-24  Score=214.77  Aligned_cols=170  Identities=28%  Similarity=0.349  Sum_probs=140.6

Q ss_pred             ccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEeecc
Q 035691          449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFM  525 (640)
Q Consensus       449 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~  525 (640)
                      ||+|+||+||+|....+|+.||+|.+....   ....+.+..|+++++.++||||+++++++     ...+..++||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence            689999999999999899999999985432   22345678899999999999999999885     3445789999999


Q ss_pred             CCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccccccc
Q 035691          526 HHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF  605 (640)
Q Consensus       526 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~  605 (640)
                      ++++|.+++.....        ..+++..+..++.|++.|+.|||+   .+++||||+|+||++++++.+||+|||.++.
T Consensus        76 ~~~~L~~~l~~~~~--------~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~  144 (277)
T cd05577          76 NGGDLKYHIYNVGE--------PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVE  144 (277)
T ss_pred             CCCcHHHHHHHcCc--------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhh
Confidence            99999998864432        237888999999999999999999   6999999999999999999999999999886


Q ss_pred             CCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          606 IPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       606 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      .....     ......++..|+|||++.+..++.
T Consensus       145 ~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~  173 (277)
T cd05577         145 LKGGK-----KIKGRAGTPGYMAPEVLQGEVYDF  173 (277)
T ss_pred             hccCC-----ccccccCCCCcCCHHHhcCCCCCc
Confidence            53211     112235788999999998877654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=8.7e-25  Score=207.70  Aligned_cols=177  Identities=24%  Similarity=0.300  Sum_probs=150.2

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~  515 (640)
                      -.+|....+||+|+|++|..++++.+.+.||+|++++.   +.........|-.+..+. +||.+|.++.+     |+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fqte  323 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQTE  323 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hccc
Confidence            35788999999999999999999999999999999643   233345566777778776 79999999887     7888


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      ...++|.||+.||+|.-+++..+.          +++..+..+..+|..||.|||+   +||++||+|.+|+|+|..|++
T Consensus       324 srlffvieyv~ggdlmfhmqrqrk----------lpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghi  390 (593)
T KOG0695|consen  324 SRLFFVIEYVNGGDLMFHMQRQRK----------LPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHI  390 (593)
T ss_pred             ceEEEEEEEecCcceeeehhhhhc----------CcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCce
Confidence            899999999999999877765443          8888899999999999999999   899999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      |+.|+|+++.--.    ....+.+++|||-|.|||++.|..|.
T Consensus       391 kltdygmcke~l~----~gd~tstfcgtpnyiapeilrgeeyg  429 (593)
T KOG0695|consen  391 KLTDYGMCKEGLG----PGDTTSTFCGTPNYIAPEILRGEEYG  429 (593)
T ss_pred             eecccchhhcCCC----CCcccccccCCCcccchhhhcccccC
Confidence            9999999984321    22334568999999999999998764

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.91  E-value=1.2e-23  Score=211.20  Aligned_cols=171  Identities=24%  Similarity=0.325  Sum_probs=131.7

Q ss_pred             cccccccceEEEEEECCC--CeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEeec
Q 035691          448 LIGTGSFGSVYKGILDPD--QTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEF  524 (640)
Q Consensus       448 ~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~  524 (640)
                      .||+|+||.||+|....+  ...+++|.+.... ....+.+.+|+.+++.++||||++++++|..     ....++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~~~~~lv~e~   76 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-----AIPYLLVFEY   76 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-----CCccEEEEec
Confidence            589999999999975422  2356677664332 2345789999999999999999999999643     4468999999


Q ss_pred             cCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccccc
Q 035691          525 MHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR  604 (640)
Q Consensus       525 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~  604 (640)
                      +++|+|.+++......      ....++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.
T Consensus        77 ~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~  147 (268)
T cd05086          77 CELGDLKSYLSQEQWH------RRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGP  147 (268)
T ss_pred             CCCCcHHHHHHhhhcc------cccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEeccccccc
Confidence            9999999998654221      1235667788999999999999998   699999999999999999999999999986


Q ss_pred             cCCCccCCCceeeccccccccccCcccCCC
Q 035691          605 FIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       605 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      ......  .........|+..|+|||++.+
T Consensus       148 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~  175 (268)
T cd05086         148 SRYKED--YIETEDDKCVPLRWLAPELVGE  175 (268)
T ss_pred             ccCcch--hhhcccCCcCcccccCchhccc
Confidence            432111  0111123457889999999753

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.91  E-value=1.5e-25  Score=230.87  Aligned_cols=173  Identities=27%  Similarity=0.402  Sum_probs=151.1

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ..++|.....+|+|.||.||||+++.+++..|+|+++.......+-...|+-+++..+|||||.++|.     +...+..
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gs-----ylr~dkl   87 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGS-----YLRRDKL   87 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhh-----hhhhcCc
Confidence            34578888999999999999999999999999999988777777788899999999999999999998     4555678


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      |+.||||.+|+|.+..+...          .+++.++..+++...+|+.|||+   ++-+|||||-.||++++.|.+|++
T Consensus        88 wicMEycgggslQdiy~~Tg----------plselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvkla  154 (829)
T KOG0576|consen   88 WICMEYCGGGSLQDIYHVTG----------PLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLA  154 (829)
T ss_pred             EEEEEecCCCcccceeeecc----------cchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeec
Confidence            99999999999998776443          27888999999999999999999   688999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGM  633 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  633 (640)
                      |||.+..+...    ......+.||++|||||+..
T Consensus       155 Dfgvsaqitat----i~KrksfiGtpywmapEvaa  185 (829)
T KOG0576|consen  155 DFGVSAQITAT----IAKRKSFIGTPYWMAPEVAA  185 (829)
T ss_pred             ccCchhhhhhh----hhhhhcccCCccccchhHHH
Confidence            99999876543    23344578999999999863

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.91  E-value=7.1e-24  Score=214.60  Aligned_cols=175  Identities=24%  Similarity=0.316  Sum_probs=137.5

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc-hhHHHHHHHHHH-HHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR-GALKSFMAECEA-LRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ++|++.+.||+|+||.||+|++..+|+.||+|+++.... .....+..|+.. ++..+||||+++++++.     .+...
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~   75 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDV   75 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcE
Confidence            368888999999999999999999999999999865432 223455566665 56678999999999964     34468


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||++ |+|.+++......      ...+++..++.++.|++.|++|||+.  .+++||||||+||+++.++.+||+
T Consensus        76 ~lv~e~~~-~~l~~~l~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~  146 (283)
T cd06617          76 WICMEVMD-TSLDKFYKKVYDK------GLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLC  146 (283)
T ss_pred             EEEhhhhc-ccHHHHHHHhccC------CCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEe
Confidence            99999997 6887776532211      13488999999999999999999982  389999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      |||+++.+.....     .....|+..|+|||++.+
T Consensus       147 dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~  177 (283)
T cd06617         147 DFGISGYLVDSVA-----KTIDAGCKPYMAPERINP  177 (283)
T ss_pred             ecccccccccccc-----cccccCCccccChhhcCC
Confidence            9999986532211     112357889999998865

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.91  E-value=1e-23  Score=213.59  Aligned_cols=174  Identities=25%  Similarity=0.335  Sum_probs=145.3

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      |...+.||+|++|.||+|....+++.||+|++........+.+.+|+.+++.++||||+++++++.     ..+..++|+
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~~~v~   95 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDELWVVM   95 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeEEEEE
Confidence            344578999999999999998899999999986555555567899999999999999999999853     345789999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      ||+++++|.+++...           .+++..+..++.|++.|++|||+   .+++||||+|+||+++.++.+|++|||+
T Consensus        96 e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~  161 (285)
T cd06648          96 EFLEGGALTDIVTHT-----------RMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGF  161 (285)
T ss_pred             eccCCCCHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEccccc
Confidence            999999999988642           26778889999999999999999   6999999999999999999999999999


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +........    ......|++.|+|||...+..++.
T Consensus       162 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~  194 (285)
T cd06648         162 CAQVSKEVP----RRKSLVGTPYWMAPEVISRLPYGT  194 (285)
T ss_pred             chhhccCCc----ccccccCCccccCHHHhcCCCCCC
Confidence            875533211    112245899999999998877654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.91  E-value=7.8e-24  Score=210.95  Aligned_cols=177  Identities=29%  Similarity=0.492  Sum_probs=143.2

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      .+|++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|++++++++||+|+++++++.     .....++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~   76 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCT-----ERSPICL   76 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEc-----cCCceEE
Confidence            46778899999999999999886 577899998854322 2357899999999999999999999853     3446899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||+++|+|.+++.....         .+++..+..++.|++.|++|||+   .+++||||||+||+++.++.+||+||
T Consensus        77 v~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~  144 (256)
T cd05112          77 VFEFMEHGCLSDYLRAQRG---------KFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDF  144 (256)
T ss_pred             EEEcCCCCcHHHHHHhCcc---------CCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCC
Confidence            9999999999998864332         26788899999999999999998   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+++.......   .......++..|+|||.+.++.++.
T Consensus       145 g~~~~~~~~~~---~~~~~~~~~~~~~aPe~~~~~~~~~  180 (256)
T cd05112         145 GMTRFVLDDQY---TSSTGTKFPVKWSSPEVFSFSKYSS  180 (256)
T ss_pred             cceeecccCcc---cccCCCccchhhcCHhHhccCCcCh
Confidence            99885532211   1111223567899999998777654

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.91  E-value=9.9e-24  Score=220.61  Aligned_cols=182  Identities=23%  Similarity=0.274  Sum_probs=146.8

Q ss_pred             HhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCC-cCC
Q 035691          438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSD-FQG  514 (640)
Q Consensus       438 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~  514 (640)
                      ...++|+..+.||+|+||.||+|++..+++.||+|++...  .......+.+|+.++++++||||+++++++.... +.+
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            3457799999999999999999999999999999998532  2333456788999999999999999999875332 123


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                      ....++||||+. +++.+++..            .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~------------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~  156 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQM------------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCT  156 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhh------------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCC
Confidence            345799999996 488777642            15677888999999999999999   69999999999999999999


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +||+|||+++......     ......||+.|+|||.+.+..++.+
T Consensus       157 ~kL~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~  197 (353)
T cd07850         157 LKILDFGLARTAGTSF-----MMTPYVVTRYYRAPEVILGMGYKEN  197 (353)
T ss_pred             EEEccCccceeCCCCC-----CCCCCcccccccCHHHHhCCCCCCc
Confidence            9999999998653321     1123457899999999988777653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.91  E-value=1.3e-23  Score=210.29  Aligned_cols=178  Identities=28%  Similarity=0.422  Sum_probs=149.2

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR-GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ++|++.+.||+|++|.||+|++..+++.||||++..... ...+.+.+|+..+.+++|+||+++++++.     .....+
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEIS   75 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeEE
Confidence            357888999999999999999998999999999865543 44578999999999999999999999953     345789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++++|.+++....          .+++..++.++.|++.|++|||+.  .+++||||+|+||+++.++.++|+|
T Consensus        76 lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~d  143 (264)
T cd06623          76 IVLEYMDGGSLADLLKKVG----------KIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIAD  143 (264)
T ss_pred             EEEEecCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEcc
Confidence            9999999999999986442          278889999999999999999982  4999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||.++.........    ....++..|+|||.+.+..++.
T Consensus       144 f~~~~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~  179 (264)
T cd06623         144 FGISKVLENTLDQC----NTFVGTVTYMSPERIQGESYSY  179 (264)
T ss_pred             CccceecccCCCcc----cceeecccccCHhhhCCCCCCc
Confidence            99998664322111    1234788999999988776654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.91  E-value=7.1e-24  Score=214.75  Aligned_cols=174  Identities=27%  Similarity=0.453  Sum_probs=142.3

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +|+..+.||+|+||.||+|++..+|+.||||.+....  ......+.+|++++++++||||+++++++     ..+...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence            3778899999999999999999899999999886433  22335788999999999999999999985     3455789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+. ++|.+++.....        ..+++..+..++.|++.|++|||+   .+++||||+|+||++++++.+|++|
T Consensus        76 ~v~e~~~-~~l~~~~~~~~~--------~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~d  143 (284)
T cd07860          76 LVFEFLH-QDLKKFMDASPL--------SGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLAD  143 (284)
T ss_pred             EEeeccc-cCHHHHHHhCCC--------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEee
Confidence            9999996 688888764332        237888999999999999999998   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      ||+++........    .....+++.|+|||++.+..
T Consensus       144 fg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~  176 (284)
T cd07860         144 FGLARAFGVPVRT----YTHEVVTLWYRAPEILLGCK  176 (284)
T ss_pred             ccchhhcccCccc----cccccccccccCCeEEecCC
Confidence            9998865322111    11224688999999887654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.91  E-value=8.5e-24  Score=210.48  Aligned_cols=171  Identities=30%  Similarity=0.490  Sum_probs=140.2

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      ++|++.+.||+|+||.||+|..  +++.||+|.+....  ..+.+.+|+.+++.++||||+++++++..      +..++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~~   75 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH------NGLYI   75 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcEE
Confidence            3578889999999999999875  68889999985432  34678999999999999999999998632      23689


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||+++|+|.+++.....        ..+++..+..++.|++.|+.|||+   .+++||||||+||+++.++.+||+||
T Consensus        76 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Df  144 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGR--------ALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDF  144 (254)
T ss_pred             EEECCCCCCHHHHHHhcCc--------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCC
Confidence            9999999999999865432        237888999999999999999998   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+++......       .....+..|+|||.+.++.++.
T Consensus       145 g~~~~~~~~~-------~~~~~~~~y~~pe~~~~~~~~~  176 (254)
T cd05083         145 GLARVGSMGV-------DNSKLPVKWTAPEALKHKKFSS  176 (254)
T ss_pred             ccceeccccC-------CCCCCCceecCHHHhccCCcCc
Confidence            9987543211       1122456899999998877664

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.91  E-value=6.6e-24  Score=216.05  Aligned_cols=176  Identities=28%  Similarity=0.389  Sum_probs=143.3

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ++|+..+.||+|+||.||+|.+..+++.||+|.++....  .....+.+|+.++++++||||+++++++....   ....
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcE
Confidence            457788999999999999999998999999999964432  22346778999999999999999999864331   2578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||+++ +|.+++.....         .+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+
T Consensus        82 ~lv~e~~~~-~L~~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~  148 (293)
T cd07843          82 YMVMEYVEH-DLKSLMETMKQ---------PFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKIC  148 (293)
T ss_pred             EEEehhcCc-CHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEe
Confidence            999999974 89888764321         37889999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      |||+++.......    ......+++.|+|||.+.+..
T Consensus       149 d~g~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~  182 (293)
T cd07843         149 DFGLAREYGSPLK----PYTQLVVTLWYRAPELLLGAK  182 (293)
T ss_pred             ecCceeeccCCcc----ccccccccccccCchhhcCCc
Confidence            9999986643211    111234788999999987654

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.91  E-value=1.1e-23  Score=210.71  Aligned_cols=168  Identities=25%  Similarity=0.366  Sum_probs=141.3

Q ss_pred             ccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEeecc
Q 035691          449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFM  525 (640)
Q Consensus       449 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~  525 (640)
                      ||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++     ..+...++||||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence            699999999999998889999999986432   23446799999999999999999999985     3445789999999


Q ss_pred             CCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccccccc
Q 035691          526 HHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF  605 (640)
Q Consensus       526 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~  605 (640)
                      ++++|.+++....          .+++..+..++.|++.|++|+|+   .+++|+||+|+||+++.++.+||+|||.++.
T Consensus        76 ~~~~L~~~l~~~~----------~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~  142 (262)
T cd05572          76 LGGELWTILRDRG----------LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKK  142 (262)
T ss_pred             CCCcHHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccc
Confidence            9999999986542          26788899999999999999999   6999999999999999999999999999986


Q ss_pred             CCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          606 IPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       606 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      .....     ......|++.|+|||.+.+..++.
T Consensus       143 ~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~  171 (262)
T cd05572         143 LKSGQ-----KTWTFCGTPEYVAPEIILNKGYDF  171 (262)
T ss_pred             cCccc-----ccccccCCcCccChhHhcCCCCCC
Confidence            64321     112235889999999988776654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>PLN03210 Resistant to P

Probab=99.91  E-value=7.5e-23  Score=242.39  Aligned_cols=300  Identities=26%  Similarity=0.334  Sum_probs=160.8

Q ss_pred             CCCCcEEeCCCCc------cccCCchhhhcCC-CCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCc
Q 035691            2 LTFLMLINLQQNN------FSGNIPHEIGRLF-QLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPP   74 (640)
Q Consensus         2 l~~L~~L~L~~n~------i~~~~p~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~   74 (640)
                      +++|+.|.+..+.      +...+|+.|..++ +|+.|.+.+|.++ .+|..| ...+|++|+|++|+|+.      +|.
T Consensus       557 m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~------L~~  628 (1153)
T PLN03210        557 MRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEK------LWD  628 (1153)
T ss_pred             CccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCccccc------ccc
Confidence            5667777775543      3334566666654 5777777777776 556655 45677777777777654      555


Q ss_pred             hhhcCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccC-cCCCCCCCcccccc
Q 035691           75 YIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARN-DLGTRKVNDLRFLD  153 (640)
Q Consensus        75 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~~  153 (640)
                      ++. .+++|+.|+|+++...+.+|. ++.+++|++|+|++|..-..+|..+..+++|+.|++++| .++.+|.       
T Consensus       629 ~~~-~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~-------  699 (1153)
T PLN03210        629 GVH-SLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPT-------  699 (1153)
T ss_pred             ccc-cCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCC-------
Confidence            443 467777777776654444443 666777777777776544456667777777777777764 3444321       


Q ss_pred             cccCCCCcceEecCCCCC-CCcCcCCCCCCCCCEEEccCCcCcccCCcCc------------------------------
Q 035691          154 SLVNCTYLEIVSLNVNSL-RSIPISVGYLPKLQVLSLFENNISGEIPSSL------------------------------  202 (640)
Q Consensus       154 ~l~~l~~L~~L~L~~N~l-~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~------------------------------  202 (640)
                      .+ ++++|+.|++++|.. ..+|..   ..+|++|++++|.+. .+|..+                              
T Consensus       700 ~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~  774 (1153)
T PLN03210        700 GI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMT  774 (1153)
T ss_pred             cC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccccccccccccccccchhhccccccccchhhh
Confidence            11 455566666665532 223321   245556666666655 333332                              


Q ss_pred             cCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccc-c------CCCCCceEEccCCcCCCCCCccCCCCCCCCEE
Q 035691          203 GNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIF-L------GQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHL  275 (640)
Q Consensus       203 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~-~------~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L  275 (640)
                      ...++|+.|+|++|...+.+|..++++++|+.|++++|.. .      .+..|+.|++++|.....+|..   .++|+.|
T Consensus       775 ~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L  851 (1153)
T PLN03210        775 MLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSRLRTFPDI---STNISDL  851 (1153)
T ss_pred             hccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCcccccccc---ccccCEe
Confidence            1223555555555554445555555555555555554321 1      1223444555544332223322   2344455


Q ss_pred             ECCCCcccCcCCccccCCCCCCeEEecC-CccCCCCCccCCCCCCCCeEeCcCC
Q 035691          276 DLSKNKLSGEIPSSLGSCVGLEYLNLSI-NSFHGPIHPGLSSLKSLEGLDLFQN  328 (640)
Q Consensus       276 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~l~~N  328 (640)
                      +|++|.|+ .+|.++..+++|++|+|++ |++. .+|..+..+++|+.++++++
T Consensus       852 ~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C  903 (1153)
T PLN03210        852 NLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC  903 (1153)
T ss_pred             ECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence            55555554 3444455555555555554 2232 23444444555555554443

syringae 6; Provisional

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.91  E-value=1.4e-23  Score=208.48  Aligned_cols=173  Identities=30%  Similarity=0.447  Sum_probs=140.0

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeecccch-hHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEeecc
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG-ALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFM  525 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~  525 (640)
                      ++||+|+||.||+|.+.. ++.||+|++...... ..+.+.+|++++++++||||+++++++.     .....++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-----QKQPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-----cCCCeEEEEEcC
Confidence            468999999999999876 999999998654333 4568999999999999999999999853     345789999999


Q ss_pred             CCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccccccc
Q 035691          526 HHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF  605 (640)
Q Consensus       526 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~  605 (640)
                      ++++|.+++.....         .+++..+..++.|++.|+.|||+   .+++||||||+||+++.++.+||+|||+++.
T Consensus        75 ~~~~l~~~l~~~~~---------~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~  142 (251)
T cd05041          75 PGGSLLTFLRKKKN---------RLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRE  142 (251)
T ss_pred             CCCcHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeecccccc
Confidence            99999999864321         26788899999999999999998   6999999999999999999999999999986


Q ss_pred             CCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          606 IPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       606 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ......  ........++..|+|||.+.++.++.
T Consensus       143 ~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~  174 (251)
T cd05041         143 EEGGIY--TVSDGLKQIPIKWTAPEALNYGRYTS  174 (251)
T ss_pred             ccCCcc--eeccccCcceeccCChHhhccCCCCc
Confidence            532111  11111122456799999998877764

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.91  E-value=1.4e-23  Score=211.80  Aligned_cols=168  Identities=25%  Similarity=0.290  Sum_probs=132.1

Q ss_pred             cccccccceEEEEEECCCCeEEEEEEeecccc---hhHHHHHHHHH---HHHhcCCCCCcceeEeeccCCcCCCceeeEE
Q 035691          448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR---GALKSFMAECE---ALRNIRHRNLVKIITACSSSDFQGNDFKALV  521 (640)
Q Consensus       448 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv  521 (640)
                      .||+|+||.||+|....+++.||+|++.....   .....+..|..   .++...||+|+++++++     ...+..++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence            48999999999999988899999999854321   11123344443   34445799999999884     444578999


Q ss_pred             eeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccc
Q 035691          522 YEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG  601 (640)
Q Consensus       522 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfG  601 (640)
                      |||+++|+|.+++....          .+++..+..++.|++.|+.|||+   .+|+||||||+||+++.++.+||+|||
T Consensus        76 ~e~~~g~~L~~~l~~~~----------~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg  142 (278)
T cd05606          76 LDLMNGGDLHYHLSQHG----------VFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLG  142 (278)
T ss_pred             EecCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCc
Confidence            99999999998885432          38899999999999999999999   699999999999999999999999999


Q ss_pred             ccccCCCccCCCceeeccccccccccCcccCCCC-CCCC
Q 035691          602 LTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS-QVST  639 (640)
Q Consensus       602 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~  639 (640)
                      +++.+....      .....|+..|+|||++.++ .++.
T Consensus       143 ~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~  175 (278)
T cd05606         143 LACDFSKKK------PHASVGTHGYMAPEVLQKGVAYDS  175 (278)
T ss_pred             CccccCccC------CcCcCCCcCCcCcHHhcCCCCCCc
Confidence            987553211      1224589999999998754 4543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.90  E-value=1.4e-23  Score=213.93  Aligned_cols=182  Identities=23%  Similarity=0.350  Sum_probs=143.1

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcC-CCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIR-HRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|+..+.||+|+||.||+|++..+++.||+|.+....  ......+.+|+.+++.++ ||||+++++++...+......
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            35888899999999999999999899999999885432  223467889999999995 699999999875544323345


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC-CCcEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN-DMIAH  596 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~-~~~~k  596 (640)
                      .++||||+++ ++.+++......     ....+++..++.++.||+.||+|||+   .+|+||||||+||+++. ++.+|
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~k  151 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRG-----PGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLK  151 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhccc-----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEE
Confidence            7999999985 888887543221     01237889999999999999999999   69999999999999998 89999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      |+|||+++.+......    .....+++.|+|||++.+.
T Consensus       152 l~dfg~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~  186 (295)
T cd07837         152 IADLGLGRAFSIPVKS----YTHEIVTLWYRAPEVLLGS  186 (295)
T ss_pred             EeecccceecCCCccc----cCCcccccCCCChHHhhCC
Confidence            9999999865322111    1122468899999988664

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.90  E-value=6.1e-24  Score=212.83  Aligned_cols=177  Identities=27%  Similarity=0.383  Sum_probs=147.5

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ++|+..+.||+|+||.||+|.++.+++.||+|++.... ....+.+.+|++++++++||||+++++++.     .....+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY-----NNGDIS   75 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeee-----cCCEEE
Confidence            35777889999999999999999899999999986543 334567899999999999999999999853     345789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +|+||+++++|.+++....         ..+++..+..++.|++.|+.|+|+.  .+++|+||||+||++++++.+||+|
T Consensus        76 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d  144 (265)
T cd06605          76 ICMEYMDGGSLDKILKEVQ---------GRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCD  144 (265)
T ss_pred             EEEEecCCCcHHHHHHHcc---------CCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEee
Confidence            9999999999999986542         2377888899999999999999982  4999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||.+........      ....|+..|+|||.+.+..++.
T Consensus       145 ~g~~~~~~~~~~------~~~~~~~~y~~PE~~~~~~~~~  178 (265)
T cd06605         145 FGVSGQLVNSLA------KTFVGTSSYMAPERIQGNDYSV  178 (265)
T ss_pred             cccchhhHHHHh------hcccCChhccCHHHHcCCCCCc
Confidence            999876532111      1145888999999998877654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=1.4e-23  Score=211.74  Aligned_cols=171  Identities=25%  Similarity=0.378  Sum_probs=142.9

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecc-cchhHHHHHHHHHHHHhcC---CCCCcceeEeeccCCcCCCce
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH-QRGALKSFMAECEALRNIR---HRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~~~~  517 (640)
                      .|+..+.||+|+||.||+|.+..+++.||+|.+... .....+.+.+|++++++++   |||++++++++.     .+..
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence            366778999999999999999889999999998644 2334567889999999986   999999999853     3457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++++|.+++...           .+++..+..++.|++.|+.|||+   .+|+|+||+|+||++++++.+++
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l  142 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKAG-----------PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKL  142 (277)
T ss_pred             EEEEEecCCCCcHHHHHHcc-----------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEE
Confidence            89999999999999987532           27788899999999999999998   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      +|||++..+.....    ......|+..|+|||.+.++
T Consensus       143 ~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~  176 (277)
T cd06917         143 CDFGVAALLNQNSS----KRSTFVGTPYWMAPEVITEG  176 (277)
T ss_pred             ccCCceeecCCCcc----ccccccCCcceeCHHHhccC
Confidence            99999987643221    11224588999999988654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.90  E-value=1.1e-23  Score=213.26  Aligned_cols=174  Identities=24%  Similarity=0.441  Sum_probs=142.4

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR-GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      +|+..+.||+|++|.||+|++..+|+.||||+++.... ...+.+.+|+.++++++||||+++++++.     ..+..++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH-----TENKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe-----eCCcEEE
Confidence            47788999999999999999998999999999965432 23466788999999999999999999954     3457899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||+++ ++.+++......       ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.+|++||
T Consensus        76 v~e~~~~-~l~~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~  144 (284)
T cd07836          76 VFEYMDK-DLKKYMDTHGVR-------GALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADF  144 (284)
T ss_pred             EEecCCc-cHHHHHHhcCCC-------CCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeec
Confidence            9999985 888887543321       237889999999999999999998   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      |+++.......    ......+++.|+|||++.+.
T Consensus       145 g~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~  175 (284)
T cd07836         145 GLARAFGIPVN----TFSNEVVTLWYRAPDVLLGS  175 (284)
T ss_pred             chhhhhcCCcc----ccccccccccccChHHhcCC
Confidence            99976532211    11123478899999998664

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=2.2e-23  Score=207.29  Aligned_cols=176  Identities=31%  Similarity=0.461  Sum_probs=147.6

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +|+..+.||+|++|.||+|+...+++.||+|.+.....  ...+.+.+|++++++++|||++++++++.     .....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence            46778999999999999999988899999999965543  45578999999999999999999999853     345789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++++|.+++....          .+++..+..++.|++.|+.|||+   .+|+||||+|+||+++.++.+||+|
T Consensus        76 ~v~e~~~~~~L~~~~~~~~----------~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d  142 (254)
T cd06627          76 IILEYAENGSLRQIIKKFG----------PFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLAD  142 (254)
T ss_pred             EEEecCCCCcHHHHHHhcc----------CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEec
Confidence            9999999999999986442          27888999999999999999998   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||.+.........    .....++..|+|||...+..++.
T Consensus       143 ~~~~~~~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~  178 (254)
T cd06627         143 FGVATKLNDVSKD----DASVVGTPYWMAPEVIEMSGAST  178 (254)
T ss_pred             cccceecCCCccc----ccccccchhhcCHhhhcCCCCCc
Confidence            9999866432211    12245889999999987665443

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.90  E-value=1.5e-23  Score=217.43  Aligned_cols=179  Identities=23%  Similarity=0.274  Sum_probs=141.0

Q ss_pred             CCcccCcccccccceEEEEEECCC--CeEEEEEEeeccc--chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCc
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPD--QTVVAVKVLFLHQ--RGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~  516 (640)
                      +|++.+.||+|+||.||+|+...+  +..||+|++....  ....+.+.+|+++++++ +||||+++++++.... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            467788999999999999999877  8899999985432  22346788999999999 5999999998754321 2234


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++++||+. ++|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+|
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~k  145 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQ----------PLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELK  145 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCC----------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEE
Confidence            5788999986 68988875432          37888999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      |+|||+++.+...............||+.|+|||++.+.
T Consensus       146 l~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~  184 (332)
T cd07857         146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSF  184 (332)
T ss_pred             eCcCCCceecccccccccccccCcccCccccCcHHHhCC
Confidence            999999986543221111112335689999999987663

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.90  E-value=2e-23  Score=209.32  Aligned_cols=175  Identities=24%  Similarity=0.309  Sum_probs=139.1

Q ss_pred             HHHHHhcCCCcccCcc--cccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCCcceeEeeccC
Q 035691          434 ESLLKATGGFSSANLI--GTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-RHRNLVKIITACSSS  510 (640)
Q Consensus       434 ~~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  510 (640)
                      .+.....+.|++.+.+  |+|+||.||+++.+.++..+|+|.+.......     .|+.....+ +||||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~-   80 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT-   80 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec-
Confidence            3444455667776776  99999999999999999999999985432221     122222222 79999999999543 


Q ss_pred             CcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC
Q 035691          511 DFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD  590 (640)
Q Consensus       511 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~  590 (640)
                          .+..++||||+++|+|.+++....          .+++..+..++.|++.|++|||+   .+++||||||+||+++
T Consensus        81 ----~~~~~iv~e~~~~~~L~~~l~~~~----------~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~  143 (267)
T PHA03390         81 ----LKGHVLIMDYIKDGDLFDLLKKEG----------KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYD  143 (267)
T ss_pred             ----CCeeEEEEEcCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEe
Confidence                447899999999999999986442          27889999999999999999999   6999999999999999


Q ss_pred             CCC-cEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          591 NDM-IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       591 ~~~-~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      .++ .++|+|||+++.....        ....|+..|+|||++.+..++.
T Consensus       144 ~~~~~~~l~dfg~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~  185 (267)
T PHA03390        144 RAKDRIYLCDYGLCKIIGTP--------SCYDGTLDYFSPEKIKGHNYDV  185 (267)
T ss_pred             CCCCeEEEecCccceecCCC--------ccCCCCCcccChhhhcCCCCCc
Confidence            998 9999999998865321        1235889999999998877764

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.90  E-value=1.3e-23  Score=213.57  Aligned_cols=170  Identities=25%  Similarity=0.342  Sum_probs=142.4

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEeeccC
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMH  526 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~~  526 (640)
                      ..||+|+||.||+|....+++.||+|++..........+.+|+.+++.++|+||+++++++.     ..+..++||||++
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~  100 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWVVMEFLE  100 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE-----eCCEEEEEEecCC
Confidence            56999999999999999899999999986544445567899999999999999999999853     4458899999999


Q ss_pred             CCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccccccC
Q 035691          527 HGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI  606 (640)
Q Consensus       527 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~  606 (640)
                      +++|.+++...           .+++..+..++.|++.|++|||+   .+++|+||+|+||+++.++.++|+|||++...
T Consensus       101 ~~~L~~~~~~~-----------~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~  166 (292)
T cd06657         101 GGALTDIVTHT-----------RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV  166 (292)
T ss_pred             CCcHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceec
Confidence            99999887432           26778889999999999999999   69999999999999999999999999998755


Q ss_pred             CCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          607 PEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       607 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      .....    ......|++.|+|||.+.+..++.
T Consensus       167 ~~~~~----~~~~~~~~~~y~~pE~~~~~~~~~  195 (292)
T cd06657         167 SKEVP----RRKSLVGTPYWMAPELISRLPYGP  195 (292)
T ss_pred             ccccc----cccccccCccccCHHHhcCCCCCc
Confidence            32211    112245889999999988776654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.90  E-value=1e-23  Score=218.98  Aligned_cols=177  Identities=26%  Similarity=0.325  Sum_probs=144.1

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      .++|.+.+.||+|+||.||+|++..+++.||||.+...  .......+.+|+.+++.++|+||+++++++..........
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45788899999999999999999999999999998543  2333456788999999999999999999875443333345


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+. ++|.+++....          .+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL  149 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ----------TLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKI  149 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC----------CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEE
Confidence            899999996 68888875432          27888999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      +|||+++......    .......++..|+|||.+.+
T Consensus       150 ~Dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~  182 (337)
T cd07858         150 CDFGLARTTSEKG----DFMTEYVVTRWYRAPELLLN  182 (337)
T ss_pred             CcCccccccCCCc----ccccccccccCccChHHHhc
Confidence            9999998653321    11123457889999998765

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=3.5e-24  Score=233.14  Aligned_cols=184  Identities=22%  Similarity=0.254  Sum_probs=136.0

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCC-eEEEEEEe--------------e---cccchhHHHHHHHHHHHHhcCCCCC
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQ-TVVAVKVL--------------F---LHQRGALKSFMAECEALRNIRHRNL  500 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~--------------~---~~~~~~~~~~~~E~~~l~~l~H~ni  500 (640)
                      ..++|++.+.||+|+||+||+|..+... ..++.|.+              .   .........+.+|+.++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            3567999999999999999998765322 22222211              0   0111233568899999999999999


Q ss_pred             cceeEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeC
Q 035691          501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHC  580 (640)
Q Consensus       501 v~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHr  580 (640)
                      |++++++.     ..+..++|+|++. +++.+++.......     ........+..++.|++.||+|||+   .+|+||
T Consensus       226 v~l~~~~~-----~~~~~~lv~e~~~-~~l~~~l~~~~~~~-----~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHr  291 (501)
T PHA03210        226 LKIEEILR-----SEANTYMITQKYD-FDLYSFMYDEAFDW-----KDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHR  291 (501)
T ss_pred             CcEeEEEE-----ECCeeEEEEeccc-cCHHHHHhhccccc-----cccccHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence            99999954     3457889999985 57777765332210     0123355677899999999999999   699999


Q ss_pred             CCCCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          581 DLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       581 dlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||||+|||++.++.+||+|||+++.+.....   ....+.+||+.|+|||++.+..++.
T Consensus       292 DLKP~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~  347 (501)
T PHA03210        292 DIKLENIFLNCDGKIVLGDFGTAMPFEKERE---AFDYGWVGTVATNSPEILAGDGYCE  347 (501)
T ss_pred             CCCHHHEEECCCCCEEEEeCCCceecCcccc---cccccccCCcCCCCchhhcCCCCCc
Confidence            9999999999999999999999987643211   1222356999999999999887765

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.90  E-value=3e-23  Score=208.80  Aligned_cols=188  Identities=28%  Similarity=0.435  Sum_probs=143.0

Q ss_pred             CcccCcccccccceEEEEEEC---CCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCC-Cc
Q 035691          443 FSSANLIGTGSFGSVYKGILD---PDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQG-ND  516 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~-~~  516 (640)
                      |.+.+.||+|+||.||+|.++   .+++.||||++...  .....+++.+|++++++++||||+++++++......+ ..
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            556789999999999999864   35789999998543  2334567889999999999999999999875432211 12


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++++||+.+|+|.+++.......    ....+++..+..++.|++.|++|||+   .+|+||||||+||++++++.+|
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~k  153 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGE----EPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVC  153 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccC----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEE
Confidence            3578999999999988875322111    11347888999999999999999998   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ++|||+++.......  ........+++.|+|||.+.+..++.
T Consensus       154 l~dfg~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~  194 (273)
T cd05074         154 VADFGLSKKIYSGDY--YRQGCASKLPVKWLALESLADNVYTT  194 (273)
T ss_pred             ECcccccccccCCcc--eecCCCccCchhhcCHhHHhcCccch
Confidence            999999986532211  11112234567899999987766554

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.90  E-value=1.8e-23  Score=214.52  Aligned_cols=176  Identities=30%  Similarity=0.389  Sum_probs=142.0

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|+++....  +....+.+|+.++++++|+||+++++++....   .+.
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LDS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CCe
Confidence            4578889999999999999999998999999999864432  22345678999999999999999999864322   246


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+.+ +|.+++....         ..+++.++..++.|++.|++|||+   .+++||||||+||++++++.+||
T Consensus        83 ~~lv~e~~~~-~l~~~l~~~~---------~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL  149 (309)
T cd07845          83 IFLVMEYCEQ-DLASLLDNMP---------TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKI  149 (309)
T ss_pred             EEEEEecCCC-CHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEE
Confidence            7999999974 8888875432         237888999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      +|||+++........    .....+++.|+|||++.+.
T Consensus       150 ~dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~  183 (309)
T cd07845         150 ADFGLARTYGLPAKP----MTPKVVTLWYRAPELLLGC  183 (309)
T ss_pred             CccceeeecCCccCC----CCcccccccccChhhhcCC
Confidence            999999866432111    1122357889999998763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.90  E-value=1.3e-23  Score=209.42  Aligned_cols=178  Identities=24%  Similarity=0.385  Sum_probs=146.1

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +|+..+.||+|+||.||+|....+|..||+|.+....  ....+.+.+|+++++.++|+||+++++.+.     .....+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~-----~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ-----ENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec-----cCCeEE
Confidence            4778899999999999999999899999999986532  233467889999999999999999999853     345789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC-cEEEc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVG  598 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~-~~kl~  598 (640)
                      +|+||+++++|.+++.....        ..+++..+..++.|++.|+.|||+   .+++|+||||+||++++++ .+|++
T Consensus        76 lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~  144 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQRG--------VLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLG  144 (257)
T ss_pred             EEEecCCCCcHHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEec
Confidence            99999999999999865332        236888999999999999999998   6999999999999999885 56999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |||.+........    ......|++.|+|||+..+..++.
T Consensus       145 d~~~~~~~~~~~~----~~~~~~~~~~~~ape~~~~~~~~~  181 (257)
T cd08225         145 DFGIARQLNDSME----LAYTCVGTPYYLSPEICQNRPYNN  181 (257)
T ss_pred             ccccchhccCCcc----cccccCCCccccCHHHHcCCCCCc
Confidence            9999986543211    112235889999999988776654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.90  E-value=1.9e-23  Score=212.36  Aligned_cols=173  Identities=25%  Similarity=0.309  Sum_probs=140.6

Q ss_pred             CCcccCcccccccceEEEEEEC---CCCeEEEEEEeeccc----chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcC
Q 035691          442 GFSSANLIGTGSFGSVYKGILD---PDQTVVAVKVLFLHQ----RGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQ  513 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  513 (640)
                      +|++.+.||+|+||.||+|+..   .+|..||+|+++...    ....+.+.+|+++++++ +|++|+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence            3677899999999999999874   478999999986432    22346788999999999 599999999884     4


Q ss_pred             CCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC
Q 035691          514 GNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM  593 (640)
Q Consensus       514 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~  593 (640)
                      .+...++||||+++++|.+++....          .+++..+..++.|++.||.|||+   .+++||||+|+||+++.++
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~  142 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQRE----------RFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNG  142 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCC
Confidence            4557899999999999999986432          26778888999999999999998   6999999999999999999


Q ss_pred             cEEEccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          594 IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       594 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      .+||+|||+++......   ........|+..|+|||.+.+.
T Consensus       143 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~  181 (290)
T cd05613         143 HVVLTDFGLSKEFHEDE---VERAYSFCGTIEYMAPDIVRGG  181 (290)
T ss_pred             CEEEeeCccceeccccc---ccccccccCCcccCChhhccCC
Confidence            99999999998653221   1112234589999999998753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.90  E-value=1.8e-23  Score=222.84  Aligned_cols=192  Identities=21%  Similarity=0.237  Sum_probs=137.7

Q ss_pred             hcCCCcccCcccccccceEEEEEEC----------------CCCeEEEEEEeecccchhHH--------------HHHHH
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILD----------------PDQTVVAVKVLFLHQRGALK--------------SFMAE  488 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~--------------~~~~E  488 (640)
                      ..++|++.++||+|+||.||+|.+.                ..++.||||++........+              .+..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4678999999999999999999752                34568999998654333222              34457


Q ss_pred             HHHHHhcCCCCC-----cceeEeeccCC---cCCCceeeEEeeccCCCChhhhcCCCCCCC--------------CCCCC
Q 035691          489 CEALRNIRHRNL-----VKIITACSSSD---FQGNDFKALVYEFMHHGSLESWLHPESASD--------------DLNYS  546 (640)
Q Consensus       489 ~~~l~~l~H~ni-----v~l~~~~~~~~---~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~--------------~~~~~  546 (640)
                      +.++.+++|.++     ++++++|....   ...+...++||||+++|+|.++++......              .....
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777776654     67777764321   112345799999999999999987432110              00001


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccc
Q 035691          547 PSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY  626 (640)
Q Consensus       547 ~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y  626 (640)
                      ....++..+..++.|++.||.|+|+   .+|+||||||+||+++.++.+||+|||+++.+.....   .......+|+.|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~---~~~~~g~~tp~Y  376 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN---FNPLYGMLDPRY  376 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc---cCccccCCCcce
Confidence            1335778889999999999999998   6999999999999999999999999999976532211   111112358899


Q ss_pred             cCcccCCCCC
Q 035691          627 AAPEYGMGSQ  636 (640)
Q Consensus       627 ~aPE~~~~~~  636 (640)
                      +|||.+....
T Consensus       377 ~aPE~l~~~~  386 (507)
T PLN03224        377 SPPEELVMPQ  386 (507)
T ss_pred             eChhhhcCCC
Confidence            9999986543

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.90  E-value=2e-23  Score=209.72  Aligned_cols=180  Identities=26%  Similarity=0.426  Sum_probs=143.8

Q ss_pred             CCcccCcccccccceEEEEEECC-CCeEEEEEEeecc----------cchhHHHHHHHHHHHHh-cCCCCCcceeEeecc
Q 035691          442 GFSSANLIGTGSFGSVYKGILDP-DQTVVAVKVLFLH----------QRGALKSFMAECEALRN-IRHRNLVKIITACSS  509 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~  509 (640)
                      +|++.+.||+|+||.||+|.+.. +++.+|+|.+...          .......+..|+.++.+ ++||||+++++++. 
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-   79 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL-   79 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence            47788999999999999999986 6789999988532          12234567788888875 79999999999953 


Q ss_pred             CCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee
Q 035691          510 SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL  589 (640)
Q Consensus       510 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl  589 (640)
                          .+...++||||+++++|.+++......      ...+++..++.++.|++.|+.|||+.  .+++|+||+|+||++
T Consensus        80 ----~~~~~~lv~e~~~~~~l~~~l~~~~~~------~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~  147 (269)
T cd08528          80 ----ENDRLYIVMDLIEGAPLGEHFNSLKEK------KQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIML  147 (269)
T ss_pred             ----cCCeEEEEEecCCCCcHHHHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEE
Confidence                445789999999999999887432111      13478889999999999999999963  589999999999999


Q ss_pred             CCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          590 DNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       590 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +.++.+||+|||++.......     ......|+..|+|||.+.+..++.
T Consensus       148 ~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~  192 (269)
T cd08528         148 GEDDKVTITDFGLAKQKQPES-----KLTSVVGTILYSCPEIVKNEPYGE  192 (269)
T ss_pred             CCCCcEEEecccceeeccccc-----ccccccCcccCcChhhhcCCCCch
Confidence            999999999999998654321     122345889999999998877654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=3.1e-25  Score=221.50  Aligned_cols=173  Identities=25%  Similarity=0.346  Sum_probs=146.7

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +.....||-|+||.|-.+........+|+|++++.   +.++.+....|-.+|...+.|.||++|..     |.+..++|
T Consensus       422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd~kyvY  496 (732)
T KOG0614|consen  422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRDSKYVY  496 (732)
T ss_pred             hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hccchhhh
Confidence            34456799999999999988755556899988533   34555778899999999999999999988     67778999


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +.||-|-||.+...++.++.          +...+...++..+.+|++|||+   ++||+|||||+|.++|.+|.+|+.|
T Consensus       497 mLmEaClGGElWTiLrdRg~----------Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVD  563 (732)
T KOG0614|consen  497 MLMEACLGGELWTILRDRGS----------FDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVD  563 (732)
T ss_pred             hhHHhhcCchhhhhhhhcCC----------cccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEee
Confidence            99999999999999976543          5666788899999999999999   7999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      ||+|+.+..     ...+.+++|||.|.|||+++..-++
T Consensus       564 FGFAKki~~-----g~KTwTFcGTpEYVAPEIILnKGHD  597 (732)
T KOG0614|consen  564 FGFAKKIGS-----GRKTWTFCGTPEYVAPEIILNKGHD  597 (732)
T ss_pred             hhhHHHhcc-----CCceeeecCCcccccchhhhccCcc
Confidence            999998753     2345678999999999999865543

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.90  E-value=2.3e-23  Score=211.32  Aligned_cols=181  Identities=25%  Similarity=0.345  Sum_probs=150.7

Q ss_pred             HhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       438 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ..++.|+..+.||+|+||.||+|.+..++..||+|++..... ..+.+.+|+++++.++|+|++++++++..     ...
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~   89 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV-----GDE   89 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-----CCE
Confidence            345667888999999999999999988899999999975544 45778999999999999999999998543     457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++|+||+++++|.+++....         ..+++..+..++.|++.|+.|||+   .+++|+|++|+||+++.++.+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l  157 (286)
T cd06614          90 LWVVMEYMDGGSLTDIITQNF---------VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKL  157 (286)
T ss_pred             EEEEEeccCCCcHHHHHHHhc---------cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEE
Confidence            899999999999999987543         137888999999999999999999   79999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||.+........    ......+++.|+|||++.+..++.+
T Consensus       158 ~d~~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~  196 (286)
T cd06614         158 ADFGFAAQLTKEKS----KRNSVVGTPYWMAPEVIKRKDYGPK  196 (286)
T ss_pred             Cccchhhhhccchh----hhccccCCcccCCHhHhcCCCCCCc
Confidence            99999875532211    1122347889999999988776653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.90  E-value=1.4e-23  Score=210.05  Aligned_cols=173  Identities=28%  Similarity=0.379  Sum_probs=140.8

Q ss_pred             ccccccceEEEEEECCCCeEEEEEEeecccc---hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEeecc
Q 035691          449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQR---GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFM  525 (640)
Q Consensus       449 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~  525 (640)
                      ||+|+||.||+|++..+|+.||+|++.....   ...+.+.+|++++++++||||+++++.+     ..+...++||||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence            6899999999999998899999999854432   3456789999999999999999998874     4456789999999


Q ss_pred             CCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccccccc
Q 035691          526 HHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF  605 (640)
Q Consensus       526 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~  605 (640)
                      ++++|.+++....          .+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++..
T Consensus        76 ~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~  142 (265)
T cd05579          76 PGGDLASLLENVG----------SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKV  142 (265)
T ss_pred             CCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchh
Confidence            9999999986432          27888999999999999999998   6999999999999999999999999999875


Q ss_pred             CCCccCC----CceeeccccccccccCcccCCCCCCCC
Q 035691          606 IPEVISS----NQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       606 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      .......    .........++..|+|||...+..++.
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~  180 (265)
T cd05579         143 GLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSK  180 (265)
T ss_pred             cccCcccccccccccccCcccCccccCHHHhcCCCCCc
Confidence            4322110    001112345788999999987766543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.90  E-value=2.7e-24  Score=222.21  Aligned_cols=178  Identities=28%  Similarity=0.385  Sum_probs=145.6

Q ss_pred             cccCcccccccceEEEEEECCCC---eEEEEEEeecccch-hHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          444 SSANLIGTGSFGSVYKGILDPDQ---TVVAVKVLFLHQRG-ALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       444 ~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ...++||+|.||.|++|.|...+   ..||||+++..... ...+|++|+.+|.+++|||+|++||+..+      ....
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------qp~m  186 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------QPAM  186 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------chhh
Confidence            45588999999999999986432   46999999765544 56899999999999999999999999543      3567


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      ||||.++.|+|.+.|+....        ..+.......++.|||.||+||-+   +++|||||.++|+++.....+||+|
T Consensus       187 MV~ELaplGSLldrLrka~~--------~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~D  255 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAKK--------AILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICD  255 (1039)
T ss_pred             HHhhhcccchHHHHHhhccc--------cceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeec
Confidence            99999999999999976222        347778889999999999999998   7999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeec-cccccccccCcccCCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSV-GLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ||+.|.+.+...  .+... ...-...|.|||.+...+||.+
T Consensus       256 FGLmRaLg~ned--~Yvm~p~rkvPfAWCaPEsLrh~kFSha  295 (1039)
T KOG0199|consen  256 FGLMRALGENED--MYVMAPQRKVPFAWCAPESLRHRKFSHA  295 (1039)
T ss_pred             ccceeccCCCCc--ceEecCCCcCcccccCHhHhcccccccc
Confidence            999998765332  22221 2223557999999999998864

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.90  E-value=3.1e-23  Score=215.96  Aligned_cols=181  Identities=24%  Similarity=0.333  Sum_probs=147.1

Q ss_pred             CHHHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeecc
Q 035691          432 SYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSS  509 (640)
Q Consensus       432 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  509 (640)
                      ..+++...+++|++.+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+.++++++||||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            34667778899999999999999999999998899999999986432  2234568889999999999999999998743


Q ss_pred             CC-cCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCee
Q 035691          510 SD-FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVL  588 (640)
Q Consensus       510 ~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiL  588 (640)
                      .. +......+++++++ +++|.+++...           .+++..+..++.|++.|++|||+   .+|+||||||+||+
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----------~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl  152 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----------KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLA  152 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEE
Confidence            32 12234567888887 77998877532           27788899999999999999999   69999999999999


Q ss_pred             eCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          589 LDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       589 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      +++++.+||+|||+++.....       .....|++.|+|||++.+
T Consensus       153 l~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~  191 (345)
T cd07877         153 VNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLN  191 (345)
T ss_pred             EcCCCCEEEeccccccccccc-------ccccccCCCccCHHHHhC
Confidence            999999999999998854321       122457899999998765

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.90  E-value=3e-23  Score=215.98  Aligned_cols=175  Identities=25%  Similarity=0.335  Sum_probs=142.6

Q ss_pred             HhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc-CC
Q 035691          438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDF-QG  514 (640)
Q Consensus       438 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~  514 (640)
                      ...++|+..+.||+|+||.||+|....++..||||++...  .....+.+.+|++++++++||||+++++++..... ..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            3567899999999999999999999989999999998532  22234568899999999999999999998643321 11


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                      ....++||||+ +++|.+++...           .+++..+..++.|++.|++|||+   .+|+||||||+||+++.++.
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~~-----------~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~  156 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKHE-----------KLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCE  156 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCC
Confidence            13468999998 67898887431           27888999999999999999999   69999999999999999999


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      +|++|||+++.....       .....+++.|+|||.+.+
T Consensus       157 ~kl~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~  189 (343)
T cd07880         157 LKILDFGLARQTDSE-------MTGYVVTRWYRAPEVILN  189 (343)
T ss_pred             EEEeecccccccccC-------ccccccCCcccCHHHHhC
Confidence            999999999865321       122357899999998865

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.90  E-value=4e-23  Score=205.70  Aligned_cols=180  Identities=24%  Similarity=0.405  Sum_probs=149.4

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +|+..+.||+|+||.||++.+..++..||+|++.....  ...+.+.+|+++++.++|||++++++.+.     .....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-----EKGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-----cCCEEE
Confidence            47778999999999999999988899999999965433  45577899999999999999999999853     346889


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +|+||+++++|.+++......      ...+++..+..++.|++.|+.|||+   .+++|+||+|+||++++++.++|+|
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d  146 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKE------GKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGD  146 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhcc------CCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECC
Confidence            999999999999988654310      1348889999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||.+.......    .......|++.|+|||...+..++.
T Consensus       147 ~~~~~~~~~~~----~~~~~~~~~~~y~~pe~~~~~~~~~  182 (258)
T cd08215         147 FGISKVLSSTV----DLAKTVVGTPYYLSPELCQNKPYNY  182 (258)
T ss_pred             ccceeecccCc----ceecceeeeecccChhHhccCCCCc
Confidence            99998654321    1122245889999999987776654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.90  E-value=3.3e-23  Score=212.31  Aligned_cols=167  Identities=26%  Similarity=0.358  Sum_probs=138.3

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ..|+..+.||+|+||.||+|....+++.||+|++....   ....+.+.+|+++++.++||||++++++|..     .+.
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-----~~~   89 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-----EHT   89 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-----CCe
Confidence            45778899999999999999998889999999985332   2334578899999999999999999999643     446


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+. |++.+++....         ..+++..+..++.|++.|+.|||+   .+|+||||+|+||++++++.+||
T Consensus        90 ~~lv~e~~~-g~l~~~~~~~~---------~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL  156 (307)
T cd06607          90 AWLVMEYCL-GSASDILEVHK---------KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKL  156 (307)
T ss_pred             EEEEHHhhC-CCHHHHHHHcc---------cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEE
Confidence            889999997 57766664322         137888999999999999999998   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGM  633 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  633 (640)
                      +|||+++.....        ....|++.|+|||++.
T Consensus       157 ~dfg~~~~~~~~--------~~~~~~~~y~aPE~~~  184 (307)
T cd06607         157 ADFGSASLVSPA--------NSFVGTPYWMAPEVIL  184 (307)
T ss_pred             eecCcceecCCC--------CCccCCccccCceeee
Confidence            999999765321        1235788999999885

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.90  E-value=1.6e-23  Score=211.44  Aligned_cols=181  Identities=28%  Similarity=0.394  Sum_probs=148.4

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcC-CCCCcceeEeeccCCcCCCc
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIR-HRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~  516 (640)
                      ++|...+.||+|+||.||+|..+.+|+.||+|++...   .....+.+..|++++.+++ ||||+++++++     ...+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEE   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCc
Confidence            3688889999999999999999989999999998542   2233467889999999998 99999999884     4456


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++++|.+++....          .+++..++.++.|++.|+.|||+   .+++|+||+|+||+++.++.++
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~  142 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRKYG----------SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIK  142 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEE
Confidence            7899999999999999986442          38889999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCC----------------ceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSN----------------QCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ++|||++..........                ........|+..|+|||+..+..++.
T Consensus       143 l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~  201 (280)
T cd05581         143 ITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGK  201 (280)
T ss_pred             ecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCCh
Confidence            99999998654322100                11222345789999999987766553

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.90  E-value=2.9e-23  Score=211.41  Aligned_cols=174  Identities=25%  Similarity=0.387  Sum_probs=139.1

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ++|+..+.||+|++|.||+|.+..+|+.||+|.+.....  +..+.+.+|++++++++||||+++++++.     .....
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence            468888999999999999999998999999999854332  33467889999999999999999999953     44578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC-CCcEEE
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN-DMIAHV  597 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~-~~~~kl  597 (640)
                      ++||||++ +++.+++.....        ...++..+..++.|++.||+|||+   .+++||||+|+||+++. ++.+||
T Consensus        77 ~lv~e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl  144 (294)
T PLN00009         77 YLVFEYLD-LDLKKHMDSSPD--------FAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKL  144 (294)
T ss_pred             EEEEeccc-ccHHHHHHhCCC--------CCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEE
Confidence            99999996 578777643322        225677888999999999999999   69999999999999985 567999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      +|||+++.......    ......|++.|+|||++.+.
T Consensus       145 ~dfg~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~  178 (294)
T PLN00009        145 ADFGLARAFGIPVR----TFTHEVVTLWYRAPEILLGS  178 (294)
T ss_pred             cccccccccCCCcc----ccccCceeecccCHHHHhCC
Confidence            99999976532211    11123478899999998764

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.90  E-value=2.8e-23  Score=210.24  Aligned_cols=172  Identities=26%  Similarity=0.431  Sum_probs=141.2

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      |+..+.||+|++|.||+|.+..+|+.||+|++....  .+..+.+.+|+++++.++|||++++++++.     ..+..++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence            566788999999999999998899999999986443  233467889999999999999999999954     3457899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||++ ++|.+++.....        ..+++..+..++.|++.||+|||+   .+++||||+|+||+++.++.+||+||
T Consensus        76 v~e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df  143 (283)
T cd07835          76 VFEFLD-LDLKKYMDSSPL--------TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADF  143 (283)
T ss_pred             EEeccC-cCHHHHHhhCCC--------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeec
Confidence            999995 689998865432        237889999999999999999998   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      |+++.+......    .....+++.|+|||++.+.
T Consensus       144 ~~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~  174 (283)
T cd07835         144 GLARAFGVPVRT----YTHEVVTLWYRAPEILLGS  174 (283)
T ss_pred             ccccccCCCccc----cCccccccCCCCCceeecC
Confidence            999865322111    1112468899999988664

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PLN03210 Resistant to P

Probab=99.90  E-value=3.2e-22  Score=237.10  Aligned_cols=288  Identities=19%  Similarity=0.216  Sum_probs=217.9

Q ss_pred             CCchhhhcCCCCCeEEcccCc------cCccCCcCCCCCC-CCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccC
Q 035691           18 NIPHEIGRLFQLRYIIFNSNT------LQGQIPVNLTHCS-ELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAG   90 (640)
Q Consensus        18 ~~p~~~~~l~~L~~L~l~~N~------l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~   90 (640)
                      ..+.+|.++.+|+.|.+..+.      +...+|..|..++ +|+.|++.+|.++.      +|..+  ...+|+.|+|++
T Consensus       549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~------lP~~f--~~~~L~~L~L~~  620 (1153)
T PLN03210        549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRC------MPSNF--RPENLVKLQMQG  620 (1153)
T ss_pred             ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCC------CCCcC--CccCCcEEECcC
Confidence            456789999999999997764      3345777787775 69999999999876      88765  378999999999


Q ss_pred             CcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCC-
Q 035691           91 NQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVN-  169 (640)
Q Consensus        91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N-  169 (640)
                      |++. .++..+..+++|++|+|++|.....+| .+..+++|++|+|++|..-..      .|..+.++++|+.|++++| 
T Consensus       621 s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~------lp~si~~L~~L~~L~L~~c~  692 (1153)
T PLN03210        621 SKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVE------LPSSIQYLNKLEDLDMSRCE  692 (1153)
T ss_pred             cccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccc------cchhhhccCCCCEEeCCCCC
Confidence            9998 467788899999999999876444566 488899999999999764322      4567889999999999985 


Q ss_pred             CCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccc-------
Q 035691          170 SLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIF-------  242 (640)
Q Consensus       170 ~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~-------  242 (640)
                      .++.+|..+ .+++|+.|++++|...+..|..   .++|++|+|++|.+. .+|..+ .+++|+.|+++++..       
T Consensus       693 ~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~  766 (1153)
T PLN03210        693 NLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERV  766 (1153)
T ss_pred             CcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccc
Confidence            677798766 6899999999999766566643   468999999999997 556554 577888887776321       


Q ss_pred             --------cCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccC
Q 035691          243 --------LGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGL  314 (640)
Q Consensus       243 --------~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~  314 (640)
                              .....|+.|+|++|...+.+|.+++++++|+.|+|++|..-+.+|..+ ++++|+.|+|++|.....+|.. 
T Consensus       767 ~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~-  844 (1153)
T PLN03210        767 QPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI-  844 (1153)
T ss_pred             cccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc-
Confidence                    112358888999888777788888889999999998875444666654 5666777777766443333332 


Q ss_pred             CCCCCCCeEeCcCCccc
Q 035691          315 SSLKSLEGLDLFQNTFQ  331 (640)
Q Consensus       315 ~~l~~L~~L~l~~N~l~  331 (640)
                        .++|++|+|++|.++
T Consensus       845 --~~nL~~L~Ls~n~i~  859 (1153)
T PLN03210        845 --STNISDLNLSRTGIE  859 (1153)
T ss_pred             --ccccCEeECCCCCCc
Confidence              245566666666555

syringae 6; Provisional

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.90  E-value=1.6e-23  Score=210.28  Aligned_cols=181  Identities=30%  Similarity=0.471  Sum_probs=140.2

Q ss_pred             CcccccccceEEEEEECCCC------eEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          447 NLIGTGSFGSVYKGILDPDQ------TVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +.||+|+||.||+|+.....      +.||+|.+.... ......+.+|+.+++.++||||++++++|..     ....+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCeE
Confidence            36899999999999976433      689999885432 2345678999999999999999999999643     34689


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC-----c
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-----I  594 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~-----~  594 (640)
                      +||||+++|+|.+++.......   .....+++.+++.++.|++.|++|||+   .+++|+||||+||+++.++     .
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~  149 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVER---FGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRV  149 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcc---cCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcc
Confidence            9999999999999986432211   011347888999999999999999998   6999999999999999877     8


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|++|||+++........  .......++..|+|||++.++.++.+
T Consensus       150 ~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~  193 (269)
T cd05044         150 VKIGDFGLARDIYKSDYY--RKEGEGLLPVRWMAPESLLDGKFTTQ  193 (269)
T ss_pred             eEECCccccccccccccc--ccCcccCCCccccCHHHHccCCcccc
Confidence            999999999865322111  11112235778999999988777653

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=3.4e-23  Score=206.84  Aligned_cols=167  Identities=28%  Similarity=0.340  Sum_probs=134.8

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeecccc---hhHHHHHHHHHHH-HhcCCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR---GALKSFMAECEAL-RNIRHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      +.||+|+||.||+|....+|+.||+|++.....   .....+..|..++ ...+|+|++++++++.     .++..++||
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence            568999999999999988999999999864332   1223345555544 3458999999999953     345789999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      ||+++++|.+++....          .+++..+..++.|++.||.|||+   .+++||||+|+||++++++.+||+|||+
T Consensus        77 e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~  143 (260)
T cd05611          77 EYLNGGDCASLIKTLG----------GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGL  143 (260)
T ss_pred             eccCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeeccc
Confidence            9999999999986432          26788899999999999999999   6999999999999999999999999999


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ++....        .....|++.|+|||.+.+..++.
T Consensus       144 ~~~~~~--------~~~~~~~~~y~~pe~~~~~~~~~  172 (260)
T cd05611         144 SRNGLE--------NKKFVGTPDYLAPETILGVGDDK  172 (260)
T ss_pred             ceeccc--------cccCCCCcCccChhhhcCCCCcc
Confidence            875432        11235788999999998876554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.90  E-value=2.1e-23  Score=216.14  Aligned_cols=183  Identities=23%  Similarity=0.305  Sum_probs=147.7

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +|++.+.||+|+||.||+|+...+++.||+|++....  ....+.+.+|+.+++.++||||+++++++...........+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999998889999999986433  34456889999999999999999999987554322334689


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||++ ++|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.++|+|
T Consensus        81 lv~e~~~-~~l~~~l~~~~----------~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~d  146 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ----------PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICD  146 (330)
T ss_pred             EEecchh-hhHHHHHhCCC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcc
Confidence            9999998 48888886432          37888999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCC-CCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS-QVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~  639 (640)
                      ||++......... ........+|+.|+|||++.+. .++.
T Consensus       147 fg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~  186 (330)
T cd07834         147 FGLARGVDPDEDE-KGFLTEYVVTRWYRAPELLLSSSRYTK  186 (330)
T ss_pred             cCceEeecccccc-cccccccccccCcCCceeeecccCCCc
Confidence            9999876432210 0112234578999999999877 4443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.90  E-value=5.2e-23  Score=204.06  Aligned_cols=176  Identities=30%  Similarity=0.411  Sum_probs=149.0

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEE
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALV  521 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv  521 (640)
                      +|+..+.||+|++|.||+|.+..+++.||+|++........+.+.+|++.++.++|++++++++++.     .....+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL-----KKDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEEEE
Confidence            4677889999999999999998889999999997655555678999999999999999999999853     33578999


Q ss_pred             eeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccc
Q 035691          522 YEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG  601 (640)
Q Consensus       522 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfG  601 (640)
                      +||+++++|.+++....         ..+++..+..++.|++.|+.|||.   .+++|+||+|+||++++++.+||+|||
T Consensus        76 ~e~~~~~~L~~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~  143 (253)
T cd05122          76 MEFCSGGSLKDLLKSTN---------QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFG  143 (253)
T ss_pred             EecCCCCcHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecc
Confidence            99999999999886542         237888999999999999999999   699999999999999999999999999


Q ss_pred             ccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          602 LTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       602 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      .+........     .....|+..|+|||.+.+..++.
T Consensus       144 ~~~~~~~~~~-----~~~~~~~~~~~~PE~~~~~~~~~  176 (253)
T cd05122         144 LSAQLSDTKA-----RNTMVGTPYWMAPEVINGKPYDY  176 (253)
T ss_pred             cccccccccc-----ccceecCCcccCHHHHcCCCCCc
Confidence            9986643221     12345889999999998776654

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.90  E-value=3.3e-23  Score=215.23  Aligned_cols=178  Identities=29%  Similarity=0.461  Sum_probs=142.6

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~  516 (640)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...  .......+..|+.+++++ +||||++++++|...   +..
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~---~~~   82 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE---NDK   82 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC---CCc
Confidence            45688889999999999999999888999999988432  223345677899999999 999999999986432   234


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||++ ++|..++...           .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+|
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~-----------~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~k  147 (337)
T cd07852          83 DIYLVFEYME-TDLHAVIRAN-----------ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVK  147 (337)
T ss_pred             eEEEEecccc-cCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEE
Confidence            6799999997 5998887543           26777888999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCC-ceeeccccccccccCcccCCCC
Q 035691          597 VGDFGLTRFIPEVISSN-QCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      |+|||+++......... ........||+.|+|||.+.+.
T Consensus       148 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  187 (337)
T cd07852         148 LADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGS  187 (337)
T ss_pred             EeeccchhccccccccccCcchhcccccccccCceeeecc
Confidence            99999998664322110 0112235689999999987653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.90  E-value=4.3e-23  Score=211.01  Aligned_cols=182  Identities=28%  Similarity=0.390  Sum_probs=144.1

Q ss_pred             HhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCC----
Q 035691          438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSD----  511 (640)
Q Consensus       438 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----  511 (640)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|+++...  ......+.+|++++++++||||+++++++....    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34567889999999999999999999899999999996443  223356788999999999999999999875432    


Q ss_pred             -cCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC
Q 035691          512 -FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD  590 (640)
Q Consensus       512 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~  590 (640)
                       ..+....++|+||+++ ++..++....         ..+++..+..++.|++.||+|||+   .+|+||||||+||+++
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~  150 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGL---------VHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLN  150 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEC
Confidence             1123378999999986 6666664331         237888999999999999999999   6999999999999999


Q ss_pred             CCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          591 NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       591 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      +++.+||+|||.++.+.....   .......++..|+|||.+.+.
T Consensus       151 ~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~  192 (302)
T cd07864         151 NKGQIKLADFGLARLYNSEES---RPYTNKVITLWYRPPELLLGE  192 (302)
T ss_pred             CCCcEEeCcccccccccCCcc---cccccceeccCccChHHhcCC
Confidence            999999999999986643221   111122467889999988654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.90  E-value=3.6e-23  Score=213.87  Aligned_cols=174  Identities=25%  Similarity=0.345  Sum_probs=142.6

Q ss_pred             HHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc
Q 035691          435 SLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDF  512 (640)
Q Consensus       435 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  512 (640)
                      ++...+++|+..+.||+|+||.||+|+...+++.||+|++...  .....+.+..|+++++.++||||+++++++..   
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---   80 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS---   80 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec---
Confidence            3445678899999999999999999999999999999988532  22334678899999999999999999998633   


Q ss_pred             CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC
Q 035691          513 QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND  592 (640)
Q Consensus       513 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~  592 (640)
                       .....++||||+ +++|.+++...           .+++..+..++.|++.|++|||+   .+|+||||+|+||+++++
T Consensus        81 -~~~~~~lv~e~~-~~~L~~~~~~~-----------~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~  144 (328)
T cd07856          81 -PLEDIYFVTELL-GTDLHRLLTSR-----------PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINEN  144 (328)
T ss_pred             -CCCcEEEEeehh-ccCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCC
Confidence             234678999998 56898887532           25667788899999999999999   699999999999999999


Q ss_pred             CcEEEccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          593 MIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       593 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      +.+||+|||.++......       ....+++.|+|||++.+
T Consensus       145 ~~~~l~dfg~~~~~~~~~-------~~~~~~~~y~aPE~~~~  179 (328)
T cd07856         145 CDLKICDFGLARIQDPQM-------TGYVSTRYYRAPEIMLT  179 (328)
T ss_pred             CCEEeCccccccccCCCc-------CCCcccccccCceeeec
Confidence            999999999998543211       12357889999998766

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.90  E-value=1.4e-23  Score=232.78  Aligned_cols=246  Identities=27%  Similarity=0.404  Sum_probs=175.0

Q ss_pred             CCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCC
Q 035691            4 FLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNI   83 (640)
Q Consensus         4 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L   83 (640)
                      +.+.|++++++++ .+|..+.  ++|+.|+|++|+|+ .+|..+.  ++|++|++++|+|+.      +|..++   ++|
T Consensus       179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lts------LP~~l~---~~L  243 (754)
T PRK15370        179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTS------IPATLP---DTI  243 (754)
T ss_pred             CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCcccc------CChhhh---ccc
Confidence            4678889998888 5676554  47889999999988 4565443  589999999888875      666543   478


Q ss_pred             CeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcce
Q 035691           84 RIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEI  163 (640)
Q Consensus        84 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~  163 (640)
                      +.|+|++|++. .+|..+.  ++|+.|+|++|+|+. +|..+.  ++|+.|+|++|+|+.++.       .+.  ++|+.
T Consensus       244 ~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~LP~-------~lp--~sL~~  308 (754)
T PRK15370        244 QEMELSINRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRTLPA-------HLP--SGITH  308 (754)
T ss_pred             cEEECcCCccC-cCChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCccccCcc-------cch--hhHHH
Confidence            88999999988 4565554  578999999999984 565543  578999999998887642       121  36888


Q ss_pred             EecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCcccc
Q 035691          164 VSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFL  243 (640)
Q Consensus       164 L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~  243 (640)
                      |++++|+++.+|..+.  ++|+.|++++|.+++ +|..+.  ++|+.|+|++|+|+ .+|..+.  ++|+.|        
T Consensus       309 L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~L--------  372 (754)
T PRK15370        309 LNVQSNSLTALPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTL--------  372 (754)
T ss_pred             HHhcCCccccCCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEE--------
Confidence            8899999988876553  678889999998884 566554  68889999999887 4555442  466666        


Q ss_pred             CCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCcccc----CCCCCCeEEecCCccC
Q 035691          244 GQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLG----SCVGLEYLNLSINSFH  307 (640)
Q Consensus       244 ~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l~~L~~L~L~~N~l~  307 (640)
                              +|++|+|+. +|..+.  .+|+.|++++|+|+ .+|..+.    .++++..|+|.+|+|+
T Consensus       373 --------dLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        373 --------DVSRNALTN-LPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             --------ECCCCcCCC-CCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence                    666666663 343333  25677777777776 4444333    3356677777777765

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.90  E-value=4e-23  Score=209.39  Aligned_cols=174  Identities=28%  Similarity=0.432  Sum_probs=142.2

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      |++.+.||+|+||.||+|....+++.||+|++....  ......+.+|+++++.++|||++++++++....   ....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence            566788999999999999999889999999997553  344567889999999999999999999975431   357899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||+++ ++.+++....         ..+++..++.++.|++.|++|||+   .+++|+||+|+||++++++.+||+||
T Consensus        78 v~e~~~~-~l~~~~~~~~---------~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~  144 (287)
T cd07840          78 VFEYMDH-DLTGLLDSPE---------VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADF  144 (287)
T ss_pred             Eeccccc-cHHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccc
Confidence            9999975 8888875432         237888999999999999999999   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      |+++.......   .......++..|+|||.+.+.
T Consensus       145 g~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~  176 (287)
T cd07840         145 GLARPYTKRNS---ADYTNRVITLWYRPPELLLGA  176 (287)
T ss_pred             cceeeccCCCc---ccccccccccccCCceeeEcc
Confidence            99986643211   111223468899999987653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=1.1e-23  Score=213.06  Aligned_cols=178  Identities=22%  Similarity=0.251  Sum_probs=143.8

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEee--cccchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCC
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF--LHQRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~  515 (640)
                      ....|++.++||+||.++||++... +.+.||+|.+.  ..+......|.+|+..|.++ .|.+||++++|     -.++
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY-----Ev~d  432 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDY-----EVTD  432 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeee-----eccC
Confidence            3445788899999999999999876 56677777663  34555668899999999999 59999999999     4557


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      .+.||||||- .-||..+|......         .+...+..+..||+.|+.++|.   .||||.||||.|+|+- +|.+
T Consensus       433 ~~lYmvmE~G-d~DL~kiL~k~~~~---------~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~L  498 (677)
T KOG0596|consen  433 GYLYMVMECG-DIDLNKILKKKKSI---------DPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRL  498 (677)
T ss_pred             ceEEEEeecc-cccHHHHHHhccCC---------CchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeE
Confidence            7999999975 45999999765432         3323678899999999999999   5999999999999985 6799


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      ||+|||+|..+..+.+.-...  .-+||+-|||||.+.....+
T Consensus       499 KLIDFGIA~aI~~DTTsI~kd--sQvGT~NYMsPEAl~~~~s~  539 (677)
T KOG0596|consen  499 KLIDFGIANAIQPDTTSIVKD--SQVGTVNYMSPEALTDMSSS  539 (677)
T ss_pred             EeeeechhcccCccccceeec--cccCcccccCHHHHhhcccc
Confidence            999999999887655443222  34699999999999876655

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.90  E-value=3.8e-23  Score=210.44  Aligned_cols=186  Identities=21%  Similarity=0.254  Sum_probs=133.0

Q ss_pred             cCCCcccCcccccccceEEEEEECCC---CeEEEEEEeecccchh-----------HHHHHHHHHHHHhcCCCCCcceeE
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPD---QTVVAVKVLFLHQRGA-----------LKSFMAECEALRNIRHRNLVKIIT  505 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l~~  505 (640)
                      .++|++.+.||+|+||+||+|++..+   +..+|+|+........           ......+...+..++|++|+++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            46789999999999999999998876   6677777653322211           012233444556678999999998


Q ss_pred             eeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCC
Q 035691          506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPS  585 (640)
Q Consensus       506 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~  585 (640)
                      ++.... ....+.++++|++.. ++.+.+....          ..++..+..++.|++.||+|||+   .+|+||||||+
T Consensus        91 ~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~----------~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~  155 (294)
T PHA02882         91 CGSFKR-CRMYYRFILLEKLVE-NTKEIFKRIK----------CKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPE  155 (294)
T ss_pred             eeeEec-CCceEEEEEEehhcc-CHHHHHHhhc----------cCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHH
Confidence            754322 122345788887643 5555543221          14567788999999999999999   69999999999


Q ss_pred             CeeeCCCCcEEEccccccccCCCccCC---CceeeccccccccccCcccCCCCCCCCC
Q 035691          586 NVLLDNDMIAHVGDFGLTRFIPEVISS---NQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       586 NiLl~~~~~~kl~DfGla~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |||++.++.+||+|||+|+.+......   .........||+.|+|||+..+..++.+
T Consensus       156 Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~  213 (294)
T PHA02882        156 NIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRR  213 (294)
T ss_pred             HEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcH
Confidence            999999999999999999866322111   0111223469999999999998887754

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.89  E-value=8.5e-23  Score=207.07  Aligned_cols=181  Identities=27%  Similarity=0.401  Sum_probs=144.1

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhc---CCCCCcceeEeeccCCcCCCce
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNI---RHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      |++.+.||+|+||.||+|+++.+++.||+|+++...  ......+.+|+.+++++   +|||++++++++...+......
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            566789999999999999998889999999996432  22235667788777666   5999999999986655433445


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .+++|||+.+ ++.+++.....        ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~--------~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l  148 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPK--------PGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKI  148 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccC--------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEE
Confidence            8999999974 88888754322        237889999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||+++.+.....     .....++..|+|||++.+..++.|
T Consensus       149 ~dfg~~~~~~~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~  186 (287)
T cd07838         149 ADFGLARIYSFEMA-----LTSVVVTLWYRAPEVLLQSSYATP  186 (287)
T ss_pred             eccCcceeccCCcc-----cccccccccccChHHhccCCCCCc
Confidence            99999986643211     112347889999999988777653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.89  E-value=9.2e-23  Score=209.99  Aligned_cols=165  Identities=27%  Similarity=0.369  Sum_probs=136.5

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      |+..+.||+|+||.||+|++..++..||+|++....   ......+..|+++++.++|||+++++++|..     +...+
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~  101 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EHTAW  101 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CCeEE
Confidence            566788999999999999998899999999986432   2234578899999999999999999999643     44689


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+. |++.+++....         ..+++.++..++.|++.|+.|||+   .+|+||||+|+||+++.++.+||+|
T Consensus       102 lv~e~~~-g~l~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~d  168 (317)
T cd06635         102 LVMEYCL-GSASDLLEVHK---------KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLAD  168 (317)
T ss_pred             EEEeCCC-CCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEec
Confidence            9999997 47777664322         237888999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGM  633 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  633 (640)
                      ||++......        ....|++.|+|||++.
T Consensus       169 fg~~~~~~~~--------~~~~~~~~y~aPE~~~  194 (317)
T cd06635         169 FGSASIASPA--------NSFVGTPYWMAPEVIL  194 (317)
T ss_pred             CCCccccCCc--------ccccCCccccChhhhh
Confidence            9998754321        1235889999999974

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.89  E-value=3.5e-23  Score=206.09  Aligned_cols=178  Identities=26%  Similarity=0.384  Sum_probs=147.8

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +|++.+.||+|+||.||++....+++.+|+|.+....  ......+..|+++++.++|+||+++++++     ......+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF-----LDGNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhh-----ccCCEEE
Confidence            4778899999999999999999899999999986543  33446788999999999999999999884     3446789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++++|.+++......      ...+++..++.++.|++.|++|||+   .+++|+||+|+||++++++.+|++|
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d  146 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKK------RKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGD  146 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEee
Confidence            999999999999988653211      1337888999999999999999998   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+++......      .....|++.|+|||...+..++.
T Consensus       147 ~g~~~~~~~~~------~~~~~~~~~~~~Pe~~~~~~~~~  180 (256)
T cd08530         147 LGISKVLKKNM------AKTQIGTPHYMAPEVWKGRPYSY  180 (256)
T ss_pred             ccchhhhccCC------cccccCCccccCHHHHCCCCCCc
Confidence            99998764321      11234788999999998877654

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.89  E-value=3e-23  Score=210.63  Aligned_cols=173  Identities=27%  Similarity=0.339  Sum_probs=136.2

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcC-CCCCcceeEeeccCCcCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIR-HRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +|+..+.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.++.++. ||||+++++++.     .....+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-----~~~~~~   79 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF-----REGDCW   79 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-----cCCcEE
Confidence            3455688999999999999999999999999986443 234467889999999996 999999999853     334678


Q ss_pred             EEeeccCCCChhhh---cCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          520 LVYEFMHHGSLESW---LHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       520 lv~e~~~~g~L~~~---l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ++|||+.. ++.++   +.....        ..+++..+..++.|++.|++|||+.  .+++||||||+||+++.++.+|
T Consensus        80 ~~~e~~~~-~l~~l~~~~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~k  148 (288)
T cd06616          80 ICMELMDI-SLDKFYKYVYEVLK--------SVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIK  148 (288)
T ss_pred             EEEecccC-CHHHHHHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEE
Confidence            99999864 44433   221111        2378889999999999999999973  4899999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      |+|||+++.......     .....|++.|+|||++.+.
T Consensus       149 l~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~  182 (288)
T cd06616         149 LCDFGISGQLVDSIA-----KTRDAGCRPYMAPERIDPS  182 (288)
T ss_pred             EeecchhHHhccCCc-----cccccCccCccCHHHhccc
Confidence            999999976532211     1123478999999998766

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.89  E-value=4.2e-23  Score=214.77  Aligned_cols=179  Identities=26%  Similarity=0.368  Sum_probs=142.1

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc-------
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDF-------  512 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-------  512 (640)
                      .++|+..+.||+|+||.||+|+...+|+.||+|++........+.+.+|++++++++||||+++++++.....       
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            4678899999999999999999999999999999976665566788999999999999999999987543321       


Q ss_pred             --CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC
Q 035691          513 --QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD  590 (640)
Q Consensus       513 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~  590 (640)
                        ......++||||++ ++|.+++...           .+++..+..++.|++.|+.|||+   .+|+||||||+||+++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----------~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~  148 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG-----------PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFIN  148 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEc
Confidence              11235789999997 5888877432           26788999999999999999998   6999999999999997


Q ss_pred             -CCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          591 -NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       591 -~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                       +++.+|++|||.++......... .......|+..|+|||++.+
T Consensus       149 ~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~  192 (342)
T cd07854         149 TEDLVLKIGDFGLARIVDPHYSHK-GYLSEGLVTKWYRSPRLLLS  192 (342)
T ss_pred             CCCceEEECCcccceecCCccccc-cccccccccccccCHHHHhC
Confidence             45688999999997653211111 11112347889999998755

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.89  E-value=6.9e-24  Score=189.07  Aligned_cols=180  Identities=23%  Similarity=0.295  Sum_probs=137.7

Q ss_pred             HHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHh-cCCCCCcceeEeeccCCcCC
Q 035691          437 LKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRN-IRHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       437 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~  514 (640)
                      +...++......||+|+||.|-+-++..+|+..|+|.+...- .+..+..++|+.+..+ ..+|.+|.++|.     +..
T Consensus        42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa-----~~r  116 (282)
T KOG0984|consen   42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGA-----LFR  116 (282)
T ss_pred             ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehh-----hhc
Confidence            333444455678999999999999999999999999996543 2344678888887665 479999999998     344


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                      ...+|+.||.|+- +|..+.+.--.      .....++...-+|+..+..||.|||+.  ..++|||+||+|||++.+|.
T Consensus       117 egdvwIcME~M~t-Sldkfy~~v~~------~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~Gq  187 (282)
T KOG0984|consen  117 EGDVWICMELMDT-SLDKFYRKVLK------KGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQ  187 (282)
T ss_pred             cccEEEeHHHhhh-hHHHHHHHHHh------cCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCc
Confidence            4568999999964 66544322110      013478888889999999999999995  78999999999999999999


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      +|+||||++..+.+......     -.|-..|||||.+..+
T Consensus       188 VKiCDFGIsG~L~dSiAkt~-----daGCkpYmaPEri~~e  223 (282)
T KOG0984|consen  188 VKICDFGISGYLVDSIAKTM-----DAGCKPYMAPERINPE  223 (282)
T ss_pred             EEEcccccceeehhhhHHHH-----hcCCCccCChhhcCcc
Confidence            99999999987754322111     2366789999998653

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.89  E-value=7.6e-23  Score=210.03  Aligned_cols=183  Identities=27%  Similarity=0.402  Sum_probs=143.3

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc---CC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--GALKSFMAECEALRNIRHRNLVKIITACSSSDF---QG  514 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---~~  514 (640)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.....  .....+.+|+++++.++||||+++++++.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            4678999999999999999999998999999999854332  223467889999999999999999988644321   22


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                      ....++||||+.+ ++...+....         ..+++..+..++.|+++||+|||+   .+|+||||||+||++++++.
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~---------~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~  153 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPS---------VKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGI  153 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccc---------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCC
Confidence            3457899999975 6766664322         238899999999999999999999   69999999999999999999


Q ss_pred             EEEccccccccCCCccCCCc-------eeeccccccccccCcccCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQ-------CSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      +||+|||+++..........       .......|++.|+|||.+.+.
T Consensus       154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  201 (311)
T cd07866         154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE  201 (311)
T ss_pred             EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCC
Confidence            99999999986543221110       111234578899999988664

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.89  E-value=1.2e-22  Score=202.29  Aligned_cols=180  Identities=27%  Similarity=0.416  Sum_probs=149.0

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +|+..+.||+|++|.||+|....+++.|++|++.....  ...+.+.+|++++++++||||+++++.+....   ....+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence            36777899999999999999998999999999865542  44578999999999999999999999864331   25789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++++|.+++....          .+++..+..++.|++.|++|||+   .+++|+||+|+||+++.++.+||+|
T Consensus        78 lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d  144 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKFG----------KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLAD  144 (260)
T ss_pred             EEEEecCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcc
Confidence            9999999999999986443          27888999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||.+.........  .......++..|+|||.+.+..++.
T Consensus       145 ~~~~~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~  182 (260)
T cd06606         145 FGCAKRLGDIETG--EGTGSVRGTPYWMAPEVIRGEEYGR  182 (260)
T ss_pred             cccEEeccccccc--ccccCCCCCccccCHhhhcCCCCCc
Confidence            9999876443210  0112345889999999987765543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.89  E-value=7.1e-23  Score=207.87  Aligned_cols=174  Identities=25%  Similarity=0.314  Sum_probs=140.4

Q ss_pred             CCcccCcccccccceEEEEEEC---CCCeEEEEEEeeccc----chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcC
Q 035691          442 GFSSANLIGTGSFGSVYKGILD---PDQTVVAVKVLFLHQ----RGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQ  513 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~  513 (640)
                      +|++.+.||+|+||.||+|+..   .+++.||||+++...    ....+.+.+|++++.++ +||+|+++++.     +.
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYA-----FQ   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhhee-----ee
Confidence            3677889999999999999863   467889999986432    22335688999999999 59999999988     44


Q ss_pred             CCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC
Q 035691          514 GNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM  593 (640)
Q Consensus       514 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~  593 (640)
                      .+...++||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+++||||+|+||+++.++
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~  142 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLYQRE----------HFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEG  142 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHhhcC----------CcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCC
Confidence            4567899999999999999885432          26788889999999999999998   6999999999999999999


Q ss_pred             cEEEccccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          594 IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       594 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      .++++|||+++.......   .......|+..|+|||.+.+..
T Consensus       143 ~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~  182 (288)
T cd05583         143 HVVLTDFGLSKEFLAEEE---ERAYSFCGTIEYMAPEVIRGGS  182 (288)
T ss_pred             CEEEEECccccccccccc---cccccccCCccccCHHHhcCCC
Confidence            999999999886533211   1112345889999999987654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.89  E-value=1.2e-22  Score=211.48  Aligned_cols=172  Identities=26%  Similarity=0.341  Sum_probs=139.1

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc-CCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDF-QGND  516 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~~  516 (640)
                      .++|...+.||+|+||.||+|++..+|+.||||++...  .......+.+|+.+++.++||||+++++++..... ....
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            46788999999999999999999889999999998542  22233568899999999999999999998754322 1223


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+.. ++..+..            ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+|
T Consensus        94 ~~~lv~e~~~~-~l~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~k  157 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG------------HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELK  157 (342)
T ss_pred             eEEEEeccccc-CHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEE
Confidence            46899999964 6766542            126788899999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      ++|||+++.....       .....|++.|+|||++.+
T Consensus       158 L~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~  188 (342)
T cd07879         158 ILDFGLARHADAE-------MTGYVVTRWYRAPEVILN  188 (342)
T ss_pred             EeeCCCCcCCCCC-------CCCceeeecccChhhhcC
Confidence            9999999854321       122357889999999876

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.3e-24  Score=201.29  Aligned_cols=177  Identities=25%  Similarity=0.316  Sum_probs=138.1

Q ss_pred             cccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEE
Q 035691          444 SSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALV  521 (640)
Q Consensus       444 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv  521 (640)
                      +..+-||-|+||.||.+++..+|+.||+|++..-  .-...+.+.+|++++.-++|.|+...++.........-...|+|
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            3457899999999999999999999999988422  22344778899999999999999998887533322222346788


Q ss_pred             eeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccc
Q 035691          522 YEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG  601 (640)
Q Consensus       522 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfG  601 (640)
                      +|.|.. ||...+-.          +..++...+.-+..||++|+.|||+   .+|.||||||.|.|++.+...||+|||
T Consensus       136 TELmQS-DLHKIIVS----------PQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFG  201 (449)
T KOG0664|consen  136 TELMQS-DLHKIIVS----------PQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFG  201 (449)
T ss_pred             HHHHHh-hhhheecc----------CCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccc
Confidence            888854 77766643          2346666778899999999999999   699999999999999999999999999


Q ss_pred             ccccCCCccCCCceeeccccccccccCcccCCCCCC
Q 035691          602 LTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV  637 (640)
Q Consensus       602 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  637 (640)
                      +||.-+....   ...+..+-|.+|+|||+++|.+.
T Consensus       202 LARvee~d~~---~hMTqEVVTQYYRAPEiLMGaRh  234 (449)
T KOG0664|consen  202 LARTWDQRDR---LNMTHEVVTQYYRAPELLMGARR  234 (449)
T ss_pred             cccccchhhh---hhhHHHHHHHHhccHHHhhcchh
Confidence            9996432211   11223346899999999999764

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.89  E-value=1.2e-22  Score=205.39  Aligned_cols=171  Identities=25%  Similarity=0.323  Sum_probs=136.1

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeecccc-hhHHHHHHHHHHHHhcC-CCCCcceeEeeccCCcCCCceeeE
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR-GALKSFMAECEALRNIR-HRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      |++.+.||+|+||.||+|....+++.||+|++..... ........|+.++.++. |+||+++++++....   ....++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~---~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK---TGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC---CCcEEE
Confidence            5667889999999999999998999999999854322 22234557888999885 999999999975431   246899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||++ |++.+++....         ..+++..+..++.|++.||+|||+   .+++||||+|+||+++. +.+||+||
T Consensus        78 v~e~~~-~~l~~~l~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~df  143 (282)
T cd07831          78 VFELMD-MNLYELIKGRK---------RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADF  143 (282)
T ss_pred             EEecCC-ccHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEec
Confidence            999997 58887775432         237889999999999999999999   69999999999999999 99999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      |+++........     ....+++.|+|||.+.++
T Consensus       144 g~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~  173 (282)
T cd07831         144 GSCRGIYSKPPY-----TEYISTRWYRAPECLLTD  173 (282)
T ss_pred             ccccccccCCCc-----CCCCCCcccCChhHhhcC
Confidence            999865432111     123578999999987543

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.89  E-value=1.1e-24  Score=201.19  Aligned_cols=168  Identities=27%  Similarity=0.328  Sum_probs=131.3

Q ss_pred             cCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHh-cCCCCCcceeEeeccCCcCCCceeeEEee
Q 035691          446 ANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRN-IRHRNLVKIITACSSSDFQGNDFKALVYE  523 (640)
Q Consensus       446 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~~~~~~lv~e  523 (640)
                      ...||.|+||+|+|-.+++.|+.+|||+++... +.+.++++.|.++..+ -++|+||+++|++.    ..+ ..|+-||
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F----~EG-dcWiCME  143 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF----SEG-DCWICME  143 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh----cCC-ceeeeHH
Confidence            467999999999999999999999999996543 4566788899876554 48999999999973    333 4689999


Q ss_pred             ccCCCChhhhc---CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          524 FMHHGSLESWL---HPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       524 ~~~~g~L~~~l---~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      .|+- ++..+.   .....        ..+++.-.-+|......||.||.+.  ..|+|||+||+|||+|..|.+|++||
T Consensus       144 LMd~-SlDklYk~vy~vq~--------~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDF  212 (361)
T KOG1006|consen  144 LMDI-SLDKLYKRVYSVQK--------SRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDF  212 (361)
T ss_pred             HHhh-hHHHHHHHHHHHHh--------ccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecc
Confidence            9953 443322   22111        3477777788889999999999885  68999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      |++..+.+....     +.-+|-..|||||.+.-
T Consensus       213 GIcGqLv~SiAk-----T~daGCrpYmAPERi~p  241 (361)
T KOG1006|consen  213 GICGQLVDSIAK-----TVDAGCRPYMAPERIDP  241 (361)
T ss_pred             cchHhHHHHHHh-----hhccCCccccChhccCC
Confidence            999876543221     12347788999999854

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.89  E-value=9.4e-23  Score=211.00  Aligned_cols=173  Identities=22%  Similarity=0.235  Sum_probs=135.7

Q ss_pred             Cccccc--ccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          447 NLIGTG--SFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       447 ~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      ..||+|  +||+||+|++..+|+.||+|++....  ....+.+.+|+.+++.++||||+++++++.     .++..++||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----TGSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-----cCCceEEEE
Confidence            346666  89999999999899999999986433  234477889999999999999999999953     455789999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      ||+.+|++.+++.....        ..+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+|++|||.
T Consensus        79 e~~~~~~l~~~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~  147 (328)
T cd08226          79 PFMAYGSANSLLKTYFP--------EGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSH  147 (328)
T ss_pred             ecccCCCHHHHHHhhcc--------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHH
Confidence            99999999998865432        237888899999999999999998   6999999999999999999999999986


Q ss_pred             cccCCCccCCC---ceeeccccccccccCcccCCCC
Q 035691          603 TRFIPEVISSN---QCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       603 a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      +..........   ........++..|+|||++.+.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  183 (328)
T cd08226         148 LYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQD  183 (328)
T ss_pred             HhhhhccCccccccccccccccCccCccChhhhcCC
Confidence            54332111100   0001112356779999999764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.89  E-value=1.2e-23  Score=195.07  Aligned_cols=170  Identities=22%  Similarity=0.293  Sum_probs=133.9

Q ss_pred             cccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCceeeEE
Q 035691          444 SSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDFKALV  521 (640)
Q Consensus       444 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lv  521 (640)
                      +....+|+|+.|.|++++++.+|..+|||.+.... ..+.++++..++++..- ++|.||+.+|+     |..+..+++.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~Gy-----Fi~n~dV~Ic  169 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGY-----FITNTDVFIC  169 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeE-----EeeCchHHHH
Confidence            34577999999999999999999999999996543 44557888888888776 59999999999     4555578899


Q ss_pred             eeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccc
Q 035691          522 YEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG  601 (640)
Q Consensus       522 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfG  601 (640)
                      ||.|.- -...+++.-.         ..+++.-.-++...+..||.||.+.  .+|+|||+||+|||+|+.|.+|++|||
T Consensus       170 MelMs~-C~ekLlkrik---------~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFG  237 (391)
T KOG0983|consen  170 MELMST-CAEKLLKRIK---------GPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFG  237 (391)
T ss_pred             HHHHHH-HHHHHHHHhc---------CCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeeccc
Confidence            998853 3333343222         2377777778999999999999884  689999999999999999999999999


Q ss_pred             ccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          602 LTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       602 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      ++.++.+.....     ...|-+.|||||.+--.
T Consensus       238 IsGrlvdSkAht-----rsAGC~~YMaPERidp~  266 (391)
T KOG0983|consen  238 ISGRLVDSKAHT-----RSAGCAAYMAPERIDPP  266 (391)
T ss_pred             ccceeecccccc-----cccCCccccCccccCCC
Confidence            998875432211     12478899999998543

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.89  E-value=1.2e-22  Score=210.99  Aligned_cols=177  Identities=24%  Similarity=0.349  Sum_probs=138.9

Q ss_pred             CCCc-ccCcccccccceEEEEEECCCCeEEEEEEeecccchh--------------HHHHHHHHHHHHhcCCCCCcceeE
Q 035691          441 GGFS-SANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA--------------LKSFMAECEALRNIRHRNLVKIIT  505 (640)
Q Consensus       441 ~~~~-~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~~  505 (640)
                      ++|. +.+.||+|+||.||+|++..+++.||||++.......              ...+.+|+++++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3454 3477999999999999999899999999985432211              125778999999999999999999


Q ss_pred             eeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCC
Q 035691          506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPS  585 (640)
Q Consensus       506 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~  585 (640)
                      ++.     ..+..++||||+. |+|.+++....          .+++.....++.|++.|++|||+   .+++||||+|+
T Consensus        88 ~~~-----~~~~~~lv~e~~~-~~l~~~l~~~~----------~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~  148 (335)
T PTZ00024         88 VYV-----EGDFINLVMDIMA-SDLKKVVDRKI----------RLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPA  148 (335)
T ss_pred             EEe-----cCCcEEEEEeccc-cCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHH
Confidence            953     4457899999997 68998885432          27788899999999999999998   69999999999


Q ss_pred             CeeeCCCCcEEEccccccccCCCccC----------CCceeeccccccccccCcccCCCCC
Q 035691          586 NVLLDNDMIAHVGDFGLTRFIPEVIS----------SNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       586 NiLl~~~~~~kl~DfGla~~~~~~~~----------~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      ||+++.++.+|++|||+++.......          ..........+++.|+|||.+.+..
T Consensus       149 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  209 (335)
T PTZ00024        149 NIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE  209 (335)
T ss_pred             HeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCC
Confidence            99999999999999999986541110          0011112234688999999987643

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.89  E-value=2.4e-22  Score=206.40  Aligned_cols=165  Identities=27%  Similarity=0.367  Sum_probs=135.9

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      |...+.||+|+||+||+|+...+++.||+|++....   ....+.+.+|+++++.++|||++++++++.     +....+
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   97 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL-----KEHTAW   97 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEEE
Confidence            455678999999999999998899999999986432   233457889999999999999999999954     345789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+. |++.+++....         ..+++.++..++.|++.|+.|||+   .+++||||+|+||++++++.+||+|
T Consensus        98 lv~e~~~-~~l~~~l~~~~---------~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~d  164 (313)
T cd06633          98 LVMEYCL-GSASDLLEVHK---------KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLAD  164 (313)
T ss_pred             EEEecCC-CCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEee
Confidence            9999996 57777764322         237888999999999999999998   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGM  633 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  633 (640)
                      ||++.....        .....|+..|+|||++.
T Consensus       165 fg~~~~~~~--------~~~~~~~~~y~aPE~~~  190 (313)
T cd06633         165 FGSASKSSP--------ANSFVGTPYWMAPEVIL  190 (313)
T ss_pred             cCCCcccCC--------CCCccccccccChhhcc
Confidence            999864321        11245889999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.88  E-value=8.8e-23  Score=226.45  Aligned_cols=247  Identities=25%  Similarity=0.375  Sum_probs=184.9

Q ss_pred             CCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCC
Q 035691           27 FQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASK  106 (640)
Q Consensus        27 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  106 (640)
                      .+.+.|+++++.++ .+|..+.  ++|+.|+|++|+|+.      +|..++   ++|+.|+|++|+|+. +|..+.  ++
T Consensus       178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lts------LP~~l~---~nL~~L~Ls~N~Lts-LP~~l~--~~  242 (754)
T PRK15370        178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELKS------LPENLQ---GNIKTLYANSNQLTS-IPATLP--DT  242 (754)
T ss_pred             cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCc------CChhhc---cCCCEEECCCCcccc-CChhhh--cc
Confidence            35678899998888 4666553  578899999888875      777654   578899999998884 455553  47


Q ss_pred             CCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcCCCCCCCCCE
Q 035691          107 LEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQV  186 (640)
Q Consensus       107 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~  186 (640)
                      |+.|+|++|+++. +|..+.  ++|+.|+|++|+|+.++.       .+.  ++|+.|++++|+|+.+|..+.  ++|+.
T Consensus       243 L~~L~Ls~N~L~~-LP~~l~--s~L~~L~Ls~N~L~~LP~-------~l~--~sL~~L~Ls~N~Lt~LP~~lp--~sL~~  308 (754)
T PRK15370        243 IQEMELSINRITE-LPERLP--SALQSLDLFHNKISCLPE-------NLP--EELRYLSVYDNSIRTLPAHLP--SGITH  308 (754)
T ss_pred             ccEEECcCCccCc-CChhHh--CCCCEEECcCCccCcccc-------ccC--CCCcEEECCCCccccCcccch--hhHHH
Confidence            8889999998884 565553  478889999988886542       222  468888888888888876553  47888


Q ss_pred             EEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCccC
Q 035691          187 LSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAV  266 (640)
Q Consensus       187 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~  266 (640)
                      |++++|.++. +|..+.  ++|+.|++++|.+++ +|..+.  ++|+.|                ++++|+|+ .+|..+
T Consensus       309 L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L----------------~Ls~N~L~-~LP~~l  365 (754)
T PRK15370        309 LNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVL----------------DVSKNQIT-VLPETL  365 (754)
T ss_pred             HHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEE----------------ECCCCCCC-cCChhh
Confidence            8888888884 454443  678888888888874 454442  456655                88888887 466655


Q ss_pred             CCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCcc----CCCCCCCCeEeCcCCccc
Q 035691          267 GNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPG----LSSLKSLEGLDLFQNTFQ  331 (640)
Q Consensus       267 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~----~~~l~~L~~L~l~~N~l~  331 (640)
                      .  ++|+.|+|++|+|+ .+|..+.  ..|+.|++++|+|+. +|..    +..++++..|++.+|++.
T Consensus       366 p--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        366 P--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             c--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCcc
Confidence            3  68999999999999 5666664  369999999999984 4543    445688999999999986

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.88  E-value=1.2e-22  Score=205.35  Aligned_cols=175  Identities=29%  Similarity=0.445  Sum_probs=143.3

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      |+..+.||+|+||.||+|+...+++.||+|++....  ....+.+..|+.++++++|+||+++++++.     .....++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence            456688999999999999999889999999996543  334467889999999999999999999854     3457899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||++ ++|.+++....         ..+++..+..++.|++.|++|||+   .+|+||||+|+||++++++.+||+||
T Consensus        76 v~e~~~-~~l~~~i~~~~---------~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~  142 (282)
T cd07829          76 VFEYCD-MDLKKYLDKRP---------GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADF  142 (282)
T ss_pred             EecCcC-cCHHHHHHhhc---------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecC
Confidence            999998 58999986542         137889999999999999999999   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCC-CCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS-QVST  639 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~  639 (640)
                      |.++.......    ......++..|+|||.+.+. .++.
T Consensus       143 g~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~  178 (282)
T cd07829         143 GLARAFGIPLR----TYTHEVVTLWYRAPEILLGSKHYST  178 (282)
T ss_pred             CcccccCCCcc----ccCccccCcCcCChHHhcCCcCCCc
Confidence            99986543211    11123457889999998766 4443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.88  E-value=1.9e-22  Score=204.20  Aligned_cols=171  Identities=27%  Similarity=0.370  Sum_probs=139.3

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeecccc-hhHHHHHHHHHHHHhcC-CCCCcceeEeeccCCcCCCceeeE
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR-GALKSFMAECEALRNIR-HRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      |++.+.||+|+||.||+|+...+++.||+|++..... .......+|+..+++++ ||||+++++++.     .+...++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-----~~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR-----ENDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh-----cCCcEEE
Confidence            5667899999999999999988899999999854322 22234567999999998 999999999853     3557899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||+ +|++.+++.....        ..+++..+..++.|++.|+.|||+   .+++|+||+|+||++++++.++|+||
T Consensus        76 v~e~~-~~~l~~~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~  143 (283)
T cd07830          76 VFEYM-EGNLYQLMKDRKG--------KPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADF  143 (283)
T ss_pred             EEecC-CCCHHHHHHhccc--------ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeec
Confidence            99999 8899988865431        237899999999999999999999   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      |.++.......     .....|+..|+|||++.+.
T Consensus       144 ~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~  173 (283)
T cd07830         144 GLAREIRSRPP-----YTDYVSTRWYRAPEILLRS  173 (283)
T ss_pred             ccceeccCCCC-----cCCCCCcccccCceeeecC
Confidence            99986543211     1224578899999988543

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.88  E-value=2.3e-22  Score=199.52  Aligned_cols=169  Identities=33%  Similarity=0.374  Sum_probs=140.8

Q ss_pred             ccccccceEEEEEECCCCeEEEEEEeecccc---hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEeecc
Q 035691          449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQR---GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFM  525 (640)
Q Consensus       449 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~  525 (640)
                      ||+|+||.||+|....+++.||+|++.....   .....+..|+++++.++||||+++++.+     ..+...++||||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence            6999999999999988899999999864432   2446789999999999999999999884     4556889999999


Q ss_pred             CCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccccccc
Q 035691          526 HHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF  605 (640)
Q Consensus       526 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~  605 (640)
                      ++++|.+++....          .+++..+..++.|++.|+.|+|+   .+++|+||+|+||+++.++.++|+|||++..
T Consensus        76 ~~~~L~~~l~~~~----------~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~  142 (250)
T cd05123          76 PGGELFSHLSKEG----------RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKE  142 (250)
T ss_pred             CCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCccee
Confidence            9999999986442          27888999999999999999999   7999999999999999999999999999986


Q ss_pred             CCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          606 IPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       606 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      .....    .......++..|+|||...+..++.
T Consensus       143 ~~~~~----~~~~~~~~~~~~~~Pe~~~~~~~~~  172 (250)
T cd05123         143 LSSEG----SRTNTFCGTPEYLAPEVLLGKGYGK  172 (250)
T ss_pred             cccCC----CcccCCcCCccccChHHhCCCCCCc
Confidence            53321    1112345788999999987766543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.88  E-value=8.3e-23  Score=198.62  Aligned_cols=176  Identities=24%  Similarity=0.318  Sum_probs=143.6

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCC--C----CCcceeEeeccCCcC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRH--R----NLVKIITACSSSDFQ  513 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~----niv~l~~~~~~~~~~  513 (640)
                      +++|.+...+|+|.||+|.+|++.+++..||||+++.- .+.+++.+-|+++++++.+  |    .+|.+.++     |.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----Fd  161 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDW-----FD  161 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----hh
Confidence            77899999999999999999999999999999999533 3455778899999999942  1    35666666     44


Q ss_pred             CCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC--
Q 035691          514 GNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN--  591 (640)
Q Consensus       514 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~--  591 (640)
                      ...+.|+|+|.+ |-++++++..+..        ..++..++..|+.|+++++.|||+   .+++|-||||+|||+.+  
T Consensus       162 yrghiCivfell-G~S~~dFlk~N~y--------~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~  229 (415)
T KOG0671|consen  162 YRGHICIVFELL-GLSTFDFLKENNY--------IPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSE  229 (415)
T ss_pred             ccCceEEEEecc-ChhHHHHhccCCc--------cccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccc
Confidence            566889999988 4499999987654        348889999999999999999999   69999999999999831  


Q ss_pred             ------------------CCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          592 ------------------DMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       592 ------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                                        ...+||+|||-|++-.+..       .+.+.|..|+|||+++|-.||..
T Consensus       230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-------s~iVsTRHYRAPEViLgLGwS~p  289 (415)
T KOG0671|consen  230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-------STIVSTRHYRAPEVILGLGWSQP  289 (415)
T ss_pred             eEEEeccCCccceeccCCCcceEEEecCCcceeccCc-------ceeeeccccCCchheeccCcCCc
Confidence                              2468999999998653321       23467999999999999998863

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.88  E-value=2e-22  Score=220.57  Aligned_cols=187  Identities=20%  Similarity=0.210  Sum_probs=125.1

Q ss_pred             hcCCCcccCcccccccceEEEEEECCC----CeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCC-cC
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPD----QTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSD-FQ  513 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~  513 (640)
                      ..++|+..+.||+|+||.||+|++..+    +..||||++.....  .+.+..|  .+....+.+++.+...+.... ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            457899999999999999999999888    89999998753221  1222222  112222333333222211110 13


Q ss_pred             CCceeeEEeeccCCCChhhhcCCCCCCCC--------C-CC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCC
Q 035691          514 GNDFKALVYEFMHHGSLESWLHPESASDD--------L-NY-SPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLK  583 (640)
Q Consensus       514 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--------~-~~-~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlk  583 (640)
                      .....++||||+++++|.+++........        . .. .........+..++.|++.||+|||+   ++|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence            45578999999999999998864321100        0 00 00112234566899999999999999   699999999


Q ss_pred             CCCeeeCC-CCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          584 PSNVLLDN-DMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       584 p~NiLl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      |+|||+++ ++.+||+|||+|+.+.....   .......||+.|||||.+...
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~---~~~~~~~~t~~Y~APE~~~~~  332 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMS  332 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc---cCCcccccCCCccChHHhhcc
Confidence            99999985 58999999999986532211   122345789999999976543

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.88  E-value=2.9e-22  Score=206.11  Aligned_cols=167  Identities=23%  Similarity=0.216  Sum_probs=130.8

Q ss_pred             ccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEeeccCCCCh
Q 035691          453 SFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSL  530 (640)
Q Consensus       453 ~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L  530 (640)
                      ++|.||.++...+++.||||++...  .....+.+.+|+++++.++||||+++++++     ...+..+++|||+++|++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~-----~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-----IVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee-----ecCCeEEEEEeccCCCCH
Confidence            3445555555668999999998654  334457899999999999999999999984     445578999999999999


Q ss_pred             hhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccccccCCCcc
Q 035691          531 ESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVI  610 (640)
Q Consensus       531 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~~~~  610 (640)
                      .+++.....        ..+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+|++|||.+..+....
T Consensus        87 ~~~l~~~~~--------~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~  155 (314)
T cd08216          87 EDLLKTHFP--------EGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG  155 (314)
T ss_pred             HHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccc
Confidence            999865432        237788889999999999999999   699999999999999999999999999887553211


Q ss_pred             CC---CceeeccccccccccCcccCCCC
Q 035691          611 SS---NQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       611 ~~---~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      ..   .........++..|+|||++.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~  183 (314)
T cd08216         156 KRQRVVHDFPKSSVKNLPWLSPEVLQQN  183 (314)
T ss_pred             ccccccccccccccccccccCHHHhcCC
Confidence            10   11112234578899999998663

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.88  E-value=2.4e-22  Score=205.99  Aligned_cols=165  Identities=27%  Similarity=0.401  Sum_probs=136.4

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      |+..+.||+|+||.||+|+...++..||+|.+...   .....+++.+|+++++.++|+|++++++++..     ....+
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   91 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTAW   91 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCeeE
Confidence            66678899999999999999989999999998532   22334678899999999999999999999643     45789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+. |++.+++....         ..+++.++..++.|++.|+.|||+   .+++||||+|+||+++.++.+||+|
T Consensus        92 lv~e~~~-~~l~~~~~~~~---------~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~d  158 (308)
T cd06634          92 LVMEYCL-GSASDLLEVHK---------KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGD  158 (308)
T ss_pred             EEEEccC-CCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECC
Confidence            9999996 58877664322         126788899999999999999998   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGM  633 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  633 (640)
                      ||++......        ....|++.|+|||.+.
T Consensus       159 fg~~~~~~~~--------~~~~~~~~y~aPE~~~  184 (308)
T cd06634         159 FGSASIMAPA--------NXFVGTPYWMAPEVIL  184 (308)
T ss_pred             cccceeecCc--------ccccCCccccCHHHHh
Confidence            9998755321        1235789999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.88  E-value=2.4e-22  Score=203.34  Aligned_cols=174  Identities=27%  Similarity=0.402  Sum_probs=142.1

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      |+..+.||+|++|.||+|....+++.+|+|.+.....  .....+..|++++++++|+||+++++++.     .+...++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-----HKGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-----cCCCEEE
Confidence            4566889999999999999988999999999864432  34467889999999999999999999853     3457899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||+++ ++.+++....         ..+++..+..++.|++.|+.|||+   .+|+|+||||+||++++++.+||+||
T Consensus        76 v~e~~~~-~l~~~l~~~~---------~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df  142 (283)
T cd05118          76 VFEFMDT-DLYKLIKDRQ---------RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADF  142 (283)
T ss_pred             EEeccCC-CHHHHHHhhc---------ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeee
Confidence            9999975 8888775432         237888999999999999999999   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCC-CCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS-QVS  638 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s  638 (640)
                      |.+........    ......++..|+|||.+.+. .++
T Consensus       143 ~~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~  177 (283)
T cd05118         143 GLARSFGSPVR----PYTHYVVTRWYRAPELLLGDKGYS  177 (283)
T ss_pred             eeeEecCCCcc----cccCccCcccccCcHHHhcCCCCC
Confidence            99986644321    11123478899999998776 443

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.88  E-value=3.4e-22  Score=203.69  Aligned_cols=175  Identities=22%  Similarity=0.291  Sum_probs=138.2

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCce
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      .++|++.+.||+|+||.||+|.+..+++.||||.++... ......+..|+.++.+. +||||++++++|.     ....
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~   88 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI-----TDSD   88 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee-----cCCe
Confidence            356788899999999999999998889999999996443 23345677788777776 4999999999964     3457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||++ +++.++.....         ..+++..+..++.|++.|++|||+.  .+|+||||+|+||++++++.+||
T Consensus        89 ~~~v~e~~~-~~l~~l~~~~~---------~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL  156 (296)
T cd06618          89 VFICMELMS-TCLDKLLKRIQ---------GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKL  156 (296)
T ss_pred             EEEEeeccC-cCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEE
Confidence            899999985 46766654321         1378888999999999999999972  48999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      +|||++..+......     ....++..|+|||.+.+..
T Consensus       157 ~dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~  190 (296)
T cd06618         157 CDFGISGRLVDSKAK-----TRSAGCAAYMAPERIDPPD  190 (296)
T ss_pred             CccccchhccCCCcc-----cCCCCCccccCHhhcCCCC
Confidence            999999865332111     1224788999999987654

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.88  E-value=2.9e-22  Score=197.15  Aligned_cols=158  Identities=23%  Similarity=0.151  Sum_probs=129.1

Q ss_pred             cccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEeeccCCCChh
Q 035691          452 GSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLE  531 (640)
Q Consensus       452 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~  531 (640)
                      |.||.||+++++.+++.||+|++....     .+.+|...+....||||+++++++     ...+..++||||+++|+|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCCHH
Confidence            789999999999999999999986543     233455555666799999999984     4456789999999999999


Q ss_pred             hhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccccccCCCccC
Q 035691          532 SWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVIS  611 (640)
Q Consensus       532 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  611 (640)
                      +++....          .+++..+..++.|++.|++|+|+   ++|+||||||+||+++.++.++++|||.+....... 
T Consensus        74 ~~l~~~~----------~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-  139 (237)
T cd05576          74 SHISKFL----------NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-  139 (237)
T ss_pred             HHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-
Confidence            9885432          27888999999999999999998   799999999999999999999999999887553211 


Q ss_pred             CCceeeccccccccccCcccCCCCCCCC
Q 035691          612 SNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       612 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                            .+..++..|+|||...+..++.
T Consensus       140 ------~~~~~~~~y~aPE~~~~~~~~~  161 (237)
T cd05576         140 ------DGEAVENMYCAPEVGGISEETE  161 (237)
T ss_pred             ------ccCCcCccccCCcccCCCCCCc
Confidence                  1224577899999987776654

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.88  E-value=2.7e-22  Score=221.72  Aligned_cols=194  Identities=26%  Similarity=0.410  Sum_probs=149.9

Q ss_pred             HHHhcCCCcccCcccccccceEEEEEEC---C----CCeEEEEEEeecc-cchhHHHHHHHHHHHHhc-CCCCCcceeEe
Q 035691          436 LLKATGGFSSANLIGTGSFGSVYKGILD---P----DQTVVAVKVLFLH-QRGALKSFMAECEALRNI-RHRNLVKIITA  506 (640)
Q Consensus       436 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~---~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~  506 (640)
                      ++...++..+.+.+|+|.||.|++|...   .    ....||||.++.. ...+.+.+..|+++|+.+ +|+||+.++|+
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            3444445556679999999999999753   1    1457999998533 345668999999999998 69999999999


Q ss_pred             eccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeC
Q 035691          507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSP------SILSFLQRLNIAINVASALEYLHHHCKKQIVHC  580 (640)
Q Consensus       507 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~------~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHr  580 (640)
                      |..     ....++|+||+..|+|.++++..+.........      ..++....+.++.|||.||+||++   +++|||
T Consensus       371 ~t~-----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHR  442 (609)
T KOG0200|consen  371 CTQ-----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHR  442 (609)
T ss_pred             ecc-----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccch
Confidence            865     447899999999999999998776111111111      238888999999999999999999   799999


Q ss_pred             CCCCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccc--cccccCcccCCCCCCCCC
Q 035691          581 DLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG--TVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       581 dlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~s~k  640 (640)
                      |+.++|||+..+..+||+|||+||......   .+......|  ...|||||.+....||.|
T Consensus       443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~---~y~~~~~~~~LP~kWmApEsl~~~~ft~k  501 (609)
T KOG0200|consen  443 DLAARNVLITKNKVIKIADFGLARDHYNKD---YYRTKSSAGTLPVKWMAPESLFDRVFTSK  501 (609)
T ss_pred             hhhhhhEEecCCCEEEEccccceeccCCCC---ceEecCCCCccceeecCHHHhccCccccc
Confidence            999999999999999999999999654322   222111122  346999999999888865

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.87  E-value=2.2e-22  Score=209.52  Aligned_cols=175  Identities=24%  Similarity=0.338  Sum_probs=142.6

Q ss_pred             HhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc-CC
Q 035691          438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDF-QG  514 (640)
Q Consensus       438 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~  514 (640)
                      ...++|+..+.||+|+||.||+|++..+++.||||++...  .....+.+.+|+.++++++||||+++++++...+. ..
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            3466789999999999999999999989999999998543  22234567889999999999999999987543322 22


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                      ....++|+||+ +++|.+++...           .+++..+..++.|++.|++|||+   .+|+||||||+||++++++.
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~-----------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~  156 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQ-----------KLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCE  156 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCC
Confidence            23478999998 56999888531           27888999999999999999999   69999999999999999999


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      +||+|||++......       .....++..|+|||.+.+
T Consensus       157 ~kL~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~  189 (343)
T cd07851         157 LKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLN  189 (343)
T ss_pred             EEEcccccccccccc-------ccCCcccccccCHHHHhC
Confidence            999999999865322       122357889999998755

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.87  E-value=2.3e-22  Score=200.85  Aligned_cols=179  Identities=24%  Similarity=0.320  Sum_probs=139.9

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecc-----cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH-----QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      +|.+.+.||+|+||.||++.+...+..+++|+++..     .......+..|+.+++.++||||+++++++     .+..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-----LERD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-----hcCC
Confidence            477889999999999999998877766777766421     122334577899999999999999999885     3345


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++++|.+++......      ...+++..++.++.|++.|+.|||+   .+++|+||+|+||++++ +.+|
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~  145 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHT------GKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLK  145 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhc------ccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEe
Confidence            689999999999999888542211      1348889999999999999999999   69999999999999975 5699


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ++|||+++.......    ......|++.|+|||.+.+..++.
T Consensus       146 l~d~g~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~  184 (260)
T cd08222         146 IGDFGVSRLLMGSCD----LATTFTGTPYYMSPEALKHQGYDS  184 (260)
T ss_pred             ecccCceeecCCCcc----cccCCCCCcCccCHHHHccCCCCc
Confidence            999999986533211    112345788999999987766654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.86  E-value=6.1e-22  Score=209.69  Aligned_cols=175  Identities=30%  Similarity=0.436  Sum_probs=134.5

Q ss_pred             CcccCcccccccce-EEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCceeeE
Q 035691          443 FSSANLIGTGSFGS-VYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       443 ~~~~~~lg~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      |...+++|.|+-|+ ||+|.+  +|+.||||++...   ......+|+..++.- +|||||++++.     -++..+.|+
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YI  580 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYI  580 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEE
Confidence            44557789998875 799999  5899999998433   234567999999988 69999999876     456678999


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC---C--CcE
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN---D--MIA  595 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~---~--~~~  595 (640)
                      ..|.|.. +|.+++.......      ....-...+.+..|++.|+++||+   -+||||||||.||||+.   +  ..+
T Consensus       581 alELC~~-sL~dlie~~~~d~------~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra  650 (903)
T KOG1027|consen  581 ALELCAC-SLQDLIESSGLDV------EMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRA  650 (903)
T ss_pred             EehHhhh-hHHHHHhccccch------hhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeE
Confidence            9999964 9999997641110      011113446788999999999999   59999999999999975   3  478


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      +|+|||+++.+....++- ....+..||-+|+|||++...+-+
T Consensus       651 ~iSDfglsKkl~~~~sS~-~r~s~~sGt~GW~APE~L~~~~~~  692 (903)
T KOG1027|consen  651 KISDFGLSKKLAGGKSSF-SRLSGGSGTSGWQAPEQLREDRKT  692 (903)
T ss_pred             EecccccccccCCCcchh-hcccCCCCcccccCHHHHhccccC
Confidence            999999999886544432 224556799999999999876654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=4.1e-21  Score=180.72  Aligned_cols=139  Identities=18%  Similarity=0.119  Sum_probs=105.7

Q ss_pred             cCcccccccceEEEEEECCCCeEEEEEEeecccch--h------------------------HHHHHHHHHHHHhcCCCC
Q 035691          446 ANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--A------------------------LKSFMAECEALRNIRHRN  499 (640)
Q Consensus       446 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~H~n  499 (640)
                      .+.||+|+||.||+|.+. +|+.||||+++.....  .                        ......|++.+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            367999999999999987 8999999999643211  0                        012345999999998887


Q ss_pred             CcceeEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCee
Q 035691          500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYL-HHHCKKQIV  578 (640)
Q Consensus       500 iv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yL-H~~~~~~iv  578 (640)
                      +.....+.     .  ...++||||++++++.......          ..++......++.|++.+|+|+ |+   .+|+
T Consensus        81 v~~p~~~~-----~--~~~~iVmE~i~g~~l~~~~~~~----------~~~~~~~~~~i~~qi~~~L~~l~H~---~gii  140 (190)
T cd05147          81 IPCPEPIL-----L--KSHVLVMEFIGDDGWAAPRLKD----------APLSESKARELYLQVIQIMRILYQD---CRLV  140 (190)
T ss_pred             CCCCcEEE-----e--cCCEEEEEEeCCCCCcchhhhc----------CCCCHHHHHHHHHHHHHHHHHHHHh---CCcc
Confidence            64433221     1  1237999999987765432211          1267788999999999999999 56   6999


Q ss_pred             eCCCCCCCeeeCCCCcEEEccccccccC
Q 035691          579 HCDLKPSNVLLDNDMIAHVGDFGLTRFI  606 (640)
Q Consensus       579 Hrdlkp~NiLl~~~~~~kl~DfGla~~~  606 (640)
                      ||||||+||+++ ++.++++|||+|...
T Consensus       141 HrDlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         141 HADLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             cCCCCHHHEEEE-CCcEEEEEccccccC
Confidence            999999999998 478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.85  E-value=2.9e-21  Score=179.24  Aligned_cols=166  Identities=26%  Similarity=0.380  Sum_probs=133.0

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCceeeE
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      .|.+.+.+|+|.||.+-.|.++++.+.+|+|.+..... ..++|.+|...--.+ .|.||+.-|++.    |++.+..++
T Consensus        25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d~YvF   99 (378)
T KOG1345|consen   25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVA----FQTSDAYVF   99 (378)
T ss_pred             hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHH----hhcCceEEE
Confidence            47788999999999999999999999999999854332 347889998765555 599999988774    677778899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee-C-CCCcEEEc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL-D-NDMIAHVG  598 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl-~-~~~~~kl~  598 (640)
                      ++||++.|+|.+-+...           .+.+....+++.|++.|++|||+   +.+||||||.+|||| + +...+|++
T Consensus       100 ~qE~aP~gdL~snv~~~-----------GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlc  165 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVEAA-----------GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLC  165 (378)
T ss_pred             eeccCccchhhhhcCcc-----------cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEee
Confidence            99999999999877543           36677889999999999999999   799999999999999 3 34589999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGM  633 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  633 (640)
                      |||..+..+.....       ..-+..|.|||...
T Consensus       166 DFG~t~k~g~tV~~-------~~~~~~y~~pe~~~  193 (378)
T KOG1345|consen  166 DFGLTRKVGTTVKY-------LEYVNNYHAPELCD  193 (378)
T ss_pred             ecccccccCceehh-------hhhhcccCCcHHHh
Confidence            99998854322111       11345688888653

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.83  E-value=3.8e-20  Score=180.16  Aligned_cols=175  Identities=34%  Similarity=0.462  Sum_probs=143.6

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeecccch-hHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEE
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG-ALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALV  521 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv  521 (640)
                      |+..+.||+|++|.||+|....+++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++..     ....+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-----PEPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-----CCceEEE
Confidence            45668899999999999999888999999999765544 56789999999999999999999998533     3578899


Q ss_pred             eeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccc
Q 035691          522 YEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG  601 (640)
Q Consensus       522 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfG  601 (640)
                      +||+++++|.+++.....         .+++..+..++.+++.++.|||.   .+++|+|++|+||+++.++.++|+|||
T Consensus        76 ~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g  143 (225)
T smart00221       76 MEYCEGGDLFDYLRKKGG---------KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFG  143 (225)
T ss_pred             EeccCCCCHHHHHHhccc---------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCc
Confidence            999999999999865332         16778899999999999999999   599999999999999999999999999


Q ss_pred             ccccCCCccCCCceeeccccccccccCcccC-CCCCC
Q 035691          602 LTRFIPEVISSNQCSSVGLKGTVGYAAPEYG-MGSQV  637 (640)
Q Consensus       602 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~  637 (640)
                      .+.........   ......++..|++||.. .+..+
T Consensus       144 ~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~  177 (225)
T smart00221      144 LARFIHRDLAA---LLKTVKGTPFYLAPEVLLGGKGY  177 (225)
T ss_pred             eeeEecCcccc---cccceeccCCcCCHhHhcCCCCC
Confidence            99876433200   11223578899999998 44333

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.83  E-value=2.2e-21  Score=175.72  Aligned_cols=169  Identities=21%  Similarity=0.379  Sum_probs=137.0

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcC-CCCCcceeEeeccCCcCCCcee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR-HRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      .++|++.+.+|+|.|+.||.|....+.+.++||+++.-.+   +.+.+|+.+++.++ ||||+++++...++.   ....
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~---Sktp  110 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPE---SKTP  110 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCcc---ccCc
Confidence            4568888999999999999999888899999999965443   56789999999996 999999999976554   3346


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC-CcEEE
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND-MIAHV  597 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~-~~~kl  597 (640)
                      .+|+||+.+.+...+..             .++...+..++.+++.||.|+|+   +||+|||+||.|+++|.. ...++
T Consensus       111 aLiFE~v~n~Dfk~ly~-------------tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrl  174 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLYP-------------TLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRL  174 (338)
T ss_pred             hhHhhhhccccHHHHhh-------------hhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeee
Confidence            79999999988776543             24445677899999999999999   799999999999999965 57999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      +|+|+|.++-.....+     ..+.+.+|--||.+..-
T Consensus       175 IDWGLAEFYHp~~eYn-----VRVASRyfKGPELLVdy  207 (338)
T KOG0668|consen  175 IDWGLAEFYHPGKEYN-----VRVASRYFKGPELLVDY  207 (338)
T ss_pred             eecchHhhcCCCceee-----eeeehhhcCCchheeec
Confidence            9999999874322211     23467888999987543

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.83  E-value=8.5e-21  Score=184.44  Aligned_cols=197  Identities=21%  Similarity=0.306  Sum_probs=155.0

Q ss_pred             CHHHHHHhcCCCcccCcccccccceEEEEEECCCC-----eEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeE
Q 035691          432 SYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQ-----TVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIIT  505 (640)
Q Consensus       432 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~  505 (640)
                      ...++.....+++...++-+|.||.||+|.+++..     +.|-||.++.+ .+-+...+..|...+..+.|||+..+.+
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            35566666777888899999999999999887433     34556766433 3345578899999999999999999999


Q ss_pred             eeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCC
Q 035691          506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPS  585 (640)
Q Consensus       506 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~  585 (640)
                      +|..    +....++++.++.-|+|+.|+...+..+.  ...+.++..+...++.|++.||+|||.   .+|||.||.++
T Consensus       355 V~ie----~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~--~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaR  425 (563)
T KOG1024|consen  355 VSIE----DYATPFVLYPATGVGNLKSFLQICRGDDP--SYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAAR  425 (563)
T ss_pred             EEee----ccCcceEEEeccCcchHHHHHHHhccCCC--ccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhh
Confidence            9843    34567888999999999999985553322  123457778889999999999999999   69999999999


Q ss_pred             CeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          586 NVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       586 NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |++||+...+||+|-.++|.+-+  ....|-.........||+||.+....||.
T Consensus       426 NCvIdd~LqVkltDsaLSRDLFP--~DYhcLGDnEnRPvkWMslEal~n~~yss  477 (563)
T KOG1024|consen  426 NCVIDDQLQVKLTDSALSRDLFP--GDYHCLGDNENRPVKWMSLEALQNSHYSS  477 (563)
T ss_pred             cceehhheeEEeccchhccccCc--ccccccCCCCCCcccccCHHHHhhhhhcc
Confidence            99999999999999999996532  22344444445678999999999888875

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.83  E-value=4.1e-21  Score=182.60  Aligned_cols=177  Identities=24%  Similarity=0.265  Sum_probs=140.5

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeec--ccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCC-Cce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQG-NDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~-~~~  517 (640)
                      .+|.-...+|.|+- .|..|.+.-.+++||+|.+..  ......++..+|..++..+.|+||++++.++....... ...
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45666677888887 788888887899999998832  23344567889999999999999999999975443221 124


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .|+|||||.. +|...+...            ++..++..+..|+..|++|+|+   .+|+||||||+||++..+..+||
T Consensus        96 ~y~v~e~m~~-nl~~vi~~e------------lDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi  159 (369)
T KOG0665|consen   96 VYLVMELMDA-NLCQVILME------------LDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKI  159 (369)
T ss_pred             HHHHHHhhhh-HHHHHHHHh------------cchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheee
Confidence            7899999965 888777622            4556788999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      .|||+|+.-...     ...+..+.|.+|+|||++.|-.+.+
T Consensus       160 ~dfg~ar~e~~~-----~~mtpyVvtRyyrapevil~~~~ke  196 (369)
T KOG0665|consen  160 LDFGLARTEDTD-----FMMTPYVVTRYYRAPEVILGMGYKE  196 (369)
T ss_pred             ccchhhcccCcc-----cccCchhheeeccCchheeccCCcc
Confidence            999999854321     2334467899999999999977654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.83  E-value=6.5e-20  Score=173.34  Aligned_cols=141  Identities=19%  Similarity=0.137  Sum_probs=108.8

Q ss_pred             cCcccccccceEEEEEECCCCeEEEEEEeecccch---------------------h-----HHHHHHHHHHHHhcCCCC
Q 035691          446 ANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG---------------------A-----LKSFMAECEALRNIRHRN  499 (640)
Q Consensus       446 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~H~n  499 (640)
                      ...||+|+||.||+|++. +|+.||||+++.....                     .     ...+..|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            467999999999999987 8999999999643210                     0     123467899999999998


Q ss_pred             CcceeEeeccCCcCCCceeeEEeeccCCCChhhh-cCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 035691          500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESW-LHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIV  578 (640)
Q Consensus       500 iv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~iv  578 (640)
                      +.....+..     .  ..++||||++++++... +..           ..++......++.|++.++.|+|+.  .+|+
T Consensus        81 i~~p~~~~~-----~--~~~lVmE~~~g~~~~~~~l~~-----------~~~~~~~~~~i~~~l~~~l~~lH~~--~giv  140 (190)
T cd05145          81 VPVPEPILL-----K--KNVLVMEFIGDDGSPAPRLKD-----------VPLEEEEAEELYEQVVEQMRRLYQE--AGLV  140 (190)
T ss_pred             CCCceEEEe-----c--CCEEEEEEecCCCchhhhhhh-----------ccCCHHHHHHHHHHHHHHHHHHHHh--CCEe
Confidence            755444321     1  23799999998854332 321           1256677889999999999999983  4999


Q ss_pred             eCCCCCCCeeeCCCCcEEEccccccccCCC
Q 035691          579 HCDLKPSNVLLDNDMIAHVGDFGLTRFIPE  608 (640)
Q Consensus       579 Hrdlkp~NiLl~~~~~~kl~DfGla~~~~~  608 (640)
                      ||||||+||+++ ++.++|+|||+|+....
T Consensus       141 HrDlkP~NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         141 HGDLSEYNILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             cCCCChhhEEEE-CCCEEEEEcccceecCC
Confidence            999999999999 78999999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.82  E-value=5.7e-20  Score=180.90  Aligned_cols=164  Identities=33%  Similarity=0.434  Sum_probs=137.6

Q ss_pred             ccceEEEEEECCCCeEEEEEEeecccchh-HHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEeeccCCCChh
Q 035691          453 SFGSVYKGILDPDQTVVAVKVLFLHQRGA-LKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLE  531 (640)
Q Consensus       453 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~  531 (640)
                      +||.||+|....+|+.||+|++....... .+.+.+|++.+++++|+||+++++++..     ....+++|||+++++|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence            58999999998889999999996554433 6789999999999999999999998643     34789999999999999


Q ss_pred             hhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccccccCCCccC
Q 035691          532 SWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVIS  611 (640)
Q Consensus       532 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  611 (640)
                      +++.....          +++..++.++.+++.|+.|||.   .+++|+||+|+||++++++.++++|||.+....... 
T Consensus        76 ~~~~~~~~----------~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-  141 (244)
T smart00220       76 DLLKKRGR----------LSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-  141 (244)
T ss_pred             HHHHhccC----------CCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc-
Confidence            99864321          6788899999999999999999   699999999999999999999999999998764321 


Q ss_pred             CCceeeccccccccccCcccCCCCCCCC
Q 035691          612 SNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       612 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                          ......++..|+|||...+..++.
T Consensus       142 ----~~~~~~~~~~~~~pE~~~~~~~~~  165 (244)
T smart00220      142 ----LLTTFVGTPEYMAPEVLLGKGYGK  165 (244)
T ss_pred             ----ccccccCCcCCCCHHHHccCCCCc
Confidence                112345788999999987766654

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.82  E-value=2.3e-20  Score=193.56  Aligned_cols=171  Identities=25%  Similarity=0.297  Sum_probs=137.2

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCcee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      +..|.....+|.|+|+.|-+|.+..+++..|||++.....    .-.+|+.++... +||||+++.+.     +.++...
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v-----~~~~~~~  391 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDV-----YEDGKEI  391 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecce-----ecCCcee
Confidence            4556677779999999999999999999999999965422    224567666555 79999999999     4556689


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee-CCCCcEEE
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL-DNDMIAHV  597 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl-~~~~~~kl  597 (640)
                      |+|||++.+|-+.+.+...+.          .. ..+..|+.+|+.|+.|||+   ++|||||+||+|||+ ++.++++|
T Consensus       392 ~~v~e~l~g~ell~ri~~~~~----------~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrl  457 (612)
T KOG0603|consen  392 YLVMELLDGGELLRRIRSKPE----------FC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRL  457 (612)
T ss_pred             eeeehhccccHHHHHHHhcch----------hH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEE
Confidence            999999999988776643322          22 5677899999999999999   699999999999999 58999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||.++..+..       ..+.+=|..|.|||+.....+|++
T Consensus       458 tyFG~a~~~~~~-------~~tp~~t~~y~APEvl~~~~yt~a  493 (612)
T KOG0603|consen  458 TYFGFWSELERS-------CDTPALTLQYVAPEVLAIQEYTEA  493 (612)
T ss_pred             EEechhhhCchh-------hcccchhhcccChhhhccCCCCcc
Confidence            999999976542       112245889999999998777753

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.82  E-value=7.1e-22  Score=203.67  Aligned_cols=282  Identities=22%  Similarity=0.233  Sum_probs=151.3

Q ss_pred             EEeCCCCccc-cCCchhhhcCCCCCeEEcccCccCcc----CCcCCCCCCCCCEEEccCCCcCC-ccccccCCchhhcCC
Q 035691            7 LINLQQNNFS-GNIPHEIGRLFQLRYIIFNSNTLQGQ----IPVNLTHCSELRTLDLVLNKLEE-NQLVGELPPYIGFTL   80 (640)
Q Consensus         7 ~L~L~~n~i~-~~~p~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~lp~~~~~~l   80 (640)
                      .|+|.++.++ ...+..|..+.+|+.|+++++.++..    ++..+...++|++|+++.|.+.. ......++..+ ..+
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l-~~~   80 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGL-TKG   80 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHH-Hhc
Confidence            5788888887 45667788888899999999998542    45556677888999998877652 11111122222 225


Q ss_pred             CCCCeeeccCCcccccCCccCcCCCC---CCEEECcCCccCc----cCCccccCC-CCCCEEEcccCcCCCCCCCccccc
Q 035691           81 PNIRIPLLAGNQFFGNIPHSISNASK---LEWLDFANNSLTA----SIPEDLGRL-RNLTRLNFARNDLGTRKVNDLRFL  152 (640)
Q Consensus        81 ~~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~Ls~N~l~~----~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~~  152 (640)
                      ++|+.|++++|.+.+..+..|..+.+   |++|++++|++++    .+...+..+ ++|+.|+|++|.++.....     
T Consensus        81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~-----  155 (319)
T cd00116          81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCE-----  155 (319)
T ss_pred             CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHH-----
Confidence            55555555555555444444433333   5555555555542    112223333 4555555555555421100     


Q ss_pred             ccccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCccc----CCcCccCCCCCCEEEccCCCCCCCC----Cc
Q 035691          153 DSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGE----IPSSLGNFTFLTELNLRGNSIRGSI----PS  224 (640)
Q Consensus       153 ~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~----~~  224 (640)
                                          .++..+..+++|++|++++|.+++.    ++..+..+++|++|+|++|.+.+..    +.
T Consensus       156 --------------------~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~  215 (319)
T cd00116         156 --------------------ALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAE  215 (319)
T ss_pred             --------------------HHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHH
Confidence                                1122233344555555555555421    1222334455666666666554322    22


Q ss_pred             cccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCccC-----CCCCCCCEEECCCCcccC----cCCccccCCCC
Q 035691          225 ALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAV-----GNLKSIPHLDLSKNKLSG----EIPSSLGSCVG  295 (640)
Q Consensus       225 ~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~  295 (640)
                      .+..+++|+.|                ++++|.+++.....+     ...+.|+.|++++|.++.    .+...+..+++
T Consensus       216 ~~~~~~~L~~L----------------~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~  279 (319)
T cd00116         216 TLASLKSLEVL----------------NLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKES  279 (319)
T ss_pred             HhcccCCCCEE----------------ecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCC
Confidence            33444555555                444444432111111     123567777777777752    22334555577


Q ss_pred             CCeEEecCCccCCC----CCccCCCC-CCCCeEeCcCCcc
Q 035691          296 LEYLNLSINSFHGP----IHPGLSSL-KSLEGLDLFQNTF  330 (640)
Q Consensus       296 L~~L~L~~N~l~~~----~~~~~~~l-~~L~~L~l~~N~l  330 (640)
                      |+++++++|.++..    ....+... +.|++||+.+|+|
T Consensus       280 L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         280 LLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             ccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence            77888888877743    33444455 6777888777765

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.81  E-value=2.9e-19  Score=171.55  Aligned_cols=166  Identities=33%  Similarity=0.526  Sum_probs=137.7

Q ss_pred             ccccccceEEEEEECCCCeEEEEEEeecccch-hHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEeeccCC
Q 035691          449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG-ALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHH  527 (640)
Q Consensus       449 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~  527 (640)
                      ||+|++|.||+++...+++.+++|++...... ..+.+.+|++.++.++|++|+++++++..     ....+++|||+++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-----ENHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-----CCeEEEEEecCCC
Confidence            68999999999999877999999999654432 34679999999999999999999999543     3578999999999


Q ss_pred             CChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC-CCcEEEccccccccC
Q 035691          528 GSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN-DMIAHVGDFGLTRFI  606 (640)
Q Consensus       528 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~-~~~~kl~DfGla~~~  606 (640)
                      ++|.+++....         ..+++..+..++.+++.++.|||+   .+++|+||+|.||+++. ++.++|+|||.+...
T Consensus        76 ~~l~~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~  143 (215)
T cd00180          76 GSLKDLLKENE---------GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLL  143 (215)
T ss_pred             CcHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEc
Confidence            99999986542         126788999999999999999999   69999999999999999 899999999999865


Q ss_pred             CCccCCCceeeccccccccccCcccCCCC
Q 035691          607 PEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       607 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      .....    ......+...|++||.....
T Consensus       144 ~~~~~----~~~~~~~~~~~~~pe~~~~~  168 (215)
T cd00180         144 TSDKS----LLKTIVGTPAYMAPEVLLGK  168 (215)
T ss_pred             cCCcc----hhhcccCCCCccChhHhccc
Confidence            43211    11123477899999998765

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.81  E-value=4.7e-22  Score=204.99  Aligned_cols=283  Identities=24%  Similarity=0.259  Sum_probs=166.0

Q ss_pred             eEEcccCccC-ccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccc------cCCccCcC
Q 035691           31 YIIFNSNTLQ-GQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFG------NIPHSISN  103 (640)
Q Consensus        31 ~L~l~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~------~~~~~~~~  103 (640)
                      .|+|+.+.++ ...+..|..+.+|+.|+++++.++.-... .++..+. ..++++.++++++.+.+      .++..|..
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~-~i~~~l~-~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~   79 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAK-ALASALR-PQPSLKELCLSLNETGRIPRGLQSLLQGLTK   79 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHH-HHHHHHh-hCCCceEEeccccccCCcchHHHHHHHHHHh
Confidence            3566666665 23334445556677777766665431111 1222222 24445555555554441      12223334


Q ss_pred             CCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCC-----cCcCC
Q 035691          104 ASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRS-----IPISV  178 (640)
Q Consensus       104 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~-----ip~~~  178 (640)
                      +++|+.|++++|.+....+..+..+.+                          . ++|++|++++|.++.     +...+
T Consensus        80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~--------------------------~-~~L~~L~ls~~~~~~~~~~~l~~~l  132 (319)
T cd00116          80 GCGLQELDLSDNALGPDGCGVLESLLR--------------------------S-SSLQELKLNNNGLGDRGLRLLAKGL  132 (319)
T ss_pred             cCceeEEEccCCCCChhHHHHHHHHhc--------------------------c-CcccEEEeeCCccchHHHHHHHHHH
Confidence            444444444444444333333333322                          1 235555555555542     22233


Q ss_pred             CCC-CCCCEEEccCCcCccc----CCcCccCCCCCCEEEccCCCCCCC----CCccccCCCCccEEeccCccccCCCCCc
Q 035691          179 GYL-PKLQVLSLFENNISGE----IPSSLGNFTFLTELNLRGNSIRGS----IPSALGNCHQLQSLDLSKTIFLGQYPVR  249 (640)
Q Consensus       179 ~~l-~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~ls~n~~~~~~~l~  249 (640)
                      ..+ ++|+.|++++|.+++.    ++..+..+++|++|+|++|.+++.    ++..+..+++|+.|              
T Consensus       133 ~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L--------------  198 (319)
T cd00116         133 KDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVL--------------  198 (319)
T ss_pred             HhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEE--------------
Confidence            444 7889999999988732    344577788999999999999842    23344555678877              


Q ss_pred             eEEccCCcCCCC----CCccCCCCCCCCEEECCCCcccCcCCcccc-----CCCCCCeEEecCCccCC----CCCccCCC
Q 035691          250 WLDLSHNHLTGP----IPLAVGNLKSIPHLDLSKNKLSGEIPSSLG-----SCVGLEYLNLSINSFHG----PIHPGLSS  316 (640)
Q Consensus       250 ~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~----~~~~~~~~  316 (640)
                        ++++|.+++.    ++..+..+++|+.|++++|.+++.....+.     ..+.|++|++++|.++.    .+...+..
T Consensus       199 --~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~  276 (319)
T cd00116         199 --DLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAE  276 (319)
T ss_pred             --eccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhc
Confidence              6666666532    345677889999999999999864333332     23799999999999972    23445677


Q ss_pred             CCCCCeEeCcCCccccccCCcccCCCCCC-CCCccccccCCCC
Q 035691          317 LKSLEGLDLFQNTFQAKSQNGDVPRKGIF-KNASAISVAGNEK  358 (640)
Q Consensus       317 l~~L~~L~l~~N~l~~~~~~~~~p~~~~~-~~~~~~~~~~n~~  358 (640)
                      +++|+++|+++|.+..............+ ..+..+++.+|||
T Consensus       277 ~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         277 KESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             CCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence            79999999999999844211111111122 4567778888775

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.81  E-value=7e-20  Score=167.34  Aligned_cols=182  Identities=25%  Similarity=0.353  Sum_probs=141.2

Q ss_pred             HhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcC-CCCCcceeEeeccCCcCCCc
Q 035691          438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR-HRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       438 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~  516 (640)
                      ...+.|.+.+.||+|+||.+|.|....+|+.||+|+-....+  .....-|..+...++ ...|..+..+     .....
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y-----~~e~~   84 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHY-----GTEKD   84 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhh-----ccccc
Confidence            345779999999999999999999999999999998632221  245678889998886 4677777666     33455


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC---CC
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN---DM  593 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~---~~  593 (640)
                      +-.+|||.. |.+|.++.....         +.++..+++-.+-|++.-++|+|.   ++++||||||+|+|..-   ..
T Consensus        85 ynvlVMdLL-GPsLEdLfnfC~---------R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~  151 (341)
T KOG1163|consen   85 YNVLVMDLL-GPSLEDLFNFCS---------RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCN  151 (341)
T ss_pred             cceeeeecc-CccHHHHHHHHh---------hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccc
Confidence            678999987 668888876443         347888999999999999999999   79999999999999963   45


Q ss_pred             cEEEccccccccCCCccCCC---ceeeccccccccccCcccCCCCCCCC
Q 035691          594 IAHVGDFGLTRFIPEVISSN---QCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       594 ~~kl~DfGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      .+.++|||+|+.+.+..+..   ........||.+|++--...|...|.
T Consensus       152 kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSR  200 (341)
T KOG1163|consen  152 KLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSR  200 (341)
T ss_pred             eEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhh
Confidence            78999999999875443321   22233467999999988777765553

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.80  E-value=3e-19  Score=170.58  Aligned_cols=180  Identities=22%  Similarity=0.317  Sum_probs=143.0

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCceee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      -.|.+.++||+|+||.++.|..--+++.||||.-....  ....+..|.+..+.+ ..++|...+.+     -+.+.+-.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYF-----GqeG~~Ni  100 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYF-----GQEGKYNI  100 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeee-----ccccchhh
Confidence            35888999999999999999988899999999764332  235677888888887 57899998876     33344567


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC-----Cc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND-----MI  594 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~-----~~  594 (640)
                      +|||.+ |-+|.++..-++         +.++..++..+|+|++.-++|+|+   +.+|+|||||+|+||..-     ..
T Consensus       101 LVidLL-GPSLEDLFD~Cg---------R~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~  167 (449)
T KOG1165|consen  101 LVIDLL-GPSLEDLFDLCG---------RRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANV  167 (449)
T ss_pred             hhhhhh-CcCHHHHHHHhc---------CcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCce
Confidence            999987 558777664332         348899999999999999999999   699999999999999743     36


Q ss_pred             EEEccccccccCCCccCCCc---eeeccccccccccCcccCCCCCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQ---CSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +.|+|||+|+.+.++.+..+   .......||.+||+--..+|...|.+
T Consensus       168 IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRR  216 (449)
T KOG1165|consen  168 IHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRR  216 (449)
T ss_pred             EEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhh
Confidence            89999999999876554432   22334679999999999999887753

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.80  E-value=6.5e-20  Score=181.09  Aligned_cols=143  Identities=31%  Similarity=0.454  Sum_probs=123.1

Q ss_pred             hcCCCcccCcccccccceEEEEEECC---CCeEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCC
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDP---DQTVVAVKVLFLHQRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~  514 (640)
                      ..+.|...++||+|.|+.||+|.+..   .++.||+|.+.....  .....+|++.|..+ .+.||+++.++     +..
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~-----~rn  106 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGC-----FRN  106 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhh-----hcc
Confidence            34557888999999999999999876   678999999865443  35688999999998 59999999998     666


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC-C
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND-M  593 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~-~  593 (640)
                      ++.+++|+||+++.+..++...             ++...+..+...+..||+++|.   .|||||||||+|+|.+.. +
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~~-------------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~  170 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYRS-------------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQ  170 (418)
T ss_pred             CCeeEEEecccCccCHHHHHhc-------------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccC
Confidence            7789999999999988888742             5667888999999999999999   699999999999999865 5


Q ss_pred             cEEEccccccc
Q 035691          594 IAHVGDFGLTR  604 (640)
Q Consensus       594 ~~kl~DfGla~  604 (640)
                      .-.|+|||+|.
T Consensus       171 rg~LvDFgLA~  181 (418)
T KOG1167|consen  171 RGVLVDFGLAQ  181 (418)
T ss_pred             CceEEechhHH
Confidence            77899999997

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=6e-19  Score=167.35  Aligned_cols=142  Identities=19%  Similarity=0.280  Sum_probs=106.7

Q ss_pred             cccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhc-----CCCCCcceeEeeccCCcCCCcee
Q 035691          444 SSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-----RHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       444 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ...+.||+|+||.||.  ++.++.. +||++........+.+.+|+++++.+     .||||++++|++.... ..+...
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~-g~g~v~   80 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC-GTGYVY   80 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC-CCeEEE
Confidence            3457899999999995  6666665 69988765444557899999999999     5799999999964431 111224


Q ss_pred             eEEeec--cCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeeeCCCCCCCeeeCC----
Q 035691          519 ALVYEF--MHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL-EYLHHHCKKQIVHCDLKPSNVLLDN----  591 (640)
Q Consensus       519 ~lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al-~yLH~~~~~~ivHrdlkp~NiLl~~----  591 (640)
                      .+||||  +.+|+|.+++....           +++.  ..++.|++.++ +|||+   .+|+||||||+||+++.    
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~~-----------~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~  144 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQCR-----------YEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISES  144 (210)
T ss_pred             EEEecCCCCcchhHHHHHHccc-----------ccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCC
Confidence            489999  55899999996421           3333  34577888777 99999   69999999999999974    


Q ss_pred             CCcEEEcc-cccccc
Q 035691          592 DMIAHVGD-FGLTRF  605 (640)
Q Consensus       592 ~~~~kl~D-fGla~~  605 (640)
                      ++.++|+| ||....
T Consensus       145 ~~~~~LiDg~G~~~~  159 (210)
T PRK10345        145 EVIPVVCDNIGESTF  159 (210)
T ss_pred             CCcEEEEECCCCcce
Confidence            34899999 555443

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.78  E-value=2.4e-19  Score=180.20  Aligned_cols=185  Identities=23%  Similarity=0.312  Sum_probs=145.5

Q ss_pred             ccCHHHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcC------CCCCcce
Q 035691          430 NVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR------HRNLVKI  503 (640)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~l  503 (640)
                      .+.+.++.  .++|.+....|+|-|++|.+|.+..-|..||||++....- -.+.=+.|+++|+++.      .-|++++
T Consensus       423 rv~igE~L--D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl  499 (752)
T KOG0670|consen  423 RVRIGELL--DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRL  499 (752)
T ss_pred             EEehhhhh--cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence            34444443  4678888899999999999999998899999999954322 2244578999999984      3477888


Q ss_pred             eEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCC
Q 035691          504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLK  583 (640)
Q Consensus       504 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlk  583 (640)
                      +..     |...++.|+|+|-+. -+|.+.|+..+..       ..+...++..++.|+..||..|..+   +|+|.|||
T Consensus       500 ~r~-----F~hknHLClVFE~Ls-lNLRevLKKyG~n-------vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIK  563 (752)
T KOG0670|consen  500 FRH-----FKHKNHLCLVFEPLS-LNLREVLKKYGRN-------VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIK  563 (752)
T ss_pred             HHH-----hhhcceeEEEehhhh-chHHHHHHHhCcc-------cceeehHHHHHHHHHHHHHHHHHhc---CeeecccC
Confidence            777     667789999999775 4899999766543       3477889999999999999999984   99999999


Q ss_pred             CCCeeeCCCC-cEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          584 PSNVLLDNDM-IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       584 p~NiLl~~~~-~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|||+.+.. .+||||||-|.+..+.    ..+  .+.-+..|+|||+++|-+|+.
T Consensus       564 PDNiLVNE~k~iLKLCDfGSA~~~~en----eit--PYLVSRFYRaPEIiLG~~yd~  614 (752)
T KOG0670|consen  564 PDNILVNESKNILKLCDFGSASFASEN----EIT--PYLVSRFYRAPEIILGLPYDY  614 (752)
T ss_pred             ccceEeccCcceeeeccCccccccccc----ccc--HHHHHHhccCcceeecCcccC
Confidence            9999998764 6799999999866432    111  122466899999999998863

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.78  E-value=1.4e-18  Score=178.45  Aligned_cols=183  Identities=24%  Similarity=0.307  Sum_probs=140.9

Q ss_pred             CCcccCcccccccceEEEEEECCCC-eEEEEEEeecccchhHHHHHHHHHHHHhcCC----CCCcceeEeeccCCcCCCc
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQ-TVVAVKVLFLHQRGALKSFMAECEALRNIRH----RNLVKIITACSSSDFQGND  516 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~~~~~~~~~~~~~  516 (640)
                      .|.+.+.||+|+||.||.|....++ ..+|+|+...........+..|+.++..+..    +++..+++...    ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            7899999999999999999987664 6788888765433332367889999998863    68888888732    3455


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC----
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND----  592 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~----  592 (640)
                      +.++||+.+ |.+|.++......        ..++..++..|+.|++.||+++|+   .|++||||||+|+++...    
T Consensus        95 ~~~iVM~l~-G~sL~dl~~~~~~--------~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~  162 (322)
T KOG1164|consen   95 FNFIVMSLL-GPSLEDLRKRNPP--------GRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSE  162 (322)
T ss_pred             eeEEEEecc-CccHHHHHHhCCC--------CCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcc
Confidence            789999977 6699987654431        348889999999999999999999   799999999999999765    


Q ss_pred             -CcEEEccccccc--cCCCccCC---Ccee-eccccccccccCcccCCCCCCCCC
Q 035691          593 -MIAHVGDFGLTR--FIPEVISS---NQCS-SVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       593 -~~~kl~DfGla~--~~~~~~~~---~~~~-~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                       ..+++.|||+|+  .+......   .... ...+.||..|+++.+..+...+++
T Consensus       163 ~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~  217 (322)
T KOG1164|consen  163 VRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR  217 (322)
T ss_pred             cceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCc
Confidence             468999999999  33221111   1111 234669999999999998887654

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.78  E-value=2.2e-21  Score=168.01  Aligned_cols=159  Identities=26%  Similarity=0.426  Sum_probs=95.6

Q ss_pred             ccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccE
Q 035691          155 LVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQS  234 (640)
Q Consensus       155 l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  234 (640)
                      +.+++.++.|.|++|+++.+|+.+..+.+|+.|++++|+|. ..|..++.++.|+.|+++-|++. ..|..|+.++.|+.
T Consensus        29 Lf~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev  106 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV  106 (264)
T ss_pred             ccchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence            33445555566666666666666666666666666666666 45556666666666666666665 55666666666666


Q ss_pred             EeccCccccCCCCCceEEccCCcCC-CCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCcc
Q 035691          235 LDLSKTIFLGQYPVRWLDLSHNHLT-GPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPG  313 (640)
Q Consensus       235 L~ls~n~~~~~~~l~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~  313 (640)
                      |                ||++|++. ...|..|-.|+.|+.|+|++|.+. .+|..++.+++|+.|.+..|.+- ..|..
T Consensus       107 l----------------dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpke  168 (264)
T KOG0617|consen  107 L----------------DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKE  168 (264)
T ss_pred             h----------------hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHH
Confidence            6                33333332 134555666666666666666665 56666666666666666666655 45666


Q ss_pred             CCCCCCCCeEeCcCCccccc
Q 035691          314 LSSLKSLEGLDLFQNTFQAK  333 (640)
Q Consensus       314 ~~~l~~L~~L~l~~N~l~~~  333 (640)
                      ++.++.|++|.+.+|+++..
T Consensus       169 ig~lt~lrelhiqgnrl~vl  188 (264)
T KOG0617|consen  169 IGDLTRLRELHIQGNRLTVL  188 (264)
T ss_pred             HHHHHHHHHHhcccceeeec
Confidence            66666666666666666633

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.78  E-value=5.2e-21  Score=165.76  Aligned_cols=132  Identities=32%  Similarity=0.518  Sum_probs=61.8

Q ss_pred             CCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCC
Q 035691           80 LPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCT  159 (640)
Q Consensus        80 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~  159 (640)
                      +.+|+.|++++|+|+ ..|..++.+++|+.|+++-|++. +.|..|+.++.|+.|||++|++..-.     .|..|..++
T Consensus        55 l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~-----lpgnff~m~  127 (264)
T KOG0617|consen   55 LKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENS-----LPGNFFYMT  127 (264)
T ss_pred             hhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcccccccccc-----CCcchhHHH
Confidence            334444444444443 23444444455555555555554 34555555555555555555544321     233344444


Q ss_pred             CcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCC
Q 035691          160 YLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIR  219 (640)
Q Consensus       160 ~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  219 (640)
                      .|..|+|+.|.+.-+|..++++++|+.|.+..|.+- ..|..++.++.|++|.+.+|+++
T Consensus       128 tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~  186 (264)
T KOG0617|consen  128 TLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT  186 (264)
T ss_pred             HHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence            444444444444444444444555555555554444 34444444555555555555444

>smart00090 RIO RIO-like kinase

Probab=99.77  E-value=3.5e-18  Score=166.37  Aligned_cols=150  Identities=19%  Similarity=0.135  Sum_probs=113.4

Q ss_pred             HHHhcCCCcccCcccccccceEEEEE-ECCCCeEEEEEEeecccch------------------------hHHHHHHHHH
Q 035691          436 LLKATGGFSSANLIGTGSFGSVYKGI-LDPDQTVVAVKVLFLHQRG------------------------ALKSFMAECE  490 (640)
Q Consensus       436 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~  490 (640)
                      +.+....|++.+.||+|+||.||+|. +..+|+.||||+++.....                        ....+..|++
T Consensus        23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  102 (237)
T smart00090       23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR  102 (237)
T ss_pred             HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence            34444457888999999999999998 6668999999998643210                        0123568999


Q ss_pred             HHHhcCCC--CCcceeEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 035691          491 ALRNIRHR--NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY  568 (640)
Q Consensus       491 ~l~~l~H~--niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~y  568 (640)
                      .+.++.+.  .+++.+++         ...++||||++++++..+.....          .........++.|++.+++|
T Consensus       103 ~L~~L~~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~~~----------~~~~~~~~~i~~qi~~~l~~  163 (237)
T smart00090      103 NLQRLYEAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLKDV----------EPEEEEEFELYDDILEEMRK  163 (237)
T ss_pred             HHHHHHhcCCCCCeeeEe---------cCceEEEEEecCCcccccccccC----------CcchHHHHHHHHHHHHHHHH
Confidence            99999753  33444432         12479999999988876542211          13445567899999999999


Q ss_pred             HhcCCCCC-eeeCCCCCCCeeeCCCCcEEEccccccccCCC
Q 035691          569 LHHHCKKQ-IVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE  608 (640)
Q Consensus       569 LH~~~~~~-ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~~  608 (640)
                      ||+   .+ |+|||+||+||+++ ++.++++|||.|...+.
T Consensus       164 LH~---~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      164 LYK---EGELVHGDLSEYNILVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             HHh---cCCEEeCCCChhhEEEE-CCCEEEEEChhhhccCC
Confidence            999   58 99999999999999 88999999999986644

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.74  E-value=7e-18  Score=160.33  Aligned_cols=144  Identities=13%  Similarity=0.105  Sum_probs=114.4

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhH---HH------HHHHHHHHHhcCCCCCcceeEeeccC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL---KS------FMAECEALRNIRHRNLVKIITACSSS  510 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~------~~~E~~~l~~l~H~niv~l~~~~~~~  510 (640)
                      .++|+..+++|+|+||.||.+..  ++..+|+|++........   +.      +.+|+..+.++.||+|+.+..++...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            57899999999999999999654  466899999964433222   22      68999999999999999998885433


Q ss_pred             CcC---CCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCe
Q 035691          511 DFQ---GNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNV  587 (640)
Q Consensus       511 ~~~---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~Ni  587 (640)
                      +..   .....++||||++|.+|.++..              .+.    ....+++.++..+|+   .+++|||++|+||
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Ni  166 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNF  166 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh--------------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHE
Confidence            211   1345789999999999988731              121    246699999999999   6999999999999


Q ss_pred             eeCCCCcEEEccccccccCC
Q 035691          588 LLDNDMIAHVGDFGLTRFIP  607 (640)
Q Consensus       588 Ll~~~~~~kl~DfGla~~~~  607 (640)
                      +++++| ++++|||..+...
T Consensus       167 li~~~g-i~liDfg~~~~~~  185 (232)
T PRK10359        167 IVSKNG-LRIIDLSGKRCTA  185 (232)
T ss_pred             EEeCCC-EEEEECCCccccc
Confidence            999988 9999999987653

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.71  E-value=8e-17  Score=153.56  Aligned_cols=144  Identities=22%  Similarity=0.172  Sum_probs=110.1

Q ss_pred             HHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccch----------------------hHHHHHHHHHHH
Q 035691          435 SLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG----------------------ALKSFMAECEAL  492 (640)
Q Consensus       435 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l  492 (640)
                      ++......|.+.+.||+|+||.||+|... +|+.||||+++.....                      ....+..|+.++
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            34444444777899999999999999886 7999999987543210                      112367789999


Q ss_pred             HhcCCCC--CcceeEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 035691          493 RNIRHRN--LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLH  570 (640)
Q Consensus       493 ~~l~H~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH  570 (640)
                      ..+.|++  ++..++.         ...++||||++++++......                .....++.+++.++.++|
T Consensus        88 ~~l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~----------------~~~~~~~~~i~~~l~~lh  142 (198)
T cd05144          88 KALYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL----------------EDPEEVLDEILEEIVKAY  142 (198)
T ss_pred             HHHHHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc----------------ccHHHHHHHHHHHHHHHH
Confidence            9998874  4444332         234899999999998765321                124568899999999999


Q ss_pred             cCCCCCeeeCCCCCCCeeeCCCCcEEEccccccccCC
Q 035691          571 HHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP  607 (640)
Q Consensus       571 ~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~  607 (640)
                      +   .+|+||||||+||++++++.++|+|||++....
T Consensus       143 ~---~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         143 K---HGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             H---CCCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            9   699999999999999999999999999997553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.71  E-value=2.5e-17  Score=165.00  Aligned_cols=137  Identities=25%  Similarity=0.378  Sum_probs=116.5

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcC-----C---CCCcceeEeeccCCc
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR-----H---RNLVKIITACSSSDF  512 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~~~~~~~~~  512 (640)
                      ++|.+.++||-|.|++||.|++....+.||+|+++.. +...+..+.||++|++++     |   .+||++++++.... 
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG-  155 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG-  155 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC-
Confidence            6788999999999999999999999999999998643 334578899999999984     2   47999999986664 


Q ss_pred             CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC
Q 035691          513 QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD  590 (640)
Q Consensus       513 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~  590 (640)
                      ..+.++|||+|++ |-+|..++.....        +.++...+..|+.||+.||.|||..  -+|||-||||+|||+-
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~Y--------rGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNY--------RGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLC  222 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCC--------CCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeee
Confidence            5567899999998 4578778765433        4589999999999999999999997  5999999999999984

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.70  E-value=1.4e-16  Score=148.08  Aligned_cols=133  Identities=19%  Similarity=0.114  Sum_probs=103.7

Q ss_pred             cccCcccccccceEEEEEECCCCeEEEEEEeecccc----hhHHHHHHHHHHHHhcC-CCCCcceeEeeccCCcCCCcee
Q 035691          444 SSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR----GALKSFMAECEALRNIR-HRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       444 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      .....|++|+||+||.+..  .+.+++.+.+.....    -....+.+|+++|+++. |+++++++++         ...
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~~   73 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DGR   73 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cCE
Confidence            3557899999999997654  677787776643322    11235889999999995 5889999876         135


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCC-CCCCeeeCCCCcEEE
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDL-KPSNVLLDNDMIAHV  597 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdl-kp~NiLl~~~~~~kl  597 (640)
                      +++|||+.|.+|......                 ....++.|++.+++++|+   .+|+|||| ||+||+++.++.++|
T Consensus        74 ~lvmeyI~G~~L~~~~~~-----------------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~L  133 (218)
T PRK12274         74 HLDRSYLAGAAMYQRPPR-----------------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAV  133 (218)
T ss_pred             EEEEeeecCccHHhhhhh-----------------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEE
Confidence            899999999988654311                 113467899999999999   69999999 799999999999999


Q ss_pred             ccccccccCC
Q 035691          598 GDFGLTRFIP  607 (640)
Q Consensus       598 ~DfGla~~~~  607 (640)
                      +|||+|....
T Consensus       134 IDFG~A~~~~  143 (218)
T PRK12274        134 IDFQLAVRGN  143 (218)
T ss_pred             EECCCceecC
Confidence            9999998543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=1.2e-16  Score=154.28  Aligned_cols=135  Identities=19%  Similarity=0.258  Sum_probs=109.3

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeecccc--------hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--------GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      +.||+|++|.||+|.+  .|..|++|+......        .....+.+|++++..++|++++....++..     ....
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD-----PENF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe-----CCCC
Confidence            5789999999999987  577899997643221        122468889999999999998776666432     2356


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||++|++|.+++...             .. .+..++.+++.++.++|+   .+++|||++|+||+++ ++.++++
T Consensus        75 ~lv~e~~~G~~L~~~~~~~-------------~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~li  136 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSN-------------GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLI  136 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhc-------------cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEE
Confidence            8999999999999887431             11 678899999999999999   6999999999999999 7899999


Q ss_pred             cccccccC
Q 035691          599 DFGLTRFI  606 (640)
Q Consensus       599 DfGla~~~  606 (640)
                      |||.++..
T Consensus       137 Df~~a~~~  144 (211)
T PRK14879        137 DFGLAEFS  144 (211)
T ss_pred             ECCcccCC
Confidence            99999864

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.69  E-value=2.1e-16  Score=173.56  Aligned_cols=139  Identities=23%  Similarity=0.254  Sum_probs=108.5

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--c------chhHHHHHHHHHHHHhcCCCCCcceeEeeccCC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--Q------RGALKSFMAECEALRNIRHRNLVKIITACSSSD  511 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  511 (640)
                      ...|...+.||+|+||.||+|.+..  ..+++|+....  .      ....+.+.+|+++++.++|++++....++..  
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--  407 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--  407 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--
Confidence            3445667899999999999998853  33444433111  1      1123568899999999999999887766432  


Q ss_pred             cCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC
Q 035691          512 FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN  591 (640)
Q Consensus       512 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~  591 (640)
                         ....++||||+++++|.+++.                  ....++.|++.++.|||+   .+++|||+||+||++ +
T Consensus       408 ---~~~~~lv~E~~~g~~L~~~l~------------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~  462 (535)
T PRK09605        408 ---PEEKTIVMEYIGGKDLKDVLE------------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-R  462 (535)
T ss_pred             ---CCCCEEEEEecCCCcHHHHHH------------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-E
Confidence               234679999999999998763                  245689999999999999   699999999999999 6


Q ss_pred             CCcEEEccccccccCC
Q 035691          592 DMIAHVGDFGLTRFIP  607 (640)
Q Consensus       592 ~~~~kl~DfGla~~~~  607 (640)
                      ++.++|+|||+++...
T Consensus       463 ~~~~~liDFGla~~~~  478 (535)
T PRK09605        463 DDRLYLIDFGLGKYSD  478 (535)
T ss_pred             CCcEEEEeCcccccCC
Confidence            7899999999998653

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.67  E-value=2.1e-16  Score=150.98  Aligned_cols=131  Identities=22%  Similarity=0.269  Sum_probs=102.8

Q ss_pred             cccccccceEEEEEECCCCeEEEEEEeeccc--------chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--------RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       448 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .||+|+||.||+|.+  +|..|++|+.....        ......+.+|++++..++|+++.....++.     .....+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-----DPDNKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-----ECCCCE
Confidence            489999999999985  57789999863221        111256788999999999887554444432     123458


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||++|++|.+++....                 ..++.|++.++.++|+   .+++|+|++|.||+++ ++.++++|
T Consensus        74 lv~e~~~g~~l~~~~~~~~-----------------~~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liD  132 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGN-----------------DELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLID  132 (199)
T ss_pred             EEEEEECCccHHHHHhhcH-----------------HHHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEE
Confidence            9999999999998764211                 0689999999999999   7999999999999999 88999999


Q ss_pred             ccccccC
Q 035691          600 FGLTRFI  606 (640)
Q Consensus       600 fGla~~~  606 (640)
                      ||+++..
T Consensus       133 fg~a~~~  139 (199)
T TIGR03724       133 FGLGKYS  139 (199)
T ss_pred             CCCCcCC
Confidence            9999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.67  E-value=6.6e-16  Score=159.38  Aligned_cols=174  Identities=37%  Similarity=0.537  Sum_probs=138.7

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeecccch---hHHHHHHHHHHHHhcCCC-CCcceeEeeccCCcCCCcee
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG---ALKSFMAECEALRNIRHR-NLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~~~~~  518 (640)
                      |...+.+|.|+||.||++.+.   ..+|+|.+......   ....+.+|+.+++.+.|+ +|+++.+++     ......
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEE
Confidence            566788999999999999986   77899998544332   367899999999999988 799999985     333347


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC-cEEE
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHV  597 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~-~~kl  597 (640)
                      +++++|+.++++.+++......       ..+.......++.|++.++.|+|.   .+++|||+||+||+++..+ .+++
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l  143 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRK-------GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKL  143 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccc-------cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEE
Confidence            8999999999999776543311       136778899999999999999999   6899999999999999988 7999


Q ss_pred             ccccccccCCCccCCCc--eeeccccccccccCcccCCC
Q 035691          598 GDFGLTRFIPEVISSNQ--CSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~  634 (640)
                      +|||.++..........  .......||..|+|||.+.+
T Consensus       144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~  182 (384)
T COG0515         144 IDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG  182 (384)
T ss_pred             eccCcceecCCCCccccccccccccccccccCCHHHhcC
Confidence            99999986543322111  12344679999999999987

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.64  E-value=1.8e-15  Score=137.46  Aligned_cols=136  Identities=21%  Similarity=0.242  Sum_probs=110.4

Q ss_pred             ccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCC--CCCcceeEeeccCCcCCCceeeEEe
Q 035691          445 SANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRH--RNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       445 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      +.+.||+|.++.||++...  +..+++|.......  ...+..|+..++.++|  ..+++++++.     ...+..+++|
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~   72 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLM   72 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEE
Confidence            3467999999999999985  37799998854433  4678899999999976  5888988874     3335689999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      ||++++.+..+                 +......++.+++.+++++|.....+++|+|++|+||+++..+.++++|||.
T Consensus        73 e~~~g~~~~~~-----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~  135 (155)
T cd05120          73 EWIEGETLDEV-----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEY  135 (155)
T ss_pred             EecCCeecccC-----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccc
Confidence            99988776543                 2345677899999999999986445799999999999999989999999999


Q ss_pred             cccC
Q 035691          603 TRFI  606 (640)
Q Consensus       603 a~~~  606 (640)
                      ++..
T Consensus       136 ~~~~  139 (155)
T cd05120         136 AGYG  139 (155)
T ss_pred             ccCC
Confidence            9854

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.60  E-value=4.9e-15  Score=139.96  Aligned_cols=137  Identities=24%  Similarity=0.222  Sum_probs=97.2

Q ss_pred             cCcccccccceEEEEEECCCCeEEEEEEeecccchh--HHH----------------------HHHHHHHHHhcCCCC--
Q 035691          446 ANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA--LKS----------------------FMAECEALRNIRHRN--  499 (640)
Q Consensus       446 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~H~n--  499 (640)
                      .+.||+|+||+||+|.+. +++.||||++.......  ...                      ...|.+.+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999987 89999999986432111  111                      135566666664443  


Q ss_pred             CcceeEeeccCCcCCCceeeEEeeccCCCChhhh-cCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 035691          500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESW-LHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIV  578 (640)
Q Consensus       500 iv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~iv  578 (640)
                      +.+.+++         ...++||||++++.+... +....           .. .....++.+++.++.++|..  .+|+
T Consensus        81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-----------~~-~~~~~~~~~~~~~l~~lh~~--~~iv  137 (187)
T cd05119          81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-----------LL-EDPEELYDQILELMRKLYRE--AGLV  137 (187)
T ss_pred             CCceEec---------CCCEEEEEEeCCCCccChhhhhhh-----------hc-ccHHHHHHHHHHHHHHHhhc--cCcC
Confidence            3444432         134899999999654321 11100           00 35678999999999999983  5899


Q ss_pred             eCCCCCCCeeeCCCCcEEEccccccccCC
Q 035691          579 HCDLKPSNVLLDNDMIAHVGDFGLTRFIP  607 (640)
Q Consensus       579 Hrdlkp~NiLl~~~~~~kl~DfGla~~~~  607 (640)
                      |||+||+||+++ ++.++++|||.+....
T Consensus       138 H~Dl~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         138 HGDLSEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             cCCCChhhEEEE-CCcEEEEECccccccc
Confidence            999999999999 8999999999997553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.59  E-value=9.1e-16  Score=167.66  Aligned_cols=177  Identities=21%  Similarity=0.260  Sum_probs=133.6

Q ss_pred             ccCcccccccceEEEEEECCCCeEEEEEEeec---ccc---hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          445 SANLIGTGSFGSVYKGILDPDQTVVAVKVLFL---HQR---GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       445 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ...++|.|++|.|+.+........++.|....   ...   .....+..|..+-..+.|||++..+..+...     ...
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~-----~~~  396 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI-----DGI  396 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc-----ccc
Confidence            45789999999888887766666666665431   111   1112366677777889999998877664322     223


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      .-+||||++ ||..++.....          +....+..+.+|+..|++|+|+   .+|.|||+|++|+++..+|.+||+
T Consensus       397 ~~~mE~~~~-Dlf~~~~~~~~----------~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~  462 (601)
T KOG0590|consen  397 LQSMEYCPY-DLFSLVMSNGK----------LTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKII  462 (601)
T ss_pred             hhhhhcccH-HHHHHHhcccc----------cchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEe
Confidence            344999999 99998865421          4556677899999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |||.+..+.-+.........+.+|+-.|+|||++.+..|.++
T Consensus       463 Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr  504 (601)
T KOG0590|consen  463 DFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPR  504 (601)
T ss_pred             ecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcc
Confidence            999998764433333345567889999999999999998763

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.58  E-value=1.7e-15  Score=168.53  Aligned_cols=182  Identities=21%  Similarity=0.237  Sum_probs=132.1

Q ss_pred             HHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcC---CCCCcceeEeeccC
Q 035691          434 ESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR---HRNLVKIITACSSS  510 (640)
Q Consensus       434 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~  510 (640)
                      .+.+.....|.+...||+|+||+||+|.... |+.||+|+=+....  + +|.-=.+++.+++   -+.|..+..+    
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~--W-EfYI~~q~~~RLk~~~~~~~~~~~~a----  762 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP--W-EFYICLQVMERLKPQMLPSIMHISSA----  762 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc--e-eeeehHHHHHhhchhhhcchHHHHHH----
Confidence            3444555668888899999999999999985 99999998643321  0 1122233445554   1233333333    


Q ss_pred             CcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC
Q 035691          511 DFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD  590 (640)
Q Consensus       511 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~  590 (640)
                       +...+.-++|+||.+.|+|.+++...          ..++|..++.++.|++..++.||.   .+|||+||||+|+++.
T Consensus       763 -~~~~~~S~lv~ey~~~Gtlld~~N~~----------~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~  828 (974)
T KOG1166|consen  763 -HVFQNASVLVSEYSPYGTLLDLINTN----------KVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLR  828 (974)
T ss_pred             -HccCCcceeeeeccccccHHHhhccC----------CCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEee
Confidence             22233457999999999999999733          348888999999999999999999   6999999999999994


Q ss_pred             -------CCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          591 -------NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       591 -------~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                             +...++|+|||.+-.+.--.  +...-.+.++|-.+-.+|+..|.+|+-
T Consensus       829 ~~~~~~~~~~~l~lIDfG~siDm~lfp--~~~~F~~~~~td~f~C~EM~~grpWtY  882 (974)
T KOG1166|consen  829 REICADSDSKGLYLIDFGRSIDMKLFP--DGTKFKAVWHTDLFDCIEMREGRPWTY  882 (974)
T ss_pred             cccCCCCcccceEEEecccceeeeEcC--CCcEEeeeeccccchhHHHhcCCCCch
Confidence                   34578999999987553211  112334567888999999999999874

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.58  E-value=1.4e-15  Score=175.40  Aligned_cols=134  Identities=15%  Similarity=0.227  Sum_probs=92.6

Q ss_pred             hcCC-CCCcceeEeeccCCc--CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 035691          494 NIRH-RNLVKIITACSSSDF--QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLH  570 (640)
Q Consensus       494 ~l~H-~niv~l~~~~~~~~~--~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH  570 (640)
                      .++| +||++++++|.....  ......+.+|||+ +++|.+++....         ..+++..++.++.||+.||.|||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~al~~lH   97 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---------RSVDAFECFHVFRQIVEIVNAAH   97 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---------ccccHHHHHHHHHHHHHHHHHHH
Confidence            3445 577778877522211  1223567788887 569999996432         23788899999999999999999


Q ss_pred             cCCCCCeeeCCCCCCCeeeCC-------------------CCcEEEccccccccCCCccCC------------Cceeecc
Q 035691          571 HHCKKQIVHCDLKPSNVLLDN-------------------DMIAHVGDFGLTRFIPEVISS------------NQCSSVG  619 (640)
Q Consensus       571 ~~~~~~ivHrdlkp~NiLl~~-------------------~~~~kl~DfGla~~~~~~~~~------------~~~~~~~  619 (640)
                      +   ++|+||||||+|||++.                   ++.+|++|||+++........            .......
T Consensus        98 ~---~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (793)
T PLN00181         98 S---QGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQIL  174 (793)
T ss_pred             h---CCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccc
Confidence            8   79999999999999954                   455667777777643210000            0001112


Q ss_pred             ccccccccCcccCCCCCCCCC
Q 035691          620 LKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       620 ~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ..||++|||||++.+..++.+
T Consensus       175 ~~gt~~Y~APE~~~~~~~~~~  195 (793)
T PLN00181        175 AMEMSWYTSPEEDNGSSSNCA  195 (793)
T ss_pred             cCCCcceEChhhhccCCCCch
Confidence            458999999999999888754

>PLN03150 hypothetical protein; Provisional

Probab=99.56  E-value=1.1e-14  Score=161.64  Aligned_cols=117  Identities=38%  Similarity=0.601  Sum_probs=103.1

Q ss_pred             CceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcC
Q 035691          248 VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQ  327 (640)
Q Consensus       248 l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  327 (640)
                      ++.|+|++|.++|.+|..++.+++|+.|+|++|++++.+|..+..+++|+.|+|++|++++.+|..+.++++|+.|+|++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            67789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CccccccCCcccCCC--CCCCCCccccccCCCCCcCCCcCCCCCCCC
Q 035691          328 NTFQAKSQNGDVPRK--GIFKNASAISVAGNEKLCGGISELKLPPCT  372 (640)
Q Consensus       328 N~l~~~~~~~~~p~~--~~~~~~~~~~~~~n~~~c~~~~~~~~p~~~  372 (640)
                      |.++     |.+|..  .....+..+.+.+|+.+|+.+.   .+.|.
T Consensus       500 N~l~-----g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~---l~~C~  538 (623)
T PLN03150        500 NSLS-----GRVPAALGGRLLHRASFNFTDNAGLCGIPG---LRACG  538 (623)
T ss_pred             Cccc-----ccCChHHhhccccCceEEecCCccccCCCC---CCCCc
Confidence            9998     677764  2233456788999999998653   34563

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.56  E-value=3.2e-14  Score=138.87  Aligned_cols=140  Identities=17%  Similarity=0.108  Sum_probs=104.2

Q ss_pred             Cccc-ccccceEEEEEECCCCeEEEEEEeeccc-------------chhHHHHHHHHHHHHhcCCCCC--cceeEeeccC
Q 035691          447 NLIG-TGSFGSVYKGILDPDQTVVAVKVLFLHQ-------------RGALKSFMAECEALRNIRHRNL--VKIITACSSS  510 (640)
Q Consensus       447 ~~lg-~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~  510 (640)
                      ..|| .|+.|+||++...  +..+|||.+....             ......+.+|++++..++|++|  ++.++++...
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            5677 7889999998774  7788999874211             1123567889999999998875  6677664322


Q ss_pred             CcCCCceeeEEeeccCC-CChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee
Q 035691          511 DFQGNDFKALVYEFMHH-GSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL  589 (640)
Q Consensus       511 ~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl  589 (640)
                      . ......++||||+++ .+|.+++....           ++..    .+.+++.++.+||+   .+|+||||||.|||+
T Consensus       115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~~~-----------l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv  175 (239)
T PRK01723        115 H-GLFYRADILIERIEGARDLVALLQEAP-----------LSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILL  175 (239)
T ss_pred             c-CcceeeeEEEEecCCCCCHHHHHhcCC-----------CCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEE
Confidence            1 111124599999997 68988875321           2322    36789999999999   699999999999999


Q ss_pred             CCCCcEEEccccccccCC
Q 035691          590 DNDMIAHVGDFGLTRFIP  607 (640)
Q Consensus       590 ~~~~~~kl~DfGla~~~~  607 (640)
                      +.++.++|+|||.++...
T Consensus       176 ~~~~~v~LIDfg~~~~~~  193 (239)
T PRK01723        176 DPDGKFWLIDFDRGELRT  193 (239)
T ss_pred             cCCCCEEEEECCCcccCC
Confidence            998999999999998653

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.55  E-value=1e-16  Score=163.51  Aligned_cols=195  Identities=29%  Similarity=0.471  Sum_probs=115.9

Q ss_pred             CCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCC
Q 035691           80 LPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCT  159 (640)
Q Consensus        80 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~  159 (640)
                      +..-...||+.|++. .+|..+..+..|+.+.|+.|.|. .+|.++.++..|++|||+.|+++..+.       .++.|+
T Consensus        74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~lp~-------~lC~lp  144 (722)
T KOG0532|consen   74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSHLPD-------GLCDLP  144 (722)
T ss_pred             ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhhcCCh-------hhhcCc
Confidence            344445566666665 44555555555666666666665 455555666666666666666655432       222222


Q ss_pred             CcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccC
Q 035691          160 YLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSK  239 (640)
Q Consensus       160 ~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~  239 (640)
                       |+.|-+++|+++.+|..++.+..|..||.+.|.|. .+|..++++.+|+.|++..|++. .+|..+..           
T Consensus       145 -Lkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~-----------  210 (722)
T KOG0532|consen  145 -LKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCS-----------  210 (722)
T ss_pred             -ceeEEEecCccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhC-----------
Confidence             55555556666555555555555555566665555 34555555555555555555555 33333332           


Q ss_pred             ccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCC---CCeEEecCCc
Q 035691          240 TIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVG---LEYLNLSINS  305 (640)
Q Consensus       240 n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~  305 (640)
                            .+|..||+|.|+++ .+|-.|..|+.|++|-|.+|.|+ ..|..++-.-.   -++|+..-++
T Consensus       211 ------LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q  271 (722)
T KOG0532|consen  211 ------LPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ  271 (722)
T ss_pred             ------CceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence                  23555688888888 78888899999999999999888 66665543222   3566666663

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.53  E-value=2.1e-16  Score=161.27  Aligned_cols=171  Identities=27%  Similarity=0.453  Sum_probs=95.3

Q ss_pred             CcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCC
Q 035691            5 LMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIR   84 (640)
Q Consensus         5 L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~   84 (640)
                      -...||+.|+++ .+|.++..+..|..|.|++|.+. .+|.++.++..|+.|||+.|+++.      +|..++  .--|+
T Consensus        77 t~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~------lp~~lC--~lpLk  146 (722)
T KOG0532|consen   77 TVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSH------LPDGLC--DLPLK  146 (722)
T ss_pred             hhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhhc------CChhhh--cCcce
Confidence            345566667666 66666666666666677777766 666666666677777777666654      666555  23355


Q ss_pred             eeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceE
Q 035691           85 IPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIV  164 (640)
Q Consensus        85 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L  164 (640)
                      .|.+++|+++ .+|..++.+..|..||.+.|.|. .+|..++++.+|+.|++..|++..++       ..+..| .|..|
T Consensus       147 vli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp-------~El~~L-pLi~l  216 (722)
T KOG0532|consen  147 VLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLP-------EELCSL-PLIRL  216 (722)
T ss_pred             eEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCC-------HHHhCC-ceeee
Confidence            5555555555 34444555555555555555555 24444555555555555555554432       223321 24445


Q ss_pred             ecCCCCCCCcCcCCCCCCCCCEEEccCCcCc
Q 035691          165 SLNVNSLRSIPISVGYLPKLQVLSLFENNIS  195 (640)
Q Consensus       165 ~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~  195 (640)
                      |++.|++..||..|.+|+.|++|-|.+|.+.
T Consensus       217 DfScNkis~iPv~fr~m~~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  217 DFSCNKISYLPVDFRKMRHLQVLQLENNPLQ  247 (722)
T ss_pred             ecccCceeecchhhhhhhhheeeeeccCCCC
Confidence            5555555555544544555555555555554

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.53  E-value=1.9e-14  Score=152.79  Aligned_cols=261  Identities=30%  Similarity=0.369  Sum_probs=175.4

Q ss_pred             eEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCC-CCCCeeeccCCcccccCCccCcCCCCCCE
Q 035691           31 YIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTL-PNIRIPLLAGNQFFGNIPHSISNASKLEW  109 (640)
Q Consensus        31 ~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  109 (640)
                      .|.++.|.+. .....+..++.++.|++.+|.+++      +|+.... + ++|+.|++++|++.. +|..+..+++|+.
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~~------i~~~~~~-~~~nL~~L~l~~N~i~~-l~~~~~~l~~L~~  167 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNITD------IPPLIGL-LKSNLKELDLSDNKIES-LPSPLRNLPNLKN  167 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCccccc------Ccccccc-chhhcccccccccchhh-hhhhhhccccccc
Confidence            5788888875 233445666888889998888876      7766653 4 388999999998884 4466788899999


Q ss_pred             EECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEc
Q 035691          110 LDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSL  189 (640)
Q Consensus       110 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L  189 (640)
                      |++++|+++. +|.....+++|+.|++++|+++.++.       ....+..|+++.+++|.+..++..+..+.++..+.+
T Consensus       168 L~l~~N~l~~-l~~~~~~~~~L~~L~ls~N~i~~l~~-------~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l  239 (394)
T COG4886         168 LDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKISDLPP-------EIELLSALEELDLSNNSIIELLSSLSNLKNLSGLEL  239 (394)
T ss_pred             cccCCchhhh-hhhhhhhhhhhhheeccCCccccCch-------hhhhhhhhhhhhhcCCcceecchhhhhccccccccc
Confidence            9999999985 55555578889999999999988643       223445688999999977777777888888888889


Q ss_pred             cCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCccCCCC
Q 035691          190 FENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNL  269 (640)
Q Consensus       190 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l  269 (640)
                      .+|++. ..+..++.+++++.|++++|.++.. +. +..+.+++.|                ++++|.++..+|......
T Consensus       240 ~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i-~~-~~~~~~l~~L----------------~~s~n~~~~~~~~~~~~~  300 (394)
T COG4886         240 SNNKLE-DLPESIGNLSNLETLDLSNNQISSI-SS-LGSLTNLREL----------------DLSGNSLSNALPLIALLL  300 (394)
T ss_pred             CCceee-eccchhccccccceecccccccccc-cc-ccccCccCEE----------------eccCccccccchhhhccc
Confidence            999887 4477788888899999999999844 33 7788888888                555555554444433322


Q ss_pred             CCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccc
Q 035691          270 KSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQ  331 (640)
Q Consensus       270 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  331 (640)
                      .....+. . +.++ ..+..+.....+...++..+... ..+..+.....+..++...+...
T Consensus       301 ~~~~~~~-~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  358 (394)
T COG4886         301 LLLELLL-N-LLLT-LKALELKLNSILLNNNILSNGET-SSPEALSILESLNNLWTLDNALD  358 (394)
T ss_pred             hhHHhhh-h-hhhh-ccccccccccccccccccccccc-ccchhhcccccccCceecccccc
Confidence            2221111 1 2222 22222333333444445555544 34455555555555555555443

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.52  E-value=1.9e-14  Score=152.76  Aligned_cols=203  Identities=33%  Similarity=0.457  Sum_probs=164.4

Q ss_pred             CEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCC-CCCEEECcCCccCccCCccccCCCCCC
Q 035691           54 RTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNAS-KLEWLDFANNSLTASIPEDLGRLRNLT  132 (640)
Q Consensus        54 ~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~  132 (640)
                      ..|+++.|.+..      -+..+. .++.++.|++.+|+++. ++.....++ +|+.|++++|++.. +|..++.+++|+
T Consensus        96 ~~l~~~~~~~~~------~~~~~~-~~~~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~~-l~~~~~~l~~L~  166 (394)
T COG4886          96 PSLDLNLNRLRS------NISELL-ELTNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIES-LPSPLRNLPNLK  166 (394)
T ss_pred             ceeecccccccc------Cchhhh-cccceeEEecCCccccc-Cccccccchhhcccccccccchhh-hhhhhhcccccc
Confidence            468999888743      112222 35789999999999995 455566664 99999999999994 667789999999


Q ss_pred             EEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEE
Q 035691          133 RLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELN  212 (640)
Q Consensus       133 ~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  212 (640)
                      .|++++|+++.++       .....++.|+.|++++|+++.+|.....+..|++|.+++|.+. ..+..+.++.++..|.
T Consensus       167 ~L~l~~N~l~~l~-------~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~  238 (394)
T COG4886         167 NLDLSFNDLSDLP-------KLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLE  238 (394)
T ss_pred             ccccCCchhhhhh-------hhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccc
Confidence            9999999999863       2333778999999999999999987766777999999999655 4677899999999999


Q ss_pred             ccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccC
Q 035691          213 LRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGS  292 (640)
Q Consensus       213 L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  292 (640)
                      +++|++. ..+..+..+++++.|                ++++|.++...+  ++.+.+|+.|++++|.+...+|.....
T Consensus       239 l~~n~~~-~~~~~~~~l~~l~~L----------------~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~~  299 (394)
T COG4886         239 LSNNKLE-DLPESIGNLSNLETL----------------DLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIALL  299 (394)
T ss_pred             cCCceee-eccchhcccccccee----------------cccccccccccc--ccccCccCEEeccCccccccchhhhcc
Confidence            9999997 446677778778777                888888884444  899999999999999999776665543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.46  E-value=1.2e-14  Score=151.26  Aligned_cols=161  Identities=29%  Similarity=0.271  Sum_probs=129.1

Q ss_pred             cccccccceEEEEE---ECCCCeEEEEEEeecccch--hHHHHHHHHHHHHhcC-CCCCcceeEeeccCCcCCCceeeEE
Q 035691          448 LIGTGSFGSVYKGI---LDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIR-HRNLVKIITACSSSDFQGNDFKALV  521 (640)
Q Consensus       448 ~lg~G~~g~Vy~~~---~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~~lv  521 (640)
                      ++|+|+||.|+.++   -.+.|..+|+|+.+.....  .......|..++..++ ||.+|++..+     ++.+...+++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHh
Confidence            37999999998653   3346778999988543221  1225567888888886 9999999877     6666788999


Q ss_pred             eeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccc
Q 035691          522 YEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG  601 (640)
Q Consensus       522 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfG  601 (640)
                      ++|..+|++...+.....          +.+.....+...++-|++++|.   .+|+|||+|++||+++.+|++|+.|||
T Consensus        76 ld~~rgg~lft~l~~~~~----------f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfg  142 (612)
T KOG0603|consen   76 LDFLRGGDLFTRLSKEVM----------FDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFG  142 (612)
T ss_pred             hhhcccchhhhccccCCc----------hHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCch
Confidence            999999999988765433          5666778889999999999999   699999999999999999999999999


Q ss_pred             ccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          602 LTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       602 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      +++...+...        .+||..|||||++.|
T Consensus       143 lske~v~~~~--------~cgt~eymApEI~~g  167 (612)
T KOG0603|consen  143 LSKEAVKEKI--------ACGTYEYRAPEIING  167 (612)
T ss_pred             hhhHhHhhhh--------cccchhhhhhHhhhc
Confidence            9986532111        169999999999984

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.43  E-value=4.2e-13  Score=142.45  Aligned_cols=141  Identities=22%  Similarity=0.233  Sum_probs=97.7

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeecccchhH----------------------------------------HHHH
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL----------------------------------------KSFM  486 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~  486 (640)
                      +.||+|++|.||+|+.+ +|+.||||+.+.......                                        -.|.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            67999999999999987 799999999854311000                                        0255


Q ss_pred             HHHHHHHhcC----CCCCcceeEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHH
Q 035691          487 AECEALRNIR----HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV  562 (640)
Q Consensus       487 ~E~~~l~~l~----H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i  562 (640)
                      +|++.+.+++    |.+-|.+-.++...    ....++||||++|+++.++.......         .   ....++.++
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~----~~~~vLvmE~i~G~~L~~~~~~~~~~---------~---~~~~ia~~~  265 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDR----TSERVLTMEWIDGIPLSDIAALDEAG---------L---DRKALAENL  265 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhh----cCCceEEEEeECCcccccHHHHHhcC---------C---CHHHHHHHH
Confidence            5666555552    33334443443221    22468999999999998875422110         1   123456666


Q ss_pred             HH-HHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccccccCC
Q 035691          563 AS-ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP  607 (640)
Q Consensus       563 ~~-al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~  607 (640)
                      +. .+..+|.   .+++|+|++|.||++++++.++++|||++..+.
T Consensus       266 ~~~~l~ql~~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       266 ARSFLNQVLR---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHHHHh---CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            55 4667787   699999999999999999999999999998764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.36  E-value=1.7e-13  Score=127.86  Aligned_cols=166  Identities=22%  Similarity=0.387  Sum_probs=125.7

Q ss_pred             cCcccccccceEEEEEECCCCeEEEEEEeecccch--hHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEee
Q 035691          446 ANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYE  523 (640)
Q Consensus       446 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e  523 (640)
                      ..+|.+...|..|+|++.  |..+++|++...+..  -.+.|..|.-.++.+.||||..++|+|..+.     ...++..
T Consensus       195 ~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp-----nlv~isq  267 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP-----NLVIISQ  267 (448)
T ss_pred             hhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC-----CceEeee
Confidence            356888899999999995  666778888654432  2367999999999999999999999986653     6789999


Q ss_pred             ccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCee-eCCCCCCCeeeCCCCcEEEccccc
Q 035691          524 FMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIV-HCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       524 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~iv-Hrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      ||+.|+|+..+++...        ...+..++.+++.+||+||+|||+.  .+++ --.+.+..+++|++.+++|+ .+=
T Consensus       268 ~mp~gslynvlhe~t~--------vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltaris-mad  336 (448)
T KOG0195|consen  268 YMPFGSLYNVLHEQTS--------VVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARIS-MAD  336 (448)
T ss_pred             eccchHHHHHHhcCcc--------EEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhhee-ccc
Confidence            9999999999987654        2356678899999999999999996  3444 44688999999999998874 222


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCCCCCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV  637 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  637 (640)
                      +++-      .++.  +..-.|.||+||.+...+-
T Consensus       337 ~kfs------fqe~--gr~y~pawmspealqrkpe  363 (448)
T KOG0195|consen  337 TKFS------FQEV--GRAYSPAWMSPEALQRKPE  363 (448)
T ss_pred             ceee------eecc--ccccCcccCCHHHHhcCch
Confidence            2210      0111  1123578999999876553

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.35  E-value=8.7e-14  Score=147.94  Aligned_cols=264  Identities=25%  Similarity=0.207  Sum_probs=124.3

Q ss_pred             CCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCC
Q 035691           28 QLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKL  107 (640)
Q Consensus        28 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  107 (640)
                      .++.++...+.+...... ...+..++.++++.|.|..      +-..+ ..+.+|+.|+|.+|+|..+.. .+..+++|
T Consensus        50 ~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~~------~~~~l-~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L  120 (414)
T KOG0531|consen   50 DLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIAK------ILNHL-SKLKSLEALDLYDNKIEKIEN-LLSSLVNL  120 (414)
T ss_pred             hhhhhcchhccccchhhh-HHHhHhHHhhccchhhhhh------hhccc-ccccceeeeeccccchhhccc-chhhhhcc
Confidence            344455555544322111 1455666666677776654      11111 124555556666666653322 14555666


Q ss_pred             CEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcC-CCCCCCCCE
Q 035691          108 EWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPIS-VGYLPKLQV  186 (640)
Q Consensus       108 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~-~~~l~~L~~  186 (640)
                      ++|+|++|+|+.+.+  +..++.|+.|++++|.|+.+        ..+..+..|+.+++++|.++.++.. ...+.+++.
T Consensus       121 ~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~~~--------~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~  190 (414)
T KOG0531|consen  121 QVLDLSFNKITKLEG--LSTLTLLKELNLSGNLISDI--------SGLESLKSLKLLDLSYNRIVDIENDELSELISLEE  190 (414)
T ss_pred             hheeccccccccccc--hhhccchhhheeccCcchhc--------cCCccchhhhcccCCcchhhhhhhhhhhhccchHH
Confidence            666666666664332  34555566666666666554        2333455555555555555554432 234455555


Q ss_pred             EEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCccC
Q 035691          187 LSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAV  266 (640)
Q Consensus       187 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~  266 (640)
                      +++.+|.+..  ...+..+..+..+++..|.++..-+.  ..+..+              .|+.+++++|.+. ..+..+
T Consensus       191 l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~~~l--~~~~~~--------------~L~~l~l~~n~i~-~~~~~~  251 (414)
T KOG0531|consen  191 LDLGGNSIRE--IEGLDLLKKLVLLSLLDNKISKLEGL--NELVML--------------HLRELYLSGNRIS-RSPEGL  251 (414)
T ss_pred             HhccCCchhc--ccchHHHHHHHHhhcccccceeccCc--ccchhH--------------HHHHHhcccCccc-cccccc
Confidence            5555555542  12233334444445555555422111  111110              0223355555555 232445


Q ss_pred             CCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCC---CCcc-CCCCCCCCeEeCcCCccc
Q 035691          267 GNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGP---IHPG-LSSLKSLEGLDLFQNTFQ  331 (640)
Q Consensus       267 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~---~~~~-~~~l~~L~~L~l~~N~l~  331 (640)
                      ..+..+..|++++|++...  ..+.....+..+.+..|.+...   .... ....+.++.+++..|+..
T Consensus       252 ~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
T KOG0531|consen  252 ENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIR  318 (414)
T ss_pred             cccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccc
Confidence            5555666666666666532  1233344455555555554421   1111 333444555555555444

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.35  E-value=3.5e-13  Score=122.92  Aligned_cols=100  Identities=26%  Similarity=0.350  Sum_probs=31.6

Q ss_pred             CCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccc-cCCCCCCEEEcccCcCCCCCCCcccccccccCCC
Q 035691           81 PNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDL-GRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCT  159 (640)
Q Consensus        81 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~  159 (640)
                      .+|+.|+|++|.|+.+  +.+..++.|++|++++|+|+.+ ++.+ ..+++|++|+|++|+|..+.     ....+..++
T Consensus        42 ~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~~L~L~~N~I~~l~-----~l~~L~~l~  113 (175)
T PF14580_consen   42 DKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQELYLSNNKISDLN-----ELEPLSSLP  113 (175)
T ss_dssp             TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCC-----CCGGGGG-T
T ss_pred             cCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCcc-ccchHHhCCcCCEEECcCCcCCChH-----HhHHHHcCC
Confidence            3344444444444432  1344556666666666666643 2223 34666666666666665542     223444555


Q ss_pred             CcceEecCCCCCCCcCc----CCCCCCCCCEEE
Q 035691          160 YLEIVSLNVNSLRSIPI----SVGYLPKLQVLS  188 (640)
Q Consensus       160 ~L~~L~L~~N~l~~ip~----~~~~l~~L~~L~  188 (640)
                      +|+.|+|.+|.+..-+.    -+..+|+|+.||
T Consensus       114 ~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD  146 (175)
T PF14580_consen  114 KLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD  146 (175)
T ss_dssp             T--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred             CcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence            55555555555544322    123345555554

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.34  E-value=2.9e-12  Score=137.46  Aligned_cols=148  Identities=18%  Similarity=0.153  Sum_probs=93.0

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecccch----------------------------------hHH----
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG----------------------------------ALK----  483 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------------------~~~----  483 (640)
                      .|+. +.||+|++|.||+|+.+.+|+.||||+.+..-..                                  ..+    
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            3555 6899999999999999877999999999533100                                  011    


Q ss_pred             --HHHHHHHHHHhcC----CCCCcceeEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHH
Q 035691          484 --SFMAECEALRNIR----HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLN  557 (640)
Q Consensus       484 --~~~~E~~~l~~l~----H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~  557 (640)
                        ++.+|+..+.+++    +...+.+-.++++    .....++||||++|+.+.++-.......    ....+....+..
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d----~st~~VLvmE~i~G~~l~d~~~l~~~g~----d~~~la~~~v~~  271 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWD----YCSETVMVMERMYGIPVSDVAALRAAGT----DMKLLAERGVEV  271 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecc----cCCCceEEEeeecCccHHhHHHHHhcCC----CHHHHHHHHHHH
Confidence              2444554444442    4444444344322    1234679999999999976421111100    000122222233


Q ss_pred             HHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC----cEEEccccccccCCC
Q 035691          558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM----IAHVGDFGLTRFIPE  608 (640)
Q Consensus       558 i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~----~~kl~DfGla~~~~~  608 (640)
                      ++.|+.       .   .|++|+|+||.||+++.++    .+++.|||++..+.+
T Consensus       272 ~~~Qif-------~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        272 FFTQVF-------R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHH-------h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            333332       2   4999999999999999888    999999999986643

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.32  E-value=3.4e-12  Score=125.44  Aligned_cols=124  Identities=28%  Similarity=0.303  Sum_probs=86.8

Q ss_pred             CCCCCcceeEeeccCC----------------------cCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHH
Q 035691          496 RHRNLVKIITACSSSD----------------------FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFL  553 (640)
Q Consensus       496 ~H~niv~l~~~~~~~~----------------------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~  553 (640)
                      +|||||++.+++.++-                      +......|+||..++. +|.+++....           .+..
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----------~s~r  341 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----------RSYR  341 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----------CchH
Confidence            6999999998764421                      1223456889888765 8888886432           4455


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee--CCCC--cEEEccccccccCCCccCCCce--eecccccccccc
Q 035691          554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL--DNDM--IAHVGDFGLTRFIPEVISSNQC--SSVGLKGTVGYA  627 (640)
Q Consensus       554 ~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl--~~~~--~~kl~DfGla~~~~~~~~~~~~--~~~~~~gt~~y~  627 (640)
                      ...-|..|+++|+.|||.   .+|.|||+|++|||+  |+++  ...|+|||++-.-....-.-.+  ......|...-|
T Consensus       342 ~~~~~laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lm  418 (598)
T KOG4158|consen  342 TGRVILAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLM  418 (598)
T ss_pred             HHHHHHHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceec
Confidence            677899999999999999   599999999999998  4555  5688999987533221110011  111234677889


Q ss_pred             CcccCCC
Q 035691          628 APEYGMG  634 (640)
Q Consensus       628 aPE~~~~  634 (640)
                      |||+...
T Consensus       419 APEi~ta  425 (598)
T KOG4158|consen  419 APEIATA  425 (598)
T ss_pred             chhhhhc
Confidence            9998754

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.31  E-value=1.4e-12  Score=118.97  Aligned_cols=143  Identities=22%  Similarity=0.221  Sum_probs=47.4

Q ss_pred             CCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCC-CCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeec
Q 035691           10 LQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLT-HCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLL   88 (640)
Q Consensus        10 L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L   88 (640)
                      |..+-|. ..| .+.+..++++|+|++|+|+.+.  .++ .+.+|+.||||+|.|+.      ++.  +..++.|+.|++
T Consensus         4 lt~~~i~-~~~-~~~n~~~~~~L~L~~n~I~~Ie--~L~~~l~~L~~L~Ls~N~I~~------l~~--l~~L~~L~~L~L   71 (175)
T PF14580_consen    4 LTANMIE-QIA-QYNNPVKLRELNLRGNQISTIE--NLGATLDKLEVLDLSNNQITK------LEG--LPGLPRLKTLDL   71 (175)
T ss_dssp             ------------------------------------S--TT-TT--EEE-TTS--S--------TT------TT--EEE-
T ss_pred             ccccccc-ccc-cccccccccccccccccccccc--chhhhhcCCCEEECCCCCCcc------ccC--ccChhhhhhccc
Confidence            4444454 333 2445556788888888887432  344 57788888888888875      332  124788888888


Q ss_pred             cCCcccccCCccCcCCCCCCEEECcCCccCccCC-ccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecC
Q 035691           89 AGNQFFGNIPHSISNASKLEWLDFANNSLTASIP-EDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLN  167 (640)
Q Consensus        89 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~  167 (640)
                      ++|+|+.+.+.....+++|++|+|++|+|..... ..+..+++|+.|+|.+|.++..+.  . -...+..+++|+.||-.
T Consensus        72 ~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~--Y-R~~vi~~lP~Lk~LD~~  148 (175)
T PF14580_consen   72 SNNRISSISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKN--Y-RLFVIYKLPSLKVLDGQ  148 (175)
T ss_dssp             -SS---S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTT--H-HHHHHHH-TT-SEETTE
T ss_pred             CCCCCCccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhh--H-HHHHHHHcChhheeCCE
Confidence            8888885533222457888888888888875322 456778888888888888865421  1 12245667788877643

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.30  E-value=2.9e-13  Score=143.94  Aligned_cols=219  Identities=29%  Similarity=0.323  Sum_probs=154.0

Q ss_pred             CCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCC
Q 035691           79 TLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNC  158 (640)
Q Consensus        79 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l  158 (640)
                      .+..++.+.++.|.|.. +-..+..+++|+.|++.+|+|.. +...+..+++|++|+|++|.|+.+        ..+..+
T Consensus        70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i--------~~l~~l  139 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKL--------EGLSTL  139 (414)
T ss_pred             HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccc--------cchhhc
Confidence            36677777788888874 33446777888888888888885 333367788888888888888876        446666


Q ss_pred             CCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCC-cCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEec
Q 035691          159 TYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIP-SSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDL  237 (640)
Q Consensus       159 ~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  237 (640)
                      +.|+.|++++|.|+.++. +..++.|+.+++++|.+..+.+ . ...+.+++.+++.+|.+...  ..+..+..+..+  
T Consensus       140 ~~L~~L~l~~N~i~~~~~-~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~--  213 (414)
T KOG0531|consen  140 TLLKELNLSGNLISDISG-LESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLL--  213 (414)
T ss_pred             cchhhheeccCcchhccC-CccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHh--
Confidence            778888888888887653 4447788888888888875444 2 46677788888888887633  233334444444  


Q ss_pred             cCccccCCCCCceEEccCCcCCCCCCccCCCCC--CCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCC
Q 035691          238 SKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLK--SIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLS  315 (640)
Q Consensus       238 s~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~  315 (640)
                                    ++..|.++..-+  +..+.  .|+.+++++|++. ..+..+..+..+..|++.+|++...  ..+.
T Consensus       214 --------------~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~  274 (414)
T KOG0531|consen  214 --------------SLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLE  274 (414)
T ss_pred             --------------hcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--cccc
Confidence                          566666663222  12222  4889999999998 5556677888899999999998753  3355


Q ss_pred             CCCCCCeEeCcCCcccc
Q 035691          316 SLKSLEGLDLFQNTFQA  332 (640)
Q Consensus       316 ~l~~L~~L~l~~N~l~~  332 (640)
                      ....+..+.+..|++..
T Consensus       275 ~~~~~~~~~~~~~~~~~  291 (414)
T KOG0531|consen  275 RLPKLSELWLNDNKLAL  291 (414)
T ss_pred             ccchHHHhccCcchhcc
Confidence            66777788888888763

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.27  E-value=3.7e-13  Score=127.39  Aligned_cols=128  Identities=25%  Similarity=0.312  Sum_probs=60.1

Q ss_pred             CCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCc
Q 035691           82 NIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYL  161 (640)
Q Consensus        82 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L  161 (640)
                      .|+.+|||+|.|+. +.++..-+|.++.|++|+|.|..+  +.+..|++|+.||||+|.++.+.       ..-..+.++
T Consensus       285 ~LtelDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~~-------Gwh~KLGNI  354 (490)
T KOG1259|consen  285 ELTELDLSGNLITQ-IDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAECV-------GWHLKLGNI  354 (490)
T ss_pred             hhhhccccccchhh-hhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhhh-------hhHhhhcCE
Confidence            34455555555542 233334445555555555555421  12445555555555555544331       111233445


Q ss_pred             ceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccC-CcCccCCCCCCEEEccCCCCCC
Q 035691          162 EIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEI-PSSLGNFTFLTELNLRGNSIRG  220 (640)
Q Consensus       162 ~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~  220 (640)
                      ++|.|+.|.|..+. .+..+-+|..||+++|+|.... ...+++++-|+.+.|.+|++.+
T Consensus       355 KtL~La~N~iE~LS-GL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~  413 (490)
T KOG1259|consen  355 KTLKLAQNKIETLS-GLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG  413 (490)
T ss_pred             eeeehhhhhHhhhh-hhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence            55555555554432 3444455555555555554211 2345555556666666666553

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.26  E-value=7.6e-13  Score=131.66  Aligned_cols=201  Identities=23%  Similarity=0.181  Sum_probs=127.8

Q ss_pred             hcCCCCCeEEcccCccCccCC--cCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccC
Q 035691           24 GRLFQLRYIIFNSNTLQGQIP--VNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSI  101 (640)
Q Consensus        24 ~~l~~L~~L~l~~N~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~  101 (640)
                      .++.+|+...|.+.... ..+  .....|++++.||||+|-+.+...+-    .+...|++|+.|+|+.|++........
T Consensus       118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~----~i~eqLp~Le~LNls~Nrl~~~~~s~~  192 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVL----KIAEQLPSLENLNLSSNRLSNFISSNT  192 (505)
T ss_pred             hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHH----HHHHhcccchhcccccccccCCccccc
Confidence            35667777777777766 333  35567778888888877776522221    223457888888888887763322221


Q ss_pred             -cCCCCCCEEECcCCccCcc-CCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcC--cC
Q 035691          102 -SNASKLEWLDFANNSLTAS-IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIP--IS  177 (640)
Q Consensus       102 -~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip--~~  177 (640)
                       ..+++|+.|.|+.+.|+.- +......+|+|+.|+|..|....+      .......+..|++|||++|.+...+  ..
T Consensus       193 ~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~------~~~~~~i~~~L~~LdLs~N~li~~~~~~~  266 (505)
T KOG3207|consen  193 TLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILI------KATSTKILQTLQELDLSNNNLIDFDQGYK  266 (505)
T ss_pred             hhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccce------ecchhhhhhHHhhccccCCcccccccccc
Confidence             2467888888888888732 223355678888888888853222      1223345567888888888888776  34


Q ss_pred             CCCCCCCCEEEccCCcCcccCC-cC-----ccCCCCCCEEEccCCCCCCCC-CccccCCCCccEE
Q 035691          178 VGYLPKLQVLSLFENNISGEIP-SS-----LGNFTFLTELNLRGNSIRGSI-PSALGNCHQLQSL  235 (640)
Q Consensus       178 ~~~l~~L~~L~L~~N~l~~~~p-~~-----~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L  235 (640)
                      .+.++.|..|+++.+.|..+.- +.     ...+++|++|+++.|+|.... -..+..+++|+.|
T Consensus       267 ~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l  331 (505)
T KOG3207|consen  267 VGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHL  331 (505)
T ss_pred             cccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhh
Confidence            5678888888888888875432 22     255788888999888885211 1223344455555

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.25  E-value=9.7e-12  Score=122.13  Aligned_cols=175  Identities=23%  Similarity=0.326  Sum_probs=104.1

Q ss_pred             cccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcC----------CCCCcceeEeeccC
Q 035691          444 SSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIR----------HRNLVKIITACSSS  510 (640)
Q Consensus       444 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~----------H~niv~l~~~~~~~  510 (640)
                      ...+.||.|+++.||.+++.++|+.+|||+.....   ....+.+.+|.-....+.          |-.++.-++.....
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            34578999999999999999999999999985333   233466666664443322          22222222222110


Q ss_pred             C----cCCC---c-----eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 035691          511 D----FQGN---D-----FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIV  578 (640)
Q Consensus       511 ~----~~~~---~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~iv  578 (640)
                      .    +...   .     ..+++|+-+ .+||.+++..-......   ........++.+..|+++.+++||+   .|++
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~---~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlV  167 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT---HSPLAFAARLSLTVQMIRLVANLHS---YGLV  167 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT---SHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred             CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc---cchhHHHHHHHHHHHHHHHHHHHhh---cceE
Confidence            0    0001   1     125677766 45887765421100000   1224456677888999999999999   6999


Q ss_pred             eCCCCCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccC
Q 035691          579 HCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYG  632 (640)
Q Consensus       579 Hrdlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  632 (640)
                      |+||||+|++++.+|.++++||+......+...   +    ...+..|.+||..
T Consensus       168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~----~~~~~~~~PPe~~  214 (288)
T PF14531_consen  168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---C----SEFPVAFTPPELE  214 (288)
T ss_dssp             EST-SGGGEEE-TTS-EEE--GGGEEETTEEEE---G----GGS-TTTS-HHHH
T ss_pred             ecccceeeEEEcCCCCEEEcChHHHeecCceee---c----cCCCcccCChhhh
Confidence            999999999999999999999998775432111   1    1245779999865

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.24  E-value=2.8e-12  Score=140.64  Aligned_cols=172  Identities=20%  Similarity=0.229  Sum_probs=123.8

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHH--HHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEA--LRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      .+...+.+|++.|=+|.+|+++ .|. |+||++-.++ .-....|.++++-  ....+|||.+.+-.+     ...+...
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~-----~~t~kAA   96 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKV-----LVTDKAA   96 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHH-----HHhhHHH
Confidence            4667789999999999999987 454 8899995554 2333444444333  445689999887655     4445567


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      |+|=+|..+ +|+|.+..+..          +.......|+.|+..|+.-+|.   .+|+|+|||.+|||+..-..+.|+
T Consensus        97 ylvRqyvkh-nLyDRlSTRPF----------L~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~Lt  162 (1431)
T KOG1240|consen   97 YLVRQYVKH-NLYDRLSTRPF----------LVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLT  162 (1431)
T ss_pred             HHHHHHHhh-hhhhhhccchH----------HHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhh
Confidence            888888865 88888764432          5566778899999999999999   799999999999999999999999


Q ss_pred             ccccccc--CCCccCC-CceeeccccccccccCcccCCC
Q 035691          599 DFGLTRF--IPEVISS-NQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       599 DfGla~~--~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      ||.--+-  ++++... ...--.+...-..|.|||.+..
T Consensus       163 DFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~  201 (1431)
T KOG1240|consen  163 DFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVS  201 (1431)
T ss_pred             cccccCCccCCCCCcccceEEEecCCceeeecChHhhhc
Confidence            9986653  2322211 1111122223347999999865

>PLN03150 hypothetical protein; Provisional

Probab=99.24  E-value=2.4e-11  Score=135.17  Aligned_cols=110  Identities=35%  Similarity=0.552  Sum_probs=101.1

Q ss_pred             CCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcC
Q 035691          207 FLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEI  286 (640)
Q Consensus       207 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  286 (640)
                      .++.|+|++|.+.+.+|..+..+++|+.|                +|++|+++|.+|..++.+++|+.|+|++|++++.+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L----------------~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~i  482 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSI----------------NLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI  482 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEE----------------ECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCC
Confidence            37889999999999999999999999888                88889999999999999999999999999999999


Q ss_pred             CccccCCCCCCeEEecCCccCCCCCccCCCC-CCCCeEeCcCCcccc
Q 035691          287 PSSLGSCVGLEYLNLSINSFHGPIHPGLSSL-KSLEGLDLFQNTFQA  332 (640)
Q Consensus       287 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~l~~N~l~~  332 (640)
                      |..++.+++|++|+|++|++++.+|..+..+ .++..+++++|+..|
T Consensus       483 P~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc  529 (623)
T PLN03150        483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLC  529 (623)
T ss_pred             chHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCcccc
Confidence            9999999999999999999999999988764 577899999998775

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.24  E-value=2.1e-12  Score=128.51  Aligned_cols=211  Identities=20%  Similarity=0.171  Sum_probs=159.5

Q ss_pred             CCCCCcEEeCCCCccccCCc-hhhhcCCCCCeEEcccCccCccCCc--CCCCCCCCCEEEccCCCcCCccccccCCchhh
Q 035691            1 NLTFLMLINLQQNNFSGNIP-HEIGRLFQLRYIIFNSNTLQGQIPV--NLTHCSELRTLDLVLNKLEENQLVGELPPYIG   77 (640)
Q Consensus         1 nl~~L~~L~L~~n~i~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~   77 (640)
                      |+..|+...|.+..+....- .....+++++.|+|++|-+..+.|-  -...|++|+.|+||.|++..  +.+   ...-
T Consensus       119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~--~~~---s~~~  193 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSN--FIS---SNTT  193 (505)
T ss_pred             hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccC--Ccc---ccch
Confidence            56788999999998873222 4678899999999999999865443  35689999999999999863  111   1112


Q ss_pred             cCCCCCCeeeccCCcccccCC-ccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCccccccccc
Q 035691           78 FTLPNIRIPLLAGNQFFGNIP-HSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLV  156 (640)
Q Consensus        78 ~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~  156 (640)
                      ..++.|+.|.|+.+.++...- .....+|+|+.|+|..|....+......-+..|+.|||++|++...+     ......
T Consensus       194 ~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~-----~~~~~~  268 (505)
T KOG3207|consen  194 LLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFD-----QGYKVG  268 (505)
T ss_pred             hhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccc-----cccccc
Confidence            248899999999999984433 23457899999999999644455556677889999999999987653     224567


Q ss_pred             CCCCcceEecCCCCCCC--cCcC-----CCCCCCCCEEEccCCcCcccC-CcCccCCCCCCEEEccCCCCCCC
Q 035691          157 NCTYLEIVSLNVNSLRS--IPIS-----VGYLPKLQVLSLFENNISGEI-PSSLGNFTFLTELNLRGNSIRGS  221 (640)
Q Consensus       157 ~l~~L~~L~L~~N~l~~--ip~~-----~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~  221 (640)
                      .++.|..|+++.+.+.+  +|+.     ...+++|++|+++.|+|.... -..+..+++|+.|....|.+...
T Consensus       269 ~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e  341 (505)
T KOG3207|consen  269 TLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE  341 (505)
T ss_pred             cccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccccc
Confidence            78899999999999988  4543     345789999999999996321 23456678889999889998743

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.23  E-value=5.1e-11  Score=110.49  Aligned_cols=131  Identities=19%  Similarity=0.132  Sum_probs=94.8

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCC-cceeEeeccCCcCCCceeeEEeecc
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNL-VKIITACSSSDFQGNDFKALVYEFM  525 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~~~~~~lv~e~~  525 (640)
                      +.++.|.++.||+++..  +..|++|+...... ....+..|+.+++.+.+.++ ++++.+.     .  ...++||||+
T Consensus         4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~--~~~~lv~e~i   73 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-----P--ETGVLITEFI   73 (170)
T ss_pred             eecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-----C--CCCeEEEEec
Confidence            56889999999999874  77899998743321 22356789999998865554 4455442     1  1247999999


Q ss_pred             CCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeeCCCCCCCeeeCCCCcEEEcccccc
Q 035691          526 HHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHC--KKQIVHCDLKPSNVLLDNDMIAHVGDFGLT  603 (640)
Q Consensus       526 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~--~~~ivHrdlkp~NiLl~~~~~~kl~DfGla  603 (640)
                      +|.++.+.    ..              ....++.+++.+++.||...  +.+++|+|++|.||+++ ++.++++|||.+
T Consensus        74 ~G~~l~~~----~~--------------~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a  134 (170)
T cd05151          74 EGSELLTE----DF--------------SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYA  134 (170)
T ss_pred             CCCccccc----cc--------------cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccc
Confidence            99877543    00              01235678999999999842  22369999999999999 668999999998


Q ss_pred             ccC
Q 035691          604 RFI  606 (640)
Q Consensus       604 ~~~  606 (640)
                      ...
T Consensus       135 ~~~  137 (170)
T cd05151         135 GMN  137 (170)
T ss_pred             cCC
Confidence            753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.21  E-value=2.2e-12  Score=132.13  Aligned_cols=112  Identities=30%  Similarity=0.441  Sum_probs=90.9

Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      .+.++.|++|..++|.+|+...+..       ...++.....++.|++.|++|      ++.+|||+||.||+...+..+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~-------e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~  395 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTG-------EERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQL  395 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcc-------cccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhh
Confidence            3678999999999999999755443       336777889999999999999      489999999999999999999


Q ss_pred             EEccccccccCCCccCC--CceeeccccccccccCcccCCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISS--NQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ||.|||+...+....+.  .....++-+||.+||+||.+.|..|+.|
T Consensus       396 kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k  442 (516)
T KOG1033|consen  396 KIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK  442 (516)
T ss_pred             hhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhh
Confidence            99999998876543311  1112234569999999999999998865

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.21  E-value=1.9e-12  Score=122.59  Aligned_cols=129  Identities=33%  Similarity=0.265  Sum_probs=79.7

Q ss_pred             CCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCC
Q 035691          181 LPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTG  260 (640)
Q Consensus       181 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~  260 (640)
                      +..|+++|||+|.|+ .+.++..-++.++.|++|+|.|..+  +.+..+++|+.|                |||+|.++ 
T Consensus       283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~L----------------DLS~N~Ls-  342 (490)
T KOG1259|consen  283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLL----------------DLSGNLLA-  342 (490)
T ss_pred             Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEe----------------ecccchhH-
Confidence            445666666666666 4555566666666666666666532  125555555555                55556555 


Q ss_pred             CCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCC-CccCCCCCCCCeEeCcCCccc
Q 035691          261 PIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPI-HPGLSSLKSLEGLDLFQNTFQ  331 (640)
Q Consensus       261 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~  331 (640)
                      .+..+-..+-+++.|.|++|.|...  ..+..+-+|.+||+++|+|.... -..++++|-|+.+.|.+|++.
T Consensus       343 ~~~Gwh~KLGNIKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~  412 (490)
T KOG1259|consen  343 ECVGWHLKLGNIKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA  412 (490)
T ss_pred             hhhhhHhhhcCEeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence            3444445556677777777777521  33555667777777777776422 245777788888888888776

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.18  E-value=4.2e-10  Score=104.90  Aligned_cols=136  Identities=21%  Similarity=0.148  Sum_probs=96.4

Q ss_pred             CcccccccceEEEEEECC------CCeEEEEEEeecc-------------c---------chhHHH----HHHHHHHHHh
Q 035691          447 NLIGTGSFGSVYKGILDP------DQTVVAVKVLFLH-------------Q---------RGALKS----FMAECEALRN  494 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~-------------~---------~~~~~~----~~~E~~~l~~  494 (640)
                      ..||.|.=+.||.|....      .+..+|||+.+..             +         ...++.    ..+|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            568999999999998653      3578999988421             0         011222    3489999999


Q ss_pred             cCC--CCCcceeEeeccCCcCCCceeeEEeeccCCCChhh-hcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-h
Q 035691          495 IRH--RNLVKIITACSSSDFQGNDFKALVYEFMHHGSLES-WLHPESASDDLNYSPSILSFLQRLNIAINVASALEYL-H  570 (640)
Q Consensus       495 l~H--~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yL-H  570 (640)
                      +..  -++++.+++         ...++||||+.++.+.. .++.           ..++......+..+++.+|.++ |
T Consensus        83 l~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lkd-----------~~~~~~~~~~i~~~i~~~l~~l~H  142 (197)
T cd05146          83 MQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLKD-----------AKLNDEEMKNAYYQVLSMMKQLYK  142 (197)
T ss_pred             HHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhhc-----------cccCHHHHHHHHHHHHHHHHHHHH
Confidence            853  466666654         13479999998754421 1211           1133345567789999999998 6


Q ss_pred             cCCCCCeeeCCCCCCCeeeCCCCcEEEccccccccC
Q 035691          571 HHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI  606 (640)
Q Consensus       571 ~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~  606 (640)
                      .   .+++|+|+++.||+++ ++.++|+|||.|-..
T Consensus       143 ~---~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         143 E---CNLVHADLSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             h---CCeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence            6   6999999999999997 467999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.17  E-value=1.3e-12  Score=126.79  Aligned_cols=91  Identities=22%  Similarity=0.328  Sum_probs=48.2

Q ss_pred             CCCCcEEeCCCCccccC----CchhhhcCCCCCeEEcccCc---cCccCCc-------CCCCCCCCCEEEccCCCcCCcc
Q 035691            2 LTFLMLINLQQNNFSGN----IPHEIGRLFQLRYIIFNSNT---LQGQIPV-------NLTHCSELRTLDLVLNKLEENQ   67 (640)
Q Consensus         2 l~~L~~L~L~~n~i~~~----~p~~~~~l~~L~~L~l~~N~---l~~~~~~-------~~~~l~~L~~L~Ls~N~l~~~~   67 (640)
                      +..++.|+||+|.+...    +.+.+.+.++|+..++++-.   +...+|.       ++..+++|++||||.|.+....
T Consensus        29 ~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g  108 (382)
T KOG1909|consen   29 MDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKG  108 (382)
T ss_pred             cCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccc
Confidence            34667777777777532    33445566677777666432   1122333       2345567777777766664322


Q ss_pred             ccccCCchhhcCCCCCCeeeccCCccc
Q 035691           68 LVGELPPYIGFTLPNIRIPLLAGNQFF   94 (640)
Q Consensus        68 ~~~~lp~~~~~~l~~L~~L~L~~N~l~   94 (640)
                      ..+ +-..+. ....|++|+|.+|.+.
T Consensus       109 ~~~-l~~ll~-s~~~L~eL~L~N~Glg  133 (382)
T KOG1909|consen  109 IRG-LEELLS-SCTDLEELYLNNCGLG  133 (382)
T ss_pred             hHH-HHHHHH-hccCHHHHhhhcCCCC
Confidence            111 111122 2556666666666654

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.14  E-value=6.7e-11  Score=110.41  Aligned_cols=84  Identities=23%  Similarity=0.211  Sum_probs=69.0

Q ss_pred             CChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccccccCC
Q 035691          528 GSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP  607 (640)
Q Consensus       528 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~  607 (640)
                      |+|.+++....         ..+++..++.|+.|++.||+|||+.   +      ||+||+++.++.+|+  ||+++...
T Consensus         1 GsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~   60 (176)
T smart00750        1 VSLADILEVRG---------RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKT   60 (176)
T ss_pred             CcHHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeec
Confidence            68888886432         2389999999999999999999993   4      999999999999999  99998653


Q ss_pred             CccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          608 EVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       608 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ..         ...||+.|||||++.+..++.|
T Consensus        61 ~~---------~~~g~~~y~aPE~~~~~~~~~~   84 (176)
T smart00750       61 PE---------QSRVDPYFMAPEVIQGQSYTEK   84 (176)
T ss_pred             cc---------cCCCcccccChHHhcCCCCcch
Confidence            21         1248999999999999887754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.12  E-value=2.5e-12  Score=124.80  Aligned_cols=247  Identities=22%  Similarity=0.269  Sum_probs=146.1

Q ss_pred             hhhhcCCCCCeEEcccCccCc----cCCcCCCCCCCCCEEEccCCCcCCcccccc----CCchhhcCCCCCCeeeccCCc
Q 035691           21 HEIGRLFQLRYIIFNSNTLQG----QIPVNLTHCSELRTLDLVLNKLEENQLVGE----LPPYIGFTLPNIRIPLLAGNQ   92 (640)
Q Consensus        21 ~~~~~l~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~----lp~~~~~~l~~L~~L~L~~N~   92 (640)
                      +.+..+..++.|+|++|.+..    .+...+...++|+.-++|.      -++|.    +|+.+-               
T Consensus        24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd------~ftGR~~~Ei~e~L~---------------   82 (382)
T KOG1909|consen   24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSD------MFTGRLKDEIPEALK---------------   82 (382)
T ss_pred             HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHh------hhcCCcHHHHHHHHH---------------
Confidence            345567788889999998863    3444566777888888862      23332    332221               


Q ss_pred             ccccCCccCcCCCCCCEEECcCCccCccCCcc----ccCCCCCCEEEcccCcCCCCCCCccc-------ccccccCCCCc
Q 035691           93 FFGNIPHSISNASKLEWLDFANNSLTASIPED----LGRLRNLTRLNFARNDLGTRKVNDLR-------FLDSLVNCTYL  161 (640)
Q Consensus        93 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~----~~~l~~L~~L~L~~N~l~~~~~~~~~-------~~~~l~~l~~L  161 (640)
                         .+..++...++|++||||.|-+...-+..    +.++.+|++|+|.+|.+.......+.       ..+....-+.|
T Consensus        83 ---~l~~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~L  159 (382)
T KOG1909|consen   83 ---MLSKALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKL  159 (382)
T ss_pred             ---HHHHHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcce
Confidence               11233444556666666666665333322    34556666667766666433211100       01123344678


Q ss_pred             ceEecCCCCCCCcCc-----CCCCCCCCCEEEccCCcCcccC----CcCccCCCCCCEEEccCCCCCCCC----CccccC
Q 035691          162 EIVSLNVNSLRSIPI-----SVGYLPKLQVLSLFENNISGEI----PSSLGNFTFLTELNLRGNSIRGSI----PSALGN  228 (640)
Q Consensus       162 ~~L~L~~N~l~~ip~-----~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~  228 (640)
                      +.+..++|++..-+.     .+...+.|+.+.++.|.|....    -..|..+++|+.|||.+|-++...    ..+++.
T Consensus       160 rv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s  239 (382)
T KOG1909|consen  160 RVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSS  239 (382)
T ss_pred             EEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcc
Confidence            888888888776443     3455677888888888876221    234677788888888888887432    234556


Q ss_pred             CCCccEEeccCccccCCCCCceEEccCCcCCCCCCccC-----CCCCCCCEEECCCCcccCc----CCccccCCCCCCeE
Q 035691          229 CHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAV-----GNLKSIPHLDLSKNKLSGE----IPSSLGSCVGLEYL  299 (640)
Q Consensus       229 l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L  299 (640)
                      +++|+.|                ++++|.+...-..+|     ...++|+.|.|.+|.|+..    +...+...+.|..|
T Consensus       240 ~~~L~El----------------~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kL  303 (382)
T KOG1909|consen  240 WPHLREL----------------NLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKL  303 (382)
T ss_pred             cchheee----------------cccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHh
Confidence            6667776                444555543222211     2356788888888888732    22334556788888


Q ss_pred             EecCCccC
Q 035691          300 NLSINSFH  307 (640)
Q Consensus       300 ~L~~N~l~  307 (640)
                      +|++|++.
T Consensus       304 nLngN~l~  311 (382)
T KOG1909|consen  304 NLNGNRLG  311 (382)
T ss_pred             cCCccccc
Confidence            88888883

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.08  E-value=7.5e-11  Score=129.56  Aligned_cols=140  Identities=29%  Similarity=0.422  Sum_probs=94.8

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      .+|..++.|..|+||.||..+++.+.+.+|+|+= ++.-           +++     ||..+.+           ..+.
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~l-----------ilR-----nilt~a~-----------npfv  134 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNL-----------ILR-----NILTFAG-----------NPFV  134 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhccc-ccch-----------hhh-----ccccccC-----------Ccce
Confidence            4678889999999999999999999999999542 2111           111     1322221           1223


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      |      ||=...++..+.          ++        .+++.|++|+|+   .+|+|||+||+|.+|..-|++|+.||
T Consensus       135 v------gDc~tllk~~g~----------lP--------vdmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDf  187 (1205)
T KOG0606|consen  135 V------GDCATLLKNIGP----------LP--------VDMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDF  187 (1205)
T ss_pred             e------chhhhhcccCCC----------Cc--------chhhHHhHhhcc---CCeecCCCCCCcceeeecccccccch
Confidence            3      333344433221          22        123789999999   79999999999999999999999999


Q ss_pred             cccccCCCcc-----------CCCceeeccccccccccCcccCCCC
Q 035691          601 GLTRFIPEVI-----------SSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       601 Gla~~~~~~~-----------~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      |+.+..-...           ...+....+++|||.|+|||++...
T Consensus       188 gLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq  233 (1205)
T KOG0606|consen  188 GLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ  233 (1205)
T ss_pred             hhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhh
Confidence            9987531100           0112234467899999999998654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.08  E-value=4.3e-11  Score=131.23  Aligned_cols=177  Identities=27%  Similarity=0.320  Sum_probs=131.3

Q ss_pred             CCCcccCcccccccceEEEEEEC-CCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcC-CCCCcceeEeeccCCcCCCc
Q 035691          441 GGFSSANLIGTGSFGSVYKGILD-PDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIR-HRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~  516 (640)
                      ..|...+.||+|+|+.|-.+... .....+|+|.+....  .........|..+-+.+. |+|++++++.     .....
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~-----~~~~~   94 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEP-----SSSPR   94 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCc-----cCCCc
Confidence            34566677999999999887764 334557777664332  223344455777666775 9999999988     44455


Q ss_pred             eeeEEeeccCCCChhhhc-CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeeeCCCCCCCeeeCCCC-
Q 035691          517 FKALVYEFMHHGSLESWL-HPESASDDLNYSPSILSFLQRLNIAINVASALEYLH-HHCKKQIVHCDLKPSNVLLDNDM-  593 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l-~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH-~~~~~~ivHrdlkp~NiLl~~~~-  593 (640)
                      ..+++++|..+|++.+.+ .....         ..+......+..|+..++.|+| +   .++.|||+||+|.+++..+ 
T Consensus        95 ~~~~~~~~s~g~~~f~~i~~~~~~---------~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~  162 (601)
T KOG0590|consen   95 SYLLSLSYSDGGSLFSKISHPDST---------GTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGS  162 (601)
T ss_pred             ccccccCcccccccccccccCCcc---------CCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCC
Confidence            788999999999999887 32221         1333455678999999999999 6   6999999999999999999 


Q ss_pred             cEEEccccccccCCCccCCCceeeccccc-cccccCcccCCCC
Q 035691          594 IAHVGDFGLTRFIPEVISSNQCSSVGLKG-TVGYAAPEYGMGS  635 (640)
Q Consensus       594 ~~kl~DfGla~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~  635 (640)
                      ..|++|||+|..+.... .........+| ++.|+|||...+.
T Consensus       163 ~l~~~df~~At~~~~~~-g~~~~~~~~~g~s~~y~a~E~~~~~  204 (601)
T KOG0590|consen  163 ALKIADFGLATAYRNKN-GAERSLKDRCGSSPPYGAPEHLSGK  204 (601)
T ss_pred             cccCCCchhhccccccC-CcceeeecccCCCCCCCCcccccch
Confidence            99999999998775411 12233344568 9999999999883

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.07  E-value=1e-10  Score=87.82  Aligned_cols=61  Identities=38%  Similarity=0.530  Sum_probs=42.5

Q ss_pred             CCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcC
Q 035691           81 PNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDL  141 (640)
Q Consensus        81 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  141 (640)
                      ++|+.|++++|+|+.+.+..|.++++|++|++++|+|+.+.|.+|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            3566666666666666666777777777777777777766667777777777777777764

...

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.05  E-value=2.6e-09  Score=103.75  Aligned_cols=145  Identities=19%  Similarity=0.181  Sum_probs=103.9

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeecccc-hhHHHHHHHHHHHHhcCC--CCCcceeEeeccCCcCCCceeeEEee
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR-GALKSFMAECEALRNIRH--RNLVKIITACSSSDFQGNDFKALVYE  523 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~~~~~~lv~e  523 (640)
                      +.++.|.++.||++... +|+.+++|+...... .....+..|+++++.+++  ..+++++.++....  .....++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence            56899999999999875 468899998754332 134578899999999975  34677777743321  1124579999


Q ss_pred             ccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 035691          524 FMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHH-------------------------------  572 (640)
Q Consensus       524 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~-------------------------------  572 (640)
                      |++|+++.+.+.. .          .++......++.++++++.+||+.                               
T Consensus        81 ~i~G~~l~~~~~~-~----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (223)
T cd05154          81 RVDGRVLRDRLLR-P----------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDAS  149 (223)
T ss_pred             EeCCEecCCCCCC-C----------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhh
Confidence            9999888765421 0          134455566677777777777642                               


Q ss_pred             ----------------------CCCCeeeCCCCCCCeeeCC--CCcEEEcccccccc
Q 035691          573 ----------------------CKKQIVHCDLKPSNVLLDN--DMIAHVGDFGLTRF  605 (640)
Q Consensus       573 ----------------------~~~~ivHrdlkp~NiLl~~--~~~~kl~DfGla~~  605 (640)
                                            .+..++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         150 RTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                  1245799999999999998  67789999998874

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.97  E-value=4.2e-10  Score=84.47  Aligned_cols=61  Identities=26%  Similarity=0.340  Sum_probs=42.1

Q ss_pred             CCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCc
Q 035691            3 TFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKL   63 (640)
Q Consensus         3 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l   63 (640)
                      ++|+.|++++|+|+...+..|.++++|++|++++|.|+.+.|.+|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            3566777777777766556677777777777777777766666777777777777776654

...

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=98.97  E-value=6.6e-10  Score=116.39  Aligned_cols=126  Identities=29%  Similarity=0.432  Sum_probs=98.8

Q ss_pred             HHhcCCCCCcceeEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 035691          492 LRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHH  571 (640)
Q Consensus       492 l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~  571 (640)
                      |+.+.|.|+.+++|.|...     ...+.|.+||..|+|.+.+....         ..+++.-...++++++.||+|+|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~---------~~~d~~F~~s~~rdi~~Gl~ylh~   66 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNED---------IKLDYFFILSFIRDISKGLAYLHN   66 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccc---------cCccHHHHHHHHHHHHHHHHHHhc
Confidence            3568999999999998544     46789999999999999997643         237788888999999999999999


Q ss_pred             CCCCCeeeCCCCCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          572 HCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       572 ~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      .  +-..|+.++++|+++|....+|++|||+....++...  ........-..-|.|||.+.+.
T Consensus        67 s--~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~--~~~~~~~~~~~lw~aPellr~~  126 (484)
T KOG1023|consen   67 S--PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAE--PEAHHPIRKALLWTAPELLRGA  126 (484)
T ss_pred             C--cceeeeeeccccceeeeeEEEEechhhhccccccccc--ccccchhHHHHhccCHHHhccc
Confidence            4  3339999999999999999999999999887643111  1111111234579999999875

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.96  E-value=3.8e-09  Score=94.90  Aligned_cols=130  Identities=24%  Similarity=0.261  Sum_probs=93.9

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEee-ccc-------chhHHHHHHHHHHHHhcCCC--CCcceeEeeccCCcCCCc
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLF-LHQ-------RGALKSFMAECEALRNIRHR--NLVKIITACSSSDFQGND  516 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~-~~~-------~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~~~~~~~~  516 (640)
                      ..+++|+=+.||.+.+.  |..+++|.=. +..       +-....-.+|+.++.+++--  +.+.++++       +.+
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-------D~~   72 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-------DPD   72 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-------cCC
Confidence            45789999999999773  5556666431 111       11235678899999988644  33444443       123


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ...++|||++|-.|++++...                 ...++..+-.-+.-||.   .+|+|+|+.++||++..+. +.
T Consensus        73 ~~~I~me~I~G~~lkd~l~~~-----------------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~  131 (204)
T COG3642          73 NGLIVMEYIEGELLKDALEEA-----------------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IY  131 (204)
T ss_pred             CCEEEEEEeCChhHHHHHHhc-----------------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EE
Confidence            456999999999999888543                 13467777778888999   6999999999999998766 88


Q ss_pred             EccccccccC
Q 035691          597 VGDFGLTRFI  606 (640)
Q Consensus       597 l~DfGla~~~  606 (640)
                      ++|||++..-
T Consensus       132 ~IDfGLg~~s  141 (204)
T COG3642         132 FIDFGLGEFS  141 (204)
T ss_pred             EEECCccccc
Confidence            8999999853

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.93  E-value=8.1e-10  Score=125.61  Aligned_cols=104  Identities=29%  Similarity=0.452  Sum_probs=50.8

Q ss_pred             CCCeEEcccCccCccCCcCCCCCCCCCEEEccCCC--cCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCC
Q 035691           28 QLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNK--LEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNAS  105 (640)
Q Consensus        28 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~--l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  105 (640)
                      ..+...+-+|.+. .++... ..++|++|-+..|.  +..      ++...|..++.|+.|||++|.=-+.+|..+++|-
T Consensus       524 ~~rr~s~~~~~~~-~~~~~~-~~~~L~tLll~~n~~~l~~------is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li  595 (889)
T KOG4658|consen  524 SVRRMSLMNNKIE-HIAGSS-ENPKLRTLLLQRNSDWLLE------ISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELV  595 (889)
T ss_pred             heeEEEEeccchh-hccCCC-CCCccceEEEeecchhhhh------cCHHHHhhCcceEEEECCCCCccCcCChHHhhhh
Confidence            3444555555544 222222 22345555555443  222      4444444555555555555444445555555555


Q ss_pred             CCCEEECcCCccCccCCccccCCCCCCEEEcccCc
Q 035691          106 KLEWLDFANNSLTASIPEDLGRLRNLTRLNFARND  140 (640)
Q Consensus       106 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  140 (640)
                      +|++|+|++..++ .+|..+++|..|.+|++..+.
T Consensus       596 ~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~  629 (889)
T KOG4658|consen  596 HLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTG  629 (889)
T ss_pred             hhhcccccCCCcc-ccchHHHHHHhhheecccccc
Confidence            5555555555555 355555555555555555544

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.84  E-value=1.7e-08  Score=90.19  Aligned_cols=143  Identities=21%  Similarity=0.245  Sum_probs=97.4

Q ss_pred             ccCcccccccceEEEEEECCCCeEEEEEEee-ccc-------chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          445 SANLIGTGSFGSVYKGILDPDQTVVAVKVLF-LHQ-------RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       445 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~-~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ....+-+|+-+.|+++.+  .|+.+.||.=. +..       +-..++..+|++.+.+++--.|..-.-++     .+..
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~-----~D~~   83 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF-----IDTY   83 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE-----EecC
Confidence            457888999999999988  57777777431 111       11246778899999887643333222221     1122


Q ss_pred             eeeEEeeccCC-CChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC--
Q 035691          517 FKALVYEFMHH-GSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM--  593 (640)
Q Consensus       517 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~--  593 (640)
                      .-.++|||.+| -++.+++...-...       ..+ ......+.+|-+.+.-||.   ..|+|+||..+||++..++  
T Consensus        84 ~~~i~ME~~~g~~~vk~~i~~~~~~~-------~~d-~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~  152 (229)
T KOG3087|consen   84 GGQIYMEFIDGASTVKDFILSTMEDE-------SED-EGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQ  152 (229)
T ss_pred             CCeEEEEeccchhHHHHHHHHHccCc-------ccc-hhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCc
Confidence            34689999987 36777775432211       111 1225788899999999999   6999999999999997665  


Q ss_pred             -cEEEcccccccc
Q 035691          594 -IAHVGDFGLTRF  605 (640)
Q Consensus       594 -~~kl~DfGla~~  605 (640)
                       .+.++|||++..
T Consensus       153 ~~~~lIdfgls~~  165 (229)
T KOG3087|consen  153 ITPILIDFGLSSV  165 (229)
T ss_pred             CceEEEeecchhc
Confidence             458999999864

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.82  E-value=3.2e-08  Score=92.02  Aligned_cols=125  Identities=22%  Similarity=0.209  Sum_probs=80.6

Q ss_pred             eEEEEEECCCCeEEEEEEeeccc-------------ch-------------hHHHHHHHHHHHHhcCCC--CCcceeEee
Q 035691          456 SVYKGILDPDQTVVAVKVLFLHQ-------------RG-------------ALKSFMAECEALRNIRHR--NLVKIITAC  507 (640)
Q Consensus       456 ~Vy~~~~~~~~~~vavK~~~~~~-------------~~-------------~~~~~~~E~~~l~~l~H~--niv~l~~~~  507 (640)
                      .||.|... +|..+|||+.+...             ..             ......+|.+.|.++..-  ++++.+.+.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            48999876 78899999984320             00             124677899999999765  567776551


Q ss_pred             ccCCcCCCceeeEEeeccC--CCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeeeCCCCC
Q 035691          508 SSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYL-HHHCKKQIVHCDLKP  584 (640)
Q Consensus       508 ~~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yL-H~~~~~~ivHrdlkp  584 (640)
                               ..++||||++  |..+..+....            +.......++.+++..+..+ |.   .+|+|+|+.+
T Consensus        80 ---------~~~ivME~I~~~G~~~~~l~~~~------------~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~  135 (188)
T PF01163_consen   80 ---------RNVIVMEYIGEDGVPLPRLKDVD------------LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSE  135 (188)
T ss_dssp             ---------TTEEEEE--EETTEEGGCHHHCG------------GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-ST
T ss_pred             ---------CCEEEEEecCCCccchhhHHhcc------------ccchhHHHHHHHHHHHHHHHHHh---cCceecCCCh
Confidence                     2369999998  54444332211            00112455677777766664 56   6999999999


Q ss_pred             CCeeeCCCCcEEEccccccccC
Q 035691          585 SNVLLDNDMIAHVGDFGLTRFI  606 (640)
Q Consensus       585 ~NiLl~~~~~~kl~DfGla~~~  606 (640)
                      .||+++++ .+.|+|||.|...
T Consensus       136 ~NIlv~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  136 YNILVDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             TSEEEETT-CEEE--GTTEEET
T ss_pred             hhEEeecc-eEEEEecCcceec
Confidence            99999887 9999999988744

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.81  E-value=4.1e-10  Score=108.51  Aligned_cols=102  Identities=23%  Similarity=0.386  Sum_probs=86.4

Q ss_pred             HHHHhcCCCCCcceeEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 035691          490 EALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYL  569 (640)
Q Consensus       490 ~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yL  569 (640)
                      .-+-.+.|.|||+++.|+.+..+.+.....++.|||+-|++..+|++.+.+.      ..+......+|+-||..|+.||
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~------~a~~~~~wkkw~tqIlsal~yL  192 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ------KALFQKAWKKWCTQILSALSYL  192 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh------hhhhHHHHHHHHHHHHhhhhhh
Confidence            3445567999999999988777667777889999999999999998755432      3466777889999999999999


Q ss_pred             hcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          570 HHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       570 H~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      |++ .++|+|+++..+-|++..+|-+||.
T Consensus       193 hs~-~PpiihgnlTc~tifiq~ngLIkig  220 (458)
T KOG1266|consen  193 HSC-DPPIIHGNLTCDTIFIQHNGLIKIG  220 (458)
T ss_pred             hcc-CCccccCCcchhheeecCCceEEec
Confidence            995 6799999999999999999999984

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.80  E-value=4.5e-09  Score=110.21  Aligned_cols=175  Identities=30%  Similarity=0.292  Sum_probs=128.6

Q ss_pred             CcccCcccc--cccceEEEEEE--CCCCeEEEEEEee--cccchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCC
Q 035691          443 FSSANLIGT--GSFGSVYKGIL--DPDQTVVAVKVLF--LHQRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       443 ~~~~~~lg~--G~~g~Vy~~~~--~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~  515 (640)
                      |....-+|+  |.+|.||.+..  +.++..+|+|.-+  ........+-.+|+...+++ .|++.|+.+..     +.+.
T Consensus       116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~e~~  190 (524)
T KOG0601|consen  116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----WEGS  190 (524)
T ss_pred             cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----cccC
Confidence            455677899  99999999998  8899999999743  22222223445677777777 49999997766     5556


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeeeCCCCCCCeeeCC
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS----ALEYLHHHCKKQIVHCDLKPSNVLLDN  591 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~----al~yLH~~~~~~ivHrdlkp~NiLl~~  591 (640)
                      ...++-+|++. .++.++.+....         .++....+.+..+..+    |+.++|+   ..++|-|+||.||+...
T Consensus       191 ~~lfiqtE~~~-~sl~~~~~~~~~---------~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~  257 (524)
T KOG0601|consen  191 GILFIQTELCG-ESLQSYCHTPCN---------FLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTS  257 (524)
T ss_pred             Ccceeeecccc-chhHHhhhcccc---------cCCchhhhhHHhhhhhcccccccccCC---Ccccccccchhheeccc
Confidence            67888888885 677777654322         2556667778888888    9999999   69999999999999998


Q ss_pred             C-CcEEEccccccccCCCccCC-CceeeccccccccccCcccCCCC
Q 035691          592 D-MIAHVGDFGLTRFIPEVISS-NQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       592 ~-~~~kl~DfGla~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      + ...++.|||+...+.+..-. .........|...|++||...+.
T Consensus       258 ~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l  303 (524)
T KOG0601|consen  258 DWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL  303 (524)
T ss_pred             ccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc
Confidence            8 89999999999877543211 11111222467789999998764

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.77  E-value=4.5e-09  Score=119.63  Aligned_cols=298  Identities=24%  Similarity=0.236  Sum_probs=178.5

Q ss_pred             CCcEEeCCCCccccCCchhhhcCCCCCeEEcccCc--cCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCC
Q 035691            4 FLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNT--LQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLP   81 (640)
Q Consensus         4 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~--l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~   81 (640)
                      ..+...+-+|.+. .++..... ++|+.|-+..|.  +..+.+..|..++.|++||||+|.     -.+.+|..+.. |-
T Consensus       524 ~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~-----~l~~LP~~I~~-Li  595 (889)
T KOG4658|consen  524 SVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNS-----SLSKLPSSIGE-LV  595 (889)
T ss_pred             heeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCC-----ccCcCChHHhh-hh
Confidence            3455666677776 44444433 379999999996  554555568889999999999753     23459988875 99


Q ss_pred             CCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCc
Q 035691           82 NIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYL  161 (640)
Q Consensus        82 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L  161 (640)
                      +|++|+|++..++ .+|..+.+|..|.+|++..+.-...+|+....|++|++|.+-.-.....    ......+.++.+|
T Consensus       596 ~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~----~~~l~el~~Le~L  670 (889)
T KOG4658|consen  596 HLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSND----KLLLKELENLEHL  670 (889)
T ss_pred             hhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccc----hhhHHhhhcccch
Confidence            9999999999998 7899999999999999999886666788888899999999887652211    1133445566666


Q ss_pred             ceEecCCCCCCCcCcCCCCCCCC----CEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCcc-EEe
Q 035691          162 EIVSLNVNSLRSIPISVGYLPKL----QVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQ-SLD  236 (640)
Q Consensus       162 ~~L~L~~N~l~~ip~~~~~l~~L----~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~  236 (640)
                      +.+....... .+-..+..+++|    +.+.+.++... ..+..+..+.+|+.|.+.++.+......++.....+. ...
T Consensus       671 ~~ls~~~~s~-~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~  748 (889)
T KOG4658|consen  671 ENLSITISSV-LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPN  748 (889)
T ss_pred             hhheeecchh-HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHH
Confidence            6666644433 111112222222    24444343333 4566788889999999999888744333322222221 000


Q ss_pred             ccCccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCC-CCccCC
Q 035691          237 LSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGP-IHPGLS  315 (640)
Q Consensus       237 ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~  315 (640)
                      ++.           +...++..- ..+.+....++|+.|++........+.+....+..+..+-+..+.+.+. .-....
T Consensus       749 l~~-----------~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~  816 (889)
T KOG4658|consen  749 LSK-----------VSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLG  816 (889)
T ss_pred             HHH-----------HHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCC
Confidence            000           011111100 1222223445677777776665545545555555555555555655544 233444


Q ss_pred             CCCCCCeEeCcCC
Q 035691          316 SLKSLEGLDLFQN  328 (640)
Q Consensus       316 ~l~~L~~L~l~~N  328 (640)
                      .++++..+.+++=
T Consensus       817 ~l~~i~~~~l~~~  829 (889)
T KOG4658|consen  817 GLPQLYWLPLSFL  829 (889)
T ss_pred             CCceeEecccCcc
Confidence            4444444444443

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.76  E-value=1.1e-07  Score=93.90  Aligned_cols=146  Identities=14%  Similarity=0.029  Sum_probs=97.8

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeecccch-----------hHHHHHHHHHHHHhcCCCCC--cceeEeeccCCcC
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG-----------ALKSFMAECEALRNIRHRNL--VKIITACSSSDFQ  513 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~~~~  513 (640)
                      +.+-+.....|+++..  .|+.|.||........           ....+.+|...+.++...+|  +..+++.......
T Consensus        28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            3444444456777766  5788999977332211           11247889988888743333  3334443211111


Q ss_pred             CCceeeEEeeccCCC-ChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC-
Q 035691          514 GNDFKALVYEFMHHG-SLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN-  591 (640)
Q Consensus       514 ~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~-  591 (640)
                      .....++|||++++- +|.+++.....        ...+......++.+++..+.-||.   .||+|+|++++|||++. 
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~~--------~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~  174 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWAT--------NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLP  174 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhcc--------cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEecc
Confidence            123467999999986 78888743211        113445667899999999999999   69999999999999975 


Q ss_pred             ------CCcEEEcccccccc
Q 035691          592 ------DMIAHVGDFGLTRF  605 (640)
Q Consensus       592 ------~~~~kl~DfGla~~  605 (640)
                            +..+.++||+.++.
T Consensus       175 ~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        175 FPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             ccCCCCCceEEEEECCcccc
Confidence                  46899999998864

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.75  E-value=1e-10  Score=123.22  Aligned_cols=129  Identities=29%  Similarity=0.216  Sum_probs=69.5

Q ss_pred             CCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCC
Q 035691          183 KLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPI  262 (640)
Q Consensus       183 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~  262 (640)
                      .|...+.++|.+. ....++.-++.|+.|||++|+++..-  .+..|+.|+.|                ||++|.++.+.
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhL----------------DlsyN~L~~vp  225 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHL----------------DLSYNCLRHVP  225 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhccccccc----------------ccccchhcccc
Confidence            4556666666665 45555555666666666666665332  45555555555                55555555333


Q ss_pred             CccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCC-ccCCCCCCCCeEeCcCCccccc
Q 035691          263 PLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIH-PGLSSLKSLEGLDLFQNTFQAK  333 (640)
Q Consensus       263 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~  333 (640)
                      --...+++ |+.|.+++|.++..  ..+.++++|+.|||++|-|.+--. .-+..|..|+.|+|.+|++-|.
T Consensus       226 ~l~~~gc~-L~~L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  226 QLSMVGCK-LQLLNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             ccchhhhh-heeeeecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence            22333333 66666666666522  234556666666666666543211 1233455566666666666543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.73  E-value=8.1e-08  Score=98.67  Aligned_cols=151  Identities=16%  Similarity=0.155  Sum_probs=113.8

Q ss_pred             cceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEeeccCC-CChhh
Q 035691          454 FGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHH-GSLES  532 (640)
Q Consensus       454 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-g~L~~  532 (640)
                      -.+.|||+...+|..|++|++..........-..-++.++++.|+|+|++.+++....| ++...++|++|.++ ++|.+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCchHHH
Confidence            46789999999999999999932222221122344678899999999999999764433 34568899999987 57877


Q ss_pred             hcCCCCCCC-----CCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccccccCC
Q 035691          533 WLHPESASD-----DLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP  607 (640)
Q Consensus       533 ~l~~~~~~~-----~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~  607 (640)
                      +.-......     .........++...|.++.|++.||.++|+   .|...+-|.|.+|+++.+.+++|+.-|+...+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            553332221     112234567889999999999999999999   699999999999999999999999888876654


Q ss_pred             C
Q 035691          608 E  608 (640)
Q Consensus       608 ~  608 (640)
                      +
T Consensus       445 ~  445 (655)
T KOG3741|consen  445 E  445 (655)
T ss_pred             C
Confidence            3

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.65  E-value=1.8e-07  Score=89.35  Aligned_cols=135  Identities=26%  Similarity=0.170  Sum_probs=94.0

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeeccc-----------------ch-----hHHHHHHHHHHHHhcCCC--
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-----------------RG-----ALKSFMAECEALRNIRHR--  498 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----------------~~-----~~~~~~~E~~~l~~l~H~--  498 (640)
                      ..+...||-|.=+.||.|... .|.++|||.-+...                 ..     .+....+|.++|.++...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            345688999999999999987 78999999774211                 00     134678899999998755  


Q ss_pred             CCcceeEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 035691          499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIV  578 (640)
Q Consensus       499 niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~iv  578 (640)
                      .+++.+++         +..++||||++|--|...--  ..         .-+......|+.++..+.    .   .|||
T Consensus       172 ~VP~P~~~---------nRHaVvMe~ieG~eL~~~r~--~~---------en~~~il~~il~~~~~~~----~---~GiV  224 (304)
T COG0478         172 KVPKPIAW---------NRHAVVMEYIEGVELYRLRL--DV---------ENPDEILDKILEEVRKAY----R---RGIV  224 (304)
T ss_pred             CCCCcccc---------ccceeeeehcccceeecccC--cc---------cCHHHHHHHHHHHHHHHH----H---cCcc
Confidence            66665544         46789999999866654321  00         011112223333433332    3   5999


Q ss_pred             eCCCCCCCeeeCCCCcEEEcccccccc
Q 035691          579 HCDLKPSNVLLDNDMIAHVGDFGLTRF  605 (640)
Q Consensus       579 Hrdlkp~NiLl~~~~~~kl~DfGla~~  605 (640)
                      |+|+.+=||+++++|.+.++||--+..
T Consensus       225 HGDlSefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         225 HGDLSEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             ccCCchheEEEecCCCEEEEeCccccc
Confidence            999999999999999999999976653

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.62  E-value=2.7e-10  Score=120.12  Aligned_cols=184  Identities=24%  Similarity=0.293  Sum_probs=101.6

Q ss_pred             chhhhcCCCCCeEEcccCccCccCCcCCCCC-CCCCEEEccCCCcCCcc--c---cccCCchhhcCCCCCCeeeccCCcc
Q 035691           20 PHEIGRLFQLRYIIFNSNTLQGQIPVNLTHC-SELRTLDLVLNKLEENQ--L---VGELPPYIGFTLPNIRIPLLAGNQF   93 (640)
Q Consensus        20 p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~--~---~~~lp~~~~~~l~~L~~L~L~~N~l   93 (640)
                      |-.+..+..|++|.|.++.|.. .- .+..+ ..|++|- -+|.+..-.  |   .|.+....  ....|...+.+.|.+
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~-~~-GL~~lr~qLe~LI-C~~Sl~Al~~v~ascggd~~ns~--~Wn~L~~a~fsyN~L  176 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLST-AK-GLQELRHQLEKLI-CHNSLDALRHVFASCGGDISNSP--VWNKLATASFSYNRL  176 (1096)
T ss_pred             CceeccccceeeEEecCcchhh-hh-hhHHHHHhhhhhh-hhccHHHHHHHHHHhccccccch--hhhhHhhhhcchhhH
Confidence            4445666778888888777763 11 11111 2344432 122221100  0   01111111  123455566677777


Q ss_pred             cccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCC
Q 035691           94 FGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRS  173 (640)
Q Consensus        94 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~  173 (640)
                      . ....++.-++.|+.|||++|+++..  +.+..++.|++|||++|++..++--      ...++ .|..|.+++|.++.
T Consensus       177 ~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l------~~~gc-~L~~L~lrnN~l~t  246 (1096)
T KOG1859|consen  177 V-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQL------SMVGC-KLQLLNLRNNALTT  246 (1096)
T ss_pred             H-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhcccccc------chhhh-hheeeeecccHHHh
Confidence            6 3445566667777777777777743  2566777777777777777765421      11233 37777777777776


Q ss_pred             cCcCCCCCCCCCEEEccCCcCcccCC-cCccCCCCCCEEEccCCCCC
Q 035691          174 IPISVGYLPKLQVLSLFENNISGEIP-SSLGNFTFLTELNLRGNSIR  219 (640)
Q Consensus       174 ip~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~  219 (640)
                      +- .+.++.+|+.||+++|-|.+.-. ..+..+..|+.|+|.+|.+-
T Consensus       247 L~-gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  247 LR-GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             hh-hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            53 35566777777777777663211 12445567777777777765

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.59  E-value=2.5e-07  Score=98.25  Aligned_cols=126  Identities=18%  Similarity=0.181  Sum_probs=100.8

Q ss_pred             EEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEeeccCCCChhhhcCCCC
Q 035691          459 KGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPES  538 (640)
Q Consensus       459 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~  538 (640)
                      .|..+.++.+|.|...+...........+-++.|+.+|||+|++++..     +..+...|+|+|.+.-  |..+++.. 
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t-----~e~~~~~ylvTErV~P--l~~~lk~l-  101 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDT-----TEEEGTLYLVTERVRP--LETVLKEL-  101 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhh-----hcccCceEEEeecccc--HHHHHHHh-
Confidence            466777899999999876665444567778899999999999999987     5556688999998753  44444322 


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccccccC
Q 035691          539 ASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI  606 (640)
Q Consensus       539 ~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~  606 (640)
                                  ....+...+.||+.||.|||+.  .+++|++|.-+.|+++..|..||++|-.+...
T Consensus       102 ------------~~~~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~  155 (690)
T KOG1243|consen  102 ------------GKEEVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKA  155 (690)
T ss_pred             ------------HHHHHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence                        2335566789999999999974  68999999999999999999999999887643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.56  E-value=5.7e-08  Score=102.05  Aligned_cols=149  Identities=26%  Similarity=0.289  Sum_probs=111.7

Q ss_pred             hcCCCcccCcccccccceEEEEEEC-CCCeEEEEEEeecccch--hHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCC
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILD-PDQTVVAVKVLFLHQRG--ALKSFMAECEALRNI-RHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~  514 (640)
                      -..+|..+..||.|.|+.|+++..+ .++..|++|.+......  ....-..|+-+...+ .|.++++....     |..
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----W~~  337 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----WSQ  337 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC-----ccc
Confidence            3457888899999999999988766 67889999987432211  112233455555555 58888887665     333


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC-C
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND-M  593 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~-~  593 (640)
                      ....++--|||++++......-.          ..+.+..++++..|++.++.++|+   +.++|+|+||+||++..+ +
T Consensus       338 ~r~~~ip~e~~~~~s~~l~~~~~----------~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~  404 (524)
T KOG0601|consen  338 LRQGYIPLEFCEGGSSSLRSVTS----------QMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGF  404 (524)
T ss_pred             cccccCchhhhcCcchhhhhHHH----------HhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchh
Confidence            44567889999999887655211          235666778899999999999998   799999999999999876 8


Q ss_pred             cEEEcccccccc
Q 035691          594 IAHVGDFGLTRF  605 (640)
Q Consensus       594 ~~kl~DfGla~~  605 (640)
                      ..++.|||++..
T Consensus       405 ~~~~~~~~~~t~  416 (524)
T KOG0601|consen  405 FSKLGDFGCWTR  416 (524)
T ss_pred             hhhccccccccc
Confidence            889999999864

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.49  E-value=2.4e-08  Score=95.22  Aligned_cols=84  Identities=29%  Similarity=0.389  Sum_probs=44.8

Q ss_pred             CCCCCEEECcCCccCc--cCCccccCCCCCCEEEcccCcCCCCCCCcccccccc-cCCCCcceEecCCCCCCC--cCcCC
Q 035691          104 ASKLEWLDFANNSLTA--SIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSL-VNCTYLEIVSLNVNSLRS--IPISV  178 (640)
Q Consensus       104 l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l-~~l~~L~~L~L~~N~l~~--ip~~~  178 (640)
                      .+.++.|||.+|+|+.  .+..-+.+||.|+.|+|+.|.+...       .+++ ..+.+|+.|-|.+..+.-  ....+
T Consensus        70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~-------I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l  142 (418)
T KOG2982|consen   70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSD-------IKSLPLPLKNLRVLVLNGTGLSWTQSTSSL  142 (418)
T ss_pred             hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCc-------cccCcccccceEEEEEcCCCCChhhhhhhh
Confidence            3456666666666652  1223345666666666666666442       0112 234556666666655543  33344


Q ss_pred             CCCCCCCEEEccCCcC
Q 035691          179 GYLPKLQVLSLFENNI  194 (640)
Q Consensus       179 ~~l~~L~~L~L~~N~l  194 (640)
                      ..+|.+++|++|.|.+
T Consensus       143 ~~lP~vtelHmS~N~~  158 (418)
T KOG2982|consen  143 DDLPKVTELHMSDNSL  158 (418)
T ss_pred             hcchhhhhhhhccchh
Confidence            5566666666666643

>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification]

Probab=98.48  E-value=2e-07  Score=84.35  Aligned_cols=105  Identities=25%  Similarity=0.251  Sum_probs=58.0

Q ss_pred             CCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCC
Q 035691           80 LPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCT  159 (640)
Q Consensus        80 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~  159 (640)
                      +.+...+||++|.+...  +.|..++.|.+|.|++|+|+.+-|.--.-+++|..|.|.+|+|..+.     ..+.+..|+
T Consensus        41 ~d~~d~iDLtdNdl~~l--~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~-----dl~pLa~~p  113 (233)
T KOG1644|consen   41 LDQFDAIDLTDNDLRKL--DNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELG-----DLDPLASCP  113 (233)
T ss_pred             ccccceecccccchhhc--ccCCCccccceEEecCCcceeeccchhhhccccceEEecCcchhhhh-----hcchhccCC
Confidence            44455556666665422  34666677777777777777655554445566777777777765542     223344555


Q ss_pred             CcceEecCCCCCCCcCc----CCCCCCCCCEEEccC
Q 035691          160 YLEIVSLNVNSLRSIPI----SVGYLPKLQVLSLFE  191 (640)
Q Consensus       160 ~L~~L~L~~N~l~~ip~----~~~~l~~L~~L~L~~  191 (640)
                      .|++|.+-+|..+.-..    -+..+|+|+.||.+.
T Consensus       114 ~L~~Ltll~Npv~~k~~YR~yvl~klp~l~~LDF~k  149 (233)
T KOG1644|consen  114 KLEYLTLLGNPVEHKKNYRLYVLYKLPSLRTLDFQK  149 (233)
T ss_pred             ccceeeecCCchhcccCceeEEEEecCcceEeehhh
Confidence            55555555555544322    123344455554443

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.47  E-value=4.3e-09  Score=88.83  Aligned_cols=36  Identities=36%  Similarity=0.531  Sum_probs=14.2

Q ss_pred             CCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCC
Q 035691          183 KLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIR  219 (640)
Q Consensus       183 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  219 (640)
                      .++.|+|++|.|+ .+|..+..++.|+.|+++.|++.
T Consensus        78 t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~  113 (177)
T KOG4579|consen   78 TATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN  113 (177)
T ss_pred             hhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc
Confidence            3344444444443 23333444444444444444433

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.45  E-value=5.9e-09  Score=88.04  Aligned_cols=73  Identities=30%  Similarity=0.384  Sum_probs=35.6

Q ss_pred             cceEecCCCCCCCcCcCC---CCCCCCCEEEccCCcCcccCCcCcc-CCCCCCEEEccCCCCCCCCCccccCCCCccEE
Q 035691          161 LEIVSLNVNSLRSIPISV---GYLPKLQVLSLFENNISGEIPSSLG-NFTFLTELNLRGNSIRGSIPSALGNCHQLQSL  235 (640)
Q Consensus       161 L~~L~L~~N~l~~ip~~~---~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  235 (640)
                      +..++|++++|-.+++..   .....|+..+|++|.+.. .|..|. ..+-++.|+|++|+|+ .+|..+..++.|+.|
T Consensus        29 ~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l  105 (177)
T KOG4579|consen   29 LHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL  105 (177)
T ss_pred             hhhcccccchhhHHHHHHHHHhCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence            444555555555444432   223345555666666653 233332 2335555555555555 444445555555544

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.44  E-value=4.7e-08  Score=93.22  Aligned_cols=213  Identities=22%  Similarity=0.281  Sum_probs=135.9

Q ss_pred             CcEEeCCCCccccCCc-hhhh-cCCCCCeEEcccCccCcc--CCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCC
Q 035691            5 LMLINLQQNNFSGNIP-HEIG-RLFQLRYIIFNSNTLQGQ--IPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTL   80 (640)
Q Consensus         5 L~~L~L~~n~i~~~~p-~~~~-~l~~L~~L~l~~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l   80 (640)
                      ++.|-+.++.|...-. ..|+ ..+.++.|+|.+|.|+.+  +...+.+++.|++|+||.|.+..  -.+.+|    ..+
T Consensus        47 ~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s--~I~~lp----~p~  120 (418)
T KOG2982|consen   47 LELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSS--DIKSLP----LPL  120 (418)
T ss_pred             hhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCC--ccccCc----ccc
Confidence            3355555666653222 2233 456788899999999864  34456788999999999888864  233344    247


Q ss_pred             CCCCeeeccCCccccc-CCccCcCCCCCCEEECcCCccCcc--CCccc----------cCCCCCCEEEcccCcCCCCCCC
Q 035691           81 PNIRIPLLAGNQFFGN-IPHSISNASKLEWLDFANNSLTAS--IPEDL----------GRLRNLTRLNFARNDLGTRKVN  147 (640)
Q Consensus        81 ~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~--~~~~~----------~~l~~L~~L~L~~N~l~~~~~~  147 (640)
                      .+|+.|.|.+..+.-. ....+..+|.++.|.+|.|.+...  .....          ..++.+..+.++-|++..+   
T Consensus       121 ~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~---  197 (418)
T KOG2982|consen  121 KNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRI---  197 (418)
T ss_pred             cceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhh---
Confidence            7889998888877632 223456788888999988854421  11222          2223333334444444332   


Q ss_pred             cccccccccCCCCcceEecCCCCCCCcCc--CCCCCCCCCEEEccCCcCcccC-CcCccCCCCCCEEEccCCCCCCCCCc
Q 035691          148 DLRFLDSLVNCTYLEIVSLNVNSLRSIPI--SVGYLPKLQVLSLFENNISGEI-PSSLGNFTFLTELNLRGNSIRGSIPS  224 (640)
Q Consensus       148 ~~~~~~~l~~l~~L~~L~L~~N~l~~ip~--~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~~  224 (640)
                                .+++..+.+..|.|+....  ....++.+..|+|+.|+|.... -+++.++++|+.|.+++|++......
T Consensus       198 ----------Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~  267 (418)
T KOG2982|consen  198 ----------FPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRG  267 (418)
T ss_pred             ----------cccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccccC
Confidence                      2567777788887776433  4555777888999999987543 35678889999999999988743322


Q ss_pred             ------cccCCCCccEEe
Q 035691          225 ------ALGNCHQLQSLD  236 (640)
Q Consensus       225 ------~~~~l~~L~~L~  236 (640)
                            -++.+++++.|+
T Consensus       268 ~err~llIaRL~~v~vLN  285 (418)
T KOG2982|consen  268 GERRFLLIARLTKVQVLN  285 (418)
T ss_pred             CcceEEEEeeccceEEec
Confidence                  245677777773

>PRK09902 hypothetical protein; Provisional

Probab=98.40  E-value=5.4e-06  Score=77.61  Aligned_cols=143  Identities=17%  Similarity=0.101  Sum_probs=100.5

Q ss_pred             ccccccceEEEEEECCCCeEEEEEEeeccc------chhHHHHHHHHHHHHhcCCC--CCcceeEeeccCCcCCCceeeE
Q 035691          449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQ------RGALKSFMAECEALRNIRHR--NLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       449 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      -|+||.+-|++-...  |..+=+|.-...-      +-....|.+|+..+.++...  .+++.. ++...........++
T Consensus        26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            467888899987764  4467777663221      22347899999999988533  344444 322111122334679


Q ss_pred             EeeccCC-CChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc--EEE
Q 035691          521 VYEFMHH-GSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI--AHV  597 (640)
Q Consensus       521 v~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~--~kl  597 (640)
                      |+|-+++ -+|.+++.....        ...+......+..+++.++.-||.   .++.|+|+.+.||+++.++.  +++
T Consensus       103 VTe~L~g~~~L~~~l~~~~~--------~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~l  171 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAV--------SPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGF  171 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCc--------CCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEE
Confidence            9997764 488888754322        124556678899999999999999   69999999999999986666  999


Q ss_pred             cccccccc
Q 035691          598 GDFGLTRF  605 (640)
Q Consensus       598 ~DfGla~~  605 (640)
                      +||.-++.
T Consensus       172 IDlEk~r~  179 (216)
T PRK09902        172 LDLEKSRR  179 (216)
T ss_pred             EEhhccch
Confidence            99987763

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.38  E-value=3.6e-06  Score=80.44  Aligned_cols=110  Identities=25%  Similarity=0.233  Sum_probs=81.5

Q ss_pred             HHHHHHHHHHHhcCCC--CCcceeEeeccCCcCCCceeeEEeeccCCC-ChhhhcCCCCCCCCCCCCCCCCCHHHHHHHH
Q 035691          483 KSFMAECEALRNIRHR--NLVKIITACSSSDFQGNDFKALVYEFMHHG-SLESWLHPESASDDLNYSPSILSFLQRLNIA  559 (640)
Q Consensus       483 ~~~~~E~~~l~~l~H~--niv~l~~~~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~  559 (640)
                      ..+.+|...+..+...  ..++.+++...... .....++|+|++++. +|.+++.....          .+......++
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~-~~~~s~lite~l~~~~~L~~~~~~~~~----------~~~~~~~~ll  124 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKG-GGYRSYLITEALPGAQDLRDLLQQWEQ----------LDPSQRRELL  124 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCC-CceeEEEEEEeCCCcccHHHHHHhhcc----------cchhhHHHHH
Confidence            4677888887777433  34555555433221 123468999999984 79888864221          2334567899


Q ss_pred             HHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC---cEEEccccccccC
Q 035691          560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM---IAHVGDFGLTRFI  606 (640)
Q Consensus       560 ~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~---~~kl~DfGla~~~  606 (640)
                      .+++..+.-||+   .+|+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       125 ~~l~~~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  125 RALARLIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999999999   6999999999999999887   8999999988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.34  E-value=2.8e-06  Score=91.09  Aligned_cols=143  Identities=20%  Similarity=0.205  Sum_probs=88.2

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeeccc----------------------ch----hH--------H------HHH
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ----------------------RG----AL--------K------SFM  486 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------------------~~----~~--------~------~~~  486 (640)
                      +-|+.++-|.||+|+.+ +|+.||||+.+..-                      .+    ..        +      .+.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            67899999999999998 69999999984321                      00    00        1      244


Q ss_pred             HHHHHHHhcC----CCCCcceeEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHH
Q 035691          487 AECEALRNIR----HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV  562 (640)
Q Consensus       487 ~E~~~l~~l~----H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i  562 (640)
                      +|+.-+.+++    ...=+++=.+|++    ......++|||++|-.+.+........         .+...+.....++
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we----~t~~~VLtmE~i~Gi~i~d~~~l~~~g---------~d~k~ia~~~~~~  276 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWE----YTTRRVLTMEWIDGIKISDIAALKSAG---------IDRKELAELLVRA  276 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehh----ccCCcEEEEEeeCCEecccHHHHHhcC---------CCHHHHHHHHHHH
Confidence            4555555442    2222333333322    223567999999998887764222211         2222222111121


Q ss_pred             HHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccccccCCC
Q 035691          563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE  608 (640)
Q Consensus       563 ~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~~  608 (640)
                      .--.-+ +    .+++|.|..|.||+++.+|.+-+.|||+...+.+
T Consensus       277 f~~q~~-~----dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         277 FLRQLL-R----DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHHH-h----cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            111112 2    3899999999999999999999999999886543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	640
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		3e-28
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		1e-05
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-27
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-05
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-25
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-23
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-17
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-17
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		3e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-14
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-14
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		6e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		9e-14
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		9e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		9e-14
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-13
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-13
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-13
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-13
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-13
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-13
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-13
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-13
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-13
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-13
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-13
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		7e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-13
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		7e-13
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		9e-13
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		9e-13
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		9e-13
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-12
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-12
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-12
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-12
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-12
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-12
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-12
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-12
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-12
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-12
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-12
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-12
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-11
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-11
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-11
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-11
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-11
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-11
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-11
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-11
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-11
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-11
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-11
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-11
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-11
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-11
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		7e-11
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		8e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		9e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-10
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-10
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-10
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-10
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-10
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-10
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-10
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		6e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		7e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		7e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		9e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		9e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-09
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-09
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-09
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-09
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		5e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		5e-09
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-09
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-09
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-09
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-09
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-09
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-09
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		7e-09
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-09
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-09
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-09
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-09
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		9e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-09
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-09
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		9e-09
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		9e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		9e-09
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-08
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-08
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-08
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-08
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-08
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-08
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-08
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-08
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-08
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-08
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-08
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-08
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-08
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-08
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-08
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-08
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-08
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-08
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-08
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-08
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-08
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-08
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		6e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-08
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		7e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		7e-08
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		7e-08
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		7e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		8e-08
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		8e-08
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		8e-08
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		8e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		9e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		9e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		9e-08
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-07
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-07
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-07
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-07
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-07
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-07
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-07
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-07
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-07
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-07
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-07
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-07
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-07
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-07
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-07
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-07
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-07
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-07
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-07
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-07
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-07
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-07
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-07
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-07
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-07
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-07
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-07
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-07
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-07
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-07
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-07
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-07
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-07
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-07
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-07
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-07
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-07
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-07
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-07
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-07
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-07
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-07
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-07
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-07
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		7e-07
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		7e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		8e-07
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		9e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		9e-07
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		9e-07
3g51_A	325	Structural Diversity Of The Active Conformation Of		9e-07
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-07
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-06
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-06
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-06
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-06
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-06
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-06
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-06
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-06
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-06
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-06
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-06
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-06
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-06
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-06
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-06
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-06
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-06
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-06
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-06
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-06
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-06
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-06
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-06
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-06
3zyn_A	321	Crystal Structure Of The N-Terminal Leucine Rich Re		6e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-06
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-06
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-06
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		7e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-06
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		7e-06
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-06
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-06
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		8e-06
3zyo_A	411	Crystal Structure Of The N-Terminal Leucine Rich Re		8e-06
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-06
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		8e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		8e-06
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		8e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		9e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-06
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-06
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		9e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-05
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-05
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-05
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-05
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-05
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-05
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-05
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-05
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-05
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-05
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-05
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-05
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-05
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-05
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-05
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-05
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-05
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-05
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-05
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-05
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-05
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-05
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-05
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-05
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-05
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-05
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-05
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-05
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-05
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-05
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-05
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-05
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-05
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-05
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-05
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-05
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		3e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		3e-05
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-05
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		3e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-05
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		4e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-05
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-05
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-05
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-05
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-05
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-05
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-05
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-05
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		5e-05
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-05
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-05
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		6e-05
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-05
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-05
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		7e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		7e-05
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		8e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		8e-05
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-05
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-05
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-05
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-05
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		8e-05
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		9e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		9e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		9e-05
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		9e-05
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-05
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-05
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		9e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-04
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-04
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-04
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-04
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-04
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-04
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-04
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-04
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-04
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-04
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-04
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-04
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-04
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-04
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-04
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-04
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-04
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-04
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-04
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-04
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-04
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-04
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-04
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-04
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-04
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-04
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-04
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-04
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-04
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-04
3zyi_A	452	Netring2 In Complex With Ngl2 Length = 452		2e-04
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-04
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-04
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-04
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-04
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-04
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-04
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		3e-04
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-04
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-04
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-04
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-04
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-04
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-04
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-04
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-04
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-04
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-04
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-04
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-04
1xeu_A	263	Crystal Structure Of Internalin C From Listeria Mon		4e-04
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-04
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-04
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-04
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-04
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-04
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-04
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-04
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-04
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-04
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-04
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		5e-04
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		5e-04
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-04
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		6e-04
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		7e-04
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-04
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-04
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-04
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-04
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-04
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		7e-04
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-04
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-04
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-04
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-04
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-04
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		8e-04
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-04
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-04
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-04
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		8e-04
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		8e-04
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-04
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		8e-04
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-04
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-04
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-04
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		8e-04
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		8e-04
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-04
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		8e-04
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-04
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		8e-04
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		8e-04
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-04
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-04
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-04
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		9e-04
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		9e-04
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		9e-04
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		9e-04

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  123 bits (309), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 129/454 (28%), Positives = 193/454 (42%), Gaps = 93/454 (20%)
Query: 13  NNFSGNIPHE-IGRLFQLRYIIFNSNTLQGQIPVNLTHCS-ELRTLDLVLNKLEENQLVG 70
           NNFSG +P + + ++  L+ +  + N   G++P +LT+ S  L TLDL       N   G
Sbjct: 325 NNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL-----SSNNFSG 379
Query: 71  ELPPYIGFTLPNIRIPL-LAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLR 129
            + P +     N    L L  N F G IP ++SN S+L  L  + N L+ +IP  LG L 
Sbjct: 380 PILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS 439
Query: 130 NLTRLNFARNDLGTRKVNDLRFLDSL------------------VNCTYLEIVSLNVNSL 171
            L  L    N L      +L ++ +L                   NCT L  +SL+ N L
Sbjct: 440 KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRL 499
Query: 172 R-SIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSAL---- 226
              IP  +G L  L +L L  N+ SG IP+ LG+   L  L+L  N   G+IP+A+    
Sbjct: 500 TGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS 559
Query: 227 ----------------------------GNCHQLQSL--------------DLSKTIFLG 244
                                       GN  + Q +              +++  ++ G
Sbjct: 560 GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGG 619
Query: 245 QYP--------VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGL 296
                      + +LD+S+N L+G IP  +G++  +  L+L  N +SG IP  +G   GL
Sbjct: 620 HTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL 679
Query: 297 EYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGN 356
             L+LS N   G I   +S+L  L  +DL  N        G +P  G F+         N
Sbjct: 680 NILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS-----GPIPEMGQFETFPPAKFLNN 734
Query: 357 EKLCGGISELKLPPCTPSESK---KRQKSNGFKL 387
             LCG      LP C PS +      Q+S+G +L
Sbjct: 735 PGLCG----YPLPRCDPSNADGYAHHQRSHGRRL 764

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/112 (38%), Positives = 64/112 (57%), Gaps = 13/112 (11%)
Query: 253 LSHNHLTGPIPLAVGNLK---SIPHLDLSKNKLSGEIP--SSLGSCVGLEYLNLSINS-- 305
           LS++H+ G    +V   K   S+  LDLS+N LSG +   +SLGSC GL++LN+S N+  
Sbjct: 81  LSNSHING----SVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLD 136
Query: 306 FHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNE 357
           F G +  GL  L SLE LDL  N+    +  G V   G  +    ++++GN+
Sbjct: 137 FPGKVSGGL-KLNSLEVLDLSANSISGANVVGWVLSDGCGE-LKHLAISGNK 186

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 125/440 (28%), Positives = 186/440 (42%), Gaps = 90/440 (20%)
Query: 13  NNFSGNIPHE-IGRLFQLRYIIFNSNTLQGQIPVNLTHCS-ELRTLDLVLNKLEENQLVG 70
           NNFSG +P + + ++  L+ +  + N   G++P +LT+ S  L TLDL       N   G
Sbjct: 328 NNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL-----SSNNFSG 382
Query: 71  ELPPYIGFTLPNIRIPL-LAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLR 129
            + P +     N    L L  N F G IP ++SN S+L  L  + N L+ +IP  LG L 
Sbjct: 383 PILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS 442
Query: 130 NLTRLNFARNDLGTRKVNDLRFLDSL------------------VNCTYLEIVSLNVNSL 171
            L  L    N L      +L ++ +L                   NCT L  +SL+ N L
Sbjct: 443 KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRL 502
Query: 172 R-SIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSAL---- 226
              IP  +G L  L +L L  N+ SG IP+ LG+   L  L+L  N   G+IP+A+    
Sbjct: 503 TGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS 562
Query: 227 ----------------------------GNCHQLQSL--------------DLSKTIFLG 244
                                       GN  + Q +              +++  ++ G
Sbjct: 563 GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGG 622
Query: 245 QYP--------VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGL 296
                      + +LD+S+N L+G IP  +G++  +  L+L  N +SG IP  +G   GL
Sbjct: 623 HTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL 682
Query: 297 EYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGN 356
             L+LS N   G I   +S+L  L  +DL  N        G +P  G F+         N
Sbjct: 683 NILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS-----GPIPEMGQFETFPPAKFLNN 737
Query: 357 EKLCGGISELKLPPCTPSES 376
             LCG      LP C PS +
Sbjct: 738 PGLCG----YPLPRCDPSNA 753

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/112 (38%), Positives = 64/112 (57%), Gaps = 13/112 (11%)
Query: 253 LSHNHLTGPIPLAVGNLK---SIPHLDLSKNKLSGEIP--SSLGSCVGLEYLNLSINS-- 305
           LS++H+ G    +V   K   S+  LDLS+N LSG +   +SLGSC GL++LN+S N+  
Sbjct: 84  LSNSHING----SVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLD 139
Query: 306 FHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNE 357
           F G +  GL  L SLE LDL  N+    +  G V   G  +    ++++GN+
Sbjct: 140 FPGKVSGGL-KLNSLEVLDLSANSISGANVVGWVLSDGCGE-LKHLAISGNK 189

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 77/207 (37%), Positives = 109/207 (52%), Gaps = 20/207 (9%)
Query: 428 LLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFM 486
           L   S   L  A+  FS+ N++G G FG VYKG L  D T+VAVK L   + +G    F 
Sbjct: 25  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERXQGGELQFQ 83
Query: 487 AECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH--PESASDDLN 544
            E E +    HRNL+++   C +        + LVY +M +GS+ S L   PES      
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTE-----RLLVYPYMANGSVASCLRERPES------ 132
Query: 545 YSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
             P  L + +R  IA+  A  L YLH HC  +I+H D+K +N+LLD +  A VGDFGL +
Sbjct: 133 -QPP-LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 190
Query: 605 FIPEVISSNQCSSVGLKGTVGYAAPEY 631
            +      +      ++GT+G+ APEY
Sbjct: 191 LMD---YKDXHVXXAVRGTIGHIAPEY 214

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/207 (35%), Positives = 106/207 (51%), Gaps = 20/207 (9%)
Query: 428 LLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFM 486
           L   S   L  A+  F + N++G G FG VYKG L  D  +VAVK L   + +G    F 
Sbjct: 17  LKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRL-ADGXLVAVKRLKEERTQGGELQFQ 75
Query: 487 AECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH--PESASDDLN 544
            E E +    HRNL+++   C +        + LVY +M +GS+ S L   PES      
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTE-----RLLVYPYMANGSVASCLRERPES------ 124
Query: 545 YSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
             P  L + +R  IA+  A  L YLH HC  +I+H D+K +N+LLD +  A VGDFGL +
Sbjct: 125 -QPP-LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
Query: 605 FIPEVISSNQCSSVGLKGTVGYAAPEY 631
            +      +      ++G +G+ APEY
Sbjct: 183 LMD---YKDXHVXXAVRGXIGHIAPEY 206

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 105/197 (53%), Gaps = 19/197 (9%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI 495
           L +AT  F    LIG G FG VYKG+L  D   VA+K         ++ F  E E L   
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSI-LSFLQ 554
           RH +LV +I  C     + N+   L+Y++M +G+L+  L+      DL   P++ +S+ Q
Sbjct: 93  RHPHLVSLIGFCD----ERNEM-ILIYKYMENGNLKRHLY----GSDL---PTMSMSWEQ 140
Query: 555 RLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQ 614
           RL I I  A  L YLH    + I+H D+K  N+LLD + +  + DFG+++   E+  ++ 
Sbjct: 141 RLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197
Query: 615 CSSVGLKGTVGYAAPEY 631
              V  KGT+GY  PEY
Sbjct: 198 XXVV--KGTLGYIDPEY 212

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/197 (36%), Positives = 105/197 (53%), Gaps = 19/197 (9%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI 495
           L +AT  F    LIG G FG VYKG+L  D   VA+K         ++ F  E E L   
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSI-LSFLQ 554
           RH +LV +I  C     + N+   L+Y++M +G+L+  L+      DL   P++ +S+ Q
Sbjct: 93  RHPHLVSLIGFCD----ERNEM-ILIYKYMENGNLKRHLY----GSDL---PTMSMSWEQ 140
Query: 555 RLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQ 614
           RL I I  A  L YLH    + I+H D+K  N+LLD + +  + DFG+++   E+  ++ 
Sbjct: 141 RLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHL 197
Query: 615 CSSVGLKGTVGYAAPEY 631
              V  KGT+GY  PEY
Sbjct: 198 XXVV--KGTLGYIDPEY 212

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 88/367 (23%), Positives = 150/367 (40%), Gaps = 72/367 (19%)
Query: 20  PHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELP------ 73
           P +   L Q++  + N  TL   +P   T C     L ++ +   +   V  L       
Sbjct: 5   PQDKQALLQIKKDLGNPTTLSSWLPT--TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 74  ------PYIGFTLPNIRIPLLAG-NQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLG 126
                 P     LP +    + G N   G IP +I+  ++L +L   + +++ +IP+ L 
Sbjct: 63  PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 127 RLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQV 186
           +++ L  L+F+ N L                               ++P S+  LP L  
Sbjct: 123 QIKTLVTLDFSYNALS-----------------------------GTLPPSISSLPNLVG 153
Query: 187 LSLFENNISGEIPSSLGNFT-FLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQ 245
           ++   N ISG IP S G+F+   T + +  N + G IP    N +               
Sbjct: 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN--------------- 198
Query: 246 YPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINS 305
             + ++DLS N L G   +  G+ K+   + L+KN L+ ++   +G    L  L+L  N 
Sbjct: 199 --LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNR 255
Query: 306 FHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGISE 365
            +G +  GL+ LK L  L++  N        G++P+ G  +     + A N+ LCG    
Sbjct: 256 IYGTLPQGLTQLKFLHSLNVSFNNLC-----GEIPQGGNLQRFDVSAYANNKCLCGS--- 307
Query: 366 LKLPPCT 372
             LP CT
Sbjct: 308 -PLPACT 313

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 88/186 (47%), Gaps = 20/186 (10%)
Query: 449 IGTGSFGSVYKGILDPDQ----TVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKII 504
           +G G+FGSV     DP Q     VVAVK L       L+ F  E E L++++H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C S+   G     L+ EF+ +GSL  +L       D          ++ L     +  
Sbjct: 81  GVCYSA---GRRNLKLIMEFLPYGSLREYLQKHKERID---------HIKLLQYTSQICK 128
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            +EYL     K+ +H DL   N+L++N+    +GDFGLT+ +P+     +    G +  +
Sbjct: 129 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESPI 184
Query: 625 GYAAPE 630
            + APE
Sbjct: 185 FWYAPE 190

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 88/186 (47%), Gaps = 20/186 (10%)
Query: 449 IGTGSFGSVYKGILDPDQ----TVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKII 504
           +G G+FGSV     DP Q     VVAVK L       L+ F  E E L++++H N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C S+   G     L+ E++ +GSL  +L       D          ++ L     +  
Sbjct: 96  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERID---------HIKLLQYTSQICK 143
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            +EYL     K+ +H DL   N+L++N+    +GDFGLT+ +P+     +    G +  +
Sbjct: 144 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESPI 199
Query: 625 GYAAPE 630
            + APE
Sbjct: 200 FWYAPE 205

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 89/186 (47%), Gaps = 20/186 (10%)
Query: 449 IGTGSFGSVYKGILDPDQ----TVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKII 504
           +G G+FGSV     DP Q     VVAVK L       L+ F  E E L++++H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C S+   G     L+ E++ +GSL  +L   +   D          ++ L     +  
Sbjct: 81  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQAHAERID---------HIKLLQYTSQICK 128
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            +EYL     K+ +H DL   N+L++N+    +GDFGLT+ +P+     +    G +  +
Sbjct: 129 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESPI 184
Query: 625 GYAAPE 630
            + APE
Sbjct: 185 FWYAPE 190

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 88/186 (47%), Gaps = 20/186 (10%)
Query: 449 IGTGSFGSVYKGILDPDQ----TVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKII 504
           +G G+FGSV     DP Q     VVAVK L       L+ F  E E L++++H N+VK  
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C S+   G     L+ E++ +GSL  +L       D          ++ L     +  
Sbjct: 77  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERID---------HIKLLQYTSQICK 124
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            +EYL     K+ +H DL   N+L++N+    +GDFGLT+ +P+     +    G +  +
Sbjct: 125 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESPI 180
Query: 625 GYAAPE 630
            + APE
Sbjct: 181 FWYAPE 186

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 88/186 (47%), Gaps = 20/186 (10%)
Query: 449 IGTGSFGSVYKGILDPDQ----TVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKII 504
           +G G+FGSV     DP Q     VVAVK L       L+ F  E E L++++H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C S+   G     L+ E++ +GSL  +L       D          ++ L     +  
Sbjct: 81  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERID---------HIKLLQYTSQICK 128
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            +EYL     K+ +H DL   N+L++N+    +GDFGLT+ +P+     +    G +  +
Sbjct: 129 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESPI 184
Query: 625 GYAAPE 630
            + APE
Sbjct: 185 FWYAPE 190

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 88/186 (47%), Gaps = 20/186 (10%)
Query: 449 IGTGSFGSVYKGILDPDQ----TVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKII 504
           +G G+FGSV     DP Q     VVAVK L       L+ F  E E L++++H N+VK  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C S+   G     L+ E++ +GSL  +L       D          ++ L     +  
Sbjct: 76  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERID---------HIKLLQYTSQICK 123
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            +EYL     K+ +H DL   N+L++N+    +GDFGLT+ +P+     +    G +  +
Sbjct: 124 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESPI 179
Query: 625 GYAAPE 630
            + APE
Sbjct: 180 FWYAPE 185

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 88/186 (47%), Gaps = 20/186 (10%)
Query: 449 IGTGSFGSVYKGILDPDQ----TVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKII 504
           +G G+FGSV     DP Q     VVAVK L       L+ F  E E L++++H N+VK  
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C S+   G     L+ E++ +GSL  +L       D          ++ L     +  
Sbjct: 82  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERID---------HIKLLQYTSQICK 129
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            +EYL     K+ +H DL   N+L++N+    +GDFGLT+ +P+     +    G +  +
Sbjct: 130 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESPI 185
Query: 625 GYAAPE 630
            + APE
Sbjct: 186 FWYAPE 191

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 88/186 (47%), Gaps = 20/186 (10%)
Query: 449 IGTGSFGSVYKGILDPDQ----TVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKII 504
           +G G+FGSV     DP Q     VVAVK L       L+ F  E E L++++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C S+   G     L+ E++ +GSL  +L       D          ++ L     +  
Sbjct: 78  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERID---------HIKLLQYTSQICK 125
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            +EYL     K+ +H DL   N+L++N+    +GDFGLT+ +P+     +    G +  +
Sbjct: 126 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESPI 181
Query: 625 GYAAPE 630
            + APE
Sbjct: 182 FWYAPE 187

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 88/186 (47%), Gaps = 20/186 (10%)
Query: 449 IGTGSFGSVYKGILDPDQ----TVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKII 504
           +G G+FGSV     DP Q     VVAVK L       L+ F  E E L++++H N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C S+   G     L+ E++ +GSL  +L       D          ++ L     +  
Sbjct: 96  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERID---------HIKLLQYTSQICK 143
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            +EYL     K+ +H DL   N+L++N+    +GDFGLT+ +P+     +    G +  +
Sbjct: 144 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESPI 199
Query: 625 GYAAPE 630
            + APE
Sbjct: 200 FWYAPE 205

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 88/186 (47%), Gaps = 20/186 (10%)
Query: 449 IGTGSFGSVYKGILDPDQ----TVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKII 504
           +G G+FGSV     DP Q     VVAVK L       L+ F  E E L++++H N+VK  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C S+   G     L+ E++ +GSL  +L       D          ++ L     +  
Sbjct: 109 GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERID---------HIKLLQYTSQICK 156
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            +EYL     K+ +H DL   N+L++N+    +GDFGLT+ +P+     +    G +  +
Sbjct: 157 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESPI 212
Query: 625 GYAAPE 630
            + APE
Sbjct: 213 FWYAPE 218

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 88/186 (47%), Gaps = 20/186 (10%)
Query: 449 IGTGSFGSVYKGILDPDQ----TVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKII 504
           +G G+FGSV     DP Q     VVAVK L       L+ F  E E L++++H N+VK  
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C S+   G     L+ E++ +GSL  +L       D          ++ L     +  
Sbjct: 83  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERID---------HIKLLQYTSQICK 130
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            +EYL     K+ +H DL   N+L++N+    +GDFGLT+ +P+     +    G +  +
Sbjct: 131 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESPI 186
Query: 625 GYAAPE 630
            + APE
Sbjct: 187 FWYAPE 192

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 88/186 (47%), Gaps = 20/186 (10%)
Query: 449 IGTGSFGSVYKGILDPDQ----TVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKII 504
           +G G+FGSV     DP Q     VVAVK L       L+ F  E E L++++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C S+   G     L+ E++ +GSL  +L       D          ++ L     +  
Sbjct: 78  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERID---------HIKLLQYTSQICK 125
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            +EYL     K+ +H DL   N+L++N+    +GDFGLT+ +P+     +    G +  +
Sbjct: 126 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESPI 181
Query: 625 GYAAPE 630
            + APE
Sbjct: 182 FWYAPE 187

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 88/186 (47%), Gaps = 20/186 (10%)
Query: 449 IGTGSFGSVYKGILDPDQ----TVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKII 504
           +G G+FGSV     DP Q     VVAVK L       L+ F  E E L++++H N+VK  
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C S+   G     L+ E++ +GSL  +L       D          ++ L     +  
Sbjct: 85  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERID---------HIKLLQYTSQICK 132
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            +EYL     K+ +H DL   N+L++N+    +GDFGLT+ +P+     +    G +  +
Sbjct: 133 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESPI 188
Query: 625 GYAAPE 630
            + APE
Sbjct: 189 FWYAPE 194

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 88/186 (47%), Gaps = 20/186 (10%)
Query: 449 IGTGSFGSVYKGILDPDQ----TVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKII 504
           +G G+FGSV     DP Q     VVAVK L       L+ F  E E L++++H N+VK  
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C S+   G     L+ E++ +GSL  +L       D          ++ L     +  
Sbjct: 84  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERID---------HIKLLQYTSQICK 131
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            +EYL     K+ +H DL   N+L++N+    +GDFGLT+ +P+     +    G +  +
Sbjct: 132 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESPI 187
Query: 625 GYAAPE 630
            + APE
Sbjct: 188 FWYAPE 193

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 88/185 (47%), Gaps = 28/185 (15%)
Query: 449 IGTGSFGSVYKGI-LDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIIT 505
           IG+G FG V+ G  L+ D+  VA+K +   + GA+  + F+ E E +  + H  LV++  
Sbjct: 15  IGSGQFGLVHLGYWLNKDK--VAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
            C            LV+EFM HG L         SD L     + +    L + ++V   
Sbjct: 70  VCLE-----QAPICLVFEFMEHGCL---------SDYLRTQRGLFAAETLLGMCLDVCEG 115
Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG 625
           + YL   C   ++H DL   N L+  + +  V DFG+TRF   V+     SS G K  V 
Sbjct: 116 MAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSSTGTKFPVK 169
Query: 626 YAAPE 630
           +A+PE
Sbjct: 170 WASPE 174

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 88/185 (47%), Gaps = 28/185 (15%)
Query: 449 IGTGSFGSVYKGI-LDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIIT 505
           IG+G FG V+ G  L+ D+  VA+K +   + GA+  + F+ E E +  + H  LV++  
Sbjct: 18  IGSGQFGLVHLGYWLNKDK--VAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 72
Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
            C            LV+EFM HG L         SD L     + +    L + ++V   
Sbjct: 73  VCLE-----QAPICLVFEFMEHGCL---------SDYLRTQRGLFAAETLLGMCLDVCEG 118
Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG 625
           + YL   C   ++H DL   N L+  + +  V DFG+TRF   V+     SS G K  V 
Sbjct: 119 MAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSSTGTKFPVK 172
Query: 626 YAAPE 630
           +A+PE
Sbjct: 173 WASPE 177

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 88/185 (47%), Gaps = 28/185 (15%)
Query: 449 IGTGSFGSVYKGI-LDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIIT 505
           IG+G FG V+ G  L+ D+  VA+K +   + GA+  + F+ E E +  + H  LV++  
Sbjct: 13  IGSGQFGLVHLGYWLNKDK--VAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
            C            LV+EFM HG L         SD L     + +    L + ++V   
Sbjct: 68  VCLE-----QAPICLVFEFMEHGCL---------SDYLRTQRGLFAAETLLGMCLDVCEG 113
Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG 625
           + YL   C   ++H DL   N L+  + +  V DFG+TRF   V+     SS G K  V 
Sbjct: 114 MAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSSTGTKFPVK 167
Query: 626 YAAPE 630
           +A+PE
Sbjct: 168 WASPE 172

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 88/183 (48%), Gaps = 22/183 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G FG VY+G+       VAVK L       ++ F+ E   ++ I+H NLV+++  C+
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 509 SSD-FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F       ++ EFM +G+L  +L   +  +        +S +  L +A  ++SA+E
Sbjct: 78  REPPFY------IITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAME 123
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYA 627
           YL    KK  +H DL   N L+  + +  V DFGL+R +         +  G K  + + 
Sbjct: 124 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTXTAHAGAKFPIKWT 177
Query: 628 APE 630
           APE
Sbjct: 178 APE 180

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 88/186 (47%), Gaps = 20/186 (10%)
Query: 449 IGTGSFGSVYKGILDPDQ----TVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKII 504
           +G G+FGSV     DP Q     VVAVK L       L+ F  E E L++++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C S+   G     L+ E++ +GSL  +L       D          ++ L     +  
Sbjct: 78  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERID---------HIKLLQYTSQICK 125
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            +EYL     K+ +H DL   N+L++N+    +GDFGLT+ +P+     +    G +  +
Sbjct: 126 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG-ESPI 181
Query: 625 GYAAPE 630
            + APE
Sbjct: 182 FWYAPE 187

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 94/184 (51%), Gaps = 21/184 (11%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA--LKSFMAECEALRNIRHRNLVKIITA 506
           IG GSFG+V++   +   + VAVK+L      A  +  F+ E   ++ +RH N+V  + A
Sbjct: 45  IGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +    Q  +  ++V E++  GSL   LH   A + L+         +RL++A +VA  +
Sbjct: 103 VT----QPPNL-SIVTEYLSRGSLYRLLHKSGAREQLDER-------RRLSMAYDVAKGM 150
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            YLH+     IVH +LK  N+L+D      V DFGL+R    + +S   SS    GT  +
Sbjct: 151 NYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR----LKASTFLSSKSAAGTPEW 205
Query: 627 AAPE 630
            APE
Sbjct: 206 MAPE 209

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 93/184 (50%), Gaps = 21/184 (11%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA--LKSFMAECEALRNIRHRNLVKIITA 506
           IG GSFG+V++   +   + VAVK+L      A  +  F+ E   ++ +RH N+V  + A
Sbjct: 45  IGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +    Q  +  ++V E++  GSL   LH   A + L+         +RL++A +VA  +
Sbjct: 103 VT----QPPNL-SIVTEYLSRGSLYRLLHKSGAREQLDER-------RRLSMAYDVAKGM 150
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            YLH+     IVH DLK  N+L+D      V DFGL+R    + +S    S    GT  +
Sbjct: 151 NYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR----LKASXFLXSKXAAGTPEW 205
Query: 627 AAPE 630
            APE
Sbjct: 206 MAPE 209

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 81/164 (49%), Gaps = 16/164 (9%)
Query: 449 IGTGSFGSV-----YKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKI 503
           +G G+FG V     Y    + D+ +VAVK L      A K F  E E L N++H ++VK 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLH---PESASDDLNYSPSILSFLQRLNIAI 560
              C   D        +V+E+M HG L  +L    P++        P+ L+  Q L+IA 
Sbjct: 81  YGVCVEGDPL-----IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
            +A+ + YL     +  VH DL   N L+  +++  +GDFG++R
Sbjct: 136 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 176

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 88/182 (48%), Gaps = 20/182 (10%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G +G VY+G+       VAVK L       ++ F+ E   ++ I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
                   F  ++ EFM +G+L  +L   +  +        +S +  L +A  ++SA+EY
Sbjct: 80  REP----PFYIII-EFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEY 126
Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           L    KK  +H DL   N L+  + +  V DFGL+R +         +  G K  + + A
Sbjct: 127 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTA 180
Query: 629 PE 630
           PE
Sbjct: 181 PE 182

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 88/182 (48%), Gaps = 20/182 (10%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G +G VY+G+       VAVK L       ++ F+ E   ++ I+H NLV+++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
                   F  ++ EFM +G+L  +L   +  +        +S +  L +A  ++SA+EY
Sbjct: 78  REP----PFYIII-EFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEY 124
Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           L    KK  +H DL   N L+  + +  V DFGL+R +         +  G K  + + A
Sbjct: 125 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTXTAHAGAKFPIKWTA 178
Query: 629 PE 630
           PE
Sbjct: 179 PE 180

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 88/183 (48%), Gaps = 22/183 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G +G VY+G+       VAVK L       ++ F+ E   ++ I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 509 SSD-FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F       ++ EFM +G+L  +L   +  +        +S +  L +A  ++SA+E
Sbjct: 80  REPPFY------IITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAME 125
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYA 627
           YL    KK  +H DL   N L+  + +  V DFGL+R +         +  G K  + + 
Sbjct: 126 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWT 179
Query: 628 APE 630
           APE
Sbjct: 180 APE 182

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 88/182 (48%), Gaps = 20/182 (10%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G +G VY+G+       VAVK L       ++ F+ E   ++ I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
                   F  ++ EFM +G+L  +L   +  +        +S +  L +A  ++SA+EY
Sbjct: 80  REP----PFYIII-EFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEY 126
Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           L    KK  +H DL   N L+  + +  V DFGL+R +         +  G K  + + A
Sbjct: 127 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTA 180
Query: 629 PE 630
           PE
Sbjct: 181 PE 182

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 89/182 (48%), Gaps = 20/182 (10%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G +G VY+G+       VAVK L       ++ F+ E   ++ I+H NLV+++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
                   F  ++ EFM +G+L  +L  E    ++N    +L     L +A  ++SA+EY
Sbjct: 81  REP----PFYIII-EFMTYGNLLDYLR-ECNRQEVN--AVVL-----LYMATQISSAMEY 127
Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           L    KK  +H DL   N L+  + +  V DFGL+R +         +  G K  + + A
Sbjct: 128 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTXTAHAGAKFPIKWTA 181
Query: 629 PE 630
           PE
Sbjct: 182 PE 183

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 88/183 (48%), Gaps = 22/183 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G +G VY+G+       VAVK L       ++ F+ E   ++ I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 509 SSD-FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F       ++ EFM +G+L  +L   +  +        +S +  L +A  ++SA+E
Sbjct: 85  REPPFY------IITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAME 130
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYA 627
           YL    KK  +H DL   N L+  + +  V DFGL+R +         +  G K  + + 
Sbjct: 131 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWT 184
Query: 628 APE 630
           APE
Sbjct: 185 APE 187

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 88/186 (47%), Gaps = 20/186 (10%)
Query: 449 IGTGSFGSVYKGILDPDQ----TVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKII 504
           +G G+FGSV     DP Q     VVAVK L       L+ F  E E L++++H N+VK  
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C S+   G     L+ E++ +GSL  +L       D          ++ L     +  
Sbjct: 79  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERID---------HIKLLQYTSQICK 126
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            +EYL     K+ +H +L   N+L++N+    +GDFGLT+ +P+     +    G +  +
Sbjct: 127 GMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPG-ESPI 182
Query: 625 GYAAPE 630
            + APE
Sbjct: 183 FWYAPE 188

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 89/182 (48%), Gaps = 20/182 (10%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G +G VY+G+       VAVK L       ++ F+ E   ++ I+H NLV+++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
                   F  ++ EFM +G+L  +L  E    ++N    +L     L +A  ++SA+EY
Sbjct: 81  REP----PF-YIITEFMTYGNLLDYLR-ECNRQEVN--AVVL-----LYMATQISSAMEY 127
Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           L    KK  +H DL   N L+  + +  V DFGL+R +         +  G K  + + A
Sbjct: 128 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAPAGAKFPIKWTA 181
Query: 629 PE 630
           PE
Sbjct: 182 PE 183

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 89/182 (48%), Gaps = 20/182 (10%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G +G VY+G+       VAVK L       ++ F+ E   ++ I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
                   F  ++ EFM +G+L  +L  E    ++N    +L     L +A  ++SA+EY
Sbjct: 85  REP----PFYIII-EFMTYGNLLDYLR-ECNRQEVN--AVVL-----LYMATQISSAMEY 131
Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           L    KK  +H DL   N L+  + +  V DFGL+R +         +  G K  + + A
Sbjct: 132 LE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTA 185
Query: 629 PE 630
           PE
Sbjct: 186 PE 187

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 88/183 (48%), Gaps = 22/183 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G +G VY+G+       VAVK L       ++ F+ E   ++ I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 509 SSD-FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F       ++ EFM +G+L  +L   +  +        +S +  L +A  ++SA+E
Sbjct: 80  REPPFY------IITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAME 125
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYA 627
           YL    KK  +H DL   N L+  + +  V DFGL+R +         +  G K  + + 
Sbjct: 126 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWT 179
Query: 628 APE 630
           APE
Sbjct: 180 APE 182

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 87/185 (47%), Gaps = 28/185 (15%)
Query: 449 IGTGSFGSVYKGI-LDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIIT 505
           IG+G FG V+ G  L+ D+  VA+K +   + GA+  + F+ E E +  + H  LV++  
Sbjct: 16  IGSGQFGLVHLGYWLNKDK--VAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
            C            LV EFM HG L         SD L     + +    L + ++V   
Sbjct: 71  VCLE-----QAPICLVTEFMEHGCL---------SDYLRTQRGLFAAETLLGMCLDVCEG 116
Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG 625
           + YL   C   ++H DL   N L+  + +  V DFG+TRF   V+     SS G K  V 
Sbjct: 117 MAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSSTGTKFPVK 170
Query: 626 YAAPE 630
           +A+PE
Sbjct: 171 WASPE 175

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 22/183 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G +G VY+G+       VAVK L       ++ F+ E   ++ I+H NLV+++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 509 SSD-FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F       ++ EFM +G+L  +L  E    ++N    +L     L +A  ++SA+E
Sbjct: 82  REPPFY------IITEFMTYGNLLDYLR-ECNRQEVN--AVVL-----LYMATQISSAME 127
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYA 627
           YL    KK  +H DL   N L+  + +  V DFGL+R +         +  G K  + + 
Sbjct: 128 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAPAGAKFPIKWT 181
Query: 628 APE 630
           APE
Sbjct: 182 APE 184

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 22/183 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G +G VY+G+       VAVK L       ++ F+ E   ++ I+H NLV+++  C+
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 509 SSD-FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F       ++ EFM +G+L  +L  E    ++N    +L     L +A  ++SA+E
Sbjct: 93  REPPFY------IITEFMTYGNLLDYLR-ECNRQEVN--AVVL-----LYMATQISSAME 138
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYA 627
           YL    KK  +H DL   N L+  + +  V DFGL+R +         +  G K  + + 
Sbjct: 139 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWT 192
Query: 628 APE 630
           APE
Sbjct: 193 APE 195

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 22/183 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G +G VY+G+       VAVK L       ++ F+ E   ++ I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 509 SSD-FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F       ++ EFM +G+L  +L  E    ++N    +L     L +A  ++SA+E
Sbjct: 85  REPPFY------IITEFMTYGNLLDYLR-ECNRQEVN--AVVL-----LYMATQISSAME 130
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYA 627
           YL    KK  +H DL   N L+  + +  V DFGL+R +         +  G K  + + 
Sbjct: 131 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTXTAHAGAKFPIKWT 184
Query: 628 APE 630
           APE
Sbjct: 185 APE 187

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 87/185 (47%), Gaps = 28/185 (15%)
Query: 449 IGTGSFGSVYKGI-LDPDQTVVAVKVLFLHQRGALKS--FMAECEALRNIRHRNLVKIIT 505
           IG+G FG V+ G  L+ D+  VA+K +   + G++    F+ E E +  + H  LV++  
Sbjct: 35  IGSGQFGLVHLGYWLNKDK--VAIKTI---KEGSMSEDDFIEEAEVMMKLSHPKLVQLYG 89
Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
            C            LV+EFM HG L         SD L     + +    L + ++V   
Sbjct: 90  VCLE-----QAPICLVFEFMEHGCL---------SDYLRTQRGLFAAETLLGMCLDVCEG 135
Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG 625
           + YL   C   ++H DL   N L+  + +  V DFG+TRF   V+     SS G K  V 
Sbjct: 136 MAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSSTGTKFPVK 189
Query: 626 YAAPE 630
           +A+PE
Sbjct: 190 WASPE 194

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 22/183 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G +G VY+G+       VAVK L       ++ F+ E   ++ I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 509 SSD-FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F       ++ EFM +G+L  +L  E    ++N    +L     L +A  ++SA+E
Sbjct: 80  REPPFY------IITEFMTYGNLLDYLR-ECNRQEVN--AVVL-----LYMATQISSAME 125
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYA 627
           YL    KK  +H DL   N L+  + +  V DFGL+R +         +  G K  + + 
Sbjct: 126 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWT 179
Query: 628 APE 630
           APE
Sbjct: 180 APE 182

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 22/183 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G +G VY+G+       VAVK L       ++ F+ E   ++ I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 509 SSD-FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F       ++ EFM +G+L  +L  E    ++N    +L     L +A  ++SA+E
Sbjct: 85  REPPFY------IITEFMTYGNLLDYLR-ECNRQEVN--AVVL-----LYMATQISSAME 130
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYA 627
           YL    KK  +H DL   N L+  + +  V DFGL+R +         +  G K  + + 
Sbjct: 131 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWT 184
Query: 628 APE 630
           APE
Sbjct: 185 APE 187

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 22/183 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G +G VY+G+       VAVK L       ++ F+ E   ++ I+H NLV+++  C+
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 509 SSD-FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F       ++ EFM +G+L  +L  E    ++N    +L     L +A  ++SA+E
Sbjct: 84  REPPFY------IITEFMTYGNLLDYLR-ECNRQEVN--AVVL-----LYMATQISSAME 129
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYA 627
           YL    KK  +H DL   N L+  + +  V DFGL+R +         +  G K  + + 
Sbjct: 130 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWT 183
Query: 628 APE 630
           APE
Sbjct: 184 APE 186

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 22/183 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G +G VY+G+       VAVK L       ++ F+ E   ++ I+H NLV+++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 509 SSD-FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F       ++ EFM +G+L  +L  E    ++N    +L     L +A  ++SA+E
Sbjct: 82  REPPFY------IITEFMTYGNLLDYLR-ECNRQEVN--AVVL-----LYMATQISSAME 127
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYA 627
           YL    KK  +H DL   N L+  + +  V DFGL+R +         +  G K  + + 
Sbjct: 128 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWT 181
Query: 628 APE 630
           APE
Sbjct: 182 APE 184

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 22/183 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G +G VY+G+       VAVK L       ++ F+ E   ++ I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 509 SSD-FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F       ++ EFM +G+L  +L  E    ++N    +L     L +A  ++SA+E
Sbjct: 85  REPPFY------IITEFMTYGNLLDYLR-ECNRQEVN--AVVL-----LYMATQISSAME 130
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYA 627
           YL    KK  +H DL   N L+  + +  V DFGL+R +         +  G K  + + 
Sbjct: 131 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWT 184
Query: 628 APE 630
           APE
Sbjct: 185 APE 187

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 22/183 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G +G VY+G+       VAVK L       ++ F+ E   ++ I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 509 SSD-FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F       ++ EFM +G+L  +L  E    ++N    +L     L +A  ++SA+E
Sbjct: 80  REPPFY------IITEFMTYGNLLDYLR-ECNRQEVN--AVVL-----LYMATQISSAME 125
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYA 627
           YL    KK  +H DL   N L+  + +  V DFGL+R +         +  G K  + + 
Sbjct: 126 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWT 179
Query: 628 APE 630
           APE
Sbjct: 180 APE 182

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 22/183 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G +G VY+G+       VAVK L       ++ F+ E   ++ I+H NLV+++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 509 SSD-FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F       ++ EFM +G+L  +L  E    ++N    +L     L +A  ++SA+E
Sbjct: 82  REPPFY------IITEFMTYGNLLDYLR-ECNRQEVN--AVVL-----LYMATQISSAME 127
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYA 627
           YL    KK  +H DL   N L+  + +  V DFGL+R +         +  G K  + + 
Sbjct: 128 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWT 181
Query: 628 APE 630
           APE
Sbjct: 182 APE 184

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/190 (33%), Positives = 92/190 (48%), Gaps = 27/190 (14%)
Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLF----LHQRGALKSFMAECEALRNIRHRNLVK 502
           N +G G FG VYKG ++   T VAVK L     +      + F  E + +   +H NLV+
Sbjct: 37  NKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++   S     G+D   LVY +M +GSL   L        L+ +P  LS+  R  IA   
Sbjct: 95  LLGFSSD----GDDL-CLVYVYMPNGSLLDRLSC------LDGTPP-LSWHMRCKIAQGA 142
Query: 563 ASALEYLH--HHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
           A+ + +LH  HH     +H D+K +N+LLD    A + DFGL R   +   +   S +  
Sbjct: 143 ANGINFLHENHH-----IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRI-- 195
Query: 621 KGTVGYAAPE 630
            GT  Y APE
Sbjct: 196 VGTTAYMAPE 205

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 88/183 (48%), Gaps = 22/183 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G +G VY+G+       VAVK L       ++ F+ E   ++ I+H NLV+++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 509 SSD-FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F       ++ EFM +G+L  +L   +  +        +S +  L +A  ++SA+E
Sbjct: 78  REPPFY------IITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAME 123
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYA 627
           YL    KK  +H DL   N L+  + +  V DFGL+R +         +  G K  + + 
Sbjct: 124 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTFTAHAGAKFPIKWT 177
Query: 628 APE 630
           APE
Sbjct: 178 APE 180

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 26/187 (13%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VA+K L   + G +  ++F+ E + ++ +RH  LV++   
Sbjct: 16  LGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 71
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S           +V E+M  GSL  +L  E+           L   Q +++A  +AS +
Sbjct: 72  VSEEPI------XIVTEYMSKGSLLDFLKGETGK--------YLRLPQLVDMAAQIASGM 117
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            Y+    +   VH DL+ +N+L+  +++  V DFGL R I +   +   +  G K  + +
Sbjct: 118 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED---NEXTARQGAKFPIKW 171
Query: 627 AAPEYGM 633
            APE  +
Sbjct: 172 TAPEAAL 178

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 88/185 (47%), Gaps = 28/185 (15%)
Query: 449 IGTGSFGSVYKGI-LDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIIT 505
           IG+G FG V+ G  L+ D+  VA+K +   + GA+  + F+ E E +  + H  LV++  
Sbjct: 15  IGSGQFGLVHLGYWLNKDK--VAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
            C            LV+EFM HG L         SD L     + +    L + ++V   
Sbjct: 70  VCLE-----QAPICLVFEFMEHGCL---------SDYLRTQRGLFAAETLLGMCLDVCEG 115
Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG 625
           + YL    +  ++H DL   N L+  + +  V DFG+TRF   V+     SS G K  V 
Sbjct: 116 MAYLE---EASVIHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSSTGTKFPVK 169
Query: 626 YAAPE 630
           +A+PE
Sbjct: 170 WASPE 174

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 88/192 (45%), Gaps = 25/192 (13%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIRHR 498
           G  +    IG+GSFG+VYKG    D   VAVK+L +       L++F  E   LR  RH 
Sbjct: 36  GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 92
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           N++  +   +          A+V ++    SL   LH            +    ++ ++I
Sbjct: 93  NILLFMGYSTKPQL------AIVTQWCEGSSLYHHLH---------IIETKFEMIKLIDI 137
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
           A   A  ++YLH    K I+H DLK +N+ L  D+   +GDFGL         S+Q    
Sbjct: 138 ARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ- 193
Query: 619 GLKGTVGYAAPE 630
            L G++ + APE
Sbjct: 194 -LSGSILWMAPE 204

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 88/192 (45%), Gaps = 25/192 (13%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIRHR 498
           G  +    IG+GSFG+VYKG    D   VAVK+L +       L++F  E   LR  RH 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           N++  +   ++         A+V ++    SL   LH                 ++ ++I
Sbjct: 65  NILLFMGYSTAPQL------AIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDI 109
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
           A   A  ++YLH    K I+H DLK +N+ L  D+   +GDFGL         S+Q    
Sbjct: 110 ARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ- 165
Query: 619 GLKGTVGYAAPE 630
            L G++ + APE
Sbjct: 166 -LSGSILWMAPE 176

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 88/182 (48%), Gaps = 20/182 (10%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G +G VY+G+       VAVK L       ++ F+ E   ++ I+H NLV+++  C+
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
                   F  ++ EFM +G+L  +L   +  +        +S +  L +A  ++SA+EY
Sbjct: 287 REP----PF-YIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEY 333
Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           L    KK  +H +L   N L+  + +  V DFGL+R +         +  G K  + + A
Sbjct: 334 LE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTA 387
Query: 629 PE 630
           PE
Sbjct: 388 PE 389

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 88/192 (45%), Gaps = 25/192 (13%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIRHR 498
           G  +    IG+GSFG+VYKG    D   VAVK+L +       L++F  E   LR  RH 
Sbjct: 35  GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 91
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           N++  +   +          A+V ++    SL   LH            +    ++ ++I
Sbjct: 92  NILLFMGYSTKPQL------AIVTQWCEGSSLYHHLH---------IIETKFEMIKLIDI 136
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
           A   A  ++YLH    K I+H DLK +N+ L  D+   +GDFGL         S+Q    
Sbjct: 137 ARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ- 192
Query: 619 GLKGTVGYAAPE 630
            L G++ + APE
Sbjct: 193 -LSGSILWMAPE 203

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 26/187 (13%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VA+K L   + G +  ++F+ E + ++ +RH  LV++   
Sbjct: 275 LGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S           +V E+M  GSL  +L  E+           L   Q +++A  +AS +
Sbjct: 331 VSEEPIY------IVTEYMSKGSLLDFLKGETGK--------YLRLPQLVDMAAQIASGM 376
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            Y+    +   VH DL+ +N+L+  +++  V DFGL R I +   +   +  G K  + +
Sbjct: 377 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKW 430
Query: 627 AAPEYGM 633
            APE  +
Sbjct: 431 TAPEAAL 437

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 87/192 (45%), Gaps = 25/192 (13%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIRHR 498
           G  +    IG+GSFG+VYKG    D   VAVK+L +       L++F  E   LR  RH 
Sbjct: 13  GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 69
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           N++  +   +          A+V ++    SL   LH                 ++ ++I
Sbjct: 70  NILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDI 114
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
           A   A  ++YLH    K I+H DLK +N+ L  D+   +GDFGL         S+Q    
Sbjct: 115 ARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ- 170
Query: 619 GLKGTVGYAAPE 630
            L G++ + APE
Sbjct: 171 -LSGSILWMAPE 181

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 89/184 (48%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VA+K L   + G +  ++F+ E + ++ +RH  LV++   
Sbjct: 192 LGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S           +V E+M  GSL  +L  E+           L   Q +++A  +AS +
Sbjct: 248 VSEEPI------YIVTEYMSKGSLLDFLKGETGK--------YLRLPQLVDMAAQIASGM 293
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            Y+    +   VH DL+ +N+L+  +++  V DFGL R I +   +   +  G K  + +
Sbjct: 294 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKW 347
Query: 627 AAPE 630
            APE
Sbjct: 348 TAPE 351

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 87/192 (45%), Gaps = 25/192 (13%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIRHR 498
           G  +    IG+GSFG+VYKG    D   VAVK+L +       L++F  E   LR  RH 
Sbjct: 13  GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 69
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           N++  +   +          A+V ++    SL   LH                 ++ ++I
Sbjct: 70  NILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDI 114
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
           A   A  ++YLH    K I+H DLK +N+ L  D+   +GDFGL         S+Q    
Sbjct: 115 ARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ- 170
Query: 619 GLKGTVGYAAPE 630
            L G++ + APE
Sbjct: 171 -LSGSILWMAPE 181

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 26/187 (13%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VA+K L   + G +  ++F+ E + ++ +RH  LV++   
Sbjct: 192 LGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S           +V E+M  GSL  +L  E+           L   Q +++A  +AS +
Sbjct: 248 VSEEPI------YIVTEYMSKGSLLDFLKGETGK--------YLRLPQLVDMAAQIASGM 293
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            Y+    +   VH DL+ +N+L+  +++  V DFGL R I +   +   +  G K  + +
Sbjct: 294 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKW 347
Query: 627 AAPEYGM 633
            APE  +
Sbjct: 348 TAPEAAL 354

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 87/192 (45%), Gaps = 25/192 (13%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIRHR 498
           G  +    IG+GSFG+VYKG    D   VAVK+L +       L++F  E   LR  RH 
Sbjct: 10  GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 66
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           N++  +   +          A+V ++    SL   LH                 ++ ++I
Sbjct: 67  NILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDI 111
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
           A   A  ++YLH    K I+H DLK +N+ L  D+   +GDFGL         S+Q    
Sbjct: 112 ARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ- 167
Query: 619 GLKGTVGYAAPE 630
            L G++ + APE
Sbjct: 168 -LSGSILWMAPE 178

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 88/184 (47%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VA+K L   + G +  ++F+ E + ++ IRH  LV++   
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKIRHEKLVQLYAV 81
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S           +V E+M  GSL  +L  E            L   Q +++A  +AS +
Sbjct: 82  VSEEPI------YIVTEYMSKGSLLDFLKGEMGK--------YLRLPQLVDMAAQIASGM 127
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            Y+    +   VH DL+ +N+L+  +++  V DFGL R I +   +   +  G K  + +
Sbjct: 128 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKW 181
Query: 627 AAPE 630
            APE
Sbjct: 182 TAPE 185

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 87/192 (45%), Gaps = 25/192 (13%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIRHR 498
           G  +    IG+GSFG+VYKG    D   VAVK+L +       L++F  E   LR  RH 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           N++  +   +          A+V ++    SL   LH                 ++ ++I
Sbjct: 65  NILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDI 109
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
           A   A  ++YLH    K I+H DLK +N+ L  D+   +GDFGL         S+Q    
Sbjct: 110 ARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ- 165
Query: 619 GLKGTVGYAAPE 630
            L G++ + APE
Sbjct: 166 -LSGSILWMAPE 176

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 88/182 (48%), Gaps = 20/182 (10%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G +G VY+G+       VAVK L       ++ F+ E   ++ I+H NLV+++  C+
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
                   F  ++ EFM +G+L  +L  E    ++N        +  L +A  ++SA+EY
Sbjct: 326 REP----PF-YIITEFMTYGNLLDYLR-ECNRQEVN-------AVVLLYMATQISSAMEY 372
Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           L    KK  +H +L   N L+  + +  V DFGL+R +         +  G K  + + A
Sbjct: 373 LE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTA 426
Query: 629 PE 630
           PE
Sbjct: 427 PE 428

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 89/184 (48%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VA+K L   + G +  ++F+ E + ++ +RH  LV++   
Sbjct: 19  LGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 74
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S           +V E+M  GSL  +L  E+           L   Q +++A  +AS +
Sbjct: 75  VSEEPIY------IVTEYMSKGSLLDFLKGETGK--------YLRLPQLVDMAAQIASGM 120
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            Y+    +   VH DL+ +N+L+  +++  V DFGL R I +   +   +  G K  + +
Sbjct: 121 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKW 174
Query: 627 AAPE 630
            APE
Sbjct: 175 TAPE 178

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/190 (33%), Positives = 91/190 (47%), Gaps = 27/190 (14%)
Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLF----LHQRGALKSFMAECEALRNIRHRNLVK 502
           N +G G FG VYKG ++   T VAVK L     +      + F  E + +   +H NLV+
Sbjct: 37  NKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++   S     G+D   LVY +M +GSL   L        L+ +P  LS+  R  IA   
Sbjct: 95  LLGFSSD----GDDL-CLVYVYMPNGSLLDRLSC------LDGTPP-LSWHMRCKIAQGA 142
Query: 563 ASALEYLH--HHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
           A+ + +LH  HH     +H D+K +N+LLD    A + DFGL R   +   +       +
Sbjct: 143 ANGINFLHENHH-----IHRDIKSANILLDEAFTAKISDFGLARASEKF--AQTVMXXRI 195
Query: 621 KGTVGYAAPE 630
            GT  Y APE
Sbjct: 196 VGTTAYMAPE 205

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 87/192 (45%), Gaps = 25/192 (13%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIRHR 498
           G  +    IG+GSFG+VYKG    D   VAVK+L +       L++F  E   LR  RH 
Sbjct: 12  GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 68
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           N++  +   +          A+V ++    SL   LH          S +     + ++I
Sbjct: 69  NILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHA---------SETKFEMKKLIDI 113
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
           A   A  ++YLH    K I+H DLK +N+ L  D    +GDFGL         S+Q    
Sbjct: 114 ARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQ- 169
Query: 619 GLKGTVGYAAPE 630
            L G++ + APE
Sbjct: 170 -LSGSILWMAPE 180

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 88/192 (45%), Gaps = 25/192 (13%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIRHR 498
           G  +    IG+GSFG+VYKG    D   VAVK+L +       L++F  E   LR  RH 
Sbjct: 36  GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 92
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           N++  +   +          A+V ++    SL   LH            +    ++ ++I
Sbjct: 93  NILLFMGYSTKPQL------AIVTQWCEGSSLYHHLH---------IIETKFEMIKLIDI 137
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
           A   A  ++YLH    K I+H DLK +N+ L  D+   +GDFGL         S+Q    
Sbjct: 138 ARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ- 193
Query: 619 GLKGTVGYAAPE 630
            L G++ + APE
Sbjct: 194 -LSGSILWMAPE 204

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 90/184 (48%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VA+K L   + G +  ++F+ E + ++ +RH  LV++   
Sbjct: 23  LGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S           +V E+M+ GSL  +L  E+           L   Q ++++  +AS +
Sbjct: 79  VSEEPI------YIVTEYMNKGSLLDFLKGETGK--------YLRLPQLVDMSAQIASGM 124
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            Y+    +   VH DL+ +N+L+  +++  V DFGL R I +   +   +  G K  + +
Sbjct: 125 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED---NEWTARQGAKFPIKW 178
Query: 627 AAPE 630
            APE
Sbjct: 179 TAPE 182

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/190 (33%), Positives = 91/190 (47%), Gaps = 27/190 (14%)
Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLF----LHQRGALKSFMAECEALRNIRHRNLVK 502
           N +G G FG VYKG ++   T VAVK L     +      + F  E + +   +H NLV+
Sbjct: 31  NKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 88
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++   S     G+D   LVY +M +GSL   L        L+ +P  LS+  R  IA   
Sbjct: 89  LLGFSSD----GDDL-CLVYVYMPNGSLLDRLSC------LDGTPP-LSWHMRCKIAQGA 136
Query: 563 ASALEYLH--HHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
           A+ + +LH  HH     +H D+K +N+LLD    A + DFGL R   +   +       +
Sbjct: 137 ANGINFLHENHH-----IHRDIKSANILLDEAFTAKISDFGLARASEKF--AQXVMXXRI 189
Query: 621 KGTVGYAAPE 630
            GT  Y APE
Sbjct: 190 VGTTAYMAPE 199

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 89/184 (48%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VA+K L   + G +  ++F+ E + ++ +RH  LV++   
Sbjct: 192 LGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S           +V E+M  GSL  +L  E+           L   Q +++A  +AS +
Sbjct: 248 VSEEPI------YIVGEYMSKGSLLDFLKGETGK--------YLRLPQLVDMAAQIASGM 293
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            Y+    +   VH DL+ +N+L+  +++  V DFGL R I +   +   +  G K  + +
Sbjct: 294 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKW 347
Query: 627 AAPE 630
            APE
Sbjct: 348 TAPE 351

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 88/192 (45%), Gaps = 25/192 (13%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIRHR 498
           G  +    IG+GSFG+VYKG    D   VAVK+L +       L++F  E   LR  RH 
Sbjct: 28  GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 84
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           N++  +   +          A+V ++    SL   LH            +    ++ ++I
Sbjct: 85  NILLFMGYSTKPQL------AIVTQWCEGSSLYHHLH---------IIETKFEMIKLIDI 129
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
           A   A  ++YLH    K I+H DLK +N+ L  D+   +GDFGL         S+Q    
Sbjct: 130 ARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ- 185
Query: 619 GLKGTVGYAAPE 630
            L G++ + APE
Sbjct: 186 -LSGSILWMAPE 196

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 90/184 (48%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VA+K L   + G +  ++F+ E + ++ +RH  LV++   
Sbjct: 23  LGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S           +V E+M+ GSL  +L  E+           L   Q ++++  +AS +
Sbjct: 79  VSEEPI------YIVTEYMNKGSLLDFLKGETGK--------YLRLPQLVDMSAQIASGM 124
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            Y+    +   VH DL+ +N+L+  +++  V DFGL R I +   +   +  G K  + +
Sbjct: 125 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKW 178
Query: 627 AAPE 630
            APE
Sbjct: 179 TAPE 182

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 87/183 (47%), Gaps = 22/183 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G +G VY G+       VAVK L       ++ F+ E   ++ I+H NLV+++  C+
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 509 -SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F       +V E+M +G+L  +L   +  +        ++ +  L +A  ++SA+E
Sbjct: 99  LEPPFY------IVTEYMPYGNLLDYLRECNREE--------VTAVVLLYMATQISSAME 144
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYA 627
           YL    KK  +H DL   N L+  + +  V DFGL+R +         +  G K  + + 
Sbjct: 145 YLE---KKNFIHRDLAARNCLVGENHVVKVADFGLSRLM---TGDTYTAHAGAKFPIKWT 198
Query: 628 APE 630
           APE
Sbjct: 199 APE 201

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VA+K L   + G +  ++F+ E + ++ +RH  LV++   
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S           +V E+M  GSL  +L  E            L   Q +++A  +AS +
Sbjct: 82  VSEEPI------YIVIEYMSKGSLLDFLKGEMGK--------YLRLPQLVDMAAQIASGM 127
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            Y+    +   VH DL+ +N+L+  +++  V DFGL R I +   +   +  G K  + +
Sbjct: 128 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED---NEXTARQGAKFPIKW 181
Query: 627 AAPE 630
            APE
Sbjct: 182 TAPE 185

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 88/192 (45%), Gaps = 25/192 (13%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIRHR 498
           G  +    IG+GSFG+VYKG    D   VAVK+L +       L++F  E   LR  RH 
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           N++  +   ++         A+V ++    SL   LH          S +     + ++I
Sbjct: 81  NILLFMGYSTAPQL------AIVTQWCEGSSLYHHLHA---------SETKFEMKKLIDI 125
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
           A   A  ++YLH    K I+H DLK +N+ L  D    +GDFGL         S+Q    
Sbjct: 126 ARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ- 181
Query: 619 GLKGTVGYAAPE 630
            L G++ + APE
Sbjct: 182 -LSGSILWMAPE 192

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 87/192 (45%), Gaps = 25/192 (13%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIRHR 498
           G  +    IG+GSFG+VYKG    D   VAVK+L +       L++F  E   LR  RH 
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           N++  +   +          A+V ++    SL   LH          S +     + ++I
Sbjct: 81  NILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHA---------SETKFEMKKLIDI 125
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
           A   A  ++YLH    K I+H DLK +N+ L  D    +GDFGL         S+Q    
Sbjct: 126 ARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ- 181
Query: 619 GLKGTVGYAAPE 630
            L G++ + APE
Sbjct: 182 -LSGSILWMAPE 192

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 87/192 (45%), Gaps = 25/192 (13%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIRHR 498
           G  +    IG+GSFG+VYKG    D   VAVK+L +       L++F  E   LR  RH 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           N++  +   +          A+V ++    SL   LH                 ++ ++I
Sbjct: 65  NILLFMGYSTKPQL------AIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDI 109
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
           A   A  ++YLH    K I+H DLK +N+ L  D+   +GDFGL         S+Q    
Sbjct: 110 ARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ- 165
Query: 619 GLKGTVGYAAPE 630
            L G++ + APE
Sbjct: 166 -LSGSILWMAPE 176

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/174 (31%), Positives = 80/174 (45%), Gaps = 33/174 (18%)
Query: 449 IGTGSFGSVYKGI---LDP--DQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKI 503
           +G G+FG V+      L P  D+ +VAVK L      A K F  E E L N++H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWL-------------HPESASDDLNYSPSIL 550
              C   D        +V+E+M HG L  +L              P  A  +L  S    
Sbjct: 83  YGVCGDGDPL-----IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS---- 133
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
              Q L+IA  +AS + YL     +  VH DL   N L+  +++  +GDFG++R
Sbjct: 134 ---QMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VA+K L   + G +  ++F+ E + ++ +RH  LV++   
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S           +V E+M  GSL  +L  E            L   Q +++A  +AS +
Sbjct: 82  VSEEPI------YIVIEYMSKGSLLDFLKGEMGK--------YLRLPQLVDMAAQIASGM 127
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            Y+    +   VH DL+ +N+L+  +++  V DFGL R I +   +   +  G K  + +
Sbjct: 128 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKW 181
Query: 627 AAPE 630
            APE
Sbjct: 182 TAPE 185

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VA+K L   + G +  ++F+ E + ++ +RH  LV++   
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S           +V E+M  GSL  +L  E            L   Q +++A  +AS +
Sbjct: 82  VSEEPI------YIVTEYMSKGSLLDFLKGEMGK--------YLRLPQLVDMAAQIASGM 127
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            Y+    +   VH DL+ +N+L+  +++  V DFGL R I +   +   +  G K  + +
Sbjct: 128 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKW 181
Query: 627 AAPE 630
            APE
Sbjct: 182 TAPE 185

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 82/184 (44%), Gaps = 25/184 (13%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIRHRNLVKIITA 506
           IG+GSFG+VYKG    D   VAVK+L +        ++F  E   LR  RH N++  +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFM-- 98
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
                +   D  A+V ++    SL   LH +                Q ++IA   A  +
Sbjct: 99  ----GYMTKDNLAIVTQWCEGSSLYKHLHVQETK---------FQMFQLIDIARQTAQGM 145
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
           +YLH    K I+H D+K +N+ L   +   +GDFGL         S Q       G+V +
Sbjct: 146 DYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQP--TGSVLW 200
Query: 627 AAPE 630
            APE
Sbjct: 201 MAPE 204

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VA+K L   + G +  ++F+ E + ++ +RH  LV++   
Sbjct: 17  LGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 72
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S           +V E+M  GSL  +L  E            L   Q +++A  +AS +
Sbjct: 73  VSEEPI------YIVTEYMSKGSLLDFLKGEMGK--------YLRLPQLVDMAAQIASGM 118
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            Y+    +   VH DL+ +N+L+  +++  V DFGL R I +   +   +  G K  + +
Sbjct: 119 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKW 172
Query: 627 AAPE 630
            APE
Sbjct: 173 TAPE 176

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VA+K L   + G +  ++F+ E + ++ +RH  LV++   
Sbjct: 15  LGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 70
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S           +V E+M  GSL  +L  E            L   Q +++A  +AS +
Sbjct: 71  VSEEPIY------IVTEYMSKGSLLDFLKGEMGK--------YLRLPQLVDMAAQIASGM 116
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            Y+    +   VH DL+ +N+L+  +++  V DFGL R I +   +   +  G K  + +
Sbjct: 117 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKW 170
Query: 627 AAPE 630
            APE
Sbjct: 171 TAPE 174

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VA+K L   + G +  ++F+ E + ++ +RH  LV++   
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S           +V E+M  GSL  +L  E            L   Q +++A  +AS +
Sbjct: 82  VSEEPI------YIVCEYMSKGSLLDFLKGEMGK--------YLRLPQLVDMAAQIASGM 127
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            Y+    +   VH DL+ +N+L+  +++  V DFGL R I +   +   +  G K  + +
Sbjct: 128 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKW 181
Query: 627 AAPE 630
            APE
Sbjct: 182 TAPE 185

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 32/197 (16%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +GTG FG V  G     Q  VA+K++   + G++    F+ E + + N+ H  LV++   
Sbjct: 32  LGTGQFGVVKYGKWR-GQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSI---LSFLQRLNIAINVA 563
           C+    Q   F  ++ E+M +G L            LNY   +       Q L +  +V 
Sbjct: 88  CTK---QRPIF--IITEYMANGCL------------LNYLREMRHRFQTQQLLEMCKDVC 130
Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
            A+EYL     KQ +H DL   N L+++  +  V DFGL+R+   V+   + SSVG K  
Sbjct: 131 EAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY---VLDDEETSSVGSKFP 184
Query: 624 VGYAAPEYGMGSQVSTN 640
           V ++ PE  M S+ S+ 
Sbjct: 185 VRWSPPEVLMYSKFSSK 201

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 18/168 (10%)
Query: 449 IGTGSFGSVYKG-----ILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKI 503
           +G G+FG V+       + + D+ +VAVK L      A + F  E E L  ++H+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDL-----NYSPSILSFLQRLNI 558
              C+    +G     +V+E+M HG L  +L        L     + +P  L   Q L +
Sbjct: 109 FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           A  VA+ + YL        VH DL   N L+   ++  +GDFG++R I
Sbjct: 164 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI 208

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 87/184 (47%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VA+K L   + G +  ++F+ E + ++ +RH  LV++   
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S           +V E+M  GSL  +L  E            L   Q +++A  +AS +
Sbjct: 82  VSEEPI------YIVTEYMSKGSLLDFLKGEMGK--------YLRLPQLVDMAAQIASGM 127
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            Y+    +   VH DL  +N+L+  +++  V DFGL R I +   +   +  G K  + +
Sbjct: 128 AYVE---RMNYVHRDLAAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKW 181
Query: 627 AAPE 630
            APE
Sbjct: 182 TAPE 185

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VA+K L   + G +  ++F+ E + ++ +RH  LV++   
Sbjct: 193 LGQGCFGEVWMGTWN-GTTRVAIKTL---KPGNMSPEAFLQEAQVMKKLRHEKLVQLYAV 248
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S           +V E+M  GSL  +L  E            L   Q +++A  +AS +
Sbjct: 249 VSEEPI------YIVTEYMSKGSLLDFLKGEMGK--------YLRLPQLVDMAAQIASGM 294
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            Y+    +   VH DL+ +N+L+  +++  V DFGL R I +   +   +  G K  + +
Sbjct: 295 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLGRLIED---NEYTARQGAKFPIKW 348
Query: 627 AAPE 630
            APE
Sbjct: 349 TAPE 352

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 87/184 (47%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VA+K L   + G +  ++F+ E + ++ +RH  LV++   
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S           +V E+M  G L  +L  E            L   Q +++A  +AS +
Sbjct: 82  VSEEPI------YIVMEYMSKGCLLDFLKGEMGK--------YLRLPQLVDMAAQIASGM 127
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            Y+    +   VH DL+ +N+L+  +++  V DFGL R I +   +   +  G K  + +
Sbjct: 128 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKW 181
Query: 627 AAPE 630
            APE
Sbjct: 182 TAPE 185

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 87/184 (47%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VA+K L   + G +  ++F+ E + ++ +RH  LV++   
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S           +V E+M  G L  +L  E            L   Q +++A  +AS +
Sbjct: 82  VSEEPI------YIVTEYMSKGCLLDFLKGEMGK--------YLRLPQLVDMAAQIASGM 127
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            Y+    +   VH DL+ +N+L+  +++  V DFGL R I +   +   +  G K  + +
Sbjct: 128 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKW 181
Query: 627 AAPE 630
            APE
Sbjct: 182 TAPE 185

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 18/168 (10%)
Query: 449 IGTGSFGSVYKG-----ILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKI 503
           +G G+FG V+       + + D+ +VAVK L      A + F  E E L  ++H+++V+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDL-----NYSPSILSFLQRLNI 558
              C+    +G     +V+E+M HG L  +L        L     + +P  L   Q L +
Sbjct: 80  FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           A  VA+ + YL        VH DL   N L+   ++  +GDFG++R I
Sbjct: 135 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI 179

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 18/168 (10%)
Query: 449 IGTGSFGSVYKG-----ILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKI 503
           +G G+FG V+       + + D+ +VAVK L      A + F  E E L  ++H+++V+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDL-----NYSPSILSFLQRLNI 558
              C+    +G     +V+E+M HG L  +L        L     + +P  L   Q L +
Sbjct: 86  FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           A  VA+ + YL        VH DL   N L+   ++  +GDFG++R I
Sbjct: 141 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI 185

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 91/193 (47%), Gaps = 21/193 (10%)
Query: 449 IGTGSFGSVYKGILDP--DQT--VVAVKVLFLHQRG-ALKSFMAECEALRNIRHRNLVKI 503
           +G G FG V     DP  D T   VAVK L     G  +     E E LRN+ H N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
              C+     GN  K L+ EF+  GSL+ +L P++ +         ++  Q+L  A+ + 
Sbjct: 89  KGICTEDG--GNGIK-LIMEFLPSGSLKEYL-PKNKNK--------INLKQQLKYAVQIC 136
Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
             ++YL     +Q VH DL   NVL++++    +GDFGLT+ I E               
Sbjct: 137 KGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDRDSP 192
Query: 624 VGYAAPEYGMGSQ 636
           V + APE  M S+
Sbjct: 193 VFWYAPECLMQSK 205

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 446 ANLIGTGSFGSVYKGIL---DPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRN 499
             ++G G FGSV +G L   D     VAVK + L    QR  ++ F++E   +++  H N
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR-EIEEFLSEAACMKDFSHPN 97
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           +++++  C     QG     ++  FM +G L ++L        L   P  +     L   
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL----LYSRLETGPKHIPLQTLLKFM 153
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           +++A  +EYL +   +  +H DL   N +L +DM   V DFGL++ I
Sbjct: 154 VDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKI 197

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 91/193 (47%), Gaps = 21/193 (10%)
Query: 449 IGTGSFGSVYKGILDP--DQT--VVAVKVLFLHQRG-ALKSFMAECEALRNIRHRNLVKI 503
           +G G FG V     DP  D T   VAVK L     G  +     E E LRN+ H N+VK 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
              C+     GN  K L+ EF+  GSL+ +L P++ +         ++  Q+L  A+ + 
Sbjct: 77  KGICTEDG--GNGIK-LIMEFLPSGSLKEYL-PKNKNK--------INLKQQLKYAVQIC 124
Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
             ++YL     +Q VH DL   NVL++++    +GDFGLT+ I E               
Sbjct: 125 KGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDRDSP 180
Query: 624 VGYAAPEYGMGSQ 636
           V + APE  M S+
Sbjct: 181 VFWYAPECLMQSK 193

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 32/197 (16%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +GTG FG V  G     Q  VA+K++   + G++    F+ E + + N+ H  LV++   
Sbjct: 16  LGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 71
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSI---LSFLQRLNIAINVA 563
           C+    Q   F  ++ E+M +G L            LNY   +       Q L +  +V 
Sbjct: 72  CTK---QRPIF--IITEYMANGCL------------LNYLREMRHRFQTQQLLEMCKDVC 114
Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
            A+EYL     KQ +H DL   N L+++  +  V DFGL+R+   V+     SSVG K  
Sbjct: 115 EAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY---VLDDEYTSSVGSKFP 168
Query: 624 VGYAAPEYGMGSQVSTN 640
           V ++ PE  M S+ S+ 
Sbjct: 169 VRWSPPEVLMYSKFSSK 185

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 32/197 (16%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +GTG FG V  G     Q  VA+K++   + G++    F+ E + + N+ H  LV++   
Sbjct: 32  LGTGQFGVVKYGKWR-GQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSI---LSFLQRLNIAINVA 563
           C+    Q   F  ++ E+M +G L            LNY   +       Q L +  +V 
Sbjct: 88  CTK---QRPIF--IITEYMANGCL------------LNYLREMRHRFQTQQLLEMCKDVC 130
Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
            A+EYL     KQ +H DL   N L+++  +  V DFGL+R+   V+     SSVG K  
Sbjct: 131 EAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY---VLDDEYTSSVGSKFP 184
Query: 624 VGYAAPEYGMGSQVSTN 640
           V ++ PE  M S+ S+ 
Sbjct: 185 VRWSPPEVLMYSKFSSK 201

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 32/197 (16%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +GTG FG V  G     Q  VA+K++   + G++    F+ E + + N+ H  LV++   
Sbjct: 12  LGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSI---LSFLQRLNIAINVA 563
           C+    Q   F  ++ E+M +G L            LNY   +       Q L +  +V 
Sbjct: 68  CTK---QRPIF--IITEYMANGCL------------LNYLREMRHRFQTQQLLEMCKDVC 110
Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
            A+EYL     KQ +H DL   N L+++  +  V DFGL+R+   V+     SSVG K  
Sbjct: 111 EAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY---VLDDEYTSSVGSKFP 164
Query: 624 VGYAAPEYGMGSQVSTN 640
           V ++ PE  M S+ S+ 
Sbjct: 165 VRWSPPEVLMYSKFSSK 181

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 32/197 (16%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +GTG FG V  G     Q  VA+K++   + G++    F+ E + + N+ H  LV++   
Sbjct: 17  LGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSI---LSFLQRLNIAINVA 563
           C+    Q   F  ++ E+M +G L            LNY   +       Q L +  +V 
Sbjct: 73  CTK---QRPIF--IITEYMANGCL------------LNYLREMRHRFQTQQLLEMCKDVC 115
Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
            A+EYL     KQ +H DL   N L+++  +  V DFGL+R+   V+     SSVG K  
Sbjct: 116 EAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY---VLDDEYTSSVGSKFP 169
Query: 624 VGYAAPEYGMGSQVSTN 640
           V ++ PE  M S+ S+ 
Sbjct: 170 VRWSPPEVLMYSKFSSK 186

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 32/197 (16%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +GTG FG V  G     Q  VA+K++   + G++    F+ E + + N+ H  LV++   
Sbjct: 23  LGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 78
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSI---LSFLQRLNIAINVA 563
           C+    Q   F  ++ E+M +G L            LNY   +       Q L +  +V 
Sbjct: 79  CTK---QRPIF--IITEYMANGCL------------LNYLREMRHRFQTQQLLEMCKDVC 121
Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
            A+EYL     KQ +H DL   N L+++  +  V DFGL+R+   V+     SSVG K  
Sbjct: 122 EAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY---VLDDEYTSSVGSKFP 175
Query: 624 VGYAAPEYGMGSQVSTN 640
           V ++ PE  M S+ S+ 
Sbjct: 176 VRWSPPEVLMYSKFSSK 192

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 88/191 (46%), Gaps = 27/191 (14%)
Query: 446 ANLIGTGSFGSVYKGILDPDQTVVAVKVLF----LHQRGALKSFMAECEALRNIRHRNLV 501
            N  G G FG VYKG ++   T VAVK L     +      + F  E +     +H NLV
Sbjct: 27  GNKXGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLV 84
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +++   S     G+D   LVY +  +GSL   L        L+ +P  LS+  R  IA  
Sbjct: 85  ELLGFSSD----GDDL-CLVYVYXPNGSLLDRLSC------LDGTPP-LSWHXRCKIAQG 132
Query: 562 VASALEYLH--HHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
            A+ + +LH  HH     +H D+K +N+LLD    A + DFGL R   +       S + 
Sbjct: 133 AANGINFLHENHH-----IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRI- 186
Query: 620 LKGTVGYAAPE 630
             GT  Y APE
Sbjct: 187 -VGTTAYXAPE 196

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 89/189 (47%), Gaps = 36/189 (19%)
Query: 449 IGTGSFGSV----YKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVK 502
           +G+G FG V    +KG  D     VAVK++   + G++    F  E + +  + H  LVK
Sbjct: 16  LGSGQFGVVKLGKWKGQYD-----VAVKMI---KEGSMSEDEFFQEAQTMMKLSHPKLVK 67
Query: 503 IITACSSSDFQGNDFK-ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
               CS       ++   +V E++ +G L ++L     S      PS     Q L +  +
Sbjct: 68  FYGVCS------KEYPIYIVTEYISNGCLLNYLR----SHGKGLEPS-----QLLEMCYD 112
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           V   + +L  H   Q +H DL   N L+D D+   V DFG+TR+   V+     SSVG K
Sbjct: 113 VCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRY---VLDDQYVSSVGTK 166
Query: 622 GTVGYAAPE 630
             V ++APE
Sbjct: 167 FPVKWSAPE 175

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 88/176 (50%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPD-QTV-VAVKVLFLHQRGALKS---FMAECE 490
           +LK T       ++G+G+FG+VYKGI  P+ +TV + V +  L++    K+   FM E  
Sbjct: 34  ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 92
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ H +LV+++  C S   Q      LV + M HG L  ++H        N    +L
Sbjct: 93  IMASMDHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLEYVHEHKD----NIGSQLL 142
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL    ++++VH DL   NVL+ +     + DFGL R +
Sbjct: 143 -----LNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 190

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 89/187 (47%), Gaps = 26/187 (13%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  + + T VA+K L   + G +  +SF+ E + ++ ++H  LV++   
Sbjct: 17  LGNGQFGEVWMGTWNGN-TKVAIKTL---KPGTMSPESFLEEAQIMKKLKHDKLVQLYAV 72
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S           +V E+M+ GSL  +L               L     +++A  VA+ +
Sbjct: 73  VSEEPI------YIVTEYMNKGSLLDFLKDGEGR--------ALKLPNLVDMAAQVAAGM 118
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            Y+    +   +H DL+ +N+L+ N +I  + DFGL R I +   +   +  G K  + +
Sbjct: 119 AYIE---RMNYIHRDLRSANILVGNGLICKIADFGLARLIED---NEXTARQGAKFPIKW 172
Query: 627 AAPEYGM 633
            APE  +
Sbjct: 173 TAPEAAL 179

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 88/176 (50%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPD-QTV-VAVKVLFLHQRGALKS---FMAECE 490
           +LK T       ++G+G+FG+VYKGI  P+ +TV + V +  L++    K+   FM E  
Sbjct: 11  ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 69
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ H +LV+++  C S   Q      LV + M HG L  ++H        N    +L
Sbjct: 70  IMASMDHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLEYVHEHKD----NIGSQLL 119
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL    ++++VH DL   NVL+ +     + DFGL R +
Sbjct: 120 -----LNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 167

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 30/195 (15%)
Query: 449 IGTGSFGSVYKG-----ILDPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIRHRNL 500
           +G GSFG VY+G     I    +T VAVK +  ++  +L+    F+ E   ++     ++
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHHV 79
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH---PESASDDLNYSPSILSFLQRLN 557
           V+++   S           +V E M HG L+S+L    PE+ ++     P++   +Q   
Sbjct: 80  VRLLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ--- 131
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
           +A  +A  + YL+    K+ VH DL   N ++ +D    +GDFG+TR I E     +   
Sbjct: 132 MAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK--- 185
Query: 618 VGLKG--TVGYAAPE 630
            G KG   V + APE
Sbjct: 186 -GGKGLLPVRWMAPE 199

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 93/193 (48%), Gaps = 30/193 (15%)
Query: 447 NLIGTGSFGSVYKGILDP---DQTVVAVKVL----FLHQRGALKSFMAECEALRNIRHRN 499
            +IG G FG V +G L      ++ VA+K L       QR   + F++E   +    H N
Sbjct: 22  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR---REFLSEASIMGQFEHPN 78
Query: 500 LVKIITACSSSDFQGNDFKALVY-EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           ++++    +      N    ++  EFM +G+L+S+L                + +Q + +
Sbjct: 79  IIRLEGVVT------NSMPVMILTEFMENGALDSFLRLNDGQ---------FTVIQLVGM 123
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISS-NQCSS 617
              +AS + YL    +   VH DL   N+L++++++  V DFGL+RF+ E  S   + SS
Sbjct: 124 LRGIASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSS 180
Query: 618 VGLKGTVGYAAPE 630
           +G K  + + APE
Sbjct: 181 LGGKIPIRWTAPE 193

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 30/195 (15%)
Query: 449 IGTGSFGSVYKG-----ILDPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIRHRNL 500
           +G GSFG VY+G     I    +T VAVK +  ++  +L+    F+ E   ++     ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHHV 82
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH---PESASDDLNYSPSILSFLQRLN 557
           V+++   S           +V E M HG L+S+L    PE+ ++     P++   +Q   
Sbjct: 83  VRLLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ--- 134
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
           +A  +A  + YL+    K+ VH DL   N ++ +D    +GDFG+TR I E     +   
Sbjct: 135 MAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK--- 188
Query: 618 VGLKG--TVGYAAPE 630
            G KG   V + APE
Sbjct: 189 -GGKGLLPVRWMAPE 202

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 30/195 (15%)
Query: 449 IGTGSFGSVYKG-----ILDPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIRHRNL 500
           +G GSFG VY+G     I    +T VAVK +  ++  +L+    F+ E   ++     ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHHV 82
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH---PESASDDLNYSPSILSFLQRLN 557
           V+++   S           +V E M HG L+S+L    PE+ ++     P++   +Q   
Sbjct: 83  VRLLGVVSKGQP-----TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ--- 134
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
           +A  +A  + YL+    K+ VH DL   N ++ +D    +GDFG+TR I E     +   
Sbjct: 135 MAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK--- 188
Query: 618 VGLKG--TVGYAAPE 630
            G KG   V + APE
Sbjct: 189 -GGKGLLPVRWMAPE 202

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 32/197 (16%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +GTG FG V  G     Q  VA+K++   + G++    F+ E + + N+ H  LV++   
Sbjct: 17  LGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSI---LSFLQRLNIAINVA 563
           C+    Q   F  ++ E+M +G L            LNY   +       Q L +  +V 
Sbjct: 73  CTK---QRPIF--IITEYMANGCL------------LNYLREMRHRFQTQQLLEMCKDVC 115
Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
            A+EYL     KQ +H DL   N L+++  +  V DFGL+R+   V+     SS G K  
Sbjct: 116 EAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY---VLDDEYTSSRGSKFP 169
Query: 624 VGYAAPEYGMGSQVSTN 640
           V ++ PE  M S+ S+ 
Sbjct: 170 VRWSPPEVLMYSKFSSK 186

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/165 (33%), Positives = 74/165 (44%), Gaps = 22/165 (13%)
Query: 449 IGTGSFGSVYKGILDP--DQT--VVAVKVLFLHQRGALKS-FMAECEALRNIRHRNLVKI 503
           +G G FG V     DP  D T  +VAVK L       L+S +  E E LR + H ++VK 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
              C     QG     LV E++  GSL  +L               +   Q L  A  + 
Sbjct: 76  KGCCED---QGEKSVQLVMEYVPLGSLRDYL-----------PRHCVGLAQLLLFAQQIC 121
Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
             + YLH    +  +H  L   NVLLDND +  +GDFGL + +PE
Sbjct: 122 EGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPE 163

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/165 (33%), Positives = 74/165 (44%), Gaps = 22/165 (13%)
Query: 449 IGTGSFGSVYKGILDP--DQT--VVAVKVLFLHQRGALKS-FMAECEALRNIRHRNLVKI 503
           +G G FG V     DP  D T  +VAVK L       L+S +  E E LR + H ++VK 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
              C     QG     LV E++  GSL  +L               +   Q L  A  + 
Sbjct: 77  KGCCED---QGEKSVQLVMEYVPLGSLRDYL-----------PRHCVGLAQLLLFAQQIC 122
Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
             + YLH    +  +H  L   NVLLDND +  +GDFGL + +PE
Sbjct: 123 EGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPE 164

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 30/195 (15%)
Query: 449 IGTGSFGSVYKG-----ILDPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIRHRNL 500
           +G GSFG VY+G     I    +T VAVK +  ++  +L+    F+ E   ++     ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHHV 82
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH---PESASDDLNYSPSILSFLQRLN 557
           V+++   S           +V E M HG L+S+L    PE+ ++     P++   +Q   
Sbjct: 83  VRLLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ--- 134
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
           +A  +A  + YL+    K+ VH DL   N ++ +D    +GDFG+TR I E     +   
Sbjct: 135 MAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRK--- 188
Query: 618 VGLKG--TVGYAAPE 630
            G KG   V + APE
Sbjct: 189 -GGKGLLPVRWMAPE 202

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 91/184 (49%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VAVK L   ++G++   +F+AE   ++ ++H+ LV++   
Sbjct: 27  LGAGQFGEVWMGYYN-GHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 82
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +           ++ E+M +GSL  +L   S           L+  + L++A  +A  +
Sbjct: 83  VTQEPI------YIITEYMENGSLVDFLKTPSGIK--------LTINKLLDMAAQIAEGM 128
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            ++    ++  +H DL+ +N+L+ + +   + DFGL R I +   +   +  G K  + +
Sbjct: 129 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED---NEXTAREGAKFPIKW 182
Query: 627 AAPE 630
            APE
Sbjct: 183 TAPE 186

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 30/195 (15%)
Query: 449 IGTGSFGSVYKG-----ILDPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIRHRNL 500
           +G GSFG VY+G     I    +T VAVK +  ++  +L+    F+ E   ++     ++
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHHV 81
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH---PESASDDLNYSPSILSFLQRLN 557
           V+++   S           +V E M HG L+S+L    PE+ ++     P++   +Q   
Sbjct: 82  VRLLGVVSKGQPT-----LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ--- 133
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
           +A  +A  + YL+    K+ VH DL   N ++ +D    +GDFG+TR I E     +   
Sbjct: 134 MAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK--- 187
Query: 618 VGLKG--TVGYAAPE 630
            G KG   V + APE
Sbjct: 188 -GGKGLLPVRWMAPE 201

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 91/184 (49%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VAVK L   ++G++   +F+AE   ++ ++H+ LV++   
Sbjct: 30  LGAGQFGEVWMGYYN-GHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 85
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +           ++ E+M +GSL  +L   S           L+  + L++A  +A  +
Sbjct: 86  VTQEPI------YIITEYMENGSLVDFLKTPSGIK--------LTINKLLDMAAQIAEGM 131
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            ++    ++  +H DL+ +N+L+ + +   + DFGL R I +   +   +  G K  + +
Sbjct: 132 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED---NEXTAREGAKFPIKW 185
Query: 627 AAPE 630
            APE
Sbjct: 186 TAPE 189

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 91/184 (49%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VAVK L   ++G++   +F+AE   ++ ++H+ LV++   
Sbjct: 29  LGAGQFGEVWMGYYN-GHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 84
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +           ++ E+M +GSL  +L   S           L+  + L++A  +A  +
Sbjct: 85  VTQEPI------YIITEYMENGSLVDFLKTPSGIK--------LTINKLLDMAAQIAEGM 130
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            ++    ++  +H DL+ +N+L+ + +   + DFGL R I +   +   +  G K  + +
Sbjct: 131 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED---NEXTAREGAKFPIKW 184
Query: 627 AAPE 630
            APE
Sbjct: 185 TAPE 188

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 91/184 (49%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VAVK L   ++G++   +F+AE   ++ ++H+ LV++   
Sbjct: 21  LGAGQFGEVWMGYYN-GHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +           ++ E+M +GSL  +L   S           L+  + L++A  +A  +
Sbjct: 77  VTQEPIY------IITEYMENGSLVDFLKTPSGIK--------LTINKLLDMAAQIAEGM 122
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            ++    ++  +H DL+ +N+L+ + +   + DFGL R I +   +   +  G K  + +
Sbjct: 123 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED---NEXTAREGAKFPIKW 176
Query: 627 AAPE 630
            APE
Sbjct: 177 TAPE 180

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 91/184 (49%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VAVK L   ++G++   +F+AE   ++ ++H+ LV++   
Sbjct: 23  LGAGQFGEVWMGYYN-GHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 78
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +           ++ E+M +GSL  +L   S           L+  + L++A  +A  +
Sbjct: 79  VTQEPIY------IITEYMENGSLVDFLKTPSGIK--------LTINKLLDMAAQIAEGM 124
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            ++    ++  +H DL+ +N+L+ + +   + DFGL R I +   +   +  G K  + +
Sbjct: 125 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED---NEXTAREGAKFPIKW 178
Query: 627 AAPE 630
            APE
Sbjct: 179 TAPE 182

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 91/184 (49%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VAVK L   ++G++   +F+AE   ++ ++H+ LV++   
Sbjct: 22  LGAGQFGEVWMGYYN-GHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 77
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +           ++ E+M +GSL  +L   S           L+  + L++A  +A  +
Sbjct: 78  VTQEPIY------IITEYMENGSLVDFLKTPSGIK--------LTINKLLDMAAQIAEGM 123
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            ++    ++  +H DL+ +N+L+ + +   + DFGL R I +   +   +  G K  + +
Sbjct: 124 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED---NEXTAREGAKFPIKW 177
Query: 627 AAPE 630
            APE
Sbjct: 178 TAPE 181

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 91/184 (49%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VAVK L   ++G++   +F+AE   ++ ++H+ LV++   
Sbjct: 31  LGAGQFGEVWMGYYN-GHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 86
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +           ++ E+M +GSL  +L   S           L+  + L++A  +A  +
Sbjct: 87  VTQEPI------YIITEYMENGSLVDFLKTPSGIK--------LTINKLLDMAAQIAEGM 132
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            ++    ++  +H DL+ +N+L+ + +   + DFGL R I +   +   +  G K  + +
Sbjct: 133 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED---NEYTAREGAKFPIKW 186
Query: 627 AAPE 630
            APE
Sbjct: 187 TAPE 190

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 91/184 (49%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VAVK L   ++G++   +F+AE   ++ ++H+ LV++   
Sbjct: 21  LGAGQFGEVWMGYYN-GHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +           ++ E+M +GSL  +L   S           L+  + L++A  +A  +
Sbjct: 77  VTQEPI------YIITEYMENGSLVDFLKTPSGIK--------LTINKLLDMAAQIAEGM 122
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            ++    ++  +H DL+ +N+L+ + +   + DFGL R I +   +   +  G K  + +
Sbjct: 123 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED---NEXTAREGAKFPIKW 176
Query: 627 AAPE 630
            APE
Sbjct: 177 TAPE 180

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 91/184 (49%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VAVK L   ++G++   +F+AE   ++ ++H+ LV++   
Sbjct: 27  LGAGQFGEVWMGYYN-GHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 82
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +           ++ E+M +GSL  +L   S           L+  + L++A  +A  +
Sbjct: 83  VTQEPI------YIITEYMENGSLVDFLKTPSGIK--------LTINKLLDMAAQIAEGM 128
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            ++    ++  +H DL+ +N+L+ + +   + DFGL R I +   +   +  G K  + +
Sbjct: 129 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED---NEYTAREGAKFPIKW 182
Query: 627 AAPE 630
            APE
Sbjct: 183 TAPE 186

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 91/184 (49%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VAVK L   ++G++   +F+AE   ++ ++H+ LV++   
Sbjct: 26  LGAGQFGEVWMGYYN-GHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 81
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +           ++ E+M +GSL  +L   S           L+  + L++A  +A  +
Sbjct: 82  VTQEPIY------IITEYMENGSLVDFLKTPSGIK--------LTINKLLDMAAQIAEGM 127
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            ++    ++  +H DL+ +N+L+ + +   + DFGL R I +   +   +  G K  + +
Sbjct: 128 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED---NEYTAREGAKFPIKW 181
Query: 627 AAPE 630
            APE
Sbjct: 182 TAPE 185

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 91/184 (49%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VAVK L   ++G++   +F+AE   ++ ++H+ LV++   
Sbjct: 21  LGAGQFGEVWMGYYN-GHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +           ++ E+M +GSL  +L   S           L+  + L++A  +A  +
Sbjct: 77  VTQEPIY------IITEYMENGSLVDFLKTPSGIK--------LTINKLLDMAAQIAEGM 122
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            ++    ++  +H DL+ +N+L+ + +   + DFGL R I +   +   +  G K  + +
Sbjct: 123 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED---NEYTAREGAKFPIKW 176
Query: 627 AAPE 630
            APE
Sbjct: 177 TAPE 180

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 91/184 (49%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VAVK L   ++G++   +F+AE   ++ ++H+ LV++   
Sbjct: 16  LGAGQFGEVWMGYYN-GHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 71
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +           ++ E+M +GSL  +L   S           L+  + L++A  +A  +
Sbjct: 72  VTQEPIY------IITEYMENGSLVDFLKTPSGIK--------LTINKLLDMAAQIAEGM 117
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            ++    ++  +H DL+ +N+L+ + +   + DFGL R I +   +   +  G K  + +
Sbjct: 118 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED---NEYTAREGAKFPIKW 171
Query: 627 AAPE 630
            APE
Sbjct: 172 TAPE 175

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 92/193 (47%), Gaps = 30/193 (15%)
Query: 447 NLIGTGSFGSVYKGILDP---DQTVVAVKVL----FLHQRGALKSFMAECEALRNIRHRN 499
            +IG G FG V +G L      ++ VA+K L       QR   + F++E   +    H N
Sbjct: 20  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR---REFLSEASIMGQFEHPN 76
Query: 500 LVKIITACSSSDFQGNDFKALVY-EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           ++++    +      N    ++  EFM +G+L+S+L                + +Q + +
Sbjct: 77  IIRLEGVVT------NSMPVMILTEFMENGALDSFLRLNDGQ---------FTVIQLVGM 121
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISS-NQCSS 617
              +AS + YL    +   VH DL   N+L++++++  V DFGL+RF+ E  S     SS
Sbjct: 122 LRGIASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSS 178
Query: 618 VGLKGTVGYAAPE 630
           +G K  + + APE
Sbjct: 179 LGGKIPIRWTAPE 191

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 30/195 (15%)
Query: 449 IGTGSFGSVYKG-----ILDPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIRHRNL 500
           +G GSFG VY+G     I    +T VAVK +  ++  +L+    F+ E   ++     ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHHV 82
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH---PESASDDLNYSPSILSFLQRLN 557
           V+++   S           +V E M HG L+S+L    PE+ ++     P++   +Q   
Sbjct: 83  VRLLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ--- 134
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
           +A  +A  + YL+    K+ VH DL   N ++ +D    +GDFG+TR I E     +   
Sbjct: 135 MAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK--- 188
Query: 618 VGLKG--TVGYAAPE 630
            G KG   V + APE
Sbjct: 189 -GGKGLLPVRWMAPE 202

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 98/226 (43%), Gaps = 35/226 (15%)
Query: 415 TVTSSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVL 474
           TV + +   R    LN+    LL+          IG G FG V  G  D     VAVK +
Sbjct: 176 TVAAQDEFYRSGWALNMKELKLLQT---------IGKGEFGDVMLG--DYRGNKVAVKCI 224
Query: 475 FLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWL 534
                   ++F+AE   +  +RH NLV+++        +G  +  +V E+M  GSL  +L
Sbjct: 225 --KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE--KGGLY--IVTEYMAKGSLVDYL 278
Query: 535 HPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI 594
                S        +L     L  +++V  A+EYL  +     VH DL   NVL+  D +
Sbjct: 279 RSRGRS--------VLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNV 327
Query: 595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN 640
           A V DFGLT+   E  S+     + +K T    APE     + ST 
Sbjct: 328 AKVSDFGLTK---EASSTQDTGKLPVKWT----APEALREKKFSTK 366

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 88/203 (43%), Gaps = 32/203 (15%)
Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRN--IRHRNLVKII 504
            LIG G +G+VYKG LD  +  VAVKV     R   ++F+ E    R   + H N+ + I
Sbjct: 19  ELIGRGRYGAVYKGSLD--ERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFI 73
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
                    G     LV E+  +GSL  +L   ++            ++    +A +V  
Sbjct: 74  VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD-----------WVSSCRLAHSVTR 122
Query: 565 ALEYLH------HHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT------RFIPEVISS 612
            L YLH       H K  I H DL   NVL+ ND    + DFGL+      R +      
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 613 NQCSSVGLKGTVGYAAPEYGMGS 635
           N  +++   GT+ Y APE   G+
Sbjct: 183 N--AAISEVGTIRYMAPEVLEGA 203

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 90/185 (48%), Gaps = 27/185 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  + + T VAVK L   + G +  ++F+ E   ++ ++H  LV++   
Sbjct: 20  LGAGQFGEVWMGYYN-NSTKVAVKTL---KPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 75
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +       +   ++ EFM  GSL  +L  +     L   P ++ F      +  +A  +
Sbjct: 76  VTK-----EEPIYIITEFMAKGSLLDFLKSDEGGKVL--LPKLIDF------SAQIAEGM 122
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS-VGLKGTVG 625
            Y+    +K  +H DL+ +NVL+   ++  + DFGL R    VI  N+ ++  G K  + 
Sbjct: 123 AYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLAR----VIEDNEYTAREGAKFPIK 175
Query: 626 YAAPE 630
           + APE
Sbjct: 176 WTAPE 180

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 82/187 (43%), Gaps = 23/187 (12%)
Query: 449 IGTGSFGSVYKGILDP--DQT--VVAVKVLFLHQRGALKS-FMAECEALRNIRHRNLVKI 503
           +G G FG V     DP  D T  +VAVK L        +S +  E + LR + H +++K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
              C  +   G     LV E++  GSL  +L   S           +   Q L  A  + 
Sbjct: 99  KGCCEDA---GAASLQLVMEYVPLGSLRDYLPRHS-----------IGLAQLLLFAQQIC 144
Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
             + YLH    +  +H DL   NVLLDND +  +GDFGL + +PE     +    G    
Sbjct: 145 EGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDG-DSP 200
Query: 624 VGYAAPE 630
           V + APE
Sbjct: 201 VFWYAPE 207

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 77/169 (45%), Gaps = 18/169 (10%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG-ALKSFMAECEALRNIRHRNLV 501
           F     +G G FG V++     D    A+K + L  R  A +  M E +AL  + H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 502 KIITAC----SSSDFQGNDFKALVY---EFMHHGSLESWLHPESASDDLNYSPSILSFLQ 554
           +   A     ++   Q +  K  +Y   +     +L+ W++     ++   S  +  FLQ
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 555 RLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT 603
                  +A A+E+LH    K ++H DLKPSN+    D +  VGDFGL 
Sbjct: 127 -------IAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLV 165

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 81/184 (44%), Gaps = 22/184 (11%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKS-FMAECEALRNIRHRNLVKIITAC 507
           IG G+FG V+ G L  D T+VAVK         LK+ F+ E   L+   H N+V++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
           +           +V E +  G   ++L  E A          L     L +  + A+ +E
Sbjct: 182 TQ-----KQPIYIVMELVQGGDFLTFLRTEGAR---------LRVKTLLQMVGDAAAGME 227
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT-VGY 626
           YL   C    +H DL   N L+    +  + DFG++R   E       +S GL+   V +
Sbjct: 228 YLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR---EEADGVXAASGGLRQVPVKW 281
Query: 627 AAPE 630
            APE
Sbjct: 282 TAPE 285

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 81/184 (44%), Gaps = 22/184 (11%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKS-FMAECEALRNIRHRNLVKIITAC 507
           IG G+FG V+ G L  D T+VAVK         LK+ F+ E   L+   H N+V++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
           +           +V E +  G   ++L  E A          L     L +  + A+ +E
Sbjct: 182 TQ-----KQPIYIVMELVQGGDFLTFLRTEGAR---------LRVKTLLQMVGDAAAGME 227
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT-VGY 626
           YL   C    +H DL   N L+    +  + DFG++R   E       +S GL+   V +
Sbjct: 228 YLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR---EEADGVYAASGGLRQVPVKW 281
Query: 627 AAPE 630
            APE
Sbjct: 282 TAPE 285

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 83/191 (43%), Gaps = 31/191 (16%)
Query: 449 IGTGSFGSVYKGILDP--DQT--VVAVKVLFL-----HQRGALKSFMAECEALRNIRHRN 499
           +G G FG V     DP  D T  +VAVK L       H+ G    +  E + LR + H +
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG----WKQEIDILRTLYHEH 77
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           ++K    C     QG     LV E++  GSL  +L   S           +   Q L  A
Sbjct: 78  IIKYKGCCED---QGEKSLQLVMEYVPLGSLRDYLPRHS-----------IGLAQLLLFA 123
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             +   + YLH    +  +H +L   NVLLDND +  +GDFGL + +PE     +    G
Sbjct: 124 QQICEGMAYLH---SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 180
Query: 620 LKGTVGYAAPE 630
               V + APE
Sbjct: 181 -DSPVFWYAPE 190

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/191 (30%), Positives = 83/191 (43%), Gaps = 31/191 (16%)
Query: 449 IGTGSFGSVYKGILDP--DQT--VVAVKVLFL-----HQRGALKSFMAECEALRNIRHRN 499
           +G G FG V     DP  D T  +VAVK L       H+ G    +  E + LR + H +
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG----WKQEIDILRTLYHEH 77
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           ++K    C     QG     LV E++  GSL  +L   S           +   Q L  A
Sbjct: 78  IIKYKGCCED---QGEKSLQLVMEYVPLGSLRDYLPRHS-----------IGLAQLLLFA 123
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             +   + YLH    +  +H +L   NVLLDND +  +GDFGL + +PE     +    G
Sbjct: 124 QQICEGMAYLH---AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 180
Query: 620 LKGTVGYAAPE 630
               V + APE
Sbjct: 181 -DSPVFWYAPE 190

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 87/192 (45%), Gaps = 26/192 (13%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG G FG V  G  D     VAVK +        ++F+AE   +  +RH NLV+++    
Sbjct: 14  IGKGEFGDVMLG--DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
               +G  +  +V E+M  GSL  +L     S        +L     L  +++V  A+EY
Sbjct: 70  EE--KGGLY--IVTEYMAKGSLVDYLRSRGRS--------VLGGDCLLKFSLDVCEAMEY 117
Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           L  +     VH DL   NVL+  D +A V DFGLT+   E  S+     + +K T    A
Sbjct: 118 LEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT----A 167
Query: 629 PEYGMGSQVSTN 640
           PE     + ST 
Sbjct: 168 PEALREKKFSTK 179

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 84/182 (46%), Gaps = 26/182 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG G FG V  G  D     VAVK +        ++F+AE   +  +RH NLV+++    
Sbjct: 20  IGKGEFGDVMLG--DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 75
Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
               +G  +  +V E+M  GSL  +L     S        +L     L  +++V  A+EY
Sbjct: 76  EE--KGGLY--IVTEYMAKGSLVDYLRSRGRS--------VLGGDCLLKFSLDVCEAMEY 123
Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           L  +     VH DL   NVL+  D +A V DFGLT+   E  S+     + +K T    A
Sbjct: 124 LEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT----A 173
Query: 629 PE 630
           PE
Sbjct: 174 PE 175

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 87/192 (45%), Gaps = 26/192 (13%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG G FG V  G  D     VAVK +        ++F+AE   +  +RH NLV+++    
Sbjct: 29  IGKGEFGDVMLG--DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
               +G  +  +V E+M  GSL  +L     S        +L     L  +++V  A+EY
Sbjct: 85  EE--KGGLY--IVTEYMAKGSLVDYLRSRGRS--------VLGGDCLLKFSLDVCEAMEY 132
Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           L  +     VH DL   NVL+  D +A V DFGLT+   E  S+     + +K T    A
Sbjct: 133 LEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT----A 182
Query: 629 PEYGMGSQVSTN 640
           PE     + ST 
Sbjct: 183 PEALREKKFSTK 194

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 32/210 (15%)
Query: 430 NVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMA 487
           N+ ++S+ K    + +  L+G GS+G V K        +VA+K         +  K  M 
Sbjct: 18  NLYFQSMEK----YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR 73
Query: 488 ECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSP 547
           E + L+ +RH NLV ++  C            LV+EF+ H  L          DDL   P
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRW-----YLVFEFVDHTIL----------DDLELFP 118
Query: 548 SILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI- 606
           + L +         + + + + H H    I+H D+KP N+L+    +  + DFG  R + 
Sbjct: 119 NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175
Query: 607 -PEVISSNQCSSVGLKGTVGYAAPEYGMGS 635
            P  +  ++ +      T  Y APE  +G 
Sbjct: 176 APGEVYDDEVA------TRWYRAPELLVGD 199

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 90/191 (47%), Gaps = 27/191 (14%)
Query: 447 NLIGTGSFGSVYKGILD----PDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLV 501
            +IG G FG VYKG+L       +  VA+K L   +       F+ E   +    H N++
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 502 KIITACSSSDFQGNDFKAL--VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           ++    S        +K +  + E+M +G+L+ +L  +             S LQ + + 
Sbjct: 110 RLEGVISK-------YKPMMIITEYMENGALDKFLREKDGE---------FSVLQLVGML 153
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             +A+ ++YL +      VH DL   N+L++++++  V DFGL+R + +   +   +S G
Sbjct: 154 RGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 210
Query: 620 LKGTVGYAAPE 630
            K  + + APE
Sbjct: 211 -KIPIRWTAPE 220

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 91/184 (49%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VAVK L   ++G++   +F+AE   ++ ++H+ LV++   
Sbjct: 17  LGAGQFGEVWMGYYN-GHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 72
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +           ++ E+M +GSL  +L   S           L+  + L++A  +A  +
Sbjct: 73  VTQEPIY------IITEYMENGSLVDFLKTPSGIK--------LTINKLLDMAAQIAEGM 118
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            ++    ++  +H +L+ +N+L+ + +   + DFGL R I +   +   +  G K  + +
Sbjct: 119 AFIE---ERNYIHRNLRAANILVSDTLSCKIADFGLARLIED---NEYTAREGAKFPIKW 172
Query: 627 AAPE 630
            APE
Sbjct: 173 TAPE 176

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 90/185 (48%), Gaps = 27/185 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  + + T VAVK L   + G +  ++F+ E   ++ ++H  LV++   
Sbjct: 21  LGAGQFGEVWMGYYN-NSTKVAVKTL---KPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 76
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +       +   ++ E+M  GSL  +L  +     L   P ++ F      +  +A  +
Sbjct: 77  VTR-----EEPIYIITEYMAKGSLLDFLKSDEGGKVL--LPKLIDF------SAQIAEGM 123
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS-VGLKGTVG 625
            Y+    +K  +H DL+ +NVL+   ++  + DFGL R    VI  N+ ++  G K  + 
Sbjct: 124 AYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLAR----VIEDNEYTAREGAKFPIK 176
Query: 626 YAAPE 630
           + APE
Sbjct: 177 WTAPE 181

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 30/195 (15%)
Query: 449 IGTGSFGSVYKG-----ILDPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIRHRNL 500
           +G GSFG VY+G     I    +T VAVK +  ++  +L+    F+ E   ++     ++
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHHV 83
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH---PESASDDLNYSPSILSFLQRLN 557
           V+++   S           +V E M HG L+S+L    PE+ ++     P++   +Q   
Sbjct: 84  VRLLGVVSKGQP-----TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ--- 135
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
           +A  +A  + YL+    K+ VH +L   N ++ +D    +GDFG+TR I E     +   
Sbjct: 136 MAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK--- 189
Query: 618 VGLKG--TVGYAAPE 630
            G KG   V + APE
Sbjct: 190 -GGKGLLPVRWMAPE 203

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 30/195 (15%)
Query: 449 IGTGSFGSVYKG-----ILDPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIRHRNL 500
           +G GSFG VY+G     I    +T VAVK +  ++  +L+    F+ E   ++     ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHHV 82
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH---PESASDDLNYSPSILSFLQRLN 557
           V+++   S           +V E M HG L+S+L    PE+ ++     P++   +Q   
Sbjct: 83  VRLLGVVSKGQP-----TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ--- 134
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
           +A  +A  + YL+    K+ VH +L   N ++ +D    +GDFG+TR I E     +   
Sbjct: 135 MAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK--- 188
Query: 618 VGLKG--TVGYAAPE 630
            G KG   V + APE
Sbjct: 189 -GGKGLLPVRWMAPE 202

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 24/171 (14%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIRHRNL 500
           +G GSFG VY+G+      D  +T VA+K +  ++  +++    F+ E   ++     ++
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEFNCHHV 75
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH---PESASDDLNYSPSILSFLQRLN 557
           V+++   S    QG     ++ E M  G L+S+L    PE  ++ +   PS+   +Q   
Sbjct: 76  VRLLGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ--- 127
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           +A  +A  + YL+ +   + VH DL   N ++  D    +GDFG+TR I E
Sbjct: 128 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE 175

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 89/185 (48%), Gaps = 28/185 (15%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+    +   T VAVK +   + G++  ++F+AE   ++ ++H  LVK+   
Sbjct: 23  LGAGQFGEVWMATYN-KHTKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 78
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +           ++ EFM  GSL  +L  +  S      P ++ F      +  +A  +
Sbjct: 79  VTKEPIY------IITEFMAKGSLLDFLKSDEGSK--QPLPKLIDF------SAQIAEGM 124
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS-VGLKGTVG 625
            ++    ++  +H DL+ +N+L+   ++  + DFGL R    VI  N+ ++  G K  + 
Sbjct: 125 AFIE---QRNYIHRDLRAANILVSASLVCKIADFGLAR----VIEDNEYTAREGAKFPIK 177
Query: 626 YAAPE 630
           + APE
Sbjct: 178 WTAPE 182

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 24/171 (14%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIRHRNL 500
           +G GSFG VY+G+      D  +T VA+K +  ++  +++    F+ E   ++     ++
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEFNCHHV 84
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH---PESASDDLNYSPSILSFLQRLN 557
           V+++   S    QG     ++ E M  G L+S+L    PE  ++ +   PS+   +Q   
Sbjct: 85  VRLLGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ--- 136
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           +A  +A  + YL+ +   + VH DL   N ++  D    +GDFG+TR I E
Sbjct: 137 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE 184

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 90/184 (48%), Gaps = 26/184 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G  G V+ G  +   T VAVK L   ++G++   +F+AE   ++ ++H+ LV++   
Sbjct: 21  LGAGQAGEVWMGYYN-GHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +           ++ E+M +GSL  +L   S           L+  + L++A  +A  +
Sbjct: 77  VTQEPIY------IITEYMENGSLVDFLKTPSGIK--------LTINKLLDMAAQIAEGM 122
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            ++    ++  +H DL+ +N+L+ + +   + DFGL R I +   +   +  G K  + +
Sbjct: 123 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED---AEXTAREGAKFPIKW 176
Query: 627 AAPE 630
            APE
Sbjct: 177 TAPE 180

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 82/191 (42%), Gaps = 27/191 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNIRHRN 499
           F     +G G FG+VY      ++ ++A+KVLF   L + G       E E   ++RH N
Sbjct: 17  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 76
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           ++++        F       L+ EF   G L   L      D+   +    +F++ L   
Sbjct: 77  ILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA----TFMEEL--- 124
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
              A AL Y H   +++++H D+KP N+L+       + DFG +   P +     C    
Sbjct: 125 ---ADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC---- 174
Query: 620 LKGTVGYAAPE 630
             GT+ Y  PE
Sbjct: 175 --GTLDYLPPE 183

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 24/171 (14%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIRHRNL 500
           +G GSFG VY+G+      D  +T VA+K +  ++  +++    F+ E   ++     ++
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEFNCHHV 77
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH---PESASDDLNYSPSILSFLQRLN 557
           V+++   S    QG     ++ E M  G L+S+L    PE  ++ +   PS+   +Q   
Sbjct: 78  VRLLGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ--- 129
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           +A  +A  + YL+ +   + VH DL   N ++  D    +GDFG+TR I E
Sbjct: 130 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 177

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 89/185 (48%), Gaps = 28/185 (15%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+    +   T VAVK +   + G++  ++F+AE   ++ ++H  LVK+   
Sbjct: 196 LGAGQFGEVWMATYN-KHTKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +           ++ EFM  GSL  +L  +  S      P ++ F      +  +A  +
Sbjct: 252 VTKEPIY------IITEFMAKGSLLDFLKSDEGSKQP--LPKLIDF------SAQIAEGM 297
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS-VGLKGTVG 625
            ++    ++  +H DL+ +N+L+   ++  + DFGL R    VI  N+ ++  G K  + 
Sbjct: 298 AFIE---QRNYIHRDLRAANILVSASLVCKIADFGLAR----VIEDNEYTAREGAKFPIK 350
Query: 626 YAAPE 630
           + APE
Sbjct: 351 WTAPE 355

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 82/191 (42%), Gaps = 27/191 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNIRHRN 499
           F     +G G FG+VY      ++ ++A+KVLF   L + G       E E   ++RH N
Sbjct: 16  FDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           ++++        F       L+ EF   G L   L      D+   +    +F++ L   
Sbjct: 76  ILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA----TFMEEL--- 123
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
              A AL Y H   +++++H D+KP N+L+       + DFG +   P +     C    
Sbjct: 124 ---ADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC---- 173
Query: 620 LKGTVGYAAPE 630
             GT+ Y  PE
Sbjct: 174 --GTLDYLPPE 182

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 24/171 (14%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIRHRNL 500
           +G GSFG VY+G+      D  +T VA+K +  ++  +++    F+ E   ++     ++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH---PESASDDLNYSPSILSFLQRLN 557
           V+++   S    QG     ++ E M  G L+S+L    PE  ++ +   PS+   +Q   
Sbjct: 91  VRLLGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ--- 142
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           +A  +A  + YL+ +   + VH DL   N ++  D    +GDFG+TR I E
Sbjct: 143 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 20/188 (10%)
Query: 447 NLIGTGSFGSVYKGIL---DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG VY G L   D  +   AVK L  +   G +  F+ E   +++  H N++ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++  C  S  +G+    L Y  M HG L +++  E+      ++P++   +      + V
Sbjct: 95  LLGICLRS--EGSPLVVLPY--MKHGDLRNFIRNET------HNPTVKDLI---GFGLQV 141
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
           A  ++YL     K+ VH DL   N +LD      V DFGL R + +    +  +  G K 
Sbjct: 142 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKL 198
Query: 623 TVGYAAPE 630
            V + A E
Sbjct: 199 PVKWMALE 206

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 24/171 (14%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIRHRNL 500
           +G GSFG VY+G+      D  +T VA+K +  ++  +++    F+ E   ++     ++
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEFNCHHV 83
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH---PESASDDLNYSPSILSFLQRLN 557
           V+++   S    QG     ++ E M  G L+S+L    PE  ++ +   PS+   +Q   
Sbjct: 84  VRLLGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ--- 135
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           +A  +A  + YL+ +   + VH DL   N ++  D    +GDFG+TR I E
Sbjct: 136 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 183

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 24/171 (14%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIRHRNL 500
           +G GSFG VY+G+      D  +T VA+K +  ++  +++    F+ E   ++     ++
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEFNCHHV 112
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH---PESASDDLNYSPSILSFLQRLN 557
           V+++   S    QG     ++ E M  G L+S+L    PE  ++ +   PS+   +Q   
Sbjct: 113 VRLLGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ--- 164
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           +A  +A  + YL+ +   + VH DL   N ++  D    +GDFG+TR I E
Sbjct: 165 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 212

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 24/171 (14%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIRHRNL 500
           +G GSFG VY+G+      D  +T VA+K +  ++  +++    F+ E   ++     ++
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEFNCHHV 84
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH---PESASDDLNYSPSILSFLQRLN 557
           V+++   S    QG     ++ E M  G L+S+L    PE  ++ +   PS+   +Q   
Sbjct: 85  VRLLGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ--- 136
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           +A  +A  + YL+ +   + VH DL   N ++  D    +GDFG+TR I E
Sbjct: 137 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 184

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 18/168 (10%)
Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL---KSFMAECEALRNIRHR-NLVK 502
           ++IG G+FG V K  +  D   +   +  + +  +    + F  E E L  + H  N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHP------ESASDDLNYSPSILSFLQRL 556
           ++ AC     +   +  L  E+  HG+L  +L        + A    N + S LS  Q L
Sbjct: 91  LLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
           + A +VA  ++YL    +KQ +H DL   N+L+  + +A + DFGL+R
Sbjct: 146 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 24/171 (14%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIRHRNL 500
           +G GSFG VY+G+      D  +T VA+K +  ++  +++    F+ E   ++     ++
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEFNCHHV 83
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH---PESASDDLNYSPSILSFLQRLN 557
           V+++   S    QG     ++ E M  G L+S+L    PE  ++ +   PS+   +Q   
Sbjct: 84  VRLLGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ--- 135
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           +A  +A  + YL+ +   + VH DL   N ++  D    +GDFG+TR I E
Sbjct: 136 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 183

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 24/171 (14%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIRHRNL 500
           +G GSFG VY+G+      D  +T VA+K +  ++  +++    F+ E   ++     ++
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEFNCHHV 81
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH---PESASDDLNYSPSILSFLQRLN 557
           V+++   S    QG     ++ E M  G L+S+L    PE  ++ +   PS+   +Q   
Sbjct: 82  VRLLGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ--- 133
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           +A  +A  + YL+ +   + VH DL   N ++  D    +GDFG+TR I E
Sbjct: 134 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 181

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 18/168 (10%)
Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL---KSFMAECEALRNIRHR-NLVK 502
           ++IG G+FG V K  +  D   +   +  + +  +    + F  E E L  + H  N++ 
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 80
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHP------ESASDDLNYSPSILSFLQRL 556
           ++ AC     +   +  L  E+  HG+L  +L        + A    N + S LS  Q L
Sbjct: 81  LLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 135
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
           + A +VA  ++YL    +KQ +H DL   N+L+  + +A + DFGL+R
Sbjct: 136 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 180

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 31/202 (15%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR-----GALKSFMAECEALRNIRH 497
           +   + +G G F +VYK        +VA+K + L  R     G  ++ + E + L+ + H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 498 RNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLN 557
            N++ ++ A     F      +LV++FM     E+ L      + L  +PS +     + 
Sbjct: 72  PNIIGLLDA-----FGHKSNISLVFDFM-----ETDLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI--PEVISSNQC 615
           +       LEYLH H    I+H DLKP+N+LLD + +  + DFGL +    P     +Q 
Sbjct: 122 L-----QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQV 173
Query: 616 SSVGLKGTVGYAAPEYGMGSQV 637
                  T  Y APE   G+++
Sbjct: 174 V------TRWYRAPELLFGARM 189

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 24/171 (14%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIRHRNL 500
           +G GSFG VY+G+      D  +T VA+K +  ++  +++    F+ E   ++     ++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH---PESASDDLNYSPSILSFLQRLN 557
           V+++   S    QG     ++ E M  G L+S+L    P  A++ +   PS+   +Q   
Sbjct: 91  VRLLGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ--- 142
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           +A  +A  + YL+ +   + VH DL   N ++  D    +GDFG+TR I E
Sbjct: 143 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 20/188 (10%)
Query: 447 NLIGTGSFGSVYKGIL---DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG VY G L   D  +   AVK L  +   G +  F+ E   +++  H N++ 
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 113
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++  C  S  +G+    L Y  M HG L +++  E+      ++P++   +      + V
Sbjct: 114 LLGICLRS--EGSPLVVLPY--MKHGDLRNFIRNET------HNPTVKDLI---GFGLQV 160
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
           A  ++YL     K+ VH DL   N +LD      V DFGL R + +    +  +  G K 
Sbjct: 161 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 217
Query: 623 TVGYAAPE 630
            V + A E
Sbjct: 218 PVKWMALE 225

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 88/189 (46%), Gaps = 22/189 (11%)
Query: 447 NLIGTGSFGSVYKGILD---PDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG V  G L      +  VA+K L   +     + F++E   +    H N++ 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +    + S         ++ EFM +GSL+S+L                + +Q + +   +
Sbjct: 99  LEGVVTKSTPV-----MIITEFMENGSLDSFLRQNDGQ---------FTVIQLVGMLRGI 144
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISS-NQCSSVGLK 621
           A+ ++YL        VH DL   N+L++++++  V DFGL+RF+ +  S     S++G K
Sbjct: 145 AAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 201
Query: 622 GTVGYAAPE 630
             + + APE
Sbjct: 202 IPIRWTAPE 210

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 24/171 (14%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIRHRNL 500
           +G GSFG VY+G+      D  +T VA+K +  ++  +++    F+ E   ++     ++
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEFNCHHV 80
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH---PESASDDLNYSPSILSFLQRLN 557
           V+++   S    QG     ++ E M  G L+S+L    P  A++ +   PS+   +Q   
Sbjct: 81  VRLLGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ--- 132
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           +A  +A  + YL+ +   + VH DL   N ++  D    +GDFG+TR I E
Sbjct: 133 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 180

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 20/188 (10%)
Query: 447 NLIGTGSFGSVYKGIL---DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG VY G L   D  +   AVK L  +   G +  F+ E   +++  H N++ 
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++  C  S  +G+    L Y  M HG L +++  E+      ++P++   +      + V
Sbjct: 115 LLGICLRS--EGSPLVVLPY--MKHGDLRNFIRNET------HNPTVKDLI---GFGLQV 161
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
           A  ++YL     K+ VH DL   N +LD      V DFGL R + +    +  +  G K 
Sbjct: 162 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 218
Query: 623 TVGYAAPE 630
            V + A E
Sbjct: 219 PVKWMALE 226

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 20/188 (10%)
Query: 447 NLIGTGSFGSVYKGIL---DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG VY G L   D  +   AVK L  +   G +  F+ E   +++  H N++ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++  C  S  +G+    L Y  M HG L +++  E+      ++P++   +      + V
Sbjct: 94  LLGICLRS--EGSPLVVLPY--MKHGDLRNFIRNET------HNPTVKDLI---GFGLQV 140
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
           A  ++YL     K+ VH DL   N +LD      V DFGL R + +    +  +  G K 
Sbjct: 141 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 197
Query: 623 TVGYAAPE 630
            V + A E
Sbjct: 198 PVKWMALE 205

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 20/188 (10%)
Query: 447 NLIGTGSFGSVYKGIL---DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG VY G L   D  +   AVK L  +   G +  F+ E   +++  H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++  C  S  +G+    L Y  M HG L +++  E+      ++P++   +      + V
Sbjct: 96  LLGICLRS--EGSPLVVLPY--MKHGDLRNFIRNET------HNPTVKDLI---GFGLQV 142
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
           A  ++YL     K+ VH DL   N +LD      V DFGL R + +    +  +  G K 
Sbjct: 143 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 199
Query: 623 TVGYAAPE 630
            V + A E
Sbjct: 200 PVKWMALE 207

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 20/188 (10%)
Query: 447 NLIGTGSFGSVYKGIL---DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG VY G L   D  +   AVK L  +   G +  F+ E   +++  H N++ 
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++  C  S  +G+    L Y  M HG L +++  E+      ++P++   +      + V
Sbjct: 88  LLGICLRS--EGSPLVVLPY--MKHGDLRNFIRNET------HNPTVKDLI---GFGLQV 134
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
           A  ++YL     K+ VH DL   N +LD      V DFGL R + +    +  +  G K 
Sbjct: 135 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 191
Query: 623 TVGYAAPE 630
            V + A E
Sbjct: 192 PVKWMALE 199

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 20/188 (10%)
Query: 447 NLIGTGSFGSVYKGIL---DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG VY G L   D  +   AVK L  +   G +  F+ E   +++  H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++  C  S  +G+    L Y  M HG L +++  E+      ++P++   +      + V
Sbjct: 96  LLGICLRS--EGSPLVVLPY--MKHGDLRNFIRNET------HNPTVKDLI---GFGLQV 142
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
           A  ++YL     K+ VH DL   N +LD      V DFGL R + +    +  +  G K 
Sbjct: 143 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 199
Query: 623 TVGYAAPE 630
            V + A E
Sbjct: 200 PVKWMALE 207

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 20/188 (10%)
Query: 447 NLIGTGSFGSVYKGIL---DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG VY G L   D  +   AVK L  +   G +  F+ E   +++  H N++ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++  C  S  +G+    L Y  M HG L +++  E+      ++P++   +      + V
Sbjct: 95  LLGICLRS--EGSPLVVLPY--MKHGDLRNFIRNET------HNPTVKDLI---GFGLQV 141
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
           A  ++YL     K+ VH DL   N +LD      V DFGL R + +    +  +  G K 
Sbjct: 142 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 198
Query: 623 TVGYAAPE 630
            V + A E
Sbjct: 199 PVKWMALE 206

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 20/188 (10%)
Query: 447 NLIGTGSFGSVYKGIL---DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG VY G L   D  +   AVK L  +   G +  F+ E   +++  H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++  C  S  +G+    L Y  M HG L +++  E+      ++P++   +      + V
Sbjct: 91  LLGICLRS--EGSPLVVLPY--MKHGDLRNFIRNET------HNPTVKDLI---GFGLQV 137
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
           A  ++YL     K+ VH DL   N +LD      V DFGL R + +    +  +  G K 
Sbjct: 138 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 194
Query: 623 TVGYAAPE 630
            V + A E
Sbjct: 195 PVKWMALE 202

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 20/188 (10%)
Query: 447 NLIGTGSFGSVYKGIL---DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG VY G L   D  +   AVK L  +   G +  F+ E   +++  H N++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++  C  S  +G+    L Y  M HG L +++  E+      ++P++   +      + V
Sbjct: 93  LLGICLRS--EGSPLVVLPY--MKHGDLRNFIRNET------HNPTVKDLI---GFGLQV 139
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
           A  ++YL     K+ VH DL   N +LD      V DFGL R + +    +  +  G K 
Sbjct: 140 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 196
Query: 623 TVGYAAPE 630
            V + A E
Sbjct: 197 PVKWMALE 204

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 24/204 (11%)
Query: 440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRH 497
           +  F   +L+G G++G V      P   +VA+K +  F     AL++ + E + L++ +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-LREIKILKHFKH 68
Query: 498 RNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLN 557
            N++ I        F+  +   ++ E M    L   +  +  SDD      I  F+ +  
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQMLSDD-----HIQYFIYQTL 122
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN---- 613
            A+ V      LH      ++H DLKPSN+L++++    V DFGL R I E  + N    
Sbjct: 123 RAVKV------LH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 614 --QCSSVGLKGTVGYAAPEYGMGS 635
             Q   V    T  Y APE  + S
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTS 197

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 80/184 (43%), Gaps = 13/184 (7%)
Query: 429 LNVSYESLLKATGGFSSANLIGTGSFGSVYKGIL-DPDQTVVAVKVLFLHQ----RGALK 483
           L    E +L     F+   ++G G FGSV +  L   D + V V V  L         ++
Sbjct: 11  LKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE 70
Query: 484 SFMAECEALRNIRHRNLVKIITACSSSDFQGN-DFKALVYEFMHHGSLESWLHPESASDD 542
            F+ E   ++   H ++ K++     S  +G      ++  FM HG L ++L     +  
Sbjct: 71  EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL----LASR 126
Query: 543 LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL 602
           +  +P  L     +   +++A  +EYL     +  +H DL   N +L  DM   V DFGL
Sbjct: 127 IGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGL 183
Query: 603 TRFI 606
           +R I
Sbjct: 184 SRKI 187

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIR 496
           AT  +     IG G++G+VYK         VA+K + +   + G   S + E   LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 497 ---HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFL 553
              H N+V+++  C++S         LV+E +    L ++L            P  L   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLD--------KAPPPGLPAE 112
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
              ++       L++LH +C   IVH DLKP N+L+ +     + DFGL R     I S 
Sbjct: 113 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR-----IYSY 164
Query: 614 QCSSVGLKGTVGYAAPEYGMGSQVST 639
           Q +   +  T+ Y APE  + S  +T
Sbjct: 165 QMALAPVVVTLWYRAPEVLLQSTYAT 190

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 24/171 (14%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQRGALKS---FMAECEALRNIRHRNL 500
           +G GSFG VY+G+      D  +T VA+K +  ++  +++    F+ E   ++     ++
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEFNCHHV 77
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH---PESASDDLNYSPSILSFLQRLN 557
           V+++   S    QG     ++ E M  G L+S+L    PE  ++ +   PS+   +Q   
Sbjct: 78  VRLLGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ--- 129
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           +A  +A  + YL+ +   + VH DL   N  +  D    +GDFG+TR I E
Sbjct: 130 MAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYE 177

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIR 496
           AT  +     IG G++G+VYK         VA+K + +   + G   S + E   LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 497 ---HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFL 553
              H N+V+++  C++S         LV+E +    L ++L            P  L   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLD--------KAPPPGLPAE 112
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
              ++       L++LH +C   IVH DLKP N+L+ +     + DFGL R     I S 
Sbjct: 113 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR-----IYSY 164
Query: 614 QCSSVGLKGTVGYAAPEYGMGSQVST 639
           Q +   +  T+ Y APE  + S  +T
Sbjct: 165 QMALFPVVVTLWYRAPEVLLQSTYAT 190

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 28/178 (15%)
Query: 449 IGTGSFGSVYK----GILDPDQ-TVVAVKVLFLHQRGALKS-FMAECEALRNIRHRNLVK 502
           IG G+FG V++    G+L  +  T+VAVK+L       +++ F  E   +    + N+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPES-------ASDDLNY-------SPS 548
           ++  C+           L++E+M +G L  +L   S       +  DL+         P 
Sbjct: 115 LLGVCAVGKPM-----CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 549 ILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
            LS  ++L IA  VA+ + YL    +++ VH DL   N L+  +M+  + DFGL+R I
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 224

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 36/198 (18%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSF------MAECEALRN 494
           G +   + +G G+FG V  G        VAVK+L    R  ++S         E + L+ 
Sbjct: 11  GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKIL---NRQKIRSLDVVGKIKREIQNLKL 67
Query: 495 IRHRNLVKIITACSS-SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFL 553
            RH +++K+    S+ +DF       +V E++  G L  ++      +++          
Sbjct: 68  FRHPHIIKLYQVISTPTDF------FMVMEYVSGGELFDYICKHGRVEEM---------- 111
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE-VISS 612
           +   +   + SA++Y H H    +VH DLKP NVLLD  M A + DFGL+  + +     
Sbjct: 112 EARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 168
Query: 613 NQCSSVGLKGTVGYAAPE 630
           + C      G+  YAAPE
Sbjct: 169 DSC------GSPNYAAPE 180

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 25/197 (12%)
Query: 449 IGTGSFGSVY--KGI-LDPDQ----TVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRN 499
           +G G+FG V   + I LD D+    T VAVK+L        L   ++E E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHP-ESASDDLNYSPS-----ILSFL 553
           ++ ++ AC+    Q      +V E+   G+L  +L   E    + +Y+PS      LS  
Sbjct: 96  IINLLGACT----QDGPLYVIV-EYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSK 150
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
             ++ A  VA  +EYL     K+ +H DL   NVL+  D +  + DFGL R I  +    
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 614 QCSSVGLKGTVGYAAPE 630
           + ++  L   V + APE
Sbjct: 208 KTTNGRL--PVKWMAPE 222

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 81/168 (48%), Gaps = 18/168 (10%)
Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL---KSFMAECEALRNIRHR-NLVK 502
           ++IG G+FG V K  +  D   +   +  + +  +    + F  E E L  + H  N++ 
Sbjct: 28  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 87
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHP------ESASDDLNYSPSILSFLQRL 556
           ++ AC     +   +  L  E+  HG+L  +L        + A    N + S LS  Q L
Sbjct: 88  LLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 142
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
           + A +VA  ++YL    +KQ +H +L   N+L+  + +A + DFGL+R
Sbjct: 143 HFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR 187

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 86/188 (45%), Gaps = 20/188 (10%)
Query: 447 NLIGTGSFGSVYKGIL---DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG VY G L   D  +   AVK L  +   G +  F+ E   +++  H N++ 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++  C  S  +G+    L Y  M HG L +++  E+      ++P++   +      + V
Sbjct: 97  LLGICLRS--EGSPLVVLPY--MKHGDLRNFIRNET------HNPTVKDLI---GFGLQV 143
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
           A  +++L     K+ VH DL   N +LD      V DFGL R + +    +  +  G K 
Sbjct: 144 AKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 200
Query: 623 TVGYAAPE 630
            V + A E
Sbjct: 201 PVKWMALE 208

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 86/188 (45%), Gaps = 20/188 (10%)
Query: 447 NLIGTGSFGSVYKGIL---DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG VY G L   D  +   AVK L  +   G +  F+ E   +++  H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++  C  S  +G+    L Y  M HG L +++  E+      ++P++   +      + V
Sbjct: 96  LLGICLRS--EGSPLVVLPY--MKHGDLRNFIRNET------HNPTVKDLI---GFGLQV 142
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
           A  +++L     K+ VH DL   N +LD      V DFGL R + +    +  +  G K 
Sbjct: 143 AKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 199
Query: 623 TVGYAAPE 630
            V + A E
Sbjct: 200 PVKWMALE 207

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 86/188 (45%), Gaps = 20/188 (10%)
Query: 447 NLIGTGSFGSVYKGIL---DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG VY G L   D  +   AVK L  +   G +  F+ E   +++  H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++  C  S  +G+    L Y  M HG L +++  E+      ++P++   +      + V
Sbjct: 155 LLGICLRS--EGSPLVVLPY--MKHGDLRNFIRNET------HNPTVKDLI---GFGLQV 201
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
           A  +++L     K+ VH DL   N +LD      V DFGL R + +    +  +  G K 
Sbjct: 202 AKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 258
Query: 623 TVGYAAPE 630
            V + A E
Sbjct: 259 PVKWMALE 266

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 25/197 (12%)
Query: 449 IGTGSFGSVY--KGI-LDPDQ----TVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRN 499
           +G G+FG V   + I LD D+    T VAVK+L        L   ++E E ++ I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASD-DLNYSPS-----ILSFL 553
           ++ ++ AC+    Q      +V E+   G+L  +L        + +Y+PS      LS  
Sbjct: 137 IINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
             ++ A  VA  +EYL     K+ +H DL   NVL+  D +  + DFGL R I  +    
Sbjct: 192 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 614 QCSSVGLKGTVGYAAPE 630
           + ++  L   V + APE
Sbjct: 249 KTTNGRL--PVKWMAPE 263

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 86/188 (45%), Gaps = 20/188 (10%)
Query: 447 NLIGTGSFGSVYKGIL---DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG VY G L   D  +   AVK L  +   G +  F+ E   +++  H N++ 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++  C  S  +G+    L Y  M HG L +++  E+      ++P++   +      + V
Sbjct: 97  LLGICLRS--EGSPLVVLPY--MKHGDLRNFIRNET------HNPTVKDLI---GFGLQV 143
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
           A  +++L     K+ VH DL   N +LD      V DFGL R + +    +  +  G K 
Sbjct: 144 AKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKL 200
Query: 623 TVGYAAPE 630
            V + A E
Sbjct: 201 PVKWMALE 208

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 86/188 (45%), Gaps = 20/188 (10%)
Query: 447 NLIGTGSFGSVYKGIL---DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG VY G L   D  +   AVK L  +   G +  F+ E   +++  H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++  C  S  +G+    L Y  M HG L +++  E+      ++P++   +      + V
Sbjct: 96  LLGICLRS--EGSPLVVLPY--MKHGDLRNFIRNET------HNPTVKDLI---GFGLQV 142
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
           A  +++L     K+ VH DL   N +LD      V DFGL R + +    +  +  G K 
Sbjct: 143 AKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 199
Query: 623 TVGYAAPE 630
            V + A E
Sbjct: 200 PVKWMALE 207

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 86/188 (45%), Gaps = 20/188 (10%)
Query: 447 NLIGTGSFGSVYKGIL---DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG VY G L   D  +   AVK L  +   G +  F+ E   +++  H N++ 
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 100
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++  C  S  +G+    L Y  M HG L +++  E+      ++P++   +      + V
Sbjct: 101 LLGICLRS--EGSPLVVLPY--MKHGDLRNFIRNET------HNPTVKDLI---GFGLQV 147
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
           A  +++L     K+ VH DL   N +LD      V DFGL R + +    +  +  G K 
Sbjct: 148 AKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 204
Query: 623 TVGYAAPE 630
            V + A E
Sbjct: 205 PVKWMALE 212

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 86/214 (40%), Gaps = 48/214 (22%)
Query: 443 FSSANLIGTGSFGSVYKGILDPD-QTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLV 501
           F    LIG+G FG V+K     D +T V  +V + +++        E +AL  + H N+V
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE-----REVKALAKLDHVNIV 68
Query: 502 KIITAC---------------SSSDFQGNDFKA----------LVYEFMHHGSLESWLHP 536
                C                SSD+   + K           +  EF   G+LE W+  
Sbjct: 69  HY-NGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 127
Query: 537 ESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH 596
                        L  +  L +   +   ++Y+H    K+++H DLKPSN+ L +     
Sbjct: 128 RRGEK--------LDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVK 176
Query: 597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPE 630
           +GDFGL   +      N       KGT+ Y +PE
Sbjct: 177 IGDFGLVTSL-----KNDGKRTRSKGTLRYMSPE 205

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 18/200 (9%)
Query: 440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRH 497
           +  F   +L+G G++G V      P   +VA+K +  F     AL++ + E + L++ +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-LREIKILKHFKH 68
Query: 498 RNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLN 557
            N++ I        F+  +   ++ E M    L   +  +  SDD      I  F+ +  
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQMLSDD-----HIQYFIYQTL 122
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
            A+ V      LH      ++H DLKPSN+L++++    V DFGL R I E  + N   +
Sbjct: 123 RAVKV------LH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 618 VGLKGTVGYAAPEYGMGSQV 637
               G   Y A  +    +V
Sbjct: 174 GQQSGMTEYVATRWYRAPEV 193

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 86/188 (45%), Gaps = 20/188 (10%)
Query: 447 NLIGTGSFGSVYKGIL---DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG VY G L   D  +   AVK L  +   G +  F+ E   +++  H N++ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++  C  S  +G+    L Y  M HG L +++  E+      ++P++   +      + V
Sbjct: 94  LLGICLRS--EGSPLVVLPY--MKHGDLRNFIRNET------HNPTVKDLI---GFGLQV 140
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
           A  +++L     K+ VH DL   N +LD      V DFGL R + +    +  +  G K 
Sbjct: 141 AKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 197
Query: 623 TVGYAAPE 630
            V + A E
Sbjct: 198 PVKWMALE 205

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIR 496
           AT  +     IG G++G+VYK         VA+K + +   + G   S + E   LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 497 ---HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFL 553
              H N+V+++  C++S         LV+E +    L ++L            P  L   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLD--------KAPPPGLPAE 112
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
              ++       L++LH +C   IVH DLKP N+L+ +     + DFGL R     I S 
Sbjct: 113 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR-----IYSY 164
Query: 614 QCSSVGLKGTVGYAAPEYGMGSQVST 639
           Q +   +  T+ Y APE  + S  +T
Sbjct: 165 QMALDPVVVTLWYRAPEVLLQSTYAT 190

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 36/198 (18%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSF------MAECEALRN 494
           G +   + +G G+FG V  G        VAVK+L    R  ++S         E + L+ 
Sbjct: 11  GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKIL---NRQKIRSLDVVGKIKREIQNLKL 67
Query: 495 IRHRNLVKIITACSS-SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFL 553
            RH +++K+    S+ +DF       +V E++  G L  ++      +++          
Sbjct: 68  FRHPHIIKLYQVISTPTDF------FMVMEYVSGGELFDYICKHGRVEEM---------- 111
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE-VISS 612
           +   +   + SA++Y H H    +VH DLKP NVLLD  M A + DFGL+  + +     
Sbjct: 112 EARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 168
Query: 613 NQCSSVGLKGTVGYAAPE 630
             C      G+  YAAPE
Sbjct: 169 TSC------GSPNYAAPE 180

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 437 LKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH-QRGALKSFMAECEALRNI 495
           + ++  F     +G G++ +VYKG+       VA+K + L  + G   + + E   ++ +
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           +H N+V++     + +        LV+EFM +  L+ ++   +  +    +P  L     
Sbjct: 61  KHENIVRLYDVIHTENKL-----TLVFEFMDN-DLKKYMDSRTVGN----TPRGLELNLV 110
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
                 +   L + H   + +I+H DLKP N+L++      +GDFGL R     +++   
Sbjct: 111 KYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS 167
Query: 616 SSVGLKGTVGYAAPEYGMGSQV 637
             V    T+ Y AP+  MGS+ 
Sbjct: 168 EVV----TLWYRAPDVLMGSRT 185

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 81/195 (41%), Gaps = 27/195 (13%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G +   L   S  D+   +  I      
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYI------ 119
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
                 +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P    +  C
Sbjct: 120 ----TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC 172
Query: 616 SSVGLKGTVGYAAPE 630
                 GT+ Y  PE
Sbjct: 173 ------GTLDYLPPE 181

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 85/193 (44%), Gaps = 26/193 (13%)
Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITA 506
            ++G G+FG V K         VA+K +        K+F+ E   L  + H N+VK+  A
Sbjct: 15  EVVGRGAFGVVCKAKWRAKD--VAIKQI--ESESERKAFIVELRQLSRVNHPNIVKLYGA 70
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
           C +          LV E+   GSL + LH    ++ L Y     +    ++  +  +  +
Sbjct: 71  CLNP-------VCLVMEYAEGGSLYNVLH---GAEPLPY----YTAAHAMSWCLQCSQGV 116
Query: 567 EYLHHHCKKQIVHCDLKPSNVLL-DNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG 625
            YLH    K ++H DLKP N+LL     +  + DFG    I   +++N       KG+  
Sbjct: 117 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-------KGSAA 169
Query: 626 YAAPEYGMGSQVS 638
           + APE   GS  S
Sbjct: 170 WMAPEVFEGSNYS 182

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 84/184 (45%), Gaps = 36/184 (19%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+    +   T VAVK +   + G++  ++F+AE   ++ ++H  LVK+   
Sbjct: 190 LGAGQFGEVWMATYN-KHTKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 245
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +           ++ EFM  GSL  +L  +  S      P ++ F      +  +A  +
Sbjct: 246 VTKEPIY------IITEFMAKGSLLDFLKSDEGSK--QPLPKLIDF------SAQIAEGM 291
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            ++    ++  +H DL+ +N+L+   ++  + DFGL R             VG K  + +
Sbjct: 292 AFIE---QRNYIHRDLRAANILVSASLVCKIADFGLAR-------------VGAKFPIKW 335
Query: 627 AAPE 630
            APE
Sbjct: 336 TAPE 339

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 25/197 (12%)
Query: 449 IGTGSFGSVY--KGI-LDPDQ----TVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRN 499
           +G G+FG V   + I LD D+    T VAVK+L        L   ++E E ++ I +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASD-DLNYSPS-----ILSFL 553
           ++ ++ AC+    Q      +V E+   G+L  +L        + +Y+PS      LS  
Sbjct: 88  IINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 142
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
             ++ A  VA  +EYL     K+ +H DL   NVL+  D +  + DFGL R I  +    
Sbjct: 143 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 199
Query: 614 QCSSVGLKGTVGYAAPE 630
           + ++  L   V + APE
Sbjct: 200 KTTNGRL--PVKWMAPE 214

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 25/197 (12%)
Query: 449 IGTGSFGSVY--KGI-LDPDQ----TVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRN 499
           +G G+FG V   + I LD D+    T VAVK+L        L   ++E E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASD-DLNYSPS-----ILSFL 553
           ++ ++ AC+    Q      +V E+   G+L  +L        + +Y+PS      LS  
Sbjct: 96  IINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 150
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
             ++ A  VA  +EYL     K+ +H DL   NVL+  D +  + DFGL R I  +    
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 614 QCSSVGLKGTVGYAAPE 630
           + ++  L   V + APE
Sbjct: 208 KTTNGRL--PVKWMAPE 222

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 27/195 (13%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+   +  I      
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI------ 114
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
                 +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P    ++ C
Sbjct: 115 ----TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC 167
Query: 616 SSVGLKGTVGYAAPE 630
                 GT+ Y  PE
Sbjct: 168 ------GTLDYLPPE 176

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 25/197 (12%)
Query: 449 IGTGSFGSVY--KGI-LDPDQ----TVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRN 499
           +G G+FG V   + I LD D+    T VAVK+L        L   ++E E ++ I +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASD-DLNYSPS-----ILSFL 553
           ++ ++ AC+    Q      +V E+   G+L  +L        + +Y+PS      LS  
Sbjct: 85  IINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 139
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
             ++ A  VA  +EYL     K+ +H DL   NVL+  D +  + DFGL R I  +    
Sbjct: 140 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 196
Query: 614 QCSSVGLKGTVGYAAPE 630
           + ++  L   V + APE
Sbjct: 197 KTTNGRL--PVKWMAPE 211

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 25/197 (12%)
Query: 449 IGTGSFGSVY--KGI-LDPDQ----TVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRN 499
           +G G+FG V   + I LD D+    T VAVK+L        L   ++E E ++ I +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASD-DLNYSPS-----ILSFL 553
           ++ ++ AC+    Q      +V E+   G+L  +L        + +Y+PS      LS  
Sbjct: 89  IINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 143
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
             ++ A  VA  +EYL     K+ +H DL   NVL+  D +  + DFGL R I  +    
Sbjct: 144 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 200
Query: 614 QCSSVGLKGTVGYAAPE 630
           + ++  L   V + APE
Sbjct: 201 KTTNGRL--PVKWMAPE 215

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 85/184 (46%), Gaps = 24/184 (13%)
Query: 447 NLIGTGSFGSVYKGILD---PDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVK 502
            ++G G FG V  G L      +  VA+K L + +     + F+ E   +    H N+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +    + S         +V E+M +GSL+S+L    A           + +Q + +   +
Sbjct: 111 LEGVVTKSKPV-----MIVTEYMENGSLDSFLRKHDAQ---------FTVIQLVGMLRGI 156
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI---PEVISSNQCSSVG 619
           AS ++YL        VH DL   N+L++++++  V DFGL+R +   PE   + +   + 
Sbjct: 157 ASGMKYLSDM---GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 620 LKGT 623
           ++ T
Sbjct: 214 IRWT 217

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 85/184 (46%), Gaps = 24/184 (13%)
Query: 447 NLIGTGSFGSVYKGILD---PDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVK 502
            ++G G FG V  G L      +  VA+K L + +     + F+ E   +    H N+++
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 98
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +    + S         +V E+M +GSL+S+L    A           + +Q + +   +
Sbjct: 99  LEGVVTKSKPV-----MIVTEYMENGSLDSFLRKHDAQ---------FTVIQLVGMLRGI 144
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI---PEVISSNQCSSVG 619
           AS ++YL        VH DL   N+L++++++  V DFGL+R +   PE   + +   + 
Sbjct: 145 ASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 201
Query: 620 LKGT 623
           ++ T
Sbjct: 202 IRWT 205

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 77/166 (46%), Gaps = 24/166 (14%)
Query: 449 IGTGSFGSVYKGILDP--DQTV-VAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G GSFG V +G  D    +TV VAVK L    L Q  A+  F+ E  A+ ++ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +     +   +      +V E    GSL   L              +L  L R   A+ V
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGH-------FLLGTLSR--YAVQV 130
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           A  + YL     K+ +H DL   N+LL    +  +GDFGL R +P+
Sbjct: 131 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 27/195 (13%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+   +  I      
Sbjct: 67  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI------ 115
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
                 +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P    ++ C
Sbjct: 116 ----TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC 168
Query: 616 SSVGLKGTVGYAAPE 630
                 GT+ Y  PE
Sbjct: 169 ------GTLDYLPPE 177

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 85/193 (44%), Gaps = 26/193 (13%)
Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITA 506
            ++G G+FG V K         VA+K +        K+F+ E   L  + H N+VK+  A
Sbjct: 14  EVVGRGAFGVVCKAKWRAKD--VAIKQI--ESESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
           C +          LV E+   GSL + LH    ++ L Y     +    ++  +  +  +
Sbjct: 70  CLNP-------VCLVMEYAEGGSLYNVLH---GAEPLPY----YTAAHAMSWCLQCSQGV 115
Query: 567 EYLHHHCKKQIVHCDLKPSNVLL-DNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG 625
            YLH    K ++H DLKP N+LL     +  + DFG    I   +++N       KG+  
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-------KGSAA 168
Query: 626 YAAPEYGMGSQVS 638
           + APE   GS  S
Sbjct: 169 WMAPEVFEGSNYS 181

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 77/166 (46%), Gaps = 24/166 (14%)
Query: 449 IGTGSFGSVYKGILDP--DQTV-VAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G GSFG V +G  D    +TV VAVK L    L Q  A+  F+ E  A+ ++ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +     +   +      +V E    GSL   L              +L  L R   A+ V
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGH-------FLLGTLSR--YAVQV 130
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           A  + YL     K+ +H DL   N+LL    +  +GDFGL R +P+
Sbjct: 131 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 77/166 (46%), Gaps = 24/166 (14%)
Query: 449 IGTGSFGSVYKGILDP--DQTV-VAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G GSFG V +G  D    +TV VAVK L    L Q  A+  F+ E  A+ ++ HRNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +     +   +      +V E    GSL   L              +L  L R   A+ V
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGH-------FLLGTLSR--YAVQV 124
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           A  + YL     K+ +H DL   N+LL    +  +GDFGL R +P+
Sbjct: 125 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 167

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 24/204 (11%)
Query: 440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRH 497
           +  F   +L+G G++G V      P   +VA+K +  F     AL++ + E + L++ +H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-LREIKILKHFKH 68
Query: 498 RNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLN 557
            N++ I        F+  +   ++ E M    L   +  +  SDD      I  F+ +  
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQMLSDD-----HIQYFIYQTL 122
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN---- 613
            A+ V      LH      ++H DLKPSN+L++++    V DFGL R I E  + N    
Sbjct: 123 RAVKV------LH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 614 --QCSSVGLKGTVGYAAPEYGMGS 635
             Q        T  Y APE  + S
Sbjct: 174 GQQSGMTEXVATRWYRAPEVMLTS 197

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 27/195 (13%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+   +  I      
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI------ 119
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
                 +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P    ++ C
Sbjct: 120 ----TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC 172
Query: 616 SSVGLKGTVGYAAPE 630
                 GT+ Y  PE
Sbjct: 173 ------GTLDYLPPE 181

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 25/210 (11%)
Query: 424 RKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVA---VKVLFLHQRG 480
           +K L  ++ Y +L      F     IG G F  VY+     D   VA   V++  L    
Sbjct: 19  QKALRPDMGYNTL----ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK 74
Query: 481 ALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESAS 540
           A    + E + L+ + H N++K      +S  + N+   +V E    G L   +      
Sbjct: 75  ARADCIKEIDLLKQLNHPNVIKYY----ASFIEDNELN-IVLELADAGDLSRMIKHFKKQ 129
Query: 541 DDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF 600
             L    ++  +       + + SALE++H    ++++H D+KP+NV +    +  +GD 
Sbjct: 130 KRLIPERTVWKYF------VQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDL 180
Query: 601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPE 630
           GL RF     SS   ++  L GT  Y +PE
Sbjct: 181 GLGRF----FSSKTTAAHSLVGTPYYMSPE 206

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 25/197 (12%)
Query: 449 IGTGSFGSVY--KGI-LDPDQ----TVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRN 499
           +G G+FG V   + I LD D+    T VAVK+L        L   ++E E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASD-DLNYSPS-----ILSFL 553
           ++ ++ AC+    Q      +V E+   G+L  +L        + +++PS      LS  
Sbjct: 96  IINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSK 150
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
             ++ A  VA  +EYL     K+ +H DL   NVL+  D +  + DFGL R I  +    
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXK 207
Query: 614 QCSSVGLKGTVGYAAPE 630
           + ++  L   V + APE
Sbjct: 208 KTTNGRL--PVKWMAPE 222

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 83/195 (42%), Gaps = 27/195 (13%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+   +  I      
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI------ 114
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
                 +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P    ++ C
Sbjct: 115 ----TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC 167
Query: 616 SSVGLKGTVGYAAPE 630
                 GT+ Y  PE
Sbjct: 168 ------GTLDYLPPE 176

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 85/184 (46%), Gaps = 24/184 (13%)
Query: 447 NLIGTGSFGSVYKGILD---PDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVK 502
            ++G G FG V  G L      +  VA+K L + +     + F+ E   +    H N+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +    + S         +V E+M +GSL+S+L    A           + +Q + +   +
Sbjct: 111 LEGVVTKSKPV-----MIVTEYMENGSLDSFLRKHDAQ---------FTVIQLVGMLRGI 156
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI---PEVISSNQCSSVG 619
           AS ++YL        VH DL   N+L++++++  V DFGL+R +   PE   + +   + 
Sbjct: 157 ASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 620 LKGT 623
           ++ T
Sbjct: 214 IRWT 217

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 77/166 (46%), Gaps = 24/166 (14%)
Query: 449 IGTGSFGSVYKGILDP--DQTV-VAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G GSFG V +G  D    +TV VAVK L    L Q  A+  F+ E  A+ ++ HRNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +     +   +      +V E    GSL   L              +L  L R   A+ V
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGH-------FLLGTLSR--YAVQV 124
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           A  + YL     K+ +H DL   N+LL    +  +GDFGL R +P+
Sbjct: 125 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 167

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 85/184 (46%), Gaps = 24/184 (13%)
Query: 447 NLIGTGSFGSVYKGILD---PDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVK 502
            ++G G FG V  G L      +  VA+K L + +     + F+ E   +    H N+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +    + S         +V E+M +GSL+S+L    A           + +Q + +   +
Sbjct: 111 LEGVVTKSKPV-----MIVTEYMENGSLDSFLRKHDAQ---------FTVIQLVGMLRGI 156
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI---PEVISSNQCSSVG 619
           AS ++YL        VH DL   N+L++++++  V DFGL+R +   PE   + +   + 
Sbjct: 157 ASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 620 LKGT 623
           ++ T
Sbjct: 214 IRWT 217

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 85/184 (46%), Gaps = 24/184 (13%)
Query: 447 NLIGTGSFGSVYKGILD---PDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVK 502
            ++G G FG V  G L      +  VA+K L + +     + F+ E   +    H N+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +    + S         +V E+M +GSL+S+L    A           + +Q + +   +
Sbjct: 111 LEGVVTKSKPV-----MIVTEYMENGSLDSFLRKHDAQ---------FTVIQLVGMLRGI 156
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI---PEVISSNQCSSVG 619
           AS ++YL        VH DL   N+L++++++  V DFGL+R +   PE   + +   + 
Sbjct: 157 ASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 620 LKGT 623
           ++ T
Sbjct: 214 IRWT 217

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 85/184 (46%), Gaps = 24/184 (13%)
Query: 447 NLIGTGSFGSVYKGILD---PDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVK 502
            ++G G FG V  G L      +  VA+K L + +     + F+ E   +    H N+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +    + S         +V E+M +GSL+S+L    A           + +Q + +   +
Sbjct: 111 LEGVVTKSKPV-----MIVTEYMENGSLDSFLRKHDAQ---------FTVIQLVGMLRGI 156
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI---PEVISSNQCSSVG 619
           AS ++YL        VH DL   N+L++++++  V DFGL+R +   PE   + +   + 
Sbjct: 157 ASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 620 LKGT 623
           ++ T
Sbjct: 214 IRWT 217

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 77/166 (46%), Gaps = 24/166 (14%)
Query: 449 IGTGSFGSVYKGILDP--DQTV-VAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G GSFG V +G  D    +TV VAVK L    L Q  A+  F+ E  A+ ++ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +     +   +      +V E    GSL   L              +L  L R   A+ V
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGH-------FLLGTLSR--YAVQV 120
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           A  + YL     K+ +H DL   N+LL    +  +GDFGL R +P+
Sbjct: 121 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 29/196 (14%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+           QR
Sbjct: 92  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QR 135
Query: 556 LNIAI-NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQ 614
               I  +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P    +  
Sbjct: 136 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL 192
Query: 615 CSSVGLKGTVGYAAPE 630
           C      GT+ Y  PE
Sbjct: 193 C------GTLDYLPPE 202

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 29/196 (14%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+           QR
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QR 109
Query: 556 LNIAI-NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQ 614
               I  +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P    +  
Sbjct: 110 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTEL 166
Query: 615 CSSVGLKGTVGYAAPE 630
           C      GT+ Y  PE
Sbjct: 167 C------GTLDYLPPE 176

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 85/184 (46%), Gaps = 24/184 (13%)
Query: 447 NLIGTGSFGSVYKGILD---PDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVK 502
            ++G G FG V  G L      +  VA+K L + +     + F+ E   +    H N+++
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +    + S         +V E+M +GSL+S+L    A           + +Q + +   +
Sbjct: 82  LEGVVTKSKPV-----MIVTEYMENGSLDSFLRKHDAQ---------FTVIQLVGMLRGI 127
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI---PEVISSNQCSSVG 619
           AS ++YL        VH DL   N+L++++++  V DFGL+R +   PE   + +   + 
Sbjct: 128 ASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 184
Query: 620 LKGT 623
           ++ T
Sbjct: 185 IRWT 188

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 77/166 (46%), Gaps = 24/166 (14%)
Query: 449 IGTGSFGSVYKGILDP--DQTV-VAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G GSFG V +G  D    +TV VAVK L    L Q  A+  F+ E  A+ ++ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +     +   +      +V E    GSL   L              +L  L R   A+ V
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGH-------FLLGTLSR--YAVQV 120
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           A  + YL     K+ +H DL   N+LL    +  +GDFGL R +P+
Sbjct: 121 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 29/196 (14%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+           QR
Sbjct: 92  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QR 135
Query: 556 LNIAI-NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQ 614
               I  +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P     + 
Sbjct: 136 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDL 192
Query: 615 CSSVGLKGTVGYAAPE 630
           C      GT+ Y  PE
Sbjct: 193 C------GTLDYLPPE 202

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 85/184 (46%), Gaps = 24/184 (13%)
Query: 447 NLIGTGSFGSVYKGILD---PDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVK 502
            ++G G FG V  G L      +  VA+K L + +     + F+ E   +    H N+++
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 108
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +    + S         +V E+M +GSL+S+L    A           + +Q + +   +
Sbjct: 109 LEGVVTKSKPV-----MIVTEYMENGSLDSFLRKHDAQ---------FTVIQLVGMLRGI 154
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI---PEVISSNQCSSVG 619
           AS ++YL        VH DL   N+L++++++  V DFGL+R +   PE   + +   + 
Sbjct: 155 ASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 211
Query: 620 LKGT 623
           ++ T
Sbjct: 212 IRWT 215

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 29/196 (14%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+           QR
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QR 109
Query: 556 LNIAI-NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQ 614
               I  +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P    +  
Sbjct: 110 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL 166
Query: 615 CSSVGLKGTVGYAAPE 630
           C      GT+ Y  PE
Sbjct: 167 C------GTLDYLPPE 176

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 77/166 (46%), Gaps = 24/166 (14%)
Query: 449 IGTGSFGSVYKGILDP--DQTV-VAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G GSFG V +G  D    +TV VAVK L    L Q  A+  F+ E  A+ ++ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +     +   +      +V E    GSL   L              +L  L R   A+ V
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGH-------FLLGTLSR--YAVQV 120
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           A  + YL     K+ +H DL   N+LL    +  +GDFGL R +P+
Sbjct: 121 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 29/196 (14%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+           QR
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QR 112
Query: 556 LNIAI-NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQ 614
               I  +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P     + 
Sbjct: 113 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDL 169
Query: 615 CSSVGLKGTVGYAAPE 630
           C      GT+ Y  PE
Sbjct: 170 C------GTLDYLPPE 179

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 28/209 (13%)
Query: 430 NVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMA 487
           N+ ++ L++    +     +G G++G VYK   D    +VA+K + L     G   + + 
Sbjct: 13  NLYFQGLMEK---YQKLEKVGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIR 68
Query: 488 ECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSP 547
           E   L+ + H N+V +I    S          LV+EFM    L+  L             
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCL-----TLVFEFMEK-DLKKVLDENKTG------- 115
Query: 548 SILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP 607
                LQ   I I +   L  + H  + +I+H DLKP N+L+++D    + DFGL R   
Sbjct: 116 -----LQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFG 170
Query: 608 EVISSNQCSSVGLKGTVGYAAPEYGMGSQ 636
             + S     V    T+ Y AP+  MGS+
Sbjct: 171 IPVRSYTHEVV----TLWYRAPDVLMGSK 195

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 28/209 (13%)
Query: 430 NVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMA 487
           N+ ++ L++    +     +G G++G VYK   D    +VA+K + L     G   + + 
Sbjct: 13  NLYFQGLMEK---YQKLEKVGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIR 68
Query: 488 ECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSP 547
           E   L+ + H N+V +I    S          LV+EFM    L+  L             
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCL-----TLVFEFMEK-DLKKVLDENKTG------- 115
Query: 548 SILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP 607
                LQ   I I +   L  + H  + +I+H DLKP N+L+++D    + DFGL R   
Sbjct: 116 -----LQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFG 170
Query: 608 EVISSNQCSSVGLKGTVGYAAPEYGMGSQ 636
             + S     V    T+ Y AP+  MGS+
Sbjct: 171 IPVRSYTHEVV----TLWYRAPDVLMGSK 195

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 82/195 (42%), Gaps = 27/195 (13%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+   +  I      
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI------ 117
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
                 +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P    +  C
Sbjct: 118 ----TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC 170
Query: 616 SSVGLKGTVGYAAPE 630
                 GT+ Y  PE
Sbjct: 171 ------GTLDYLPPE 179

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 82/195 (42%), Gaps = 27/195 (13%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+   +  I      
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI------ 119
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
                 +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P    +  C
Sbjct: 120 ----TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC 172
Query: 616 SSVGLKGTVGYAAPE 630
                 GT+ Y  PE
Sbjct: 173 ------GTLDYLPPE 181

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 87/189 (46%), Gaps = 22/189 (11%)
Query: 447 NLIGTGSFGSVYKGILD---PDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG V  G L      +  VA+K L   +     + F++E   +    H N++ 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +    + S         ++ EFM +GSL+S+L                + +Q + +   +
Sbjct: 73  LEGVVTKSTP-----VMIITEFMENGSLDSFLRQNDGQ---------FTVIQLVGMLRGI 118
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISS-NQCSSVGLK 621
           A+ ++YL        VH  L   N+L++++++  V DFGL+RF+ +  S     S++G K
Sbjct: 119 AAGMKYL---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 175
Query: 622 GTVGYAAPE 630
             + + APE
Sbjct: 176 IPIRWTAPE 184

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 85/201 (42%), Gaps = 35/201 (17%)
Query: 443 FSSANLIGTGSFGSVYKGILDPD-QTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLV 501
           F    LIG+G FG V+K     D +T V  +V + +++        E +AL  + H N+V
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE-----REVKALAKLDHVNIV 67
Query: 502 KIITAC----------SSSDFQGNDFKALV--YEFMHHGSLESWLHPESASDDLNYSPSI 549
                C          SS +   +  K L    EF   G+LE W+               
Sbjct: 68  HY-NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-------- 118
Query: 550 LSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEV 609
           L  +  L +   +   ++Y+H    K++++ DLKPSN+ L +     +GDFGL   +   
Sbjct: 119 LDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL--- 172
Query: 610 ISSNQCSSVGLKGTVGYAAPE 630
              N       KGT+ Y +PE
Sbjct: 173 --KNDGKRXRSKGTLRYMSPE 191

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 82/191 (42%), Gaps = 27/191 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNIRHRN 499
           F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++RH N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           ++++        F       L+ E+   G++   L   S  D+   +  I          
Sbjct: 74  ILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYI---------- 118
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             +A+AL Y H    K+++H D+KP N+LL ++    + DFG +   P    +  C    
Sbjct: 119 TELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLC---- 171
Query: 620 LKGTVGYAAPE 630
             GT+ Y  PE
Sbjct: 172 --GTLDYLPPE 180

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 82/195 (42%), Gaps = 27/195 (13%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+   +  I      
Sbjct: 83  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI------ 131
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
                 +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P    +  C
Sbjct: 132 ----TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC 184
Query: 616 SSVGLKGTVGYAAPE 630
                 GT+ Y  PE
Sbjct: 185 ------GTLDYLPPE 193

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 29/196 (14%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+           QR
Sbjct: 65  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QR 108
Query: 556 LNIAI-NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQ 614
               I  +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P    +  
Sbjct: 109 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL 165
Query: 615 CSSVGLKGTVGYAAPE 630
           C      GT+ Y  PE
Sbjct: 166 C------GTLDYLPPE 175

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 84/184 (45%), Gaps = 24/184 (13%)
Query: 447 NLIGTGSFGSVYKGILD---PDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVK 502
            ++G G FG V  G L      +  VA+K L + +     + F+ E   +    H N+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +    + S         +V E+M +GSL+S+L    A           + +Q + +   +
Sbjct: 111 LEGVVTKSKPV-----MIVTEYMENGSLDSFLRKHDAQ---------FTVIQLVGMLRGI 156
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI---PEVISSNQCSSVG 619
           AS ++YL        VH DL   N+L++++++  V DFGL R +   PE   + +   + 
Sbjct: 157 ASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIP 213
Query: 620 LKGT 623
           ++ T
Sbjct: 214 IRWT 217

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 89/186 (47%), Gaps = 25/186 (13%)
Query: 449 IGTGSFGSVYKGI-LDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKII 504
           IG G FG V++GI + P+   +AV +            + F+ E   +R   H ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
              + +         ++ E    G L S+L     S DL    S++ +      A  +++
Sbjct: 78  GVITENPVW------IIMELCTLGELRSFLQVRKFSLDL---ASLILY------AYQLST 122
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
           AL YL     K+ VH D+   NVL+ ++    +GDFGL+R++ +  S+   +S G K  +
Sbjct: 123 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--STXXKASKG-KLPI 176
Query: 625 GYAAPE 630
            + APE
Sbjct: 177 KWMAPE 182

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 29/196 (14%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+           QR
Sbjct: 70  RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QR 113
Query: 556 LNIAI-NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQ 614
               I  +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P    +  
Sbjct: 114 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL 170
Query: 615 CSSVGLKGTVGYAAPE 630
           C      GT+ Y  PE
Sbjct: 171 C------GTLDYLPPE 180

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 86/195 (44%), Gaps = 32/195 (16%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL------KSFMAECEAL-RNI 495
           F    +IG GSFG V       ++   AVKVL   Q+ A+      K  M+E   L +N+
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL---QKKAILKKKEEKHIMSERNVLLKNV 96
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           +H  LV +        FQ  D    V ++++ G L   L  E            L    R
Sbjct: 97  KHPFLVGL-----HFSFQTADKLYFVLDYINGGELFYHLQRERC---------FLEPRAR 142
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
              A  +ASAL YLH      IV+ DLKP N+LLD+     + DFGL +   E I  N  
Sbjct: 143 F-YAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNST 195
Query: 616 SSVGLKGTVGYAAPE 630
           +S    GT  Y APE
Sbjct: 196 TST-FCGTPEYLAPE 209

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 82/195 (42%), Gaps = 27/195 (13%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+   +  I      
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI------ 119
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
                 +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P    +  C
Sbjct: 120 ----TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC 172
Query: 616 SSVGLKGTVGYAAPE 630
                 GT+ Y  PE
Sbjct: 173 ------GTLDYLPPE 181

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 82/195 (42%), Gaps = 27/195 (13%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+   +  I      
Sbjct: 69  RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI------ 117
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
                 +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P    +  C
Sbjct: 118 ----TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC 170
Query: 616 SSVGLKGTVGYAAPE 630
                 GT+ Y  PE
Sbjct: 171 ------GTLDYLPPE 179

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 89/186 (47%), Gaps = 25/186 (13%)
Query: 449 IGTGSFGSVYKGI-LDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKII 504
           IG G FG V++GI + P+   +AV +            + F+ E   +R   H ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
              + +         ++ E    G L S+L     S DL    S++ +      A  +++
Sbjct: 78  GVITENPVW------IIMELCTLGELRSFLQVRKYSLDL---ASLILY------AYQLST 122
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
           AL YL     K+ VH D+   NVL+ ++    +GDFGL+R++ +  S+   +S G K  +
Sbjct: 123 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--STYYKASKG-KLPI 176
Query: 625 GYAAPE 630
            + APE
Sbjct: 177 KWMAPE 182

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 89/186 (47%), Gaps = 25/186 (13%)
Query: 449 IGTGSFGSVYKGI-LDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKII 504
           IG G FG V++GI + P+   +AV +            + F+ E   +R   H ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
              + +         ++ E    G L S+L     S DL    S++ +      A  +++
Sbjct: 78  GVITENPVW------IIMELCTLGELRSFLQVRKYSLDL---ASLILY------AYQLST 122
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
           AL YL     K+ VH D+   NVL+ ++    +GDFGL+R++ +  S+   +S G K  +
Sbjct: 123 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--STYYKASKG-KLPI 176
Query: 625 GYAAPE 630
            + APE
Sbjct: 177 KWMAPE 182

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 94/197 (47%), Gaps = 25/197 (12%)
Query: 449 IGTGSFGSVY--KGI-LDPDQ----TVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRN 499
           +G G+FG V   + I LD D+    T VAVK+L        L   ++E E ++ I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASD-DLNYSPS-----ILSFL 553
           ++ ++ AC+    Q      +V E+   G+L  +L        +  Y+PS      LS  
Sbjct: 81  IINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 135
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
             ++ A  VA  +EYL     K+ +H DL   NVL+  D +  + DFGL R I  +    
Sbjct: 136 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 614 QCSSVGLKGTVGYAAPE 630
           + ++  L   V + APE
Sbjct: 193 KTTNGRL--PVKWMAPE 207

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 89/186 (47%), Gaps = 25/186 (13%)
Query: 449 IGTGSFGSVYKGI-LDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKII 504
           IG G FG V++GI + P+   +AV +            + F+ E   +R   H ++VK+I
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
              + +         ++ E    G L S+L     S DL    S++ +      A  +++
Sbjct: 106 GVITENPVW------IIMELCTLGELRSFLQVRKYSLDL---ASLILY------AYQLST 150
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
           AL YL     K+ VH D+   NVL+ ++    +GDFGL+R++ +  S+   +S G K  +
Sbjct: 151 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--STYYKASKG-KLPI 204
Query: 625 GYAAPE 630
            + APE
Sbjct: 205 KWMAPE 210

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 82/195 (42%), Gaps = 27/195 (13%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+   +  I      
Sbjct: 63  RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI------ 111
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
                 +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P    +  C
Sbjct: 112 ----TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC 164
Query: 616 SSVGLKGTVGYAAPE 630
                 GT+ Y  PE
Sbjct: 165 ------GTLDYLPPE 173

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 79/176 (44%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V  +  R A      K  + E  
Sbjct: 45  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAY 103
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 104 VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL---- 153
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFGL + +
Sbjct: 154 -----LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 201

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 29/196 (14%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+           QR
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QR 109
Query: 556 LNIAI-NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQ 614
               I  +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P    +  
Sbjct: 110 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXL 166
Query: 615 CSSVGLKGTVGYAAPE 630
           C      GT+ Y  PE
Sbjct: 167 C------GTLDYLPPE 176

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 94/197 (47%), Gaps = 25/197 (12%)
Query: 449 IGTGSFGSVY--KGI-LDPDQ----TVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRN 499
           +G G+FG V   + I LD D+    T VAVK+L        L   ++E E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASD-DLNYSPS-----ILSFL 553
           ++ ++ AC+    Q      +V E+   G+L  +L        +  Y+PS      LS  
Sbjct: 96  IINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 150
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
             ++ A  VA  +EYL     K+ +H DL   NVL+  D +  + DFGL R I  +    
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 614 QCSSVGLKGTVGYAAPE 630
           + ++  L   V + APE
Sbjct: 208 KTTNGRL--PVKWMAPE 222

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 88/195 (45%), Gaps = 30/195 (15%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALK---SFMAECEALRNIRH 497
           G +   + +G G+FG V  G  +     VAVK+L   +  +L        E + L+  RH
Sbjct: 16  GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH 75
Query: 498 RNLVKIITACSS-SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
            +++K+    S+ SD        +V E++  G L  ++     +  L+   S   F Q  
Sbjct: 76  PHIIKLYQVISTPSDI------FMVMEYVSGGELFDYI---CKNGRLDEKESRRLFQQ-- 124
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE-VISSNQC 615
                + S ++Y H H    +VH DLKP NVLLD  M A + DFGL+  + +       C
Sbjct: 125 -----ILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC 176
Query: 616 SSVGLKGTVGYAAPE 630
                 G+  YAAPE
Sbjct: 177 ------GSPNYAAPE 185

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 89/186 (47%), Gaps = 25/186 (13%)
Query: 449 IGTGSFGSVYKGI-LDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKII 504
           IG G FG V++GI + P+   +AV +            + F+ E   +R   H ++VK+I
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
              + +         ++ E    G L S+L     S DL    S++ +      A  +++
Sbjct: 81  GVITENPVW------IIMELCTLGELRSFLQVRKYSLDL---ASLILY------AYQLST 125
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
           AL YL     K+ VH D+   NVL+ ++    +GDFGL+R++ +  S+   +S G K  +
Sbjct: 126 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--STYYKASKG-KLPI 179
Query: 625 GYAAPE 630
            + APE
Sbjct: 180 KWMAPE 185

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 81/195 (41%), Gaps = 27/195 (13%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+   +  I      
Sbjct: 67  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI------ 115
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
                 +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P       C
Sbjct: 116 ----TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC 168
Query: 616 SSVGLKGTVGYAAPE 630
                 GT+ Y  PE
Sbjct: 169 ------GTLDYLPPE 177

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 84/184 (45%), Gaps = 24/184 (13%)
Query: 447 NLIGTGSFGSVYKGILD---PDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVK 502
            ++G G FG V  G L      +  VA+K L + +     + F+ E   +    H N+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +    + S         +V E+M +GSL+S+L    A           + +Q + +   +
Sbjct: 111 LEGVVTKSKPV-----MIVTEYMENGSLDSFLRKHDAQ---------FTVIQLVGMLRGI 156
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI---PEVISSNQCSSVG 619
           AS ++YL        VH DL   N+L++++++  V DFGL R +   PE   + +   + 
Sbjct: 157 ASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213
Query: 620 LKGT 623
           ++ T
Sbjct: 214 IRWT 217

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 83/195 (42%), Gaps = 27/195 (13%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G +   L   S  D+   +  I      
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYI------ 119
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
                 +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P   SS + 
Sbjct: 120 ----TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRX 169
Query: 616 SSVGLKGTVGYAAPE 630
               L GT+ Y  PE
Sbjct: 170 X---LXGTLDYLPPE 181

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 81/191 (42%), Gaps = 27/191 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNIRHRN 499
           F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++RH N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           ++++        F       L+ E+   G++   L   S  D+   +  I          
Sbjct: 74  ILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYI---------- 118
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             +A+AL Y H    K+++H D+KP N+LL ++    + DFG +   P       C    
Sbjct: 119 TELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC---- 171
Query: 620 LKGTVGYAAPE 630
             GT+ Y  PE
Sbjct: 172 --GTLDYLPPE 180

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 29/196 (14%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F  +    L+ E+   G++   L   S  D+           QR
Sbjct: 66  RHPNILRLYGY-----FHDSTRVYLILEYAPLGTVYRELQKLSKFDE-----------QR 109
Query: 556 LNIAI-NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQ 614
               I  +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P    +  
Sbjct: 110 TATYITELANALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAAL 166
Query: 615 CSSVGLKGTVGYAAPE 630
           C      GT+ Y  PE
Sbjct: 167 C------GTLDYLPPE 176

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 86/196 (43%), Gaps = 29/196 (14%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+           QR
Sbjct: 67  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QR 110
Query: 556 LNIAI-NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQ 614
               I  +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P   SS +
Sbjct: 111 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAP---SSRR 164
Query: 615 CSSVGLKGTVGYAAPE 630
            +   L GT+ Y  PE
Sbjct: 165 TT---LSGTLDYLPPE 177

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 89/186 (47%), Gaps = 25/186 (13%)
Query: 449 IGTGSFGSVYKGI-LDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKII 504
           IG G FG V++GI + P+   +AV +            + F+ E   +R   H ++VK+I
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
              + +         ++ E    G L S+L     S DL    S++ +      A  +++
Sbjct: 80  GVITENPVW------IIMELCTLGELRSFLQVRKYSLDL---ASLILY------AYQLST 124
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
           AL YL     K+ VH D+   NVL+ ++    +GDFGL+R++ +  S+   +S G K  +
Sbjct: 125 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--STYYKASKG-KLPI 178
Query: 625 GYAAPE 630
            + APE
Sbjct: 179 KWMAPE 184

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 89/186 (47%), Gaps = 25/186 (13%)
Query: 449 IGTGSFGSVYKGI-LDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKII 504
           IG G FG V++GI + P+   +AV +            + F+ E   +R   H ++VK+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
              + +         ++ E    G L S+L     S DL    S++ +      A  +++
Sbjct: 83  GVITENPVW------IIMELCTLGELRSFLQVRKYSLDL---ASLILY------AYQLST 127
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
           AL YL     K+ VH D+   NVL+ ++    +GDFGL+R++ +  S+   +S G K  +
Sbjct: 128 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--STYYKASKG-KLPI 181
Query: 625 GYAAPE 630
            + APE
Sbjct: 182 KWMAPE 187

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 89/186 (47%), Gaps = 25/186 (13%)
Query: 449 IGTGSFGSVYKGI-LDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKII 504
           IG G FG V++GI + P+   +AV +            + F+ E   +R   H ++VK+I
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
              + +         ++ E    G L S+L     S DL    S++ +      A  +++
Sbjct: 75  GVITENPVW------IIMELCTLGELRSFLQVRKYSLDL---ASLILY------AYQLST 119
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
           AL YL     K+ VH D+   NVL+ ++    +GDFGL+R++ +  S+   +S G K  +
Sbjct: 120 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--STYYKASKG-KLPI 173
Query: 625 GYAAPE 630
            + APE
Sbjct: 174 KWMAPE 179

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 89/186 (47%), Gaps = 25/186 (13%)
Query: 449 IGTGSFGSVYKGI-LDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKII 504
           IG G FG V++GI + P+   +AV +            + F+ E   +R   H ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
              + +         ++ E    G L S+L     S DL    S++ +      A  +++
Sbjct: 458 GVITENPVW------IIMELCTLGELRSFLQVRKFSLDL---ASLILY------AYQLST 502
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
           AL YL     K+ VH D+   NVL+ ++    +GDFGL+R++ +  S+   +S G K  +
Sbjct: 503 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--STYYKASKG-KLPI 556
Query: 625 GYAAPE 630
            + APE
Sbjct: 557 KWMAPE 562

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 82/195 (42%), Gaps = 27/195 (13%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+   +  I      
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI------ 117
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
                 +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P    +  C
Sbjct: 118 ----TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC 170
Query: 616 SSVGLKGTVGYAAPE 630
                 GT+ Y  PE
Sbjct: 171 ------GTLDYLPPE 179

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 25/209 (11%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALK-----SFMAECEALR 493
           AT  +     IG G++G+VYK         VA+K + +   G        S + E   LR
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 494 NIR---HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            +    H N+V+++  C++S         LV+E +    L ++L            P  L
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLD--------KAPPPGL 117
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVI 610
                 ++       L++LH +C   IVH DLKP N+L+ +     + DFGL R     I
Sbjct: 118 PAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR-----I 169
Query: 611 SSNQCSSVGLKGTVGYAAPEYGMGSQVST 639
            S Q +   +  T+ Y APE  + S  +T
Sbjct: 170 YSYQMALTPVVVTLWYRAPEVLLQSTYAT 198

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 29/196 (14%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+           QR
Sbjct: 66  RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QR 109
Query: 556 LNIAI-NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQ 614
               I  +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P    +  
Sbjct: 110 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAAL 166
Query: 615 CSSVGLKGTVGYAAPE 630
           C      GT+ Y  PE
Sbjct: 167 C------GTLDYLPPE 176

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 87/191 (45%), Gaps = 28/191 (14%)
Query: 447 NLIGTGSFGSVYKGILD-PDQTVVAVKVLFL---HQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG V  G L  P +  VAV +  L   +     + F+ E   +    H N+V 
Sbjct: 49  RVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVH 108
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +    +    +G     +V EFM +G+L+++L                + +Q + +   +
Sbjct: 109 LEGVVT----RGKPV-MIVIEFMENGALDAFLRKHDGQ---------FTVIQLVGMLRGI 154
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI---PEVISSNQCSSVG 619
           A+ + YL        VH DL   N+L++++++  V DFGL+R I   PE +     ++ G
Sbjct: 155 AAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVY----TTTG 207
Query: 620 LKGTVGYAAPE 630
            K  V + APE
Sbjct: 208 GKIPVRWTAPE 218

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 81/195 (41%), Gaps = 27/195 (13%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+   +  I      
Sbjct: 68  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI------ 116
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
                 +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P       C
Sbjct: 117 ----TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC 169
Query: 616 SSVGLKGTVGYAAPE 630
                 GT+ Y  PE
Sbjct: 170 ------GTLDYLPPE 178

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 82/196 (41%), Gaps = 29/196 (14%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+           QR
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QR 109
Query: 556 LNIAI-NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQ 614
               I  +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P       
Sbjct: 110 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL 166
Query: 615 CSSVGLKGTVGYAAPE 630
           C      GT+ Y  PE
Sbjct: 167 C------GTLDYLPPE 176

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 78/166 (46%), Gaps = 23/166 (13%)
Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLF--LHQRGALKSFMAECE---ALRNIRHRNLV 501
            ++G+G FG+V+KG+  P+   + + V    +  +   +SF A  +   A+ ++ H ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +++  C  S  Q      LV +++  GSL   +     +      P +L     LN  + 
Sbjct: 97  RLLGLCPGSSLQ------LVTQYLPLGSLLDHVRQHRGA----LGPQLL-----LNWGVQ 141
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP 607
           +A  + YL  H    +VH +L   NVLL +     V DFG+   +P
Sbjct: 142 IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 184

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 81/195 (41%), Gaps = 27/195 (13%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+   +  I      
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI------ 117
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
                 +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P       C
Sbjct: 118 ----TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC 170
Query: 616 SSVGLKGTVGYAAPE 630
                 GT+ Y  PE
Sbjct: 171 ------GTLDYLPPE 179

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 37/209 (17%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRN--IRHR 498
           G      +   G FG V+K  L  D   VAVK+  L  +   +S+ +E E      ++H 
Sbjct: 15  GSLQLLEIKARGRFGCVWKAQLMND--FVAVKIFPLQDK---QSWQSEREIFSTPGMKHE 69
Query: 499 NLVKIITACSSSDFQGNDFKA---LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           NL++ I A    + +G++ +    L+  F   GSL  +L             +I+++ + 
Sbjct: 70  NLLQFIAA----EKRGSNLEVELWLITAFHDKGSLTDYL-----------KGNIITWNEL 114
Query: 556 LNIAINVASALEYLHHHC--------KKQIVHCDLKPSNVLLDNDMIAHVGDFGLT-RFI 606
            ++A  ++  L YLH           K  I H D K  NVLL +D+ A + DFGL  RF 
Sbjct: 115 CHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFE 174
Query: 607 PEVISSNQCSSVGLKGTVGYAAPEYGMGS 635
           P         + G  GT  Y APE   G+
Sbjct: 175 P---GKPPGDTHGQVGTRRYMAPEVLEGA 200

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 91/196 (46%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L++++   SA   +   P I S+L +L    
Sbjct: 68  VKLLDVIHTENKL-----YLVFEFLHQ-DLKTFMD-ASALTGIPL-PLIKSYLFQL---- 115
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 116 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 168
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 169 --TLWYRAPEILLGCK 182

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 78/166 (46%), Gaps = 23/166 (13%)
Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLF--LHQRGALKSFMAECE---ALRNIRHRNLV 501
            ++G+G FG+V+KG+  P+   + + V    +  +   +SF A  +   A+ ++ H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +++  C  S  Q      LV +++  GSL   +     +      P +L     LN  + 
Sbjct: 79  RLLGLCPGSSLQ------LVTQYLPLGSLLDHVRQHRGA----LGPQLL-----LNWGVQ 123
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP 607
           +A  + YL  H    +VH +L   NVLL +     V DFG+   +P
Sbjct: 124 IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 84/184 (45%), Gaps = 24/184 (13%)
Query: 447 NLIGTGSFGSVYKGILD---PDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVK 502
            ++G G FG V  G L      +  VA+K L + +     + F+ E   +    H N+++
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +    + S         +V E M +GSL+S+L    A           + +Q + +   +
Sbjct: 82  LEGVVTKSKPV-----MIVTEXMENGSLDSFLRKHDAQ---------FTVIQLVGMLRGI 127
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI---PEVISSNQCSSVG 619
           AS ++YL        VH DL   N+L++++++  V DFGL+R +   PE   + +   + 
Sbjct: 128 ASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 184
Query: 620 LKGT 623
           ++ T
Sbjct: 185 IRWT 188

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 84/184 (45%), Gaps = 24/184 (13%)
Query: 447 NLIGTGSFGSVYKGILD---PDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVK 502
            ++G G FG V  G L      +  VA+K L + +     + F+ E   +    H N+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +    + S         +V E M +GSL+S+L    A           + +Q + +   +
Sbjct: 111 LEGVVTKSKPV-----MIVTEXMENGSLDSFLRKHDAQ---------FTVIQLVGMLRGI 156
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI---PEVISSNQCSSVG 619
           AS ++YL        VH DL   N+L++++++  V DFGL+R +   PE   + +   + 
Sbjct: 157 ASGMKYLSDMGA---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 620 LKGT 623
           ++ T
Sbjct: 214 IRWT 217

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 434 ESLLKATGGFSSANLIGTGSFGSVYKGI-LDPDQTVVAVKVLFLH--QRGALKSFMAECE 490
           + L +A   +     IG G++G V+K   L      VA+K + +   + G   S + E  
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 491 ALRNIR---HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSP 547
            LR++    H N+V++   C+ S         LV+E +    L ++L       D    P
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-------DKVPEP 115
Query: 548 SILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP 607
            + +   + ++   +   L++LH H   ++VH DLKP N+L+ +     + DFGL R   
Sbjct: 116 GVPTETIK-DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR--- 168
Query: 608 EVISSNQCSSVGLKGTVGYAAPEYGMGSQVST 639
             I S Q +   +  T+ Y APE  + S  +T
Sbjct: 169 --IYSFQMALTSVVVTLWYRAPEVLLQSSYAT 198

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 84/184 (45%), Gaps = 24/184 (13%)
Query: 447 NLIGTGSFGSVYKGILD---PDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVK 502
            ++G G FG V  G L      +  VA+K L + +     + F+ E   +    H N+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +    + S         +V E M +GSL+S+L    A           + +Q + +   +
Sbjct: 111 LEGVVTKSKPV-----MIVTEXMENGSLDSFLRKHDAQ---------FTVIQLVGMLRGI 156
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI---PEVISSNQCSSVG 619
           AS ++YL        VH DL   N+L++++++  V DFGL+R +   PE   + +   + 
Sbjct: 157 ASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 620 LKGT 623
           ++ T
Sbjct: 214 IRWT 217

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 36/202 (17%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTV---VAVKVLFL---HQRGALKSFMAECEALRNIR 496
           +   + +G G   +VY   L  D  +   VA+K +F+    +   LK F  E      + 
Sbjct: 13  YKIVDKLGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH---PESASDDLNYSPSILSFL 553
           H+N+V +I        + +D   LV E++   +L  ++    P S    +N++  IL  +
Sbjct: 70  HQNIVSMIDVD-----EEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGI 124
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
           +                H    +IVH D+KP N+L+D++    + DFG+ + + E  S  
Sbjct: 125 K----------------HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET-SLT 167
Query: 614 QCSSVGLKGTVGYAAPEYGMGS 635
           Q + V   GTV Y +PE   G 
Sbjct: 168 QTNHV--LGTVQYFSPEQAKGE 187

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 72  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 119
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 120 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-- 172
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 173 --TLWYRAPEILLGXK 186

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 65  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 112
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 113 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-- 165
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 166 --TLWYRAPEILLGXK 179

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 66  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 113
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 114 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-- 166
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 167 --TLWYRAPEILLGCK 180

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 68  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 115
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 116 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 168
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 169 --TLWYRAPEILLGCK 182

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 67  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 114
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 115 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 167
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 168 --TLWYRAPEILLGCK 181

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 69  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 116
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 117 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 169
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 170 --TLWYRAPEILLGCK 183

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 65  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 112
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 113 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-- 165
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 166 --TLWYRAPEILLGCK 179

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 66  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 113
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 114 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 166
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 167 --TLWYRAPEILLGCK 180

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 65  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 112
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 113 --LQGLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-- 165
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 166 --TLWYRAPEILLGCK 179

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 82/195 (42%), Gaps = 27/195 (13%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+   +  I      
Sbjct: 68  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI------ 116
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
                 +A+AL Y H    K+++H D+KP N+LL +     + +FG +   P    +  C
Sbjct: 117 ----TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC 169
Query: 616 SSVGLKGTVGYAAPE 630
                 GT+ Y  PE
Sbjct: 170 ------GTLDYLPPE 178

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 72  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 119
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 120 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-- 172
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 173 --TLWYRAPEILLGCK 186

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 83/196 (42%), Gaps = 29/196 (14%)
Query: 439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNI 495
           A   F     +G G FG+VY       + ++A+KVLF   L + G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH N++++        F       L+ E+   G++   L   S  D+           QR
Sbjct: 69  RHPNILRLY-----GYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----------QR 112
Query: 556 LNIAI-NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQ 614
               I  +A+AL Y H    K+++H D+KP N+LL +     + +FG +   P    +  
Sbjct: 113 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTL 169
Query: 615 CSSVGLKGTVGYAAPE 630
           C      GT+ Y  PE
Sbjct: 170 C------GTLDYLPPE 179

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 68  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 115
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 116 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 168
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 169 --TLWYRAPEILLGCK 182

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 85/196 (43%), Gaps = 33/196 (16%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMA-----ECEALRNI 495
           G +     +G GSFG V           VA+K++  +++   KS M      E   LR +
Sbjct: 4   GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKII--NKKVLAKSDMQGRIEREISYLRLL 61
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH +++K+     S D        +V E+  +   +  +  +  S+          F Q+
Sbjct: 62  RHPHIIKLYDVIKSKDEI-----IMVIEYAGNELFDYIVQRDKMSEQ-----EARRFFQQ 111
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEV-ISSNQ 614
                 + SA+EY H H   +IVH DLKP N+LLD  +   + DFGL+  + +       
Sbjct: 112 ------IISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS 162
Query: 615 CSSVGLKGTVGYAAPE 630
           C      G+  YAAPE
Sbjct: 163 C------GSPNYAAPE 172

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 67  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 114
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 115 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 167
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 168 --TLWYRAPEILLGCK 181

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 66  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 113
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 114 --LQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 166
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 167 --TLWYRAPEILLGCK 180

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 65  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 112
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 113 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-- 165
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 166 --TLWYRAPEILLGCK 179

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 64  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 111
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 112 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-- 164
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 165 --TLWYRAPEILLGCK 178

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 67  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 114
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 115 --LQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 167
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 168 --TLWYRAPEILLGCK 181

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 64  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 111
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 112 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 164
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 165 --TLWYRAPEILLGCK 178

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 434 ESLLKATGGFSSANLIGTGSFGSVYKGI-LDPDQTVVAVKVLFLH--QRGALKSFMAECE 490
           + L +A   +     IG G++G V+K   L      VA+K + +   + G   S + E  
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 491 ALRNIR---HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSP 547
            LR++    H N+V++   C+ S         LV+E +    L ++L       D    P
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-------DKVPEP 115
Query: 548 SILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP 607
            + +   + ++   +   L++LH H   ++VH DLKP N+L+ +     + DFGL R   
Sbjct: 116 GVPTETIK-DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR--- 168
Query: 608 EVISSNQCSSVGLKGTVGYAAPEYGMGSQVST 639
             I S Q +   +  T+ Y APE  + S  +T
Sbjct: 169 --IYSFQMALTSVVVTLWYRAPEVLLQSSYAT 198

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 65  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 112
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 113 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 165
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 166 --TLWYRAPEILLGCK 179

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 434 ESLLKATGGFSSANLIGTGSFGSVYKGI-LDPDQTVVAVKVLFLH--QRGALKSFMAECE 490
           + L +A   +     IG G++G V+K   L      VA+K + +   + G   S + E  
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 491 ALRNIR---HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSP 547
            LR++    H N+V++   C+ S         LV+E +    L ++L       D    P
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-------DKVPEP 115
Query: 548 SILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP 607
            + +   + ++   +   L++LH H   ++VH DLKP N+L+ +     + DFGL R   
Sbjct: 116 GVPTETIK-DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR--- 168
Query: 608 EVISSNQCSSVGLKGTVGYAAPEYGMGSQVST 639
             I S Q +   +  T+ Y APE  + S  +T
Sbjct: 169 --IYSFQMALTSVVVTLWYRAPEVLLQSSYAT 198

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 85/196 (43%), Gaps = 33/196 (16%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMA-----ECEALRNI 495
           G +     +G GSFG V           VA+K++  +++   KS M      E   LR +
Sbjct: 13  GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKII--NKKVLAKSDMQGRIEREISYLRLL 70
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH +++K+     S D        +V E+  +   +  +  +  S+          F Q+
Sbjct: 71  RHPHIIKLYDVIKSKDEI-----IMVIEYAGNELFDYIVQRDKMSEQ-----EARRFFQQ 120
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEV-ISSNQ 614
                 + SA+EY H H   +IVH DLKP N+LLD  +   + DFGL+  + +       
Sbjct: 121 ------IISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS 171
Query: 615 CSSVGLKGTVGYAAPE 630
           C      G+  YAAPE
Sbjct: 172 C------GSPNYAAPE 181

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 24/196 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITA 506
           IG G+FG V+K         VA+K + +   + G   + + E + L+ ++H N+V +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 507 CSSSDFQGNDFKA---LVYEFMHH---GSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           C +     N  KA   LV++F  H   G L + L   + S+       I   +Q L    
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSE-------IKRVMQML---- 134
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
              + L Y+H   + +I+H D+K +NVL+  D +  + DFGL R      +S        
Sbjct: 135 --LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNR 189
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y  PE  +G +
Sbjct: 190 VVTLWYRPPELLLGER 205

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 69  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 116
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 117 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-- 169
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 170 --TLWYRAPEILLGCK 183

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 64  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 111
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 112 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-- 164
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 165 --TLWYRAPEILLGCK 178

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 87/186 (46%), Gaps = 25/186 (13%)
Query: 449 IGTGSFGSVYKGI-LDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKII 504
           IG G FG V++GI + P+   +AV +            + F+ E   +R   H ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
              + +         ++ E    G L S+L     S DL    S++ +      A  +++
Sbjct: 78  GVITENPVW------IIMELCTLGELRSFLQVRKFSLDL---ASLILY------AYQLST 122
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
           AL YL     K+ VH D+   NVL+       +GDFGL+R++ +  S+   +S G K  +
Sbjct: 123 ALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMED--STYYKASKG-KLPI 176
Query: 625 GYAAPE 630
            + APE
Sbjct: 177 KWMAPE 182

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 85/196 (43%), Gaps = 33/196 (16%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMA-----ECEALRNI 495
           G +     +G GSFG V           VA+K++  +++   KS M      E   LR +
Sbjct: 14  GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKII--NKKVLAKSDMQGRIEREISYLRLL 71
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH +++K+     S D        +V E+  +   +  +  +  S+          F Q+
Sbjct: 72  RHPHIIKLYDVIKSKDEI-----IMVIEYAGNELFDYIVQRDKMSEQ-----EARRFFQQ 121
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEV-ISSNQ 614
                 + SA+EY H H   +IVH DLKP N+LLD  +   + DFGL+  + +       
Sbjct: 122 ------IISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS 172
Query: 615 CSSVGLKGTVGYAAPE 630
           C      G+  YAAPE
Sbjct: 173 C------GSPNYAAPE 182

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 87/186 (46%), Gaps = 25/186 (13%)
Query: 449 IGTGSFGSVYKGI-LDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKII 504
           IG G FG V++GI + P+   +AV +            + F+ E   +R   H ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
              + +         ++ E    G L S+L     S DL    S++ +      A  +++
Sbjct: 458 GVITENPVW------IIMELCTLGELRSFLQVRKFSLDL---ASLILY------AYQLST 502
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
           AL YL     K+ VH D+   NVL+       +GDFGL+R++ +  S+   +S G K  +
Sbjct: 503 ALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMED--STYYKASKG-KLPI 556
Query: 625 GYAAPE 630
            + APE
Sbjct: 557 KWMAPE 562

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 66  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 113
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 114 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 166
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 167 --TLWYRAPEILLGCK 180

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 64  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 111
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 112 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 164
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 165 --TLWYRAPEILLGCK 178

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 65  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 112
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 113 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 165
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 166 --TLWYRAPEILLGCK 179

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 15  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQY----- 122
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFGL + +
Sbjct: 123 ----LLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 171

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 85/196 (43%), Gaps = 33/196 (16%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMA-----ECEALRNI 495
           G +     +G GSFG V           VA+K++  +++   KS M      E   LR +
Sbjct: 8   GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKII--NKKVLAKSDMQGRIEREISYLRLL 65
Query: 496 RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           RH +++K+     S D        +V E+  +   +  +  +  S+          F Q+
Sbjct: 66  RHPHIIKLYDVIKSKDEI-----IMVIEYAGNELFDYIVQRDKMSEQ-----EARRFFQQ 115
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEV-ISSNQ 614
                 + SA+EY H H   +IVH DLKP N+LLD  +   + DFGL+  + +       
Sbjct: 116 ------IISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS 166
Query: 615 CSSVGLKGTVGYAAPE 630
           C      G+  YAAPE
Sbjct: 167 C------GSPNYAAPE 176

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 65  VKLLDVIHTENKL-----YLVFEFLHQ-DLKDFMD-ASALTGIPL-PLIKSYLFQL---- 112
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 113 --LQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 165
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 166 --TLWYRAPEILLGCK 179

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQY----- 120
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFGL + +
Sbjct: 121 ----LLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 169

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQY----- 121
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFGL + +
Sbjct: 122 ----LLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 170

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 12  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQY----- 119
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFGL + +
Sbjct: 120 ----LLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 168

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 65  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 112
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 113 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 165
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 166 --TLWYRAPEILLGCK 179

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 12  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGXLLDYVREHKDNIGSQY----- 119
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFGL + +
Sbjct: 120 ----LLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 168

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 65  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 112
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 113 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 165
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 166 --TLWYRAPEILLGCK 179

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL---- 119
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFGL + +
Sbjct: 120 -----LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 18  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQY----- 125
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFGL + +
Sbjct: 126 ----LLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 174

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 36  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 94
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 95  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQY----- 143
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFGL + +
Sbjct: 144 ----LLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 192

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQY----- 121
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFGL + +
Sbjct: 122 ----LLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 170

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 79/191 (41%), Gaps = 27/191 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNIRHRN 499
           F     +G G FG+VY         +VA+KVLF   + + G       E E   ++ H N
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPN 84
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           ++++        F       L+ E+   G L   L  +S + D   + +I+  L      
Sbjct: 85  ILRLYNY-----FYDRRRIYLILEYAPRGELYKELQ-KSCTFDEQRTATIMEEL------ 132
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
              A AL Y H    K+++H D+KP N+LL       + DFG +   P +     C    
Sbjct: 133 ---ADALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMC---- 182
Query: 620 LKGTVGYAAPE 630
             GT+ Y  PE
Sbjct: 183 --GTLDYLPPE 191

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQY----- 120
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFGL + +
Sbjct: 121 ----LLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 169

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 78/168 (46%), Gaps = 22/168 (13%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNLV 501
           +G G+FG VY+G +     DP    VAVK L     ++  L  F+ E   +  + H+N+V
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKLNHQNIV 111
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           + I     S       + ++ E M  G L+S+L            PS L+ L  L++A +
Sbjct: 112 RCIGVSLQSLP-----RFILLELMAGGDLKSFLRETRPRPS---QPSSLAMLDLLHVARD 163
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLD---NDMIAHVGDFGLTRFI 606
           +A   +YL  +     +H D+   N LL       +A +GDFG+ R I
Sbjct: 164 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 208

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL---- 122
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFGL + +
Sbjct: 123 -----LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 170

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGXLLDYVREHKDNIGSQYL---- 119
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFGL + +
Sbjct: 120 -----LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQY----- 118
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFGL + +
Sbjct: 119 ----LLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 79/194 (40%), Gaps = 29/194 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F    ++G GSF            TVV  + L   +  A+K         R+I   N V 
Sbjct: 32  FKFGKILGEGSFS-----------TVVLARELATSREYAIKILEK-----RHIIKENKVP 75
Query: 503 IITACSS--SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ---RLN 557
            +T      S      F  L + F     L   L      + L Y   I SF +   R  
Sbjct: 76  YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 135
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI-PEVISSNQCS 616
            A  + SALEYLH    K I+H DLKP N+LL+ DM   + DFG  + + PE   S Q  
Sbjct: 136 TA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE---SKQAR 188
Query: 617 SVGLKGTVGYAAPE 630
           +    GT  Y +PE
Sbjct: 189 ANAFVGTAQYVSPE 202

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 21  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 79
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 80  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL---- 129
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFGL + +
Sbjct: 130 -----LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 177

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 78/168 (46%), Gaps = 22/168 (13%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNLV 501
           +G G+FG VY+G +     DP    VAVK L     ++  L  F+ E   +  + H+N+V
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKLNHQNIV 97
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           + I     S       + ++ E M  G L+S+L            PS L+ L  L++A +
Sbjct: 98  RCIGVSLQSLP-----RFILLELMAGGDLKSFLRETRPRPS---QPSSLAMLDLLHVARD 149
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLD---NDMIAHVGDFGLTRFI 606
           +A   +YL  +     +H D+   N LL       +A +GDFG+ R I
Sbjct: 150 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 194

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 85/198 (42%), Gaps = 44/198 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA-------LKSFMAECEALRNIRHRNLV 501
           IG G FG V+KG L  D++VVA+K L L             + F  E   + N+ H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWL----HPESASDDLNYSPSILSFLQRLN 557
           K+     +          +V EF+  G L   L    HP             + +  +L 
Sbjct: 87  KLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHP-------------IKWSVKLR 126
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN-----DMIAHVGDFGLTRFIPEVISS 612
           + +++A  +EY+ +     IVH DL+  N+ L +      + A V DFGL++        
Sbjct: 127 LMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-------Q 178
Query: 613 NQCSSVGLKGTVGYAAPE 630
           +  S  GL G   + APE
Sbjct: 179 SVHSVSGLLGNFQWMAPE 196

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 80/199 (40%), Gaps = 29/199 (14%)
Query: 438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRH 497
           K    F    ++G GSF            TVV  + L   +  A+K         R+I  
Sbjct: 7   KRPEDFKFGKILGEGSFS-----------TVVLARELATSREYAIKILEK-----RHIIK 50
Query: 498 RNLVKIITACSS--SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ- 554
            N V  +T      S      F  L + F     L   L      + L Y   I SF + 
Sbjct: 51  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 110
Query: 555 --RLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI-PEVIS 611
             R   A  + SALEYLH    K I+H DLKP N+LL+ DM   + DFG  + + PE   
Sbjct: 111 CTRFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE--- 163
Query: 612 SNQCSSVGLKGTVGYAAPE 630
           S Q  +    GT  Y +PE
Sbjct: 164 SKQARANXFVGTAQYVSPE 182

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL---- 119
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFGL + +
Sbjct: 120 -----LNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQY----- 121
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFGL + +
Sbjct: 122 ----LLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 170

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 17  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 75
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 76  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQY----- 124
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFGL + +
Sbjct: 125 ----LLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 173

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 80/199 (40%), Gaps = 29/199 (14%)
Query: 438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRH 497
           K    F    ++G GSF            TVV  + L   +  A+K         R+I  
Sbjct: 6   KRPEDFKFGKILGEGSFS-----------TVVLARELATSREYAIKILEK-----RHIIK 49
Query: 498 RNLVKIITACSS--SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ- 554
            N V  +T      S      F  L + F     L   L      + L Y   I SF + 
Sbjct: 50  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 109
Query: 555 --RLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI-PEVIS 611
             R   A  + SALEYLH    K I+H DLKP N+LL+ DM   + DFG  + + PE   
Sbjct: 110 CTRFYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE--- 162
Query: 612 SNQCSSVGLKGTVGYAAPE 630
           S Q  +    GT  Y +PE
Sbjct: 163 SKQARANXFVGTAQYVSPE 181

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 86/194 (44%), Gaps = 34/194 (17%)
Query: 447 NLIGTGSFGSVYKGILD---PDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG V  G L      +  VA+K L   +     + F++E   +    H N++ 
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 94
Query: 503 ---IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
              ++T C            ++ E+M +GSL+++L                + +Q + + 
Sbjct: 95  LEGVVTKCKPV--------MIITEYMENGSLDAFLRKNDGR---------FTVIQLVGML 137
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI---PEVISSNQCS 616
             + S ++YL        VH DL   N+L++++++  V DFG++R +   PE   + +  
Sbjct: 138 RGIGSGMKYLSDM---SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR-- 192
Query: 617 SVGLKGTVGYAAPE 630
             G K  + + APE
Sbjct: 193 --GGKIPIRWTAPE 204

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 80/199 (40%), Gaps = 29/199 (14%)
Query: 438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRH 497
           K    F    ++G GSF            TVV  + L   +  A+K         R+I  
Sbjct: 4   KRPEDFKFGKILGEGSFS-----------TVVLARELATSREYAIKILEK-----RHIIK 47
Query: 498 RNLVKIITACSS--SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ- 554
            N V  +T      S      F  L + F     L   L      + L Y   I SF + 
Sbjct: 48  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 107
Query: 555 --RLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI-PEVIS 611
             R   A  + SALEYLH    K I+H DLKP N+LL+ DM   + DFG  + + PE   
Sbjct: 108 CTRFYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE--- 160
Query: 612 SNQCSSVGLKGTVGYAAPE 630
           S Q  +    GT  Y +PE
Sbjct: 161 SKQARANXFVGTAQYVSPE 179

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 8   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 66
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 67  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQY----- 115
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFGL + +
Sbjct: 116 ----LLNWCVQIAEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 164

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 20/167 (11%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G G+FG VY+G +     DP    VAVK L  ++       F+ E   +    H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
            I     S       + ++ E M  G L+S+L            PS L+ L  L++A ++
Sbjct: 113 CIGVSLQSLP-----RFILLELMAGGDLKSFLRETRPRPS---QPSSLAMLDLLHVARDI 164
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLD---NDMIAHVGDFGLTRFI 606
           A   +YL  +     +H D+   N LL       +A +GDFG+ R I
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 208

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 16/166 (9%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF--LHQRGALKSFMAECEALRNIRHRNL 500
           +   +LIGTGS+G V +     ++ VVA+K +          K  + E   L  + H ++
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++      D +  D   +V E             +S    L  +P  L+ L    +  
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIA-----------DSDFKKLFRTPVYLTELHIKTLLY 163
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           N+   ++Y+H      I+H DLKP+N L++ D    V DFGL R +
Sbjct: 164 NLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 80/199 (40%), Gaps = 29/199 (14%)
Query: 438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRH 497
           K    F    ++G GSF            TVV  + L   +  A+K         R+I  
Sbjct: 5   KRPEDFKFGKILGEGSFS-----------TVVLARELATSREYAIKILEK-----RHIIK 48
Query: 498 RNLVKIITACSS--SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ- 554
            N V  +T      S      F  L + F     L   L      + L Y   I SF + 
Sbjct: 49  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 108
Query: 555 --RLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI-PEVIS 611
             R   A  + SALEYLH    K I+H DLKP N+LL+ DM   + DFG  + + PE   
Sbjct: 109 CTRFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE--- 161
Query: 612 SNQCSSVGLKGTVGYAAPE 630
           S Q  +    GT  Y +PE
Sbjct: 162 SKQARANXFVGTAQYVSPE 180

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 79/194 (40%), Gaps = 29/194 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F    ++G GSF            TVV  + L   +  A+K         R+I   N V 
Sbjct: 35  FKFGKILGEGSFS-----------TVVLARELATSREYAIKILEK-----RHIIKENKVP 78
Query: 503 IITACSS--SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ---RLN 557
            +T      S      F  L + F     L   L      + L Y   I SF +   R  
Sbjct: 79  YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 138
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI-PEVISSNQCS 616
            A  + SALEYLH    K I+H DLKP N+LL+ DM   + DFG  + + PE   S Q  
Sbjct: 139 TA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE---SKQAR 191
Query: 617 SVGLKGTVGYAAPE 630
           +    GT  Y +PE
Sbjct: 192 ANSFVGTAQYVSPE 205

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 86/194 (44%), Gaps = 34/194 (17%)
Query: 447 NLIGTGSFGSVYKGILD---PDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG V  G L      +  VA+K L   +     + F++E   +    H N++ 
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 79
Query: 503 ---IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
              ++T C            ++ E+M +GSL+++L                + +Q + + 
Sbjct: 80  LEGVVTKCKPV--------MIITEYMENGSLDAFLRKNDGR---------FTVIQLVGML 122
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI---PEVISSNQCS 616
             + S ++YL        VH DL   N+L++++++  V DFG++R +   PE   + +  
Sbjct: 123 RGIGSGMKYLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR-- 177
Query: 617 SVGLKGTVGYAAPE 630
             G K  + + APE
Sbjct: 178 --GGKIPIRWTAPE 189

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 22/188 (11%)
Query: 447 NLIGTGSFGSVYKGILD-PDQTVVAVKVLFL---HQRGALKSFMAECEALRNIRHRNLVK 502
            +IG+G  G V  G L  P Q  V V +  L   +     + F++E   +    H N+++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +    +           +V E+M +GSL+++L                + +Q + +   V
Sbjct: 115 LEGVVTR-----GRLAMIVTEYMENGSLDTFLRTHDGQ---------FTIMQLVGMLRGV 160
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
            + + YL        VH DL   NVL+D++++  V DFGL+R + E       ++ G K 
Sbjct: 161 GAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL-EDDPDAAXTTTGGKI 216
Query: 623 TVGYAAPE 630
            + + APE
Sbjct: 217 PIRWTAPE 224

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 79/194 (40%), Gaps = 29/194 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F    ++G GSF            TVV  + L   +  A+K         R+I   N V 
Sbjct: 31  FKFGKILGEGSFS-----------TVVLARELATSREYAIKILEK-----RHIIKENKVP 74
Query: 503 IITACSS--SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ---RLN 557
            +T      S      F  L + F     L   L      + L Y   I SF +   R  
Sbjct: 75  YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 134
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI-PEVISSNQCS 616
            A  + SALEYLH    K I+H DLKP N+LL+ DM   + DFG  + + PE   S Q  
Sbjct: 135 TA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE---SKQAR 187
Query: 617 SVGLKGTVGYAAPE 630
           +    GT  Y +PE
Sbjct: 188 ANSFVGTAQYVSPE 201

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 86/194 (44%), Gaps = 34/194 (17%)
Query: 447 NLIGTGSFGSVYKGILD---PDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG V  G L      +  VA+K L   +     + F++E   +    H N++ 
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 73
Query: 503 ---IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
              ++T C            ++ E+M +GSL+++L                + +Q + + 
Sbjct: 74  LEGVVTKCKPV--------MIITEYMENGSLDAFLRKNDGR---------FTVIQLVGML 116
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI---PEVISSNQCS 616
             + S ++YL        VH DL   N+L++++++  V DFG++R +   PE   + +  
Sbjct: 117 RGIGSGMKYLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR-- 171
Query: 617 SVGLKGTVGYAAPE 630
             G K  + + APE
Sbjct: 172 --GGKIPIRWTAPE 183

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 22/168 (13%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNLV 501
           +G G+FG VY+G +     DP    VAVK L     ++  L  F+ E   +    H+N+V
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIV 137
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           + I     S       + ++ E M  G L+S+L            PS L+ L  L++A +
Sbjct: 138 RCIGVSLQSLP-----RFILLELMAGGDLKSFLRETRPRPS---QPSSLAMLDLLHVARD 189
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLD---NDMIAHVGDFGLTRFI 606
           +A   +YL  +     +H D+   N LL       +A +GDFG+ R I
Sbjct: 190 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 234

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 22/168 (13%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNLV 501
           +G G+FG VY+G +     DP    VAVK L     ++  L  F+ E   +    H+N+V
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIV 113
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           + I     S       + ++ E M  G L+S+L            PS L+ L  L++A +
Sbjct: 114 RCIGVSLQSLP-----RFILLELMAGGDLKSFLRETRPRPS---QPSSLAMLDLLHVARD 165
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLD---NDMIAHVGDFGLTRFI 606
           +A   +YL  +     +H D+   N LL       +A +GDFG+ R I
Sbjct: 166 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 210

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 22/168 (13%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNLV 501
           +G G+FG VY+G +     DP    VAVK L     ++  L  F+ E   +    H+N+V
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIV 111
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           + I     S       + ++ E M  G L+S+L            PS L+ L  L++A +
Sbjct: 112 RCIGVSLQSLP-----RFILMELMAGGDLKSFLRETRPRPS---QPSSLAMLDLLHVARD 163
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLD---NDMIAHVGDFGLTRFI 606
           +A   +YL  +     +H D+   N LL       +A +GDFG+ R I
Sbjct: 164 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 208

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 5   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 64  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL---- 113
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFGL + +
Sbjct: 114 -----LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 22/188 (11%)
Query: 447 NLIGTGSFGSVYKGILD-PDQTVVAVKVLFL---HQRGALKSFMAECEALRNIRHRNLVK 502
            +IG+G  G V  G L  P Q  V V +  L   +     + F++E   +    H N+++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +    +           +V E+M +GSL+++L                + +Q + +   V
Sbjct: 115 LEGVVTR-----GRLAMIVTEYMENGSLDTFLRTHDGQ---------FTIMQLVGMLRGV 160
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
            + + YL        VH DL   NVL+D++++  V DFGL+R + E       ++ G K 
Sbjct: 161 GAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL-EDDPDAAYTTTGGKI 216
Query: 623 TVGYAAPE 630
            + + APE
Sbjct: 217 PIRWTAPE 224

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 22/168 (13%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNLV 501
           +G G+FG VY+G +     DP    VAVK L     ++  L  F+ E   +    H+N+V
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIV 114
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           + I     S       + ++ E M  G L+S+L            PS L+ L  L++A +
Sbjct: 115 RCIGVSLQSLP-----RFILLELMAGGDLKSFLRETRPRPS---QPSSLAMLDLLHVARD 166
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLD---NDMIAHVGDFGLTRFI 606
           +A   +YL  +     +H D+   N LL       +A +GDFG+ R I
Sbjct: 167 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 211

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 69/159 (43%), Gaps = 23/159 (14%)
Query: 446 ANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKI 503
             LIG G FG VY G    +   VA++++ + +     LK+F  E  A R  RH N+V  
Sbjct: 38  GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
           + AC S         A++       +L S +       D+N +           IA  + 
Sbjct: 95  MGACMSPPHL-----AIITSLCKGRTLYSVVRDAKIVLDVNKT---------RQIAQEIV 140
Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL 602
             + YLH    K I+H DLK  NV  DN  +  + DFGL
Sbjct: 141 KGMGYLH---AKGILHKDLKSKNVFYDNGKVV-ITDFGL 175

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 79/194 (40%), Gaps = 29/194 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F    ++G GSF            TVV  + L   +  A+K         R+I   N V 
Sbjct: 34  FKFGKILGEGSFS-----------TVVLARELATSREYAIKILEK-----RHIIKENKVP 77
Query: 503 IITACSS--SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ---RLN 557
            +T      S      F  L + F     L   L      + L Y   I SF +   R  
Sbjct: 78  YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 137
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI-PEVISSNQCS 616
            A  + SALEYLH    K I+H DLKP N+LL+ DM   + DFG  + + PE   S Q  
Sbjct: 138 TA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE---SKQAR 190
Query: 617 SVGLKGTVGYAAPE 630
           +    GT  Y +PE
Sbjct: 191 ANXFVGTAQYVSPE 204

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 89/219 (40%), Gaps = 37/219 (16%)
Query: 437 LKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR 496
           L+    F    ++G G+FG V K     D    A+K +  H    L + ++E   L ++ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLN 60
Query: 497 H-------------RNLVKIITACSSSDFQGNDFKALVY---EFMHHGSLESWLHPESAS 540
           H             RN VK +TA           K+ ++   E+  +G+L   +H    S
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKK--------KSTLFIQMEYCENGTLYDLIH----S 108
Query: 541 DDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF 600
           ++LN        L R      +  AL Y+H    + I+H DLKP N+ +D      +GDF
Sbjct: 109 ENLNQQRDEYWRLFR-----QILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDF 160
Query: 601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST 639
           GL + +   +   +  S  L G+        G    V+T
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVAT 199

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 79/194 (40%), Gaps = 29/194 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F    ++G GSF            TVV  + L   +  A+K         R+I   N V 
Sbjct: 34  FKFGKILGEGSFS-----------TVVLARELATSREYAIKILEK-----RHIIKENKVP 77
Query: 503 IITACSS--SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ---RLN 557
            +T      S      F  L + F     L   L      + L Y   I SF +   R  
Sbjct: 78  YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 137
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI-PEVISSNQCS 616
            A  + SALEYLH    K I+H DLKP N+LL+ DM   + DFG  + + PE   S Q  
Sbjct: 138 TA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE---SKQAR 190
Query: 617 SVGLKGTVGYAAPE 630
           +    GT  Y +PE
Sbjct: 191 ANXFVGTAQYVSPE 204

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 22/168 (13%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNLV 501
           +G G+FG VY+G +     DP    VAVK L     ++  L  F+ E   +    H+N+V
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIV 103
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           + I     S       + ++ E M  G L+S+L            PS L+ L  L++A +
Sbjct: 104 RCIGVSLQSLP-----RFILLELMAGGDLKSFLRETRPRPS---QPSSLAMLDLLHVARD 155
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLD---NDMIAHVGDFGLTRFI 606
           +A   +YL  +     +H D+   N LL       +A +GDFG+ R I
Sbjct: 156 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 200

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 22/168 (13%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNLV 501
           +G G+FG VY+G +     DP    VAVK L     ++  L  F+ E   +    H+N+V
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIV 88
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           + I     S       + ++ E M  G L+S+L            PS L+ L  L++A +
Sbjct: 89  RCIGVSLQSLP-----RFILLELMAGGDLKSFLRETRPRPS---QPSSLAMLDLLHVARD 140
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLD---NDMIAHVGDFGLTRFI 606
           +A   +YL  +     +H D+   N LL       +A +GDFG+ R I
Sbjct: 141 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 185

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 22/168 (13%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNLV 501
           +G G+FG VY+G +     DP    VAVK L     ++  L  F+ E   +    H+N+V
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIV 97
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           + I     S       + ++ E M  G L+S+L            PS L+ L  L++A +
Sbjct: 98  RCIGVSLQSLP-----RFILLELMAGGDLKSFLRETRPRPS---QPSSLAMLDLLHVARD 149
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLD---NDMIAHVGDFGLTRFI 606
           +A   +YL  +     +H D+   N LL       +A +GDFG+ R I
Sbjct: 150 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 194

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 79/194 (40%), Gaps = 29/194 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F    ++G GSF            TVV  + L   +  A+K         R+I   N V 
Sbjct: 34  FKFGKILGEGSFS-----------TVVLARELATSREYAIKILEK-----RHIIKENKVP 77
Query: 503 IITACSS--SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ---RLN 557
            +T      S      F  L + F     L   L      + L Y   I SF +   R  
Sbjct: 78  YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 137
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI-PEVISSNQCS 616
            A  + SALEYLH    K I+H DLKP N+LL+ DM   + DFG  + + PE   S Q  
Sbjct: 138 TA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE---SKQAR 190
Query: 617 SVGLKGTVGYAAPE 630
           +    GT  Y +PE
Sbjct: 191 ANXFVGTAQYVSPE 204

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 24/196 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITA 506
           IG G+FG V+K         VA+K + +   + G   + + E + L+ ++H N+V +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 507 CSSSDFQGNDFKA---LVYEFMHH---GSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           C +     N  K    LV++F  H   G L + L   + S+       I   +Q L    
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE-------IKRVMQML---- 134
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
              + L Y+H   + +I+H D+K +NVL+  D +  + DFGL R      +S        
Sbjct: 135 --LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNR 189
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y  PE  +G +
Sbjct: 190 VVTLWYRPPELLLGER 205

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 22/168 (13%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNLV 501
           +G G+FG VY+G +     DP    VAVK L     ++  L  F+ E   +    H+N+V
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIV 96
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           + I     S       + ++ E M  G L+S+L            PS L+ L  L++A +
Sbjct: 97  RCIGVSLQSLP-----RFILMELMAGGDLKSFLRETRPRPS---QPSSLAMLDLLHVARD 148
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLD---NDMIAHVGDFGLTRFI 606
           +A   +YL  +     +H D+   N LL       +A +GDFG+ R I
Sbjct: 149 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 193

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 79/194 (40%), Gaps = 29/194 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F    ++G GSF            TVV  + L   +  A+K         R+I   N V 
Sbjct: 32  FKFGKILGEGSFS-----------TVVLARELATSREYAIKILEK-----RHIIKENKVP 75
Query: 503 IITACSS--SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ---RLN 557
            +T      S      F  L + F     L   L      + L Y   I SF +   R  
Sbjct: 76  YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 135
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI-PEVISSNQCS 616
            A  + SALEYLH    K I+H DLKP N+LL+ DM   + DFG  + + PE   S Q  
Sbjct: 136 TA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE---SKQAR 188
Query: 617 SVGLKGTVGYAAPE 630
           +    GT  Y +PE
Sbjct: 189 ANXFVGTAQYVSPE 202

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 79/194 (40%), Gaps = 29/194 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F    ++G GSF            TVV  + L   +  A+K         R+I   N V 
Sbjct: 35  FKFGKILGEGSFS-----------TVVLARELATSREYAIKILEK-----RHIIKENKVP 78
Query: 503 IITACSS--SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ---RLN 557
            +T      S      F  L + F     L   L      + L Y   I SF +   R  
Sbjct: 79  YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 138
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI-PEVISSNQCS 616
            A  + SALEYLH    K I+H DLKP N+LL+ DM   + DFG  + + PE   S Q  
Sbjct: 139 TA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE---SKQAR 191
Query: 617 SVGLKGTVGYAAPE 630
           +    GT  Y +PE
Sbjct: 192 ANXFVGTAQYVSPE 205

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 22/168 (13%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNLV 501
           +G G+FG VY+G +     DP    VAVK L     ++  L  F+ E   +    H+N+V
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIV 123
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           + I     S       + ++ E M  G L+S+L            PS L+ L  L++A +
Sbjct: 124 RCIGVSLQSLP-----RFILLELMAGGDLKSFLRETRPRPS---QPSSLAMLDLLHVARD 175
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLD---NDMIAHVGDFGLTRFI 606
           +A   +YL  +     +H D+   N LL       +A +GDFG+ R I
Sbjct: 176 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 220

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 79/194 (40%), Gaps = 29/194 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F    ++G GSF            TVV  + L   +  A+K         R+I   N V 
Sbjct: 16  FKFGKILGEGSFS-----------TVVLARELATSREYAIKILEK-----RHIIKENKVP 59
Query: 503 IITACSS--SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ---RLN 557
            +T      S      F  L + F     L   L      + L Y   I SF +   R  
Sbjct: 60  YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 119
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI-PEVISSNQCS 616
            A  + SALEYLH    K I+H DLKP N+LL+ DM   + DFG  + + PE   S Q  
Sbjct: 120 TA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE---SKQAR 172
Query: 617 SVGLKGTVGYAAPE 630
           +    GT  Y +PE
Sbjct: 173 ANXFVGTAQYVSPE 186

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 79/194 (40%), Gaps = 29/194 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F    ++G GSF            TVV  + L   +  A+K         R+I   N V 
Sbjct: 31  FKFGKILGEGSFS-----------TVVLARELATSREYAIKILEK-----RHIIKENKVP 74
Query: 503 IITACSS--SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ---RLN 557
            +T      S      F  L + F     L   L      + L Y   I SF +   R  
Sbjct: 75  YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 134
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI-PEVISSNQCS 616
            A  + SALEYLH    K I+H DLKP N+LL+ DM   + DFG  + + PE   S Q  
Sbjct: 135 TA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE---SKQAR 187
Query: 617 SVGLKGTVGYAAPE 630
           +    GT  Y +PE
Sbjct: 188 ANXFVGTAQYVSPE 201

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 79/194 (40%), Gaps = 29/194 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F    ++G GSF            TVV  + L   +  A+K         R+I   N V 
Sbjct: 32  FKFGKILGEGSFS-----------TVVLARELATSREYAIKILEK-----RHIIKENKVP 75
Query: 503 IITACSS--SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ---RLN 557
            +T      S      F  L + F     L   L      + L Y   I SF +   R  
Sbjct: 76  YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 135
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI-PEVISSNQCS 616
            A  + SALEYLH    K I+H DLKP N+LL+ DM   + DFG  + + PE   S Q  
Sbjct: 136 TA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE---SKQAR 188
Query: 617 SVGLKGTVGYAAPE 630
           +    GT  Y +PE
Sbjct: 189 ANXFVGTAQYVSPE 202

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 22/168 (13%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNLV 501
           +G G+FG VY+G +     DP    VAVK L     ++  L  F+ E   +    H+N+V
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIV 96
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           + I     S       + ++ E M  G L+S+L            PS L+ L  L++A +
Sbjct: 97  RCIGVSLQSLP-----RFILLELMAGGDLKSFLRETRPRPS---QPSSLAMLDLLHVARD 148
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLD---NDMIAHVGDFGLTRFI 606
           +A   +YL  +     +H D+   N LL       +A +GDFG+ R I
Sbjct: 149 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 193

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 79/194 (40%), Gaps = 29/194 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F    ++G GSF            TVV  + L   +  A+K         R+I   N V 
Sbjct: 37  FKFGKILGEGSFS-----------TVVLARELATSREYAIKILEK-----RHIIKENKVP 80
Query: 503 IITACSS--SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ---RLN 557
            +T      S      F  L + F     L   L      + L Y   I SF +   R  
Sbjct: 81  YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 140
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI-PEVISSNQCS 616
            A  + SALEYLH    K I+H DLKP N+LL+ DM   + DFG  + + PE   S Q  
Sbjct: 141 TA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE---SKQAR 193
Query: 617 SVGLKGTVGYAAPE 630
           +    GT  Y +PE
Sbjct: 194 ANXFVGTAQYVSPE 207

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 79/194 (40%), Gaps = 29/194 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F    ++G GSF            TVV  + L   +  A+K         R+I   N V 
Sbjct: 34  FKFGKILGEGSFS-----------TVVLARELATSREYAIKILEK-----RHIIKENKVP 77
Query: 503 IITACSS--SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ---RLN 557
            +T      S      F  L + F     L   L      + L Y   I SF +   R  
Sbjct: 78  YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 137
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI-PEVISSNQCS 616
            A  + SALEYLH    K I+H DLKP N+LL+ DM   + DFG  + + PE   S Q  
Sbjct: 138 TA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE---SKQAR 190
Query: 617 SVGLKGTVGYAAPE 630
           +    GT  Y +PE
Sbjct: 191 ANXFVGTAQYVSPE 204

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 79/194 (40%), Gaps = 29/194 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F    ++G GSF            TVV  + L   +  A+K         R+I   N V 
Sbjct: 34  FKFGKILGEGSFS-----------TVVLARELATSREYAIKILEK-----RHIIKENKVP 77
Query: 503 IITACSS--SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ---RLN 557
            +T      S      F  L + F     L   L      + L Y   I SF +   R  
Sbjct: 78  YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 137
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI-PEVISSNQCS 616
            A  + SALEYLH    K I+H DLKP N+LL+ DM   + DFG  + + PE   S Q  
Sbjct: 138 TA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE---SKQAR 190
Query: 617 SVGLKGTVGYAAPE 630
           +    GT  Y +PE
Sbjct: 191 ANXFVGTAQYVSPE 204

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 24/196 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITA 506
           IG G+FG V+K         VA+K + +   + G   + + E + L+ ++H N+V +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 507 CSSSDFQGNDFKA---LVYEFMHH---GSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           C +     N  K    LV++F  H   G L + L   + S+       I   +Q L    
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE-------IKRVMQML---- 134
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
              + L Y+H   + +I+H D+K +NVL+  D +  + DFGL R      +S        
Sbjct: 135 --LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNR 189
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y  PE  +G +
Sbjct: 190 VVTLWYRPPELLLGER 205

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 88/196 (44%), Gaps = 24/196 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITA 506
           IG G+FG V+K         VA+K + +   + G   + + E + L+ ++H N+V +I  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 507 CSSSDFQGNDFKA---LVYEFMHH---GSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           C +     N  K    LV++F  H   G L + L   + S+       I   +Q L    
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE-------IKRVMQML---- 133
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
              + L Y+H   + +I+H D+K +NVL+  D +  + DFGL R      +S        
Sbjct: 134 --LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNR 188
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y  PE  +G +
Sbjct: 189 VVTLWYRPPELLLGER 204

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 83/189 (43%), Gaps = 24/189 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI--RHRNLVKIITA 506
           IG G FG V++G    ++  VAVK+    +    +S+  E E  + +  RH N++  I A
Sbjct: 50  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 104
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +  +        LV ++  HGSL  +L+         Y+ ++   ++   +A++ AS L
Sbjct: 105 DNKDNGTWTQL-WLVSDYHEHGSLFDYLN--------RYTVTVEGMIK---LALSTASGL 152
Query: 567 EYLHHHC-----KKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
            +LH        K  I H DLK  N+L+  +    + D GL         +   +     
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 622 GTVGYAAPE 630
           GT  Y APE
Sbjct: 213 GTKRYMAPE 221

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/71 (43%), Positives = 40/71 (56%), Gaps = 7/71 (9%)
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI-PEVISSNQCSSVG 619
            + SALEYLH    K I+H DLKP N+LL+ DM   + DFG  + + PE   S Q  +  
Sbjct: 140 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE---SKQARANS 193
Query: 620 LKGTVGYAAPE 630
             GT  Y +PE
Sbjct: 194 FVGTAQYVSPE 204

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 89/197 (45%), Gaps = 25/197 (12%)
Query: 449 IGTGSFGSVYK----GI-LDPDQTVVAVKVLFLHQRGA---LKSFMAECEALRNI-RHRN 499
           +G G+FG V      GI  D  +  V V V  L        L   ++E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPE-----SASDDLNYSPS-ILSFL 553
           ++ ++ AC+    Q      +V E+   G+L  +L          S D+N  P   ++F 
Sbjct: 103 IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFK 157
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
             ++    +A  +EYL     ++ +H DL   NVL+  + +  + DFGL R I  +    
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXK 214
Query: 614 QCSSVGLKGTVGYAAPE 630
           + ++  L   V + APE
Sbjct: 215 KTTNGRL--PVKWMAPE 229

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 83/189 (43%), Gaps = 24/189 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI--RHRNLVKIITA 506
           IG G FG V++G    ++  VAVK+    +    +S+  E E  + +  RH N++  I A
Sbjct: 37  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 91
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +  +        LV ++  HGSL  +L+         Y+ ++   ++   +A++ AS L
Sbjct: 92  DNKDNGTWTQL-WLVSDYHEHGSLFDYLN--------RYTVTVEGMIK---LALSTASGL 139
Query: 567 EYLHHHC-----KKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
            +LH        K  I H DLK  N+L+  +    + D GL         +   +     
Sbjct: 140 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 199
Query: 622 GTVGYAAPE 630
           GT  Y APE
Sbjct: 200 GTKRYMAPE 208

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/71 (43%), Positives = 40/71 (56%), Gaps = 7/71 (9%)
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI-PEVISSNQCSSVG 619
            + SALEYLH    K I+H DLKP N+LL+ DM   + DFG  + + PE   S Q  +  
Sbjct: 138 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE---SKQARANX 191
Query: 620 LKGTVGYAAPE 630
             GT  Y +PE
Sbjct: 192 FVGTAQYVSPE 202

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+  + L     G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 65  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 112
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 113 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-- 165
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 166 --TLWYRAPEILLGCK 179

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+  + L     G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+H   L+ ++   SA   +   P I S+L +L    
Sbjct: 64  VKLLDVIHTENKL-----YLVFEFLHQ-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 111
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 112 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-- 164
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 165 --TLWYRAPEILLGCK 178

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 86/184 (46%), Gaps = 20/184 (10%)
Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITAC 507
           ++G G++G VY G    +Q  +A+K +        +    E    ++++H+N+V+ + + 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS- 87
Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F  N F  +  E +  GSL + L   S    L  +   + F  +      +   L+
Sbjct: 88  ----FSENGFIKIFMEQVPGGSLSALLR--SKWGPLKDNEQTIGFYTK-----QILEGLK 136
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDN-DMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
           YLH +   QIVH D+K  NVL++    +  + DFG ++ +  +   N C+     GT+ Y
Sbjct: 137 YLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI---NPCTET-FTGTLQY 189
Query: 627 AAPE 630
            APE
Sbjct: 190 MAPE 193

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 82/197 (41%), Gaps = 35/197 (17%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKS-----FMAECEALRNIRH 497
           F    ++G GSF +V            A+K+L   +R  +K         E + +  + H
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 498 RNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ--- 554
              VK+        FQ ++       +  +G L            L Y   I SF +   
Sbjct: 97  PFFVKLYFC-----FQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCT 139
Query: 555 RLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI-PEVISSN 613
           R   A  + SALEYLH    K I+H DLKP N+LL+ DM   + DFG  + + PE   S 
Sbjct: 140 RFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE---SK 192
Query: 614 QCSSVGLKGTVGYAAPE 630
           Q  +    GT  Y +PE
Sbjct: 193 QARANXFVGTAQYVSPE 209

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 77/176 (43%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL---- 121
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFG  + +
Sbjct: 122 -----LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL 169

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 89/197 (45%), Gaps = 25/197 (12%)
Query: 449 IGTGSFGSVYK----GI-LDPDQTVVAVKVLFLHQRGA---LKSFMAECEALRNI-RHRN 499
           +G G+FG V      GI  D  +  V V V  L        L   ++E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPE-----SASDDLNYSPS-ILSFL 553
           ++ ++ AC+    Q      +V E+   G+L  +L          S D+N  P   ++F 
Sbjct: 103 IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
             ++    +A  +EYL     ++ +H DL   NVL+  + +  + DFGL R I  +    
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXK 214
Query: 614 QCSSVGLKGTVGYAAPE 630
           + ++  L   V + APE
Sbjct: 215 KTTNGRL--PVKWMAPE 229

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 77/176 (43%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL---- 121
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFG  + +
Sbjct: 122 -----LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL 169

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 24/200 (12%)
Query: 438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRH 497
           +  G +     +GTG FG V + I       VA+K     Q  + K+    C  ++ ++ 
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQC--RQELSPKNRERWCLEIQIMKK 68
Query: 498 RNLVKIITACSSSD----FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFL 553
            N   +++A    D       ND   L  E+   G L  +L+       L   P I + L
Sbjct: 69  LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP-IRTLL 127
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD---NDMIAHVGDFGLTRFIPEVI 610
                  +++SAL YLH +   +I+H DLKP N++L      +I  + D G   +  E+ 
Sbjct: 128 S------DISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG---YAKELD 175
Query: 611 SSNQCSSVGLKGTVGYAAPE 630
               C+     GT+ Y APE
Sbjct: 176 QGELCTE--FVGTLQYLAPE 193

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 24/200 (12%)
Query: 438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRH 497
           +  G +     +GTG FG V + I       VA+K     Q  + K+    C  ++ ++ 
Sbjct: 12  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQC--RQELSPKNRERWCLEIQIMKK 69
Query: 498 RNLVKIITACSSSD----FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFL 553
            N   +++A    D       ND   L  E+   G L  +L+       L   P I + L
Sbjct: 70  LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP-IRTLL 128
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD---NDMIAHVGDFGLTRFIPEVI 610
                  +++SAL YLH +   +I+H DLKP N++L      +I  + D G   +  E+ 
Sbjct: 129 S------DISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG---YAKELD 176
Query: 611 SSNQCSSVGLKGTVGYAAPE 630
               C+     GT+ Y APE
Sbjct: 177 QGELCTE--FVGTLQYLAPE 194

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 84/198 (42%), Gaps = 44/198 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA-------LKSFMAECEALRNIRHRNLV 501
           IG G FG V+KG L  D++VVA+K L L             + F  E   + N+ H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWL----HPESASDDLNYSPSILSFLQRLN 557
           K+     +          +V EF+  G L   L    HP             + +  +L 
Sbjct: 87  KLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHP-------------IKWSVKLR 126
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN-----DMIAHVGDFGLTRFIPEVISS 612
           + +++A  +EY+ +     IVH DL+  N+ L +      + A V DFG ++        
Sbjct: 127 LMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-------Q 178
Query: 613 NQCSSVGLKGTVGYAAPE 630
           +  S  GL G   + APE
Sbjct: 179 SVHSVSGLLGNFQWMAPE 196

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 77/176 (43%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL---- 121
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFG  + +
Sbjct: 122 -----LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL 169

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 83/189 (43%), Gaps = 24/189 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI--RHRNLVKIITA 506
           IG G FG V++G    ++  VAVK+    +    +S+  E E  + +  RH N++  I A
Sbjct: 14  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 68
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +  +        LV ++  HGSL  +L+         Y+ ++   ++   +A++ AS L
Sbjct: 69  DNKDNGTWTQL-WLVSDYHEHGSLFDYLN--------RYTVTVEGMIK---LALSTASGL 116
Query: 567 EYLHHHC-----KKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
            +LH        K  I H DLK  N+L+  +    + D GL         +   +     
Sbjct: 117 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 176
Query: 622 GTVGYAAPE 630
           GT  Y APE
Sbjct: 177 GTKRYMAPE 185

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/72 (41%), Positives = 40/72 (55%), Gaps = 10/72 (13%)
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
           A  V  ALEYLH    K I++ DLKP N+LLD +    + DFG  +++P+V       + 
Sbjct: 112 AAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-------TY 161
Query: 619 GLKGTVGYAAPE 630
            L GT  Y APE
Sbjct: 162 XLCGTPDYIAPE 173

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 77/176 (43%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 15  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL---- 123
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFG  + +
Sbjct: 124 -----LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL 171

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 83/186 (44%), Gaps = 24/186 (12%)
Query: 452 GSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSD 511
           G FG V+K  L  +   VAVK+  +  + + ++   E  +L  ++H N+++ I A     
Sbjct: 35  GRFGCVWKAQLLNE--YVAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRGT 91
Query: 512 FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHH 571
               D   L+  F   GSL  +L             +++S+ +  +IA  +A  L YLH 
Sbjct: 92  SVDVDL-WLITAFHEKGSLSDFL-----------KANVVSWNELCHIAETMARGLAYLHE 139
Query: 572 HC-------KKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
                    K  I H D+K  NVLL N++ A + DFGL        S+    + G  GT 
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG--DTHGQVGTR 197
Query: 625 GYAAPE 630
            Y APE
Sbjct: 198 RYMAPE 203

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 77/176 (43%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 18  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL---- 126
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFG  + +
Sbjct: 127 -----LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL 174

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 83/189 (43%), Gaps = 24/189 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI--RHRNLVKIITA 506
           IG G FG V++G    ++  VAVK+    +    +S+  E E  + +  RH N++  I A
Sbjct: 17  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 71
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +  +        LV ++  HGSL  +L+         Y+ ++   ++   +A++ AS L
Sbjct: 72  DNKDNGTWTQL-WLVSDYHEHGSLFDYLN--------RYTVTVEGMIK---LALSTASGL 119
Query: 567 EYLHHHC-----KKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
            +LH        K  I H DLK  N+L+  +    + D GL         +   +     
Sbjct: 120 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 179
Query: 622 GTVGYAAPE 630
           GT  Y APE
Sbjct: 180 GTKRYMAPE 188

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 77/176 (43%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++ +G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 18  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQY----- 125
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFGL + +
Sbjct: 126 ----LLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 174

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 86/184 (46%), Gaps = 20/184 (10%)
Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITAC 507
           ++G G++G VY G    +Q  +A+K +        +    E    ++++H+N+V+ + + 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS- 73
Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F  N F  +  E +  GSL + L   S    L  +   + F  +      +   L+
Sbjct: 74  ----FSENGFIKIFMEQVPGGSLSALLR--SKWGPLKDNEQTIGFYTK-----QILEGLK 122
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDN-DMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
           YLH +   QIVH D+K  NVL++    +  + DFG ++ +  +   N C+     GT+ Y
Sbjct: 123 YLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI---NPCTET-FTGTLQY 175
Query: 627 AAPE 630
            APE
Sbjct: 176 MAPE 179

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 83/189 (43%), Gaps = 24/189 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI--RHRNLVKIITA 506
           IG G FG V++G    ++  VAVK+    +    +S+  E E  + +  RH N++  I A
Sbjct: 12  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 66
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +  +        LV ++  HGSL  +L+         Y+ ++   ++   +A++ AS L
Sbjct: 67  DNKDNGTWTQL-WLVSDYHEHGSLFDYLN--------RYTVTVEGMIK---LALSTASGL 114
Query: 567 EYLHHHC-----KKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
            +LH        K  I H DLK  N+L+  +    + D GL         +   +     
Sbjct: 115 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 174
Query: 622 GTVGYAAPE 630
           GT  Y APE
Sbjct: 175 GTKRYMAPE 183

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 83/189 (43%), Gaps = 24/189 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI--RHRNLVKIITA 506
           IG G FG V++G    ++  VAVK+    +    +S+  E E  + +  RH N++  I A
Sbjct: 11  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 65
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +  +        LV ++  HGSL  +L+         Y+ ++   ++   +A++ AS L
Sbjct: 66  DNKDNGTWTQL-WLVSDYHEHGSLFDYLN--------RYTVTVEGMIK---LALSTASGL 113
Query: 567 EYLHHHC-----KKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
            +LH        K  I H DLK  N+L+  +    + D GL         +   +     
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173
Query: 622 GTVGYAAPE 630
           GT  Y APE
Sbjct: 174 GTKRYMAPE 182

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 86/200 (43%), Gaps = 29/200 (14%)
Query: 441 GGFSSANLIGTGSFGSVY--KGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIR 496
           G +     IG G+F  V   + +L   +  VAVK++   Q    +L+    E   ++ + 
Sbjct: 15  GNYRLQKTIGKGNFAKVKLARHVLTGRE--VAVKIIDKTQLNPTSLQKLFREVRIMKILN 72
Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H N+VK+     +          LV E+   G +  +L    A   +    +   F Q  
Sbjct: 73  HPNIVKLFEVIETEKTL-----YLVMEYASGGEVFDYL---VAHGRMKEKEARAKFRQ-- 122
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                + SA++Y H   +K IVH DLK  N+LLD DM   + DFG   F  E    N+  
Sbjct: 123 -----IVSAVQYCH---QKYIVHRDLKAENLLLDGDMNIKIADFG---FSNEFTVGNKLD 171
Query: 617 SVGLKGTVGYAAPEYGMGSQ 636
           +    G+  YAAPE   G +
Sbjct: 172 T--FCGSPPYAAPELFQGKK 189

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 77/176 (43%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL---- 119
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFG  + +
Sbjct: 120 -----LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL 167

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 86/200 (43%), Gaps = 29/200 (14%)
Query: 441 GGFSSANLIGTGSFGSVY--KGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIR 496
           G +     IG G+F  V   + IL   +  VAVK++   Q    +L+    E   ++ + 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKE--VAVKIIDKTQLNSSSLQKLFREVRIMKVLN 71
Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H N+VK+     +          LV E+   G +  +L    A   +    +   F Q  
Sbjct: 72  HPNIVKLFEVIETEKTL-----YLVMEYASGGEVFDYL---VAHGRMKEKEARAKFRQ-- 121
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                + SA++Y H   +K IVH DLK  N+LLD DM   + DFG   F  E    N+  
Sbjct: 122 -----IVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFG---FSNEFTFGNKLD 170
Query: 617 SVGLKGTVGYAAPEYGMGSQ 636
           +    G+  YAAPE   G +
Sbjct: 171 TFC--GSPPYAAPELFQGKK 188

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 86/200 (43%), Gaps = 29/200 (14%)
Query: 441 GGFSSANLIGTGSFGSVY--KGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIR 496
           G +     IG G+F  V   + IL   +  VAVK++   Q    +L+    E   ++ + 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKE--VAVKIIDKTQLNSSSLQKLFREVRIMKVLN 71
Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H N+VK+     +          LV E+   G +  +L    A   +    +   F Q  
Sbjct: 72  HPNIVKLFEVIETEKTL-----YLVMEYASGGEVFDYL---VAHGRMKEKEARAKFRQ-- 121
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                + SA++Y H   +K IVH DLK  N+LLD DM   + DFG   F  E    N+  
Sbjct: 122 -----IVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFG---FSNEFTFGNKLD 170
Query: 617 SVGLKGTVGYAAPEYGMGSQ 636
           +    G+  YAAPE   G +
Sbjct: 171 TFC--GSPPYAAPELFQGKK 188

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 77/176 (43%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++ +G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 18  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQY----- 125
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFGL + +
Sbjct: 126 ----LLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 174

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 89/197 (45%), Gaps = 25/197 (12%)
Query: 449 IGTGSFGSVYK----GI-LDPDQTVVAVKVLFLHQRGA---LKSFMAECEALRNI-RHRN 499
           +G G+FG V      GI  D  +  V V V  L        L   ++E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPE-----SASDDLNYSPS-ILSFL 553
           ++ ++ AC+    Q      +V E+   G+L  +L          S D+N  P   ++F 
Sbjct: 103 IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
             ++    +A  +EYL     ++ +H DL   NVL+  + +  + DFGL R I  +    
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYK 214
Query: 614 QCSSVGLKGTVGYAAPE 630
           + ++  L   V + APE
Sbjct: 215 KTTNGRL--PVKWMAPE 229

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 22/168 (13%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNLV 501
           +G G+FG VY+G +     DP    VAVK L     ++  L  F+ E   +    H+N+V
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL-DFLMEALIISKFNHQNIV 97
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           + I     S       + ++ E M  G L+S+L            PS L+ L  L++A +
Sbjct: 98  RCIGVSLQSLP-----RFILLELMAGGDLKSFLRETRPRPS---QPSSLAMLDLLHVARD 149
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLD---NDMIAHVGDFGLTRFI 606
           +A   +YL  +     +H D+   N LL       +A +GDFG+ + I
Sbjct: 150 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDI 194

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 84/198 (42%), Gaps = 44/198 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA-------LKSFMAECEALRNIRHRNLV 501
           IG G FG V+KG L  D++VVA+K L L             + F  E   + N+ H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWL----HPESASDDLNYSPSILSFLQRLN 557
           K+     +          +V EF+  G L   L    HP             + +  +L 
Sbjct: 87  KLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHP-------------IKWSVKLR 126
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN-----DMIAHVGDFGLTRFIPEVISS 612
           + +++A  +EY+ +     IVH DL+  N+ L +      + A V DF L++        
Sbjct: 127 LMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-------Q 178
Query: 613 NQCSSVGLKGTVGYAAPE 630
           +  S  GL G   + APE
Sbjct: 179 SVHSVSGLLGNFQWMAPE 196

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 30/205 (14%)
Query: 446 ANLIGTGSFGSVYKGI---LDPDQTVVAVKVLFLHQRG---ALKSFMAECEALRNI-RHR 498
             ++G+G+FG V       +      + V V  L ++      ++ M+E + +  +  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPES---ASDDLNYSPS------- 548
           N+V ++ AC+ S   G  +  L++E+  +G L ++L  +    + D++ Y          
Sbjct: 110 NIVNLLGACTLS---GPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 549 ---ILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF 605
              +L+F   L  A  VA  +E+L     K  VH DL   NVL+ +  +  + DFGL R 
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 606 IPEVISSNQCSSVGLKGTVGYAAPE 630
           I  +  SN       +  V + APE
Sbjct: 222 I--MSDSNYVVRGNARLPVKWMAPE 244

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 77/176 (43%), Gaps = 24/176 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL-----KSFMAECE 490
           +LK T  F    ++ +G+FG+VYKG+  P+   V + V     R A      K  + E  
Sbjct: 11  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +    Y     
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQY----- 118
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                LN  + +A  + YL     +++VH DL   NVL+       + DFGL + +
Sbjct: 119 ----LLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 89/200 (44%), Gaps = 35/200 (17%)
Query: 438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFM-----AECEAL 492
           +  G +     +G GSFG V        Q  VA+K  F+ ++   KS M      E   L
Sbjct: 6   RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALK--FISRQLLKKSDMHMRVEREISYL 63
Query: 493 RNIRHRNLVKIITACSS-SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILS 551
           + +RH +++K+    ++ +D        +V E+      +  +  +  ++D         
Sbjct: 64  KLLRHPHIIKLYDVITTPTDI------VMVIEYAGGELFDYIVEKKRMTEDEGRR----- 112
Query: 552 FLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEV-I 610
           F Q+      +  A+EY H H   +IVH DLKP N+LLD+++   + DFGL+  + +   
Sbjct: 113 FFQQ------IICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163
Query: 611 SSNQCSSVGLKGTVGYAAPE 630
               C      G+  YAAPE
Sbjct: 164 LKTSC------GSPNYAAPE 177

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 89/197 (45%), Gaps = 25/197 (12%)
Query: 449 IGTGSFGSVYK----GI-LDPDQTVVAVKVLFLHQRGA---LKSFMAECEALRNI-RHRN 499
           +G G+FG V      GI  D  +  V V V  L        L   ++E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPE-----SASDDLNYSPS-ILSFL 553
           ++ ++ AC+    Q      +V E+   G+L  +L          S D+N  P   ++F 
Sbjct: 103 IITLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
             ++    +A  +EYL     ++ +H DL   NVL+  + +  + DFGL R I  +    
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 614 QCSSVGLKGTVGYAAPE 630
           + ++  L   V + APE
Sbjct: 215 KTTNGRL--PVKWMAPE 229

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 89/197 (45%), Gaps = 25/197 (12%)
Query: 449 IGTGSFGSVYK----GI-LDPDQTVVAVKVLFLHQRGA---LKSFMAECEALRNI-RHRN 499
           +G G+FG V      GI  D  +  V V V  L        L   ++E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPE-----SASDDLNYSPS-ILSFL 553
           ++ ++ AC+    Q      +V E+   G+L  +L          S D+N  P   ++F 
Sbjct: 103 IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
             ++    +A  +EYL     ++ +H DL   NVL+  + +  + DFGL R I  +    
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 614 QCSSVGLKGTVGYAAPE 630
           + ++  L   V + APE
Sbjct: 215 KTTNGRL--PVKWMAPE 229

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+E +H   L++++   SA   +   P I S+L +L    
Sbjct: 64  VKLLDVIHTENKL-----YLVFEHVHQ-DLKTFMD-ASALTGIPL-PLIKSYLFQL---- 111
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 112 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-- 164
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 165 --TLWYRAPEILLGCK 178

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 71/161 (44%), Gaps = 17/161 (10%)
Query: 446 ANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIIT 505
             ++G G FG   K        V+ +K L        ++F+ E + +R + H N++K I 
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
                D + N     + E++  G+L   +     S D  Y  S     QR++ A ++AS 
Sbjct: 75  VL-YKDKRLN----FITEYIKGGTLRGII----KSMDSQYPWS-----QRVSFAKDIASG 120
Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           + YLH      I+H DL   N L+  +    V DFGL R +
Sbjct: 121 MAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLM 158

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 87/189 (46%), Gaps = 17/189 (8%)
Query: 449 IGTGSFGSVYKGI---LDPDQTVVAVKVLFLHQRG---ALKSFMAECEALRNI-RHRNLV 501
           +G G+FG V +     L  +  V+ V V  L         ++ M+E + + ++ +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
            ++ AC+     G     ++ E+  +G L ++L  ++ +D        L     L+ +  
Sbjct: 114 NLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 168
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           VA  + +L     K  +H D+   NVLL N  +A +GDFGL R I  +  SN       +
Sbjct: 169 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI--MNDSNYIVKGNAR 223
Query: 622 GTVGYAAPE 630
             V + APE
Sbjct: 224 LPVKWMAPE 232

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 87/189 (46%), Gaps = 17/189 (8%)
Query: 449 IGTGSFGSVYKGI---LDPDQTVVAVKVLFLHQRG---ALKSFMAECEALRNI-RHRNLV 501
           +G G+FG V +     L  +  V+ V V  L         ++ M+E + + ++ +H N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
            ++ AC+     G     ++ E+  +G L ++L  ++ +D        L     L+ +  
Sbjct: 106 NLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 160
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           VA  + +L     K  +H D+   NVLL N  +A +GDFGL R I  +  SN       +
Sbjct: 161 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI--MNDSNYIVKGNAR 215
Query: 622 GTVGYAAPE 630
             V + APE
Sbjct: 216 LPVKWMAPE 224

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 26/200 (13%)
Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPD----QTVVAVKVLFLHQR-GALKSFMAECE 490
           +LK T       ++G+G+FG+VYKGI  PD    +  VA+KVL  +    A K  + E  
Sbjct: 13  ILKETE-LRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 71
Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            +  +    + +++  C +S  Q      LV + M +G L          D +  +   L
Sbjct: 72  VMAGVGSPYVSRLLGICLTSTVQ------LVTQLMPYGCL---------LDHVRENRGRL 116
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVI 610
                LN  + +A  + YL      ++VH DL   NVL+ +     + DFGL R +   I
Sbjct: 117 GSQDLLNWCMQIAKGMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLD--I 171
Query: 611 SSNQCSSVGLKGTVGYAAPE 630
              +  + G K  + + A E
Sbjct: 172 DETEYHADGGKVPIKWMALE 191

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 94/194 (48%), Gaps = 29/194 (14%)
Query: 443 FSSANLIGTGSFGSVY--KGILDPDQ-TVVAVKVL---FLHQRGALKSFMAECEALRNIR 496
           F    ++G GSFG V+  + +  PD   + A+KVL    L  R  +++ M E + L ++ 
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKM-ERDILADVN 88
Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H  +VK+  A     FQ      L+ +F+  G L + L     S ++ ++   + F    
Sbjct: 89  HPFVVKLHYA-----FQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKF---- 134
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +A  L++LH      I++ DLKP N+LLD +    + DFGL++   E I  ++  
Sbjct: 135 -YLAELALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---EAI-DHEKK 186
Query: 617 SVGLKGTVGYAAPE 630
           +    GTV Y APE
Sbjct: 187 AYSFCGTVEYMAPE 200

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 85/200 (42%), Gaps = 29/200 (14%)
Query: 441 GGFSSANLIGTGSFGSVY--KGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIR 496
           G +     IG G+F  V   + IL   +  VAVK++   Q    +L+    E   ++ + 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKE--VAVKIIDKTQLNSSSLQKLFREVRIMKVLN 71
Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H N+VK+     +          LV E+   G +  +L    A   +    +   F Q  
Sbjct: 72  HPNIVKLFEVIETEKTL-----YLVMEYASGGEVFDYL---VAHGRMKEKEARAKFRQ-- 121
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                + SA++Y H   +K IVH DLK  N+LLD DM   + DFG   F  E    N+  
Sbjct: 122 -----IVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFG---FSNEFTFGNKLD 170
Query: 617 SVGLKGTVGYAAPEYGMGSQ 636
           +    G   YAAPE   G +
Sbjct: 171 AFC--GAPPYAAPELFQGKK 188

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 78/198 (39%), Gaps = 38/198 (19%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +GTG+FG V++          A K +        ++   E + +  +RH  LV +  A  
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-- 116
Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
              F+ ++   ++YEFM  G L      E  +D+ N               ++   A+EY
Sbjct: 117 ---FEDDNEMVMIYEFMSGGELF-----EKVADEHN--------------KMSEDEAVEY 154
Query: 569 LHHHCK-------KQIVHCDLKPSNVLLDNDMIAHVG--DFGLTRFIPEVISSNQCSSVG 619
           +   CK          VH DLKP N++        +   DFGLT      +   Q   V 
Sbjct: 155 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH----LDPKQSVKV- 209
Query: 620 LKGTVGYAAPEYGMGSQV 637
             GT  +AAPE   G  V
Sbjct: 210 TTGTAEFAAPEVAEGKPV 227

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 78/198 (39%), Gaps = 38/198 (19%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +GTG+FG V++          A K +        ++   E + +  +RH  LV +  A  
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-- 222
Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
              F+ ++   ++YEFM  G L      E  +D+ N               ++   A+EY
Sbjct: 223 ---FEDDNEMVMIYEFMSGGELF-----EKVADEHN--------------KMSEDEAVEY 260
Query: 569 LHHHCK-------KQIVHCDLKPSNVLLDNDMIAHVG--DFGLTRFIPEVISSNQCSSVG 619
           +   CK          VH DLKP N++        +   DFGLT      +   Q   V 
Sbjct: 261 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH----LDPKQSVKV- 315
Query: 620 LKGTVGYAAPEYGMGSQV 637
             GT  +AAPE   G  V
Sbjct: 316 TTGTAEFAAPEVAEGKPV 333

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 89/197 (45%), Gaps = 25/197 (12%)
Query: 449 IGTGSFGSVYK----GI-LDPDQTVVAVKVLFLHQRGA---LKSFMAECEALRNI-RHRN 499
           +G G+FG V      GI  D  +  V V V  L        L   ++E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPE-----SASDDLNYSPS-ILSFL 553
           ++ ++ AC+    Q      +V E+   G+L  +L          S D+N  P   ++F 
Sbjct: 103 IIHLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
             ++    +A  +EYL     ++ +H DL   NVL+  + +  + DFGL R I  +    
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 614 QCSSVGLKGTVGYAAPE 630
           + ++  L   V + APE
Sbjct: 215 KTTNGRL--PVKWMAPE 229

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 101/238 (42%), Gaps = 31/238 (13%)
Query: 414 RTVTSSESSSRKDLLLNVS-YESLLKATGGFSSANL-----IGTGSFGSVYK----GI-L 462
           R  T   S++   +L  VS YE        F    L     +G G FG V      GI  
Sbjct: 48  RITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDK 107
Query: 463 DPDQTVVAVKVLFLHQRGA---LKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDFK 518
           D  +  V V V  L        L   ++E E ++ I +H+N++ ++ AC+    Q     
Sbjct: 108 DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT----QDGPLY 163
Query: 519 ALVYEFMHHGSLESWLHPESA-----SDDLNYSPS-ILSFLQRLNIAINVASALEYLHHH 572
            +V E+   G+L  +L          S D+N  P   ++F   ++    +A  +EYL   
Sbjct: 164 VIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL--- 219
Query: 573 CKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPE 630
             ++ +H DL   NVL+  + +  + DFGL R I  +    + ++  L   V + APE
Sbjct: 220 ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL--PVKWMAPE 275

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 82/195 (42%), Gaps = 36/195 (18%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F+    IG GSFG V+KGI +  Q VVA+K++ L +       +           +  + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-----------QQEIT 57
Query: 503 IITACSS---SDFQGNDFK----ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           +++ C S   + + G+  K     ++ E++  G         SA D L   P  L   Q 
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG---------SALDLLE--PGPLDETQI 106
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
             I   +   L+YLH   K   +H D+K +NVLL       + DFG    +   ++  Q 
Sbjct: 107 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFG----VAGQLTDTQI 159
Query: 616 SSVGLKGTVGYAAPE 630
                 GT  + APE
Sbjct: 160 KRNTFVGTPFWMAPE 174

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 82/195 (42%), Gaps = 36/195 (18%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F+    IG GSFG V+KGI +  Q VVA+K++ L +       +           +  + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-----------QQEIT 57
Query: 503 IITACSS---SDFQGNDFK----ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           +++ C S   + + G+  K     ++ E++  G         SA D L   P  L   Q 
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG---------SALDLLE--PGPLDETQI 106
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
             I   +   L+YLH   K   +H D+K +NVLL       + DFG    +   ++  Q 
Sbjct: 107 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFG----VAGQLTDTQI 159
Query: 616 SSVGLKGTVGYAAPE 630
                 GT  + APE
Sbjct: 160 KRNXFVGTPFWMAPE 174

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 86/191 (45%), Gaps = 28/191 (14%)
Query: 447 NLIGTGSFGSVYKGILD---PDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG V  G L      +  VA+K L + +     + F+ E   +    H N++ 
Sbjct: 28  RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIH 87
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +    + S         +V E+M +GSL+++L                + +Q + +   +
Sbjct: 88  LEGVVTKSKPV-----MIVTEYMENGSLDTFLKKNDGQ---------FTVIQLVGMLRGI 133
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI---PEVISSNQCSSVG 619
           ++ ++YL        VH DL   N+L++++++  V DFGL+R +   PE   + +    G
Sbjct: 134 SAGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR----G 186
Query: 620 LKGTVGYAAPE 630
            K  + + APE
Sbjct: 187 GKIPIRWTAPE 197

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 80/195 (41%), Gaps = 36/195 (18%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F+    IG GSFG V+KGI +  Q VVA+K++ L +                   +  + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-----------EDEIEDIQQEIT 73
Query: 503 IITACSSS---DFQGNDFKA----LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           +++ C SS    + G+  K     ++ E++  G         SA D L   P      Q 
Sbjct: 74  VLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGG---------SALDLLRAGP--FDEFQI 122
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
             +   +   L+YLH   K   +H D+K +NVLL       + DFG    +   ++  Q 
Sbjct: 123 ATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFG----VAGQLTDTQI 175
Query: 616 SSVGLKGTVGYAAPE 630
                 GT  + APE
Sbjct: 176 KRNTFVGTPFWMAPE 190

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 84/195 (43%), Gaps = 36/195 (18%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F+  + IG GSFG VYKGI +  + VVA+K++ L +       + +            + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQE-----------IT 69
Query: 503 IITACSS---SDFQGNDFKA----LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           +++ C S   + + G+  K+    ++ E++  GS    L P    +   Y  +IL     
Sbjct: 70  VLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEE--TYIATILR---- 123
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
                 +   L+YLH   K   +H D+K +NVLL       + DFG    +   ++  Q 
Sbjct: 124 -----EILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFG----VAGQLTDTQI 171
Query: 616 SSVGLKGTVGYAAPE 630
                 GT  + APE
Sbjct: 172 KRNXFVGTPFWMAPE 186

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 86/200 (43%), Gaps = 29/200 (14%)
Query: 441 GGFSSANLIGTGSFGSVY--KGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIR 496
           G +     IG G+F  V   + IL   +  VAVK++   Q    +L+    E   ++ + 
Sbjct: 7   GNYRLLKTIGKGNFAKVKLARHILTGKE--VAVKIIDKTQLNSSSLQKLFREVRIMKVLN 64
Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H N+VK+     +          LV E+   G +  +L    A   +    +   F Q  
Sbjct: 65  HPNIVKLFEVIETEKTL-----YLVMEYASGGEVFDYL---VAHGWMKEKEARAKFRQ-- 114
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                + SA++Y H   +K IVH DLK  N+LLD DM   + DFG   F  E    N+  
Sbjct: 115 -----IVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFG---FSNEFTFGNKLD 163
Query: 617 SVGLKGTVGYAAPEYGMGSQ 636
           +    G+  YAAPE   G +
Sbjct: 164 TFC--GSPPYAAPELFQGKK 181

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+    L+ ++   SA   +   P I S+L +L    
Sbjct: 68  VKLLDVIHTENKL-----YLVFEFLSM-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 115
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 116 --LQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 168
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 169 --TLWYRAPEILLGCK 182

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 81/195 (41%), Gaps = 36/195 (18%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F+    IG GSFG V+KGI +  Q VVA+K++ L +                   +  + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-----------EDEIEDIQQEIT 77
Query: 503 IITACSS---SDFQGNDFK----ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           +++ C S   + + G+  K     ++ E++  G         SA D L   P  L   Q 
Sbjct: 78  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG---------SALDLLE--PGPLDETQI 126
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
             I   +   L+YLH   K   +H D+K +NVLL       + DFG    +   ++  Q 
Sbjct: 127 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFG----VAGQLTDTQI 179
Query: 616 SSVGLKGTVGYAAPE 630
                 GT  + APE
Sbjct: 180 KRNTFVGTPFWMAPE 194

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 31/216 (14%)
Query: 437 LKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR 496
           L+    F    ++G G+FG V K     D    A+K +  H    L + ++E   L ++ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLN 60
Query: 497 H-------------RNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDL 543
           H             RN VK +TA      +   F  +  E+  + +L   +H    S++L
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKK---KSTLFIQM--EYCENRTLYDLIH----SENL 111
Query: 544 NYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT 603
           N        L R      +  AL Y+H    + I+H DLKP N+ +D      +GDFGL 
Sbjct: 112 NQQRDEYWRLFR-----QILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLA 163
Query: 604 RFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST 639
           + +   +   +  S  L G+        G    V+T
Sbjct: 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVAT 199

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 86/200 (43%), Gaps = 29/200 (14%)
Query: 441 GGFSSANLIGTGSFGSVY--KGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIR 496
           G +     IG G+F  V   + IL   +  VAV+++   Q    +L+    E   ++ + 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKE--VAVRIIDKTQLNSSSLQKLFREVRIMKVLN 71
Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H N+VK+     +          LV E+   G +  +L    A   +    +   F Q  
Sbjct: 72  HPNIVKLFEVIETEKTL-----YLVMEYASGGEVFDYL---VAHGRMKEKEARAKFRQ-- 121
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                + SA++Y H   +K IVH DLK  N+LLD DM   + DFG   F  E    N+  
Sbjct: 122 -----IVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFG---FSNEFTFGNKLD 170
Query: 617 SVGLKGTVGYAAPEYGMGSQ 636
           +    G+  YAAPE   G +
Sbjct: 171 TFC--GSPPYAAPELFQGKK 188

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 88/197 (44%), Gaps = 25/197 (12%)
Query: 449 IGTGSFGSVYK----GI-LDPDQTVVAVKVLFLHQRGA---LKSFMAECEALRNI-RHRN 499
           +G G+FG V      GI  D  +  V V V  L        L   ++E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPE-----SASDDLNYSPS-ILSFL 553
           ++ ++ AC+    Q      +V E+   G+L  +L          S D+N  P   ++F 
Sbjct: 103 IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
             ++    +A  +EYL     ++ +H DL   NVL+  + +  + DFGL R I  +    
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 614 QCSSVGLKGTVGYAAPE 630
             ++  L   V + APE
Sbjct: 215 NTTNGRL--PVKWMAPE 229

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+    L+ ++   SA   +   P I S+L +L    
Sbjct: 66  VKLLDVIHTENKL-----YLVFEFLSM-DLKKFMD-ASALTGIPL-PLIKSYLFQL---- 113
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 114 --LQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 166
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 167 --TLWYRAPEILLGCK 180

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 91/219 (41%), Gaps = 54/219 (24%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR----------HR 498
           +G G++G V+K I      VVAVK +F        +F    +A R  R          H 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIMILTELSGHE 69
Query: 499 NLVKIITACSSSDFQGNDFKA-LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLN 557
           N+V ++    +     ND    LV+++M     E+ LH    ++       IL  + +  
Sbjct: 70  NIVNLLNVLRAD----NDRDVYLVFDYM-----ETDLHAVIRAN-------ILEPVHKQY 113
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF----------IP 607
           +   +   ++YLH      ++H D+KPSN+LL+ +    V DFGL+R           IP
Sbjct: 114 VVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
Query: 608 EVISSN-------QCSSVGLKGTVGYAAPEYGMGSQVST 639
             I+ N       Q        T  Y APE  +GS   T
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYT 209

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+    L+ ++   SA   +   P I S+L +L    
Sbjct: 68  VKLLDVIHTENKL-----YLVFEFLSM-DLKDFMD-ASALTGIPL-PLIKSYLFQL---- 115
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 116 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 168
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 169 --TLWYRAPEILLGCK 182

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 88/197 (44%), Gaps = 25/197 (12%)
Query: 449 IGTGSFGSVYK----GI-LDPDQTVVAVKVLFLHQRGA---LKSFMAECEALRNI-RHRN 499
           +G G FG V      GI  D  +  V V V  L        L   ++E E ++ I +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPE-----SASDDLNYSPS-ILSFL 553
           ++ ++ AC+    Q      +V E+   G+L  +L          S D+N  P   ++F 
Sbjct: 90  IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 144
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
             ++    +A  +EYL     ++ +H DL   NVL+  + +  + DFGL R I  +    
Sbjct: 145 DLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYK 201
Query: 614 QCSSVGLKGTVGYAAPE 630
           + ++  L   V + APE
Sbjct: 202 KTTNGRL--PVKWMAPE 216

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 82/195 (42%), Gaps = 36/195 (18%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F+    IG GSFG V+KGI +  Q VVA+K++ L +       +           +  + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-----------QQEIT 72
Query: 503 IITACSS---SDFQGNDFK----ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           +++ C S   + + G+  K     ++ E++  G         SA D L   P  L   Q 
Sbjct: 73  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG---------SALDLLE--PGPLDETQI 121
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
             I   +   L+YLH   K   +H D+K +NVLL       + DFG    +   ++  Q 
Sbjct: 122 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFG----VAGQLTDTQI 174
Query: 616 SSVGLKGTVGYAAPE 630
                 GT  + APE
Sbjct: 175 KRNXFVGTPFWMAPE 189

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 88/197 (44%), Gaps = 25/197 (12%)
Query: 449 IGTGSFGSVYK----GI-LDPDQTVVAVKVLFLHQRGA---LKSFMAECEALRNI-RHRN 499
           +G G FG V      GI  D  +  V V V  L        L   ++E E ++ I +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPE-----SASDDLNYSPS-ILSFL 553
           ++ ++ AC+    Q      +V E+   G+L  +L          S D+N  P   ++F 
Sbjct: 92  IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 146
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
             ++    +A  +EYL     ++ +H DL   NVL+  + +  + DFGL R I  +    
Sbjct: 147 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 203
Query: 614 QCSSVGLKGTVGYAAPE 630
           + ++  L   V + APE
Sbjct: 204 KTTNGRL--PVKWMAPE 218

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        LV+EF+    L+ ++   SA   +   P I S+L +L    
Sbjct: 67  VKLLDVIHTENKL-----YLVFEFLSM-DLKDFMD-ASALTGIPL-PLIKSYLFQL---- 114
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 115 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 167
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 168 --TLWYRAPEILLGCK 181

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 88/197 (44%), Gaps = 25/197 (12%)
Query: 449 IGTGSFGSVYK----GI-LDPDQTVVAVKVLFLHQRGA---LKSFMAECEALRNI-RHRN 499
           +G G FG V      GI  D  +  V V V  L        L   ++E E ++ I +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPE-----SASDDLNYSPS-ILSFL 553
           ++ ++ AC+    Q      +V E+   G+L  +L          S D+N  P   ++F 
Sbjct: 95  IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 149
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
             ++    +A  +EYL     ++ +H DL   NVL+  + +  + DFGL R I  +    
Sbjct: 150 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 206
Query: 614 QCSSVGLKGTVGYAAPE 630
           + ++  L   V + APE
Sbjct: 207 KTTNGRL--PVKWMAPE 221

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 94/194 (48%), Gaps = 29/194 (14%)
Query: 443 FSSANLIGTGSFGSVY--KGILDPD-QTVVAVKVL---FLHQRGALKSFMAECEALRNIR 496
           F    ++G GSFG V+  K I   D + + A+KVL    L  R  +++ M E + L  + 
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVN 85
Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H  +VK+  A     FQ      L+ +F+  G L + L     S ++ ++   + F    
Sbjct: 86  HPFIVKLHYA-----FQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFY--- 132
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +A AL++LH      I++ DLKP N+LLD +    + DFGL++   E I  ++  
Sbjct: 133 --LAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK---ESI-DHEKK 183
Query: 617 SVGLKGTVGYAAPE 630
           +    GTV Y APE
Sbjct: 184 AYSFCGTVEYMAPE 197

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 88/190 (46%), Gaps = 27/190 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVKIITAC 507
           +G G++ +VYKG       +VA+K + L H+ GA  + + E   L++++H N+V +    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
            +          LV+E++    L+ +L  +   + +N     L   Q L         L 
Sbjct: 70  HTEKSL-----TLVFEYLDK-DLKQYL--DDCGNIINMHNVKLFLFQLLR-------GLA 114
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF--IPEVISSNQCSSVGLKGTVG 625
           Y H   +++++H DLKP N+L++      + DFGL R   IP     N+        T+ 
Sbjct: 115 YCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV------TLW 165
Query: 626 YAAPEYGMGS 635
           Y  P+  +GS
Sbjct: 166 YRPPDILLGS 175

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 85/200 (42%), Gaps = 29/200 (14%)
Query: 441 GGFSSANLIGTGSFGSVY--KGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIR 496
           G +     IG G+F  V   + IL   +  VAV+++   Q    +L+    E   ++ + 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKE--VAVRIIDKTQLNSSSLQKLFREVRIMKVLN 71
Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H N+VK+     +          LV E+   G +  +L    A   +    +   F Q  
Sbjct: 72  HPNIVKLFEVIETEKTL-----YLVMEYASGGEVFDYL---VAHGRMKEKEARAKFRQ-- 121
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                + SA++Y H   +K IVH DLK  N+LLD DM   + DFG   F  E    N+  
Sbjct: 122 -----IVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFG---FSNEFTFGNKLD 170
Query: 617 SVGLKGTVGYAAPEYGMGSQ 636
                G+  YAAPE   G +
Sbjct: 171 EFC--GSPPYAAPELFQGKK 188

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 94/194 (48%), Gaps = 29/194 (14%)
Query: 443 FSSANLIGTGSFGSVY--KGILDPD-QTVVAVKVL---FLHQRGALKSFMAECEALRNIR 496
           F    ++G GSFG V+  K I   D + + A+KVL    L  R  +++ M E + L  + 
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVN 84
Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H  +VK+  A     FQ      L+ +F+  G L + L     S ++ ++   + F    
Sbjct: 85  HPFIVKLHYA-----FQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFY--- 131
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +A AL++LH      I++ DLKP N+LLD +    + DFGL++   E I  ++  
Sbjct: 132 --LAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK---ESI-DHEKK 182
Query: 617 SVGLKGTVGYAAPE 630
           +    GTV Y APE
Sbjct: 183 AYSFCGTVEYMAPE 196

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 80/186 (43%), Gaps = 23/186 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G+FG VYK        + A KV+       L+ +M E + L +  H N+VK++ A  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF- 103
Query: 509 SSDFQGNDFKALVYEFMHHGSLES-WLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
              +  N+   L+ EF   G++++  L  E         P   S +Q   +      AL 
Sbjct: 104 ---YYENNLWILI-EFCAGGAVDAVMLELE--------RPLTESQIQV--VCKQTLDALN 149
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYA 627
           YLH +   +I+H DLK  N+L   D    + DFG++      I           GT  + 
Sbjct: 150 YLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD----SFIGTPYWM 202
Query: 628 APEYGM 633
           APE  M
Sbjct: 203 APEVVM 208

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 94/194 (48%), Gaps = 29/194 (14%)
Query: 443 FSSANLIGTGSFGSVY--KGILDPD-QTVVAVKVL---FLHQRGALKSFMAECEALRNIR 496
           F    ++G GSFG V+  K I   D + + A+KVL    L  R  +++ M E + L  + 
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVN 84
Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H  +VK+  A     FQ      L+ +F+  G L + L     S ++ ++   + F    
Sbjct: 85  HPFIVKLHYA-----FQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFY--- 131
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +A AL++LH      I++ DLKP N+LLD +    + DFGL++   E I  ++  
Sbjct: 132 --LAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK---ESI-DHEKK 182
Query: 617 SVGLKGTVGYAAPE 630
           +    GTV Y APE
Sbjct: 183 AYSFCGTVEYMAPE 196

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 82/205 (40%), Gaps = 38/205 (18%)
Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-----RGALKSFMAECEALRNIRHRNLV 501
            +IG G FG VY+     D+  VAVK    H         +++   E +    ++H N++
Sbjct: 13  EIIGIGGFGKVYRAFWIGDE--VAVKAA-RHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
            +   C            LV EF   G L   L  +         P IL     +N A+ 
Sbjct: 70  ALRGVCLKEPNL-----CLVMEFARGGPLNRVLSGK------RIPPDIL-----VNWAVQ 113
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLL-----DNDM---IAHVGDFGLTRFIPEVISSN 613
           +A  + YLH      I+H DLK SN+L+     + D+   I  + DFGL R        +
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR------EWH 167
Query: 614 QCSSVGLKGTVGYAAPEYGMGSQVS 638
           + + +   G   + APE    S  S
Sbjct: 168 RTTKMSAAGAYAWMAPEVIRASMFS 192

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 81/191 (42%), Gaps = 24/191 (12%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           F    ++G GSFG V    +     + AVKVL    + Q   ++  M E   L   R+  
Sbjct: 25  FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
            +  +  C    FQ  D    V EF++ G L   +      D+           +    A
Sbjct: 85  FLTQLFCC----FQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA----------RARFYA 130
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             + SAL +LH    K I++ DLK  NVLLD++    + DFG+ +   E I  N  ++  
Sbjct: 131 AEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGI-CNGVTTAT 183
Query: 620 LKGTVGYAAPE 630
             GT  Y APE
Sbjct: 184 FCGTPDYIAPE 194

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 79/186 (42%), Gaps = 23/186 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G+FG VYK        + A KV+       L+ +M E + L +  H N+VK++ A  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF- 103
Query: 509 SSDFQGNDFKALVYEFMHHGSLES-WLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
              +  N+   L+ EF   G++++  L  E            L+  Q   +      AL 
Sbjct: 104 ---YYENNLWILI-EFCAGGAVDAVMLELERP----------LTESQIQVVCKQTLDALN 149
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYA 627
           YLH +   +I+H DLK  N+L   D    + DFG++      I           GT  + 
Sbjct: 150 YLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRD----SFIGTPYWM 202
Query: 628 APEYGM 633
           APE  M
Sbjct: 203 APEVVM 208

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 83/197 (42%), Gaps = 21/197 (10%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSF---MAECEALRNIRHRN 499
           F    ++G G FG V+   +     + A K L   +    K +   M E + L  +  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           +V +  A     F+      LV   M+ G +   ++     +     P  + +       
Sbjct: 247 IVSLAYA-----FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY------T 295
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             + S LE+LH   ++ I++ DLKP NVLLD+D    + D GL       + + Q  + G
Sbjct: 296 AQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV----ELKAGQTKTKG 348
Query: 620 LKGTVGYAAPEYGMGSQ 636
             GT G+ APE  +G +
Sbjct: 349 YAGTPGFMAPELLLGEE 365

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 78/184 (42%), Gaps = 13/184 (7%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL-FLHQRGALKSFM-AECEALRNIRHRNLVKIITA 506
           IGTGS+G   K     D  ++  K L +     A K  + +E   LR ++H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
                 + N    +V E+   G L S +   +          +L  + +L +A+      
Sbjct: 74  IID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
               H     ++H DLKP+NV LD      +GDFGL R    +++ +   +    GT  Y
Sbjct: 131 SDGGH----TVLHRDLKPANVFLDGKQNVKLGDFGLAR----ILNHDTSFAKAFVGTPYY 182
Query: 627 AAPE 630
            +PE
Sbjct: 183 MSPE 186

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 83/197 (42%), Gaps = 21/197 (10%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSF---MAECEALRNIRHRN 499
           F    ++G G FG V+   +     + A K L   +    K +   M E + L  +  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           +V +  A     F+      LV   M+ G +   ++     +     P  + +       
Sbjct: 247 IVSLAYA-----FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY------T 295
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             + S LE+LH   ++ I++ DLKP NVLLD+D    + D GL       + + Q  + G
Sbjct: 296 AQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV----ELKAGQTKTKG 348
Query: 620 LKGTVGYAAPEYGMGSQ 636
             GT G+ APE  +G +
Sbjct: 349 YAGTPGFMAPELLLGEE 365

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 83/197 (42%), Gaps = 21/197 (10%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSF---MAECEALRNIRHRN 499
           F    ++G G FG V+   +     + A K L   +    K +   M E + L  +  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           +V +  A     F+      LV   M+ G +   ++     +     P  + +       
Sbjct: 247 IVSLAYA-----FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY------T 295
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             + S LE+LH   ++ I++ DLKP NVLLD+D    + D GL       + + Q  + G
Sbjct: 296 AQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV----ELKAGQTKTKG 348
Query: 620 LKGTVGYAAPEYGMGSQ 636
             GT G+ APE  +G +
Sbjct: 349 YAGTPGFMAPELLLGEE 365

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 83/197 (42%), Gaps = 21/197 (10%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSF---MAECEALRNIRHRN 499
           F    ++G G FG V+   +     + A K L   +    K +   M E + L  +  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           +V +  A     F+      LV   M+ G +   ++     +     P  + +       
Sbjct: 247 IVSLAYA-----FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY------T 295
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             + S LE+LH   ++ I++ DLKP NVLLD+D    + D GL       + + Q  + G
Sbjct: 296 AQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV----ELKAGQTKTKG 348
Query: 620 LKGTVGYAAPEYGMGSQ 636
             GT G+ APE  +G +
Sbjct: 349 YAGTPGFMAPELLLGEE 365

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 89/214 (41%), Gaps = 47/214 (21%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--------------------------FL 476
           ++  + IG GS+G V     + D T  A+KVL                           +
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 477 HQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHP 536
             RG ++    E   L+ + H N+VK++      D    D   +V+E ++ G +      
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKLVEVL---DDPNEDHLYMVFELVNQGPVMEVPTL 131
Query: 537 ESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH 596
           +  S+D         + Q L         +EYLH+   ++I+H D+KPSN+L+  D    
Sbjct: 132 KPLSED-----QARFYFQDL------IKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIK 177
Query: 597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPE 630
           + DFG++    E   S+   S  + GT  + APE
Sbjct: 178 IADFGVSN---EFKGSDALLSNTV-GTPAFMAPE 207

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 87/219 (39%), Gaps = 37/219 (16%)
Query: 437 LKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR 496
           L+    F    ++G G+FG V K     D    A+K +  H    L + ++E   L ++ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLN 60
Query: 497 H-------------RNLVKIITACSSSDFQGNDFKALVY---EFMHHGSLESWLHPESAS 540
           H             RN VK  TA           K+ ++   E+  + +L   +H    S
Sbjct: 61  HQYVVRYYAAWLERRNFVKPXTAVKK--------KSTLFIQXEYCENRTLYDLIH----S 108
Query: 541 DDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF 600
           ++LN        L R      +  AL Y+H    + I+H +LKP N+ +D      +GDF
Sbjct: 109 ENLNQQRDEYWRLFR-----QILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDF 160
Query: 601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST 639
           GL + +   +   +  S  L G+        G    V+T
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVAT 199

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 85/204 (41%), Gaps = 27/204 (13%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNL 500
           ++    IG G++G V        +T VA+K +  F HQ    ++ + E + L   RH N+
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRT-LREIQILLRFRHENV 103
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           + I     +S  +      +V + M    L   L  +  S+D      I  FL       
Sbjct: 104 IGIRDILRASTLEAMRDVYIVQDLME-TDLYKLLKSQQLSND-----HICYFL------Y 151
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L+Y+H      ++H DLKPSN+L++      + DFGL R     I+  +    G 
Sbjct: 152 QILRGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLAR-----IADPEHDHTGF 203
Query: 621 ----KGTVGYAAPEYGMGSQVSTN 640
                 T  Y APE  + S+  T 
Sbjct: 204 LTEXVATRWYRAPEIMLNSKGYTK 227

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 79/186 (42%), Gaps = 23/186 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G+FG VYK        + A KV+       L+ +M E + L +  H N+VK++ A  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF- 103
Query: 509 SSDFQGNDFKALVYEFMHHGSLES-WLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
              +  N+   L+ EF   G++++  L  E            L+  Q   +      AL 
Sbjct: 104 ---YYENNLWILI-EFCAGGAVDAVMLELERP----------LTESQIQVVCKQTLDALN 149
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYA 627
           YLH +   +I+H DLK  N+L   D    + DFG++      I           GT  + 
Sbjct: 150 YLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRD----XFIGTPYWM 202
Query: 628 APEYGM 633
           APE  M
Sbjct: 203 APEVVM 208

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 79/184 (42%), Gaps = 13/184 (7%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL-FLHQRGALKSFM-AECEALRNIRHRNLVKIITA 506
           IGTGS+G   K     D  ++  K L +     A K  + +E   LR ++H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
                 + N    +V E+   G L S +   +          +L  + +L +A+      
Sbjct: 74  IID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
               H     ++H DLKP+NV LD      +GDFGL R    +++ ++  +    GT  Y
Sbjct: 131 SDGGH----TVLHRDLKPANVFLDGKQNVKLGDFGLAR----ILNHDEDFAKEFVGTPYY 182
Query: 627 AAPE 630
            +PE
Sbjct: 183 MSPE 186

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 91/195 (46%), Gaps = 23/195 (11%)
Query: 449 IGTGSFGSVYKGI---LDPDQTVVAVKVLFLHQRG---ALKSFMAECEALRNI-RHRNLV 501
           +G G+FG V +     L  +  V+ V V  L         ++ M+E + + ++ +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASD-DLNYSPS-----ILSFLQR 555
            ++ AC+     G     ++ E+  +G L ++L  +     + +Y+PS      LS    
Sbjct: 114 NLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDL 168
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
           L+ +  VA  + +L     K  +H D+   NVLL N  +A +GDFGL R I  +  SN  
Sbjct: 169 LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI--MNDSNYI 223
Query: 616 SSVGLKGTVGYAAPE 630
                +  V + APE
Sbjct: 224 VKGNARLPVKWMAPE 238

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 28/196 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITA 506
           IG G++G+V+K        +VA+K + L     G   S + E   L+ ++H+N+V++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL--- 66
Query: 507 CSSSDFQGNDFK-ALVYEFMHHGSLESWLHPESASDDLNYSPSIL-SFLQRLNIAINVAS 564
               D   +D K  LV+EF     L+ +   +S + DL+  P I+ SFL +L        
Sbjct: 67  ---HDVLHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLD--PEIVKSFLFQL------LK 112
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            L + H    + ++H DLKP N+L++ +    + DFGL R     +       V    T+
Sbjct: 113 GLGFCH---SRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV----TL 165
Query: 625 GYAAPEYGMGSQVSTN 640
            Y  P+   G+++ + 
Sbjct: 166 WYRPPDVLFGAKLYST 181

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 88/197 (44%), Gaps = 25/197 (12%)
Query: 449 IGTGSFGSVYK----GI-LDPDQTVVAVKVLFLHQRGA---LKSFMAECEALRNI-RHRN 499
           +G G+FG V      GI  D  +  V V V  L        L   ++E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPE-----SASDDLNYSPS-ILSFL 553
           ++ ++ AC+    Q      +V  +   G+L  +L          S D+N  P   ++F 
Sbjct: 103 IINLLGACT----QDGPLYVIV-AYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
             ++    +A  +EYL     ++ +H DL   NVL+  + +  + DFGL R I  +    
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 614 QCSSVGLKGTVGYAAPE 630
           + ++  L   V + APE
Sbjct: 215 KTTNGRL--PVKWMAPE 229

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 87/197 (44%), Gaps = 36/197 (18%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           F   NL+G GSF  VY+         VA+K++    +++ G ++    E +    ++H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH----PESASDDLNYSPSILSFLQR 555
           ++++        F+ +++  LV E  H+G +  +L     P S ++  ++   I++    
Sbjct: 73  ILELYNY-----FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT---- 123
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR--FIPEVISSN 613
                     + YLH H    I+H DL  SN+LL  +M   + DFGL     +P      
Sbjct: 124 ---------GMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT 171
Query: 614 QCSSVGLKGTVGYAAPE 630
            C      GT  Y +PE
Sbjct: 172 LC------GTPNYISPE 182

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 78/184 (42%), Gaps = 13/184 (7%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL-FLHQRGALKSFM-AECEALRNIRHRNLVKIITA 506
           IGTGS+G   K     D  ++  K L +     A K  + +E   LR ++H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
                 + N    +V E+   G L S +   +          +L  + +L +A+      
Sbjct: 74  IID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
               H     ++H DLKP+NV LD      +GDFGL R    +++ +   +    GT  Y
Sbjct: 131 SDGGH----TVLHRDLKPANVFLDGKQNVKLGDFGLAR----ILNHDTSFAKTFVGTPYY 182
Query: 627 AAPE 630
            +PE
Sbjct: 183 MSPE 186

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 39/205 (19%)
Query: 441 GGFSSANLIGTGSFGSVY--KGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIR 496
           G +     IG G+F  V   + IL   +  VA+K++   Q    +L+    E   ++ + 
Sbjct: 12  GNYRLLKTIGKGNFAKVKLARHILTGRE--VAIKIIDKTQLNPTSLQKLFREVRIMKILN 69
Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H N+VK+     +          L+ E+   G +  +L    A   +    +   F Q  
Sbjct: 70  HPNIVKLFEVIETEKTL-----YLIMEYASGGEVFDYL---VAHGRMKEKEARSKFRQ-- 119
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                + SA++Y H   +K+IVH DLK  N+LLD DM   + DFG          SN+  
Sbjct: 120 -----IVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGF---------SNEF- 161
Query: 617 SVGLK-----GTVGYAAPEYGMGSQ 636
           +VG K     G+  YAAPE   G +
Sbjct: 162 TVGGKLDTFCGSPPYAAPELFQGKK 186

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 82/185 (44%), Gaps = 22/185 (11%)
Query: 449 IGTGSFGSVYKGI--LDPDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVKIIT 505
           +G G+FGSV +G+  +   Q  VA+KVL    ++   +  M E + +  + +  +V++I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
            C +          LV E    G L  +L  +     ++    +L           V+  
Sbjct: 78  VCQAEALM------LVMEMAGGGPLHKFLVGKREEIPVSNVAELLH---------QVSMG 122
Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG 625
           ++YL    +K  VH DL   NVLL N   A + DFGL++ +    S     S G K  + 
Sbjct: 123 MKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG-KWPLK 178
Query: 626 YAAPE 630
           + APE
Sbjct: 179 WYAPE 183

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 83/187 (44%), Gaps = 14/187 (7%)
Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIIT 505
            +IG+G+   V      P +  VA+K + L + + ++   + E +A+    H N+V   T
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
           +     F   D   LV + +  GS+   +    A  +  +   +L       I   V   
Sbjct: 81  S-----FVVKDELWLVMKLLSGGSVLDIIKHIVAKGE--HKSGVLDESTIATILREVLEG 133
Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE--VISSNQCSSVGLKGT 623
           LEYLH + +   +H D+K  N+LL  D    + DFG++ F+     I+ N+     + GT
Sbjct: 134 LEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GT 189
Query: 624 VGYAAPE 630
             + APE
Sbjct: 190 PCWMAPE 196

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 83/191 (43%), Gaps = 14/191 (7%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLV 501
           +    +IG+G+   V      P +  VA+K + L + + ++   + E +A+    H N+V
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 71
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
              T+     F   D   LV + +  GS+   +    A  +  +   +L       I   
Sbjct: 72  SYYTS-----FVVKDELWLVMKLLSGGSVLDIIKHIVAKGE--HKSGVLDESTIATILRE 124
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE--VISSNQCSSVG 619
           V   LEYLH   K   +H D+K  N+LL  D    + DFG++ F+     I+ N+     
Sbjct: 125 VLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 181
Query: 620 LKGTVGYAAPE 630
           + GT  + APE
Sbjct: 182 V-GTPCWMAPE 191

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 88/193 (45%), Gaps = 21/193 (10%)
Query: 449 IGTGSFGSVYKGI---LDPDQTVVAVKVLFLHQRG---ALKSFMAECEALRNI-RHRNLV 501
           +G G+FG V +     L  +  V+ V V  L         ++ M+E + + ++ +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPES----ASDDLNYSPSILSFLQRLN 557
            ++ AC+     G     ++ E+  +G L ++L  +S           + S LS    L+
Sbjct: 114 NLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLH 168
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
            +  VA  + +L     K  +H D+   NVLL N  +A +GDFGL R I  +  SN    
Sbjct: 169 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI--MNDSNYIVK 223
Query: 618 VGLKGTVGYAAPE 630
              +  V + APE
Sbjct: 224 GNARLPVKWMAPE 236

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 85/195 (43%), Gaps = 28/195 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRH--RN 499
           +   ++IG G    V + +        AVK++ +  +R + +      EA R   H  R 
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 500 LV---KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           +     IIT   S  ++ + F  LV++ M  G L  +L  + A          LS  +  
Sbjct: 156 VAGHPHIITLIDS--YESSSFMFLVFDLMRKGELFDYLTEKVA----------LSEKETR 203
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT-RFIPEVISSNQC 615
           +I  ++  A+ +LH      IVH DLKP N+LLD++M   + DFG +    P       C
Sbjct: 204 SIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC 260
Query: 616 SSVGLKGTVGYAAPE 630
                 GT GY APE
Sbjct: 261 ------GTPGYLAPE 269

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 78/191 (40%), Gaps = 25/191 (13%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           F    L+G G+FG V            A+K+L    +  +  +   + E   L+N RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           L  +  A     FQ +D    V E+ + G L   L  E       ++     F       
Sbjct: 67  LTALKYA-----FQTHDRLCFVMEYANGGELFFHLSRERV-----FTEERARFY-----G 111
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             + SALEYLH    + +V+ D+K  N++LD D    + DFGL +   E IS        
Sbjct: 112 AEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKT- 164
Query: 620 LKGTVGYAAPE 630
             GT  Y APE
Sbjct: 165 FCGTPEYLAPE 175

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 78/191 (40%), Gaps = 25/191 (13%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           F    L+G G+FG V            A+K+L    +  +  +   + E   L+N RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           L  +  A     FQ +D    V E+ + G L   L  E       ++     F       
Sbjct: 67  LTALKYA-----FQTHDRLCFVMEYANGGELFFHLSRERV-----FTEERARFY-----G 111
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             + SALEYLH    + +V+ D+K  N++LD D    + DFGL +   E IS        
Sbjct: 112 AEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKT- 164
Query: 620 LKGTVGYAAPE 630
             GT  Y APE
Sbjct: 165 FCGTPEYLAPE 175

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 84/182 (46%), Gaps = 8/182 (4%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G  G V+  + +     VA+K + L    ++K  + E + +R + H N+VK+     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
            S  Q  D    + E      ++ ++  + A + L   P +L    RL     +   L+Y
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLA-NVLEQGP-LLEEHARL-FMYQLLRGLKY 135
Query: 569 LHHHCKKQIVHCDLKPSNVLLD-NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYA 627
           +H      ++H DLKP+N+ ++  D++  +GDFGL R +    S     S GL  T  Y 
Sbjct: 136 IH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYR 191
Query: 628 AP 629
           +P
Sbjct: 192 SP 193

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 87/198 (43%), Gaps = 33/198 (16%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL---------KSFMAECEALR 493
           +    ++G G    V + I  P     AVK++ +   G+          ++ + E + LR
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 494 NIR-HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSF 552
            +  H N++++        ++ N F  LV++ M  G L  +L     ++ +  S      
Sbjct: 79  KVSGHPNIIQL-----KDTYETNTFFFLVFDLMKKGELFDYL-----TEKVTLSEKETRK 128
Query: 553 LQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISS 612
           + R  + +  A     LH   K  IVH DLKP N+LLD+DM   + DFG   F  ++   
Sbjct: 129 IMRALLEVICA-----LH---KLNIVHRDLKPENILLDDDMNIKLTDFG---FSCQLDPG 177
Query: 613 NQCSSVGLKGTVGYAAPE 630
            +  SV   GT  Y APE
Sbjct: 178 EKLRSVC--GTPSYLAPE 193

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/191 (23%), Positives = 81/191 (42%), Gaps = 26/191 (13%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRN 499
           F     IG GSFG V     +  + + A+K +      +R  +++   E + ++ + H  
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           LV +  +     FQ  +   +V + +  G L   L       ++++    +         
Sbjct: 77  LVNLWYS-----FQDEEDMFMVVDLLLGGDLRYHLQ-----QNVHFKEETVKLF-----I 121
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             +  AL+YL +   ++I+H D+KP N+LLD     H+ DF +   +P      +     
Sbjct: 122 CELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP-----RETQITT 173
Query: 620 LKGTVGYAAPE 630
           + GT  Y APE
Sbjct: 174 MAGTKPYMAPE 184

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 78/191 (40%), Gaps = 25/191 (13%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           F    L+G G+FG V            A+K+L    +  +  +   + E   L+N RH  
Sbjct: 10  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 69
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           L  +  A     FQ +D    V E+ + G L   L  E       ++     F       
Sbjct: 70  LTALKYA-----FQTHDRLCFVMEYANGGELFFHLSRERV-----FTEERARFY-----G 114
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             + SALEYLH    + +V+ D+K  N++LD D    + DFGL +   E IS        
Sbjct: 115 AEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKT- 167
Query: 620 LKGTVGYAAPE 630
             GT  Y APE
Sbjct: 168 FCGTPEYLAPE 178

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 86/204 (42%), Gaps = 37/204 (18%)
Query: 441 GGFSSANLIGTGSFGSVY--KGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIR 496
           G +     IG G+F  V   + IL   +  VA+K++   Q    +L+    E   ++ + 
Sbjct: 15  GNYRLLKTIGKGNFAKVKLARHILTGRE--VAIKIIDKTQLNPTSLQKLFREVRIMKILN 72
Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H N+VK+     +          L+ E+   G +  +L    A   +    +   F Q  
Sbjct: 73  HPNIVKLFEVIETEKTL-----YLIMEYASGGEVFDYL---VAHGRMKEKEARSKFRQ-- 122
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                + SA++Y H   +K+IVH DLK  N+LLD DM   + DFG          SN+ +
Sbjct: 123 -----IVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGF---------SNEFT 165
Query: 617 SVG----LKGTVGYAAPEYGMGSQ 636
             G      G   YAAPE   G +
Sbjct: 166 VGGKLDAFCGAPPYAAPELFQGKK 189

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 88/197 (44%), Gaps = 25/197 (12%)
Query: 449 IGTGSFGSVYK----GI-LDPDQTVVAVKVLFLHQRGA---LKSFMAECEALRNI-RHRN 499
           +G G+FG V      GI  D  +  V V V  L        L   ++E E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPE-----SASDDLNYSPS-ILSFL 553
           ++ ++ AC+    Q      +V  +   G+L  +L          S D+N  P   ++F 
Sbjct: 103 IINLLGACT----QDGPLYVIV-GYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
             ++    +A  +EYL     ++ +H DL   NVL+  + +  + DFGL R I  +    
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 614 QCSSVGLKGTVGYAAPE 630
           + ++  L   V + APE
Sbjct: 215 KTTNGRL--PVKWMAPE 229

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 24/205 (11%)
Query: 449 IGTGSFGSVYKG-ILDP---DQT-VVAVKVLFLHQRGALKS-FMAECEALRNIRHRNLVK 502
           +G   FG VYKG +  P   +QT  VA+K L     G L+  F  E      ++H N+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWL---HPES---ASDDLNYSPSILSFLQRL 556
           ++   +      +   ++++ +  HG L  +L    P S   ++DD     S L     +
Sbjct: 94  LLGVVTK-----DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 148
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
           ++   +A+ +EYL  H    +VH DL   NVL+ + +   + D GL R   EV +++   
Sbjct: 149 HLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFR---EVYAADYYK 202
Query: 617 SVGLK-GTVGYAAPEYGMGSQVSTN 640
            +G     + + APE  M  + S +
Sbjct: 203 LLGNSLLPIRWMAPEAIMYGKFSID 227

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 79/191 (41%), Gaps = 25/191 (13%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           F    L+G G+FG V            A+K+L    +  +  +   + E   L+N RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           L  +  A     FQ +D    V E+ + G L   L  E       ++     F       
Sbjct: 67  LTALKYA-----FQTHDRLCFVMEYANGGELFFHLSRERV-----FTEERARFY-----G 111
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             + SALEYLH    + +V+ D+K  N++LD D    + DFGL +   E IS    +   
Sbjct: 112 AEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDG-ATMKX 164
Query: 620 LKGTVGYAAPE 630
             GT  Y APE
Sbjct: 165 FCGTPEYLAPE 175

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 79/191 (41%), Gaps = 25/191 (13%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           F    L+G G+FG V            A+K+L    +  +  +   + E   L+N RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           L  +  A     FQ +D    V E+ + G L   L  E       ++     F       
Sbjct: 67  LTALKYA-----FQTHDRLCFVMEYANGGELFFHLSRERV-----FTEERARFY-----G 111
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             + SALEYLH    + +V+ D+K  N++LD D    + DFGL +   E IS    +   
Sbjct: 112 AEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDG-ATMKX 164
Query: 620 LKGTVGYAAPE 630
             GT  Y APE
Sbjct: 165 FCGTPEYLAPE 175

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 24/220 (10%)
Query: 414 RTVTSSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKV 473
           R+ + S++S  +++ ++++          F    L+G G+FG V            A+K+
Sbjct: 124 RSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI 183
Query: 474 L---FLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSL 530
           L    +  +  +   + E   L+N RH      +TA   S FQ +D    V E+ + G L
Sbjct: 184 LKKEVIVAKDEVAHTLTENRVLQNSRH----PFLTALKYS-FQTHDRLCFVMEYANGGEL 238
Query: 531 ESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD 590
             + H    S +  +S     F         + SAL+YLH   +K +V+ DLK  N++LD
Sbjct: 239 --FFH---LSRERVFSEDRARFY-----GAEIVSALDYLH--SEKNVVYRDLKLENLMLD 286
Query: 591 NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPE 630
            D    + DFGL +   E I           GT  Y APE
Sbjct: 287 KDGHIKITDFGLCK---EGIKDGATMKT-FCGTPEYLAPE 322

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 24/220 (10%)
Query: 414 RTVTSSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKV 473
           R+ + S++S  +++ ++++          F    L+G G+FG V            A+K+
Sbjct: 121 RSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI 180
Query: 474 L---FLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSL 530
           L    +  +  +   + E   L+N RH      +TA   S FQ +D    V E+ + G L
Sbjct: 181 LKKEVIVAKDEVAHTLTENRVLQNSRH----PFLTALKYS-FQTHDRLCFVMEYANGGEL 235
Query: 531 ESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD 590
             + H    S +  +S     F         + SAL+YLH   +K +V+ DLK  N++LD
Sbjct: 236 --FFH---LSRERVFSEDRARFY-----GAEIVSALDYLH--SEKNVVYRDLKLENLMLD 283
Query: 591 NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPE 630
            D    + DFGL +   E I           GT  Y APE
Sbjct: 284 KDGHIKITDFGLCK---EGIKDGATMKT-FCGTPEYLAPE 319

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 71/159 (44%), Gaps = 19/159 (11%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKS----FMAECEALRNIRHRNLVKII 504
           IG GSF +VYKG+    +T V V    L  R   KS    F  E E L+ ++H N+V+  
Sbjct: 34  IGRGSFKTVYKGL--DTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFY 91
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
            +  S+  +G     LV E    G+L+++L          +    +  L+  +    +  
Sbjct: 92  DSWEST-VKGKKCIVLVTELXTSGTLKTYLK--------RFKVXKIKVLR--SWCRQILK 140
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVGDFGL 602
            L++LH      I+H DLK  N+ +        +GD GL
Sbjct: 141 GLQFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGL 178

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 79/191 (41%), Gaps = 25/191 (13%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           F    L+G G+FG V            A+K+L    +  +  +   + E   L+N RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           L  +  A     FQ +D    V E+ + G L   L  E       ++     F       
Sbjct: 67  LTALKYA-----FQTHDRLCFVMEYANGGELFFHLSRERV-----FTEERARFY-----G 111
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             + SALEYLH    + +V+ D+K  N++LD D    + DFGL +   E IS    +   
Sbjct: 112 AEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDG-ATMKX 164
Query: 620 LKGTVGYAAPE 630
             GT  Y APE
Sbjct: 165 FCGTPEYLAPE 175

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 24/205 (11%)
Query: 449 IGTGSFGSVYKG-ILDP---DQT-VVAVKVLFLHQRGALKS-FMAECEALRNIRHRNLVK 502
           +G   FG VYKG +  P   +QT  VA+K L     G L+  F  E      ++H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWL---HPES---ASDDLNYSPSILSFLQRL 556
           ++   +      +   ++++ +  HG L  +L    P S   ++DD     S L     +
Sbjct: 77  LLGVVTK-----DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
           ++   +A+ +EYL  H    +VH DL   NVL+ + +   + D GL R   EV +++   
Sbjct: 132 HLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFR---EVYAADYYK 185
Query: 617 SVGLK-GTVGYAAPEYGMGSQVSTN 640
            +G     + + APE  M  + S +
Sbjct: 186 LLGNSLLPIRWMAPEAIMYGKFSID 210

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 79/191 (41%), Gaps = 25/191 (13%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           F    L+G G+FG V            A+K+L    +  +  +   + E   L+N RH  
Sbjct: 12  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 71
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           L  +  A     FQ +D    V E+ + G L   L  E       ++     F       
Sbjct: 72  LTALKYA-----FQTHDRLCFVMEYANGGELFFHLSRERV-----FTEERARFY-----G 116
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             + SALEYLH    + +V+ D+K  N++LD D    + DFGL +   E IS    +   
Sbjct: 117 AEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDG-ATMKX 169
Query: 620 LKGTVGYAAPE 630
             GT  Y APE
Sbjct: 170 FCGTPEYLAPE 180

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 29/206 (14%)
Query: 430 NVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMA 487
           N+ ++S+      +S    IG+G    V++ +L+  + + A+K + L +     L S+  
Sbjct: 17  NLYFQSMSVKGRIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRN 75
Query: 488 ECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLE--SWLHPESASDDLNY 545
           E   L  ++  +  KII      D++  D    +Y  M  G+++  SWL  + + D    
Sbjct: 76  EIAYLNKLQQHS-DKIIRLY---DYEITD--QYIYMVMECGNIDLNSWLKKKKSIDPW-- 127
Query: 546 SPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT-R 604
                   +R +   N+  A+  +H H    IVH DLKP+N L+ + M+  + DFG+  +
Sbjct: 128 --------ERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQ 175
Query: 605 FIPEVISSNQCSSVGLKGTVGYAAPE 630
             P+  S  + S V   GTV Y  PE
Sbjct: 176 MQPDTTSVVKDSQV---GTVNYMPPE 198

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 82/196 (41%), Gaps = 23/196 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++    + +        L   F H           SA   +   P I S+L +L    
Sbjct: 68  VKLLDVIHTEN-------KLYLVFEHVDQDLKKFMDASALTGIPL-PLIKSYLFQL---- 115
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                L + H H   +++H DLKP N+L++ +    + DFGL R     + +     V  
Sbjct: 116 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 168
Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 169 --TLWYRAPEILLGCK 182

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 80/189 (42%), Gaps = 23/189 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKV-LFLHQRGALKSFMAECEALRNIRHRNLVKIITAC 507
           IG G++G VYK   +  +T    K+ L     G   + + E   L+ ++H N+VK+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
            +        K LV  F H          +     L+     L  +   +  + + + + 
Sbjct: 70  HTK-------KRLVLVFEHLD--------QDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYA 627
           Y H    ++++H DLKP N+L++ +    + DFGL R     +       V    T+ Y 
Sbjct: 115 YCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYR 167
Query: 628 APEYGMGSQ 636
           AP+  MGS+
Sbjct: 168 APDVLMGSK 176

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 88/200 (44%), Gaps = 41/200 (20%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTV---VAVKVLF---LHQRGALKSFMAECEALRNIR 496
           +    ++G GSFG V   IL  D+      AVKV+    + Q+   +S + E + L+ + 
Sbjct: 34  YKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H N++K+        F+   +  LV E    G L           D   S    S +   
Sbjct: 91  HPNIMKLYEF-----FEDKGYFYLVGEVYTGGELF----------DEIISRKRFSEVDAA 135
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN---DMIAHVGDFGLTRFIPEVISSN 613
            I   V S + Y+H   K +IVH DLKP N+LL++   D    + DFGL        S++
Sbjct: 136 RIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGL--------STH 184
Query: 614 QCSSVGLK---GTVGYAAPE 630
             +S  +K   GT  Y APE
Sbjct: 185 FEASKKMKDKIGTAYYIAPE 204

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 35/199 (17%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL---------KSFMAECEALR 493
           +    ++G G    V + I  P     AVK++ +   G+          ++ + E + LR
Sbjct: 6   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 65
Query: 494 NIR-HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSF 552
            +  H N++++        ++ N F  LV++ M  G L  +L     ++ +  S      
Sbjct: 66  KVSGHPNIIQL-----KDTYETNTFFFLVFDLMKKGELFDYL-----TEKVTLSEKETRK 115
Query: 553 LQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT-RFIPEVIS 611
           + R  + +  A     LH   K  IVH DLKP N+LLD+DM   + DFG + +  P    
Sbjct: 116 IMRALLEVICA-----LH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL 167
Query: 612 SNQCSSVGLKGTVGYAAPE 630
              C      GT  Y APE
Sbjct: 168 REVC------GTPSYLAPE 180

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 80/189 (42%), Gaps = 23/189 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKV-LFLHQRGALKSFMAECEALRNIRHRNLVKIITAC 507
           IG G++G VYK   +  +T    K+ L     G   + + E   L+ ++H N+VK+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
            +        K LV  F H          +     L+     L  +   +  + + + + 
Sbjct: 70  HTK-------KRLVLVFEHLD--------QDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYA 627
           Y H    ++++H DLKP N+L++ +    + DFGL R     +       V    T+ Y 
Sbjct: 115 YCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYR 167
Query: 628 APEYGMGSQ 636
           AP+  MGS+
Sbjct: 168 APDVLMGSK 176

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 445 SANLIGTGSFGSVYKG-ILDPDQTVV--AVKVL-FLHQRGALKSFMAECEALRNIRHRNL 500
           S  +IG G FG VY G  +D  Q  +  A+K L  + +   +++F+ E   +R + H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           + +I      +        ++  +M HG L  ++     +  +     ++SF       +
Sbjct: 85  LALIGIMLPPE----GLPHVLLPYMCHGDLLQFIRSPQRNPTVK---DLISF------GL 131
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
            VA  +EYL    +++ VH DL   N +LD      V DFGL R I
Sbjct: 132 QVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDI 174

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 80/189 (42%), Gaps = 23/189 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKV-LFLHQRGALKSFMAECEALRNIRHRNLVKIITAC 507
           IG G++G VYK   +  +T    K+ L     G   + + E   L+ ++H N+VK+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
            +        K LV  F H          +     L+     L  +   +  + + + + 
Sbjct: 70  HTK-------KRLVLVFEHLD--------QDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYA 627
           Y H    ++++H DLKP N+L++ +    + DFGL R     +       V    T+ Y 
Sbjct: 115 YCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYR 167
Query: 628 APEYGMGSQ 636
           AP+  MGS+
Sbjct: 168 APDVLMGSK 176

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/257 (22%), Positives = 93/257 (36%), Gaps = 71/257 (27%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG-ALKSFMAECEALRNIRHRNLV 501
           F     +G G FG V++     D    A+K + L  R  A +  M E +AL  + H  +V
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 502 KIITAC-------------------SSSDF------------------------------ 512
           +   A                     S+D+                              
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 513 QGNDFKALVY---EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYL 569
           Q +  K  +Y   +     +L+ W++   + +D  +          L+I I +A A+E+L
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC-------LHIFIQIAEAVEFL 180
Query: 570 HHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQ--------CSSVGLK 621
           H    K ++H DLKPSN+    D +  VGDFGL   + +               +  G  
Sbjct: 181 H---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQV 237
Query: 622 GTVGYAAPEYGMGSQVS 638
           GT  Y +PE   G+  S
Sbjct: 238 GTKLYMSPEQIHGNNYS 254

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 82/188 (43%), Gaps = 23/188 (12%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F     +G GS+GSVYK I      +VA+K + +     L+  + E   ++     ++VK
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
                  S F+  D   +V E+   GS+         SD +      L+  +   I  + 
Sbjct: 89  YY----GSYFKNTDL-WIVMEYCGAGSV---------SDIIRLRNKTLTEDEIATILQST 134
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
              LEYLH   K   +H D+K  N+LL+ +  A + DFG+   + + ++        + G
Sbjct: 135 LKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNX----VIG 187
Query: 623 TVGYAAPE 630
           T  + APE
Sbjct: 188 TPFWMAPE 195

>pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 83/200 (41%), Gaps = 32/200 (16%)
Query: 153 DSLVNCTYLEIVSLNVNSLRSIPI-SVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTEL 211
           D+  +  +LEI+ L+ N +R I + +   LP L  L LF+N ++     +    + L EL
Sbjct: 53  DTFKHLRHLEILQLSKNLVRKIEVGAFNGLPSLNTLELFDNRLTTVPTQAFEYLSKLREL 112
Query: 212 NLRGNSIRGSIPS-ALGNCHQLQSLDL---------SKTIFLGQYPVRWLDLSHNHLTGP 261
            LR N I  SIPS A      L+ LDL         S+  F G   +R+L+         
Sbjct: 113 WLRNNPIE-SIPSYAFNRVPSLRRLDLGELKRLEYISEAAFEGLVNLRYLN--------- 162
Query: 262 IPLAVGNLKSIP---------HLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHP 312
             L + NLK IP          L+LS N+L    P S      L  L L           
Sbjct: 163 --LGMCNLKDIPNLTALVRLEELELSGNRLDLIRPGSFQGLTSLRKLWLMHAQVATIERN 220
Query: 313 GLSSLKSLEGLDLFQNTFQA 332
               LKSLE L+L  N   +
Sbjct: 221 AFDDLKSLEELNLSHNNLMS 240

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 35/199 (17%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL---------KSFMAECEALR 493
           +    ++G G    V + I  P     AVK++ +   G+          ++ + E + LR
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 494 NIR-HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSF 552
            +  H N++++        ++ N F  LV++ M  G L  +L     ++ +  S      
Sbjct: 79  KVSGHPNIIQL-----KDTYETNTFFFLVFDLMKKGELFDYL-----TEKVTLSEKETRK 128
Query: 553 LQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT-RFIPEVIS 611
           + R  + +  A     LH   K  IVH DLKP N+LLD+DM   + DFG + +  P    
Sbjct: 129 IMRALLEVICA-----LH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL 180
Query: 612 SNQCSSVGLKGTVGYAAPE 630
              C      GT  Y APE
Sbjct: 181 REVC------GTPSYLAPE 193

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 80/191 (41%), Gaps = 24/191 (12%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           F    L+G G+FG V            A+K+L    +  +  +   + E   L+N RH  
Sbjct: 10  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH-- 67
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
               +TA   S FQ +D    V E+ + G L   L  E       +S     F       
Sbjct: 68  --PFLTALKYS-FQTHDRLCFVMEYANGGELFFHLSRERV-----FSEDRARFY-----G 114
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             + SAL+YLH   +K +V+ DLK  N++LD D    + DFGL +   E I     +   
Sbjct: 115 AEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDG-ATMKX 168
Query: 620 LKGTVGYAAPE 630
             GT  Y APE
Sbjct: 169 FCGTPEYLAPE 179

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 80/191 (41%), Gaps = 24/191 (12%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           F    L+G G+FG V            A+K+L    +  +  +   + E   L+N RH  
Sbjct: 12  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH-- 69
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
               +TA   S FQ +D    V E+ + G L   L  E       +S     F       
Sbjct: 70  --PFLTALKYS-FQTHDRLCFVMEYANGGELFFHLSRERV-----FSEDRARFY-----G 116
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             + SAL+YLH   +K +V+ DLK  N++LD D    + DFGL +   E I     +   
Sbjct: 117 AEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDG-ATMKX 170
Query: 620 LKGTVGYAAPE 630
             GT  Y APE
Sbjct: 171 FCGTPEYLAPE 181

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 83/188 (44%), Gaps = 23/188 (12%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++    IG G+ G+VY  +       VA++ + L Q+   +  + E   +R  ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
            +     S   G++   +V E++  GSL   +  E+  D+   +      LQ        
Sbjct: 82  YL----DSYLVGDEL-WVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQ-------- 127
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
             ALE+LH +   Q++H D+K  N+LL  D    + DFG        I+  Q     + G
Sbjct: 128 --ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSTMVG 178
Query: 623 TVGYAAPE 630
           T  + APE
Sbjct: 179 TPYWMAPE 186

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 83/188 (44%), Gaps = 23/188 (12%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++    IG G+ G+VY  +       VA++ + L Q+   +  + E   +R  ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
            +     S   G++   +V E++  GSL   +  E+  D+   +      LQ        
Sbjct: 82  YL----DSYLVGDEL-WVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQ-------- 127
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
             ALE+LH +   Q++H D+K  N+LL  D    + DFG        I+  Q     + G
Sbjct: 128 --ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA----QITPEQSKRSXMVG 178
Query: 623 TVGYAAPE 630
           T  + APE
Sbjct: 179 TPYWMAPE 186

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 46/203 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNLVKIITA 506
           +G G++G VYK I       VA+K + L   + G   + + E   L+ ++HRN++++   
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIEL--- 98
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
              S    N    L++E+  +  L+ ++     + D++    I SFL +L   +N   + 
Sbjct: 99  --KSVIHHNHRLHLIFEYAEN-DLKKYM---DKNPDVSMR-VIKSFLYQLINGVNFCHS- 150
Query: 567 EYLHHHCKKQIVHCDLKPSNVLL-----DNDMIAHVGDFGLTR--------FIPEVISSN 613
                   ++ +H DLKP N+LL         +  +GDFGL R        F  E+I   
Sbjct: 151 --------RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--- 199
Query: 614 QCSSVGLKGTVGYAAPEYGMGSQ 636
                    T+ Y  PE  +GS+
Sbjct: 200 ---------TLWYRPPEILLGSR 213

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 80/191 (41%), Gaps = 24/191 (12%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           F    L+G G+FG V            A+K+L    +  +  +   + E   L+N RH  
Sbjct: 11  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH-- 68
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
               +TA   S FQ +D    V E+ + G L   L  E       +S     F       
Sbjct: 69  --PFLTALKYS-FQTHDRLCFVMEYANGGELFFHLSRERV-----FSEDRARFY-----G 115
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             + SAL+YLH   +K +V+ DLK  N++LD D    + DFGL +   E I     +   
Sbjct: 116 AEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDG-ATMKX 169
Query: 620 LKGTVGYAAPE 630
             GT  Y APE
Sbjct: 170 FCGTPEYLAPE 180

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 83/188 (44%), Gaps = 23/188 (12%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++    IG G+ G+VY  +       VA++ + L Q+   +  + E   +R  ++ N+V 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
            +     S   G++   +V E++  GSL   +  E+  D+   +      LQ        
Sbjct: 83  YL----DSYLVGDEL-WVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQ-------- 128
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
             ALE+LH +   Q++H D+K  N+LL  D    + DFG        I+  Q     + G
Sbjct: 129 --ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA----QITPEQSKRSXMVG 179
Query: 623 TVGYAAPE 630
           T  + APE
Sbjct: 180 TPYWMAPE 187

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 29/193 (15%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIRHRNL 500
           +S    IG+G    V++ +L+  + + A+K + L +     L S+  E   L  ++  + 
Sbjct: 11  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 68
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLE--SWLHPESASDDLNYSPSILSFLQRLNI 558
            KII      D++  D    +Y  M  G+++  SWL  + + D            +R + 
Sbjct: 69  DKIIRLY---DYEITD--QYIYMVMECGNIDLNSWLKKKKSIDPW----------ERKSY 113
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT-RFIPEVISSNQCSS 617
             N+  A+  +H H    IVH DLKP+N L+ + M+  + DFG+  +  P+  S  + S 
Sbjct: 114 WKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQ 169
Query: 618 VGLKGTVGYAAPE 630
           V   GTV Y  PE
Sbjct: 170 V---GTVNYMPPE 179

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 83/188 (44%), Gaps = 23/188 (12%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++    IG G+ G+VY  +       VA++ + L Q+   +  + E   +R  ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
            +     S   G++   +V E++  GSL   +  E+  D+   +      LQ        
Sbjct: 82  YL----DSYLVGDEL-WVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQ-------- 127
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
             ALE+LH +   Q++H D+K  N+LL  D    + DFG        I+  Q     + G
Sbjct: 128 --ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA----QITPEQSKRSEMVG 178
Query: 623 TVGYAAPE 630
           T  + APE
Sbjct: 179 TPYWMAPE 186

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 29/193 (15%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIRHRNL 500
           +S    IG+G    V++ +L+  + + A+K + L +     L S+  E   L  ++  + 
Sbjct: 14  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 71
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLE--SWLHPESASDDLNYSPSILSFLQRLNI 558
            KII      D++  D    +Y  M  G+++  SWL  + + D            +R + 
Sbjct: 72  DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKKSIDPW----------ERKSY 116
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT-RFIPEVISSNQCSS 617
             N+  A+  +H H    IVH DLKP+N L+ + M+  + DFG+  +  P+  S  + S 
Sbjct: 117 WKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQ 172
Query: 618 VGLKGTVGYAAPE 630
           V   GTV Y  PE
Sbjct: 173 V---GTVNYMPPE 182

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/72 (40%), Positives = 39/72 (54%), Gaps = 8/72 (11%)
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
           A  +   LE LH   +++IV+ DLKP N+LLD+     + D GL   +PE  +       
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK----- 343
Query: 619 GLKGTVGYAAPE 630
           G  GTVGY APE
Sbjct: 344 GRVGTVGYMAPE 355

>pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 84/200 (42%), Gaps = 32/200 (16%)
Query: 153 DSLVNCTYLEIVSLNVNSLRSIPI-SVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTEL 211
           D+  +  +LEI+ L+ N +R I + +   LP L  L LF+N ++     +    + L EL
Sbjct: 53  DTFKHLRHLEILQLSKNLVRKIEVGAFNGLPSLNTLELFDNRLTTVPTQAFEYLSKLREL 112
Query: 212 NLRGNSIRGSIPS-ALGNCHQLQSLDL---------SKTIFLGQYPVRWLDLSHNHLTGP 261
            LR N I  SIPS A      L+ LDL         S+  F G   +R+L+         
Sbjct: 113 WLRNNPIE-SIPSYAFNRVPSLRRLDLGELKRLEYISEAAFEGLVNLRYLN--------- 162
Query: 262 IPLAVGNLKSIPH---------LDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHP 312
             L + NLK IP+         L+LS N+L    P S      L  L L           
Sbjct: 163 --LGMCNLKDIPNLTALVRLEELELSGNRLDLIRPGSFQGLTSLRKLWLMHAQVATIERN 220
Query: 313 GLSSLKSLEGLDLFQNTFQA 332
               LKSLE L+L  N   +
Sbjct: 221 AFDDLKSLEELNLSHNNLMS 240

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 88/200 (44%), Gaps = 41/200 (20%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTV---VAVKVLF---LHQRGALKSFMAECEALRNIR 496
           +    ++G GSFG V   IL  D+      AVKV+    + Q+   +S + E + L+ + 
Sbjct: 28  YKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H N++K+        F+   +  LV E    G L           D   S    S +   
Sbjct: 85  HPNIMKLYEF-----FEDKGYFYLVGEVYTGGELF----------DEIISRKRFSEVDAA 129
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN---DMIAHVGDFGLTRFIPEVISSN 613
            I   V S + Y+H   K +IVH DLKP N+LL++   D    + DFGL        S++
Sbjct: 130 RIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGL--------STH 178
Query: 614 QCSSVGLK---GTVGYAAPE 630
             +S  +K   GT  Y APE
Sbjct: 179 FEASKKMKDKIGTAYYIAPE 198

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/72 (40%), Positives = 39/72 (54%), Gaps = 8/72 (11%)
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
           A  +   LE LH   +++IV+ DLKP N+LLD+     + D GL   +PE  +       
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK----- 343
Query: 619 GLKGTVGYAAPE 630
           G  GTVGY APE
Sbjct: 344 GRVGTVGYMAPE 355

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 29/193 (15%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIRHRNL 500
           +S    IG+G    V++ +L+  + + A+K + L +     L S+  E   L  ++  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 115
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLE--SWLHPESASDDLNYSPSILSFLQRLNI 558
            KII      D++  D    +Y  M  G+++  SWL  + + D            +R + 
Sbjct: 116 DKIIRLY---DYEITD--QYIYMVMECGNIDLNSWLKKKKSIDPW----------ERKSY 160
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT-RFIPEVISSNQCSS 617
             N+  A+  +H H    IVH DLKP+N L+ + M+  + DFG+  +  P+  S  + S 
Sbjct: 161 WKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQ 216
Query: 618 VGLKGTVGYAAPE 630
           V   GTV Y  PE
Sbjct: 217 V---GTVNYMPPE 226

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 93/196 (47%), Gaps = 28/196 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITA 506
           IG G++G+V+K        +VA+K + L     G   S + E   L+ ++H+N+V++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL--- 66
Query: 507 CSSSDFQGNDFK-ALVYEFMHHGSLESWLHPESASDDLNYSPSIL-SFLQRLNIAINVAS 564
               D   +D K  LV+EF     L+ +   +S + DL+  P I+ SFL +L        
Sbjct: 67  ---HDVLHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLD--PEIVKSFLFQL------LK 112
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            L + H    + ++H DLKP N+L++ +    + +FGL R     +       V    T+
Sbjct: 113 GLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV----TL 165
Query: 625 GYAAPEYGMGSQVSTN 640
            Y  P+   G+++ + 
Sbjct: 166 WYRPPDVLFGAKLYST 181

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 88/200 (44%), Gaps = 41/200 (20%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTV---VAVKVLF---LHQRGALKSFMAECEALRNIR 496
           +    ++G GSFG V   IL  D+      AVKV+    + Q+   +S + E + L+ + 
Sbjct: 51  YKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H N++K+        F+   +  LV E    G L           D   S    S +   
Sbjct: 108 HPNIMKLYEF-----FEDKGYFYLVGEVYTGGELF----------DEIISRKRFSEVDAA 152
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN---DMIAHVGDFGLTRFIPEVISSN 613
            I   V S + Y+H   K +IVH DLKP N+LL++   D    + DFGL        S++
Sbjct: 153 RIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGL--------STH 201
Query: 614 QCSSVGLK---GTVGYAAPE 630
             +S  +K   GT  Y APE
Sbjct: 202 FEASKKMKDKIGTAYYIAPE 221

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNL 500
           +++ + IG G++G V     + ++  VA+K +  F HQ    ++ + E + L   RH N+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRHENI 83
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           + I     +   +      +V + M    L   L  +  S+D      I  FL +     
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSND-----HICYFLYQ----- 132
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L+Y+H      ++H DLKPSN+LL+      + DFGL R + +    +       
Sbjct: 133 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLAR-VADPDHDHTGFLTEY 187
Query: 621 KGTVGYAAPEYGMGSQVST 639
             T  Y APE  + S+  T
Sbjct: 188 VATRWYRAPEIMLNSKGYT 206

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 29/193 (15%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIRHRNL 500
           +S    IG+G    V++ +L+  + + A+K + L +     L S+  E   L  ++  + 
Sbjct: 10  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 67
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLE--SWLHPESASDDLNYSPSILSFLQRLNI 558
            KII      D++  D    +Y  M  G+++  SWL  + + D            +R + 
Sbjct: 68  DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKKSIDPW----------ERKSY 112
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT-RFIPEVISSNQCSS 617
             N+  A+  +H H    IVH DLKP+N L+ + M+  + DFG+  +  P+  S  + S 
Sbjct: 113 WKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQ 168
Query: 618 VGLKGTVGYAAPE 630
           V   GTV Y  PE
Sbjct: 169 V---GTVNYMPPE 178

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 26/173 (15%)
Query: 449 IGTGSFGSVYKG-ILDPDQTV----VAVKVLFLHQRGAL----KSFMAECEALRNIRHR- 498
           +G G+FG V +      D+T     VAVK+L   + GA     ++ M+E + L +I H  
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 93
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPS-----ILSFL 553
           N+V ++ AC+     G     +V EF   G+L ++L  +  ++ + Y P       L+  
Sbjct: 94  NVVNLLGACTKP---GGPLMVIV-EFCKFGNLSTYLRSKR-NEFVPYKPEDLYKDFLTLE 148
Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
             +  +  VA  +E+L     ++ +H DL   N+LL    +  + DFGL R I
Sbjct: 149 HLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDI 198

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 88/200 (44%), Gaps = 41/200 (20%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTV---VAVKVLF---LHQRGALKSFMAECEALRNIR 496
           +    ++G GSFG V   IL  D+      AVKV+    + Q+   +S + E + L+ + 
Sbjct: 52  YKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H N++K+        F+   +  LV E    G L           D   S    S +   
Sbjct: 109 HPNIMKLYEF-----FEDKGYFYLVGEVYTGGELF----------DEIISRKRFSEVDAA 153
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN---DMIAHVGDFGLTRFIPEVISSN 613
            I   V S + Y+H   K +IVH DLKP N+LL++   D    + DFGL        S++
Sbjct: 154 RIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGL--------STH 202
Query: 614 QCSSVGLK---GTVGYAAPE 630
             +S  +K   GT  Y APE
Sbjct: 203 FEASKKMKDKIGTAYYIAPE 222

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNL 500
           +++ + IG G++G V     + ++  VA+K +  F HQ    ++ + E + L   RH N+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRHENI 83
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           + I     +   +      +V + M    L   L  +  S+D      I  FL +     
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSND-----HICYFLYQ----- 132
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L+Y+H      ++H DLKPSN+LL+      + DFGL R + +    +       
Sbjct: 133 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEY 187
Query: 621 KGTVGYAAPEYGMGSQVST 639
             T  Y APE  + S+  T
Sbjct: 188 VATRWYRAPEIMLNSKGYT 206

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNL 500
           +++ + IG G++G V     + ++  VA+K +  F HQ    ++ + E + L   RH N+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRHENI 83
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           + I     +   +      +V + M    L   L  +  S+D      I  FL +     
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSND-----HICYFLYQ----- 132
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L+Y+H      ++H DLKPSN+LL+      + DFGL R + +    +       
Sbjct: 133 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEY 187
Query: 621 KGTVGYAAPEYGMGSQVST 639
             T  Y APE  + S+  T
Sbjct: 188 VATRWYRAPEIMLNSKGYT 206

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 98/247 (39%), Gaps = 47/247 (19%)
Query: 421 SSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG 480
           SS R++L       SLL+    +     IG GS+G V   I +  + + A+K++  ++  
Sbjct: 8   SSGRENLYFQGG--SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65
Query: 481 AL-----KSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH 535
            +     +    E   ++ + H N+ ++        ++   +  LV E  H G L   L+
Sbjct: 66  QINPKDVERIKTEVRLMKKLHHPNIARLYEV-----YEDEQYICLVMELCHGGHLLDKLN 120
Query: 536 ----------------------PESASDDLNYS----PSILSFLQRL----NIAINVASA 565
                                 PE   + +N S       L F+QR     NI   + SA
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180
Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG--DFGLTRFIPEVISSNQCSSVGLKGT 623
           L YLH+   + I H D+KP N L   +    +   DFGL++   ++ +          GT
Sbjct: 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
Query: 624 VGYAAPE 630
             + APE
Sbjct: 238 PYFVAPE 244

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 29/193 (15%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIRHRNL 500
           +S    IG+G    V++ +L+  + + A+K + L +     L S+  E   L  ++  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 115
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLE--SWLHPESASDDLNYSPSILSFLQRLNI 558
            KII      D++  D    +Y  M  G+++  SWL  + + D            +R + 
Sbjct: 116 DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKKSIDPW----------ERKSY 160
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT-RFIPEVISSNQCSS 617
             N+  A+  +H H    IVH DLKP+N L+ + M+  + DFG+  +  P+  S  + S 
Sbjct: 161 WKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQ 216
Query: 618 VGLKGTVGYAAPE 630
           V   GTV Y  PE
Sbjct: 217 V---GTVNYMPPE 226

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 29/175 (16%)
Query: 449 IGTGSFGSVYKG-ILDPDQTV----VAVKVLFLHQRGAL----KSFMAECEALRNIRHR- 498
           +G G+FG V +      D+T     VAVK+L   + GA     ++ M+E + L +I H  
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 92
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH-------PESASDDLNYSPSILS 551
           N+V ++ AC+     G     +V EF   G+L ++L        P    +DL      L+
Sbjct: 93  NVVNLLGACTKP---GGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKTPEDL--YKDFLT 146
Query: 552 FLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
               +  +  VA  +E+L     ++ +H DL   N+LL    +  + DFGL R I
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 198

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNL 500
           +++ + IG G++G V     + ++  VA+K +  F HQ    ++ + E + L   RH N+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRHENI 83
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           + I     +   +      +V + M    L   L  +  S+D      I  FL +     
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSND-----HICYFLYQ----- 132
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L+Y+H      ++H DLKPSN+LL+      + DFGL R + +    +       
Sbjct: 133 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 187
Query: 621 KGTVGYAAPEYGMGSQVST 639
             T  Y APE  + S+  T
Sbjct: 188 VATRWYRAPEIMLNSKGYT 206

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNL 500
           +++ + IG G++G V     + ++  VA+K +  F HQ    ++ + E + L   RH N+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRHENI 87
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           + I     +   +      +V + M    L   L  +  S+D      I  FL +     
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSND-----HICYFLYQ----- 136
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L+Y+H      ++H DLKPSN+LL+      + DFGL R + +    +       
Sbjct: 137 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEY 191
Query: 621 KGTVGYAAPEYGMGSQVST 639
             T  Y APE  + S+  T
Sbjct: 192 VATRWYRAPEIMLNSKGYT 210

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 87/193 (45%), Gaps = 21/193 (10%)
Query: 449 IGTGSFGSVYKGI---LDPDQTVVAVKVLFLHQRG---ALKSFMAECEALRNI-RHRNLV 501
           +G G+FG V +     L  +  V+ V V  L         ++ M+E + + ++ +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPES----ASDDLNYSPSILSFLQRLN 557
            ++ AC+     G     ++ E+  +G L ++L  +S           + S  S    L+
Sbjct: 114 NLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
            +  VA  + +L     K  +H D+   NVLL N  +A +GDFGL R I  +  SN    
Sbjct: 169 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI--MNDSNYIVK 223
Query: 618 VGLKGTVGYAAPE 630
              +  V + APE
Sbjct: 224 GNARLPVKWMAPE 236

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 86/199 (43%), Gaps = 19/199 (9%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNL 500
           +++ + IG G++G V     + ++  VA+K +  F HQ    ++ + E + L   RH N+
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRHENI 103
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           + I     +   +      LV   M    L   L  +  S+D      I  FL +     
Sbjct: 104 IGINDIIRAPTIEQMKDVYLVTHLMG-ADLYKLLKTQHLSND-----HICYFLYQ----- 152
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L+Y+H      ++H DLKPSN+LL+      + DFGL R + +    +       
Sbjct: 153 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEY 207
Query: 621 KGTVGYAAPEYGMGSQVST 639
             T  Y APE  + S+  T
Sbjct: 208 VATRWYRAPEIMLNSKGYT 226

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNL 500
           +++ + IG G++G V     + ++  VA+K +  F HQ    ++ + E + L   RH N+
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRHENI 91
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           + I     +   +      +V + M    L   L  +  S+D      I  FL +     
Sbjct: 92  IGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSND-----HICYFLYQ----- 140
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L+Y+H      ++H DLKPSN+LL+      + DFGL R + +    +       
Sbjct: 141 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 195
Query: 621 KGTVGYAAPEYGMGSQVST 639
             T  Y APE  + S+  T
Sbjct: 196 VATRWYRAPEIMLNSKGYT 214

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNL 500
           +++ + IG G++G V     + ++  VA+K +  F HQ    ++ + E + L   RH N+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRHENI 83
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           + I     +   +      +V + M    L   L  +  S+D      I  FL +     
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSND-----HICYFLYQ----- 132
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L+Y+H      ++H DLKPSN+LL+      + DFGL R + +    +       
Sbjct: 133 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 187
Query: 621 KGTVGYAAPEYGMGSQVST 639
             T  Y APE  + S+  T
Sbjct: 188 VATRWYRAPEIMLNSKGYT 206

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 90/219 (41%), Gaps = 28/219 (12%)
Query: 418 SSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH 477
           +S+S +R   L  +   +L    G F    L+G G++G VYKG       + A+KV+ + 
Sbjct: 3   ASDSPARS--LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV- 59
Query: 478 QRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDFK-ALVYEFMHHGSLESWLH 535
                +    E   L+    HRN+     A    +  G D +  LV EF   GS+   + 
Sbjct: 60  TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 536 PESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA 595
                   N   + L       I   +   L +LH H   +++H D+K  NVLL  +   
Sbjct: 120 --------NTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEV 168
Query: 596 HVGDFGLTRFIPEVISSNQCSSVGLK----GTVGYAAPE 630
            + DFG        +S+    +VG +    GT  + APE
Sbjct: 169 KLVDFG--------VSAQLDRTVGRRNTFIGTPYWMAPE 199

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNL 500
           +++ + IG G++G V     + ++  VA+K +  F HQ    ++ + E + L   RH N+
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRHENI 103
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           + I     +   +      +V + M    L   L  +  S+D      I  FL +     
Sbjct: 104 IGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSND-----HICYFLYQ----- 152
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L+Y+H      ++H DLKPSN+LL+      + DFGL R + +    +       
Sbjct: 153 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 207
Query: 621 KGTVGYAAPEYGMGSQVST 639
             T  Y APE  + S+  T
Sbjct: 208 VATRWYRAPEIMLNSKGYT 226

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNL 500
           +++ + IG G++G V     + ++  VA+K +  F HQ    ++ + E + L   RH N+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRHENI 85
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           + I     +   +      +V + M    L   L  +  S+D      I  FL +     
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSND-----HICYFLYQ----- 134
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L+Y+H      ++H DLKPSN+LL+      + DFGL R + +    +       
Sbjct: 135 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 189
Query: 621 KGTVGYAAPEYGMGSQVST 639
             T  Y APE  + S+  T
Sbjct: 190 VATRWYRAPEIMLNSKGYT 208

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 82/185 (44%), Gaps = 22/185 (11%)
Query: 449 IGTGSFGSVYKGI--LDPDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVKIIT 505
           +G G+FGSV +G+  +   Q  VA+KVL    ++   +  M E + +  + +  +V++I 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
            C +          LV E    G L  +L  +     ++    +L           V+  
Sbjct: 404 VCQAEALM------LVMEMAGGGPLHKFLVGKREEIPVSNVAELLH---------QVSMG 448
Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG 625
           ++YL    +K  VH +L   NVLL N   A + DFGL++ +    S     S G K  + 
Sbjct: 449 MKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG-KWPLK 504
Query: 626 YAAPE 630
           + APE
Sbjct: 505 WYAPE 509

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNL 500
           +++ + IG G++G V     + ++  VA+K +  F HQ    ++ + E + L   RH N+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRT-LREIKILLRFRHENI 87
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           + I     +   +      +V + M    L   L  +  S+D      I  FL +     
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSND-----HICYFLYQ----- 136
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L+Y+H      ++H DLKPSN+LL+      + DFGL R + +    +       
Sbjct: 137 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEY 191
Query: 621 KGTVGYAAPEYGMGSQVST 639
             T  Y APE  + S+  T
Sbjct: 192 VATRWYRAPEIMLNSKGYT 210

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNL 500
           +++ + IG G++G V     + ++  VA+K +  F HQ    ++ + E + L   RH N+
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRHENI 88
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           + I     +   +      +V + M    L   L  +  S+D      I  FL +     
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSND-----HICYFLYQ----- 137
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L+Y+H      ++H DLKPSN+LL+      + DFGL R + +    +       
Sbjct: 138 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 192
Query: 621 KGTVGYAAPEYGMGSQVST 639
             T  Y APE  + S+  T
Sbjct: 193 VATRWYRAPEIMLNSKGYT 211

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNL 500
           +++ + IG G++G V     + ++  VA+K +  F HQ    ++ + E + L   RH N+
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRHENI 89
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           + I     +   +      +V + M    L   L  +  S+D      I  FL +     
Sbjct: 90  IGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSND-----HICYFLYQ----- 138
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L+Y+H      ++H DLKPSN+LL+      + DFGL R + +    +       
Sbjct: 139 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 193
Query: 621 KGTVGYAAPEYGMGSQVST 639
             T  Y APE  + S+  T
Sbjct: 194 VATRWYRAPEIMLNSKGYT 212

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNL 500
           +++ + IG G++G V     + ++  VA+K +  F HQ    ++ + E + L   RH N+
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRHENI 80
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           + I     +   +      +V + M    L   L  +  S+D      I  FL +     
Sbjct: 81  IGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSND-----HICYFLYQ----- 129
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L+Y+H      ++H DLKPSN+LL+      + DFGL R + +    +       
Sbjct: 130 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 184
Query: 621 KGTVGYAAPEYGMGSQVST 639
             T  Y APE  + S+  T
Sbjct: 185 VATRWYRAPEIMLNSKGYT 203

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNL 500
           +++ + IG G++G V     + ++  VA+K +  F HQ    ++ + E + L   RH N+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRHENI 87
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           + I     +   +      +V + M    L   L  +  S+D      I  FL +     
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSND-----HICYFLYQ----- 136
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L+Y+H      ++H DLKPSN+LL+      + DFGL R + +    +       
Sbjct: 137 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 191
Query: 621 KGTVGYAAPEYGMGSQVST 639
             T  Y APE  + S+  T
Sbjct: 192 VATRWYRAPEIMLNSKGYT 210

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNL 500
           +++ + IG G++G V     + ++  VA+K +  F HQ    ++ + E + L   RH N+
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRHENI 81
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           + I     +   +      +V + M    L   L  +  S+D      I  FL +     
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSND-----HICYFLYQ----- 130
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L+Y+H      ++H DLKPSN+LL+      + DFGL R + +    +       
Sbjct: 131 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 185
Query: 621 KGTVGYAAPEYGMGSQVST 639
             T  Y APE  + S+  T
Sbjct: 186 VATRWYRAPEIMLNSKGYT 204

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNL 500
           +++ + IG G++G V     + ++  VA+K +  F HQ    ++ + E + L   RH N+
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRHENI 81
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           + I     +   +      +V + M    L   L  +  S+D      I  FL +     
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSND-----HICYFLYQ----- 130
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L+Y+H      ++H DLKPSN+LL+      + DFGL R + +    +       
Sbjct: 131 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 185
Query: 621 KGTVGYAAPEYGMGSQVST 639
             T  Y APE  + S+  T
Sbjct: 186 VATRWYRAPEIMLNSKGYT 204

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 79/189 (41%), Gaps = 29/189 (15%)
Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIIT 505
           +++GTG+F  V        Q +VA+K +      G   S   E   L  I+H N+V +  
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL-- 81
Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
                 ++      L+ + +  G L   +  +    + + S  I   L           A
Sbjct: 82  ---DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL----------DA 128
Query: 566 LEYLHHHCKKQIVHCDLKPSNVL---LDNDMIAHVGDFGLTRF-IPEVISSNQCSSVGLK 621
           ++YLH      IVH DLKP N+L   LD D    + DFGL++   P  + S  C      
Sbjct: 129 VKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC------ 179
Query: 622 GTVGYAAPE 630
           GT GY APE
Sbjct: 180 GTPGYVAPE 188

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 82/200 (41%), Gaps = 29/200 (14%)
Query: 441 GGFSSANLIGTGSFGSVY--KGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIR 496
           G +     IG G+F  V   + IL   +  VAVK++   Q    +L+    E    + + 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKE--VAVKIIDKTQLNSSSLQKLFREVRIXKVLN 71
Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H N+VK+     +          LV E+   G +  +L    A        +   F Q  
Sbjct: 72  HPNIVKLFEVIETEKTL-----YLVXEYASGGEVFDYL---VAHGRXKEKEARAKFRQ-- 121
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                + SA++Y H   +K IVH DLK  N+LLD D    + DFG   F  E    N+  
Sbjct: 122 -----IVSAVQYCH---QKFIVHRDLKAENLLLDADXNIKIADFG---FSNEFTFGNKLD 170
Query: 617 SVGLKGTVGYAAPEYGMGSQ 636
           +    G   YAAPE   G +
Sbjct: 171 A--FCGAPPYAAPELFQGKK 188

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 80/193 (41%), Gaps = 29/193 (15%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLV 501
           +   +++GTG+F  V        Q +VA+K +      G   S   E   L  I+H N+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
            +        ++      L+ + +  G L   +  +    + + S  I   L        
Sbjct: 80  AL-----DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL-------- 126
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVL---LDNDMIAHVGDFGLTRF-IPEVISSNQCSS 617
              A++YLH      IVH DLKP N+L   LD D    + DFGL++   P  + S  C  
Sbjct: 127 --DAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC-- 179
Query: 618 VGLKGTVGYAAPE 630
               GT GY APE
Sbjct: 180 ----GTPGYVAPE 188

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 27/203 (13%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNL 500
           +++ + IG G++G V     + ++  VA+K +  F HQ    ++ + E + L   RH N+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRHENI 87
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           + I     +   +      +V + M    L   L  +  S+D      I  FL +     
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSND-----HICYFLYQ----- 136
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L+Y+H      ++H DLKPSN+LL+      + DFGL R     ++       G 
Sbjct: 137 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-----VADPDHDHTGF 187
Query: 621 ----KGTVGYAAPEYGMGSQVST 639
                 T  Y APE  + S+  T
Sbjct: 188 LXEXVATRWYRAPEIMLNSKGYT 210

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 27/203 (13%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNL 500
           +++ + IG G++G V     + ++  VA+K +  F HQ    ++ + E + L   RH N+
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRHENI 88
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           + I     +   +      +V + M    L   L  +  S+D      I  FL +     
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSND-----HICYFLYQ----- 137
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L+Y+H      ++H DLKPSN+LL+      + DFGL R     ++       G 
Sbjct: 138 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-----VADPDHDHTGF 188
Query: 621 ----KGTVGYAAPEYGMGSQVST 639
                 T  Y APE  + S+  T
Sbjct: 189 LXEXVATRWYRAPEIMLNSKGYT 211

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 79/189 (41%), Gaps = 29/189 (15%)
Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIIT 505
           +++GTG+F  V        Q +VA+K +      G   S   E   L  I+H N+V +  
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVAL-- 81
Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
                 ++      L+ + +  G L   +  +    + + S  I   L           A
Sbjct: 82  ---DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL----------DA 128
Query: 566 LEYLHHHCKKQIVHCDLKPSNVL---LDNDMIAHVGDFGLTRF-IPEVISSNQCSSVGLK 621
           ++YLH      IVH DLKP N+L   LD D    + DFGL++   P  + S  C      
Sbjct: 129 VKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC------ 179
Query: 622 GTVGYAAPE 630
           GT GY APE
Sbjct: 180 GTPGYVAPE 188

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNL 500
           +++ + IG G++G V     + ++  VA+K +  F HQ    ++ + E + L   RH N+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRHENI 87
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           + I     +   +      +V + M    L   L  +  S+D      I  FL +     
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKCQHLSND-----HICYFLYQ----- 136
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L+Y+H      ++H DLKPSN+LL+      + DFGL R + +    +       
Sbjct: 137 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 191
Query: 621 KGTVGYAAPEYGMGSQVST 639
             T  Y APE  + S+  T
Sbjct: 192 VATRWYRAPEIMLNSKGYT 210

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 88/204 (43%), Gaps = 29/204 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++   +IG GSFG VY+  L     +VA+K +   +R   +    E + +R + H N+V+
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 81
Query: 503 IITACSSSDFQGND-FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +     SS  + ++ +  LV +++         H   A   L   P I   L        
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL---PVIYVKL----YMYQ 134
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVGDFG----LTRFIPEVISSNQCS 616
           +  +L Y+H      I H D+KP N+LLD D  +  + DFG    L R  P V  S  CS
Sbjct: 135 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXICS 189
Query: 617 SVGLKGTVGYAAPEYGMGSQVSTN 640
                    Y APE   G+   T+
Sbjct: 190 RY-------YRAPELIFGATDYTS 206

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 88/204 (43%), Gaps = 29/204 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++   +IG GSFG VY+  L     +VA+K +   +R   +    E + +R + H N+V+
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 78
Query: 503 IITACSSSDFQGND-FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +     SS  + ++ +  LV +++         H   A   L   P I   L        
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL---PVIYVKL----YMYQ 131
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVGDFG----LTRFIPEVISSNQCS 616
           +  +L Y+H      I H D+KP N+LLD D  +  + DFG    L R  P V  S  CS
Sbjct: 132 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXICS 186
Query: 617 SVGLKGTVGYAAPEYGMGSQVSTN 640
                    Y APE   G+   T+
Sbjct: 187 RY-------YRAPELIFGATDYTS 203

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 29/206 (14%)
Query: 430 NVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMA 487
           N+ ++S+      +S    IG+G    V++ +L+  + + A+K + L +     L S+  
Sbjct: 17  NLYFQSMSVKGRIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRN 75
Query: 488 ECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLE--SWLHPESASDDLNY 545
           E   L  ++  +  KII      D++  D    +Y  M  G+++  SWL  + + D    
Sbjct: 76  EIAYLNKLQQHS-DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKKKSIDPW-- 127
Query: 546 SPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT-R 604
                   +R +   N+  A+  +H H    IVH DLKP+N L+ + M+  + DFG+  +
Sbjct: 128 --------ERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQ 175
Query: 605 FIPEVISSNQCSSVGLKGTVGYAAPE 630
             P+     + S V   GTV Y  PE
Sbjct: 176 MQPDXXXVVKDSQV---GTVNYMPPE 198

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 79/189 (41%), Gaps = 29/189 (15%)
Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIIT 505
           +++GTG+F  V        Q +VA+K +      G   S   E   L  I+H N+V +  
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVAL-- 81
Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
                 ++      L+ + +  G L   +  +    + + S  I   L           A
Sbjct: 82  ---DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL----------DA 128
Query: 566 LEYLHHHCKKQIVHCDLKPSNVL---LDNDMIAHVGDFGLTRF-IPEVISSNQCSSVGLK 621
           ++YLH      IVH DLKP N+L   LD D    + DFGL++   P  + S  C      
Sbjct: 129 VKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC------ 179
Query: 622 GTVGYAAPE 630
           GT GY APE
Sbjct: 180 GTPGYVAPE 188

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 29/199 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++   +IG GSFG VY+  L     +VA+K +   +R   +    E + +R + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 77
Query: 503 IITACSSSDFQGND-FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +     SS  + ++ +  LV +++         H   A   L   P I   L        
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL---PVIYVKL----YMYQ 130
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVGDFG----LTRFIPEVISSNQCS 616
           +  +L Y+H      I H D+KP N+LLD D  +  + DFG    L R  P V  S  CS
Sbjct: 131 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXICS 185
Query: 617 SVGLKGTVGYAAPEYGMGS 635
                    Y APE   G+
Sbjct: 186 RY-------YRAPELIFGA 197

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNL 500
           +++ + IG G++G V     + ++  VA+K +  F HQ    ++ + E + L   RH N+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLAFRHENI 85
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           + I     +   +      +V + M    L   L  +  S+D      I  FL +     
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSND-----HICYFLYQ----- 134
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L+Y+H      ++H DLKPSN+LL+      + DFGL R + +    +       
Sbjct: 135 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 189
Query: 621 KGTVGYAAPEYGMGSQVST 639
             T  Y APE  + S+  T
Sbjct: 190 VATRWYRAPEIMLNSKGYT 208

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 29/204 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++   +IG GSFG VY+  L     +VA+K +   Q  A K+   E + +R + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--QGKAFKN--RELQIMRKLDHCNIVR 77
Query: 503 IITACSSSDFQGND-FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +     SS  + ++ +  LV +++         H   A   L   P I   L    +   
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL---PVIYVKLYMYQL--- 131
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVGDFG----LTRFIPEVISSNQCS 616
              +L Y+H      I H D+KP N+LLD D  +  + DFG    L R  P V  S  CS
Sbjct: 132 -FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICS 185
Query: 617 SVGLKGTVGYAAPEYGMGSQVSTN 640
                    Y APE   G+   T+
Sbjct: 186 RY-------YRAPELIFGATDYTS 202

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 29/199 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++   +IG GSFG VY+  L     +VA+K +   +R   +    E + +R + H N+V+
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 96
Query: 503 IITACSSSDFQGND-FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +     SS  + ++ +  LV +++         H   A   L   P I   L        
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL---PVIYVKL----YMYQ 149
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVGDFG----LTRFIPEVISSNQCS 616
           +  +L Y+H      I H D+KP N+LLD D  +  + DFG    L R  P V  S  CS
Sbjct: 150 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXICS 204
Query: 617 SVGLKGTVGYAAPEYGMGS 635
                    Y APE   G+
Sbjct: 205 RY-------YRAPELIFGA 216

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 29/199 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++   +IG GSFG VY+  L     +VA+K +   +R   +    E + +R + H N+V+
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 85
Query: 503 IITACSSSDFQGND-FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +     SS  + ++ +  LV +++         H   A   L   P I   L        
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL---PVIYVKL----YMYQ 138
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVGDFG----LTRFIPEVISSNQCS 616
           +  +L Y+H      I H D+KP N+LLD D  +  + DFG    L R  P V  S  CS
Sbjct: 139 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXICS 193
Query: 617 SVGLKGTVGYAAPEYGMGS 635
                    Y APE   G+
Sbjct: 194 RY-------YRAPELIFGA 205

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 29/199 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++   +IG GSFG VY+  L     +VA+K +   +R   +    E + +R + H N+V+
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 89
Query: 503 IITACSSSDFQGND-FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +     SS  + ++ +  LV +++         H   A   L   P I   L        
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL---PVIYVKL----YMYQ 142
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVGDFG----LTRFIPEVISSNQCS 616
           +  +L Y+H      I H D+KP N+LLD D  +  + DFG    L R  P V  S  CS
Sbjct: 143 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXICS 197
Query: 617 SVGLKGTVGYAAPEYGMGS 635
                    Y APE   G+
Sbjct: 198 RY-------YRAPELIFGA 209

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 29/199 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++   +IG GSFG VY+  L     +VA+K +   +R   +    E + +R + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 77
Query: 503 IITACSSSDFQGND-FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +     SS  + ++ +  LV +++         H   A   L   P I   L        
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL---PVIYVKL----YMYQ 130
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVGDFG----LTRFIPEVISSNQCS 616
           +  +L Y+H      I H D+KP N+LLD D  +  + DFG    L R  P V  S  CS
Sbjct: 131 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXICS 185
Query: 617 SVGLKGTVGYAAPEYGMGS 635
                    Y APE   G+
Sbjct: 186 RY-------YRAPELIFGA 197

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 82/171 (47%), Gaps = 24/171 (14%)
Query: 449 IGTGSFGSVYKG-ILDPDQTV----VAVKVLFLHQRGAL----KSFMAECEALRNIRHR- 498
           +G G+FG V +      D+T     VAVK+L   + GA     ++ M+E + L +I H  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 91
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFL---QR 555
           N+V ++ AC+     G     +V EF   G+L ++L  +  ++ + Y      FL     
Sbjct: 92  NVVNLLGACTKP---GGPLMVIV-EFCKFGNLSTYLRSKR-NEFVPYKDLYKDFLTLEHL 146
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           +  +  VA  +E+L     ++ +H DL   N+LL    +  + DFGL R I
Sbjct: 147 IXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDI 194

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 29/199 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++   +IG GSFG VY+  L     +VA+K +   +R   +    E + +R + H N+V+
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 89
Query: 503 IITACSSSDFQGND-FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +     SS  + ++ +  LV +++         H   A   L   P I   L        
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL---PVIYVKL----YMYQ 142
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVGDFG----LTRFIPEVISSNQCS 616
           +  +L Y+H      I H D+KP N+LLD D  +  + DFG    L R  P V  S  CS
Sbjct: 143 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXICS 197
Query: 617 SVGLKGTVGYAAPEYGMGS 635
                    Y APE   G+
Sbjct: 198 RY-------YRAPELIFGA 209

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 82/176 (46%), Gaps = 30/176 (17%)
Query: 449 IGTGSFGSVYKG-ILDPDQTV----VAVKVLFLHQRGAL----KSFMAECEALRNIRHR- 498
           +G G+FG V +      D+T     VAVK+L   + GA     ++ M+E + L +I H  
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 128
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPES--------ASDDLNYSPSIL 550
           N+V ++ AC+     G     +V EF   G+L ++L  +         A +DL      L
Sbjct: 129 NVVNLLGACTKP---GGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDL--YKDFL 182
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           +    +  +  VA  +E+L     ++ +H DL   N+LL    +  + DFGL R I
Sbjct: 183 TLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 235

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 88/204 (43%), Gaps = 29/204 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++   +IG GSFG VY+  L     +VA+K +   +R   +    E + +R + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 77
Query: 503 IITACSSSDFQGND-FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +     SS  + ++ +  LV +++         H   A   L   P I   L    +   
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL---PVIYVKLYMYQL--- 131
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVGDFG----LTRFIPEVISSNQCS 616
              +L Y+H      I H D+KP N+LLD D  +  + DFG    L R  P V  S  CS
Sbjct: 132 -FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICS 185
Query: 617 SVGLKGTVGYAAPEYGMGSQVSTN 640
                    Y APE   G+   T+
Sbjct: 186 RY-------YRAPELIFGATDYTS 202

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 80/192 (41%), Gaps = 35/192 (18%)
Query: 443 FSSANLI-----GTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQR-GALKSFMAECEA 491
           F   NL+     G G FG V K            T VAVK+L  +     L+  ++E   
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 492 LRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNY------ 545
           L+ + H +++K+  ACS      +    L+ E+  +GSL  +L  ES      Y      
Sbjct: 80  LKQVNHPHVIKLYGACSQ-----DGPLLLIVEYAKYGSLRGFLR-ESRKVGPGYLGSGGS 133
Query: 546 ---------SPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH 596
                        L+    ++ A  ++  ++YL    + ++VH DL   N+L+       
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMK 190
Query: 597 VGDFGLTRFIPE 608
           + DFGL+R + E
Sbjct: 191 ISDFGLSRDVYE 202

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNL 500
           +++ + IG G++G V     + ++  VA+K +  F HQ    ++ + E + L   RH N+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRT-LREIKILLAFRHENI 85
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           + I     +   +      +V + M    L   L  +  S+D      I  FL +     
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSND-----HICYFLYQ----- 134
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L+Y+H      ++H DLKPSN+LL+      + DFGL R + +    +       
Sbjct: 135 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLAR-VADPDHDHTGFLTEY 189
Query: 621 KGTVGYAAPEYGMGSQVST 639
             T  Y APE  + S+  T
Sbjct: 190 VATRWYRAPEIMLNSKGYT 208

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 82/176 (46%), Gaps = 30/176 (17%)
Query: 449 IGTGSFGSVYKG-ILDPDQTV----VAVKVLFLHQRGAL----KSFMAECEALRNIRHR- 498
           +G G+FG V +      D+T     VAVK+L   + GA     ++ M+E + L +I H  
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 93
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPE--------SASDDLNYSPSIL 550
           N+V ++ AC+     G     +V EF   G+L ++L  +         A +DL      L
Sbjct: 94  NVVNLLGACTKP---GGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKEAPEDL--YKDFL 147
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           +    +  +  VA  +E+L     ++ +H DL   N+LL    +  + DFGL R I
Sbjct: 148 TLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 200

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 84/189 (44%), Gaps = 25/189 (13%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++    IG G+ G+VY  +       VA++ + L Q+   +  + E   +R  ++ N+V 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
            +     S   G++   +V E++  GSL   +  E+  D+   +      LQ        
Sbjct: 83  YL----DSYLVGDEL-WVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQ-------- 128
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL-TRFIPEVISSNQCSSVGLK 621
             ALE+LH +   Q++H ++K  N+LL  D    + DFG   +  PE     Q     + 
Sbjct: 129 --ALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSTMV 178
Query: 622 GTVGYAAPE 630
           GT  + APE
Sbjct: 179 GTPYWMAPE 187

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 85/203 (41%), Gaps = 37/203 (18%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTV---VAVKVLF---LHQRGALKSFMAECEALRNIR 496
           +    ++G GSFG V   IL  D+      AVKV+    + Q+   +S + E + L+ + 
Sbjct: 28  YKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H N+ K+        F+   +  LV E    G L           D   S    S +   
Sbjct: 85  HPNIXKLYEF-----FEDKGYFYLVGEVYTGGELF----------DEIISRKRFSEVDAA 129
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN---DMIAHVGDFGL-TRFIPEVISS 612
            I   V S + Y H   K +IVH DLKP N+LL++   D    + DFGL T F       
Sbjct: 130 RIIRQVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXK 186
Query: 613 NQCSSVGLKGTVGYAAPEYGMGS 635
           ++       GT  Y APE   G+
Sbjct: 187 DKI------GTAYYIAPEVLHGT 203

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 29/199 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++   +IG GSFG VY+  L     +VA+K +   +R   +    E + +R + H N+V+
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 90
Query: 503 IITACSSSDFQGND-FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +     SS  + ++ +  LV +++         H   A   L   P I   L        
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL---PVIYVKL----YMYQ 143
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVGDFG----LTRFIPEVISSNQCS 616
           +  +L Y+H      I H D+KP N+LLD D  +  + DFG    L R  P V  S  CS
Sbjct: 144 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICS 198
Query: 617 SVGLKGTVGYAAPEYGMGS 635
                    Y APE   G+
Sbjct: 199 RY-------YRAPELIFGA 210

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 87/199 (43%), Gaps = 29/199 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++   +IG GSFG VY+  L     +VA+K +   Q  A K+   E + +R + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--QGKAFKN--RELQIMRKLDHCNIVR 77
Query: 503 IITACSSSDFQGND-FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +     SS  + ++ +  LV +++         H   A   L   P I   L    +   
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL---PVIYVKLYMYQL--- 131
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVGDFG----LTRFIPEVISSNQCS 616
              +L Y+H      I H D+KP N+LLD D  +  + DFG    L R  P V  S  CS
Sbjct: 132 -FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICS 185
Query: 617 SVGLKGTVGYAAPEYGMGS 635
                    Y APE   G+
Sbjct: 186 RY-------YRAPELIFGA 197

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNL 500
           +++ + IG G++G V     + ++  VA++ +  F HQ    ++ + E + L   RH N+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRT-LREIKILLRFRHENI 87
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           + I     +   +      +V + M    L   L  +  S+D      I  FL +     
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSND-----HICYFLYQ----- 136
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L+Y+H      ++H DLKPSN+LL+      + DFGL R + +    +       
Sbjct: 137 -ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 191
Query: 621 KGTVGYAAPEYGMGSQVST 639
             T  Y APE  + S+  T
Sbjct: 192 VATRWYRAPEIMLNSKGYT 210

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 82/176 (46%), Gaps = 30/176 (17%)
Query: 449 IGTGSFGSVYKG-ILDPDQTV----VAVKVLFLHQRGAL----KSFMAECEALRNIRHR- 498
           +G G+FG V +      D+T     VAVK+L   + GA     ++ M+E + L +I H  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 82
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPES--------ASDDLNYSPSIL 550
           N+V ++ AC+     G     +V EF   G+L ++L  +         A +DL      L
Sbjct: 83  NVVNLLGACTKP---GGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDL--YKDFL 136
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           +    +  +  VA  +E+L     ++ +H DL   N+LL    +  + DFGL R I
Sbjct: 137 TLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 189

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 30/181 (16%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQR-GALKSFMAECEALRNIRHRNLVK 502
           +G G FG V K            T VAVK+L  +     L+  ++E   L+ + H +++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNY---------------SP 547
           +  ACS      +    L+ E+  +GSL  +L  ES      Y                 
Sbjct: 91  LYGACSQ-----DGPLLLIVEYAKYGSLRGFLR-ESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 548 SILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP 607
             L+    ++ A  ++  ++YL    + ++VH DL   N+L+       + DFGL+R + 
Sbjct: 145 RALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 608 E 608
           E
Sbjct: 202 E 202

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 29/199 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++   +IG GSFG VY+  L     +VA+K +   +R   +    E + +R + H N+V+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 111
Query: 503 IITACSSSDFQGND-FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +     SS  + ++ +  LV +++         H   A   L   P I   L        
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL---PVIYVKL----YMYQ 164
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVGDFG----LTRFIPEVISSNQCS 616
           +  +L Y+H      I H D+KP N+LLD D  +  + DFG    L R  P V  S  CS
Sbjct: 165 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXICS 219
Query: 617 SVGLKGTVGYAAPEYGMGS 635
                    Y APE   G+
Sbjct: 220 RY-------YRAPELIFGA 231

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 81/193 (41%), Gaps = 32/193 (16%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI--RHRNLVKIITA 506
           IG G +G V+ G    ++  VAVKV F  +     S+  E E  + +  RH N++  I A
Sbjct: 45  IGKGRYGEVWMGKWRGEK--VAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFIAA 99
Query: 507 CSSSDFQGNDFKALVY---EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
               D +G      +Y   ++  +GSL  +L             + L     L +A +  
Sbjct: 100 ----DIKGTGSWTQLYLITDYHENGSLYDYL-----------KSTTLDAKSMLKLAYSSV 144
Query: 564 SALEYLHHHC-----KKQIVHCDLKPSNVLLDNDMIAHVGDFGLT-RFIPEVISSNQCSS 617
           S L +LH        K  I H DLK  N+L+  +    + D GL  +FI +    +   +
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204
Query: 618 VGLKGTVGYAAPE 630
             + GT  Y  PE
Sbjct: 205 TRV-GTKRYMPPE 216

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 89/193 (46%), Gaps = 29/193 (15%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIRHRNL 500
           +S    IG+G    V++ +L+  + + A+K + L +     L S+  E   L  ++  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 115
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLE--SWLHPESASDDLNYSPSILSFLQRLNI 558
            KII      D++  D    +Y  M  G+++  SWL  + + D            +R + 
Sbjct: 116 DKIIRLY---DYEITD--QYIYMVMECGNIDLNSWLKKKKSIDPW----------ERKSY 160
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT-RFIPEVISSNQCSS 617
             N+  A+  +H H    IVH DLKP+N L+ + M+  + DFG+  +  P+  S  + S 
Sbjct: 161 WKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQ 216
Query: 618 VGLKGTVGYAAPE 630
           V   G V Y  PE
Sbjct: 217 V---GAVNYMPPE 226

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 80/192 (41%), Gaps = 30/192 (15%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI--RHRNLVKIITA 506
           +G G +G V++G    +   VAVK+         KS+  E E    +  RH N++  I +
Sbjct: 45  VGKGRYGEVWRGSWQGEN--VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIAS 99
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
             +S         L+  +   GSL  +L             + L  +  L I +++AS L
Sbjct: 100 DMTSRHSSTQL-WLITHYHEMGSLYDYLQL-----------TTLDTVSCLRIVLSIASGL 147
Query: 567 EYLH-----HHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG-- 619
            +LH        K  I H DLK  N+L+  +    + D GL   +    S+NQ   VG  
Sbjct: 148 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA--VMHSQSTNQL-DVGNN 204
Query: 620 -LKGTVGYAAPE 630
              GT  Y APE
Sbjct: 205 PRVGTKRYMAPE 216

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 62/146 (42%), Gaps = 26/146 (17%)
Query: 488 ECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSP 547
           E   L+++ H N++K+        F+   +  LV EF   G L   +      D+ + + 
Sbjct: 96  EISLLKSLDHPNIIKLFDV-----FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA- 149
Query: 548 SILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND---MIAHVGDFGLTR 604
                    NI   + S + YLH H    IVH D+KP N+LL+N    +   + DFGL+ 
Sbjct: 150 ---------NIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSS 197
Query: 605 FIPEVISSNQCSSVGLKGTVGYAAPE 630
           F      S         GT  Y APE
Sbjct: 198 FF-----SKDYKLRDRLGTAYYIAPE 218

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 29/199 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++   +IG GSFG VY+  L     +VA+K +   +R   +    E + +R + H N+V+
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 82
Query: 503 IITACSSSDFQGND-FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +     SS  + ++ +  LV +++         H   A   L   P I   L    +   
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL---PVIYVKLYMYQL--- 136
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVGDFG----LTRFIPEVISSNQCS 616
              +L Y+H      I H D+KP N+LLD D  +  + DFG    L R  P V  S  CS
Sbjct: 137 -FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICS 190
Query: 617 SVGLKGTVGYAAPEYGMGS 635
                    Y APE   G+
Sbjct: 191 RY-------YRAPELIFGA 202

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 75/167 (44%), Gaps = 31/167 (18%)
Query: 438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-- 495
           + T  F     IG+G FGSV+K +   D  + A+K      +  L   + E  ALR +  
Sbjct: 4   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVYA 59
Query: 496 -----RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
                +H ++V+  +A +      +D   +  E+ + GSL         +D ++ +  I+
Sbjct: 60  HAVLGQHSHVVRYFSAWAE-----DDHMLIQNEYCNGGSL---------ADAISENYRIM 105
Query: 551 SFLQRL---NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI 594
           S+ +     ++ + V   L Y+H      +VH D+KPSN+ +    I
Sbjct: 106 SYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSI 149

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 35/204 (17%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI--RHRNLVKIITA 506
           +G G +G V++G+   +   VAVK+         +S+  E E    +  RH N++  I +
Sbjct: 16  VGKGRYGEVWRGLWHGES--VAVKIFSSRDE---QSWFRETEIYNTVLLRHDNILGFIAS 70
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
             +S         L+  +  HGSL  +L  ++    L            L +A++ A  L
Sbjct: 71  DMTSRNSSTQL-WLITHYHEHGSLYDFLQRQTLEPHLA-----------LRLAVSAACGL 118
Query: 567 EYLH-----HHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
            +LH        K  I H D K  NVL+ +++   + D GL      V+ S     + + 
Sbjct: 119 AHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA-----VMHSQGSDYLDIG 173
Query: 622 -----GTVGYAAPEYGMGSQVSTN 640
                GT  Y APE  +  Q+ T+
Sbjct: 174 NNPRVGTKRYMAPEV-LDEQIRTD 196

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 75/167 (44%), Gaps = 31/167 (18%)
Query: 438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-- 495
           + T  F     IG+G FGSV+K +   D  + A+K      +  L   + E  ALR +  
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVYA 61
Query: 496 -----RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
                +H ++V+  +A +      +D   +  E+ + GSL         +D ++ +  I+
Sbjct: 62  HAVLGQHSHVVRYFSAWAE-----DDHMLIQNEYCNGGSL---------ADAISENYRIM 107
Query: 551 SFLQRL---NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI 594
           S+ +     ++ + V   L Y+H      +VH D+KPSN+ +    I
Sbjct: 108 SYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSI 151

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 82/176 (46%), Gaps = 30/176 (17%)
Query: 449 IGTGSFGSVYKG-ILDPDQTV----VAVKVLFLHQRGAL----KSFMAECEALRNIRHR- 498
           +G G+FG V +      D+T     VAVK+L   + GA     ++ M+E + L +I H  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 91
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPES--------ASDDLNYSPSIL 550
           N+V ++ AC+     G     +V EF   G+L ++L  +         A +DL      L
Sbjct: 92  NVVNLLGACTKP---GGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDL--YKDFL 145
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           +    +  +  VA  +E+L     ++ +H DL   N+LL    +  + DFGL R I
Sbjct: 146 TLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 198

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 82/176 (46%), Gaps = 30/176 (17%)
Query: 449 IGTGSFGSVYKG-ILDPDQTV----VAVKVLFLHQRGAL----KSFMAECEALRNIRHR- 498
           +G G+FG V +      D+T     VAVK+L   + GA     ++ M+E + L +I H  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 91
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPES--------ASDDLNYSPSIL 550
           N+V ++ AC+     G     +V EF   G+L ++L  +         A +DL      L
Sbjct: 92  NVVNLLGACTKP---GGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDL--YKDFL 145
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           +    +  +  VA  +E+L     ++ +H DL   N+LL    +  + DFGL R I
Sbjct: 146 TLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 198

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 75/167 (44%), Gaps = 31/167 (18%)
Query: 438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-- 495
           + T  F     IG+G FGSV+K +   D  + A+K      +  L   + E  ALR +  
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVYA 61
Query: 496 -----RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
                +H ++V+  +A +      +D   +  E+ + GSL         +D ++ +  I+
Sbjct: 62  HAVLGQHSHVVRYFSAWAE-----DDHMLIQNEYCNGGSL---------ADAISENYRIM 107
Query: 551 SFLQRL---NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI 594
           S+ +     ++ + V   L Y+H      +VH D+KPSN+ +    I
Sbjct: 108 SYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSI 151

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 87/199 (43%), Gaps = 29/199 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++   +IG GSFG VY+  L     +VA+K +   Q  A K+   E + +R + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--QGKAFKN--RELQIMRKLDHCNIVR 77
Query: 503 IITACSSSDFQGND-FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +     SS  + ++ +  LV +++         H   A   L   P I   L    +   
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTL---PVIYVKLYMYQL--- 131
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVGDFG----LTRFIPEVISSNQCS 616
              +L Y+H      I H D+KP N+LLD D  +  + DFG    L R  P V  S  CS
Sbjct: 132 -FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXICS 185
Query: 617 SVGLKGTVGYAAPEYGMGS 635
                    Y APE   G+
Sbjct: 186 RY-------YRAPELIFGA 197

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 82/176 (46%), Gaps = 30/176 (17%)
Query: 449 IGTGSFGSVYKG-ILDPDQTV----VAVKVLFLHQRGAL----KSFMAECEALRNIRHR- 498
           +G G+FG V +      D+T     VAVK+L   + GA     ++ M+E + L +I H  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 91
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPES--------ASDDLNYSPSIL 550
           N+V ++ AC+     G     +V EF   G+L ++L  +         A +DL      L
Sbjct: 92  NVVNLLGACTKP---GGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDL--YKDFL 145
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           +    +  +  VA  +E+L     ++ +H DL   N+LL    +  + DFGL R I
Sbjct: 146 TLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 198

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 75/167 (44%), Gaps = 31/167 (18%)
Query: 438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-- 495
           + T  F     IG+G FGSV+K +   D  + A+K      +  L   + E  ALR +  
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVYA 63
Query: 496 -----RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
                +H ++V+  +A +      +D   +  E+ + GSL         +D ++ +  I+
Sbjct: 64  HAVLGQHSHVVRYFSAWAE-----DDHMLIQNEYCNGGSL---------ADAISENYRIM 109
Query: 551 SFLQRL---NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI 594
           S+ +     ++ + V   L Y+H      +VH D+KPSN+ +    I
Sbjct: 110 SYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSI 153

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 74/192 (38%), Gaps = 26/192 (13%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           FS   +IG G FG VY         + A+K L    +  +K    E  AL      +LV 
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSLVS 247
Query: 503 I----ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
                   C S  F   D  + + + M+ G             DL+Y  S        ++
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGG-------------DLHYHLSQHGVFSEADM 294
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
               A  +  L H   + +V+ DLKP+N+LLD      + D GL     +       +SV
Sbjct: 295 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASV 351
Query: 619 GLKGTVGYAAPE 630
              GT GY APE
Sbjct: 352 ---GTHGYMAPE 360

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 29/199 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++   +IG GSFG VY+  L     +VA+K +   +R   +    E + +R + H N+V+
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 156
Query: 503 IITACSSSDFQGND-FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +     SS  + ++ +  LV +++         H   A   L   P I   L        
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL---PVIYVKL----YMYQ 209
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVGDFG----LTRFIPEVISSNQCS 616
           +  +L Y+H      I H D+KP N+LLD D  +  + DFG    L R  P V  S  CS
Sbjct: 210 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICS 264
Query: 617 SVGLKGTVGYAAPEYGMGS 635
                    Y APE   G+
Sbjct: 265 RY-------YRAPELIFGA 276

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 74/192 (38%), Gaps = 26/192 (13%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           FS   +IG G FG VY         + A+K L    +  +K    E  AL      +LV 
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSLVS 246
Query: 503 I----ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
                   C S  F   D  + + + M+ G             DL+Y  S        ++
Sbjct: 247 TGDCPFIVCMSYAFHTPDKLSFILDLMNGG-------------DLHYHLSQHGVFSEADM 293
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
               A  +  L H   + +V+ DLKP+N+LLD      + D GL     +       +SV
Sbjct: 294 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASV 350
Query: 619 GLKGTVGYAAPE 630
              GT GY APE
Sbjct: 351 ---GTHGYMAPE 359

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 29/199 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++   +IG GSFG VY+  L     +VA+K +   +R   +    E + +R + H N+V+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 111
Query: 503 IITACSSSDFQGND-FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +     SS  + ++ +  LV +++         H   A   L   P I   L        
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL---PVIYVKL----YMYQ 164
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVGDFG----LTRFIPEVISSNQCS 616
           +  +L Y+H      I H D+KP N+LLD D  +  + DFG    L R  P V  S  CS
Sbjct: 165 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICS 219
Query: 617 SVGLKGTVGYAAPEYGMGS 635
                    Y APE   G+
Sbjct: 220 RY-------YRAPELIFGA 231

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 29/199 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++   +IG GSFG VY+  L     +VA+K +   +R   +    E + +R + H N+V+
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 115
Query: 503 IITACSSSDFQGND-FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +     SS  + ++ +  LV +++         H   A   L   P I   L        
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL---PVIYVKL----YMYQ 168
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVGDFG----LTRFIPEVISSNQCS 616
           +  +L Y+H      I H D+KP N+LLD D  +  + DFG    L R  P V  S  CS
Sbjct: 169 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICS 223
Query: 617 SVGLKGTVGYAAPEYGMGS 635
                    Y APE   G+
Sbjct: 224 RY-------YRAPELIFGA 235

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 29/199 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++   +IG GSFG VY+  L     +VA+K +   +R   +    E + +R + H N+V+
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 113
Query: 503 IITACSSSDFQGND-FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +     SS  + ++ +  LV +++         H   A   L   P I   L        
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL---PVIYVKL----YMYQ 166
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVGDFG----LTRFIPEVISSNQCS 616
           +  +L Y+H      I H D+KP N+LLD D  +  + DFG    L R  P V  S  CS
Sbjct: 167 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICS 221
Query: 617 SVGLKGTVGYAAPEYGMGS 635
                    Y APE   G+
Sbjct: 222 RY-------YRAPELIFGA 233

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 80/192 (41%), Gaps = 30/192 (15%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI--RHRNLVKIITA 506
           +G G +G V++G    +   VAVK+         KS+  E E    +  RH N++  I +
Sbjct: 16  VGKGRYGEVWRGSWQGEN--VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIAS 70
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
             +S         L+  +   GSL  +L             + L  +  L I +++AS L
Sbjct: 71  DMTSRHSSTQL-WLITHYHEMGSLYDYLQL-----------TTLDTVSCLRIVLSIASGL 118
Query: 567 EYLH-----HHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG-- 619
            +LH        K  I H DLK  N+L+  +    + D GL   +    S+NQ   VG  
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA--VMHSQSTNQL-DVGNN 175
Query: 620 -LKGTVGYAAPE 630
              GT  Y APE
Sbjct: 176 PRVGTKRYMAPE 187

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 29/199 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++   +IG GSFG VY+  L     +VA+K +   +R   +    E + +R + H N+V+
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 105
Query: 503 IITACSSSDFQGND-FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +     SS  + ++ +  LV +++         H   A   L   P I   L        
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL---PVIYVKL----YMYQ 158
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVGDFG----LTRFIPEVISSNQCS 616
           +  +L Y+H      I H D+KP N+LLD D  +  + DFG    L R  P V  S  CS
Sbjct: 159 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICS 213
Query: 617 SVGLKGTVGYAAPEYGMGS 635
                    Y APE   G+
Sbjct: 214 RY-------YRAPELIFGA 225

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 74/192 (38%), Gaps = 26/192 (13%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           FS   +IG G FG VY         + A+K L    +  +K    E  AL      +LV 
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSLVS 247
Query: 503 I----ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
                   C S  F   D  + + + M+ G             DL+Y  S        ++
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGG-------------DLHYHLSQHGVFSEADM 294
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
               A  +  L H   + +V+ DLKP+N+LLD      + D GL     +       +SV
Sbjct: 295 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASV 351
Query: 619 GLKGTVGYAAPE 630
              GT GY APE
Sbjct: 352 ---GTHGYMAPE 360

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 74/192 (38%), Gaps = 26/192 (13%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           FS   +IG G FG VY         + A+K L    +  +K    E  AL      +LV 
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSLVS 247
Query: 503 I----ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
                   C S  F   D  + + + M+ G             DL+Y  S        ++
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGG-------------DLHYHLSQHGVFSEADM 294
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
               A  +  L H   + +V+ DLKP+N+LLD      + D GL     +       +SV
Sbjct: 295 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASV 351
Query: 619 GLKGTVGYAAPE 630
              GT GY APE
Sbjct: 352 ---GTHGYMAPE 360

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 76/181 (41%), Gaps = 30/181 (16%)
Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQR-GALKSFMAECEALRNIRHRNLVK 502
           +G G FG V K            T VAVK+L  +     L+  ++E   L+ + H +++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNY---------------SP 547
           +  ACS      +    L+ E+  +GSL  +L  ES      Y                 
Sbjct: 91  LYGACSQ-----DGPLLLIVEYAKYGSLRGFLR-ESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 548 SILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP 607
             L+    ++ A  ++  ++YL    +  +VH DL   N+L+       + DFGL+R + 
Sbjct: 145 RALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 608 E 608
           E
Sbjct: 202 E 202

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 78/184 (42%), Gaps = 22/184 (11%)
Query: 449 IGTGSFGS--VYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITA 506
           IG GSFG   + K   D  Q V+    +        +    E   L N++H N+V+    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY--- 88
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
                F+ N    +V ++   G L   ++ +           +    Q L+  + +  AL
Sbjct: 89  --RESFEENGSLYIVMDYCEGGDLFKRINAQKGV--------LFQEDQILDWFVQICLAL 138
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
           +++H    ++I+H D+K  N+ L  D    +GDFG+ R    V++S    +    GT  Y
Sbjct: 139 KHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIAR----VLNSTVELARACIGTPYY 191
Query: 627 AAPE 630
            +PE
Sbjct: 192 LSPE 195

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 80/192 (41%), Gaps = 30/192 (15%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI--RHRNLVKIITA 506
           +G G +G V++G    +   VAVK+         KS+  E E    +  RH N++  I +
Sbjct: 16  VGKGRYGEVWRGSWQGEN--VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIAS 70
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
             +S         L+  +   GSL  +L             + L  +  L I +++AS L
Sbjct: 71  DMTSRHSSTQL-WLITHYHEMGSLYDYLQL-----------TTLDTVSCLRIVLSIASGL 118
Query: 567 EYLH-----HHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG-- 619
            +LH        K  I H DLK  N+L+  +    + D GL   +    S+NQ   VG  
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA--VMHSQSTNQL-DVGNN 175
Query: 620 -LKGTVGYAAPE 630
              GT  Y APE
Sbjct: 176 PRVGTKRYMAPE 187

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 85/199 (42%), Gaps = 29/199 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++   +IG GSFG VY+  L     +VA+K +   +R   +    E + +R + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 77
Query: 503 I-ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +     SS + +   +  LV +++         H   A   L   P I   L    +   
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTL---PVIYVKLYMYQL--- 131
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVGDFG----LTRFIPEVISSNQCS 616
              +L Y+H      I H D+KP N+LLD D  +  + DFG    L R  P V  S  CS
Sbjct: 132 -FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXICS 185
Query: 617 SVGLKGTVGYAAPEYGMGS 635
                    Y APE   G+
Sbjct: 186 RY-------YRAPELIFGA 197

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 82/171 (47%), Gaps = 24/171 (14%)
Query: 449 IGTGSFGSVYKG-ILDPDQTV----VAVKVLFLHQRGAL----KSFMAECEALRNIRHR- 498
           +G G+FG V +      D+T     VAVK+L   + GA     ++ M+E + L +I H  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 91
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFL---QR 555
           N+V ++ AC+     G     +V EF   G+L ++L  +  ++ + Y      FL     
Sbjct: 92  NVVNLLGACTKP---GGPLMVIV-EFCKFGNLSTYLRSKR-NEFVPYKDLYKDFLTLEHL 146
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           +  +  VA  +E+L     ++ +H DL   N+LL    +  + DFGL R I
Sbjct: 147 ICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDI 194

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 76/169 (44%), Gaps = 28/169 (16%)
Query: 447 NLIGTGSFGSVYKGIL---DPDQTVVAVKVLFLHQRGAL---KSFMAECEALRNIRHRNL 500
            ++G G FG VY+G+      ++  VAVK     +   L   + FM+E   ++N+ H ++
Sbjct: 30  RILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEKFMSEAVIMKNLDHPHI 87
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK+I               ++ E   +G L  +L     S         L  L  +  ++
Sbjct: 88  VKLIGIIEEEP------TWIIMELYPYGELGHYLERNKNS---------LKVLTLVLYSL 132
Query: 561 NVASALEYLHH-HCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
            +  A+ YL   +C    VH D+   N+L+ +     +GDFGL+R+I +
Sbjct: 133 QICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIED 177

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 67/166 (40%), Gaps = 29/166 (17%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA---LKSFMAECEALRNIRHRN 499
           FS    IG GSFG+VY      +  VVA+K +    + +    +  + E   L+ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPE----SASDDLNYSPSILSFLQR 555
            ++                   Y   +     +WL  E    SASD L      L  ++ 
Sbjct: 116 TIQ-------------------YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI 156
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG 601
             +       L YLH H    ++H D+K  N+LL    +  +GDFG
Sbjct: 157 AAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 199

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 76/168 (45%), Gaps = 28/168 (16%)
Query: 448 LIGTGSFGSVYKGIL---DPDQTVVAVKVLFLHQRGAL---KSFMAECEALRNIRHRNLV 501
           ++G G FG VY+G+      ++  VAVK     +   L   + FM+E   ++N+ H ++V
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           K+I               ++ E   +G L  +L     S         L  L  +  ++ 
Sbjct: 77  KLIGIIEEEP------TWIIMELYPYGELGHYLERNKNS---------LKVLTLVLYSLQ 121
Query: 562 VASALEYLHH-HCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           +  A+ YL   +C    VH D+   N+L+ +     +GDFGL+R+I +
Sbjct: 122 ICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIED 165

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 30/176 (17%)
Query: 449 IGTGSFGSVYKG-ILDPDQTV----VAVKVLFLHQRGAL----KSFMAECEALRNIRHR- 498
           +G G+FG V +      D+T     VAVK+L   + GA     ++ M+E + L +I H  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 82
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPES--------ASDDLNYSPSIL 550
           N+V ++ AC+     G     ++ EF   G+L ++L  +         A +DL      L
Sbjct: 83  NVVNLLGACTKP---GGPL-MVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL--YKDFL 136
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           +    +  +  VA  +E+L     ++ +H DL   N+LL    +  + DFGL R I
Sbjct: 137 TLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 189

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 30/176 (17%)
Query: 449 IGTGSFGSVYKG-ILDPDQTV----VAVKVLFLHQRGAL----KSFMAECEALRNIRHR- 498
           +G G+FG V +      D+T     VAVK+L   + GA     ++ M+E + L +I H  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 82
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPES--------ASDDLNYSPSIL 550
           N+V ++ AC+     G     ++ EF   G+L ++L  +         A +DL      L
Sbjct: 83  NVVNLLGACTKP---GGPL-MVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL--YKDFL 136
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           +    +  +  VA  +E+L     ++ +H DL   N+LL    +  + DFGL R I
Sbjct: 137 TLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 189

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 30/176 (17%)
Query: 449 IGTGSFGSVYKG-ILDPDQTV----VAVKVLFLHQRGAL----KSFMAECEALRNIRHR- 498
           +G G+FG V +      D+T     VAVK+L   + GA     ++ M+E + L +I H  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 82
Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPES--------ASDDLNYSPSIL 550
           N+V ++ AC+     G     ++ EF   G+L ++L  +         A +DL      L
Sbjct: 83  NVVNLLGACTKP---GGPL-MVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL--YKDFL 136
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           +    +  +  VA  +E+L     ++ +H DL   N+LL    +  + DFGL R I
Sbjct: 137 TLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 189

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 34/204 (16%)
Query: 449 IGTGSFGSVYKGI---LDPDQTVVAVKVLFLHQRG---ALKSFMAECEALRNI-RHRNLV 501
           +G G+FG V +     L  +  V+ V V  L         ++ M+E + + ++ +H N+V
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSL--------ESWLHPESAS-------DDLNYS 546
            ++ AC+     G     ++ E+  +G L        E+ L P  A        D  +  
Sbjct: 99  NLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGR 153
Query: 547 PSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           P  L     L+ +  VA  + +L     K  +H D+   NVLL N  +A +GDFGL R I
Sbjct: 154 P--LELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 208
Query: 607 PEVISSNQCSSVGLKGTVGYAAPE 630
             +  SN       +  V + APE
Sbjct: 209 --MNDSNYIVKGNARLPVKWMAPE 230

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 81/186 (43%), Gaps = 24/186 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG---ALK-SFMAECEALRNIRHRNLVKII 504
           +G+G+FG+V KG     + V  V V  L       ALK   +AE   ++ + +  +V++I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C +  +       LV E    G L  +L       D N    I+  + +      V+ 
Sbjct: 79  GICEAESWM------LVMEMAELGPLNKYLQQNRHVKDKN----IIELVHQ------VSM 122
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            ++YL    +   VH DL   NVLL     A + DFGL++ +    +  +  + G K  V
Sbjct: 123 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHG-KWPV 178
Query: 625 GYAAPE 630
            + APE
Sbjct: 179 KWYAPE 184

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 76/168 (45%), Gaps = 28/168 (16%)
Query: 448 LIGTGSFGSVYKGIL---DPDQTVVAVKVLFLHQRGAL---KSFMAECEALRNIRHRNLV 501
           ++G G FG VY+G+      ++  VAVK     +   L   + FM+E   ++N+ H ++V
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           K+I               ++ E   +G L  +L     S         L  L  +  ++ 
Sbjct: 73  KLIGIIEEEP------TWIIMELYPYGELGHYLERNKNS---------LKVLTLVLYSLQ 117
Query: 562 VASALEYLHH-HCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           +  A+ YL   +C    VH D+   N+L+ +     +GDFGL+R+I +
Sbjct: 118 ICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIED 161

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 65/159 (40%), Gaps = 25/159 (15%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G+FG VYK        + A KV+       L+ ++ E E L    H  +VK++ A  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA-- 84
Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLH----PESASDDLNYSPSILSFLQRLNIAINVAS 564
                          + H G L  W+     P  A D +     +   L    I +    
Sbjct: 85  ---------------YYHDGKL--WIMIEFCPGGAVDAIML--ELDRGLTEPQIQVVCRQ 125
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT 603
            LE L+    K+I+H DLK  NVL+  +    + DFG++
Sbjct: 126 MLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS 164

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 79/186 (42%), Gaps = 24/186 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG---ALK-SFMAECEALRNIRHRNLVKII 504
           +G+G+FG+V KG     + V  V V  L       ALK   +AE   ++ + +  +V++I
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C +  +       LV E    G L  +L       D N           + +   V+ 
Sbjct: 437 GICEAESWM------LVMEMAELGPLNKYLQQNRHVKDKNI----------IELVHQVSM 480
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            ++YL    +   VH DL   NVLL     A + DFGL++ +    +  +  + G K  V
Sbjct: 481 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWPV 536
Query: 625 GYAAPE 630
            + APE
Sbjct: 537 KWYAPE 542

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 77/190 (40%), Gaps = 30/190 (15%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNL 500
           GGF+    I       V+ G + P   ++       HQR  +     E    R++ H+++
Sbjct: 28  GGFAKCFEISDADTKEVFAGKIVPKSLLLKP-----HQREKMS---MEISIHRSLAHQHV 79
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           V          F+ NDF  +V E     SL        A  +    P    +L+++ +  
Sbjct: 80  VGF-----HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE----PEARYYLRQIVLGC 130
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                 +YLH   + +++H DLK  N+ L+ D+   +GDFGL       +  +      L
Sbjct: 131 ------QYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA----TKVEYDGERKKTL 177
Query: 621 KGTVGYAAPE 630
            GT  Y APE
Sbjct: 178 CGTPNYIAPE 187

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 15/206 (7%)
Query: 427 LLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKS 484
           LL   S++        +     IG G++G V           VA+K +          K 
Sbjct: 40  LLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKR 99
Query: 485 FMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLN 544
            + E + L++ +H N++ I      +   G +FK+ VY  +    +ES LH       + 
Sbjct: 100 TLRELKILKHFKHDNIIAIKDILRPTVPYG-EFKS-VYVVL--DLMESDLH------QII 149
Query: 545 YSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
           +S   L+          +   L+Y+H     Q++H DLKPSN+L++ +    +GDFG+ R
Sbjct: 150 HSSQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMAR 206
Query: 605 FIPEVISSNQCSSVGLKGTVGYAAPE 630
            +    + +Q        T  Y APE
Sbjct: 207 GLCTSPAEHQYFMTEYVATRWYRAPE 232

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 77/190 (40%), Gaps = 30/190 (15%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNL 500
           GGF+    I       V+ G + P   ++       HQR  +     E    R++ H+++
Sbjct: 28  GGFAKCFEISDADTKEVFAGKIVPKSLLLKP-----HQREKMS---MEISIHRSLAHQHV 79
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           V          F+ NDF  +V E     SL        A  +    P    +L+++ +  
Sbjct: 80  VGF-----HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE----PEARYYLRQIVLGC 130
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                 +YLH   + +++H DLK  N+ L+ D+   +GDFGL       +  +      L
Sbjct: 131 ------QYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA----TKVEYDGERKKTL 177
Query: 621 KGTVGYAAPE 630
            GT  Y APE
Sbjct: 178 CGTPNYIAPE 187

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 67/166 (40%), Gaps = 29/166 (17%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA---LKSFMAECEALRNIRHRN 499
           FS    IG GSFG+VY      +  VVA+K +    + +    +  + E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPE----SASDDLNYSPSILSFLQR 555
            ++                   Y   +     +WL  E    SASD L      L  ++ 
Sbjct: 77  TIQ-------------------YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI 117
Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG 601
             +       L YLH H    ++H D+K  N+LL    +  +GDFG
Sbjct: 118 AAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 160

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 79/190 (41%), Gaps = 30/190 (15%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNL 500
           GGF+    I       V+ G + P   ++       HQR  +     E    R++ H+++
Sbjct: 50  GGFAKCFEISDADTKEVFAGKIVPKSLLLKP-----HQREKMS---MEISIHRSLAHQHV 101
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           V          F+ NDF  +V E     SL        A  +    P    +L+++ +  
Sbjct: 102 VGF-----HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE----PEARYYLRQIVLGC 152
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                 +YLH   + +++H DLK  N+ L+ D+   +GDFGL     +V    +   V L
Sbjct: 153 ------QYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT---KVEYDGERKKV-L 199
Query: 621 KGTVGYAAPE 630
            GT  Y APE
Sbjct: 200 CGTPNYIAPE 209

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 77/190 (40%), Gaps = 30/190 (15%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNL 500
           GGF+    I       V+ G + P   ++       HQR  +     E    R++ H+++
Sbjct: 32  GGFAKCFEISDADTKEVFAGKIVPKSLLLKP-----HQREKMS---MEISIHRSLAHQHV 83
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           V          F+ NDF  +V E     SL        A  +    P    +L+++ +  
Sbjct: 84  VGF-----HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE----PEARYYLRQIVLGC 134
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                 +YLH   + +++H DLK  N+ L+ D+   +GDFGL       +  +      L
Sbjct: 135 ------QYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA----TKVEYDGERKKTL 181
Query: 621 KGTVGYAAPE 630
            GT  Y APE
Sbjct: 182 CGTPNYIAPE 191

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 86/199 (43%), Gaps = 24/199 (12%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALK-SFMAECEALRNIRHRNLV 501
           F   + +G G+ G V K    P   ++A K++ L  + A++   + E + L       +V
Sbjct: 18  FERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 77
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
               A     F  +   ++  E M  GSL+  L      +       IL       ++I 
Sbjct: 78  GFYGA-----FYSDGEISICMEHMDGGSLDQVL-----KEAKRIPEEILG-----KVSIA 122
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           V   L YL    K QI+H D+KPSN+L+++     + DFG++    ++I S   S V   
Sbjct: 123 VLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV--- 174
Query: 622 GTVGYAAPEYGMGSQVSTN 640
           GT  Y APE   G+  S  
Sbjct: 175 GTRSYMAPERLQGTHYSVQ 193

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 79/186 (42%), Gaps = 24/186 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG---ALK-SFMAECEALRNIRHRNLVKII 504
           +G+G+FG+V KG     + V  V V  L       ALK   +AE   ++ + +  +V++I
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C +  +       LV E    G L  +L       D N           + +   V+ 
Sbjct: 438 GICEAESWM------LVMEMAELGPLNKYLQQNRHVKDKNI----------IELVHQVSM 481
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            ++YL    +   VH DL   NVLL     A + DFGL++ +    +  +  + G K  V
Sbjct: 482 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWPV 537
Query: 625 GYAAPE 630
            + APE
Sbjct: 538 KWYAPE 543

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 81/186 (43%), Gaps = 24/186 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG---ALK-SFMAECEALRNIRHRNLVKII 504
           +G+G+FG+V KG     + V  V V  L       ALK   +AE   ++ + +  +V++I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C +  +       LV E    G L  +L       D N    I+  + +      V+ 
Sbjct: 95  GICEAESWM------LVMEMAELGPLNKYLQQNRHVKDKN----IIELVHQ------VSM 138
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            ++YL    +   VH DL   NVLL     A + DFGL++ +    +  +  + G K  V
Sbjct: 139 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWPV 194
Query: 625 GYAAPE 630
            + APE
Sbjct: 195 KWYAPE 200

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 81/186 (43%), Gaps = 24/186 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG---ALK-SFMAECEALRNIRHRNLVKII 504
           +G+G+FG+V KG     + V  V V  L       ALK   +AE   ++ + +  +V++I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C +  +       LV E    G L  +L       D N    I+  + +      V+ 
Sbjct: 95  GICEAESWM------LVMEMAELGPLNKYLQQNRHVKDKN----IIELVHQ------VSM 138
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            ++YL    +   VH DL   NVLL     A + DFGL++ +    +  +  + G K  V
Sbjct: 139 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWPV 194
Query: 625 GYAAPE 630
            + APE
Sbjct: 195 KWYAPE 200

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/197 (22%), Positives = 78/197 (39%), Gaps = 28/197 (14%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNL 500
           +     IG GS+G V+K        +VA+K     +   +  K  + E   L+ ++H NL
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           V ++       F+      LV+E+  H  L              Y   +   L + +I  
Sbjct: 65  VNLLEV-----FRRKRRLHLVFEYCDHTVLHELD---------RYQRGVPEHLVK-SITW 109
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI--PEVISSNQCSSV 618
               A+ + H H     +H D+KP N+L+    +  + DFG  R +  P     ++ +  
Sbjct: 110 QTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-- 164
Query: 619 GLKGTVGYAAPEYGMGS 635
               T  Y +PE  +G 
Sbjct: 165 ----TRWYRSPELLVGD 177

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 83/192 (43%), Gaps = 39/192 (20%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV        +  VAVK L       +H R   +    E   L++++H N++ 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYR----ELRLLKHLKHENVIG 91
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           ++     A S  DF     +  +   +    L + +  ++ SD+       + FL     
Sbjct: 92  LLDVFTPATSIEDFS----EVYLVTTLMGADLNNIVKSQALSDEH------VQFL----- 136
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
              +   L+Y+H      I+H DLKPSNV ++ D    + DFGL R   E ++       
Sbjct: 137 VYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT------- 186
Query: 619 GLKGTVGYAAPE 630
           G   T  Y APE
Sbjct: 187 GYVATRWYRAPE 198

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 65/159 (40%), Gaps = 25/159 (15%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G+FG VYK        + A KV+       L+ ++ E E L    H  +VK++ A  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA-- 76
Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLH----PESASDDLNYSPSILSFLQRLNIAINVAS 564
                          + H G L  W+     P  A D +     +   L    I +    
Sbjct: 77  ---------------YYHDGKL--WIMIEFCPGGAVDAIML--ELDRGLTEPQIQVVCRQ 117
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT 603
            LE L+    K+I+H DLK  NVL+  +    + DFG++
Sbjct: 118 MLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS 156

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 81/186 (43%), Gaps = 24/186 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG---ALK-SFMAECEALRNIRHRNLVKII 504
           +G+G+FG+V KG     + V  V V  L       ALK   +AE   ++ + +  +V++I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C +  +       LV E    G L  +L       D N    I+  + +      V+ 
Sbjct: 79  GICEAESWM------LVMEMAELGPLNKYLQQNRHVKDKN----IIELVHQ------VSM 122
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            ++YL    +   VH DL   NVLL     A + DFGL++ +    +  +  + G K  V
Sbjct: 123 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWPV 178
Query: 625 GYAAPE 630
            + APE
Sbjct: 179 KWYAPE 184

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 79/190 (41%), Gaps = 30/190 (15%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNL 500
           GGF+    I       V+ G + P   ++       HQR  +     E    R++ H+++
Sbjct: 52  GGFAKCFEISDADTKEVFAGKIVPKSLLLKP-----HQREKMS---MEISIHRSLAHQHV 103
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           V          F+ NDF  +V E     SL        A  +    P    +L+++ +  
Sbjct: 104 VGF-----HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE----PEARYYLRQIVLGC 154
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                 +YLH   + +++H DLK  N+ L+ D+   +GDFGL     +V    +   V L
Sbjct: 155 ------QYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT---KVEYDGERKKV-L 201
Query: 621 KGTVGYAAPE 630
            GT  Y APE
Sbjct: 202 CGTPNYIAPE 211

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 79/190 (41%), Gaps = 30/190 (15%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNL 500
           GGF+    I       V+ G + P   ++       HQR  +     E    R++ H+++
Sbjct: 26  GGFAKCFEISDADTKEVFAGKIVPKSLLLKP-----HQREKMS---MEISIHRSLAHQHV 77
Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           V          F+ NDF  +V E     SL        A  +    P    +L+++ +  
Sbjct: 78  VGF-----HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE----PEARYYLRQIVLGC 128
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
                 +YLH   + +++H DLK  N+ L+ D+   +GDFGL     +V    +   V L
Sbjct: 129 ------QYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT---KVEYDGERKKV-L 175
Query: 621 KGTVGYAAPE 630
            GT  Y APE
Sbjct: 176 CGTPNYIAPE 185

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 81/186 (43%), Gaps = 24/186 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG---ALK-SFMAECEALRNIRHRNLVKII 504
           +G+G+FG+V KG     + V  V V  L       ALK   +AE   ++ + +  +V++I
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C +  +       LV E    G L  +L       D N    I+  + +      V+ 
Sbjct: 93  GICEAESWM------LVMEMAELGPLNKYLQQNRHVKDKN----IIELVHQ------VSM 136
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            ++YL    +   VH DL   NVLL     A + DFGL++ +    +  +  + G K  V
Sbjct: 137 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWPV 192
Query: 625 GYAAPE 630
            + APE
Sbjct: 193 KWYAPE 198

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 15/206 (7%)
Query: 427 LLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKS 484
           LL   S++        +     IG G++G V           VA+K +          K 
Sbjct: 41  LLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKR 100
Query: 485 FMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLN 544
            + E + L++ +H N++ I      +   G +FK+ VY  +    +ES LH       + 
Sbjct: 101 TLRELKILKHFKHDNIIAIKDILRPTVPYG-EFKS-VYVVL--DLMESDLH------QII 150
Query: 545 YSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
           +S   L+          +   L+Y+H     Q++H DLKPSN+L++ +    +GDFG+ R
Sbjct: 151 HSSQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMAR 207
Query: 605 FIPEVISSNQCSSVGLKGTVGYAAPE 630
            +    + +Q        T  Y APE
Sbjct: 208 GLCTSPAEHQYFMTEYVATRWYRAPE 233

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 81/186 (43%), Gaps = 24/186 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG---ALK-SFMAECEALRNIRHRNLVKII 504
           +G+G+FG+V KG     + V  V V  L       ALK   +AE   ++ + +  +V++I
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C +  +       LV E    G L  +L       D N    I+  + +      V+ 
Sbjct: 73  GICEAESWM------LVMEMAELGPLNKYLQQNRHVKDKN----IIELVHQ------VSM 116
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            ++YL    +   VH DL   NVLL     A + DFGL++ +    +  +  + G K  V
Sbjct: 117 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWPV 172
Query: 625 GYAAPE 630
            + APE
Sbjct: 173 KWYAPE 178

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 81/186 (43%), Gaps = 24/186 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG---ALK-SFMAECEALRNIRHRNLVKII 504
           +G+G+FG+V KG     + V  V V  L       ALK   +AE   ++ + +  +V++I
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C +  +       LV E    G L  +L       D N    I+  + +      V+ 
Sbjct: 75  GICEAESWM------LVMEMAELGPLNKYLQQNRHVKDKN----IIELVHQ------VSM 118
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            ++YL    +   VH DL   NVLL     A + DFGL++ +    +  +  + G K  V
Sbjct: 119 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWPV 174
Query: 625 GYAAPE 630
            + APE
Sbjct: 175 KWYAPE 180

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 81/186 (43%), Gaps = 24/186 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG---ALK-SFMAECEALRNIRHRNLVKII 504
           +G+G+FG+V KG     + V  V V  L       ALK   +AE   ++ + +  +V++I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C +  +       LV E    G L  +L       D N    I+  + +      V+ 
Sbjct: 85  GICEAESWM------LVMEMAELGPLNKYLQQNRHVKDKN----IIELVHQ------VSM 128
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            ++YL    +   VH DL   NVLL     A + DFGL++ +    +  +  + G K  V
Sbjct: 129 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWPV 184
Query: 625 GYAAPE 630
            + APE
Sbjct: 185 KWYAPE 190

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 84/196 (42%), Gaps = 28/196 (14%)
Query: 441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNL 500
           GGFS  +L+     G  Y           A+K +  H++   +    E +  R   H N+
Sbjct: 40  GGFSYVDLVEGLHDGHFY-----------ALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 501 VKIITACSSSDFQGNDFKA-LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           ++++  C     +G   +A L+  F   G+L  W   E   D  N+    L+  Q L + 
Sbjct: 89  LRLVAYCLRE--RGAKHEAWLLLPFFKRGTL--WNEIERLKDKGNF----LTEDQILWLL 140
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG-LTRFIPEVISSNQCSSV 618
           + +   LE +H    K   H DLKP+N+LL ++    + D G + +    V  S Q  ++
Sbjct: 141 LGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 619 ----GLKGTVGYAAPE 630
                 + T+ Y APE
Sbjct: 198 QDWAAQRCTISYRAPE 213

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 75/188 (39%), Gaps = 16/188 (8%)
Query: 421 SSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQ 478
           SS R++L    +    +K    +   +LIG GS+G VY          VA+K +      
Sbjct: 8   SSGRENLYFQGAIIKNVKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFED 67
Query: 479 RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPES 538
               K  + E   L  ++   ++++       D    D   +V E             +S
Sbjct: 68  LIDCKRILREITILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEI-----------ADS 116
Query: 539 ASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG 598
               L  +P  L+      I  N+    +++H   +  I+H DLKP+N LL+ D    + 
Sbjct: 117 DLKKLFKTPIFLTEQHVKTILYNLLLGEKFIH---ESGIIHRDLKPANCLLNQDCSVKIC 173
Query: 599 DFGLTRFI 606
           DFGL R I
Sbjct: 174 DFGLARTI 181

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 24/199 (12%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALK-SFMAECEALRNIRHRNLV 501
           F   + +G G+ G V+K    P   V+A K++ L  + A++   + E + L       +V
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
               A     F  +   ++  E M  GSL+  L              IL       ++I 
Sbjct: 95  GFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILG-----KVSIA 139
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           V   L YL    K +I+H D+KPSN+L+++     + DFG++    ++I S   S V   
Sbjct: 140 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV--- 191
Query: 622 GTVGYAAPEYGMGSQVSTN 640
           GT  Y +PE   G+  S  
Sbjct: 192 GTRSYMSPERLQGTHYSVQ 210

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           + S   +G+G++GSV   I       VA+K L   F  +  A +++  E   L++++H N
Sbjct: 44  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHEN 102
Query: 500 LVKIITACSSSDFQGN--DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLN 557
           ++ ++   + +    N  DF  LV  FM    L+  +  E + + + Y            
Sbjct: 103 VIGLLDVFTPASSLRNFYDF-YLVMPFMQ-TDLQKIMGMEFSEEKIQY------------ 148
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
           +   +   L+Y+H      +VH DLKP N+ ++ D    + DFGL R             
Sbjct: 149 LVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEM 198
Query: 618 VGLKGTVGYAAPE 630
            G   T  Y APE
Sbjct: 199 TGYVVTRWYRAPE 211

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 29/204 (14%)
Query: 444 SSANLIGTGSFGSVYK----GILDPDQTV-VAVKVL----FLHQRGALKSFMAECEALRN 494
           S    +G G+FG V +    G++  D  + VAVK+L     L +R AL S +     L N
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 495 IRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLN-YSPSILSFL 553
             H N+V ++ AC+     G     ++ E+  +G L ++L  +  S   +  SP+I+   
Sbjct: 109 --HMNIVNLLGACT---IGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 161
Query: 554 QRL-------NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           +         + +  VA  + +L     K  +H DL   N+LL +  I  + DFGL R I
Sbjct: 162 ELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHI 218
Query: 607 PEVISSNQCSSVGLKGTVGYAAPE 630
                SN       +  V + APE
Sbjct: 219 KN--DSNYVVKGNARLPVKWMAPE 240

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 24/199 (12%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALK-SFMAECEALRNIRHRNLV 501
           F   + +G G+ G V+K    P   V+A K++ L  + A++   + E + L       +V
Sbjct: 27  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 86
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
               A     F  +   ++  E M  GSL+  L              IL       ++I 
Sbjct: 87  GFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILG-----KVSIA 131
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           V   L YL    K +I+H D+KPSN+L+++     + DFG++    ++I S   S V   
Sbjct: 132 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFV--- 183
Query: 622 GTVGYAAPEYGMGSQVSTN 640
           GT  Y +PE   G+  S  
Sbjct: 184 GTRSYMSPERLQGTHYSVQ 202

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 77/188 (40%), Gaps = 29/188 (15%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEA--LRNIRHRNLVKIITA 506
           +G G+F  V + +  P     A K++   +  A      E EA   R ++H N+V++  +
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S   F       LV++ +  G L   +       + + S  I   L+ +N         
Sbjct: 72  ISEEGFH-----YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN--------- 117
Query: 567 EYLHHHCK-KQIVHCDLKPSNVLLDND---MIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
                HC    IVH DLKP N+LL +        + DFGL       +  +Q +  G  G
Sbjct: 118 -----HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAI----EVQGDQQAWFGFAG 168
Query: 623 TVGYAAPE 630
           T GY +PE
Sbjct: 169 TPGYLSPE 176

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 77/187 (41%), Gaps = 27/187 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEA--LRNIRHRNLVKIITA 506
           +G G+F  V + +        A K++   +  A      E EA   R ++H N+V++  +
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S   F       LV++ +  G L   +       + + S  I   L+ +N         
Sbjct: 99  ISEEGFH-----YLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVN--------- 144
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDND---MIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
            ++H H    IVH DLKP N+LL +        + DFGL       +   Q +  G  GT
Sbjct: 145 -HIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLAI----EVQGEQQAWFGFAGT 196
Query: 624 VGYAAPE 630
            GY +PE
Sbjct: 197 PGYLSPE 203

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 83/192 (43%), Gaps = 39/192 (20%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV        +  VAVK L       +H R   +    E   L++++H N++ 
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYR----ELRLLKHLKHENVIG 83
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           ++     A S  DF     +  +   +    L + +  ++ SD+       + FL     
Sbjct: 84  LLDVFTPATSIEDFS----EVYLVTTLMGADLNNIVKCQALSDEH------VQFL----- 128
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
              +   L+Y+H      I+H DLKPSNV ++ D    + DFGL R   E ++       
Sbjct: 129 VYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMT------- 178
Query: 619 GLKGTVGYAAPE 630
           G   T  Y APE
Sbjct: 179 GYVATRWYRAPE 190

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 24/199 (12%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALK-SFMAECEALRNIRHRNLV 501
           F   + +G G+ G V+K    P   V+A K++ L  + A++   + E + L       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
               A     F  +   ++  E M  GSL+  L              IL       ++I 
Sbjct: 68  GFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILG-----KVSIA 112
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           V   L YL    K +I+H D+KPSN+L+++     + DFG++    ++I S   S V   
Sbjct: 113 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV--- 164
Query: 622 GTVGYAAPEYGMGSQVSTN 640
           GT  Y +PE   G+  S  
Sbjct: 165 GTRSYMSPERLQGTHYSVQ 183

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 82/198 (41%), Gaps = 38/198 (19%)
Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALK-----SFMAECEALRNIRHRNLVK 502
           ++G GSFG V K      Q   AVKV+    + + K     + + E E L+ + H N++K
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVI---NKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 503 IITACS-SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +      SS F       +V E    G L   +       + + +           I   
Sbjct: 86  LFEILEDSSSF------YIVGELYTGGELFDEIIKRKRFSEHDAA----------RIIKQ 129
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDN---DMIAHVGDFGL-TRFIPEVISSNQCSS 617
           V S + Y+H H    IVH DLKP N+LL++   D    + DFGL T F       ++   
Sbjct: 130 VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-- 184
Query: 618 VGLKGTVGYAAPEYGMGS 635
               GT  Y APE   G+
Sbjct: 185 ----GTAYYIAPEVLRGT 198

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 83/192 (43%), Gaps = 39/192 (20%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV        +  VAVK L       +H R   +    E   L++++H N++ 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYR----ELRLLKHLKHENVIG 91
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           ++     A S  DF     +  +   +    L + +  ++ SD+       + FL     
Sbjct: 92  LLDVFTPATSIEDFS----EVYLVTTLMGADLNNIVKCQALSDEH------VQFL----- 136
Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
              +   L+Y+H      I+H DLKPSNV ++ D    + DFGL R   E ++       
Sbjct: 137 VYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT------- 186
Query: 619 GLKGTVGYAAPE 630
           G   T  Y APE
Sbjct: 187 GYVATRWYRAPE 198

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 76/186 (40%), Gaps = 27/186 (14%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G+G++G+V   +       VA+K L+   +  L  K    E   L+++RH N++ ++  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 507 CSSSDFQGNDFK--ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
            +  D   +DF    LV  FM     +   H +   D + +            +   +  
Sbjct: 93  FTP-DETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF------------LVYQMLK 139
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            L Y+H      I+H DLKP N+ ++ D    + DFGL R              G   T 
Sbjct: 140 GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------QADSEMXGXVVTR 189
Query: 625 GYAAPE 630
            Y APE
Sbjct: 190 WYRAPE 195

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 78/189 (41%), Gaps = 21/189 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPD-QTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLV 501
           +     +G G F   Y+ I D D + V A KV+   +   LK    E  +     H++L 
Sbjct: 28  YMRGRFLGKGGFAKCYE-ITDMDTKEVFAGKVV--PKSMLLKPHQKEKMSTEIAIHKSLD 84
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
                     F+ +DF  +V E     SL        A  +    P    F+++      
Sbjct: 85  NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTE----PEARYFMRQ------ 134
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
               ++YLH++   +++H DLK  N+ L++DM   +GDFGL       I  +      L 
Sbjct: 135 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA----TKIEFDGERKKDLC 187
Query: 622 GTVGYAAPE 630
           GT  Y APE
Sbjct: 188 GTPNYIAPE 196

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 24/199 (12%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALK-SFMAECEALRNIRHRNLV 501
           F   + +G G+ G V+K    P   V+A K++ L  + A++   + E + L       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
               A     F  +   ++  E M  GSL+  L              IL       ++I 
Sbjct: 68  GFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILG-----KVSIA 112
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           V   L YL    K +I+H D+KPSN+L+++     + DFG++    ++I S   S V   
Sbjct: 113 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV--- 164
Query: 622 GTVGYAAPEYGMGSQVSTN 640
           GT  Y +PE   G+  S  
Sbjct: 165 GTRSYMSPERLQGTHYSVQ 183

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 24/199 (12%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALK-SFMAECEALRNIRHRNLV 501
           F   + +G G+ G V+K    P   V+A K++ L  + A++   + E + L       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
               A     F  +   ++  E M  GSL+  L              IL       ++I 
Sbjct: 68  GFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILG-----KVSIA 112
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           V   L YL    K +I+H D+KPSN+L+++     + DFG++    ++I S   S V   
Sbjct: 113 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV--- 164
Query: 622 GTVGYAAPEYGMGSQVSTN 640
           GT  Y +PE   G+  S  
Sbjct: 165 GTRSYMSPERLQGTHYSVQ 183

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 42/206 (20%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKS----------FMAECEAL 492
           +S+ + +G+G+FG V+  +       V VK  F+ +   L+              E   L
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVK--FIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 493 RNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGS---LESWLHPESASDDLNYSPSI 549
             + H N++K++       F+   F  LV E   HGS   L +++      D+      +
Sbjct: 84  SRVEHANIIKVLDI-----FENQGFFQLVME--KHGSGLDLFAFIDRHPRLDE-----PL 131
Query: 550 LSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE- 608
            S++ R      + SA+ YL     K I+H D+K  N+++  D    + DFG   ++   
Sbjct: 132 ASYIFR-----QLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183
Query: 609 VISSNQCSSVGLKGTVGYAAPEYGMG 634
            +    C      GT+ Y APE  MG
Sbjct: 184 KLFYTFC------GTIEYCAPEVLMG 203

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 24/199 (12%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALK-SFMAECEALRNIRHRNLV 501
           F   + +G G+ G V+K    P   V+A K++ L  + A++   + E + L       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
               A     F  +   ++  E M  GSL+  L              IL       ++I 
Sbjct: 68  GFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILG-----KVSIA 112
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           V   L YL    K +I+H D+KPSN+L+++     + DFG++    ++I S   S V   
Sbjct: 113 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV--- 164
Query: 622 GTVGYAAPEYGMGSQVSTN 640
           GT  Y +PE   G+  S  
Sbjct: 165 GTRSYMSPERLQGTHYSVQ 183

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 23/182 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG GS G V           VAVK + L ++   +    E   +R+  H N+V +     
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMY---- 108
Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
           SS   G++   +V EF+  G+L   +     +++           Q   + ++V  AL Y
Sbjct: 109 SSYLVGDEL-WVVMEFLEGGALTDIVTHTRMNEE-----------QIATVCLSVLRALSY 156
Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           LH+   + ++H D+K  ++LL +D    + DFG    + + +   +     L GT  + A
Sbjct: 157 LHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKX----LVGTPYWMA 209
Query: 629 PE 630
           PE
Sbjct: 210 PE 211

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 24/199 (12%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALK-SFMAECEALRNIRHRNLV 501
           F   + +G G+ G V+K    P   V+A K++ L  + A++   + E + L       +V
Sbjct: 70  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 129
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
               A     F  +   ++  E M  GSL+  L              IL       ++I 
Sbjct: 130 GFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILG-----KVSIA 174
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           V   L YL    K +I+H D+KPSN+L+++     + DFG++    ++I S   S V   
Sbjct: 175 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV--- 226
Query: 622 GTVGYAAPEYGMGSQVSTN 640
           GT  Y +PE   G+  S  
Sbjct: 227 GTRSYMSPERLQGTHYSVQ 245

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 71/163 (43%), Gaps = 19/163 (11%)
Query: 449 IGTGSFGSVYKGILDP--DQT--VVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKII 504
           +G G+FGSV     DP  D T  +VAVK L        + F  E + L+ +    +VK  
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
                S   G     LV E++  G L  +L    A  D +         + L  +  +  
Sbjct: 78  GV---SYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS---------RLLLYSSQICK 125
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP 607
            +EYL     ++ VH DL   N+L++++    + DFGL + +P
Sbjct: 126 GMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 165

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 71/163 (43%), Gaps = 19/163 (11%)
Query: 449 IGTGSFGSVYKGILDP--DQT--VVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKII 504
           +G G+FGSV     DP  D T  +VAVK L        + F  E + L+ +    +VK  
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
                S   G     LV E++  G L  +L    A  D +         + L  +  +  
Sbjct: 79  GV---SYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS---------RLLLYSSQICK 126
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP 607
            +EYL     ++ VH DL   N+L++++    + DFGL + +P
Sbjct: 127 GMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 166

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 71/163 (43%), Gaps = 19/163 (11%)
Query: 449 IGTGSFGSVYKGILDP--DQT--VVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKII 504
           +G G+FGSV     DP  D T  +VAVK L        + F  E + L+ +    +VK  
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
                S   G     LV E++  G L  +L    A  D +         + L  +  +  
Sbjct: 75  GV---SYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDAS---------RLLLYSSQICK 122
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP 607
            +EYL     ++ VH DL   N+L++++    + DFGL + +P
Sbjct: 123 GMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 162

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 77/188 (40%), Gaps = 29/188 (15%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEA--LRNIRHRNLVKIITA 506
           +G G+F  V + +  P     A K++   +  A      E EA   R ++H N+V++  +
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S   F       LV++ +  G L   +       + + S  I   L+ +N         
Sbjct: 72  ISEEGFH-----YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN--------- 117
Query: 567 EYLHHHCK-KQIVHCDLKPSNVLLDND---MIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
                HC    IVH DLKP N+LL +        + DFGL       +  +Q +  G  G
Sbjct: 118 -----HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAI----EVQGDQQAWFGFAG 168
Query: 623 TVGYAAPE 630
           T GY +PE
Sbjct: 169 TPGYLSPE 176

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/189 (22%), Positives = 80/189 (42%), Gaps = 24/189 (12%)
Query: 449 IGTGSFGSVYKGILDP-------DQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLV 501
           +G G+F  ++KG+           +T V +KVL    R   +SF      +  + H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
                C   D        LV EF+  GSL+++         L  + + ++ L +L +A  
Sbjct: 76  LNYGVCVCGDEN-----ILVQEFVKFGSLDTY---------LKKNKNCINILWKLEVAKQ 121
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           +A+A+ +L  +    ++H ++   N+LL  +     G+    +     IS        L+
Sbjct: 122 LAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ 178
Query: 622 GTVGYAAPE 630
             + +  PE
Sbjct: 179 ERIPWVPPE 187

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 71/163 (43%), Gaps = 19/163 (11%)
Query: 449 IGTGSFGSVYKGILDP--DQT--VVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKII 504
           +G G+FGSV     DP  D T  +VAVK L        + F  E + L+ +    +VK  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
                S   G     LV E++  G L  +L    A  D +         + L  +  +  
Sbjct: 91  GV---SYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS---------RLLLYSSQICK 138
Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP 607
            +EYL     ++ VH DL   N+L++++    + DFGL + +P
Sbjct: 139 GMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 24/199 (12%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALK-SFMAECEALRNIRHRNLV 501
           F   + +G G+ G V+K    P   V+A K++ L  + A++   + E + L       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
               A     F  +   ++  E M  GSL+  L              IL       ++I 
Sbjct: 68  GFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILG-----KVSIA 112
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           V   L YL    K +I+H D+KPSN+L+++     + DFG++    ++I S   S V   
Sbjct: 113 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV--- 164
Query: 622 GTVGYAAPEYGMGSQVSTN 640
           GT  Y +PE   G+  S  
Sbjct: 165 GTRSYMSPERLQGTHYSVQ 183

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 82/182 (45%), Gaps = 23/182 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG GS G V    +     +VAVK + L ++   +    E   +R+ +H N+V++  +  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 216
Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
              +   D   +V EF+  G+L         +D + +  + ++  Q   + + V  AL  
Sbjct: 217 ---YLVGDELWVVMEFLEGGAL---------TDIVTH--TRMNEEQIAAVCLAVLQALSV 262
Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           LH    + ++H D+K  ++LL +D    + DFG    + + +   +     L GT  + A
Sbjct: 263 LH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX----LVGTPYWMA 315
Query: 629 PE 630
           PE
Sbjct: 316 PE 317

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 29/204 (14%)
Query: 444 SSANLIGTGSFGSVYK----GILDPDQTV-VAVKVL----FLHQRGALKSFMAECEALRN 494
           S    +G G+FG V +    G++  D  + VAVK+L     L +R AL S +     L N
Sbjct: 42  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 101
Query: 495 IRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLN-YSPSILSFL 553
             H N+V ++ AC+     G     ++ E+  +G L ++L  +  S   +  SP+I+   
Sbjct: 102 --HMNIVNLLGACT---IGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 154
Query: 554 QRL-------NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           +         + +  VA  + +L     K  +H DL   N+LL +  I  + DFGL R I
Sbjct: 155 ELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI 211
Query: 607 PEVISSNQCSSVGLKGTVGYAAPE 630
                SN       +  V + APE
Sbjct: 212 KN--DSNYVVKGNARLPVKWMAPE 233

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 79/193 (40%), Gaps = 29/193 (15%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLV 501
           F     +GTG+F  V          + AVK +     +G   S   E   LR I+H N+V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
            +        ++  +   LV + +  G L   +  +       Y+    S L R      
Sbjct: 84  AL-----EDIYESPNHLYLVMQLVSGGELFDRIVEKGF-----YTEKDASTLIR-----Q 128
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLL---DNDMIAHVGDFGLTRFIPE-VISSNQCSS 617
           V  A+ YLH   +  IVH DLKP N+L    D +    + DFGL++   +  + S  C  
Sbjct: 129 VLDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTAC-- 183
Query: 618 VGLKGTVGYAAPE 630
               GT GY APE
Sbjct: 184 ----GTPGYVAPE 192

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 29/204 (14%)
Query: 444 SSANLIGTGSFGSVYK----GILDPDQTV-VAVKVL----FLHQRGALKSFMAECEALRN 494
           S    +G G+FG V +    G++  D  + VAVK+L     L +R AL S +     L N
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 495 IRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLN-YSPSILSFL 553
             H N+V ++ AC+     G     ++ E+  +G L ++L  +  S   +  SP+I+   
Sbjct: 109 --HMNIVNLLGACT---IGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 161
Query: 554 QRL-------NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           +         + +  VA  + +L     K  +H DL   N+LL +  I  + DFGL R I
Sbjct: 162 ELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI 218
Query: 607 PEVISSNQCSSVGLKGTVGYAAPE 630
                SN       +  V + APE
Sbjct: 219 KN--DSNYVVKGNARLPVKWMAPE 240

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG GS G V    +     +VAVK + L ++   +    E   +R+ +H N+V++  +  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 96
Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
              +   D   +V EF+  G+L   +     +++           Q   + + V  AL  
Sbjct: 97  ---YLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----------QIAAVCLAVLQALSV 142
Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           LH    + ++H D+K  ++LL +D    + DFG    + + +   +     L GT  + A
Sbjct: 143 LH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX----LVGTPYWMA 195
Query: 629 PE 630
           PE
Sbjct: 196 PE 197

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 29/204 (14%)
Query: 444 SSANLIGTGSFGSVYK----GILDPDQTV-VAVKVL----FLHQRGALKSFMAECEALRN 494
           S    +G G+FG V +    G++  D  + VAVK+L     L +R AL S +     L N
Sbjct: 44  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 103
Query: 495 IRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLN-YSPSILSFL 553
             H N+V ++ AC+     G     ++ E+  +G L ++L  +  S   +  SP+I+   
Sbjct: 104 --HMNIVNLLGACT---IGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 156
Query: 554 QRL-------NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           +         + +  VA  + +L     K  +H DL   N+LL +  I  + DFGL R I
Sbjct: 157 ELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI 213
Query: 607 PEVISSNQCSSVGLKGTVGYAAPE 630
                SN       +  V + APE
Sbjct: 214 KN--DSNYVVKGNARLPVKWMAPE 235

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 29/204 (14%)
Query: 444 SSANLIGTGSFGSVYK----GILDPDQTV-VAVKVL----FLHQRGALKSFMAECEALRN 494
           S    +G G+FG V +    G++  D  + VAVK+L     L +R AL S +     L N
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 495 IRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLN-YSPSILSFL 553
             H N+V ++ AC+     G     ++ E+  +G L ++L  +  S   +  SP+I+   
Sbjct: 86  --HMNIVNLLGACT---IGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 554 QRL-------NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           +         + +  VA  + +L     K  +H DL   N+LL +  I  + DFGL R I
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 607 PEVISSNQCSSVGLKGTVGYAAPE 630
                SN       +  V + APE
Sbjct: 196 KN--DSNYVVKGNARLPVKWMAPE 217

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG GS G V    +     +VAVK + L ++   +    E   +R+ +H N+V++  +  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 89
Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
              +   D   +V EF+  G+L   +     +++           Q   + + V  AL  
Sbjct: 90  ---YLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----------QIAAVCLAVLQALSV 135
Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           LH    + ++H D+K  ++LL +D    + DFG    + + +   +     L GT  + A
Sbjct: 136 LH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX----LVGTPYWMA 188
Query: 629 PE 630
           PE
Sbjct: 189 PE 190

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG GS G V    +     +VAVK + L ++   +    E   +R+ +H N+V++  +  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 85
Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
              +   D   +V EF+  G+L   +     +++           Q   + + V  AL  
Sbjct: 86  ---YLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----------QIAAVCLAVLQALSV 131
Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           LH    + ++H D+K  ++LL +D    + DFG    + + +   +     L GT  + A
Sbjct: 132 LH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX----LVGTPYWMA 184
Query: 629 PE 630
           PE
Sbjct: 185 PE 186

>pdb|3ZYI|A Chain A, Netring2 In Complex With Ngl2 Length = 452

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 92/209 (44%), Gaps = 55/209 (26%)
Query: 130 NLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPI-SVGYLPKLQVLS 188
           N   LN   N++   + +  R L       +LE++ L  NS+R I + +   L  L  L 
Sbjct: 76  NTRYLNLMENNIQMIQADTFRHLH------HLEVLQLGRNSIRQIEVGAFNGLASLNTLE 129
Query: 189 LFENNISGEIPSSLGNFTFLT---ELNLRGNSIRGSIPS-ALGNCHQLQSLDL------- 237
           LF+N ++  IPS  G F +L+   EL LR N I  SIPS A      L  LDL       
Sbjct: 130 LFDNWLT-VIPS--GAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE 185
Query: 238 --SKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVG 295
             S+  F G + +++L+           L + N+K +P+L                  VG
Sbjct: 186 YISEGAFEGLFNLKYLN-----------LGMCNIKDMPNLT---------------PLVG 219
Query: 296 LEYLNLSINSF----HGPIHPGLSSLKSL 320
           LE L +S N F     G  H GLSSLK L
Sbjct: 220 LEELEMSGNHFPEIRPGSFH-GLSSLKKL 247

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG GS G V    +     +VAVK + L ++   +    E   +R+ +H N+V++  +  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 94
Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
              +   D   +V EF+  G+L   +     +++           Q   + + V  AL  
Sbjct: 95  ---YLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----------QIAAVCLAVLQALSV 140
Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           LH    + ++H D+K  ++LL +D    + DFG    + + +   +     L GT  + A
Sbjct: 141 LH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX----LVGTPYWMA 193
Query: 629 PE 630
           PE
Sbjct: 194 PE 195

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG GS G V    +     +VAVK + L ++   +    E   +R+ +H N+V++  +  
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 139
Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
              +   D   +V EF+  G+L   +     +++           Q   + + V  AL  
Sbjct: 140 ---YLVGDELWVVMEFLEGGALTDIVTHTRMNEE-----------QIAAVCLAVLQALSV 185
Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAA 628
           LH    + ++H D+K  ++LL +D    + DFG    + + +   +     L GT  + A
Sbjct: 186 LH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX----LVGTPYWMA 238
Query: 629 PE 630
           PE
Sbjct: 239 PE 240

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 78/189 (41%), Gaps = 21/189 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPD-QTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLV 501
           +     +G G F   Y+ I D D + V A KV+   +   LK    E  +     H++L 
Sbjct: 44  YMRGRFLGKGGFAKCYE-ITDMDTKEVFAGKVV--PKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
                     F+ +DF  +V E     SL        A  +    P    F+++      
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTE----PEARYFMRQ------ 150
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
               ++YLH++   +++H DLK  N+ L++DM   +GDFGL       I  +      L 
Sbjct: 151 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA----TKIEFDGERKKDLC 203
Query: 622 GTVGYAAPE 630
           GT  Y APE
Sbjct: 204 GTPNYIAPE 212

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/76 (39%), Positives = 38/76 (50%), Gaps = 11/76 (14%)
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN---DMIAHVGDFGLTRFIPEVISSNQ 614
           I   V S + YLH H    IVH DLKP N+LL++   D +  + DFGL+      +  NQ
Sbjct: 141 IIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLS-----AVFENQ 192
Query: 615 CSSVGLKGTVGYAAPE 630
                  GT  Y APE
Sbjct: 193 KKMKERLGTAYYIAPE 208

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 78/189 (41%), Gaps = 21/189 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPD-QTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLV 501
           +     +G G F   Y+ I D D + V A KV+   +   LK    E  +     H++L 
Sbjct: 44  YMRGRFLGKGGFAKCYE-ITDMDTKEVFAGKVV--PKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
                     F+ +DF  +V E     SL        A  +    P    F+++      
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTE----PEARYFMRQ------ 150
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
               ++YLH++   +++H DLK  N+ L++DM   +GDFGL       I  +      L 
Sbjct: 151 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA----TKIEFDGERKKTLC 203
Query: 622 GTVGYAAPE 630
           GT  Y APE
Sbjct: 204 GTPNYIAPE 212

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 30/192 (15%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F   + +G G+   VY+      Q   A+KVL   +    K    E   L  + H N++K
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIK 112
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +        F+     +LV E +  G L   +  +    + + + ++   L+        
Sbjct: 113 L-----KEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILE-------- 159
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDN---DMIAHVGDFGLTRFIP-EVISSNQCSSV 618
             A+ YLH +    IVH DLKP N+L      D    + DFGL++ +  +V+    C   
Sbjct: 160 --AVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--- 211
Query: 619 GLKGTVGYAAPE 630
              GT GY APE
Sbjct: 212 ---GTPGYCAPE 220

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 106/248 (42%), Gaps = 48/248 (19%)
Query: 128 LRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVL 187
           L NLT++NF+ N L          +  L N T L  + +N N +  I   +  L  L  L
Sbjct: 62  LNNLTQINFSNNQLTD--------ITPLKNLTKLVDILMNNNQIADI-TPLANLTNLTGL 112
Query: 188 SLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYP 247
           +LF N I+   P  L N T L  L L  N+I  S  SAL     LQ              
Sbjct: 113 TLFNNQITDIDP--LKNLTNLNRLELSSNTI--SDISALSGLTSLQQ------------- 155
Query: 248 VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFH 307
              L+ S N +T   PLA  NL ++  LD+S NK+S    S L     LE L ++ N+  
Sbjct: 156 ---LNFSSNQVTDLKPLA--NLTTLERLDISSNKVSD--ISVLAKLTNLESL-IATNNQI 207
Query: 308 GPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNE-----KLCG- 361
             I P L  L +L+ L L  N  +      D+       N + + +A N+      L G 
Sbjct: 208 SDITP-LGILTNLDELSLNGNQLK------DIGTLASLTNLTDLDLANNQISNLAPLSGL 260
Query: 362 -GISELKL 368
             ++ELKL
Sbjct: 261 TKLTELKL 268

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 78/189 (41%), Gaps = 21/189 (11%)
Query: 443 FSSANLIGTGSFGSVYKGILDPD-QTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLV 501
           +     +G G F   Y+ I D D + V A KV+   +   LK    E  +     H++L 
Sbjct: 44  YMRGRFLGKGGFAKCYE-ITDMDTKEVFAGKVV--PKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
                     F+ +DF  +V E     SL        A  +    P    F+++      
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTE----PEARYFMRQ------ 150
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
               ++YLH++   +++H DLK  N+ L++DM   +GDFGL       I  +      L 
Sbjct: 151 TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA----TKIEFDGERKKXLC 203
Query: 622 GTVGYAAPE 630
           GT  Y APE
Sbjct: 204 GTPNYIAPE 212

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 66/163 (40%), Gaps = 19/163 (11%)
Query: 444 SSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKI 503
           S   ++G G FG V+K         +A K++        +    E   +  + H NL+++
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
             A  S     ND   LV E++  G L   +  ES +            L  L+  + + 
Sbjct: 152 YDAFESK----NDI-VLVMEYVDGGELFDRIIDESYN------------LTELDTILFMK 194
Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG--DFGLTR 604
              E + H  +  I+H DLKP N+L  N     +   DFGL R
Sbjct: 195 QICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLAR 237

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/189 (22%), Positives = 82/189 (43%), Gaps = 24/189 (12%)
Query: 449 IGTGSFGSVYKGILDP-------DQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLV 501
           +G G+F  ++KG+           +T V +KVL    R   +SF      +  + H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
                C    F G++   LV EF+  GSL+++         L  + + ++ L +L +A  
Sbjct: 76  LNYGVC----FCGDE-NILVQEFVKFGSLDTY---------LKKNKNCINILWKLEVAKQ 121
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           +A A+ +L  +    ++H ++   N+LL  +     G+    +     IS        L+
Sbjct: 122 LAWAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ 178
Query: 622 GTVGYAAPE 630
             + +  PE
Sbjct: 179 ERIPWVPPE 187

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 85/200 (42%), Gaps = 26/200 (13%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALK-SFMAECEALRNIRHRNLV 501
           F   + +G G+ G V+K    P   V+A K++ L  + A++   + E + L       +V
Sbjct: 11  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 70
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
               A     F  +   ++  E M  GSL+  L              IL       ++I 
Sbjct: 71  GFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILG-----KVSIA 115
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT-RFIPEVISSNQCSSVGL 620
           V   L YL    K +I+H D+KPSN+L+++     + DFG++ + I E+ +         
Sbjct: 116 VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANE-------F 166
Query: 621 KGTVGYAAPEYGMGSQVSTN 640
            GT  Y +PE   G+  S  
Sbjct: 167 VGTRSYMSPERLQGTHYSVQ 186

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 83/197 (42%), Gaps = 36/197 (18%)
Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALK-----SFMAECEALRNIRHRNLVK 502
           ++G GSFG V K      Q   AVKV+    + + K     + + E E L+ + H N++K
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVI---NKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 503 IITACS-SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +      SS F       +V E    G L   +       + + +           I   
Sbjct: 86  LFEILEDSSSF------YIVGELYTGGELFDEIIKRKRFSEHDAA----------RIIKQ 129
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDN---DMIAHVGDFGLTRFIPEVISSNQCSSV 618
           V S + Y+H H    IVH DLKP N+LL++   D    + DFGL+    +  ++     +
Sbjct: 130 VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRI 184
Query: 619 GLKGTVGYAAPEYGMGS 635
              GT  Y APE   G+
Sbjct: 185 ---GTAYYIAPEVLRGT 198

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 83/197 (42%), Gaps = 36/197 (18%)
Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALK-----SFMAECEALRNIRHRNLVK 502
           ++G GSFG V K      Q   AVKV+    + + K     + + E E L+ + H N++K
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVI---NKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 503 IITACS-SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +      SS F       +V E    G L   +       + + +           I   
Sbjct: 86  LFEILEDSSSF------YIVGELYTGGELFDEIIKRKRFSEHDAA----------RIIKQ 129
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDN---DMIAHVGDFGLTRFIPEVISSNQCSSV 618
           V S + Y+H H    IVH DLKP N+LL++   D    + DFGL+    +  ++     +
Sbjct: 130 VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRI 184
Query: 619 GLKGTVGYAAPEYGMGS 635
              GT  Y APE   G+
Sbjct: 185 ---GTAYYIAPEVLRGT 198

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 67/145 (46%), Gaps = 16/145 (11%)
Query: 455 GSVYKGILDPDQTVVAVKVLFLHQRGALKS--FMAECEALRNIRHRNLVKIITACSSSDF 512
           G ++KG    +  VV  KVL +      KS  F  EC  LR   H N++ ++ AC S   
Sbjct: 24  GELWKGRWQGNDIVV--KVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP-- 79
Query: 513 QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHH 572
                  L+  +M +GSL + LH     +  N+   ++   Q +  A+++A  + +L H 
Sbjct: 80  -PAPHPTLITHWMPYGSLYNVLH-----EGTNF---VVDQSQAVKFALDMARGMAFL-HT 129
Query: 573 CKKQIVHCDLKPSNVLLDNDMIAHV 597
            +  I    L   +V++D DM A +
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARI 154

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 82/193 (42%), Gaps = 29/193 (15%)
Query: 446 ANLIGTGSFGSVYKGILDPDQTVVAVKVL----FLHQRGALKSFMAECEALRNIRHRNLV 501
           ++++G G+  +V++G       + A+KV     FL     +   M E E L+ + H+N+V
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR---PVDVQMREFEVLKKLNHKNIV 70
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           K+      +  +    K L+ EF   GSL + L            PS    L      I 
Sbjct: 71  KLFAIEEETTTR---HKVLIMEFCPCGSLYTVLE----------EPSNAYGLPESEFLIV 117
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLL----DNDMIAHVGDFGLTRFIPEVISSNQCSS 617
           +   +  ++H  +  IVH ++KP N++     D   +  + DFG  R   E+    Q   
Sbjct: 118 LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQF-- 172
Query: 618 VGLKGTVGYAAPE 630
           V L GT  Y  P+
Sbjct: 173 VXLYGTEEYLHPD 185

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 81/195 (41%), Gaps = 39/195 (20%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKS---------FMAECEALRNIRHRN 499
           +G+G+ G V           VA+K++   ++ A+ S            E E L+ + H  
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           ++KI     + D+       +V E M  G L         +  L  +   L F Q L   
Sbjct: 77  IIKIKNFFDAEDYY------IVLELMEGGEL---FDKVVGNKRLKEATCKLYFYQML--- 124
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLL---DNDMIAHVGDFGLTRFIPEV-ISSNQC 615
                A++YLH +    I+H DLKP NVLL   + D +  + DFG ++ + E  +    C
Sbjct: 125 ----LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 177
Query: 616 SSVGLKGTVGYAAPE 630
                 GT  Y APE
Sbjct: 178 ------GTPTYLAPE 186

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 81/195 (41%), Gaps = 39/195 (20%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKS---------FMAECEALRNIRHRN 499
           +G+G+ G V           VA+K++   ++ A+ S            E E L+ + H  
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEILKKLNHPC 75
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           ++KI     + D+       +V E M  G L         +  L  +   L F Q L   
Sbjct: 76  IIKIKNFFDAEDYY------IVLELMEGGEL---FDKVVGNKRLKEATCKLYFYQML--- 123
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLL---DNDMIAHVGDFGLTRFIPEV-ISSNQC 615
                A++YLH +    I+H DLKP NVLL   + D +  + DFG ++ + E  +    C
Sbjct: 124 ----LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 176
Query: 616 SSVGLKGTVGYAAPE 630
                 GT  Y APE
Sbjct: 177 ------GTPTYLAPE 185

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 81/195 (41%), Gaps = 39/195 (20%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKS---------FMAECEALRNIRHRN 499
           +G+G+ G V           VA+K++   ++ A+ S            E E L+ + H  
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           ++KI     + D+       +V E M  G L         +  L  +   L F Q L   
Sbjct: 77  IIKIKNFFDAEDYY------IVLELMEGGEL---FDKVVGNKRLKEATCKLYFYQML--- 124
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLL---DNDMIAHVGDFGLTRFIPEV-ISSNQC 615
                A++YLH +    I+H DLKP NVLL   + D +  + DFG ++ + E  +    C
Sbjct: 125 ----LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 177
Query: 616 SSVGLKGTVGYAAPE 630
                 GT  Y APE
Sbjct: 178 ------GTPTYLAPE 186

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 86  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKXQKLTDDH------VQFL--- 130
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 131 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT----- 180
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 181 --GYVATRWYRAPE 192

>pdb|1XEU|A Chain A, Crystal Structure Of Internalin C From Listeria Monocytogenes Length = 263

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 74/158 (46%), Gaps = 37/158 (23%)
Query: 71  ELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRN 130
           EL     F   N  I  LAG QFF N          L+ L  ++N ++     DL  L++
Sbjct: 39  ELSGVQNFNGDNSNIQSLAGMQFFTN----------LKELHLSHNQIS-----DLSPLKD 83
Query: 131 LTRL---NFARNDLGTR-------------KVNDLRFLDSLVNCTYLEIVSLNVNSLRSI 174
           LT+L   +  RN L                  N+LR  DSL++   LEI+S+  N L+SI
Sbjct: 84  LTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNELRDTDSLIHLKNLEILSIRNNKLKSI 143
Query: 175 PISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELN 212
            + +G+L KL+VL L  N I     ++ G  T L ++N
Sbjct: 144 -VMLGFLSKLEVLDLHGNEI-----TNTGGLTRLKKVN 175

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 63/148 (42%), Gaps = 29/148 (19%)
Query: 487 AECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYS 546
            E E L+ + H  ++KI     + D+       +V E M  G L         +  L  +
Sbjct: 203 TEIEILKKLNHPCIIKIKNFFDAEDYY------IVLELMEGGEL---FDKVVGNKRLKEA 253
Query: 547 PSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL---DNDMIAHVGDFGLT 603
              L F Q L        A++YLH +    I+H DLKP NVLL   + D +  + DFG +
Sbjct: 254 TCKLYFYQML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHS 303
Query: 604 RFIPEV-ISSNQCSSVGLKGTVGYAAPE 630
           + + E  +    C      GT  Y APE
Sbjct: 304 KILGETSLMRTLC------GTPTYLAPE 325

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 81/195 (41%), Gaps = 39/195 (20%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKS---------FMAECEALRNIRHRN 499
           +G+G+ G V           VA+K++   ++ A+ S            E E L+ + H  
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEILKKLNHPC 82
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           ++KI     + D+       +V E M  G L         +  L  +   L F Q L   
Sbjct: 83  IIKIKNFFDAEDYY------IVLELMEGGEL---FDKVVGNKRLKEATCKLYFYQML--- 130
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLL---DNDMIAHVGDFGLTRFIPEV-ISSNQC 615
                A++YLH +    I+H DLKP NVLL   + D +  + DFG ++ + E  +    C
Sbjct: 131 ----LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 183
Query: 616 SSVGLKGTVGYAAPE 630
                 GT  Y APE
Sbjct: 184 ------GTPTYLAPE 192

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 82/198 (41%), Gaps = 39/198 (19%)
Query: 446 ANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKS---------FMAECEALRNIR 496
           +  +G+G+ G V           VA+K++   ++ A+ S            E E L+ + 
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H  ++KI     + D+       +V E M  G L         +  L  +   L F Q L
Sbjct: 74  HPCIIKIKNFFDAEDYY------IVLELMEGGEL---FDKVVGNKRLKEATCKLYFYQML 124
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLL---DNDMIAHVGDFGLTRFIPEV-ISS 612
                   A++YLH +    I+H DLKP NVLL   + D +  + DFG ++ + E  +  
Sbjct: 125 -------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174
Query: 613 NQCSSVGLKGTVGYAAPE 630
             C      GT  Y APE
Sbjct: 175 TLC------GTPTYLAPE 186

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 84/193 (43%), Gaps = 29/193 (15%)
Query: 446 ANLIGTGSFGSVYKGILDPDQTVVAVKVL----FLHQRGALKSFMAECEALRNIRHRNLV 501
           ++++G G+  +V++G       + A+KV     FL     +   M E E L+ + H+N+V
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR---PVDVQMREFEVLKKLNHKNIV 70
Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           K+      +       K L+ EF   GSL + L   S +  L  S  ++       +  +
Sbjct: 71  KLFAIEEETT---TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI-------VLRD 120
Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLL----DNDMIAHVGDFGLTRFIPEVISSNQCSS 617
           V   + +L    +  IVH ++KP N++     D   +  + DFG  R   E+    Q   
Sbjct: 121 VVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQF-- 172
Query: 618 VGLKGTVGYAAPE 630
           V L GT  Y  P+
Sbjct: 173 VSLYGTEEYLHPD 185

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 63/148 (42%), Gaps = 29/148 (19%)
Query: 487 AECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYS 546
            E E L+ + H  ++KI     + D+       +V E M  G L         +  L  +
Sbjct: 189 TEIEILKKLNHPCIIKIKNFFDAEDYY------IVLELMEGGEL---FDKVVGNKRLKEA 239
Query: 547 PSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL---DNDMIAHVGDFGLT 603
              L F Q L        A++YLH +    I+H DLKP NVLL   + D +  + DFG +
Sbjct: 240 TCKLYFYQML-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289
Query: 604 RFIPEV-ISSNQCSSVGLKGTVGYAAPE 630
           + + E  +    C      GT  Y APE
Sbjct: 290 KILGETSLMRTLC------GTPTYLAPE 311

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 84/200 (42%), Gaps = 30/200 (15%)
Query: 442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLV 501
            +++  +IG GSFG V++  L     V   KVL   Q    K+   E + +R ++H N+V
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL---QDKRFKN--RELQIMRIVKHPNVV 95
Query: 502 KIIT-ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
            +     S+ D +   F  LV E++          PE+      +   +   +  L I +
Sbjct: 96  DLKAFFYSNGDKKDEVFLNLVLEYV----------PETVYRASRHYAKLKQTMPMLLIKL 145
Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVGDFGLTRFI----PEVISSNQC 615
            +   L  L +     I H D+KP N+LLD    +  + DFG  + +    P V  S  C
Sbjct: 146 YMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV--SXIC 203
Query: 616 SSVGLKGTVGYAAPEYGMGS 635
           S         Y APE   G+
Sbjct: 204 SRY-------YRAPELIFGA 216

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           IG+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 90
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 91  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 135
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 136 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT----- 185
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 186 --GYVATRWYRAPE 197

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 78/192 (40%), Gaps = 29/192 (15%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F    ++G+G+F  V+         + A+K +         S   E   L+ I+H N+V 
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70
Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +        ++      LV + +  G L   +       + + S  I            V
Sbjct: 71  L-----EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ----------QV 115
Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLL----DNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
            SA++YLH +    IVH DLKP N+L     +N  I  + DFGL++     I S  C   
Sbjct: 116 LSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIM-ITDFGLSKMEQNGIMSTAC--- 168
Query: 619 GLKGTVGYAAPE 630
              GT GY APE
Sbjct: 169 ---GTPGYVAPE 177

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 82/191 (42%), Gaps = 23/191 (12%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           F    +IG G+F  V    +     V A+K++    + +RG +  F  E + L N   R 
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           + ++  A     FQ  ++  LV E+   G L + L          +   I + + R  +A
Sbjct: 123 ITQLHFA-----FQDENYLYLVMEYYVGGDLLTLLS--------KFGERIPAEMARFYLA 169
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             +  A++ +H   +   VH D+KP N+LLD      + DFG      ++ +     S+ 
Sbjct: 170 -EIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCL---KLRADGTVRSLV 222
Query: 620 LKGTVGYAAPE 630
             GT  Y +PE
Sbjct: 223 AVGTPDYLSPE 233

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 86  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKXQKLTDDH------VQFL--- 130
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 131 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----- 180
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 181 --GYVATRWYRAPE 192

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 81/202 (40%), Gaps = 34/202 (16%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRN------IR 496
           F    ++G GSFG V+           A+K L   +   L     EC  +          
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKAL--KKDVVLMDDDVECTMVEKRVLSLAWE 77
Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H  L  +   C+   FQ  +    V E+++ G L    H +S      +  S  +F    
Sbjct: 78  HPFLTHMF--CT---FQTKENLFFVMEYLNGGDL--MYHIQSCH---KFDLSRATF---- 123
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR--FIPEVISSNQ 614
             A  +   L++LH    K IV+ DLK  N+LLD D    + DFG+ +   + +  ++  
Sbjct: 124 -YAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEF 179
Query: 615 CSSVGLKGTVGYAAPEYGMGSQ 636
           C      GT  Y APE  +G +
Sbjct: 180 C------GTPDYIAPEILLGQK 195

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 105/248 (42%), Gaps = 48/248 (19%)
Query: 128 LRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVL 187
           L NLT++NF+ N L          +  L N T L  + +N N +  I   +  L  L  L
Sbjct: 62  LNNLTQINFSNNQLTD--------ITPLKNLTKLVDILMNNNQIADI-TPLANLTNLTGL 112
Query: 188 SLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYP 247
           +LF N I+   P  L N T L  L L  N+I  S  SAL     LQ              
Sbjct: 113 TLFNNQITDIDP--LKNLTNLNRLELSSNTI--SDISALSGLTSLQQ------------- 155
Query: 248 VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFH 307
              L  S N +T   PLA  NL ++  LD+S NK+S    S L     LE L ++ N+  
Sbjct: 156 ---LSFSSNQVTDLKPLA--NLTTLERLDISSNKVSD--ISVLAKLTNLESL-IATNNQI 207
Query: 308 GPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNE-----KLCG- 361
             I P L  L +L+ L L  N  +      D+       N + + +A N+      L G 
Sbjct: 208 SDITP-LGILTNLDELSLNGNQLK------DIGTLASLTNLTDLDLANNQISNLAPLSGL 260
Query: 362 -GISELKL 368
             ++ELKL
Sbjct: 261 TKLTELKL 268

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 105/248 (42%), Gaps = 48/248 (19%)
Query: 128 LRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVL 187
           L NLT++NF+ N L          +  L N T L  + +N N +  I   +  L  L  L
Sbjct: 62  LNNLTQINFSNNQLTD--------ITPLKNLTKLVDILMNNNQIADI-TPLANLTNLTGL 112
Query: 188 SLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYP 247
           +LF N I+   P  L N T L  L L  N+I  S  SAL     LQ              
Sbjct: 113 TLFNNQITDIDP--LKNLTNLNRLELSSNTI--SDISALSGLTSLQQ------------- 155
Query: 248 VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFH 307
              L  S N +T   PLA  NL ++  LD+S NK+S    S L     LE L ++ N+  
Sbjct: 156 ---LSFSSNQVTDLKPLA--NLTTLERLDISSNKVSD--ISVLAKLTNLESL-IATNNQI 207
Query: 308 GPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNE-----KLCG- 361
             I P L  L +L+ L L  N  +      D+       N + + +A N+      L G 
Sbjct: 208 SDITP-LGILTNLDELSLNGNQLK------DIGTLASLTNLTDLDLANNQISNLAPLSGL 260
Query: 362 -GISELKL 368
             ++ELKL
Sbjct: 261 TKLTELKL 268

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 84/196 (42%), Gaps = 26/196 (13%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL----FLHQRG-ALKSFMAECEALRNIRH 497
           +    +IG G+F  V + I        AVK++    F    G + +    E      ++H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 498 RNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLN 557
            ++V+++   SS     +    +V+EFM    L  +   + A     YS ++ S   R  
Sbjct: 86  PHIVELLETYSS-----DGMLYMVFEFMDGADL-CFEIVKRADAGFVYSEAVASHYMR-- 137
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLL---DNDMIAHVGDFGLTRFIPEVISSNQ 614
               +  AL Y H +    I+H D+KP NVLL   +N     +GDFG+   + E    + 
Sbjct: 138 ---QILEALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGE----SG 187
Query: 615 CSSVGLKGTVGYAAPE 630
             + G  GT  + APE
Sbjct: 188 LVAGGRVGTPHFMAPE 203

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 84/204 (41%), Gaps = 27/204 (13%)
Query: 438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL------KSFMAECEA 491
           K  G +   +L+G GS+G V K +LD  +T+    V  L ++          +   E + 
Sbjct: 2   KLIGKYLMGDLLGEGSYGKV-KEVLD-SETLCRRAVKILKKKKLRRIPNGEANVKKEIQL 59
Query: 492 LRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSI-L 550
           LR +RH+N+++++      D   N+ K  +Y  M +             + L+  P    
Sbjct: 60  LRRLRHKNVIQLV------DVLYNEEKQKMYMVMEYCVC-------GMQEMLDSVPEKRF 106
Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVI 610
              Q       +   LEYLH    + IVH D+KP N+LL       +   G+   +    
Sbjct: 107 PVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163
Query: 611 SSNQCSSVGLKGTVGYAAPEYGMG 634
           + + C +   +G+  +  PE   G
Sbjct: 164 ADDTCRTS--QGSPAFQPPEIANG 185

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 96
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 97  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 141
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 142 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT----- 191
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 192 --GYVATRWYRAPE 203

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 65/163 (39%), Gaps = 16/163 (9%)
Query: 446 ANLIGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNLVKI 503
            +LIG GS+G VY       +  VA+K +          K  + E   L  ++   ++++
Sbjct: 31  KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRL 90
Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
                  D    D   +V E             +S    L  +P  L+      I  N+ 
Sbjct: 91  YDLIIPDDLLKFDELYIVLEIA-----------DSDLKKLFKTPIFLTEEHIKTILYNLL 139
Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
               ++H   +  I+H DLKP+N LL+ D    V DFGL R I
Sbjct: 140 LGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 90
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 91  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 135
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 136 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT----- 185
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 186 --GYVATRWYRAPE 197

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 80/187 (42%), Gaps = 30/187 (16%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMA--ECEALRNIRHRNLVKIITA 506
           +G+G+FG V++ +      V   K  F++    L  +    E   +  + H  L+ +  A
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAK--FINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
                F+      L+ EF+  G L   +    A++D       +S  + +N        L
Sbjct: 117 -----FEDKYEMVLILEFLSGGELFDRI----AAEDYK-----MSEAEVINYMRQACEGL 162
Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG--DFGL-TRFIPEVISSNQCSSVGLKGT 623
           +++H H    IVH D+KP N++ +    + V   DFGL T+  P+ I     +      T
Sbjct: 163 KHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA------T 213
Query: 624 VGYAAPE 630
             +AAPE
Sbjct: 214 AEFAAPE 220

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 83/187 (44%), Gaps = 26/187 (13%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG G++GSV K +  P   ++AVK         ++S + E E  + +   ++V   + C 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVK--------RIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 509 S-SDFQGNDFKA----LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
               F G  F+     +  E M     + + +  S  DD+     IL       I +   
Sbjct: 82  YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDV-IPEEILG-----KITLATV 135
Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
            AL +L  + K  I+H D+KPSN+LLD      + DFG++  + + I+  + +     G 
Sbjct: 136 KALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA-----GC 188
Query: 624 VGYAAPE 630
             Y APE
Sbjct: 189 RPYMAPE 195

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 80/191 (41%), Gaps = 23/191 (12%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           F    +IG G+FG V    L     V A+K+L    + +R     F  E + L N   + 
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           +  +  A     FQ ++   LV ++   G L + L   S  +D         +L  + IA
Sbjct: 136 ITTLHYA-----FQDDNNLYLVMDYYVGGDLLTLL---SKFEDRLPEEMARFYLAEMVIA 187
Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
           I+    L Y+H          D+KP N+L+D +    + DFG    + E       SSV 
Sbjct: 188 IDSVHQLHYVHR---------DIKPDNILMDMNGHIRLADFGSCLKLME--DGTVQSSVA 236
Query: 620 LKGTVGYAAPE 630
           + GT  Y +PE
Sbjct: 237 V-GTPDYISPE 246

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           + S   +G+G++GSV   I       VA+K L   F  +  A +++  E   L++++H N
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHEN 84
Query: 500 LVKIITACSSSDFQGN--DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLN 557
           ++ ++   + +    N  DF  LV  FM    L+  +  + + + + Y            
Sbjct: 85  VIGLLDVFTPASSLRNFYDF-YLVMPFMQ-TDLQKIMGLKFSEEKIQY------------ 130
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
           +   +   L+Y+H      +VH DLKP N+ ++ D    + DFGL R             
Sbjct: 131 LVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEM 180
Query: 618 VGLKGTVGYAAPE 630
            G   T  Y APE
Sbjct: 181 TGYVVTRWYRAPE 193

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 93  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 137
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 138 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT----- 187
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 188 --GYVATRWYRAPE 199

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 86  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKSQKLTDDH------VQFL--- 130
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 131 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMT----- 180
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 181 --GYVATRWYRAPE 192

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 93  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 137
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 138 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT----- 187
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 188 --GYVATRWYRAPE 199

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 93  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 137
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 138 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT----- 187
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 188 --GYVATRWYRAPE 199

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 97
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 98  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 142
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 143 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----- 192
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 193 --GYVATRWYRAPE 204

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 97
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 98  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 142
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 143 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----- 192
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 193 --GYVATRWYRAPE 204

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 86  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 130
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 131 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----- 180
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 181 --GYVATRWYRAPE 192

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 86  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 130
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 131 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----- 180
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 181 --GYVATRWYRAPE 192

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 87
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 88  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 132
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 133 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----- 182
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 183 --GYVATRWYRAPE 194

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 87
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 88  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 132
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 133 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----- 182
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 183 --GYVATRWYRAPE 194

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR----ELRLLKHMKHENVIG 97
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 98  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 142
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 143 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----- 192
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 193 --GYVATRWYRAPE 204

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 82/193 (42%), Gaps = 41/193 (21%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRN--- 499
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 81
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRLN 557
           L+ + T   S + + ND    VY   H     L + +  +  +DD       + FL    
Sbjct: 82  LLDVFTPARSLE-EFND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL---- 126
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
               +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++      
Sbjct: 127 -IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA------ 176
Query: 618 VGLKGTVGYAAPE 630
            G   T  Y APE
Sbjct: 177 -GFVATRWYRAPE 188

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 86  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 130
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 131 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----- 180
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 181 --GYVATRWYRAPE 192

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 96
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 97  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 141
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 142 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----- 191
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 192 --GYVATRWYRAPE 203

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 86  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 130
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 131 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA----- 180
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 181 --GFVATRWYRAPE 192

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 86  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 130
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 131 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----- 180
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 181 --GYVATRWYRAPE 192

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 86  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 130
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 131 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----- 180
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 181 --GYVATRWYRAPE 192

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 82/193 (42%), Gaps = 41/193 (21%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRN--- 499
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 82
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRLN 557
           L+ + T   S + + ND    VY   H     L + +  +  +DD       + FL    
Sbjct: 83  LLDVFTPARSLE-EFND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL---- 127
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
               +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++      
Sbjct: 128 -IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT------ 177
Query: 618 VGLKGTVGYAAPE 630
            G   T  Y APE
Sbjct: 178 -GYVATRWYRAPE 189

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 86  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 130
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 131 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----- 180
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 181 --GYVATRWYRAPE 192

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 108
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 109 LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 153
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 154 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----- 203
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 204 --GYVATRWYRAPE 215

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 92
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 93  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 137
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 138 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----- 187
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 188 --GYVATRWYRAPE 199

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 91
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 92  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 136
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 137 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----- 186
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 187 --GYVATRWYRAPE 198

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 105
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 106 LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 150
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 151 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----- 200
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 201 --GYVATRWYRAPE 212

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 82/193 (42%), Gaps = 41/193 (21%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRN--- 499
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N   
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 81
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRLN 557
           L+ + T   S + + ND    VY   H     L + +  +  +DD       + FL    
Sbjct: 82  LLDVFTPARSLE-EFND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL---- 126
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
               +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++      
Sbjct: 127 -IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT------ 176
Query: 618 VGLKGTVGYAAPE 630
            G   T  Y APE
Sbjct: 177 -GYVATRWYRAPE 188

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 86  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 130
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 131 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----- 180
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 181 --GYVATRWYRAPE 192

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 86  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 130
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 131 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA----- 180
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 181 --GFVATRWYRAPE 192

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 104
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 105 LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 149
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 150 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----- 199
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 200 --GYVATRWYRAPE 211

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 40/173 (23%), Positives = 71/173 (41%), Gaps = 20/173 (11%)
Query: 469 VAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFM 525
           VAVKVL             F  E +    + H  +V +  A   ++        +V E++
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY-ATGEAETPAGPLPYIVMEYV 98
Query: 526 HHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPS 585
              +L   +H E            ++  + + +  +   AL + H   +  I+H D+KP+
Sbjct: 99  DGVTLRDIVHTEGP----------MTPKRAIEVIADACQALNFSH---QNGIIHRDVKPA 145
Query: 586 NVLLDNDMIAHVGDFGLTRFIPEVISSNQCS-SVGLKGTVGYAAPEYGMGSQV 637
           N+++       V DFG+ R I +  S N  + +  + GT  Y +PE   G  V
Sbjct: 146 NIMISATNAVKVMDFGIARAIAD--SGNSVTQTAAVIGTAQYLSPEQARGDSV 196

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 83
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 84  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 128
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 129 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----- 178
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 179 --GYVATRWYRAPE 190

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 90
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 91  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 135
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 136 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----- 185
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 186 --GYVATRWYRAPE 197

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 43/194 (22%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N++ 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 84
Query: 503 IIT----ACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRL 556
           ++     A S  +F  ND    VY   H     L + +  +  +DD       + FL   
Sbjct: 85  LLDVFTPARSLEEF--ND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL--- 129
Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++     
Sbjct: 130 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----- 179
Query: 617 SVGLKGTVGYAAPE 630
             G   T  Y APE
Sbjct: 180 --GYVATRWYRAPE 191

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 82/193 (42%), Gaps = 41/193 (21%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRN--- 499
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 85
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRLN 557
           L+ + T   S + + ND    VY   H     L + +  +  +DD       + FL    
Sbjct: 86  LLDVFTPARSLE-EFND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL---- 130
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
               +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++      
Sbjct: 131 -IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT------ 180
Query: 618 VGLKGTVGYAAPE 630
            G   T  Y APE
Sbjct: 181 -GYVATRWYRAPE 192

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 82/193 (42%), Gaps = 41/193 (21%)
Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRN--- 499
           +G+G++GSV           VAVK L       +H +   +    E   L++++H N   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIG 82
Query: 500 LVKIITACSSSDFQGNDFKALVYEFMH--HGSLESWLHPESASDDLNYSPSILSFLQRLN 557
           L+ + T   S + + ND    VY   H     L + +  +  +DD       + FL    
Sbjct: 83  LLDVFTPARSLE-EFND----VYLVTHLMGADLNNIVKCQKLTDDH------VQFL---- 127
Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
               +   L+Y+H      I+H DLKPSN+ ++ D    + DFGL R   + ++      
Sbjct: 128 -IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT------ 177
Query: 618 VGLKGTVGYAAPE 630
            G   T  Y APE
Sbjct: 178 -GYVATRWYRAPE 189

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	640
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-78
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-67
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-59
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-37
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-28
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-71
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-36
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-65
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-61
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	5e-52
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-52
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-51
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-46
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-44
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-35
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-33
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-17
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-07
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-48
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-47
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-43
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-42
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-36
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-30
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-47
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-45
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-45
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-41
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-37
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-34
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-18
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-12
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	9e-47
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-43
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-36
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-34
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-31
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-27
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-19
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-42
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-41
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-41
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-41
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-40
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-40
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-40
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-40
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-40
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-38
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-33
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-27
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-12
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-40
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-39
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-39
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-38
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-37
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-34
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-33
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-28
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-23
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-15
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-10
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-37
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-37
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-36
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-35
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-33
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-12
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-35
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-33
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-28
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-27
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-25
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-15
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-32
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-30
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-25
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-19
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-19
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-31
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-25
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-19
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-12
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-27
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-25
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	6e-24
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	6e-22
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-30
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-18
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-18
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-11
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-30
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-28
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-23
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-18
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-30
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-29
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-26
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-23
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-19
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-19
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-15
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-29
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-29
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-23
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-21
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	9e-20
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-18
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-12
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-29
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	9e-29
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-28
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-28
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-25
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-20
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-13
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-28
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-28
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-28
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-27
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-14
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-28
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-28
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	8e-28
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-27
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-27
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-27
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-27
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-27
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-27
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-26
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-21
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-17
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-27
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	8e-27
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-27
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-26
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-26
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-26
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-26
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-26
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-26
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-25
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-22
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-19
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-18
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-18
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-26
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-25
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-23
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-22
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-26
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-26
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-26
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-26
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-26
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	9e-26
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-26
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-25
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-25
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-25
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-25
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-25
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-25
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-25
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-25
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-25
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-25
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-25
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-25
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-25
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-25
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-25
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	9e-25
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	6e-22
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-16
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-06
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-24
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-24
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-24
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-24
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-21
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-14
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-24
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-24
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-24
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-24
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-24
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-24
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-24
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-19
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-08
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-24
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-24
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-24
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	8e-24
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-23
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-23
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-23
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-23
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-23
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-22
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-22
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-22
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-17
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-15
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-22
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-22
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-22
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	7e-22
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-20
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-14
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	7e-22
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-19
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-16
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-14
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-22
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-20
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-20
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-17
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-05
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-21
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-21
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-21
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-21
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-21
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-19
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-17
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-09
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-21
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-21
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-21
3ork_A	311	Serine/threonine protein kinase; structural genomi	8e-21
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	9e-21
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-20
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-20
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-20
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-12
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	8e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-14
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-08
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-19
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-19
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-18
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-16
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-16
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-12
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-19
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-19
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	7e-19
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-18
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-18
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-17
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-11
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-10
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-06
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-18
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-18
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-18
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-12
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-18
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-18
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	8e-18
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	9e-18
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	7e-12
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-11
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-17
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-16
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-16
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-12
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-05
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-17
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-17
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-11
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-17
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-17
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-15
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-12
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-09
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-08
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-17
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-17
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-17
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-17
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-17
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-17
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-17
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-17
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-17
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-11
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-17
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	9e-17
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-16
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-16
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-16
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-16
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-16
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-16
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-16
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-16
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-16
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-16
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-16
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-16
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	8e-16
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-15
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-15
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-15
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-15
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-15
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-15
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	5e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-12
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-15
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-15
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-15
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-15
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-15
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-15
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-15
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-15
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-15
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-15
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-15
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-15
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-15
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	7e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-08
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	9e-15
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-15
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-14
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-14
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-14
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-14
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-14
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-14
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-05
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-14
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-14
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-14
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-14
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-14
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	5e-14
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-12
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-12
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	9e-08
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	8e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-09
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-07
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	7e-14
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-14
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-13
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-13
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-12
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-13
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	5e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	6e-10
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	5e-09
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-13
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-13
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-13
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-13
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-13
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-13
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-13
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-13
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-13
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-13
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-13
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-12
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-12
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-12
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-12
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	7e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-12
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	9e-12
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	9e-12
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-11
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-11
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-09
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-11
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-11
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-11
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-11
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	7e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	8e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-10
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-10
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-10
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-10
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-10
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-10
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	9e-10
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-10
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-06
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	1e-09
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	5e-06
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	3e-04
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	9e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-08
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	5e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	6e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	8e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-05
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	1e-07
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	9e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	6e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-06
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	8e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-05
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	8e-07
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	3e-05
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	2e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-06
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	4e-06
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	9e-06
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	4e-04
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	5e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	5e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	9e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  264 bits (676), Expect = 2e-78
 Identities = 97/385 (25%), Positives = 146/385 (37%), Gaps = 68/385 (17%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           +L+ L  + L  N   G IP E+  +  L  +I + N L G+IP  L++C+ L  + L  
Sbjct: 440 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISL-- 497

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
                N+L GE+P +IG  L N+ I  L+ N F GNIP  + +   L WLD   N    +
Sbjct: 498 ---SNNRLTGEIPKWIG-RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGT 553

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLR---SIPIS 177
           IP  + +       NF             +    + N    +      N L         
Sbjct: 554 IPAAMFKQSGKIAANFIAG----------KRYVYIKNDGMKKECHGAGNLLEFQGIRSEQ 603

Query: 178 VGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDL 237
           +  L      ++      G    +  N   +  L++  N + G IP  +G+   L  L+L
Sbjct: 604 LNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNL 663

Query: 238 SKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLE 297
                            HN ++G IP  VG+L+ +  LDLS NKL G IP ++ +   L 
Sbjct: 664 G----------------HNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 707

Query: 298 YLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNE 357
            ++LS N+  GPI                             P  G F+         N 
Sbjct: 708 EIDLSNNNLSGPI-----------------------------PEMGQFETFPPAKFLNNP 738

Query: 358 KLCGGISELKLPPCTPSESKKRQKS 382
            LCG      LP C PS +      
Sbjct: 739 GLCGYP----LPRCDPSNADGYAHH 759

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  233 bits (596), Expect = 3e-67
 Identities = 90/350 (25%), Positives = 141/350 (40%), Gaps = 37/350 (10%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIG-RLFQLRYIIFNSNTLQGQIPVNLT---HCSELRTL 56
           + + L  +N+  N          G +L  L  +  ++N++ G   V       C EL+ L
Sbjct: 124 SCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHL 183

Query: 57  DLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNS 116
            +       N++ G++         N+    ++ N F   IP  + + S L+ LD + N 
Sbjct: 184 AI-----SGNKISGDVDV---SRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNK 234

Query: 117 LTASIPEDLGRLRNLTRLNFARNDL-GTRKVNDLRFLDSLVNCTYLEIVSLNVNSLR-SI 174
           L+      +     L  LN + N   G             +    L+ +SL  N     I
Sbjct: 235 LSGDFSRAISTCTELKLLNISSNQFVGPI---------PPLPLKSLQYLSLAENKFTGEI 285

Query: 175 PISV-GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIP-SALGNCHQL 232
           P  + G    L  L L  N+  G +P   G+ + L  L L  N+  G +P   L     L
Sbjct: 286 PDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGL 345

Query: 233 QSLDLSKTIFLGQYP---------VRWLDLSHNHLTGPIPLAVGN--LKSIPHLDLSKNK 281
           + LDLS   F G+ P         +  LDLS N+ +GPI   +      ++  L L  N 
Sbjct: 346 KVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNG 405

Query: 282 LSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQ 331
            +G+IP +L +C  L  L+LS N   G I   L SL  L  L L+ N  +
Sbjct: 406 FTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 455

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  210 bits (537), Expect = 4e-59
 Identities = 84/340 (24%), Positives = 143/340 (42%), Gaps = 43/340 (12%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
            +T + L +   N     +   +  L  L  +  +++ + G +       + L +LD   
Sbjct: 51  KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLD--- 106

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
             L  N L G +                           S+ + S L++L+ ++N+L   
Sbjct: 107 --LSRNSLSGPVTT-----------------------LTSLGSCSGLKFLNVSSNTLDFP 141

Query: 121 IP-EDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVG 179
                  +L +L  L+ + N +    V      D    C  L+ ++++ N +    + V 
Sbjct: 142 GKVSGGLKLNSLEVLDLSANSISGANVVGWVLSD---GCGELKHLAISGNKISG-DVDVS 197

Query: 180 YLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSK 239
               L+ L +  NN S  IP  LG+ + L  L++ GN + G    A+  C +L+ L++S 
Sbjct: 198 RCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISS 256

Query: 240 TIFLGQYPV------RWLDLSHNHLTGPIPLAV-GNLKSIPHLDLSKNKLSGEIPSSLGS 292
             F+G  P       ++L L+ N  TG IP  + G   ++  LDLS N   G +P   GS
Sbjct: 257 NQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGS 316

Query: 293 CVGLEYLNLSINSFHGPIHPG-LSSLKSLEGLDLFQNTFQ 331
           C  LE L LS N+F G +    L  ++ L+ LDL  N F 
Sbjct: 317 CSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFS 356

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  146 bits (370), Expect = 7e-37
 Identities = 59/227 (25%), Positives = 100/227 (44%), Gaps = 24/227 (10%)

Query: 153 DSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPS--SLGNFTFLTE 210
            SL++ T LE + L+ + +            L  L L  N++SG + +  SLG+ + L  
Sbjct: 71  SSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKF 130

Query: 211 LNLRGNSIRGSIP-SALGNCHQLQSLDLSKTIFLGQYP-----------VRWLDLSHNHL 258
           LN+  N++      S     + L+ LDLS     G              ++ L +S N +
Sbjct: 131 LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKI 190

Query: 259 TGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLK 318
           +G + +      ++  LD+S N  S  IP  LG C  L++L++S N   G     +S+  
Sbjct: 191 SGDVDV--SRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCT 247

Query: 319 SLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGISE 365
            L+ L++  N F      G +P     K+   +S+A N K  G I +
Sbjct: 248 ELKLLNISSNQF-----VGPIP-PLPLKSLQYLSLAEN-KFTGEIPD 287

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  119 bits (301), Expect = 3e-28
 Identities = 46/167 (27%), Positives = 68/167 (40%), Gaps = 17/167 (10%)

Query: 179 GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLS 238
             +  + + S   N     + SSL + T L  L L  + I GS+         L SLDLS
Sbjct: 50  DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLS 108

Query: 239 KTIFLGQYPV----------RWLDLSHNHLTGPIPL-AVGNLKSIPHLDLSKNKLSGEIP 287
           +    G              ++L++S N L  P  +     L S+  LDLS N +SG   
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168

Query: 288 SSL---GSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQ 331
                   C  L++L +S N   G +   +S   +LE LD+  N F 
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDV--DVSRCVNLEFLDVSSNNFS 213

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  233 bits (596), Expect = 1e-71
 Identities = 85/342 (24%), Positives = 143/342 (41%), Gaps = 64/342 (18%)

Query: 34  FNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAG-NQ 92
             + T  G +    T    +  LDL    L        +P  +   LP +    + G N 
Sbjct: 33  CCNRTWLGVLCDTDTQTYRVNNLDLSGLNL---PKPYPIPSSLAN-LPYLNFLYIGGINN 88

Query: 93  FFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDL-GTRKVNDLRF 151
             G IP +I+  ++L +L   + +++ +IP+ L +++ L  L+F+ N L G         
Sbjct: 89  LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG--------- 139

Query: 152 LDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFL-TE 210
                                ++P S+  LP L  ++   N ISG IP S G+F+ L T 
Sbjct: 140 ---------------------TLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS 178

Query: 211 LNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLK 270
           + +  N + G IP    N +                 + ++DLS N L G   +  G+ K
Sbjct: 179 MTISRNRLTGKIPPTFANLN-----------------LAFVDLSRNMLEGDASVLFGSDK 221

Query: 271 SIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTF 330
           +   + L+KN L+ ++   +G    L  L+L  N  +G +  GL+ LK L  L++  N  
Sbjct: 222 NTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280

Query: 331 QAKSQNGDVPRKGIFKNASAISVAGNEKLCGGISELKLPPCT 372
                 G++P+ G  +     + A N+ LCG      LP CT
Sbjct: 281 C-----GEIPQGGNLQRFDVSAYANNKCLCGSP----LPACT 313

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  136 bits (346), Expect = 4e-36
 Identities = 47/191 (24%), Positives = 75/191 (39%), Gaps = 25/191 (13%)

Query: 149 LRFLDSLVNCTYL----EIVSLNVNSLR-SIPISVGYLPKLQVLSLFENNISGE--IPSS 201
           L+    L N T L            +    +  +     ++  L L   N+     IPSS
Sbjct: 12  LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSS 71

Query: 202 LGNFTFLTELNLRG-NSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTG 260
           L N  +L  L + G N++ G IP A+    QL                 +L ++H +++G
Sbjct: 72  LANLPYLNFLYIGGINNLVGPIPPAIAKLTQLH----------------YLYITHTNVSG 115

Query: 261 PIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSL 320
            IP  +  +K++  LD S N LSG +P S+ S   L  +    N   G I     S   L
Sbjct: 116 AIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL 175

Query: 321 -EGLDLFQNTF 330
              + + +N  
Sbjct: 176 FTSMTISRNRL 186

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  216 bits (553), Expect = 3e-65
 Identities = 74/208 (35%), Positives = 108/208 (51%), Gaps = 16/208 (7%)

Query: 432 SYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR-GALKSFMAECE 490
           S   L  A+  FS+ N++G G FG VYKG L  D T+VAVK L   +  G    F  E E
Sbjct: 21  SLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            +    HRNL+++   C +        + LVY +M +GS+ S L       +   S   L
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTE-----RLLVYPYMANGSVASCLR------ERPESQPPL 128

Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVI 610
            + +R  IA+  A  L YLH HC  +I+H D+K +N+LLD +  A VGDFGL + +    
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188

Query: 611 SSNQCSSVGLKGTVGYAAPEYGMGSQVS 638
           +     +  ++GT+G+ APEY    + S
Sbjct: 189 TH---VTTAVRGTIGHIAPEYLSTGKSS 213

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  205 bits (524), Expect = 4e-61
 Identities = 70/220 (31%), Positives = 104/220 (47%), Gaps = 17/220 (7%)

Query: 417 TSSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL 476
             S S         V    L +AT  F    LIG G FG VYKG+L  D   VA+K    
Sbjct: 15  ALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTP 73

Query: 477 HQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHP 536
                ++ F  E E L   RH +LV +I  C   +        L+Y++M +G+L+  L+ 
Sbjct: 74  ESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM-----ILIYKYMENGNLKRHLY- 127

Query: 537 ESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH 596
                  +     +S+ QRL I I  A  L YLH      I+H D+K  N+LLD + +  
Sbjct: 128 -----GSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179

Query: 597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ 636
           + DFG+++   E+  ++   S  +KGT+GY  PEY +  +
Sbjct: 180 ITDFGISKKGTELDQTH--LSTVVKGTLGYIDPEYFIKGR 217

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  180 bits (459), Expect = 5e-52
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 29/210 (13%)

Query: 432 SYESLLKATGGFSS------ANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA---- 481
           S+  L   T  F         N +G G FG VYKG ++   T VAVK L           
Sbjct: 16  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEEL 73

Query: 482 LKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASD 541
            + F  E + +   +H NLV+++   S  D        LVY +M +GSL   L     + 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDD-----LCLVYVYMPNGSLLDRLSCLDGTP 128

Query: 542 DLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG 601
            L++         R  IA   A+ + +LH +     +H D+K +N+LLD    A + DFG
Sbjct: 129 PLSWH-------MRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFG 178

Query: 602 LTRFIPEVISSNQCSSVGLKGTVGYAAPEY 631
           L R   +   +   S +   GT  Y APE 
Sbjct: 179 LARASEKFAQTVMTSRI--VGTTAYMAPEA 206

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  188 bits (479), Expect = 7e-52
 Identities = 59/364 (16%), Positives = 106/364 (29%), Gaps = 46/364 (12%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
                   N +          +   L  L  +   +     ++P  L    E++ +++  
Sbjct: 223 ICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVAC 282

Query: 61  NKL---EENQLVGELPPYIGFTLPNIRIPLLAGNQFF-GNIPHSISNASKLEWLDFANNS 116
           N+    E+ +   +           I+I  +  N      +  S+    KL  L+   N 
Sbjct: 283 NRGISGEQLKDDWQALADAPV-GEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQ 341

Query: 117 LTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLV-NCTYLEIVSLNVNSLRSIP 175
           L   +P   G    L  LN A N +            +       +E +S   N L+ IP
Sbjct: 342 LEGKLPA-FGSEIKLASLNLAYNQITE-------IPANFCGFTEQVENLSFAHNKLKYIP 393

Query: 176 --ISVGYLPKLQVLSLFENNISG-------EIPSSLGNFTFLTELNLRGNSIRGSIPSAL 226
                  +  +  +    N I          +  +      ++ +NL  N I        
Sbjct: 394 NIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELF 453

Query: 227 GNCHQLQSLDLS--------KTIFLGQYPV-------RWLDLSHNHLTG-PIPLAVGNLK 270
                L S++L         K     +            +DL  N LT          L 
Sbjct: 454 STGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLP 513

Query: 271 SIPHLDLSKNKLSGEIPSSLGSCVGLEYL------NLSINSFHGPIHPGLSSLKSLEGLD 324
            +  +DLS N  S   P+   +   L+        +   N        G++   SL  L 
Sbjct: 514 YLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQ 572

Query: 325 LFQN 328
           +  N
Sbjct: 573 IGSN 576

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  186 bits (475), Expect = 2e-51
 Identities = 50/334 (14%), Positives = 117/334 (35%), Gaps = 31/334 (9%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQ----IPVNLTHCSELRTL 56
           +   +  ++L+    SG +P  IG+L +L  +   S+  +       P  ++        
Sbjct: 79  SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQK 138

Query: 57  DLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNS 116
             +    ++  +    P        ++    +  +    +I  S     K   +   +N+
Sbjct: 139 QKMRMHYQKTFV-DYDPR---EDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNN 194

Query: 117 LTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNS-LRSIP 175
           +T  + + + RL  L +     +              +   C   E  +       ++  
Sbjct: 195 IT-FVSKAVMRLTKLRQFYMGNSP-----------FVAENICEAWENENSEYAQQYKTED 242

Query: 176 ISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSL 235
           +    L  L  + ++      ++P+ L     +  +N+  N    S      +   L   
Sbjct: 243 LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGI-SGEQLKDDWQALADA 301

Query: 236 DLSKTIFLGQYPVRWLDLSHNHL-TGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCV 294
            + + I       + + + +N+L T P+  ++  +K +  L+   N+L G++P + GS +
Sbjct: 302 PVGEKI-------QIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEI 353

Query: 295 GLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
            L  LNL+ N             + +E L    N
Sbjct: 354 KLASLNLAYNQITEIPANFCGFTEQVENLSFAHN 387

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  172 bits (439), Expect = 2e-46
 Identities = 53/377 (14%), Positives = 114/377 (30%), Gaps = 55/377 (14%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           + + L+   +  +    +I        +   I   SN +   +   +   ++LR   +  
Sbjct: 157 DFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGN 215

Query: 61  NK--------------LEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASK 106
           +                E  Q            L ++    +        +P  +    +
Sbjct: 216 SPFVAENICEAWENENSEYAQQYKTEDLKWD-NLKDLTDVEVYNCPNLTKLPTFLKALPE 274

Query: 107 LEWLDFANNSLTA--------SIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNC 158
           ++ ++ A N   +            D      +  +    N+L T          SL   
Sbjct: 275 MQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKT-----FPVETSLQKM 329

Query: 159 TYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSI 218
             L ++    N L     + G   KL  L+L  N I+    +  G    +  L+   N +
Sbjct: 330 KKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKL 389

Query: 219 RGSIPSAL--GNCHQLQSLDLSKTIFLGQYP---------------VRWLDLSHNHLTGP 261
           +  IP+     +   + ++D S                        V  ++LS+N ++  
Sbjct: 390 K-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKF 448

Query: 262 IPLAVGNLKSIPHLDLSKNKLSG-------EIPSSLGSCVGLEYLNLSINSFHG-PIHPG 313
                     +  ++L  N L+        +   +  +   L  ++L  N          
Sbjct: 449 PKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFR 508

Query: 314 LSSLKSLEGLDLFQNTF 330
            ++L  L G+DL  N+F
Sbjct: 509 ATTLPYLVGIDLSYNSF 525

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  166 bits (422), Expect = 5e-44
 Identities = 52/350 (14%), Positives = 111/350 (31%), Gaps = 47/350 (13%)

Query: 1   NLTFLMLINLQQNNF-SGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLV 59
               + +I +  NN  +  +   + ++ +L  +    N L+G++P       +L +L+L 
Sbjct: 303 VGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLA 361

Query: 60  LNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPH--SISNASKLEWLDFANNSL 117
            N++ E      +P         +     A N+    IP+     + S +  +DF+ N +
Sbjct: 362 YNQITE------IPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKSVSVMSAIDFSYNEI 414

Query: 118 T-------ASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNS 170
                     +     +  N++ +N + N +           +     + L  ++L  N 
Sbjct: 415 GSVDGKNFDPLDPTPFKGINVSSINLSNNQISKF------PKELFSTGSPLSSINLMGNM 468

Query: 171 LRSIPI--------SVGYLPKLQVLSLFENNISGEIPS-SLGNFTFLTELNLRGNSIRGS 221
           L  IP         +      L  + L  N ++            +L  ++L  NS    
Sbjct: 469 LTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK- 527

Query: 222 IPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNK 281
            P+   N   L+   +              D   N      P  +    S+  L +  N 
Sbjct: 528 FPTQPLNSSTLKGFGIR----------NQRDAQGNRTLREWPEGITLCPSLTQLQIGSND 577

Query: 282 LSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQ 331
           +   +   +     +  L++  N         +          LF +  Q
Sbjct: 578 IRK-VNEKITP--NISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  140 bits (356), Expect = 2e-35
 Identities = 31/245 (12%), Positives = 79/245 (32%), Gaps = 21/245 (8%)

Query: 100 SISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCT 159
           S+++  ++  L       +  +P+ +G+L  L  L    +    +    L     +    
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGE--KVNERLFGPKGISANM 133

Query: 160 YLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNIS-----GEIPSSLGNFTFLTELNLR 214
             E               V Y P+     L ++ I+       I  S       T++   
Sbjct: 134 SDEQKQKMRMHY--QKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQL 191

Query: 215 GNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPV---RWLDLSHNHLTGPIPLAVGNLKS 271
            N+I   +  A+    +L+   +  + F+ +         +  +        L   NLK 
Sbjct: 192 SNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKD 250

Query: 272 IPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFH--------GPIHPGLSSLKSLEGL 323
           +  +++       ++P+ L +   ++ +N++ N                     + ++ +
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310

Query: 324 DLFQN 328
            +  N
Sbjct: 311 YIGYN 315

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  135 bits (341), Expect = 1e-33
 Identities = 39/307 (12%), Positives = 90/307 (29%), Gaps = 56/307 (18%)

Query: 41  GQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHS 100
            Q  V+L     +  L L                               G    G +P +
Sbjct: 71  AQPGVSLNSNGRVTGLSL------------------------------EGFGASGRVPDA 100

Query: 101 ISNASKLEWLDFANNSLT----ASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLV 156
           I   ++LE L   ++          P+ +    +  +    R            F+D   
Sbjct: 101 IGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHY------QKTFVDYDP 154

Query: 157 NCTYLEIVSLNVNS---LRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNL 213
              + +++   +NS    +SI  S     K   +    NNI+  +  ++   T L +  +
Sbjct: 155 REDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYM 213

Query: 214 RGNSIRGSIPSALGNCHQLQSLDLSKTI--FLGQYP-VRWLDLSHNHLTGPIPLAVGNLK 270
             +                +     KT          +  +++ +      +P  +  L 
Sbjct: 214 GNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALP 273

Query: 271 SIPHLDLSKNKL--------SGEIPSSLGSCVGLEYLNLSINSF-HGPIHPGLSSLKSLE 321
            +  ++++ N+           +  +       ++ + +  N+    P+   L  +K L 
Sbjct: 274 EMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLG 333

Query: 322 GLDLFQN 328
            L+   N
Sbjct: 334 MLECLYN 340

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 84.7 bits (210), Expect = 3e-17
 Identities = 20/153 (13%), Positives = 42/153 (27%), Gaps = 15/153 (9%)

Query: 192 NNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPV--- 248
           +    +   SL +   +T L+L G    G +P A+G   +L+ L L          +   
Sbjct: 67  DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126

Query: 249 ---------RWLDLSHNHLTGPIP--LAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLE 297
                            H            +   +    ++ +     I  S    +   
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186

Query: 298 YLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTF 330
            +    N+    +   +  L  L    +  + F
Sbjct: 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPF 218

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 52.4 bits (126), Expect = 4e-07
 Identities = 15/84 (17%), Positives = 30/84 (35%), Gaps = 4/84 (4%)

Query: 252 DLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIH 311
           +   +       +++ +   +  L L     SG +P ++G    LE L L  +       
Sbjct: 63  NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122

Query: 312 P----GLSSLKSLEGLDLFQNTFQ 331
                G+S+  S E     +  +Q
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQ 146

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  171 bits (436), Expect = 1e-48
 Identities = 57/216 (26%), Positives = 89/216 (41%), Gaps = 28/216 (12%)

Query: 429 LNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAE 488
           +++  E+L   +       +   G FG V+K         VAVK+  +  +   +S+  E
Sbjct: 12  VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ--LLNEYVAVKIFPIQDK---QSWQNE 66

Query: 489 CE--ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYS 546
            E  +L  ++H N+++ I A         D   L+  F   GSL  +L            
Sbjct: 67  YEVYSLPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLKANV-------- 117

Query: 547 PSILSFLQRLNIAINVASALEYLHHH-------CKKQIVHCDLKPSNVLLDNDMIAHVGD 599
              +S+ +  +IA  +A  L YLH          K  I H D+K  NVLL N++ A + D
Sbjct: 118 ---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174

Query: 600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS 635
           FGL          +   + G  GT  Y APE   G+
Sbjct: 175 FGLALKFEA--GKSAGDTHGQVGTRRYMAPEVLEGA 208

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  179 bits (455), Expect = 1e-47
 Identities = 55/367 (14%), Positives = 110/367 (29%), Gaps = 57/367 (15%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQG---------QIPVNLTHCS 51
           NL  L  + L        +P  +  L +L+ +    N             ++  +     
Sbjct: 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGP 548

Query: 52  ELRTLDLVLNKLEENQLVGELPPYIGFT-LPNIRIPLLAGNQFFGNIPHSISNASKLEWL 110
           +++   +  N LEE       P       +  + +     N+       +     KL  L
Sbjct: 549 KIQIFYMGYNNLEE------FPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDL 600

Query: 111 DFANNSLTASIPEDLGR-LRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVN 169
               N +   IPED       +  L F+ N L       +  + +  +   +  V  + N
Sbjct: 601 KLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKL-----KYIPNIFNAKSVYVMGSVDFSYN 654

Query: 170 SLRSIPISVG------YLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIR---- 219
            + S   ++              ++L  N I           + ++ + L  N +     
Sbjct: 655 KIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPE 714

Query: 220 ---GSIPSALGNCHQLQSLDLS--------KTIFLGQYPV-RWLDLSHNHLTGPIPLAVG 267
                      N + L ++DL                 P    +D+S+N  +   P    
Sbjct: 715 NSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPL 773

Query: 268 NLKSIPHLDLSK------NKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLE 321
           N   +    +        N++  + P+ + +C  L  L +  N     +   L     L 
Sbjct: 774 NSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLY 830

Query: 322 GLDLFQN 328
            LD+  N
Sbjct: 831 ILDIADN 837

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  166 bits (423), Expect = 1e-43
 Identities = 47/343 (13%), Positives = 99/343 (28%), Gaps = 53/343 (15%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
                   N        N       L  L  +   +     Q+P  L    EL++L++  
Sbjct: 465 IAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIAC 524

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
           N+                               +  +        K++      N+L   
Sbjct: 525 NRGIS---------------------AAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEF 563

Query: 121 IPE-DLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVG 179
                L ++  L  L+           N +R L++      L  + L+ N +  IP    
Sbjct: 564 PASASLQKMVKLGLLDCVH--------NKVRHLEAFGTNVKLTDLKLDYNQIEEIPEDFC 615

Query: 180 -YLPKLQVLSLFENNISGEIPS--SLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLD 236
            +  +++ L    N +   IP+  +  +   +  ++   N I     +   +    + ++
Sbjct: 616 AFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGIN 674

Query: 237 LSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLS-------GEIPSS 289
            S            + LS+N +             I  + LS N ++            +
Sbjct: 675 AST-----------VTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGN 723

Query: 290 LGSCVGLEYLNLSINSFHG-PIHPGLSSLKSLEGLDLFQNTFQ 331
             +   L  ++L  N           ++L  L  +D+  N F 
Sbjct: 724 YKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS 766

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  161 bits (409), Expect = 8e-42
 Identities = 53/351 (15%), Positives = 109/351 (31%), Gaps = 40/351 (11%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           N   +  ++L      G +P  IG+L +L+ + F +++      +           +   
Sbjct: 321 NNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERK 380

Query: 61  N--KLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLT 118
           +  ++   ++  +    +   L ++    +  N     I      + K   +    N +T
Sbjct: 381 HRIRMHYKKMFLDYDQRL--NLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT 438

Query: 119 ASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVN-SLRSIPIS 177
             I + + RL  L  + FA +                      E  + +      +  +S
Sbjct: 439 -FISKAIQRLTKLQIIYFANSPFT-----------YDNIAVDWEDANSDYAKQYENEELS 486

Query: 178 VGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRG---------SIPSALGN 228
              L  L  + L+      ++P  L +   L  LN+  N              +      
Sbjct: 487 WSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDT 546

Query: 229 CHQLQSLDLS--------KTIFLGQYP-VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSK 279
             ++Q   +          +  L +   +  LD  HN +        G    +  L L  
Sbjct: 547 GPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLEAF--GTNVKLTDLKLDY 604

Query: 280 NKLSGEIPSSLGSCVG-LEYLNLSINSFHG-PIHPGLSSLKSLEGLDLFQN 328
           N++  EIP    +    +E L  S N     P      S+  +  +D   N
Sbjct: 605 NQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYN 654

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  146 bits (369), Expect = 1e-36
 Identities = 49/345 (14%), Positives = 114/345 (33%), Gaps = 37/345 (10%)

Query: 8   INLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQ 67
            N + + +      ++    ++  +       +G++P  +   +EL+ L    +      
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETV-- 361

Query: 68  LVGELPPYIGFTLPNIRIPLLAGNQFFGNIPH-SISNASKLEWLDFANNSLTASIPEDLG 126
                    G       +     ++   +     +    +L   D   +++    PE + 
Sbjct: 362 ----SGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN-RNPE-MK 415

Query: 127 RLRNLTRLNFARNDLGTRKVNDLRFL-DSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQ 185
            ++  +R++     +G    N + F+  ++   T L+I+    +      I+V      +
Sbjct: 416 PIKKDSRISLKDTQIGNLT-NRITFISKAIQRLTKLQIIYFANSPFTYDNIAVD----WE 470

Query: 186 VLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQ 245
             +            S  N   LT++ L        +P  L +  +LQSL+++    +  
Sbjct: 471 DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530

Query: 246 YPV-----------------RWLDLSHNHLTG-PIPLAVGNLKSIPHLDLSKNKLSGEIP 287
             +                 +   + +N+L   P   ++  +  +  LD   NK+     
Sbjct: 531 AQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HL 588

Query: 288 SSLGSCVGLEYLNLSINSFHGPIHPGL-SSLKSLEGLDLFQNTFQ 331
            + G+ V L  L L  N     I     +    +EGL    N  +
Sbjct: 589 EAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK 632

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  125 bits (315), Expect = 5e-30
 Identities = 50/300 (16%), Positives = 93/300 (31%), Gaps = 45/300 (15%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLF-QLRYIIFNSNTLQGQIP--VNLTHCSELRTLD 57
               L  + L  N     IP +      Q+  + F+ N L+  IP   N      + ++D
Sbjct: 593 TNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVD 650

Query: 58  LVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSL 117
              NK+              +   N     L+ N+         +  S +  +  +NN +
Sbjct: 651 FSYNKIGSEG-RNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLM 709

Query: 118 TA-------SIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNS 170
           T+           +      LT ++   N L T   +D R         YL  + ++ N 
Sbjct: 710 TSIPENSLKPKDGNYKNTYLLTTIDLRFNKL-TSLSDDFRAT----TLPYLSNMDVSYNC 764

Query: 171 LRSIPISVGYLPKLQVLSLFE------NNISGEIPSSLGNFTFLTELNLRGNSIRGSIPS 224
             S P       +L+   +        N I  + P+ +     L +L +  N IR  +  
Sbjct: 765 FSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDE 823

Query: 225 ALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLT-GPIPLAVGNLKS-IPHLDLSKNKL 282
            L        L               LD++ N      +      +++ +  L   K + 
Sbjct: 824 KL-----TPQL-------------YILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD 865

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  174 bits (444), Expect = 8e-47
 Identities = 67/364 (18%), Positives = 123/364 (33%), Gaps = 36/364 (9%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           N+T L   NL  N           R  QL  +    NT+    P        L+ L+L  
Sbjct: 26  NITVL---NLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQH 82

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
           N+L       +L         N+    L  N       +       L  LD ++N L+++
Sbjct: 83  NELS------QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSST 136

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSI-PISVG 179
                 +L NL  L  + N +   K  +L         + L+ + L+ N ++   P    
Sbjct: 137 KLGTQVQLENLQELLLSNNKIQALKSEELDIF----ANSSLKKLELSSNQIKEFSPGCFH 192

Query: 180 YLPKLQVLSLFENNISGEIPSSLGNF---TFLTELNLRGNSIRGSIPSALGNCH--QLQS 234
            + +L  L L    +   +   L      T +  L+L  + +  +  +         L  
Sbjct: 193 AIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTM 252

Query: 235 LDLS--------KTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKN------ 280
           LDLS           F     + +  L +N++      ++  L ++ +L+L ++      
Sbjct: 253 LDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSI 312

Query: 281 ---KLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNG 337
               L      S      LE+LN+  N   G      + L +L+ L L  +    ++   
Sbjct: 313 SLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTN 372

Query: 338 DVPR 341
           +   
Sbjct: 373 ETFV 376

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  169 bits (430), Expect = 6e-45
 Identities = 67/364 (18%), Positives = 118/364 (32%), Gaps = 44/364 (12%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVN---------LTHCS 51
            L  L    L+ NN      H +  LF +RY+    +  +  I +               
Sbjct: 270 WLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLK 329

Query: 52  ELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSIS----NASKL 107
            L  L++  N +        +   +   L N++   L+ +        + +      S L
Sbjct: 330 CLEHLNMEDNDIPG------IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPL 383

Query: 108 EWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLN 167
             L+   N ++    +    L +L  L+   N++  +++              +  + L+
Sbjct: 384 HILNLTKNKISKIESDAFSWLGHLEVLDLGLNEI-GQELTG----QEWRGLENIFEIYLS 438

Query: 168 VNSLRSIPISV-GYLPKLQVLSLFENNISG--EIPSSLGNFTFLTELNLRGNSIRGSIPS 224
            N    +  +    +P LQ L L    +      PS       LT L+L  N+I      
Sbjct: 439 YNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD 498

Query: 225 ALGNCHQLQSLDLS--------KTIFLGQYPV--------RWLDLSHNHLTGPIPLAVGN 268
            L    +L+ LDL         K    G              L+L  N           +
Sbjct: 499 MLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKD 558

Query: 269 LKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLS-SLKSLEGLDLFQ 327
           L  +  +DL  N L+    S   + V L+ LNL  N            + ++L  LD+  
Sbjct: 559 LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRF 618

Query: 328 NTFQ 331
           N F 
Sbjct: 619 NPFD 622

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  169 bits (430), Expect = 7e-45
 Identities = 64/356 (17%), Positives = 120/356 (33%), Gaps = 39/356 (10%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
             + L  +++  N  S   P    +L  L+ +    N L          C+ L  L L+ 
Sbjct: 47  RYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMS 106

Query: 61  NKLEE-------------------NQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSI 101
           N +++                   N L           L N++  LL+ N+        +
Sbjct: 107 NSIQKIKNNPFVKQKNLITLDLSHNGLSS-TKLGTQVQLENLQELLLSNNKIQALKSEEL 165

Query: 102 SNA--SKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCT 159
                S L+ L+ ++N +    P     +  L  L      LG      L    +    T
Sbjct: 166 DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELAN---T 222

Query: 160 YLEIVSLNVNSLRSIPISVGY---LPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGN 216
            +  +SL+ + L +   +         L +L L  NN++     S      L    L  N
Sbjct: 223 SIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYN 282

Query: 217 SIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLD 276
           +I+     +L     ++ L+L ++            +S   L      +   LK + HL+
Sbjct: 283 NIQHLFSHSLHGLFNVRYLNLKRSFT-------KQSISLASLPKIDDFSFQWLKCLEHLN 335

Query: 277 LSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLS----SLKSLEGLDLFQN 328
           +  N + G   +     + L+YL+LS +          +    +   L  L+L +N
Sbjct: 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKN 391

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  159 bits (403), Expect = 2e-41
 Identities = 60/328 (18%), Positives = 103/328 (31%), Gaps = 29/328 (8%)

Query: 5   LMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLE 64
               ++   +           L  L ++    N + G      T    L+ L L  +   
Sbjct: 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTS 366

Query: 65  ENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPED 124
              L  E           + I  L  N+       + S    LE LD   N +   +   
Sbjct: 367 LRTLTNETFV--SLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424

Query: 125 -LGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVG---Y 180
               L N+  +  + N             +S      L+ + L   +L+++  S      
Sbjct: 425 EWRGLENIFEIYLSYNKY------LQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP 478

Query: 181 LPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSI--------RGSIPSALGNCHQL 232
           L  L +L L  NNI+      L     L  L+L+ N++         G     L     L
Sbjct: 479 LRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHL 538

Query: 233 QSLDLS--------KTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSG 284
             L+L           +F   + ++ +DL  N+L         N  S+  L+L KN ++ 
Sbjct: 539 HILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITS 598

Query: 285 EIPSSLG-SCVGLEYLNLSINSFHGPIH 311
                 G +   L  L++  N F     
Sbjct: 599 VEKKVFGPAFRNLTELDMRFNPFDCTCE 626

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  147 bits (374), Expect = 1e-37
 Identities = 68/296 (22%), Positives = 107/296 (36%), Gaps = 31/296 (10%)

Query: 52  ELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLD 111
                D    KL +      +P  +     NI +  L  NQ       + +  S+L  LD
Sbjct: 5   SHEVADCSHLKLTQ------VPDDL---PTNITVLNLTHNQLRRLPAANFTRYSQLTSLD 55

Query: 112 FANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSL 171
              N+++   PE   +L  L  LN   N+L   +++D     +   CT L  + L  NS+
Sbjct: 56  VGFNTISKLEPELCQKLPMLKVLNLQHNEL--SQLSD----KTFAFCTNLTELHLMSNSI 109

Query: 172 RSI-PISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCH 230
           + I          L  L L  N +S     +      L EL L  N I+      L    
Sbjct: 110 QKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFA 169

Query: 231 --QLQSLDLS--------KTIFLGQYPVRWLDLSHNHLTGPIPLAVG---NLKSIPHLDL 277
              L+ L+LS           F     +  L L++  L   +   +       SI +L L
Sbjct: 170 NSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSL 229

Query: 278 SKNKLSGEIPSSLGSC--VGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQ 331
           S ++LS    ++        L  L+LS N+ +   +   + L  LE   L  N  Q
Sbjct: 230 SNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQ 285

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  137 bits (347), Expect = 4e-34
 Identities = 65/323 (20%), Positives = 111/323 (34%), Gaps = 57/323 (17%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLT----HCSELRTL 56
            L  L  +N++ N+  G   +    L  L+Y+  +++    +   N T      S L  L
Sbjct: 327 WLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHIL 386

Query: 57  DLVLNKLEE-------------------NQLVGELPPYIGFTLPNIRIPLLAGNQFFGNI 97
           +L  NK+ +                   N++  EL       L NI    L+ N++    
Sbjct: 387 NLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLT 446

Query: 98  PHSISNASKLEWLDFANNSLT--ASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSL 155
            +S +    L+ L     +L    S P     LRNLT L+ + N++     +       L
Sbjct: 447 RNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD------ML 500

Query: 156 VNCTYLEIVSLNVNSLRSI---------PISVGYLPKLQVLSLFENNISGEIPSSLGNFT 206
                LEI+ L  N+L  +            +  L  L +L+L  N           +  
Sbjct: 501 EGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLF 560

Query: 207 FLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAV 266
            L  ++L  N++     S   N   L+S                L+L  N +T       
Sbjct: 561 ELKIIDLGLNNLNTLPASVFNNQVSLKS----------------LNLQKNLITSVEKKVF 604

Query: 267 G-NLKSIPHLDLSKNKLSGEIPS 288
           G   +++  LD+  N       S
Sbjct: 605 GPAFRNLTELDMRFNPFDCTCES 627

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 88.1 bits (219), Expect = 3e-18
 Identities = 41/263 (15%), Positives = 73/263 (27%), Gaps = 30/263 (11%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQG--QIPVNLTHCSELRTLDL 58
            L  +  I L  N +     +    +  L+ ++     L+     P        L  LDL
Sbjct: 428 GLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDL 487

Query: 59  VLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQ--------FFGNIPHSISNASKLEWL 110
                  N +   +   +   L  + I  L  N           G   + +   S L  L
Sbjct: 488 -----SNNNIAN-INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHIL 541

Query: 111 DFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNS 170
           +  +N       E    L  L  ++   N+L T             N   L+ ++L  N 
Sbjct: 542 NLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA------SVFNNQVSLKSLNLQKNL 595

Query: 171 LRSIPISV--GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSI----PS 224
           + S+   V       L  L +  N       S      ++ E +     +        P 
Sbjct: 596 ITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPP 655

Query: 225 ALGNCHQLQSLDLSK-TIFLGQY 246
                  ++  D S        +
Sbjct: 656 HYHG-FPVRLFDTSSCKDSAHHH 677

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 69.6 bits (171), Expect = 1e-12
 Identities = 22/124 (17%), Positives = 34/124 (27%), Gaps = 19/124 (15%)

Query: 205 FTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPL 264
                  +     +   +P            DL          +  L+L+HN L      
Sbjct: 3   TVSHEVADCSHLKLT-QVPD-----------DLPTN-------ITVLNLTHNQLRRLPAA 43

Query: 265 AVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLD 324
                  +  LD+  N +S   P        L+ LNL  N          +   +L  L 
Sbjct: 44  NFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH 103

Query: 325 LFQN 328
           L  N
Sbjct: 104 LMSN 107

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  167 bits (424), Expect = 9e-47
 Identities = 58/216 (26%), Positives = 86/216 (39%), Gaps = 28/216 (12%)

Query: 432 SYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECE- 490
           +               LIG G +G+VYKG LD  +  VAVKV     R   ++F+ E   
Sbjct: 4   AASEPSLDLDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFANR---QNFINEKNI 58

Query: 491 -ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSI 549
             +  + H N+ + I         G     LV E+  +GSL  +L   +           
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----------- 107

Query: 550 LSFLQRLNIAINVASALEYLH------HHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT 603
             ++    +A +V   L YLH       H K  I H DL   NVL+ ND    + DFGL+
Sbjct: 108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167

Query: 604 RFI----PEVISSNQCSSVGLKGTVGYAAPEYGMGS 635
             +             +++   GT+ Y APE   G+
Sbjct: 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGA 203

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  162 bits (412), Expect = 7e-43
 Identities = 63/357 (17%), Positives = 115/357 (32%), Gaps = 32/357 (8%)

Query: 5   LMLINLQQNNFSGNIPHEIG---RLFQLRYIIFNSNTLQGQIP-VNLTHCSELRTLDLVL 60
           L  + L+ N  S N+           ++  ++      +G +   + +    L  L +  
Sbjct: 202 LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE 261

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
            +L       +    +   L N+    L             S     + L+  N      
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQHLELVNCKFGQF 319

Query: 121 IPEDLGRLRNLTRLNFARNDLGT-RKVNDLRFLD--------------SLVNCTYLEIVS 165
               L  L+ LT  +    +  +   +  L FLD              S    T L+ + 
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379

Query: 166 LNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSS-LGNFTFLTELNLRGNSIRGSIPS 224
           L+ N + ++  +   L +L+ L    +N+      S   +   L  L++     R +   
Sbjct: 380 LSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439

Query: 225 ALGNCHQLQSLDLSKTIFLGQYP---------VRWLDLSHNHLTGPIPLAVGNLKSIPHL 275
                  L+ L ++   F   +          + +LDLS   L    P A  +L S+  L
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499

Query: 276 DLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSL-KSLEGLDLFQNTFQ 331
           ++S N               L+ L+ S+N         L     SL  L+L QN F 
Sbjct: 500 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 556

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  144 bits (364), Expect = 1e-36
 Identities = 67/371 (18%), Positives = 107/371 (28%), Gaps = 53/371 (14%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           +   L   +L  N       +      +L+ +  +   +Q          S L TL L  
Sbjct: 29  STKNL---DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLIL-- 83

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLT-A 119
                N +           L +++  +             I +   L+ L+ A+N +   
Sbjct: 84  ---TGNPIQSLALGAFSG-LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139

Query: 120 SIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVG 179
            +PE    L NL  L+ + N + +    DLR L  +        + L++N +  I     
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL--NLSLDLSLNPMNFIQPGAF 197

Query: 180 YLPKLQVLSLFENNISGEIPS-SLGNFTFLTELNLRGNSIRGS------IPSALGNCHQL 232
              +L  L+L  N  S  +    +     L    L     R          SAL     L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257

Query: 233 QSLDLS-----------KTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNK 281
              +               +F     V    L    +      +        HL+L   K
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCK 315

Query: 282 LS-------------------GEIPSSLGSCVGLEYLNLSIN--SFHGPIHPGLSSLKSL 320
                                G    S      LE+L+LS N  SF G          SL
Sbjct: 316 FGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375

Query: 321 EGLDLFQNTFQ 331
           + LDL  N   
Sbjct: 376 KYLDLSFNGVI 386

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  136 bits (344), Expect = 5e-34
 Identities = 55/316 (17%), Positives = 108/316 (34%), Gaps = 36/316 (11%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           NLT         + +  +I      L  +      S T++     + ++    + L+LV 
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVN 313

Query: 61  NKLEE--------------NQLVGELPPYIGFTLPNIRIPLLAGNQ--FFGNIPHSISNA 104
            K  +                  G         LP++    L+ N   F G    S    
Sbjct: 314 CKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGT 372

Query: 105 SKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIV 164
           + L++LD + N +  ++  +   L  L  L+F  ++L       +      ++   L  +
Sbjct: 373 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL-----KQMSEFSVFLSLRNLIYL 426

Query: 165 SLNVNSLRSIPISV-GYLPKLQVLSLFENNISGEI-PSSLGNFTFLTELNLRGNSIRGSI 222
            ++    R     +   L  L+VL +  N+      P        LT L+L    +    
Sbjct: 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 486

Query: 223 PSALGNCHQLQSLDLS--------KTIFLGQYPVRWLDLSHNHLTGPIPLAVGNL-KSIP 273
           P+A  +   LQ L++S           +     ++ LD S NH+       + +   S+ 
Sbjct: 487 PTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLA 546

Query: 274 HLDLSKNKLSGEIPSS 289
            L+L++N  +      
Sbjct: 547 FLNLTQNDFACTCEHQ 562

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  128 bits (323), Expect = 3e-31
 Identities = 51/313 (16%), Positives = 95/313 (30%), Gaps = 41/313 (13%)

Query: 42  QIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSI 101
           +IP NL      + LDL       N L            P +++  L+  +       + 
Sbjct: 21  KIPDNLP--FSTKNLDL-----SFNPLRHLGSYSFFS-FPELQVLDLSRCEIQTIEDGAY 72

Query: 102 SNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYL 161
            + S L  L    N + +        L +L +L     +L + +         + +   L
Sbjct: 73  QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF------PIGHLKTL 126

Query: 162 EIVSLNVNSLRSIPI--SVGYLPKLQVLSLFENNISGEIPSSLGNFTFLT----ELNLRG 215
           + +++  N ++S  +      L  L+ L L  N I     + L     +      L+L  
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186

Query: 216 NSIRGSIPSALGNCHQLQSLDLS---------KTIFLGQYPVRWLDLSHNHLTGPIPLAV 266
           N +    P A      L  L L          KT   G   +    L          L  
Sbjct: 187 NPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245

Query: 267 ---GNLKSIPHLDLSKNKLS------GEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSL 317
                L+ + +L + + +L+       +I         +   +L   +         S  
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYN 303

Query: 318 KSLEGLDLFQNTF 330
              + L+L    F
Sbjct: 304 FGWQHLELVNCKF 316

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  115 bits (289), Expect = 5e-27
 Identities = 48/187 (25%), Positives = 73/187 (39%), Gaps = 15/187 (8%)

Query: 159 TYLEIVSLNVNSLRSI-PISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNS 217
              + + L+ N LR +   S    P+LQVL L    I      +  + + L+ L L GN 
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87

Query: 218 IRGSIPSALGNCHQLQSLDLSKTIFLGQYPV--------RWLDLSHNHLTG-PIPLAVGN 268
           I+     A      LQ L   +T                + L+++HN +    +P    N
Sbjct: 88  IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147

Query: 269 LKSIPHLDLSKNKLSGEIPSSLGSCVGLEY----LNLSINSFHGPIHPGLSSLKSLEGLD 324
           L ++ HLDLS NK+     + L     +      L+LS+N  +  I PG      L  L 
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLT 206

Query: 325 LFQNTFQ 331
           L  N   
Sbjct: 207 LRNNFDS 213

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 89.7 bits (223), Expect = 7e-19
 Identities = 26/135 (19%), Positives = 47/135 (34%), Gaps = 18/135 (13%)

Query: 197 EIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHN 256
           +IP +L        L+L  N +R     +  +  +LQ LDLS                  
Sbjct: 21  KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLS----------------RC 62

Query: 257 HLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSS 316
            +      A  +L  +  L L+ N +      +      L+ L     +     +  +  
Sbjct: 63  EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122

Query: 317 LKSLEGLDLFQNTFQ 331
           LK+L+ L++  N  Q
Sbjct: 123 LKTLKELNVAHNLIQ 137

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  154 bits (391), Expect = 3e-42
 Identities = 59/184 (32%), Positives = 92/184 (50%), Gaps = 21/184 (11%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA--LKSFMAECEALRNIRHRNLVKIITA 506
           IG GSFG+V++       + VAVK+L      A  +  F+ E   ++ +RH N+V  + A
Sbjct: 45  IGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +    Q  +  ++V E++  GSL   LH        + +   L   +RL++A +VA  +
Sbjct: 103 VT----QPPNL-SIVTEYLSRGSLYRLLHK-------SGAREQLDERRRLSMAYDVAKGM 150

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            YLH+     IVH +LK  N+L+D      V DFGL+R    + +S   SS    GT  +
Sbjct: 151 NYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR----LKASTFLSSKSAAGTPEW 205

Query: 627 AAPE 630
            APE
Sbjct: 206 MAPE 209

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  151 bits (383), Expect = 3e-41
 Identities = 49/183 (26%), Positives = 77/183 (42%), Gaps = 26/183 (14%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G+FG V K         VA+K +        K+F+ E   L  + H N+VK+  AC 
Sbjct: 16  VGRGAFGVVCKAKWR--AKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKLYGACL 71

Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
           +          LV E+   GSL + LH               +    ++  +  +  + Y
Sbjct: 72  NP-------VCLVMEYAEGGSLYNVLHGAE-------PLPYYTAAHAMSWCLQCSQGVAY 117

Query: 569 LHHHCKKQIVHCDLKPSNVLLD-NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYA 627
           LH    K ++H DLKP N+LL     +  + DFG    I   +++N       KG+  + 
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-------KGSAAWM 170

Query: 628 APE 630
           APE
Sbjct: 171 APE 173

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  150 bits (380), Expect = 5e-41
 Identities = 48/191 (25%), Positives = 75/191 (39%), Gaps = 24/191 (12%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECE--ALRNIRHRNLVKII 504
             +G G +G V++G        VAVK+         KS+  E E      +RH N++  I
Sbjct: 14  ECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFI 68

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
            +  +S         L+  +   GSL  +L   +           L  +  L I +++AS
Sbjct: 69  ASDMTSRHSSTQL-WLITHYHEMGSLYDYLQLTT-----------LDTVSCLRIVLSIAS 116

Query: 565 ALEYLH-----HHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
            L +LH        K  I H DLK  N+L+  +    + D GL     +  +     +  
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176

Query: 620 LKGTVGYAAPE 630
             GT  Y APE
Sbjct: 177 RVGTKRYMAPE 187

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  150 bits (380), Expect = 1e-40
 Identities = 48/191 (25%), Positives = 69/191 (36%), Gaps = 24/191 (12%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECE--ALRNIRHRNLVKII 504
             IG G +G V+ G        VAVKV F  +     S+  E E      +RH N++  I
Sbjct: 43  KQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFI 97

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
            A             L+ ++  +GSL  +L   +           L     L +A +  S
Sbjct: 98  AADIKGTGSWTQL-YLITDYHENGSLYDYLKSTT-----------LDAKSMLKLAYSSVS 145

Query: 565 ALEYLH-----HHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
            L +LH        K  I H DLK  N+L+  +    + D GL        +        
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205

Query: 620 LKGTVGYAAPE 630
             GT  Y  PE
Sbjct: 206 RVGTKRYMPPE 216

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  148 bits (376), Expect = 2e-40
 Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 36/194 (18%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-------RGALKSFMAECEALRNIRHRNLV 501
           IG G FG V+KG L  D++VVA+K L L             + F  E   + N+ H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           K+     +          +V EF+  G L   L  +            + +  +L + ++
Sbjct: 87  KLYGLMHNP-------PRMVMEFVPCGDLYHRLLDK---------AHPIKWSVKLRLMLD 130

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDN-----DMIAHVGDFGLTRFIPEVISSNQCS 616
           +A  +EY+  +    IVH DL+  N+ L +      + A V DFGL++           S
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-------S 182

Query: 617 SVGLKGTVGYAAPE 630
             GL G   + APE
Sbjct: 183 VSGLLGNFQWMAPE 196

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  147 bits (374), Expect = 2e-40
 Identities = 41/184 (22%), Positives = 71/184 (38%), Gaps = 25/184 (13%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA--LKSFMAECEALRNIRHRNLVKIITA 506
           +     G ++KG        + VKVL +        + F  EC  LR   H N++ ++ A
Sbjct: 18  LNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
           C S          L+  +M +GSL + LH          +  ++   Q +  A+++A  +
Sbjct: 76  CQSPP---APHPTLITHWMPYGSLYNVLH--------EGTNFVVDQSQAVKFALDMARGM 124

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            +LH   +  I    L   +V++D DM A +    +              S G      +
Sbjct: 125 AFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF---------QSPGRMYAPAW 174

Query: 627 AAPE 630
            APE
Sbjct: 175 VAPE 178

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  154 bits (392), Expect = 3e-40
 Identities = 75/345 (21%), Positives = 127/345 (36%), Gaps = 27/345 (7%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           +L      ++   + S  +   +  +  +  I    +             S L+ LDL  
Sbjct: 229 SLWLGTFEDMDDEDISPAVFEGLCEM-SVESINLQKHYFFNISSNTFHCFSGLQELDLTA 287

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
             L E      LP  +   L  ++  +L+ N+F      S SN   L  L    N+    
Sbjct: 288 THLSE------LPSGL-VGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLE 340

Query: 121 IPED-LGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISV- 178
           +    L  L NL  L+ + +D+ T    +      L N ++L+ ++L+ N   S+     
Sbjct: 341 LGTGCLENLENLRELDLSHDDIETSDCCN----LQLRNLSHLQSLNLSYNEPLSLKTEAF 396

Query: 179 GYLPKLQVLSLFENNISG-EIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDL 237
              P+L++L L    +   +  S   N   L  LNL  + +  S          LQ L+L
Sbjct: 397 KECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNL 456

Query: 238 S----KTIFLGQYPV-------RWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEI 286
                    + +            L LS   L+     A  +LK + H+DLS N+L+   
Sbjct: 457 QGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSS 516

Query: 287 PSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQ 331
             +L    G+ YLNL+ N     +   L  L     ++L QN   
Sbjct: 517 IEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLD 560

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  154 bits (391), Expect = 4e-40
 Identities = 70/347 (20%), Positives = 125/347 (36%), Gaps = 27/347 (7%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           N   L  + L  N+ S     +     +L+ + F +N +      +++   +   L L L
Sbjct: 127 NQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNL 186

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNAS--KLEWLDFANNSLT 118
           N    N +   + P   F     +     G Q    I   + N++   L    F +    
Sbjct: 187 NG---NDI-AGIEPGA-FDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE 241

Query: 119 ASIPEDLGRLR--NLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPI 176
              P     L   ++  +N  ++      ++     ++    + L+ + L    L  +P 
Sbjct: 242 DISPAVFEGLCEMSVESINLQKHYF--FNISS----NTFHCFSGLQELDLTATHLSELPS 295

Query: 177 SVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPS-ALGNCHQLQSL 235
            +  L  L+ L L  N        S  NF  LT L+++GN+ R  + +  L N   L+ L
Sbjct: 296 GLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLREL 355

Query: 236 DLS----------KTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSG- 284
           DLS                   ++ L+LS+N        A      +  LDL+  +L   
Sbjct: 356 DLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVK 415

Query: 285 EIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQ 331
           +  S   +   L+ LNLS +            L +L+ L+L  N F 
Sbjct: 416 DAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFP 462

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  149 bits (377), Expect = 3e-38
 Identities = 62/341 (18%), Positives = 105/341 (30%), Gaps = 27/341 (7%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           +   L       N           RL  L ++      +             L TL L  
Sbjct: 34  STECL---EFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTA 90

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
           N L        +          ++                + N   LE L   +N +++ 
Sbjct: 91  NPLI------FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI 144

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGY 180
                     L  L+F  N +      D+  L    N +    ++LN N +  I      
Sbjct: 145 KLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLS----LNLNGNDIAGIEPGAFD 200

Query: 181 LPKLQVLSLFENNISGEIPSSLGNFTF--LTELNLRGNSIRGSIPSALGNCH--QLQSLD 236
               Q L+         I   L N T   L              P+         ++S++
Sbjct: 201 SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESIN 260

Query: 237 LSK--------TIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPS 288
           L K          F     ++ LDL+  HL+  +P  +  L ++  L LS NK       
Sbjct: 261 LQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQI 319

Query: 289 SLGSCVGLEYLNLSINSFHGPIHPG-LSSLKSLEGLDLFQN 328
           S  +   L +L++  N+    +  G L +L++L  LDL  +
Sbjct: 320 SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD 360

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  132 bits (335), Expect = 8e-33
 Identities = 55/360 (15%), Positives = 117/360 (32%), Gaps = 62/360 (17%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
             + L  ++L   + S  +P  +  L  L+ ++ ++N  +    ++ ++   L  L +  
Sbjct: 276 CFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSI-- 332

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQ--FFGNIPHSISNASKLEWLDFANNSLT 118
              + N    EL       L N+R   L+ +           + N S L+ L+ + N   
Sbjct: 333 ---KGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL 389

Query: 119 ASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISV 178
           +   E       L  L+ A   L               N   L++++L+ + L      +
Sbjct: 390 SLKTEAFKECPQLELLDLAFTRL-----KVKDAQSPFQNLHLLKVLNLSHSLLDISSEQL 444

Query: 179 ----------------------------GYLPKLQVLSLFENNISGEIPSSLGNFTFLTE 210
                                         L +L++L L   ++S     +  +   +  
Sbjct: 445 FDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNH 504

Query: 211 LNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLK 270
           ++L  N +  S   AL +   +                  L+L+ NH++  +P  +  L 
Sbjct: 505 VDLSHNRLTSSSIEALSHLKGIY-----------------LNLASNHISIILPSLLPILS 547

Query: 271 SIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTF 330
               ++L +N L     +       LE+   ++            +   L G+ L   T 
Sbjct: 548 QQRTINLRQNPLDCTCSNIY----FLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTL 603

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  115 bits (291), Expect = 3e-27
 Identities = 44/295 (14%), Positives = 82/295 (27%), Gaps = 29/295 (9%)

Query: 48  THCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKL 107
                 +T +     L E      +P  +     +      + N        + S    L
Sbjct: 9   IEKEVNKTYNCENLGLNE------IPGTL---PNSTECLEFSFNVLPTIQNTTFSRLINL 59

Query: 108 EWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLN 167
            +LD     +     +       L  L    N L    + +     +L     L+ +   
Sbjct: 60  TFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL--IFMAE----TALSGPKALKHLFFI 113

Query: 168 VNSLRSI-PISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSAL 226
              + SI  I +     L+ L L  N+IS            L  L+ + N+I       +
Sbjct: 114 QTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173

Query: 227 GNCHQLQSLDLS-KTIFLGQYP--------VRWLDLSHNHLTGPIPLAVGN--LKSIPHL 275
            +  Q  +L L+     +             + L+         I   + N  ++S+   
Sbjct: 174 SSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLG 233

Query: 276 DLSKNKLSGEIPSSLGSCVG--LEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
                      P+         +E +NL  + F             L+ LDL   
Sbjct: 234 TFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTAT 288

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 68.9 bits (169), Expect = 2e-12
 Identities = 39/211 (18%), Positives = 70/211 (33%), Gaps = 20/211 (9%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEI-GRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLV 59
               L L++L                L  L+ +  + + L             L+ L+L 
Sbjct: 398 ECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQ 457

Query: 60  LNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTA 119
            N   +             TL  + I +L+         H+ ++   +  +D ++N LT+
Sbjct: 458 GNHFPKGN---IQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS 514

Query: 120 SIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLV---------NCT-----YLEIVS 165
           S  E L  L+ +  LN A N +     + L  L             +CT     +LE   
Sbjct: 515 SSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEWYK 573

Query: 166 LNVNSLRSIP-ISVGYLPKLQVLSLFENNIS 195
            N+  L           P L+ + L +  +S
Sbjct: 574 ENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  149 bits (377), Expect = 4e-40
 Identities = 49/191 (25%), Positives = 78/191 (40%), Gaps = 24/191 (12%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECE--ALRNIRHRNLVKII 504
             IG G FG V++G        VAVK+    +    +S+  E E      +RH N++  I
Sbjct: 48  ESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFI 102

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
            A +  +        LV ++  HGSL  +L+  +           ++    + +A++ AS
Sbjct: 103 AADNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYT-----------VTVEGMIKLALSTAS 150

Query: 565 ALEYLH-----HHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
            L +LH        K  I H DLK  N+L+  +    + D GL         +   +   
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210

Query: 620 LKGTVGYAAPE 630
             GT  Y APE
Sbjct: 211 RVGTKRYMAPE 221

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  145 bits (368), Expect = 1e-39
 Identities = 45/194 (23%), Positives = 73/194 (37%), Gaps = 36/194 (18%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL----FLHQRGALKSFMAECEALRNIRHRNLVKII 504
           IG G FG VY+         VAVK             +++   E +    ++H N++ + 
Sbjct: 15  IGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C     +  +   LV EF   G L   L  +            +     +N A+ +A 
Sbjct: 73  GVCL----KEPNL-CLVMEFARGGPLNRVLSGKR-----------IPPDILVNWAVQIAR 116

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH--------VGDFGLTRFIPEVISSNQCS 616
            + YLH      I+H DLK SN+L+   +           + DFGL R        ++ +
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW------HRTT 170

Query: 617 SVGLKGTVGYAAPE 630
            +   G   + APE
Sbjct: 171 KMSAAGAYAWMAPE 184

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  144 bits (365), Expect = 5e-39
 Identities = 57/184 (30%), Positives = 84/184 (45%), Gaps = 25/184 (13%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITA 506
           IG+GSFG+VYKG    D   VAVK+L +       L++F  E   LR  RH N++  +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            ++         A+V ++    SL   LH                  + ++IA   A  +
Sbjct: 89  STAPQL------AIVTQWCEGSSLYHHLHASETK---------FEMKKLIDIARQTARGM 133

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
           +YLH    K I+H DLK +N+ L  D    +GDFGL         S+Q     L G++ +
Sbjct: 134 DYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE--QLSGSILW 188

Query: 627 AAPE 630
            APE
Sbjct: 189 MAPE 192

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  145 bits (369), Expect = 3e-37
 Identities = 57/348 (16%), Positives = 98/348 (28%), Gaps = 35/348 (10%)

Query: 1   NLTFLMLINLQQNNFSGNI------PHEIGRLFQLRYIIF--NSNTLQGQIPVNLTHCSE 52
           NL  L +  L    F          P  +  L  +    F            V     + 
Sbjct: 227 NLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLAN 286

Query: 53  LRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDF 112
           +  + L    ++       L           +   +   Q        +     L+ L  
Sbjct: 287 VSAMSLAGVSIKY------LED--VPKHFKWQSLSIIRCQLKQFPTLDLPF---LKSLTL 335

Query: 113 ANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLR 172
             N    SI      L +L+ L+ +RN L          L        L  + L+ N   
Sbjct: 336 TMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDL----GTNSLRHLDLSFNGAI 389

Query: 173 SIPISVGYLPKLQVLSLFENNISGEIP-SSLGNFTFLTELNLRGNSIRGSIPSALGNCHQ 231
            +  +   L +LQ L    + +      S+  +   L  L++   + +            
Sbjct: 390 IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTS 449

Query: 232 LQSLDLS---------KTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKL 282
           L +L ++           +F     + +LDLS   L          L  +  L++S N L
Sbjct: 450 LNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL 509

Query: 283 SGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTF 330
                S       L  L+ S N             KSL   +L  N+ 
Sbjct: 510 LFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  137 bits (346), Expect = 3e-34
 Identities = 59/320 (18%), Positives = 115/320 (35%), Gaps = 34/320 (10%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           ++T      L   N   +   +   L  +  +     +++     ++    + ++L ++ 
Sbjct: 260 DVTIDEF-RLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIR 316

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
            +L++              LP ++   L  N+  G+I         L +LD + N+L+ S
Sbjct: 317 CQLKQFP---------TLDLPFLKSLTLTMNK--GSISFKKVALPSLSYLDLSRNALSFS 365

Query: 121 IPEDLGRL--RNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIP--I 176
                  L   +L  L+ + N              + +    L+ +    ++L+ +    
Sbjct: 366 GCCSYSDLGTNSLRHLDLSFNGAIIMS-------ANFMGLEELQHLDFQHSTLKRVTEFS 418

Query: 177 SVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPS-ALGNCHQLQSL 235
           +   L KL  L +   N   +        T L  L + GNS + +  S    N   L  L
Sbjct: 419 AFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFL 478

Query: 236 DLS--------KTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIP 287
           DLS          +F   + ++ L++SHN+L          L S+  LD S N++     
Sbjct: 479 DLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKG 538

Query: 288 SSLGSCVGLEYLNLSINSFH 307
                   L + NL+ NS  
Sbjct: 539 ILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  134 bits (339), Expect = 2e-33
 Identities = 65/370 (17%), Positives = 117/370 (31%), Gaps = 49/370 (13%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQG-QIPVNLTHCSELRTLDLV 59
            LT L  +   +   +      IG+L  L+ +    N +   ++P   ++ + L  +DL 
Sbjct: 102 GLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLS 161

Query: 60  LNKLEENQLVGELPPYIGFTLPNIRIPL----LAGNQFFGNIPHSISNASKLEWLDFANN 115
            N ++       +       L           ++ N     I        KL  L    N
Sbjct: 162 YNYIQ------TITVNDLQFLRENPQVNLSLDMSLNP-IDFIQDQAFQGIKLHELTLRGN 214

Query: 116 SLTASIPEDLGR-LRNLTRLNFARNDLGTR---KVNDLRFLDSLVNCTYLEIVSLNVNSL 171
             +++I +   + L  L        +       ++ +   ++ L + T  E      N  
Sbjct: 215 FNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDF 274

Query: 172 RSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSI------------- 218
               +    L  +  +SL   +I       +        L++    +             
Sbjct: 275 SDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKS 332

Query: 219 ------RGSIPSALGNCHQLQSLDLSK----------TIFLGQYPVRWLDLSHNHLTGPI 262
                 +GSI         L  LDLS+             LG   +R LDLS N     +
Sbjct: 333 LTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-M 391

Query: 263 PLAVGNLKSIPHLDLSKNKLSGEIP-SSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLE 321
                 L+ + HLD   + L      S+  S   L YL++S  +           L SL 
Sbjct: 392 SANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLN 451

Query: 322 GLDLFQNTFQ 331
            L +  N+F+
Sbjct: 452 TLKMAGNSFK 461

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  120 bits (302), Expect = 1e-28
 Identities = 64/335 (19%), Positives = 110/335 (32%), Gaps = 39/335 (11%)

Query: 8   INLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQ 67
                   S  +P +I      + I  + N L+     + ++ SEL+ LDL   ++E   
Sbjct: 16  YQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET-- 70

Query: 68  LVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGR 127
               +       L ++   +L GN      P S S  + LE L      L +     +G+
Sbjct: 71  ----IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQ 126

Query: 128 LRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISV-----GYLP 182
           L  L +LN A N +     +  +      N T L  V L+ N +++I ++          
Sbjct: 127 LITLKKLNVAHNFI-----HSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQ 181

Query: 183 KLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPS-ALGNCHQLQSLDLSKTI 241
               L +  N I      +      L EL LRGN    +I    L N   L    L    
Sbjct: 182 VNLSLDMSLNPIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGE 240

Query: 242 F----------------LGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGE 285
           F                L    +    L++ +      +    L ++  + L+   +   
Sbjct: 241 FKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY- 299

Query: 286 IPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSL 320
               +      + L++            L  LKSL
Sbjct: 300 -LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSL 333

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  102 bits (257), Expect = 5e-23
 Identities = 34/178 (19%), Positives = 60/178 (33%), Gaps = 15/178 (8%)

Query: 164 VSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIP 223
                  L  +P  +      + + L  N +      S  NF+ L  L+L    I     
Sbjct: 16  YQCMDQKLSKVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIED 73

Query: 224 SALGNCHQLQSLDLS--------KTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHL 275
            A    H L +L L+           F G   +  L      L       +G L ++  L
Sbjct: 74  KAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKL 133

Query: 276 DLSKNKLSG-EIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLK----SLEGLDLFQN 328
           +++ N +   ++P+   +   L +++LS N         L  L+        LD+  N
Sbjct: 134 NVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 79.7 bits (197), Expect = 1e-15
 Identities = 25/146 (17%), Positives = 47/146 (32%), Gaps = 19/146 (13%)

Query: 186 VLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQ 245
                +  +S ++P  +   +    ++L  N ++     +  N  +LQ LDLS       
Sbjct: 15  TYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLS------- 64

Query: 246 YPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINS 305
                       +      A   L  + +L L+ N +    P S      LE L      
Sbjct: 65  ---------RCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115

Query: 306 FHGPIHPGLSSLKSLEGLDLFQNTFQ 331
                   +  L +L+ L++  N   
Sbjct: 116 LASLESFPIGQLITLKKLNVAHNFIH 141

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 24/133 (18%), Positives = 41/133 (30%), Gaps = 20/133 (15%)

Query: 196 GEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSH 255
           G +   +     +T        +   +P            D+  +        + +DLS 
Sbjct: 2   GSLNPCIEVVPNIT-YQCMDQKLS-KVPD-----------DIPSST-------KNIDLSF 41

Query: 256 NHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLS 315
           N L      +  N   +  LDLS+ ++      +      L  L L+ N          S
Sbjct: 42  NPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFS 101

Query: 316 SLKSLEGLDLFQN 328
            L SLE L   + 
Sbjct: 102 GLTSLENLVAVET 114

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  139 bits (351), Expect = 7e-37
 Identities = 43/192 (22%), Positives = 75/192 (39%), Gaps = 27/192 (14%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G G FG   K        V+ +K L        ++F+ E + +R + H N++K I    
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
               +       + E++  G+L   +    +            + QR++ A ++AS + Y
Sbjct: 78  ----KDKRL-NFITEYIKGGTLRGIIKSMDSQ---------YPWSQRVSFAKDIASGMAY 123

Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK------- 621
           LH      I+H DL   N L+  +    V DFGL R + +  +  +      K       
Sbjct: 124 LH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180

Query: 622 ---GTVGYAAPE 630
              G   + APE
Sbjct: 181 TVVGNPYWMAPE 192

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  139 bits (351), Expect = 8e-37
 Identities = 51/187 (27%), Positives = 77/187 (41%), Gaps = 24/187 (12%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKII 504
            LIG G FG VY G    +   VA++++ + +     LK+F  E  A R  RH N+V  +
Sbjct: 39  ELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
            AC S         A++       +L S +               L   +   IA  +  
Sbjct: 96  GACMSPPH-----LAIITSLCKGRTLYSVVRDAKIV---------LDVNKTRQIAQEIVK 141

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV-GLKGT 623
            + YLH    K I+H DLK  NV  DN  +  + DFGL      + +  +   +    G 
Sbjct: 142 GMGYLH---AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGW 197

Query: 624 VGYAAPE 630
           + + APE
Sbjct: 198 LCHLAPE 204

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  137 bits (348), Expect = 3e-36
 Identities = 50/339 (14%), Positives = 97/339 (28%), Gaps = 48/339 (14%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           + +    +  Q +         + +  +      N             + +  +      
Sbjct: 10  HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTG 65

Query: 61  NKLEENQLVGELPPYIGF-TLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTA 119
             L+           +   T P      L         P      S L+ +      L  
Sbjct: 66  RALKA------TADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGLM- 117

Query: 120 SIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSL-NVNSLRSIPISV 178
            +P+ + +   L  L  ARN L            S+ +   L  +S+     L  +P  +
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLRA-------LPASIASLNRLRELSIRACPELTELPEPL 170

Query: 179 G---------YLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNC 229
                      L  LQ L L    I   +P+S+ N   L  L +R + +  ++  A+ + 
Sbjct: 171 ASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHL 228

Query: 230 HQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSS 289
            +L+ LDL                    L    P   G    +  L L        +P  
Sbjct: 229 PKLEELDLR---------------GCTALRN-YPPIFGGRAPLKRLILKDCSNLLTLPLD 272

Query: 290 LGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
           +     LE L+L        +   ++ L +   + +  +
Sbjct: 273 IHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  136 bits (344), Expect = 1e-35
 Identities = 49/308 (15%), Positives = 101/308 (32%), Gaps = 31/308 (10%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSE--LRTLDL 58
                   +  + + +    +        +        L+      L   ++     L+L
Sbjct: 34  QWQRHYNADRNRWHSAWRQAN----SNNPQIETRTGRALK-ATADLLEDATQPGRVALEL 88

Query: 59  VLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLT 118
               L +       P      L +++   +        +P ++   + LE L  A N L 
Sbjct: 89  RSVPLPQ------FPDQAF-RLSHLQHMTIDAAGL-MELPDTMQQFAGLETLTLARNPLR 140

Query: 119 ASIPEDLGRLRNLTRLNFAR-NDLGT--RKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIP 175
            ++P  +  L  L  L+     +L      +              L+ + L    +RS+P
Sbjct: 141 -ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLP 199

Query: 176 ISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSL 235
            S+  L  L+ L +  + +S  +  ++ +   L EL+LRG +   + P   G    L+ L
Sbjct: 200 ASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRL 258

Query: 236 DLSKTIFLGQYPV--------RWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKN---KLSG 284
            L     L   P+          LDL        +P  +  L +   + +  +   +L  
Sbjct: 259 ILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318

Query: 285 EIPSSLGS 292
             P +  +
Sbjct: 319 HRPVARPA 326

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  128 bits (325), Expect = 4e-33
 Identities = 50/267 (18%), Positives = 100/267 (37%), Gaps = 36/267 (13%)

Query: 94  FGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARN------------DL 141
            G+  H   ++S  E L F  ++      + L + +     +  R              +
Sbjct: 1   MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQI 60

Query: 142 GTRKVNDLRFL-DSLVNCTYLEIVSLNV--NSLRSIPISVGYLPKLQVLSLFENNISGEI 198
            TR    L+   D L + T    V+L +    L   P     L  LQ +++    +  E+
Sbjct: 61  ETRTGRALKATADLLEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM-EL 119

Query: 199 PSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYP----------- 247
           P ++  F  L  L L  N +R ++P+++ + ++L+ L +     L + P           
Sbjct: 120 PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178

Query: 248 ------VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNL 301
                 ++ L L    +   +P ++ NL+++  L +  + LS  +  ++     LE L+L
Sbjct: 179 HQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDL 236

Query: 302 SINSFHGPIHPGLSSLKSLEGLDLFQN 328
              +      P       L+ L L   
Sbjct: 237 RGCTALRNYPPIFGGRAPLKRLILKDC 263

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 66.1 bits (162), Expect = 7e-12
 Identities = 27/153 (17%), Positives = 50/153 (32%), Gaps = 11/153 (7%)

Query: 7   LINLQQNNFSGN----IPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNK 62
           L+NLQ           +P  I  L  L+ +   ++ L   +   + H  +L  LDL    
Sbjct: 182 LVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGC- 239

Query: 63  LEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIP 122
                L    PP  G     ++  +L        +P  I   ++LE LD       + +P
Sbjct: 240 ---TALR-NYPPIFGG-RAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLP 294

Query: 123 EDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSL 155
             + +L     +    +       +      + 
Sbjct: 295 SLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  136 bits (345), Expect = 1e-35
 Identities = 72/334 (21%), Positives = 122/334 (36%), Gaps = 38/334 (11%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
            L  +  + +     + +I   I  L  L Y+  N N +    P  L++  +L  L +  
Sbjct: 42  ELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGT 97

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
           NK+ +          +   L N+R   L  +      P  ++N +K+  L+   N    S
Sbjct: 98  NKITD-------ISALQ-NLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-S 146

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGY 180
               L  +  L  L    + +          +  + N T L  +SLN N +  I   +  
Sbjct: 147 DLSPLSNMTGLNYLTVTESKVKD--------VTPIANLTDLYSLSLNYNQIEDIS-PLAS 197

Query: 181 LPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKT 240
           L  L   + + N I+   P  + N T L  L +  N I    P  L N  QL  L++   
Sbjct: 198 LTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTN 253

Query: 241 IF-----LGQYP-VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCV 294
                  +     ++ L++  N ++    L   NL  +  L L+ N+L  E    +G   
Sbjct: 254 QISDINAVKDLTKLKMLNVGSNQISDISVL--NNLSQLNSLFLNNNQLGNEDMEVIGGLT 311

Query: 295 GLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
            L  L LS N         L+SL  ++  D    
Sbjct: 312 NLTTLFLSQNHITDI--RPLASLSKMDSADFANQ 343

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  128 bits (324), Expect = 9e-33
 Identities = 62/334 (18%), Positives = 116/334 (34%), Gaps = 62/334 (18%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           +L   +   LQ+ + +  +      L  +  ++     +   I   + + + L  L+L  
Sbjct: 20  DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNG 75

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
           N++ +      + P                          +SN  KL  L    N +T  
Sbjct: 76  NQITD------ISP--------------------------LSNLVKLTNLYIGTNKIT-- 101

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGY 180
               L  L NL  L    +      ++D+  L +L     +  ++L  N   S    +  
Sbjct: 102 DISALQNLTNLRELYLNED-----NISDISPLANLTK---MYSLNLGANHNLSDLSPLSN 153

Query: 181 LPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKT 240
           +  L  L++ E+ +    P  + N T L  L+L  N I    P  L +   L        
Sbjct: 154 MTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVN 209

Query: 241 -----IFLGQYP-VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCV 294
                  +     +  L + +N +T   PL   NL  +  L++  N++S    +++    
Sbjct: 210 QITDITPVANMTRLNSLKIGNNKITDLSPL--ANLSQLTWLEIGTNQISD--INAVKDLT 265

Query: 295 GLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
            L+ LN+  N         L++L  L  L L  N
Sbjct: 266 KLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNN 297

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  114 bits (287), Expect = 7e-28
 Identities = 51/236 (21%), Positives = 92/236 (38%), Gaps = 28/236 (11%)

Query: 100 SISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCT 159
             ++ ++         S+T  +      L ++T+L  A   + +        +  +   T
Sbjct: 17  PDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--------IQGIEYLT 66

Query: 160 YLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIR 219
            LE ++LN N +  I   +  L KL  L +  N I+    S+L N T L EL L  ++I 
Sbjct: 67  NLEYLNLNGNQITDIS-PLSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNIS 123

Query: 220 GSIPSALGNCHQLQSLDLSKTIFLGQYPV-------RWLDLSHNHLTGPIPLAVGNLKSI 272
              P  L N  ++ SL+L     L             +L ++ + +    P+   NL  +
Sbjct: 124 DISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTPI--ANLTDL 179

Query: 273 PHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
             L L+ N++    P  L S   L Y    +N         ++++  L  L +  N
Sbjct: 180 YSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDI--TPVANMTRLNSLKIGNN 231

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  112 bits (283), Expect = 2e-27
 Identities = 60/283 (21%), Positives = 107/283 (37%), Gaps = 44/283 (15%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           NLT L  + L ++N S   P  +  L ++  +   +N     +   L++ + L  L +  
Sbjct: 108 NLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTE 164

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
           +K+++   +  L         ++    L  NQ     P  +++ + L +     N +T  
Sbjct: 165 SKVKDVTPIANLT--------DLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDI 214

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGY 180
            P  +  +  L  L    N +          L  L N + L  + +  N +  I  +V  
Sbjct: 215 TP--VANMTRLNSLKIGNNKITD--------LSPLANLSQLTWLEIGTNQISDIN-AVKD 263

Query: 181 LPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKT 240
           L KL++L++  N IS    S L N + L  L L  N +       +G    L +L LS  
Sbjct: 264 LTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLS-- 319

Query: 241 IFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLS 283
                          NH+T   PLA  +L  +   D +   + 
Sbjct: 320 --------------QNHITDIRPLA--SLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  105 bits (264), Expect = 8e-25
 Identities = 47/225 (20%), Positives = 83/225 (36%), Gaps = 26/225 (11%)

Query: 110 LDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVN 169
           L      +    P     L    R    +  +          + +      +  + +   
Sbjct: 5   LATLPAPINQIFP--DADLAEGIRAVLQKASVTD--------VVTQEELESITKLVVAGE 54

Query: 170 SLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNC 229
            + SI   + YL  L+ L+L  N I+   P  L N   LT L +  N I  +  SAL N 
Sbjct: 55  KVASIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNL 109

Query: 230 HQLQSLDLSKT-----IFLGQYP-VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLS 283
             L+ L L++        L     +  L+L  NH    +   + N+  + +L ++++K+ 
Sbjct: 110 TNLRELYLNEDNISDISPLANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVK 168

Query: 284 GEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
              P  + +   L  L+L+ N         L+SL SL     + N
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDI--SPLASLTSLHYFTAYVN 209

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 77.2 bits (191), Expect = 2e-15
 Identities = 27/151 (17%), Positives = 56/151 (37%), Gaps = 16/151 (10%)

Query: 184 LQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKT--- 240
              L+     I+   P    +        L+  S+   +         +  L ++     
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 241 --IFLGQYP-VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLE 297
               +     + +L+L+ N +T   PL   NL  + +L +  NK++    S+L +   L 
Sbjct: 58  SIQGIEYLTNLEYLNLNGNQITDISPL--SNLVKLTNLYIGTNKIT--DISALQNLTNLR 113

Query: 298 YLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
            L L+ ++        L++L  +  L+L  N
Sbjct: 114 ELYLNEDNISDI--SPLANLTKMYSLNLGAN 142

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  129 bits (327), Expect = 2e-32
 Identities = 76/334 (22%), Positives = 122/334 (36%), Gaps = 42/334 (12%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
            L   M   L + N +  +      L Q+  +  +   ++      + + + L  ++   
Sbjct: 22  ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSN 77

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
           N+L +      + P     L  +   L+  NQ     P  ++N + L  L   NN +T  
Sbjct: 78  NQLTD------ITPLKN--LTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDI 127

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGY 180
            P  L  L NL RL  + N +          + +L   T L+ +S         P+    
Sbjct: 128 DP--LKNLTNLNRLELSSNTI--------SDISALSGLTSLQQLSFGNQVTDLKPL--AN 175

Query: 181 LPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSK- 239
           L  L+ L +  N +S    S L   T L  L    N I    P  LG    L  L L+  
Sbjct: 176 LTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGN 231

Query: 240 -----TIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCV 294
                        +  LDL++N ++   PL    L  +  L L  N++S   P  L    
Sbjct: 232 QLKDIGTLASLTNLTDLDLANNQISNLAPL--SGLTKLTELKLGANQISNISP--LAGLT 287

Query: 295 GLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
            L  L L+ N         +S+LK+L  L L+ N
Sbjct: 288 ALTNLELNENQLEDI--SPISNLKNLTYLTLYFN 319

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  122 bits (309), Expect = 5e-30
 Identities = 77/349 (22%), Positives = 129/349 (36%), Gaps = 46/349 (13%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           NLT L+ I +  N  +   P  +  L  L  +   +N +    P  L + + L  L+L  
Sbjct: 88  NLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSS 143

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
           N + +          +   L +++  L  GNQ     P  ++N + LE LD ++N ++  
Sbjct: 144 NTISD-------ISALS-GLTSLQQ-LSFGNQVTDLKP--LANLTTLERLDISSNKVS-- 190

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKV--------------NDLRFLDSLVNCTYLEIVSL 166
               L +L NL  L    N +                   N L+ + +L + T L  + L
Sbjct: 191 DISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDL 250

Query: 167 NVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSAL 226
             N + ++   +  L KL  L L  N IS   P  L   T LT L L  N +    P  +
Sbjct: 251 ANNQISNLA-PLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--I 305

Query: 227 GNCHQLQSLDLSKTIFLGQYPV------RWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKN 280
            N   L  L L         PV      + L   +N ++    L   NL +I  L    N
Sbjct: 306 SNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDVSSL--ANLTNINWLSAGHN 363

Query: 281 KLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNT 329
           ++S   P  L +   +  L L+  ++        +++     +      
Sbjct: 364 QISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGA 410

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  107 bits (270), Expect = 4e-25
 Identities = 60/248 (24%), Positives = 94/248 (37%), Gaps = 32/248 (12%)

Query: 100 SISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKV------------- 146
           + +  ++         ++T ++      L  +T L   R  + +                
Sbjct: 19  TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFS 76

Query: 147 -NDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNF 205
            N L  +  L N T L  + +N N +  I   +  L  L  L+LF N I+   P  L N 
Sbjct: 77  NNQLTDITPLKNLTKLVDILMNNNQIADIT-PLANLTNLTGLTLFNNQITDIDP--LKNL 133

Query: 206 TFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTI-----FLGQYPVRWLDLSHNHLTG 260
           T L  L L  N+I     SAL     LQ L     +           +  LD+S N ++ 
Sbjct: 134 TNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD 191

Query: 261 PIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSL 320
              L    L ++  L  + N++S   P  LG    L+ L+L+ N         L+SL +L
Sbjct: 192 ISVL--AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNL 245

Query: 321 EGLDLFQN 328
             LDL  N
Sbjct: 246 TDLDLANN 253

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 90.0 bits (224), Expect = 3e-19
 Identities = 38/188 (20%), Positives = 68/188 (36%), Gaps = 18/188 (9%)

Query: 147 NDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFT 206
             +  + +           L   ++    +S   L ++  L      I       +    
Sbjct: 12  TPINQIFTDTALAEKMKTVLGKTNVTDT-VSQTDLDQVTTLQADRLGIK--SIDGVEYLN 68

Query: 207 FLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKT-----IFLGQYP-VRWLDLSHNHLTG 260
            LT++N   N +    P  L N  +L  + ++         L     +  L L +N +T 
Sbjct: 69  NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITD 126

Query: 261 PIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSL 320
             PL   NL ++  L+LS N +S    S+L     L+ L+             L++L +L
Sbjct: 127 IDPL--KNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTL 179

Query: 321 EGLDLFQN 328
           E LD+  N
Sbjct: 180 ERLDISSN 187

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 89.3 bits (222), Expect = 5e-19
 Identities = 62/298 (20%), Positives = 99/298 (33%), Gaps = 38/298 (12%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
            LT L  +    N  S   P  +G L  L  +  N N L+      L   + L  LDL  
Sbjct: 197 KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 252

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
           N++        L P  G  L  +    L  NQ     P  ++  + L  L+   N L   
Sbjct: 253 NQISN------LAPLSG--LTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI 302

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGY 180
            P  +  L+NLT L    N++          +  + + T L+ +    N +  +  S+  
Sbjct: 303 SP--ISNLKNLTYLTLYFNNISD--------ISPVSSLTKLQRLFFYNNKVSDVS-SLAN 351

Query: 181 LPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKT 240
           L  +  LS   N IS   P  L N T +T+L L   +   +  +   N     ++     
Sbjct: 352 LTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTG 409

Query: 241 I--------FLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSL 290
                      G Y     D++ N  +               +       SG +   L
Sbjct: 410 ALIAPATISDGGSY--TEPDITWNLPSY-TNEVSYTFSQPVTIGKGTTTFSGTVTQPL 464

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  124 bits (312), Expect = 6e-31
 Identities = 77/382 (20%), Positives = 146/382 (38%), Gaps = 52/382 (13%)

Query: 1   NLTFLMLINLQQNNFSGN----IPHEI-GRLFQLRYIIFNSNTLQGQIPVNLTHCSELRT 55
               + L N +   F  +    +P  +     Q+  +  N   ++        +   ++ 
Sbjct: 38  GFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQK 97

Query: 56  LDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSI-SNASKLEWLDFAN 114
           L +  N +        LPP++   +P + + +L  N    ++P  I  N  KL  L  +N
Sbjct: 98  LYMGFNAIR------YLPPHVFQNVPLLTVLVLERND-LSSLPRGIFHNTPKLTTLSMSN 150

Query: 115 NSLTASIPEDLGR-LRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRS 173
           N+L   I +D  +   +L  L  + N L      DL  + S      L   +++ N L +
Sbjct: 151 NNLE-RIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPS------LFHANVSYNLLST 200

Query: 174 IPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQ 233
           + I       ++ L    N+I+  +   +     LT L L+ N++     + L N   L 
Sbjct: 201 LAI----PIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLV 251

Query: 234 SLDLS--------KTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGE 285
            +DLS           F+    +  L +S+N L   + L    + ++  LDLS N L   
Sbjct: 252 EVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-H 309

Query: 286 IPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIF 345
           +  +      LE L L  NS    +     +  +L+ L L  N +           + +F
Sbjct: 310 VERNQPQFDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDWD------CNSLRALF 360

Query: 346 KNASAISVAGNEKLCGGISELK 367
           +N +  +V   ++ C    +L+
Sbjct: 361 RNVARPAVDDADQHCKIDYQLE 382

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  108 bits (272), Expect = 1e-25
 Identities = 68/331 (20%), Positives = 127/331 (38%), Gaps = 47/331 (14%)

Query: 2   LTFLMLINLQQNNFSGNIPH--EIGRLFQLRYIIFNSNTLQGQIPVN-LTHCSELRTLDL 58
               +  ++  +  + ++    E   L   + + F ++T++ ++P   L    ++  L+L
Sbjct: 18  QYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNL 76

Query: 59  VLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLT 118
              ++EE      +  Y       I+   +  N      PH   N   L  L    N L+
Sbjct: 77  NDLQIEE------IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130

Query: 119 ASIPEDL-GRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPIS 177
            S+P  +      LT L+ + N+L   ++ D    D+    T L+ + L+ N L  + +S
Sbjct: 131 -SLPRGIFHNTPKLTTLSMSNNNL--ERIED----DTFQATTSLQNLQLSSNRLTHVDLS 183

Query: 178 VGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDL 237
           +  +P L   ++  N +S     +L     + EL+   NSI   +   +        L  
Sbjct: 184 L--IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV-----NVEL-- 228

Query: 238 SKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLE 297
                        L L HN+LT      + N   +  +DLS N+L   +         LE
Sbjct: 229 -----------TILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE 275

Query: 298 YLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
            L +S N     ++     + +L+ LDL  N
Sbjct: 276 RLYISNNRLVA-LNLYGQPIPTLKVLDLSHN 305

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 89.3 bits (222), Expect = 3e-19
 Identities = 50/241 (20%), Positives = 86/241 (35%), Gaps = 26/241 (10%)

Query: 97  IPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLV 156
           I  ++        +     +       +   L N   + F  + +  RK+        L 
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM--RKLPA----ALLD 66

Query: 157 NCTYLEIVSLNVNSLRSIPISV-GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRG 215
           +   +E+++LN   +  I      Y   +Q L +  N I    P    N   LT L L  
Sbjct: 67  SFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLER 126

Query: 216 NSIRGSIPSALGNCHQLQSLDLS--------KTIFLGQYPVRWLDLSHNHLTGPIPLAVG 267
           N +         N  +L +L +S           F     ++ L LS N LT    + + 
Sbjct: 127 NDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---VDLS 183

Query: 268 NLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQ 327
            + S+ H ++S N L     S+L   + +E L+ S NS +  +   +     L  L L  
Sbjct: 184 LIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQH 235

Query: 328 N 328
           N
Sbjct: 236 N 236

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 27/171 (15%), Positives = 57/171 (33%), Gaps = 10/171 (5%)

Query: 167 NVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSAL 226
                + I  ++ Y      + +                     +  + +++R    + L
Sbjct: 6   RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 65

Query: 227 GNCHQLQSLDLS--------KTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLS 278
            +  Q++ L+L+           F   + ++ L +  N +    P    N+  +  L L 
Sbjct: 66  DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 125

Query: 279 KNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPG-LSSLKSLEGLDLFQN 328
           +N LS        +   L  L++S N+    I      +  SL+ L L  N
Sbjct: 126 RNDLSSLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSN 175

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  120 bits (303), Expect = 3e-30
 Identities = 44/163 (26%), Positives = 76/163 (46%), Gaps = 12/163 (7%)

Query: 449 IGTGSFGSVYKGIL---DPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNLVKI 503
           +G G FGSV +G L   D     VAVK +      +  ++ F++E   +++  H N++++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
           +  C     QG     ++  FM +G L ++L            P  +     L   +++A
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETG----PKHIPLQTLLKFMVDIA 157

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
             +EYL     +  +H DL   N +L +DM   V DFGL++ I
Sbjct: 158 LGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI 197

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  124 bits (313), Expect = 4e-30
 Identities = 68/337 (20%), Positives = 128/337 (37%), Gaps = 36/337 (10%)

Query: 2   LTFLMLINLQQNNFSGNIPH--EIGRLFQLRYIIFNSNTLQGQIPVN-LTHCSELRTLDL 58
               +  ++  +  + ++    E   L   + + F ++T++ ++P   L    ++  L+L
Sbjct: 24  QYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNL 82

Query: 59  VLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLT 118
              ++EE      +  Y       I+   +  N      PH   N   L  L    N L+
Sbjct: 83  NDLQIEE------IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136

Query: 119 ASIPEDL-GRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPIS 177
            S+P  +      LT L+ + N+L   ++ D    D+    T L+ + L+ N L  + +S
Sbjct: 137 -SLPRGIFHNTPKLTTLSMSNNNL--ERIED----DTFQATTSLQNLQLSSNRLTHVDLS 189

Query: 178 VGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDL 237
           +  +P L   ++  N +     S+L     + EL+   NSI   +        +L  L L
Sbjct: 190 L--IPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKL 239

Query: 238 SK------TIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLG 291
                      L    +  +DLS+N L   +      ++ +  L +S N+L   +     
Sbjct: 240 QHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQ 298

Query: 292 SCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
               L+ L+LS N     +         LE L L  N
Sbjct: 299 PIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHN 334

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 88.8 bits (220), Expect = 1e-18
 Identities = 50/241 (20%), Positives = 86/241 (35%), Gaps = 26/241 (10%)

Query: 97  IPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLV 156
           I  ++        +     +       +   L N   + F  + +  RK+        L 
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM--RKLPA----ALLD 72

Query: 157 NCTYLEIVSLNVNSLRSIPISV-GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRG 215
           +   +E+++LN   +  I      Y   +Q L +  N I    P    N   LT L L  
Sbjct: 73  SFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLER 132

Query: 216 NSIRGSIPSALGNCHQLQSLDLS--------KTIFLGQYPVRWLDLSHNHLTGPIPLAVG 267
           N +         N  +L +L +S           F     ++ L LS N LT    + + 
Sbjct: 133 NDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---VDLS 189

Query: 268 NLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQ 327
            + S+ H ++S N L     S+L   + +E L+ S NS +  +   +     L  L L  
Sbjct: 190 LIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQH 241

Query: 328 N 328
           N
Sbjct: 242 N 242

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 88.8 bits (220), Expect = 1e-18
 Identities = 69/370 (18%), Positives = 135/370 (36%), Gaps = 57/370 (15%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEI-GRLFQLRYIIFNSNTLQGQIPVN-LTHCSELRTLDL 58
           N+  L ++ L++N+ S ++P  I     +L  +  ++N L+ +I  +     + L+ L L
Sbjct: 121 NVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQL 178

Query: 59  VLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLT 118
             N+L        +       +P++    ++ N        +++    +E LD ++NS+ 
Sbjct: 179 SSNRLTH------VDL---SLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN 224

Query: 119 ASIPEDLGRLRNLTRLNFARNDLGT----RKVNDLRFLD------------SLVNCTYLE 162
             +   +     LT L    N+L           L  +D              V    LE
Sbjct: 225 -VVRGPV--NVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE 281

Query: 163 IVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSI 222
            + ++ N L ++ +    +P L+VL L  N++   +  +   F  L  L L  NSI  ++
Sbjct: 282 RLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TL 339

Query: 223 PSALGNCHQLQSLDLSK--------TIFLGQYPVRWLDLSHNHLTGPIPLAVG------- 267
              L   H L++L LS                    +D +  H      L  G       
Sbjct: 340 K--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESD 397

Query: 268 -NLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLF 326
                     ++   +  ++  + G C   + +N   +  H     G   L+  E L+  
Sbjct: 398 KPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAE 457

Query: 327 QNTFQAKSQN 336
            N  +A+ Q 
Sbjct: 458 VNELRAEVQQ 467

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 66.1 bits (161), Expect = 2e-11
 Identities = 28/173 (16%), Positives = 63/173 (36%), Gaps = 14/173 (8%)

Query: 167 NVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTF--LTELNLRGNSIRGSIPS 224
                + I  ++ Y      + +  +  + ++     + T      +  + +++R    +
Sbjct: 12  RQPEYKCIDSNLQYDCVFYDVHI--DMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAA 69

Query: 225 ALGNCHQLQSLDLS--------KTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLD 276
            L +  Q++ L+L+           F   + ++ L +  N +    P    N+  +  L 
Sbjct: 70  LLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129

Query: 277 LSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPG-LSSLKSLEGLDLFQN 328
           L +N LS        +   L  L++S N+    I      +  SL+ L L  N
Sbjct: 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSN 181

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  120 bits (302), Expect = 4e-30
 Identities = 56/261 (21%), Positives = 93/261 (35%), Gaps = 28/261 (10%)

Query: 80  LPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARN 139
               +I  +  +     +     +A  ++ LD + N L+     DL     L  LN + N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 140 DLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIP 199
            L             L + + L  + LN N ++ + +     P ++ L    NNIS  + 
Sbjct: 69  VLYE--------TLDLESLSTLRTLDLNNNYVQELLV----GPSIETLHAANNNIS-RVS 115

Query: 200 SSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLS--------KTIFLGQYP-VRW 250
            S         + L  N I        G   ++Q LDL                   +  
Sbjct: 116 CS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH 173

Query: 251 LDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPI 310
           L+L +N +   +   V     +  LDLS NKL+  +     S  G+ +++L  N     I
Sbjct: 174 LNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-I 229

Query: 311 HPGLSSLKSLEGLDLFQNTFQ 331
              L   ++LE  DL  N F 
Sbjct: 230 EKALRFSQNLEHFDLRGNGFH 250

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  113 bits (286), Expect = 5e-28
 Identities = 55/321 (17%), Positives = 105/321 (32%), Gaps = 59/321 (18%)

Query: 19  IPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGF 78
           I        + +      ++L+  +         ++ LDL  N L +             
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQ------------- 48

Query: 79  TLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFAR 138
                 I               ++  +KLE L+ ++N L      DL  L  L  L+   
Sbjct: 49  ------IS-----------AADLAPFTKLELLNLSSNVLY-ETL-DLESLSTLRTLDLNN 89

Query: 139 NDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEI 198
           N +             L+    +E +    N++  +  S       + + L  N I+   
Sbjct: 90  NYVQ-----------ELLVGPSIETLHAANNNISRVSCSR--GQGKKNIYLANNKITMLR 136

Query: 199 PSSLGNFTFLTELNLRGNSIRG-SIPSALGNCHQLQSLDLS--------KTIFLGQYPVR 249
               G  + +  L+L+ N I   +      +   L+ L+L           +   +  ++
Sbjct: 137 DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAK--LK 194

Query: 250 WLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFH-G 308
            LDLS N L   +     +   +  + L  NKL   I  +L     LE+ +L  N FH G
Sbjct: 195 TLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG 252

Query: 309 PIHPGLSSLKSLEGLDLFQNT 329
            +    S  + ++ +      
Sbjct: 253 TLRDFFSKNQRVQTVAKQTVK 273

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 98.9 bits (247), Expect = 6e-23
 Identities = 50/254 (19%), Positives = 89/254 (35%), Gaps = 31/254 (12%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           +   +  ++L  N  S     ++    +L  +  +SN L  +   +L   S LRTLDL  
Sbjct: 32  SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL-DLESLSTLRTLDLNN 89

Query: 61  NKLEE--------------NQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASK 106
           N ++E              N +   +    G    NI    LA N+            S+
Sbjct: 90  NYVQELLVGPSIETLHAANNNI-SRVSCSRGQGKKNIY---LANNKITMLRDLDEGCRSR 145

Query: 107 LEWLDFANNSLTA-SIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVS 165
           +++LD   N +   +  E       L  LN   N +          +   V    L+ + 
Sbjct: 146 VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI--------YDVKGQVVFAKLKTLD 197

Query: 166 LNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIR-GSIPS 224
           L+ N L  +         +  +SL  N +   I  +L     L   +LRGN    G++  
Sbjct: 198 LSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256

Query: 225 ALGNCHQLQSLDLS 238
                 ++Q++   
Sbjct: 257 FFSKNQRVQTVAKQ 270

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 31/162 (19%), Positives = 63/162 (38%), Gaps = 14/162 (8%)

Query: 173 SIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQL 232
           +I        + ++  + ++++   + S   +   + EL+L GN +     + L    +L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 233 QSLDLS----KTI--FLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEI 286
           + L+LS               +R LDL++N++       +    SI  L  + N +S  +
Sbjct: 61  ELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RV 114

Query: 287 PSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
             S G   G + + L+ N               ++ LDL  N
Sbjct: 115 SCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLN 154

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  119 bits (301), Expect = 5e-30
 Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 13/164 (7%)

Query: 449 IGTGSFGSVYKGIL---DPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNLVKI 503
           +G G FGSV +  L   D     VAVK+L   +     ++ F+ E   ++   H ++ K+
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 504 ITACSSSDFQGNDFKAL-VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +     S  +G     + +  FM HG L ++L      ++    P  L     +   +++
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN----PFNLPLQTLVRFMVDI 146

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           A  +EYL     +  +H DL   N +L  DM   V DFGL+R I
Sbjct: 147 ACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKI 187

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  124 bits (312), Expect = 1e-29
 Identities = 63/358 (17%), Positives = 117/358 (32%), Gaps = 38/358 (10%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEI-GRLFQLRYIIFNSNTLQGQIPVN-LTHCSELRTLDL 58
            L  L L+ L        I  E    L  LR +   S+ +   +  +       L  L L
Sbjct: 46  FLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRL 104

Query: 59  VLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFG-NIPHSISNASKLEWLDFANNSL 117
               L +  L           L  +    L+ NQ     +  S    + L+ +DF++N +
Sbjct: 105 YFCGLSDAVLKDGYFRN----LKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI 160

Query: 118 TASIPEDLGRLR--NLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIP 175
                 +L  L+   L+  + A N L +R   D     +      LEI+ ++ N      
Sbjct: 161 FLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDI 220

Query: 176 -------------ISVGYLPKLQVLSLFENNISGEIPSSLGNF--TFLTELNLRGNSIRG 220
                         S+     +       +NI     ++      + +  L+L    +  
Sbjct: 221 TGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFS 280

Query: 221 SIPSALGNCHQLQSLDLS--------KTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSI 272
                      L+ L+L+           F G   ++ L+LS+N L          L  +
Sbjct: 281 LNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKV 340

Query: 273 PHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTF 330
            ++DL KN ++     +      L+ L+L  N+        +  + S+  + L  N  
Sbjct: 341 AYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKL 393

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  114 bits (286), Expect = 2e-26
 Identities = 71/361 (19%), Positives = 121/361 (33%), Gaps = 43/361 (11%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVN-LTHCSELRTLDLV 59
            L     + L  N            L QL+ +   S      I      +   LR LDL 
Sbjct: 22  VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81

Query: 60  LNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNI--PHSISNASKLEWLDFANNSL 117
            +K+        L P     L ++    L        +       N   L  LD + N +
Sbjct: 82  SSKIY------FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQI 135

Query: 118 TA-SIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIP- 175
            +  +    G+L +L  ++F+ N +     ++L  L        L   SL  NSL S   
Sbjct: 136 RSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGK----TLSFFSLAANSLYSRVS 191

Query: 176 ------ISVGYLPKLQVLSL------------FENNISGEIPSSLGNFTFLTELNLRGNS 217
                 ++      L++L +            F N IS     SL     +       ++
Sbjct: 192 VDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251

Query: 218 IRGSIPSALGNCHQ--LQSLDLS--------KTIFLGQYPVRWLDLSHNHLTGPIPLAVG 267
           I+    +      +  ++ LDLS          +F     ++ L+L++N +      A  
Sbjct: 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFY 311

Query: 268 NLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQ 327
            L ++  L+LS N L     S+      + Y++L  N            L+ L+ LDL  
Sbjct: 312 GLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRD 371

Query: 328 N 328
           N
Sbjct: 372 N 372

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  103 bits (258), Expect = 5e-23
 Identities = 60/349 (17%), Positives = 113/349 (32%), Gaps = 43/349 (12%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLT---HCSELRTLD 57
           N   + +     N  S +    +     +    F  + ++     N       S +R LD
Sbjct: 214 NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLD 272

Query: 58  LVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSL 117
           L    +        L   +  TL ++++  LA N+       +      L+ L+ + N L
Sbjct: 273 LSHGFVFS------LNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326

Query: 118 TASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPIS 177
                 +   L  +  ++  +N +   +    +FL+ L      + + L  N+L +I   
Sbjct: 327 GELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKL------QTLDLRDNALTTIHF- 379

Query: 178 VGYLPKLQVLSLFENNISGEIPSSLGNFTF-LTELNLRGNSIRG-SIPSALGNCHQLQSL 235
              +P +  + L  N +      +L         ++L  N +    I   L     LQ L
Sbjct: 380 ---IPSIPDIFLSGNKLV-----TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQIL 431

Query: 236 DLSKT---------IFLGQYPVRWLDLSHNHLTGPIPLAV-----GNLKSIPHLDLSKNK 281
            L++                 +  L L  N L       +       L  +  L L+ N 
Sbjct: 432 ILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNY 491

Query: 282 LSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTF 330
           L+   P        L  L+L+ N              +LE LD+ +N  
Sbjct: 492 LNSLPPGVFSHLTALRGLSLNSNRLTVL--SHNDLPANLEILDISRNQL 538

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 92.6 bits (230), Expect = 1e-19
 Identities = 47/266 (17%), Positives = 83/266 (31%), Gaps = 42/266 (15%)

Query: 97  IPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLV 156
           +P  ++     E L  + N +          L  L  L           ++     ++  
Sbjct: 19  VPQVLNT---TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYT-PLTIDK----EAFR 70

Query: 157 NCTYLEIVSLNVNSLRSIPISV-GYLPKLQVLSLFENNISGEI--PSSLGNFTFLTELNL 213
           N   L I+ L  + +  +       L  L  L L+   +S  +       N   LT L+L
Sbjct: 71  NLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDL 130

Query: 214 RGNSIRG-SIPSALGNCHQLQSLDLSKTIF----------LGQYPVRWLDLSHNHLTGPI 262
             N IR   +  + G  + L+S+D S              L    + +  L+ N L   +
Sbjct: 131 SKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRV 190

Query: 263 PLAVGNL------KSIPHLDLSKNKLSGEIPS------------SLGSCVGLEYLNLSIN 304
            +  G          +  LD+S N  + +I              SL     +       +
Sbjct: 191 SVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFH 250

Query: 305 SFHGPIHPGLSSLK--SLEGLDLFQN 328
           +   P     + L   S+  LDL   
Sbjct: 251 NIKDPDQNTFAGLARSSVRHLDLSHG 276

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 90.2 bits (224), Expect = 6e-19
 Identities = 47/214 (21%), Positives = 71/214 (33%), Gaps = 25/214 (11%)

Query: 150 RFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLT 209
            F   +    +         +L  +P     L   + L L  N I     SS      L 
Sbjct: 3   SFDGRIAFYRF--------CNLTQVPQV---LNTTERLLLSFNYIRTVTASSFPFLEQLQ 51

Query: 210 ELNLRGNSIRGSI-PSALGNCHQLQSLDLS--------KTIFLGQYPVRWLDLSHNHLTG 260
            L L       +I   A  N   L+ LDL            F G + +  L L    L+ 
Sbjct: 52  LLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSD 111

Query: 261 PI--PLAVGNLKSIPHLDLSKNKLSG-EIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSL 317
            +       NLK++  LDLSKN++    +  S G    L+ ++ S N         L  L
Sbjct: 112 AVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171

Query: 318 --KSLEGLDLFQNTFQAKSQNGDVPRKGIFKNAS 349
             K+L    L  N+  ++           F+N  
Sbjct: 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMV 205

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 79.5 bits (196), Expect = 2e-15
 Identities = 56/309 (18%), Positives = 91/309 (29%), Gaps = 54/309 (17%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
            L  L ++NL  N  +         L  L+ +  + N L      N     ++  +DL  
Sbjct: 288 TLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQF---------------FGNIPHSISNAS 105
           N +        +       L  ++   L  N                    +        
Sbjct: 348 NHIAI------IQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINL 401

Query: 106 KLEWLDFANNSLTA-SIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIV 164
               +  + N L    I   L R+ +L  L   +N       +      +      LE +
Sbjct: 402 TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRF-----SSCSGDQTPSENPSLEQL 456

Query: 165 SLNVNSLRSIPISV------GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSI 218
            L  N L+    +         L  LQVL L  N ++   P    + T L  L+L  N +
Sbjct: 457 FLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516

Query: 219 RGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLS 278
                             LS         +  LD+S N L  P P    +L  +   D++
Sbjct: 517 T----------------VLSHNDLPAN--LEILDISRNQLLAPNPDVFVSLSVL---DIT 555

Query: 279 KNKLSGEIP 287
            NK   E  
Sbjct: 556 HNKFICECE 564

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  116 bits (293), Expect = 5e-29
 Identities = 50/165 (30%), Positives = 75/165 (45%), Gaps = 20/165 (12%)

Query: 449 IGTGSFGSVYKGILDPDQ----TVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVKI 503
           +G G FG V     DP+       VAVK L        +     E E LRN+ H N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
              C+     G +   L+ EF+  GSL+ +L               ++  Q+L  A+ + 
Sbjct: 89  KGICTED---GGNGIKLIMEFLPSGSLKEYLPKNKNK---------INLKQQLKYAVQIC 136

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
             ++YL     +Q VH DL   NVL++++    +GDFGLT+ I  
Sbjct: 137 KGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  120 bits (303), Expect = 8e-29
 Identities = 63/361 (17%), Positives = 125/361 (34%), Gaps = 33/361 (9%)

Query: 1   NLTFLML-INLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVN-LTHCSELRTLDL 58
            +  L L ++L  N  +  I     +  +L  +   +N     +    +   + L    L
Sbjct: 174 QMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRL 232

Query: 59  VLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQ---FFGNIPHSISNASKLEWLDFANN 115
           VL +      + +        L N+ I          +  +I    +  + +      + 
Sbjct: 233 VLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSV 292

Query: 116 SLTASIPED--LGRLRNLTRLNFARNDLGTRKVNDLRFLD----------SLVNCTYLEI 163
           ++   + +       ++L  +N       T K+  L+ L           S V+   LE 
Sbjct: 293 TIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEF 351

Query: 164 VSLNVNSLRSIPI---SVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRG 220
           + L+ N L        S      L+ L L  N +   + S+      L  L+ + ++++ 
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ 410

Query: 221 SIP-SALGNCHQLQSLDLS--------KTIFLGQYPVRWLDLSHNHLTGPIPLAV-GNLK 270
               S   +   L  LD+S          IF G   +  L ++ N         +   L+
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 470

Query: 271 SIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTF 330
           ++  LDLS+ +L    P++  S   L+ LN++ N            L SL+ + L  N +
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530

Query: 331 Q 331
            
Sbjct: 531 D 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  103 bits (259), Expect = 2e-23
 Identities = 55/305 (18%), Positives = 101/305 (33%), Gaps = 49/305 (16%)

Query: 3   TFLMLINLQQNNFSGN----IPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDL 58
            F  L N+   +        +       F  +++   +        + L     L+ L  
Sbjct: 277 LFNCLTNVSSFSLVSVTIERVKDFSY-NFGWQHLELVNCKFGQFPTLKLKS---LKRLTF 332

Query: 59  VLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQ--FFGNIPHSISNASKLEWLDFANNS 116
             NK            +    LP++    L+ N   F G    S    + L++LD + N 
Sbjct: 333 TSNKGGN--------AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384

Query: 117 LTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPI 176
           +  ++  +   L  L  L+F  ++L  +++++     SL N  YL    ++    R    
Sbjct: 385 VI-TMSSNFLGLEQLEHLDFQHSNL--KQMSEFSVFLSLRNLIYL---DISHTHTRVAFN 438

Query: 177 SV-GYLPKLQVLSLFENNISGEIPS-SLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQS 234
            +   L  L+VL +  N+               LT L+L    +    P+A  +   LQ 
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498

Query: 235 LDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCV 294
           L+++                 N L          L S+  + L  N           SC 
Sbjct: 499 LNMA----------------SNQLKSVPDGIFDRLTSLQKIWLHTNPWD-------CSCP 535

Query: 295 GLEYL 299
            ++YL
Sbjct: 536 RIDYL 540

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 96.7 bits (241), Expect = 4e-21
 Identities = 53/250 (21%), Positives = 91/250 (36%), Gaps = 25/250 (10%)

Query: 88  LAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVN 147
           L+ N       +S  +  +L+ LD +   +          L +L+ L    N +  + + 
Sbjct: 35  LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI--QSLA 92

Query: 148 DLRFLDSLVNCTYLEIVSLNVNSLRSIPISV-GYLPKLQVLSLFENNI-SGEIPSSLGNF 205
                 +    + L+ +     +L S+     G+L  L+ L++  N I S ++P    N 
Sbjct: 93  L----GAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148

Query: 206 TFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLA 265
           T L  L+L  N I+    + L   HQ+  L+LS            LDLS N +   I   
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS------------LDLSLNPMNF-IQPG 195

Query: 266 VGNLKSIPHLDLSKNKLSGEIPS-SLGSCVGLEYLNLSINSFHGP---IHPGLSSLKSLE 321
                 +  L L  N  S  +    +    GLE   L +  F           S+L+ L 
Sbjct: 196 AFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC 255

Query: 322 GLDLFQNTFQ 331
            L + +    
Sbjct: 256 NLTIEEFRLA 265

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 92.1 bits (229), Expect = 9e-20
 Identities = 53/314 (16%), Positives = 104/314 (33%), Gaps = 32/314 (10%)

Query: 29  LRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLL 88
            + +  + N L+     +     EL+ LDL   +++       +      +L ++   +L
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT------IEDGAYQSLSHLSTLIL 83

Query: 89  AGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVND 148
            GN        + S  S L+ L     +L +     +G L+ L  LN A N +       
Sbjct: 84  TGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI-----QS 138

Query: 149 LRFLDSLVNCTYLEIVSLNVNSLRSIPISV-GYLPKLQV----LSLFENNISGEIPSSLG 203
            +  +   N T LE + L+ N ++SI  +    L ++ +    L L  N ++  I     
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF 197

Query: 204 NFTFLTELNLRGNSIRGSIPS-ALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPI 262
               L +L LR N    ++    +     L+   L    F           +  +L    
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF----------RNEGNLEKFD 247

Query: 263 PLAVGNLKSIP--HLDLSKNKLSG-EIPSSLGSCVGLEYLNLSINSFHG-PIHPGLSSLK 318
             A+  L ++      L+       +I         +   +L   +             +
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQ 307

Query: 319 SLEGLDLFQNTFQA 332
            LE ++     F  
Sbjct: 308 HLELVNCKFGQFPT 321

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 88.6 bits (220), Expect = 1e-18
 Identities = 46/188 (24%), Positives = 71/188 (37%), Gaps = 15/188 (7%)

Query: 159 TYLEIVSLNVNSLRSIPISV-GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNS 217
              + + L+ N LR +        P+LQVL L    I      +  + + L+ L L GN 
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87

Query: 218 IRGSIPSALGNCHQLQSLDLS--------KTIFLGQYPVRWLDLSHNHLT-GPIPLAVGN 268
           I+     A      LQ L                    ++ L+++HN +    +P    N
Sbjct: 88  IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147

Query: 269 LKSIPHLDLSKNKLSGEIPSSLGSCVGLEY----LNLSINSFHGPIHPGLSSLKSLEGLD 324
           L ++ HLDLS NK+     + L     +      L+LS+N  +  I PG      L  L 
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLT 206

Query: 325 LFQNTFQA 332
           L  N    
Sbjct: 207 LRNNFDSL 214

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 67.0 bits (164), Expect = 8e-12
 Identities = 26/135 (19%), Positives = 47/135 (34%), Gaps = 18/135 (13%)

Query: 197 EIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHN 256
           +IP +L        L+L  N +R     +  +  +LQ                 LDLS  
Sbjct: 21  KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQ----------------VLDLSRC 62

Query: 257 HLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSS 316
            +      A  +L  +  L L+ N +      +      L+ L     +     +  +  
Sbjct: 63  EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122

Query: 317 LKSLEGLDLFQNTFQ 331
           LK+L+ L++  N  Q
Sbjct: 123 LKTLKELNVAHNLIQ 137

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  117 bits (295), Expect = 9e-29
 Identities = 48/195 (24%), Positives = 76/195 (38%), Gaps = 48/195 (24%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA----LKSFMAECEALRNIRHRNLVKII 504
           IG G+FG V+ G L  D T+VAVK     +          F+ E   L+   H N+V++I
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSC---RETLPPDLKAKFLQEARILKQYSHPNIVRLI 178

Query: 505 TACSSSD--FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
             C+     +       +V E +  G   ++L  E A          L     L +  + 
Sbjct: 179 GVCTQKQPIY-------IVMELVQGGDFLTFLRTEGAR---------LRVKTLLQMVGDA 222

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI---------------- 606
           A+ +EYL     K  +H DL   N L+    +  + DFG++R                  
Sbjct: 223 AAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPV 279

Query: 607 ----PEVISSNQCSS 617
               PE ++  + SS
Sbjct: 280 KWTAPEALNYGRYSS 294

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  115 bits (290), Expect = 9e-29
 Identities = 50/164 (30%), Positives = 80/164 (48%), Gaps = 19/164 (11%)

Query: 449 IGTGSFGSVYKGILDPDQ----TVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKII 504
           +G G+FGSV     DP Q     VVAVK L       L+ F  E E L++++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C S+  +      L+ E++ +GSL  +L               +  ++ L     +  
Sbjct: 78  GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKER---------IDHIKLLQYTSQICK 125

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
            +EYL     K+ +H DL   N+L++N+    +GDFGLT+ +P+
Sbjct: 126 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  115 bits (290), Expect = 2e-28
 Identities = 50/164 (30%), Positives = 80/164 (48%), Gaps = 19/164 (11%)

Query: 449 IGTGSFGSVYKGILDPDQ----TVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKII 504
           +G G+FGSV     DP Q     VVAVK L       L+ F  E E L++++H N+VK  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C S+  +      L+ E++ +GSL  +L               +  ++ L     +  
Sbjct: 109 GVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKER---------IDHIKLLQYTSQICK 156

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
            +EYL     K+ +H DL   N+L++N+    +GDFGLT+ +P+
Sbjct: 157 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  118 bits (296), Expect = 2e-28
 Identities = 53/356 (14%), Positives = 107/356 (30%), Gaps = 45/356 (12%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           N     +  +  ++    +       + ++ +  + N L      +L   ++L  L+L  
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67

Query: 61  NKLEE-----------------NQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISN 103
           N L E                 N +  EL        P+I     A N     +    S 
Sbjct: 68  NVLYETLDLESLSTLRTLDLNNNYV-QELLV-----GPSIETLHAANNN-ISRVS--CSR 118

Query: 104 ASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEI 163
               + +  ANN +T     D G    +  L+   N++ T     + F +   +   LE 
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-----VNFAELAASSDTLEH 173

Query: 164 VSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIP 223
           ++L  N +  +   V    KL+ L L  N ++  +     +   +T ++LR N +   I 
Sbjct: 174 LNLQYNFIYDVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIE 230

Query: 224 SALGNCHQLQSLDLS----KTIFLGQYPVRWL---DLSHNHLTGPIPLAVGNLKSIPHLD 276
            AL     L+  DL         L  +  +      ++   +                  
Sbjct: 231 KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290

Query: 277 LSKNKLSGEIPSSLGSCVGLEYLNLSINSFHG----PIHPGLSSLKSLEGLDLFQN 328
                            + L+    ++ S  G     +     +      +D  + 
Sbjct: 291 YGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKE 346

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  108 bits (270), Expect = 4e-25
 Identities = 58/366 (15%), Positives = 112/366 (30%), Gaps = 47/366 (12%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           +   +  ++L  N  S     ++    +L  +  +SN L  +   +L   S LRTLDL  
Sbjct: 32  SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL-DLESLSTLRTLDLNN 89

Query: 61  NKLEE--------------NQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASK 106
           N ++E              N +   +    G    NI    LA N+            S+
Sbjct: 90  NYVQELLVGPSIETLHAANNNI-SRVSCSRGQGKKNIY---LANNKITMLRDLDEGCRSR 145

Query: 107 LEWLDFANNSLTA-SIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVS 165
           +++LD   N +   +  E       L  LN   N +          +   V    L+ + 
Sbjct: 146 VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI--------YDVKGQVVFAKLKTLD 197

Query: 166 LNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIR-GSIPS 224
           L+ N L  +         +  +SL  N +   I  +L     L   +LRGN    G++  
Sbjct: 198 LSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256

Query: 225 ALGNCHQLQSLD------LSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLS 278
                 ++Q++       L+                         L       +  L   
Sbjct: 257 FFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE---DLPAPFADRLIALKRK 313

Query: 279 KNKL-------SGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQ 331
           ++ L       +  +     +      ++     +   I       ++   L+  +    
Sbjct: 314 EHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD 373

Query: 332 AKSQNG 337
            +  NG
Sbjct: 374 EQVSNG 379

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 92.2 bits (229), Expect = 8e-20
 Identities = 42/348 (12%), Positives = 99/348 (28%), Gaps = 31/348 (8%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
               +  ++   NN S  +    G+    + I   +N +     ++    S ++ LDL  
Sbjct: 97  VGPSIETLHAANNNIS-RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDL-- 151

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
              + N++       +  +   +    L  N  + ++   +   +KL+ LD ++N L   
Sbjct: 152 ---KLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-F 205

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGY 180
           +  +      +T ++   N L            +L     LE   L  N      +   +
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLVL-------IEKALRFSQNLEHFDLRGNGFHCGTLRDFF 258

Query: 181 LPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLS-- 238
               +V ++ +  +      +    T  T  +                   L+  + +  
Sbjct: 259 SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALL 318

Query: 239 ----------KTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPS 288
                     +     Q   R +D         I       ++   L+  K  L  ++ +
Sbjct: 319 SGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSN 378

Query: 289 SLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQN 336
              +   L+             H        L+ L      ++     
Sbjct: 379 GRRAHAELDGTLQQAVGQIELQHA-TEEQSPLQLLRAIVKRYEEMYVE 425

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 69.9 bits (171), Expect = 8e-13
 Identities = 37/293 (12%), Positives = 87/293 (29%), Gaps = 24/293 (8%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           +   L  +NLQ N    ++  ++    +L+ +  +SN L   +       + +  + L  
Sbjct: 167 SSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRN 223

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQF-FGNIPHSISNASKLEWLDF-ANNSLT 118
           NKL        +   +     N+    L GN F  G +    S   +++ +       LT
Sbjct: 224 NKLVL------IEKALR-FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLT 276

Query: 119 ASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISV 178
               E+           +   DL     + L  L    +     ++S   +    +    
Sbjct: 277 GQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEH----ALLSGQGSETERLECER 332

Query: 179 GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLS 238
               + + +   +      I            L  +  ++   + +      +L      
Sbjct: 333 ENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQ 392

Query: 239 -------KTIFLGQYPVRWLDLSHN-HLTGPIPLAVGNLKSIPHLDLSKNKLS 283
                  +     Q P++ L      +    +        +I   D+ ++K +
Sbjct: 393 AVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  114 bits (288), Expect = 3e-28
 Identities = 42/164 (25%), Positives = 67/164 (40%), Gaps = 19/164 (11%)

Query: 449 IGTGSFGSVYKGILDPDQ----TVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKII 504
           +G G+FGSV     DP       +VAVK L        + F  E + L+ +    +VK  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
                    G     LV E++  G L  +L    A          L   + L  +  +  
Sbjct: 91  GVSYGP---GRQSLRLVMEYLPSGCLRDFLQRHRAR---------LDASRLLLYSSQICK 138

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
            +EYL     ++ VH DL   N+L++++    + DFGL + +P 
Sbjct: 139 GMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  113 bits (286), Expect = 3e-28
 Identities = 47/166 (28%), Positives = 69/166 (41%), Gaps = 24/166 (14%)

Query: 449 IGTGSFGSVYKGIL---DPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G GSFG V +G           VAVK L    L Q  A+  F+ E  A+ ++ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +     +   +      +V E    GSL   L                        A+ V
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGH---------FLLGTLSRYAVQV 130

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           A  + YL     K+ +H DL   N+LL    +  +GDFGL R +P+
Sbjct: 131 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  118 bits (298), Expect = 3e-28
 Identities = 68/324 (20%), Positives = 113/324 (34%), Gaps = 71/324 (21%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           ++T L    +  NN + ++P       +LR +  + N L   +PV      EL      L
Sbjct: 62  HITTL---VIPDNNLT-SLPALPP---ELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPL 113

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
             L                   +    + GNQ   ++P        L+ L  ++N L  S
Sbjct: 114 THLPAL-------------PSGLCKLWIFGNQL-TSLPVLPPG---LQELSVSDNQLA-S 155

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGY 180
           +P     L  L   N           N L  L  L   + L+ +S++ N L S+P     
Sbjct: 156 LPALPSELCKLWAYN-----------NQLTSLPML--PSGLQELSVSDNQLASLPTLPS- 201

Query: 181 LPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKT 240
             +L  L  + N ++  +P+       L EL + GN +  S+P                 
Sbjct: 202 --ELYKLWAYNNRLT-SLPALPSG---LKELIVSGNRLT-SLPVLPSE------------ 242

Query: 241 IFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLN 300
                  ++ L +S N LT  +P+    L     L + +N+L+  +P SL        +N
Sbjct: 243 -------LKELMVSGNRLTS-LPMLPSGLL---SLSVYRNQLT-RLPESLIHLSSETTVN 290

Query: 301 LSINSFHGPIHPGLSSLKSLEGLD 324
           L  N         L  + S  G  
Sbjct: 291 LEGNPLSERTLQALREITSAPGYS 314

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  114 bits (288), Expect = 5e-27
 Identities = 59/288 (20%), Positives = 108/288 (37%), Gaps = 41/288 (14%)

Query: 50  CSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEW 109
            +    L++  + L        LP  +     +I   ++  N    ++P        L  
Sbjct: 39  NNGNAVLNVGESGLT------TLPDCLP---AHITTLVIPDNN-LTSLPALPPE---LRT 85

Query: 110 LDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVN--------CTYL 161
           L+ + N LT S+P     L  L+  +     L     + L  L    N           L
Sbjct: 86  LEVSGNQLT-SLPVLPPGLLELSIFSNPLTHL-PALPSGLCKLWIFGNQLTSLPVLPPGL 143

Query: 162 EIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGS 221
           + +S++ N L S+P       +L  L  + N ++  +P        L EL++  N +  S
Sbjct: 144 QELSVSDNQLASLPAL---PSELCKLWAYNNQLT-SLPMLPSG---LQELSVSDNQLA-S 195

Query: 222 IPSALGNCHQLQSLDLSKTIFLGQYP-VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKN 280
           +P+     ++L + +   T        ++ L +S N LT  +P+    LK    L +S N
Sbjct: 196 LPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS-LPVLPSELKE---LMVSGN 251

Query: 281 KLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
           +L+  +P        L  L++  N     +   L  L S   ++L  N
Sbjct: 252 RLT-SLPMLPSG---LLSLSVYRNQLTR-LPESLIHLSSETTVNLEGN 294

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 74.5 bits (183), Expect = 4e-14
 Identities = 45/235 (19%), Positives = 77/235 (32%), Gaps = 39/235 (16%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
            L  L   ++  N  + ++P     L +L      +N L   +P+  +    L+ L +  
Sbjct: 142 GLQEL---SVSDNQLA-SLPALPSELCKLW---AYNNQLT-SLPMLPSG---LQELSVSD 190

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
           N+L        LP      L  +       N+   ++P   S    L+ L  + N LT S
Sbjct: 191 NQLAS------LPTLPS-ELYKLW---AYNNRL-TSLPALPSG---LKELIVSGNRLT-S 235

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGY 180
           +P        L  L  + N L +                 L   S+  N L  +P S+ +
Sbjct: 236 LPVLPS---ELKELMVSGNRLTS-------LPMLPSGLLSL---SVYRNQLTRLPESLIH 282

Query: 181 LPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSL 235
           L     ++L  N +S     +L   T     +        +  SA      L   
Sbjct: 283 LSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLA 337

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  116 bits (293), Expect = 6e-28
 Identities = 51/184 (27%), Positives = 89/184 (48%), Gaps = 20/184 (10%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITA 506
           + +G G +G VY+G+       VAVK L       ++ F+ E   ++ I+H NLV+++  
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
           C+    +   F  ++ EFM +G+L  +L           +   +S +  L +A  ++SA+
Sbjct: 285 CT----REPPFY-IITEFMTYGNLLDYLR--------ECNRQEVSAVVLLYMATQISSAM 331

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
           EYL    KK  +H +L   N L+  + +  V DFGL+R +         +  G K  + +
Sbjct: 332 EYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKW 385

Query: 627 AAPE 630
            APE
Sbjct: 386 TAPE 389

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  113 bits (285), Expect = 7e-28
 Identities = 39/165 (23%), Positives = 74/165 (44%), Gaps = 23/165 (13%)

Query: 449 IGTGSFGSVYKGILDPD----QTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVKI 503
           +G+G+FG+VYKG+  P+    +  VA+K L       A K  + E   + ++ + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
           +  C +S  Q      L+ + M  G L  ++     +         +     LN  + +A
Sbjct: 83  LGICLTSTVQ------LITQLMPFGCLLDYVREHKDN---------IGSQYLLNWCVQIA 127

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
             + YL     +++VH DL   NVL+       + DFGL + +  
Sbjct: 128 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  113 bits (284), Expect = 8e-28
 Identities = 49/165 (29%), Positives = 70/165 (42%), Gaps = 22/165 (13%)

Query: 449 IGTGSFGSVYKGILDPDQ----TVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVKI 503
           +G G FG V     DP       +VAVK L           +  E + LR + H +++K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
              C  +         LV E++  GSL  +L   S           +   Q L  A  + 
Sbjct: 99  KGCCEDAGAASL---QLVMEYVPLGSLRDYLPRHS-----------IGLAQLLLFAQQIC 144

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
             + YLH    +  +H DL   NVLLDND +  +GDFGL + +PE
Sbjct: 145 EGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  111 bits (281), Expect = 1e-27
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 21/162 (12%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G +G VY+G+       VAVK L   +   +  + F+ E   ++ I+H NLV+++  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
           C+    +   F  ++ EFM +G+L  +L           +   +S +  L +A  ++SA+
Sbjct: 78  CT----REPPF-YIITEFMTYGNLLDYLR--------ECNRQEVSAVVLLYMATQISSAM 124

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           EYL    KK  +H DL   N L+  + +  V DFGL+R +  
Sbjct: 125 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  112 bits (282), Expect = 2e-27
 Identities = 41/165 (24%), Positives = 75/165 (45%), Gaps = 23/165 (13%)

Query: 449 IGTGSFGSVYKGILDPD----QTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVKI 503
           +G+G FG+V+KG+  P+    +  V +KV+     R + ++      A+ ++ H ++V++
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
           +  C  S  Q      LV +++  GSL   +     +         L     LN  + +A
Sbjct: 81  LGLCPGSSLQ------LVTQYLPLGSLLDHVRQHRGA---------LGPQLLLNWGVQIA 125

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
             + YL    +  +VH +L   NVLL +     V DFG+   +P 
Sbjct: 126 KGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  112 bits (282), Expect = 2e-27
 Identities = 48/173 (27%), Positives = 79/173 (45%), Gaps = 24/173 (13%)

Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKI 503
           +G G+FG V+         + D+ +VAVK L      A + F  E E L  ++H+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 504 ITACSSSD--FQGNDFKALVYEFMHHGSLESWL-----HPESASDDLNYSPSILSFLQRL 556
              C+             +V+E+M HG L  +L       +  +   + +P  L   Q L
Sbjct: 109 FGVCTEGRPLL-------MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161

Query: 557 NIAINVASALEYL-HHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
            +A  VA+ + YL   H     VH DL   N L+   ++  +GDFG++R I  
Sbjct: 162 AVASQVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 210

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  112 bits (281), Expect = 3e-27
 Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 14/164 (8%)

Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G GSFG VY+G+      D  +T VA+K +           F+ E   ++     ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++   S    QG     ++ E M  G L+S+L     +   N   +  S  + + +A  +
Sbjct: 93  LLGVVS----QGQPT-LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           A  + YL+     + VH DL   N ++  D    +GDFG+TR I
Sbjct: 148 ADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 188

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  111 bits (279), Expect = 3e-27
 Identities = 45/164 (27%), Positives = 73/164 (44%), Gaps = 20/164 (12%)

Query: 447 NLIGTGSFGSVYKGIL---DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG VY G L   D  +   AVK L  +   G +  F+ E   +++  H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++  C  S+        +V  +M HG L +++  E+ +          +    +   + V
Sbjct: 91  LLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHN---------PTVKDLIGFGLQV 137

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           A  ++YL     K+ VH DL   N +LD      V DFGL R +
Sbjct: 138 AKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  114 bits (287), Expect = 3e-27
 Identities = 67/298 (22%), Positives = 117/298 (39%), Gaps = 27/298 (9%)

Query: 42  QIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSI 101
            +P  +   +E R LDL  N+++       L      + P++    L  N      P + 
Sbjct: 25  AVPEGI--PTETRLLDLGKNRIKT------LNQDEFASFPHLEELELNENIVSAVEPGAF 76

Query: 102 SNASKLEWLDFANNSLTASIPED-LGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTY 160
           +N   L  L   +N L   IP      L NLT+L+ + N +        + L +L     
Sbjct: 77  NNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNL----- 130

Query: 161 LEIVSLNVNSLRSIPISV-GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIR 219
            + + +  N L  I       L  L+ L+L + N++     +L +   L  L LR  +I 
Sbjct: 131 -KSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN 189

Query: 220 GSIPSALGNCHQLQSLDLSKTIFLGQYP--------VRWLDLSHNHLTGPIPLAVGNLKS 271
                +    ++L+ L++S   +L            +  L ++H +LT    LAV +L  
Sbjct: 190 AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVY 249

Query: 272 IPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPG-LSSLKSLEGLDLFQN 328
           +  L+LS N +S    S L   + L+ + L        + P     L  L  L++  N
Sbjct: 250 LRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAV-VEPYAFRGLNYLRVLNVSGN 306

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  112 bits (283), Expect = 1e-26
 Identities = 68/314 (21%), Positives = 109/314 (34%), Gaps = 25/314 (7%)

Query: 29  LRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLL 88
            R +    N ++            L  L+L  N +        + P     L N+R   L
Sbjct: 34  TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS------AVEPGAFNNLFNLRTLGL 87

Query: 89  AGNQFFGNIPHSI-SNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVN 147
             N+    IP  + +  S L  LD + N +   +      L NL  L    NDL      
Sbjct: 88  RSNR-LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHR 146

Query: 148 DLRFLDSLVNCTYLEIVSLNVNSLRSIPISV-GYLPKLQVLSLFENNISGEIPSSLGNFT 206
               L+S      LE ++L   +L SIP     +L  L VL L   NI+     S     
Sbjct: 147 AFSGLNS------LEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLY 200

Query: 207 FLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKT--------IFLGQYPVRWLDLSHNHL 258
            L  L +       ++         L SL ++                 +R+L+LS+N +
Sbjct: 201 RLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPI 260

Query: 259 TGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGL-SSL 317
           +      +  L  +  + L   +L+   P +      L  LN+S N     +   +  S+
Sbjct: 261 STIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTT-LEESVFHSV 319

Query: 318 KSLEGLDLFQNTFQ 331
            +LE L L  N   
Sbjct: 320 GNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 96.7 bits (241), Expect = 2e-21
 Identities = 67/304 (22%), Positives = 112/304 (36%), Gaps = 45/304 (14%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEI-GRLFQLRYIIFNSNTLQGQIPVN-LTHCSELRTLDL 58
           +   L  + L +N  S  +       LF LR +   SN L+  IP+   T  S L  LD+
Sbjct: 54  SFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDI 111

Query: 59  VLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLT 118
             NK+        L  Y+   L N++   +  N        + S  + LE L     +LT
Sbjct: 112 SENKIVI------LLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT 165

Query: 119 ASIPEDLGRLRNLTRLNFARNDLGT------RKVNDLRFLD------------SLVNCTY 160
           +   E L  L  L  L     ++        +++  L+ L+            + +    
Sbjct: 166 SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLN 225

Query: 161 LEIVSLNVNSLRSIPISV-GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIR 219
           L  +S+   +L ++P     +L  L+ L+L  N IS    S L     L E+ L G  + 
Sbjct: 226 LTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA 285

Query: 220 GSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSK 279
                            +    F G   +R L++S N LT        ++ ++  L L  
Sbjct: 286 ----------------VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDS 329

Query: 280 NKLS 283
           N L+
Sbjct: 330 NPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 84.0 bits (208), Expect = 2e-17
 Identities = 40/176 (22%), Positives = 64/176 (36%), Gaps = 14/176 (7%)

Query: 163 IVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSI 222
            V  +     ++P  +    + ++L L +N I         +F  L EL L  N +    
Sbjct: 15  AVLCHRKRFVAVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVE 72

Query: 223 PSALGNCHQLQSLDLS--------KTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPH 274
           P A  N   L++L L           +F G   +  LD+S N +   +     +L ++  
Sbjct: 73  PGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKS 132

Query: 275 LDLSKNKLSGEIPS-SLGSCVGLEYLNLSINSFHGPIHPG-LSSLKSLEGLDLFQN 328
           L++  N L   I   +      LE L L   +    I    LS L  L  L L   
Sbjct: 133 LEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTS-IPTEALSHLHGLIVLRLRHL 186

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  109 bits (275), Expect = 8e-27
 Identities = 46/184 (25%), Positives = 91/184 (49%), Gaps = 26/184 (14%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G G FG V+ G  +   T VAVK L   ++G++   +F+AE   ++ ++H+ LV++   
Sbjct: 21  LGAGQFGEVWMGYYN-GHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +           ++ E+M +GSL  +L           S   L+  + L++A  +A  +
Sbjct: 77  VTQEPIY------IITEYMENGSLVDFLK--------TPSGIKLTINKLLDMAAQIAEGM 122

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            ++    ++  +H DL+ +N+L+ + +   + DFGL R I +   +   +  G K  + +
Sbjct: 123 AFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED---NEYTAREGAKFPIKW 176

Query: 627 AAPE 630
            APE
Sbjct: 177 TAPE 180

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  112 bits (283), Expect = 8e-27
 Identities = 43/186 (23%), Positives = 86/186 (46%), Gaps = 26/186 (13%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA--LKSFMAECEALRNIRHRNLVKII 504
             +G G FG V+    +   T VAVK +   + G+  +++F+AE   ++ ++H  LVK+ 
Sbjct: 194 KKLGAGQFGEVWMATYN-KHTKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLVKLH 249

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
              +           ++ EFM  GSL  +L         +   S     + ++ +  +A 
Sbjct: 250 AVVTKEPIY------IITEFMAKGSLLDFLK--------SDEGSKQPLPKLIDFSAQIAE 295

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            + ++    ++  +H DL+ +N+L+   ++  + DFGL R I +   +   +  G K  +
Sbjct: 296 GMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIED---NEYTAREGAKFPI 349

Query: 625 GYAAPE 630
            + APE
Sbjct: 350 KWTAPE 355

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  110 bits (276), Expect = 8e-27
 Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 20/164 (12%)

Query: 447 NLIGTGSFGSVYKGIL---DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG VY G       ++   A+K L  + +   +++F+ E   +R + H N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +I        +G     ++  +M HG L  ++     +          +    ++  + V
Sbjct: 87  LIGIMLPP--EGLPH--VLLPYMCHGDLLQFIRSPQRN---------PTVKDLISFGLQV 133

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           A  +EYL    +++ VH DL   N +LD      V DFGL R I
Sbjct: 134 ARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDI 174

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  112 bits (281), Expect = 2e-26
 Identities = 50/186 (26%), Positives = 85/186 (45%), Gaps = 26/186 (13%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKS--FMAECEALRNIRHRNLVKII 504
             +G G FG V+ G      T VA+K L   + G +    F+ E + ++ +RH  LV++ 
Sbjct: 190 VKLGQGCFGEVWMGTW-NGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 245

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
              S           +V E+M  GSL  +L           +   L   Q +++A  +AS
Sbjct: 246 AVVSEEPIY------IVTEYMSKGSLLDFLK--------GETGKYLRLPQLVDMAAQIAS 291

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            + Y+    +   VH DL+ +N+L+  +++  V DFGL R I +   +   +  G K  +
Sbjct: 292 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPI 345

Query: 625 GYAAPE 630
            + APE
Sbjct: 346 KWTAPE 351

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  108 bits (271), Expect = 2e-26
 Identities = 53/186 (28%), Positives = 83/186 (44%), Gaps = 30/186 (16%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +G+G FG V  G     Q  VAVK++   + G++    F  E + +  + H  LVK    
Sbjct: 16  LGSGQFGVVKLGKWK-GQYDVAVKMI---KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 507 CSSSD--FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
           CS     +       +V E++ +G L ++L               L   Q L +  +V  
Sbjct: 72  CSKEYPIY-------IVTEYISNGCLLNYLRSHGKG---------LEPSQLLEMCYDVCE 115

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            + +L      Q +H DL   N L+D D+   V DFG+TR++ +       SSVG K  V
Sbjct: 116 GMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD---DQYVSSVGTKFPV 169

Query: 625 GYAAPE 630
            ++APE
Sbjct: 170 KWSAPE 175

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  112 bits (281), Expect = 2e-26
 Identities = 52/184 (28%), Positives = 77/184 (41%), Gaps = 34/184 (18%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG G FG V  G        VAVK +        ++F+AE   +  +RH NLV+++    
Sbjct: 201 IGKGEFGDVMLGDYRG--NKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 256

Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
               +      +V E+M  GSL  +L         +   S+L     L  +++V  A+EY
Sbjct: 257 ----EEKGGLYIVTEYMAKGSLVDYLR--------SRGRSVLGGDCLLKFSLDVCEAMEY 304

Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI---------------PEVISSN 613
           L        VH DL   NVL+  D +A V DFGLT+                 PE +   
Sbjct: 305 LE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREK 361

Query: 614 QCSS 617
           + S+
Sbjct: 362 KFST 365

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  110 bits (277), Expect = 2e-26
 Identities = 44/164 (26%), Positives = 73/164 (44%), Gaps = 20/164 (12%)

Query: 447 NLIGTGSFGSVYKGIL---DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG VY G L   D  +   AVK L  +   G +  F+ E   +++  H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++  C  S+        +V  +M HG L +++  E+ +          +    +   + V
Sbjct: 155 LLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHN---------PTVKDLIGFGLQV 201

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           A  +++L     K+ VH DL   N +LD      V DFGL R +
Sbjct: 202 AKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  108 bits (273), Expect = 3e-26
 Identities = 39/165 (23%), Positives = 74/165 (44%), Gaps = 23/165 (13%)

Query: 449 IGTGSFGSVYKGILDPD----QTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVKI 503
           +G+G+FG+VYKG+  P+    +  VA+K L       A K  + E   + ++ + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
           +  C +S  Q      L+ + M  G L  ++     +         +     LN  + +A
Sbjct: 83  LGICLTSTVQ------LITQLMPFGCLLDYVREHKDN---------IGSQYLLNWCVQIA 127

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
             + YL     +++VH DL   NVL+       + DFGL + +  
Sbjct: 128 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  112 bits (282), Expect = 3e-26
 Identities = 54/323 (16%), Positives = 111/323 (34%), Gaps = 25/323 (7%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQG-------QIPVNLTHCSEL 53
           ++ +L L +     F  +          ++ + F  + L         ++   +   SE+
Sbjct: 197 SVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV 256

Query: 54  RTLDLVLNKLEE--NQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLD 111
              D  LN L +        +          IR   +     F ++    S   K++ + 
Sbjct: 257 EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRIT 316

Query: 112 FANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSL 171
             N+ +          L++L  L+ + N +    + +     +  +   L+ + L+ N L
Sbjct: 317 VENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPS---LQTLVLSQNHL 373

Query: 172 RSIPISVGY---LPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGN 228
           RS+  +      L  L  L +  N     +P S      +  LNL    IR  + +    
Sbjct: 374 RSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT--CI 429

Query: 229 CHQLQSLDLS----KTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSG 284
              L+ LD+S     +  L    ++ L +S N L   +P        +  + +S+N+L  
Sbjct: 430 PQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKT-LP-DASLFPVLLVMKISRNQLKS 487

Query: 285 EIPSSLGSCVGLEYLNLSINSFH 307
                      L+ + L  N + 
Sbjct: 488 VPDGIFDRLTSLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  108 bits (271), Expect = 6e-25
 Identities = 47/377 (12%), Positives = 112/377 (29%), Gaps = 47/377 (12%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
               L ++ L+ +  +         L  L ++  + N L           S L+ L+L+ 
Sbjct: 48  ACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMG 107

Query: 61  NKLEE--------------------NQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHS 100
           N  +                      +   E+       L ++    +           S
Sbjct: 108 NPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQS 167

Query: 101 ISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSL--VNC 158
           + +   +  L    +     +      L ++  L     +L   + + L   +    +  
Sbjct: 168 LKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK 227

Query: 159 TYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTF----------- 207
                  L   S   +   + Y+ +L  +   +  ++G    +                 
Sbjct: 228 LAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVT 287

Query: 208 LTELNLRGNSIRGSIPSALGNCHQLQSLDLSKT--------IFLGQYPVRWLDLSHNHLT 259
           +  L++    +   + +      +++ + +  +               + +LDLS N + 
Sbjct: 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347

Query: 260 ---GPIPLAVGNLKSIPHLDLSKNKLS--GEIPSSLGSCVGLEYLNLSINSFHGPIHPGL 314
                     G   S+  L LS+N L    +    L +   L  L++S N+FH P+    
Sbjct: 348 EEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSC 406

Query: 315 SSLKSLEGLDLFQNTFQ 331
              + +  L+L     +
Sbjct: 407 QWPEKMRFLNLSSTGIR 423

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  100 bits (250), Expect = 3e-22
 Identities = 55/333 (16%), Positives = 110/333 (33%), Gaps = 19/333 (5%)

Query: 2   LTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVN-LTHCSELRTLDLVL 60
              +  ++L  N  +     ++     L+ +I  S+ +   I  +       L  LDL  
Sbjct: 25  TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSD 83

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFG-NIPHSISNASKLEWLDFANNSLTA 119
           N L        L       L +++   L GN +    +     N + L+ L   N    +
Sbjct: 84  NHLS------SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFS 137

Query: 120 SIPE-DLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIP-IS 177
            I   D   L +L  L      L   +   L+ +        +  ++L+++    +  I 
Sbjct: 138 EIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSI------RDIHHLTLHLSESAFLLEIF 191

Query: 178 VGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQS--L 235
              L  ++ L L + N++    S L      + +             +     +L    L
Sbjct: 192 ADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL 251

Query: 236 DLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVG 295
           +LS+  F         D + +       L      +I  L + +  L  ++ +       
Sbjct: 252 ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK 311

Query: 296 LEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
           ++ + +  +            LKSLE LDL +N
Sbjct: 312 VKRITVENSKVFLVPCSFSQHLKSLEFLDLSEN 344

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 90.2 bits (224), Expect = 4e-19
 Identities = 46/246 (18%), Positives = 78/246 (31%), Gaps = 19/246 (7%)

Query: 97  IPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLV 156
           IP  ++  + ++ LD + N +T     DL    NL  L    + + T + +    L    
Sbjct: 20  IPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSL---- 73

Query: 157 NCTYLEIVSLNVNSLRSIPISV-GYLPKLQVLSLFENNISG-EIPSSLGNFTFLTELNLR 214
               LE + L+ N L S+  S  G L  L+ L+L  N      + S   N T L  L + 
Sbjct: 74  --GSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIG 131

Query: 215 GNSIRGSIP-SALGNCHQLQSLDLS--------KTIFLGQYPVRWLDLSHNHLTGPIPLA 265
                  I          L  L++                  +  L L  +     + + 
Sbjct: 132 NVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIF 191

Query: 266 VGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDL 325
              L S+ +L+L    L+    S L        +               + L  L    L
Sbjct: 192 ADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL 251

Query: 326 FQNTFQ 331
             +  +
Sbjct: 252 ELSEVE 257

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 88.6 bits (220), Expect = 1e-18
 Identities = 48/224 (21%), Positives = 81/224 (36%), Gaps = 26/224 (11%)

Query: 110 LDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVN 169
            D  + S T SIP  L     +  L+ + N +      DLR       C  L+++ L  +
Sbjct: 10  CDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLR------ACANLQVLILKSS 60

Query: 170 SLRSIPISV-GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRG-SIPSALG 227
            + +I       L  L+ L L +N++S    S  G  + L  LNL GN  +   + S   
Sbjct: 61  RINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFP 120

Query: 228 NCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIP 287
           N   LQ+L +                +    +    +    L S+  L++    L     
Sbjct: 121 NLTNLQTLRIG---------------NVETFSEIRRIDFAGLTSLNELEIKALSLRNYQS 165

Query: 288 SSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQ 331
            SL S   + +L L ++     +      L S+  L+L      
Sbjct: 166 QSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLA 209

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 86.7 bits (215), Expect = 5e-18
 Identities = 36/184 (19%), Positives = 62/184 (33%), Gaps = 14/184 (7%)

Query: 156 VNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRG 215
           ++C    +      S  SIP  +     ++ L L  N I+      L     L  L L+ 
Sbjct: 2   LSCDASGVCDGRSRSFTSIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59

Query: 216 NSIRGSIPSALGNCHQLQSLDLS--------KTIFLGQYPVRWLDLSHNHLTG-PIPLAV 266
           + I      A  +   L+ LDLS         + F     +++L+L  N      +    
Sbjct: 60  SRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLF 119

Query: 267 GNLKSIPHLDLSKNKLSGEIP-SSLGSCVGLEYLNLSINSFHGPIHPG-LSSLKSLEGLD 324
            NL ++  L +   +   EI          L  L +   S         L S++ +  L 
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN-YQSQSLKSIRDIHHLT 178

Query: 325 LFQN 328
           L  +
Sbjct: 179 LHLS 182

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  111 bits (279), Expect = 3e-26
 Identities = 53/335 (15%), Positives = 105/335 (31%), Gaps = 57/335 (17%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           + TFL       +N +  +P E   +          +  +   P            ++ +
Sbjct: 9   SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGN-----GEQREMAV 62

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
           ++L +                      L       ++P    +   LE L  + NSLT  
Sbjct: 63  SRLRDCL------------DRQAHELELNNLG-LSSLPELPPH---LESLVASCNSLT-E 105

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGY 180
           +PE    L++L   N     L                   LE + ++ N L  +P  +  
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSD-------------LPPLLEYLGVSNNQLEKLP-ELQN 151

Query: 181 LPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLS-- 238
              L+++ +  N++  ++P    +   L  +    N +   +P  L N   L ++     
Sbjct: 152 SSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNN 205

Query: 239 --KTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGL 296
             K +      +  +   +N L       + NL  +  +    N L   +P    S   L
Sbjct: 206 SLKKLPDLPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEAL 262

Query: 297 EYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQ 331
              +  +              +SL  LD+ +N F 
Sbjct: 263 NVRDNYLTDLP-------ELPQSLTFLDVSENIFS 290

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  108 bits (271), Expect = 4e-25
 Identities = 69/325 (21%), Positives = 125/325 (38%), Gaps = 57/325 (17%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           +L  L++ N      S   P        L Y+  ++N L+ ++P  L + S L+ +D+  
Sbjct: 112 SLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDN 162

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
           N L++      LP       P++       NQ        + N   L  +   NNSL   
Sbjct: 163 NSLKK------LPD----LPPSLEFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK-K 209

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGY 180
           +P+    L ++   N           N L  L  L N  +L  +  + N L+++P     
Sbjct: 210 LPDLPLSLESIVAGN-----------NILEELPELQNLPFLTTIYADNNLLKTLPDL--- 255

Query: 181 LPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSK- 239
            P L+ L++ +N ++ ++P    + TFL       + +    P+       L  L+ S  
Sbjct: 256 PPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPN-------LYYLNASSN 307

Query: 240 --TIFLGQYP-VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGL 296
                    P +  L++S+N L   +P     L+    L  S N L+ E+P    +   L
Sbjct: 308 EIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFNHLA-EVPELPQN---L 359

Query: 297 EYLNLSINSFHGPIHPGLSSLKSLE 321
           + L++  N           S++ L 
Sbjct: 360 KQLHVEYNPLRE-FPDIPESVEDLR 383

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  103 bits (258), Expect = 1e-23
 Identities = 49/258 (18%), Positives = 81/258 (31%), Gaps = 25/258 (9%)

Query: 78  FTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFA 137
            +   ++ PL   +     +P    N         A +    + P   G  R +      
Sbjct: 8   VSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLR 66

Query: 138 RNDLGTRKVNDLRF--LDSL-VNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNI 194
                     +L    L SL     +LE +  + NSL  +P     L  L V +     +
Sbjct: 67  DCLDRQAHELELNNLGLSSLPELPPHLESLVASCNSLTELPELPQSLKSLLVDNNNLKAL 126

Query: 195 SGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSK---TIFLGQYP-VRW 250
           S   P        L  L +  N +   +P  L N   L+ +D+            P + +
Sbjct: 127 SDLPPL-------LEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEF 177

Query: 251 LDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPI 310
           +   +N L     L   NL  +  +    N L  ++P    S   LE +    N      
Sbjct: 178 IAAGNNQLEELPEL--QNLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGNNILEEL- 230

Query: 311 HPGLSSLKSLEGLDLFQN 328
            P L +L  L  +    N
Sbjct: 231 -PELQNLPFLTTIYADNN 247

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 98.9 bits (247), Expect = 3e-22
 Identities = 63/330 (19%), Positives = 122/330 (36%), Gaps = 50/330 (15%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           N +FL +I++  N+    +P        L +I   +N L+ ++P  L +   L  +    
Sbjct: 151 NSSFLKIIDVDNNSLK-KLPDLPP---SLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADN 204

Query: 61  NKLEE---------------NQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNAS 105
           N L++               N L  E  P +   LP +       N     +P    +  
Sbjct: 205 NSLKKLPDLPLSLESIVAGNNIL--EELPELQ-NLPFLTTIYADNNLL-KTLPDLPPS-- 258

Query: 106 KLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVN-------- 157
            LE L+  +N LT  +PE    L  L       + L +    +L +L++  N        
Sbjct: 259 -LEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGL-SELPPNLYYLNASSNEIRSLCDL 315

Query: 158 CTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNS 217
              LE ++++ N L  +P      P+L+ L    N+++ E+P    N   L +L++  N 
Sbjct: 316 PPSLEELNVSNNKLIELPAL---PPRLERLIASFNHLA-EVPELPQN---LKQLHVEYNP 368

Query: 218 IRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDL 277
           +R   P    +   L+       +      ++ L +  N L    P    +++    L +
Sbjct: 369 LR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLRE-FPDIPESVE---DLRM 423

Query: 278 SKNKLSGEIPSSLGSCVGLEYLNLSINSFH 307
           +  ++      +  +   LE      +  H
Sbjct: 424 NSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  107 bits (269), Expect = 4e-26
 Identities = 49/158 (31%), Positives = 71/158 (44%), Gaps = 19/158 (12%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITA 506
             IG G FG V  G        VAVK +        ++F+AE   +  +RH NLV+++  
Sbjct: 27  QTIGKGEFGDVMLGDYRG--NKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 82

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
                 +      +V E+M  GSL  +L         +   S+L     L  +++V  A+
Sbjct: 83  IV----EEKGGLYIVTEYMAKGSLVDYLR--------SRGRSVLGGDCLLKFSLDVCEAM 130

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
           EYL        VH DL   NVL+  D +A V DFGLT+
Sbjct: 131 EYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  107 bits (269), Expect = 5e-26
 Identities = 42/163 (25%), Positives = 70/163 (42%), Gaps = 21/163 (12%)

Query: 449 IGTGSFGSVYKGILDPD--QTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVKIIT 505
           +G G+FGSV +G+      Q  VA+KVL    ++   +  M E + +  + +  +V++I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
            C +          LV E    G L  +L  +            +       +   V+  
Sbjct: 78  VCQAEALM------LVMEMAGGGPLHKFLVGKREE---------IPVSNVAELLHQVSMG 122

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           ++YL    +K  VH DL   NVLL N   A + DFGL++ +  
Sbjct: 123 MKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  106 bits (268), Expect = 7e-26
 Identities = 39/164 (23%), Positives = 67/164 (40%), Gaps = 23/164 (14%)

Query: 449 IGTGSFGSVYKGILDPD--QTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNLVKII 504
           +G+G+FG+V KG          VAVK+L    +        +AE   ++ + +  +V++I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             C +  +       LV E    G L  +L               +     + +   V+ 
Sbjct: 85  GICEAESWM------LVMEMAELGPLNKYLQ----------QNRHVKDKNIIELVHQVSM 128

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
            ++YL    +   VH DL   NVLL     A + DFGL++ +  
Sbjct: 129 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  107 bits (270), Expect = 7e-26
 Identities = 41/167 (24%), Positives = 72/167 (43%), Gaps = 31/167 (18%)

Query: 449 IGTGSFGSVYKGILDP---DQTVVAVKVLFLHQRGA----LKSFMAECEALRNIRHRNLV 501
           IG+G  G V  G L         VA+K L   + G      + F++E   +    H N++
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKAL---KAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 502 KIITACSSSD--FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           ++    +             +V E+M +GSL+++L                + +Q + + 
Sbjct: 114 RLEGVVTRGRLAM-------IVTEYMENGSLDTFLRTHDGQ---------FTIMQLVGML 157

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
             V + + YL        VH DL   NVL+D++++  V DFGL+R +
Sbjct: 158 RGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  107 bits (269), Expect = 8e-26
 Identities = 43/174 (24%), Positives = 74/174 (42%), Gaps = 26/174 (14%)

Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQRGA----LKSFMAECEALRNI-RHR 498
           +G G+FG V +              VAVK+L   + GA     ++ M+E + L +I  H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 91

Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWL------HPESASDDLNYSPSILSF 552
           N+V ++ AC+           ++ EF   G+L ++L               +     L+ 
Sbjct: 92  NVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147

Query: 553 LQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
              +  +  VA  +E+L     ++ +H DL   N+LL    +  + DFGL R I
Sbjct: 148 EHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDI 198

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  106 bits (267), Expect = 9e-26
 Identities = 43/164 (26%), Positives = 71/164 (43%), Gaps = 22/164 (13%)

Query: 449 IGTGSFGSVYKGILDPD---QTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVKII 504
           IG G FG V++GI          VA+K           + F+ E   +R   H ++VK+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
              + +         ++ E    G L S+L     S         L     +  A  +++
Sbjct: 83  GVITENPVW------IIMELCTLGELRSFLQVRKYS---------LDLASLILYAYQLST 127

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           AL YL     K+ VH D+   NVL+ ++    +GDFGL+R++ +
Sbjct: 128 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  106 bits (266), Expect = 9e-26
 Identities = 52/186 (27%), Positives = 84/186 (45%), Gaps = 30/186 (16%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           IG+G FG V+ G    ++  VA+K +   + GA+  + F+ E E +  + H  LV++   
Sbjct: 16  IGSGQFGLVHLGYWL-NKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 507 CSSSD--FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
           C              LV EFM HG L  +L  +             +    L + ++V  
Sbjct: 72  CLEQAPIC-------LVTEFMEHGCLSDYLRTQRGL---------FAAETLLGMCLDVCE 115

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            + YL    +  ++H DL   N L+  + +  V DFG+TRF+ +       SS G K  V
Sbjct: 116 GMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD---DQYTSSTGTKFPV 169

Query: 625 GYAAPE 630
            +A+PE
Sbjct: 170 KWASPE 175

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  106 bits (267), Expect = 1e-25
 Identities = 51/172 (29%), Positives = 76/172 (44%), Gaps = 25/172 (14%)

Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKI 503
           +G G+FG V+           D+ +VAVK L      A K F  E E L N++H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 504 ITACSSSD--FQGNDFKALVYEFMHHGSLESWL------HPESASDDLNYSPSILSFLQR 555
              C   D          +V+E+M HG L  +L                 +   L   Q 
Sbjct: 83  YGVCGDGDPLI-------MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135

Query: 556 LNIAINVASALEYL-HHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           L+IA  +AS + YL   H     VH DL   N L+  +++  +GDFG++R +
Sbjct: 136 LHIASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSRDV 183

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  110 bits (276), Expect = 1e-25
 Identities = 50/186 (26%), Positives = 86/186 (46%), Gaps = 26/186 (13%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKS--FMAECEALRNIRHRNLVKII 504
             +G G FG V+ G  +   T VA+K L   + G +    F+ E + ++ +RH  LV++ 
Sbjct: 273 VKLGQGCFGEVWMGTWN-GTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 328

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
              S           +V E+M  GSL  +L           +   L   Q +++A  +AS
Sbjct: 329 AVVSEEPIY------IVTEYMSKGSLLDFLK--------GETGKYLRLPQLVDMAAQIAS 374

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            + Y+    +   VH DL+ +N+L+  +++  V DFGL R I +   +   +  G K  +
Sbjct: 375 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPI 428

Query: 625 GYAAPE 630
            + APE
Sbjct: 429 KWTAPE 434

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  105 bits (265), Expect = 1e-25
 Identities = 53/186 (28%), Positives = 87/186 (46%), Gaps = 30/186 (16%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIITA 506
           +GTG FG V  G     Q  VA+K++   + G++    F+ E + + N+ H  LV++   
Sbjct: 32  LGTGQFGVVKYGKWR-GQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 507 CSSSD--FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
           C+     F       ++ E+M +G L ++L                   Q L +  +V  
Sbjct: 88  CTKQRPIF-------IITEYMANGCLLNYLREMRHR---------FQTQQLLEMCKDVCE 131

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
           A+EYL     KQ +H DL   N L+++  +  V DFGL+R++ +       SSVG K  V
Sbjct: 132 AMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---DEYTSSVGSKFPV 185

Query: 625 GYAAPE 630
            ++ PE
Sbjct: 186 RWSPPE 191

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  107 bits (268), Expect = 2e-25
 Identities = 49/171 (28%), Positives = 76/171 (44%), Gaps = 24/171 (14%)

Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G G+FG VY+G +     DP    VAVK L  +        F+ E   +    H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 503 IITACSSSD--FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
            I     S   F       ++ E M  G L+S+L     +      PS L+ L  L++A 
Sbjct: 98  CIGVSLQSLPRF-------ILMELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLHVAR 147

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDN---DMIAHVGDFGLTRFIPE 608
           ++A   +YL    +   +H D+   N LL       +A +GDFG+ R I  
Sbjct: 148 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 195

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  107 bits (270), Expect = 2e-25
 Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 28/189 (14%)

Query: 449 IGTGSFGSVYKGIL---DPDQTVVAVKVL----FLHQRGALKSFMAECEALRNIRHRNLV 501
           +G G FG V  G L      +  VA+K L       QR   + F+ E   +    H N++
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR---RDFLGEASIMGQFDHPNII 109

Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           ++    + S         +V E+M +GSL+S+L    A           + +Q + +   
Sbjct: 110 RLEGVVTKSKPV-----MIVTEYMENGSLDSFLRKHDAQ---------FTVIQLVGMLRG 155

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           +AS ++YL        VH DL   N+L++++++  V DFGL R + E       ++ G K
Sbjct: 156 IASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVL-EDDPEAAYTTRGGK 211

Query: 622 GTVGYAAPE 630
             + + +PE
Sbjct: 212 IPIRWTSPE 220

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  105 bits (264), Expect = 2e-25
 Identities = 41/164 (25%), Positives = 71/164 (43%), Gaps = 22/164 (13%)

Query: 449 IGTGSFGSVYKGIL---DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVKII 504
           +G G FG VY+G+      ++  VAVK           + FM+E   ++N+ H ++VK+I
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
                          ++ E   +G L  +L     S         L  L  +  ++ +  
Sbjct: 80  GIIEEEPTW------IIMELYPYGELGHYLERNKNS---------LKVLTLVLYSLQICK 124

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           A+ YL        VH D+   N+L+ +     +GDFGL+R+I +
Sbjct: 125 AMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  106 bits (267), Expect = 2e-25
 Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 18/168 (10%)

Query: 447 NLIGTGSFGSVYKGILDPDQ--TVVAVKVL-FLHQRGALKSFMAECEALRNI-RHRNLVK 502
           ++IG G+FG V K  +  D      A+K +     +   + F  E E L  +  H N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWL------HPESASDDLNYSPSILSFLQRL 556
           ++ AC    +       L  E+  HG+L  +L        + A    N + S LS  Q L
Sbjct: 91  LLGACEHRGYL-----YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
           + A +VA  ++YL    +KQ +H DL   N+L+  + +A + DFGL+R
Sbjct: 146 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  106 bits (267), Expect = 2e-25
 Identities = 50/192 (26%), Positives = 86/192 (44%), Gaps = 33/192 (17%)

Query: 449 IGTGSFGSVYKGIL----DPDQTVVAVKVL----FLHQRGALKSFMAECEALRNIRHRNL 500
           IG G FG VYKG+L       +  VA+K L       QR     F+ E   +    H N+
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR---VDFLGEAGIMGQFSHHNI 108

Query: 501 VKIITACSSSD--FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           +++    S             ++ E+M +G+L+ +L  +             S LQ + +
Sbjct: 109 IRLEGVISKYKPMM-------IITEYMENGALDKFLREKDGE---------FSVLQLVGM 152

Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
              +A+ ++YL        VH DL   N+L++++++  V DFGL+R + E       ++ 
Sbjct: 153 LRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEATYTTS 208

Query: 619 GLKGTVGYAAPE 630
           G K  + + APE
Sbjct: 209 GGKIPIRWTAPE 220

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  106 bits (266), Expect = 2e-25
 Identities = 42/180 (23%), Positives = 75/180 (41%), Gaps = 32/180 (17%)

Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G G FG V K            T VAVK+L        L+  ++E   L+ + H +++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 503 IITACSSSD--FQGNDFKALVYEFMHHGSLESWL--------------HPESASDDLNYS 546
           +  ACS             L+ E+  +GSL  +L                 ++S   +  
Sbjct: 91  LYGACSQDGPLL-------LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143

Query: 547 PSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
              L+    ++ A  ++  ++YL    + ++VH DL   N+L+       + DFGL+R +
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  106 bits (267), Expect = 2e-25
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 25/174 (14%)

Query: 447 NLIGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQRGA----LKSFMAECEALRNI-R 496
             +G G+FG V +        +     VAVK+L   +  A     ++ M+E + + ++ +
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML---KSTAHADEKEALMSELKIMSHLGQ 108

Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWL----HPESASDDLNYSPSILSF 552
           H N+V ++ AC+     G     ++ E+  +G L ++L               + S  S 
Sbjct: 109 HENIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163

Query: 553 LQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
              L+ +  VA  + +L     K  +H D+   NVLL N  +A +GDFGL R I
Sbjct: 164 RDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 214

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  105 bits (265), Expect = 3e-25
 Identities = 42/178 (23%), Positives = 74/178 (41%), Gaps = 33/178 (18%)

Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQRGA----LKSFMAECEALRNI-RHR 498
           +G G+FG V +              VAVK+L   +  A     ++ M+E + L  +  H 
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKML---KPSAHLTEREALMSELKVLSYLGNHM 87

Query: 499 NLVKIITACSSSD--FQGNDFKALVYEFMHHGSLESWL--------HPESASDDLNYSPS 548
           N+V ++ AC+             ++ E+  +G L ++L          +++   +     
Sbjct: 88  NIVNLLGACTIGGPTL-------VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 549 ILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
            L     L+ +  VA  + +L     K  +H DL   N+LL +  I  + DFGL R I
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDI 195

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  104 bits (263), Expect = 3e-25
 Identities = 42/173 (24%), Positives = 70/173 (40%), Gaps = 26/173 (15%)

Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G   FG VYKG L           VA+K L    +    + F  E      ++H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76

Query: 503 IITACSSSD--FQGNDFKALVYEFMHHGSLESWLH------PESASDDLNYSPSILSFLQ 554
           ++   +             +++ +  HG L  +L          ++DD     S L    
Sbjct: 77  LLGVVTKDQPLS-------MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129

Query: 555 RLNIAINVASALEYL-HHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
            +++   +A+ +EYL  HH     VH DL   NVL+ + +   + D GL R +
Sbjct: 130 FVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREV 178

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  109 bits (273), Expect = 3e-25
 Identities = 41/163 (25%), Positives = 70/163 (42%), Gaps = 21/163 (12%)

Query: 449 IGTGSFGSVYKGILDPD--QTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVKIIT 505
           +G G+FGSV +G+      Q  VA+KVL    ++   +  M E + +  + +  +V++I 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
            C +          LV E    G L  +L  +            +       +   V+  
Sbjct: 404 VCQAEALM------LVMEMAGGGPLHKFLVGKREE---------IPVSNVAELLHQVSMG 448

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPE 608
           ++YL    +K  VH +L   NVLL N   A + DFGL++ +  
Sbjct: 449 MKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  106 bits (267), Expect = 4e-25
 Identities = 50/172 (29%), Positives = 77/172 (44%), Gaps = 26/172 (15%)

Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G G+FG VY+G +     DP    VAVK L  +        F+ E   +    H+N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 503 IITACSSSD--FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
            I     S   F       ++ E M  G L+S+L     +      PS L+ L  L++A 
Sbjct: 139 CIGVSLQSLPRF-------ILLELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLHVAR 188

Query: 561 NVASALEYL-HHHCKKQIVHCDLKPSNVLLDN---DMIAHVGDFGLTRFIPE 608
           ++A   +YL  +H     +H D+   N LL       +A +GDFG+ R I  
Sbjct: 189 DIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 236

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  103 bits (260), Expect = 8e-25
 Identities = 52/199 (26%), Positives = 84/199 (42%), Gaps = 26/199 (13%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG-ALKSFMAECEALRNIRHRNLVK---- 502
            +G G FG V++     D    A+K + L  R  A +  M E +AL  + H  +V+    
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 503 IITACSSSDFQGNDFKALVY---EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
            +   ++   Q +  K  +Y   +     +L+ W++     ++   S  +  FLQ     
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ----- 126

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI--------PEVIS 611
             +A A+E+LH    K ++H DLKPSN+    D +  VGDFGL   +             
Sbjct: 127 --IAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 612 SNQCSSVGLKGTVGYAAPE 630
                  G  GT  Y +PE
Sbjct: 182 PAYARHTGQVGTKLYMSPE 200

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  107 bits (269), Expect = 9e-25
 Identities = 58/308 (18%), Positives = 102/308 (33%), Gaps = 50/308 (16%)

Query: 7   LINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHC--SELRTLDLVLNKLE 64
           L      N       +    +            + +    L  C  ++   L L    L 
Sbjct: 13  LSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLS 72

Query: 65  ENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPED 124
                  LP  +    P I +  +  N    ++P   ++   LE+LD  +N L+ ++PE 
Sbjct: 73  S------LPDNLP---PQITVLEITQNAL-ISLPELPAS---LEYLDACDNRLS-TLPEL 118

Query: 125 LGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKL 184
              L++L   N           N L  L  L     LE ++ + N L  +P        L
Sbjct: 119 PASLKHLDVDN-----------NQLTMLPELP--ALLEYINADNNQLTMLPEL---PTSL 162

Query: 185 QVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLG 244
           +VLS+  N ++  +P    +   L  L++  N +  S+P+     H  +  ++       
Sbjct: 163 EVLSVRNNQLT-FLPELPES---LEALDVSTNLLE-SLPAVPVRNHHSEETEI------- 210

Query: 245 QYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSIN 304
                +     N +T  IP  + +L     + L  N LS  I  SL         +    
Sbjct: 211 -----FFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRI 264

Query: 305 SFHGPIHP 312
            F      
Sbjct: 265 YFSMSDGQ 272

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 98.9 bits (246), Expect = 6e-22
 Identities = 47/292 (16%), Positives = 86/292 (29%), Gaps = 41/292 (14%)

Query: 50  CSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNA--SKL 107
                   L  N    N +                   L G          +     ++ 
Sbjct: 5   LPINNNFSLSQN-SFYNTIS-GTYADYFSAWDKWEKQALPGENR-NEAVSLLKECLINQF 61

Query: 108 EWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLN 167
             L     +L+ S+P++L     +T L   +N L +         +   +  YL+     
Sbjct: 62  SELQLNRLNLS-SLPDNLPP--QITVLEITQNALIS-------LPELPASLEYLD---AC 108

Query: 168 VNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALG 227
            N L ++P        L+ L +  N ++  +P        L  +N   N +   +P    
Sbjct: 109 DNRLSTLPEL---PASLKHLDVDNNQLT-MLPELPAL---LEYINADNNQLT-MLPELPT 160

Query: 228 NCHQLQSLDLSKTIFLGQYPV-----RWLDLSHNHLTGPIPLAVGNLKSIP----HLDLS 278
           +   L+ L +     L   P        LD+S N L   +P                   
Sbjct: 161 S---LEVLSVRNN-QLTFLPELPESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCR 215

Query: 279 KNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTF 330
           +N+++  IP ++ S      + L  N     I   LS   +       +  F
Sbjct: 216 ENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 81.2 bits (200), Expect = 3e-16
 Identities = 50/276 (18%), Positives = 85/276 (30%), Gaps = 48/276 (17%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
                 L    +N     +      + Q   +  N   L   +P NL    ++  L++  
Sbjct: 35  KWEKQALPGENRNEAVSLLK--ECLINQFSELQLNRLNLS-SLPDNL--PPQITVLEITQ 89

Query: 61  NKLEE---------------NQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNAS 105
           N L                 N+L   LP        +++   +  NQ    +P   +   
Sbjct: 90  NALISLPELPASLEYLDACDNRLS-TLPELPA----SLKHLDVDNNQL-TMLPELPAL-- 141

Query: 106 KLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVS 165
            LE+++  NN LT  +PE    L  L+  N           N L FL  L     LE + 
Sbjct: 142 -LEYINADNNQLT-MLPELPTSLEVLSVRN-----------NQLTFLPELPES--LEALD 186

Query: 166 LNVNSLRSIPISVGYLPKLQ----VLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGS 221
           ++ N L S+P         +         EN I+  IP ++ +      + L  N +   
Sbjct: 187 VSTNLLESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSR 245

Query: 222 IPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNH 257
           I  +L            +  F      +        
Sbjct: 246 IRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLA 281

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 35/213 (16%), Positives = 62/213 (29%), Gaps = 31/213 (14%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           +L  L   ++  N  +  +P        L YI  ++N L   +P   T    L  L +  
Sbjct: 121 SLKHL---DVDNNQLT-MLPELPA---LLEYINADNNQLT-MLPELPTS---LEVLSVRN 169

Query: 61  NKLEE---------------NQLVGELPPYIG--FTLPNIRIPL-LAGNQFFGNIPHSIS 102
           N+L                 N L   LP             I      N+   +IP +I 
Sbjct: 170 NQLTFLPELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRI-THIPENIL 227

Query: 103 NASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLE 162
           +      +   +N L++ I E L +       +  R                L +     
Sbjct: 228 SLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAW 287

Query: 163 IVSLNVNSLRSIPISVGYLPKLQVLSLFENNIS 195
                 + +  I  +  +       S F + +S
Sbjct: 288 FPENKQSDVSQIWHAFEHEEHANTFSAFLDRLS 320

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  104 bits (262), Expect = 1e-24
 Identities = 47/181 (25%), Positives = 75/181 (41%), Gaps = 34/181 (18%)

Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
           IG G+FG V++            T+VAVK+L           F  E   +    + N+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 503 IITACSSSD--FQGNDFKALVYEFMHHGSLESWL--------------HPESASDDLNYS 546
           ++  C+             L++E+M +G L  +L                 + +   +  
Sbjct: 115 LLGVCAVGKPMC-------LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167

Query: 547 PSILSFLQRLNIAINVASALEYLH-HHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF 605
           P  LS  ++L IA  VA+ + YL         VH DL   N L+  +M+  + DFGL+R 
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGLSRN 223

Query: 606 I 606
           I
Sbjct: 224 I 224

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  103 bits (260), Expect = 1e-24
 Identities = 39/188 (20%), Positives = 73/188 (38%), Gaps = 15/188 (7%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITAC 507
            +G G F  V       D    A+K +  H++   +    E +  R   H N+++++  C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
                  ++   L+  F   G+L + +       +       L+  Q L + + +   LE
Sbjct: 96  LRERGAKHEAW-LLLPFFKRGTLWNEIERLKDKGNF------LTEDQILWLLLGICRGLE 148

Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK-----G 622
            +H    K   H DLKP+N+LL ++    + D G        +  ++ +           
Sbjct: 149 AIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205

Query: 623 TVGYAAPE 630
           T+ Y APE
Sbjct: 206 TISYRAPE 213

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  104 bits (261), Expect = 1e-24
 Identities = 42/178 (23%), Positives = 78/178 (43%), Gaps = 33/178 (18%)

Query: 449 IGTGSFGSVYKGIL-------DPDQTVVAVKVLFLHQRGA----LKSFMAECEALRNI-R 496
           +G G+FG V              +   VAVK+L   +  A    L   ++E E ++ I +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMIGK 99

Query: 497 HRNLVKIITACSSSD--FQGNDFKALVYEFMHHGSLESWL------HPESASDDLNYSPS 548
           H+N++ ++ AC+     +       ++ E+   G+L  +L        E + D       
Sbjct: 100 HKNIINLLGACTQDGPLY-------VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152

Query: 549 ILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
            ++F   ++    +A  +EYL     ++ +H DL   NVL+  + +  + DFGL R I
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  103 bits (260), Expect = 2e-24
 Identities = 62/284 (21%), Positives = 97/284 (34%), Gaps = 42/284 (14%)

Query: 81  PNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARND 140
           P+  +  L  N+          N   L  L   NN ++   P     L  L RL  ++N 
Sbjct: 52  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111

Query: 141 LGTRKVNDLRFLDSL---------------VNCTYLEIVSLNVNSLRSIPISVGY---LP 182
           L        + L  L                    + +V L  N L+S  I  G    + 
Sbjct: 112 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 171

Query: 183 KLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPS-ALGNCHQLQSLDLS--- 238
           KL  + + + NI+  IP  L     LTEL+L GN I   + + +L   + L  L LS   
Sbjct: 172 KLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNS 227

Query: 239 -----KTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSS---- 289
                         +R L L++N L   +P  + + K I  + L  N +S  I S+    
Sbjct: 228 ISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS-AIGSNDFCP 285

Query: 290 ---LGSCVGLEYLNLSINSF-HGPIHPGL-SSLKSLEGLDLFQN 328
                       ++L  N   +  I P     +     + L   
Sbjct: 286 PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 94.3 bits (235), Expect = 3e-21
 Identities = 57/290 (19%), Positives = 106/290 (36%), Gaps = 42/290 (14%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           NL  L  + L  N  S   P     L +L  +  + N L+ ++P  +     L+ L +  
Sbjct: 74  NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHE 130

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQF-FGNIPHSI-SNASKLEWLDFANNSLT 118
           N++ +      +   +   L  + +  L  N      I +       KL ++  A+ ++T
Sbjct: 131 NEITK------VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184

Query: 119 ASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISV 178
            +IP+ L    +LT L+   N +   KV+      SL     L  + L+ NS+ ++    
Sbjct: 185 -TIPQGL--PPSLTELHLDGNKI--TKVDA----ASLKGLNNLAKLGLSFNSISAVDNGS 235

Query: 179 -GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSA----LGNCHQLQ 233
               P L+ L L  N +  ++P  L +  ++  + L  N+I  +I S      G   +  
Sbjct: 236 LANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKA 293

Query: 234 SLDLSKTIFLGQYPVRWLDLSHNHLTGPI--PLAVGNLKSIPHLDLSKNK 281
           S                + L  N +      P     +     + L   K
Sbjct: 294 SY-------------SGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 73.5 bits (181), Expect = 3e-14
 Identities = 42/180 (23%), Positives = 65/180 (36%), Gaps = 13/180 (7%)

Query: 157 NCT-YLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRG 215
            C  +L +V  +   L  +P  +   P   +L L  N I+        N   L  L L  
Sbjct: 28  RCQCHLRVVQCSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILIN 85

Query: 216 NSIRGSIPSALGNCHQLQSLDLS----KTIFLGQYP-VRWLDLSHNHLTGPIPLAVGNLK 270
           N I    P A     +L+ L LS    K +       ++ L +  N +T         L 
Sbjct: 86  NKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLN 145

Query: 271 SIPHLDLSKNKL-SGEIPS-SLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
            +  ++L  N L S  I + +      L Y+ ++  +    I  GL    SL  L L  N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGN 202

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  102 bits (256), Expect = 2e-24
 Identities = 49/195 (25%), Positives = 79/195 (40%), Gaps = 31/195 (15%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITA 506
            LIG+G FG V+K     D     +K +  +   A +    E +AL  + H N+V     
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVHYNGC 72

Query: 507 --------CSSSDFQGNDFKALVY---EFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
                    +SS          ++   EF   G+LE W+               L  +  
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--------KRRGEKLDKVLA 124

Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
           L +   +   ++Y+H    K++++ DLKPSN+ L +     +GDFGL   +      N  
Sbjct: 125 LELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-----KNDG 176

Query: 616 SSVGLKGTVGYAAPE 630
                KGT+ Y +PE
Sbjct: 177 KRTRSKGTLRYMSPE 191

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  104 bits (261), Expect = 2e-24
 Identities = 48/176 (27%), Positives = 79/176 (44%), Gaps = 29/176 (16%)

Query: 449 IGTGSFGSVYKGIL-------DPDQTVVAVKVLFLHQRGA----LKSFMAECEALRNI-R 496
           +G G+FG V                T VAVK+L   +  A    L   ++E E ++ I +
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML---KSDATEKDLSDLISEMEMMKMIGK 133

Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWL------HPESASDDLNYSPSIL 550
           H+N++ ++ AC+    Q      ++ E+   G+L  +L        E + +  +     L
Sbjct: 134 HKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           S    ++ A  VA  +EYL     K+ +H DL   NVL+  D +  + DFGL R I
Sbjct: 189 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 241

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  103 bits (260), Expect = 3e-24
 Identities = 42/178 (23%), Positives = 77/178 (43%), Gaps = 33/178 (18%)

Query: 449 IGTGSFGSVYKGIL-------DPDQTVVAVKVLFLHQRGA----LKSFMAECEALRNI-R 496
           +G G FG V              +   VAVK+L   +  A    L   ++E E ++ I +
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMIGK 145

Query: 497 HRNLVKIITACSSSD--FQGNDFKALVYEFMHHGSLESWL------HPESASDDLNYSPS 548
           H+N++ ++ AC+     +       ++ E+   G+L  +L        E + D       
Sbjct: 146 HKNIINLLGACTQDGPLY-------VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198

Query: 549 ILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
            ++F   ++    +A  +EYL     ++ +H DL   NVL+  + +  + DFGL R I
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI 253

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  102 bits (256), Expect = 4e-24
 Identities = 44/188 (23%), Positives = 76/188 (40%), Gaps = 27/188 (14%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--GALKSFMAECEALRNIRHRNL--VK 502
             IG+G    V++  L+  + + A+K + L +     L S+  E   L  ++  +   ++
Sbjct: 34  KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +           + +  +V E   +  L SWL         +  P             N+
Sbjct: 93  LYDY-----EITDQYIYMVMEC-GNIDLNSWLK-----KKKSIDPWERKS-----YWKNM 136

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
             A+  +H H    IVH DLKP+N L+ + M+  + DFG+   +    +S    S    G
Sbjct: 137 LEAVHTIHQH---GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS--QVG 190

Query: 623 TVGYAAPE 630
           TV Y  PE
Sbjct: 191 TVNYMPPE 198

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  102 bits (255), Expect = 4e-24
 Identities = 47/201 (23%), Positives = 83/201 (41%), Gaps = 31/201 (15%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITA- 506
           ++G G+FG V K     D    A+K +   +   L + ++E   L ++ H+ +V+   A 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNHQYVVRYYAAW 71

Query: 507 ----CSSSDFQGNDFKALVY---EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
                          K+ ++   E+  +G+L   +H E+ +   +    +  F Q     
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL--FRQ----- 124

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             +  AL Y+H    + I+H DLKP N+ +D      +GDFGL + +   +   +  S  
Sbjct: 125 --ILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 620 LK----------GTVGYAAPE 630
           L           GT  Y A E
Sbjct: 180 LPGSSDNLTSAIGTAMYVATE 200

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  102 bits (257), Expect = 5e-24
 Identities = 46/183 (25%), Positives = 79/183 (43%), Gaps = 38/183 (20%)

Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQRGA----LKSFMAECEALRNI-RHR 498
           +G+G+FG V                VAVK+L   +  A     ++ M+E + +  +  H 
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKML---KEKADSSEREALMSELKMMTQLGSHE 109

Query: 499 NLVKIITACSSSD--FQGNDFKALVYEFMHHGSLESWL-------------HPESASDDL 543
           N+V ++ AC+ S   +       L++E+  +G L ++L             +      + 
Sbjct: 110 NIVNLLGACTLSGPIY-------LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162

Query: 544 NYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT 603
               ++L+F   L  A  VA  +E+L     K  VH DL   NVL+ +  +  + DFGL 
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLA 219

Query: 604 RFI 606
           R I
Sbjct: 220 RDI 222

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  102 bits (255), Expect = 5e-24
 Identities = 50/248 (20%), Positives = 89/248 (35%), Gaps = 21/248 (8%)

Query: 97  IPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLV 156
           +P  I   S    L+  +N L +       +L  LT+L+ + N L  +            
Sbjct: 22  VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDF---- 75

Query: 157 NCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSS--LGNFTFLTELNLR 214
             T L+ + L+ N + ++  +   L +L+ L    +N+  ++       +   L  L++ 
Sbjct: 76  GTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDIS 134

Query: 215 GNSIRGSIPSALGNCHQLQSLDLSK---------TIFLGQYPVRWLDLSHNHLTGPIPLA 265
               R +          L+ L ++           IF     + +LDLS   L    P A
Sbjct: 135 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 194

Query: 266 VGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGL--SSLKSLEGL 323
             +L S+  L++S N               L+ L+ S+N                SL  L
Sbjct: 195 FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT-SKKQELQHFPSSLAFL 253

Query: 324 DLFQNTFQ 331
           +L QN F 
Sbjct: 254 NLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 56/305 (18%), Positives = 91/305 (29%), Gaps = 60/305 (19%)

Query: 8   INLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQ 67
           I       + ++P  I        +   SN LQ          ++L  L L  N L    
Sbjct: 12  IRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS--- 65

Query: 68  LVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDL-G 126
                     F   +++   L+ N     +  +     +LE LDF +++L       +  
Sbjct: 66  -FKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 123

Query: 127 RLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISV-GYLPKLQ 185
            LRNL  L+                              ++    R     +   L  L+
Sbjct: 124 SLRNLIYLD------------------------------ISHTHTRVAFNGIFNGLSSLE 153

Query: 186 VLSLFENNISGEIPS-SLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLG 244
           VL +  N+               LT L+L    +   +     N   L SL         
Sbjct: 154 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNS--LSSL--------- 201

Query: 245 QYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSL--GSCVGLEYLNLS 302
               + L++SHN+           L S+  LD S N +               L +LNL+
Sbjct: 202 ----QVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLT 256

Query: 303 INSFH 307
            N F 
Sbjct: 257 QNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 29/145 (20%), Positives = 57/145 (39%), Gaps = 12/145 (8%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEI-GRLFQLRYIIFNSNTLQGQIPVN-LTHCSELRTLDL 58
           +L  L+ +++   +      + I   L  L  +    N+ Q     +  T    L  LDL
Sbjct: 124 SLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182

Query: 59  VLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLT 118
              +LE+      L P    +L ++++  ++ N FF          + L+ LD++ N + 
Sbjct: 183 SQCQLEQ------LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236

Query: 119 ASIPEDL--GRLRNLTRLNFARNDL 141
            +  +        +L  LN  +ND 
Sbjct: 237 -TSKKQELQHFPSSLAFLNLTQNDF 260

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  105 bits (264), Expect = 6e-24
 Identities = 44/194 (22%), Positives = 73/194 (37%), Gaps = 30/194 (15%)

Query: 448 LIGTGSFGSVYKG---ILDPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVKI 503
            I  G  G +Y      ++     V +K L       A    MAE + L  + H ++V+I
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRP--VVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
                 +D  G+    +V E++   SL+     +            L   + +   + + 
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------------LPVAEAIAYLLEIL 192

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
            AL YLH      +V+ DLKP N++L  + +  + D G    I      N    +   GT
Sbjct: 193 PALSYLHSI---GLVYNDLKPENIMLTEEQLK-LIDLGAVSRI------NSFGYLY--GT 240

Query: 624 VGYAAPEYGMGSQV 637
            G+ APE       
Sbjct: 241 PGFQAPEIVRTGPT 254

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  102 bits (256), Expect = 6e-24
 Identities = 44/188 (23%), Positives = 80/188 (42%), Gaps = 27/188 (14%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIRHRNL--VK 502
             IG+G    V++  L+  + + A+K + L +     L S+  E   L  ++  +   ++
Sbjct: 15  KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +           + +  +V E   +  L SWL  + +          +   +R +   N+
Sbjct: 74  LYDY-----EITDQYIYMVMEC-GNIDLNSWLKKKKS----------IDPWERKSYWKNM 117

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
             A+  +H H    IVH DLKP+N L+ + M+  + DFG+   +    +S    S    G
Sbjct: 118 LEAVHTIHQH---GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQ--VG 171

Query: 623 TVGYAAPE 630
           TV Y  PE
Sbjct: 172 TVNYMPPE 179

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  102 bits (256), Expect = 8e-24
 Identities = 27/207 (13%), Positives = 44/207 (21%), Gaps = 38/207 (18%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNIRHRNLV--- 501
            +  G    V+           A+KV      + R  L+       A   +   +     
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 502 ------------------KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDL 543
                                      D        L+        LE      S  D +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLF---STLDFV 184

Query: 544 NYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLT 603
                    L    +   +      L       +VH    P N+ +  D    +GD    
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL 241

Query: 604 RFIPEVISSNQCSSVGLKGTVGYAAPE 630
             +          +      V YA  E
Sbjct: 242 WKVGTR-----GPASS--VPVTYAPRE 261

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  101 bits (253), Expect = 8e-24
 Identities = 45/186 (24%), Positives = 69/186 (37%), Gaps = 26/186 (13%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA--LKSFMAECEALRNI-RHRNLVKII 504
            +G GS+G V+K     D  + AVK      RG       +AE  +   + +H   V++ 
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
            A     ++      L  E     SL                 + L   Q      +   
Sbjct: 124 QA-----WEEGGILYLQTELCG-PSL---------QQHCEAWGASLPEAQVWGYLRDTLL 168

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
           AL +LH    + +VH D+KP+N+ L       +GDFGL       + +     V  +G  
Sbjct: 169 ALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLV----ELGTAGAGEV-QEGDP 220

Query: 625 GYAAPE 630
            Y APE
Sbjct: 221 RYMAPE 226

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  104 bits (262), Expect = 1e-23
 Identities = 43/162 (26%), Positives = 70/162 (43%), Gaps = 22/162 (13%)

Query: 449 IGTGSFGSVYKGILDPD---QTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVKII 504
           IG G FG V++GI          VA+K           + F+ E   +R   H ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
              + +         ++ E    G L S+L     S         L     +  A  +++
Sbjct: 458 GVITENPVW------IIMELCTLGELRSFLQVRKFS---------LDLASLILYAYQLST 502

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           AL YL     K+ VH D+   NVL+ ++    +GDFGL+R++
Sbjct: 503 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  100 bits (251), Expect = 1e-23
 Identities = 39/173 (22%), Positives = 73/173 (42%), Gaps = 32/173 (18%)

Query: 449 IGTGSFGSVYKGIL-------DPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLV 501
           +G G+F  ++KG+           +T V +KVL    R   +SF      +  + H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
                C   D        LV EF+  GSL+++L               ++ L +L +A  
Sbjct: 76  LNYGVCVCGDEN-----ILVQEFVKFGSLDTYLKKNKNC---------INILWKLEVAKQ 121

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLD--------NDMIAHVGDFGLTRFI 606
           +A+A+ +L    +  ++H ++   N+LL         N     + D G++  +
Sbjct: 122 LAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  102 bits (256), Expect = 1e-23
 Identities = 49/228 (21%), Positives = 91/228 (39%), Gaps = 31/228 (13%)

Query: 409 RLRRKRTVTSSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTV 468
           +  R+   +    +   D   + + E +      +S    IG+G    V++  L+  + +
Sbjct: 24  KFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQV-LNEKKQI 82

Query: 469 VAVKVLFLHQRG--ALKSFMAECEALRNIRHRNL--VKIITACSSSDFQGNDFKALVYEF 524
            A+K + L +     L S+  E   L  ++  +   +++       D++  D    +Y  
Sbjct: 83  YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY------DYEITDQY--IYMV 134

Query: 525 M--HHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDL 582
           M   +  L SWL               +   +R +   N+  A+  +H H    IVH DL
Sbjct: 135 MECGNIDLNSWLK----------KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDL 181

Query: 583 KPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPE 630
           KP+N L+ + M+  + DFG+   +    +S    S    G V Y  PE
Sbjct: 182 KPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQ--VGAVNYMPPE 226

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  100 bits (250), Expect = 2e-23
 Identities = 51/217 (23%), Positives = 88/217 (40%), Gaps = 25/217 (11%)

Query: 415 TVTSSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVL 474
           ++ S+E    +  LL   YE             ++G G++G VY G    +Q  +A+K +
Sbjct: 1   SMRSTEEGDCESDLLEYDYEYDENGDR-----VVLGKGTYGIVYAGRDLSNQVRIAIKEI 55

Query: 475 FLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWL 534
                   +    E    ++++H+N+V+       S  +    K +  E +  GSL + L
Sbjct: 56  PERDSRYSQPLHEEIALHKHLKHKNIVQ----YLGSFSENGFIK-IFMEQVPGGSLSALL 110

Query: 535 HPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM- 593
             +      N         Q L         L+YLH     QIVH D+K  NVL++    
Sbjct: 111 RSKWGPLKDNEQTIGFYTKQIL-------EGLKYLH---DNQIVHRDIKGDNVLINTYSG 160

Query: 594 IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPE 630
           +  + DFG ++     ++     +    GT+ Y APE
Sbjct: 161 VLKISDFGTSK----RLAGINPCTETFTGTLQYMAPE 193

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  100 bits (251), Expect = 2e-23
 Identities = 46/188 (24%), Positives = 79/188 (42%), Gaps = 23/188 (12%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITA 506
           ++G G+  +V++G       + A+KV         +   M E E L+ + H+N+VK+   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-- 73

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +  +      K L+ EF   GSL + L   S +  L  S  ++           V   +
Sbjct: 74  -AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD-------VVGGM 125

Query: 567 EYLHHHCKKQIVHCDLKPSNVLL----DNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
            +L    +  IVH ++KP N++     D   +  + DFG  R + +     Q  S  L G
Sbjct: 126 NHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED---DEQFVS--LYG 177

Query: 623 TVGYAAPE 630
           T  Y  P+
Sbjct: 178 TEEYLHPD 185

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 98.2 bits (245), Expect = 2e-22
 Identities = 42/192 (21%), Positives = 76/192 (39%), Gaps = 36/192 (18%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA--LKSFMAECEALRNIRHRNLVKIIT 505
            IG GSFG         D     +K + + +  +   +    E   L N++H N+V+   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLH-------PESASDDLNYSPSILSFLQRLNI 558
           +     F+ N    +V ++   G L   ++        E                Q L+ 
Sbjct: 91  S-----FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQED---------------QILDW 130

Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
            + +  AL+++H    ++I+H D+K  N+ L  D    +GDFG+ R +    +     + 
Sbjct: 131 FVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARAC 185

Query: 619 GLKGTVGYAAPE 630
              GT  Y +PE
Sbjct: 186 --IGTPYYLSPE 195

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 46/186 (24%), Positives = 78/186 (41%), Gaps = 21/186 (11%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG---ALKSFMAECEALRNIRHRNLVKII 504
            IG G F  VY+     D   VA+K + +       A    + E + L+ + H N++K  
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
            +     F  ++   +V E    G L   +        L      +         + + S
Sbjct: 99  AS-----FIEDNELNIVLELADAGDLSRMIKHFKKQKRL------IPERTVWKYFVQLCS 147

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
           ALE++H    ++++H D+KP+NV +    +  +GD GL R      SS   ++  L GT 
Sbjct: 148 ALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGR----FFSSKTTAAHSLVGTP 200

Query: 625 GYAAPE 630
            Y +PE
Sbjct: 201 YYMSPE 206

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 99.1 bits (247), Expect = 3e-22
 Identities = 55/245 (22%), Positives = 91/245 (37%), Gaps = 20/245 (8%)

Query: 97  IPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLV 156
           +P  I   S   +L+   N++     +    L +L  L   RN +  R++       +  
Sbjct: 69  VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI--RQIEV----GAFN 120

Query: 157 NCTYLEIVSLNVNSLRSIPISV-GYLPKLQVLSLFENNISGEIPS-SLGNFTFLTELNL- 213
               L  + L  N L  IP     YL KL+ L L  N I   IPS +      L  L+L 
Sbjct: 121 GLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLG 179

Query: 214 RGNSIRGSIPSALGNCHQLQSLDLS----KTI--FLGQYPVRWLDLSHNHLTGPIPLAVG 267
               +      A      L+ L+L     K +        +  L++S NH     P +  
Sbjct: 180 ELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMSGNHFPEIRPGSFH 239

Query: 268 NLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPG-LSSLKSLEGLDLF 326
            L S+  L +  +++S    ++      L  LNL+ N+    +     + L+ L  L L 
Sbjct: 240 GLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS-LPHDLFTPLRYLVELHLH 298

Query: 327 QNTFQ 331
            N + 
Sbjct: 299 HNPWN 303

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 84.4 bits (209), Expect = 2e-17
 Identities = 51/276 (18%), Positives = 94/276 (34%), Gaps = 37/276 (13%)

Query: 8   INLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQ 67
           +   +   S  +P  I      RY+    N +Q        H   L  L L  N + +  
Sbjct: 59  VVCTRRGLS-EVPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ-- 113

Query: 68  LVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPED-LG 126
               +       L ++    L  N        +    SKL  L   NN +  SIP     
Sbjct: 114 ----IEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFN 168

Query: 127 RLRNLTRLNFARNDLGTRKVNDLRFL--DSLVNCTYLEIVSLNVNSLRSIPISVGYLPKL 184
           R+ +L RL+             L ++   +      L+ ++L + +++ +P ++  L  L
Sbjct: 169 RVPSLMRLDLGEL-------KKLEYISEGAFEGLFNLKYLNLGMCNIKDMP-NLTPLVGL 220

Query: 185 QVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLG 244
           + L +  N+     P S    + L +L +  + +     +A      L            
Sbjct: 221 EELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL------------ 268

Query: 245 QYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKN 280
                 L+L+HN+L+         L+ +  L L  N
Sbjct: 269 ----VELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 77.1 bits (190), Expect = 4e-15
 Identities = 47/223 (21%), Positives = 80/223 (35%), Gaps = 20/223 (8%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEI-GRLFQLRYIIFNSNTLQGQIPVN-LTHCSELRTLDL 58
           +L  L ++ L +N+    I       L  L  +    N L   IP     + S+LR L L
Sbjct: 97  HLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWL 154

Query: 59  VLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSI-SNASKLEWLDFANNSL 117
             N +E       +P Y    +P++    L   +    I          L++L+    ++
Sbjct: 155 RNNPIES------IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI 208

Query: 118 TASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPIS 177
              +P +L  L  L  L  + N     +      L SL      + + +  + +  I  +
Sbjct: 209 K-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSL------KKLWVMNSQVSLIERN 260

Query: 178 V-GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIR 219
               L  L  L+L  NN+S           +L EL+L  N   
Sbjct: 261 AFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 98.0 bits (244), Expect = 4e-22
 Identities = 46/188 (24%), Positives = 79/188 (42%), Gaps = 23/188 (12%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITA 506
           ++G G+  +V++G       + A+KV         +   M E E L+ + H+N+VK+   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-- 73

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +  +      K L+ EF   GSL + L   S +  L  S  ++           V   +
Sbjct: 74  -AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD-------VVGGM 125

Query: 567 EYLHHHCKKQIVHCDLKPSNVLL----DNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
            +L    +  IVH ++KP N++     D   +  + DFG  R + +     Q  S  L G
Sbjct: 126 NHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED---DEQFVS--LYG 177

Query: 623 TVGYAAPE 630
           T  Y  P+
Sbjct: 178 TEEYLHPD 185

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 95.9 bits (239), Expect = 4e-22
 Identities = 48/193 (24%), Positives = 77/193 (39%), Gaps = 31/193 (16%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIIT 505
            IG GSF +VYKG+       VA   L   +  +   + F  E E L+ ++H N+V+   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLH-----PESASDDLNYSPSILSFLQRLNIAI 560
           +  S+         LV E M  G+L+++L              ++   IL          
Sbjct: 93  SWESTVKGKKCI-VLVTELMTSGTLKTYLKRFKVMKIKVLR--SWCRQIL---------- 139

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLD-NDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
                L++LH      I+H DLK  N+ +        +GD GL      +  ++   +V 
Sbjct: 140 ---KGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAV- 190

Query: 620 LKGTVGYAAPEYG 632
             GT  + APE  
Sbjct: 191 -IGTPEFMAPEMY 202

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 95.4 bits (238), Expect = 6e-22
 Identities = 47/189 (24%), Positives = 73/189 (38%), Gaps = 21/189 (11%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA--LKSFMAECEALRNIRHRNLVKIIT 505
            IGTGS+G   K     D  ++  K L          +  ++E   LR ++H N+V+   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 506 ACSSSDFQGNDFKAL--VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
                         L  V E+   G L S +   +           L     L +   + 
Sbjct: 73  R-----IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY------LDEEFVLRVMTQLT 121

Query: 564 SALEYLH--HHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
            AL+  H        ++H DLKP+NV LD      +GDFGL R    +++ +   +    
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR----ILNHDTSFAKTFV 177

Query: 622 GTVGYAAPE 630
           GT  Y +PE
Sbjct: 178 GTPYYMSPE 186

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 96.2 bits (240), Expect = 7e-22
 Identities = 57/315 (18%), Positives = 98/315 (31%), Gaps = 51/315 (16%)

Query: 49  HCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLE 108
           HC  LR +      L+       +P  I    P+  +  L  N               L 
Sbjct: 32  HCH-LRVVQCSDLGLKA------VPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLY 81

Query: 109 WLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVN---DLRFLD------------ 153
            L   NN ++    +    LR L +L  ++N L     N    L  L             
Sbjct: 82  ALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKG 141

Query: 154 SLVNCTYLEIVSLNVNSLRSIPISVGYL--PKLQVLSLFENNISGEIPSSLGNFTFLTEL 211
                  +  + +  N L +     G     KL  L + E  ++  IP  L     L EL
Sbjct: 142 VFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNEL 198

Query: 212 NLRGNSIRGSIPS-ALGNCHQLQSLDLS--------KTIFLGQYPVRWLDLSHNHLTGPI 262
           +L  N I+ +I    L    +L  L L                  +R L L +N L+  +
Sbjct: 199 HLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-V 256

Query: 263 PLAVGNLKSIPHLDLSKNKLSGEIPSS-------LGSCVGLEYLNLSINSF-HGPIHPGL 314
           P  + +LK +  + L  N ++ ++  +                ++L  N   +  + P  
Sbjct: 257 PAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPAT 315

Query: 315 -SSLKSLEGLDLFQN 328
              +     +     
Sbjct: 316 FRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 58/289 (20%), Positives = 101/289 (34%), Gaps = 41/289 (14%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
            L  L  + L  N  S         L +L+ +  + N L  +IP NL   S L  L +  
Sbjct: 76  GLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHD 132

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQF-FGNIPHSISNASKLEWLDFANNSLTA 119
           N++ +      +P  +   L N+    + GN            +  KL +L  +   LT 
Sbjct: 133 NRIRK------VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT- 185

Query: 120 SIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISV- 178
            IP+DL     L  L+   N +  + +      + L+  + L  + L  N +R I     
Sbjct: 186 GIPKDL--PETLNELHLDHNKI--QAIEL----EDLLRYSKLYRLGLGHNQIRMIENGSL 237

Query: 179 GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSA----LGNCHQLQS 234
            +LP L+ L L  N +S  +P+ L +   L  + L  N+I   +       +G   +   
Sbjct: 238 SFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAY 295

Query: 235 LDLSKTIFLGQYPVRWLDLSHNHLTGPI--PLAVGNLKSIPHLDLSKNK 281
                           + L +N +      P     +     +     K
Sbjct: 296 Y-------------NGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 38/179 (21%), Positives = 63/179 (35%), Gaps = 12/179 (6%)

Query: 157 NCT-YLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRG 215
            C  +L +V  +   L+++P  +   P   +L L  N+IS            L  L L  
Sbjct: 30  GCHCHLRVVQCSDLGLKAVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVN 87

Query: 216 NSIRGSIPSALGNCHQLQSLDLS----KTIFLGQYP-VRWLDLSHNHLTGPIPLAVGNLK 270
           N I      A     +LQ L +S      I       +  L +  N +          L+
Sbjct: 88  NKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLR 147

Query: 271 SIPHLDLSKNKL-SGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
           ++  +++  N L +          + L YL +S     G I   L   ++L  L L  N
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPKDL--PETLNELHLDHN 203

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 97.9 bits (244), Expect = 7e-22
 Identities = 66/236 (27%), Positives = 102/236 (43%), Gaps = 25/236 (10%)

Query: 105 SKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIV 164
           ++   +     +L   +P+ +    N   LN   N +   KVN  + L       +LEI+
Sbjct: 43  NQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHL------RHLEIL 93

Query: 165 SLNVNSLRSIPISV-GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIP 223
            L+ N +R+I I     L  L  L LF+N ++     +    + L EL LR N I  SIP
Sbjct: 94  QLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIP 152

Query: 224 S-ALGNCHQLQSLDLSKT---------IFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIP 273
           S A      L+ LDL +           F G   +R+L+L+  +L   IP  +  L  + 
Sbjct: 153 SYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLD 210

Query: 274 HLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPG-LSSLKSLEGLDLFQN 328
            LDLS N LS   P S    + L+ L +  +     I      +L+SL  ++L  N
Sbjct: 211 ELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV-IERNAFDNLQSLVEINLAHN 265

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 89.4 bits (222), Expect = 4e-19
 Identities = 58/282 (20%), Positives = 105/282 (37%), Gaps = 35/282 (12%)

Query: 28  QLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPL 87
           Q   +I     L+ ++P  ++  +  R L+L  N+++       +       L ++ I  
Sbjct: 44  QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQI------IKVNSFKHLRHLEILQ 94

Query: 88  LAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPED-LGRLRNLTRLNFARNDLGTRKV 146
           L+ N        + +  + L  L+  +N LT +IP      L  L  L    N + +   
Sbjct: 95  LSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPS 153

Query: 147 NDLRFLDSLVNCTYLEIVSLNVNSLRSIPISV-GYLPKLQVLSLFENNISGEIPSSLGNF 205
                + SL     L++    +  L  I       L  L+ L+L   N+  EIP+ L   
Sbjct: 154 YAFNRIPSL---RRLDL--GELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPL 206

Query: 206 TFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLA 265
             L EL+L GN +    P +      LQ L +                  + +      A
Sbjct: 207 IKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMI----------------QSQIQVIERNA 250

Query: 266 VGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFH 307
             NL+S+  ++L+ N L+            LE ++L  N ++
Sbjct: 251 FDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 80.9 bits (200), Expect = 2e-16
 Identities = 45/178 (25%), Positives = 69/178 (38%), Gaps = 13/178 (7%)

Query: 164 VSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIP 223
           V     +LR +P  +      ++L+L EN I     +S  +   L  L L  N IR    
Sbjct: 48  VICVRKNLREVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEI 105

Query: 224 SALGNCHQLQSLDLSK--------TIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHL 275
            A      L +L+L            F+    ++ L L +N +      A   + S+  L
Sbjct: 106 GAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRL 165

Query: 276 DLSKNKLSGEIPS-SLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQA 332
           DL + K    I   +      L YLNL++ +      P L+ L  L+ LDL  N   A
Sbjct: 166 DLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLSA 221

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 46/222 (20%), Positives = 82/222 (36%), Gaps = 18/222 (8%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVN-LTHCSELRTLDLV 59
           +L  L ++ L +N+           L  L  +    N L   IP     + S+L+ L L 
Sbjct: 86  HLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLR 144

Query: 60  LNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSI-SNASKLEWLDFANNSLT 118
            N +E       +P Y    +P++R   L   +    I        S L +L+ A  +L 
Sbjct: 145 NNPIES------IPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR 198

Query: 119 ASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISV 178
             IP +L  L  L  L+ + N L   +    + L  L      + + +  + ++ I  + 
Sbjct: 199 -EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHL------QKLWMIQSQIQVIERNA 250

Query: 179 -GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIR 219
              L  L  ++L  NN++            L  ++L  N   
Sbjct: 251 FDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 97.8 bits (244), Expect = 9e-22
 Identities = 59/340 (17%), Positives = 118/340 (34%), Gaps = 63/340 (18%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
             T L  +    N  + N+   +  L +L Y+  ++N L     ++++    L  L+   
Sbjct: 83  QNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCAR 136

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
           N L E  +              +       N+    +   ++  ++L  LD + N +T  
Sbjct: 137 NTLTEIDVSH---------NTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITEL 185

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGY 180
              D+ + + L RLN   N++          LD L     L  +  + N L  I ++   
Sbjct: 186 ---DVSQNKLLNRLNCDTNNI--------TKLD-LNQNIQLTFLDCSSNKLTEIDVT--P 231

Query: 181 LPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSA---------LGNCHQ 231
           L +L       N ++ E+  S    + LT L+     +   I               C +
Sbjct: 232 LTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL-EIDLTHNTQLIYFQAEGCRK 287

Query: 232 LQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLG 291
           ++ LD++    L       LD     +T    L +     + +L L+  +L+ E+   + 
Sbjct: 288 IKELDVTHNTQL-----YLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELD--VS 336

Query: 292 SCVGLEYLNLS---INSFHGPIHPGLSSLKSLEGLDLFQN 328
               L+ L+     I  F       +  + +L      + 
Sbjct: 337 HNTKLKSLSCVNAHIQDF-----SSVGKIPALNNNFEAEG 371

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 91.7 bits (228), Expect = 8e-20
 Identities = 60/317 (18%), Positives = 100/317 (31%), Gaps = 46/317 (14%)

Query: 29  LRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLL 88
               +  +  +Q    ++    + L +LD   + +       ++      T   +   + 
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT------DMTGIEKLT--GLTKLIC 71

Query: 89  AGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVND 148
             N     +   +S  + L +L   +N LT ++   +  L  LT LN   N L    V+ 
Sbjct: 72  TSNN-ITTLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKLDVSQ 125

Query: 149 LRFLDSLV------------NCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISG 196
              L  L             + T L  +  ++N   +    V    +L  L    N I+ 
Sbjct: 126 NPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKL-DVTPQTQLTTLDCSFNKITE 184

Query: 197 EIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLS----KTIFLGQYP-VRWL 251
                +     L  LN   N+I   +   L    QL  LD S      I +     + + 
Sbjct: 185 ---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEIDVTPLTQLTYF 238

Query: 252 DLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIH 311
           D S N LT    L V  L  +  L   +  L  EI   L     L Y           + 
Sbjct: 239 DCSVNPLT---ELDVSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD 292

Query: 312 PGLSSLKSLEGLDLFQN 328
             ++    L  LD    
Sbjct: 293 --VTHNTQLYLLDCQAA 307

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 91.7 bits (228), Expect = 9e-20
 Identities = 58/257 (22%), Positives = 98/257 (38%), Gaps = 34/257 (13%)

Query: 78  FTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFA 137
           F   N    + A  +       S    + L  LD  N+S+T  +   + +L  LT+L   
Sbjct: 15  FPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICT 72

Query: 138 RNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGE 197
            N++ T        LD L   T L  ++ + N L ++ ++   L KL  L+   N ++  
Sbjct: 73  SNNITT--------LD-LSQNTNLTYLACDSNKLTNLDVT--PLTKLTYLNCDTNKLT-- 119

Query: 198 IPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPV------RWL 251
               +     LT LN   N++   I   + +  QL  LD      + +  V        L
Sbjct: 120 -KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLDVTPQTQLTTL 175

Query: 252 DLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIH 311
           D S N +T    L V   K +  L+   N ++ ++   L   + L +L+ S N       
Sbjct: 176 DCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKL---TE 226

Query: 312 PGLSSLKSLEGLDLFQN 328
             ++ L  L   D   N
Sbjct: 227 IDVTPLTQLTYFDCSVN 243

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 83.2 bits (206), Expect = 5e-17
 Identities = 56/328 (17%), Positives = 110/328 (33%), Gaps = 50/328 (15%)

Query: 1   NLTFLMLINLQQNNFSGN--IPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDL 58
           NL    L  L   N   N     ++ +   L Y+    NTL     ++++H ++L  LD 
Sbjct: 99  NLDVTPLTKLTYLNCDTNKLTKLDVSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDC 155

Query: 59  VLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLT 118
            LNK      V             +     + N+    +   +S    L  L+   N++T
Sbjct: 156 HLNKKITKLDVTPQT--------QLTTLDCSFNKI-TELD--VSQNKLLNRLNCDTNNIT 204

Query: 119 ASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSL------------VNCTYLEIVSL 166
             +  DL +   LT L+ + N L    V  L  L                  + L  +  
Sbjct: 205 -KL--DLNQNIQLTFLDCSSNKLTEIDVTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHC 261

Query: 167 NVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSAL 226
               L  I ++  +  +L            E+   + + T L  L+ +   I   +   L
Sbjct: 262 IQTDLLEIDLT--HNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--L 314

Query: 227 GNCHQLQSLDLS----KTIFLGQYP-VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNK 281
               +L  L L+      + +     ++ L   + H+      +VG + ++ +   ++ +
Sbjct: 315 SQNPKLVYLYLNNTELTELDVSHNTKLKSLSCVNAHIQD-FS-SVGKIPALNNNFEAEGQ 372

Query: 282 LSGEIPSSLGS-----CVGLEYLNLSIN 304
                  +L +      V  + L+   N
Sbjct: 373 TITMPKETLTNNSLTIAVSPDLLDQFGN 400

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 34/226 (15%), Positives = 68/226 (30%), Gaps = 39/226 (17%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
               L  ++   N  +  I   +  L QL Y   + N L     ++++  S+L TL  + 
Sbjct: 210 QNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQ 263

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
             L E  L              +      G +    +   +++ ++L  LD     +T  
Sbjct: 264 TDLLEIDLTH---------NTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-E 311

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKV-------------NDLRFLDSLVNCTYLEIVSLN 167
           +  DL +   L  L     +L    V               ++   S+     L      
Sbjct: 312 L--DLSQNPKLVYLYLNNTELTELDVSHNTKLKSLSCVNAHIQDFSSVGKIPALNNNFEA 369

Query: 168 VNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNL 213
                ++P        L +       +S ++    GN   +   + 
Sbjct: 370 EGQTITMPKETLTNNSLTI------AVSPDLLDQFGNPMNIEPGDG 409

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 98.6 bits (245), Expect = 1e-21
 Identities = 49/198 (24%), Positives = 79/198 (39%), Gaps = 20/198 (10%)

Query: 438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH-QRGALKSFMAECEALRNIR 496
           +  G +     +GTG FG V + I       VA+K           + +  E + ++ + 
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70

Query: 497 HRNLVKII-TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
           H N+V              ND   L  E+   G L  +L+       L     I + L  
Sbjct: 71  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK-EGPIRTLLSD 129

Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD---NDMIAHVGDFGLTRFIPEVISS 612
           +      +SAL YLH   + +I+H DLKP N++L      +I  + D G  + + +    
Sbjct: 130 I------SSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ---G 177

Query: 613 NQCSSVGLKGTVGYAAPE 630
             C+     GT+ Y APE
Sbjct: 178 ELCTE--FVGTLQYLAPE 193

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 49/199 (24%), Positives = 82/199 (41%), Gaps = 34/199 (17%)

Query: 448 LIGTGSFGSVYKG---ILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLV 501
            +G G   +VY     IL+     VA+K +      +   LK F  E      + H+N+V
Sbjct: 18  KLGGGGMSTVYLAEDTILN---IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74

Query: 502 KIITACSSSDFQGNDFKA--LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
            +I      D    +     LV E++   +L  ++               LS    +N  
Sbjct: 75  SMI------D-VDEEDDCYYLVMEYIEGPTLSEYIESHGP----------LSVDTAINFT 117

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             +   +++ H     +IVH D+KP N+L+D++    + DFG+ + + E  S  Q + V 
Sbjct: 118 NQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET-SLTQTNHV- 172

Query: 620 LKGTVGYAAPEYGMGSQVS 638
             GTV Y +PE   G    
Sbjct: 173 -LGTVQYFSPEQAKGEATD 190

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 45/196 (22%), Positives = 75/196 (38%), Gaps = 23/196 (11%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR-HRNLVKIITA 506
           ++  G F  VY+          A+K L  ++    ++ + E   ++ +  H N+V+  +A
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 507 CSSSDFQGNDFKALVYEFMHH--GSLESWLHPESASDDLNYSPSI--LSFLQRLNIAINV 562
            S    + +  +A          G L          + L    S   LS    L I    
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQL---------VEFLKKMESRGPLSCDTVLKIFYQT 145

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI---PEVISSNQCSSVG 619
             A++++H   K  I+H DLK  N+LL N     + DFG    I   P+   S Q  ++ 
Sbjct: 146 CRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204

Query: 620 LK-----GTVGYAAPE 630
            +      T  Y  PE
Sbjct: 205 EEEITRNTTPMYRTPE 220

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 93.8 bits (234), Expect = 2e-21
 Identities = 46/193 (23%), Positives = 78/193 (40%), Gaps = 39/193 (20%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNIRHRNLVKI 503
             +G G FG+VY       + ++A+KVLF   L + G       E E   ++RH N++++
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLN------ 557
                   F       L+ E+   G++   L                    + +      
Sbjct: 75  YGY-----FHDATRVYLILEYAPLGTVYRELQKL----------------SKFDEQRTAT 113

Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
               +A+AL Y H    K+++H D+KP N+LL +     + DFG +   P    ++ C  
Sbjct: 114 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-- 168

Query: 618 VGLKGTVGYAAPE 630
               GT+ Y  PE
Sbjct: 169 ----GTLDYLPPE 177

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 96.7 bits (241), Expect = 2e-21
 Identities = 72/365 (19%), Positives = 119/365 (32%), Gaps = 42/365 (11%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEI-GRLFQLRYIIFNSNTLQGQIPVN-LTHCSELRTLDL 58
            L  L  + ++Q      I +     L  L  +  + N    Q+        + L  L L
Sbjct: 52  RLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTL 110

Query: 59  VLNKLEENQLVGELPPYIGFT-LPNIRIPLLAGNQFFGNIPHSI-SNASKLEWLDFANNS 116
               L+   L G       F  L ++ + +L  N      P S   N  +   LD   N 
Sbjct: 111 TQCNLDGAVLSGNF-----FKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165

Query: 117 LTASIPEDLGRL--RNLTRLNFARNDLGTRKVNDLRFL--DSLVNCTYLEIVSLNVNSLR 172
           + +   EDL     ++ T L  +   L       L +    +    T +  + L+ N  +
Sbjct: 166 VKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFK 225

Query: 173 SIPISV--GYLPKLQVLSLFENNISGEIPS-------SLGNFTF-------LTELNLRGN 216
                     +   ++ SL  +N      S          NFTF       +   +L  +
Sbjct: 226 ESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKS 285

Query: 217 SIRGSIPS-ALGNCHQLQSLDLSK--------TIFLGQYPVRWLDLSHNHLTGPIPLAVG 267
            I  ++      +   L+ L L++          F G   +  L+LS N L         
Sbjct: 286 KIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFE 344

Query: 268 NLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPG-LSSLKSLEGLDLF 326
           NL  +  LDLS N +      S      L+ L L  N     +  G    L SL+ + L 
Sbjct: 345 NLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKS-VPDGIFDRLTSLQKIWLH 403

Query: 327 QNTFQ 331
            N + 
Sbjct: 404 TNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 91.3 bits (227), Expect = 1e-19
 Identities = 63/342 (18%), Positives = 122/342 (35%), Gaps = 50/342 (14%)

Query: 29  LRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLL 88
           + Y+  + N++      + +   +L+ L +     E+      +       L ++ I  L
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKV-----EQQTPGLVIRNNTFRGLSSLIILKL 86

Query: 89  AGNQFFGNIPHSI-SNASKLEWLDFANNSLTAS-IPEDL-GRLRNLTRLNFARNDLGTRK 145
             NQ F  +     +  + LE L     +L  + +  +    L +L  L    N++  +K
Sbjct: 87  DYNQ-FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI--KK 143

Query: 146 VNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGY-----------LPKLQVLSLFENNI 194
           +    F  ++       ++ L  N ++SI                 L  + +  + E  +
Sbjct: 144 IQPASFFLNMRR---FHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWL 200

Query: 195 SGEIPSSLGNFTFLTELNLRGNSIRGSIPSA---LGNCHQLQSL---------------- 235
             E   +    T +T L+L GN  + S+           ++QSL                
Sbjct: 201 GWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTN 260

Query: 236 --DLSKTIFLGQYP--VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLG 291
             D     F G     V+  DLS + +   +     +   +  L L++N+++    ++  
Sbjct: 261 FKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFW 320

Query: 292 SCVGLEYLNLSINSFHGPIHPGL-SSLKSLEGLDLFQNTFQA 332
               L  LNLS N     I   +  +L  LE LDL  N  +A
Sbjct: 321 GLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSYNHIRA 361

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 83.6 bits (207), Expect = 3e-17
 Identities = 63/324 (19%), Positives = 106/324 (32%), Gaps = 56/324 (17%)

Query: 43  IPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSI- 101
           +P ++ +      +DL LN + E      L       L +++   +        I ++  
Sbjct: 28  LPAHVNY------VDLSLNSIAE------LNETSFSRLQDLQFLKVEQQTPGLVIRNNTF 75

Query: 102 SNASKLEWLDFANNSLTASIPED-LGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTY 160
              S L  L    N     +       L NL  L   + +L    ++   F   L +   
Sbjct: 76  RGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSG-NFFKPLTS--- 130

Query: 161 LEIVSLNVNSLRSI-PISV-GYLPKLQVLSLFENNISGEIPSSLGNFT--FLTELNLRGN 216
           LE++ L  N+++ I P S    + +  VL L  N +       L NF     T L L   
Sbjct: 131 LEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSI 190

Query: 217 SIR--------GSIPSALGNCHQLQSLDLS---------------------KTIFLGQYP 247
           +++                    + +LDLS                     +++ L    
Sbjct: 191 TLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSY 250

Query: 248 VRWLDLSHNHLTGPIPLAVGNLK--SIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINS 305
                  H +   P       L+   +   DLSK+K+   + S       LE L L+ N 
Sbjct: 251 NMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNE 310

Query: 306 FHGPIHPG-LSSLKSLEGLDLFQN 328
            +  I       L  L  L+L QN
Sbjct: 311 IN-KIDDNAFWGLTHLLKLNLSQN 333

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 31/183 (16%), Positives = 54/183 (29%), Gaps = 35/183 (19%)

Query: 156 VNCTYLEIVSLNVNSLRSIP-ISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLR 214
             C            L  +P +       +  + L  N+I+    +S      L  L + 
Sbjct: 15  AICINR--------GLHQVPELP----AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVE 62

Query: 215 GNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAV-GNLKSIP 273
             +    I +       L SL               L L +N     +       L ++ 
Sbjct: 63  QQTPGLVIRN--NTFRGLSSL-------------IILKLDYNQFLQ-LETGAFNGLANLE 106

Query: 274 HLDLSKNKL-SGEIPS-SLGSCVGLEYLNLSINSFHGPIHPG--LSSLKSLEGLDLFQNT 329
            L L++  L    +          LE L L  N+    I P     +++    LDL  N 
Sbjct: 107 VLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKK-IQPASFFLNMRRFHVLDLTFNK 165

Query: 330 FQA 332
            ++
Sbjct: 166 VKS 168

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 93.4 bits (233), Expect = 3e-21
 Identities = 44/198 (22%), Positives = 76/198 (38%), Gaps = 49/198 (24%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNIRHRNLVKII 504
            +G G F   ++      + V A K++    L +    +    E    R++ H+++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLH-------PESASDDLNYSPSILSFLQRLN 557
                  F+ NDF  +V E     SL            PE+             +L+++ 
Sbjct: 82  GF-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY-----------YLRQI- 124

Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
                    +YLH   + +++H DLK  N+ L+ D+   +GDFGL         + +   
Sbjct: 125 -----VLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGL---------ATKVEY 167

Query: 618 VGLK-----GTVGYAAPE 630
            G +     GT  Y APE
Sbjct: 168 DGERKKVLCGTPNYIAPE 185

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 93.9 bits (234), Expect = 4e-21
 Identities = 44/198 (22%), Positives = 76/198 (38%), Gaps = 49/198 (24%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNIRHRNLVKII 504
            +G G F   ++      + V A K++    L +    +    E    R++ H+++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLH-------PESASDDLNYSPSILSFLQRLN 557
                  F+ NDF  +V E     SL            PE+             +L+++ 
Sbjct: 108 GF-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY-----------YLRQI- 150

Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
                    +YLH   + +++H DLK  N+ L+ D+   +GDFGL         + +   
Sbjct: 151 -----VLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGL---------ATKVEY 193

Query: 618 VGLK-----GTVGYAAPE 630
            G +     GT  Y APE
Sbjct: 194 DGERKKVLCGTPNYIAPE 211

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 95.1 bits (236), Expect = 4e-21
 Identities = 32/205 (15%), Positives = 58/205 (28%), Gaps = 32/205 (15%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRH------- 497
           ++G     +  +           V V +  +     A+K    E   LR +R        
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 498 RNLVKIITACSSSDFQG-NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL------ 550
           +  ++ I                +  +      L  +        +L     +L      
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 551 ----SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                   RL + + V   L  LHH+    +VH  L+P +++LD      +  F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 607 PEVISSNQCSSVGLKGTVGYAAPEY 631
                S            G+A PE 
Sbjct: 262 GASAVS--------PIGRGFAPPET 278

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 92.7 bits (231), Expect = 8e-21
 Identities = 44/203 (21%), Positives = 77/203 (37%), Gaps = 36/203 (17%)

Query: 448 LIGTGSFGSVYKG---ILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLV 501
           ++G G    V+         D   VAVKVL             F  E +    + H  +V
Sbjct: 19  ILGFGGMSEVHLARDLRDHRD---VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75

Query: 502 KIITACSSSDFQGNDFKA------LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR 555
            +       D  G           +V E++   +L   +H E            ++  + 
Sbjct: 76  AVY------D-TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----------MTPKRA 118

Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQC 615
           + +  +   AL + H +    I+H D+KP+N+++       V DFG+ R I +  +S   
Sbjct: 119 IEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175

Query: 616 SSVGLKGTVGYAAPEYGMGSQVS 638
           ++  + GT  Y +PE   G  V 
Sbjct: 176 TAAVI-GTAQYLSPEQARGDSVD 197

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 93.0 bits (231), Expect = 9e-21
 Identities = 48/244 (19%), Positives = 84/244 (34%), Gaps = 71/244 (29%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVK-VLFLHQRGALKSFMAECEALRNIRHRNLVKIITA 506
            +G G FG V++     D    A+K +   ++  A +  M E +AL  + H  +V+   A
Sbjct: 13  CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72

Query: 507 CSSSDFQGNDF------------------------------------------------- 517
              +  +                                                     
Sbjct: 73  WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132

Query: 518 KALVY---EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCK 574
           K  +Y   +     +L+ W++   + +D  +   +  F+Q       +A A+E+LH    
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQ-------IAEAVEFLH---S 182

Query: 575 KQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK--------GTVGY 626
           K ++H DLKPSN+    D +  VGDFGL   + +        +            GT  Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 627 AAPE 630
            +PE
Sbjct: 243 MSPE 246

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 49/222 (22%), Positives = 88/222 (39%), Gaps = 48/222 (21%)

Query: 417 TSSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLF- 475
           T+     ++   ++  ++ + +          +G G FG+VY      ++ ++A+KVLF 
Sbjct: 1   TALAEMPKRKFTID-DFD-IGR---------PLGKGKFGNVYLAREKQNKFIMALKVLFK 49

Query: 476 --LHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESW 533
             L + G       E E   ++RH N++++        F       L+ EF   G L   
Sbjct: 50  SQLEKEGVEHQLRREIEIQSHLRHPNILRMYNY-----FHDRKRIYLMLEFAPRGELYKE 104

Query: 534 LH-----PESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVL 588
           L       E  S    +        +       +A AL Y H   +++++H D+KP N+L
Sbjct: 105 LQKHGRFDEQRSA--TF------MEE-------LADALHYCH---ERKVIHRDIKPENLL 146

Query: 589 LDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPE 630
           +       + DFG +   P +     C      GT+ Y  PE
Sbjct: 147 MGYKGELKIADFGWSVHAPSLRRRTMC------GTLDYLPPE 182

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 93.1 bits (231), Expect = 1e-20
 Identities = 36/205 (17%), Positives = 65/205 (31%), Gaps = 32/205 (15%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR---GALKSFMAECEALRNIRH------- 497
           ++G     +  +           V V +  +R    A+K    E   LR +R        
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 498 RNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESW--LHPESASDDLNYSPSILSFLQ- 554
           +  ++ I                V        + S   L+P   S+   +   +LS    
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 555 --------RLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
                   RL + + V   L  LHH+    +VH  L+P +++LD      +  F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 607 PEVISSNQCSSVGLKGTVGYAAPEY 631
              + S+         + G+  PE 
Sbjct: 257 GARVVSS--------VSRGFEPPEL 273

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 91.1 bits (227), Expect = 2e-20
 Identities = 45/199 (22%), Positives = 82/199 (41%), Gaps = 50/199 (25%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMAECEALRNIRHRNLVKII 504
           L+G GSF  VY+         VA+K++    +++ G ++    E +    ++H +++++ 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLH--------PESASDDLNYSPSILSFLQRL 556
                  F+ +++  LV E  H+G +  +L          E+     ++        Q  
Sbjct: 78  NY-----FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR----HF------MHQ-- 120

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                + + + YLH      I+H DL  SN+LL  +M   + DFGL         + Q  
Sbjct: 121 -----IITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGL---------ATQLK 163

Query: 617 SVGLK-----GTVGYAAPE 630
               K     GT  Y +PE
Sbjct: 164 MPHEKHYTLCGTPNYISPE 182

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 92.1 bits (229), Expect = 2e-20
 Identities = 35/199 (17%), Positives = 67/199 (33%), Gaps = 34/199 (17%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMA-----------------ECEA 491
           +  G F  +       D    A+K          + F                   E + 
Sbjct: 39  LNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 492 LRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILS 551
           + +I++   +              D   ++YE+M + S+  +       D        + 
Sbjct: 97  ITDIKNEYCLTCEGI-----ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF--IP 149

Query: 552 FLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVIS 611
                 I  +V ++  Y+H+   K I H D+KPSN+L+D +    + DFG + ++ +   
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207

Query: 612 SNQCSSVGLKGTVGYAAPE 630
                     GT  +  PE
Sbjct: 208 KGSR------GTYEFMPPE 220

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 45/230 (19%), Positives = 77/230 (33%), Gaps = 23/230 (10%)

Query: 114 NNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRS 173
              L  ++P  +       R+    N +        R   +L   T L    L+ N L  
Sbjct: 20  QQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNL---TIL---WLHSNVLAR 70

Query: 174 IPISV-GYLPKLQVLSLFENNISGEIPSS-LGNFTFLTELNLRGNSIRGSIPS-ALGNCH 230
           I  +    L  L+ L L +N     +  +       L  L+L    ++  +         
Sbjct: 71  IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLA 129

Query: 231 QLQSLDLS--------KTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKL 282
            LQ L L            F     +  L L  N ++     A   L S+  L L +N++
Sbjct: 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189

Query: 283 SGEIPSSLGSCVGLEYLNLSINSFHGPIHPG-LSSLKSLEGLDLFQNTFQ 331
           +   P +      L  L L  N+    +    L+ L++L+ L L  N + 
Sbjct: 190 AHVHPHAFRDLGRLMTLYLFANNLSA-LPTEALAPLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 48/241 (19%), Positives = 87/241 (36%), Gaps = 32/241 (13%)

Query: 42  QIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSI 101
            +PV +   +  + + L  N++        +P        N+ I  L  N        + 
Sbjct: 25  AVPVGIP--AASQRIFLHGNRISH------VPAASFRACRNLTILWLHSNVLARIDAAAF 76

Query: 102 SNASKLEWLDFANNSLTASIPED-LGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTY 160
           +  + LE LD ++N+   S+       L  L  L+  R  L  +++              
Sbjct: 77  TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL--QELGP----GLFRGLAA 130

Query: 161 LEIVSLNVNSLRSIPISV-GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIR 219
           L+ + L  N+L+++P      L  L  L L  N IS     +      L  L L  N + 
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190

Query: 220 GSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSK 279
              P A  +  +L +                L L  N+L+     A+  L+++ +L L+ 
Sbjct: 191 HVHPHAFRDLGRLMT----------------LYLFANNLSALPTEALAPLRALQYLRLND 234

Query: 280 N 280
           N
Sbjct: 235 N 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 41/196 (20%), Positives = 67/196 (34%), Gaps = 18/196 (9%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVN-LTHCSELRTLDLV 59
               L ++ L  N  +         L  L  +  + N     +          L TL L 
Sbjct: 54  ACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113

Query: 60  LNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSI-SNASKLEWLDFANNSLT 118
              L+      EL P +   L  ++   L  N     +P     +   L  L    N ++
Sbjct: 114 RCGLQ------ELGPGLFRGLAALQYLYLQDNA-LQALPDDTFRDLGNLTHLFLHGNRIS 166

Query: 119 ASIPED-LGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPIS 177
            S+PE     L +L RL   +N +    V+      +  +   L  + L  N+L ++P  
Sbjct: 167 -SVPERAFRGLHSLDRLLLHQNRV--AHVHP----HAFRDLGRLMTLYLFANNLSALPTE 219

Query: 178 V-GYLPKLQVLSLFEN 192
               L  LQ L L +N
Sbjct: 220 ALAPLRALQYLRLNDN 235

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 42/200 (21%), Positives = 76/200 (38%), Gaps = 38/200 (19%)

Query: 448 LIGTGSFGSVYKG---ILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLV 501
           L+G G  G VY+    + +    +VA+K++                E      ++  ++V
Sbjct: 41  LVGRGGMGDVYEAEDTVRE---RIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97

Query: 502 KIITACSSSDF---QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
            I       DF    G  +  +    ++   L + L  +            L+  + + I
Sbjct: 98  PIH------DFGEIDGQLY--VDMRLINGVDLAAMLRRQGP----------LAPPRAVAI 139

Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
              + SAL+  H        H D+KP N+L+  D  A++ DFG+        +  + + +
Sbjct: 140 VRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIAS----ATTDEKLTQL 192

Query: 619 G-LKGTVGYAAPEYGMGSQV 637
           G   GT+ Y APE    S  
Sbjct: 193 GNTVGTLYYMAPERFSESHA 212

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 92.5 bits (229), Expect = 8e-20
 Identities = 64/293 (21%), Positives = 95/293 (32%), Gaps = 37/293 (12%)

Query: 29  LRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLL 88
           +   I  S  ++ QI       +E    +L    + +     EL         N  I  +
Sbjct: 1   MGETITVSTPIK-QIF-PDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSV 58

Query: 89  AGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVND 148
            G          I     +  L    N LT  I + L  L+NL  L    N     K+ D
Sbjct: 59  QG----------IQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDEN-----KIKD 101

Query: 149 LRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFL 208
           L  L  L     L+ +SL  N +  I   + +LP+L+ L L  N I+    + L   T L
Sbjct: 102 LSSLKDLKK---LKSLSLEHNGISDIN-GLVHLPQLESLYLGNNKIT--DITVLSRLTKL 155

Query: 209 TELNLRGNSIRGSIPSALGNCHQLQSLDLSK------TIFLGQYPVRWLDLSHNHLTGPI 262
             L+L  N I   I   L    +LQ+L LSK          G   +  L+L         
Sbjct: 156 DTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNKP 213

Query: 263 PLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLS 315
                NL     +  +   L      S        Y   ++          +S
Sbjct: 214 INHQSNLVVPNTVKNTDGSLVTPEIISDDGD----YEKPNVKWHLPEFTNEVS 262

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 85.9 bits (212), Expect = 1e-17
 Identities = 45/208 (21%), Positives = 77/208 (37%), Gaps = 39/208 (18%)

Query: 123 EDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLP 182
                     + N  +       V D    + L +   +   + ++ S++ I     YLP
Sbjct: 15  FPDDAFAETIKDNLKKK-----SVTDAVTQNELNSIDQIIANNSDIKSVQGI----QYLP 65

Query: 183 KLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIF 242
            +  L L  N ++ +I   L N   L  L L  N I+  + S+L +  +L+         
Sbjct: 66  NVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLK--------- 112

Query: 243 LGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLS 302
                   L L HN ++    L   +L  +  L L  NK++    + L     L+ L+L 
Sbjct: 113 -------SLSLEHNGISDINGLV--HLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLE 161

Query: 303 INSFHGPIH--PGLSSLKSLEGLDLFQN 328
            N     I     L+ L  L+ L L +N
Sbjct: 162 DN----QISDIVPLAGLTKLQNLYLSKN 185

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 74.8 bits (183), Expect = 3e-14
 Identities = 44/272 (16%), Positives = 96/272 (35%), Gaps = 33/272 (12%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
                +  NL++ + +  +      L  +  II N++ ++  +   + +   +  L L  
Sbjct: 19  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNG 74

Query: 61  NKLEENQLVGELPP----YIGF----------TLPNIRIPLLAGNQFFGNIPHSISNASK 106
           NKL + + +  L      ++             L  ++   L  N    +I   + +  +
Sbjct: 75  NKLTDIKPLTNLKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEHNGI-SDING-LVHLPQ 132

Query: 107 LEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSL 166
           LE L   NN +T      L RL  L  L+   N     +++D+  L  L     L+ + L
Sbjct: 133 LESLYLGNNKIT--DITVLSRLTKLDTLSLEDN-----QISDIVPLAGLTK---LQNLYL 182

Query: 167 NVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSAL 226
           + N +  +  ++  L  L VL LF      +  +   N      +     S+    P  +
Sbjct: 183 SKNHISDLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEII 239

Query: 227 GNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHL 258
            +    +  ++   +      V ++      +
Sbjct: 240 SDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTI 271

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 56.7 bits (136), Expect = 2e-08
 Identities = 25/129 (19%), Positives = 46/129 (35%), Gaps = 18/129 (13%)

Query: 208 LTELNLRGNSIRGSIPSALGNCHQLQSLDLSKT-----IFLGQYP-VRWLDLSHNHLTGP 261
           + E       I+  I        +    +L K      +   +   +  +  +++ +   
Sbjct: 1   MGETITVSTPIK-QI-FPDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSV 58

Query: 262 IPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIH--PGLSSLKS 319
             +    L ++  L L+ NKL+ +I   L +   L +L L  N     I     L  LK 
Sbjct: 59  QGIQ--YLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDEN----KIKDLSSLKDLKK 110

Query: 320 LEGLDLFQN 328
           L+ L L  N
Sbjct: 111 LKSLSLEHN 119

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 42/210 (20%), Positives = 78/210 (37%), Gaps = 44/210 (20%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA--LKSFMAECEALRNI-RHRN 499
           F     IG+G FGSV+K +   D  + A+K       G+   ++ + E  A   + +H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           +V+  +A     +  +D   +  E+ + GSL   +       +     S     +  ++ 
Sbjct: 73  VVRYFSA-----WAEDDHMLIQNEYCNGGSLADAI------SENYRIMSYFKEAELKDLL 121

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDND-------------------MIAHVGDF 600
           + V   L Y+H      +VH D+KPSN+ +                      ++  +GD 
Sbjct: 122 LQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178

Query: 601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPE 630
           G    I              +G   + A E
Sbjct: 179 GHVTRISSPQV--------EEGDSRFLANE 200

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 58/293 (19%), Positives = 101/293 (34%), Gaps = 34/293 (11%)

Query: 43  IPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSIS 102
           IP  LT    +++LDL  N++        +         N++  +L  N        S S
Sbjct: 46  IPSGLT--EAVKSLDLSNNRITY------ISNSDLQRCVNLQALVLTSNGINTIEEDSFS 97

Query: 103 NASKLEWLDFANNSLTASIPEDL-GRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYL 161
           +   LE LD + N L+ ++       L +LT LN   N   T  + +      L     L
Sbjct: 98  SLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKT--LGETSLFSHLTKLQIL 154

Query: 162 EIVSLNVNSLRSIPISV-GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRG 220
            +   N+++   I       L  L+ L +  +++    P SL +   ++ L L       
Sbjct: 155 RV--GNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI- 211

Query: 221 SIPS-ALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHL---D 276
            +    +     ++ L+L           R  DL   H +        +L          
Sbjct: 212 LLLEIFVDVTSSVECLEL-----------RDTDLDTFHFSELSTGETNSLIKKFTFRNVK 260

Query: 277 LSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPG-LSSLKSLEGLDLFQN 328
           ++   L  ++   L    GL  L  S N     +  G    L SL+ + L  N
Sbjct: 261 ITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 85.2 bits (211), Expect = 5e-18
 Identities = 52/261 (19%), Positives = 90/261 (34%), Gaps = 28/261 (10%)

Query: 91  NQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLR 150
           +    +IP  ++    ++ LD +NN +T     DL R  NL  L    N + T + +   
Sbjct: 40  SGSLNSIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFS 97

Query: 151 FLDSLVNCTYLEIVSLNVNSLRSIPISV-GYLPKLQVLSLFENNISGEIPSSL-GNFTFL 208
            L SL    +L    L+ N L ++  S    L  L  L+L  N       +SL  + T L
Sbjct: 98  SLGSL---EHL---DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKL 151

Query: 209 TELNLRGNSIRGSIPS-ALGNCHQLQSLDLS--------KTIFLGQYPVRWLDLSHNHLT 259
             L +        I          L+ L++                  V  L L      
Sbjct: 152 QILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211

Query: 260 GPIPLAVGNLKSIPHLDLSKNKLSG----EIPS----SLGSCVGLEYLNLSINSFHGPIH 311
             + + V    S+  L+L    L      E+ +    SL        + ++  S    + 
Sbjct: 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVM 270

Query: 312 PGLSSLKSLEGLDLFQNTFQA 332
             L+ +  L  L+  +N  ++
Sbjct: 271 KLLNQISGLLELEFSRNQLKS 291

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 51/292 (17%), Positives = 92/292 (31%), Gaps = 42/292 (14%)

Query: 3   TFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNL-THCSELRTLDLVLN 61
             +  ++L  N  +     ++ R   L+ ++  SN +   I  +  +    L  LDL  N
Sbjct: 52  EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110

Query: 62  KLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSI-SNASKLEWLDFANNSLTAS 120
            L        L       L ++    L GN +      S+ S+ +KL+ L   N      
Sbjct: 111 YLSN------LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTK 164

Query: 121 IPED-LGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIP-ISV 178
           I       L  L  L    +DL  +         SL +   +  + L++     +  I V
Sbjct: 165 IQRKDFAGLTFLEELEIDASDL--QSYEP----KSLKSIQNVSHLILHMKQHILLLEIFV 218

Query: 179 GYLPKLQVLSLFENNISG----EIPS----SLGNFTFLTELNLRGNSIRGSIPSALGNCH 230
                ++ L L + ++      E+ +    SL        + +   S+   +   L    
Sbjct: 219 DVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQIS 277

Query: 231 QLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKL 282
            L  L+ S                 N L          L S+  + L  N  
Sbjct: 278 GLLELEFS----------------RNQLKSVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 79.4 bits (196), Expect = 4e-16
 Identities = 41/246 (16%), Positives = 75/246 (30%), Gaps = 38/246 (15%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEI-GRLFQLRYIIFNSNTLQGQIPVNL-THCSELRTLDL 58
               L  + L  N  +  I  +    L  L ++  + N L   +  +     S L  L+L
Sbjct: 74  RCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNL 131

Query: 59  VLNKLEENQLVGELPPYIGFT-LPNIRIPLLAGNQFFGNIPHSI-SNASKLEWLDFANNS 116
           + N  +       L     F+ L  ++I  +     F  I     +  + LE L+   + 
Sbjct: 132 LGNPYKT------LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185

Query: 117 LTA-----------------------SIPEDL-GRLRNLTRLNFARNDLGTRKVNDLRFL 152
           L +                        + E       ++  L     DL T   ++L   
Sbjct: 186 LQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTG 245

Query: 153 --DSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTE 210
             +SL+       V +   SL  +   +  +  L  L    N +           T L +
Sbjct: 246 ETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQK 305

Query: 211 LNLRGN 216
           + L  N
Sbjct: 306 IWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 40/187 (21%), Positives = 67/187 (35%), Gaps = 16/187 (8%)

Query: 154 SLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNL 213
           + ++C    I   +  SL SIP   G    ++ L L  N I+    S L     L  L L
Sbjct: 26  ASLSCDRNGICKGSSGSLNSIPS--GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVL 83

Query: 214 RGNSIRGSIPS-ALGNCHQLQSLDLSK--------TIFLGQYPVRWLDLSHNHLTGPIPL 264
             N I  +I   +  +   L+ LDLS         + F     + +L+L  N        
Sbjct: 84  TSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGET 142

Query: 265 AV-GNLKSIPHLDLSKNKLSGEIPS-SLGSCVGLEYLNLSINSFHGPIHPG-LSSLKSLE 321
           ++  +L  +  L +       +I          LE L +  +       P  L S++++ 
Sbjct: 143 SLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS-YEPKSLKSIQNVS 201

Query: 322 GLDLFQN 328
            L L   
Sbjct: 202 HLILHMK 208

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 89.4 bits (222), Expect = 3e-19
 Identities = 50/199 (25%), Positives = 83/199 (41%), Gaps = 39/199 (19%)

Query: 443 FSSANLIGTGSFGS-VYKGILDPDQTVVAVKVLFLHQRGALKSFMA----ECEALRNI-R 496
           F   +++G G+ G+ VY+G+ D     VAVK +       L    +    E + LR    
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFD--NRDVAVKRI-------LPECFSFADREVQLLRESDE 76

Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H N+++    C+    +   F+ +  E     +L+         + +         L+ +
Sbjct: 77  HPNVIRYF--CT---EKDRQFQYIAIELCA-ATLQ---------EYVEQKDFAHLGLEPI 121

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN-----DMIAHVGDFGLTRFIPEVIS 611
            +     S L +LH      IVH DLKP N+L+        + A + DFGL + +     
Sbjct: 122 TLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178

Query: 612 SNQCSSVGLKGTVGYAAPE 630
           S    S G+ GT G+ APE
Sbjct: 179 SFSRRS-GVPGTEGWIAPE 196

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 87.9 bits (218), Expect = 4e-19
 Identities = 50/225 (22%), Positives = 81/225 (36%), Gaps = 27/225 (12%)

Query: 409 RLRRKRTVTSSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTV 468
           +L+R    T           L        +     +    +G GSFG V++         
Sbjct: 26  KLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQ 85

Query: 469 VAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHG 528
            AVK + L         + E  A   +    +V +      +  +G     +  E +  G
Sbjct: 86  CAVKKVRLE-----VFRVEELVACAGLSSPRIVPLY----GAVREGPWVN-IFMELLEGG 135

Query: 529 SLESWLHPESASDDLNYSPSILSFL-QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNV 587
           SL   +       +       L +L Q L         LEYLH    ++I+H D+K  NV
Sbjct: 136 SLGQLIKQMGCLPE----DRALYYLGQAL-------EGLEYLH---TRRILHGDVKADNV 181

Query: 588 LLDND-MIAHVGDFGL-TRFIPEVISSNQCSSVGLKGTVGYAAPE 630
           LL +D   A + DFG      P+ +  +  +   + GT  + APE
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 89.1 bits (221), Expect = 4e-19
 Identities = 44/203 (21%), Positives = 85/203 (41%), Gaps = 32/203 (15%)

Query: 443 FSSANLIGTGSFGSV-YKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALR-NIRHRNL 500
             S  ++G GS G+V ++G        VAVK +           + E + L  +  H N+
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRP--VAVKRM---LIDFCDIALMEIKLLTESDDHPNV 71

Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           ++    CS      + F  +  E  +  +L+  +    + +  + +  +      +++  
Sbjct: 72  IRYY--CS---ETTDRFLYIALELCN-LNLQDLV---ESKNVSDENLKLQKEYNPISLLR 122

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDN-------------DMIAHVGDFGLTRFIP 607
            +AS + +LH     +I+H DLKP N+L+               ++   + DFGL + + 
Sbjct: 123 QIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179

Query: 608 EVISSNQCSSVGLKGTVGYAAPE 630
              SS + +     GT G+ APE
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPE 202

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 87.6 bits (217), Expect = 7e-19
 Identities = 43/219 (19%), Positives = 73/219 (33%), Gaps = 45/219 (20%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKV-----LFLHQRGALKSFMAECEALRNIRHRNLVKI 503
           IG GS+G V   I +  + + A+K+     +       ++    E   ++ + H N+ ++
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSL------------------------------ESW 533
                   ++   +  LV E  H G L                                 
Sbjct: 94  YEV-----YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148

Query: 534 LHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM 593
               S          +       NI   + SAL YLH    + I H D+KP N L   + 
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNK 205

Query: 594 IAHV--GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPE 630
              +   DFGL++   ++ +          GT  + APE
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 87.3 bits (216), Expect = 1e-18
 Identities = 34/200 (17%), Positives = 68/200 (34%), Gaps = 31/200 (15%)

Query: 447 NLIGTGSFGSVYKGI-----LDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLV 501
           +L+G G+F  VY+          ++    +KV                E L+       +
Sbjct: 71  HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130

Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           K  +A         +   LV E   +G+L + ++        N    ++     ++ A+ 
Sbjct: 131 KFYSA-----HLFQNGSVLVGELYSYGTLLNAINLYK-----NTPEKVMPQGLVISFAMR 180

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG-----------DFGLTRFIPEVI 610
           +   +E +H     +I+H D+KP N +L N  +               D G +  +    
Sbjct: 181 MLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237

Query: 611 SSNQCSSVGLKGTVGYAAPE 630
                ++     T G+   E
Sbjct: 238 KGTIFTAK--CETSGFQCVE 255

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 88.4 bits (219), Expect = 1e-18
 Identities = 57/335 (17%), Positives = 109/335 (32%), Gaps = 32/335 (9%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           N  F  ++++     +      I  + +     +  + L             L  ++   
Sbjct: 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTW 234

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
           N       +        F++ N++   L G   F +  +S ++   L      ++     
Sbjct: 235 NSFIRILQLVWHTTVWYFSISNVK---LQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFP 291

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISV-G 179
                    N+   NF  +     ++  +     +    +L     + N L        G
Sbjct: 292 QSYIYEIFSNMNIKNFTVSGT---RMVHMLCPSKISPFLHL---DFSNNLLTDTVFENCG 345

Query: 180 YLPKLQVLSLFENNISGEIPSSLGNF---TFLTELNLRGNSIRGSIPSALGNCHQLQSLD 236
           +L +L+ L L  N +  E+            L +L++  NS+        G+C   +SL 
Sbjct: 346 HLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKK--GDCSWTKSL- 401

Query: 237 LSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGL 296
                         L++S N LT  I   +     I  LDL  NK+   IP  +     L
Sbjct: 402 ------------LSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEAL 446

Query: 297 EYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQ 331
           + LN++ N            L SL+ + L  N + 
Sbjct: 447 QELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 84.1 bits (208), Expect = 3e-17
 Identities = 48/340 (14%), Positives = 110/340 (32%), Gaps = 34/340 (10%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           +L    ++ +    +      +   L        +      +    +   S     +L L
Sbjct: 137 HLNISKVLLVLGETYG--EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLEL 194

Query: 61  NKLEENQLVGELPPYIGF-----TLPNIRIPLLAGNQFFGNIPHSISN---ASKLEWLDF 112
           + ++      +   ++       T P +    L   +   N    I      + + +   
Sbjct: 195 SNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSI 254

Query: 113 ANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLV--NCTYLEIVSLNVNS 170
           +N  L   +          +    + + +     +   F  S +    + + I +  V+ 
Sbjct: 255 SNVKLQGQLDFRDFDYSGTSLKALSIHQV---VSDVFGFPQSYIYEIFSNMNIKNFTVSG 311

Query: 171 LRSIPISV-GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNC 229
            R + +     +     L    N ++  +  + G+ T L  L L+ N             
Sbjct: 312 TRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMN------------- 358

Query: 230 HQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAV-GNLKSIPHLDLSKNKLSGEIPS 288
            QL+ L     +      ++ LD+S N ++           KS+  L++S N L+  I  
Sbjct: 359 -QLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR 417

Query: 289 SLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
            L     ++ L+L  N     I   +  L++L+ L++  N
Sbjct: 418 CLPP--RIKVLDLHSNKIKS-IPKQVVKLEALQELNVASN 454

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 68.0 bits (166), Expect = 4e-12
 Identities = 52/352 (14%), Positives = 106/352 (30%), Gaps = 44/352 (12%)

Query: 9   NLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEE--- 65
           N+ QN  S     +I  L +LR +I + N +Q           EL  LDL  NKL +   
Sbjct: 27  NISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISC 86

Query: 66  -------------NQLVGELPPYIGFT-LPNIRIPLLAGNQFFGNIPHSISNASKLEWLD 111
                        N     LP    F  +  ++   L+      +    I++ +  + L 
Sbjct: 87  HPTVNLKHLDLSFNAF-DALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLL 145

Query: 112 FANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDL--RFLDSLVNCTYLEIVSL--- 166
               +      ED   L++    +        ++ + +    + ++ N     I  +   
Sbjct: 146 VLGETYGE--KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLED 203

Query: 167 -NVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNF---TFLTELNLRGNSIRGSI 222
              +   SI   +   PKL  L+L     +      +      T +   ++    ++G +
Sbjct: 204 NKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQL 263

Query: 223 PSALGNC--HQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKN 280
                +     L++L +               +  +    P         ++   + + +
Sbjct: 264 DFRDFDYSGTSLKALSI-------------HQVVSDVFGFPQSYIYEIFSNMNIKNFTVS 310

Query: 281 KLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQA 332
                            +L+ S N     +      L  LE L L  N  + 
Sbjct: 311 GTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE 362

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 65.7 bits (160), Expect = 2e-11
 Identities = 38/172 (22%), Positives = 62/172 (36%), Gaps = 10/172 (5%)

Query: 163 IVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSI 222
           +V  + N L  +P       K  +L++ +N IS    S + + + L  L +  N I+   
Sbjct: 4   LVDRSKNGLIHVPK--DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61

Query: 223 PSALGNCHQLQSLDLS----KTIFLGQYP-VRWLDLSHNHLTG-PIPLAVGNLKSIPHLD 276
            S      +L+ LDLS      I       ++ LDLS N     PI    GN+  +  L 
Sbjct: 62  ISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG 121

Query: 277 LSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
           LS   L       +      + L +   ++     P    L+      L   
Sbjct: 122 LSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPE--GLQDFNTESLHIV 171

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 42/238 (17%), Positives = 69/238 (28%), Gaps = 34/238 (14%)

Query: 97  IPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLV 156
           +P  +S   K   L+ + N ++     D+  L  L  L  + N +  + ++   F     
Sbjct: 15  VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRI--QYLDISVF-KFNQ 69

Query: 157 NCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNI-SGEIPSSLGNFTFLTELNLRG 215
               LE + L+ N L  I         L+ L L  N   +  I    GN + L  L L  
Sbjct: 70  E---LEYLDLSHNKLVKISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLST 124

Query: 216 NSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHL 275
                           L+   +   I         L L   +     P     L+     
Sbjct: 125 T--------------HLEKSSVLP-IAHLNISKVLLVLGETYGEKEDP---EGLQDFNTE 166

Query: 276 DLSKNKLSGEIPSSL-----GSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
            L     + +    +      +   LE  N+            LS L  L+      N
Sbjct: 167 SLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSN 224

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 47.9 bits (114), Expect = 8e-06
 Identities = 26/101 (25%), Positives = 41/101 (40%), Gaps = 11/101 (10%)

Query: 248 VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFH 307
              L++S N+++      + +L  +  L +S N++     S       LEYL+LS N   
Sbjct: 23  TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82

Query: 308 G-PIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKN 347
               HP      +L+ LDL  N F        +P    F N
Sbjct: 83  KISCHP----TVNLKHLDLSFNAFD------ALPICKEFGN 113

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 84.9 bits (211), Expect = 3e-18
 Identities = 51/193 (26%), Positives = 77/193 (39%), Gaps = 41/193 (21%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITAC 507
           ++G+G+F  V+         + A+K +         S   E   L+ I+H N+V +    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI- 74

Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDL----NYSPSILSFLQRLNIAINVA 563
               ++      LV + +  G L          D +     Y+    S + +      V 
Sbjct: 75  ----YESTTHYYLVMQLVSGGEL---------FDRILERGVYTEKDASLVIQ-----QVL 116

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDND------MIAHVGDFGLTRFIPEVISSNQCSS 617
           SA++YLH   +  IVH DLKP N+L          MI    DFGL++     I S  C  
Sbjct: 117 SAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMIT---DFGLSKMEQNGIMSTAC-- 168

Query: 618 VGLKGTVGYAAPE 630
               GT GY APE
Sbjct: 169 ----GTPGYVAPE 177

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 85.3 bits (212), Expect = 3e-18
 Identities = 49/216 (22%), Positives = 82/216 (37%), Gaps = 57/216 (26%)

Query: 447 NLIGTGSFGSVYKGILDPDQT--VVAVKVLFLHQRGALKSFMAECE-----ALRNI---- 495
             IG G++G V+K   D       VA+K + +             E      +R +    
Sbjct: 17  AEIGEGAYGKVFKAR-DLKNGGRFVALKRVRVQT---------GEEGMPLSTIREVAVLR 66

Query: 496 -----RHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
                 H N+V++   C+ S         LV+E +    L ++L  +   +    + +I 
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPEPGVPTETIK 123

Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI---- 606
             + +L         L++LH H    +VH DLKP N+L+ +     + DFGL R      
Sbjct: 124 DMMFQL------LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174

Query: 607 ---PEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST 639
                V+            T+ Y APE  + S  +T
Sbjct: 175 ALTSVVV------------TLWYRAPEVLLQSSYAT 198

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 84.9 bits (211), Expect = 3e-18
 Identities = 51/210 (24%), Positives = 85/210 (40%), Gaps = 43/210 (20%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVK-VLFLHQRGALKSFMAECEALRNI---------R 496
             IG G++G+VYK         VA+K V   +  G           +R +          
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGL--PISTVREVALLRRLEAFE 72

Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H N+V+++  C++S         LV+E +    L ++L  + A      + +I   +++ 
Sbjct: 73  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQF 129

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI-------PEV 609
                    L++LH +    IVH DLKP N+L+ +     + DFGL R         P V
Sbjct: 130 ------LRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV 180

Query: 610 ISSNQCSSVGLKGTVGYAAPEYGMGSQVST 639
           +            T+ Y APE  + S  +T
Sbjct: 181 V------------TLWYRAPEVLLQSTYAT 198

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 82.3 bits (204), Expect = 3e-18
 Identities = 25/165 (15%), Positives = 64/165 (38%), Gaps = 18/165 (10%)

Query: 128 LRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVL 187
           + +LT +  A        V DL  ++   N   ++ +++N     +    +  L  L+ L
Sbjct: 43  MNSLTYITLANI-----NVTDLTGIEYAHN---IKDLTINNIHATNYN-PISGLSNLERL 93

Query: 188 SLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYP 247
            +   +++ +   +L   T LT L++  ++   SI + +    ++ S+DLS    +    
Sbjct: 94  RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM 153

Query: 248 V-------RWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGE 285
                   + L++  + +     +   +   +  L      + G+
Sbjct: 154 PLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 78.5 bits (194), Expect = 6e-17
 Identities = 35/191 (18%), Positives = 65/191 (34%), Gaps = 26/191 (13%)

Query: 138 RNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGE 197
              LG     ++     + + TY+ + ++NV  L  I     Y   ++ L++   + +  
Sbjct: 27  NGLLGQSSTANITEAQ-MNSLTYITLANINVTDLTGI----EYAHNIKDLTINNIHATN- 80

Query: 198 IPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNH 257
             + +   + L  L + G  +       L     L  LD+S                H+ 
Sbjct: 81  -YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS----------------HSA 123

Query: 258 LTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSL 317
               I   +  L  +  +DLS N    +I   L +   L+ LN+  +  H     G+   
Sbjct: 124 HDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDY--RGIEDF 180

Query: 318 KSLEGLDLFQN 328
             L  L  F  
Sbjct: 181 PKLNQLYAFSQ 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 67.3 bits (165), Expect = 4e-13
 Identities = 23/154 (14%), Positives = 59/154 (38%), Gaps = 12/154 (7%)

Query: 181 LPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKT 240
                   L +++ +    + + +   LT + L   ++   + + +   H ++ L ++  
Sbjct: 22  FKAYLNGLLGQSSTANITEAQMNS---LTYITLANINVT-DL-TGIEYAHNIKDLTINNI 76

Query: 241 -----IFLGQYP-VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCV 294
                  +     +  L +    +T      +  L S+  LD+S +     I + + +  
Sbjct: 77  HATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP 136

Query: 295 GLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
            +  ++LS N     I P L +L  L+ L++  +
Sbjct: 137 KVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFD 169

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 66.1 bits (162), Expect = 1e-12
 Identities = 23/152 (15%), Positives = 55/152 (36%), Gaps = 16/152 (10%)

Query: 46  NLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNAS 105
            + +   ++ L +          +          L N+    + G     +   ++S  +
Sbjct: 61  GIEYAHNIKDLTINNIHATNYNPIS--------GLSNLERLRIMGKDVTSDKIPNLSGLT 112

Query: 106 KLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVS 165
            L  LD ++++   SI   +  L  +  ++ + N      + D+  L +L     L+ ++
Sbjct: 113 SLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG----AITDIMPLKTLPE---LKSLN 165

Query: 166 LNVNSLRSIPISVGYLPKLQVLSLFENNISGE 197
           +  + +      +   PKL  L  F   I G+
Sbjct: 166 IQFDGVHDYR-GIEDFPKLNQLYAFSQTIGGK 196

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 84.7 bits (210), Expect = 6e-18
 Identities = 45/192 (23%), Positives = 74/192 (38%), Gaps = 30/192 (15%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKV-----LFLHQRGALKSFMAECEALRNIRHRNLVKI 503
           IG G F  V + I        AVK+            + +    E      ++H ++V++
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLH--PESASDDLNYSPSILSFLQRLNIAIN 561
           +       +  +    +V+EFM    L        + A     YS ++ S   R      
Sbjct: 92  LET-----YSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMR-----Q 138

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLL---DNDMIAHVGDFGLTRFIPEVISSNQCSSV 618
           +  AL Y H +    I+H D+KP  VLL   +N     +G FG+   + E    +   + 
Sbjct: 139 ILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE----SGLVAG 191

Query: 619 GLKGTVGYAAPE 630
           G  GT  + APE
Sbjct: 192 GRVGTPHFMAPE 203

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 83.9 bits (208), Expect = 7e-18
 Identities = 45/198 (22%), Positives = 74/198 (37%), Gaps = 41/198 (20%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           +     +G G+FG VYK        + A KV+       L+ ++ E E L    H  +VK
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI-- 560
           ++ A     +  +    ++ EF   G++            +      L+  Q   I +  
Sbjct: 81  LLGA-----YYHDGKLWIMIEFCPGGAV---------DAIMLELDRGLTEPQ---IQVVC 123

Query: 561 -NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG----LTR-------FI-- 606
             +  AL +LH    K+I+H DLK  NVL+  +    + DFG      +       FI  
Sbjct: 124 RQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGT 180

Query: 607 -----PEVISSNQCSSVG 619
                PEV+         
Sbjct: 181 PYWMAPEVVMCETMKDTP 198

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 84.6 bits (210), Expect = 8e-18
 Identities = 46/163 (28%), Positives = 75/163 (46%), Gaps = 20/163 (12%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMA--ECEALRNIRHRNLVKIITA 506
           IG G+FG V+K         VA+K + +          A  E + L+ ++H N+V +I  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84

Query: 507 CSSSDFQGNDFKA---LVYEFMHHGSLESWLHPESASDDLNYSPS-ILSFLQRLNIAINV 562
           C +     N  K    LV++F  H  L   L     +  + ++ S I   +Q L      
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEH-DLAGLLS----NVLVKFTLSEIKRVMQMLL----- 134

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF 605
            + L Y+H +   +I+H D+K +NVL+  D +  + DFGL R 
Sbjct: 135 -NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 173

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 82.7 bits (205), Expect = 9e-18
 Identities = 54/241 (22%), Positives = 87/241 (36%), Gaps = 31/241 (12%)

Query: 97  IPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLV 156
           IP ++      + LD + N L             L  L+ +R ++ T +        SL 
Sbjct: 22  IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG---AYQSLS 76

Query: 157 NCTYLEIVSLNVNSLRSIPISV-GYLPKLQVLSLFENNISGEIPSSL-GNFTFLTELNLR 214
           + + L    L  N ++S+ +     L  LQ L   E N++  + +   G+   L ELN+ 
Sbjct: 77  HLSTL---ILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVA 132

Query: 215 GNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIP- 273
            N I+ S          L +L               LDLS N +       +  L  +P 
Sbjct: 133 HNLIQ-SFKLP-EYFSNLTNL-------------EHLDLSSNKIQSIYCTDLRVLHQMPL 177

Query: 274 ---HLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTF 330
               LDLS N ++  I       + L+ L L  N            L SL+ + L  N +
Sbjct: 178 LNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 236

Query: 331 Q 331
            
Sbjct: 237 D 237

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 65.4 bits (160), Expect = 7e-12
 Identities = 38/213 (17%), Positives = 73/213 (34%), Gaps = 17/213 (7%)

Query: 9   NLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNL-THCSELRTLDLVLNKLEENQ 67
           +L  N       +      +L+ +  +   +Q  I        S L TL L  N ++   
Sbjct: 34  DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQS-- 90

Query: 68  LVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSI-SNASKLEWLDFANNSLTASIPED-- 124
               L       L +++  +        ++ +    +   L+ L+ A+N +  S      
Sbjct: 91  ----LALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEY 144

Query: 125 LGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIV-SLNVNSLRSIPISVGYLPK 183
              L NL  L+ + N + +    DL     L     L +   L++N +  I        +
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDL---RVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR 201

Query: 184 LQVLSLFENNISGEIPSSLGNFTFLTELNLRGN 216
           L+ L+L  N +           T L ++ L  N
Sbjct: 202 LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 62.7 bits (153), Expect = 5e-11
 Identities = 43/193 (22%), Positives = 72/193 (37%), Gaps = 29/193 (15%)

Query: 156 VNCTYLEIVSLNVNSLRSIPISVGYLPK-LQVLSLFENNISGEIPSSLGNFTFLTELNLR 214
             C           +   IP +   LP   + L L  N +      S  +F  L  L+L 
Sbjct: 12  YQCME--------LNFYKIPDN---LPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 60

Query: 215 GNSIRGSIPS-ALGNCHQLQSLDLSK--------TIFLGQYPVRWLDLSHNHLTGPIPLA 265
              I+ +I   A  +   L +L L+           F G   ++ L     +L       
Sbjct: 61  RCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119

Query: 266 VGNLKSIPHLDLSKNKL-SGEIPSSLGSCVGLEYLNLSINSFHGPIHPG----LSSLKSL 320
           +G+LK++  L+++ N + S ++P    +   LE+L+LS N     I+      L  +  L
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLL 178

Query: 321 EG-LDLFQNTFQA 332
              LDL  N    
Sbjct: 179 NLSLDLSLNPMNF 191

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 83.4 bits (206), Expect = 1e-17
 Identities = 54/228 (23%), Positives = 72/228 (31%), Gaps = 30/228 (13%)

Query: 103 NASKLEWLDFANNSLTASIPEDLGRL--RNLTRLNFARNDLGTRKVNDLRFLDSLVNC-- 158
             S L+ L   N  +T + P  L      +L  LN       TR      +L  L     
Sbjct: 93  GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR----DAWLAELQQWLK 148

Query: 159 TYLEIVSLNVNSLRSIPIS-VGYLPKLQVLSLFENNISGEIPSS----LGNFTFLTELNL 213
             L+++S+      +     V   P L  L L +N   GE           F  L  L L
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208

Query: 214 RGN---SIRGSIPSALGNCHQLQSLDLSK---------TIFLGQYPVRWLDLSHNHLTGP 261
           R     +  G   +      QLQ LDLS                  +  L+LS   L   
Sbjct: 209 RNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQV 268

Query: 262 IPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGP 309
                  L     LDLS N+L    PS       +  L+L  N F   
Sbjct: 269 PKGLPAKLSV---LDLSYNRLD-RNPSPDE-LPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 44/244 (18%), Positives = 74/244 (30%), Gaps = 23/244 (9%)

Query: 102 SNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYL 161
              S    L   +         D+ +  +L RL      + +R +     +  +     L
Sbjct: 41  GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100

Query: 162 EIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTF----LTELNLRGNS 217
            + +L V      P+     P L +L+L   + +           +    L  L++    
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160

Query: 218 IRGSIPSALGNCHQLQSLDLSKTIFLGQYPV------------RWLDLSHNHLT---GPI 262
                   +     L +LDLS    LG+  +            + L L +  +    G  
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220

Query: 263 PLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVG-LEYLNLSINSFHGPIHPGLSSLKSLE 321
                    +  LDLS N L     +        L  LNLS       +  GL +   L 
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPA--KLS 277

Query: 322 GLDL 325
            LDL
Sbjct: 278 VLDL 281

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 79.6 bits (196), Expect = 2e-16
 Identities = 40/263 (15%), Positives = 76/263 (28%), Gaps = 33/263 (12%)

Query: 8   INLQQNNFSGNIPHEIGRLF---QLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLE 64
           + ++       I     R+     L+ +   +  + G  P  L   +      L L  + 
Sbjct: 73  LTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVS 132

Query: 65  ENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPED 124
                  L     +  P +++  +A           +     L  LD ++N         
Sbjct: 133 WATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192

Query: 125 ----LGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVG- 179
                 +   L  L      + T          + V    L+ + L+ NSLR    +   
Sbjct: 193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQ---LQGLDLSHNSLRDAAGAPSC 249

Query: 180 -YLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLS 238
            +  +L  L+L    +  ++P  L     L+ L+L  N +    PS      +L  +   
Sbjct: 250 DWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLD-RNPSPD----ELPQV--- 298

Query: 239 KTIFLGQYPVRWLDLSHNHLTGP 261
                       L L  N     
Sbjct: 299 ----------GNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 66.1 bits (161), Expect = 6e-12
 Identities = 54/229 (23%), Positives = 79/229 (34%), Gaps = 24/229 (10%)

Query: 113 ANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLR 172
           A N L A+  E  G  R+L  L   R D           + SL +   L + +  + S  
Sbjct: 27  AFNCLGAADVELYGGGRSLEYL-LKRVDTEADLGQFTDIIKSL-SLKRLTVRAARIPSRI 84

Query: 173 SIPI-SVGYLPKLQVLSLFENNISGEIPSSLGNFTF--LTELNLRGNSIRGSIPSALGNC 229
                 V  +  LQ L+L    ++G  P  L   T   L  LNLR  S      + L   
Sbjct: 85  LFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAEL 143

Query: 230 HQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSS 289
            Q     L           + L ++  H        V    ++  LDLS N   GE    
Sbjct: 144 QQWLKPGL-----------KVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192

Query: 290 LGSCVG----LEYLNLS---INSFHGPIHPGLSSLKSLEGLDLFQNTFQ 331
              C      L+ L L    + +  G      ++   L+GLDL  N+ +
Sbjct: 193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLR 241

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 25/166 (15%), Positives = 53/166 (31%), Gaps = 14/166 (8%)

Query: 198 IPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNH 257
                     +  L+L+  ++R +   +      L+ L +S         ++ L L +  
Sbjct: 55  EADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISG--------LQELTLENLE 106

Query: 258 LTG--PIPLAVGNLKSIPHLDLSKNKLSGE--IPSSLGSCV--GLEYLNLSINSFHGPIH 311
           +TG  P PL       +  L+L     +      + L   +  GL+ L+++         
Sbjct: 107 VTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSC 166

Query: 312 PGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNE 357
             +    +L  LDL  N    +           F     +++    
Sbjct: 167 EQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 48/212 (22%), Positives = 86/212 (40%), Gaps = 25/212 (11%)

Query: 123 EDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLP 182
                L N  ++   ++++            +  +   +  +S     + +I   V YL 
Sbjct: 13  FPDPALANAIKIAAGKSNVTD--------TVTQADLDGITTLSAFGTGVTTIE-GVQYLN 63

Query: 183 KLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKT-- 240
            L  L L +N I+    + L N T +TEL L GN +     SA+     +++LDL+ T  
Sbjct: 64  NLIGLELKDNQITD--LAPLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQI 119

Query: 241 ---IFLGQYP-VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGL 296
                L     ++ L L  N +T   PLA   L ++ +L +   ++S ++ + L +   L
Sbjct: 120 TDVTPLAGLSNLQVLYLDLNQITNISPLA--GLTNLQYLSIGNAQVS-DL-TPLANLSKL 175

Query: 297 EYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
             L    N         L+SL +L  + L  N
Sbjct: 176 TTLKADDNKISDI--SPLASLPNLIEVHLKNN 205

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 81.7 bits (202), Expect = 4e-17
 Identities = 48/273 (17%), Positives = 93/273 (34%), Gaps = 36/273 (13%)

Query: 46  NLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNAS 105
                +    +    + + +     +L          I      G      I   +   +
Sbjct: 14  PDPALANAIKIAAGKSNVTDTVTQADLD--------GITTLSAFGTGV-TTIEG-VQYLN 63

Query: 106 KLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVS 165
            L  L+  +N +T  +   L  L  +T L  + N      + ++  +  L +   L+   
Sbjct: 64  NLIGLELKDNQIT-DLAP-LKNLTKITELELSGN-----PLKNVSAIAGLQSIKTLD--- 113

Query: 166 LNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSA 225
           L    +  +   +  L  LQVL L  N I+  I S L   T L  L++    +   + + 
Sbjct: 114 LTSTQITDVT-PLAGLSNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVS-DL-TP 168

Query: 226 LGNCHQLQSLDLSKT-----IFLGQYP-VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSK 279
           L N  +L +L            L   P +  + L +N ++   PLA  N  ++  + L+ 
Sbjct: 169 LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTN 226

Query: 280 NKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHP 312
             ++ +      +   L   N+       PI P
Sbjct: 227 QTITNQPVFYNNN---LVVPNVVKGPSGAPIAP 256

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 46/238 (19%), Positives = 95/238 (39%), Gaps = 27/238 (11%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
            L  L+ + L+ N  + ++   +  L ++  +  + N L+  +   +     ++TLDL  
Sbjct: 61  YLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTS 116

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
            ++ +   +  L         N+++  L  NQ   NI   ++  + L++L   N  ++  
Sbjct: 117 TQITDVTPLAGLS--------NLQVLYLDLNQI-TNIS-PLAGLTNLQYLSIGNAQVS-D 165

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGY 180
           +   L  L  LT L    N     K++D+  L SL N   L  V L  N +  +   +  
Sbjct: 166 L-TPLANLSKLTTLKADDN-----KISDISPLASLPN---LIEVHLKNNQISDVS-PLAN 215

Query: 181 LPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLS 238
              L +++L    I+ +      N        ++G S     P+ + +     S +L+
Sbjct: 216 TSNLFIVTLTNQTITNQPVFYNNNLVVP--NVVKGPSGAPIAPATISDNGTYASPNLT 271

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 83.4 bits (207), Expect = 2e-17
 Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 25/163 (15%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKS---FMA--ECEALRNIRHRNLVKI 503
           +G G F +VYK        +VA+K + L  R   K      A  E + L+ + H N++ +
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPS-ILSFLQRLNIAINV 562
           + A     F      +LV++FM    LE  +      + L  +PS I +++         
Sbjct: 78  LDA-----FGHKSNISLVFDFMET-DLEVIIK----DNSLVLTPSHIKAYMLMT------ 121

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF 605
              LEYLH H    I+H DLKP+N+LLD + +  + DFGL + 
Sbjct: 122 LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS 161

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 85.3 bits (211), Expect = 2e-17
 Identities = 56/353 (15%), Positives = 115/353 (32%), Gaps = 37/353 (10%)

Query: 3   TFLMLINLQQNNFSGNIPHEIGRL-FQLRYIIFNSNTLQG-QIPVNLTHCSELRTLDLVL 60
              +L++L   +  G     +      + +++F+ N+L   Q+ +++     L+  ++ L
Sbjct: 171 LSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKL 230

Query: 61  NKLEENQL------VGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFAN 114
           N     +L      +   P  +  TL +I        + F            +E+L+  N
Sbjct: 231 NDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPR-----PVEYLNIYN 285

Query: 115 NSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLV--NCTYLEIVSLNVNSLR 172
            ++T  I  +          +     +   K     F    +      + I  L+++   
Sbjct: 286 LTITERIDREEFTYSETALKSLMIEHV---KNQVFLFSKEALYSVFAEMNIKMLSISDTP 342

Query: 173 SIPISV-GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQ 231
            I +           L+  +N  +  +         L  L L+ N ++ +          
Sbjct: 343 FIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKN 401

Query: 232 LQSLDLS------------KTIFLGQYPVRWLDLSHNHLT-GPIPLAVGNLKSIPHLDLS 278
           + SL+                       +  L+LS N LT          +K    LDL 
Sbjct: 402 MSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVK---VLDLH 458

Query: 279 KNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQ 331
            N++   IP  +     L+ LN++ N            L SL+ + L  N + 
Sbjct: 459 NNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWD 510

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 79.1 bits (195), Expect = 1e-15
 Identities = 52/318 (16%), Positives = 106/318 (33%), Gaps = 37/318 (11%)

Query: 1   NLTFLMLINLQQNNFSG----NIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHC---SEL 53
            L  L L N++ N+ +         E+ R   L  +         +  V L        +
Sbjct: 219 ALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPV 278

Query: 54  RTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFA 113
             L++    + E  +  E   Y    L ++ I  +    F  +     S  +++     +
Sbjct: 279 EYLNIYNLTITER-IDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLS 337

Query: 114 NNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRS 173
            +              + T LNF +N       +  +   +L     L+ + L  N L++
Sbjct: 338 ISDTPFIHMVCPPSPSSFTFLNFTQNVFTD---SVFQGCSTLKR---LQTLILQRNGLKN 391

Query: 174 IPISVGYLPKLQVLSLFENNI----SGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNC 229
                     +  L   + ++    S     +      +  LNL  N + GS+   L   
Sbjct: 392 FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP-- 449

Query: 230 HQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSS 289
            +++                 LDL +N +   IP  V +L+++  L+++ N+L       
Sbjct: 450 PKVK----------------VLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKSVPDGV 492

Query: 290 LGSCVGLEYLNLSINSFH 307
                 L+Y+ L  N + 
Sbjct: 493 FDRLTSLQYIWLHDNPWD 510

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 69.9 bits (171), Expect = 1e-12
 Identities = 59/363 (16%), Positives = 118/363 (32%), Gaps = 42/363 (11%)

Query: 9   NLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNL-THCSELRTLDLVLNKLEE-- 65
           +L QN+ S     +I  L +LR +  + N ++  +  ++     +L  LD+  N+L+   
Sbjct: 58  SLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQNIS 116

Query: 66  --------------NQLVGELPPYIGFT-LPNIRIPLLAGNQFFGNIPHSISNASKLEW- 109
                         N     LP    F  L  +    L+  +F   +         L   
Sbjct: 117 CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKF-RQLDLLPVAHLHLSCI 174

Query: 110 -LDFANNSLTASIPEDLGRL-RNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLN 167
            LD  +  +     E L      +  L F  N L + +VN        +  + +++   N
Sbjct: 175 LLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDEN 234

Query: 168 VNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNF---TFLTELNLRGNSIRGSIPS 224
              L +    +   P L  ++L     + +    L  F     +  LN+   +I   I  
Sbjct: 235 CQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDR 294

Query: 225 ALG-------------NCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKS 271
                           +      L   + ++     +    LS +       +   +  S
Sbjct: 295 EEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSS 354

Query: 272 IPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFH--GPIHPGLSSLKSLEGLDLFQNT 329
              L+ ++N  +  +     +   L+ L L  N       +     ++ SLE LD+  N+
Sbjct: 355 FTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNS 414

Query: 330 FQA 332
             +
Sbjct: 415 LNS 417

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 45/208 (21%), Positives = 78/208 (37%), Gaps = 30/208 (14%)

Query: 105 SKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLV--NCTYLE 162
            + + L  + NS++     D+  L  L  L  + N + +        LD  V      LE
Sbjct: 52  PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS--------LDFHVFLFNQDLE 103

Query: 163 IVSLNVNSLRSIPISVGYLPKLQVLSLFENNI-SGEIPSSLGNFTFLTELNLRGNSIRGS 221
            + ++ N L++I      +  L+ L L  N+     +    GN T LT L L        
Sbjct: 104 YLDVSHNRLQNISCCP--MASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAA----- 156

Query: 222 IPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLK-SIPHLDLSKN 280
                    + + LDL     L       LDL   H+ G    ++     ++ HL    N
Sbjct: 157 ---------KFRQLDLLPVAHL-HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPN 206

Query: 281 KL-SGEIPSSLGSCVGLEYLNLSINSFH 307
            L S ++  S+ +   L+  N+ +N  +
Sbjct: 207 SLFSVQVNMSVNALGHLQLSNIKLNDEN 234

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 54.9 bits (132), Expect = 6e-08
 Identities = 37/150 (24%), Positives = 61/150 (40%), Gaps = 22/150 (14%)

Query: 158 CTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNS 217
                +V  +  +L  +P      P+ + LSL +N+IS      +   + L  L L  N 
Sbjct: 30  NELESMVDYSNRNLTHVPK--DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHN- 86

Query: 218 IRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDL 277
                        +++SLD    +F     + +LD+SHN L     ++   + S+ HLDL
Sbjct: 87  -------------RIRSLDFHVFLFNQD--LEYLDVSHNRLQN---ISCCPMASLRHLDL 128

Query: 278 SKNKL-SGEIPSSLGSCVGLEYLNLSINSF 306
           S N      +    G+   L +L LS   F
Sbjct: 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKF 158

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 47/187 (25%), Positives = 74/187 (39%), Gaps = 26/187 (13%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFL-HQRGALKSFMAECE-ALRNIRHRNLVKIITA 506
           IG G++GSV K +  P   ++AVK +         K  + + +  +R+     +V+    
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ---- 85

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
              + F+  D   +  E M   S + +     +  D      IL       I +    AL
Sbjct: 86  FYGALFREGDCW-ICMELM-STSFDKFYKYVYSVLDDVIPEEILGK-----ITLATVKAL 138

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG- 625
            +L      +I+H D+KPSN+LLD      + DFG        IS     S+      G 
Sbjct: 139 NHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFG--------ISGQLVDSIAKTRDAGC 188

Query: 626 --YAAPE 630
             Y APE
Sbjct: 189 RPYMAPE 195

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 51/197 (25%), Positives = 77/197 (39%), Gaps = 43/197 (21%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKS---------FMAECEALRNI-RHR 498
           +G G    V + I  P     AVK++ +   G+  +          + E + LR +  H 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDL----NYSPSILSFLQ 554
           N++++        ++ N F  LV++ M  G L          D L      S      + 
Sbjct: 85  NIIQLKDT-----YETNTFFFLVFDLMKKGEL---------FDYLTEKVTLSEKETRKIM 130

Query: 555 RLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI-PEVISSN 613
           R      +   +  LH      IVH DLKP N+LLD+DM   + DFG +  + P      
Sbjct: 131 R-----ALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE 182

Query: 614 QCSSVGLKGTVGYAAPE 630
            C      GT  Y APE
Sbjct: 183 VC------GTPSYLAPE 193

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 81.8 bits (203), Expect = 3e-17
 Identities = 49/199 (24%), Positives = 87/199 (43%), Gaps = 42/199 (21%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--GALKSFMAECEALRNIRHRNLVKIITA 506
           IG G++G+V+K        +VA+K + L     G   S + E   L+ ++H+N+V++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH-- 67

Query: 507 CSSSD-FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
               D    +    LV+EF     L+ +   +S + DL+    + SFL +L         
Sbjct: 68  ----DVLHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLD-PEIVKSFLFQL------LKG 113

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI--------PEVISSNQCSS 617
           L + H      ++H DLKP N+L++ +    + +FGL R           EV+       
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV------- 163

Query: 618 VGLKGTVGYAAPEYGMGSQ 636
                T+ Y  P+   G++
Sbjct: 164 -----TLWYRPPDVLFGAK 177

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 82.2 bits (204), Expect = 3e-17
 Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 41/198 (20%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--GALKSFMAECEALRNIRHRNLVKIITA 506
           +G G++G VYK   D    +VA+K + L     G   + + E   L+ + H N+V +I  
Sbjct: 29  VGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
                        LV+EFM    L+  L  +     L     I  +L +L         +
Sbjct: 88  -----IHSERCLTLVFEFMEK-DLKKVL--DENKTGLQ-DSQIKIYLYQL------LRGV 132

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR--------FIPEVISSNQCSSV 618
            + H H   +I+H DLKP N+L+++D    + DFGL R        +  EV+        
Sbjct: 133 AHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-------- 181

Query: 619 GLKGTVGYAAPEYGMGSQ 636
               T+ Y AP+  MGS+
Sbjct: 182 ----TLWYRAPDVLMGSK 195

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 83.2 bits (206), Expect = 4e-17
 Identities = 46/199 (23%), Positives = 76/199 (38%), Gaps = 47/199 (23%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL--------FLHQRGALKSFMAECEALRNIRHRNL 500
           +G+G+ G V           VA++++           +     +   E E L+ + H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWL-----HPESASDDLNYSPSILSFLQR 555
           +KI     + D+       +V E M  G L   +       E+             F Q 
Sbjct: 203 IKIKNFFDAEDYY------IVLELMEGGELFDKVVGNKRLKEATCKLY--------FYQ- 247

Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL---DNDMIAHVGDFGLTRFI-PEVIS 611
                 +  A++YLH +    I+H DLKP NVLL   + D +  + DFG ++ +    + 
Sbjct: 248 ------MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 298

Query: 612 SNQCSSVGLKGTVGYAAPE 630
              C      GT  Y APE
Sbjct: 299 RTLC------GTPTYLAPE 311

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 81.9 bits (203), Expect = 4e-17
 Identities = 47/202 (23%), Positives = 78/202 (38%), Gaps = 45/202 (22%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           F    ++G GSF +V            A+K+L    + +   +     E + +  + H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI- 558
            VK+        FQ ++       +  +G L                   L +++++   
Sbjct: 92  FVKLYFT-----FQDDEKLYFGLSYAKNGEL-------------------LKYIRKIGSF 127

Query: 559 --------AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV--GDFGLTRFIPE 608
                      + SALEYLH    K I+H DLKP N+LL+ DM  H+   DFG  + +  
Sbjct: 128 DETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDM--HIQITDFGTAKVLSP 182

Query: 609 VISSNQCSSVGLKGTVGYAAPE 630
                + +S    GT  Y +PE
Sbjct: 183 ESKQARANS--FVGTAQYVSPE 202

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 82.2 bits (203), Expect = 4e-17
 Identities = 45/183 (24%), Positives = 76/183 (41%), Gaps = 24/183 (13%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVKIITAC 507
           +G G+ G V+K    P   V+A K++ L  +       + E + L       +V      
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG----F 96

Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
             + +   +   +  E M  GSL          D +      +       ++I V   L 
Sbjct: 97  YGAFYSDGEIS-ICMEHMDGGSL----------DQVLKKAGRIPEQILGKVSIAVIKGLT 145

Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYA 627
           YL    K +I+H D+KPSN+L+++     + DFG++    ++I S   S V   GT  Y 
Sbjct: 146 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV---GTRSYM 197

Query: 628 APE 630
           +PE
Sbjct: 198 SPE 200

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 81.2 bits (201), Expect = 4e-17
 Identities = 41/157 (26%), Positives = 64/157 (40%), Gaps = 17/157 (10%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA-LKSFMAECEALRNIRHRNLVKIITAC 507
           IG+G+   V      P +  VA+K + L +    +   + E +A+    H N+V   T+ 
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS- 81

Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI---NVAS 564
               F   D   LV + +  GS+   +  +       +   +L       IA     V  
Sbjct: 82  ----FVVKDELWLVMKLLSGGSVLDII--KHIVAKGEHKSGVLDEST---IATILREVLE 132

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG 601
            LEYLH   K   +H D+K  N+LL  D    + DFG
Sbjct: 133 GLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFG 166

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 82.5 bits (204), Expect = 4e-17
 Identities = 42/185 (22%), Positives = 74/185 (40%), Gaps = 26/185 (14%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           +G+G+FG V++ +      V   K +         +   E   +  + H  L+ +  A  
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-- 116

Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
              F+      L+ EF+  G L   +    A++D   S + +    R          L++
Sbjct: 117 ---FEDKYEMVLILEFLSGGELFDRI----AAEDYKMSEAEVINYMR-----QACEGLKH 164

Query: 569 LHHHCKKQIVHCDLKPSNVLLDNDMIAHV--GDFGLTRFI-PEVISSNQCSSVGLKGTVG 625
           +H   +  IVH D+KP N++ +    + V   DFGL   + P+ I            T  
Sbjct: 165 MH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT------ATAE 215

Query: 626 YAAPE 630
           +AAPE
Sbjct: 216 FAAPE 220

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 81.6 bits (202), Expect = 5e-17
 Identities = 45/187 (24%), Positives = 77/187 (41%), Gaps = 37/187 (19%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
             S   IG GS G V           VAVK++ L ++   +    E   +R+ +H N+V+
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +  +     +   +   ++ EF+  G+L           D+  S   L+  Q   +   V
Sbjct: 107 MYKS-----YLVGEELWVLMEFLQGGAL----------TDI-VSQVRLNEEQIATVCEAV 150

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG----LTR-------FI----- 606
             AL YLH    + ++H D+K  ++LL  D    + DFG    +++        +     
Sbjct: 151 LQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYW 207

Query: 607 --PEVIS 611
             PEVIS
Sbjct: 208 MAPEVIS 214

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 81.6 bits (202), Expect = 5e-17
 Identities = 52/190 (27%), Positives = 80/190 (42%), Gaps = 25/190 (13%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR-HRNLVKIITA 506
           ++G G+   V   I        AVK++             E E L   + HRN++++I  
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
                F+  D   LV+E M  GS+ S +H        +++    S + +     +VASAL
Sbjct: 80  -----FEEEDRFYLVFEKMRGGSILSHIHKRR-----HFNELEASVVVQ-----DVASAL 124

Query: 567 EYLHHHCKKQIVHCDLKPSNVLL---DNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK-- 621
           ++LH    K I H DLKP N+L    +      + DF L   I      +  S+  L   
Sbjct: 125 DFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181

Query: 622 -GTVGYAAPE 630
            G+  Y APE
Sbjct: 182 CGSAEYMAPE 191

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 81.5 bits (202), Expect = 6e-17
 Identities = 51/203 (25%), Positives = 90/203 (44%), Gaps = 41/203 (20%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR-GALKSFMAECEALRNIRHRNLV 501
           +   + +G G++ +VYKG       +VA+K + L    GA  + + E   L++++H N+V
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 63

Query: 502 KIITACSSSD-FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
            +       D         LV+E++    L+ +L  +   + +N   ++  FL +L    
Sbjct: 64  TLH------DIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNIIN-MHNVKLFLFQL---- 109

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF--IP------EVISS 612
                L Y H     +++H DLKP N+L++      + DFGL R   IP      EV+  
Sbjct: 110 --LRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-- 162

Query: 613 NQCSSVGLKGTVGYAAPEYGMGS 635
                     T+ Y  P+  +GS
Sbjct: 163 ----------TLWYRPPDILLGS 175

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 80.9 bits (200), Expect = 6e-17
 Identities = 53/235 (22%), Positives = 102/235 (43%), Gaps = 25/235 (10%)

Query: 100 SISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCT 159
           + +  + ++ +   N+ +  S+ + +  L N+T+L    N     K+ D++ L +L N  
Sbjct: 41  TQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGN-----KLTDIKPLANLKNLG 93

Query: 160 YLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIR 219
           +L    L+ N ++ +  S+  L KL+ LSL  N IS +I + L +   L  L L  N I 
Sbjct: 94  WL---FLDENKVKDLS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKI- 146

Query: 220 GSIPSALGNCHQLQSLDLSKT-----IFLGQYP-VRWLDLSHNHLTGPIPLAVGNLKSIP 273
            +  + L    +L +L L        + L     ++ L LS NH++    LA   LK++ 
Sbjct: 147 -TDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDLRALA--GLKNLD 203

Query: 274 HLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
            L+L   +   +  +   + V    +  +  S   P    +S     E  ++  +
Sbjct: 204 VLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPE--IISDDGDYEKPNVKWH 256

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 43/218 (19%), Positives = 77/218 (35%), Gaps = 25/218 (11%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
            L  +  I    ++   ++   I  L  +  +  N N L   I   L +   L  L L  
Sbjct: 44  ELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDE 99

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
           NK+++   + +L          ++   L  N    +I   + +  +LE L   NN +T  
Sbjct: 100 NKVKDLSSLKDLK--------KLKSLSLEHNGI-SDING-LVHLPQLESLYLGNNKIT-- 147

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGY 180
               L RL  L  L+   N +          +  L   T L+ + L+ N +  +  ++  
Sbjct: 148 DITVLSRLTKLDTLSLEDNQI--------SDIVPLAGLTKLQNLYLSKNHISDLR-ALAG 198

Query: 181 LPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSI 218
           L  L VL LF      +  +   N      +     S+
Sbjct: 199 LKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 81.3 bits (201), Expect = 7e-17
 Identities = 49/192 (25%), Positives = 74/192 (38%), Gaps = 41/192 (21%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA---LKSFMAECEALRNIRHRN 499
           FS    IG GSFG+VY      +  VVA+K +    + +    +  + E   L+ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
            ++         +       LV E+   GS          SD L      L  ++   IA
Sbjct: 116 TIQYRGC-----YLREHTAWLVMEYC-LGSA---------SDLLEVHKKPLQEVE---IA 157

Query: 560 I---NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG----LTR---FI--- 606
                    L YLH      ++H D+K  N+LL    +  +GDFG    +     F+   
Sbjct: 158 AVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTP 214

Query: 607 ----PEVISSNQ 614
               PEVI +  
Sbjct: 215 YWMAPEVILAMD 226

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 80.4 bits (199), Expect = 9e-17
 Identities = 42/190 (22%), Positives = 78/190 (41%), Gaps = 37/190 (19%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++    IG G+ G+VY  +       VA++ + L Q+   +  + E   +R  ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
            + +     +   D   +V E++  GSL           D+  + + +   Q   +    
Sbjct: 82  YLDS-----YLVGDELWVVMEYLAGGSL----------TDV-VTETCMDEGQIAAVCREC 125

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG----LTR-------FI----- 606
             ALE+LH     Q++H D+K  N+LL  D    + DFG    +T         +     
Sbjct: 126 LQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182

Query: 607 --PEVISSNQ 614
             PEV++   
Sbjct: 183 MAPEVVTRKA 192

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 47/199 (23%), Positives = 76/199 (38%), Gaps = 47/199 (23%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL--------FLHQRGALKSFMAECEALRNIRHRNL 500
           +G+G+ G V           VA+K++           +     +   E E L+ + H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSL-----ESWLHPESASDDLNYSPSILSFLQR 555
           +KI     + D+       +V E M  G L      +    E+             F Q 
Sbjct: 78  IKIKNFFDAEDYY------IVLELMEGGELFDKVVGNKRLKEATCKLY--------FYQ- 122

Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL---DNDMIAHVGDFGLTRFI-PEVIS 611
                 +  A++YLH +    I+H DLKP NVLL   + D +  + DFG ++ +    + 
Sbjct: 123 ------MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 173

Query: 612 SNQCSSVGLKGTVGYAAPE 630
              C      GT  Y APE
Sbjct: 174 RTLC------GTPTYLAPE 186

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 79.9 bits (198), Expect = 1e-16
 Identities = 48/199 (24%), Positives = 88/199 (44%), Gaps = 38/199 (19%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQR-GALKSFMAECEALRNIRHRNLVKIITAC 507
           +G G++ +VYKG+       VA+K + L    G   + + E   ++ ++H N+V++    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72

Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWL-HPESASDDLNYSPSIL-SFLQRLNIAINVASA 565
            + +        LV+EFM +  L+ ++      +       +++  F  +L         
Sbjct: 73  HTEN---KLT--LVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL------LQG 120

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI--------PEVISSNQCSS 617
           L + H +   +I+H DLKP N+L++      +GDFGL R           EV+       
Sbjct: 121 LAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV------- 170

Query: 618 VGLKGTVGYAAPEYGMGSQ 636
                T+ Y AP+  MGS+
Sbjct: 171 -----TLWYRAPDVLMGSR 184

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 81.1 bits (200), Expect = 2e-16
 Identities = 37/189 (19%), Positives = 63/189 (33%), Gaps = 27/189 (14%)

Query: 450 GTGSFGSVYKGILDPDQTVVAVKVLFL--HQRGALKSFMAECEALRNIRHRNLVKIITAC 507
           G     +V      P    V V+ + L       +     E    +   H N+V      
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT- 94

Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI---NVAS 564
               F  ++   +V  FM +GS +          DL      +  +  L IA     V  
Sbjct: 95  ----FIADNELWVVTSFMAYGSAK----------DL-ICTHFMDGMNELAIAYILQGVLK 139

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
           AL+Y+HH      VH  +K S++L+  D   ++        +       +      K +V
Sbjct: 140 ALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196

Query: 625 G---YAAPE 630
               + +PE
Sbjct: 197 KVLPWLSPE 205

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 79.1 bits (196), Expect = 2e-16
 Identities = 50/200 (25%), Positives = 86/200 (43%), Gaps = 45/200 (22%)

Query: 449 IGTGSFGSVYKGILDPDQT--VVAVKVLFLHQR--GALKSFMAECEALRNIRHRNLVKII 504
           IG G++G VYK     +      A+K + L +   G   + + E   L+ ++H N+VK+ 
Sbjct: 10  IGEGTYGVVYKAQ---NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
               +          LV+E +    L+  L  +     L  S +  SFL +L       +
Sbjct: 67  DVIHTKK---RLV--LVFEHLDQ-DLKKLL--DVCEGGLE-SVTAKSFLLQL------LN 111

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR--------FIPEVISSNQCS 616
            + Y H     +++H DLKP N+L++ +    + DFGL R        +  E++      
Sbjct: 112 GIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV------ 162

Query: 617 SVGLKGTVGYAAPEYGMGSQ 636
                 T+ Y AP+  MGS+
Sbjct: 163 ------TLWYRAPDVLMGSK 176

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 58/225 (25%), Positives = 88/225 (39%), Gaps = 38/225 (16%)

Query: 418 SSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH 477
           S  S S    L  +   +L    G F    L+G G++G VYKG       + A+KV+ + 
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60

Query: 478 QRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDFKA-LVYEFMHHGSLESWLH 535
                +    E   L+    HRN+     A    +  G D +  LV EF   GS+     
Sbjct: 61  G-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV----- 114

Query: 536 PESASDDLNYSPSILSFLQRLNIAI---NVASALEYLHHHCKKQIVHCDLKPSNVLLDND 592
                 DL    +  + L+   IA     +   L +LH   + +++H D+K  NVLL  +
Sbjct: 115 -----TDL-IKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTEN 165

Query: 593 MIAHVGDFG----LTR-------FI-------PEVISSNQCSSVG 619
               + DFG    L R       FI       PEVI+ ++     
Sbjct: 166 AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDAT 210

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 49/194 (25%), Positives = 76/194 (39%), Gaps = 44/194 (22%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA-LKSFMAECEALRNIRHRNLV 501
           F+    IG GSFG V+KGI +  Q VVA+K++ L +    ++    E   L       + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI- 560
           K   +     +  +    ++ E++  GS    L P                L    IA  
Sbjct: 84  KYYGS-----YLKDTKLWIIMEYLGGGSALDLLEPGP--------------LDETQIATI 124

Query: 561 --NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG----LTR-------FI- 606
              +   L+YLH    ++ +H D+K +NVLL       + DFG    LT        F+ 
Sbjct: 125 LREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVG 181

Query: 607 ------PEVISSNQ 614
                 PEVI  + 
Sbjct: 182 TPFWMAPEVIKQSA 195

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 78.4 bits (194), Expect = 3e-16
 Identities = 44/192 (22%), Positives = 69/192 (35%), Gaps = 40/192 (20%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG GS+G V   +    +   A K +  +    +  F  E E ++++ H N++++     
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-- 74

Query: 509 SSDFQGNDFKALVYEFMHHGSL------ESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
              F+ N    LV E    G L      +       A+                 I  +V
Sbjct: 75  ---FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR----------------IMKDV 115

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDN---DMIAHVGDFGLTRFI-PEVISSNQCSSV 618
            SA+ Y H      + H DLKP N L      D    + DFGL     P  +   +    
Sbjct: 116 LSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--- 169

Query: 619 GLKGTVGYAAPE 630
              GT  Y +P+
Sbjct: 170 ---GTPYYVSPQ 178

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 78.5 bits (194), Expect = 4e-16
 Identities = 41/190 (21%), Positives = 71/190 (37%), Gaps = 27/190 (14%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL----FLHQRGALKSFMAECEALRNIRHRNLVK- 502
           L+G GS+G V + +        AVK+L             +   E + LR +RH+N+++ 
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 503 --IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
             ++               +V E+   G  E  +             +   F Q      
Sbjct: 72  VDVLYNEEKQKM------YMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQ------ 117

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   LEYLH      IVH D+KP N+LL       +   G+   +    + + C +   
Sbjct: 118 -LIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-- 171

Query: 621 KGTVGYAAPE 630
           +G+  +  PE
Sbjct: 172 QGSPAFQPPE 181

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 79.8 bits (197), Expect = 4e-16
 Identities = 41/208 (19%), Positives = 78/208 (37%), Gaps = 47/208 (22%)

Query: 449 IGTGSFGSVYKGILDPDQT--VVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITA 506
           +G G++G VYK      +     A+K +     G   S   E   LR ++H N++ +   
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQI--EGTGISMSACREIALLRELKHPNVISLQKV 86

Query: 507 CSSSDFQGNDFKALVYEFMHH---GSLESWLHPESASDDLNYSPSIL-SFLQRLNIAINV 562
             S     +    L++++  H     ++     ++    +     ++ S L ++      
Sbjct: 87  FLSH---ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL----- 138

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH----VGDFGLTRF-----------IP 607
              + YLH +    ++H DLKP+N+L+  +        + D G  R             P
Sbjct: 139 -DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194

Query: 608 EVISSNQCSSVGLKGTVGYAAPEYGMGS 635
            V+            T  Y APE  +G+
Sbjct: 195 VVV------------TFWYRAPELLLGA 210

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 78.4 bits (194), Expect = 6e-16
 Identities = 37/189 (19%), Positives = 69/189 (36%), Gaps = 35/189 (18%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMA-ECEALRNIRHRNLVKIITAC 507
           +G G FG V++ +    +     K  F+  +G  +  +  E   L   RHRN++ +  + 
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAK--FVKVKGTDQVLVKKEISILNIARHRNILHLHES- 69

Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F+  +   +++EF+    +   +     +     +   +           V  AL+
Sbjct: 70  ----FESMEELVMIFEFISGLDIFERI----NTSAFELNEREIVSYVH-----QVCEALQ 116

Query: 568 YLHHHCKKQIVHCDLKPSNVLLDND-----MIAHVGDFGLTRFI-PEVISSNQCSSVGLK 621
           +LH H    I H D++P N++          I    +FG  R + P              
Sbjct: 117 FLHSH---NIGHFDIRPENIIYQTRRSSTIKII---EFGQARQLKPGDNFRLLF------ 164

Query: 622 GTVGYAAPE 630
               Y APE
Sbjct: 165 TAPEYYAPE 173

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 79.7 bits (197), Expect = 7e-16
 Identities = 50/192 (26%), Positives = 77/192 (40%), Gaps = 37/192 (19%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKIIT 505
           +G GSFG V            AVKV+    + Q+   +S + E + L+ + H N++K+  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
                 F+   +  LV E    G L   +          +S    +      I   V S 
Sbjct: 94  F-----FEDKGYFYLVGEVYTGGELFDEIISRK-----RFSEVDAA-----RIIRQVLSG 138

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDND------MIAHVGDFGLTRFI-PEVISSNQCSSV 618
           + Y+H +   +IVH DLKP N+LL++        I    DFGL+          ++    
Sbjct: 139 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRII---DFGLSTHFEASKKMKDKI--- 189

Query: 619 GLKGTVGYAAPE 630
              GT  Y APE
Sbjct: 190 ---GTAYYIAPE 198

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 78.6 bits (194), Expect = 8e-16
 Identities = 47/194 (24%), Positives = 73/194 (37%), Gaps = 32/194 (16%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA--LKSFMAECEALRNIRHRNL 500
            S   ++G G FG V+K         +A K   +  RG    +    E   +  + H NL
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAK--IIKTRGMKDKEEVKNEISVMNQLDHANL 148

Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           +++  A     F+  +   LV E++  G L          D +      L+ L  +    
Sbjct: 149 IQLYDA-----FESKNDIVLVMEYVDGGEL---------FDRIIDESYNLTELDTILFMK 194

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLL---DNDMIAHVGDFGLTRFI-PEVISSNQCS 616
            +   + ++H      I+H DLKP N+L    D   I  + DFGL R   P         
Sbjct: 195 QICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIK-IIDFGLARRYKPREKLKVNF- 249

Query: 617 SVGLKGTVGYAAPE 630
                GT  + APE
Sbjct: 250 -----GTPEFLAPE 258

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 79.5 bits (196), Expect = 1e-15
 Identities = 50/230 (21%), Positives = 87/230 (37%), Gaps = 36/230 (15%)

Query: 411 RRKRTVTSSESSSRKDLLLNVSYESLLKATGGFSS----ANLIGTGSFGSVYKGILDPDQ 466
           R K TV+S+  +   D+      + +                +GTG+FG V++       
Sbjct: 123 RGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATG 182

Query: 467 TVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMH 526
              A K +        ++   E + +  +RH  LV +  A     F+ ++   ++YEFM 
Sbjct: 183 NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMVMIYEFMS 237

Query: 527 HGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSN 586
            G L          + +    + +S  + +     V   L ++H   +   VH DLKP N
Sbjct: 238 GGEL---------FEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPEN 285

Query: 587 VLLDND-----MIAHVGDFGLTRFI-PEVISSNQCSSVGLKGTVGYAAPE 630
           ++          +    DFGLT  + P+             GT  +AAPE
Sbjct: 286 IMFTTKRSNELKLI---DFGLTAHLDPKQSVKVTT------GTAEFAAPE 326

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 46/190 (24%), Positives = 76/190 (40%), Gaps = 31/190 (16%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITAC 507
           +G+G+FG V+            +K +   + +  ++   AE E L+++ H N++KI    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV- 88

Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F+      +V E    G L   +   + +     S   ++ L +      + +AL 
Sbjct: 89  ----FEDYHNMYIVMETCEGGELLERIV-SAQARGKALSEGYVAELMK-----QMMNALA 138

Query: 568 YLHHHCKKQIVHCDLKPSNVLLDND------MIAHVGDFGLTRFI-PEVISSNQCSSVGL 620
           Y H      +VH DLKP N+L  +        I    DFGL      +  S+N       
Sbjct: 139 YFHSQ---HVVHKDLKPENILFQDTSPHSPIKII---DFGLAELFKSDEHSTNAA----- 187

Query: 621 KGTVGYAAPE 630
            GT  Y APE
Sbjct: 188 -GTALYMAPE 196

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 78.9 bits (195), Expect = 1e-15
 Identities = 39/191 (20%), Positives = 71/191 (37%), Gaps = 35/191 (18%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITA 506
           +G G+F  V + +        A  ++   +      +    E    R ++H N+V++  +
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDL----NYSPSILSFLQRLNIAINV 562
                        L+++ +  G L          +D+     YS +  S   +      +
Sbjct: 79  -----ISEEGHHYLIFDLVTGGEL---------FEDIVAREYYSEADASHCIQ-----QI 119

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLL---DNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
             A+ + H      +VH +LKP N+LL          + DFGL   +       Q +  G
Sbjct: 120 LEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE----GEQQAWFG 172

Query: 620 LKGTVGYAAPE 630
             GT GY +PE
Sbjct: 173 FAGTPGYLSPE 183

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 49/189 (25%), Positives = 75/189 (39%), Gaps = 32/189 (16%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKIIT 505
           +G GSFG V K      Q   AVKV+       +    + + E E L+ + H N++K+  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFE 88

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
                  + +    +V E    G L   +          +S    + + +      V S 
Sbjct: 89  I-----LEDSSSFYIVGELYTGGELFDEIIKRK-----RFSEHDAARIIK-----QVFSG 133

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLL---DNDMIAHVGDFGLTRFI-PEVISSNQCSSVGLK 621
           + Y+H H    IVH DLKP N+LL   + D    + DFGL+          ++       
Sbjct: 134 ITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI------ 184

Query: 622 GTVGYAAPE 630
           GT  Y APE
Sbjct: 185 GTAYYIAPE 193

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 42/184 (22%), Positives = 75/184 (40%), Gaps = 21/184 (11%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFL-HQRGALKSFMAECE-ALRNIRHRNLVKIITA 506
           +G G++G V K    P   ++AVK +         K  + + + ++R +     V     
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT---- 70

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
              + F+  D   +  E M   SL+ +         +      +       IA+++  AL
Sbjct: 71  FYGALFREGDVW-ICMELM-DTSLDKFY------KQVIDKGQTIPEDILGKIAVSIVKAL 122

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
           E+LH   K  ++H D+KPSNVL++      + DFG++     ++           G   Y
Sbjct: 123 EHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDID--AGCKPY 175

Query: 627 AAPE 630
            APE
Sbjct: 176 MAPE 179

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 79.5 bits (196), Expect = 1e-15
 Identities = 48/196 (24%), Positives = 73/196 (37%), Gaps = 34/196 (17%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAE---CEALRNIR 496
           FS   +IG G FG VY         + A+K L    +  +      + E      +    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250

Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
              +V +  A     F   D  + + + M+ G L   L          +S + + F    
Sbjct: 251 CPFIVCMSYA-----FHTPDKLSFILDLMNGGDLHYHLSQHG-----VFSEADMRFY--- 297

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV--GDFGLTRFIPEVISSNQ 614
             A  +   LE++H    + +V+ DLKP+N+LLD     HV   D GL     +      
Sbjct: 298 --AAEIILGLEHMH---NRFVVYRDLKPANILLDEH--GHVRISDLGLACDFSKKKPHAS 350

Query: 615 CSSVGLKGTVGYAAPE 630
                  GT GY APE
Sbjct: 351 V------GTHGYMAPE 360

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 49/193 (25%), Positives = 77/193 (39%), Gaps = 43/193 (22%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           F     +G GS+GSVYK I      +VA+K + +     L+  + E   ++     ++VK
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI-- 560
              +     +  N    +V E+   GS+         SD +      L+  +   IA   
Sbjct: 89  YYGS-----YFKNTDLWIVMEYCGAGSV---------SDIIRLRNKTLTEDE---IATIL 131

Query: 561 -NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG----LTR-------FI-- 606
            +    LEYLH     + +H D+K  N+LL+ +  A + DFG    LT         I  
Sbjct: 132 QSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGT 188

Query: 607 -----PEVISSNQ 614
                PEVI    
Sbjct: 189 PFWMAPEVIQEIG 201

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 47/194 (24%), Positives = 74/194 (38%), Gaps = 25/194 (12%)

Query: 96  NIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSL 155
           ++P           L  + N L       L     LT+LN  R +L       L+   +L
Sbjct: 28  DLPKD------TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-----LQVDGTL 76

Query: 156 VNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRG 215
                L  + L+ N L+S+P+    LP L VL +  N ++     +L     L EL L+G
Sbjct: 77  PV---LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG 133

Query: 216 NSIRGSIPS-ALGNCHQLQSLDLS--------KTIFLGQYPVRWLDLSHNHLTGPIPLAV 266
           N ++ ++P   L    +L+ L L+          +  G   +  L L  N L   IP   
Sbjct: 134 NELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGF 191

Query: 267 GNLKSIPHLDLSKN 280
                +P   L  N
Sbjct: 192 FGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 74.8 bits (184), Expect = 5e-15
 Identities = 53/230 (23%), Positives = 84/230 (36%), Gaps = 30/230 (13%)

Query: 100 SISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCT 159
            +S  +    ++    +LT ++P DL   ++ T L+ + N L T  +  L         T
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATL---MPYTRLT 58

Query: 160 YLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIR 219
            L   +L+   L  + +    LP L  L L  N +   +P        LT L++  N   
Sbjct: 59  QL---NLDRAELTKLQVDGT-LPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFN--- 110

Query: 220 GSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSK 279
                      +L SL        G   ++ L L  N L    P  +     +  L L+ 
Sbjct: 111 -----------RLTSL--PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN 157

Query: 280 NKLSGEIPSSL-GSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
           N L+ E+P+ L      L+ L L  NS +  I  G      L    L  N
Sbjct: 158 NNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 66.3 bits (162), Expect = 4e-12
 Identities = 51/221 (23%), Positives = 76/221 (34%), Gaps = 28/221 (12%)

Query: 1   NLTFLMLINLQQNNFS---GNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLD 57
            +   + +N  + N +    ++P +   L        + N L       L   + L  L+
Sbjct: 8   KVASHLEVNCDKRNLTALPPDLPKDTTILH------LSENLLYTFSLATLMPYTRLTQLN 61

Query: 58  LVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSL 117
           L   +L       +L       LP +    L+ NQ   ++P        L  LD + N L
Sbjct: 62  LDRAELT------KLQVDGT--LPVLGTLDLSHNQ-LQSLPLLGQTLPALTVLDVSFNRL 112

Query: 118 TASIPEDL-GRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPI 176
           T S+P      L  L  L    N+L   K      L        L   SL  N+L  +P 
Sbjct: 113 T-SLPLGALRGLGELQELYLKGNEL---KTLPPGLLTPTPKLEKL---SLANNNLTELPA 165

Query: 177 SV-GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGN 216
            +   L  L  L L EN++   IP        L    L GN
Sbjct: 166 GLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 46/192 (23%), Positives = 76/192 (39%), Gaps = 38/192 (19%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKII 504
            IG GSFG V     +  + + A+K +      +R  +++   E + ++ + H  LV + 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLH-----PESASDDLNYSPSILSFLQRLNIA 559
            +     FQ  +   +V + +  G L   L       E                 +L I 
Sbjct: 82  YS-----FQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV--------------KLFIC 122

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL-TRFIPEVISSNQCSSV 618
             +  AL+YL     ++I+H D+KP N+LLD     H+ DF +      E   +      
Sbjct: 123 -ELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--- 175

Query: 619 GLKGTVGYAAPE 630
              GT  Y APE
Sbjct: 176 ---GTKPYMAPE 184

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 44/193 (22%), Positives = 73/193 (37%), Gaps = 40/193 (20%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKIIT 505
           +G G+F  V + +        A K++    L  R   +    E    R ++H N+V++  
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHD 72

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDL----NYSPSILSFLQRLNIAIN 561
           +      Q   F  LV++ +  G L          +D+     YS +  S   +      
Sbjct: 73  S-----IQEESFHYLVFDLVTGGEL---------FEDIVAREFYSEADASHCIQ-----Q 113

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLL---DNDMIAHVGDFGLTRFI-PEVISSNQCSS 617
           +  ++ Y H +    IVH +LKP N+LL          + DFGL   +            
Sbjct: 114 ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA-- 168

Query: 618 VGLKGTVGYAAPE 630
               GT GY +PE
Sbjct: 169 ----GTPGYLSPE 177

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 76.5 bits (189), Expect = 2e-15
 Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 20/162 (12%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKII 504
            L+G GS+G V K        +VA+K        +   K  M E + L+ +RH NLV ++
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
                   +      LV+EF+ H ++   L  E   + L+Y   +  +L ++       +
Sbjct: 91  EV-----CKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQ-VVQKYLFQI------IN 135

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
            + + H H    I+H D+KP N+L+    +  + DFG  R +
Sbjct: 136 GIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL 174

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 49/196 (25%), Positives = 78/196 (39%), Gaps = 42/196 (21%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL--------FLHQRGALKSFMAECEALRNIR-HRN 499
           IG G    V + +        AVK++                ++   E   LR +  H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDL----NYSPSILSFLQR 555
           ++ +I +     ++ + F  LV++ M  G L          D L      S      + R
Sbjct: 162 IITLIDS-----YESSSFMFLVFDLMRKGEL---------FDYLTEKVALSEKETRSIMR 207

Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI-PEVISSNQ 614
                ++  A+ +LH +    IVH DLKP N+LLD++M   + DFG +  + P       
Sbjct: 208 -----SLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLREL 259

Query: 615 CSSVGLKGTVGYAAPE 630
           C      GT GY APE
Sbjct: 260 C------GTPGYLAPE 269

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 39/189 (20%), Positives = 68/189 (35%), Gaps = 31/189 (16%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEA---LRNIRHRNLVKII 504
           ++G G  G V +          A+K+L         S  A  E     +     ++V I+
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLL-------YDSPKARQEVDHHWQASGGPHIVCIL 88

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
               +          ++ E M  G L           D  ++    + + R     ++ +
Sbjct: 89  DVYENMHHGKRCL-LIIMECMEGGEL---FSRIQERGDQAFTEREAAEIMR-----DIGT 139

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLL---DNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           A+++LH H    I H D+KP N+L    + D +  + DFG  +   +      C      
Sbjct: 140 AIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC------ 190

Query: 622 GTVGYAAPE 630
            T  Y APE
Sbjct: 191 YTPYYVAPE 199

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 50/187 (26%), Positives = 76/187 (40%), Gaps = 30/187 (16%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITAC 507
            +G G+   VY+      Q   A+KVL   +    K    E   L  + H N++K+    
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEI- 116

Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F+     +LV E +  G L   +  +       YS    +   +      +  A+ 
Sbjct: 117 ----FETPTEISLVLELVTGGELFDRIVEKG-----YYSERDAADAVK-----QILEAVA 162

Query: 568 YLHHHCKKQIVHCDLKPSNVLL---DNDMIAHVGDFGLTRFI-PEVISSNQCSSVGLKGT 623
           YLH +    IVH DLKP N+L      D    + DFGL++ +  +V+    C      GT
Sbjct: 163 YLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC------GT 213

Query: 624 VGYAAPE 630
            GY APE
Sbjct: 214 PGYCAPE 220

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 76.6 bits (189), Expect = 4e-15
 Identities = 44/193 (22%), Positives = 73/193 (37%), Gaps = 40/193 (20%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKIIT 505
           +G G+F  V + +        A K++    L  R   +    E    R ++H N+V++  
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHD 95

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDL----NYSPSILSFLQRLNIAIN 561
           +      Q   F  LV++ +  G L          +D+     YS +  S   +      
Sbjct: 96  S-----IQEESFHYLVFDLVTGGEL---------FEDIVAREFYSEADASHCIQ-----Q 136

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLL---DNDMIAHVGDFGLTRFI-PEVISSNQCSS 617
           +  ++ Y H +    IVH +LKP N+LL          + DFGL   +            
Sbjct: 137 ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA-- 191

Query: 618 VGLKGTVGYAAPE 630
               GT GY +PE
Sbjct: 192 ----GTPGYLSPE 200

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 49/196 (25%), Positives = 76/196 (38%), Gaps = 49/196 (25%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR-HRNLVKIITAC 507
           +G GSF    K +        AVK++        +    E  AL+    H N+VK+    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEV- 74

Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDL----NYSPSILSFLQRLNIAINVA 563
               F       LV E ++ G L          + +    ++S +  S++ R      + 
Sbjct: 75  ----FHDQLHTFLVMELLNGGEL---------FERIKKKKHFSETEASYIMR-----KLV 116

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDND------MIAHVGDFGLTRFIPEVISSNQCSS 617
           SA+ ++H      +VH DLKP N+L  ++       I    DFG  R  P         +
Sbjct: 117 SAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKII---DFGFARLKPP-------DN 163

Query: 618 VGLK---GTVGYAAPE 630
             LK    T+ YAAPE
Sbjct: 164 QPLKTPCFTLHYAAPE 179

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 77.5 bits (191), Expect = 4e-15
 Identities = 52/196 (26%), Positives = 82/196 (41%), Gaps = 31/196 (15%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           F    ++G G FG V+   +     + A K L    L +R   +  M E + L  +  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ---RL 556
           +V +  A     F+      LV   M+ G +   ++     +          F +     
Sbjct: 247 IVSLAYA-----FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG--------FQEPRAIF 293

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV--GDFGLTRFIPEVISSNQ 614
             A  + S LE+LH   ++ I++ DLKP NVLLD+D   +V   D GL     E+ +   
Sbjct: 294 YTA-QIVSGLEHLH---QRNIIYRDLKPENVLLDDD--GNVRISDLGLAV---ELKAGQT 344

Query: 615 CSSVGLKGTVGYAAPE 630
            +  G  GT G+ APE
Sbjct: 345 KTK-GYAGTPGFMAPE 359

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 77.5 bits (191), Expect = 4e-15
 Identities = 51/197 (25%), Positives = 80/197 (40%), Gaps = 36/197 (18%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           F    ++G G FG V    +     + A K L    + +R      + E + L  +  R 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ---RL 556
           +V +  A     ++  D   LV   M+ G L+  ++    +           F +     
Sbjct: 246 VVSLAYA-----YETKDALCLVLTLMNGGDLKFHIYHMGQA----------GFPEARAVF 290

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV--GDFGLTRFIPEVISSNQ 614
             A  +   LE LH   +++IV+ DLKP N+LLD+    H+   D GL   +PE  +   
Sbjct: 291 YAA-EICCGLEDLH---RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKG 344

Query: 615 -CSSVGLKGTVGYAAPE 630
                   GTVGY APE
Sbjct: 345 RV------GTVGYMAPE 355

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 76.7 bits (189), Expect = 5e-15
 Identities = 39/162 (24%), Positives = 72/162 (44%), Gaps = 24/162 (14%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITA-C 507
           IG GSFG VY+  L     +VA+K +   +R   +    E + +R + H N+V++     
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFY 117

Query: 508 SSSDFQGNDFKALVYEFM----HHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
           SS + +   +  LV +++    +  +       ++          +  ++ +L       
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-----VKLYMYQL------F 166

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVGDFGLTR 604
            +L Y+H      I H D+KP N+LLD D  +  + DFG  +
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 76.7 bits (189), Expect = 5e-15
 Identities = 45/193 (23%), Positives = 74/193 (38%), Gaps = 29/193 (15%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           +    +IG G+FG V        + V A+K+L    + +R     F  E + +       
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           +V++  A     FQ + +  +V E+M  G L + +      +             R   A
Sbjct: 131 VVQLFYA-----FQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW----------ARFYTA 175

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV--GDFGLTRFIPEVISSNQCSS 617
             V  AL+ +H       +H D+KP N+LLD     H+   DFG      ++        
Sbjct: 176 -EVVLALDAIH---SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCM---KMNKEGMVRC 226

Query: 618 VGLKGTVGYAAPE 630
               GT  Y +PE
Sbjct: 227 DTAVGTPDYISPE 239

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 75.3 bits (186), Expect = 5e-15
 Identities = 37/160 (23%), Positives = 66/160 (41%), Gaps = 20/160 (12%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITA 506
           IG GS+G V+K        +VA+K     +      K  + E   L+ ++H NLV ++  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
                F+      LV+E+  H ++   L  +     +     + S   +         A+
Sbjct: 71  -----FRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVP-EHLVKSITWQT------LQAV 115

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
            + H H     +H D+KP N+L+    +  + DFG  R +
Sbjct: 116 NFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL 152

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 77.0 bits (190), Expect = 5e-15
 Identities = 47/228 (20%), Positives = 79/228 (34%), Gaps = 39/228 (17%)

Query: 412 RKRTVTSSESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAV 471
           R+      +  +   + +      L +    +     +G+G++G V            A+
Sbjct: 11  RENLYFQGDLQATPGMFITSKKGHLSEM---YQRVKKLGSGAYGEVLLCRDKVTHVERAI 67

Query: 472 KVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGS 529
           K++        +    + E   L+ + H N++K+        F+      LV E    G 
Sbjct: 68  KIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF-----FEDKRNYYLVMECYKGGE 122

Query: 530 LESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL 589
           L   +          ++           I   V S + YLH H    IVH DLKP N+LL
Sbjct: 123 LFDEIIHRM-----KFNEV-----DAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLL 169

Query: 590 DND------MIAHVGDFGLTRFI-PEVISSNQCSSVGLKGTVGYAAPE 630
           ++        I    DFGL+     +     +       GT  Y APE
Sbjct: 170 ESKEKDALIKIV---DFGLSAVFENQKKMKERL------GTAYYIAPE 208

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 76.3 bits (188), Expect = 6e-15
 Identities = 49/193 (25%), Positives = 83/193 (43%), Gaps = 27/193 (13%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           F    +IG G+F  V    +     V A+K++    + +RG +  F  E + L N   R 
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           + ++  A     FQ  ++  LV E+   G L + L          +   I + + R  +A
Sbjct: 123 ITQLHFA-----FQDENYLYLVMEYYVGGDLLTLLS--------KFGERIPAEMARFYLA 169

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV--GDFGLTRFIPEVISSNQCSS 617
             +  A++ +H   +   VH D+KP N+LLD     H+   DFG      ++ +     S
Sbjct: 170 -EIVMAIDSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCL---KLRADGTVRS 220

Query: 618 VGLKGTVGYAAPE 630
           +   GT  Y +PE
Sbjct: 221 LVAVGTPDYLSPE 233

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 74.3 bits (183), Expect = 7e-15
 Identities = 48/209 (22%), Positives = 81/209 (38%), Gaps = 40/209 (19%)

Query: 123 EDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLP 182
                L N  + N  +       V DL     L     ++  + + ++++S+   + +  
Sbjct: 13  FPDPGLANAVKQNLGKQ-----SVTDLVSQKELSG---VQNFNGDNSNIQSLA-GMQFFT 63

Query: 183 KLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIF 242
            L+ L L  N IS ++ S L + T L EL++  N ++            L  +  +    
Sbjct: 64  NLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK-----------NLNGIPSAC--- 107

Query: 243 LGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLS 302
                +  L L +N L     L   +LK++  L +  NKL   I   LG    LE L+L 
Sbjct: 108 -----LSRLFLDNNELRDTDSLI--HLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLH 158

Query: 303 INSFHGPIH--PGLSSLKSLEGLDLFQNT 329
            N     I    GL+ LK +  +DL    
Sbjct: 159 GN----EITNTGGLTRLKKVNWIDLTGQK 183

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 36/189 (19%), Positives = 62/189 (32%), Gaps = 24/189 (12%)

Query: 101 ISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTY 160
               +     +    S+T         L  +   N   +      +  L  +    N   
Sbjct: 15  DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNS-----NIQSLAGMQFFTNLKE 67

Query: 161 LEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRG 220
           L +     N +  +   +  L KL+ LS+  N +             L+ L L  N +  
Sbjct: 68  LHLSH---NQISDLS-PLKDLTKLEELSVNRNRLKNLNGIPSAC---LSRLFLDNNEL-- 118

Query: 221 SIPSALGNCHQLQSLDLS----KTI-FLGQYP-VRWLDLSHNHLTGPIPLAVGNLKSIPH 274
               +L +   L+ L +     K+I  LG    +  LDL  N +T    L    LK +  
Sbjct: 119 RDTDSLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEITNTGGLT--RLKKVNW 176

Query: 275 LDLSKNKLS 283
           +DL+  K  
Sbjct: 177 IDLTGQKCV 185

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 36/237 (15%), Positives = 79/237 (33%), Gaps = 33/237 (13%)

Query: 7   LINLQQNNFSGNIPHEI---GRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKL 63
           L N  + N       ++     L  ++    +++ +Q  +   +   + L+ L L  N++
Sbjct: 18  LANAVKQNLGKQSVTDLVSQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQI 75

Query: 64  EENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISN--ASKLEWLDFANNSLTASI 121
            +   + +L          +    +  N+       +++   ++ L  L   NN L    
Sbjct: 76  SDLSPLKDLT--------KLEELSVNRNRL-----KNLNGIPSACLSRLFLDNNELR--D 120

Query: 122 PEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYL 181
            + L  L+NL  L+   N     K+  +  L  L     LE++ L+ N + +    +  L
Sbjct: 121 TDSLIHLKNLEILSIRNN-----KLKSIVMLGFLSK---LEVLDLHGNEITNTG-GLTRL 171

Query: 182 PKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLS 238
            K+  + L       E               ++    R   P  + N        + 
Sbjct: 172 KKVNWIDLTGQKCVNEPVKYQPELYIT--NTVKDPDGRWISPYYISNGGSYVDGCVL 226

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 76.3 bits (188), Expect = 9e-15
 Identities = 50/191 (26%), Positives = 73/191 (38%), Gaps = 36/191 (18%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITA 506
           +G GSFG V K      Q   AVKV+           + + E E L+ + H N++K+   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
                 + +    +V E    G L   +          +S    +      I   V S +
Sbjct: 90  -----LEDSSSFYIVGELYTGGELFDEIIKRK-----RFSEHDAA-----RIIKQVFSGI 134

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDND------MIAHVGDFGLTRFI-PEVISSNQCSSVG 619
            Y+H H    IVH DLKP N+LL++        I    DFGL+          ++     
Sbjct: 135 TYMHKH---NIVHRDLKPENILLESKEKDCDIKII---DFGLSTCFQQNTKMKDRI---- 184

Query: 620 LKGTVGYAAPE 630
             GT  Y APE
Sbjct: 185 --GTAYYIAPE 193

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 75.9 bits (187), Expect = 9e-15
 Identities = 49/199 (24%), Positives = 80/199 (40%), Gaps = 39/199 (19%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           F    +IG G+FG V    L     V A+K+L    + +R     F  E + L N   + 
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH------PESASDDLNYSPSILSFL 553
           +  +  A     FQ ++   LV ++   G L + L       PE  +             
Sbjct: 136 ITTLHYA-----FQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA------------- 177

Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV--GDFGLTRFIPEVIS 611
            R  +A  +  A++ +H   +   VH D+KP N+L+D +   H+   DFG      +++ 
Sbjct: 178 -RFYLA-EMVIAIDSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCL---KLME 227

Query: 612 SNQCSSVGLKGTVGYAAPE 630
                S    GT  Y +PE
Sbjct: 228 DGTVQSSVAVGTPDYISPE 246

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 39/187 (20%), Positives = 67/187 (35%), Gaps = 30/187 (16%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFL-HQRGALKSFMAECEAL-RNIRHRNLVKIITA 506
           +G+G+ G V+K        V+AVK +     +   K  + + + + ++     +V+    
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQ---- 88

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
           C  +     D   +  E M   +                    +       + + +  AL
Sbjct: 89  CFGTFITNTDVF-IAMELMGTCAE----------KLKKRMQGPIPERILGKMTVAIVKAL 137

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG- 625
            YL    K  ++H D+KPSN+LLD      + DFG        IS           + G 
Sbjct: 138 YYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFG--------ISGRLVDDKAKDRSAGC 187

Query: 626 --YAAPE 630
             Y APE
Sbjct: 188 AAYMAPE 194

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 51/205 (24%), Positives = 85/205 (41%), Gaps = 50/205 (24%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--GALKSFMAECEALRNIRHRNLVKIITA 506
           +G G++G VYK I       VA+K + L     G   + + E   L+ ++HRN++++   
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK-- 99

Query: 507 CSSSD-FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPS-ILSFLQRLNIAINVAS 564
                    N    L++E+  +  L+ ++         + S   I SFL +L       +
Sbjct: 100 ----SVIHHNHRLHLIFEYAEN-DLKKYMDKNP-----DVSMRVIKSFLYQL------IN 143

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG-----DFGLTRF--IP------EVIS 611
            + + H     + +H DLKP N+LL     +        DFGL R   IP      E+I 
Sbjct: 144 GVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII- 199

Query: 612 SNQCSSVGLKGTVGYAAPEYGMGSQ 636
                      T+ Y  PE  +GS+
Sbjct: 200 -----------TLWYRPPEILLGSR 213

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 50/193 (25%), Positives = 75/193 (38%), Gaps = 43/193 (22%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMA-----ECEALRNIRHRNLVKI 503
           IG G+F  V           VA+K++    +  L          E   ++ + H N+VK+
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKII---DKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79

Query: 504 ITACSSSD--FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
                +    +       L+ E+   G +  +L    A   +    +   F Q       
Sbjct: 80  FEVIETEKTLY-------LIMEYASGGEVFDYL---VAHGRMKEKEARSKFRQ------- 122

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG-L 620
           + SA++Y H      IVH DLK  N+LLD DM   + DFG          SN+ +  G L
Sbjct: 123 IVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGF---------SNEFTVGGKL 170

Query: 621 KGTVG---YAAPE 630
               G   YAAPE
Sbjct: 171 DAFCGAPPYAAPE 183

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 42/241 (17%), Positives = 72/241 (29%), Gaps = 23/241 (9%)

Query: 97  IPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLV 156
           IP  +        L F    L            +L ++  ++ND+    +    F  +L 
Sbjct: 24  IPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV-LEVIEADVF-SNLP 79

Query: 157 NCTYLEIVSLNVNSLRSIPISV-GYLPKLQVLSLFENNISGEIPS-SLGNFTFLTELNLR 214
               + I     N+L  I       LP LQ L +    I   +P     +      L+++
Sbjct: 80  KLHEIRI--EKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQ 136

Query: 215 GNSIRGSIPSAL--GNCHQLQSLDLSK--------TIFLGQYPVRWLDLSHNHLTGPIPL 264
            N    +I      G   +   L L+K        + F G          +N+L      
Sbjct: 137 DNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPND 196

Query: 265 AVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLD 324
                     LD+S+ ++       L +   L   +           P L  L +L    
Sbjct: 197 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK----KLPTLEKLVALMEAS 252

Query: 325 L 325
           L
Sbjct: 253 L 253

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 72.9 bits (179), Expect = 5e-14
 Identities = 42/225 (18%), Positives = 73/225 (32%), Gaps = 27/225 (12%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEI-GRLFQLRYI-IFNSNTLQGQIPVN-LTHCSELRTLD 57
               L  I + QN+    I  ++   L +L  I I  +N L   I      +   L+ L 
Sbjct: 52  GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLL 110

Query: 58  LVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISN--ASKLEWLDFANN 115
           +    ++       LP           +  +  N     I  +     + +   L    N
Sbjct: 111 ISNTGIKH------LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN 164

Query: 116 SLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFL--DSLVNCTYLEIVSLNVNSLRS 173
            +   I         L  LN + N       N+L  L  D     +   I+ ++   + S
Sbjct: 165 GIQ-EIHNSAFNGTQLDELNLSDN-------NNLEELPNDVFHGASGPVILDISRTRIHS 216

Query: 174 IPISV-GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNS 217
           +P      L KL+  S +      ++P+ L     L E +L   S
Sbjct: 217 LPSYGLENLKKLRARSTYNLK---KLPT-LEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 30/180 (16%), Positives = 54/180 (30%), Gaps = 40/180 (22%)

Query: 185 QVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSK----- 239
           +V    E+ ++ EIPS L       EL      +R     A      L+ +++S+     
Sbjct: 12  RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68

Query: 240 -----------------------------TIFLGQYPVRWLDLSHNHLTGPIPLAVGNLK 270
                                          F     +++L +S+  +     +   +  
Sbjct: 69  VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 128

Query: 271 SIPHLDLSKNKLSGEIPSSL--GSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
               LD+  N     I  +   G       L L+ N     IH    +   L+ L+L  N
Sbjct: 129 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDN 187

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 44/202 (21%), Positives = 71/202 (35%), Gaps = 54/202 (26%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL--------FLHQRGALKSFMAECEALRNIRHRNL 500
           +G+G+FG V+  +       V VK +           +   L     E   L  + H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 501 VKIITACSSSDFQGNDFKALVYEF-----------MHHGSLESWLHPESASDDLNYSPSI 549
           +K++       F+   F  LV E              H  L      E  +  +      
Sbjct: 92  IKVLDI-----FENQGFFQLVMEKHGSGLDLFAFIDRHPRL-----DEPLASYI------ 135

Query: 550 LSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI-PE 608
             F Q       + SA+ YL       I+H D+K  N+++  D    + DFG   ++   
Sbjct: 136 --FRQ-------LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183

Query: 609 VISSNQCSSVGLKGTVGYAAPE 630
            +    C      GT+ Y APE
Sbjct: 184 KLFYTFC------GTIEYCAPE 199

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 36/164 (21%), Positives = 64/164 (39%), Gaps = 22/164 (13%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITA-C 507
            G G+FG+V  G        VA+K +    R   +      + L  + H N+V++ +   
Sbjct: 31  AGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPNIVQLQSYFY 89

Query: 508 SSSDFQGND-FKALVYEFM----HHGSLESWLHPESASDDLNYSPSILSFL-QRLNIAIN 561
           +  +    D +  +V E++    H      +    +    L     I  FL Q +     
Sbjct: 90  TLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPIL-----IKVFLFQLI----- 139

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLD-NDMIAHVGDFGLTR 604
              ++  LH      + H D+KP NVL++  D    + DFG  +
Sbjct: 140 --RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 51/218 (23%), Positives = 82/218 (37%), Gaps = 65/218 (29%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL--------------------------FLHQRGA 481
            IG GS+G V     + D T  A+KVL                           +  RG 
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 482 LKSFMAECEALRNIRHRNLVK----IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPE 537
           ++    E   L+ + H N+VK    +        +       +V+E ++ G +      +
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLY-------MVFELVNQGPVMEVPTLK 132

Query: 538 SASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV 597
             S+D     +   F         +   +EYLH+    +I+H D+KPSN+L+  D    +
Sbjct: 133 PLSEDQ----ARFYFQD-------LIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKI 178

Query: 598 GDFGLTRFIPEVISSNQCSSVG--LKGTVG---YAAPE 630
            DFG+         SN+       L  TVG   + APE
Sbjct: 179 ADFGV---------SNEFKGSDALLSNTVGTPAFMAPE 207

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 22/168 (13%), Positives = 48/168 (28%), Gaps = 39/168 (23%)

Query: 448 LIGTGSFGSVYKGILDPDQT---VVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLV 501
             G       ++ +   D      VA+  +    +     L+  ++    L  I    + 
Sbjct: 38  FHGGVPPLQFWQAL---DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94

Query: 502 KIITACSSSDF-QGNDFKALVYEFMHHGSL----ESWLHPESASDDLNYSPSILSFLQRL 556
           +++      D         +V E++  GSL    ++   P  A                +
Sbjct: 95  RVL------DVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA----------------I 132

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
               ++A+A +  H      +      PS V +  D    +       
Sbjct: 133 RAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATMP 177

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 74.4 bits (183), Expect = 3e-14
 Identities = 47/201 (23%), Positives = 79/201 (39%), Gaps = 41/201 (20%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVL-------------FLHQRGALKSFMAECEALR 493
             +G+G++G V         +  A+KV+               +     +    E   L+
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 494 NIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFL 553
           ++ H N++K+        F+   +  LV EF   G L   +          +        
Sbjct: 102 SLDHPNIIKLFDV-----FEDKKYFYLVTEFYEGGELFEQIINRH-----KFDEC----- 146

Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN-DMIAH--VGDFGLTRFI-PEV 609
              NI   + S + YLH H    IVH D+KP N+LL+N + + +  + DFGL+ F   + 
Sbjct: 147 DAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY 203

Query: 610 ISSNQCSSVGLKGTVGYAAPE 630
              ++       GT  Y APE
Sbjct: 204 KLRDRL------GTAYYIAPE 218

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 73.6 bits (181), Expect = 5e-14
 Identities = 54/189 (28%), Positives = 78/189 (41%), Gaps = 30/189 (15%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKII 504
           L+G G+FG V            A+K+L    +  +  +   + E   L+N RH  L  + 
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ---RLNIAIN 561
            +     FQ +D    V E+ + G L   L  E              F +   R   A  
Sbjct: 215 YS-----FQTHDRLCFVMEYANGGELFFHLSRER------------VFSEDRARFYGA-E 256

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           + SAL+YLH   +K +V+ DLK  N++LD D    + DFGL +   E I           
Sbjct: 257 IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKT-FC 310

Query: 622 GTVGYAAPE 630
           GT  Y APE
Sbjct: 311 GTPEYLAPE 319

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 73.5 bits (181), Expect = 5e-14
 Identities = 52/273 (19%), Positives = 82/273 (30%), Gaps = 45/273 (16%)

Query: 102 SNASKLEWLDFANNSLTASIPEDLGRL----RNLTRLNFARNDLGTRKVNDLRFLDSLVN 157
               +LE L     SL+A+  E L  +     +   L  + ND+    V  L        
Sbjct: 139 DPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSP 198

Query: 158 CTYLEIVSLNVNSL-----RSIPISVGYLPKLQVLSLFENNISGE-----IPSSLGNFTF 207
           C  LE + L    +     R +   V     L+ L+L  N +         P  L   + 
Sbjct: 199 CQ-LEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSR 257

Query: 208 LTELNLRGNSIR----GSIPSALGNCHQLQSLDLSK-------------TIFLGQYPVRW 250
           L  L +    I     G +   L     L+ L L+              T+      +  
Sbjct: 258 LRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLES 317

Query: 251 LDLSHNHLTG----PIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVG-----LEYLNL 301
           L +     T          +   + +  L +S N+L       L   +G     L  L L
Sbjct: 318 LWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWL 377

Query: 302 SINSFH----GPIHPGLSSLKSLEGLDLFQNTF 330
           +           +   L +  SL  LDL  N  
Sbjct: 378 ADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 68.8 bits (169), Expect = 2e-12
 Identities = 58/328 (17%), Positives = 99/328 (30%), Gaps = 74/328 (22%)

Query: 47  LTHCSELRTLDLVLNKLEEN--QLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNA 104
           L     L  L+L  N+L +     V +     G   P+                      
Sbjct: 52  LRVNPALAELNLRSNELGDVGVHCVLQ-----GLQTPS---------------------- 84

Query: 105 SKLEWLDFANNSLTA----SIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTY 160
            K++ L   N  LT      +   L  L  L  L+ + N LG   +  L        C  
Sbjct: 85  CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR- 143

Query: 161 LEIVSLNVNSL-----RSIPISVGYLPKLQVLSLFENNISGE----IPSSLGNFTF-LTE 210
           LE + L   SL       +   +   P  + L++  N+I+      +   L +    L  
Sbjct: 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEA 203

Query: 211 LNLRGNSIR----GSIPSALGNCHQLQSLDLS-------------KTIFLGQYPVRWLDL 253
           L L    +       +   + +   L+ L L                +      +R L +
Sbjct: 204 LKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWI 263

Query: 254 SHNHLTGP----IPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVG-----LEYLNLSIN 304
               +T      +   +   +S+  L L+ N+L  E    L   +      LE L +   
Sbjct: 264 WECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 323

Query: 305 SFHG----PIHPGLSSLKSLEGLDLFQN 328
           SF           L+  + L  L +  N
Sbjct: 324 SFTAACCSHFSSVLAQNRFLLELQISNN 351

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 67.7 bits (166), Expect = 4e-12
 Identities = 53/296 (17%), Positives = 88/296 (29%), Gaps = 76/296 (25%)

Query: 105 SKLEWLDFANNSLT-ASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEI 163
             ++ LD     L+ A   E L  L+    +      L   +  D+    +L     L  
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI--SSALRVNPALAE 60

Query: 164 VSLNVNSLRSIPISVGYL--------PKLQVLSLFENNISGE----IPSSLGNFTFLTEL 211
           ++L  N L    + V  +         K+Q LSL    ++G     + S+L     L EL
Sbjct: 61  LNLRSNELG--DVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQEL 118

Query: 212 NLRGNSIRGS---------------------------------IPSALGNCHQLQSLDLS 238
           +L  N +  +                                 + S L      + L +S
Sbjct: 119 HLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVS 178

Query: 239 ---------KTIFLG----QYPVRWLDLSHNHLT----GPIPLAVGNLKSIPHLDLSKNK 281
                    + +  G       +  L L    +T      +   V +  S+  L L  NK
Sbjct: 179 NNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK 238

Query: 282 LSGE-----IPSSLGSCVGLEYLNLSINSFHGP----IHPGLSSLKSLEGLDLFQN 328
           L         P  L     L  L +            +   L + +SL+ L L  N
Sbjct: 239 LGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGN 294

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 53.8 bits (130), Expect = 9e-08
 Identities = 50/305 (16%), Positives = 90/305 (29%), Gaps = 50/305 (16%)

Query: 47  LTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQF----FGNIPHSIS 102
           L    + + L +  N +     V  L   +  +   +    L           ++   ++
Sbjct: 166 LRAKPDFKELTVSNNDIN-EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVA 224

Query: 103 NASKLEWLDFANNSLTAS-----IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVN 157
           + + L  L   +N L         P  L     L  L      +  +   DL     L  
Sbjct: 225 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDL--CRVLRA 282

Query: 158 CTYLEIVSLNVNSLRS---IPISVG---YLPKLQVLSLFENNISGE----IPSSLGNFTF 207
              L+ +SL  N L       +         +L+ L +   + +        S L    F
Sbjct: 283 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRF 342

Query: 208 LTELNLRGNSIRGS----IPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLT---- 259
           L EL +  N +  +    +   LG    +               +R L L+   ++    
Sbjct: 343 LLELQISNNRLEDAGVRELCQGLGQPGSV---------------LRVLWLADCDVSDSSC 387

Query: 260 GPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLG-----SCVGLEYLNLSINSFHGPIHPGL 314
             +   +    S+  LDLS N L       L          LE L L    +   +   L
Sbjct: 388 SSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 447

Query: 315 SSLKS 319
            +L+ 
Sbjct: 448 QALEK 452

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 72.6 bits (178), Expect = 6e-14
 Identities = 42/184 (22%), Positives = 71/184 (38%), Gaps = 23/184 (12%)

Query: 97  IPHSISNASKLEWLDFANNSLTASIPE-DLGRLRNLTRLNFARNDLGTRKVNDLRFLDSL 155
           +P S+   S    LD ++N+L+    E    RL NL  L  + N L    ++     ++ 
Sbjct: 33  VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL--NFISS----EAF 84

Query: 156 VNCTYLEIVSLNVNSLRSIPISV-GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLR 214
           V    L  + L+ N L ++   +   L  L+VL L+ N+I     ++  +   L +L L 
Sbjct: 85  VPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLS 144

Query: 215 GNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPH 274
            N I       + + ++L  L               LDLS N L       +  L +   
Sbjct: 145 QNQISRFPVELIKDGNKLPKL-------------MLLDLSSNKLKKLPLTDLQKLPAWVK 191

Query: 275 LDLS 278
             L 
Sbjct: 192 NGLY 195

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 66.0 bits (161), Expect = 8e-12
 Identities = 44/188 (23%), Positives = 68/188 (36%), Gaps = 39/188 (20%)

Query: 157 NCT-YLEIVSLNVNSLRSIPISVGYLPK-LQVLSLFENNISGEIPS--SLGNFTFLTELN 212
           NC     I+S +   L ++P S   LP    +L L  NN+S  + +  +    T L  L 
Sbjct: 15  NCLCASNILSCSKQQLPNVPQS---LPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLL 70

Query: 213 LRGNSIRGSIPS-ALGNCHQLQSLDLSK--------TIFLGQYPVRWLDLSHNHLTGPIP 263
           L  N +   I S A      L+ LDLS          +F     +  L L +NH+     
Sbjct: 71  LSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDR 129

Query: 264 LAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGL 323
            A  ++  +  L LS+N++S                   +           + L  L  L
Sbjct: 130 NAFEDMAQLQKLYLSQNQIS----------------RFPVELIKD-----GNKLPKLMLL 168

Query: 324 DLFQNTFQ 331
           DL  N  +
Sbjct: 169 DLSSNKLK 176

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 64.5 bits (157), Expect = 3e-11
 Identities = 42/200 (21%), Positives = 67/200 (33%), Gaps = 34/200 (17%)

Query: 113 ANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLR 172
           +   L  ++P+ L        L+ + N+L   ++        L N   L    L+ N L 
Sbjct: 26  SKQQLP-NVPQSL--PSYTALLDLSHNNL--SRLRAEWTPTRLTNLHSL---LLSHNHLN 77

Query: 173 SIPISV-GYLPKLQVLSLFENNISGEIPS-SLGNFTFLTELNLRGNSIRGSIPS-ALGNC 229
            I       +P L+ L L  N++   +      +   L  L L  N I   +   A  + 
Sbjct: 78  FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDM 135

Query: 230 HQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIP----LAVGNLKSIPHLDLSKNKLSGE 285
            QLQ                 L LS N ++   P         L  +  LDLS NKL   
Sbjct: 136 AQLQ----------------KLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLKKL 178

Query: 286 IPSSLGSCVGLEYLNLSINS 305
             + L          L +++
Sbjct: 179 PLTDLQKLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 40/181 (22%), Positives = 61/181 (33%), Gaps = 27/181 (14%)

Query: 43  IPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFT-LPNIRIPLLAGNQFFGNIPHSI 101
           +P +L   S    LDL  N L        L      T L N+   LL+ N     I    
Sbjct: 33  VPQSLP--SYTALLDLSHNNLSR------LRAEWTPTRLTNLHSLLLSHNHL-NFISSEA 83

Query: 102 -SNASKLEWLDFANNSLTASIPED-LGRLRNLTRLNFARNDLGTRKVNDLRFLDSLV--N 157
                 L +LD ++N L  ++ E     L+ L  L    N +          +D     +
Sbjct: 84  FVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHI--------VVVDRNAFED 134

Query: 158 CTYLEIVSLNVNSLRSIP----ISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNL 213
              L+ + L+ N +   P         LPKL +L L  N +     + L       +  L
Sbjct: 135 MAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194

Query: 214 R 214
            
Sbjct: 195 Y 195

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 51.4 bits (123), Expect = 5e-07
 Identities = 41/192 (21%), Positives = 66/192 (34%), Gaps = 42/192 (21%)

Query: 8   INLQQNNFSGNIPHEI--GRLFQLRYIIFNSNTLQGQIPVN-LTHCSELRTLDLVLNKLE 64
           ++L  NN S  +  E    RL  L  ++ + N L   I          LR LDL  N L 
Sbjct: 44  LDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH 101

Query: 65  ENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPED 124
                         TL                     S+   LE L   NN +   +  +
Sbjct: 102 --------------TLD----------------EFLFSDLQALEVLLLYNNHIV-VVDRN 130

Query: 125 -LGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISV-GYLP 182
               +  L +L  ++N +    V  ++  + L     L ++ L+ N L+ +P++    LP
Sbjct: 131 AFEDMAQLQKLYLSQNQISRFPVELIKDGNKL---PKLMLLDLSSNKLKKLPLTDLQKLP 187

Query: 183 KLQVLSL-FENN 193
                 L   NN
Sbjct: 188 AWVKNGLYLHNN 199

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 71.9 bits (177), Expect = 7e-14
 Identities = 42/193 (21%), Positives = 68/193 (35%), Gaps = 35/193 (18%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G F  V K          A K +         +  + +    E   LR + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +        ++      L+ E +  G L  +L     +   + S    +   +      +
Sbjct: 80  LHDV-----YENRTDVVLILELVSGGELFDFL-----AQKESLSEEEATSFIK-----QI 124

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLL----DNDMIAHVGDFGLTRFI-PEVISSNQCSS 617
              + YLH    K+I H DLKP N++L           + DFGL   I   V   N    
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-- 179

Query: 618 VGLKGTVGYAAPE 630
               GT  + APE
Sbjct: 180 ----GTPEFVAPE 188

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 72.4 bits (178), Expect = 8e-14
 Identities = 42/196 (21%), Positives = 68/196 (34%), Gaps = 41/196 (20%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL------FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G+G F  V K          A K +         +    +    E   LR + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +        ++      L+ E +  G L  +L     +   + S    +   +      +
Sbjct: 80  LHDV-----YENRTDVVLILELVSGGELFDFL-----AQKESLSEEEATSFIK-----QI 124

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDND-------MIAHVGDFGLTRFI-PEVISSNQ 614
              + YLH    K+I H DLKP N++L +         +    DFGL   I   V   N 
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLI---DFGLAHEIEDGVEFKNI 178

Query: 615 CSSVGLKGTVGYAAPE 630
                  GT  + APE
Sbjct: 179 F------GTPEFVAPE 188

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 46/192 (23%), Positives = 69/192 (35%), Gaps = 35/192 (18%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA--LKSFMAECEALRNIRHR-NLVKIIT 505
           +G G F  V + I        A K L   +RG       + E   L   +    ++ +  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
                 ++      L+ E+   G + S   PE A      S + +  L +      +   
Sbjct: 97  V-----YENTSEIILILEYAAGGEIFSLCLPELAE---MVSENDVIRLIK-----QILEG 143

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDND------MIAHVGDFGLTRFI-PEVISSNQCSSV 618
           + YLH   +  IVH DLKP N+LL +        I    DFG++R I             
Sbjct: 144 VYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIV---DFGMSRKIGHACELREIM--- 194

Query: 619 GLKGTVGYAAPE 630
              GT  Y APE
Sbjct: 195 ---GTPEYLAPE 203

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 70.7 bits (174), Expect = 1e-13
 Identities = 45/196 (22%), Positives = 71/196 (36%), Gaps = 41/196 (20%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKV-----LFLHQRGALK-SFMAECEALRNIRHRNLVK 502
           +G+G F  V K          A K      L   +RG  +     E   LR IRH N++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +        F+      L+ E +  G L  +L     ++  + +    +   +      +
Sbjct: 73  LHDI-----FENKTDVVLILELVSGGELFDFL-----AEKESLTEDEATQFLK-----QI 117

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDND-------MIAHVGDFGLTRFI-PEVISSNQ 614
              + YLH    K+I H DLKP N++L +         +    DFG+   I       N 
Sbjct: 118 LDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLI---DFGIAHKIEAGNEFKNI 171

Query: 615 CSSVGLKGTVGYAAPE 630
                  GT  + APE
Sbjct: 172 F------GTPEFVAPE 181

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 70.7 bits (174), Expect = 1e-13
 Identities = 54/191 (28%), Positives = 81/191 (42%), Gaps = 36/191 (18%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKII 504
            +G G+FG V  G        VAVK+L    +     +     E + L+  RH +++K+ 
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 505 TACSSSD--FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
              S+    F       +V E++  G L  ++        +    +   F Q       +
Sbjct: 78  QVISTPTDFF-------MVMEYVSGGELFDYI---CKHGRVEEMEARRLFQQ-------I 120

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK- 621
            SA++Y H H    +VH DLKP NVLLD  M A + DFGL        S+       L+ 
Sbjct: 121 LSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGL--------SNMMSDGEFLRT 169

Query: 622 --GTVGYAAPE 630
             G+  YAAPE
Sbjct: 170 SCGSPNYAAPE 180

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 45/194 (23%), Positives = 76/194 (39%), Gaps = 18/194 (9%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKIIT 505
           IGTGS+G V +     ++ VVA+K +   F       +    E   L  + H ++VK++ 
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHVVKVLD 119

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
                D +  D   +V E       +S          L  +P  L+ L    +  N+   
Sbjct: 120 IVIPKDVEKFDELYVVLEIA-----DSDFK------KLFRTPVYLTELHIKTLLYNLLVG 168

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG 625
           ++Y+H      I+H DLKP+N L++ D    V DFGL R +    + N    +  +    
Sbjct: 169 VKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225

Query: 626 YAAPEYGMGSQVST 639
                    +    
Sbjct: 226 NLVTFPHTKNLKRQ 239

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 72.9 bits (178), Expect = 1e-13
 Identities = 41/242 (16%), Positives = 82/242 (33%), Gaps = 12/242 (4%)

Query: 5   LMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLE 64
           L   +L                   +  +            +     +L   +L + K  
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVL-LKDRPECWCRDSATDEQLFRCELSVEKST 362

Query: 65  ENQ-------LVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSL 117
             Q        + EL P   + L  I + + A          ++   S L+ +D    + 
Sbjct: 363 VLQSELESCKELQELEPENKWCLLTIILLMRA-LDPLLYEKETLQYFSTLKAVDPMRAAY 421

Query: 118 TASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPIS 177
              +        ++ ++ +A   +      DL  L  L     +  + L+ N LR++P +
Sbjct: 422 LDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLRALPPA 481

Query: 178 VGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRG-SIPSALGNCHQLQSLD 236
           +  L  L+VL   +N +   +   + N   L EL L  N ++  +    L +C +L  L+
Sbjct: 482 LAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 539

Query: 237 LS 238
           L 
Sbjct: 540 LQ 541

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 71.7 bits (175), Expect = 3e-13
 Identities = 42/241 (17%), Positives = 77/241 (31%), Gaps = 33/241 (13%)

Query: 7   LINLQQNNFSGNI----PHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNK 62
              L +   S         E+    +L+ +   +      I + +     L      L  
Sbjct: 348 DEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQY 407

Query: 63  LEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIP 122
               + V  +                  ++F           + +  L  A+  LT    
Sbjct: 408 FSTLKAVDPM---------RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV--L 456

Query: 123 EDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLP 182
             L +L  +T L+ + N L            +L     LE++  + N+L ++   V  LP
Sbjct: 457 CHLEQLLLVTHLDLSHNRLRA-------LPPALAALRCLEVLQASDNALENVD-GVANLP 508

Query: 183 KLQVLSLFENNISG-EIPSSLGNFTFLTELNLRGNSI------RGSIPSALGNCHQLQSL 235
           +LQ L L  N +        L +   L  LNL+GNS+      +  +   L     + S+
Sbjct: 509 RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML---PSVSSI 565

Query: 236 D 236
            
Sbjct: 566 L 566

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 69.4 bits (169), Expect = 2e-12
 Identities = 41/234 (17%), Positives = 75/234 (32%), Gaps = 35/234 (14%)

Query: 98  PHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVN 157
               +   +L   + +    T  +  +L   + L  L           +  +R LD L  
Sbjct: 342 CRDSATDEQLFRCELSVEKSTV-LQSELESCKELQELEPENKWCLLTIILLMRALDPL-- 398

Query: 158 CTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNS 217
             Y +      ++L+++        +   L    +    E       +  +  L+L    
Sbjct: 399 -LYEKETLQYFSTLKAVDP-----MRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKD 452

Query: 218 IRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDL 277
           +     + L +  QL  +               LDLSHN L   +P A+  L+ +  L  
Sbjct: 453 L-----TVLCHLEQLLLV-------------THLDLSHNRLRA-LPPALAALRCLEVLQA 493

Query: 278 SKNKLSGEIPSSLGSCVGLEYLNLS---INSFHGPIHPGLSSLKSLEGLDLFQN 328
           S N L   +   + +   L+ L L    +          L S   L  L+L  N
Sbjct: 494 SDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQP--LVSCPRLVLLNLQGN 543

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 47/262 (17%), Positives = 85/262 (32%), Gaps = 58/262 (22%)

Query: 101 ISNASKLEWLDFANNSL----------TASIPEDLGRLRNLTRLNFARNDLGTRKVNDLR 150
           I++   LE  +F++                + + L +   L  +  + N  G      L 
Sbjct: 56  IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLI 115

Query: 151 FLDSLVNCTYLEIVSLNVNSL--------------RSIPISVGYLPKLQVLSLFENNISG 196
             D L   T LE + L+ N L               ++       P L+ +    N +  
Sbjct: 116 --DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 173

Query: 197 E----IPSSLGNFTFLTELNLRGNSIR-----GSIPSALGNCHQLQSLDLSKTIF----- 242
                   +  +   L  + +  N IR       +   L  C +L+ LDL    F     
Sbjct: 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS 233

Query: 243 ------LGQYP-VRWLDLSHNHLT--GPIPLA----VGNLKSIPHLDLSKNKLSGEIPSS 289
                 L  +P +R L L+   L+  G   +           +  L L  N++  +   +
Sbjct: 234 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRT 293

Query: 290 LGSCVG-----LEYLNLSINSF 306
           L + +      L +L L+ N F
Sbjct: 294 LKTVIDEKMPDLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 64.0 bits (156), Expect = 5e-11
 Identities = 45/251 (17%), Positives = 83/251 (33%), Gaps = 55/251 (21%)

Query: 107 LEWLDFANNSLTA----SIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLE 162
           +E      +++T     S+   L    ++  +  + N +GT     L   +++ +   LE
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWL--SENIASKKDLE 63

Query: 163 IVSLNVNSLRS----IPISVGYL-------PKLQVLSLFENNISGE----IPSSLGNFTF 207
           I   +          IP ++  L       PKL  + L +N         +   L   T 
Sbjct: 64  IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123

Query: 208 LTELNLRGNSIR----GSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGP-- 261
           L  L L  N +       I  AL      +    +  +       R +    N L     
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPL-------RSIICGRNRLENGSM 176

Query: 262 --IPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKS 319
                   + + +  + + +N +  E         G+E+L          +  GL+  + 
Sbjct: 177 KEWAKTFQSHRLLHTVKMVQNGIRPE---------GIEHL----------LLEGLAYCQE 217

Query: 320 LEGLDLFQNTF 330
           L+ LDL  NTF
Sbjct: 218 LKVLDLQDNTF 228

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 60.5 bits (147), Expect = 6e-10
 Identities = 41/281 (14%), Positives = 84/281 (29%), Gaps = 64/281 (22%)

Query: 47  LTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASK 106
           +    +L   +         ++  E+P                  +       ++    K
Sbjct: 56  IASKKDLEIAEFSDIFT--GRVKDEIP---------------EALRLLLQ---ALLKCPK 95

Query: 107 LEWLDFANNSLT----ASIPEDLGRLRNLTRLNFARNDLGT-------RKVNDLRFLDSL 155
           L  +  ++N+        + + L +   L  L    N LG        R + +L      
Sbjct: 96  LHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKA 155

Query: 156 VNCTYLEIVSLNVNSL-----RSIPISVGYLPKLQVLSLFENNISGE-----IPSSLGNF 205
            N   L  +    N L     +    +      L  + + +N I  E     +   L   
Sbjct: 156 KNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC 215

Query: 206 TFLTELNLRGNSI--RG--SIPSALGNCHQLQSLDLS-------------KTIFLGQYP- 247
             L  L+L+ N+    G  ++  AL +   L+ L L+                   +   
Sbjct: 216 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIG 275

Query: 248 VRWLDLSHNHLT--GPIPLA---VGNLKSIPHLDLSKNKLS 283
           ++ L L +N +       L       +  +  L+L+ N+ S
Sbjct: 276 LQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 31/198 (15%), Positives = 58/198 (29%), Gaps = 49/198 (24%)

Query: 184 LQVLSLFENNISGE----IPSSLGNFTFLTELNLRGNSI--RG--SIPSALGNCHQLQSL 235
           ++  SL  + I+ E    + + L     + E+ L GN+I       +   + +   L+  
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 236 DLSKTIFLGQYP-------------------VRWLDLSHNHLT--GPIPLAVG--NLKSI 272
           + S  IF G+                     +  + LS N        PL         +
Sbjct: 66  EFSD-IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124

Query: 273 PHLDLSKNKLSGE-------------IPSSLGSCVGLEYLNLSINSFHGP----IHPGLS 315
            HL L  N L  +             +     +   L  +    N               
Sbjct: 125 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 184

Query: 316 SLKSLEGLDLFQNTFQAK 333
           S + L  + + QN  + +
Sbjct: 185 SHRLLHTVKMVQNGIRPE 202

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 71.5 bits (176), Expect = 2e-13
 Identities = 53/198 (26%), Positives = 84/198 (42%), Gaps = 35/198 (17%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNLVK---I 503
           IG G++G V     + ++  VA+K +  F HQ    ++   E + L   RH N++    I
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFL--QRLNIAIN 561
           I A +       D   +V + M     E+ L+    +  L  S   + +   Q L     
Sbjct: 94  IRAPTIEQM--KDV-YIVQDLM-----ETDLYKLLKTQHL--SNDHICYFLYQILR---- 139

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
               L+Y+H      ++H DLKPSN+LL+      + DFGL R    V   +   +  L 
Sbjct: 140 ---GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR----VADPDHDHTGFLT 189

Query: 622 GTVG---YAAPEYGMGSQ 636
             V    Y APE  + S+
Sbjct: 190 EYVATRWYRAPEIMLNSK 207

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 71.1 bits (175), Expect = 2e-13
 Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 34/201 (16%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL--FLHQRGALKSFMAECEALRNIRHRNLVK---I 503
           +G G++G V      P   +VA+K +  F     AL++   E + L++ +H N++    I
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENIITIFNI 77

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFL--QRLNIAIN 561
               S  +F  N+   ++ E M     ++ LH   ++  L  S   + +   Q L     
Sbjct: 78  QRPDSFENF--NEV-YIIQELM-----QTDLHRVISTQML--SDDHIQYFIYQTLR---- 123

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
              A++ LH      ++H DLKPSN+L++++    V DFGL R I E  + N   +    
Sbjct: 124 ---AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177

Query: 622 GTVGYA------APEYGMGSQ 636
           G V +       APE  + S 
Sbjct: 178 GMVEFVATRWYRAPEVMLTSA 198

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 43/189 (22%), Positives = 70/189 (37%), Gaps = 35/189 (18%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEAL-RNIRHRNLVKIITAC 507
           IG GS+    + I        AVK++      + +    E E L R  +H N++ +    
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKII----DKSKRDPTEEIEILLRYGQHPNIITLKDV- 84

Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               +    +  +V E M  G L   +  +       +S    S +        +   +E
Sbjct: 85  ----YDDGKYVYVVTELMKGGELLDKILRQK-----FFSEREASAVLF-----TITKTVE 130

Query: 568 YLHHHCKKQIVHCDLKPSNVLL----DNDMIAHVGDFGLTRFI--PEVISSNQCSSVGLK 621
           YLH    + +VH DLKPSN+L      N     + DFG  + +     +    C      
Sbjct: 131 YLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC------ 181

Query: 622 GTVGYAAPE 630
            T  + APE
Sbjct: 182 YTANFVAPE 190

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 40/204 (19%), Positives = 78/204 (38%), Gaps = 38/204 (18%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVK-VLFLHQRGALKSFMAECEALRNIRHRNLVKII--- 504
           +G G  G V+  + +     VA+K ++    +    +   E + +R + H N+VK+    
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVFEIL 77

Query: 505 ----TACSSSDFQGNDFKA--LVYEFMHHGSLESWLHPESASDDLNYSPSILSFL--QRL 556
               +  +       +  +  +V E+M     E+ L        L            Q L
Sbjct: 78  GPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPL--LEEHARLFMYQLL 130

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD-NDMIAHVGDFGLTRFIPEVISSNQC 615
                    L+Y+H      ++H DLKP+N+ ++  D++  +GDFGL R    ++  +  
Sbjct: 131 R-------GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLAR----IMDPHYS 176

Query: 616 SSVGLKGTVG---YAAPEYGMGSQ 636
               L   +    Y +P   +   
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPN 200

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 69.5 bits (171), Expect = 3e-13
 Identities = 42/190 (22%), Positives = 64/190 (33%), Gaps = 33/190 (17%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMA----ECEALRNIRHRNLVKI 503
            +G G++G V   +    +  VAVK++                 E    + + H N+VK 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKMLNHENVVKF 70

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
                  + Q      L  E+   G L   +        +    +   F Q       + 
Sbjct: 71  YGHRREGNIQ-----YLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQ-------LM 115

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
           + + YLH      I H D+KP N+LLD      + DFGL       +         L   
Sbjct: 116 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLAT-----VFRYNNRERLLNKM 167

Query: 624 VG---YAAPE 630
            G   Y APE
Sbjct: 168 CGTLPYVAPE 177

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 42/194 (21%), Positives = 69/194 (35%), Gaps = 37/194 (19%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKV-----LFLHQRGALK-SFMAECEALRNIRHRNLVK 502
           +G+G F  V K          A K          +RG  +     E   L+ I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +        ++      L+ E +  G L      +  ++  + +    +   +      +
Sbjct: 79  LHEV-----YENKTDVILILELVAGGELF-----DFLAEKESLTEEEATEFLK-----QI 123

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLL-----DNDMIAHVGDFGLTRFI-PEVISSNQCS 616
            + + YLH     QI H DLKP N++L         I  + DFGL   I       N   
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIK-IIDFGLAHKIDFGNEFKNIF- 178

Query: 617 SVGLKGTVGYAAPE 630
                GT  + APE
Sbjct: 179 -----GTPEFVAPE 187

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 44/188 (23%), Positives = 71/188 (37%), Gaps = 24/188 (12%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVK--- 502
           IG GS+G VY       +  VA+K +   F       +    E   L  ++   +++   
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDYIIRLYD 92

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +I       F  ++   +V E       +S L        L  +P  L+      I  N+
Sbjct: 93  LIIPDDLLKF--DEL-YIVLEIA-----DSDLK------KLFKTPIFLTEEHIKTILYNL 138

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
                ++H   +  I+H DLKP+N LL+ D    V DFGL R I     +N  + +    
Sbjct: 139 LLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195

Query: 623 TVGYAAPE 630
             G     
Sbjct: 196 EPGPHNKN 203

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 47/196 (23%), Positives = 74/196 (37%), Gaps = 38/196 (19%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           F     +GTGSFG V            A+K+L    + +   ++  + E   L+ +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH-----PESASDDLNYSPSILSFLQ 554
           LVK+  +     F+ N    +V E++  G + S L       E  +              
Sbjct: 103 LVKLEFS-----FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-------------- 143

Query: 555 RLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQ 614
           R   A  +    EYLH      +++ DLKP N+L+D      V DFG  + +     +  
Sbjct: 144 RFYAA-QIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-- 197

Query: 615 CSSVGLKGTVGYAAPE 630
                L GT    APE
Sbjct: 198 -----LCGTPEALAPE 208

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 71.0 bits (174), Expect = 4e-13
 Identities = 55/191 (28%), Positives = 83/191 (43%), Gaps = 36/191 (18%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKII 504
            +G G+FG V  G  +     VAVK+L    +     +     E + L+  RH +++K+ 
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 505 TACSSSD--FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
              S+    F       +V E++  G L  ++     +  L+   S   F Q       +
Sbjct: 83  QVISTPSDIF-------MVMEYVSGGELFDYI---CKNGRLDEKESRRLFQQ-------I 125

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK- 621
            S ++Y H H    +VH DLKP NVLLD  M A + DFGL        S+       L+ 
Sbjct: 126 LSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGL--------SNMMSDGEFLRT 174

Query: 622 --GTVGYAAPE 630
             G+  YAAPE
Sbjct: 175 SCGSPNYAAPE 185

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 69.5 bits (171), Expect = 5e-13
 Identities = 50/198 (25%), Positives = 79/198 (39%), Gaps = 52/198 (26%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKII 504
            +GTGSFG V+      +    A+KVL    + +   ++    E   L  + H  ++++ 
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI------ 558
                  FQ      ++ +++  G L                    S L++         
Sbjct: 73  GT-----FQDAQQIFMIMDYIEGGEL-------------------FSLLRKSQRFPNPVA 108

Query: 559 ---AINVASALEYLHHHCKKQIVHCDLKPSNVLLDND---MIAHVGDFGLTRFIPEVISS 612
              A  V  ALEYLH      I++ DLKP N+LLD +    I    DFG  +++P+V  +
Sbjct: 109 KFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKIT---DFGFAKYVPDVTYT 162

Query: 613 NQCSSVGLKGTVGYAAPE 630
                  L GT  Y APE
Sbjct: 163 -------LCGTPDYIAPE 173

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 70.1 bits (172), Expect = 5e-13
 Identities = 41/189 (21%), Positives = 68/189 (35%), Gaps = 32/189 (16%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEA---LRNIRHRNLVKIIT 505
           +G G  G V +      Q   A+K+L            A  E     R  +  ++V+I+ 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD 122

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
              +  + G     +V E +  G L           D  ++    S + +     ++  A
Sbjct: 123 VYENL-YAGRKCLLIVMECLDGGEL---FSRIQDRGDQAFTEREASEIMK-----SIGEA 173

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLL---DNDMIAHVGDFGLTRFI-PEVISSNQCSSVGLK 621
           ++YLH      I H D+KP N+L      + I  + DFG  +        +  C      
Sbjct: 174 IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC------ 224

Query: 622 GTVGYAAPE 630
            T  Y APE
Sbjct: 225 YTPYYVAPE 233

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 69.3 bits (170), Expect = 6e-13
 Identities = 42/190 (22%), Positives = 64/190 (33%), Gaps = 33/190 (17%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMA----ECEALRNIRHRNLVKI 503
            +G G++G V   +    +  VAVK++                 E    + + H N+VK 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKMLNHENVVKF 70

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
                  + Q      L  E+   G L   +        +    +   F Q +       
Sbjct: 71  YGHRREGNIQ-----YLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLM------- 115

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
           + + YLH      I H D+KP N+LLD      + DFGL       +         L   
Sbjct: 116 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLAT-----VFRYNNRERLLNKM 167

Query: 624 VG---YAAPE 630
            G   Y APE
Sbjct: 168 CGTLPYVAPE 177

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 69.2 bits (170), Expect = 6e-13
 Identities = 57/196 (29%), Positives = 80/196 (40%), Gaps = 45/196 (22%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKII 504
           L+G G+FG V            A+K+L    +  +  +   + E   L+N RH  L  + 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ---RLNIAIN 561
            A     FQ +D    V E+ + G L   L  E              F +   R   A  
Sbjct: 72  YA-----FQTHDRLCFVMEYANGGELFFHLSRER------------VFTEERARFYGA-E 113

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV--GDFGLTRFIPEVISSNQ----- 614
           + SALEYLH    + +V+ D+K  N++LD D   H+   DFGL +   E IS        
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKD--GHIKITDFGLCK---EGISDGATMKTF 165

Query: 615 CSSVGLKGTVGYAAPE 630
           C      GT  Y APE
Sbjct: 166 C------GTPEYLAPE 175

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 69.2 bits (169), Expect = 8e-13
 Identities = 43/220 (19%), Positives = 73/220 (33%), Gaps = 68/220 (30%)

Query: 449 IGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQRGA----LKSFMAECEALRNI-RHR 498
           +G G+FG V +              VAVK+L   + GA     ++ M+E + L +I  H 
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 86

Query: 499 NLVKIITACSSSDF------------------------------------QGNDFKALVY 522
           N+V ++ AC+                                        QG D+   + 
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146

Query: 523 EFMHHGSL----------------ESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
             +                     +S    E      +     L+    +  +  VA  +
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           E+L     ++ +H DL   N+LL    +  + DFGL R I
Sbjct: 207 EFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 69.3 bits (170), Expect = 8e-13
 Identities = 39/172 (22%), Positives = 60/172 (34%), Gaps = 35/172 (20%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKS--FMAECEALRNIR---------H 497
           I +GS+G+V  G+ D +   VA+K +F                   R +R         H
Sbjct: 30  ISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 498 RNLVK---IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFL- 553
            N++    I           +    LV E M      + L        +  SP  + +  
Sbjct: 89  PNILGLRDIFVHFEEPAM--HKL-YLVTELM-----RTDLAQVIHDQRIVISPQHIQYFM 140

Query: 554 -QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
              L         L  LH   +  +VH DL P N+LL ++    + DF L R
Sbjct: 141 YHILL-------GLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR 182

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 68.5 bits (168), Expect = 2e-12
 Identities = 39/169 (23%), Positives = 70/169 (41%), Gaps = 32/169 (18%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG GSFG V++  L      VA+K +   +R   +    E + +R ++H N+V +     
Sbjct: 48  IGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKNR----ELQIMRIVKHPNVVDLKAFFY 102

Query: 509 SSDFQGNDFKA-LVYEFMHHGSLESWLHPESASDDL-NYSPSILSFLQRLNIAI------ 560
           S+  + ++    LV E++               + +   S       Q + + +      
Sbjct: 103 SNGDKKDEVFLNLVLEYV--------------PETVYRASRHYAKLKQTMPMLLIKLYMY 148

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLD-NDMIAHVGDFGLTR-FIP 607
            +  +L Y+H      I H D+KP N+LLD    +  + DFG  +  I 
Sbjct: 149 QLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 50/200 (25%), Positives = 76/200 (38%), Gaps = 55/200 (27%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKII 504
            +G GSFG V        Q  VA+K +    L +         E   L+ +RH +++K+ 
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 505 TACSSSD--FQGNDFKALVYEF---------MHHGSLESWLHPESASDDLNYSPSILSFL 553
              ++            +V E+         +    +      E       +      F 
Sbjct: 76  DVITTPTDIV-------MVIEYAGGELFDYIVEKKRM-----TEDEG--RRF------FQ 115

Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN 613
           Q       +  A+EY H H    IVH DLKP N+LLD+++   + DFGL        S+ 
Sbjct: 116 Q-------IICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGL--------SNI 157

Query: 614 QCSSVGLK---GTVGYAAPE 630
                 LK   G+  YAAPE
Sbjct: 158 MTDGNFLKTSCGSPNYAAPE 177

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 46/197 (23%), Positives = 81/197 (41%), Gaps = 39/197 (19%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR----------HR 498
           +G G++G V+K I      VVAVK +F        +F    +A R  R          H 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIMILTELSGHE 69

Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFL--QRL 556
           N+V ++    + +    D   LV+++M     E+ LH    ++ L   P    ++  Q +
Sbjct: 70  NIVNLLNVLRADND--RDV-YLVFDYM-----ETDLHAVIRANIL--EPVHKQYVVYQLI 119

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
                    ++YLH      ++H D+KPSN+LL+ +    V DFGL+R    +       
Sbjct: 120 K-------VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169

Query: 617 SVGLKGTVGYAAPEYGM 633
            + +         +  +
Sbjct: 170 PLSINENTENFDDDQPI 186

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 36/183 (19%), Positives = 65/183 (35%), Gaps = 34/183 (18%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKII---- 504
           +GTGSFG V +          A+K +    R   +    E + ++ + H N++K++    
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDYFY 70

Query: 505 --TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASD--DLN----YSPSILSFLQRL 556
                     Q  D    +    +  +        + S    LN    Y P  L  + + 
Sbjct: 71  TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130

Query: 557 NIAIN--------------VASALEYLHHHCKKQIVHCDLKPSNVLLD-NDMIAHVGDFG 601
            I                 +  A+ ++H      I H D+KP N+L++  D    + DFG
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFG 187

Query: 602 LTR 604
             +
Sbjct: 188 SAK 190

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 67.0 bits (164), Expect = 4e-12
 Identities = 49/210 (23%), Positives = 86/210 (40%), Gaps = 44/210 (20%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           + +   IG+G+ G V        +  VA+K L   F +Q  A +++  E   ++ + H+N
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKN 85

Query: 500 LVK---IITACSSSDFQGNDFKA--LVYEFMHHGSLESWLHPESASDDLNYSPSILSFL- 553
           ++    + T   S +    +F+   +V E M     ++ L      +        +S+L 
Sbjct: 86  IIGLLNVFTPQKSLE----EFQDVYIVMELM-----DANLCQVIQME---LDHERMSYLL 133

Query: 554 -QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISS 612
            Q L         +++LH      I+H DLKPSN+++ +D    + DFGL R        
Sbjct: 134 YQMLC-------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---- 179

Query: 613 NQCSSVGLKGTVG---YAAPEYGMGSQVST 639
               S  +   V    Y APE  +G     
Sbjct: 180 ----SFMMTPYVVTRYYRAPEVILGMGYKE 205

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 67.0 bits (164), Expect = 4e-12
 Identities = 51/195 (26%), Positives = 73/195 (37%), Gaps = 46/195 (23%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGAL--KSFMAECEALRNIRHRNLVKIIT 505
            IG+G+FG          + +VAVK +   +RGA   ++   E    R++RH N+V+   
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYI---ERGAAIDENVQREIINHRSLRHPNIVRFKE 83

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWL-----HPESASDDLNYSPSILSFLQRLNIAI 560
              +         A++ E+   G L   +       E  +           F Q+L    
Sbjct: 84  VILTPTHL-----AIIMEYASGGELYERICNAGRFSEDEA---------RFFFQQL---- 125

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH--VGDFGLTRFIPEVISSNQCSSV 618
              S + Y H     QI H DLK  N LLD        + DFG         S +     
Sbjct: 126 --LSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGY--------SKSSVLHS 172

Query: 619 GLKGTVG---YAAPE 630
             K TVG   Y APE
Sbjct: 173 QPKSTVGTPAYIAPE 187

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 66.4 bits (163), Expect = 6e-12
 Identities = 58/199 (29%), Positives = 89/199 (44%), Gaps = 49/199 (24%)

Query: 448 LIGTGSFGSVY---KGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLV 501
           ++G GSFG V+   K      + + A+KVL    L  R  +++   E + L  + H  +V
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIV 89

Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ---RLNI 558
           K+  A     FQ      L+ +F+  G L + L  E              F +   +  +
Sbjct: 90  KLHYA-----FQTEGKLYLILDFLRGGDLFTRLSKEV------------MFTEEDVKFYL 132

Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV--GDFGLTRFIPEVISSNQ-- 614
           A  +A AL++LH      I++ DLKP N+LLD +   H+   DFGL++   E I   +  
Sbjct: 133 A-ELALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSK---ESIDHEKKA 183

Query: 615 ---CSSVGLKGTVGYAAPE 630
              C      GTV Y APE
Sbjct: 184 YSFC------GTVEYMAPE 196

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 66.5 bits (163), Expect = 7e-12
 Identities = 64/197 (32%), Positives = 87/197 (44%), Gaps = 46/197 (23%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEAL-RNIRHRNLVKI 503
           +IG GSFG V       ++   AVKVL    + ++   K  M+E   L +N++H  LV +
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ---RLNIAI 560
             +     FQ  D    V ++++ G L   L  E              FL+   R   A 
Sbjct: 105 HFS-----FQTADKLYFVLDYINGGELFYHLQRER------------CFLEPRARFYAA- 146

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV--GDFGLTRFIPEVISSNQ---- 614
            +ASAL YLH      IV+ DLKP N+LLD+    H+   DFGL +   E I  N     
Sbjct: 147 EIASALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCK---ENIEHNSTTST 198

Query: 615 -CSSVGLKGTVGYAAPE 630
            C      GT  Y APE
Sbjct: 199 FC------GTPEYLAPE 209

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 66.6 bits (163), Expect = 7e-12
 Identities = 45/166 (27%), Positives = 72/166 (43%), Gaps = 32/166 (19%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVK--- 502
           +G+G++G+V   +       VA+K L   F  +  A +++  E   L+++RH N++    
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGLLD 91

Query: 503 IITACSSSDFQGNDFKA--LVYEFMHHGSLESWLHPESASDDLNYSPSILSFL--QRLNI 558
           + T   + D    DF    LV  FM      + L      + L      + FL  Q L  
Sbjct: 92  VFTPDETLD----DFTDFYLVMPFM-----GTDLGKLMKHEKL--GEDRIQFLVYQMLK- 139

Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
                  L Y+H      I+H DLKP N+ ++ D    + DFGL R
Sbjct: 140 ------GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 176

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 66.3 bits (162), Expect = 8e-12
 Identities = 32/181 (17%), Positives = 72/181 (39%), Gaps = 28/181 (15%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR--------HRN 499
            +G G F +V+      + T VA+K++   +    ++   E + L+ +            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 500 LVKIITACSSSDFQGNDFK--ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLN 557
              I+      + +G +     +V+E +   +L + +          +    L ++++  
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIK------KYEHRGIPLIYVKQ-- 135

Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH------VGDFGLTRFIPEVIS 611
           I+  +   L+Y+H  C   I+H D+KP NVL++            + D G   +  E  +
Sbjct: 136 ISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193

Query: 612 S 612
           +
Sbjct: 194 N 194

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 65.8 bits (161), Expect = 9e-12
 Identities = 44/213 (20%), Positives = 72/213 (33%), Gaps = 70/213 (32%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL---------FLHQRGALKSFMAECEALRNIR-- 496
           L+G G FG+V+ G    D+  VA+KV+          L           E   L  +   
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL---EVALLWKVGAG 94

Query: 497 --HRNLVKIITACSSSDFQGNDFKA-LVYEF-----------MHHGSLESWLHPESASDD 542
             H  +++++      D+        LV E               G L      E  S  
Sbjct: 95  GGHPGVIRLL------DWFETQEGFMLVLERPLPAQDLFDYITEKGPL-----GEGPSRC 143

Query: 543 LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM----IAHVG 598
                    F Q       V +A+++ H      +VH D+K  N+L+D       +    
Sbjct: 144 F--------FGQ-------VVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLI--- 182

Query: 599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEY 631
           DFG    + +   ++        GT  Y+ PE+
Sbjct: 183 DFGSGALLHDEPYTDFD------GTRVYSPPEW 209

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 65.6 bits (161), Expect = 9e-12
 Identities = 52/202 (25%), Positives = 80/202 (39%), Gaps = 53/202 (26%)

Query: 448 LIGTGSFGSVY---KGILDPDQTVVAVKVL----FLHQRGALKSFMAECEALRNIRHRNL 500
           ++G G +G V+   K        + A+KVL     +          AE   L  ++H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83

Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH-----PESASDDLNYSPSILSFLQR 555
           V +I A     FQ      L+ E++  G L   L       E  +               
Sbjct: 84  VDLIYA-----FQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA--------------C 124

Query: 556 LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV--GDFGLTRFIPEVISSN 613
             +A  ++ AL +LH   +K I++ DLKP N++L++    HV   DFGL +   E I   
Sbjct: 125 FYLA-EISMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCK---ESIHDG 175

Query: 614 Q-----CSSVGLKGTVGYAAPE 630
                 C      GT+ Y APE
Sbjct: 176 TVTHTFC------GTIEYMAPE 191

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 44/208 (21%), Positives = 77/208 (37%), Gaps = 56/208 (26%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLF---LHQRGALKSFMA---ECEALRNIRHR--N 499
           L+G+G FGSVY GI   D   VA+K +    +   G L +      E   L+ +      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 500 LVKIITACSSSDFQGNDFKA-LVYEF-----------MHHGSLESWLHPESASDDLNYSP 547
           +++++      D+        L+ E               G+L      E  +       
Sbjct: 110 VIRLL------DWFERPDSFVLILERPEPVQDLFDFITERGAL-----QEELARSF---- 154

Query: 548 SILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD-NDMIAHVGDFGLTRFI 606
               F Q       V  A+ + H+     ++H D+K  N+L+D N     + DFG    +
Sbjct: 155 ----FWQ-------VLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL 200

Query: 607 PEVISSNQCSSVGLKGTVGYAAPEYGMG 634
            + + ++        GT  Y+ PE+   
Sbjct: 201 KDTVYTDFD------GTRVYSPPEWIRY 222

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 66.6 bits (162), Expect = 1e-11
 Identities = 49/197 (24%), Positives = 75/197 (38%), Gaps = 46/197 (23%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEAL-RNIRHRNLVKI 503
           ++G GSFG V          + AVK+L    + Q   ++  M E   L    +   L ++
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ---RLNIAI 560
            +      FQ  D    V E+++ G L   +                 F +       A 
Sbjct: 408 HSC-----FQTMDRLYFVMEYVNGGDLMYHIQQVG------------RFKEPHAVFYAA- 449

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV--GDFGLTRFIPEVISSNQ---- 614
            +A  L +L     K I++ DLK  NV+LD++   H+   DFG+ +   E I        
Sbjct: 450 EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCK---ENIWDGVTTKT 501

Query: 615 -CSSVGLKGTVGYAAPE 630
            C      GT  Y APE
Sbjct: 502 FC------GTPDYIAPE 512

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 45/166 (27%), Positives = 72/166 (43%), Gaps = 32/166 (19%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVK--- 502
           +G+G++GSV           VAVK L   F     A +++  E   L++++H N++    
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95

Query: 503 IITACSSSDFQGNDFKA--LVYEFMHHGSLESWLHPESASDDLNYSPSILSFL--QRLNI 558
           + T   S +    +F    LV   M      + L+       L  +   + FL  Q L  
Sbjct: 96  VFTPARSLE----EFNDVYLVTHLM-----GADLNNIVKCQKL--TDDHVQFLIYQILR- 143

Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
                  L+Y+H      I+H DLKPSN+ ++ D    + DFGL R
Sbjct: 144 ------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 180

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 53/200 (26%), Positives = 77/200 (38%), Gaps = 25/200 (12%)

Query: 107 LEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSL 166
            + LD  +N L++   +   RL  L  L    N L T           L N   LE + +
Sbjct: 39  TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAG---IFKELKN---LETLWV 92

Query: 167 NVNSLRSIPISV-GYLPKLQVLSLFENNISGEIPSSL-GNFTFLTELNLRGNSIRGSIPS 224
             N L+++PI V   L  L  L L  N +   +P  +  + T LT L+L  N ++ S+P 
Sbjct: 93  TDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPK 150

Query: 225 ALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSG 284
             G   +L SL               L L +N L      A   L  +  L L  N+L  
Sbjct: 151 --GVFDKLTSLK-------------ELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKR 195

Query: 285 EIPSSLGSCVGLEYLNLSIN 304
               +  S   L+ L L  N
Sbjct: 196 VPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 51/218 (23%), Positives = 82/218 (37%), Gaps = 30/218 (13%)

Query: 114 NNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRS 173
           +  LT +IP ++    +  +L+   N L +           L     L    LN N L++
Sbjct: 25  SKKLT-AIPSNI--PADTKKLDLQSNKLSSLPSKAF---HRLTKLRLL---YLNDNKLQT 75

Query: 174 IPISV-GYLPKLQVLSLFENNISGEIPSSL-GNFTFLTELNLRGNSIRGSIPSALGNCHQ 231
           +P  +   L  L+ L + +N +   +P  +      L EL L  N              Q
Sbjct: 76  LPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRN--------------Q 120

Query: 232 LQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAV-GNLKSIPHLDLSKNKLSGEIPSSL 290
           L+SL     +F     + +L L +N L   +P  V   L S+  L L  N+L      + 
Sbjct: 121 LKSL--PPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLKRVPEGAF 177

Query: 291 GSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
                L+ L L  N           SL+ L+ L L +N
Sbjct: 178 DKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 48/212 (22%), Positives = 76/212 (35%), Gaps = 39/212 (18%)

Query: 156 VNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRG 215
           V+C+           L +IP         + L L  N +S     +    T L  L L  
Sbjct: 21  VDCSS--------KKLTAIPS--NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLND 70

Query: 216 NSIRGSIPS-ALGNCHQLQSLDLSK--------TIFLGQYPVRWLDLSHNHLTGPIPLAV 266
           N ++ ++P+        L++L ++          +F     +  L L  N L   +P  V
Sbjct: 71  NKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKS-LPPRV 128

Query: 267 -GNLKSIPHLDLSKNKLSGEIPS----SLGSCVGLEYLNLSINSFHGPIHPGL-SSLKSL 320
             +L  + +L L  N+L   +P      L S   L+ L L  N     +  G    L  L
Sbjct: 129 FDSLTKLTYLSLGYNELQ-SLPKGVFDKLTS---LKELRLYNNQLKR-VPEGAFDKLTEL 183

Query: 321 EGLDLFQNTFQAKSQNGDVPRKGIFKNASAIS 352
           + L L  N  Q K     VP  G F +   + 
Sbjct: 184 KTLKLDNN--QLKR----VPE-GAFDSLEKLK 208

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 65.3 bits (159), Expect = 3e-11
 Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 44/211 (20%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           + +   IG+G+ G V           VA+K L   F +Q  A +++  E   ++ + H+N
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKN 122

Query: 500 LVK---IITACSSSDFQGNDFKA--LVYEFMHHGSLESWLHPESASDDLNYSPSILSFL- 553
           ++    + T   + +    +F+   LV E M     ++ L      +        +S+L 
Sbjct: 123 IISLLNVFTPQKTLE----EFQDVYLVMELM-----DANLCQVIQME---LDHERMSYLL 170

Query: 554 -QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISS 612
            Q L         +++LH      I+H DLKPSN+++ +D    + DFGL R        
Sbjct: 171 YQMLC-------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---- 216

Query: 613 NQCSSVGLKGTVG---YAAPEYGMGSQVSTN 640
               S  +   V    Y APE  +G     N
Sbjct: 217 ----SFMMTPYVVTRYYRAPEVILGMGYKEN 243

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 64.2 bits (157), Expect = 4e-11
 Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 43/177 (24%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           + S   +G+G++GSV   I       VA+K L   F  +  A +++  E   L++++H N
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHEN 84

Query: 500 LVK---IITACSSSDFQGNDFKA--LVYEFMHHGSLESWLHPESASDDLNYSPSILS--- 551
           ++    + T  SS      +F    LV  FM     ++ L                S   
Sbjct: 85  VIGLLDVFTPASSLR----NFYDFYLVMPFM-----QTDLQ--------KIMGLKFSEEK 127

Query: 552 ---FL-QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
               + Q L         L+Y+H      +VH DLKP N+ ++ D    + DFGL R
Sbjct: 128 IQYLVYQMLK-------GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 61.6 bits (150), Expect = 4e-11
 Identities = 34/153 (22%), Positives = 61/153 (39%), Gaps = 23/153 (15%)

Query: 96  NIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSL 155
            +  ++S     + L  + N++   I   L  + NL  L+  RN +  +K+ +L  +   
Sbjct: 39  KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLI--KKIENLDAV--- 91

Query: 156 VNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNIS--GEIPSSLGNFTFLTELNL 213
                LE + ++ N + S+   +  L  L+VL +  N I+  GEI   L     L +L L
Sbjct: 92  --ADTLEELWISYNQIASLS-GIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLL 147

Query: 214 RGNSIRGSIPSA----------LGNCHQLQSLD 236
            GN +                 +     L+ LD
Sbjct: 148 AGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 53.1 bits (128), Expect = 3e-08
 Identities = 42/182 (23%), Positives = 70/182 (38%), Gaps = 36/182 (19%)

Query: 157 NCTYLEIVSLN--VNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLR 214
             T  E V L+  +  +  +  ++  L   + L+L  NNI  +I SSL     L  L+L 
Sbjct: 21  VATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLG 78

Query: 215 GNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPH 274
            N I+  I +       L+                 L +S+N +     +    L ++  
Sbjct: 79  RNLIK-KIENLDAVADTLEE----------------LWISYNQIASLSGIE--KLVNLRV 119

Query: 275 LDLSKNKLS--GEIPSSLGSCVGLEYLNLSINSFHGPIHPG----------LSSLKSLEG 322
           L +S NK++  GEI   L +   LE L L+ N  +                +  L +L+ 
Sbjct: 120 LYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKK 178

Query: 323 LD 324
           LD
Sbjct: 179 LD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 30/144 (20%), Positives = 43/144 (29%), Gaps = 50/144 (34%)

Query: 187 LSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQY 246
           L      I  ++ ++L        L L  N+I   I S+L     L              
Sbjct: 30  LHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENL-------------- 72

Query: 247 PVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSF 306
             R L L  N            +K I +LD   + L              E L +S N  
Sbjct: 73  --RILSLGRN-----------LIKKIENLDAVADTL--------------EELWISYNQ- 104

Query: 307 HGPIH--PGLSSLKSLEGLDLFQN 328
              I    G+  L +L  L +  N
Sbjct: 105 ---IASLSGIEKLVNLRVLYMSNN 125

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 34/192 (17%), Positives = 61/192 (31%), Gaps = 56/192 (29%)

Query: 9   NLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPV--NLTHCSELRTLDLVLNKLEEN 66
           +         +   +  L   +++  ++N     I    +L+    LR L L  N +++ 
Sbjct: 31  HGMIPPIE-KMDATLSTLKACKHLALSTN----NIEKISSLSGMENLRILSLGRNLIKK- 84

Query: 67  QLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLG 126
                                         I +  + A  LE L  + N +  S+   + 
Sbjct: 85  ------------------------------IENLDAVADTLEELWISYNQIA-SL-SGIE 112

Query: 127 RLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPIS--------- 177
           +L NL  L  + N     K+ +   +D L     LE + L  N L +             
Sbjct: 113 KLVNLRVLYMSNN-----KITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRI 167

Query: 178 --VGYLPKLQVL 187
             V  LP L+ L
Sbjct: 168 EVVKRLPNLKKL 179

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 64.0 bits (156), Expect = 4e-11
 Identities = 44/202 (21%), Positives = 79/202 (39%), Gaps = 37/202 (18%)

Query: 448 LIGTGSFGSVYKGILDPDQTV-----VAVKV-------LF----LHQRGALKSFMAECEA 491
            IG G FG +Y   ++  ++V       VKV       LF     +QR A    + +   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 492 LRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHG-SLESWLHPESASDDLNYSPSIL 550
            R +++  + K        D  G  ++ ++ +    G  L+              +    
Sbjct: 102 TRKLKYLGVPKYW-GSGLHDKNGKSYRFMIMDRF--GSDLQ---------KIYEANAKRF 149

Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD--NDMIAHVGDFGL-TRFIP 607
           S    L +++ +   LEY+H     + VH D+K SN+LL+  N    ++ D+GL  R+ P
Sbjct: 150 SRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206

Query: 608 EVISS--NQCSSVGLKGTVGYA 627
           E +             GT+ + 
Sbjct: 207 EGVHKAYAADPKRCHDGTIEFT 228

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 63.8 bits (156), Expect = 5e-11
 Identities = 48/197 (24%), Positives = 71/197 (36%), Gaps = 46/197 (23%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEAL-RNIRHRNLVKI 503
           ++G GSFG V+           A+K L    +     ++  M E   L     H  L  +
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ---RLNIAI 560
                   FQ  +    V E+++ G L   +                 F         A 
Sbjct: 84  FCT-----FQTKENLFFVMEYLNGGDLMYHIQSCH------------KFDLSRATFYAA- 125

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV--GDFGLTRFIPEVISSNQ---- 614
            +   L++LH    K IV+ DLK  N+LLD D   H+   DFG+ +   E +  +     
Sbjct: 126 EIILGLQFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCK---ENMLGDAKTNT 177

Query: 615 -CSSVGLKGTVGYAAPE 630
            C      GT  Y APE
Sbjct: 178 FC------GTPDYIAPE 188

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 63.4 bits (155), Expect = 7e-11
 Identities = 48/201 (23%), Positives = 76/201 (37%), Gaps = 54/201 (26%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNI-----RHRN 499
           ++G GSFG V          + AVK+L    + Q   ++  M E    + +     +   
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE----KRVLALPGKPPF 82

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ---RL 556
           L ++ +      FQ  D    V E+++ G L   +                 F +     
Sbjct: 83  LTQLHSC-----FQTMDRLYFVMEYVNGGDLMYHIQQVG------------RFKEPHAVF 125

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV--GDFGLTRFIPEVISSNQ 614
             A  +A  L +L     K I++ DLK  NV+LD++   H+   DFG+ +   E I    
Sbjct: 126 YAA-EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCK---ENIWDGV 176

Query: 615 -----CSSVGLKGTVGYAAPE 630
                C      GT  Y APE
Sbjct: 177 TTKTFC------GTPDYIAPE 191

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 63.2 bits (154), Expect = 8e-11
 Identities = 35/204 (17%), Positives = 74/204 (36%), Gaps = 43/204 (21%)

Query: 449 IGTGSFGSVYKGI--------LDPDQTVVAVKV------LF----LHQRGALKSFMAECE 490
               + G +Y+            P +   ++K+      LF      QR A    + + +
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHG-SLESWLHPESASDDLNYSPS- 548
            L +     +   +          + ++ LV   +  G SL+           L+ SP  
Sbjct: 110 KLYSTPLLAIPTCM----GFGVHQDKYRFLVLPSL--GRSLQ---------SALDVSPKH 154

Query: 549 ILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL--DNDMIAHVGDFGL-TRF 605
           +LS    L +A  +  ALE+LH     + VH ++   N+ +  ++     +  +G   R+
Sbjct: 155 VLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211

Query: 606 IPEV--ISSNQCSSVGLKGTVGYA 627
            P    ++  + S    +G + + 
Sbjct: 212 CPSGKHVAYVEGSRSPHEGDLEFI 235

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 62.6 bits (151), Expect = 1e-10
 Identities = 35/201 (17%), Positives = 54/201 (26%), Gaps = 35/201 (17%)

Query: 435 SLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKS---------- 484
           S    T        IG G FG V++ I   D T VA+K++ +     +            
Sbjct: 14  SHCLPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEIL 71

Query: 485 ----FMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMH----HGSLESWLHP 536
                  E   L           I   S    QG+    L+  + H     GS       
Sbjct: 72  PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDF 131

Query: 537 ESA-------------SDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLK 583
                            D       + S     +I   + ++L       +    H DL 
Sbjct: 132 FKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLH 189

Query: 584 PSNVLLDNDMIAHVGDFGLTR 604
             NVLL    +  +      +
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGK 210

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 62.2 bits (152), Expect = 1e-10
 Identities = 47/204 (23%), Positives = 75/204 (36%), Gaps = 60/204 (29%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKI- 503
           +IG GS+  V    L     + A+KV+    ++    +     E    +++      +  
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE----KHV----FEQAS 67

Query: 504 ----ITACSSSDFQGNDFKALVYEF------MHHGSLESWLHPESASDDLNYSPSILSFL 553
               +    S  FQ       V E+      M H   +  L  E A              
Sbjct: 68  NHPFLVGLHSC-FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------------- 112

Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV--GDFGLTRFIPEVIS 611
            R   A  ++ AL YLH   ++ I++ DLK  NVLLD++   H+   D+G+ +   E + 
Sbjct: 113 -RFYSAE-ISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCK---EGLR 162

Query: 612 SNQ-----CSSVGLKGTVGYAAPE 630
                   C      GT  Y APE
Sbjct: 163 PGDTTSTFC------GTPNYIAPE 180

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 48/204 (23%), Positives = 77/204 (37%), Gaps = 60/204 (29%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNI-----RHRN 499
           +IG GS+  V    L     + A++V+    ++    +     E    +++      H  
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTE----KHVFEQASNHPF 114

Query: 500 LVKIITACSSSDFQGNDFKALVYEF------MHHGSLESWLHPESASDDLNYSPSILSFL 553
           LV + +      FQ       V E+      M H   +  L  E A              
Sbjct: 115 LVGLHSC-----FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------------- 155

Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV--GDFGLTRFIPEVIS 611
            R   A  ++ AL YLH   ++ I++ DLK  NVLLD++   H+   D+G+ +   E + 
Sbjct: 156 -RFYSAE-ISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCK---EGLR 205

Query: 612 SNQ-----CSSVGLKGTVGYAAPE 630
                   C      GT  Y APE
Sbjct: 206 PGDTTSTFC------GTPNYIAPE 223

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 49/198 (24%), Positives = 86/198 (43%), Gaps = 43/198 (21%)

Query: 448 LIGTGSFGSVY---KGILDPDQTVVAVKVL----FLHQRGALKSFMAECEALRNIRHRN- 499
           ++GTG++G V+   K        + A+KVL     + +    +    E + L +IR    
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH-----PESASDDLNYSPSILSFLQ 554
           LV +  A     FQ      L+ ++++ G L + L       E                 
Sbjct: 121 LVTLHYA-----FQTETKLHLILDYINGGELFTHLSQRERFTEHEV-------------- 161

Query: 555 RLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV--GDFGLTRFIPEVISS 612
           ++ +   +  ALE+LH   K  I++ D+K  N+LLD++   HV   DFGL++   E ++ 
Sbjct: 162 QIYVG-EIVLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSK---EFVAD 212

Query: 613 NQCSSVGLKGTVGYAAPE 630
               +    GT+ Y AP+
Sbjct: 213 ETERAYDFCGTIEYMAPD 230

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 37/161 (22%), Positives = 68/161 (42%), Gaps = 28/161 (17%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR-HRNLVKII-TA 506
           +G G +  V++ I   +   V VK+L   ++   K    E + L N+R   N++ +    
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIV 100

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFL-QRLNIAINVASA 565
                       ALV+E +++   +      +  D       I  ++ + L        A
Sbjct: 101 KDPVSRT----PALVFEHVNNTDFKQLYQTLTDYD-------IRFYMYEILK-------A 142

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDND-MIAHVGDFGLTRF 605
           L+Y H      I+H D+KP NV++D++     + D+GL  F
Sbjct: 143 LDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 36/171 (21%), Positives = 61/171 (35%), Gaps = 28/171 (16%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEA---LRNIRHRNLVKIIT 505
           +G G  G V +      Q   A+K+L            A  E     R  +  ++V+I+ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD 78

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
              +  + G     +V E +  G L           D  ++    S + +     ++  A
Sbjct: 79  VYENL-YAGRKCLLIVMECLDGGEL---FSRIQDRGDQAFTEREASEIMK-----SIGEA 129

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLL---DNDMIAHVGDFGLTRFIPEVISSN 613
           ++YLH      I H D+KP N+L      + I  + DFG      E     
Sbjct: 130 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTGEK 174

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 48/216 (22%), Positives = 81/216 (37%), Gaps = 36/216 (16%)

Query: 107 LEWLDFANNSLTASIPED-LGRLRNLTRLNFARNDLGTRKVNDLRFL-----DSLVNCTY 160
            + L      L  +IP      L N++R+  + +         L+ L      +L   T+
Sbjct: 33  TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSID-------VTLQQLESHSFYNLSKVTH 84

Query: 161 LEIVSLNVNSLRSIPISV-GYLPKLQVLSLFENNISGEIP--SSLGNFTFLTELNLRGNS 217
           +EI   N  +L  I       LP L+ L +F   +    P  + + +      L +  N 
Sbjct: 85  IEI--RNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNP 141

Query: 218 IRGSIPSAL--GNCHQLQSLDLSK--------TIFLGQYPVRWLDLSHN-HLTGPIPLAV 266
              SIP     G C++  +L L            F G   +  + L+ N +LT     A 
Sbjct: 142 YMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGT-KLDAVYLNKNKYLTVIDKDAF 200

Query: 267 GNLKSIPH-LDLSKNKLSGEIPSSLGSCVGLEYLNL 301
           G + S P  LD+S+  ++  +PS       L+ L  
Sbjct: 201 GGVYSGPSLLDVSQTSVT-ALPS--KGLEHLKELIA 233

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 58.5 bits (142), Expect = 9e-10
 Identities = 43/215 (20%), Positives = 71/215 (33%), Gaps = 37/215 (17%)

Query: 51  SELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIP-HSISNASKLEW 109
              +TL L+   L        +P +    LPNI    ++ +     +  HS  N SK+  
Sbjct: 31  PSTQTLKLIETHLRT------IPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTH 84

Query: 110 LDFANNSLTASIPED-LGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVS--- 165
           ++  N      I  D L  L  L  L      L  +   DL  + S      LEI     
Sbjct: 85  IEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL--KMFPDLTKVYSTDIFFILEITDNPY 142

Query: 166 --------------------LNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSL--G 203
                               L  N   S+        KL  + L +N     I      G
Sbjct: 143 MTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGG 202

Query: 204 NFTFLTELNLRGNSIRGSIPS-ALGNCHQLQSLDL 237
            ++  + L++   S+  ++PS  L +  +L + + 
Sbjct: 203 VYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 27/174 (15%), Positives = 51/174 (29%), Gaps = 46/174 (26%)

Query: 158 CTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPS-SLGNFTFLTELNLRGN 216
           C   E   +    ++ IP      P  Q L L E ++   IPS +  N   ++ + +  +
Sbjct: 10  CHQEEDFRVTCKDIQRIP---SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSID 65

Query: 217 SIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLD 276
                          LQ L+                            +  NL  + H++
Sbjct: 66  V-------------TLQQLE--------------------------SHSFYNLSKVTHIE 86

Query: 277 LSKNKLSGEIPSS-LGSCVGLEYLNLSINSFHG-PIHPGLSSLKSLEGLDLFQN 328
           +   +    I    L     L++L +        P    + S      L++  N
Sbjct: 87  IRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDN 140

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 56/316 (17%), Positives = 101/316 (31%), Gaps = 73/316 (23%)

Query: 47  LTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASK 106
            +    + +LDL LN L     V      +     N                      + 
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTV-----ELIQAFAN--------------------TPAS 52

Query: 107 LEWLDFANNSLTASIPEDLGRL-----RNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYL 161
           +  L+ + NSL     ++L ++      N+T LN + N L  +  ++L    + +  T +
Sbjct: 53  VTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFT-I 111

Query: 162 EIVSLNVNSLRSIPISVGYL--------PKLQVLSLFENNISGE----IPSSLGNF-TFL 208
            ++ L  N       S              +  L+L  N++  +    +   L      +
Sbjct: 112 TVLDLGWNDFS--SKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANV 169

Query: 209 TELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLT--GPIPLA- 265
             LNLRGN++     + L     L S+  S         V  LDLS N L       LA 
Sbjct: 170 NSLNLRGNNLASKNCAELAKF--LASIPAS---------VTSLDLSANLLGLKSYAELAY 218

Query: 266 --VGNLKSIPHLDLSKNKLSGE----IPSSLGSCVGLEYLNLSINSFHGP-------IHP 312
                   +  L+L  N L G     +     S   L+ + L  +            +  
Sbjct: 219 IFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGA 278

Query: 313 GLSSLKSLEGLDLFQN 328
              +++ +  +D    
Sbjct: 279 AFPNIQKIILVDKNGK 294

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 41/193 (21%), Positives = 60/193 (31%), Gaps = 44/193 (22%)

Query: 182 PKLQVLSLFENNISGEIPSSLG-----NFTFLTELNLRGNSIR----GSIPSALGNCH-Q 231
             +  L L  NN+       L          +T LNL GNS+       +   L      
Sbjct: 22  HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81

Query: 232 LQSLDLS-------------KTIFLGQYPVRWLDLSHNHLT--GPIPLA---VGNLKSIP 273
           + SL+LS             KT+    + +  LDL  N  +                SI 
Sbjct: 82  VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141

Query: 274 HLDLSKNKLSGE----IPSSLGSC-VGLEYLNLSINSFHGPIHPGLSSL--------KSL 320
            L+L  N L  +    +   L +    +  LNL  N+         + L         S+
Sbjct: 142 SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA---SKNCAELAKFLASIPASV 198

Query: 321 EGLDLFQNTFQAK 333
             LDL  N    K
Sbjct: 199 TSLDLSANLLGLK 211

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 41/199 (20%), Positives = 74/199 (37%), Gaps = 34/199 (17%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKV----------LF----LHQRGALKSFMAECEALR 493
            IG+G FG +Y           A  V          LF     +QR A K  + +    +
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 494 NIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFL 553
            + +  +         ++F+G  ++ +V E +    L+              + +     
Sbjct: 104 QLDYLGIPLFY-GSGLTEFKGRSYRFMVMERLGI-DLQ---------KISGQNGT-FKKS 151

Query: 554 QRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD--NDMIAHVGDFGL-TRFIPEV- 609
             L + I +   LEY+H     + VH D+K +N+LL   N    ++ D+GL  R+ P   
Sbjct: 152 TVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208

Query: 610 -ISSNQCSSVGLKGTVGYA 627
                +    G  GT+ + 
Sbjct: 209 HKQYQENPRKGHNGTIEFT 227

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 50/177 (28%), Positives = 63/177 (35%), Gaps = 29/177 (16%)

Query: 108 EWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLN 167
           E LD  +  L          L  LT LN   N L T         D L     L  + L 
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAG---VFDDLTE---LGTLGLA 91

Query: 168 VNSLRSIPISV-GYLPKLQVLSLFENNISGEIPSSLGNF---TFLTELNLRGNSIRGSIP 223
            N L S+P+ V  +L +L  L L  N +   +PS  G F   T L EL L  N       
Sbjct: 92  NNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPS--GVFDRLTKLKELRLNTN------- 141

Query: 224 SALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKN 280
                  QLQS  +    F     ++ L LS N L      A   L  +  + L  N
Sbjct: 142 -------QLQS--IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 44/156 (28%), Positives = 63/156 (40%), Gaps = 17/156 (10%)

Query: 88  LAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDL-GRLRNLTRLNFARNDLGTRKV 146
           L           +    +KL WL+   N L  ++   +   L  L  L  A N L    +
Sbjct: 42  LQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQL--ASL 98

Query: 147 NDLRFLDSLVNCTYLEIVSLNVNSLRSIPISV-GYLPKLQVLSLFENNISGEIPSSLGNF 205
               F D L     L    L  N L+S+P  V   L KL+ L L  N +   IP+  G F
Sbjct: 99  PLGVF-DHLTQLDKL---YLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPA--GAF 151

Query: 206 ---TFLTELNLRGNSIRGSIP-SALGNCHQLQSLDL 237
              T L  L+L  N ++ S+P  A     +LQ++ L
Sbjct: 152 DKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITL 186

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 46/175 (26%), Positives = 64/175 (36%), Gaps = 39/175 (22%)

Query: 166 LNVNSLRSIPISV-GYLPKLQVLSLFENNISGEIPSSLGNF---TFLTELNLRGNSIRGS 221
           L    L ++  +    L KL  L+L  N +   + +  G F   T L  L L  N     
Sbjct: 42  LQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSA--GVFDDLTELGTLGLANN----- 93

Query: 222 IPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAV----GNLKSIPHLDL 277
                    QL SL     +F     +  L L  N L   +P  V      LK    L L
Sbjct: 94  ---------QLASL--PLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLK---ELRL 138

Query: 278 SKNKLSGEIPS----SLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
           + N+L   IP+     L +   L+ L+LS N      H     L  L+ + LF N
Sbjct: 139 NTNQLQ-SIPAGAFDKLTN---LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 60.3 bits (146), Expect = 1e-09
 Identities = 37/254 (14%), Positives = 74/254 (29%), Gaps = 24/254 (9%)

Query: 85  IPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGR-LRNLTRLNFARNDLGT 143
           +P   G   +  I    S+ + LE +      +T    E + +  +N   L  +      
Sbjct: 85  VPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLS----SC 140

Query: 144 RKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISV-----GYLPKLQVLSL--FENNISG 196
              +          C  L+ + L  + +  +              L  L++    + +S 
Sbjct: 141 EGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSF 200

Query: 197 EIPSSLG-NFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSH 255
                L      L  L L        + + L    QL+ L              +     
Sbjct: 201 SALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTG----------GYTAEVR 250

Query: 256 NHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGP-IHPGL 314
             +   + +A+   K +  L    + +   +P+    C  L  LNLS  +     +   L
Sbjct: 251 PDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLL 310

Query: 315 SSLKSLEGLDLFQN 328
                L+ L +   
Sbjct: 311 CQCPKLQRLWVLDY 324

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 48.7 bits (116), Expect = 5e-06
 Identities = 39/297 (13%), Positives = 81/297 (27%), Gaps = 27/297 (9%)

Query: 47  LTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQF---FGNIPHSISN 103
              C  L+ LDL  + ++   + G    +   T  ++    ++       F  +   ++ 
Sbjct: 152 AATCRNLKELDLRESDVD--DVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTR 209

Query: 104 ASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEI 163
              L+ L          +   L R   L  L         R         +L  C  L  
Sbjct: 210 CPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRC 269

Query: 164 VSLNVN-SLRSIPISVGYLPKLQVLSLFENNISGE-IPSSLGNFTFLTELNLRGNSIRGS 221
           +S   +     +P       +L  L+L    +    +   L     L  L +        
Sbjct: 270 LSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAG 329

Query: 222 IPSALGNCHQLQSLDLSKTIFLGQYPVRWL-DLSHNHLTGPIPLAVGNLKSIPHLDLSKN 280
           +      C  L+ L +  +      P   L +     +             +  +     
Sbjct: 330 LEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSV-------SMGCPKLESVLYFCR 382

Query: 281 KLSGEIPSSLG-SCVGLEYLNLSINSFHGPIHP-------GLSSL----KSLEGLDL 325
           +++     ++  +   +    L I     P +        G  ++    K L  L L
Sbjct: 383 QMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSL 439

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 34/318 (10%), Positives = 78/318 (24%), Gaps = 58/318 (18%)

Query: 28  QLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPL 87
            L+ +  N      ++   L    +L  L       E    V             +R   
Sbjct: 212 NLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLS 271

Query: 88  LAGNQFFGNIPHSISNASKLEWLDFANNSLT-ASIPEDLGRLRNLTRLNFARN------- 139
              +     +P   S  S+L  L+ +  ++    + + L +   L RL            
Sbjct: 272 GFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLE 331

Query: 140 ---------------------DLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSL--RSIPI 176
                                      + +   +   + C  LE V      +   ++  
Sbjct: 332 VLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALIT 391

Query: 177 SVGYLPKLQVLSLFENNISGEIPSSLG-----------NFTFLTELNLRGNSIRGSIPSA 225
                P +    L           +L            +   L  L+L G          
Sbjct: 392 IARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYI 451

Query: 226 LGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGE 285
                +++ L ++               + +   G   +      S+  L++       +
Sbjct: 452 GTYAKKMEMLSVAF--------------AGDSDLGMHHVL-SGCDSLRKLEIRDCPFGDK 496

Query: 286 -IPSSLGSCVGLEYLNLS 302
            + ++      +  L +S
Sbjct: 497 ALLANASKLETMRSLWMS 514

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 56/201 (27%), Positives = 79/201 (39%), Gaps = 54/201 (26%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNI-----RHRN 499
           ++G GSFG V    +     + AVKVL    + Q   ++  M E    + I      H  
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE----KRILSLARNHPF 85

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQ---RL 556
           L ++        FQ  D    V EF++ G L   +                 F +   R 
Sbjct: 86  LTQLFCC-----FQTPDRLFFVMEFVNGGDLMFHIQKSR------------RFDEARARF 128

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV--GDFGLTRFIPEVISSNQ 614
             A  + SAL +LH    K I++ DLK  NVLLD++   H    DFG+ +   E I +  
Sbjct: 129 YAA-EIISALMFLH---DKGIIYRDLKLDNVLLDHE--GHCKLADFGMCK---EGICNGV 179

Query: 615 -----CSSVGLKGTVGYAAPE 630
                C      GT  Y APE
Sbjct: 180 TTATFC------GTPDYIAPE 194

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 40/175 (22%), Positives = 74/175 (42%), Gaps = 30/175 (17%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL-----FLHQRGALKSFMAECEALRNIRHR---N 499
           +IG GSFG V K         VA+K++     F  Q         E   L ++R +   N
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ------AAEEIRILEHLRKQDKDN 157

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
            + +I    +  F+ +    + +E +   +L   +          +    L  +++   A
Sbjct: 158 TMNVIHMLENFTFRNHIC--MTFELLSM-NLYELIK------KNKFQGFSLPLVRK--FA 206

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH--VGDFGLTRFIPEVISS 612
            ++   L+ LH +   +I+HCDLKP N+LL     +   V DFG + +  + + +
Sbjct: 207 HSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYT 258

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 56.6 bits (137), Expect = 3e-09
 Identities = 36/174 (20%), Positives = 61/174 (35%), Gaps = 28/174 (16%)

Query: 156 VNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRG 215
           V+C            L  IP        +  + L +N I    P +   +  L  ++L  
Sbjct: 16  VDCRG--------KGLTEIPT--NLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSN 65

Query: 216 NSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAV-GNLKSIPH 274
           N I   +         L+SL               L L  N +T  +P ++   L S+  
Sbjct: 66  NQIS-ELAP--DAFQGLRSL-------------NSLVLYGNKITE-LPKSLFEGLFSLQL 108

Query: 275 LDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
           L L+ NK++     +      L  L+L  N          S L++++ + L QN
Sbjct: 109 LLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 46.2 bits (110), Expect = 9e-06
 Identities = 30/152 (19%), Positives = 50/152 (32%), Gaps = 21/152 (13%)

Query: 43  IPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSI- 101
           +P  +T       + L  N ++       +PP        +R   L+ NQ    +     
Sbjct: 30  LPETIT------EIRLEQNTIKV------IPPGAFSPYKKLRRIDLSNNQI-SELAPDAF 76

Query: 102 SNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYL 161
                L  L    N +T         L +L  L    N +    +    F   L     L
Sbjct: 77  QGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKI--NCLRVDAF-QDL---HNL 130

Query: 162 EIVSLNVNSLRSIPISV-GYLPKLQVLSLFEN 192
            ++SL  N L++I       L  +Q + L +N
Sbjct: 131 NLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 55.1 bits (133), Expect = 3e-09
 Identities = 31/100 (31%), Positives = 42/100 (42%), Gaps = 2/100 (2%)

Query: 140 DLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIP 199
            L   + N+ +          LE +S     L SI   +  L KL+ L L +N +SG + 
Sbjct: 23  VLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIAN-LPKLNKLKKLELSDNRVSGGLE 81

Query: 200 SSLGNFTFLTELNLRGNSIRG-SIPSALGNCHQLQSLDLS 238
                   LT LNL GN I+  S    L     L+SLDL 
Sbjct: 82  VLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLF 121

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 54.3 bits (131), Expect = 5e-09
 Identities = 24/140 (17%), Positives = 41/140 (29%), Gaps = 14/140 (10%)

Query: 103 NASKLEWLDFANNSLTA-SIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYL 161
             S ++ L   N+      +         L  L+     L +        + +L     L
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS--------IANLPKLNKL 66

Query: 162 EIVSLNVNSLRSI-PISVGYLPKLQVLSLFENNISG-EIPSSLGNFTFLTELNLRGNSIR 219
           + + L+ N +     +     P L  L+L  N I        L     L  L+L    + 
Sbjct: 67  KKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126

Query: 220 GSI---PSALGNCHQLQSLD 236
                  +      QL  LD
Sbjct: 127 NLNDYRENVFKLLPQLTYLD 146

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 50.8 bits (122), Expect = 9e-08
 Identities = 21/109 (19%), Positives = 40/109 (36%), Gaps = 8/109 (7%)

Query: 204 NFTFLTELNLRGNSI-RGSIPSALGNCHQLQSLDLSK------TIFLGQYPVRWLDLSHN 256
             + + EL L  +    G +        +L+ L                  ++ L+LS N
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPKLNKLKKLELSDN 74

Query: 257 HLTGPIPLAVGNLKSIPHLDLSKNKLSG-EIPSSLGSCVGLEYLNLSIN 304
            ++G + +      ++ HL+LS NK+        L     L+ L+L   
Sbjct: 75  RVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 47.4 bits (113), Expect = 1e-06
 Identities = 29/146 (19%), Positives = 56/146 (38%), Gaps = 22/146 (15%)

Query: 49  HCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASK-- 106
             S+++ L L  ++  E +L G     +      +                SI+N  K  
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEG-----LTDEFEELEFLSTINVGL-----TSIANLPKLN 64

Query: 107 -LEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVS 165
            L+ L+ ++N ++  +     +  NLT LN + N     K+ DL  ++ L     L+ + 
Sbjct: 65  KLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGN-----KIKDLSTIEPLKKLENLKSLD 119

Query: 166 LNVNSLRSIP----ISVGYLPKLQVL 187
           L    + ++          LP+L  L
Sbjct: 120 LFNCEVTNLNDYRENVFKLLPQLTYL 145

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 44.7 bits (106), Expect = 1e-05
 Identities = 22/101 (21%), Positives = 40/101 (39%), Gaps = 10/101 (9%)

Query: 97  IPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLV 156
           +        +LE+L   N  LT SI  +L +L  L +L  + N +               
Sbjct: 34  LEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAE------ 85

Query: 157 NCTYLEIVSLNVNSLRSIPI--SVGYLPKLQVLSLFENNIS 195
            C  L  ++L+ N ++ +     +  L  L+ L LF   ++
Sbjct: 86  KCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.4 bits (100), Expect = 8e-05
 Identities = 16/85 (18%), Positives = 33/85 (38%), Gaps = 4/85 (4%)

Query: 157 NCTYLEIVSLNVNSLRSIPI--SVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLR 214
             + ++ + L+ +      +        +L+ LS     ++  I ++L     L +L L 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72

Query: 215 GNSIRGSIPSALGNCHQLQSLDLSK 239
            N + G +      C  L  L+LS 
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSG 97

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.0 bits (94), Expect = 4e-04
 Identities = 23/106 (21%), Positives = 39/106 (36%), Gaps = 9/106 (8%)

Query: 35  NSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFF 94
           NS + +G++        EL  L  +   L     +  LP      L  ++   L+ N+  
Sbjct: 26  NSRSNEGKLEGLTDEFEELEFLSTINVGLTS---IANLP-----KLNKLKKLELSDNRVS 77

Query: 95  GNIPHSISNASKLEWLDFANNSLTA-SIPEDLGRLRNLTRLNFARN 139
           G +         L  L+ + N +   S  E L +L NL  L+    
Sbjct: 78  GGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 55.1 bits (133), Expect = 4e-09
 Identities = 34/100 (34%), Positives = 43/100 (43%), Gaps = 2/100 (2%)

Query: 140 DLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIP 199
            L   K ND +          LE +SL    L S+   +  LPKL+ L L EN I G + 
Sbjct: 30  VLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN-LPKLPKLKKLELSENRIFGGLD 88

Query: 200 SSLGNFTFLTELNLRGNSIRG-SIPSALGNCHQLQSLDLS 238
                   LT LNL GN ++  S    L     L+SLDL 
Sbjct: 89  MLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLF 128

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 49.7 bits (119), Expect = 3e-07
 Identities = 29/142 (20%), Positives = 46/142 (32%), Gaps = 21/142 (14%)

Query: 204 NFTFLTELNLRGNSIR-GSIPSALGNCHQLQSLDLSK------TIFLGQYPVRWLDLSHN 256
               + EL L       G I         L+ L L        +       ++ L+LS N
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPKLPKLKKLELSEN 81

Query: 257 HLTGPIPLAVGNLKSIPHLDLSKNKLS--GEIPSSLGSCVGLEYLNLSINSFHGPI--HP 312
            + G + +    L ++ HL+LS NKL     +   L     L+ L+L        +    
Sbjct: 82  RIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC----EVTNLN 136

Query: 313 G-----LSSLKSLEGLDLFQNT 329
                    L  L  LD +   
Sbjct: 137 DYRESVFKLLPQLTYLDGYDRE 158

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.4 bits (113), Expect = 2e-06
 Identities = 31/144 (21%), Positives = 55/144 (38%), Gaps = 22/144 (15%)

Query: 51  SELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASK---L 107
           + +R L L   K  + ++ G     +     N+    L           S+SN  K   L
Sbjct: 24  AAVRELVLDNCKSNDGKIEG-----LTAEFVNLEFLSLINVGL-----ISVSNLPKLPKL 73

Query: 108 EWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLN 167
           + L+ + N +   +     +L NLT LN + N     K+ D+  L+ L     L+ + L 
Sbjct: 74  KKLELSENRIFGGLDMLAEKLPNLTHLNLSGN-----KLKDISTLEPLKKLECLKSLDLF 128

Query: 168 VNSLRSIP----ISVGYLPKLQVL 187
              + ++          LP+L  L
Sbjct: 129 NCEVTNLNDYRESVFKLLPQLTYL 152

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.0 bits (104), Expect = 3e-05
 Identities = 24/103 (23%), Positives = 42/103 (40%), Gaps = 10/103 (9%)

Query: 95  GNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDS 154
           G I    +    LE+L   N  L  S+  +L +L  L +L  + N +    ++ L     
Sbjct: 39  GKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRI-FGGLDML----- 90

Query: 155 LVNCTYLEIVSLNVNSLRSIP--ISVGYLPKLQVLSLFENNIS 195
                 L  ++L+ N L+ I     +  L  L+ L LF   ++
Sbjct: 91  AEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 26/106 (24%), Positives = 38/106 (35%), Gaps = 9/106 (8%)

Query: 35  NSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFF 94
           N  +  G+I         L  L L+   L     V  LP      LP ++   L+ N+ F
Sbjct: 33  NCKSNDGKIEGLTAEFVNLEFLSLINVGLIS---VSNLPK-----LPKLKKLELSENRIF 84

Query: 95  GNIPHSISNASKLEWLDFANNSLTA-SIPEDLGRLRNLTRLNFARN 139
           G +         L  L+ + N L   S  E L +L  L  L+    
Sbjct: 85  GGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 57.8 bits (140), Expect = 4e-09
 Identities = 46/176 (26%), Positives = 76/176 (43%), Gaps = 28/176 (15%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVL-----FLHQRGALKSFMAECEALRNIRHR--- 498
           +LIG GSFG V K     +Q  VA+K++     FL+Q         E   L  +      
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA------QIEVRLLELMNKHDTE 113

Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
               I+       F+ +    LV+E + + +L   L       + N+    L+  ++   
Sbjct: 114 MKYYIVHLKRHFMFRNHLC--LVFEMLSY-NLYDLL------RNTNFRGVSLNLTRK--F 162

Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH--VGDFGLTRFIPEVISS 612
           A  + +AL +L    +  I+HCDLKP N+LL N   +   + DFG +  + + I  
Sbjct: 163 AQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ 217

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 42/192 (21%), Positives = 75/192 (39%), Gaps = 25/192 (13%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR-----HRNLVKI 503
           +G G F +V+       +  VA+KV+   +    ++ + E   L+++R       N   +
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPNREMV 103

Query: 504 ITACSSSDFQGNDFK--ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +         G +     +V+E + H  L  W+         NY    L  +++  I   
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGH-HLLKWII------KSNYQGLPLPCVKK--IIQQ 154

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           V   L+YLH  C  +I+H D+KP N+LL       V +  + R   E     +  +    
Sbjct: 155 VLQGLDYLHTKC--RIIHTDIKPENILL------SVNEQYIRRLAAEATEWQRSGAPPPS 206

Query: 622 GTVGYAAPEYGM 633
           G+    AP    
Sbjct: 207 GSAVSTAPATAG 218

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 54.6 bits (132), Expect = 4e-08
 Identities = 37/180 (20%), Positives = 70/180 (38%), Gaps = 41/180 (22%)

Query: 448 LIGTGSFGSVYKGI-LDPDQTVVAVKVL-----FLHQRGALKSFMAECEALRNIRHR--- 498
            +G G+FG V + +     ++ VA+K++     +     A      E   L+ I+ +   
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA--ARL----EINVLKKIKEKDKE 79

Query: 499 NLVKIITACSSSDFQGN---DFKAL---VYEFMHHGSLESWLHPESASDDLNYSPSILSF 552
           N    +      +F G+    F+ L    +EF+                  N+ P  L  
Sbjct: 80  NKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKEN---------------NFQPYPLPH 124

Query: 553 LQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISS 612
           ++   +A  +  AL +LH +   Q+ H DLKP N+L  N     + +   +     V ++
Sbjct: 125 VRH--MAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 37/162 (22%), Positives = 61/162 (37%), Gaps = 26/162 (16%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG G+FG +  G        VA+K      +        E    + +   + +  +    
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIK--LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74

Query: 509 SSDFQGNDFKALVYEFMHHG-SLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
                   + A+V E +  G SLE         D  +      S    L IAI + S +E
Sbjct: 75  PCG----KYNAMVLELL--GPSLE---------DLFDLCDRTFSLKTVLMIAIQLISRME 119

Query: 568 YLHHHCKKQIVHCDLKPSNVLL-----DNDMIAHVGDFGLTR 604
           Y+H    K +++ D+KP N L+         + H+ DF L +
Sbjct: 120 YVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 53.2 bits (128), Expect = 5e-08
 Identities = 33/130 (25%), Positives = 49/130 (37%), Gaps = 8/130 (6%)

Query: 88  LAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDL-GRLRNLTRLNFARNDLGTRKV 146
           L  NQ     P    +   L+ L   +N L  ++P  +   L  LT L+   N L    V
Sbjct: 47  LHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQL---TV 102

Query: 147 NDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFT 206
                 D LV+   L    +  N L  +P  +  L  L  L+L +N +      +    +
Sbjct: 103 LPSAVFDRLVHLKEL---FMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159

Query: 207 FLTELNLRGN 216
            LT   L GN
Sbjct: 160 SLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 42/142 (29%), Positives = 57/142 (40%), Gaps = 24/142 (16%)

Query: 108 EWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFL-----DSLVNCTYLE 162
           + L   +N +T   P     L NL  L    N LG         L     DSL   T L 
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA--------LPVGVFDSLTQLTVL- 93

Query: 163 IVSLNVNSLRSIPISV-GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGS 221
              L  N L  +P +V   L  L+ L +  N ++ E+P  +   T LT L L  N ++ S
Sbjct: 94  --DLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-S 149

Query: 222 IPSALGNCHQLQSLDLSKTIFL 243
           IP   G   +L SL      +L
Sbjct: 150 IPH--GAFDRLSSL---THAYL 166

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 47/174 (27%), Positives = 63/174 (36%), Gaps = 29/174 (16%)

Query: 156 VNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRG 215
           V+C              S+P   G     Q+L L +N I+   P    +   L EL L  
Sbjct: 24  VDCRS--------KRHASVPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGS 73

Query: 216 NSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAV-GNLKSIPH 274
           N              QL +L     +F     +  LDL  N LT  +P AV   L  +  
Sbjct: 74  N--------------QLGAL--PVGVFDSLTQLTVLDLGTNQLTV-LPSAVFDRLVHLKE 116

Query: 275 LDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
           L +  NKL+ E+P  +     L +L L  N      H     L SL    LF N
Sbjct: 117 LFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 52.7 bits (127), Expect = 6e-08
 Identities = 25/117 (21%), Positives = 45/117 (38%), Gaps = 9/117 (7%)

Query: 102 SNASKLEWLDFANNSLTASIPED-LGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTY 160
               +L  ++F+NN +T  I E        +  +    N L   +    +    L +   
Sbjct: 54  KKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL---ENVQHKMFKGLESLKT 109

Query: 161 LEIVSLNVNSLRSIPISV-GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGN 216
           L    L  N +  +       L  +++LSL++N I+   P +      L+ LNL  N
Sbjct: 110 L---MLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 52.4 bits (126), Expect = 8e-08
 Identities = 30/133 (22%), Positives = 52/133 (39%), Gaps = 12/133 (9%)

Query: 159 TYLEIVSLNVNSLRSIPISVGY--LPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGN 216
            Y   + LN N    +  +  +  LP+L+ ++   N I+     +    + + E+ L  N
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91

Query: 217 SIRGSIPS-ALGNCHQLQSLDLS--------KTIFLGQYPVRWLDLSHNHLTGPIPLAVG 267
            +  ++          L++L L            F+G   VR L L  N +T   P A  
Sbjct: 92  RLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFD 150

Query: 268 NLKSIPHLDLSKN 280
            L S+  L+L  N
Sbjct: 151 TLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 31/153 (20%), Positives = 51/153 (33%), Gaps = 22/153 (14%)

Query: 43  IPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFT-LPNIRIPLLAGNQFFGNIPHSI 101
           IP           L L  N+         L     F  LP +R    + N+   +I    
Sbjct: 30  IPQYTA------ELRLNNNEFTV------LEATGIFKKLPQLRKINFSNNKI-TDIEEGA 76

Query: 102 -SNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTY 160
              AS +  +   +N L     +    L +L  L    N +    V +  F   L   + 
Sbjct: 77  FEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRI--TCVGNDSF-IGL---SS 130

Query: 161 LEIVSLNVNSLRSIPISV-GYLPKLQVLSLFEN 192
           + ++SL  N + ++       L  L  L+L  N
Sbjct: 131 VRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 54.3 bits (131), Expect = 6e-08
 Identities = 39/181 (21%), Positives = 67/181 (37%), Gaps = 27/181 (14%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL-----FLHQRGALKSFMAECEALRNIRHR--NL 500
            +G G+FG V       ++   AVKV+     +     A      E + L+ I++   N 
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRS--AKI----EADILKKIQNDDINN 95

Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
             I+       +  +    L++E +   SL   +         NY+   +  ++     I
Sbjct: 96  NNIVKYHGKFMYYDHMC--LIFEPLGP-SLYEII------TRNNYNGFHIEDIKL--YCI 144

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +  AL YL       + H DLKP N+LLD+                + I   +  S G+
Sbjct: 145 EILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201

Query: 621 K 621
           K
Sbjct: 202 K 202

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 53.5 bits (129), Expect = 8e-08
 Identities = 46/187 (24%), Positives = 75/187 (40%), Gaps = 29/187 (15%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG+GSFG +Y G        VA+K      +        E +  + ++    +  I  C 
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIK--LECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 74

Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
           +      D+  +V E +   SLE         D  N+     S    L +A  + S +EY
Sbjct: 75  AEG----DYNVMVMELLGP-SLE---------DLFNFCSRKFSLKTVLLLADQMISRIEY 120

Query: 569 LHHHCKKQIVHCDLKPSNVLL---DNDMIAHVGDFGL-TRFIPEVISSNQC----SSVGL 620
           +H    K  +H D+KP N L+       + ++ DFGL  ++      ++Q      +  L
Sbjct: 121 IHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR--DARTHQHIPYRENKNL 175

Query: 621 KGTVGYA 627
            GT  YA
Sbjct: 176 TGTARYA 182

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.1 bits (129), Expect = 1e-07
 Identities = 61/434 (14%), Positives = 123/434 (28%), Gaps = 108/434 (24%)

Query: 246 YPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLS-GEIPSSLGSCVGLEYLNLSIN 304
           + + WL+L + +    +   +  L       +  N  S  +  S++   +      L   
Sbjct: 182 FKIFWLNLKNCNSPETVLEMLQKL----LYQIDPNWTSRSDHSSNIKLRIHSIQAELR-R 236

Query: 305 SFHGPIHPG----LSSLKSLEGLDLFQNTFQAK----SQNGDVPRKGIFKNASAISVAGN 356
                 +      L ++++ +  + F      K    ++   V         + IS+  +
Sbjct: 237 LLKSKPYENCLLVLLNVQNAKAWNAF--NLSCKILLTTRFKQVTDFLSAATTTHISLDHH 294

Query: 357 EK------------LCGGISELKLPPCTPSESKKRQKSNGFKLMIPLLSGLVGLVLVMSL 404
                                  LP     E              P    ++   +   L
Sbjct: 295 SMTLTPDEVKSLLLKYLDCRPQDLPR----EVLT---------TNPRRLSIIAESIRDGL 341

Query: 405 LIIDRLRR------KRTVTSS----ESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSF 454
              D  +          + SS    E +  + +     ++ L      F  +  I T   
Sbjct: 342 ATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM-----FDRL----SVFPPSAHIPTILL 392

Query: 455 GSVYKGILDPDQTVVAVKVLFLHQRGALK---------------SFMAECEALRNIRHRN 499
             ++  ++  D  VV  K   LH+   ++                   + E    + HR+
Sbjct: 393 SLIWFDVIKSDVMVVVNK---LHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL-HRS 448

Query: 500 LV---KIITACSSSDFQGNDFKALVYEF-MHHGSLESWLHPESASDDLNYSPSI---LSF 552
           +V    I     S D          Y    HH      L      + +     +     F
Sbjct: 449 IVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHH------LKNIEHPERMTLFRMVFLDFRF 502

Query: 553 LQR--------LNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR 604
           L++         N + ++ + L+ L  + K  I  CD  P    L N ++    DF L +
Sbjct: 503 LEQKIRHDSTAWNASGSILNTLQQLKFY-KPYI--CDNDPKYERLVNAIL----DF-LPK 554

Query: 605 FIPEVISSNQCSSV 618
               +I S     +
Sbjct: 555 IEENLICSKYTDLL 568

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.0 bits (121), Expect = 1e-06
 Identities = 96/579 (16%), Positives = 182/579 (31%), Gaps = 174/579 (30%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLF-QLRYIIFNSNTLQGQIPVNLTHCSELRTLDLV 59
           N  FLM   ++        P  + R++ + R  ++N N  Q     N++       L   
Sbjct: 90  NYKFLM-SPIKTEQ---RQPSMMTRMYIEQRDRLYNDN--QVFAKYNVSRLQPYLKLRQA 143

Query: 60  LNKLEENQLV---GELPPYIGF--------TLPNIRIPLLAGNQFFGNIPHSISNASKLE 108
           L +L   + V   G L    G            + ++      + F              
Sbjct: 144 LLELRPAKNVLIDGVL----GSGKTWVALDVCLSYKVQCKMDFKIF-------------- 185

Query: 109 WLDFANNSLTASIPEDLGRLRNLTRLNF-ARNDLGTR---KVNDL-----RFLDS--LVN 157
           WL+  N +   ++ E L +L      N+ +R+D  +    +++ +     R L S    N
Sbjct: 186 WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN 245

Query: 158 CTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNS 217
           C  L ++  NV + +               + F  N+S +I   L      T      + 
Sbjct: 246 C--LLVLL-NVQNAK-------------AWNAF--NLSCKI---L----LTTRFKQVTDF 280

Query: 218 IRGSIPSALGNCHQLQSL--DLSKTIFLGQYPVRWL-----DLSHNHLTGPIPLAVG--- 267
           +  +  + +   H   +L  D  K++ L     ++L     DL    LT   P  +    
Sbjct: 281 LSAATTTHISLDHHSMTLTPDEVKSLLL-----KYLDCRPQDLPREVLTT-NPRRLSIIA 334

Query: 268 -NLKSIPH-----LDLSKNKLSGEIPSSLGSCVGLE-------YLNLSINSF--HGPIHP 312
            +++           ++ +KL+  I SSL     LE       +  LS+  F     I  
Sbjct: 335 ESIRDGLATWDNWKHVNCDKLTTIIESSLNV---LEPAEYRKMFDRLSV--FPPSAHIPT 389

Query: 313 G-LSSL---KSLEGLDLFQNTFQAKS---QNGDVPRKGI------FKNASAISVAGNEKL 359
             LS +        + +  N     S   +        I       K       A +  +
Sbjct: 390 ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSI 449

Query: 360 CGGISELKLPPCTPSESKKRQKSN-------GFKLMIPLLSGLVGLVLVMSLLIID-R-L 410
              +    +P    S+       +       G  L        + L     ++ +D R L
Sbjct: 450 ---VDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTL---FRMVFLDFRFL 503

Query: 411 RRK-RTVTSS--ESSSRKDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKG-ILDPDQ 466
            +K R  +++   S S  + L  + +                        YK  I D D 
Sbjct: 504 EQKIRHDSTAWNASGSILNTLQQLKF------------------------YKPYICDNDP 539

Query: 467 TVVAVKVLFLHQR-GALKSFMAECEA-LRNIRHRNLVKI 503
                      +   A+  F+ + E  L   ++ +L++I
Sbjct: 540 K--------YERLVNAILDFLPKIEENLICSKYTDLLRI 570

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.2 bits (106), Expect = 6e-05
 Identities = 38/341 (11%), Positives = 93/341 (27%), Gaps = 88/341 (25%)

Query: 310 IHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKL----CGGISE 365
           +   L  L+  + + +           G     G  K   A+ V  + K+       I  
Sbjct: 140 LRQALLELRPAKNVLID----------GV---LGSGKTWVALDVCLSYKVQCKMDFKIFW 186

Query: 366 LKLPPC-TPSESKKRQKSNGFKLMIPLLSG---------------------LVGLVLVMS 403
           L L  C +P    +  +   +++     S                      L        
Sbjct: 187 LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC 246

Query: 404 LLIIDRLRRKRT-----------VTSSESSSRKDLL-LNVSYESLLKATGGFSSANLIGT 451
           LL++  ++  +            +T+        L     ++ SL   +   +   +   
Sbjct: 247 LLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL 306

Query: 452 GSFGSVYKGILD--PDQTVVAVKV--LFLHQRGA-LKSFMAECEALRNIRHRNLVKIITA 506
                         P +    +      L      ++  +A  +  +++    L  II +
Sbjct: 307 --LLKYLDCRPQDLPRE---VLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIES 361

Query: 507 C----SSSDFQGNDFKALVYEFMHH-----GSLES-WLHPESASDDLNYSPSILSFLQRL 556
                  ++++   F  L   F          L   W     +   +     +++ L + 
Sbjct: 362 SLNVLEPAEYRKM-FDRLSV-FPPSAHIPTILLSLIWFDVIKSDVMV-----VVNKLHKY 414

Query: 557 N-IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH 596
           + +      +   +        ++ +LK     L+N+   H
Sbjct: 415 SLVEKQPKESTISIPS------IYLELKVK---LENEYALH 446

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 52/247 (21%), Positives = 93/247 (37%), Gaps = 30/247 (12%)

Query: 101 ISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTY 160
            S+ S  + LD    +L   +   L     L++   A     +     L    S     +
Sbjct: 43  ASDESLWQTLDLTGKNLHPDVTGRL-----LSQGVIAFRCPRSFMDQPLAEHFSPFRVQH 97

Query: 161 LEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSI-- 218
           +++ +  +    ++   +    KLQ LSL    +S  I ++L   + L  LNL G S   
Sbjct: 98  MDLSNSVIEV-STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFS 156

Query: 219 RGSIPSALGNCHQLQSLDLSKTIFLGQYPV-----------RWLDLS--HNHLT-GPIPL 264
             ++ + L +C +L  L+LS      +  V             L+LS    +L    +  
Sbjct: 157 EFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLST 216

Query: 265 AVGNLKSIPHLDLSK-NKLSGEIPSSLGSCVGLEYLNLS----INSFHGPIHPGLSSLKS 319
            V    ++ HLDLS    L  +          L++L+LS    I      +   L  + +
Sbjct: 217 LVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP-ETLLE--LGEIPT 273

Query: 320 LEGLDLF 326
           L+ L +F
Sbjct: 274 LKTLQVF 280

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 50.3 bits (120), Expect = 9e-07
 Identities = 41/210 (19%), Positives = 79/210 (37%), Gaps = 24/210 (11%)

Query: 101 ISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTY 160
           +S  SKL+ L      L+  I   L +  NL RLN +    G    ++      L +C+ 
Sbjct: 114 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS----GCSGFSEFALQTLLSSCSR 169

Query: 161 LEIVSL----NVNSLRSIPISVGYLPKLQVLSLFE--NNISGEIPSSLG-NFTFLTELNL 213
           L+ ++L    +                +  L+L     N+     S+L      L  L+L
Sbjct: 170 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 229

Query: 214 RG-NSIRGSIPSALGNCHQLQSLDLSKT--------IFLGQYP-VRWLDLSHNHLTGPIP 263
                ++          + LQ L LS+         + LG+ P ++ L +      G + 
Sbjct: 230 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 289

Query: 264 LAVGNLKSIPHLDLSKNKLSGEIPSSLGSC 293
           L     +++PHL ++ +  +     ++G+ 
Sbjct: 290 LL---KEALPHLQINCSHFTTIARPTIGNK 316

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 31/174 (17%), Positives = 68/174 (39%), Gaps = 29/174 (16%)

Query: 448 LIGTGSFGSVYKGI-LDPDQTVVAVKVL-----FLHQRGALKSFMAECEALRNIRHR--- 498
            +G G+FG V + I        VAVK++     +     A      E + L ++      
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEA--ARS----EIQVLEHLNTTDPN 74

Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI 558
           +  + +      +  G+    +V+E +   S   ++       +  + P  L  +++  +
Sbjct: 75  STFRCVQMLEWFEHHGHIC--IVFELLGL-STYDFI------KENGFLPFRLDHIRK--M 123

Query: 559 AINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISS 612
           A  +  ++ +LH +   ++ H DLKP N+L          +  + R    +I+ 
Sbjct: 124 AYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 52.6 bits (125), Expect = 2e-07
 Identities = 30/220 (13%), Positives = 73/220 (33%), Gaps = 17/220 (7%)

Query: 34  FNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQF 93
            + + +   I  N    +    L       EE ++       +   L  + +      + 
Sbjct: 122 EDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKG 181

Query: 94  FGNIPHSISNASKLEWLDFANNSLTASIPEDLG--RLRNLTRLNF---ARNDLGTRKVND 148
             N+         L+ L+  +  L  S+ ED+    L NL +L       +      +N 
Sbjct: 182 TNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNV 241

Query: 149 LRFLDSLVNCTYLEIVSLNVNSLRSIPISV----GYLPKLQVLSLFENNISGE----IPS 200
            R L S      L+ + +     +++ + +      LP+L+ + +    ++ E    +  
Sbjct: 242 FRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLD 301

Query: 201 SLGNFTFLTELNLRGNSI----RGSIPSALGNCHQLQSLD 236
            +     L  +N++ N +    +  +  +L     +    
Sbjct: 302 HVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQ 341

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 51.5 bits (122), Expect = 4e-07
 Identities = 41/211 (19%), Positives = 71/211 (33%), Gaps = 35/211 (16%)

Query: 110 LDFANNSLTASIPEDLGR-LRNLTRLNFARNDLGTRKVNDLRFLDSLVNC-TYLEIVSLN 167
           +DF    ++     DL   L  +  LN    +L  +  N+L            LEI+S  
Sbjct: 149 IDFEEQEISWIEQVDLSPVLDAMPLLN----NLKIKGTNNLSIGKKPRPNLKSLEIISGG 204

Query: 168 VNSLRSIPISVGYLPKLQVLSLF---ENNISGEIPSSL------GNFTFLTELNLRGNSI 218
           +       I    LP L+ L L+   E+       +          F  L  L +     
Sbjct: 205 LPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEE 264

Query: 219 RGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLT--GPIPLAVGNLKSIPHL- 275
           +  +         L  L               +D+S   LT  G   L   ++  I HL 
Sbjct: 265 QNVVVEMFLESDILPQL-------------ETMDISAGVLTDEGARLLL-DHVDKIKHLK 310

Query: 276 --DLSKNKLSGEIPSSLGSCVGLEYLNLSIN 304
             ++  N LS E+   L   + ++ +++S +
Sbjct: 311 FINMKYNYLSDEMKKELQKSLPMK-IDVSDS 340

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 51.1 bits (121), Expect = 6e-07
 Identities = 25/188 (13%), Positives = 57/188 (30%), Gaps = 22/188 (11%)

Query: 127 RLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQV 186
                  ++F   ++   +  DL  +  L     L  + +   +  SI       P L+ 
Sbjct: 142 EGLFWGDIDFEEQEISWIEQVDLSPV--LDAMPLLNNLKIKGTNNLSIGKKP--RPNLKS 197

Query: 187 LSLFENNISGEIPSSLG--NFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLG 244
           L +    +   +   +   +   L +L L            +                  
Sbjct: 198 LEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMN--------VFRPLFSKD 249

Query: 245 QYP-VRWLDLSHNHLTGPIPLAVGNLKSIPHL---DLSKNKLSGE----IPSSLGSCVGL 296
           ++P ++WL +        +         +P L   D+S   L+ E    +   +     L
Sbjct: 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHL 309

Query: 297 EYLNLSIN 304
           +++N+  N
Sbjct: 310 KFINMKYN 317

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.0 bits (120), Expect = 3e-07
 Identities = 31/159 (19%), Positives = 56/159 (35%), Gaps = 23/159 (14%)

Query: 186 VLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLS----KTI 241
           ++ L    I  +      N     EL+LRG  I   I +      Q  ++D S    + +
Sbjct: 1   MVKLTAELIE-QAAQ-YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL 57

Query: 242 --FLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLS--GEIPSSLGSCVGLE 297
             F     ++ L +++N +          L  +  L L+ N L   G++   L S   L 
Sbjct: 58  DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLT 116

Query: 298 YLNLSINSFHGPI--HPG-----LSSLKSLEGLDLFQNT 329
           YL +  N    P+          +  +  +  LD  +  
Sbjct: 117 YLCILRN----PVTNKKHYRLYVIYKVPQVRVLDFQKVK 151

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.0 bits (120), Expect = 3e-07
 Identities = 31/150 (20%), Positives = 52/150 (34%), Gaps = 26/150 (17%)

Query: 46  NLTHCSELRTLDLVLNKLE--ENQLVGELPPYIGFTLPNIRIPLLAGNQF--FGNIPHSI 101
             T+    R LDL   K+   EN         +G TL        + N+       P   
Sbjct: 14  QYTNAVRDRELDLRGYKIPVIEN---------LGATLDQFDAIDFSDNEIRKLDGFPLL- 63

Query: 102 SNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYL 161
               +L+ L   NN +          L +LT L    N      + +L  LD L +   L
Sbjct: 64  ---RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN-----SLVELGDLDPLASLKSL 115

Query: 162 EIVSLNVNSLRSIP----ISVGYLPKLQVL 187
             + +  N + +        +  +P+++VL
Sbjct: 116 TYLCILRNPVTNKKHYRLYVIYKVPQVRVL 145

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.0 bits (120), Expect = 3e-07
 Identities = 27/123 (21%), Positives = 43/123 (34%), Gaps = 6/123 (4%)

Query: 117 LTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPI 176
           LTA + E   +  N  R      DL   K+  +  L +       + +  + N +R +  
Sbjct: 4   LTAELIEQAAQYTNAVRDREL--DLRGYKIPVIENLGA--TLDQFDAIDFSDNEIRKLD- 58

Query: 177 SVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRG-SIPSALGNCHQLQSL 235
               L +L+ L +  N I             LTEL L  NS+        L +   L  L
Sbjct: 59  GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYL 118

Query: 236 DLS 238
            + 
Sbjct: 119 CIL 121

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 47.0 bits (112), Expect = 3e-06
 Identities = 13/93 (13%), Positives = 23/93 (24%), Gaps = 2/93 (2%)

Query: 147 NDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFT 206
             +       N      + L    +  I      L +   +   +N I  ++        
Sbjct: 7   ELIEQAAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLR 64

Query: 207 FLTELNLRGNSIRGSIPSALGNCHQLQSLDLSK 239
            L  L +  N I             L  L L+ 
Sbjct: 65  RLKTLLVNNNRICRIGEGLDQALPDLTELILTN 97

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 51/206 (24%), Positives = 83/206 (40%), Gaps = 36/206 (17%)

Query: 147 NDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNF- 205
             +    +      ++ +  N + ++S+   + YLP ++ L+L  N +       +    
Sbjct: 29  KSVTDAVTQNELNSIDQIIANNSDIKSVQ-GIQYLPNVRYLALGGNKLH-----DISALK 82

Query: 206 --TFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIP 263
             T LT L L GN              QLQSL     +F     ++ L L  N L   +P
Sbjct: 83  ELTNLTYLILTGN--------------QLQSL--PNGVFDKLTNLKELVLVENQLQS-LP 125

Query: 264 LAVGN-LKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGL-SSLKSLE 321
             V + L ++ +L+L+ N+L             L  L+LS N     +  G+   L  L+
Sbjct: 126 DGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLK 184

Query: 322 GLDLFQNTFQAKSQNGDVPRKGIFKN 347
            L L+QN  Q KS    VP  G+F  
Sbjct: 185 DLRLYQN--QLKS----VPD-GVFDR 203

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 53/199 (26%), Positives = 83/199 (41%), Gaps = 29/199 (14%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPV--NLTHCSELRTLDL 58
            L  +  I    ++        I  L  +RY+    N L   I     LT    L  L L
Sbjct: 39  ELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKLH-DISALKELT---NLTYLIL 92

Query: 59  VLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNA-SKLEWLDFANNSL 117
             N+L+       LP  +   L N++  +L  NQ   ++P  + +  + L +L+ A+N L
Sbjct: 93  TGNQLQS------LPNGVFDKLTNLKELVLVENQL-QSLPDGVFDKLTNLTYLNLAHNQL 145

Query: 118 TASIPEDL-GRLRNLTRLNFARNDLGT--RKVNDLRFLDSLVNCTYLEIVSLNVNSLRSI 174
             S+P+ +  +L NLT L+ + N L +    V      D L     L    L  N L+S+
Sbjct: 146 Q-SLPKGVFDKLTNLTELDLSYNQLQSLPEGV-----FDKLTQLKDL---RLYQNQLKSV 196

Query: 175 PISV-GYLPKLQVLSLFEN 192
           P  V   L  LQ + L +N
Sbjct: 197 PDGVFDRLTSLQYIWLHDN 215

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 50.4 bits (121), Expect = 7e-07
 Identities = 43/193 (22%), Positives = 70/193 (36%), Gaps = 39/193 (20%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG GSFG +++G    +   VA+K  F  +R        E    + +     +  +    
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 75

Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
               Q      LV + +   SLE         D L+      S       A  + + ++ 
Sbjct: 76  ----QEGLHNVLVIDLLGP-SLE---------DLLDLCGRKFSVKTVAMAAKQMLARVQS 121

Query: 569 LHHHCKKQIVHCDLKPSNVLL-----DNDMIAHVGDFGLTRF---------IPEVISSNQ 614
           +H   +K +V+ D+KP N L+      N  + +V DFG+ +F         IP       
Sbjct: 122 IH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP------Y 172

Query: 615 CSSVGLKGTVGYA 627
                L GT  Y 
Sbjct: 173 REKKNLSGTARYM 185

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 50.5 bits (120), Expect = 7e-07
 Identities = 22/126 (17%), Positives = 33/126 (26%), Gaps = 18/126 (14%)

Query: 158 CTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPS-SLGNFTFLTELNLRGN 216
                 +    +        +     L  L +        +    L     L  L +  +
Sbjct: 7   PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66

Query: 217 SIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLD 276
            +R   P A     +L                  L+LS N L       V  L S+  L 
Sbjct: 67  GLRFVAPDAFHFTPRL----------------SRLNLSFNALESLSWKTVQGL-SLQELV 109

Query: 277 LSKNKL 282
           LS N L
Sbjct: 110 LSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 22/98 (22%), Positives = 33/98 (33%), Gaps = 7/98 (7%)

Query: 96  NIPHSISNASKLEWLDFANNSLTASIP-EDLGRLRNLTRLNFARNDLGTRKVNDLRFLDS 154
           +  H +  A  L  L   N      +   DL  L  L  L   ++ L     +   F   
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 155 LVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFEN 192
           L        ++L+ N+L S+         LQ L L  N
Sbjct: 82  L------SRLNLSFNALESLSWKTVQGLSLQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.4 bits (112), Expect = 8e-06
 Identities = 22/112 (19%), Positives = 35/112 (31%), Gaps = 18/112 (16%)

Query: 197 EIPSSLGNFTFLTELNLRGNSIRGSIPS-ALGNCHQLQSLDLSKTIFLGQYPVRWLDLSH 255
           +    L     LTEL +        +    L    +L++L +                  
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV----------------K 65

Query: 256 NHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFH 307
           + L    P A      +  L+LS N L   +       + L+ L LS N  H
Sbjct: 66  SGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 45.9 bits (108), Expect = 2e-05
 Identities = 22/109 (20%), Positives = 34/109 (31%), Gaps = 11/109 (10%)

Query: 114 NNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFL--DSLVNCTYLEIVSLNVNSL 171
                      L    NLT L              L+ L    L     L  +++  + L
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQ-------QHLQHLELRDLRGLGELRNLTIVKSGL 68

Query: 172 RSIPISV-GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIR 219
           R +      + P+L  L+L  N +   +         L EL L GN + 
Sbjct: 69  RFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 50.5 bits (121), Expect = 8e-07
 Identities = 32/155 (20%), Positives = 51/155 (32%), Gaps = 21/155 (13%)

Query: 102 SNASKLEWLDFANNSLTASIPEDLGR-LRNLTRLNFARNDLGTRKVNDL-RFLDSLVNCT 159
           S    L+ ++ A+  L  +    L        +L    N LG     DL   L  L +  
Sbjct: 98  SGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL--LHDQC 155

Query: 160 YLEIVSLNVNSLRSIPISVGYL-------PKLQVLSLFENNISGE----IPSSLGNFTFL 208
            +  + L+ N L +    V  L         +  LSL    +  E    + + L     L
Sbjct: 156 QITTLRLSNNPLTA--AGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQL 213

Query: 209 TELNLRGNSIRGS----IPSALGNCHQLQSLDLSK 239
            ELN+  N    +    +  A      L+ L L  
Sbjct: 214 QELNVAYNGAGDTAALALARAAREHPSLELLHLYF 248

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 36/162 (22%), Positives = 53/162 (32%), Gaps = 24/162 (14%)

Query: 183 KLQVLSLFENNISGEIPSSLGN-FTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTI 241
            L  ++L    +      +L   F    +L L+ NS+       L     L         
Sbjct: 102 ALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDL--RDLLLHDQCQ--- 156

Query: 242 FLGQYPVRWLDLSHNHLT--GPIPLAVG--NLKSIPHLDLSKNKLSGE----IPSSLGSC 293
                 +  L LS+N LT  G   L  G     S+ HL L    L  E    + + L   
Sbjct: 157 ------ITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRN 210

Query: 294 VGLEYLNLSINSFHGP----IHPGLSSLKSLEGLDLFQNTFQ 331
             L+ LN++ N         +        SLE L L+ N   
Sbjct: 211 RQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS 252

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 30/208 (14%), Positives = 64/208 (30%), Gaps = 31/208 (14%)

Query: 102 SNASKLEWLDFANNSLTAS----IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVN 157
            +  ++  L  +NN LTA+    + E L    ++T L+     LG   +  L     L  
Sbjct: 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELL--AAQLDR 209

Query: 158 CTYLEIVSLNVNSL-----RSIPISVGYLPKLQVLSLFENNIS-------GEIPSSLGNF 205
              L+ +++  N        ++  +    P L++L L+ N +S        ++  +    
Sbjct: 210 NRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGG 269

Query: 206 TFLTELNLRGNSI----RGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGP 261
             +      G ++       +     N +      + + + L        DL  +     
Sbjct: 270 ARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQRHLELLL-----RDLEDSRGATL 324

Query: 262 IPLAVGNL----KSIPHLDLSKNKLSGE 285
            P     L      +  L          
Sbjct: 325 NPWRKAQLLRVEGEVRALLEQLGSSGSP 352

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 38/159 (23%), Positives = 65/159 (40%), Gaps = 22/159 (13%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG+GSFG +Y G        VA+K    + +      + E +  R ++    +  +    
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKIYRILQGGTGIPNVRWFG 72

Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
                  D+  LV + +   SLE         D  N+    LS    L +A  + + +E+
Sbjct: 73  VEG----DYNVLVMDLLGP-SLE---------DLFNFCSRKLSLKTVLMLADQMINRVEF 118

Query: 569 LHHHCKKQIVHCDLKPSNVLL---DNDMIAHVGDFGLTR 604
           +H    K  +H D+KP N L+         ++ DFGL +
Sbjct: 119 VH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 26/148 (17%), Positives = 49/148 (33%), Gaps = 10/148 (6%)

Query: 102 SNASKLEWLDFANNSLT----ASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVN 157
               +LE++    + +T     SI   L  L +   +   R +  T    D      L+ 
Sbjct: 375 QGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIG 434

Query: 158 CTYLEIVSLNVNSL----RSIPISVGYLPKLQVLSLFENNISGE-IPSSLGNFTFLTELN 212
           C  L   +  +         +     Y P ++ + L     S E +         L +L 
Sbjct: 435 CKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLE 494

Query: 213 LRGNSI-RGSIPSALGNCHQLQSLDLSK 239
           +RG      +I +A+     L+ L +  
Sbjct: 495 MRGCCFSERAIAAAVTKLPSLRYLWVQG 522

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 47.6 bits (113), Expect = 9e-06
 Identities = 41/264 (15%), Positives = 79/264 (29%), Gaps = 23/264 (8%)

Query: 49  HCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSIS----NA 104
              +L TL L            +    I      I+  L+  + F       +     + 
Sbjct: 136 RADDLETLKLDKCS----GFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHN 191

Query: 105 SKLEWLDFANNSLTASIPEDLGRL----RNLTRLNFARNDLGTRKVNDLRFLDSLVNCTY 160
           + LE L+F         P+DL  +    R+L  +     ++    +  + F  +  N   
Sbjct: 192 TSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEI----LELVGFFKAAANLEE 247

Query: 161 LEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRG 220
               SLN +            P+             E+P        + +L+L    +  
Sbjct: 248 FCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLET 307

Query: 221 -SIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSK 279
               + +  C  L+ L+    I  G   +  L      L     L +        ++  +
Sbjct: 308 EDHCTLIQKCPNLEVLETRNVI--GDRGLEVLAQYCKQLKR---LRIERGADEQGMEDEE 362

Query: 280 NKLSGEIPSSLG-SCVGLEYLNLS 302
             +S     +L   C  LEY+ + 
Sbjct: 363 GLVSQRGLIALAQGCQELEYMAVY 386

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 42.2 bits (99), Expect = 4e-04
 Identities = 48/312 (15%), Positives = 90/312 (28%), Gaps = 41/312 (13%)

Query: 25  RLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIR 84
            L +      N +    +  +NL    +L  L L       + +     P +      IR
Sbjct: 244 NLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGL-------SYMGPNEMPILFPFAAQIR 296

Query: 85  IPLLAGNQFFGNIPHS-ISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFAR----- 138
              L           + I     LE L+  N      +       + L RL   R     
Sbjct: 297 KLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQ 356

Query: 139 -NDLGTRKVNDLRFLDSLVNCTYLEIVSLNVN-----SLRSIPISVGYLPKLQVLSL-FE 191
             +     V+    +     C  LE +++ V+     SL SI   +  L   +++ L  E
Sbjct: 357 GMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDRE 416

Query: 192 NNISGE-----IPSSLGNFTFLTELNLRGNSIRGSIPS--ALG-NCHQLQSLDLSKT--- 240
             I+       + S L     L            +      +G     ++ + L      
Sbjct: 417 ERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGES 476

Query: 241 ------IFLGQYPVRWLDLSHNHLTGP-IPLAVGNLKSIPHLDLSKNKLSGEIPSSLGS- 292
                    G   ++ L++     +   I  AV  L S+ +L +   + S      +   
Sbjct: 477 DEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMA 536

Query: 293 --CVGLEYLNLS 302
                +E +   
Sbjct: 537 RPYWNIELIPSR 548

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 46.6 bits (111), Expect = 5e-06
 Identities = 30/107 (28%), Positives = 44/107 (41%), Gaps = 9/107 (8%)

Query: 88  LAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDL-GRLRNLTRLNFARNDLGTRKV 146
           L  N             + L  L    N L  S+P  +  +L +LT LN + N L   + 
Sbjct: 35  LETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQL---QS 90

Query: 147 NDLRFLDSLVNCTYLEIVSLNVNSLRSIPISV-GYLPKLQVLSLFEN 192
                 D L     L   +LN N L+S+P  V   L +L+ L L++N
Sbjct: 91  LPNGVFDKLTQLKEL---ALNTNQLQSLPDGVFDKLTQLKDLRLYQN 134

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 42/140 (30%), Positives = 65/140 (46%), Gaps = 19/140 (13%)

Query: 108 EWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLN 167
            +LD   NSL +        L +LT+L    N L +         + L + TYL   +L+
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNG---VFNKLTSLTYL---NLS 84

Query: 168 VNSLRSIPISV-GYLPKLQVLSLFENNISGEIPSSLGNF---TFLTELNLRGNSIRGSIP 223
            N L+S+P  V   L +L+ L+L  N +   +P   G F   T L +L L  N ++ S+P
Sbjct: 85  TNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPD--GVFDKLTQLKDLRLYQNQLK-SVP 140

Query: 224 SALGNCHQLQSLDLSKTIFL 243
              G   +L SL   + I+L
Sbjct: 141 D--GVFDRLTSL---QYIWL 155

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 29/107 (27%), Positives = 46/107 (42%), Gaps = 10/107 (9%)

Query: 88  LAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDL-GRLRNLTRLNFARNDLGTRKV 146
           L GNQF   +P  +SN   L  +D +NN ++ ++       +  L  L  + N L  R +
Sbjct: 38  LDGNQF-TLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRL--RCI 93

Query: 147 NDLRFLDSLVNCTYLEIVSLNVNSLRSIPISV-GYLPKLQVLSLFEN 192
               F D L +   L   SL+ N +  +P      L  L  L++  N
Sbjct: 94  PPRTF-DGLKSLRLL---SLHGNDISVVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 28/116 (24%), Positives = 44/116 (37%), Gaps = 18/116 (15%)

Query: 166 LNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSA 225
           L+ N    +P  +     L ++ L  N IS     S  N T L  L L  N         
Sbjct: 38  LDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN--------- 88

Query: 226 LGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPL-AVGNLKSIPHLDLSKN 280
                +L+   +    F G   +R L L  N ++  +P  A  +L ++ HL +  N
Sbjct: 89  -----RLRC--IPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 41.1 bits (97), Expect = 3e-04
 Identities = 34/103 (33%), Positives = 43/103 (41%), Gaps = 10/103 (9%)

Query: 251 LDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPI 310
           L L  N  T  +P  + N K +  +DLS N++S     S  +   L  L LS N     I
Sbjct: 36  LYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC-I 93

Query: 311 HPGL-SSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAIS 352
            P     LKSL  L L  N          VP  G F + SA+S
Sbjct: 94  PPRTFDGLKSLRLLSLHGN--DISV----VPE-GAFNDLSALS 129

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 44.6 bits (106), Expect = 2e-05
 Identities = 32/109 (29%), Positives = 49/109 (44%), Gaps = 8/109 (7%)

Query: 110 LDFANNSLTASIPEDL-GRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNV 168
           L   +N L     + L GRL +L +L   RN L    +    F +   +   L    L  
Sbjct: 34  LLLNDNELGRISSDGLFGRLPHLVKLELKRNQL--TGIEPNAF-EGASHIQEL---QLGE 87

Query: 169 NSLRSIPISV-GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGN 216
           N ++ I   +   L +L+ L+L++N IS  +P S  +   LT LNL  N
Sbjct: 88  NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 40.8 bits (96), Expect = 5e-04
 Identities = 19/91 (20%), Positives = 30/91 (32%), Gaps = 13/91 (14%)

Query: 106 KLEWLDFANNSLTASIPEDL-GRLRNLTRLNFARNDLGT--RKVNDLRFLDSLVNCTYLE 162
            L  L+   N LT  I  +      ++  L    N +     K+    F   L     L 
Sbjct: 55  HLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIKEISNKM----F-LGLHQLKTL- 107

Query: 163 IVSLNVNSLRSIPISV-GYLPKLQVLSLFEN 192
             +L  N +  +      +L  L  L+L  N
Sbjct: 108 --NLYDNQISCVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 40.0 bits (94), Expect = 9e-04
 Identities = 32/132 (24%), Positives = 45/132 (34%), Gaps = 23/132 (17%)

Query: 114 NNSLTA---SIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNS 170
              L      IP         T L    N+L   +++       L +   L    L  N 
Sbjct: 17  GRGLKEIPRDIPLHT------TELLLNDNEL--GRISSDGLFGRLPHLVKL---ELKRNQ 65

Query: 171 LRSIPISV-GYLPKLQVLSLFENNISGEIPSSLGNF---TFLTELNLRGNSIRGSIP-SA 225
           L  I  +       +Q L L EN I  EI +    F     L  LNL  N I   +   +
Sbjct: 66  LTGIEPNAFEGASHIQELQLGENKIK-EISN--KMFLGLHQLKTLNLYDNQIS-CVMPGS 121

Query: 226 LGNCHQLQSLDL 237
             + + L SL+L
Sbjct: 122 FEHLNSLTSLNL 133

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 41.5 bits (98), Expect = 2e-04
 Identities = 27/110 (24%), Positives = 46/110 (41%), Gaps = 7/110 (6%)

Query: 108 EWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLN 167
             L+  +N L +       +L  LT+L+ ++N + +         D L   T L    L+
Sbjct: 31  TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPD---GVFDKLTKLTIL---YLH 84

Query: 168 VNSLRSIPISV-GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGN 216
            N L+S+P  V   L +L+ L+L  N +           T L ++ L  N
Sbjct: 85  ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	640
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	100.0
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	100.0
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	100.0
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.98
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.98
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.98
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.98
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.97
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.97
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.97
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.97
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.97
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.97
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.97
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.97
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.97
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.97
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.97
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.97
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.97
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.97
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.97
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.97
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.97
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.97
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.97
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.97
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.97
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.97
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.97
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.97
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.97
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.96
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.96
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.96
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.96
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.96
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.96
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.96
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.96
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.96
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.96
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.96
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.96
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.96
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.96
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.96
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.96
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.96
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.96
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.96
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.96
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.96
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.96
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.96
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.96
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.96
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.96
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.96
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.96
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.96
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.96
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.96
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.96
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.96
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.96
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.96
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.96
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.96
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.96
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.96
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.96
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.96
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.96
3niz_A	311	Rhodanese family protein; structural genomics, str	99.96
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.96
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.96
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.96
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.96
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.96
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.96
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.95
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.95
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.95
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.95
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.95
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.95
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.95
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.95
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.95
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.95
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.95
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.95
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.95
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.95
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.95
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.95
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.95
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.95
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.95
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.95
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.95
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.95
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.95
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.95
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.95
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.95
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.95
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.95
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.95
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.95
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.95
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.95
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.95
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.95
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.95
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.95
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.95
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.95
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.95
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.95
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.95
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.95
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.95
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.95
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.95
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.95
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.95
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.95
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.95
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.95
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.95
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.95
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.95
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.95
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.95
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.95
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.95
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.95
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.95
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.95
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.95
3bhy_A	283	Death-associated protein kinase 3; death associate	99.95
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.95
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.95
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.95
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.95
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.95
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.95
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.95
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.95
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.95
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.95
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.95
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.95
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.95
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.95
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.95
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.95
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.95
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.95
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.95
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.95
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.95
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.95
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.95
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.95
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.95
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.95
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.95
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.95
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.95
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.95
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.95
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.95
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.95
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.95
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.95
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.95
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.95
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.95
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.95
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.95
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.95
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.94
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.94
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.94
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.94
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.94
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.94
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.94
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.94
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.94
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.94
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.94
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.94
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.94
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.94
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.94
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.94
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.94
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.94
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.94
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.94
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.94
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.94
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.94
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.94
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.94
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.94
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.94
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.94
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.94
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.94
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.94
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.94
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.94
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.94
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.94
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.94
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.94
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.94
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.94
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.94
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.94
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.94
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.94
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.94
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.94
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.94
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.94
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.94
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.93
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.93
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.93
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.93
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.93
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.93
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.93
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.93
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.93
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.93
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.93
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.93
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.93
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.93
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.93
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.93
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.93
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.93
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.92
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.92
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.92
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.92
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.92
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.92
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.92
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.92
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.92
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.92
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.91
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.91
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.91
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.9
3uqc_A	286	Probable conserved transmembrane protein; structur	99.9
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.9
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.9
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.89
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.89
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.88
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.88
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.88
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.87
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.87
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.87
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.87
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.87
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.86
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.86
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.86
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.86
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.86
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.85
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.85
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.84
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.84
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.84
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.83
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.83
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.83
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.82
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.81
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.8
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.8
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.8
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.79
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.79
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.79
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.79
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.78
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.78
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.76
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.74
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.74
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.73
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.72
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.72
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.7
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.69
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.69
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.66
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.66
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.64
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.6
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.59
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.58
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.58
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.57
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.55
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.55
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.52
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.45
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.44
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.41
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.4
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.4
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.33
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.27
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.22
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.09
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.99
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.97
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.92
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.58
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.57
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.56
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.5
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.44
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.43
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.33
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.31
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.29
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.12
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.94
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.92
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.87
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.81
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.57
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.56
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.53
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.53
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.43
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.42
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.41
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.23
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.85
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.79
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.67
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.54
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.53
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.41
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.41
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.11
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	95.97
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.74
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.19
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	87.81
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	87.2
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	83.56

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=3.8e-49  Score=452.52  Aligned_cols=360  Identities=33%  Similarity=0.548  Sum_probs=306.6

Q ss_pred             CCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcC-CCCCCCCCEEEccCCCcC-----------------
Q 035691            3 TFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVN-LTHCSELRTLDLVLNKLE-----------------   64 (640)
Q Consensus         3 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~-----------------   64 (640)
                      ++|++|+|++|++++..|..|+.+++|++|++++|.+++.+|.. |..+++|++|+|++|+++                 
T Consensus       294 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L  373 (768)
T 3rgz_A          294 DTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTL  373 (768)
T ss_dssp             TTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEE
T ss_pred             CcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEE
Confidence            66777777777777777777777777777777777777666654 677777777777766653                 


Q ss_pred             ---CccccccCCchhhc-CCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCc
Q 035691           65 ---ENQLVGELPPYIGF-TLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARND  140 (640)
Q Consensus        65 ---~~~~~~~lp~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  140 (640)
                         .|.+.|.+|+.+.. .+++|+.|+|++|++++.+|..|.++++|++|+|++|++++..|..|..+++|++|+|++|+
T Consensus       374 ~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~  453 (768)
T 3rgz_A          374 DLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNM  453 (768)
T ss_dssp             ECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred             EccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCc
Confidence               12333444444432 26678888888888888888888889999999999999988888889999999999999999


Q ss_pred             CCCCCCCcccccccccCCCCcceEecCCCCCCC-cCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCC
Q 035691          141 LGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRS-IPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIR  219 (640)
Q Consensus       141 l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  219 (640)
                      +++.      .+..+..+++|++|++++|+++. +|..+..+++|++|+|++|++++.+|.+|+.+++|++|+|++|++.
T Consensus       454 l~~~------~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  527 (768)
T 3rgz_A          454 LEGE------IPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFS  527 (768)
T ss_dssp             CCSC------CCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCE
T ss_pred             ccCc------CCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCccc
Confidence            8876      56778889999999999999996 8888999999999999999999999999999999999999999999


Q ss_pred             CCCCccccCCCCccEEeccCccccCC------------------------------------------------------
Q 035691          220 GSIPSALGNCHQLQSLDLSKTIFLGQ------------------------------------------------------  245 (640)
Q Consensus       220 ~~~~~~~~~l~~L~~L~ls~n~~~~~------------------------------------------------------  245 (640)
                      +.+|..++.+++|+.|++++|.+.+.                                                      
T Consensus       528 ~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  607 (768)
T 3rgz_A          528 GNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRL  607 (768)
T ss_dssp             EECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGG
T ss_pred             CcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhcc
Confidence            99999999999999999999876531                                                      


Q ss_pred             ------------------------CCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEe
Q 035691          246 ------------------------YPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNL  301 (640)
Q Consensus       246 ------------------------~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  301 (640)
                                              ..|+.|||++|+++|.+|..|+++++|+.|+|++|+++|.+|..|+++++|+.|||
T Consensus       608 ~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdL  687 (768)
T 3rgz_A          608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDL  687 (768)
T ss_dssp             GGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEEC
T ss_pred             ccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEEC
Confidence                                    23678999999999999999999999999999999999999999999999999999


Q ss_pred             cCCccCCCCCccCCCCCCCCeEeCcCCccccccCCcccCCCCCCCCCccccccCCCCCcCCCcCCCCCCCCCCccc
Q 035691          302 SINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGISELKLPPCTPSESK  377 (640)
Q Consensus       302 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~~~~p~~~~~~~~  377 (640)
                      ++|+++|.+|..+..+++|++||+++|+++     |.+|..+.+.++....+.||+++||.|.    +.|......
T Consensus       688 s~N~l~g~ip~~l~~l~~L~~L~ls~N~l~-----g~iP~~~~~~~~~~~~~~gN~~Lcg~~l----~~C~~~~~~  754 (768)
T 3rgz_A          688 SSNKLDGRIPQAMSALTMLTEIDLSNNNLS-----GPIPEMGQFETFPPAKFLNNPGLCGYPL----PRCDPSNAD  754 (768)
T ss_dssp             CSSCCEECCCGGGGGCCCCSEEECCSSEEE-----EECCSSSSGGGSCGGGGCSCTEEESTTS----CCCCSCC--
T ss_pred             CCCcccCcCChHHhCCCCCCEEECcCCccc-----ccCCCchhhccCCHHHhcCCchhcCCCC----cCCCCCccC
Confidence            999999999999999999999999999999     8999999999999999999999999873    367544443

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=3e-44  Score=411.95  Aligned_cols=347  Identities=33%  Similarity=0.481  Sum_probs=285.6

Q ss_pred             CCCCCcEEeCCCCccccCCchhhhcC-CCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcC
Q 035691            1 NLTFLMLINLQQNNFSGNIPHEIGRL-FQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFT   79 (640)
Q Consensus         1 nl~~L~~L~L~~n~i~~~~p~~~~~l-~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~   79 (640)
                      ++++|++|+|++|.+++.+|..+..+ ++|++|+|++|.+++.+|..|..+++|++|+|++|+++     |.+|...+..
T Consensus       267 ~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~-----~~ip~~~l~~  341 (768)
T 3rgz_A          267 PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFS-----GELPMDTLLK  341 (768)
T ss_dssp             CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEE-----EECCHHHHTT
T ss_pred             ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCccc-----CcCCHHHHhc
Confidence            35678888888888888888877765 88999999999998888888999999999999877664     3455554445


Q ss_pred             CCCCCeeeccCCcccccCCccCc-------------------------C--CCCCCEEECcCCccCccCCccccCCCCCC
Q 035691           80 LPNIRIPLLAGNQFFGNIPHSIS-------------------------N--ASKLEWLDFANNSLTASIPEDLGRLRNLT  132 (640)
Q Consensus        80 l~~L~~L~L~~N~l~~~~~~~~~-------------------------~--l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  132 (640)
                      +++|+.|+|++|++++.+|..+.                         .  +++|++|+|++|++++.+|..|..+++|+
T Consensus       342 l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~  421 (768)
T 3rgz_A          342 MRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELV  421 (768)
T ss_dssp             CTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCC
T ss_pred             CCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCC
Confidence            55555555555555555554443                         3  55677777777777777788888888888


Q ss_pred             EEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCC-cCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEE
Q 035691          133 RLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRS-IPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTEL  211 (640)
Q Consensus       133 ~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  211 (640)
                      +|+|++|++++.      .+..+.++++|+.|++++|.++. +|..+..+++|++|++++|.+++.+|..|.++++|++|
T Consensus       422 ~L~Ls~N~l~~~------~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  495 (768)
T 3rgz_A          422 SLHLSFNYLSGT------IPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWI  495 (768)
T ss_dssp             EEECCSSEEESC------CCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEE
T ss_pred             EEECcCCcccCc------ccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEE
Confidence            888888888765      56778888999999999999986 88888889999999999999999999999999999999


Q ss_pred             EccCCCCCCCCCccccCCCCccEEeccCccccC--------CCCCceEEccCCcCCCCCCcc------------------
Q 035691          212 NLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLG--------QYPVRWLDLSHNHLTGPIPLA------------------  265 (640)
Q Consensus       212 ~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~--------~~~l~~L~Ls~N~l~~~~~~~------------------  265 (640)
                      +|++|++++.+|.+|+.+++|+.|++++|.+.+        +..|++|++++|+++|.+|..                  
T Consensus       496 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~  575 (768)
T 3rgz_A          496 SLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRY  575 (768)
T ss_dssp             ECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEE
T ss_pred             EccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccc
Confidence            999999999999999999999999999998764        345899999999988776653                  


Q ss_pred             ----------------------------------------------------CCCCCCCCEEECCCCcccCcCCccccCC
Q 035691          266 ----------------------------------------------------VGNLKSIPHLDLSKNKLSGEIPSSLGSC  293 (640)
Q Consensus       266 ----------------------------------------------------~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  293 (640)
                                                                          |+.+++|+.|||++|+++|.+|..|+.+
T Consensus       576 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l  655 (768)
T 3rgz_A          576 VYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSM  655 (768)
T ss_dssp             EEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGC
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhcc
Confidence                                                                3446789999999999999999999999


Q ss_pred             CCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCcccCCC-CCCCCCccccccCCCCCcCCCc
Q 035691          294 VGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRK-GIFKNASAISVAGNEKLCGGIS  364 (640)
Q Consensus       294 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~p~~-~~~~~~~~~~~~~n~~~c~~~~  364 (640)
                      ++|+.|+|++|++++.+|..|+++++|+.|||++|+++     |.+|.. +.++.+..+++++|+. .|..|
T Consensus       656 ~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~-----g~ip~~l~~l~~L~~L~ls~N~l-~g~iP  721 (768)
T 3rgz_A          656 PYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLD-----GRIPQAMSALTMLTEIDLSNNNL-SGPIP  721 (768)
T ss_dssp             TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCE-----ECCCGGGGGCCCCSEEECCSSEE-EEECC
T ss_pred             ccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCccc-----CcCChHHhCCCCCCEEECcCCcc-cccCC
Confidence            99999999999999999999999999999999999999     777765 6678889999999874 55443

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=7.1e-43  Score=391.61  Aligned_cols=340  Identities=21%  Similarity=0.237  Sum_probs=303.9

Q ss_pred             CCCCCcEEeCCCCccccC-----------------Cchhhh--cCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCC
Q 035691            1 NLTFLMLINLQQNNFSGN-----------------IPHEIG--RLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLN   61 (640)
Q Consensus         1 nl~~L~~L~L~~n~i~~~-----------------~p~~~~--~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N   61 (640)
                      ++++|++|+|++|+|++.                 +|+.++  ++++|++|+|++|.+.+.+|..|.++++|++|+|++|
T Consensus       204 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n  283 (636)
T 4eco_A          204 RLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN  283 (636)
T ss_dssp             GCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTC
T ss_pred             cccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCC
Confidence            478999999999999986                 999988  9999999999999999999999999999999999988


Q ss_pred             C-cCCccccc-cCCchhhc-----CCCCCCeeeccCCcccccCCc--cCcCCCCCCEEECcCCccCccCCccccCCCCCC
Q 035691           62 K-LEENQLVG-ELPPYIGF-----TLPNIRIPLLAGNQFFGNIPH--SISNASKLEWLDFANNSLTASIPEDLGRLRNLT  132 (640)
Q Consensus        62 ~-l~~~~~~~-~lp~~~~~-----~l~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  132 (640)
                      + ++     | .+|..++.     .+++|+.|+|++|+++ .+|.  .|+++++|++|+|++|++++.+| .|..+++|+
T Consensus       284 ~~l~-----~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~  356 (636)
T 4eco_A          284 RGIS-----GEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLA  356 (636)
T ss_dssp             TTSC-----HHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEES
T ss_pred             CCCc-----cccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCC
Confidence            7 54     4 57777654     2499999999999999 7787  89999999999999999998888 999999999


Q ss_pred             EEEcccCcCCCCCCCcccccccccCCCC-cceEecCCCCCCCcCcCCCCCC--CCCEEEccCCcCcccCCcCcc------
Q 035691          133 RLNFARNDLGTRKVNDLRFLDSLVNCTY-LEIVSLNVNSLRSIPISVGYLP--KLQVLSLFENNISGEIPSSLG------  203 (640)
Q Consensus       133 ~L~L~~N~l~~~~~~~~~~~~~l~~l~~-L~~L~L~~N~l~~ip~~~~~l~--~L~~L~L~~N~l~~~~p~~~~------  203 (640)
                      +|+|++|+++.       .+..+.++++ |++|++++|.++.+|..+..++  +|++|++++|.+++..|..|.      
T Consensus       357 ~L~L~~N~l~~-------lp~~l~~l~~~L~~L~Ls~N~l~~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~  429 (636)
T 4eco_A          357 SLNLAYNQITE-------IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTP  429 (636)
T ss_dssp             EEECCSSEEEE-------CCTTSEEECTTCCEEECCSSCCSSCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSC
T ss_pred             EEECCCCcccc-------ccHhhhhhcccCcEEEccCCcCcccchhhhhcccCccCEEECcCCcCCCcchhhhccccccc
Confidence            99999999985       4566888999 9999999999999998877654  899999999999999999998      


Q ss_pred             -CCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCC---------------CCceEEccCCcCCCCCCccCC
Q 035691          204 -NFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQY---------------PVRWLDLSHNHLTGPIPLAVG  267 (640)
Q Consensus       204 -~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~---------------~l~~L~Ls~N~l~~~~~~~~~  267 (640)
                       .+++|++|+|++|+++...+..+..+++|+.|++++|.+...+               .|++|+|++|+++ .+|..+.
T Consensus       430 ~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~  508 (636)
T 4eco_A          430 FKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFR  508 (636)
T ss_dssp             CCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGS
T ss_pred             ccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhh
Confidence             8889999999999999666666778999999999999876432               6899999999999 6777776


Q ss_pred             --CCCCCCEEECCCCcccCcCCccccCCCCCCeEEe------cCCccCCCCCccCCCCCCCCeEeCcCCccccccCCccc
Q 035691          268 --NLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNL------SINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDV  339 (640)
Q Consensus       268 --~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  339 (640)
                        .+++|+.|+|++|+|++ +|..+..+++|++|+|      ++|++.+.+|..+..+++|++|+|++|.++.      +
T Consensus       509 ~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~------i  581 (636)
T 4eco_A          509 ATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK------V  581 (636)
T ss_dssp             TTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCCB------C
T ss_pred             hccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcCCc------c
Confidence              99999999999999997 8999999999999999      5688899999999999999999999999964      3


Q ss_pred             CCCCCCCCCccccccCCCCCcCCC
Q 035691          340 PRKGIFKNASAISVAGNEKLCGGI  363 (640)
Q Consensus       340 p~~~~~~~~~~~~~~~n~~~c~~~  363 (640)
                      |.. ..+.+..+++++|++.|-..
T Consensus       582 p~~-~~~~L~~L~Ls~N~l~~~~~  604 (636)
T 4eco_A          582 NEK-ITPNISVLDIKDNPNISIDL  604 (636)
T ss_dssp             CSC-CCTTCCEEECCSCTTCEEEC
T ss_pred             CHh-HhCcCCEEECcCCCCccccH
Confidence            432 33789999999999987543

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=2.1e-42  Score=387.27  Aligned_cols=198  Identities=21%  Similarity=0.142  Sum_probs=137.8

Q ss_pred             CcceEecCCCCCCCc---CcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCC-ccccCCCCccEE
Q 035691          160 YLEIVSLNVNSLRSI---PISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIP-SALGNCHQLQSL  235 (640)
Q Consensus       160 ~L~~L~L~~N~l~~i---p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L  235 (640)
                      +|++|++++|.++.+   |..+..+++|++|++++|.+.+ +|..|..+++|++|++++|++.+..| ..|..+++|+.|
T Consensus       351 ~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L  429 (606)
T 3vq2_A          351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYL  429 (606)
T ss_dssp             TCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEE
T ss_pred             CCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEE
Confidence            334444444444332   3333444555555555555553 44566677777777777777776666 567777777777


Q ss_pred             eccCccccC--------CCCCceEEccCCcCCC-CCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCcc
Q 035691          236 DLSKTIFLG--------QYPVRWLDLSHNHLTG-PIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSF  306 (640)
Q Consensus       236 ~ls~n~~~~--------~~~l~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  306 (640)
                      ++++|.+.+        +..|++|++++|++++ .+|..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++
T Consensus       430 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l  509 (606)
T 3vq2_A          430 DISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL  509 (606)
T ss_dssp             ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred             ECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcC
Confidence            777775433        3457888888888876 4677888888888888888888877788888888888888888888


Q ss_pred             CCCCCccCCCCCCCCeEeCcCCccccccCCcccCCCCCCC-CCccccccCCCCCcCCC
Q 035691          307 HGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFK-NASAISVAGNEKLCGGI  363 (640)
Q Consensus       307 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~p~~~~~~-~~~~~~~~~n~~~c~~~  363 (640)
                      ++..|..|..+++|++|||++|+++..+..     ...++ ++..+++.+|+|.|.++
T Consensus       510 ~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~-----~~~l~~~L~~l~l~~N~~~c~c~  562 (606)
T 3vq2_A          510 LFLDSSHYNQLYSLSTLDCSFNRIETSKGI-----LQHFPKSLAFFNLTNNSVACICE  562 (606)
T ss_dssp             SCEEGGGTTTCTTCCEEECTTSCCCCEESC-----GGGSCTTCCEEECCSCCCCCSST
T ss_pred             CCcCHHHccCCCcCCEEECCCCcCcccCHh-----HhhhcccCcEEEccCCCcccCCc
Confidence            887788888888888888888888743321     12233 57888999999988765

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.4e-42  Score=372.43  Aligned_cols=329  Identities=19%  Similarity=0.142  Sum_probs=212.7

Q ss_pred             CCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCC
Q 035691            4 FLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNI   83 (640)
Q Consensus         4 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L   83 (640)
                      +++.|||++|+|++..|..|.++++|++|+|++|.|++..|.+|.++++|++|+|++|+|+.      +|...|..+++|
T Consensus        33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~------~~~~~~~~l~~L  106 (477)
T 2id5_A           33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKL------IPLGVFTGLSNL  106 (477)
T ss_dssp             TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCS------CCTTSSTTCTTC
T ss_pred             CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCc------cCcccccCCCCC
Confidence            45555555555555555555555555555555555555555555555555555555555543      555554455555


Q ss_pred             CeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcce
Q 035691           84 RIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEI  163 (640)
Q Consensus        84 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~  163 (640)
                      +.|+|++|++++..|..|.++++|++|+|++|+++++.+..|.++++|++|+|++|+++.+      .+..+.++++|+.
T Consensus       107 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~------~~~~l~~l~~L~~  180 (477)
T 2id5_A          107 TKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSI------PTEALSHLHGLIV  180 (477)
T ss_dssp             CEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSC------CHHHHTTCTTCCE
T ss_pred             CEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCccc------ChhHhcccCCCcE
Confidence            5555555555555555555555555555555555555555555555555555555555544      2233445555555


Q ss_pred             EecCCCCCCCcCc-CCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccc
Q 035691          164 VSLNVNSLRSIPI-SVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIF  242 (640)
Q Consensus       164 L~L~~N~l~~ip~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~  242 (640)
                      |++++|.++.++. .+..+++|++|++++|.+.+.+|..+....+|+.|+|++|++++..+..|..+++|+.|       
T Consensus       181 L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L-------  253 (477)
T 2id5_A          181 LRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFL-------  253 (477)
T ss_dssp             EEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEE-------
T ss_pred             EeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCee-------
Confidence            5555555555332 44455555555555555444444444444455555555555554333445555555555       


Q ss_pred             cCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCe
Q 035691          243 LGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEG  322 (640)
Q Consensus       243 ~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  322 (640)
                               +|++|++++..+..|..+++|+.|+|++|++++..|..|..+++|++|+|++|+|++..+..|..+++|++
T Consensus       254 ---------~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  324 (477)
T 2id5_A          254 ---------NLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLET  324 (477)
T ss_dssp             ---------ECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCE
T ss_pred             ---------ECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCE
Confidence                     88999999888899999999999999999999999999999999999999999999988889999999999


Q ss_pred             EeCcCCccccccCCcccCCCCCCCCCccccccCCCCCcCCCcC
Q 035691          323 LDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGISE  365 (640)
Q Consensus       323 L~l~~N~l~~~~~~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~  365 (640)
                      |+|++|+|.|.|...++..     ......+.++...|..|..
T Consensus       325 L~l~~N~l~c~c~~~~~~~-----~~~~~~~~~~~~~C~~p~~  362 (477)
T 2id5_A          325 LILDSNPLACDCRLLWVFR-----RRWRLNFNRQQPTCATPEF  362 (477)
T ss_dssp             EECCSSCEECSGGGHHHHT-----TTTSSCCTTCCCBEEESGG
T ss_pred             EEccCCCccCccchHhHHh-----hhhccccCccCceeCCchH
Confidence            9999999999886544322     1223456677888877653

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=5.6e-42  Score=397.08  Aligned_cols=357  Identities=21%  Similarity=0.174  Sum_probs=208.7

Q ss_pred             CCCCCcEEeCCCCccccCC-chhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCc-hhhc
Q 035691            1 NLTFLMLINLQQNNFSGNI-PHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPP-YIGF   78 (640)
Q Consensus         1 nl~~L~~L~L~~n~i~~~~-p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~-~~~~   78 (640)
                      ++++|++|||++|.+.+.+ |.+|.++++|++|+|++|.|++..|.+|.++++|++|+|++|.+++     .+|. ..+.
T Consensus        46 ~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~-----~~~~~~~~~  120 (844)
T 3j0a_A           46 FLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSD-----AVLKDGYFR  120 (844)
T ss_dssp             SCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSS-----CCSTTCCCS
T ss_pred             ccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCc-----ccccCcccc
Confidence            4677888888888554444 6778888888888888888887778888888888888888777653     2232 2355


Q ss_pred             CCCCCCeeeccCCcccccCC-ccCcCCCCCCEEECcCCccCccCCccccCC--CC-------------------------
Q 035691           79 TLPNIRIPLLAGNQFFGNIP-HSISNASKLEWLDFANNSLTASIPEDLGRL--RN-------------------------  130 (640)
Q Consensus        79 ~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l--~~-------------------------  130 (640)
                      .+++|+.|+|++|.+++..+ ..|+++++|++|+|++|.+++..+..|..+  ++                         
T Consensus       121 ~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~  200 (844)
T 3j0a_A          121 NLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNP  200 (844)
T ss_dssp             SCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCT
T ss_pred             ccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCc
Confidence            67777777777777776654 467777777777777777766655555433  33                         


Q ss_pred             -----CCEEEcccCcCCCCCCCccc-------------------------------------------------------
Q 035691          131 -----LTRLNFARNDLGTRKVNDLR-------------------------------------------------------  150 (640)
Q Consensus       131 -----L~~L~L~~N~l~~~~~~~~~-------------------------------------------------------  150 (640)
                           |+.|+|++|.++......+.                                                       
T Consensus       201 ~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~  280 (844)
T 3j0a_A          201 FRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFS  280 (844)
T ss_dssp             TTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCE
T ss_pred             cccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccc
Confidence                 44455544433221100000                                                       


Q ss_pred             -ccccccCCCCcceEecCCCCCCCc-CcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccC
Q 035691          151 -FLDSLVNCTYLEIVSLNVNSLRSI-PISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGN  228 (640)
Q Consensus       151 -~~~~l~~l~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  228 (640)
                       .+..|..+++|+.|+|++|.++.+ |..+..+++|++|+|++|.+++..|..|.++++|+.|+|++|++.+..+..|.+
T Consensus       281 ~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~  360 (844)
T 3j0a_A          281 LNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKF  360 (844)
T ss_dssp             ECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCS
T ss_pred             cChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcC
Confidence             122344555566666666666553 334555666666666666666555666666666666666666666555556666


Q ss_pred             CCCccEEeccCccccC------------------------------------------------CCCCceEEccCCcCCC
Q 035691          229 CHQLQSLDLSKTIFLG------------------------------------------------QYPVRWLDLSHNHLTG  260 (640)
Q Consensus       229 l~~L~~L~ls~n~~~~------------------------------------------------~~~l~~L~Ls~N~l~~  260 (640)
                      +++|+.|++++|.+.+                                                +..|+.|+|++|++++
T Consensus       361 l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~  440 (844)
T 3j0a_A          361 LEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSS  440 (844)
T ss_dssp             CCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCC
T ss_pred             CCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccc
Confidence            6666666666655432                                                1223334444444332


Q ss_pred             CCCc-cCCCCCCCCEEECCCCccc-----CcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCcccccc
Q 035691          261 PIPL-AVGNLKSIPHLDLSKNKLS-----GEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKS  334 (640)
Q Consensus       261 ~~~~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  334 (640)
                      ..+. .+..+++|+.|+|++|.++     +..+..|.++++|+.|+|++|.|++.+|..|..+++|++|+|++|.++..+
T Consensus       441 ~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~  520 (844)
T 3j0a_A          441 CSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLS  520 (844)
T ss_dssp             CCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCC
T ss_pred             cccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccC
Confidence            2111 1222333333333333332     122234555566666666666666666666666666666666666665443


Q ss_pred             CC-----------------cccCCCCCCCCCccccccCCCCCcCCCc
Q 035691          335 QN-----------------GDVPRKGIFKNASAISVAGNEKLCGGIS  364 (640)
Q Consensus       335 ~~-----------------~~~p~~~~~~~~~~~~~~~n~~~c~~~~  364 (640)
                      ..                 +..|  ..+..+..+++.+|||.|.+..
T Consensus       521 ~~~~~~~L~~L~Ls~N~l~~~~~--~~~~~L~~l~l~~Np~~C~c~~  565 (844)
T 3j0a_A          521 HNDLPANLEILDISRNQLLAPNP--DVFVSLSVLDITHNKFICECEL  565 (844)
T ss_dssp             CCCCCSCCCEEEEEEECCCCCCS--CCCSSCCEEEEEEECCCCSSSC
T ss_pred             hhhhhccccEEECCCCcCCCCCh--hHhCCcCEEEecCCCccccccc
Confidence            32                 2222  3366788999999999997653

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=4.6e-42  Score=370.76  Aligned_cols=345  Identities=19%  Similarity=0.162  Sum_probs=250.8

Q ss_pred             CCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCc-cCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCC
Q 035691            3 TFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQG-QIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLP   81 (640)
Q Consensus         3 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~   81 (640)
                      ++|++|||++|+|++..|..|.++++|++|++++|.+.+ +.+..|.++++|++|||++|+++.      +++..+..++
T Consensus        30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~------~~~~~~~~l~  103 (455)
T 3v47_A           30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ------LETGAFNGLA  103 (455)
T ss_dssp             TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCE------ECTTTTTTCT
T ss_pred             CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCc------cChhhccCcc
Confidence            568999999999998889999999999999999999974 446789999999999999998875      5555666799


Q ss_pred             CCCeeeccCCcccccCCcc--CcCCCCCCEEECcCCccCccCCcc-ccCCCCCCEEEcccCcCCCCCCCcccccccccCC
Q 035691           82 NIRIPLLAGNQFFGNIPHS--ISNASKLEWLDFANNSLTASIPED-LGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNC  158 (640)
Q Consensus        82 ~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l  158 (640)
                      +|+.|+|++|++++..|..  |.++++|++|+|++|++++..|.. |.++++|++|+|++|+++....      ..+..+
T Consensus       104 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~------~~l~~l  177 (455)
T 3v47_A          104 NLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICE------EDLLNF  177 (455)
T ss_dssp             TCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCT------TTSGGG
T ss_pred             cCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccCh------hhhhcc
Confidence            9999999999998755544  999999999999999999887776 8999999999999999988743      334433


Q ss_pred             --CCcceEecCCCCCCCcCcC---------CCCCCCCCEEEccCCcCcccCCcCccCC---CCCCEEEccCCCCCCC---
Q 035691          159 --TYLEIVSLNVNSLRSIPIS---------VGYLPKLQVLSLFENNISGEIPSSLGNF---TFLTELNLRGNSIRGS---  221 (640)
Q Consensus       159 --~~L~~L~L~~N~l~~ip~~---------~~~l~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~---  221 (640)
                        .+|+.|++++|.+..++..         +..+++|++|++++|.+.+..|..+...   ++|+.|++++|.+.+.   
T Consensus       178 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~  257 (455)
T 3v47_A          178 QGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFG  257 (455)
T ss_dssp             TTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTT
T ss_pred             ccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccc
Confidence              6788899999988886642         3356788999999998887776655433   5666666666544321   


Q ss_pred             -------CCccccCC--CCccEEeccCccccC--------CCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccC
Q 035691          222 -------IPSALGNC--HQLQSLDLSKTIFLG--------QYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSG  284 (640)
Q Consensus       222 -------~~~~~~~l--~~L~~L~ls~n~~~~--------~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  284 (640)
                             .+..+..+  ++|+.|++++|.+.+        +..|++|+|++|++++..|..|.++++|+.|+|++|++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  337 (455)
T 3v47_A          258 HTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGS  337 (455)
T ss_dssp             CCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred             hhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCC
Confidence                   11122222  456666666665432        3346666777777776666677777777777777777766


Q ss_pred             cCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCcccCCCCCCCCCccccccCCCCCcCCC
Q 035691          285 EIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGI  363 (640)
Q Consensus       285 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~p~~~~~~~~~~~~~~~n~~~c~~~  363 (640)
                      ..|..|..+++|++|+|++|++++..|..|..+++|++|+|++|+++..+..    ....++.++.+++.+|++.|..+
T Consensus       338 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          338 IDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDG----IFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             ECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTT----TTTTCTTCCEEECCSSCBCCCTT
T ss_pred             cChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHh----HhccCCcccEEEccCCCcccCCC
Confidence            6666667777777777777777666666777777777777777776632211    01345566667777777766554

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=6.4e-41  Score=375.20  Aligned_cols=323  Identities=21%  Similarity=0.221  Sum_probs=154.5

Q ss_pred             CCCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCC
Q 035691            2 LTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLP   81 (640)
Q Consensus         2 l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~   81 (640)
                      +++|++|+|++|+|++..|.+|.++++|++|+|++|++++..|.+|.++++|++|+|++|+|+.      +++..+..++
T Consensus        56 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~------l~~~~~~~l~  129 (606)
T 3t6q_A           56 LINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS------IDFIPLHNQK  129 (606)
T ss_dssp             CTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSC------GGGSCCTTCT
T ss_pred             CccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCccc------CCcchhccCC
Confidence            3444444444444444444444444444444444444444444444444444444444444443      3333334455


Q ss_pred             CCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCC--EEEcccCcCCCCCCCccccc-------
Q 035691           82 NIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLT--RLNFARNDLGTRKVNDLRFL-------  152 (640)
Q Consensus        82 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~--~L~L~~N~l~~~~~~~~~~~-------  152 (640)
                      +|+.|+|++|++++..+..+..+++|++|+|++|++++..|..|+.+++|+  .|++++|.+++++...+...       
T Consensus       130 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l  209 (606)
T 3t6q_A          130 TLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNF  209 (606)
T ss_dssp             TCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEEC
T ss_pred             cccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhcccccccc
Confidence            555555555555554333333455555555555555555555555556555  55666665554433222110       


Q ss_pred             ------------------------------------ccccCCC--CcceEecCCCCCCCcCcC-CCCCCCCCEEEccCCc
Q 035691          153 ------------------------------------DSLVNCT--YLEIVSLNVNSLRSIPIS-VGYLPKLQVLSLFENN  193 (640)
Q Consensus       153 ------------------------------------~~l~~l~--~L~~L~L~~N~l~~ip~~-~~~l~~L~~L~L~~N~  193 (640)
                                                          ..+.++.  +|+.|++++|.++.++.. +..+++|++|++++|.
T Consensus       210 ~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  289 (606)
T 3t6q_A          210 GGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATH  289 (606)
T ss_dssp             TTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSC
T ss_pred             CCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCc
Confidence                                                0000000  344444444444443332 4445555555555555


Q ss_pred             CcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCcccc---------CCCCCceEEccCCcCCCCC--
Q 035691          194 ISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFL---------GQYPVRWLDLSHNHLTGPI--  262 (640)
Q Consensus       194 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~---------~~~~l~~L~Ls~N~l~~~~--  262 (640)
                      ++ .+|..+..+++|++|++++|++.+..|..+..+++|+.|++++|.+.         .+..|++|++++|.+++..  
T Consensus       290 l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~  368 (606)
T 3t6q_A          290 LS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCC  368 (606)
T ss_dssp             CS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEES
T ss_pred             cC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCc
Confidence            55 34444555555555555555555444445555555555555554322         2233455555555554433  


Q ss_pred             CccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCc-cCCCCCCCCeEeCcCCccc
Q 035691          263 PLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHP-GLSSLKSLEGLDLFQNTFQ  331 (640)
Q Consensus       263 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~  331 (640)
                      +..+..+++|+.|++++|++++..|..|..+++|++|++++|++++..|. .+..+++|++|++++|.++
T Consensus       369 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~  438 (606)
T 3t6q_A          369 NLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLD  438 (606)
T ss_dssp             TTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCB
T ss_pred             chhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccC
Confidence            44455555555555555555544444555555555555555555443332 2444555555555555444

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=2.1e-41  Score=379.15  Aligned_cols=187  Identities=18%  Similarity=0.138  Sum_probs=170.7

Q ss_pred             ccccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCC-cCccCCCCCCEEEccCCCCCCCCCccccCCCC
Q 035691          153 DSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIP-SSLGNFTFLTELNLRGNSIRGSIPSALGNCHQ  231 (640)
Q Consensus       153 ~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  231 (640)
                      ..+..+++|++|++++|.++.+|..+..+++|++|++++|.+.+..| ..|..+++|++|++++|++.+..|..|.++++
T Consensus       370 ~~~~~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  449 (606)
T 3vq2_A          370 YSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTS  449 (606)
T ss_dssp             HHHHCCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTT
T ss_pred             hhhccCCcccEeECCCCccccchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCC
Confidence            34567899999999999999999889999999999999999998887 78999999999999999999999999999999


Q ss_pred             ccEEeccCccccC---------CCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEec
Q 035691          232 LQSLDLSKTIFLG---------QYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLS  302 (640)
Q Consensus       232 L~~L~ls~n~~~~---------~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  302 (640)
                      |+.|++++|.+.+         +..|+.|+|++|++++..|..|.++++|+.|+|++|++++.+|..|..+++|++|+|+
T Consensus       450 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~  529 (606)
T 3vq2_A          450 LNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCS  529 (606)
T ss_dssp             CCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECT
T ss_pred             CCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECC
Confidence            9999999997654         3458999999999999999999999999999999999999999999999999999999


Q ss_pred             CCccCCCCCccCCCCC-CCCeEeCcCCccccccCCcccC
Q 035691          303 INSFHGPIHPGLSSLK-SLEGLDLFQNTFQAKSQNGDVP  340 (640)
Q Consensus       303 ~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~~~p  340 (640)
                      +|+++ .+|..+..++ +|++|++++|+|.|.|...+..
T Consensus       530 ~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~~~  567 (606)
T 3vq2_A          530 FNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQKFL  567 (606)
T ss_dssp             TSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTTHHHH
T ss_pred             CCcCc-ccCHhHhhhcccCcEEEccCCCcccCCccHHHH
Confidence            99999 5666688887 6999999999999988654443

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-41  Score=375.80  Aligned_cols=348  Identities=20%  Similarity=0.163  Sum_probs=238.7

Q ss_pred             CCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCC
Q 035691            4 FLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNI   83 (640)
Q Consensus         4 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L   83 (640)
                      +++.|||++|+|++..+..|.++++|++|+|++|+++++.|.+|.++++|++|+|++|+++.      +|+..+..+++|
T Consensus        29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~------~~~~~~~~l~~L  102 (570)
T 2z63_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS------LALGAFSGLSSL  102 (570)
T ss_dssp             SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE------ECTTTTTTCTTC
T ss_pred             cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCc------cCHhhhcCcccc
Confidence            46666666666666666666666666666666666666666666666666666666666654      555555556666


Q ss_pred             CeeeccCCcccccCCccCcCCCCCCEEECcCCccCcc-CCccccCCCCCCEEEcccCcCCCCCCC---------------
Q 035691           84 RIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS-IPEDLGRLRNLTRLNFARNDLGTRKVN---------------  147 (640)
Q Consensus        84 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~---------------  147 (640)
                      +.|+|++|++++..+..|+++++|++|+|++|.+++. .|..|+++++|++|++++|+++.++..               
T Consensus       103 ~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L  182 (570)
T 2z63_A          103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL  182 (570)
T ss_dssp             CEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEE
T ss_pred             ccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhc
Confidence            6666666666655554566666666666666666542 355566666666666666655443211               


Q ss_pred             -------------ccc----------------------------------------------------------------
Q 035691          148 -------------DLR----------------------------------------------------------------  150 (640)
Q Consensus       148 -------------~~~----------------------------------------------------------------  150 (640)
                                   .+.                                                                
T Consensus       183 ~l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l  262 (570)
T 2z63_A          183 DLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF  262 (570)
T ss_dssp             ECTTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEE
T ss_pred             ccCCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhh
Confidence                         110                                                                


Q ss_pred             -----------ccccccCCCCcceEecCCCCCCCcCcCCCC---------------------------------------
Q 035691          151 -----------FLDSLVNCTYLEIVSLNVNSLRSIPISVGY---------------------------------------  180 (640)
Q Consensus       151 -----------~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~---------------------------------------  180 (640)
                                 .++.+..+++|+.|++++|.++.+|..+..                                       
T Consensus       263 ~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~  342 (570)
T 2z63_A          263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS  342 (570)
T ss_dssp             EEEETTEEESCSTTTTGGGTTCSEEEEESCEECSCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCC
T ss_pred             hhhcchhhhhhchhhhcCcCcccEEEecCccchhhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccc
Confidence                       012234456777777777777766654433                                       


Q ss_pred             ---CCCCCEEEccCCcCcccC--CcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccC---------CC
Q 035691          181 ---LPKLQVLSLFENNISGEI--PSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLG---------QY  246 (640)
Q Consensus       181 ---l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~---------~~  246 (640)
                         +++|++|++++|.+++..  |..+.++++|++|++++|.+.+..+. |..+++|+.|++++|.+.+         +.
T Consensus       343 ~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~  421 (570)
T 2z63_A          343 EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLR  421 (570)
T ss_dssp             CCBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCT
T ss_pred             cccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCC
Confidence               445555555555555432  44556666777777777776644443 7778888888888775543         34


Q ss_pred             CCceEEccCCcCCCCCCccCCCCCCCCEEECCCCccc-CcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeC
Q 035691          247 PVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLS-GEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDL  325 (640)
Q Consensus       247 ~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  325 (640)
                      .|++|++++|.+++..|..|.++++|+.|+|++|+++ +.+|..|..+++|++|+|++|++++..|..|..+++|++|++
T Consensus       422 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  501 (570)
T 2z63_A          422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM  501 (570)
T ss_dssp             TCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeC
Confidence            5888999999998888889999999999999999997 578889999999999999999999888999999999999999


Q ss_pred             cCCccccccCCcccCC-CCCCCCCccccccCCCCCcCCC
Q 035691          326 FQNTFQAKSQNGDVPR-KGIFKNASAISVAGNEKLCGGI  363 (640)
Q Consensus       326 ~~N~l~~~~~~~~~p~-~~~~~~~~~~~~~~n~~~c~~~  363 (640)
                      ++|.++..     .|. ...++.+..+++.+|++.|..+
T Consensus       502 ~~n~l~~~-----~~~~~~~l~~L~~L~l~~N~~~~~~~  535 (570)
T 2z63_A          502 ASNQLKSV-----PDGIFDRLTSLQKIWLHTNPWDCSCP  535 (570)
T ss_dssp             CSSCCSCC-----CTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             CCCcCCCC-----CHHHhhcccCCcEEEecCCcccCCCc
Confidence            99998843     332 2456788999999999988654

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=3e-40  Score=369.74  Aligned_cols=338  Identities=17%  Similarity=0.113  Sum_probs=298.7

Q ss_pred             CCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCC
Q 035691            3 TFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPN   82 (640)
Q Consensus         3 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~   82 (640)
                      ..+++|||++|.|++..|..|.++++|++|+|++|+++++.|.+|.++++|++|+|++|+++.      +++..+..+++
T Consensus        33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~------~~~~~~~~l~~  106 (606)
T 3t6q_A           33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIF------MAETALSGPKA  106 (606)
T ss_dssp             TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSE------ECTTTTSSCTT
T ss_pred             CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccc------cChhhhccccc
Confidence            368999999999999999999999999999999999999999999999999999999999875      66666778999


Q ss_pred             CCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcc
Q 035691           83 IRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLE  162 (640)
Q Consensus        83 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~  162 (640)
                      |+.|+|++|++++..|..|+++++|++|+|++|++++..+..+..+++|++|+|++|+++.+      .+..+..+++|+
T Consensus       107 L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~------~~~~~~~l~~L~  180 (606)
T 3t6q_A          107 LKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYL------SKEDMSSLQQAT  180 (606)
T ss_dssp             CCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEE------CHHHHHTTTTCC
T ss_pred             ccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCccccc------Chhhhhhhcccc
Confidence            99999999999998889999999999999999999986656666799999999999999876      456678888898


Q ss_pred             --eEecCCCCCCCcCcCCCCCC----------------------------------------------------CCCEEE
Q 035691          163 --IVSLNVNSLRSIPISVGYLP----------------------------------------------------KLQVLS  188 (640)
Q Consensus       163 --~L~L~~N~l~~ip~~~~~l~----------------------------------------------------~L~~L~  188 (640)
                        .|++++|.++.+++......                                                    +|+.|+
T Consensus       181 ~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~  260 (606)
T 3t6q_A          181 NLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESIN  260 (606)
T ss_dssp             SEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEE
T ss_pred             eeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEE
Confidence              89999999998655433222                                                    678899


Q ss_pred             ccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccC--------CCCCceEEccCCcCCC
Q 035691          189 LFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLG--------QYPVRWLDLSHNHLTG  260 (640)
Q Consensus       189 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~--------~~~l~~L~Ls~N~l~~  260 (640)
                      +++|.++++.+..|..+++|++|++++|+++ .+|..+..+++|+.|++++|.+.+        +..|++|++++|.+.+
T Consensus       261 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~  339 (606)
T 3t6q_A          261 LQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRL  339 (606)
T ss_dssp             CTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCC
T ss_pred             eecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCccc
Confidence            9999999888888999999999999999999 778889999999999999997654        4569999999999986


Q ss_pred             CCC-ccCCCCCCCCEEECCCCcccCcC--CccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCc
Q 035691          261 PIP-LAVGNLKSIPHLDLSKNKLSGEI--PSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNG  337 (640)
Q Consensus       261 ~~~-~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  337 (640)
                      .+| ..|..+++|++|++++|++++..  |..+..+++|++|++++|++++..|..|..+++|++|++++|.++.     
T Consensus       340 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-----  414 (606)
T 3t6q_A          340 ELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV-----  414 (606)
T ss_dssp             BCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEEC-----
T ss_pred             ccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCC-----
Confidence            665 45999999999999999999766  7889999999999999999999999999999999999999999983     


Q ss_pred             ccCC--CCCCCCCccccccCCCC
Q 035691          338 DVPR--KGIFKNASAISVAGNEK  358 (640)
Q Consensus       338 ~~p~--~~~~~~~~~~~~~~n~~  358 (640)
                      ..|.  ...++.+..+++++|..
T Consensus       415 ~~~~~~~~~l~~L~~L~l~~n~l  437 (606)
T 3t6q_A          415 KDAQSPFQNLHLLKVLNLSHSLL  437 (606)
T ss_dssp             CTTCCTTTTCTTCCEEECTTCCC
T ss_pred             cccchhhhCcccCCEEECCCCcc
Confidence            3222  24567888999998864

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=5.1e-41  Score=376.58  Aligned_cols=322  Identities=18%  Similarity=0.270  Sum_probs=282.7

Q ss_pred             ccccCCchhhhcCCCCCeEEcccCccCcc-----------------CCcCCC--CCCCCCEEEccCCCcCCccccccCCc
Q 035691           14 NFSGNIPHEIGRLFQLRYIIFNSNTLQGQ-----------------IPVNLT--HCSELRTLDLVLNKLEENQLVGELPP   74 (640)
Q Consensus        14 ~i~~~~p~~~~~l~~L~~L~l~~N~l~~~-----------------~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~lp~   74 (640)
                      ++++ +|.+|+++++|++|+|++|.+++.                 +|..+.  ++++|++|+|++|++.     |.+|.
T Consensus       194 ~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~-----~~~p~  267 (636)
T 4eco_A          194 NITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNL-----TKLPT  267 (636)
T ss_dssp             EEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTC-----SSCCT
T ss_pred             CCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCC-----ccChH
Confidence            4455 889999999999999999999985                 999999  9999999999987765     46886


Q ss_pred             hhhcCCCCCCeeeccCCc-ccc-cCCccCcCC------CCCCEEECcCCccCccCCc--cccCCCCCCEEEcccCcCCCC
Q 035691           75 YIGFTLPNIRIPLLAGNQ-FFG-NIPHSISNA------SKLEWLDFANNSLTASIPE--DLGRLRNLTRLNFARNDLGTR  144 (640)
Q Consensus        75 ~~~~~l~~L~~L~L~~N~-l~~-~~~~~~~~l------~~L~~L~Ls~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~  144 (640)
                      .+. .+++|+.|+|++|+ +++ .+|..++++      ++|++|+|++|+++ .+|.  .|+.+++|++|+|++|++++.
T Consensus       268 ~l~-~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~  345 (636)
T 4eco_A          268 FLK-ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGK  345 (636)
T ss_dssp             TTT-TCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEE
T ss_pred             HHh-cCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccc
Confidence            655 59999999999998 998 889888876      99999999999999 6887  899999999999999999832


Q ss_pred             CCCcccccccccCCCCcceEecCCCCCCCcCcCCCCCCC-CCEEEccCCcCcccCCcCccCCC--CCCEEEccCCCCCCC
Q 035691          145 KVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPK-LQVLSLFENNISGEIPSSLGNFT--FLTELNLRGNSIRGS  221 (640)
Q Consensus       145 ~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~  221 (640)
                            .+ .+..+++|+.|++++|+++.+|..+..+++ |++|++++|.++ .+|..+..++  +|++|++++|++.+.
T Consensus       346 ------ip-~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~  417 (636)
T 4eco_A          346 ------LP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSV  417 (636)
T ss_dssp             ------CC-CCEEEEEESEEECCSSEEEECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTT
T ss_pred             ------hh-hhCCCCCCCEEECCCCccccccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCc
Confidence                  34 678889999999999999999999999999 999999999999 7888888765  999999999999999


Q ss_pred             CCcccc-------CCCCccEEeccCccccCC--------CCCceEEccCCcCCCCCCccCCCCC-------CCCEEECCC
Q 035691          222 IPSALG-------NCHQLQSLDLSKTIFLGQ--------YPVRWLDLSHNHLTGPIPLAVGNLK-------SIPHLDLSK  279 (640)
Q Consensus       222 ~~~~~~-------~l~~L~~L~ls~n~~~~~--------~~l~~L~Ls~N~l~~~~~~~~~~l~-------~L~~L~Ls~  279 (640)
                      +|..|.       .+++|+.|++++|.+...        ..|++|+|++|+++...+..+....       +|+.|+|++
T Consensus       418 ~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~  497 (636)
T 4eco_A          418 DGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRF  497 (636)
T ss_dssp             TTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCS
T ss_pred             chhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcC
Confidence            999998       888999999999987643        4589999999999955555555443       999999999


Q ss_pred             CcccCcCCcccc--CCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCC------ccccccCCcccCCC-CCCCCCcc
Q 035691          280 NKLSGEIPSSLG--SCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN------TFQAKSQNGDVPRK-GIFKNASA  350 (640)
Q Consensus       280 N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N------~l~~~~~~~~~p~~-~~~~~~~~  350 (640)
                      |+|+ .+|..+.  .+++|++|+|++|++++ +|..+..+++|++|+|++|      .+.     +.+|.. ..++.++.
T Consensus       498 N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~-----~~~p~~l~~l~~L~~  570 (636)
T 4eco_A          498 NKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTL-----REWPEGITLCPSLTQ  570 (636)
T ss_dssp             SCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCC-----CCCCTTGGGCSSCCE
T ss_pred             CcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCccc-----ccChHHHhcCCCCCE
Confidence            9999 7888887  99999999999999998 8999999999999999654      444     566654 56788999


Q ss_pred             ccccCCCC
Q 035691          351 ISVAGNEK  358 (640)
Q Consensus       351 ~~~~~n~~  358 (640)
                      +++++|..
T Consensus       571 L~Ls~N~l  578 (636)
T 4eco_A          571 LQIGSNDI  578 (636)
T ss_dssp             EECCSSCC
T ss_pred             EECCCCcC
Confidence            99999975

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=1.8e-40  Score=358.37  Aligned_cols=334  Identities=19%  Similarity=0.185  Sum_probs=291.0

Q ss_pred             cEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCe
Q 035691            6 MLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRI   85 (640)
Q Consensus         6 ~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~   85 (640)
                      +.++.++++++ .+|. +  .++|++|+|++|.|++..|..|.++++|++|+|++|.+.     +.+++..+..+++|+.
T Consensus        13 ~~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~-----~~i~~~~~~~l~~L~~   83 (455)
T 3v47_A           13 YNAICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPG-----LVIRNNTFRGLSSLII   83 (455)
T ss_dssp             TEEECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTT-----CEECTTTTTTCTTCCE
T ss_pred             cccCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCccc-----ceECcccccccccCCE
Confidence            46888999998 5665 3  378999999999999988999999999999999988875     3577888888999999


Q ss_pred             eeccCCcccccCCccCcCCCCCCEEECcCCccCccCCcc--ccCCCCCCEEEcccCcCCCCCCCccccccc-ccCCCCcc
Q 035691           86 PLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPED--LGRLRNLTRLNFARNDLGTRKVNDLRFLDS-LVNCTYLE  162 (640)
Q Consensus        86 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~-l~~l~~L~  162 (640)
                      |+|++|++++..|..|+++++|++|+|++|++++..+..  |..+++|++|+|++|+++.+      .+.. +.++++|+
T Consensus        84 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~------~~~~~~~~l~~L~  157 (455)
T 3v47_A           84 LKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKI------QPASFFLNMRRFH  157 (455)
T ss_dssp             EECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSC------CCCGGGGGCTTCC
T ss_pred             EeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCcc------CcccccCCCCccc
Confidence            999999999999999999999999999999999755544  99999999999999999987      3343 78899999


Q ss_pred             eEecCCCCCCCc-CcCCCCC--CCCCEEEccCCcCcccCCcCc--------cCCCCCCEEEccCCCCCCCCCccccCC--
Q 035691          163 IVSLNVNSLRSI-PISVGYL--PKLQVLSLFENNISGEIPSSL--------GNFTFLTELNLRGNSIRGSIPSALGNC--  229 (640)
Q Consensus       163 ~L~L~~N~l~~i-p~~~~~l--~~L~~L~L~~N~l~~~~p~~~--------~~l~~L~~L~L~~N~l~~~~~~~~~~l--  229 (640)
                      +|++++|.++.+ |..+..+  .+|+.|++++|.+.+..+..+        ..+++|++|++++|++.+..|..+..+  
T Consensus       158 ~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~  237 (455)
T 3v47_A          158 VLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIA  237 (455)
T ss_dssp             EEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTT
T ss_pred             EEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhcccc
Confidence            999999999985 5555544  689999999999997666543        367899999999999998888877665  


Q ss_pred             -CCccEEeccCccccCC--------------------CCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCc
Q 035691          230 -HQLQSLDLSKTIFLGQ--------------------YPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPS  288 (640)
Q Consensus       230 -~~L~~L~ls~n~~~~~--------------------~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  288 (640)
                       ++|+.|++++|...+.                    ..+++|++++|++++..|..|..+++|+.|+|++|++++..|.
T Consensus       238 ~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~  317 (455)
T 3v47_A          238 GTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDN  317 (455)
T ss_dssp             TCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTT
T ss_pred             ccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChh
Confidence             8999999998854332                    4699999999999999999999999999999999999988899


Q ss_pred             cccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCcccCC-CCCCCCCccccccCCCCC
Q 035691          289 SLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPR-KGIFKNASAISVAGNEKL  359 (640)
Q Consensus       289 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~p~-~~~~~~~~~~~~~~n~~~  359 (640)
                      .|.++++|++|+|++|.+++..|..|..+++|++|+|++|.++.     ..|. ...++++..+++.+|...
T Consensus       318 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-----~~~~~~~~l~~L~~L~L~~N~l~  384 (455)
T 3v47_A          318 AFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA-----LGDQSFLGLPNLKELALDTNQLK  384 (455)
T ss_dssp             TTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCE-----ECTTTTTTCTTCCEEECCSSCCS
T ss_pred             HhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccc-----cChhhccccccccEEECCCCccc
Confidence            99999999999999999999889999999999999999999983     3333 256788999999998753

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=6.5e-41  Score=382.23  Aligned_cols=336  Identities=20%  Similarity=0.225  Sum_probs=250.3

Q ss_pred             CCcEEeCCCCccccCCchhhhcCCCCCeEEc-ccCccCcc----------------------------------------
Q 035691            4 FLMLINLQQNNFSGNIPHEIGRLFQLRYIIF-NSNTLQGQ----------------------------------------   42 (640)
Q Consensus         4 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l-~~N~l~~~----------------------------------------   42 (640)
                      .++.|+|++|+++|.+|++|++|++|++|+| ++|.++|.                                        
T Consensus       324 ~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l  403 (876)
T 4ecn_A          324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDL  403 (876)
T ss_dssp             CEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHH
T ss_pred             CEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHH
Confidence            5778888999998888888889999999988 77654333                                        


Q ss_pred             ------------------------------------CCcCCCCCCCCCEEEccCCCcCC------------ccccccCCc
Q 035691           43 ------------------------------------IPVNLTHCSELRTLDLVLNKLEE------------NQLVGELPP   74 (640)
Q Consensus        43 ------------------------------------~~~~~~~l~~L~~L~Ls~N~l~~------------~~~~~~lp~   74 (640)
                                                          +|..|.++++|++|+|++|+|+.            +.+.|.+|+
T Consensus       404 ~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~  483 (876)
T 4ecn_A          404 LQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENE  483 (876)
T ss_dssp             HHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS
T ss_pred             HHHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCCh
Confidence                                                67778888889999988888765            223335777


Q ss_pred             hh-hcCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCc-cCc-cCCccccCCC-------CCCEEEcccCcCCCC
Q 035691           75 YI-GFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNS-LTA-SIPEDLGRLR-------NLTRLNFARNDLGTR  144 (640)
Q Consensus        75 ~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~-~~~~~~~~l~-------~L~~L~L~~N~l~~~  144 (640)
                      .+ |..+++|+.|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..++.++       +|++|+|++|+++.+
T Consensus       484 ~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~i  563 (876)
T 4ecn_A          484 ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEF  563 (876)
T ss_dssp             CCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBC
T ss_pred             hhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCcc
Confidence            76 4468888888888888888888888888888888888887 887 6776555544       888888888888743


Q ss_pred             CCCcccccc--cccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCC-CCEEEccCCCCCCC
Q 035691          145 KVNDLRFLD--SLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTF-LTELNLRGNSIRGS  221 (640)
Q Consensus       145 ~~~~~~~~~--~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~  221 (640)
                             |.  .+.++++|+.|+|++|+++.+| .+..+++|+.|+|++|.++ .+|..+..+++ |+.|+|++|+++ .
T Consensus       564 -------p~~~~l~~L~~L~~L~Ls~N~l~~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~  633 (876)
T 4ecn_A          564 -------PASASLQKMVKLGLLDCVHNKVRHLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-Y  633 (876)
T ss_dssp             -------CCHHHHTTCTTCCEEECTTSCCCBCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-S
T ss_pred             -------CChhhhhcCCCCCEEECCCCCcccch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-c
Confidence                   34  6778888888888888888888 7778888888888888888 67777888888 888888888888 6


Q ss_pred             CCccccCCCC--ccEEeccCccccCCC-------------CCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcC
Q 035691          222 IPSALGNCHQ--LQSLDLSKTIFLGQY-------------PVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEI  286 (640)
Q Consensus       222 ~~~~~~~l~~--L~~L~ls~n~~~~~~-------------~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  286 (640)
                      +|..+..++.  |+.|++++|.+.+..             .|+.|+|++|+++..++..+..+++|+.|+|++|+|+ .+
T Consensus       634 lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~i  712 (876)
T 4ecn_A          634 IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SI  712 (876)
T ss_dssp             CCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CC
T ss_pred             CchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-cc
Confidence            6777776654  888888888775432             4677788888777443344457777777777777777 44


Q ss_pred             CccccC--------CCCCCeEEecCCccCCCCCccCC--CCCCCCeEeCcCCccccccCCcccCCC-CCCCCCccccccC
Q 035691          287 PSSLGS--------CVGLEYLNLSINSFHGPIHPGLS--SLKSLEGLDLFQNTFQAKSQNGDVPRK-GIFKNASAISVAG  355 (640)
Q Consensus       287 p~~~~~--------l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~l~~N~l~~~~~~~~~p~~-~~~~~~~~~~~~~  355 (640)
                      |..+..        +++|+.|+|++|+|+ .+|..+.  .+++|+.|+|++|+++.      +|.. ..++++..+++++
T Consensus       713 p~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~------lp~~l~~L~~L~~L~Ls~  785 (876)
T 4ecn_A          713 PENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS------FPTQPLNSSQLKAFGIRH  785 (876)
T ss_dssp             CTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS------CCCGGGGCTTCCEEECCC
T ss_pred             ChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc------cchhhhcCCCCCEEECCC
Confidence            443322        227777777777777 5566665  77777777777777773      3322 4456667777766


Q ss_pred             CC
Q 035691          356 NE  357 (640)
Q Consensus       356 n~  357 (640)
                      |+
T Consensus       786 N~  787 (876)
T 4ecn_A          786 QR  787 (876)
T ss_dssp             CB
T ss_pred             CC
Confidence            55

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=2.1e-40  Score=378.06  Aligned_cols=336  Identities=21%  Similarity=0.231  Sum_probs=291.7

Q ss_pred             CCCCCcEEeCCCCcccc-----------------CCchhhh--cCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCC
Q 035691            1 NLTFLMLINLQQNNFSG-----------------NIPHEIG--RLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLN   61 (640)
Q Consensus         1 nl~~L~~L~L~~n~i~~-----------------~~p~~~~--~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N   61 (640)
                      +|++|++|+|++|+|++                 .+|+.++  ++++|++|+|++|.+.+.+|..|.++++|++|+|++|
T Consensus       446 ~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N  525 (876)
T 4ecn_A          446 RLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN  525 (876)
T ss_dssp             GCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTC
T ss_pred             cCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCC
Confidence            47899999999999998                 3898877  9999999999999999999999999999999999988


Q ss_pred             C-cCCccccc-cCCchhh------cCCCCCCeeeccCCcccccCCc--cCcCCCCCCEEECcCCccCccCCccccCCCCC
Q 035691           62 K-LEENQLVG-ELPPYIG------FTLPNIRIPLLAGNQFFGNIPH--SISNASKLEWLDFANNSLTASIPEDLGRLRNL  131 (640)
Q Consensus        62 ~-l~~~~~~~-~lp~~~~------~~l~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  131 (640)
                      + ++     | .+|..++      ..+++|+.|+|++|+++ .+|.  .|+++++|++|+|++|+++ .+| .|+.+++|
T Consensus       526 ~~ls-----g~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L  597 (876)
T 4ecn_A          526 RGIS-----AAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKL  597 (876)
T ss_dssp             TTSC-----HHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEE
T ss_pred             CCcc-----cccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcc
Confidence            7 54     4 4666543      34569999999999999 7787  8999999999999999999 677 89999999


Q ss_pred             CEEEcccCcCCCCCCCcccccccccCCCC-cceEecCCCCCCCcCcCCCCCCC--CCEEEccCCcCcccCCcCc---c--
Q 035691          132 TRLNFARNDLGTRKVNDLRFLDSLVNCTY-LEIVSLNVNSLRSIPISVGYLPK--LQVLSLFENNISGEIPSSL---G--  203 (640)
Q Consensus       132 ~~L~L~~N~l~~~~~~~~~~~~~l~~l~~-L~~L~L~~N~l~~ip~~~~~l~~--L~~L~L~~N~l~~~~p~~~---~--  203 (640)
                      +.|+|++|+++.+       +..+.++++ |+.|++++|.++.+|..+..++.  |+.|+|++|.+.+.+|...   .  
T Consensus       598 ~~L~Ls~N~l~~l-------p~~l~~l~~~L~~L~Ls~N~L~~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~  670 (876)
T 4ecn_A          598 TDLKLDYNQIEEI-------PEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDY  670 (876)
T ss_dssp             SEEECCSSCCSCC-------CTTSCEECTTCCEEECCSSCCCSCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTC
T ss_pred             eEEECcCCccccc-------hHHHhhccccCCEEECcCCCCCcCchhhhccccCCCCEEECcCCcCCCccccchhhhccc
Confidence            9999999999854       456888898 99999999999999988776654  9999999999998766432   2  


Q ss_pred             CCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCC---------------CCceEEccCCcCCCCCCccCC-
Q 035691          204 NFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQY---------------PVRWLDLSHNHLTGPIPLAVG-  267 (640)
Q Consensus       204 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~---------------~l~~L~Ls~N~l~~~~~~~~~-  267 (640)
                      .+++|+.|+|++|+++..++..+..+++|+.|+|++|.+...+               .|+.|+|++|+|+ .+|..+. 
T Consensus       671 ~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~  749 (876)
T 4ecn_A          671 KGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRA  749 (876)
T ss_dssp             CCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGST
T ss_pred             cCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhhh
Confidence            3458999999999999554455668999999999999875322               6899999999999 6788887 


Q ss_pred             -CCCCCCEEECCCCcccCcCCccccCCCCCCeEEecC------CccCCCCCccCCCCCCCCeEeCcCCccccccCCcccC
Q 035691          268 -NLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSI------NSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVP  340 (640)
Q Consensus       268 -~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~------N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~p  340 (640)
                       .+++|+.|+|++|+|++ +|..+..+++|+.|+|++      |++.+.+|..|..+++|++|+|++|++..      +|
T Consensus       750 ~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L~~------Ip  822 (876)
T 4ecn_A          750 TTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK------VD  822 (876)
T ss_dssp             TTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCCB------CC
T ss_pred             ccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCCCc------cC
Confidence             99999999999999996 799999999999999976      88899999999999999999999999963      34


Q ss_pred             CCCCCCCCccccccCCCCCc
Q 035691          341 RKGIFKNASAISVAGNEKLC  360 (640)
Q Consensus       341 ~~~~~~~~~~~~~~~n~~~c  360 (640)
                      .. ..+++..+++++|++..
T Consensus       823 ~~-l~~~L~~LdLs~N~l~~  841 (876)
T 4ecn_A          823 EK-LTPQLYILDIADNPNIS  841 (876)
T ss_dssp             SC-CCSSSCEEECCSCTTCE
T ss_pred             Hh-hcCCCCEEECCCCCCCc
Confidence            33 33688999999998754

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=7.8e-40  Score=368.23  Aligned_cols=350  Identities=21%  Similarity=0.212  Sum_probs=275.6

Q ss_pred             CCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCC
Q 035691            3 TFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPN   82 (640)
Q Consensus         3 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~   82 (640)
                      +++++|||++|+|+++.|.+|.++++|++|+|++|+|+++.|.+|.++++|++|+|++|+|+.      +|+..|.++++
T Consensus        52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~------l~~~~f~~L~~  125 (635)
T 4g8a_A           52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS------LALGAFSGLSS  125 (635)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE------ECGGGGTTCTT
T ss_pred             cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCC------CCHHHhcCCCC
Confidence            368999999999998888999999999999999999998889999999999999999999986      99999999999


Q ss_pred             CCeeeccCCcccccCCccCcCCCCCCEEECcCCccCcc-CCccccCCCCCCEEEcccCcCCCCCCCccccc---------
Q 035691           83 IRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS-IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFL---------  152 (640)
Q Consensus        83 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~---------  152 (640)
                      |+.|+|++|+|+++.+..|+++++|++|+|++|+++.. .|..++.+++|++|+|++|+|+.+....+...         
T Consensus       126 L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~  205 (635)
T 4g8a_A          126 LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS  205 (635)
T ss_dssp             CCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCE
T ss_pred             CCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhh
Confidence            99999999999999888999999999999999999864 57889999999999999999876543221100         


Q ss_pred             --------------------------------------------------------------------------------
Q 035691          153 --------------------------------------------------------------------------------  152 (640)
Q Consensus       153 --------------------------------------------------------------------------------  152 (640)
                                                                                                      
T Consensus       206 ~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~  285 (635)
T 4g8a_A          206 LDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE  285 (635)
T ss_dssp             EECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEE
T ss_pred             hhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhh
Confidence                                                                                            


Q ss_pred             ------------------------------------ccccCCCCcceEecCCCCCCCcCc--------------------
Q 035691          153 ------------------------------------DSLVNCTYLEIVSLNVNSLRSIPI--------------------  176 (640)
Q Consensus       153 ------------------------------------~~l~~l~~L~~L~L~~N~l~~ip~--------------------  176 (640)
                                                          ..+.....|+.|++.+|.+..++.                    
T Consensus       286 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~  365 (635)
T 4g8a_A          286 FRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAF  365 (635)
T ss_dssp             EEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBC
T ss_pred             hhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCc
Confidence                                                000111234445555554443221                    


Q ss_pred             CCCCCCCCCEEEccCCcCccc-------------------------CCcCccCCCCCCEEEccCCCCCCCCC-ccccCCC
Q 035691          177 SVGYLPKLQVLSLFENNISGE-------------------------IPSSLGNFTFLTELNLRGNSIRGSIP-SALGNCH  230 (640)
Q Consensus       177 ~~~~l~~L~~L~L~~N~l~~~-------------------------~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~  230 (640)
                      ....+++|+.|++++|.+...                         .+..+..+++|+.+++++|......+ ..|..+.
T Consensus       366 ~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~  445 (635)
T 4g8a_A          366 SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR  445 (635)
T ss_dssp             CCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCT
T ss_pred             ccccccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhcccccccccccccccc
Confidence            112356777788877776421                         22345556666667776665544433 4577788


Q ss_pred             CccEEeccCcccc--------CCCCCceEEccCCcC-CCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEe
Q 035691          231 QLQSLDLSKTIFL--------GQYPVRWLDLSHNHL-TGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNL  301 (640)
Q Consensus       231 ~L~~L~ls~n~~~--------~~~~l~~L~Ls~N~l-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  301 (640)
                      +++.++++.|.+.        +...++.|+|++|++ .+..|..|..+++|++|+|++|+|++.+|..|.++++|++|+|
T Consensus       446 ~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~L  525 (635)
T 4g8a_A          446 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM  525 (635)
T ss_dssp             TCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             ccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEEC
Confidence            8888888887654        344588999999974 4467889999999999999999999888999999999999999


Q ss_pred             cCCccCCCCCccCCCCCCCCeEeCcCCccccccCCcccCCC-CCC-CCCccccccCCCCCcCCC
Q 035691          302 SINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRK-GIF-KNASAISVAGNEKLCGGI  363 (640)
Q Consensus       302 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~p~~-~~~-~~~~~~~~~~n~~~c~~~  363 (640)
                      ++|+|++..|..|..+++|++|||++|+++..     .|.. ..+ +++..+++++|||.|.+.
T Consensus       526 s~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~-----~~~~l~~l~~~L~~L~L~~Np~~C~C~  584 (635)
T 4g8a_A          526 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS-----KKQELQHFPSSLAFLNLTQNDFACTCE  584 (635)
T ss_dssp             TTSCCCBCCCGGGTTCTTCCEEECTTSCCCBC-----CSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred             CCCcCCCCChhHHhCCCCCCEEECCCCcCCCC-----CHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence            99999998899999999999999999999843     3332 223 578889999999999654

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.9e-40  Score=361.07  Aligned_cols=340  Identities=20%  Similarity=0.219  Sum_probs=275.1

Q ss_pred             CCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCC
Q 035691            3 TFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPN   82 (640)
Q Consensus         3 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~   82 (640)
                      ++|++|+|++|.|++..|..|.++++|++|+|++|+|++..|..|.++++|++|||++|+|+.      +|..   .+++
T Consensus        21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~------lp~~---~l~~   91 (520)
T 2z7x_B           21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK------ISCH---PTVN   91 (520)
T ss_dssp             TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCE------EECC---CCCC
T ss_pred             ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceee------cCcc---ccCC
Confidence            579999999999998888999999999999999999998889999999999999999999975      7766   5999


Q ss_pred             CCeeeccCCcccc-cCCccCcCCCCCCEEECcCCccCccCCccccCCCCC--CEEEcccCcC--CCCCCCcccccc----
Q 035691           83 IRIPLLAGNQFFG-NIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNL--TRLNFARNDL--GTRKVNDLRFLD----  153 (640)
Q Consensus        83 L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L--~~L~L~~N~l--~~~~~~~~~~~~----  153 (640)
                      |+.|+|++|++++ ..|..|+++++|++|+|++|+|++   ..|..+++|  ++|+|++|.+  ....+..+....    
T Consensus        92 L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l  168 (520)
T 2z7x_B           92 LKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESL  168 (520)
T ss_dssp             CSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEE
T ss_pred             ccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceE
Confidence            9999999999998 478999999999999999999986   457778888  9999999988  333222211100    


Q ss_pred             ----------------c------------------------------ccC---------------------------CCC
Q 035691          154 ----------------S------------------------------LVN---------------------------CTY  160 (640)
Q Consensus       154 ----------------~------------------------------l~~---------------------------l~~  160 (640)
                                      .                              +..                           +++
T Consensus       169 ~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~  248 (520)
T 2z7x_B          169 HIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTT  248 (520)
T ss_dssp             EEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSS
T ss_pred             EEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCc
Confidence                            0                              111                           125


Q ss_pred             cceEecCCCCCC-CcCcCC-----CCCCCCCEEEccCCcCcccCC-c-------------------------CccCCCCC
Q 035691          161 LEIVSLNVNSLR-SIPISV-----GYLPKLQVLSLFENNISGEIP-S-------------------------SLGNFTFL  208 (640)
Q Consensus       161 L~~L~L~~N~l~-~ip~~~-----~~l~~L~~L~L~~N~l~~~~p-~-------------------------~~~~l~~L  208 (640)
                      |++|++++|+++ .+|..+     ..+++|+.+++++|.+  .+| .                         .+..+++|
T Consensus       249 L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L  326 (520)
T 2z7x_B          249 VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPF  326 (520)
T ss_dssp             CSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCC
T ss_pred             ccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccccchhhCCcc
Confidence            777777777777 477766     5565555555555555  122 1                         12678999


Q ss_pred             CEEEccCCCCCCCCCccccCCCCccEEeccCccccC----------CCCCceEEccCCcCCCCCCc-cCCCCCCCCEEEC
Q 035691          209 TELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLG----------QYPVRWLDLSHNHLTGPIPL-AVGNLKSIPHLDL  277 (640)
Q Consensus       209 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~----------~~~l~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L  277 (640)
                      ++|++++|++++..|..++.+++|+.|++++|.+.+          +..|++|++++|++++.+|. .|..+++|+.|+|
T Consensus       327 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L  406 (520)
T 2z7x_B          327 LHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNM  406 (520)
T ss_dssp             CEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEEC
T ss_pred             cEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEEC
Confidence            999999999999899999999999999999997763          45699999999999984554 5899999999999


Q ss_pred             CCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCcccCCCCCCCCCccccccCCC
Q 035691          278 SKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNE  357 (640)
Q Consensus       278 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~p~~~~~~~~~~~~~~~n~  357 (640)
                      ++|++++..|..+.  ++|++|+|++|+++ .+|..+..+++|++|+|++|+++..+..    ....++.+..+++.+|+
T Consensus       407 s~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~----~~~~l~~L~~L~l~~N~  479 (520)
T 2z7x_B          407 SSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDG----IFDRLTSLQKIWLHTNP  479 (520)
T ss_dssp             CSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTT----TTTTCTTCCEEECCSSC
T ss_pred             cCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHH----HhccCCcccEEECcCCC
Confidence            99999988887765  78999999999999 6777777999999999999999844322    12456788999999999


Q ss_pred             CCcCCC
Q 035691          358 KLCGGI  363 (640)
Q Consensus       358 ~~c~~~  363 (640)
                      +.|.++
T Consensus       480 ~~c~c~  485 (520)
T 2z7x_B          480 WDCSCP  485 (520)
T ss_dssp             BCCCHH
T ss_pred             CcccCC
Confidence            988654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.5e-39  Score=369.09  Aligned_cols=345  Identities=21%  Similarity=0.187  Sum_probs=238.5

Q ss_pred             CCCcEEeCCCCccccCCchhhhcCCC--CCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCC
Q 035691            3 TFLMLINLQQNNFSGNIPHEIGRLFQ--LRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTL   80 (640)
Q Consensus         3 ~~L~~L~L~~n~i~~~~p~~~~~l~~--L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l   80 (640)
                      ++|+.|++++|.+++..|..|..++.  |++|++++|++++..|..|..+++|++|+|++|+++.      +++..+..+
T Consensus       222 ~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~------~~~~~~~~l  295 (680)
T 1ziw_A          222 TSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH------LFSHSLHGL  295 (680)
T ss_dssp             SCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSE------ECTTTTTTC
T ss_pred             ccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCc------cChhhhcCC
Confidence            56777777777777666666766644  7777777777776666667777777777777666653      333333344


Q ss_pred             CCCCeeeccCCcccc-----cCC----ccCcCCCCCCEEECcCCccCccCCccccCCCC---------------------
Q 035691           81 PNIRIPLLAGNQFFG-----NIP----HSISNASKLEWLDFANNSLTASIPEDLGRLRN---------------------  130 (640)
Q Consensus        81 ~~L~~L~L~~N~l~~-----~~~----~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~---------------------  130 (640)
                      ++|+.|+|++|...+     .+|    ..|..+++|++|++++|+++++.+..|.++++                     
T Consensus       296 ~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f  375 (680)
T 1ziw_A          296 FNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETF  375 (680)
T ss_dssp             TTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTT
T ss_pred             CCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhh
Confidence            455555554443221     111    13444444555555555544444444444444                     


Q ss_pred             -------CCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCC-cC-cCCCCCCCCCEEEccCCcCcccCCcC
Q 035691          131 -------LTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRS-IP-ISVGYLPKLQVLSLFENNISGEIPSS  201 (640)
Q Consensus       131 -------L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~-ip-~~~~~l~~L~~L~L~~N~l~~~~p~~  201 (640)
                             |+.|+|++|+++.+      .+..|..+++|+.|++++|.++. +| ..+..+++|++|++++|++.+..+..
T Consensus       376 ~~~~~~~L~~L~L~~n~l~~~------~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~  449 (680)
T 1ziw_A          376 VSLAHSPLHILNLTKNKISKI------ESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNS  449 (680)
T ss_dssp             GGGTTSCCCEEECTTSCCCEE------CTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTT
T ss_pred             cccccCcCceEECCCCCCCeE------ChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhh
Confidence                   45555555555444      34566777888888888888865 55 46677788888888888888777778


Q ss_pred             ccCCCCCCEEEccCCCCC--CCCCccccCCCCccEEeccCccccC--------CCCCceEEccCCcCCCCCC--------
Q 035691          202 LGNFTFLTELNLRGNSIR--GSIPSALGNCHQLQSLDLSKTIFLG--------QYPVRWLDLSHNHLTGPIP--------  263 (640)
Q Consensus       202 ~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~ls~n~~~~--------~~~l~~L~Ls~N~l~~~~~--------  263 (640)
                      |..+++|+.|++++|.+.  +..|..|.++++|+.|++++|.+.+        +..|++|+|++|++++..+        
T Consensus       450 ~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~  529 (680)
T 1ziw_A          450 FALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPI  529 (680)
T ss_dssp             TTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCC
T ss_pred             hhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcc
Confidence            888888888888888876  4677888888888888888886543        3457888999888875422        


Q ss_pred             ccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCcccCCCC
Q 035691          264 LAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKG  343 (640)
Q Consensus       264 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~p~~~  343 (640)
                      ..|.++++|+.|+|++|+++...+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|.++......    .+
T Consensus       530 ~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~----~~  605 (680)
T 1ziw_A          530 YFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKV----FG  605 (680)
T ss_dssp             CTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHH----HH
T ss_pred             hhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhH----hc
Confidence            34788889999999999998555567888999999999999999888888889999999999999888433211    01


Q ss_pred             -CCCCCccccccCCCCCcCCC
Q 035691          344 -IFKNASAISVAGNEKLCGGI  363 (640)
Q Consensus       344 -~~~~~~~~~~~~n~~~c~~~  363 (640)
                       .++++..+++.+|||.|.+.
T Consensus       606 ~~~~~L~~l~l~~N~~~c~c~  626 (680)
T 1ziw_A          606 PAFRNLTELDMRFNPFDCTCE  626 (680)
T ss_dssp             HHHTTCSEEECTTCCCCBCCC
T ss_pred             ccccccCEEEccCCCcccCCc
Confidence             35678899999999999765

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=1.2e-39  Score=361.27  Aligned_cols=340  Identities=19%  Similarity=0.187  Sum_probs=263.6

Q ss_pred             CCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCC
Q 035691            3 TFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPN   82 (640)
Q Consensus         3 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~   82 (640)
                      ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|.+|.++++|++|||++|+|++      +|..   .+++
T Consensus        52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~------lp~~---~l~~  122 (562)
T 3a79_B           52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN------ISCC---PMAS  122 (562)
T ss_dssp             TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCE------ECSC---CCTT
T ss_pred             CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCc------cCcc---cccc
Confidence            578899999999998888889999999999999999998888899999999999999998875      7766   5899


Q ss_pred             CCeeeccCCccccc-CCccCcCCCCCCEEECcCCccCccCCccccCCCCC--CEEEcccCcC--CCCCCCcccccc----
Q 035691           83 IRIPLLAGNQFFGN-IPHSISNASKLEWLDFANNSLTASIPEDLGRLRNL--TRLNFARNDL--GTRKVNDLRFLD----  153 (640)
Q Consensus        83 L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L--~~L~L~~N~l--~~~~~~~~~~~~----  153 (640)
                      |+.|+|++|++++. .|..|+++++|++|+|++|++++.   .|..+++|  ++|+|++|++  +...+..+....    
T Consensus       123 L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l  199 (562)
T 3a79_B          123 LRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL  199 (562)
T ss_dssp             CSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEE
T ss_pred             CCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceE
Confidence            99999999999874 468899999999999999998863   45555666  9999999988  554332222110    


Q ss_pred             ----------------cccCCC-------------------------------------------------------Ccc
Q 035691          154 ----------------SLVNCT-------------------------------------------------------YLE  162 (640)
Q Consensus       154 ----------------~l~~l~-------------------------------------------------------~L~  162 (640)
                                      .+..++                                                       +|+
T Consensus       200 ~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~  279 (562)
T 3a79_B          200 HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVE  279 (562)
T ss_dssp             EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEE
T ss_pred             EEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhccccc
Confidence                            011112                                                       566


Q ss_pred             eEecCCCCCC-CcCcCC-----CCC--------------------------CCCCEEEccCCcCcccCCcCccCCCCCCE
Q 035691          163 IVSLNVNSLR-SIPISV-----GYL--------------------------PKLQVLSLFENNISGEIPSSLGNFTFLTE  210 (640)
Q Consensus       163 ~L~L~~N~l~-~ip~~~-----~~l--------------------------~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  210 (640)
                      +|++++|.++ .+|..+     ..+                          .+|++|++++|.+....  ....+++|++
T Consensus       280 ~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~  357 (562)
T 3a79_B          280 YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTF  357 (562)
T ss_dssp             EEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCE
T ss_pred             EEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceE
Confidence            6666666666 366544     222                          23555555555554211  1267899999


Q ss_pred             EEccCCCCCCCCCccccCCCCccEEeccCccccC----------CCCCceEEccCCcCCC-CCCccCCCCCCCCEEECCC
Q 035691          211 LNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLG----------QYPVRWLDLSHNHLTG-PIPLAVGNLKSIPHLDLSK  279 (640)
Q Consensus       211 L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~----------~~~l~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~  279 (640)
                      |++++|++++..|..|.++++|+.|++++|.+.+          +..|++|++++|++++ ..+..|..+++|+.|+|++
T Consensus       358 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~  437 (562)
T 3a79_B          358 LNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSS  437 (562)
T ss_dssp             EECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCS
T ss_pred             EECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCC
Confidence            9999999998899999999999999999997764          3458999999999998 4455699999999999999


Q ss_pred             CcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCcccCCCCCCCCCccccccCCCCC
Q 035691          280 NKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKL  359 (640)
Q Consensus       280 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~p~~~~~~~~~~~~~~~n~~~  359 (640)
                      |++++..|..+.  ++|++|+|++|+|+ .+|..+..+++|++|+|++|+++..+..    ....++.+..+++.+|+|.
T Consensus       438 n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~----~~~~l~~L~~L~l~~N~~~  510 (562)
T 3a79_B          438 NMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDG----VFDRLTSLQYIWLHDNPWD  510 (562)
T ss_dssp             SCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTT----STTTCTTCCCEECCSCCBC
T ss_pred             CCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHH----HHhcCCCCCEEEecCCCcC
Confidence            999887777665  68999999999998 5666666999999999999999844322    1345678889999999999


Q ss_pred             cCCC
Q 035691          360 CGGI  363 (640)
Q Consensus       360 c~~~  363 (640)
                      |.++
T Consensus       511 c~c~  514 (562)
T 3a79_B          511 CTCP  514 (562)
T ss_dssp             CCHH
T ss_pred             CCcc
Confidence            9765

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=4.3e-40  Score=364.04  Aligned_cols=344  Identities=18%  Similarity=0.175  Sum_probs=243.0

Q ss_pred             CCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCC
Q 035691            3 TFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPN   82 (640)
Q Consensus         3 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~   82 (640)
                      ++|++|||++|+|++..|..|.++++|++|+|++|++++..|.+|.++++|++|||++|+++.      +|+..+..+++
T Consensus        26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~------~~~~~~~~l~~   99 (549)
T 2z81_A           26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSS------LSSSWFGPLSS   99 (549)
T ss_dssp             TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCS------CCHHHHTTCTT
T ss_pred             CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCc------cCHHHhccCCC
Confidence            479999999999999999999999999999999999999889999999999999999999986      88887778999


Q ss_pred             CCeeeccCCccccc-CCccCcCCCCCCEEECcCCc-cCccCCccccCCCCCCEEEcccCcCCCCCCCccccccc------
Q 035691           83 IRIPLLAGNQFFGN-IPHSISNASKLEWLDFANNS-LTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDS------  154 (640)
Q Consensus        83 L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~------  154 (640)
                      |+.|+|++|++++. .|..|+++++|++|++++|+ ++.+.+..|.++++|++|++++|++++..+..+.....      
T Consensus       100 L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l  179 (549)
T 2z81_A          100 LKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL  179 (549)
T ss_dssp             CCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEE
T ss_pred             CcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEec
Confidence            99999999999974 57789999999999999998 56555578999999999999999998753332211110      


Q ss_pred             ------------ccCCCCcceEecCCCCCCCcC---cCC-CCC-------------------------------------
Q 035691          155 ------------LVNCTYLEIVSLNVNSLRSIP---ISV-GYL-------------------------------------  181 (640)
Q Consensus       155 ------------l~~l~~L~~L~L~~N~l~~ip---~~~-~~l-------------------------------------  181 (640)
                                  +..+++|++|++++|+++.++   ..+ ..+                                     
T Consensus       180 ~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~  259 (549)
T 2z81_A          180 HLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFD  259 (549)
T ss_dssp             ECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEE
T ss_pred             ccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccc
Confidence                        124677888888888777642   111 011                                     


Q ss_pred             --------------------------------------------------CCCCEEEccCCcCcccCCcCc-cCCCCCCE
Q 035691          182 --------------------------------------------------PKLQVLSLFENNISGEIPSSL-GNFTFLTE  210 (640)
Q Consensus       182 --------------------------------------------------~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~  210 (640)
                                                                        ++|++|++++|.+. .+|..+ ..+++|++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~  338 (549)
T 2z81_A          260 DCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEF  338 (549)
T ss_dssp             SCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCE
T ss_pred             cccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccE
Confidence                                                              23444444444444 234333 45777778


Q ss_pred             EEccCCCCCCCCC---ccccCCCCccEEeccCcccc----------CCCCCceEEccCCcCCCCCCccCCCCCCCCEEEC
Q 035691          211 LNLRGNSIRGSIP---SALGNCHQLQSLDLSKTIFL----------GQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDL  277 (640)
Q Consensus       211 L~L~~N~l~~~~~---~~~~~l~~L~~L~ls~n~~~----------~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  277 (640)
                      |+|++|++.+..|   ..++.+++|+.|++++|.+.          .+..|++|++++|+++ .+|..+..+++|++|+|
T Consensus       339 L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~L  417 (549)
T 2z81_A          339 LDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNL  417 (549)
T ss_dssp             EECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEEC
T ss_pred             EEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEEC
Confidence            8888887776553   33667777888888777653          2345777888888877 56667777777777777


Q ss_pred             CCCcccCcCCccc------------------cCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCccc
Q 035691          278 SKNKLSGEIPSSL------------------GSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDV  339 (640)
Q Consensus       278 s~N~l~~~~p~~~------------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  339 (640)
                      ++|+|+. +|..+                  ..+++|++|+|++|+|+ .+|. ...+++|++|||++|+++     +..
T Consensus       418 s~N~l~~-l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~-----~~~  489 (549)
T 2z81_A          418 SSTGIRV-VKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLK-----SVP  489 (549)
T ss_dssp             TTSCCSC-CCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCC-----CCC
T ss_pred             CCCCccc-ccchhcCCceEEECCCCChhhhcccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccC-----CcC
Confidence            7777763 33322                  14555556666666555 2333 244556666666666665     222


Q ss_pred             CC-CCCCCCCccccccCCCCCcCC
Q 035691          340 PR-KGIFKNASAISVAGNEKLCGG  362 (640)
Q Consensus       340 p~-~~~~~~~~~~~~~~n~~~c~~  362 (640)
                      |. ...++.+..+++++|+|.|..
T Consensus       490 ~~~~~~l~~L~~L~l~~N~~~~~~  513 (549)
T 2z81_A          490 DGIFDRLTSLQKIWLHTNPWDCSC  513 (549)
T ss_dssp             TTGGGGCTTCCEEECCSSCBCCCH
T ss_pred             HHHHhcCcccCEEEecCCCccCCC
Confidence            22 134556666677777766644

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=4.6e-39  Score=356.51  Aligned_cols=327  Identities=18%  Similarity=0.230  Sum_probs=259.9

Q ss_pred             CcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCC
Q 035691            5 LMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIR   84 (640)
Q Consensus         5 L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~   84 (640)
                      .+++|+++|++++ +|..+.  ++|++|+|++|.|++..|.+|.++++|++|+|++|+|+.      +++..|..+++|+
T Consensus        33 ~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~------~~~~~~~~l~~L~  103 (562)
T 3a79_B           33 ESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS------LDFHVFLFNQDLE  103 (562)
T ss_dssp             CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCE------ECTTTTTTCTTCC
T ss_pred             CcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCc------CCHHHhCCCCCCC
Confidence            4789999999995 776664  899999999999998888999999999999999999985      7777777899999


Q ss_pred             eeeccCCcccccCCccCcCCCCCCEEECcCCccCcc-CCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcce
Q 035691           85 IPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS-IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEI  163 (640)
Q Consensus        85 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~  163 (640)
                      .|+|++|+|+.+ |..  .+++|++|+|++|++++. .|..|+++++|++|+|++|+++..      ....+.++ +|++
T Consensus       104 ~L~Ls~N~l~~l-p~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~------~~~~l~~L-~L~~  173 (562)
T 3a79_B          104 YLDVSHNRLQNI-SCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL------DLLPVAHL-HLSC  173 (562)
T ss_dssp             EEECTTSCCCEE-CSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT------TTGGGTTS-CEEE
T ss_pred             EEECCCCcCCcc-Ccc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC------chhhhhhc-eeeE
Confidence            999999999965 444  899999999999999974 368999999999999999999764      22233333 4499


Q ss_pred             EecCCCCC--CC-cCcCCCCCC----------------------------------------------------------
Q 035691          164 VSLNVNSL--RS-IPISVGYLP----------------------------------------------------------  182 (640)
Q Consensus       164 L~L~~N~l--~~-ip~~~~~l~----------------------------------------------------------  182 (640)
                      |++++|.+  +. .|..+..+.                                                          
T Consensus       174 L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~  253 (562)
T 3a79_B          174 ILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLN  253 (562)
T ss_dssp             EEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEE
T ss_pred             EEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceE
Confidence            99999988  44 343333222                                                          


Q ss_pred             -----------------------CCCEEEccCCcCcccCCcCc-----cCCC--------------------------CC
Q 035691          183 -----------------------KLQVLSLFENNISGEIPSSL-----GNFT--------------------------FL  208 (640)
Q Consensus       183 -----------------------~L~~L~L~~N~l~~~~p~~~-----~~l~--------------------------~L  208 (640)
                                             +|++|++++|.+++.+|..+     ..++                          +|
T Consensus       254 L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L  333 (562)
T 3a79_B          254 VTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNI  333 (562)
T ss_dssp             EEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCC
T ss_pred             EEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcc
Confidence                                   67777777777777777665     3333                          35


Q ss_pred             CEEEccCCCCCCCCCccccCCCCccEEeccCccccC--------CCCCceEEccCCcCCCCC--CccCCCCCCCCEEECC
Q 035691          209 TELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLG--------QYPVRWLDLSHNHLTGPI--PLAVGNLKSIPHLDLS  278 (640)
Q Consensus       209 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~--------~~~l~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~Ls  278 (640)
                      ++|++++|.+....  .+..+++|+.|++++|.+.+        +..|++|+|++|++++..  |..|..+++|+.|+|+
T Consensus       334 ~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~  411 (562)
T 3a79_B          334 KMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVS  411 (562)
T ss_dssp             SEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECT
T ss_pred             eEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECC
Confidence            55666666554221  12788999999999998765        445899999999999744  5679999999999999


Q ss_pred             CCcccCcCC-ccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCcccCCCCCCCCCccccccCCC
Q 035691          279 KNKLSGEIP-SSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNE  357 (640)
Q Consensus       279 ~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~p~~~~~~~~~~~~~~~n~  357 (640)
                      +|++++.+| ..|..+++|++|+|++|++++..|..+.  ++|++|+|++|.++..+..     ...++.+..+++.+|.
T Consensus       412 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~-----~~~l~~L~~L~L~~N~  484 (562)
T 3a79_B          412 LNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKD-----VTHLQALQELNVASNQ  484 (562)
T ss_dssp             TSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTT-----TTSSCCCSEEECCSSC
T ss_pred             CCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChh-----hcCCCCCCEEECCCCC
Confidence            999998455 4688999999999999999887776654  7999999999999843221     2456788999999997


Q ss_pred             CC
Q 035691          358 KL  359 (640)
Q Consensus       358 ~~  359 (640)
                      ..
T Consensus       485 l~  486 (562)
T 3a79_B          485 LK  486 (562)
T ss_dssp             CC
T ss_pred             CC
Confidence            54

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.9e-39  Score=350.98  Aligned_cols=323  Identities=22%  Similarity=0.169  Sum_probs=270.3

Q ss_pred             cEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCe
Q 035691            6 MLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRI   85 (640)
Q Consensus         6 ~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~   85 (640)
                      +.++.++++++ .+|..+.  +++++|+|++|+|++..+..|.++++|++|+|++|.|+.      +++..|..+++|+.
T Consensus        14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~------~~~~~~~~l~~L~~   84 (477)
T 2id5_A           14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA------VEPGAFNNLFNLRT   84 (477)
T ss_dssp             TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCE------ECTTTTTTCTTCCE
T ss_pred             CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCE------eChhhhhCCccCCE
Confidence            56788888888 5665553  578899999999988888889999999999999888875      65666667889999


Q ss_pred             eeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEe
Q 035691           86 PLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVS  165 (640)
Q Consensus        86 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~  165 (640)
                      |+|++|+++++.+..|.++++|++|+|++|++++..|..|..+++|++|+|++|.++.+      .+..|.++++|+.|+
T Consensus        85 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~------~~~~~~~l~~L~~L~  158 (477)
T 2id5_A           85 LGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYI------SHRAFSGLNSLEQLT  158 (477)
T ss_dssp             EECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEE------CTTSSTTCTTCCEEE
T ss_pred             EECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCcccee------ChhhccCCCCCCEEE
Confidence            99999998887777888889999999999999888888888889999999999988876      345677888888888


Q ss_pred             cCCCCCCCcCc-CCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccC
Q 035691          166 LNVNSLRSIPI-SVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLG  244 (640)
Q Consensus       166 L~~N~l~~ip~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~  244 (640)
                      +++|.++.+|. .+..+++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.+|..+....+|+.|         
T Consensus       159 l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L---------  229 (477)
T 2id5_A          159 LEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSL---------  229 (477)
T ss_dssp             EESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEE---------
T ss_pred             CCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEE---------
Confidence            88888888765 46778888888888888888888888888888888888888776666655555566666         


Q ss_pred             CCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEe
Q 035691          245 QYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLD  324 (640)
Q Consensus       245 ~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  324 (640)
                             +|++|++++..+..|..+++|+.|+|++|++++..+..|..+++|++|+|++|++++..|..|..+++|++|+
T Consensus       230 -------~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  302 (477)
T 2id5_A          230 -------SITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLN  302 (477)
T ss_dssp             -------EEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEE
T ss_pred             -------ECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEE
Confidence                   8889999976667899999999999999999988888999999999999999999999999999999999999


Q ss_pred             CcCCccccccCCcccCCCCCCCCCccccccCCCCCcCCC
Q 035691          325 LFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGI  363 (640)
Q Consensus       325 l~~N~l~~~~~~~~~p~~~~~~~~~~~~~~~n~~~c~~~  363 (640)
                      |++|.++......    ...++++..+++.+|+|.|.+.
T Consensus       303 L~~N~l~~~~~~~----~~~l~~L~~L~l~~N~l~c~c~  337 (477)
T 2id5_A          303 VSGNQLTTLEESV----FHSVGNLETLILDSNPLACDCR  337 (477)
T ss_dssp             CCSSCCSCCCGGG----BSCGGGCCEEECCSSCEECSGG
T ss_pred             CCCCcCceeCHhH----cCCCcccCEEEccCCCccCccc
Confidence            9999998543211    1346788999999999999754

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=8.9e-39  Score=362.70  Aligned_cols=344  Identities=22%  Similarity=0.171  Sum_probs=243.0

Q ss_pred             CCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCC
Q 035691            3 TFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPN   82 (640)
Q Consensus         3 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~   82 (640)
                      ++|++|+|++|+|++..+..|.++++|++|+|++|.+++..|.+|.++++|++|+|++|+|+.      +|+..+..+++
T Consensus        25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~------l~~~~~~~l~~   98 (680)
T 1ziw_A           25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQ------LSDKTFAFCTN   98 (680)
T ss_dssp             TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCC------CCTTTTTTCTT
T ss_pred             CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCc------cChhhhccCCC
Confidence            357778888888877666677778888888888888777777777777888888887777765      77766666777


Q ss_pred             CCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccc-----------
Q 035691           83 IRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRF-----------  151 (640)
Q Consensus        83 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----------  151 (640)
                      |+.|+|++|+++++.|..|+++++|++|+|++|.+++..|..|.++++|++|+|++|.++.++...+..           
T Consensus        99 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L  178 (680)
T 1ziw_A           99 LTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLEL  178 (680)
T ss_dssp             CSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEEC
T ss_pred             CCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEEC
Confidence            777777777777777777777777777777777777777777777777777777777776653221110           


Q ss_pred             ---------cccccC---------------------------CCCcceEecCCCCCCCc-CcCCCCCC--CCCEEEccCC
Q 035691          152 ---------LDSLVN---------------------------CTYLEIVSLNVNSLRSI-PISVGYLP--KLQVLSLFEN  192 (640)
Q Consensus       152 ---------~~~l~~---------------------------l~~L~~L~L~~N~l~~i-p~~~~~l~--~L~~L~L~~N  192 (640)
                               +..+..                           .++|+.|++++|.++.+ |..+..++  +|++|+|++|
T Consensus       179 ~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n  258 (680)
T 1ziw_A          179 SSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYN  258 (680)
T ss_dssp             TTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTS
T ss_pred             CCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCC
Confidence                     001111                           13445555555555552 33444443  3888888888


Q ss_pred             cCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCcc-----------------ccCCCCCceEEccC
Q 035691          193 NISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTI-----------------FLGQYPVRWLDLSH  255 (640)
Q Consensus       193 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~-----------------~~~~~~l~~L~Ls~  255 (640)
                      .+++..|..|..+++|++|+|++|++.+..|.+|.++++|+.|++++|.                 |..+..|++|++++
T Consensus       259 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~  338 (680)
T 1ziw_A          259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMED  338 (680)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCS
T ss_pred             CcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCC
Confidence            8887777888888888888888888888888888888888888887652                 33456688899999


Q ss_pred             CcCCCCCCccCCCCCCCCEEECCCCcccC--cCCccccCC--CCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccc
Q 035691          256 NHLTGPIPLAVGNLKSIPHLDLSKNKLSG--EIPSSLGSC--VGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQ  331 (640)
Q Consensus       256 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  331 (640)
                      |++++..+..|.++++|++|++++|.++.  ..+..|..+  ++|+.|++++|++++..|..|..+++|++|++++|.+.
T Consensus       339 n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  418 (680)
T 1ziw_A          339 NDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIG  418 (680)
T ss_dssp             CCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCE
T ss_pred             CccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCc
Confidence            99998888888888888888888887532  222333332  46777777888887777777888888888888888776


Q ss_pred             cccCCcccCC--CCCCCCCccccccCCC
Q 035691          332 AKSQNGDVPR--KGIFKNASAISVAGNE  357 (640)
Q Consensus       332 ~~~~~~~~p~--~~~~~~~~~~~~~~n~  357 (640)
                           +.+|.  ...++++..+++++|.
T Consensus       419 -----~~~~~~~~~~l~~L~~L~Ls~n~  441 (680)
T 1ziw_A          419 -----QELTGQEWRGLENIFEIYLSYNK  441 (680)
T ss_dssp             -----EECCSGGGTTCTTCCEEECCSCS
T ss_pred             -----cccCcccccCcccccEEecCCCC
Confidence                 33331  1345566677777765

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=8.8e-39  Score=359.64  Aligned_cols=334  Identities=22%  Similarity=0.224  Sum_probs=276.9

Q ss_pred             CCCCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCC
Q 035691            1 NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTL   80 (640)
Q Consensus         1 nl~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l   80 (640)
                      +|++|++|||++|+|+++.|.+|.++++|++|+|++|+|++..+.+|.++++|++|+|++|+|+.      +|+..|..+
T Consensus        74 ~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~------l~~~~~~~L  147 (635)
T 4g8a_A           74 SFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS------LENFPIGHL  147 (635)
T ss_dssp             TCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCC------STTCCCTTC
T ss_pred             CCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCC------CChhhhhcC
Confidence            47899999999999998888999999999999999999998888899999999999999999986      888888889


Q ss_pred             CCCCeeeccCCccccc-CCccCcCCCCCCEEECcCCccCccCCccccCCCC-----------------------------
Q 035691           81 PNIRIPLLAGNQFFGN-IPHSISNASKLEWLDFANNSLTASIPEDLGRLRN-----------------------------  130 (640)
Q Consensus        81 ~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-----------------------------  130 (640)
                      ++|+.|+|++|++++. .|..++.+++|++|+|++|+|+++.+..|..+.+                             
T Consensus       148 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~  227 (635)
T 4g8a_A          148 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLH  227 (635)
T ss_dssp             TTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEE
T ss_pred             cccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhh
Confidence            9999999999999864 5788899999999999999998776655443222                             


Q ss_pred             --------------------------------------------------------------------------------
Q 035691          131 --------------------------------------------------------------------------------  130 (640)
Q Consensus       131 --------------------------------------------------------------------------------  130 (640)
                                                                                                      
T Consensus       228 ~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~  307 (635)
T 4g8a_A          228 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTN  307 (635)
T ss_dssp             EEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTT
T ss_pred             hhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcc
Confidence                                                                                            


Q ss_pred             ----------------------CCEEEcccCcCCCCCCCcccc-------------cccccCCCCcceEecCCCCCCC--
Q 035691          131 ----------------------LTRLNFARNDLGTRKVNDLRF-------------LDSLVNCTYLEIVSLNVNSLRS--  173 (640)
Q Consensus       131 ----------------------L~~L~L~~N~l~~~~~~~~~~-------------~~~l~~l~~L~~L~L~~N~l~~--  173 (640)
                                            |+.|++++|.+..++...+..             .....++++|+.|+++.|.+..  
T Consensus       308 l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~  387 (635)
T 4g8a_A          308 VSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKG  387 (635)
T ss_dssp             CSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEE
T ss_pred             cccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhcccccccc
Confidence                                  223333333332221111100             1122346777778877777643  


Q ss_pred             ------------------------cCcCCCCCCCCCEEEccCCcCcccCC-cCccCCCCCCEEEccCCCCCCCCCccccC
Q 035691          174 ------------------------IPISVGYLPKLQVLSLFENNISGEIP-SSLGNFTFLTELNLRGNSIRGSIPSALGN  228 (640)
Q Consensus       174 ------------------------ip~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  228 (640)
                                              ++..+..+++|+.++++.|.+....+ ..|..+++++.+++++|.+.+..+..+..
T Consensus       388 ~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~  467 (635)
T 4g8a_A          388 CCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG  467 (635)
T ss_dssp             ECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTT
T ss_pred             ccccchhhhhhhhhhhccccccccccccccccccccchhhhhcccccccccccccccccccccccccccccccccccccc
Confidence                                    23345667889999999887765544 56889999999999999999999999999


Q ss_pred             CCCccEEeccCccc---------cCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeE
Q 035691          229 CHQLQSLDLSKTIF---------LGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYL  299 (640)
Q Consensus       229 l~~L~~L~ls~n~~---------~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  299 (640)
                      +++|+.|++++|.+         ..+..|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|
T Consensus       468 ~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L  547 (635)
T 4g8a_A          468 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL  547 (635)
T ss_dssp             CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEE
T ss_pred             chhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEE
Confidence            99999999999853         345679999999999999999999999999999999999999999999999999999


Q ss_pred             EecCCccCCCCCccCCCC-CCCCeEeCcCCccccccCCcccC
Q 035691          300 NLSINSFHGPIHPGLSSL-KSLEGLDLFQNTFQAKSQNGDVP  340 (640)
Q Consensus       300 ~L~~N~l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~~~~~~p  340 (640)
                      ||++|+|++..|..|..+ ++|++|+|++|+|.|.|...+..
T Consensus       548 ~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~~~  589 (635)
T 4g8a_A          548 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFL  589 (635)
T ss_dssp             ECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGHHHH
T ss_pred             ECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcHHHH
Confidence            999999999999999998 68999999999999999765443

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.3e-38  Score=336.52  Aligned_cols=327  Identities=21%  Similarity=0.211  Sum_probs=265.6

Q ss_pred             CCCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCC
Q 035691            2 LTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLP   81 (640)
Q Consensus         2 l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~   81 (640)
                      +++++.|++++|.++...+..|..+++|++|++++|.+++..+..|..+++|++|+|++|+++.      +|+..+..++
T Consensus        44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~------~~~~~~~~l~  117 (390)
T 3o6n_A           44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY------LPPHVFQNVP  117 (390)
T ss_dssp             GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCC------CCTTTTTTCT
T ss_pred             cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCc------CCHHHhcCCC
Confidence            5789999999999997777778999999999999999998888899999999999999999986      7878778899


Q ss_pred             CCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCc
Q 035691           82 NIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYL  161 (640)
Q Consensus        82 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L  161 (640)
                      +|+.|+|++|+++.+.+..|.++++|++|+|++|++++..|..|..+++|++|+|++|+++.++         +..+++|
T Consensus       118 ~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---------~~~l~~L  188 (390)
T 3o6n_A          118 LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---------LSLIPSL  188 (390)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---------GGGCTTC
T ss_pred             CCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---------ccccccc
Confidence            9999999999999877777899999999999999999988899999999999999999998762         4556889


Q ss_pred             ceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCcc
Q 035691          162 EIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTI  241 (640)
Q Consensus       162 ~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~  241 (640)
                      +.|++++|.++.++.    .++|++|++++|.+... |..+  .++|+.|++++|.+++.  ..+..+++|+.|++++|.
T Consensus       189 ~~L~l~~n~l~~~~~----~~~L~~L~l~~n~l~~~-~~~~--~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~  259 (390)
T 3o6n_A          189 FHANVSYNLLSTLAI----PIAVEELDASHNSINVV-RGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNE  259 (390)
T ss_dssp             SEEECCSSCCSEEEC----CSSCSEEECCSSCCCEE-ECCC--CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSC
T ss_pred             ceeecccccccccCC----CCcceEEECCCCeeeec-cccc--cccccEEECCCCCCccc--HHHcCCCCccEEECCCCc
Confidence            999999999887542    35789999999999855 3332  47899999999999854  578889999999888776


Q ss_pred             cc--------CCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCcc
Q 035691          242 FL--------GQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPG  313 (640)
Q Consensus       242 ~~--------~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~  313 (640)
                      +.        .+..|+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|++|+|++|+++...   
T Consensus       260 l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~---  334 (390)
T 3o6n_A          260 LEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---  334 (390)
T ss_dssp             CCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---
T ss_pred             CCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC---
Confidence            54        33457778888888874 5566677888888888888887 56666777888888888888887542   


Q ss_pred             CCCCCCCCeEeCcCCccccccCCcccCCCCCCCCCccccccCCCCCcCCC
Q 035691          314 LSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGI  363 (640)
Q Consensus       314 ~~~l~~L~~L~l~~N~l~~~~~~~~~p~~~~~~~~~~~~~~~n~~~c~~~  363 (640)
                      +..+++|++|++++|+|.|.+.....      ..+....+.+++..|..+
T Consensus       335 ~~~~~~L~~L~l~~N~~~~~~~~~~~------~~~~~~~~~~~~~~c~~~  378 (390)
T 3o6n_A          335 LSTHHTLKNLTLSHNDWDCNSLRALF------RNVARPAVDDADQHCKID  378 (390)
T ss_dssp             CCTTCCCSEEECCSSCEEHHHHHHHT------TTCCTTTBCCCCSCCCTT
T ss_pred             chhhccCCEEEcCCCCccchhHHHHH------HHHHhhcccccCceeccc
Confidence            66778888888888888876543322      233334455666666543

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=1.7e-38  Score=353.93  Aligned_cols=330  Identities=21%  Similarity=0.210  Sum_probs=276.7

Q ss_pred             CCCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCC
Q 035691            2 LTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLP   81 (640)
Q Consensus         2 l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~   81 (640)
                      +++++.|++++|.+....+..|..+++|++|+|++|.|++..|..|..+++|++|+|++|.|+.      +|+..+..++
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~------~~~~~~~~l~  123 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY------LPPHVFQNVP  123 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCC------CCTTTTTTCT
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCC------CCHHHHcCCC
Confidence            5788999999999998777889999999999999999998888899999999999999999886      8888888899


Q ss_pred             CCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCc
Q 035691           82 NIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYL  161 (640)
Q Consensus        82 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L  161 (640)
                      +|+.|+|++|.|+++.+..|+++++|++|+|++|.|++..|..|.++++|++|+|++|.++.++         +..+++|
T Consensus       124 ~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---------~~~l~~L  194 (597)
T 3oja_B          124 LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---------LSLIPSL  194 (597)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---------GGGCTTC
T ss_pred             CCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---------hhhhhhh
Confidence            9999999999999888888999999999999999999999999999999999999999998763         4456789


Q ss_pred             ceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCcc
Q 035691          162 EIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTI  241 (640)
Q Consensus       162 ~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~  241 (640)
                      +.|++++|.++.++    ..++|+.|++++|.+....+. +  .++|+.|+|++|.+++  +..+..+++|+.|+|++|.
T Consensus       195 ~~L~l~~n~l~~l~----~~~~L~~L~ls~n~l~~~~~~-~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~  265 (597)
T 3oja_B          195 FHANVSYNLLSTLA----IPIAVEELDASHNSINVVRGP-V--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNE  265 (597)
T ss_dssp             SEEECCSSCCSEEE----CCTTCSEEECCSSCCCEEECS-C--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSC
T ss_pred             hhhhcccCcccccc----CCchhheeeccCCcccccccc-c--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCc
Confidence            99999999888754    235789999999998854433 3  2689999999999885  3678889999999888886


Q ss_pred             ccC--------CCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCcc
Q 035691          242 FLG--------QYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPG  313 (640)
Q Consensus       242 ~~~--------~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~  313 (640)
                      +.+        +..|+.|+|++|.+++ +|..+..+++|+.|+|++|+++ .+|..+..+++|++|+|++|++++..   
T Consensus       266 l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---  340 (597)
T 3oja_B          266 LEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---  340 (597)
T ss_dssp             CCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---
T ss_pred             cCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---
Confidence            543        4457888999999985 5677788999999999999998 67778888999999999999998653   


Q ss_pred             CCCCCCCCeEeCcCCccccccCCcccCCCCCCCCCccccccCCCCCcCCCcCC
Q 035691          314 LSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGISEL  366 (640)
Q Consensus       314 ~~~l~~L~~L~l~~N~l~~~~~~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~~  366 (640)
                      +..+++|+.|++++|+|.|.+...+      +..+....+.+++..|+.+...
T Consensus       341 ~~~~~~L~~L~l~~N~~~~~~~~~~------~~~~~~~~~~~~~~~C~~~~~~  387 (597)
T 3oja_B          341 LSTHHTLKNLTLSHNDWDCNSLRAL------FRNVARPAVDDADQHCKIDYQL  387 (597)
T ss_dssp             CCTTCCCSEEECCSSCEEHHHHHHH------TTTCCTTTBCCCCCCCCTTCEE
T ss_pred             hhhcCCCCEEEeeCCCCCChhHHHH------HHHHhhhccccccccCCcchhc
Confidence            6778899999999999987664332      3334444567777888765443

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=2.3e-38  Score=350.19  Aligned_cols=323  Identities=20%  Similarity=0.185  Sum_probs=243.1

Q ss_pred             CCCCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCC
Q 035691            1 NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTL   80 (640)
Q Consensus         1 nl~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l   80 (640)
                      ++++|++|+|++|+|++..|.+|.++++|++|+|++|++++..|..|.++++|++|||++|+++...    +|. .+..+
T Consensus        48 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~----~~~-~~~~l  122 (549)
T 2z81_A           48 ACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLG----VTS-LFPNL  122 (549)
T ss_dssp             SCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSC----SSC-SCTTC
T ss_pred             cCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccc----hhh-hhhcc
Confidence            4678899999999998888888999999999999999998777777888999999999988876411    122 23346


Q ss_pred             CCCCeeeccCCc-ccccCCccCcCCCCCCEEECcCCccCccCCcccc------------------------CCCCCCEEE
Q 035691           81 PNIRIPLLAGNQ-FFGNIPHSISNASKLEWLDFANNSLTASIPEDLG------------------------RLRNLTRLN  135 (640)
Q Consensus        81 ~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~------------------------~l~~L~~L~  135 (640)
                      ++|+.|+|++|+ +....+..|.++++|++|++++|++++..|..|.                        .+++|++|+
T Consensus       123 ~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~  202 (549)
T 2z81_A          123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLE  202 (549)
T ss_dssp             TTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEE
T ss_pred             CCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEE
Confidence            666666666666 3333345666666666666666666665555543                        356777777


Q ss_pred             cccCcCCCCCCCccc-----------------------------------------------------------------
Q 035691          136 FARNDLGTRKVNDLR-----------------------------------------------------------------  150 (640)
Q Consensus       136 L~~N~l~~~~~~~~~-----------------------------------------------------------------  150 (640)
                      |++|++++.+.....                                                                 
T Consensus       203 L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~  282 (549)
T 2z81_A          203 LRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGK  282 (549)
T ss_dssp             EESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTT
T ss_pred             ccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcc
Confidence            777777664210000                                                                 


Q ss_pred             ------------------------------------------ccccc-cCCCCcceEecCCCCCCC-cC---cCCCCCCC
Q 035691          151 ------------------------------------------FLDSL-VNCTYLEIVSLNVNSLRS-IP---ISVGYLPK  183 (640)
Q Consensus       151 ------------------------------------------~~~~l-~~l~~L~~L~L~~N~l~~-ip---~~~~~l~~  183 (640)
                                                                .+..+ .++++|++|++++|+++. +|   ..+..+++
T Consensus       283 L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~  362 (549)
T 2z81_A          283 VETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPS  362 (549)
T ss_dssp             CCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTT
T ss_pred             cccccccccccchhhhcccchhhhhhcccceEEEeccCccccCCHHHHhcCccccEEEccCCccccccccchhhhhcccc
Confidence                                                      01111 346778888888888876 33   23567788


Q ss_pred             CCEEEccCCcCcccCC--cCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCC-----CCCceEEccCC
Q 035691          184 LQVLSLFENNISGEIP--SSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQ-----YPVRWLDLSHN  256 (640)
Q Consensus       184 L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~-----~~l~~L~Ls~N  256 (640)
                      |++|+|++|.+++..+  ..+..+++|++|+|++|+++ .+|..+..+++|+.|++++|.+...     ..|++|+|++|
T Consensus       363 L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~~~~L~~L~Ls~N  441 (549)
T 2z81_A          363 LQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNN  441 (549)
T ss_dssp             CCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCCCTTSCTTCSEEECCSS
T ss_pred             CcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcccccchhcCCceEEECCCC
Confidence            8888888888875433  45788888888888888888 5677888888899999998887643     35889999999


Q ss_pred             cCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccC
Q 035691          257 HLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQ  335 (640)
Q Consensus       257 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  335 (640)
                      +|++.+    ..+++|++|+|++|+|+ .+|. ...+++|++|+|++|++++.+|..|..+++|++|++++|+|.|.+.
T Consensus       442 ~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  514 (549)
T 2z81_A          442 NLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  514 (549)
T ss_dssp             CCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred             Chhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence            998643    57899999999999999 6676 5678999999999999999999999999999999999999997664

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8.5e-40  Score=333.81  Aligned_cols=179  Identities=22%  Similarity=0.333  Sum_probs=148.8

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++....  ....+.+.+|+++|++++|||||++++++     .+++..
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-----~~~~~~   98 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-----EENGSL   98 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-----EECCEE
Confidence            57899999999999999999999999999999996543  34467899999999999999999999995     455689


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      |+|||||+||+|.+++...+.        ..+++..+..|+.||+.||+|||+   ++|+||||||+|||++.++.+||+
T Consensus        99 yiVmEy~~gg~L~~~i~~~~~--------~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~  167 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINAQKG--------VLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLG  167 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHTTT--------CCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEEC
T ss_pred             EEEEeCCCCCcHHHHHHHcCC--------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEc
Confidence            999999999999999964432        237888999999999999999999   799999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |||+|+.+...    .....+.+||+.|||||++.+..|+.
T Consensus       168 DFGla~~~~~~----~~~~~~~~GT~~YmAPE~l~~~~y~~  204 (350)
T 4b9d_A          168 DFGIARVLNST----VELARACIGTPYYLSPEICENKPYNN  204 (350)
T ss_dssp             STTEESCCCHH----HHHHHHHHSCCTTCCHHHHTTCCCCH
T ss_pred             ccccceeecCC----cccccccCCCccccCHHHHCCCCCCc
Confidence            99999976421    11223467999999999999988874

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1e-39  Score=332.61  Aligned_cols=177  Identities=24%  Similarity=0.318  Sum_probs=155.1

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      +.|+..+.||+|+||+||+|+++.+|+.||||+++.......+.+.+|+++|++++|||||++++++     .+++..|+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEE
Confidence            4588889999999999999999999999999999776666667789999999999999999999995     44568999


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      |||||+||+|.+++...           .+++..+..++.||+.||+|||+   .+|+||||||+|||++.+|.+||+||
T Consensus       149 vmEy~~gg~L~~~l~~~-----------~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DF  214 (346)
T 4fih_A          149 VMEFLEGGALTDIVTHT-----------RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDF  214 (346)
T ss_dssp             EECCCTTEEHHHHHHHS-----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCC
T ss_pred             EEeCCCCCcHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecC
Confidence            99999999999998632           27889999999999999999999   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |+|+.+....    ....+.+||+.|||||++.+..|+.+
T Consensus       215 Gla~~~~~~~----~~~~~~~GTp~YmAPEvl~~~~y~~~  250 (346)
T 4fih_A          215 GFCAQVSKEV----PRRKSLVGTPYWMAPELISRLPYGPE  250 (346)
T ss_dssp             TTCEECCSSS----CCBCCCCSCGGGCCHHHHTTCCBCTH
T ss_pred             cCceecCCCC----CcccccccCcCcCCHHHHCCCCCCcH
Confidence            9998764321    12334689999999999999888753

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.5e-38  Score=349.44  Aligned_cols=156  Identities=24%  Similarity=0.269  Sum_probs=138.2

Q ss_pred             CcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCC
Q 035691            5 LMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIR   84 (640)
Q Consensus         5 L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~   84 (640)
                      .+.++.++.+++ .+|..+.  +++++|+|++|.++++.+.+|.++++|++|||++|+|+.      +++..|..+++|+
T Consensus         9 ~~~~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~------i~~~~~~~l~~L~   79 (570)
T 2z63_A            9 NITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT------IEDGAYQSLSHLS   79 (570)
T ss_dssp             TTEEECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCE------ECTTTTTTCTTCC
T ss_pred             CcEEEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCc------cCcccccCchhCC
Confidence            456888888888 6776553  579999999999998889999999999999999999875      8888888899999


Q ss_pred             eeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceE
Q 035691           85 IPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIV  164 (640)
Q Consensus        85 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L  164 (640)
                      .|+|++|++++..|..|.++++|++|++++|++++..+..|+++++|++|+|++|.++.+.     .+..+.++++|++|
T Consensus        80 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~-----lp~~~~~l~~L~~L  154 (570)
T 2z63_A           80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK-----LPEYFSNLTNLEHL  154 (570)
T ss_dssp             EEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCC-----CCGGGGGCTTCCEE
T ss_pred             EEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceec-----ChhhhcccCCCCEE
Confidence            9999999999999999999999999999999999877778999999999999999998753     35678888889999


Q ss_pred             ecCCCCCCCc
Q 035691          165 SLNVNSLRSI  174 (640)
Q Consensus       165 ~L~~N~l~~i  174 (640)
                      ++++|.++.+
T Consensus       155 ~l~~n~l~~~  164 (570)
T 2z63_A          155 DLSSNKIQSI  164 (570)
T ss_dssp             ECTTSCCCEE
T ss_pred             eCcCCcccee
Confidence            9888887764

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=9.2e-38  Score=361.75  Aligned_cols=277  Identities=22%  Similarity=0.169  Sum_probs=213.7

Q ss_pred             CCCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCcc-CCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCC
Q 035691            2 LTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQ-IPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTL   80 (640)
Q Consensus         2 l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l   80 (640)
                      .++|+.|||++|.|++..|..|.++++|++|+|++|.+.+. .|.+|.++++|++|+|++|.|+.      +++..+..+
T Consensus        23 p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~------~~p~~~~~l   96 (844)
T 3j0a_A           23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYF------LHPDAFQGL   96 (844)
T ss_dssp             CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCE------ECTTSSCSC
T ss_pred             CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcc------cCHhHccCC
Confidence            46899999999999999999999999999999999965544 48899999999999999999875      666677789


Q ss_pred             CCCCeeeccCCcccccCCcc--CcCCCCCCEEECcCCccCccCC-ccccCCCCCCEEEcccCcCCCCCCCccccc-----
Q 035691           81 PNIRIPLLAGNQFFGNIPHS--ISNASKLEWLDFANNSLTASIP-EDLGRLRNLTRLNFARNDLGTRKVNDLRFL-----  152 (640)
Q Consensus        81 ~~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~-----  152 (640)
                      ++|+.|+|++|.+++..|..  |.++++|++|||++|.+++..+ ..|+++++|++|+|++|.++......+...     
T Consensus        97 ~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L  176 (844)
T 3j0a_A           97 FHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTL  176 (844)
T ss_dssp             SSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSS
T ss_pred             cccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCcc
Confidence            99999999999999866655  9999999999999999998765 579999999999999999987644332211     


Q ss_pred             ---------------ccccCCCC------cceEecCCCCCCC-cCcCC--------------------------------
Q 035691          153 ---------------DSLVNCTY------LEIVSLNVNSLRS-IPISV--------------------------------  178 (640)
Q Consensus       153 ---------------~~l~~l~~------L~~L~L~~N~l~~-ip~~~--------------------------------  178 (640)
                                     ..+..+.+      |+.|++++|.++. +|..+                                
T Consensus       177 ~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~  256 (844)
T 3j0a_A          177 SFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPD  256 (844)
T ss_dssp             CCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGG
T ss_pred             ceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCC
Confidence                           11122222      6677777775543 22111                                


Q ss_pred             ----CC--CCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccC--------
Q 035691          179 ----GY--LPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLG--------  244 (640)
Q Consensus       179 ----~~--l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~--------  244 (640)
                          ..  .++|+.|+|++|.+.+..|..|..+++|+.|+|++|++++..|.+|.++++|+.|++++|.+.+        
T Consensus       257 ~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  336 (844)
T 3j0a_A          257 QNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYG  336 (844)
T ss_dssp             GTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSS
T ss_pred             hhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcC
Confidence                11  2567777777777777777777777777888887777777777777777778888777776543        


Q ss_pred             CCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccC
Q 035691          245 QYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSG  284 (640)
Q Consensus       245 ~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  284 (640)
                      +..|++|++++|++++..+..|.++++|+.|+|++|.+++
T Consensus       337 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~  376 (844)
T 3j0a_A          337 LPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT  376 (844)
T ss_dssp             CTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC
T ss_pred             CCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc
Confidence            3347777787777777777777777777777777777763

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.3e-38  Score=345.57  Aligned_cols=315  Identities=18%  Similarity=0.179  Sum_probs=256.4

Q ss_pred             CCCCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCC
Q 035691            1 NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTL   80 (640)
Q Consensus         1 nl~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l   80 (640)
                      ++++|++|+|++|+|++..|..|.++++|++|+|++|+|+ .+|..  .+++|++|||++|+|+..    .+|. .+..+
T Consensus        43 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l~~~----~~p~-~~~~l  114 (520)
T 2z7x_B           43 SLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDAL----PICK-EFGNM  114 (520)
T ss_dssp             TCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSSCCSSC----CCCG-GGGGC
T ss_pred             ccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccCCccccc----cchh-hhccC
Confidence            4789999999999999988999999999999999999999 45554  899999999999998751    1344 44569


Q ss_pred             CCCCeeeccCCcccccCCccCcCCCCC--CEEECcCCcc--CccCCccccCCC---------------------------
Q 035691           81 PNIRIPLLAGNQFFGNIPHSISNASKL--EWLDFANNSL--TASIPEDLGRLR---------------------------  129 (640)
Q Consensus        81 ~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~Ls~N~l--~~~~~~~~~~l~---------------------------  129 (640)
                      ++|+.|+|++|+|++   ..|..+++|  ++|+|++|++  ++..|..|..+.                           
T Consensus       115 ~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~  191 (520)
T 2z7x_B          115 SQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVAN  191 (520)
T ss_dssp             TTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSE
T ss_pred             CcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccc
Confidence            999999999999986   456677777  8899988888  666666655533                           


Q ss_pred             --------------------------------------------------------CCCEEEcccCcCCCCCCCcccccc
Q 035691          130 --------------------------------------------------------NLTRLNFARNDLGTRKVNDLRFLD  153 (640)
Q Consensus       130 --------------------------------------------------------~L~~L~L~~N~l~~~~~~~~~~~~  153 (640)
                                                                              +|++|++++|++++.      .+.
T Consensus       192 L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~------~p~  265 (520)
T 2z7x_B          192 LELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQ------LDF  265 (520)
T ss_dssp             EEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESC------CCC
T ss_pred             eeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCc------ccc
Confidence                                                                    566666677766632      222


Q ss_pred             cc-----cCCCCc--------------------------ceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCc
Q 035691          154 SL-----VNCTYL--------------------------EIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSL  202 (640)
Q Consensus       154 ~l-----~~l~~L--------------------------~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~  202 (640)
                      .+     .++++|                          +.|++++|.+..++. ...+++|++|++++|.+++..|..+
T Consensus       266 ~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~Ls~n~l~~~~~~~~  344 (520)
T 2z7x_B          266 RDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLC-PSKISPFLHLDFSNNLLTDTVFENC  344 (520)
T ss_dssp             CCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCC-CSSCCCCCEEECCSSCCCTTTTTTC
T ss_pred             chhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccc-hhhCCcccEEEeECCccChhhhhhh
Confidence            22     444444                          445555554444321 2578999999999999999899999


Q ss_pred             cCCCCCCEEEccCCCCCC--CCCccccCCCCccEEeccCccccC---------CCCCceEEccCCcCCCCCCccCCCCCC
Q 035691          203 GNFTFLTELNLRGNSIRG--SIPSALGNCHQLQSLDLSKTIFLG---------QYPVRWLDLSHNHLTGPIPLAVGNLKS  271 (640)
Q Consensus       203 ~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~ls~n~~~~---------~~~l~~L~Ls~N~l~~~~~~~~~~l~~  271 (640)
                      ..+++|++|+|++|++++  .+|..|..+++|+.|++++|.+.+         +..|++|++++|++++..|..+.  ++
T Consensus       345 ~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~  422 (520)
T 2z7x_B          345 GHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PR  422 (520)
T ss_dssp             CCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TT
T ss_pred             ccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--cc
Confidence            999999999999999997  456789999999999999998765         24589999999999988887765  79


Q ss_pred             CCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCC
Q 035691          272 IPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQN  336 (640)
Q Consensus       272 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  336 (640)
                      |+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|++|++++|+++|.|..
T Consensus       423 L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~  486 (520)
T 2z7x_B          423 IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  486 (520)
T ss_dssp             CCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             CCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCCc
Confidence            999999999999 7888888999999999999999965555699999999999999999987754

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=9.3e-40  Score=327.98  Aligned_cols=179  Identities=25%  Similarity=0.382  Sum_probs=155.1

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++...   +....+.+.+|+++|++++|||||+++++     +++++.
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~-----~~~~~~  106 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDEK  106 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE-----EECSSE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE-----EEeCCE
Confidence            4589999999999999999999999999999999643   33455789999999999999999999999     455668


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .|+|||||+||+|.+++...+          .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||
T Consensus       107 ~yivmEy~~gG~L~~~i~~~~----------~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl  173 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRKIG----------SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQI  173 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEE
T ss_pred             EEEEEecCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEE
Confidence            999999999999999996533          38899999999999999999999   79999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|||+|+.+.....  .....+.+||+.|||||++.+..++.
T Consensus       174 ~DFGla~~~~~~~~--~~~~~~~~GTp~YmAPEvl~~~~y~~  213 (311)
T 4aw0_A          174 TDFGTAKVLSPESK--QARANSFVGTAQYVSPELLTEKSACK  213 (311)
T ss_dssp             CCCTTCEECCTTTT--CCCBCCCCSCGGGCCHHHHHHSCBCH
T ss_pred             EEcCCceecCCCCC--cccccCcccCcccCCHHHHcCCCCCc
Confidence            99999997643221  22234568999999999998887764

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.7e-39  Score=334.73  Aligned_cols=177  Identities=24%  Similarity=0.318  Sum_probs=155.5

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      +.|+..+.||+|+||+||+|+++.+|+.||||++........+.+.+|+.+|+.++|||||++++++     .+++..|+
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EECCEEEE
Confidence            4688999999999999999999999999999999776666667899999999999999999999995     44568999


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      |||||+||+|.+++...           .+++..+..|+.||+.||+|||+   .+||||||||+|||++.+|.+||+||
T Consensus       226 VmEy~~gG~L~~~i~~~-----------~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DF  291 (423)
T 4fie_A          226 VMEFLEGGALTDIVTHT-----------RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDF  291 (423)
T ss_dssp             EEECCTTEEHHHHHHHS-----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCC
T ss_pred             EEeCCCCCcHHHHHhcc-----------CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecC
Confidence            99999999999998532           27889999999999999999999   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |+|+.+....    ....+.+||+.|||||++.+..|+.+
T Consensus       292 Gla~~~~~~~----~~~~~~~GTp~YmAPEvl~~~~y~~~  327 (423)
T 4fie_A          292 GFCAQVSKEV----PRRKSLVGTPYWMAPELISRLPYGPE  327 (423)
T ss_dssp             TTCEECCSSC----CCBCCCEECTTTCCHHHHTTCCBCTH
T ss_pred             ccceECCCCC----ccccccccCcCcCCHHHHCCCCCCcH
Confidence            9998764321    12335679999999999999888753

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=325.00  Aligned_cols=190  Identities=26%  Similarity=0.411  Sum_probs=147.4

Q ss_pred             CCCcccCcccccccceEEEEEEC-----CCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILD-----PDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      ++|.+.+.||+|+||+||+|+++     .+++.||||+++.......++|.+|+++|++++|||||+++|+|..     .
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~  115 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-----G  115 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----C
Confidence            34567789999999999999875     3688999999977666677899999999999999999999999743     3


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCC-----CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDD-----LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD  590 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~-----~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~  590 (640)
                      ...++|||||++|+|.++++.......     .......++|.+++.|+.||+.||+|||+   ++|+||||||+|||++
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVG  192 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEEC
Confidence            478999999999999999976433211     11122458999999999999999999999   6999999999999999


Q ss_pred             CCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          591 NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       591 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +++.+||+|||+|+.......  .......+||+.|||||++.+..+|.|
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~--~~~~~~~~gt~~ymAPE~~~~~~~~~~  240 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDY--YRVGGRTMLPIRWMPPESILYRKFTTE  240 (329)
T ss_dssp             TTTEEEECCCC------------------CCCCGGGCCHHHHTTCCCCHH
T ss_pred             CCCcEEEcccccceeccCCCc--ceecCcccccccccChhhhcCCCCCcc
Confidence            999999999999986643211  112234579999999999999988753

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=8.8e-37  Score=330.13  Aligned_cols=319  Identities=24%  Similarity=0.306  Sum_probs=209.0

Q ss_pred             CCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCC
Q 035691            3 TFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPN   82 (640)
Q Consensus         3 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~   82 (640)
                      ++|+.|++++|.+.. +| .+..+++|++|+|++|.+++..+  |..+++|++|++++|+++.      +++  +..+++
T Consensus        46 ~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~------~~~--~~~l~~  113 (466)
T 1o6v_A           46 DQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD------ITP--LANLTN  113 (466)
T ss_dssp             HTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC------CGG--GTTCTT
T ss_pred             ccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCcccc------Chh--hcCCCC
Confidence            345555555555552 33 25555555555555555553332  5555555555555555543      332  334555


Q ss_pred             CCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCC-------------------ccccCCCCCCEEEcccCcCCC
Q 035691           83 IRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIP-------------------EDLGRLRNLTRLNFARNDLGT  143 (640)
Q Consensus        83 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-------------------~~~~~l~~L~~L~L~~N~l~~  143 (640)
                      |+.|+|++|++++..+  |.++++|++|++++|.+++..+                   ..+..+++|++|++++|.++.
T Consensus       114 L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~  191 (466)
T 1o6v_A          114 LTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD  191 (466)
T ss_dssp             CCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCC
T ss_pred             CCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCC
Confidence            5555555555554322  5555555555555555543211                   126667777777777777765


Q ss_pred             CCCCcccccccccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCC
Q 035691          144 RKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIP  223 (640)
Q Consensus       144 ~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~  223 (640)
                      +        ..+..+++|+.|++++|.++.++. +..+++|++|++++|.+++.  ..+..+++|++|++++|.+.+..+
T Consensus       192 ~--------~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~  260 (466)
T 1o6v_A          192 I--------SVLAKLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP  260 (466)
T ss_dssp             C--------GGGGGCTTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred             C--------hhhccCCCCCEEEecCCccccccc-ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh
Confidence            4        236677778888888888777554 55677788888888887743  357777888888888888876554


Q ss_pred             ccccCCCCccEEeccCccccC------CCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCC
Q 035691          224 SALGNCHQLQSLDLSKTIFLG------QYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLE  297 (640)
Q Consensus       224 ~~~~~l~~L~~L~ls~n~~~~------~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  297 (640)
                        +..+++|+.|++++|.+.+      +..|+.|++++|++++..+  +..+++|+.|+|++|++++..|  +..+++|+
T Consensus       261 --~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~  334 (466)
T 1o6v_A          261 --LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQ  334 (466)
T ss_dssp             --GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCC
T ss_pred             --hhcCCCCCEEECCCCccCccccccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCC
Confidence              7778888888888876544      3457888888888876544  7778888888888888886655  67788888


Q ss_pred             eEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCcccCCCCCCCCCccccccCCCCCc
Q 035691          298 YLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLC  360 (640)
Q Consensus       298 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~p~~~~~~~~~~~~~~~n~~~c  360 (640)
                      +|++++|++++.  ..+..+++|++|++++|+++     +..| ...++.+..+++.+|++..
T Consensus       335 ~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~-----~~~~-~~~l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          335 RLFFYNNKVSDV--SSLANLTNINWLSAGHNQIS-----DLTP-LANLTRITQLGLNDQAWTN  389 (466)
T ss_dssp             EEECCSSCCCCC--GGGTTCTTCCEEECCSSCCC-----BCGG-GTTCTTCCEEECCCEEEEC
T ss_pred             EeECCCCccCCc--hhhccCCCCCEEeCCCCccC-----ccch-hhcCCCCCEEeccCCcccC
Confidence            888888888764  46778888888888888887     3344 4556677788888887654

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=1.3e-36  Score=315.98  Aligned_cols=298  Identities=23%  Similarity=0.324  Sum_probs=231.9

Q ss_pred             CCCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCC
Q 035691            2 LTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLP   81 (640)
Q Consensus         2 l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~   81 (640)
                      +++|+.|++++|.+.. +| .+..+++|++|++++|++++..+  |..+++|++|+|++|+++.      +|  .+..++
T Consensus        43 l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~------~~--~~~~l~  110 (347)
T 4fmz_A           43 LESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD------IS--ALQNLT  110 (347)
T ss_dssp             HTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC------CG--GGTTCT
T ss_pred             cccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC------ch--HHcCCC
Confidence            5678999999999984 44 48899999999999999985544  8899999999999998875      44  255689


Q ss_pred             CCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCc
Q 035691           82 NIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYL  161 (640)
Q Consensus        82 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L  161 (640)
                      +|+.|+|++|++++..+  +..+++|++|++++|...... ..+..+++|++|++++|.+...+        .+..+++|
T Consensus       111 ~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~--------~~~~l~~L  179 (347)
T 4fmz_A          111 NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVT--------PIANLTDL  179 (347)
T ss_dssp             TCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCG--------GGGGCTTC
T ss_pred             cCCEEECcCCcccCchh--hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCch--------hhccCCCC
Confidence            99999999999986544  888999999999999666444 44889999999999999988762        27788999


Q ss_pred             ceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCcc
Q 035691          162 EIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTI  241 (640)
Q Consensus       162 ~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~  241 (640)
                      +.|++++|.++.++. +..+++|++|++++|.+.+..+  +..+++|++|++++|++++..+  +..+++|+.|++++|.
T Consensus       180 ~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~  254 (347)
T 4fmz_A          180 YSLSLNYNQIEDISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQ  254 (347)
T ss_dssp             SEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             CEEEccCCccccccc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCc
Confidence            999999999998876 7778999999999999986544  8889999999999999986544  8888999999777775


Q ss_pred             ccC------CCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCC
Q 035691          242 FLG------QYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLS  315 (640)
Q Consensus       242 ~~~------~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~  315 (640)
                      +.+      ...|++|++++|++++.  ..+..+++|+.|++++|++++..|..|..+++|++|+|++|++++..|  +.
T Consensus       255 l~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~  330 (347)
T 4fmz_A          255 ISDINAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LA  330 (347)
T ss_dssp             CCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GG
T ss_pred             cCCChhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hh
Confidence            433      34467777777777653  346667777777777777776666667777777777777777766544  66


Q ss_pred             CCCCCCeEeCcCCccc
Q 035691          316 SLKSLEGLDLFQNTFQ  331 (640)
Q Consensus       316 ~l~~L~~L~l~~N~l~  331 (640)
                      .+++|++|++++|+++
T Consensus       331 ~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          331 SLSKMDSADFANQVIK  346 (347)
T ss_dssp             GCTTCSEESSSCC---
T ss_pred             hhhccceeehhhhccc
Confidence            6777777777777664

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.5e-39  Score=323.30  Aligned_cols=190  Identities=28%  Similarity=0.432  Sum_probs=151.9

Q ss_pred             CCCcccCcccccccceEEEEEEC-----CCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILD-----PDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      ++|.+.+.||+|+||+||+|++.     .+++.||||+++.......++|.+|+++|++++|||||+++|+|..     +
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~   87 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-----G   87 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----C
Confidence            45678899999999999999875     3688999999976666667889999999999999999999999743     3


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCC---CCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASD---DLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND  592 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~  592 (640)
                      +..++|||||++|+|.++++..+...   .....+..++|.++..|+.||+.||+|||+   ++|+||||||+|||++++
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCC
Confidence            47899999999999999996532100   001112458999999999999999999999   699999999999999999


Q ss_pred             CcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          593 MIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       593 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +.+||+|||+|+.......  ........||+.|||||++.+.++|.|
T Consensus       165 ~~~Ki~DFGla~~~~~~~~--~~~~~~~~gt~~ymAPE~~~~~~~~~k  210 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTE  210 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGC--EEETTTEEECGGGCCHHHHHHCCCCHH
T ss_pred             CcEEECCcccceecCCCCc--eeecCceecChhhcCHHHHcCCCCCch
Confidence            9999999999986543211  122233468999999999999888753

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3e-38  Score=318.45  Aligned_cols=189  Identities=26%  Similarity=0.409  Sum_probs=145.2

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc-------C
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDF-------Q  513 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-------~  513 (640)
                      +|++.+.||+|+||+||+|+++.+|+.||||+++... ....+.+.+|+++|++++|||||++++++...+.       .
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            5888999999999999999999999999999996544 3345789999999999999999999999754321       1


Q ss_pred             CCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC
Q 035691          514 GNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM  593 (640)
Q Consensus       514 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~  593 (640)
                      ...+.|+|||||++|+|.+++......       ...++..++.|+.|++.||+|||+   ++|+||||||+|||++.++
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~-------~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~  155 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCTI-------EERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDD  155 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCSG-------GGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCCC-------ChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCC
Confidence            233579999999999999999754432       235667788999999999999999   6999999999999999999


Q ss_pred             cEEEccccccccCCCccCCC--------ceeeccccccccccCcccCCCCCCCCC
Q 035691          594 IAHVGDFGLTRFIPEVISSN--------QCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       594 ~~kl~DfGla~~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      .+||+|||+|+.+.......        .....+.+||+.|||||++.+..++.|
T Consensus       156 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~  210 (299)
T 4g31_A          156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK  210 (299)
T ss_dssp             CEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTH
T ss_pred             cEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCH
Confidence            99999999999764322111        112234679999999999999988763

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.1e-38  Score=314.60  Aligned_cols=177  Identities=26%  Similarity=0.394  Sum_probs=146.3

Q ss_pred             cccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEE
Q 035691          444 SSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALV  521 (640)
Q Consensus       444 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv  521 (640)
                      .+.+.||+|+||+||+|+++.+++.||+|++...  .....+.|.+|+++|++++|||||+++++|... ...+...++|
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~~~~~~lv  107 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-ETTEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec-cCCCcEEEEE
Confidence            5567899999999999999999999999999643  234457899999999999999999999997442 1234568999


Q ss_pred             eeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC-CCcEEEccc
Q 035691          522 YEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN-DMIAHVGDF  600 (640)
Q Consensus       522 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~-~~~~kl~Df  600 (640)
                      ||||++|+|.+++....          .+++..+..|+.||+.||+|||+. .++|+||||||+|||++. ++.+||+||
T Consensus       108 mEy~~gg~L~~~l~~~~----------~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DF  176 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFK----------VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             EECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred             EeCCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeC
Confidence            99999999999996532          388999999999999999999983 123999999999999984 799999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|+.....      ...+.+||+.|||||++.+ +++.
T Consensus       177 Gla~~~~~~------~~~~~~GTp~YmAPE~~~~-~y~~  208 (290)
T 3fpq_A          177 GLATLKRAS------FAKAVIGTPEFMAPEMYEE-KYDE  208 (290)
T ss_dssp             TGGGGCCTT------SBEESCSSCCCCCGGGGGT-CCCT
T ss_pred             cCCEeCCCC------ccCCcccCccccCHHHcCC-CCCc
Confidence            999854321      2234689999999999865 5665

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.3e-38  Score=310.97  Aligned_cols=174  Identities=28%  Similarity=0.407  Sum_probs=138.4

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++...   .....+.+.+|+++|++++|||||++++++     .+++.
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~   87 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKDE   87 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECCE
Confidence            6899999999999999999999999999999999643   233456799999999999999999999994     45568


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .|+||||| +|+|.+++....          .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||
T Consensus        88 ~~ivmEy~-~g~L~~~l~~~~----------~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl  153 (275)
T 3hyh_A           88 IIMVIEYA-GNELFDYIVQRD----------KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKI  153 (275)
T ss_dssp             EEEEEECC-CEEHHHHHHHSC----------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEE
T ss_pred             EEEEEeCC-CCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEE
Confidence            99999999 679999886443          38899999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      +|||+|+.....     ....+.+||+.|||||++.+..++
T Consensus       154 ~DFGla~~~~~~-----~~~~~~~GT~~Y~APE~~~~~~y~  189 (275)
T 3hyh_A          154 ADFGLSNIMTDG-----NFLKTSCGSPNYAAPEVISGKLYA  189 (275)
T ss_dssp             CCSSCC--------------------CTTSCHHHHSSSSCC
T ss_pred             eecCCCeecCCC-----CccCCeeECcccCChhhhcCCCCC
Confidence            999999865432     122346799999999999988764

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2e-38  Score=322.24  Aligned_cols=178  Identities=25%  Similarity=0.270  Sum_probs=147.4

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .+.|+..+.||+|+||+||+|+++.+|+.||||+++....     ..+|+.+++.++|||||++++++     .+++..|
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~-----~~~~~~~  126 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAV-----REGPWVN  126 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEE-----EETTEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence            3457788899999999999999999999999999965432     24799999999999999999995     4456899


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC-cEEEc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVG  598 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~-~~kl~  598 (640)
                      +|||||+||+|.++++..+          .+++..+..++.||+.||+|||+   ++|+||||||+|||++.+| .+||+
T Consensus       127 ivmEy~~gg~L~~~l~~~~----------~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~  193 (336)
T 4g3f_A          127 IFMELLEGGSLGQLIKQMG----------CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALC  193 (336)
T ss_dssp             EEECCCTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEEC
T ss_pred             EEEeccCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEe
Confidence            9999999999999996433          28899999999999999999999   6999999999999999988 69999


Q ss_pred             cccccccCCCccCC-CceeeccccccccccCcccCCCCCCCCC
Q 035691          599 DFGLTRFIPEVISS-NQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       599 DfGla~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |||+|+.+...... .......++||+.|||||++.+..++.|
T Consensus       194 DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~  236 (336)
T 4g3f_A          194 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK  236 (336)
T ss_dssp             CCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTH
T ss_pred             eCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcH
Confidence            99999976532211 1122334679999999999999988753

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=2.6e-36  Score=311.65  Aligned_cols=290  Identities=18%  Similarity=0.186  Sum_probs=174.9

Q ss_pred             CCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCC
Q 035691            4 FLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNI   83 (640)
Q Consensus         4 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L   83 (640)
                      +|+.+++++|.++ .+|..+.  ++|++|++++|.+++..|..|.++++|++|+|++|+|+.      +++..+..+++|
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~------~~~~~~~~l~~L  104 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK------IHEKAFSPLRKL  104 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE------ECGGGSTTCTTC
T ss_pred             cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCc------cCHhHhhCcCCC
Confidence            3566666666666 4454442  466666666666665556666666666666666666653      444444556666


Q ss_pred             CeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcce
Q 035691           84 RIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEI  163 (640)
Q Consensus        84 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~  163 (640)
                      +.|+|++|+++.+ |..+.  ++|++|++++|+++.+.+..|.++++|++|++++|.++..+.    .+..+..+ +|+.
T Consensus       105 ~~L~L~~n~l~~l-~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~----~~~~~~~l-~L~~  176 (332)
T 2ft3_A          105 QKLYISKNHLVEI-PPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGF----EPGAFDGL-KLNY  176 (332)
T ss_dssp             CEEECCSSCCCSC-CSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGS----CTTSSCSC-CCSC
T ss_pred             CEEECCCCcCCcc-Ccccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCC----CcccccCC-ccCE
Confidence            6666666666633 33322  566666666666665555556666666666666666653211    22344444 6666


Q ss_pred             EecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCcccc
Q 035691          164 VSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFL  243 (640)
Q Consensus       164 L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~  243 (640)
                      |++++|+++.+|..+.  ++|++|++++|.+++..+..|..+++|+.|+|++|++++..+.+|..+++|+.|        
T Consensus       177 L~l~~n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L--------  246 (332)
T 2ft3_A          177 LRISEAKLTGIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLREL--------  246 (332)
T ss_dssp             CBCCSSBCSSCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEE--------
T ss_pred             EECcCCCCCccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEE--------
Confidence            6666666666665543  566666666666666555666666666666666666666555566666666666        


Q ss_pred             CCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCC------CCCCeEEecCCccC--CCCCccCC
Q 035691          244 GQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSC------VGLEYLNLSINSFH--GPIHPGLS  315 (640)
Q Consensus       244 ~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~L~~N~l~--~~~~~~~~  315 (640)
                              +|++|+++ .+|..+..+++|+.|++++|+|++..+..|..+      ..|+.|++++|++.  +..|..|.
T Consensus       247 --------~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~  317 (332)
T 2ft3_A          247 --------HLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFR  317 (332)
T ss_dssp             --------ECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGT
T ss_pred             --------ECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCccccc
Confidence                    55556665 455566666677777777777765555555442      45666777777665  45566666


Q ss_pred             CCCCCCeEeCcCCc
Q 035691          316 SLKSLEGLDLFQNT  329 (640)
Q Consensus       316 ~l~~L~~L~l~~N~  329 (640)
                      .+++|+.+++++|+
T Consensus       318 ~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          318 CVTDRLAIQFGNYK  331 (332)
T ss_dssp             TBCCSTTEEC----
T ss_pred             ccchhhhhhccccc
Confidence            66677777666663

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=5.8e-36  Score=308.78  Aligned_cols=291  Identities=19%  Similarity=0.215  Sum_probs=225.3

Q ss_pred             CCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCC
Q 035691            4 FLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNI   83 (640)
Q Consensus         4 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L   83 (640)
                      +|+.++++++.++ .+|..+.  ++|++|++++|+|++..+..|.++++|++|+|++|+|+.      +++..+..+++|
T Consensus        32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~------~~~~~~~~l~~L  102 (330)
T 1xku_A           32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK------ISPGAFAPLVKL  102 (330)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCC------BCTTTTTTCTTC
T ss_pred             CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCe------eCHHHhcCCCCC
Confidence            5778888888887 5565443  578888888888887777788888888888888888775      555555668888


Q ss_pred             CeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcce
Q 035691           84 RIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEI  163 (640)
Q Consensus        84 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~  163 (640)
                      +.|+|++|+++.. |..+.  ++|++|++++|++++..+..|.++++|++|++++|.++..+.    .+..+.++++|++
T Consensus       103 ~~L~Ls~n~l~~l-~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~----~~~~~~~l~~L~~  175 (330)
T 1xku_A          103 ERLYLSKNQLKEL-PEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI----ENGAFQGMKKLSY  175 (330)
T ss_dssp             CEEECCSSCCSBC-CSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGB----CTTGGGGCTTCCE
T ss_pred             CEEECCCCcCCcc-Chhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCc----ChhhccCCCCcCE
Confidence            8888888888854 44433  688888888888887777778888888888888888865321    3456777888888


Q ss_pred             EecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCcccc
Q 035691          164 VSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFL  243 (640)
Q Consensus       164 L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~  243 (640)
                      |++++|.++.+|..+.  ++|++|++++|.+++..|..|..+++|++|+|++|++++..+..|..+++|+.|        
T Consensus       176 L~l~~n~l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L--------  245 (330)
T 1xku_A          176 IRIADTNITTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLREL--------  245 (330)
T ss_dssp             EECCSSCCCSCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEE--------
T ss_pred             EECCCCccccCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEE--------
Confidence            8888888888877654  788888888888888778888888888888888888887777778888888777        


Q ss_pred             CCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCC------CCCCeEEecCCccCC--CCCccCC
Q 035691          244 GQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSC------VGLEYLNLSINSFHG--PIHPGLS  315 (640)
Q Consensus       244 ~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~L~~N~l~~--~~~~~~~  315 (640)
                              +|++|+++ .+|..+..+++|++|+|++|+|++..+..|...      ..|+.|++++|++..  +.|..|.
T Consensus       246 --------~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~  316 (330)
T 1xku_A          246 --------HLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR  316 (330)
T ss_dssp             --------ECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGT
T ss_pred             --------ECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccc
Confidence                    77777777 667778888888888888888887776766543      678888888888863  5677888


Q ss_pred             CCCCCCeEeCcCCc
Q 035691          316 SLKSLEGLDLFQNT  329 (640)
Q Consensus       316 ~l~~L~~L~l~~N~  329 (640)
                      .+.+++.++|++|+
T Consensus       317 ~~~~l~~l~L~~N~  330 (330)
T 1xku_A          317 CVYVRAAVQLGNYK  330 (330)
T ss_dssp             TCCCGGGEEC----
T ss_pred             cccceeEEEecccC
Confidence            88888888888874

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.2e-38  Score=318.23  Aligned_cols=189  Identities=24%  Similarity=0.319  Sum_probs=150.4

Q ss_pred             CCcccCcccccccceEEEEEEC-----CCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          442 GFSSANLIGTGSFGSVYKGILD-----PDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      ++++.+.||+|+||+||+|++.     .+++.||||+++... ....++|.+|+.++++++|||||+++|+|..     .
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-----~  101 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK-----D  101 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----S
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-----C
Confidence            3456788999999999999874     367899999996443 3345789999999999999999999999743     3


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCC------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDL------NYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL  589 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl  589 (640)
                      ...++|||||++|+|.++|.........      ......++|..+..|+.|||.||+|||+   .+||||||||+|||+
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl  178 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLV  178 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEE
Confidence            4679999999999999999654321110      1112458999999999999999999999   699999999999999


Q ss_pred             CCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          590 DNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       590 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ++++.+||+|||+|+.......  .......+||+.|||||++.++.+|.|
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~--~~~~~~~~gt~~ymAPE~l~~~~~s~k  227 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADY--YKLLGNSLLPIRWMAPEAIMYGKFSID  227 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGC--BCSSSSSCBCGGGCCHHHHHHCCCCHH
T ss_pred             CCCCCEEECCcccceeccCCCc--eeEecccccCCcccCHHHHhCCCCCcc
Confidence            9999999999999986643211  112234579999999999999888753

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.4e-36  Score=321.06  Aligned_cols=308  Identities=20%  Similarity=0.178  Sum_probs=270.4

Q ss_pred             cCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCC
Q 035691           25 RLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNA  104 (640)
Q Consensus        25 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  104 (640)
                      .+.++++|++++|.++...+..|..+++|++|+|++|.|+.      +++..+..+++|+.|+|++|.+++..|..|.++
T Consensus        43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~------~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  116 (390)
T 3o6n_A           43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE------IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV  116 (390)
T ss_dssp             GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCE------ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred             ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccc------cChhhccCCCCcCEEECCCCCCCcCCHHHhcCC
Confidence            46899999999999997666678999999999999999875      777777789999999999999999999999999


Q ss_pred             CCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcCCCCCCCC
Q 035691          105 SKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKL  184 (640)
Q Consensus       105 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L  184 (640)
                      ++|++|+|++|+++.+.+..|..+++|++|+|++|+++.+      .+..+.++++|++|++++|.++.++  +..+++|
T Consensus       117 ~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~------~~~~~~~l~~L~~L~l~~n~l~~~~--~~~l~~L  188 (390)
T 3o6n_A          117 PLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERI------EDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSL  188 (390)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBC------CTTTTSSCTTCCEEECCSSCCSBCC--GGGCTTC
T ss_pred             CCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCcc------ChhhccCCCCCCEEECCCCcCCccc--ccccccc
Confidence            9999999999999987777789999999999999999987      4466888999999999999999875  4567999


Q ss_pred             CEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccC------CCCCceEEccCCcC
Q 035691          185 QVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLG------QYPVRWLDLSHNHL  258 (640)
Q Consensus       185 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~------~~~l~~L~Ls~N~l  258 (640)
                      +.|++++|.+++.     ...++|++|++++|.+... |..  ..++|+.|++++|.+.+      ...|++|++++|.+
T Consensus       189 ~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~~~l~~l~~L~~L~Ls~n~l  260 (390)
T 3o6n_A          189 FHANVSYNLLSTL-----AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNEL  260 (390)
T ss_dssp             SEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCC
T ss_pred             ceeeccccccccc-----CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCcccHHHcCCCCccEEECCCCcC
Confidence            9999999999853     3457899999999999855 332  34799999999998754      45699999999999


Q ss_pred             CCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCcc
Q 035691          259 TGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGD  338 (640)
Q Consensus       259 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  338 (640)
                      ++..|..|..+++|+.|+|++|+++ .+|..+..+++|++|+|++|+++ .+|..+..+++|++|++++|+++..+    
T Consensus       261 ~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~----  334 (390)
T 3o6n_A          261 EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK----  334 (390)
T ss_dssp             CEEESGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC----
T ss_pred             CCcChhHccccccCCEEECCCCcCc-ccCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC----
Confidence            9988999999999999999999999 46777788999999999999998 46777888999999999999998442    


Q ss_pred             cCCCCCCCCCccccccCCCCCcCCC
Q 035691          339 VPRKGIFKNASAISVAGNEKLCGGI  363 (640)
Q Consensus       339 ~p~~~~~~~~~~~~~~~n~~~c~~~  363 (640)
                         ...++.+..+++.+|+|.|.+.
T Consensus       335 ---~~~~~~L~~L~l~~N~~~~~~~  356 (390)
T 3o6n_A          335 ---LSTHHTLKNLTLSHNDWDCNSL  356 (390)
T ss_dssp             ---CCTTCCCSEEECCSSCEEHHHH
T ss_pred             ---chhhccCCEEEcCCCCccchhH
Confidence               3457789999999999998654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1e-37  Score=314.09  Aligned_cols=174  Identities=30%  Similarity=0.459  Sum_probs=140.9

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ..+++.+.+.||+|+||+||+|+++.   .||||+++...  ....+.|.+|+++|++++|||||+++|+|..      +
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~  104 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------D  104 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------S
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------C
Confidence            34567888999999999999998752   59999986443  3445789999999999999999999998732      2


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++|||||++|+|.+++.....         .+++.++..|+.||+.||+|||+   ++||||||||+|||+++++.+|
T Consensus       105 ~~~iVmEy~~gGsL~~~l~~~~~---------~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~K  172 (307)
T 3omv_A          105 NLAIVTQWCEGSSLYKHLHVQET---------KFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVK  172 (307)
T ss_dssp             SCEEEEECCSSCBHHHHHHTSCC---------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEE
T ss_pred             eEEEEEEcCCCCCHHHHHhhcCC---------CCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEE
Confidence            47899999999999999965432         38999999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      |+|||+|+.......  .......+||+.|||||++.+.
T Consensus       173 i~DFGla~~~~~~~~--~~~~~~~~GT~~ymAPE~l~~~  209 (307)
T 3omv_A          173 IGDFGLATVKSRWSG--SQQVEQPTGSVLWMAPEVIRMQ  209 (307)
T ss_dssp             ECCCSSCBC--------------CCCCTTSCCHHHHHCC
T ss_pred             EeeccCceecccCCc--ceeecccccCCCccCHHHhhcc
Confidence            999999987643221  1123346799999999998643

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=3.8e-35  Score=315.14  Aligned_cols=290  Identities=22%  Similarity=0.205  Sum_probs=247.4

Q ss_pred             CCCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCC
Q 035691            2 LTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLP   81 (640)
Q Consensus         2 l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~   81 (640)
                      +++|++|+|++|.|++. | .|..+++|++|++++|+|++. |  +..+++|++|+|++|+|+.      +|   +..++
T Consensus        41 l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~------~~---~~~l~  106 (457)
T 3bz5_A           41 LATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN------LD---VTPLT  106 (457)
T ss_dssp             HTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC------CC---CTTCT
T ss_pred             cCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce------ee---cCCCC
Confidence            68899999999999965 5 699999999999999999974 4  8999999999999999986      44   45699


Q ss_pred             CCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCc
Q 035691           82 NIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYL  161 (640)
Q Consensus        82 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L  161 (640)
                      +|+.|+|++|++++. |  ++.+++|++|++++|+++++ +  ++.+++|++|++++|+..+.      .  .+..+++|
T Consensus       107 ~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~------~--~~~~l~~L  172 (457)
T 3bz5_A          107 KLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITK------L--DVTPQTQL  172 (457)
T ss_dssp             TCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCC------C--CCTTCTTC
T ss_pred             cCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCcccc------c--ccccCCcC
Confidence            999999999999985 4  89999999999999999974 3  88999999999999954322      1  36778999


Q ss_pred             ceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCcc
Q 035691          162 EIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTI  241 (640)
Q Consensus       162 ~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~  241 (640)
                      +.|++++|+++.+|  +..+++|+.|++++|.+++.   .+..+++|++|++++|++++ +|  +..+++|+.|++++|.
T Consensus       173 ~~L~ls~n~l~~l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~  244 (457)
T 3bz5_A          173 TTLDCSFNKITELD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNP  244 (457)
T ss_dssp             CEEECCSSCCCCCC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSC
T ss_pred             CEEECCCCccceec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCc
Confidence            99999999999987  78899999999999999975   38899999999999999997 45  8899999999999998


Q ss_pred             ccCCC-----CC----------ceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCc--------cccCCCCCCe
Q 035691          242 FLGQY-----PV----------RWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPS--------SLGSCVGLEY  298 (640)
Q Consensus       242 ~~~~~-----~l----------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~--------~~~~l~~L~~  298 (640)
                      +.+.+     .|          +.|++++|.+.+.+|  ++.+++|+.|+|++|+..+.+|.        .+.++++|++
T Consensus       245 l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~  322 (457)
T 3bz5_A          245 LTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVY  322 (457)
T ss_dssp             CSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCE
T ss_pred             CCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCE
Confidence            86543     23          455666666555555  57889999999999987766654        3566789999


Q ss_pred             EEecCCccCCCCCccCCCCCCCCeEeCcCCcccc
Q 035691          299 LNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQA  332 (640)
Q Consensus       299 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  332 (640)
                      |+|++|+|++. +  +..+++|+.||+++|+++.
T Consensus       323 L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~  353 (457)
T 3bz5_A          323 LYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD  353 (457)
T ss_dssp             EECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB
T ss_pred             EECCCCccccc-c--cccCCcCcEEECCCCCCCC
Confidence            99999999985 3  8999999999999999984

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.4e-38  Score=317.79  Aligned_cols=177  Identities=28%  Similarity=0.307  Sum_probs=143.7

Q ss_pred             CCCcccCcccccccceEEEEEEC---CCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILD---PDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      ++|++.+.||+|+||+||+|++.   .+++.||||+++...  ......+.+|+++|++++|||||++++++     .++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-----QTE   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-----EET
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EEC
Confidence            46899999999999999999873   468899999996432  22335688999999999999999999994     455


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      +..|+|||||+||+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+|||++.+|.+
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~~~----------~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~v  165 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSKEV----------MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHI  165 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCE
Confidence            68999999999999999996543          28899999999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+|||+|+......    ....+.+||+.|||||++.+..++.
T Consensus       166 Kl~DFGla~~~~~~~----~~~~~~~GT~~YmAPE~~~~~~y~~  205 (304)
T 3ubd_A          166 KLTDFGLSKESIDHE----KKAYSFCGTVEYMAPEVVNRRGHTQ  205 (304)
T ss_dssp             EEESSEEEEC---------CCCCSCCCCGGGCCHHHHHTSCCCT
T ss_pred             EecccccceeccCCC----ccccccccCcccCCHHHhccCCCCC
Confidence            999999998653221    1223467999999999999988875

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=2.9e-35  Score=318.24  Aligned_cols=314  Identities=25%  Similarity=0.351  Sum_probs=241.4

Q ss_pred             CCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCC
Q 035691           12 QNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGN   91 (640)
Q Consensus        12 ~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N   91 (640)
                      .+.+.+.++  ...+.+|+.|++++|.++. +|. +..+++|++|||++|.++.      +|+  +..+++|+.|+|++|
T Consensus        33 ~~~~~~~i~--~~~l~~l~~L~l~~~~i~~-l~~-~~~l~~L~~L~Ls~n~l~~------~~~--~~~l~~L~~L~l~~n  100 (466)
T 1o6v_A           33 KTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDG-VEYLNNLTQINFSNNQLTD------ITP--LKNLTKLVDILMNNN  100 (466)
T ss_dssp             CSSTTSEEC--HHHHHTCCEEECCSSCCCC-CTT-GGGCTTCCEEECCSSCCCC------CGG--GTTCTTCCEEECCSS
T ss_pred             ccccccccC--hhHhccccEEecCCCCCcc-Ccc-hhhhcCCCEEECCCCccCC------chh--hhccccCCEEECCCC
Confidence            344444444  2456789999999999984 554 8899999999999999986      665  567999999999999


Q ss_pred             cccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCC-------------cccccccccCC
Q 035691           92 QFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVN-------------DLRFLDSLVNC  158 (640)
Q Consensus        92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-------------~~~~~~~l~~l  158 (640)
                      ++++..+  |.++++|++|+|++|++++..+  +..+++|++|+|++|.++.++.-             .+.....+.++
T Consensus       101 ~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l  176 (466)
T 1o6v_A          101 QIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANL  176 (466)
T ss_dssp             CCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTC
T ss_pred             ccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCChhhccCCcccEeecCCcccCchhhccC
Confidence            9997766  9999999999999999997544  89999999999999999876320             00011235667


Q ss_pred             CCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEecc
Q 035691          159 TYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLS  238 (640)
Q Consensus       159 ~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls  238 (640)
                      ++|+.|++++|.++.++. +..+++|++|++++|.+.+..|  +..+++|++|++++|++++.  ..+..+++|+.|+++
T Consensus       177 ~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~  251 (466)
T 1o6v_A          177 TTLERLDISSNKVSDISV-LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLA  251 (466)
T ss_dssp             TTCCEEECCSSCCCCCGG-GGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECC
T ss_pred             CCCCEEECcCCcCCCChh-hccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECC
Confidence            788888888888877653 6677888888888888876554  67778888888888888754  357788888888888


Q ss_pred             CccccC------CCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCc
Q 035691          239 KTIFLG------QYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHP  312 (640)
Q Consensus       239 ~n~~~~------~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~  312 (640)
                      +|.+.+      +..|+.|++++|.+++..+  +..+++|+.|+|++|++++..+  +..+++|++|+|++|++++..| 
T Consensus       252 ~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-  326 (466)
T 1o6v_A          252 NNQISNLAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-  326 (466)
T ss_dssp             SSCCCCCGGGTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-
T ss_pred             CCccccchhhhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-
Confidence            886544      3457888888888886544  7788888888888888886544  7778888888888888887655 


Q ss_pred             cCCCCCCCCeEeCcCCccccccCCcccCCCCCCCCCccccccCCCC
Q 035691          313 GLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEK  358 (640)
Q Consensus       313 ~~~~l~~L~~L~l~~N~l~~~~~~~~~p~~~~~~~~~~~~~~~n~~  358 (640)
                       +..+++|++|++++|+++..      +....++++..+++.+|..
T Consensus       327 -~~~l~~L~~L~l~~n~l~~~------~~l~~l~~L~~L~l~~n~l  365 (466)
T 1o6v_A          327 -VSSLTKLQRLFFYNNKVSDV------SSLANLTNINWLSAGHNQI  365 (466)
T ss_dssp             -GGGCTTCCEEECCSSCCCCC------GGGTTCTTCCEEECCSSCC
T ss_pred             -hccCccCCEeECCCCccCCc------hhhccCCCCCEEeCCCCcc
Confidence             67888888888888888743      3334566778888888764

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=5.2e-36  Score=333.96  Aligned_cols=308  Identities=20%  Similarity=0.185  Sum_probs=272.3

Q ss_pred             cCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCC
Q 035691           25 RLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNA  104 (640)
Q Consensus        25 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  104 (640)
                      .+.+++.|++++|.+..+.+..|..+++|++|+|++|.|+.      +++..+..+++|+.|+|++|.|++..|..|+++
T Consensus        49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~------~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  122 (597)
T 3oja_B           49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE------IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV  122 (597)
T ss_dssp             GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCE------ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred             cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCC------CChHHhcCCCCCCEEECCCCcCCCCCHHHHcCC
Confidence            46789999999999997777778999999999999999875      777777789999999999999999999999999


Q ss_pred             CCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcCCCCCCCC
Q 035691          105 SKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKL  184 (640)
Q Consensus       105 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L  184 (640)
                      ++|++|+|++|.|+++++..|.++++|++|+|++|.++.+      .+..|.++++|++|++++|.++.++  +..+++|
T Consensus       123 ~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~------~~~~~~~l~~L~~L~L~~N~l~~~~--~~~l~~L  194 (597)
T 3oja_B          123 PLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERI------EDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSL  194 (597)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBC------CTTTTTTCTTCCEEECTTSCCSBCC--GGGCTTC
T ss_pred             CCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCC------ChhhhhcCCcCcEEECcCCCCCCcC--hhhhhhh
Confidence            9999999999999987777889999999999999999987      4567889999999999999999886  4557899


Q ss_pred             CEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccC------CCCCceEEccCCcC
Q 035691          185 QVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLG------QYPVRWLDLSHNHL  258 (640)
Q Consensus       185 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~------~~~l~~L~Ls~N~l  258 (640)
                      +.|++++|.+++     +...++|+.|++++|.+....+..   .++|+.|++++|.+.+      +..|+.|+|++|.+
T Consensus       195 ~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~~~~l~~l~~L~~L~Ls~N~l  266 (597)
T 3oja_B          195 FHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNEL  266 (597)
T ss_dssp             SEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCC
T ss_pred             hhhhcccCcccc-----ccCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCCChhhccCCCCCEEECCCCcc
Confidence            999999999985     345578999999999998554433   2689999999998764      45699999999999


Q ss_pred             CCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCcc
Q 035691          259 TGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGD  338 (640)
Q Consensus       259 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  338 (640)
                      ++.+|..|+.+++|+.|+|++|++++ +|..+..+++|+.|+|++|.++ .+|..+..+++|++|+|++|.++..+    
T Consensus       267 ~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~----  340 (597)
T 3oja_B          267 EKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK----  340 (597)
T ss_dssp             CEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC----
T ss_pred             CCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC----
Confidence            99999999999999999999999995 6777888999999999999998 57778899999999999999998432    


Q ss_pred             cCCCCCCCCCccccccCCCCCcCCC
Q 035691          339 VPRKGIFKNASAISVAGNEKLCGGI  363 (640)
Q Consensus       339 ~p~~~~~~~~~~~~~~~n~~~c~~~  363 (640)
                         ...++.+..+++++|+|.|.+.
T Consensus       341 ---~~~~~~L~~L~l~~N~~~~~~~  362 (597)
T 3oja_B          341 ---LSTHHTLKNLTLSHNDWDCNSL  362 (597)
T ss_dssp             ---CCTTCCCSEEECCSSCEEHHHH
T ss_pred             ---hhhcCCCCEEEeeCCCCCChhH
Confidence               3456789999999999999754

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=1.1e-36  Score=311.23  Aligned_cols=255  Identities=29%  Similarity=0.460  Sum_probs=221.8

Q ss_pred             CCCCeeeccCCcccc--cCCccCcCCCCCCEEECcC-CccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccC
Q 035691           81 PNIRIPLLAGNQFFG--NIPHSISNASKLEWLDFAN-NSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVN  157 (640)
Q Consensus        81 ~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~  157 (640)
                      .+++.|+|++|.+++  .+|..|.++++|++|+|++ |.+++.+|..|..+++|++|+|++|++++.      .+..|.+
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~------~p~~~~~  123 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA------IPDFLSQ  123 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEE------CCGGGGG
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCc------CCHHHhC
Confidence            567888888888887  7888888888888888884 888888888888888888888888888754      4567788


Q ss_pred             CCCcceEecCCCCCCC-cCcCCCCCCCCCEEEccCCcCcccCCcCccCCC-CCCEEEccCCCCCCCCCccccCCCCccEE
Q 035691          158 CTYLEIVSLNVNSLRS-IPISVGYLPKLQVLSLFENNISGEIPSSLGNFT-FLTELNLRGNSIRGSIPSALGNCHQLQSL  235 (640)
Q Consensus       158 l~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  235 (640)
                      +++|++|++++|.++. +|..+..+++|++|+|++|.+++.+|..+..++ +|++|+|++|++++.+|..|..++ |+.|
T Consensus       124 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L  202 (313)
T 1ogq_A          124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFV  202 (313)
T ss_dssp             CTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEE
T ss_pred             CCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEE
Confidence            8888888888888884 788888889999999999999888899999988 899999999999988888888876 7777


Q ss_pred             eccCccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCC
Q 035691          236 DLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLS  315 (640)
Q Consensus       236 ~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~  315 (640)
                                      ++++|++++.+|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..|.
T Consensus       203 ----------------~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~  265 (313)
T 1ogq_A          203 ----------------DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLT  265 (313)
T ss_dssp             ----------------ECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGG
T ss_pred             ----------------ECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHh
Confidence                            7888888888899999999999999999999866665 88889999999999999989999999


Q ss_pred             CCCCCCeEeCcCCccccccCCcccCCCCCCCCCccccccCCCCCcCCCc
Q 035691          316 SLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGIS  364 (640)
Q Consensus       316 ~l~~L~~L~l~~N~l~~~~~~~~~p~~~~~~~~~~~~~~~n~~~c~~~~  364 (640)
                      .+++|++|+|++|+++     +.+|..+.++.+..+++.+|+++||.|.
T Consensus       266 ~l~~L~~L~Ls~N~l~-----~~ip~~~~l~~L~~l~l~~N~~lc~~p~  309 (313)
T 1ogq_A          266 QLKFLHSLNVSFNNLC-----GEIPQGGNLQRFDVSAYANNKCLCGSPL  309 (313)
T ss_dssp             GCTTCCEEECCSSEEE-----EECCCSTTGGGSCGGGTCSSSEEESTTS
T ss_pred             cCcCCCEEECcCCccc-----ccCCCCccccccChHHhcCCCCccCCCC
Confidence            9999999999999998     7788777888999999999999999764

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.6e-37  Score=310.21  Aligned_cols=179  Identities=27%  Similarity=0.315  Sum_probs=139.6

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEE
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALV  521 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv  521 (640)
                      +|.+.+.||+|+||+||+|++  +|+.||||+++..... ...++.|+..+.+++|||||+++++|.... ......++|
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV   79 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV   79 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEE
Confidence            466778999999999999998  5899999999644322 123445666667889999999999986542 222367999


Q ss_pred             eeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          522 YEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHH-----CKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       522 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~-----~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ||||++|+|.++++..           .++|..+.+++.|++.||+|||+.     +.++|+||||||+|||++.++.+|
T Consensus        80 ~Ey~~~gsL~~~l~~~-----------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~K  148 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRY-----------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  148 (303)
T ss_dssp             EECCTTCBHHHHHHHC-----------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             ecCCCCCcHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEE
Confidence            9999999999999643           278899999999999999999974     235899999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      |+|||+|+................+||+.|||||++.+.
T Consensus       149 i~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~  187 (303)
T 3hmm_A          149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS  187 (303)
T ss_dssp             ECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTC
T ss_pred             EEeCCCCccccCCCCceeeecccccccccccCHHHhccc
Confidence            999999987643222111223345799999999999765

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6.9e-37  Score=314.81  Aligned_cols=201  Identities=22%  Similarity=0.302  Sum_probs=158.9

Q ss_pred             cCHHHHHHhcCCCcccCcccccccceEEEEEECCC-----CeEEEEEEeeccc-chhHHHHHHHHHHHHhcCC-CCCcce
Q 035691          431 VSYESLLKATGGFSSANLIGTGSFGSVYKGILDPD-----QTVVAVKVLFLHQ-RGALKSFMAECEALRNIRH-RNLVKI  503 (640)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H-~niv~l  503 (640)
                      ++..+++...++|++.+.||+|+||+||+|++...     ++.||||++.... ....++|.+|+++|.+++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            34455666678899999999999999999997543     3689999996443 3345789999999999965 899999


Q ss_pred             eEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCC------CCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 035691          504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASD------DLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQI  577 (640)
Q Consensus       504 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~i  577 (640)
                      +|+|..    .+...++|||||++|+|.++|+......      ........+++..+..|+.|||.||+|||+   ++|
T Consensus       134 ~g~~~~----~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~i  206 (353)
T 4ase_A          134 LGACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKC  206 (353)
T ss_dssp             EEEECC----TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTC
T ss_pred             EEEEEe----cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCe
Confidence            999843    2346799999999999999996432210      000112448999999999999999999999   699


Q ss_pred             eeCCCCCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          578 VHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       578 vHrdlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |||||||+|||+++++.+||+|||+|+.+.....  .......+||+.|||||++.+..||.|
T Consensus       207 iHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~--~~~~~~~~gt~~ymAPE~l~~~~y~~k  267 (353)
T 4ase_A          207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRVYTIQ  267 (353)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTT--SEEETTEEECGGGCCHHHHHHCCCCHH
T ss_pred             ecCccCccceeeCCCCCEEECcchhhhhcccCCC--ceeeccccccccccCHHHHhcCCCCCc
Confidence            9999999999999999999999999997643221  223344579999999999999888753

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.8e-36  Score=312.86  Aligned_cols=184  Identities=23%  Similarity=0.326  Sum_probs=152.2

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCC-cCCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSD-FQGND  516 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~~  516 (640)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++...  ....+.+.+|+++|+.++|||||++++++.... +....
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            357999999999999999999999999999999996432  334567899999999999999999999975432 44556


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..|+|||||+ |+|.+++....          .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+|
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~----------~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~K  198 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQ----------PLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELK  198 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSS----------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEE
T ss_pred             EEEEEEeCCC-CCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEE
Confidence            7899999996 68999986543          38899999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV  637 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  637 (640)
                      |+|||+|+.+............+.+||++|||||++.+..+
T Consensus       199 i~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~  239 (398)
T 4b99_A          199 IGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHE  239 (398)
T ss_dssp             ECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSC
T ss_pred             EeecceeeecccCccccccccccceeChHhcCHHHhcCCCC
Confidence            99999999764332222233445789999999999988654

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=2.4e-34  Score=298.91  Aligned_cols=300  Identities=21%  Similarity=0.273  Sum_probs=260.7

Q ss_pred             hhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccC
Q 035691           22 EIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSI  101 (640)
Q Consensus        22 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~  101 (640)
                      .+..+++|++|++++|.+.. +|. +..+++|++|++++|++++      +|+  +..+++|+.|+|++|.++..  ..|
T Consensus        39 ~~~~l~~L~~L~l~~~~i~~-~~~-~~~~~~L~~L~l~~n~i~~------~~~--~~~l~~L~~L~L~~n~i~~~--~~~  106 (347)
T 4fmz_A           39 TQEELESITKLVVAGEKVAS-IQG-IEYLTNLEYLNLNGNQITD------ISP--LSNLVKLTNLYIGTNKITDI--SAL  106 (347)
T ss_dssp             CHHHHTTCSEEECCSSCCCC-CTT-GGGCTTCCEEECCSSCCCC------CGG--GTTCTTCCEEECCSSCCCCC--GGG
T ss_pred             cchhcccccEEEEeCCcccc-chh-hhhcCCccEEEccCCcccc------chh--hhcCCcCCEEEccCCcccCc--hHH
Confidence            46788999999999999984 443 8899999999999999986      665  56799999999999999964  469


Q ss_pred             cCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcCCCCC
Q 035691          102 SNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYL  181 (640)
Q Consensus       102 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l  181 (640)
                      .++++|++|+|++|++++..+  +..+++|++|++++|.....       ...+..+++|++|++++|.+..++. +..+
T Consensus       107 ~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~-------~~~~~~l~~L~~L~l~~~~~~~~~~-~~~l  176 (347)
T 4fmz_A          107 QNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSD-------LSPLSNMTGLNYLTVTESKVKDVTP-IANL  176 (347)
T ss_dssp             TTCTTCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCC-------CGGGTTCTTCCEEECCSSCCCCCGG-GGGC
T ss_pred             cCCCcCCEEECcCCcccCchh--hccCCceeEEECCCCCCccc-------ccchhhCCCCcEEEecCCCcCCchh-hccC
Confidence            999999999999999997544  89999999999999965442       2348899999999999999999776 7789


Q ss_pred             CCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccC------CCCCceEEccC
Q 035691          182 PKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLG------QYPVRWLDLSH  255 (640)
Q Consensus       182 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~------~~~l~~L~Ls~  255 (640)
                      ++|++|++++|.+.+..+  +..+++|+.|++++|.+.+..+  +..+++|+.|++++|.+.+      ...|++|++++
T Consensus       177 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~  252 (347)
T 4fmz_A          177 TDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGT  252 (347)
T ss_dssp             TTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCS
T ss_pred             CCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcchhcCCCCCEEECCC
Confidence            999999999999996544  8899999999999999996655  8999999999999997654      45689999999


Q ss_pred             CcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccC
Q 035691          256 NHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQ  335 (640)
Q Consensus       256 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  335 (640)
                      |.+++.  ..+..+++|+.|++++|++++.  ..+..+++|++|++++|++++..|..+..+++|++|++++|+++..  
T Consensus       253 n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~--  326 (347)
T 4fmz_A          253 NQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI--  326 (347)
T ss_dssp             SCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCC--
T ss_pred             CccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccc--
Confidence            999964  5789999999999999999964  4689999999999999999998899999999999999999999843  


Q ss_pred             CcccCCCCCCCCCccccccCCC
Q 035691          336 NGDVPRKGIFKNASAISVAGNE  357 (640)
Q Consensus       336 ~~~~p~~~~~~~~~~~~~~~n~  357 (640)
                         .| ...++.+..+++.+|+
T Consensus       327 ---~~-~~~l~~L~~L~l~~N~  344 (347)
T 4fmz_A          327 ---RP-LASLSKMDSADFANQV  344 (347)
T ss_dssp             ---GG-GGGCTTCSEESSSCC-
T ss_pred             ---cC-hhhhhccceeehhhhc
Confidence               23 4557788899999886

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=4.9e-34  Score=294.33  Aligned_cols=268  Identities=20%  Similarity=0.210  Sum_probs=237.5

Q ss_pred             CCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCC
Q 035691            3 TFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPN   82 (640)
Q Consensus         3 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~   82 (640)
                      +.|+.|+|++|+|++..+..|.++++|++|+|++|.+++..|..|..+++|++|+|++|+|+.      +|..++   ++
T Consensus        52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~------l~~~~~---~~  122 (330)
T 1xku_A           52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE------LPEKMP---KT  122 (330)
T ss_dssp             TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB------CCSSCC---TT
T ss_pred             CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCc------cChhhc---cc
Confidence            468999999999998888899999999999999999998889999999999999999999985      777664   79


Q ss_pred             CCeeeccCCcccccCCccCcCCCCCCEEECcCCccCc--cCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCC
Q 035691           83 IRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTA--SIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTY  160 (640)
Q Consensus        83 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~  160 (640)
                      |+.|++++|++++..+..|.++++|++|++++|.++.  ..+..|.++++|++|++++|.++.++.       .+.  ++
T Consensus       123 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~-------~~~--~~  193 (330)
T 1xku_A          123 LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ-------GLP--PS  193 (330)
T ss_dssp             CCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCS-------SCC--TT
T ss_pred             ccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCc-------ccc--cc
Confidence            9999999999999988999999999999999999974  678899999999999999999998643       222  78


Q ss_pred             cceEecCCCCCCCc-CcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccC
Q 035691          161 LEIVSLNVNSLRSI-PISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSK  239 (640)
Q Consensus       161 L~~L~L~~N~l~~i-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~  239 (640)
                      |+.|++++|.++.+ |..+..+++|++|+|++|.+++..+..|..+++|++|+|++|+++ .+|..+..+++|+.|    
T Consensus       194 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L----  268 (330)
T 1xku_A          194 LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVV----  268 (330)
T ss_dssp             CSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEE----
T ss_pred             CCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEE----
Confidence            99999999999996 567889999999999999999888889999999999999999999 778889999999988    


Q ss_pred             ccccCCCCCceEEccCCcCCCCCCccCCCC------CCCCEEECCCCcccC--cCCccccCCCCCCeEEecCCc
Q 035691          240 TIFLGQYPVRWLDLSHNHLTGPIPLAVGNL------KSIPHLDLSKNKLSG--EIPSSLGSCVGLEYLNLSINS  305 (640)
Q Consensus       240 n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l------~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~  305 (640)
                                  ++++|+|++..+..|...      ..|+.|++++|.+..  ..|..|..+.+|+.++|++|+
T Consensus       269 ------------~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          269 ------------YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             ------------ECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             ------------ECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence                        777788887777777543      789999999999974  567889999999999999995

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=6.2e-34  Score=305.73  Aligned_cols=286  Identities=21%  Similarity=0.216  Sum_probs=241.7

Q ss_pred             CCCCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCC
Q 035691            1 NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTL   80 (640)
Q Consensus         1 nl~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l   80 (640)
                      ++++|++|+|++|+|++. |  ++.+++|++|++++|+|++. +  +.++++|++|+|++|+|+.      +|   +..+
T Consensus        62 ~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~------l~---~~~l  126 (457)
T 3bz5_A           62 KLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK------LD---VSQN  126 (457)
T ss_dssp             GCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC------CC---CTTC
T ss_pred             ccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe------ec---CCCC
Confidence            368999999999999975 4  99999999999999999975 4  8999999999999999976      54   4569


Q ss_pred             CCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCC
Q 035691           81 PNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTY  160 (640)
Q Consensus        81 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~  160 (640)
                      ++|+.|++++|++++.   .++++++|++|++++|+..+.+  .+..+++|++|++++|++++++         +..+++
T Consensus       127 ~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l~---------l~~l~~  192 (457)
T 3bz5_A          127 PLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITELD---------VSQNKL  192 (457)
T ss_dssp             TTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCCC---------CTTCTT
T ss_pred             CcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccceec---------cccCCC
Confidence            9999999999999985   3889999999999999655445  4889999999999999998862         667899


Q ss_pred             cceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCC-------Ccc
Q 035691          161 LEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCH-------QLQ  233 (640)
Q Consensus       161 L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-------~L~  233 (640)
                      |+.|++++|+++.++  +..+++|++|++++|++++ +|  +..+++|+.|++++|++++..+..+.++.       +|+
T Consensus       193 L~~L~l~~N~l~~~~--l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~  267 (457)
T 3bz5_A          193 LNRLNCDTNNITKLD--LNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLL  267 (457)
T ss_dssp             CCEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCS
T ss_pred             CCEEECcCCcCCeec--cccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCC
Confidence            999999999999984  7889999999999999997 55  88999999999999999987766665554       556


Q ss_pred             EEeccCcccc------CCCCCceEEccCCcCCCCCCc--------cCCCCCCCCEEECCCCcccCcCCccccCCCCCCeE
Q 035691          234 SLDLSKTIFL------GQYPVRWLDLSHNHLTGPIPL--------AVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYL  299 (640)
Q Consensus       234 ~L~ls~n~~~------~~~~l~~L~Ls~N~l~~~~~~--------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  299 (640)
                      .|++++|.+.      .+..|+.|++++|...+.+|.        .+.++++|+.|++++|+|++. +  +..+++|+.|
T Consensus       268 ~L~l~~n~~~~~~~~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L  344 (457)
T 3bz5_A          268 EIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL-D--VSHNTKLKSL  344 (457)
T ss_dssp             CCCCTTCTTCCEEECTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C--CTTCTTCSEE
T ss_pred             EEECCCCccCCcccccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc-c--cccCCcCcEE
Confidence            6677777543      346689999999987665553        367778999999999999974 3  8999999999


Q ss_pred             EecCCccCCCCCccCCCCCCCCeEeCcCCccc
Q 035691          300 NLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQ  331 (640)
Q Consensus       300 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  331 (640)
                      ++++|+|++        ++.|..|++++|.+.
T Consensus       345 ~l~~N~l~~--------l~~L~~L~l~~n~l~  368 (457)
T 3bz5_A          345 SCVNAHIQD--------FSSVGKIPALNNNFE  368 (457)
T ss_dssp             ECCSSCCCB--------CTTGGGSSGGGTSEE
T ss_pred             ECCCCCCCC--------ccccccccccCCcEE
Confidence            999999986        245666677777776

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=3.4e-34  Score=295.73  Aligned_cols=267  Identities=19%  Similarity=0.201  Sum_probs=237.4

Q ss_pred             CCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCC
Q 035691            3 TFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPN   82 (640)
Q Consensus         3 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~   82 (640)
                      ++|+.|+|++|+|++..|..|.++++|++|++++|++++..|.+|..+++|++|+|++|+|+.      +|..++   ++
T Consensus        54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~------l~~~~~---~~  124 (332)
T 2ft3_A           54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVE------IPPNLP---SS  124 (332)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCCS------CCSSCC---TT
T ss_pred             CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCCc------cCcccc---cc
Confidence            479999999999998888899999999999999999998889999999999999999999985      887765   79


Q ss_pred             CCeeeccCCcccccCCccCcCCCCCCEEECcCCccCc--cCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCC
Q 035691           83 IRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTA--SIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTY  160 (640)
Q Consensus        83 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~  160 (640)
                      |+.|++++|++++..+..|.++++|++|++++|.++.  ..+..|..+ +|++|++++|+++.++.       .+.  ++
T Consensus       125 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l~~-------~~~--~~  194 (332)
T 2ft3_A          125 LVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIPK-------DLP--ET  194 (332)
T ss_dssp             CCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSCCS-------SSC--SS
T ss_pred             CCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCccCc-------ccc--CC
Confidence            9999999999999888899999999999999999963  778889988 99999999999998743       222  68


Q ss_pred             cceEecCCCCCCCcC-cCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccC
Q 035691          161 LEIVSLNVNSLRSIP-ISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSK  239 (640)
Q Consensus       161 L~~L~L~~N~l~~ip-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~  239 (640)
                      |++|++++|.++.++ ..+..+++|++|+|++|.+++..+..|..+++|++|+|++|+++ .+|..+..+++|+.|    
T Consensus       195 L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L----  269 (332)
T 2ft3_A          195 LNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVV----  269 (332)
T ss_dssp             CSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEE----
T ss_pred             CCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEE----
Confidence            999999999999966 57888999999999999999988889999999999999999999 778889999999998    


Q ss_pred             ccccCCCCCceEEccCCcCCCCCCccCCCC------CCCCEEECCCCccc--CcCCccccCCCCCCeEEecCCc
Q 035691          240 TIFLGQYPVRWLDLSHNHLTGPIPLAVGNL------KSIPHLDLSKNKLS--GEIPSSLGSCVGLEYLNLSINS  305 (640)
Q Consensus       240 n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l------~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~  305 (640)
                                  ++++|+|++..+..|...      .+|+.|++++|.+.  ...|..|..+++|+.|++++|+
T Consensus       270 ------------~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          270 ------------YLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             ------------ECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             ------------ECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence                        777788887777777653      67999999999998  6778899999999999999985

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=8.3e-34  Score=304.48  Aligned_cols=313  Identities=24%  Similarity=0.263  Sum_probs=180.1

Q ss_pred             CCCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCC-------------CEEEccCCCcCC---
Q 035691            2 LTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSEL-------------RTLDLVLNKLEE---   65 (640)
Q Consensus         2 l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L-------------~~L~Ls~N~l~~---   65 (640)
                      .++|++|++++|++ +.+|++|+++++|++|++++|.+++.+|..++.+.+|             ++|++++|.++.   
T Consensus        10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~   88 (454)
T 1jl5_A           10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPE   88 (454)
T ss_dssp             -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCS
T ss_pred             cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCC
Confidence            46788999999999 6889889999999999999999988888888877653             777777776654   


Q ss_pred             ------------ccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCE
Q 035691           66 ------------NQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTR  133 (640)
Q Consensus        66 ------------~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  133 (640)
                                  |.+.+ +|..    +++|+.|++++|++++.. ..   .++|++|++++|++++ +| .|+++++|++
T Consensus        89 ~~~~L~~L~l~~n~l~~-lp~~----~~~L~~L~l~~n~l~~l~-~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~  157 (454)
T 1jl5_A           89 LPPHLESLVASCNSLTE-LPEL----PQSLKSLLVDNNNLKALS-DL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKI  157 (454)
T ss_dssp             CCTTCSEEECCSSCCSS-CCCC----CTTCCEEECCSSCCSCCC-SC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCE
T ss_pred             CcCCCCEEEccCCcCCc-cccc----cCCCcEEECCCCccCccc-CC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCE
Confidence                        11111 3321    244555555555554321 11   1567777777777775 45 4777777777


Q ss_pred             EEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEc
Q 035691          134 LNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNL  213 (640)
Q Consensus       134 L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  213 (640)
                      |++++|++++++.       .   ..+|++|++++|+++.+| .+..+++|++|++++|.+++ +|...   ++|++|++
T Consensus       158 L~l~~N~l~~lp~-------~---~~~L~~L~L~~n~l~~l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l  222 (454)
T 1jl5_A          158 IDVDNNSLKKLPD-------L---PPSLEFIAAGNNQLEELP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVA  222 (454)
T ss_dssp             EECCSSCCSCCCC-------C---CTTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEEC
T ss_pred             EECCCCcCcccCC-------C---cccccEEECcCCcCCcCc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEEC
Confidence            7777777776532       1   136777777777777766 46667777777777777764 33322   46777777


Q ss_pred             cCCCCCCCCCccccCCCCccEEeccCccccCC----CCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccC--cCC
Q 035691          214 RGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQ----YPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSG--EIP  287 (640)
Q Consensus       214 ~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~----~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p  287 (640)
                      ++|+++ .+| .|+.+++|+.|++++|.+.+.    ..|+.|++++|++++ +|..   +++|+.|++++|++++  ..|
T Consensus       223 ~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~l~~~~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~~~~  296 (454)
T 1jl5_A          223 GNNILE-ELP-ELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSELP  296 (454)
T ss_dssp             CSSCCS-SCC-CCTTCTTCCEEECCSSCCSSCCSCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESCCC
T ss_pred             cCCcCC-ccc-ccCCCCCCCEEECCCCcCCcccccccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcccCcC
Confidence            777776 445 377777777777777776653    246777777777775 3332   2566666666666664  122


Q ss_pred             ccc-------------cCC-CCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCcccCCCCCCCCCccccc
Q 035691          288 SSL-------------GSC-VGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISV  353 (640)
Q Consensus       288 ~~~-------------~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~p~~~~~~~~~~~~~  353 (640)
                      ..+             ..+ ++|++|++++|++++ +|..   +++|++|++++|.++.      +|.  .+++++.+++
T Consensus       297 ~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~------lp~--~l~~L~~L~L  364 (454)
T 1jl5_A          297 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE------VPE--LPQNLKQLHV  364 (454)
T ss_dssp             TTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC------CCC--CCTTCCEEEC
T ss_pred             CcCCEEECcCCcCCcccCCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc------ccc--hhhhccEEEC
Confidence            111             112 367777777777765 3433   4677777777777763      333  3566777777


Q ss_pred             cCCCCC
Q 035691          354 AGNEKL  359 (640)
Q Consensus       354 ~~n~~~  359 (640)
                      ++|+..
T Consensus       365 ~~N~l~  370 (454)
T 1jl5_A          365 EYNPLR  370 (454)
T ss_dssp             CSSCCS
T ss_pred             CCCCCC
Confidence            777653

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=3.1e-35  Score=300.57  Aligned_cols=251  Identities=25%  Similarity=0.438  Sum_probs=209.9

Q ss_pred             CCCCEEEccCCCcCCccccc--cCCchhhcCCCCCCeeeccC-CcccccCCccCcCCCCCCEEECcCCccCccCCccccC
Q 035691           51 SELRTLDLVLNKLEENQLVG--ELPPYIGFTLPNIRIPLLAG-NQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGR  127 (640)
Q Consensus        51 ~~L~~L~Ls~N~l~~~~~~~--~lp~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  127 (640)
                      .++++|+|++|.++     |  .+|+.+. .+++|+.|+|++ |.+.+.+|..|+++++|++|+|++|++++..|..|..
T Consensus        50 ~~l~~L~L~~~~l~-----~~~~~~~~l~-~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~  123 (313)
T 1ogq_A           50 YRVNNLDLSGLNLP-----KPYPIPSSLA-NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ  123 (313)
T ss_dssp             CCEEEEEEECCCCS-----SCEECCGGGG-GCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGG
T ss_pred             ceEEEEECCCCCcc-----CCcccChhHh-CCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhC
Confidence            46777777766654     3  3565444 477777777774 7777778888888888888888888888778888888


Q ss_pred             CCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCC-CcCcCCCCCC-CCCEEEccCCcCcccCCcCccCC
Q 035691          128 LRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLR-SIPISVGYLP-KLQVLSLFENNISGEIPSSLGNF  205 (640)
Q Consensus       128 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~-~ip~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l  205 (640)
                      +++|++|+|++|++++.      .+..+.++++|++|++++|+++ .+|..+..++ +|++|++++|.+++.+|..|..+
T Consensus       124 l~~L~~L~Ls~N~l~~~------~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l  197 (313)
T 1ogq_A          124 IKTLVTLDFSYNALSGT------LPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL  197 (313)
T ss_dssp             CTTCCEEECCSSEEESC------CCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGC
T ss_pred             CCCCCEEeCCCCccCCc------CChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCC
Confidence            88888888888888754      4566777888888888888888 4888888887 89999999999999999999988


Q ss_pred             CCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCc
Q 035691          206 TFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGE  285 (640)
Q Consensus       206 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  285 (640)
                      + |++|+|++|++++..|..|..+++|+.|                +|++|++++.+|. +..+++|++|+|++|+|++.
T Consensus       198 ~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L----------------~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~  259 (313)
T 1ogq_A          198 N-LAFVDLSRNMLEGDASVLFGSDKNTQKI----------------HLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGT  259 (313)
T ss_dssp             C-CSEEECCSSEEEECCGGGCCTTSCCSEE----------------ECCSSEECCBGGG-CCCCTTCCEEECCSSCCEEC
T ss_pred             c-ccEEECcCCcccCcCCHHHhcCCCCCEE----------------ECCCCceeeecCc-ccccCCCCEEECcCCcccCc
Confidence            7 9999999999998899999999999888                7777777765555 88899999999999999999


Q ss_pred             CCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCcccc
Q 035691          286 IPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQA  332 (640)
Q Consensus       286 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  332 (640)
                      +|..|..+++|++|+|++|++++.+|.. ..+++|+.|++++|+.-|
T Consensus       260 ~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc  305 (313)
T 1ogq_A          260 LPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLC  305 (313)
T ss_dssp             CCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEE
T ss_pred             CChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCcc
Confidence            9999999999999999999999888876 889999999999999654

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=1.4e-32  Score=294.86  Aligned_cols=300  Identities=25%  Similarity=0.306  Sum_probs=203.2

Q ss_pred             CCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCC
Q 035691            3 TFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPN   82 (640)
Q Consensus         3 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~   82 (640)
                      ++|+.|++++|.+++ +|..   +++|++|++++|++++ +|..   .++|++|++++|+++.      +|.  +..+++
T Consensus        91 ~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~------lp~--~~~l~~  154 (454)
T 1jl5_A           91 PHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK------LPE--LQNSSF  154 (454)
T ss_dssp             TTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS------CCC--CTTCTT
T ss_pred             CCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC------Ccc--cCCCCC
Confidence            468889999998886 5643   3788888888888885 3321   2688899998888875      673  556888


Q ss_pred             CCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcc
Q 035691           83 IRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLE  162 (640)
Q Consensus        83 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~  162 (640)
                      |+.|++++|++++ +|..+   ++|++|++++|++++ +| .|+++++|++|++++|++++++.    .      .++|+
T Consensus       155 L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~----~------~~~L~  218 (454)
T 1jl5_A          155 LKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPD----L------PLSLE  218 (454)
T ss_dssp             CCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCC----C------CTTCC
T ss_pred             CCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCC----C------cCccc
Confidence            8899999888886 45443   588888998888886 45 58888888888888888887532    1      14788


Q ss_pred             eEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccc
Q 035691          163 IVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIF  242 (640)
Q Consensus       163 ~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~  242 (640)
                      +|++++|.++.+|. +..+++|++|++++|++++ +|..   +++|+.|++++|++++ +|..   +++|+.|++++|.+
T Consensus       219 ~L~l~~n~l~~lp~-~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l  289 (454)
T 1jl5_A          219 SIVAGNNILEELPE-LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIF  289 (454)
T ss_dssp             EEECCSSCCSSCCC-CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCC
T ss_pred             EEECcCCcCCcccc-cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCcc
Confidence            88888888888874 7778888888888888885 4432   3678888888888875 4433   36788888888877


Q ss_pred             cCC----CCCceEEccCCcCCCCCCccCCCC-CCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCC
Q 035691          243 LGQ----YPVRWLDLSHNHLTGPIPLAVGNL-KSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSL  317 (640)
Q Consensus       243 ~~~----~~l~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  317 (640)
                      .+.    ..|++|++++|++++. +    .+ ++|+.|++++|++++ +|..   +++|++|++++|++++ +|.   .+
T Consensus       290 ~~l~~~~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l  356 (454)
T 1jl5_A          290 SGLSELPPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LP  356 (454)
T ss_dssp             SEESCCCTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CC
T ss_pred             CcccCcCCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hh
Confidence            663    2477788888877742 2    22 477778888887774 5543   4677777777777774 444   36


Q ss_pred             CCCCeEeCcCCccccccCCcccCCC-CCC-------------CCCccccccCCCCC
Q 035691          318 KSLEGLDLFQNTFQAKSQNGDVPRK-GIF-------------KNASAISVAGNEKL  359 (640)
Q Consensus       318 ~~L~~L~l~~N~l~~~~~~~~~p~~-~~~-------------~~~~~~~~~~n~~~  359 (640)
                      ++|++|++++|+++..+   .+|.. +.+             ++++.+++++|+..
T Consensus       357 ~~L~~L~L~~N~l~~l~---~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~  409 (454)
T 1jl5_A          357 QNLKQLHVEYNPLREFP---DIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR  409 (454)
T ss_dssp             TTCCEEECCSSCCSSCC---CCCTTCCEEECCC-----------------------
T ss_pred             hhccEEECCCCCCCcCC---CChHHHHhhhhcccccccccccCcCCEEECCCCcCC
Confidence            77777777777777422   23322 112             55677777777654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.4e-34  Score=315.54  Aligned_cols=175  Identities=26%  Similarity=0.328  Sum_probs=146.1

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHH---HHHHHhcCCCCCcceeEeeccCCcCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAE---CEALRNIRHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~H~niv~l~~~~~~~~~~~  514 (640)
                      ++|++.++||+|+||+||+|+++.+|+.||||+++...   ........+|   +.+++.++|||||+++++     +++
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~-----f~~  263 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----FHT  263 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE-----EEC
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEE-----EEE
Confidence            56889999999999999999999999999999996432   2222333444   566677899999999999     556


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                      .+..|+|||||+||+|.+++....          .+++..+..++.||+.||+|||+   .+||||||||+|||++.+|.
T Consensus       264 ~~~lylVmEy~~GGdL~~~l~~~~----------~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~  330 (689)
T 3v5w_A          264 PDKLSFILDLMNGGDLHYHLSQHG----------VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGH  330 (689)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSC
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCC
Confidence            678999999999999999996543          38899999999999999999999   69999999999999999999


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCC-CCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS-QVST  639 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~  639 (640)
                      +||+|||+|+.+...      ...+.+||+.|||||++.++ .|+.
T Consensus       331 vKL~DFGlA~~~~~~------~~~t~~GTp~YmAPEvl~~~~~y~~  370 (689)
T 3v5w_A          331 VRISDLGLACDFSKK------KPHASVGTHGYMAPEVLQKGVAYDS  370 (689)
T ss_dssp             EEECCCTTCEECSSC------CCCSCCSCGGGCCHHHHSTTCCCCT
T ss_pred             EEecccceeeecCCC------CCCCccCCcCccCHHHHhCCCCCCc
Confidence            999999999876432      22346899999999999754 5553

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=100.00  E-value=1e-33  Score=288.63  Aligned_cols=260  Identities=20%  Similarity=0.209  Sum_probs=190.5

Q ss_pred             CCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCcc--CCccccCCCCCCEEEcccCcCCCCCCCcccccccccCC
Q 035691           81 PNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS--IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNC  158 (640)
Q Consensus        81 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l  158 (640)
                      ++|+.|+|++|+++.+.+..|.++++|++|+|++|+++..  .+..+..+++|++|+|++|.++.+       +..+.++
T Consensus        28 ~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~l-------~~~~~~l  100 (306)
T 2z66_A           28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM-------SSNFLGL  100 (306)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEEEE-------EEEEETC
T ss_pred             CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccccC-------hhhcCCC
Confidence            3455555555555544444455666666666666666532  244555566666666666666542       2345566


Q ss_pred             CCcceEecCCCCCCCcCc--CCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCC-CCCccccCCCCccEE
Q 035691          159 TYLEIVSLNVNSLRSIPI--SVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRG-SIPSALGNCHQLQSL  235 (640)
Q Consensus       159 ~~L~~L~L~~N~l~~ip~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L  235 (640)
                      ++|++|++++|.++.++.  .+..+++|++|++++|.+.+..+..|.++++|++|+|++|.+.+ ..|..|..+++|+.|
T Consensus       101 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L  180 (306)
T 2z66_A          101 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL  180 (306)
T ss_dssp             TTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred             CCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEE
Confidence            666666666666666543  56778888888888888888888888888999999999998876 577888888888888


Q ss_pred             eccCccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCC
Q 035691          236 DLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLS  315 (640)
Q Consensus       236 ~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~  315 (640)
                                      ++++|++++..|..|..+++|+.|+|++|++++..+..|..+++|++|+|++|++++..|..+.
T Consensus       181 ----------------~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  244 (306)
T 2z66_A          181 ----------------DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ  244 (306)
T ss_dssp             ----------------ECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCC
T ss_pred             ----------------ECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHH
Confidence                            7778888877788999999999999999999977777899999999999999999999999999


Q ss_pred             CCC-CCCeEeCcCCccccccCCcccCCCCCCCCCccccccCCCCCcCCCcC
Q 035691          316 SLK-SLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGISE  365 (640)
Q Consensus       316 ~l~-~L~~L~l~~N~l~~~~~~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~  365 (640)
                      .++ +|++|+|++|+++|.+...+++.+  +.....+.+..+...|..|..
T Consensus       245 ~~~~~L~~L~L~~N~~~~~c~~~~~~~~--l~~~~~~~~~~~~~~C~~p~~  293 (306)
T 2z66_A          245 HFPSSLAFLNLTQNDFACTCEHQSFLQW--IKDQRQLLVEVERMECATPSD  293 (306)
T ss_dssp             CCCTTCCEEECTTCCEECSGGGHHHHHH--HHHTGGGBSCGGGCBEEESGG
T ss_pred             hhhccCCEEEccCCCeecccChHHHHHH--HHhhhhhhccccccccCCchh
Confidence            985 999999999999987754433332  233344455566777776654

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.6e-34  Score=295.19  Aligned_cols=179  Identities=26%  Similarity=0.329  Sum_probs=145.2

Q ss_pred             HHhcCCCcccCcccccccceEEEEEEC---CCCeEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCc
Q 035691          437 LKATGGFSSANLIGTGSFGSVYKGILD---PDQTVVAVKVLFLHQRGALKSFMAECEALRNI-RHRNLVKIITACSSSDF  512 (640)
Q Consensus       437 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  512 (640)
                      ....+.|++.+.||+|+||+||+|+++   .+++.||||++....  ....+.+|+++|+.+ +|||||++++++     
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~-----   89 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCF-----   89 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEE-----
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEE-----
Confidence            345678999999999999999999874   467899999985433  335688999999998 699999999984     


Q ss_pred             CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC
Q 035691          513 QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND  592 (640)
Q Consensus       513 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~  592 (640)
                      .+.++.|+|||||++|+|.+++.             .+++..+..++.|++.||+|||+   .+|+||||||+|||++.+
T Consensus        90 ~~~~~~~lvmE~~~g~~L~~~~~-------------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~  153 (361)
T 4f9c_A           90 RKNDHVVIAMPYLEHESFLDILN-------------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRR  153 (361)
T ss_dssp             EETTEEEEEEECCCCCCHHHHHT-------------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETT
T ss_pred             EECCEEEEEEeCCCcccHHHHHc-------------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCC
Confidence            45668999999999999999983             27788999999999999999999   699999999999999876


Q ss_pred             -CcEEEccccccccCCCccCC------------------------CceeeccccccccccCcccCCCCC-CC
Q 035691          593 -MIAHVGDFGLTRFIPEVISS------------------------NQCSSVGLKGTVGYAAPEYGMGSQ-VS  638 (640)
Q Consensus       593 -~~~kl~DfGla~~~~~~~~~------------------------~~~~~~~~~gt~~y~aPE~~~~~~-~s  638 (640)
                       +.+||+|||+|+........                        ......+.+||++|||||++.+.+ ++
T Consensus       154 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~  225 (361)
T 4f9c_A          154 LKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQT  225 (361)
T ss_dssp             TTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCC
T ss_pred             CCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCC
Confidence             89999999999865321100                        001123457999999999998865 44

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=8.3e-34  Score=311.65  Aligned_cols=177  Identities=26%  Similarity=0.360  Sum_probs=154.5

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      ++|++.+.||+|+||.||+|+++.+|+.||+|++........+.+.+|+++|+.++|||||++++++     .+....++
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~i  231 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMVM  231 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEE
Confidence            5789999999999999999999999999999999776666667899999999999999999999994     55668999


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC--CcEEEc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND--MIAHVG  598 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~--~~~kl~  598 (640)
                      |||||+||+|.+++.....         .+++..+..++.||+.||+|||+   .+|+||||||+|||++.+  +.+||+
T Consensus       232 v~E~~~gg~L~~~i~~~~~---------~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~  299 (573)
T 3uto_A          232 IYEFMSGGELFEKVADEHN---------KMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLI  299 (573)
T ss_dssp             EEECCCCCBHHHHHTCTTS---------CEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEEC
T ss_pred             EEeecCCCcHHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEe
Confidence            9999999999999864432         38899999999999999999999   699999999999999854  899999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |||+|+.+...     ......+||+.|||||++.+..++.
T Consensus       300 DFG~a~~~~~~-----~~~~~~~GT~~y~APEv~~~~~y~~  335 (573)
T 3uto_A          300 DFGLTAHLDPK-----QSVKVTTGTAEFAAPEVAEGKPVGY  335 (573)
T ss_dssp             CCSSCEECCTT-----SEEEEECSSGGGCCHHHHTTCCBCH
T ss_pred             eccceeEccCC-----CceeeeEECccccCHHHhCCCCCCc
Confidence            99999976432     1223457999999999999988763

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=100.00  E-value=4.8e-32  Score=290.74  Aligned_cols=255  Identities=25%  Similarity=0.263  Sum_probs=226.7

Q ss_pred             CCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCC
Q 035691           52 ELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNL  131 (640)
Q Consensus        52 ~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  131 (640)
                      ....++.+++.|+.      +|..++   ++++.|+|++|+|+++.+..|.++++|++|+|++|+|+++.+..|.++++|
T Consensus        44 ~~~~v~c~~~~l~~------iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L  114 (440)
T 3zyj_A           44 QFSKVICVRKNLRE------VPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL  114 (440)
T ss_dssp             TSCEEECCSCCCSS------CCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSC
T ss_pred             CCCEEEeCCCCcCc------CCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccC
Confidence            46788998888876      887664   688999999999999999999999999999999999999888999999999


Q ss_pred             CEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCc-CCCCCCCCCEEEccC-CcCcccCCcCccCCCCCC
Q 035691          132 TRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPI-SVGYLPKLQVLSLFE-NNISGEIPSSLGNFTFLT  209 (640)
Q Consensus       132 ~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~  209 (640)
                      ++|+|++|+|+.++      +..|.++++|++|+|++|.++.+|. .+..+++|++|+|++ |.+..+.+..|.++++|+
T Consensus       115 ~~L~L~~n~l~~~~------~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~  188 (440)
T 3zyj_A          115 NTLELFDNRLTTIP------NGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLR  188 (440)
T ss_dssp             CEEECCSSCCSSCC------TTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCC
T ss_pred             CEEECCCCcCCeeC------HhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccC
Confidence            99999999999873      3567888999999999999999766 677899999999999 566666667899999999


Q ss_pred             EEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCcc
Q 035691          210 ELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSS  289 (640)
Q Consensus       210 ~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  289 (640)
                      +|+|++|+++. +| .+..+++|+.|                +|++|+|++..|..|.++++|+.|+|++|+|++..+..
T Consensus       189 ~L~L~~n~l~~-~~-~~~~l~~L~~L----------------~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  250 (440)
T 3zyj_A          189 YLNLAMCNLRE-IP-NLTPLIKLDEL----------------DLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNA  250 (440)
T ss_dssp             EEECTTSCCSS-CC-CCTTCSSCCEE----------------ECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTS
T ss_pred             eecCCCCcCcc-cc-ccCCCcccCEE----------------ECCCCccCccChhhhccCccCCEEECCCCceeEEChhh
Confidence            99999999984 44 46777777777                88889999888999999999999999999999999999


Q ss_pred             ccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCccc
Q 035691          290 LGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDV  339 (640)
Q Consensus       290 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  339 (640)
                      |.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|.|.|...++
T Consensus       251 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l~~l  300 (440)
T 3zyj_A          251 FDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDILWL  300 (440)
T ss_dssp             STTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTTHHH
T ss_pred             hcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCchHH
Confidence            99999999999999999998899999999999999999999999865443

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=100.00  E-value=6e-32  Score=291.05  Aligned_cols=253  Identities=23%  Similarity=0.213  Sum_probs=225.4

Q ss_pred             CCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCC
Q 035691           52 ELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNL  131 (640)
Q Consensus        52 ~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  131 (640)
                      ....++.+++.++.      +|..+.   ++++.|+|++|+|+++.|..|.++++|++|+|++|+|+++.+..|.++++|
T Consensus        55 ~~~~v~c~~~~l~~------iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L  125 (452)
T 3zyi_A           55 QFSKVVCTRRGLSE------VPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL  125 (452)
T ss_dssp             SSCEEECCSSCCSS------CCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred             CCcEEEECCCCcCc------cCCCCC---CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccC
Confidence            45788998888876      787653   689999999999999999999999999999999999999888999999999


Q ss_pred             CEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCc-CCCCCCCCCEEEccC-CcCcccCCcCccCCCCCC
Q 035691          132 TRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPI-SVGYLPKLQVLSLFE-NNISGEIPSSLGNFTFLT  209 (640)
Q Consensus       132 ~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~  209 (640)
                      ++|+|++|+|+.++      +..|.++++|++|+|++|.++.+|. .+..+++|++|++++ |.+..+.+..|.++++|+
T Consensus       126 ~~L~L~~n~l~~~~------~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~  199 (452)
T 3zyi_A          126 NTLELFDNWLTVIP------SGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLK  199 (452)
T ss_dssp             CEEECCSSCCSBCC------TTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCC
T ss_pred             CEEECCCCcCCccC------hhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCC
Confidence            99999999999873      3557788999999999999999776 677899999999999 667766667899999999


Q ss_pred             EEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCcc
Q 035691          210 ELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSS  289 (640)
Q Consensus       210 ~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  289 (640)
                      +|+|++|++++. | .+..+++|+.|                +|++|++++..|..|.++++|+.|+|++|++++..|..
T Consensus       200 ~L~L~~n~l~~~-~-~~~~l~~L~~L----------------~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  261 (452)
T 3zyi_A          200 YLNLGMCNIKDM-P-NLTPLVGLEEL----------------EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNA  261 (452)
T ss_dssp             EEECTTSCCSSC-C-CCTTCTTCCEE----------------ECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTT
T ss_pred             EEECCCCccccc-c-cccccccccEE----------------ECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHH
Confidence            999999999854 4 47777777777                88889999888999999999999999999999999999


Q ss_pred             ccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCc
Q 035691          290 LGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNG  337 (640)
Q Consensus       290 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  337 (640)
                      |.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|.|.|...
T Consensus       262 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~~  309 (452)
T 3zyi_A          262 FDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDIL  309 (452)
T ss_dssp             TTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTTH
T ss_pred             hcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCch
Confidence            999999999999999999988899999999999999999999998654

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.2e-33  Score=288.83  Aligned_cols=277  Identities=20%  Similarity=0.169  Sum_probs=165.1

Q ss_pred             CCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCC
Q 035691           29 LRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLE  108 (640)
Q Consensus        29 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  108 (640)
                      ....++++|.++ .+|..+.  ++|++|+|++|+|+.      +|+..+..+++|+.|+|++|++++..|..|.++++|+
T Consensus        33 ~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~------~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  103 (353)
T 2z80_A           33 NGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITY------ISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLE  103 (353)
T ss_dssp             TSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCE------ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             CeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcc------cCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCC
Confidence            334555555555 3343332  355555555555543      4444444455555555555555555555555555555


Q ss_pred             EEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCC-CCCCc-CcCCCCCCCCCE
Q 035691          109 WLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVN-SLRSI-PISVGYLPKLQV  186 (640)
Q Consensus       109 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N-~l~~i-p~~~~~l~~L~~  186 (640)
                      +|+|++|+|+++.+..|.++++|++|+|++|+++.++.     ...+.++++|++|++++| .++.+ |..+..+++|++
T Consensus       104 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~-----~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~  178 (353)
T 2z80_A          104 HLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGE-----TSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEE  178 (353)
T ss_dssp             EEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCS-----SCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEE
T ss_pred             EEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCc-----hhhhccCCCCcEEECCCCccccccCHHHccCCCCCCE
Confidence            55555555554444445555555555555555554321     023445555555555555 34443 234445555555


Q ss_pred             EEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCccC
Q 035691          187 LSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAV  266 (640)
Q Consensus       187 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~  266 (640)
                      |++++|.+++..|..|..+++|++|++++|++....+..+..+++|+.|                ++++|++++..+..+
T Consensus       179 L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L----------------~L~~n~l~~~~~~~l  242 (353)
T 2z80_A          179 LEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECL----------------ELRDTDLDTFHFSEL  242 (353)
T ss_dssp             EEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEE----------------EEESCBCTTCCCC--
T ss_pred             EECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEE----------------ECCCCcccccccccc
Confidence            5555555555555555555555555555555543332233344555555                777777776655443


Q ss_pred             C---CCCCCCEEECCCCcccC----cCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccC
Q 035691          267 G---NLKSIPHLDLSKNKLSG----EIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQ  335 (640)
Q Consensus       267 ~---~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  335 (640)
                      .   ....++.++|++|.+++    .+|..+..+++|++|+|++|+++...+..|..+++|++|+|++|++.|.+.
T Consensus       243 ~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          243 STGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             ----CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             ccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence            3   45678889999998875    367788999999999999999996555567999999999999999997664

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.98  E-value=5.4e-33  Score=289.33  Aligned_cols=280  Identities=15%  Similarity=0.154  Sum_probs=231.0

Q ss_pred             CcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCC
Q 035691            5 LMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIR   84 (640)
Q Consensus         5 L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~   84 (640)
                      ....|+++|+++ .+|..+.  ++|++|++++|++++..+..|.++++|++|+|++|+|+.      +++..+..+++|+
T Consensus        33 ~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~------~~~~~~~~l~~L~  103 (353)
T 2z80_A           33 NGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT------IEEDSFSSLGSLE  103 (353)
T ss_dssp             TSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCE------ECTTTTTTCTTCC
T ss_pred             CeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCc------cCHhhcCCCCCCC
Confidence            456889999999 6676555  589999999999998777799999999999999999875      7777777899999


Q ss_pred             eeeccCCcccccCCccCcCCCCCCEEECcCCccCccCC-ccccCCCCCCEEEcccC-cCCCCCCCcccccccccCCCCcc
Q 035691           85 IPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIP-EDLGRLRNLTRLNFARN-DLGTRKVNDLRFLDSLVNCTYLE  162 (640)
Q Consensus        85 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~~~l~~l~~L~  162 (640)
                      .|+|++|++++..+..|.++++|++|+|++|+++.+.+ ..|..+++|++|++++| .++.+      .+..|.++++|+
T Consensus       104 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~------~~~~~~~l~~L~  177 (353)
T 2z80_A          104 HLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKI------QRKDFAGLTFLE  177 (353)
T ss_dssp             EEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEE------CTTTTTTCCEEE
T ss_pred             EEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCcccccc------CHHHccCCCCCC
Confidence            99999999998777779999999999999999997555 58999999999999999 47665      345688899999


Q ss_pred             eEecCCCCCCCc-CcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCcccc---CCCCccEEecc
Q 035691          163 IVSLNVNSLRSI-PISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALG---NCHQLQSLDLS  238 (640)
Q Consensus       163 ~L~L~~N~l~~i-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~ls  238 (640)
                      +|++++|.++.+ |..+..+++|++|++++|.+....+..+..+++|+.|+|++|++++..+..+.   ....++.++++
T Consensus       178 ~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~  257 (353)
T 2z80_A          178 ELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFR  257 (353)
T ss_dssp             EEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEE
T ss_pred             EEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccc
Confidence            999999999995 77889999999999999999865555566789999999999999977665443   24455555444


Q ss_pred             CccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCC
Q 035691          239 KTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIH  311 (640)
Q Consensus       239 ~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~  311 (640)
                      ++           ++++|.+. .+|..+..+++|+.|+|++|+|+...+..|..+++|++|+|++|++++..|
T Consensus       258 ~~-----------~l~~~~l~-~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          258 NV-----------KITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             SC-----------BCCHHHHH-HHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             cc-----------cccCcchh-hhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence            33           33344443 467889999999999999999995444446999999999999999986543

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.98  E-value=3.6e-31  Score=283.94  Aligned_cols=248  Identities=22%  Similarity=0.234  Sum_probs=182.1

Q ss_pred             CCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCC
Q 035691           28 QLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKL  107 (640)
Q Consensus        28 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  107 (640)
                      ..+.++.+++.++ .+|..+.  ++++.|+|++|+|+.      +++..|..+++|+.|+|++|+|+++.+..|.++++|
T Consensus        44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~------~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L  114 (440)
T 3zyj_A           44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQI------IKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL  114 (440)
T ss_dssp             TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCE------ECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSC
T ss_pred             CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCe------eCHHHhhCCCCCCEEECCCCcCCccChhhccCCccC
Confidence            3556777777776 5555444  567777777777664      555566667777777777777777777777777777


Q ss_pred             CEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCC-CCCCCcCc-CCCCCCCCC
Q 035691          108 EWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNV-NSLRSIPI-SVGYLPKLQ  185 (640)
Q Consensus       108 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~-N~l~~ip~-~~~~l~~L~  185 (640)
                      ++|+|++|+|+.+.+..|..+++|++|+|++|+|+.++      ...|.++++|+.|++++ |.+..++. .+..+++|+
T Consensus       115 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~------~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~  188 (440)
T 3zyj_A          115 NTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIP------SYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLR  188 (440)
T ss_dssp             CEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEEC------TTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCC
T ss_pred             CEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccC------HHHhhhCcccCEeCCCCCCCcceeCcchhhcccccC
Confidence            77777777777666667777777777777777777652      34566777777777777 44555555 466677888


Q ss_pred             EEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCcc
Q 035691          186 VLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLA  265 (640)
Q Consensus       186 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~  265 (640)
                      +|+|++|.++. +| .+..+++|++|+|++|+|++..|..|.++++|+.|                +|++|+|++..+..
T Consensus       189 ~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L----------------~L~~n~l~~~~~~~  250 (440)
T 3zyj_A          189 YLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKL----------------WMIQSQIQVIERNA  250 (440)
T ss_dssp             EEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEE----------------ECTTCCCCEECTTS
T ss_pred             eecCCCCcCcc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEE----------------ECCCCceeEEChhh
Confidence            88888888873 44 37777888888888888887777788888877777                67777777777778


Q ss_pred             CCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCC
Q 035691          266 VGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHG  308 (640)
Q Consensus       266 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  308 (640)
                      |.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++..
T Consensus       251 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C  293 (440)
T 3zyj_A          251 FDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC  293 (440)
T ss_dssp             STTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred             hcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence            8888888888888888887777777888888888888888764

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.98  E-value=5.9e-32  Score=275.65  Aligned_cols=272  Identities=23%  Similarity=0.265  Sum_probs=176.0

Q ss_pred             eEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCccccc--CCccCcCCCCCC
Q 035691           31 YIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGN--IPHSISNASKLE  108 (640)
Q Consensus        31 ~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~  108 (640)
                      .++++++.++ .+|..+.  ++|++|+|++|+|+.      +|...+..+++|+.|+|++|+++..  .+..+..+++|+
T Consensus        11 ~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~------i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~   81 (306)
T 2z66_A           11 EIRCNSKGLT-SVPTGIP--SSATRLELESNKLQS------LPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLK   81 (306)
T ss_dssp             EEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCC------CCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCC
T ss_pred             EEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCc------cCHhHhhccccCCEEECCCCccCcccCcccccccccccC
Confidence            4555555555 3343332  455556665555543      5555555555666666666655522  244555566677


Q ss_pred             EEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCC-cCcCCCCCCCCCEE
Q 035691          109 WLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRS-IPISVGYLPKLQVL  187 (640)
Q Consensus       109 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L  187 (640)
                      +|+|++|.++. +|..|..+++|++|+|++|+++.++.     ...+.++++|++|++++|.++. .|..+..+++|++|
T Consensus        82 ~L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~-----~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  155 (306)
T 2z66_A           82 YLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSE-----FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL  155 (306)
T ss_dssp             EEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTT-----TTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEE
T ss_pred             EEECCCCcccc-ChhhcCCCCCCCEEECCCCccccccc-----chhhhhccCCCEEECCCCcCCccchhhcccCcCCCEE
Confidence            77777776663 45556666777777777776665421     1345566677777777777765 34456667778888


Q ss_pred             EccCCcCcc-cCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCccC
Q 035691          188 SLFENNISG-EIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAV  266 (640)
Q Consensus       188 ~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~  266 (640)
                      ++++|.+.+ ..|..|..+++|++|+|++|++++..|..|..+++|+.|                +|++|++++..+..|
T Consensus       156 ~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L----------------~L~~N~l~~~~~~~~  219 (306)
T 2z66_A          156 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL----------------NMSHNNFFSLDTFPY  219 (306)
T ss_dssp             ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE----------------ECTTSCCSBCCSGGG
T ss_pred             ECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEE----------------ECCCCccCccChhhc
Confidence            888887775 567777778888888888888877777777777777777                666777776666677


Q ss_pred             CCCCCCCEEECCCCcccCcCCccccCCC-CCCeEEecCCccCCCCCc--cCCCCCCCCeEeCcCCccccc
Q 035691          267 GNLKSIPHLDLSKNKLSGEIPSSLGSCV-GLEYLNLSINSFHGPIHP--GLSSLKSLEGLDLFQNTFQAK  333 (640)
Q Consensus       267 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~l~~N~l~~~  333 (640)
                      ..+++|+.|+|++|++++..|..+..++ +|++|+|++|++++..+.  ....+...+.+.+..+.+.|.
T Consensus       220 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~  289 (306)
T 2z66_A          220 KCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECA  289 (306)
T ss_dssp             TTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEE
T ss_pred             cCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccC
Confidence            7788888888888888877777777774 788888888888754321  122233455556666666653

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.98  E-value=4.4e-31  Score=284.27  Aligned_cols=248  Identities=21%  Similarity=0.199  Sum_probs=196.0

Q ss_pred             CCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCC
Q 035691           28 QLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKL  107 (640)
Q Consensus        28 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  107 (640)
                      ....++.+++.++ .+|..+.  ++|++|+|++|+|+.      +++..|..+++|+.|+|++|+|+++.+..|.++++|
T Consensus        55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~------~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L  125 (452)
T 3zyi_A           55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQM------IQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL  125 (452)
T ss_dssp             SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCE------ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred             CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCce------ECHHHcCCCCCCCEEECCCCccCCcChhhccCcccC
Confidence            3566777777777 4565444  578888888777764      666666678888888888888888877888888888


Q ss_pred             CEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCC-CCCCCcCc-CCCCCCCCC
Q 035691          108 EWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNV-NSLRSIPI-SVGYLPKLQ  185 (640)
Q Consensus       108 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~-N~l~~ip~-~~~~l~~L~  185 (640)
                      ++|+|++|+|+.+.+..|..+++|++|+|++|+|+.++      ...|.++++|+.|++++ |.+..+|. .+..+++|+
T Consensus       126 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~------~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~  199 (452)
T 3zyi_A          126 NTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIP------SYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLK  199 (452)
T ss_dssp             CEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEEC------TTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCC
T ss_pred             CEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeC------HhHHhcCCcccEEeCCCCCCccccChhhccCCCCCC
Confidence            88888888888777777888888888888888887663      34567778888888887 55666665 467788888


Q ss_pred             EEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCcc
Q 035691          186 VLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLA  265 (640)
Q Consensus       186 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~  265 (640)
                      +|+|++|.+++. | .+..+++|++|+|++|+|++..|..|.++++|+.|                +|++|++++..+..
T Consensus       200 ~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L----------------~L~~n~l~~~~~~~  261 (452)
T 3zyi_A          200 YLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKL----------------WVMNSQVSLIERNA  261 (452)
T ss_dssp             EEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEE----------------ECTTSCCCEECTTT
T ss_pred             EEECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEE----------------EeCCCcCceECHHH
Confidence            888888888854 4 47788888888888888888888888888888888                77778888778888


Q ss_pred             CCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCC
Q 035691          266 VGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHG  308 (640)
Q Consensus       266 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  308 (640)
                      |.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++..
T Consensus       262 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C  304 (452)
T 3zyi_A          262 FDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC  304 (452)
T ss_dssp             TTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred             hcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence            8888999999999999987777788888889999999998864

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.97  E-value=3.4e-33  Score=302.62  Aligned_cols=246  Identities=22%  Similarity=0.206  Sum_probs=197.3

Q ss_pred             CCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCC
Q 035691           80 LPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCT  159 (640)
Q Consensus        80 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~  159 (640)
                      .++|+.|+|++|.|++..|..|.++++|++|+|++|.|++..|  |..+++|++|+|++|.|++++           ..+
T Consensus        33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----------~~~   99 (487)
T 3oja_A           33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----------VGP   99 (487)
T ss_dssp             GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----------ECT
T ss_pred             CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----------CCC
Confidence            3478889999999988888889999999999999999987665  889999999999999887652           237


Q ss_pred             CcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCcccc-CCCCccEEecc
Q 035691          160 YLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALG-NCHQLQSLDLS  238 (640)
Q Consensus       160 ~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~ls  238 (640)
                      +|+.|++++|.++.+|..  .+++|++|+|++|.|++..|..|..+++|++|+|++|.+++.+|..|. .+++|+.|   
T Consensus       100 ~L~~L~L~~N~l~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L---  174 (487)
T 3oja_A          100 SIETLHAANNNISRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL---  174 (487)
T ss_dssp             TCCEEECCSSCCCCEEEC--CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEE---
T ss_pred             CcCEEECcCCcCCCCCcc--ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEE---
Confidence            899999999999987653  358899999999999998898999999999999999999988888876 78888888   


Q ss_pred             CccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCC
Q 035691          239 KTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLK  318 (640)
Q Consensus       239 ~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  318 (640)
                                   +|++|.|++..+  +..+++|+.|+|++|+|++ +|..|..+++|+.|+|++|.|++ +|..+..++
T Consensus       175 -------------~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~  237 (487)
T 3oja_A          175 -------------NLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQ  237 (487)
T ss_dssp             -------------ECTTSCCCEEEC--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCT
T ss_pred             -------------ecCCCccccccc--cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCC
Confidence                         777777775533  3458999999999999995 55558899999999999999985 677789999


Q ss_pred             CCCeEeCcCCccccccCCcccCCCCCCCCCcccccc-------CCCCCcCCC
Q 035691          319 SLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVA-------GNEKLCGGI  363 (640)
Q Consensus       319 ~L~~L~l~~N~l~~~~~~~~~p~~~~~~~~~~~~~~-------~n~~~c~~~  363 (640)
                      +|+.|++++|++.|.+....+   ..++.+..+.+.       +|++.|.++
T Consensus       238 ~L~~L~l~~N~l~c~~~~~~~---~~l~~L~~l~~~~~~~~~~~~~~~c~~~  286 (487)
T 3oja_A          238 NLEHFDLRGNGFHCGTLRDFF---SKNQRVQTVAKQTVKKLTGQNEEECTVP  286 (487)
T ss_dssp             TCCEEECTTCCBCHHHHHHHH---TTCHHHHHHHHHHHHHHTSSSSCCCSST
T ss_pred             CCCEEEcCCCCCcCcchHHHH---HhCCCCcEEeccccccccCCCcccccCC
Confidence            999999999999864322111   223344444444       666666543

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.97  E-value=7.9e-31  Score=264.41  Aligned_cols=252  Identities=20%  Similarity=0.177  Sum_probs=172.5

Q ss_pred             CEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCE
Q 035691           54 RTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTR  133 (640)
Q Consensus        54 ~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  133 (640)
                      ++++.+++.++.      +|..+   .++|+.|+|++|+|++..+..|.++++|++|+|++|+++++.|..|.++++|++
T Consensus        14 ~~~~c~~~~l~~------ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~   84 (285)
T 1ozn_A           14 VTTSCPQQGLQA------VPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQ   84 (285)
T ss_dssp             CEEECCSSCCSS------CCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred             eEEEcCcCCccc------CCcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCE
Confidence            456666666654      55432   345566666666666555566666666666666666666655666666666666


Q ss_pred             EEcccCc-CCCCCCCcccccccccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEE
Q 035691          134 LNFARND-LGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELN  212 (640)
Q Consensus       134 L~L~~N~-l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  212 (640)
                      |+|++|+ ++.++                             |..+..+++|++|++++|.+++..|..|.++++|++|+
T Consensus        85 L~l~~n~~l~~~~-----------------------------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  135 (285)
T 1ozn_A           85 LDLSDNAQLRSVD-----------------------------PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY  135 (285)
T ss_dssp             EECCSCTTCCCCC-----------------------------TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred             EeCCCCCCccccC-----------------------------HHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEE
Confidence            6666664 44331                             33455566777777777777766677777777777777


Q ss_pred             ccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccC
Q 035691          213 LRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGS  292 (640)
Q Consensus       213 L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  292 (640)
                      |++|++++..+..|..+++|+.|                +|++|++++..+..|..+++|+.|+|++|++++..|..|..
T Consensus       136 l~~n~l~~~~~~~~~~l~~L~~L----------------~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  199 (285)
T 1ozn_A          136 LQDNALQALPDDTFRDLGNLTHL----------------FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD  199 (285)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEE----------------ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTT
T ss_pred             CCCCcccccCHhHhccCCCccEE----------------ECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccC
Confidence            77777776666667777777777                66677777666667888888888888888888777888888


Q ss_pred             CCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCcccCCCCCCCCCccccccCCCCCcCCCc
Q 035691          293 CVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGIS  364 (640)
Q Consensus       293 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~p~~~~~~~~~~~~~~~n~~~c~~~~  364 (640)
                      +++|++|+|++|++++..+..+..+++|++|++++|++.|.+...+..     ..+.......+...|..|.
T Consensus       200 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~-----~~l~~~~~~~~~~~c~~p~  266 (285)
T 1ozn_A          200 LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLW-----AWLQKFRGSSSEVPCSLPQ  266 (285)
T ss_dssp             CTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHH-----HHHHHCCSEECCCBEEESG
T ss_pred             cccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHH-----HHHHhcccccCccccCCch
Confidence            888888888888888877777888889999999999988766442221     1223334456666676654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.97  E-value=2e-32  Score=291.17  Aligned_cols=182  Identities=25%  Similarity=0.272  Sum_probs=153.3

Q ss_pred             CHHHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeec
Q 035691          432 SYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACS  508 (640)
Q Consensus       432 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~  508 (640)
                      .+.++....++|++.++||+|+||+||+|+++.+++.||||++....   ....+.+.+|+.++..++|||||+++++| 
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-  143 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-  143 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence            34556666788999999999999999999999999999999996432   22234588999999999999999999995 


Q ss_pred             cCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCee
Q 035691          509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVL  588 (640)
Q Consensus       509 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiL  588 (640)
                          .+....++|||||++|+|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+|||
T Consensus       144 ----~~~~~~~lV~Ey~~gg~L~~~l~~~~---------~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NIL  207 (437)
T 4aw2_A          144 ----QDDNNLYLVMDYYVGGDLLTLLSKFE---------DRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNIL  207 (437)
T ss_dssp             ----ECSSEEEEEECCCTTCBHHHHHHTTT---------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEE
T ss_pred             ----eeCCEEEEEEecCCCCcHHHHHHHcc---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHee
Confidence                44558899999999999999997532         238899999999999999999999   69999999999999


Q ss_pred             eCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCC
Q 035691          589 LDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGM  633 (640)
Q Consensus       589 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  633 (640)
                      ++.++.+||+|||+|+......   .......+||+.|+|||++.
T Consensus       208 l~~~g~vkL~DFGla~~~~~~~---~~~~~~~~GT~~Y~APE~l~  249 (437)
T 4aw2_A          208 MDMNGHIRLADFGSCLKLMEDG---TVQSSVAVGTPDYISPEILQ  249 (437)
T ss_dssp             ECTTSCEEECCCTTCEECCTTS---CEECCSCCSCGGGCCHHHHH
T ss_pred             EcCCCCEEEcchhhhhhcccCC---CcccccccCCcCeeChHHHh
Confidence            9999999999999998654321   12223457999999999987

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=1e-34  Score=313.72  Aligned_cols=348  Identities=16%  Similarity=0.094  Sum_probs=212.9

Q ss_pred             CCCCcEEeCCCCccccCCchh-hhcCCCCCeEEcccCccCc----cCCcCCCCCCCCCEEEccCCCcCCccccccCCchh
Q 035691            2 LTFLMLINLQQNNFSGNIPHE-IGRLFQLRYIIFNSNTLQG----QIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYI   76 (640)
Q Consensus         2 l~~L~~L~L~~n~i~~~~p~~-~~~l~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~   76 (640)
                      +++|+.|||++|+++...... +..+++|++|+|++|.++.    .++..+..+++|++|||++|++.+     ..+..+
T Consensus         2 ~~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~-----~~~~~l   76 (461)
T 1z7x_W            2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGD-----VGVHCV   76 (461)
T ss_dssp             CEEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHH-----HHHHHH
T ss_pred             CccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCCh-----HHHHHH
Confidence            356788888888887554433 7788888888888888874    345667777888888888877753     122233


Q ss_pred             hcCCC----CCCeeeccCCcccc----cCCccCcCCCCCCEEECcCCccCccCCcccc-----CCCCCCEEEcccCcCCC
Q 035691           77 GFTLP----NIRIPLLAGNQFFG----NIPHSISNASKLEWLDFANNSLTASIPEDLG-----RLRNLTRLNFARNDLGT  143 (640)
Q Consensus        77 ~~~l~----~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~  143 (640)
                      +..++    +|+.|+|++|+|+.    .++..|..+++|++|+|++|.++...+..+.     ..++|++|+|++|+++.
T Consensus        77 ~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~  156 (461)
T 1z7x_W           77 LQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSA  156 (461)
T ss_dssp             HHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBG
T ss_pred             HHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCH
Confidence            33344    68888888888873    4577788888888888888888754443322     35578888888887765


Q ss_pred             CCCCcccccccccCCCCcceEecCCCCCCCc-CcCCC-----CCCCCCEEEccCCcCccc----CCcCccCCCCCCEEEc
Q 035691          144 RKVNDLRFLDSLVNCTYLEIVSLNVNSLRSI-PISVG-----YLPKLQVLSLFENNISGE----IPSSLGNFTFLTELNL  213 (640)
Q Consensus       144 ~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~i-p~~~~-----~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L  213 (640)
                      .....  .+..+..+++|++|++++|.++.. +..+.     ..++|++|++++|.+++.    ++..+..+++|++|+|
T Consensus       157 ~~~~~--l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L  234 (461)
T 1z7x_W          157 ASCEP--LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELAL  234 (461)
T ss_dssp             GGHHH--HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEEC
T ss_pred             HHHHH--HHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEec
Confidence            42111  234455667777777777776652 11121     245677777777777643    3555666677777777


Q ss_pred             cCCCCCCCC-----CccccCCCCccEEeccCccccC------------CCCCceEEccCCcCCCCCCccCC-----CCCC
Q 035691          214 RGNSIRGSI-----PSALGNCHQLQSLDLSKTIFLG------------QYPVRWLDLSHNHLTGPIPLAVG-----NLKS  271 (640)
Q Consensus       214 ~~N~l~~~~-----~~~~~~l~~L~~L~ls~n~~~~------------~~~l~~L~Ls~N~l~~~~~~~~~-----~l~~  271 (640)
                      ++|+++...     +..+..+++|+.|++++|.+..            ...|++|++++|.+++..+..+.     ..++
T Consensus       235 s~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~  314 (461)
T 1z7x_W          235 GSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQ  314 (461)
T ss_dssp             CSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCC
T ss_pred             cCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCcc
Confidence            777765432     2223346677777777765543            34567777777766543332222     2256


Q ss_pred             CCEEECCCCcccCc----CCccccCCCCCCeEEecCCccCCCCCccCCC-----CCCCCeEeCcCCccccccCCcccCCC
Q 035691          272 IPHLDLSKNKLSGE----IPSSLGSCVGLEYLNLSINSFHGPIHPGLSS-----LKSLEGLDLFQNTFQAKSQNGDVPRK  342 (640)
Q Consensus       272 L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~l~~N~l~~~~~~~~~p~~  342 (640)
                      |+.|+|++|.+++.    ++..+..+++|++|+|++|.+++..+..+..     .++|++|+|++|.++.... ..+|..
T Consensus       315 L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~-~~l~~~  393 (461)
T 1z7x_W          315 LESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSC-SSLAAT  393 (461)
T ss_dssp             CCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHH-HHHHHH
T ss_pred             ceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhH-HHHHHH
Confidence            77777777776644    3445555667777777777665443333322     5567777777776652110 012211


Q ss_pred             -CCCCCCccccccCCC
Q 035691          343 -GIFKNASAISVAGNE  357 (640)
Q Consensus       343 -~~~~~~~~~~~~~n~  357 (640)
                       ..++++..+++.+|+
T Consensus       394 l~~~~~L~~L~l~~N~  409 (461)
T 1z7x_W          394 LLANHSLRELDLSNNC  409 (461)
T ss_dssp             HHHCCCCCEEECCSSS
T ss_pred             HHhCCCccEEECCCCC
Confidence             224455666666664

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=5.7e-34  Score=307.89  Aligned_cols=328  Identities=20%  Similarity=0.146  Sum_probs=259.9

Q ss_pred             CCCCcEEeCCCCcccc----CCchhhhcCCCCCeEEcccCccCccCCcCC-CCCC----CCCEEEccCCCcCCccccccC
Q 035691            2 LTFLMLINLQQNNFSG----NIPHEIGRLFQLRYIIFNSNTLQGQIPVNL-THCS----ELRTLDLVLNKLEENQLVGEL   72 (640)
Q Consensus         2 l~~L~~L~L~~n~i~~----~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~~l~----~L~~L~Ls~N~l~~~~~~~~l   72 (640)
                      +++|++|+|++|+|++    .++..+..+++|++|+|++|.+++..+..+ ..++    +|++|+|++|+|+.... +.+
T Consensus        27 ~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~-~~l  105 (461)
T 1z7x_W           27 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC-GVL  105 (461)
T ss_dssp             HTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGH-HHH
T ss_pred             cCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHH-HHH
Confidence            5789999999999985    356778889999999999999986444333 3344    79999999999874211 123


Q ss_pred             CchhhcCCCCCCeeeccCCcccccCCccCc-----CCCCCCEEECcCCccCccC----CccccCCCCCCEEEcccCcCCC
Q 035691           73 PPYIGFTLPNIRIPLLAGNQFFGNIPHSIS-----NASKLEWLDFANNSLTASI----PEDLGRLRNLTRLNFARNDLGT  143 (640)
Q Consensus        73 p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~  143 (640)
                      |.. +..+++|+.|+|++|.+++..+..+.     ..++|++|+|++|++++..    +..+..+++|++|+|++|.++.
T Consensus       106 ~~~-l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~  184 (461)
T 1z7x_W          106 SST-LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINE  184 (461)
T ss_dssp             HHH-TTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred             HHH-HccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcch
Confidence            333 44689999999999999866554433     3678999999999999743    5667788999999999999876


Q ss_pred             CCCCccccccccc-CCCCcceEecCCCCCCC-----cCcCCCCCCCCCEEEccCCcCcccC-----CcCccCCCCCCEEE
Q 035691          144 RKVNDLRFLDSLV-NCTYLEIVSLNVNSLRS-----IPISVGYLPKLQVLSLFENNISGEI-----PSSLGNFTFLTELN  212 (640)
Q Consensus       144 ~~~~~~~~~~~l~-~l~~L~~L~L~~N~l~~-----ip~~~~~l~~L~~L~L~~N~l~~~~-----p~~~~~l~~L~~L~  212 (640)
                      .....+  ...+. ..++|+.|++++|.++.     ++..+..+++|++|++++|.+.+..     +..+..+++|++|+
T Consensus       185 ~~~~~l--~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~  262 (461)
T 1z7x_W          185 AGVRVL--CQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLW  262 (461)
T ss_dssp             HHHHHH--HHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEE
T ss_pred             HHHHHH--HHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEE
Confidence            422111  11111 35699999999999987     4666777899999999999998543     33344689999999


Q ss_pred             ccCCCCCCC----CCccccCCCCccEEeccCccccC-------------CCCCceEEccCCcCCCC----CCccCCCCCC
Q 035691          213 LRGNSIRGS----IPSALGNCHQLQSLDLSKTIFLG-------------QYPVRWLDLSHNHLTGP----IPLAVGNLKS  271 (640)
Q Consensus       213 L~~N~l~~~----~~~~~~~l~~L~~L~ls~n~~~~-------------~~~l~~L~Ls~N~l~~~----~~~~~~~l~~  271 (640)
                      |++|.++..    ++..+..+++|+.|++++|.+.+             ...|++|++++|.+++.    ++..+..+++
T Consensus       263 L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~  342 (461)
T 1z7x_W          263 IWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRF  342 (461)
T ss_dssp             CTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSS
T ss_pred             CcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCC
Confidence            999999864    56778889999999999998742             14799999999999865    4667778899


Q ss_pred             CCEEECCCCcccCcCCccccC-----CCCCCeEEecCCccCC----CCCccCCCCCCCCeEeCcCCccccc
Q 035691          272 IPHLDLSKNKLSGEIPSSLGS-----CVGLEYLNLSINSFHG----PIHPGLSSLKSLEGLDLFQNTFQAK  333 (640)
Q Consensus       272 L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~  333 (640)
                      |+.|+|++|++++..+..+..     .++|++|+|++|.+++    .+|..+..+++|++||+++|+++..
T Consensus       343 L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~  413 (461)
T 1z7x_W          343 LLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA  413 (461)
T ss_dssp             CCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred             ccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence            999999999998765555543     6799999999999986    6788888999999999999999843

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.97  E-value=6.7e-31  Score=264.93  Aligned_cols=253  Identities=21%  Similarity=0.193  Sum_probs=158.8

Q ss_pred             CeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCCE
Q 035691           30 RYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEW  109 (640)
Q Consensus        30 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  109 (640)
                      +.++++++.++ .+|..+  .++|++|+|++|+|+.      +|+..+..+++|+.|+|++|.+++..|..|.++++|++
T Consensus        14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~------~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~   84 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISH------VPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQ   84 (285)
T ss_dssp             CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCE------ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred             eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCc------cCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCE
Confidence            45666666666 344433  3567777777766654      55555556777777777777777777777888888888


Q ss_pred             EECcCCc-cCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcC-CCCCCCCCEE
Q 035691          110 LDFANNS-LTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPIS-VGYLPKLQVL  187 (640)
Q Consensus       110 L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~-~~~l~~L~~L  187 (640)
                      |+|++|+ ++...|..|..+++|++|+|++|+++.+      .+..+.++++|++|++++|.++.+|.. +..+++|++|
T Consensus        85 L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~------~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  158 (285)
T 1ozn_A           85 LDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQEL------GPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHL  158 (285)
T ss_dssp             EECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCC------CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             EeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEE------CHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEE
Confidence            8888886 7766677788888888888888887765      234455666666666666666665543 5556667777


Q ss_pred             EccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCccCC
Q 035691          188 SLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVG  267 (640)
Q Consensus       188 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~  267 (640)
                      +|++|.+++..+..|..+++|++|+|++|++++..|..|..+++|+.|                ++++|++++..+..|.
T Consensus       159 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L----------------~l~~n~l~~~~~~~~~  222 (285)
T 1ozn_A          159 FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL----------------YLFANNLSALPTEALA  222 (285)
T ss_dssp             ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE----------------ECCSSCCSCCCHHHHT
T ss_pred             ECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEe----------------eCCCCcCCcCCHHHcc
Confidence            777776665555566666666666666666666656666666666655                5555566655555566


Q ss_pred             CCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccC
Q 035691          268 NLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGL  314 (640)
Q Consensus       268 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~  314 (640)
                      .+++|+.|+|++|.+....+.. .-+..++.+..+.|.+....|..+
T Consensus       223 ~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~l  268 (285)
T 1ozn_A          223 PLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRL  268 (285)
T ss_dssp             TCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGGG
T ss_pred             cCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchHh
Confidence            6666666666666665322210 011123333444555554444443

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.97  E-value=3.1e-31  Score=273.28  Aligned_cols=178  Identities=28%  Similarity=0.340  Sum_probs=152.1

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||+||+|+.+.+|+.||+|+++..   .....+.+.+|+.+++.++||||+++++++     .....
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~~   79 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSSE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCCE
Confidence            5688899999999999999999999999999999643   234457789999999999999999999995     44558


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++....          .+++..+..++.||+.||+|||+   .+|+||||||+||+++.++.+||
T Consensus        80 ~~lv~E~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL  146 (337)
T 1o6l_A           80 LCFVMEYANGGELFFHLSRER----------VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKI  146 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEE
T ss_pred             EEEEEeCCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEE
Confidence            899999999999999886432          37888999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||+++.....    .......+||+.|+|||++.+..++.+
T Consensus       147 ~DFG~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~  185 (337)
T 1o6l_A          147 TDFGLCKEGISD----GATMKTFCGTPEYLAPEVLEDNDYGRA  185 (337)
T ss_dssp             CCCTTCBCSCCT----TCCBCCCEECGGGCCGGGGSSSCBCTT
T ss_pred             eeccchhhcccC----CCcccccccChhhCChhhhcCCCCCch
Confidence            999999854321    112234579999999999998887754

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.97  E-value=1.8e-30  Score=266.83  Aligned_cols=236  Identities=19%  Similarity=0.197  Sum_probs=163.6

Q ss_pred             CCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCC
Q 035691           51 SELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRN  130 (640)
Q Consensus        51 ~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  130 (640)
                      ++++.|+|++|.|+.      +|+.++. +++|+.|+|++|.|+ .+|..|+++++|++|+|++|+++ .+|..|..+++
T Consensus        81 ~~l~~L~L~~n~l~~------lp~~l~~-l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~  151 (328)
T 4fcg_A           81 PGRVALELRSVPLPQ------FPDQAFR-LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNR  151 (328)
T ss_dssp             TTCCEEEEESSCCSS------CCSCGGG-GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTT
T ss_pred             cceeEEEccCCCchh------cChhhhh-CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcC
Confidence            456666666666553      5555543 666666666666666 55666666666666666666666 45666666666


Q ss_pred             CCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCE
Q 035691          131 LTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTE  210 (640)
Q Consensus       131 L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  210 (640)
                      |++|+|++|++.+.      .+..+..      .        .++..+..+++|++|+|++|.|+ .+|..+..+++|++
T Consensus       152 L~~L~L~~n~~~~~------~p~~~~~------~--------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~  210 (328)
T 4fcg_A          152 LRELSIRACPELTE------LPEPLAS------T--------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKS  210 (328)
T ss_dssp             CCEEEEEEETTCCC------CCSCSEE------E--------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCE
T ss_pred             CCEEECCCCCCccc------cChhHhh------c--------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCE
Confidence            66666666554433      1221111      0        01122334677888888888887 66777888888888


Q ss_pred             EEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccc
Q 035691          211 LNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSL  290 (640)
Q Consensus       211 L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~  290 (640)
                      |+|++|++++ +|..+..+++|+.|                +|++|++.+.+|..|+.+++|+.|+|++|.+.+.+|..+
T Consensus       211 L~L~~N~l~~-l~~~l~~l~~L~~L----------------~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~  273 (328)
T 4fcg_A          211 LKIRNSPLSA-LGPAIHHLPKLEEL----------------DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDI  273 (328)
T ss_dssp             EEEESSCCCC-CCGGGGGCTTCCEE----------------ECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTG
T ss_pred             EEccCCCCCc-CchhhccCCCCCEE----------------ECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhh
Confidence            8888888874 45567777777777                777777777788888888888888888888888888888


Q ss_pred             cCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccc
Q 035691          291 GSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAK  333 (640)
Q Consensus       291 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  333 (640)
                      ..+++|++|+|++|++.+.+|..+..+++|+.+++..|.+...
T Consensus       274 ~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~~l  316 (328)
T 4fcg_A          274 HRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQL  316 (328)
T ss_dssp             GGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSCC-
T ss_pred             hcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHHHH
Confidence            8888888888888888888888888888888888888777644

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.97  E-value=3.4e-30  Score=264.76  Aligned_cols=227  Identities=22%  Similarity=0.229  Sum_probs=138.2

Q ss_pred             CCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCC
Q 035691           27 FQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASK  106 (640)
Q Consensus        27 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  106 (640)
                      .+++.|+|++|.++ .+|..+..+++|++|+|++|.|+.      +|..+. .+++|+.|+|++|+++ .+|..|.++++
T Consensus        81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~~------lp~~~~-~l~~L~~L~Ls~n~l~-~lp~~l~~l~~  151 (328)
T 4fcg_A           81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME------LPDTMQ-QFAGLETLTLARNPLR-ALPASIASLNR  151 (328)
T ss_dssp             TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCCC------CCSCGG-GGTTCSEEEEESCCCC-CCCGGGGGCTT
T ss_pred             cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCccc------hhHHHh-ccCCCCEEECCCCccc-cCcHHHhcCcC
Confidence            45555555555555 444445555555555555555543      444332 3555555555555555 44555555556


Q ss_pred             CCEEECcCCccCccCCcccc---------CCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcC
Q 035691          107 LEWLDFANNSLTASIPEDLG---------RLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPIS  177 (640)
Q Consensus       107 L~~L~Ls~N~l~~~~~~~~~---------~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~  177 (640)
                      |++|+|++|++.+.+|..+.         ++++|++|+|++|+++.+       +..+.++++|++|++++|.++.+|..
T Consensus       152 L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~l-------p~~l~~l~~L~~L~L~~N~l~~l~~~  224 (328)
T 4fcg_A          152 LRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSL-------PASIANLQNLKSLKIRNSPLSALGPA  224 (328)
T ss_dssp             CCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCCCC-------CGGGGGCTTCCEEEEESSCCCCCCGG
T ss_pred             CCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcCcc-------hHhhcCCCCCCEEEccCCCCCcCchh
Confidence            66666665555555555443         366666666666666643       34456666666666666666666666


Q ss_pred             CCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCc
Q 035691          178 VGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNH  257 (640)
Q Consensus       178 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~  257 (640)
                      +..+++|++|+|++|.+.+.+|..|.++++|++|+|++|++.+.+|..+.++++|+.|                +|++|+
T Consensus       225 l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L----------------~L~~n~  288 (328)
T 4fcg_A          225 IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKL----------------DLRGCV  288 (328)
T ss_dssp             GGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEE----------------ECTTCT
T ss_pred             hccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEE----------------eCCCCC
Confidence            6666677777777766666666667777777777777766666666666666666666                666666


Q ss_pred             CCCCCCccCCCCCCCCEEECCCCcccCc
Q 035691          258 LTGPIPLAVGNLKSIPHLDLSKNKLSGE  285 (640)
Q Consensus       258 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  285 (640)
                      +.+.+|..++.+++|+.+++..|.+...
T Consensus       289 ~~~~iP~~l~~L~~L~~l~l~~~~~~~l  316 (328)
T 4fcg_A          289 NLSRLPSLIAQLPANCIILVPPHLQAQL  316 (328)
T ss_dssp             TCCCCCGGGGGSCTTCEEECCGGGSCC-
T ss_pred             chhhccHHHhhccCceEEeCCHHHHHHH
Confidence            6666777777777777777766665543

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.97  E-value=4.3e-29  Score=276.01  Aligned_cols=257  Identities=25%  Similarity=0.267  Sum_probs=186.9

Q ss_pred             CCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCC
Q 035691            4 FLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNI   83 (640)
Q Consensus         4 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L   83 (640)
                      .++.|++++|+|+ .+|..+.  ++|++|+|++|.|+ .+|.   .+++|++|||++|+|+.      +|.    .+++|
T Consensus        41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~------lp~----~l~~L  103 (622)
T 3g06_A           41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS------LPV----LPPGL  103 (622)
T ss_dssp             CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC------CCC----CCTTC
T ss_pred             CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc------CCC----CCCCC
Confidence            4778888888888 6666554  67888888888887 4444   56788888888888765      665    46788


Q ss_pred             CeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcce
Q 035691           84 RIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEI  163 (640)
Q Consensus        84 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~  163 (640)
                      +.|+|++|+|+++.+    .+++|+.|+|++|+|+. +|..   +++|++|+|++|+++.++.          .+++|+.
T Consensus       104 ~~L~Ls~N~l~~l~~----~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l~~----------~~~~L~~  165 (622)
T 3g06_A          104 LELSIFSNPLTHLPA----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASLPA----------LPSELCK  165 (622)
T ss_dssp             CEEEECSCCCCCCCC----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCCCC----------CCTTCCE
T ss_pred             CEEECcCCcCCCCCC----CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCcCC----------ccCCCCE
Confidence            888888888876433    46778888888888885 4432   4778888888888876531          2356778


Q ss_pred             EecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCcccc
Q 035691          164 VSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFL  243 (640)
Q Consensus       164 L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~  243 (640)
                      |++++|.|+.+|   ..+++|+.|++++|.|++ +|..   +++|+.|++++|.++. +|..   +++|+.|        
T Consensus       166 L~L~~N~l~~l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~~~---~~~L~~L--------  226 (622)
T 3g06_A          166 LWAYNNQLTSLP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKEL--------  226 (622)
T ss_dssp             EECCSSCCSCCC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CCCC---CTTCCEE--------
T ss_pred             EECCCCCCCCCc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-cCCC---CCCCCEE--------
Confidence            888888888877   345778888888888875 4432   3678888888888873 3332   3556665        


Q ss_pred             CCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeE
Q 035691          244 GQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGL  323 (640)
Q Consensus       244 ~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  323 (640)
                              +|++|+|++ +|   ..+++|+.|+|++|+|+ .+|.   .+++|+.|+|++|+|+ .+|..|..+++|+.|
T Consensus       227 --------~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L  289 (622)
T 3g06_A          227 --------IVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTV  289 (622)
T ss_dssp             --------ECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEE
T ss_pred             --------EccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEE
Confidence                    777777775 44   45578888888888888 4555   5577888888888888 567778888888888


Q ss_pred             eCcCCccc
Q 035691          324 DLFQNTFQ  331 (640)
Q Consensus       324 ~l~~N~l~  331 (640)
                      +|++|+++
T Consensus       290 ~L~~N~l~  297 (622)
T 3g06_A          290 NLEGNPLS  297 (622)
T ss_dssp             ECCSCCCC
T ss_pred             EecCCCCC
Confidence            88888887

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.97  E-value=5.6e-31  Score=268.92  Aligned_cols=183  Identities=24%  Similarity=0.409  Sum_probs=153.6

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .++|...+.||+|+||+||+|++..+++.||+|++...+....+.+.+|++++++++||||+++++++.     .+...+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY-----KDKRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe-----cCCeeE
Confidence            356788899999999999999999999999999986666666788999999999999999999999964     345789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++|+|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|
T Consensus        84 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~D  151 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMD---------SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVAD  151 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCC---------TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECC
T ss_pred             EEEEecCCCcHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEee
Confidence            9999999999999996533         238899999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCC----------ceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSN----------QCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+++.+.......          ........||+.|+|||++.+..++.
T Consensus       152 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  201 (310)
T 3s95_A          152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDE  201 (310)
T ss_dssp             CTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCT
T ss_pred             cccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCc
Confidence            99998764322111          00111457999999999999888775

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.97  E-value=5.1e-31  Score=267.40  Aligned_cols=177  Identities=25%  Similarity=0.327  Sum_probs=153.7

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .++|+..+.||+|+||.||+|++..+++.||||++........+.+.+|+.+++.++||||+++++++.     ..+..+
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~   93 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW   93 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEE-----ECCEEE
Confidence            357889999999999999999999899999999997666666678999999999999999999999954     345789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++|+|.+++...           .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|
T Consensus        94 lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~D  159 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTET-----------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTD  159 (297)
T ss_dssp             EEEECCTTCBHHHHHHHS-----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECC
T ss_pred             EEEECCCCCCHHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEee
Confidence            999999999999998642           27888999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+++.......    ......||+.|+|||++.+..++.
T Consensus       160 fg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~  195 (297)
T 3fxz_A          160 FGFCAQITPEQS----KRSTMVGTPYWMAPEVVTRKAYGP  195 (297)
T ss_dssp             CTTCEECCSTTC----CBCCCCSCGGGCCHHHHHCSCBCT
T ss_pred             CCCceecCCccc----ccCCccCCcCccChhhhcCCCCCc
Confidence            999986643221    223356999999999998887765

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.97  E-value=7.3e-31  Score=269.69  Aligned_cols=177  Identities=27%  Similarity=0.368  Sum_probs=152.1

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ..++|++.+.||+|+||.||+|++..+|+.||||++....  ....+.+.+|+++++.++||||+++++++.     ...
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~   87 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-----TEK   87 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECC
Confidence            4567999999999999999999999899999999996542  334567899999999999999999999953     455


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+|
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~k  154 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVAHG----------RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIK  154 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEE
T ss_pred             EEEEEEECCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEE
Confidence            7899999999999999986432          27888999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      |+|||+++.....     ......+||+.|+|||++.+..++
T Consensus       155 l~DFG~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~  191 (328)
T 3fe3_A          155 IADFGFSNEFTVG-----GKLDAFCGAPPYAAPELFQGKKYD  191 (328)
T ss_dssp             ECSTTCCGGGSSS-----CGGGTTSSSGGGCCHHHHHTCCCC
T ss_pred             EeeccCceecCCC-----CccccccCCcceeCcccccCCCcC
Confidence            9999999865422     122345799999999999887764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.97  E-value=3.2e-31  Score=274.94  Aligned_cols=179  Identities=28%  Similarity=0.321  Sum_probs=147.2

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCC
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~  514 (640)
                      ..++|++.+.||+|+||+||+|+++.+|+.||||+++..   .....+.+.+|..+++.+ +||||+++++++     .+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~   95 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QT   95 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----Ee
Confidence            346899999999999999999999999999999999643   233456788999999988 799999999994     44


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                      ....++||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.
T Consensus        96 ~~~~~lv~E~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~  162 (353)
T 3txo_A           96 PDRLFFVMEFVNGGDLMFHIQKSR----------RFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGH  162 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCC
Confidence            568999999999999999986432          27889999999999999999999   69999999999999999999


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +||+|||+|+.....    .......+||+.|+|||++.+..++.
T Consensus       163 ikL~DFG~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~  203 (353)
T 3txo_A          163 CKLADFGMCKEGICN----GVTTATFCGTPDYIAPEILQEMLYGP  203 (353)
T ss_dssp             EEECCCTTCBCSCC-------------CCGGGCCHHHHHHHHCTT
T ss_pred             EEEccccceeecccC----CccccccCCCcCeEChhhcCCCCcCC
Confidence            999999999854221    12233467999999999987765553

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.97  E-value=9.4e-31  Score=270.38  Aligned_cols=181  Identities=25%  Similarity=0.335  Sum_probs=151.9

Q ss_pred             HHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCc
Q 035691          437 LKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNI-RHRNLVKIITACSSSDF  512 (640)
Q Consensus       437 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  512 (640)
                      ....++|.+.+.||+|+||+||+|+++.+|+.||||+++...   ....+.+..|..++..+ +||||+++++++     
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----   87 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----   87 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----
Confidence            345678999999999999999999999999999999996432   33456788999999887 999999999995     


Q ss_pred             CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC
Q 035691          513 QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND  592 (640)
Q Consensus       513 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~  592 (640)
                      .+....++||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.+
T Consensus        88 ~~~~~~~lv~E~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~  154 (345)
T 1xjd_A           88 QTKENLFFVMEYLNGGDLMYHIQSCH----------KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKD  154 (345)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTT
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCC
Confidence            44568999999999999999986432          27888999999999999999999   699999999999999999


Q ss_pred             CcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          593 MIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       593 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +.+||+|||+|+.....    .......+||+.|+|||++.+..++.
T Consensus       155 g~vkL~DFG~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~  197 (345)
T 1xjd_A          155 GHIKIADFGMCKENMLG----DAKTNTFCGTPDYIAPEILLGQKYNH  197 (345)
T ss_dssp             SCEEECCCTTCBCCCCT----TCCBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred             CCEEEeEChhhhhcccC----CCcccCCCCCcccCChhhhcCCCCCC
Confidence            99999999999854221    11223467999999999999887764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.97  E-value=5.9e-31  Score=276.20  Aligned_cols=178  Identities=24%  Similarity=0.287  Sum_probs=149.9

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~  515 (640)
                      .++|++.++||+|+||+||+|+++.+++.||||+++...   ....+.+..|..++.++ +|||||++++++     .+.
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~~  125 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTE  125 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----ECS
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----EEC
Confidence            356888999999999999999999999999999996542   22335688999999887 899999999994     455


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      ...++||||+++|+|.+++....          .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+
T Consensus       126 ~~~~lV~E~~~gg~L~~~l~~~~----------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~i  192 (396)
T 4dc2_A          126 SRLFFVIEYVNGGDLMFHMQRQR----------KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHI  192 (396)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCE
Confidence            68999999999999999886432          38899999999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+|||+|+.....    .......+||+.|+|||++.+..++.
T Consensus       193 kL~DFGla~~~~~~----~~~~~~~~gt~~Y~aPE~l~~~~~~~  232 (396)
T 4dc2_A          193 KLTDYGMCKEGLRP----GDTTSTFCGTPNYIAPEILRGEDYGF  232 (396)
T ss_dssp             EECCCTTCBCCCCT----TCCBCCCCBCGGGCCHHHHTTCCBCT
T ss_pred             EEeecceeeecccC----CCccccccCCcccCCchhhcCCCCCh
Confidence            99999999853221    11233467999999999999988764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.97  E-value=2.8e-31  Score=280.16  Aligned_cols=182  Identities=23%  Similarity=0.281  Sum_probs=153.1

Q ss_pred             HHHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeecc
Q 035691          433 YESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSS  509 (640)
Q Consensus       433 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  509 (640)
                      +.++....++|++.+.||+|+||+||+|+++.+++.||+|++....   ....+.+.+|+.+++.++|||||++++++  
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~--  138 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF--  138 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE--
Confidence            3455566788999999999999999999999999999999996422   22335688999999999999999999995  


Q ss_pred             CCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee
Q 035691          510 SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL  589 (640)
Q Consensus       510 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl  589 (640)
                         .+....++|||||++|+|.+++...           .+++..+..++.|++.||+|||+   .+|+||||||+|||+
T Consensus       139 ---~~~~~~~lV~E~~~gg~L~~~l~~~-----------~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl  201 (410)
T 3v8s_A          139 ---QDDRYLYMVMEYMPGGDLVNLMSNY-----------DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLL  201 (410)
T ss_dssp             ---ECSSEEEEEECCCTTEEHHHHHHHC-----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEE
T ss_pred             ---EECCEEEEEEeCCCCCcHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeE
Confidence               4456899999999999999998532           27888999999999999999999   699999999999999


Q ss_pred             CCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          590 DNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       590 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      +.++.+||+|||+|+.....   ........+||+.|+|||++.+..
T Consensus       202 ~~~g~ikL~DFG~a~~~~~~---~~~~~~~~~gt~~Y~APE~l~~~~  245 (410)
T 3v8s_A          202 DKSGHLKLADFGTCMKMNKE---GMVRCDTAVGTPDYISPEVLKSQG  245 (410)
T ss_dssp             CTTSCEEECCCTTCEECCTT---SEEECCSCCSCGGGCCHHHHHTTT
T ss_pred             CCCCCEEEeccceeEeeccC---CcccccCCcCCccccCHHHhhccC
Confidence            99999999999999865432   112233567999999999997654

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.97  E-value=1.5e-31  Score=273.95  Aligned_cols=257  Identities=19%  Similarity=0.164  Sum_probs=135.4

Q ss_pred             CcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCC
Q 035691            5 LMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIR   84 (640)
Q Consensus         5 L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~   84 (640)
                      ++.++++.+.+....+..+..+++|++|+|++|+|++..|..|..+++|++|+|++|+++.      +++  +..+++|+
T Consensus        12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~------~~~--~~~l~~L~   83 (317)
T 3o53_A           12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE------TLD--LESLSTLR   83 (317)
T ss_dssp             EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEE------EEE--ETTCTTCC
T ss_pred             eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCc------chh--hhhcCCCC
Confidence            5566666666665555555666677777777777776666667777777777777666643      222  33455666


Q ss_pred             eeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceE
Q 035691           85 IPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIV  164 (640)
Q Consensus        85 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L  164 (640)
                      .|+|++|+|++..     ..++|++|++++|++++..+..   +++|++|+|++|+++.+      .+..+..+++|++|
T Consensus        84 ~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~------~~~~~~~l~~L~~L  149 (317)
T 3o53_A           84 TLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITML------RDLDEGCRSRVQYL  149 (317)
T ss_dssp             EEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSG------GGBCTGGGSSEEEE
T ss_pred             EEECcCCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCc------cchhhhccCCCCEE
Confidence            6666666655432     1255556666666555443322   34455555555555544      22334444445555


Q ss_pred             ecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCcc-CCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCcccc
Q 035691          165 SLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLG-NFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFL  243 (640)
Q Consensus       165 ~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~  243 (640)
                      ++++|.++.                       ..+..+. .+++|++|+|++|.|++..+  ...+++|+.|        
T Consensus       150 ~Ls~N~l~~-----------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~l~~L~~L--------  196 (317)
T 3o53_A          150 DLKLNEIDT-----------------------VNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTL--------  196 (317)
T ss_dssp             ECTTSCCCE-----------------------EEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEE--------
T ss_pred             ECCCCCCCc-----------------------ccHHHHhhccCcCCEEECCCCcCccccc--ccccccCCEE--------
Confidence            555555444                       4333332 34445555555555443211  1123444444        


Q ss_pred             CCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccC-CCCCccCCCCCCCCe
Q 035691          244 GQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFH-GPIHPGLSSLKSLEG  322 (640)
Q Consensus       244 ~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~  322 (640)
                              +|++|++++ +|..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++ +..|..+..+++|+.
T Consensus       197 --------~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~  266 (317)
T 3o53_A          197 --------DLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT  266 (317)
T ss_dssp             --------ECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHH
T ss_pred             --------ECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceE
Confidence                    444444442 2223555555555555555555 34445555555555555555555 444455555555555


Q ss_pred             EeCc
Q 035691          323 LDLF  326 (640)
Q Consensus       323 L~l~  326 (640)
                      |+++
T Consensus       267 l~l~  270 (317)
T 3o53_A          267 VAKQ  270 (317)
T ss_dssp             HHHH
T ss_pred             EECC
Confidence            5555

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.97  E-value=1.5e-30  Score=266.19  Aligned_cols=175  Identities=29%  Similarity=0.370  Sum_probs=151.3

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||+||+|+.+.+|+.||+|+++...   ....+.+.+|+.+++.++||||+++++++     .+...
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~   80 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ   80 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCCE
Confidence            46888999999999999999999999999999996432   23456788999999999999999999995     44568


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||
T Consensus        81 ~~lv~e~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL  147 (318)
T 1fot_A           81 IFMIMDYIEGGELFSLLRKSQ----------RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKI  147 (318)
T ss_dssp             EEEEECCCCSCBHHHHHHHTS----------SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEE
T ss_pred             EEEEEeCCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEE
Confidence            899999999999999986432          27888999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||+++.....       ....+||+.|+|||++.+..++.+
T Consensus       148 ~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~  183 (318)
T 1fot_A          148 TDFGFAKYVPDV-------TYTLCGTPDYIAPEVVSTKPYNKS  183 (318)
T ss_dssp             CCCSSCEECSSC-------BCCCCSCTTTCCHHHHTTCCBCTT
T ss_pred             eecCcceecCCc-------cccccCCccccCHhHhcCCCCCcc
Confidence            999999865431       123569999999999998887754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.97  E-value=2.3e-30  Score=265.64  Aligned_cols=188  Identities=27%  Similarity=0.295  Sum_probs=158.1

Q ss_pred             cccCHHHHHHhcCC----------CcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCC
Q 035691          429 LNVSYESLLKATGG----------FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHR  498 (640)
Q Consensus       429 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~  498 (640)
                      ..++.+++..+++.          |...+.||+|+||.||+|++..+|+.||||++........+.+.+|+.+++.++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            34566776666543          56667899999999999999989999999999766666667899999999999999


Q ss_pred             CCcceeEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 035691          499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIV  578 (640)
Q Consensus       499 niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~iv  578 (640)
                      ||+++++++..     ....++||||+++|+|.+++...           .+++..+..++.|++.||+|||+   .+|+
T Consensus       103 niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~-----------~l~~~~~~~i~~qi~~~L~~LH~---~~iv  163 (321)
T 2c30_A          103 NVVEMYKSYLV-----GEELWVLMEFLQGGALTDIVSQV-----------RLNEEQIATVCEAVLQALAYLHA---QGVI  163 (321)
T ss_dssp             TBCCEEEEEEE-----TTEEEEEECCCCSCBHHHHHTTC-----------CCCHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred             CcceEEEEEEE-----CCEEEEEEecCCCCCHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHH---CCee
Confidence            99999999643     45789999999999999998532           27889999999999999999999   6999


Q ss_pred             eCCCCCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          579 HCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       579 Hrdlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||||||+||+++.++.+||+|||+++.......    ......||+.|+|||++.+..++.
T Consensus       164 H~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~  220 (321)
T 2c30_A          164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP----KRKSLVGTPYWMAPEVISRSLYAT  220 (321)
T ss_dssp             CCCCSGGGEEECTTCCEEECCCTTCEECCSSSC----CBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred             cCCCCHHHEEECCCCcEEEeeeeeeeecccCcc----ccccccCCccccCHhhhcCCCCCc
Confidence            999999999999999999999999986643211    122356999999999998887765

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.97  E-value=4.4e-31  Score=278.92  Aligned_cols=183  Identities=25%  Similarity=0.292  Sum_probs=153.9

Q ss_pred             cCHHHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEee
Q 035691          431 VSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITAC  507 (640)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~  507 (640)
                      +.+++.....++|++.+.||+|+||+||+|+++.+|+.||||++....   ....+.+.+|..++..++||||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            345566666788999999999999999999999999999999996432   23345688999999999999999999995


Q ss_pred             ccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCe
Q 035691          508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNV  587 (640)
Q Consensus       508 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~Ni  587 (640)
                           .+....|+||||+++|+|.+++....         ..+++..+..++.||+.||+|||+   .+|+||||||+||
T Consensus       131 -----~~~~~~~lVmE~~~gg~L~~~l~~~~---------~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NI  193 (412)
T 2vd5_A          131 -----QDENYLYLVMEYYVGGDLLTLLSKFG---------ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNI  193 (412)
T ss_dssp             -----ECSSEEEEEECCCCSCBHHHHHHHHS---------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGE
T ss_pred             -----eeCCEEEEEEcCCCCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHe
Confidence                 44568999999999999999996432         137889999999999999999999   6999999999999


Q ss_pred             eeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCC
Q 035691          588 LLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGM  633 (640)
Q Consensus       588 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  633 (640)
                      |++.++.+||+|||+|+......   .......+||+.|+|||++.
T Consensus       194 Lld~~g~vkL~DFGla~~~~~~~---~~~~~~~~Gt~~Y~APE~l~  236 (412)
T 2vd5_A          194 LLDRCGHIRLADFGSCLKLRADG---TVRSLVAVGTPDYLSPEILQ  236 (412)
T ss_dssp             EECTTSCEEECCCTTCEECCTTS---CEECSSCCSCGGGCCHHHHH
T ss_pred             eecCCCCEEEeechhheeccCCC---ccccceeccccCcCCHHHHh
Confidence            99999999999999998664321   11223457999999999987

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.97  E-value=1.7e-30  Score=268.95  Aligned_cols=177  Identities=24%  Similarity=0.285  Sum_probs=150.5

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCc
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++....   ....+.+.+|..+++++ +|||||++++++     .+..
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~~   83 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTES   83 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----EeCC
Confidence            46888899999999999999999999999999996542   33456788999999988 899999999995     4456


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+|
T Consensus        84 ~~~lv~e~~~gg~L~~~l~~~~----------~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~k  150 (345)
T 3a8x_A           84 RLFFVIEYVNGGDLMFHMQRQR----------KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIK  150 (345)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEE
Confidence            8899999999999999986432          27889999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|||+++......    ......+||+.|+|||++.+..++.
T Consensus       151 L~DFG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~  189 (345)
T 3a8x_A          151 LTDYGMCKEGLRPG----DTTSTFCGTPNYIAPEILRGEDYGF  189 (345)
T ss_dssp             ECCGGGCBCSCCTT----CCBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred             EEeccccccccCCC----CcccccCCCccccCccccCCCCCCh
Confidence            99999998542211    1223457999999999999887764

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.97  E-value=2e-30  Score=266.28  Aligned_cols=193  Identities=35%  Similarity=0.573  Sum_probs=159.7

Q ss_pred             ccCHHHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeecc
Q 035691          430 NVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSS  509 (640)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  509 (640)
                      .+.+.++...+++|+..+.||+|+||.||+|+++ +++.||||++........+.+.+|+++++.++||||++++++|. 
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-  105 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD-  105 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC-
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-
Confidence            4455566678899999999999999999999975 78999999987666666788999999999999999999999953 


Q ss_pred             CCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee
Q 035691          510 SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL  589 (640)
Q Consensus       510 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl  589 (640)
                          .....++||||+++|+|.+++......      ...+++..++.++.|++.||+|||+   .+|+||||||+||++
T Consensus       106 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~  172 (321)
T 2qkw_B          106 ----ERNEMILIYKYMENGNLKRHLYGSDLP------TMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILL  172 (321)
T ss_dssp             ----CTTCCEEEEECCTTCBTGGGSSSSCCC------SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEE
T ss_pred             ----CCCeEEEEEEcCCCCcHHHHHhccCCC------ccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEE
Confidence                445789999999999999999654321      1348899999999999999999999   699999999999999


Q ss_pred             CCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          590 DNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       590 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +.++.+||+|||+++........  .......||+.|+|||++.+..++.
T Consensus       173 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~  220 (321)
T 2qkw_B          173 DENFVPKITDFGISKKGTELDQT--HLSTVVKGTLGYIDPEYFIKGRLTE  220 (321)
T ss_dssp             CTTCCEEECCCTTCEECSSSSCC--CCBCCCEEETTTCCHHHHHHCBCCT
T ss_pred             CCCCCEEEeeccccccccccccc--ccccccCCCccccCHHHhcCCCCCc
Confidence            99999999999999865432111  1122345899999999998777664

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.97  E-value=3.1e-30  Score=269.81  Aligned_cols=171  Identities=25%  Similarity=0.397  Sum_probs=148.0

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+++++.++|||||++++++     .+...
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~~   89 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QDEED   89 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCCE
Confidence            46888999999999999999999999999999996432   34457889999999999999999999995     44557


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+.+|+|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~----------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL  156 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQNV----------HFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHI  156 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHTTC----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEE
T ss_pred             EEEEEecCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEE
Confidence            899999999999999987542          27889999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      +|||+|+.+...     ......+||+.|+|||++.+
T Consensus       157 ~DFG~a~~~~~~-----~~~~~~~gt~~Y~aPE~~~~  188 (384)
T 4fr4_A          157 TDFNIAAMLPRE-----TQITTMAGTKPYMAPEMFSS  188 (384)
T ss_dssp             CCCTTCEECCTT-----CCBCCCCSCGGGCCGGGTCC
T ss_pred             eccceeeeccCC-----CceeccCCCccccCCeeecc
Confidence            999999866432     12234579999999999974

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.97  E-value=3.3e-30  Score=268.05  Aligned_cols=177  Identities=24%  Similarity=0.314  Sum_probs=151.3

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccch------hHHHHHHHHHHHHhcCCCCCcceeEeeccCCcC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG------ALKSFMAECEALRNIRHRNLVKIITACSSSDFQ  513 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  513 (640)
                      .+.|++.+.||+|+||.||+|+++.+|+.||+|++......      ..+.+.+|+.+++.++||||+++++++     .
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~   85 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-----E   85 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-----E
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-----E
Confidence            45688999999999999999999999999999999654321      347899999999999999999999995     4


Q ss_pred             CCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC
Q 035691          514 GNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM  593 (640)
Q Consensus       514 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~  593 (640)
                      +....++||||+++|+|.+++....          .+++..+..++.||+.||.|||+   .+|+||||||+||++++++
T Consensus        86 ~~~~~~lv~e~~~gg~L~~~l~~~~----------~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~  152 (361)
T 2yab_A           86 NRTDVVLILELVSGGELFDFLAQKE----------SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKN  152 (361)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHTTCS----------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTT
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCC
Confidence            4557899999999999999996532          37899999999999999999999   6999999999999998877


Q ss_pred             ----cEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          594 ----IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       594 ----~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                          .+||+|||+++......     .....+||+.|+|||++.+..++.
T Consensus       153 ~~~~~vkl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~  197 (361)
T 2yab_A          153 IPIPHIKLIDFGLAHEIEDGV-----EFKNIFGTPEFVAPEIVNYEPLGL  197 (361)
T ss_dssp             SSSCCEEECCCSSCEECCTTC-----CCCCCCSCGGGCCHHHHTTCCCCT
T ss_pred             CCccCEEEEecCCceEcCCCC-----ccccCCCCccEECchHHcCCCCCc
Confidence                79999999998764321     122356999999999998887764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.97  E-value=2.4e-30  Score=266.74  Aligned_cols=189  Identities=27%  Similarity=0.407  Sum_probs=151.1

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc-------
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDF-------  512 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-------  512 (640)
                      ++|++.+.||+|+||.||+|+++.+|+.||||++.... ....+.+.+|++++++++|||||+++++|.....       
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            45888999999999999999999999999999996543 3455789999999999999999999998754321       


Q ss_pred             ---------------------------------------------CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCC
Q 035691          513 ---------------------------------------------QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSP  547 (640)
Q Consensus       513 ---------------------------------------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  547 (640)
                                                                   ..+.+.++||||+++|+|.+++......       
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------  158 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL-------  158 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG-------
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc-------
Confidence                                                         1123479999999999999999765432       


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccccccCCCccCCC--------ceeecc
Q 035691          548 SILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSN--------QCSSVG  619 (640)
Q Consensus       548 ~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~--------~~~~~~  619 (640)
                      ...++..++.++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++.........        ......
T Consensus       159 ~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T 3qd2_B          159 EDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG  235 (332)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCS
T ss_pred             cchhhHHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccc
Confidence            235677789999999999999999   699999999999999999999999999998765432110        112234


Q ss_pred             ccccccccCcccCCCCCCCC
Q 035691          620 LKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       620 ~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ..||+.|+|||++.+..++.
T Consensus       236 ~~gt~~y~aPE~~~~~~~~~  255 (332)
T 3qd2_B          236 QVGTKLYMSPEQIHGNNYSH  255 (332)
T ss_dssp             CC-CGGGSCHHHHHCCCCCT
T ss_pred             cCCCcCccChHHhcCCCCcc
Confidence            56999999999998887765

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.97  E-value=1.5e-30  Score=269.68  Aligned_cols=179  Identities=25%  Similarity=0.262  Sum_probs=151.8

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCC
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~  514 (640)
                      ..++|++.+.||+|+||+||+|+++.+|+.||||+++..   .....+.+..|..++..+ +||+|+++++++     .+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~   92 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT   92 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----EC
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----Ec
Confidence            356799999999999999999999989999999999643   234457788999999987 899999999984     44


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                      ....++||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.
T Consensus        93 ~~~~~lv~E~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~  159 (353)
T 2i0e_A           93 MDRLYFVMEYVNGGDLMYHIQQVG----------RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGH  159 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCc
Confidence            568999999999999999986432          27889999999999999999999   69999999999999999999


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +||+|||+|+.....    .......+||+.|+|||++.+..++.
T Consensus       160 vkL~DFG~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~  200 (353)
T 2i0e_A          160 IKIADFGMCKENIWD----GVTTKTFCGTPDYIAPEIIAYQPYGK  200 (353)
T ss_dssp             EEECCCTTCBCCCCT----TCCBCCCCSCGGGCCHHHHTTCCBST
T ss_pred             EEEEeCCcccccccC----CcccccccCCccccChhhhcCCCcCC
Confidence            999999999854221    11233467999999999999887764

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=3.9e-31  Score=270.21  Aligned_cols=250  Identities=22%  Similarity=0.239  Sum_probs=196.4

Q ss_pred             hhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhh------cCCCCCCeeeccCCccccc
Q 035691           23 IGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIG------FTLPNIRIPLLAGNQFFGN   96 (640)
Q Consensus        23 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~------~~l~~L~~L~L~~N~l~~~   96 (640)
                      ++...+|++|++++|.+  .+|..+...  |++|+|++|+++.    +.+|...+      ..+++|+.|+|++|++++.
T Consensus        39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~----~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~  110 (312)
T 1wwl_A           39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRA----ARIPSRILFGALRVLGISGLQELTLENLEVTGT  110 (312)
T ss_dssp             EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEE----EECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSC
T ss_pred             EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccC----CCcCHHHHHHHHHhcCcCCccEEEccCCcccch
Confidence            45667788888888888  566655544  8888888887754    23444443      2478899999999999888


Q ss_pred             CCccC--cCCCCCCEEECcCCccCccCCccccCC-----CCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCC
Q 035691           97 IPHSI--SNASKLEWLDFANNSLTASIPEDLGRL-----RNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVN  169 (640)
Q Consensus        97 ~~~~~--~~l~~L~~L~Ls~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N  169 (640)
                      .|..+  ..+++|++|+|++|++++. |..|..+     ++|++|+|++|+++.+      .++.|.++++|++|++++|
T Consensus       111 ~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~------~~~~~~~l~~L~~L~Ls~N  183 (312)
T 1wwl_A          111 APPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNF------SCEQVRVFPALSTLDLSDN  183 (312)
T ss_dssp             CCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCC------CTTTCCCCSSCCEEECCSC
T ss_pred             hHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccc------hHHHhccCCCCCEEECCCC
Confidence            88876  8889999999999999876 7777777     8899999999999887      3466778889999999999


Q ss_pred             CCCC---cCcCC--CCCCCCCEEEccCCcCcc---cCCcCccCCCCCCEEEccCCCCCCCCC-ccccCCCCccEEeccCc
Q 035691          170 SLRS---IPISV--GYLPKLQVLSLFENNISG---EIPSSLGNFTFLTELNLRGNSIRGSIP-SALGNCHQLQSLDLSKT  240 (640)
Q Consensus       170 ~l~~---ip~~~--~~l~~L~~L~L~~N~l~~---~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~ls~n  240 (640)
                      ++..   +|..+  ..+++|++|+|++|.|++   .....+..+++|++|+|++|++++.+| ..+..+++|+.|     
T Consensus       184 ~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L-----  258 (312)
T 1wwl_A          184 PELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSL-----  258 (312)
T ss_dssp             TTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEE-----
T ss_pred             CcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEE-----
Confidence            8765   24444  778999999999999983   222445678899999999999987775 456667778777     


Q ss_pred             cccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCC
Q 035691          241 IFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHG  308 (640)
Q Consensus       241 ~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  308 (640)
                                 +|++|+|+ .+|..+.  ++|+.|+|++|+|++. |. +..+++|++|+|++|+|++
T Consensus       259 -----------~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          259 -----------NLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             -----------ECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             -----------ECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence                       77788888 5666665  8899999999999865 65 8899999999999999875

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=2.6e-31  Score=271.53  Aligned_cols=247  Identities=26%  Similarity=0.244  Sum_probs=202.9

Q ss_pred             CCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCccc-ccCCccCc-------CCCCCCEEECcCCccC
Q 035691           47 LTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFF-GNIPHSIS-------NASKLEWLDFANNSLT  118 (640)
Q Consensus        47 ~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~-------~l~~L~~L~Ls~N~l~  118 (640)
                      +...++|+.|++++|.+ .      +|..++..   |+.|+|++|+++ ..+|..+.       ++++|++|+|++|+++
T Consensus        39 ~~~~~~L~~l~l~~n~l-~------~p~~~~~~---L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~  108 (312)
T 1wwl_A           39 YGGGRSLEYLLKRVDTE-A------DLGQFTDI---IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT  108 (312)
T ss_dssp             EEEEEECTTHHHHCCTT-C------CCHHHHHH---HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCB
T ss_pred             EccCCCceeEeeccccc-c------cHHHHHHH---HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCccc
Confidence            45667899999998888 4      78777653   899999999994 55666665       7899999999999999


Q ss_pred             ccCCccc--cCCCCCCEEEcccCcCCCCCCCcccccccccCC-----CCcceEecCCCCCCCcC-cCCCCCCCCCEEEcc
Q 035691          119 ASIPEDL--GRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNC-----TYLEIVSLNVNSLRSIP-ISVGYLPKLQVLSLF  190 (640)
Q Consensus       119 ~~~~~~~--~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l-----~~L~~L~L~~N~l~~ip-~~~~~l~~L~~L~L~  190 (640)
                      +..|..+  ..+++|++|+|++|++++.+       ..+.++     ++|++|++++|+++.++ ..+..+++|++|+|+
T Consensus       109 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-------~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  181 (312)
T 1wwl_A          109 GTAPPPLLEATGPDLNILNLRNVSWATRD-------AWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLS  181 (312)
T ss_dssp             SCCCCCSSSCCSCCCSEEEEESCBCSSSS-------SHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECC
T ss_pred             chhHHHHHHhcCCCccEEEccCCCCcchh-------HHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECC
Confidence            8888876  89999999999999998862       233444     88999999999998866 678889999999999


Q ss_pred             CCcCccc--CCcCc--cCCCCCCEEEccCCCCCCC---CCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCC
Q 035691          191 ENNISGE--IPSSL--GNFTFLTELNLRGNSIRGS---IPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIP  263 (640)
Q Consensus       191 ~N~l~~~--~p~~~--~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~  263 (640)
                      +|++.+.  .|..+  ..+++|++|+|++|+|++.   ....+..+++|+.|                +|++|++++..|
T Consensus       182 ~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L----------------~Ls~N~l~~~~~  245 (312)
T 1wwl_A          182 DNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGL----------------DLSHNSLRDAAG  245 (312)
T ss_dssp             SCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEE----------------ECTTSCCCSSCC
T ss_pred             CCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEE----------------ECCCCcCCcccc
Confidence            9988754  23333  7889999999999998832   22344566777777                888888987775


Q ss_pred             -ccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccc
Q 035691          264 -LAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQ  331 (640)
Q Consensus       264 -~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  331 (640)
                       ..+..+++|+.|+|++|+|+ .+|..+.  ++|++|+|++|+|++. |. +..+++|++|+|++|+++
T Consensus       246 ~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~  309 (312)
T 1wwl_A          246 APSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL  309 (312)
T ss_dssp             CSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred             hhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence             56778899999999999999 7787776  8999999999999976 55 999999999999999998

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.96  E-value=5.9e-31  Score=269.49  Aligned_cols=261  Identities=20%  Similarity=0.183  Sum_probs=207.5

Q ss_pred             CCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCC
Q 035691           53 LRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLT  132 (640)
Q Consensus        53 L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  132 (640)
                      ++.++++.+.+..      .+..++..+++|+.|+|++|+|++..|..|.++++|++|+|++|++++..+  |..+++|+
T Consensus        12 l~i~~ls~~~l~~------~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~   83 (317)
T 3o53_A           12 YKIEKVTDSSLKQ------ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLR   83 (317)
T ss_dssp             EEEESCCTTTHHH------HHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCC
T ss_pred             eeEeeccccchhh------hHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCC
Confidence            3445666555543      555566667788888888888888888888899999999999999987554  88899999


Q ss_pred             EEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEE
Q 035691          133 RLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELN  212 (640)
Q Consensus       133 ~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  212 (640)
                      +|+|++|++++++           ..++|++|++++|+++.++...  +++|++|++++|.+++..+..|..+++|++|+
T Consensus        84 ~L~Ls~n~l~~l~-----------~~~~L~~L~l~~n~l~~~~~~~--~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  150 (317)
T 3o53_A           84 TLDLNNNYVQELL-----------VGPSIETLHAANNNISRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLD  150 (317)
T ss_dssp             EEECCSSEEEEEE-----------ECTTCCEEECCSSCCSEEEECC--CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEE
T ss_pred             EEECcCCcccccc-----------CCCCcCEEECCCCccCCcCccc--cCCCCEEECCCCCCCCccchhhhccCCCCEEE
Confidence            9999999887642           2378999999999998876533  68899999999999988888999999999999


Q ss_pred             ccCCCCCCCCCccc-cCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCcccc
Q 035691          213 LRGNSIRGSIPSAL-GNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLG  291 (640)
Q Consensus       213 L~~N~l~~~~~~~~-~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  291 (640)
                      |++|++++..+..+ ..+++|+.|                +|++|.+++..  ....+++|++|+|++|+|++ +|..|.
T Consensus       151 Ls~N~l~~~~~~~~~~~l~~L~~L----------------~L~~N~l~~~~--~~~~l~~L~~L~Ls~N~l~~-l~~~~~  211 (317)
T 3o53_A          151 LKLNEIDTVNFAELAASSDTLEHL----------------NLQYNFIYDVK--GQVVFAKLKTLDLSSNKLAF-MGPEFQ  211 (317)
T ss_dssp             CTTSCCCEEEGGGGGGGTTTCCEE----------------ECTTSCCCEEE--CCCCCTTCCEEECCSSCCCE-ECGGGG
T ss_pred             CCCCCCCcccHHHHhhccCcCCEE----------------ECCCCcCcccc--cccccccCCEEECCCCcCCc-chhhhc
Confidence            99999998777776 478888888                77777777542  23358999999999999994 566699


Q ss_pred             CCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCcccCCCCCCCCCccccccCCC
Q 035691          292 SCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNE  357 (640)
Q Consensus       292 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~p~~~~~~~~~~~~~~~n~  357 (640)
                      .+++|++|+|++|++++ +|..+..+++|+.|++++|++.|.+....+   ..++.+..+.+.++.
T Consensus       212 ~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~---~~~~~L~~l~l~~~~  273 (317)
T 3o53_A          212 SAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFF---SKNQRVQTVAKQTVK  273 (317)
T ss_dssp             GGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHHHHHHHH---HTCHHHHHHHHHHHH
T ss_pred             ccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCcCHHHHH---hccccceEEECCCch
Confidence            99999999999999994 678899999999999999999964322222   234455666666443

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.96  E-value=2.7e-30  Score=261.64  Aligned_cols=180  Identities=25%  Similarity=0.419  Sum_probs=148.1

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.++++++||||+++++++     ....
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~   84 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDD   84 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSS
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCC
Confidence            467899999999999999999999999999999985432   33457899999999999999999999995     3455


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+|
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~k  151 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIESHG----------PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLK  151 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEE
T ss_pred             eEEEEEeCCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEE
Confidence            7899999999999999986432          27889999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |+|||+++.......   .......||+.|+|||++.+..++.+
T Consensus       152 l~Dfg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~  192 (294)
T 4eqm_A          152 IFDFGIAKALSETSL---TQTNHVLGTVQYFSPEQAKGEATDEC  192 (294)
T ss_dssp             ECCCSSSTTC----------------CCSSCCHHHHHTCCCCTT
T ss_pred             EEeCCCccccccccc---cccCccccCccccCHhHhcCCCCCch
Confidence            999999986643211   12223569999999999988877653

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.96  E-value=6.8e-30  Score=275.47  Aligned_cols=186  Identities=26%  Similarity=0.372  Sum_probs=140.9

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      .++|++.+.||+|+||+||+|+++.+++.||||++...  .....+.+.+|+++++.++|||||++++++....+.....
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            46799999999999999999999999999999998543  3334578999999999999999999999986655555667


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .|+||||+. |+|.+++....          .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~~----------~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl  197 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTPV----------YLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKV  197 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSSC----------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEE
T ss_pred             EEEEEeccc-cchhhhcccCC----------CCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEee
Confidence            899999985 68998886432          38899999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCC-----------------------ceeeccccccccccCcccCC-CCCCCC
Q 035691          598 GDFGLTRFIPEVISSN-----------------------QCSSVGLKGTVGYAAPEYGM-GSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~-----------------------~~~~~~~~gt~~y~aPE~~~-~~~~s~  639 (640)
                      +|||+|+.........                       .....+.+||++|+|||++. +..++.
T Consensus       198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~  263 (458)
T 3rp9_A          198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTE  263 (458)
T ss_dssp             CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCT
T ss_pred             cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCc
Confidence            9999998764221100                       01234467899999999864 444554

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.96  E-value=3.3e-30  Score=267.15  Aligned_cols=174  Identities=26%  Similarity=0.314  Sum_probs=150.6

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||.||+|+++.+|+.||||++....   ....+.+.+|+.+++.++||||+++++++     .+...
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~  115 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcCCE
Confidence            46888899999999999999999999999999996432   23457889999999999999999999995     44568


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||
T Consensus       116 ~~lv~e~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL  182 (350)
T 1rdq_E          116 LYMVMEYVAGGEMFSHLRRIG----------RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV  182 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEE
T ss_pred             EEEEEcCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEE
Confidence            899999999999999986432          27888999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|||+++.....       ....+||+.|+|||++.+..++.
T Consensus       183 ~DFg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~  217 (350)
T 1rdq_E          183 TDFGFAKRVKGR-------TWTLCGTPEALAPEIILSKGYNK  217 (350)
T ss_dssp             CCCTTCEECSSC-------BCCCEECGGGCCHHHHTTCCBCT
T ss_pred             cccccceeccCC-------cccccCCccccCHHHhcCCCCCC
Confidence            999999865432       12356999999999999887764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=6.5e-30  Score=262.08  Aligned_cols=177  Identities=21%  Similarity=0.272  Sum_probs=150.5

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++.++||||+++++++.     +....+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~   77 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFE-----SMEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEe-----cCCEEE
Confidence            467899999999999999999999999999999986443 34467889999999999999999999953     445789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC--CCcEEE
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN--DMIAHV  597 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~--~~~~kl  597 (640)
                      +||||+++|+|.+++....         ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.  ++.+||
T Consensus        78 lv~e~~~g~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl  145 (321)
T 1tki_A           78 MIFEFISGLDIFERINTSA---------FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKI  145 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSS---------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEE
T ss_pred             EEEEeCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEE
Confidence            9999999999999986432         237889999999999999999999   69999999999999987  789999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|||+++.+....     ......||+.|+|||++.+..++.
T Consensus       146 ~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~  182 (321)
T 1tki_A          146 IEFGQARQLKPGD-----NFRLLFTAPEYYAPEVHQHDVVST  182 (321)
T ss_dssp             CCCTTCEECCTTC-----EEEEEESCGGGSCHHHHTTCEECH
T ss_pred             EECCCCeECCCCC-----ccccccCChhhcCcHHhcCCCCCc
Confidence            9999998764321     122346899999999998876553

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.96  E-value=2.3e-29  Score=255.45  Aligned_cols=176  Identities=27%  Similarity=0.382  Sum_probs=144.2

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc--------------------------hhHHHHHHHHHHHH
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--------------------------GALKSFMAECEALR  493 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  493 (640)
                      .++|++.+.||+|+||.||+|++..+++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            4678999999999999999999999999999999954321                          12356889999999


Q ss_pred             hcCCCCCcceeEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 035691          494 NIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHC  573 (640)
Q Consensus       494 ~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~  573 (640)
                      +++||||+++++++...   .....++||||+++|+|.+++..           ..+++..+..++.|++.||+|||+  
T Consensus        92 ~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~--  155 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVPTL-----------KPLSEDQARFYFQDLIKGIEYLHY--  155 (298)
T ss_dssp             TCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSSCS-----------SCCCHHHHHHHHHHHHHHHHHHHH--
T ss_pred             hCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHH--
Confidence            99999999999997542   24578999999999999886532           237889999999999999999999  


Q ss_pred             CCCeeeCCCCCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          574 KKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       574 ~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                       .+|+||||||+||+++.++.+||+|||+++......    .......||+.|+|||++.+..
T Consensus       156 -~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~  213 (298)
T 2zv2_A          156 -QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD----ALLSNTVGTPAFMAPESLSETR  213 (298)
T ss_dssp             -TTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSS----CEECCCCSCGGGCCGGGCCTTC
T ss_pred             -CCeeccCCCHHHEEECCCCCEEEecCCCcccccccc----ccccCCcCCccccChhhhccCC
Confidence             699999999999999999999999999998664321    1123356999999999998754

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.96  E-value=6.2e-30  Score=278.55  Aligned_cols=179  Identities=28%  Similarity=0.376  Sum_probs=152.6

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      .++|+..+.||+|+||.||+|+++.+|+.||||++...   .......+.+|+++++.++|||||++++++     .+..
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~~  257 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKD  257 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----eeCC
Confidence            45688899999999999999999999999999999643   233456788999999999999999999985     4456


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++|+|.+++.....        ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+|
T Consensus       258 ~l~lVmEy~~gg~L~~~l~~~~~--------~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vK  326 (576)
T 2acx_A          258 ALCLVLTLMNGGDLKFHIYHMGQ--------AGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIR  326 (576)
T ss_dssp             EEEEEECCCCSCBHHHHHHSSSS--------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeE
Confidence            89999999999999999865432        238899999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|||+|+.+....     .....+||+.|+|||++.+..++.
T Consensus       327 L~DFGla~~~~~~~-----~~~~~~GT~~Y~APEvl~~~~~~~  364 (576)
T 2acx_A          327 ISDLGLAVHVPEGQ-----TIKGRVGTVGYMAPEVVKNERYTF  364 (576)
T ss_dssp             ECCCTTCEECCTTC-----CEECCCSCGGGCCHHHHTTCEESS
T ss_pred             EEecccceecccCc-----cccccCCCccccCHHHHcCCCCCc
Confidence            99999998764321     122357999999999999877664

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.96  E-value=3.8e-30  Score=264.71  Aligned_cols=199  Identities=38%  Similarity=0.591  Sum_probs=162.5

Q ss_pred             ccccccCHHHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCCccee
Q 035691          426 DLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR-GALKSFMAECEALRNIRHRNLVKII  504 (640)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~  504 (640)
                      .....++++++....++|+..+.||+|+||.||+|+.. +|+.||||++..... .....+.+|+++++.++||||++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   93 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR   93 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence            34567889999999999999999999999999999865 789999999964432 2234689999999999999999999


Q ss_pred             EeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCC
Q 035691          505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKP  584 (640)
Q Consensus       505 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp  584 (640)
                      ++|.     .....++||||+++|+|.+++......      ...+++..+..++.|++.||+|||+.+.++|+||||||
T Consensus        94 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp  162 (326)
T 3uim_A           94 GFCM-----TPTERLLVYPYMANGSVASCLRERPES------QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKA  162 (326)
T ss_dssp             EEEC-----CSSCCEEEEECCTTCBHHHHHHCCSTT------CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSG
T ss_pred             EEEe-----cCCceEEEEEeccCCCHHHHHHhcccc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCch
Confidence            9964     344678999999999999999764432      13488999999999999999999994344999999999


Q ss_pred             CCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          585 SNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       585 ~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +||+++.++.+||+|||+++.......   .......||+.|+|||++.+..++.
T Consensus       163 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~  214 (326)
T 3uim_A          163 ANILLDEEFEAVVGDFGLAKLMDYKDT---HVTTAVRGTIGHIAPEYLSTGKSSE  214 (326)
T ss_dssp             GGEEECTTCCEEECCCSSCEECCSSSS---CEECCCCSCGGGCCHHHHHHSEECH
T ss_pred             hhEEECCCCCEEeccCccccccCcccc---cccccccCCcCccCHHHhccCCCCc
Confidence            999999999999999999987643221   2223356999999999987766553

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.96  E-value=1.3e-29  Score=264.26  Aligned_cols=177  Identities=23%  Similarity=0.379  Sum_probs=150.1

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++....  ....+.+.+|+.+++.++|||||++++++.     ....
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~  102 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF  102 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence            356889999999999999999999999999999996443  334567899999999999999999999953     4457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC---Cc
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND---MI  594 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~---~~  594 (640)
                      .++||||+++|+|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+||+++.+   +.
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~  169 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVARE----------FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAA  169 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTTCS----------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCC
T ss_pred             EEEEEecCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCC
Confidence            899999999999999886442          27889999999999999999999   699999999999999865   45


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +||+|||+++......     .....+||+.|+|||++.+..++.
T Consensus       170 ~kl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~  209 (362)
T 2bdw_A          170 VKLADFGLAIEVNDSE-----AWHGFAGTPGYLSPEVLKKDPYSK  209 (362)
T ss_dssp             EEECCCTTCBCCTTCC-----SCCCSCSCTTTCCHHHHTTCCCCT
T ss_pred             EEEeecCcceEecCCc-----ccccCCCCccccCHHHHccCCCCc
Confidence            9999999998664321     122356999999999999887765

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.96  E-value=8.7e-30  Score=271.86  Aligned_cols=178  Identities=20%  Similarity=0.281  Sum_probs=149.4

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++....  ....+.+.+|+++++.++|||||++++++     .....
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~~   84 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEGH   84 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSSE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECCE
Confidence            456889999999999999999999999999999996543  23456789999999999999999999995     44568


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC---CCCc
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD---NDMI  594 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~---~~~~  594 (640)
                      .++||||+++|+|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+||+++   .++.
T Consensus        85 ~~lv~E~~~gg~L~~~i~~~~----------~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~  151 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVARE----------YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAA  151 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHHCS----------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCC
T ss_pred             EEEEEEeCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCc
Confidence            899999999999999886442          27889999999999999999999   6999999999999998   4678


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +||+|||+|+......    .......||+.|+|||++.+..++.
T Consensus       152 vkL~DFG~a~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~  192 (444)
T 3soa_A          152 VKLADFGLAIEVEGEQ----QAWFGFAGTPGYLSPEVLRKDPYGK  192 (444)
T ss_dssp             EEECCCSSCBCCCTTC----CBCCCSCSCGGGCCHHHHTTCCBCT
T ss_pred             EEEccCceeEEecCCC----ceeecccCCcccCCHHHhcCCCCCC
Confidence            9999999998664321    1123457999999999999887765

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.96  E-value=3.1e-30  Score=269.25  Aligned_cols=177  Identities=32%  Similarity=0.386  Sum_probs=141.0

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHH-HHhcCCCCCcceeEeeccCCcCCCc
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEA-LRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ++|++.+.||+|+||+||+|+++.+++.||||++....   ......+..|..+ ++.++|||||++++++     .+.+
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~~~~  112 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTAD  112 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----ECSS
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EeCC
Confidence            46888999999999999999999999999999996543   2233556777776 4678999999999995     4456


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..|+||||+++|+|.+++....          .+++..+..++.||+.||+|||+   .+|+||||||+||+++.++.+|
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ik  179 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRER----------CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIV  179 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEE
Confidence            8999999999999999986432          27788899999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|||+++.....    .......+||+.|+|||++.+..++.
T Consensus       180 L~DFG~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~  218 (373)
T 2r5t_A          180 LTDFGLCKENIEH----NSTTSTFCGTPEYLAPEVLHKQPYDR  218 (373)
T ss_dssp             ECCCCBCGGGBCC----CCCCCSBSCCCCCCCHHHHTTCCCCT
T ss_pred             EeeCccccccccC----CCccccccCCccccCHHHhCCCCCCc
Confidence            9999999854221    11233467999999999999887764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.96  E-value=1e-29  Score=260.91  Aligned_cols=178  Identities=22%  Similarity=0.319  Sum_probs=148.1

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR-GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      .++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.+++.++|||||++++++.     .....
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~   80 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ   80 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCCeE
Confidence            4678999999999999999999999999999999964432 23467889999999999999999999954     44578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~  147 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEPDI----------GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKIS  147 (323)
T ss_dssp             EEEEECCTTEEGGGGSBTTT----------BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEEcCCCCcHHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEE
Confidence            99999999999999986443          37889999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV  637 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  637 (640)
                      |||+++.+.....  .......+||+.|+|||++.+..+
T Consensus       148 Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~  184 (323)
T 3tki_A          148 DFGLATVFRYNNR--ERLLNKMCGTLPYVAPELLKRREF  184 (323)
T ss_dssp             CCTTCEECEETTE--ECCBCSCCSCGGGSCHHHHHCSSB
T ss_pred             EeeccceeccCCc--ccccCCCccCcCccCcHHhccCCC
Confidence            9999986532211  111234579999999999987664

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.96  E-value=1.1e-29  Score=275.82  Aligned_cols=181  Identities=26%  Similarity=0.372  Sum_probs=152.9

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|...+.||+|+||+||+|+++.+|+.||||++....   ....+.+.+|++++++++|||||++++++     .....
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~~~  259 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ETKTD  259 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----eeCCE
Confidence            56888899999999999999999999999999996432   23456789999999999999999999984     44567


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .|+||||++||+|.+++......      ...+++..+..++.||+.||+|||+   .+|+||||||+||+++.+|.+||
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~------~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL  330 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDED------NPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRI  330 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTT------SCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEE
T ss_pred             EEEEEEeccCCCHHHHHHHhhcc------cccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEE
Confidence            89999999999999998654321      1348899999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|||+++.+.....    .....+||+.|+|||++.+..++.
T Consensus       331 ~DFGla~~~~~~~~----~~~~~~GT~~Y~APE~l~~~~~~~  368 (543)
T 3c4z_A          331 SDLGLAVELKAGQT----KTKGYAGTPGFMAPELLLGEEYDF  368 (543)
T ss_dssp             CCCTTCEECCTTCC----CBCCCCSCTTTSCHHHHTTCCBCT
T ss_pred             eecceeeeccCCCc----ccccccCCccccChhhhcCCCCCh
Confidence            99999987643211    123357999999999999887765

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.96  E-value=1.5e-29  Score=265.39  Aligned_cols=178  Identities=21%  Similarity=0.271  Sum_probs=151.4

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .+.|++.+.||+|+||.||+|++..+|+.||+|++..........+.+|+++++.++|||||++++++.     .....+
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCEEE
Confidence            356889999999999999999999999999999997665555578999999999999999999999953     445789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC--CCcEEE
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN--DMIAHV  597 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~--~~~~kl  597 (640)
                      +||||+++|+|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+||+++.  .+.+||
T Consensus       125 lv~E~~~gg~L~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL  192 (387)
T 1kob_A          125 LILEFLSGGELFDRIAAED---------YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKI  192 (387)
T ss_dssp             EEEECCCCCBHHHHTTCTT---------CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEE
T ss_pred             EEEEcCCCCcHHHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEE
Confidence            9999999999999986543         238899999999999999999999   69999999999999974  478999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|||+++......     ......||+.|+|||++.+..++.
T Consensus       193 ~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~  229 (387)
T 1kob_A          193 IDFGLATKLNPDE-----IVKVTTATAEFAAPEIVDREPVGF  229 (387)
T ss_dssp             CCCTTCEECCTTS-----CEEEECSSGGGCCHHHHTTCCBCH
T ss_pred             EecccceecCCCc-----ceeeeccCCCccCchhccCCCCCC
Confidence            9999998764321     112346999999999998877653

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.96  E-value=2.5e-29  Score=258.43  Aligned_cols=176  Identities=23%  Similarity=0.282  Sum_probs=149.8

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc------hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR------GALKSFMAECEALRNIRHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  514 (640)
                      +.|.+.+.||+|+||.||+|+++.+|+.||+|++.....      ...+.+.+|+.+++.++||||+++++++.     .
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~   85 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE-----N   85 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence            347888999999999999999999999999999964432      13578999999999999999999999953     4


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC-
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-  593 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~-  593 (640)
                      ....++||||+++|+|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++ 
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~  152 (326)
T 2y0a_A           86 KTDVILILELVAGGELFDFLAEKE----------SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNV  152 (326)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTSS----------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSS
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcC----------CcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCC
Confidence            457899999999999999986432          37889999999999999999999   6999999999999999887 


Q ss_pred             ---cEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          594 ---IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       594 ---~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                         .+||+|||+++......     ......||+.|+|||++.+..++.
T Consensus       153 ~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~  196 (326)
T 2y0a_A          153 PKPRIKIIDFGLAHKIDFGN-----EFKNIFGTPEFVAPEIVNYEPLGL  196 (326)
T ss_dssp             SSCCEEECCCTTCEECCTTS-----CCCCCCSCTTTCCHHHHTTCCCCT
T ss_pred             CCCCEEEEECCCCeECCCCC-----ccccccCCcCcCCceeecCCCCCc
Confidence               89999999998764321     112346999999999998887764

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.96  E-value=7.9e-30  Score=264.94  Aligned_cols=181  Identities=23%  Similarity=0.307  Sum_probs=149.1

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-----chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-----RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      +.|++.+.||+|+||.||+|+++.+|+.||||++....     ....+.+.+|+.+++.++|||||++++++.     ..
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~   98 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS-----SD   98 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eC
Confidence            45888999999999999999999999999999995432     123578999999999999999999999954     44


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc-
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI-  594 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~-  594 (640)
                      ...++||||+++|+|.+++......      ...+++..+..++.|++.||+|||+   .+|+||||||+||+++.++. 
T Consensus        99 ~~~~lv~e~~~g~~L~~~l~~~~~~------~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~  169 (351)
T 3c0i_A           99 GMLYMVFEFMDGADLCFEIVKRADA------GFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENS  169 (351)
T ss_dssp             TEEEEEEECCSSCBHHHHHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTT
T ss_pred             CEEEEEEeCCCCCCHHHHHHHhccc------CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCC
Confidence            5789999999999998877532211      1237888999999999999999999   69999999999999986654 


Q ss_pred             --EEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          595 --AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       595 --~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                        +||+|||+++......    ......+||+.|+|||++.+..++.
T Consensus       170 ~~vkl~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~  212 (351)
T 3c0i_A          170 APVKLGGFGVAIQLGESG----LVAGGRVGTPHFMAPEVVKREPYGK  212 (351)
T ss_dssp             CCEEECCCTTCEECCTTS----CBCCCCCSCGGGCCHHHHTTCCBCT
T ss_pred             CcEEEecCcceeEecCCC----eeecCCcCCcCccCHHHHcCCCCCc
Confidence              9999999998764321    1123356999999999999887764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.96  E-value=5.8e-30  Score=263.05  Aligned_cols=181  Identities=25%  Similarity=0.433  Sum_probs=146.6

Q ss_pred             CCCcccCcccccccceEEEEEECCCC---eEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQ---TVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ++|++.+.||+|+||.||+|++..++   ..||||+++.. .....+.+.+|+.+++.++||||+++++++     ....
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~  123 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----TRGR  123 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CGGG
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence            46788899999999999999997544   45999999654 334457899999999999999999999995     3445


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++|+|.+++.....         .+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+|
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~k  191 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTHDG---------QFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCK  191 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTTT---------CSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEE
T ss_pred             ccEEEeeCCCCCcHHHHHHhccc---------CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEE
Confidence            78999999999999999964432         38899999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|||+++........ ........+|+.|+|||++.+..++.
T Consensus       192 l~Dfg~a~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~  233 (325)
T 3kul_A          192 VSDFGLSRVLEDDPDA-AYTTTGGKIPIRWTAPEAIAFRTFSS  233 (325)
T ss_dssp             ECCCSSCEECC----C-CEECC---CCGGGSCHHHHHHCEECH
T ss_pred             ECCCCcccccccCccc-eeeccCCCCcccccCHhHhcCCCCCc
Confidence            9999999876543221 22223345788999999987766553

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.96  E-value=2.6e-30  Score=261.95  Aligned_cols=184  Identities=29%  Similarity=0.430  Sum_probs=148.4

Q ss_pred             cCCCcccCcccccccceEEEEE----ECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGI----LDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      .++|++.+.||+|+||.||+|+    ...+++.||||++........+.+.+|++++++++||||++++++|...   +.
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GR   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH---HH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CC
Confidence            3568889999999999999998    4568999999999766666668899999999999999999999997432   23


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      ...++||||+++|+|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~  153 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHK---------ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRV  153 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCG---------GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEE
T ss_pred             CceEEEEEeCCCCCHHHHHHhcc---------cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeE
Confidence            35789999999999999986543         237889999999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+|||+++........ ........||+.|+|||++.+..++.
T Consensus       154 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~  196 (295)
T 3ugc_A          154 KIGDFGLTKVLPQDKEF-FKVKEPGESPIFWYAPESLTESKFSV  196 (295)
T ss_dssp             EECCCCSCC--------------CTTCGGGGCCHHHHHHCCCCH
T ss_pred             EEccCcccccccCCcce-eeeccCCCCccceeCcHHhcCCCCCh
Confidence            99999999876432211 11222345788899999998777664

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.96  E-value=1.9e-29  Score=255.27  Aligned_cols=177  Identities=24%  Similarity=0.404  Sum_probs=146.0

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ++|++.+.||+|+||+||+|+++.+++.||||++....  ....+.+.+|+.++++++||||+++++++.     .+...
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence            46888999999999999999999999999999996443  334578899999999999999999999954     44578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||+++ ++.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+
T Consensus        77 ~lv~e~~~~-~l~~~~~~~~---------~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~  143 (292)
T 3o0g_A           77 TLVFEFCDQ-DLKKYFDSCN---------GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLA  143 (292)
T ss_dssp             EEEEECCSE-EHHHHHHHTT---------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred             EEEEecCCC-CHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEe
Confidence            999999986 5555443222         238889999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCC-CCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ-VST  639 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~  639 (640)
                      |||+++.......    ......||+.|+|||++.+.. ++.
T Consensus       144 Dfg~~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~  181 (292)
T 3o0g_A          144 NFGLARAFGIPVR----CYSAEVVTLWYRPPDVLFGAKLYST  181 (292)
T ss_dssp             CCTTCEECCSCCS----CCCSCCSCGGGCCHHHHTTCSCCCT
T ss_pred             ecccceecCCccc----cccCCccccCCcChHHHcCCCCcCc
Confidence            9999986643211    122346899999999998766 443

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.96  E-value=1e-29  Score=258.36  Aligned_cols=176  Identities=27%  Similarity=0.387  Sum_probs=143.5

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHh--cCCCCCcceeEeeccCCcCCCce
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRN--IRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      .++|++.+.||+|+||.||+|++  +++.||||++...   ....+..|.+++..  ++||||+++++++... ......
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~-~~~~~~   80 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTS-RHSSTQ   80 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE-ETTEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccc-cCCCce
Confidence            45789999999999999999988  6899999998543   23556677777776  7999999999987543 233456


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeeeCCCCCCCeee
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLH--------HHCKKQIVHCDLKPSNVLL  589 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH--------~~~~~~ivHrdlkp~NiLl  589 (640)
                      .++||||+++|+|.++++..           .+++..++.++.|++.||+|||        +   .+|+||||||+||++
T Consensus        81 ~~lv~e~~~~g~L~~~l~~~-----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill  146 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQLT-----------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILV  146 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTTC-----------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEE
T ss_pred             eEEehhhccCCCHHHHHhhc-----------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEE
Confidence            89999999999999999532           2788999999999999999999        6   799999999999999


Q ss_pred             CCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          590 DNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       590 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      +.++.+||+|||+|+.................||+.|+|||++.+.
T Consensus       147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  192 (301)
T 3q4u_A          147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDET  192 (301)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTC
T ss_pred             cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCc
Confidence            9999999999999986543222111122334799999999999876

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.96  E-value=6.4e-30  Score=260.74  Aligned_cols=185  Identities=31%  Similarity=0.462  Sum_probs=143.5

Q ss_pred             HHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc
Q 035691          435 SLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDF  512 (640)
Q Consensus       435 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  512 (640)
                      ++....++|++.+.||+|+||.||+|++  +|+.||||++....  ....+.+.+|++++++++||||+++++++.    
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----  104 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT----  104 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE----
Confidence            3334456788899999999999999987  58899999986443  334568999999999999999999999953    


Q ss_pred             CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeeCCCCCCCeeeC
Q 035691          513 QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQ--IVHCDLKPSNVLLD  590 (640)
Q Consensus       513 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~--ivHrdlkp~NiLl~  590 (640)
                       .....++||||+++|+|.+++......       ..+++..++.++.|++.||+|||+   .+  |+||||||+||+++
T Consensus       105 -~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~  173 (309)
T 3p86_A          105 -QPPNLSIVTEYLSRGSLYRLLHKSGAR-------EQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVD  173 (309)
T ss_dssp             -STTCCEEEEECCTTCBHHHHHHSTTHH-------HHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEEC
T ss_pred             -ECCceEEEEecCCCCcHHHHHhhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEe
Confidence             344689999999999999999754321       237889999999999999999999   57  99999999999999


Q ss_pred             CCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          591 NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       591 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      .++.+||+|||+++......    .......||+.|+|||++.+..++.+
T Consensus       174 ~~~~~kL~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~  219 (309)
T 3p86_A          174 KKYTVKVCDFGLSRLKASTF----LSSKSAAGTPEWMAPEVLRDEPSNEK  219 (309)
T ss_dssp             TTCCEEECCCC---------------------CCTTSCHHHHTTCCCCTT
T ss_pred             CCCcEEECCCCCCccccccc----cccccCCCCccccChhhhcCCCCCch
Confidence            99999999999998543221    12233569999999999998887754

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.96  E-value=1.1e-29  Score=265.45  Aligned_cols=185  Identities=17%  Similarity=0.183  Sum_probs=148.3

Q ss_pred             HHhcCCCcccCcccccccceEEEEE-----ECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcC---CCCCcceeEeec
Q 035691          437 LKATGGFSSANLIGTGSFGSVYKGI-----LDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR---HRNLVKIITACS  508 (640)
Q Consensus       437 ~~~~~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~  508 (640)
                      ....++|.+.+.||+|+||.||+|+     ...+++.||||++....   ...+..|+++++.++   |+||+++++++.
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            3445678899999999999999994     56688999999985433   356788888888886   999999999964


Q ss_pred             cCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCee
Q 035691          509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVL  588 (640)
Q Consensus       509 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiL  588 (640)
                           ..+..++|||||++|+|.+++......     ....+++..++.|+.|++.||+|||+   .+|+||||||+|||
T Consensus       138 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIl  204 (365)
T 3e7e_A          138 -----FQNGSVLVGELYSYGTLLNAINLYKNT-----PEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFI  204 (365)
T ss_dssp             -----CSSCEEEEECCCCSCBHHHHHHHHHTS-----TTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEE
T ss_pred             -----cCCCcEEEEeccCCCcHHHHHHHhhcc-----cccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEE
Confidence                 344779999999999999999642210     01348999999999999999999999   69999999999999


Q ss_pred             eCC-----------CCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          589 LDN-----------DMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       589 l~~-----------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ++.           ++.+||+|||+|+.+....  ........+||+.|||||++.+..++.
T Consensus       205 l~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~  264 (365)
T 3e7e_A          205 LGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP--KGTIFTAKCETSGFQCVEMLSNKPWNY  264 (365)
T ss_dssp             ECGGGTCC------CTTEEECCCTTCEEGGGSC--TTEEECCSSCTTSCCCHHHHTTCCBST
T ss_pred             ecccccCccccccccCCEEEeeCchhhhhhccC--CCceeeeecCCCCCCChHHhcCCCCCc
Confidence            998           8999999999997653221  122334467999999999999988775

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.96  E-value=9e-30  Score=261.87  Aligned_cols=178  Identities=26%  Similarity=0.306  Sum_probs=140.0

Q ss_pred             cCCCcccCcccccccceEEEEEEC---CCCeEEEEEEeeccc----chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILD---PDQTVVAVKVLFLHQ----RGALKSFMAECEALRNIRHRNLVKIITACSSSDF  512 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  512 (640)
                      .++|++.+.||+|+||.||+|+..   .+|+.||+|+++...    ......+.+|+.+++.++||||+++++++.    
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----   91 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ----   91 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE----
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE----
Confidence            356889999999999999999984   589999999996432    233456889999999999999999999953    


Q ss_pred             CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC
Q 035691          513 QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND  592 (640)
Q Consensus       513 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~  592 (640)
                       .....++||||+++|+|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+||+++.+
T Consensus        92 -~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~  157 (327)
T 3a62_A           92 -TGGKLYLILEYLSGGELFMQLEREG----------IFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQ  157 (327)
T ss_dssp             -CSSCEEEEEECCTTEEHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTT
T ss_pred             -cCCEEEEEEeCCCCCcHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCC
Confidence             4457899999999999999986432          27788899999999999999999   699999999999999999


Q ss_pred             CcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          593 MIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       593 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +.+||+|||+++......    ......+||+.|+|||++.+..++.
T Consensus       158 ~~~kl~Dfg~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~  200 (327)
T 3a62_A          158 GHVKLTDFGLCKESIHDG----TVTHTFCGTIEYMAPEILMRSGHNR  200 (327)
T ss_dssp             SCEEECCCSCC--------------CTTSSCCTTSCHHHHTTSCCCT
T ss_pred             CcEEEEeCCcccccccCC----ccccccCCCcCccCHhhCcCCCCCC
Confidence            999999999998543211    1123456999999999998887764

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.96  E-value=4.1e-29  Score=254.86  Aligned_cols=185  Identities=28%  Similarity=0.412  Sum_probs=149.8

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc-----hhHHHHHHHHHHHHhcC---CCCCcceeEeeccC
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR-----GALKSFMAECEALRNIR---HRNLVKIITACSSS  510 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~  510 (640)
                      ..++|++.+.||+|+||+||+|++..+++.||||++.....     .....+.+|+++++.++   ||||++++++|...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            46789999999999999999999998999999999964321     12356677887777664   99999999998655


Q ss_pred             CcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC
Q 035691          511 DFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD  590 (640)
Q Consensus       511 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~  590 (640)
                      ........++||||+. |+|.+++.....        ..+++..+..++.|++.||+|||+   .+|+||||||+||+++
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~  154 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP--------PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVT  154 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT--------TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC--------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEc
Confidence            4333446899999997 599999875443        238899999999999999999999   6999999999999999


Q ss_pred             CCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          591 NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       591 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      .++.+||+|||+++......     ......||+.|+|||++.+..++.+
T Consensus       155 ~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~  199 (308)
T 3g33_A          155 SGGTVKLADFGLARIYSYQM-----ALTPVVVTLWYRAPEVLLQSTYATP  199 (308)
T ss_dssp             TTSCEEECSCSCTTTSTTCC-----CSGGGGCCCSSCCHHHHHTSCCCST
T ss_pred             CCCCEEEeeCccccccCCCc-----ccCCccccccccCchHHcCCCCCch
Confidence            99999999999998664321     1234568999999999988887764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.96  E-value=3.7e-30  Score=262.95  Aligned_cols=185  Identities=23%  Similarity=0.367  Sum_probs=145.2

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      .++|++.+.||+|+||.||+|++..+++.||||++....   ......+.+|+.++++++||||+++++++.... ....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~   89 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   89 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence            467899999999999999999999899999999996542   233467899999999999999999999975432 1223


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++|+|.+++....          .+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.+|
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~k  156 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEG----------PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVK  156 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEE
T ss_pred             ccEEEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEE
Confidence            4589999999999999986432          27888999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|||+++.+...... ........||+.|+|||++.+..++.
T Consensus       157 l~Dfg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~  198 (311)
T 3ork_A          157 VMDFGIARAIADSGNS-VTQTAAVIGTAQYLSPEQARGDSVDA  198 (311)
T ss_dssp             ECCCSCC-------------------CCTTCCHHHHHTCCCCH
T ss_pred             EeeccCcccccccccc-cccccccCcCcccCCHHHhcCCCCCc
Confidence            9999999866432211 11223356899999999998877764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.96  E-value=1.9e-29  Score=259.62  Aligned_cols=174  Identities=26%  Similarity=0.369  Sum_probs=147.8

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      .++|.+.+.||+|+||.||+|++..+++.||||++....   ....+.+.+|+.+++.++||||+++++++.     ...
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~   82 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-----TPT   82 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCC
Confidence            467899999999999999999999999999999996432   223467899999999999999999999954     345


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+ +|+|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+||++++++.+|
T Consensus        83 ~~~lv~E~~-~g~l~~~l~~~~----------~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~k  148 (336)
T 3h4j_B           83 DIVMVIEYA-GGELFDYIVEKK----------RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVK  148 (336)
T ss_dssp             EEEEEECCC-CEEHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEE
T ss_pred             EEEEEEECC-CCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEE
Confidence            789999999 689988885432          27889999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV  637 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  637 (640)
                      |+|||+++.......     ....+||+.|+|||++.+..+
T Consensus       149 l~DFG~s~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~  184 (336)
T 3h4j_B          149 IADFGLSNIMTDGNF-----LKTSCGSPNYAAPEVINGKLY  184 (336)
T ss_dssp             ECCSSCTBTTTTSBT-----TCCCTTSTTTSCGGGSCCSGG
T ss_pred             EEEeccceeccCCcc-----cccccCCcCcCCHHHHcCCCC
Confidence            999999986643211     123469999999999988765

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.96  E-value=1.8e-29  Score=263.96  Aligned_cols=190  Identities=23%  Similarity=0.381  Sum_probs=150.5

Q ss_pred             cCCCcccCcccccccceEEEEEEC-------CCCeEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCCcceeEeeccC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILD-------PDQTVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRNLVKIITACSSS  510 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  510 (640)
                      .++|++.+.||+|+||.||+|++.       .++..||||+++... ....+.+.+|+++++.+ +|||||+++++|.  
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--  157 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--  157 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC--
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc--
Confidence            356888899999999999999863       356789999996543 34457899999999999 8999999999964  


Q ss_pred             CcCCCceeeEEeeccCCCChhhhcCCCCCCCC------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCC
Q 035691          511 DFQGNDFKALVYEFMHHGSLESWLHPESASDD------LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKP  584 (640)
Q Consensus       511 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp  584 (640)
                         .....++||||+++|+|.+++........      .......+++..++.++.|++.||+|||+   .+|+||||||
T Consensus       158 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp  231 (370)
T 2psq_A          158 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAA  231 (370)
T ss_dssp             ---SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCG
T ss_pred             ---cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccch
Confidence               34468999999999999999975432100      01112357899999999999999999999   6999999999


Q ss_pred             CCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          585 SNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       585 ~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +||+++.++.+||+|||+++........  .......||+.|+|||++.+..++.
T Consensus       232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~  284 (370)
T 2psq_A          232 RNVLVTENNVMKIADFGLARDINNIDYY--KKTTNGRLPVKWMAPEALFDRVYTH  284 (370)
T ss_dssp             GGEEECTTCCEEECCCSSCEETTCCCTT--CTTTTTTSCGGGCCHHHHHTCCCCH
T ss_pred             hhEEECCCCCEEEccccCCcccCcccce--ecccCCCcccceECHhHhcCCCCCc
Confidence            9999999999999999999866432211  1122345789999999998877764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.96  E-value=3.2e-29  Score=256.99  Aligned_cols=175  Identities=26%  Similarity=0.368  Sum_probs=147.3

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ++|.+.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++...   .....+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~~   85 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHKV   85 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CCceEE
Confidence            56888999999999999999999999999999996433 34457788999999999999999999987533   234679


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee----CCCCcE
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL----DNDMIA  595 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl----~~~~~~  595 (640)
                      +||||+++|+|.+++......       ..+++..++.++.|++.||+|||+   .+|+||||||+||++    +.++.+
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~  155 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSNA-------YGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVY  155 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGGT-------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEE
T ss_pred             EEEeCCCCCCHHHHHHHhccc-------cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceE
Confidence            999999999999999754321       238899999999999999999999   699999999999999    888899


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGM  633 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  633 (640)
                      ||+|||+++......     ......||+.|+|||++.
T Consensus       156 kL~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~  188 (319)
T 4euu_A          156 KLTDFGAARELEDDE-----QFVSLYGTEEYLHPDMYE  188 (319)
T ss_dssp             EECCCTTCEECCTTC-----CBCCCCSCGGGCCHHHHH
T ss_pred             EEccCCCceecCCCC-----ceeecccCCCccCHHHhh
Confidence            999999998764322     112346999999999986

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.96  E-value=4e-29  Score=268.81  Aligned_cols=180  Identities=23%  Similarity=0.273  Sum_probs=145.3

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc-CCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDF-QGND  516 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~~  516 (640)
                      .++|++.+.||+|+||+||+|++..+|+.||||++...  .....+.+.+|+.+++.++|||||++++++..... ....
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            56799999999999999999999999999999999643  33445788999999999999999999999754432 2335


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||++++ +.+.+..            .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+|
T Consensus       141 ~~~lv~E~~~~~-l~~~~~~------------~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~k  204 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQM------------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLK  204 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHTS------------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEE
T ss_pred             eEEEEEeCCCCC-HHHHHhh------------cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEE
Confidence            689999999875 6555532            27788899999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |+|||+|+......     .....+||++|+|||++.+..++.+
T Consensus       205 l~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~  243 (464)
T 3ttj_A          205 ILDFGLARTAGTSF-----MMTPYVVTRYYRAPEVILGMGYKEN  243 (464)
T ss_dssp             ECCCCCC-----CC-----CC----CCCTTCCHHHHTTCCCCTT
T ss_pred             EEEEEeeeecCCCc-----ccCCCcccccccCHHHHcCCCCCHH
Confidence            99999998654321     1234579999999999999888754

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.96  E-value=4.4e-29  Score=266.71  Aligned_cols=186  Identities=25%  Similarity=0.316  Sum_probs=149.7

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      .++|++.+.||+|+||.||+|++..+++.||||++...  .....+.+.+|+++++.++|||||++++++....+.....
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            56799999999999999999999999999999999643  3334578999999999999999999999986655444467


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .|+||||++ |+|.+++....          .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~----------~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL  170 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI----------FLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKV  170 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEE
T ss_pred             EEEEEecCC-cCHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEE
Confidence            899999987 59999986432          38899999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCC------------------ceeeccccccccccCcccCC-CCCCCC
Q 035691          598 GDFGLTRFIPEVISSN------------------QCSSVGLKGTVGYAAPEYGM-GSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~------------------~~~~~~~~gt~~y~aPE~~~-~~~~s~  639 (640)
                      +|||+|+.........                  .......+||++|+|||++. +..++.
T Consensus       171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~  231 (432)
T 3n9x_A          171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTK  231 (432)
T ss_dssp             CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCT
T ss_pred             ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCc
Confidence            9999998764321110                  01124567999999999864 444543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.96  E-value=9.7e-30  Score=266.26  Aligned_cols=181  Identities=25%  Similarity=0.457  Sum_probs=138.3

Q ss_pred             CCCcccCcccccccceEEEEEEC---CCCeEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          441 GGFSSANLIGTGSFGSVYKGILD---PDQTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ++|++.+.||+|+||.||+|++.   .++..||||+++.. .....+.|.+|+.++++++||||++++++|.     ...
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~  119 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT-----KSK  119 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SSS
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCC
Confidence            46888999999999999999876   46778999999654 3345578999999999999999999999964     345


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++|+|.+++....         ..+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.+|
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~k  187 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHD---------AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCK  187 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTT---------TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEE
T ss_pred             ceEEEEeCCCCCcHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEE
Confidence            6899999999999999996543         238899999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|||+++........ ........+|+.|+|||++.+..++.
T Consensus       188 l~Dfg~a~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~  229 (373)
T 2qol_A          188 VSDFGLGRVLEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTS  229 (373)
T ss_dssp             ECCC-----------------------CTTSCHHHHHHCCCCH
T ss_pred             ECcCccccccccCCcc-ceeccCCCcCCCccChhhhccCCcCc
Confidence            9999999876432211 11122234678899999998777654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.96  E-value=1.8e-29  Score=263.03  Aligned_cols=176  Identities=24%  Similarity=0.258  Sum_probs=141.7

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ..++|++.+.||+|+||.||+|+++.+++.||||++..... ..+.+.+|+.+++.++|||||++++++.     .....
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~   91 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHL   91 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCEE
Confidence            35679999999999999999999999999999999964332 2367889999999999999999999954     44578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc--EE
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI--AH  596 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~--~k  596 (640)
                      ++||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.  +|
T Consensus        92 ~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~k  158 (361)
T 3uc3_A           92 AIIMEYASGGELYERICNAG----------RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLK  158 (361)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEE
T ss_pred             EEEEEeCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEE
Confidence            99999999999999885432          27889999999999999999999   69999999999999987765  99


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      |+|||+++.....     ......+||+.|+|||++.+..++
T Consensus       159 l~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~  195 (361)
T 3uc3_A          159 ICDFGYSKSSVLH-----SQPKSTVGTPAYIAPEVLLRQEYD  195 (361)
T ss_dssp             ECCCCCC--------------------CTTSCHHHHHCSSCC
T ss_pred             EeecCcccccccc-----CCCCCCcCCCCcCChhhhcCCCCC
Confidence            9999999843221     112234699999999999887764

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.96  E-value=5.5e-30  Score=275.05  Aligned_cols=179  Identities=27%  Similarity=0.328  Sum_probs=141.4

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      .++|++.+.||+|+||.||+|++..+|+.||||++...   .......+.+|+.+++.++||||++++++|.     ..+
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-----~~~  221 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----THD  221 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE-----ETT
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-----eCC
Confidence            35688999999999999999999999999999999643   2334467889999999999999999999964     345


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++|+|.+++....          .+++..+..++.|++.||+|||+.  .+|+||||||+|||++.++.+|
T Consensus       222 ~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~k  289 (446)
T 4ejn_A          222 RLCFVMEYANGGELFFHLSRER----------VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIK  289 (446)
T ss_dssp             EEEEEECCCSSCBHHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEE
T ss_pred             EEEEEEeeCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEE
Confidence            7899999999999999886432          378899999999999999999962  4899999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|||+|+.....    .......+||+.|+|||++.+..++.
T Consensus       290 l~DFG~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~  328 (446)
T 4ejn_A          290 ITDFGLCKEGIKD----GATMKTFCGTPEYLAPEVLEDNDYGR  328 (446)
T ss_dssp             ECCCCCCCTTCC---------CCSSSCGGGCCHHHHHTSCCCT
T ss_pred             EccCCCceeccCC----CcccccccCCccccCHhhcCCCCCCC
Confidence            9999999854321    11223467999999999998888765

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.96  E-value=3.4e-29  Score=281.01  Aligned_cols=179  Identities=25%  Similarity=0.276  Sum_probs=152.8

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCC
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~  514 (640)
                      ..++|++.+.||+|+||+||+|+++.+++.||||+++..   .....+.+..|..++..+ +||+|++++++     +++
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~-----~~~  413 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----FQT  413 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE-----CBC
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----EEe
Confidence            456799999999999999999999999999999999643   233457788999999987 79999999998     556


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                      .+..|+||||+++|+|.+++....          .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.
T Consensus       414 ~~~~~lV~E~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~  480 (674)
T 3pfq_A          414 MDRLYFVMEYVNGGDLMYHIQQVG----------RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGH  480 (674)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSC
T ss_pred             CCEEEEEEeCcCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCc
Confidence            668999999999999999986532          27889999999999999999999   69999999999999999999


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +||+|||+|+.....    .......+||+.|+|||++.+..++.
T Consensus       481 ikL~DFGla~~~~~~----~~~~~~~~GT~~Y~APE~l~~~~~~~  521 (674)
T 3pfq_A          481 IKIADFGMCKENIWD----GVTTKTFCGTPDYIAPEIIAYQPYGK  521 (674)
T ss_dssp             EEECCCTTCEECCCT----TCCBCCCCSCSSSCCHHHHTCCCBST
T ss_pred             EEEeecceeeccccC----CcccccccCCCcccCHhhhcCCCCCc
Confidence            999999999854321    11233467999999999999888775

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.96  E-value=2.5e-29  Score=263.03  Aligned_cols=172  Identities=25%  Similarity=0.297  Sum_probs=141.7

Q ss_pred             cCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEeecc
Q 035691          446 ANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFM  525 (640)
Q Consensus       446 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~  525 (640)
                      .+.||+|+||.||+|++..+|+.||+|+++.......+.+.+|++++++++|||||++++++.     .....++||||+
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~lv~E~~  168 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKNDIVLVMEYV  168 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEEECC
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEEEEeCC
Confidence            568999999999999999999999999997665556678999999999999999999999964     345789999999


Q ss_pred             CCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee--CCCCcEEEcccccc
Q 035691          526 HHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL--DNDMIAHVGDFGLT  603 (640)
Q Consensus       526 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl--~~~~~~kl~DfGla  603 (640)
                      ++|+|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+||++  ++++.+||+|||++
T Consensus       169 ~~~~L~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a  236 (373)
T 2x4f_A          169 DGGELFDRIIDES---------YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLA  236 (373)
T ss_dssp             TTCEEHHHHHHTG---------GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSC
T ss_pred             CCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCc
Confidence            9999998885432         237888999999999999999999   699999999999999  67789999999999


Q ss_pred             ccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          604 RFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       604 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +.+.....     .....||+.|+|||++.+..++.
T Consensus       237 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~  267 (373)
T 2x4f_A          237 RRYKPREK-----LKVNFGTPEFLAPEVVNYDFVSF  267 (373)
T ss_dssp             EECCTTCB-----CCCCCSSCTTCCHHHHTTCBCCH
T ss_pred             eecCCccc-----cccccCCCcEeChhhccCCCCCc
Confidence            87643211     12346999999999998877653

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.96  E-value=5.4e-29  Score=267.50  Aligned_cols=175  Identities=29%  Similarity=0.414  Sum_probs=150.1

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      .++|.+.+.||+|+||.||+|++..+|+.||||++....   ....+.+.+|+.+++.++||||+++++++.     ...
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----~~~   89 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-----TPS   89 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECC
Confidence            357888999999999999999999999999999996432   233567899999999999999999999954     345


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+|
T Consensus        90 ~~~lv~E~~~gg~L~~~l~~~~----------~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vk  156 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYICKNG----------RLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAK  156 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTTSSS----------SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeE
Confidence            7899999999999999986432          37889999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV  637 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  637 (640)
                      |+|||+++......     .....+||+.|+|||++.+..+
T Consensus       157 L~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~  192 (476)
T 2y94_A          157 IADFGLSNMMSDGE-----FLRTSCGSPNYAAPEVISGRLY  192 (476)
T ss_dssp             ECCCSSCEECCTTC-----CBCCCCSCSTTCCHHHHTTCCB
T ss_pred             EEeccchhhccccc-----cccccCCCcCeEChhhccCCCC
Confidence            99999998664321     1223569999999999988765

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.96  E-value=3.8e-29  Score=256.15  Aligned_cols=183  Identities=27%  Similarity=0.470  Sum_probs=136.1

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|+++... ....+.+.+|++++++++|||||++++++     ..++..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~   78 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKL   78 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeE
Confidence            467889999999999999999999899999999996543 33446788999999999999999999995     345578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||++ |+|.+++.......    .+..+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+
T Consensus        79 ~lv~e~~~-~~L~~~l~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~  150 (317)
T 2pmi_A           79 TLVFEFMD-NDLKKYMDSRTVGN----TPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLG  150 (317)
T ss_dssp             EEEEECCC-CBHHHHHHHHHSSS----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEEecC-CCHHHHHHhccccc----cccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEEC
Confidence            99999998 59998885432111    11348889999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCC-CCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS-QVST  639 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~  639 (640)
                      |||+++.......    ......||+.|+|||++.+. .++.
T Consensus       151 Dfg~~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~  188 (317)
T 2pmi_A          151 DFGLARAFGIPVN----TFSSEVVTLWYRAPDVLMGSRTYST  188 (317)
T ss_dssp             CCSSCEETTSCCC----CCCCCCSCCTTCCHHHHTTCCCCCT
T ss_pred             cCccceecCCCcc----cCCCCcccccccCchHhhCCCCCCc
Confidence            9999986643211    11234689999999999874 3443

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.96  E-value=3.1e-29  Score=258.32  Aligned_cols=180  Identities=24%  Similarity=0.325  Sum_probs=149.3

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCcee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      .++|++.+.||+|+||.||+|++..+|+.||||++.....  .+.+.+|+++++++ +||||+++++++.     .....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~-----~~~~~   80 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGP-----CGKYN   80 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEE-----ETTEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEe-----cCCcc
Confidence            4678999999999999999999988999999999864432  24588999999999 9999999999954     34578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc----
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI----  594 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~----  594 (640)
                      ++||||+ +|+|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.    
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~  147 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLCD---------RTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQ  147 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHTT---------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTT
T ss_pred             EEEEEeC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCc
Confidence            9999999 999999986432         238899999999999999999999   69999999999999998887    


Q ss_pred             -EEEccccccccCCCccCCC---ceeeccccccccccCcccCCCCCCCC
Q 035691          595 -AHVGDFGLTRFIPEVISSN---QCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       595 -~kl~DfGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                       +||+|||+++.+.......   ........||+.|+|||++.+..++.
T Consensus       148 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  196 (330)
T 2izr_A          148 VIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSR  196 (330)
T ss_dssp             SEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH
T ss_pred             eEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCc
Confidence             9999999998764332211   11123467999999999999887764

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.96  E-value=4.6e-29  Score=263.17  Aligned_cols=185  Identities=18%  Similarity=0.172  Sum_probs=151.8

Q ss_pred             hcCCCcccCccccc--ccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCC
Q 035691          439 ATGGFSSANLIGTG--SFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       439 ~~~~~~~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  514 (640)
                      ..++|++.+.||+|  +||.||+|+++.+|+.||||++....  ....+.+.+|+.+++.++|||||++++++.     .
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~   97 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----A   97 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----E
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE-----E
Confidence            35678899999999  99999999999999999999996543  334567889999999999999999999954     4


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                      ....++|||||++|+|.+++.....        ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~  166 (389)
T 3gni_B           98 DNELWVVTSFMAYGSAKDLICTHFM--------DGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGK  166 (389)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTCT--------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCC
T ss_pred             CCEEEEEEEccCCCCHHHHHhhhcc--------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCC
Confidence            4578999999999999999865432        237889999999999999999999   69999999999999999999


Q ss_pred             EEEccccccccCCCccC---CCceeeccccccccccCcccCCC--CCCCC
Q 035691          595 AHVGDFGLTRFIPEVIS---SNQCSSVGLKGTVGYAAPEYGMG--SQVST  639 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~--~~~s~  639 (640)
                      +||+|||.+........   .........+||+.|+|||++.+  ..++.
T Consensus       167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  216 (389)
T 3gni_B          167 VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA  216 (389)
T ss_dssp             EEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCT
T ss_pred             EEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCc
Confidence            99999999875422111   01111223468999999999987  45553

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.96  E-value=7.4e-30  Score=276.44  Aligned_cols=233  Identities=22%  Similarity=0.228  Sum_probs=146.3

Q ss_pred             CCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCC
Q 035691           52 ELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNL  131 (640)
Q Consensus        52 ~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  131 (640)
                      +|++|||++|.|+.      +++..+..+++|+.|+|++|.|++..|  |..+++|++|+|++|.|+++.+     .++|
T Consensus        35 ~L~~L~Ls~n~l~~------~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L  101 (487)
T 3oja_A           35 NVKELDLSGNPLSQ------ISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSI  101 (487)
T ss_dssp             GCCEEECCSSCCCC------CCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTC
T ss_pred             CccEEEeeCCcCCC------CCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCc
Confidence            44444444444433      333333344445555555555544433  5566666666666666664322     2566


Q ss_pred             CEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCc-CcCCCCCCCCCEEEccCCcCcccCCcCcc-CCCCCC
Q 035691          132 TRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSI-PISVGYLPKLQVLSLFENNISGEIPSSLG-NFTFLT  209 (640)
Q Consensus       132 ~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~  209 (640)
                      ++|+|++|.|+.++.         ..+++|+.|+|++|.++.+ |..+..+++|++|+|++|.|++..|..|. .+++|+
T Consensus       102 ~~L~L~~N~l~~~~~---------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~  172 (487)
T 3oja_A          102 ETLHAANNNISRVSC---------SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE  172 (487)
T ss_dssp             CEEECCSSCCCCEEE---------CCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCC
T ss_pred             CEEECcCCcCCCCCc---------cccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCccc
Confidence            666666666665421         1235566666666666664 44556667777777777777776666665 677777


Q ss_pred             EEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCcc
Q 035691          210 ELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSS  289 (640)
Q Consensus       210 ~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  289 (640)
                      +|+|++|.|++..+  +..+++|+.|                +|++|.|++. |..|..+++|+.|+|++|.|+ .+|..
T Consensus       173 ~L~Ls~N~l~~~~~--~~~l~~L~~L----------------~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~-~lp~~  232 (487)
T 3oja_A          173 HLNLQYNFIYDVKG--QVVFAKLKTL----------------DLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKA  232 (487)
T ss_dssp             EEECTTSCCCEEEC--CCCCTTCCEE----------------ECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTT
T ss_pred             EEecCCCccccccc--cccCCCCCEE----------------ECCCCCCCCC-CHhHcCCCCccEEEecCCcCc-ccchh
Confidence            77777777775522  2245666666                6667777753 334777788888888888887 46667


Q ss_pred             ccCCCCCCeEEecCCccC-CCCCccCCCCCCCCeEeCc
Q 035691          290 LGSCVGLEYLNLSINSFH-GPIHPGLSSLKSLEGLDLF  326 (640)
Q Consensus       290 ~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~  326 (640)
                      +..+++|+.|++++|++. +.+|..+..++.|+.++++
T Consensus       233 l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             CCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             hccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence            777788888888888877 5566777777778777776

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.96  E-value=1.6e-29  Score=263.73  Aligned_cols=201  Identities=22%  Similarity=0.318  Sum_probs=158.0

Q ss_pred             ccCHHHHHHhcCCCcccCcccccccceEEEEE-----ECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCCcc
Q 035691          430 NVSYESLLKATGGFSSANLIGTGSFGSVYKGI-----LDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRNLVK  502 (640)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~  502 (640)
                      .+...++....++|++.+.||+|+||.||+|+     ...+++.||||+++... ....+.+.+|+++++++ +|||||+
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            44556666777889999999999999999998     45677899999996543 33456799999999999 7999999


Q ss_pred             eeEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCC----------------------------------------
Q 035691          503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDD----------------------------------------  542 (640)
Q Consensus       503 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~----------------------------------------  542 (640)
                      ++++|...    +...++||||+++|+|.+++........                                        
T Consensus        91 ~~~~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (359)
T 3vhe_A           91 LLGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSG  166 (359)
T ss_dssp             EEEEECST----TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------
T ss_pred             eeeeeecC----CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccc
Confidence            99997432    3457899999999999999975432100                                        


Q ss_pred             ----------------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccccccC
Q 035691          543 ----------------LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI  606 (640)
Q Consensus       543 ----------------~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~  606 (640)
                                      .......+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  243 (359)
T 3vhe_A          167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDI  243 (359)
T ss_dssp             -----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred             cccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeee
Confidence                            00001238899999999999999999999   69999999999999999999999999999866


Q ss_pred             CCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          607 PEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       607 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      .....  ........||+.|+|||++.+..++.
T Consensus       244 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~  274 (359)
T 3vhe_A          244 YKDPD--YVRKGDARLPLKWMAPETIFDRVYTI  274 (359)
T ss_dssp             TSCTT--CEEC--CEECGGGCCHHHHHHCCCCH
T ss_pred             ccccc--chhccccCCCceeEChhhhcCCCCCc
Confidence            43222  12223356899999999988777653

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.96  E-value=3.3e-29  Score=259.91  Aligned_cols=175  Identities=27%  Similarity=0.359  Sum_probs=135.1

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .+.|++.+.||+|+||.||+|++..+++.||||++....  ..+.+.+|++++++++||||+++++++.     .....+
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~  124 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEIS  124 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeEE
Confidence            456889999999999999999999899999999996433  3356889999999999999999999964     345789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC---CCcEE
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN---DMIAH  596 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~---~~~~k  596 (640)
                      +||||+++|+|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+||+++.   ++.+|
T Consensus       125 lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~k  191 (349)
T 2w4o_A          125 LVLELVTGGELFDRIVEKG----------YYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLK  191 (349)
T ss_dssp             EEECCCCSCBHHHHHTTCS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEE
T ss_pred             EEEEeCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEE
Confidence            9999999999999986542          27889999999999999999999   69999999999999975   88999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|||+++......     ......||+.|+|||++.+..++.
T Consensus       192 l~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~  229 (349)
T 2w4o_A          192 IADFGLSKIVEHQV-----LMKTVCGTPGYCAPEILRGCAYGP  229 (349)
T ss_dssp             ECCCC---------------------CGGGSCHHHHTTCCCCT
T ss_pred             EccCccccccCccc-----ccccccCCCCccCHHHhcCCCCCc
Confidence            99999998654321     122356999999999999887765

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.96  E-value=6.1e-29  Score=253.82  Aligned_cols=176  Identities=28%  Similarity=0.411  Sum_probs=143.6

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      .++|++.+.||+|+||.||+|++. +|+.||+|++....  ....+.+.+|++++++++||||+++++++     .....
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   93 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSERC   93 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCSSC
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccCCE
Confidence            467889999999999999999996 69999999995432  33356789999999999999999999995     34457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++ ++.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||
T Consensus        94 ~~lv~e~~~~-~l~~~~~~~~---------~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl  160 (311)
T 3niz_A           94 LTLVFEFMEK-DLKKVLDENK---------TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKL  160 (311)
T ss_dssp             EEEEEECCSE-EHHHHHHTCT---------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEE
T ss_pred             EEEEEcCCCC-CHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEE
Confidence            8999999985 7887775433         237889999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCC-CCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS-QVS  638 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s  638 (640)
                      +|||+++.......    ......||+.|+|||++.+. .++
T Consensus       161 ~Dfg~a~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~  198 (311)
T 3niz_A          161 ADFGLARAFGIPVR----SYTHEVVTLWYRAPDVLMGSKKYS  198 (311)
T ss_dssp             CCCTTCEETTSCCC-------CCCCCCTTCCHHHHTTCCSCC
T ss_pred             ccCcCceecCCCcc----cccCCcccCCcCCHHHhcCCCCCC
Confidence            99999986643211    12234689999999998774 344

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.96  E-value=2.4e-29  Score=260.92  Aligned_cols=196  Identities=23%  Similarity=0.325  Sum_probs=149.2

Q ss_pred             HHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc-----cchhHHHHHHHHHHHHhcCCCCCcceeEeecc
Q 035691          435 SLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH-----QRGALKSFMAECEALRNIRHRNLVKIITACSS  509 (640)
Q Consensus       435 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  509 (640)
                      ++....++|++.+.||+|+||.||+|++..+++.||+|++...     .....+.+.+|++++++++|||||++++++. 
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-   98 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE-   98 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc-
Confidence            3455567799999999999999999999999999999999543     2345578999999999999999999999963 


Q ss_pred             CCcCCCceeeEEeeccCCCChhhhcCCCCCCCC------------------------------CCCCCCCCCHHHHHHHH
Q 035691          510 SDFQGNDFKALVYEFMHHGSLESWLHPESASDD------------------------------LNYSPSILSFLQRLNIA  559 (640)
Q Consensus       510 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------------------------------~~~~~~~~~~~~~~~i~  559 (640)
                          .....++||||+++|+|.+++........                              .......+++..+..++
T Consensus        99 ----~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  174 (345)
T 3hko_A           99 ----DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM  174 (345)
T ss_dssp             ----CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHH
T ss_pred             ----cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHH
Confidence                44578999999999999999852110000                              00001124567788999


Q ss_pred             HHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC--cEEEccccccccCCCccCCCceeeccccccccccCcccCCC--C
Q 035691          560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM--IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG--S  635 (640)
Q Consensus       560 ~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~  635 (640)
                      .|++.||+|||+   .+|+||||||+||+++.++  .+||+|||+++.+...............||+.|+|||++.+  .
T Consensus       175 ~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  251 (345)
T 3hko_A          175 RQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE  251 (345)
T ss_dssp             HHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSS
T ss_pred             HHHHHHHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCC
Confidence            999999999999   6999999999999998776  89999999998664322222222334569999999999875  4


Q ss_pred             CCC
Q 035691          636 QVS  638 (640)
Q Consensus       636 ~~s  638 (640)
                      .++
T Consensus       252 ~~~  254 (345)
T 3hko_A          252 SYG  254 (345)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            444

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.96  E-value=3.4e-29  Score=261.32  Aligned_cols=191  Identities=25%  Similarity=0.304  Sum_probs=159.8

Q ss_pred             cccccccCHHHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcC-----CCC
Q 035691          425 KDLLLNVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR-----HRN  499 (640)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~n  499 (640)
                      .+....+++++.....++|++.+.||+|+||.||+|++..+++.||||++... ....+.+..|+.+++.++     |||
T Consensus        19 ~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~   97 (360)
T 3llt_A           19 DDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNN   97 (360)
T ss_dssp             -CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred             CccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCC
Confidence            34556677777778889999999999999999999999989999999998632 334467788999999986     999


Q ss_pred             CcceeEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 035691          500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVH  579 (640)
Q Consensus       500 iv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivH  579 (640)
                      ||++++++.     ..+..++||||+ +++|.+++.....        ..+++..+..++.|++.||+|||+   .+|+|
T Consensus        98 iv~~~~~~~-----~~~~~~lv~e~~-~~~L~~~~~~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH  160 (360)
T 3llt_A           98 IVKYHGKFM-----YYDHMCLIFEPL-GPSLYEIITRNNY--------NGFHIEDIKLYCIEILKALNYLRK---MSLTH  160 (360)
T ss_dssp             BCCEEEEEE-----ETTEEEEEECCC-CCBHHHHHHHTTT--------CCCCHHHHHHHHHHHHHHHHHHHH---TTEEC
T ss_pred             eecccceee-----ECCeeEEEEcCC-CCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHH---CCeee
Confidence            999999954     345789999999 8999999865432        237889999999999999999999   69999


Q ss_pred             CCCCCCCeeeCC-------------------------CCcEEEccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          580 CDLKPSNVLLDN-------------------------DMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       580 rdlkp~NiLl~~-------------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      |||||+|||++.                         ++.+||+|||+|+......       ....||+.|+|||++.+
T Consensus       161 rDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-------~~~~gt~~y~aPE~~~~  233 (360)
T 3llt_A          161 TDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-------GSIINTRQYRAPEVILN  233 (360)
T ss_dssp             SCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-------CSCCSCGGGCCHHHHTT
T ss_pred             CCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-------cCccCcccccCcHHHcC
Confidence            999999999975                         7899999999998643311       23468999999999999


Q ss_pred             CCCCCC
Q 035691          635 SQVSTN  640 (640)
Q Consensus       635 ~~~s~k  640 (640)
                      ..++.+
T Consensus       234 ~~~~~~  239 (360)
T 3llt_A          234 LGWDVS  239 (360)
T ss_dssp             CCCCTT
T ss_pred             CCCCCc
Confidence            888764

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.96  E-value=4.2e-29  Score=256.37  Aligned_cols=180  Identities=30%  Similarity=0.396  Sum_probs=145.6

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ..++|++.+.||+|+||.||+|++.  ++.||||++..... ....+..|+.++++++|||||++++++.... ......
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~   97 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDL   97 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceE
Confidence            3457889999999999999999885  89999999965433 3345677999999999999999999976532 123457


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------CCCCeeeCCCCCCCeeeCC
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHH-------CKKQIVHCDLKPSNVLLDN  591 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~-------~~~~ivHrdlkp~NiLl~~  591 (640)
                      ++||||+++|+|.+++...           .+++..++.++.|++.||+|||+.       +.++|+||||||+||+++.
T Consensus        98 ~lv~e~~~~g~L~~~l~~~-----------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~  166 (322)
T 3soc_A           98 WLITAFHEKGSLSDFLKAN-----------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN  166 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHC-----------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECT
T ss_pred             EEEEecCCCCCHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECC
Confidence            9999999999999999542           278899999999999999999982       0129999999999999999


Q ss_pred             CCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          592 DMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       592 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      ++.+||+|||+|+.+.....  ........||+.|+|||++.+.
T Consensus       167 ~~~~kL~DFg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~  208 (322)
T 3soc_A          167 NLTACIADFGLALKFEAGKS--AGDTHGQVGTRRYMAPEVLEGA  208 (322)
T ss_dssp             TCCEEECCCTTCEEECTTSC--CCCCTTCCCCGGGCCHHHHTTC
T ss_pred             CCeEEEccCCcccccccccC--ccccccCccCccccCHhhcccc
Confidence            99999999999986643222  1122335699999999999874

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.96  E-value=8.7e-29  Score=260.94  Aligned_cols=183  Identities=26%  Similarity=0.433  Sum_probs=139.8

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcC-CCCCcceeEeeccCCcCCC
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIR-HRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~  515 (640)
                      ..++|++.+.||+|+||.||+|++..+|+.||||++...  .....+.+.+|+.++..+. |||||++++++...   ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~   83 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---ND   83 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TS
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CC
Confidence            356899999999999999999999999999999998533  3344567889999999997 99999999997532   23


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      ...++|||||+ |+|.+++...           .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+
T Consensus        84 ~~~~lv~e~~~-~~L~~~~~~~-----------~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~  148 (388)
T 3oz6_A           84 RDVYLVFDYME-TDLHAVIRAN-----------ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHV  148 (388)
T ss_dssp             SCEEEEEECCS-EEHHHHHHHT-----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCE
T ss_pred             CEEEEEecccC-cCHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCE
Confidence            46899999998 5898888532           27788899999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccC-----------------CCceeeccccccccccCcccCCC-CCCCC
Q 035691          596 HVGDFGLTRFIPEVIS-----------------SNQCSSVGLKGTVGYAAPEYGMG-SQVST  639 (640)
Q Consensus       596 kl~DfGla~~~~~~~~-----------------~~~~~~~~~~gt~~y~aPE~~~~-~~~s~  639 (640)
                      ||+|||+|+.+.....                 .........+||++|+|||++.+ ..++.
T Consensus       149 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  210 (388)
T 3oz6_A          149 KVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTK  210 (388)
T ss_dssp             EECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCT
T ss_pred             EecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCC
Confidence            9999999986532110                 00112234679999999999987 44543

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=9.4e-28  Score=265.30  Aligned_cols=248  Identities=25%  Similarity=0.323  Sum_probs=208.6

Q ss_pred             CCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCC
Q 035691            3 TFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPN   82 (640)
Q Consensus         3 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~   82 (640)
                      ++|+.|+|++|+|+ .+|.   .+++|++|+|++|+|++ +|.   .+++|++|+|++|+|+.      +|.    .+++
T Consensus        61 ~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~------l~~----~l~~  122 (622)
T 3g06_A           61 AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTH------LPA----LPSG  122 (622)
T ss_dssp             TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCCC------CCC----CCTT
T ss_pred             CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCC------CCC----CCCC
Confidence            57999999999999 5565   67999999999999994 555   77999999999999986      766    4789


Q ss_pred             CCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcc
Q 035691           83 IRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLE  162 (640)
Q Consensus        83 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~  162 (640)
                      |+.|+|++|+|+++ |..   +++|++|+|++|+|++ +|.   .+++|+.|++++|.|+.++          ..+++|+
T Consensus       123 L~~L~L~~N~l~~l-p~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~l~----------~~~~~L~  184 (622)
T 3g06_A          123 LCKLWIFGNQLTSL-PVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTSLP----------MLPSGLQ  184 (622)
T ss_dssp             CCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCC----------CCCTTCC
T ss_pred             cCEEECCCCCCCcC-CCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCCCc----------ccCCCCc
Confidence            99999999999974 443   4899999999999996 443   3578999999999999864          2458899


Q ss_pred             eEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccc
Q 035691          163 IVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIF  242 (640)
Q Consensus       163 ~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~  242 (640)
                      .|++++|.|+.+|..   +++|+.|++++|.|+. +|..   +++|+.|+|++|+|++ +|   ..+++|+.|       
T Consensus       185 ~L~Ls~N~l~~l~~~---~~~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L-------  246 (622)
T 3g06_A          185 ELSVSDNQLASLPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LP---VLPSELKEL-------  246 (622)
T ss_dssp             EEECCSSCCSCCCCC---CTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEE-------
T ss_pred             EEECCCCCCCCCCCc---cchhhEEECcCCcccc-cCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEE-------
Confidence            999999999998864   4789999999999994 5543   4889999999999995 44   445677777       


Q ss_pred             cCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCC
Q 035691          243 LGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLK  318 (640)
Q Consensus       243 ~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  318 (640)
                               +|++|+|++ +|.   .+++|+.|+|++|+|+ .+|..|.++++|+.|+|++|++++..|..+..++
T Consensus       247 ---------~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          247 ---------MVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             ---------ECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             ---------ECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence                     888888884 444   5789999999999999 7788999999999999999999988887766554

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.96  E-value=5.8e-30  Score=264.51  Aligned_cols=171  Identities=20%  Similarity=0.255  Sum_probs=138.3

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--------chhHHHHHHHHHHHHhcC---------CCCCcce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--------RGALKSFMAECEALRNIR---------HRNLVKI  503 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l  503 (640)
                      ++|++.+.||+|+||+||+|++  +|+.||||++....        ....+.+.+|+.++++++         |||||++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            4577889999999999999998  68999999996542        223478899999999886         8888887


Q ss_pred             eEeeccC-------------------------CcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHH
Q 035691          504 ITACSSS-------------------------DFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNI  558 (640)
Q Consensus       504 ~~~~~~~-------------------------~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i  558 (640)
                      .+++...                         ++......++||||+++|++.+.+..           ..+++..+..+
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----------~~~~~~~~~~i  166 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----------KLSSLATAKSI  166 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----------TCCCHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----------cCCCHHHHHHH
Confidence            7764311                         01125678999999999977666632           12788999999


Q ss_pred             HHHHHHHHHHHh-cCCCCCeeeCCCCCCCeeeCCCC--------------------cEEEccccccccCCCccCCCceee
Q 035691          559 AINVASALEYLH-HHCKKQIVHCDLKPSNVLLDNDM--------------------IAHVGDFGLTRFIPEVISSNQCSS  617 (640)
Q Consensus       559 ~~~i~~al~yLH-~~~~~~ivHrdlkp~NiLl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~  617 (640)
                      +.|++.||+||| +   .+|+||||||+|||++.++                    .+||+|||+|+.....        
T Consensus       167 ~~qi~~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--------  235 (336)
T 2vuw_A          167 LHQLTASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--------  235 (336)
T ss_dssp             HHHHHHHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------
T ss_pred             HHHHHHHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--------
Confidence            999999999999 7   6999999999999999887                    8999999999865321        


Q ss_pred             ccccccccccCcccCCCCC
Q 035691          618 VGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       618 ~~~~gt~~y~aPE~~~~~~  636 (640)
                       ..+||+.|||||++.+..
T Consensus       236 -~~~gt~~y~aPE~~~g~~  253 (336)
T 2vuw_A          236 -IVVFCDVSMDEDLFTGDG  253 (336)
T ss_dssp             -EEECCCCTTCSGGGCCCS
T ss_pred             -cEEEeecccChhhhcCCC
Confidence             236999999999998764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.96  E-value=9.4e-29  Score=253.96  Aligned_cols=169  Identities=26%  Similarity=0.297  Sum_probs=126.6

Q ss_pred             cCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcC-CCCCcceeEeeccCCcCCCceeeEEeec
Q 035691          446 ANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR-HRNLVKIITACSSSDFQGNDFKALVYEF  524 (640)
Q Consensus       446 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~~lv~e~  524 (640)
                      .+.||+|+||.||+|+++.+++.||||++...   ....+.+|+.+++.+. ||||+++++++.     +....++||||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~~~~~~lv~e~   87 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFH-----DQLHTFLVMEL   87 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSEEEEEECC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----cCCEEEEEEEc
Confidence            47899999999999999999999999998543   3356789999999997 999999999953     45578999999


Q ss_pred             cCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC---cEEEcccc
Q 035691          525 MHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM---IAHVGDFG  601 (640)
Q Consensus       525 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~---~~kl~DfG  601 (640)
                      +++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++   .+||+|||
T Consensus        88 ~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg  154 (325)
T 3kn6_A           88 LNGGELFERIKKKK----------HFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFG  154 (325)
T ss_dssp             CCSCBHHHHHHHCS----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred             cCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccc
Confidence            99999999986542          37899999999999999999999   6999999999999997665   89999999


Q ss_pred             ccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          602 LTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       602 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +++......    ......+||+.|+|||++.+..++.
T Consensus       155 ~a~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~  188 (325)
T 3kn6_A          155 FARLKPPDN----QPLKTPCFTLHYAAPELLNQNGYDE  188 (325)
T ss_dssp             TCEECCC--------------------------CCCCH
T ss_pred             cceecCCCC----CcccccCCCcCccCHHHhcCCCCCC
Confidence            998654321    1122346899999999998887764

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.96  E-value=4.1e-29  Score=249.55  Aligned_cols=178  Identities=29%  Similarity=0.475  Sum_probs=147.9

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .++|++.+.||+|+||.||+|++. +++.||+|++..... ..+.+.+|++++++++||||+++++++.     .....+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   81 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPIC   81 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEE
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCceE
Confidence            356788899999999999999987 688899999964433 3467999999999999999999999953     345689


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++|+|.+++.....         .+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.+||+|
T Consensus        82 lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~D  149 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQRG---------LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSD  149 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTTT---------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECC
T ss_pred             EEEEeCCCCcHHHHHHhcCc---------ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecc
Confidence            99999999999999965432         37889999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+++......   ........||+.|+|||++.+..++.
T Consensus       150 fg~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~  186 (269)
T 4hcu_A          150 FGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFSFSRYSS  186 (269)
T ss_dssp             TTGGGGBCCHH---HHSTTSTTCCGGGCCHHHHHHCCCCH
T ss_pred             ccccccccccc---cccccCcccccccCCHHHhcCCCCCc
Confidence            99998654321   11122345788999999988776653

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.95  E-value=8e-30  Score=267.60  Aligned_cols=182  Identities=27%  Similarity=0.397  Sum_probs=148.0

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ..++|.+.+.||+|+||.||+|++..+++.||||+++... ....+.|.+|++++++++|||||+++++|.     ....
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~  186 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQP  186 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC-----SSSS
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----cCCC
Confidence            3456788899999999999999999899999999986442 233457889999999999999999999964     3346


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl  254 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTEG---------ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKI  254 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHHG---------GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEE
T ss_pred             cEEEEEcCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEE
Confidence            899999999999999986432         237888999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|||+++.......  ........+++.|+|||++.++.++.
T Consensus       255 ~DfG~s~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~  294 (377)
T 3cbl_A          255 SDFGMSREEADGVY--AASGGLRQVPVKWTAPEALNYGRYSS  294 (377)
T ss_dssp             CCGGGCEECTTSEE--ECCSSCCEEEGGGSCHHHHHHCEEEH
T ss_pred             CcCCCceecCCCce--eecCCCCCCCcCcCCHhHhccCCCCc
Confidence            99999986432111  00111123577899999987766553

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.95  E-value=7.2e-29  Score=251.73  Aligned_cols=182  Identities=27%  Similarity=0.426  Sum_probs=145.9

Q ss_pred             CCcccCcccccccceEEEEEECCC---CeEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPD---QTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      .|++.+.||+|+||.||+|++..+   +..||+|.+... .....+.+.+|+.++++++||||++++++|..    .+..
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~  101 (298)
T 3f66_A           26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGS  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SSSC
T ss_pred             ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc----CCCc
Confidence            477789999999999999997533   346899988543 33455789999999999999999999998743    3456


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++....         ..+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.+||
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl  169 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNET---------HNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKV  169 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCTT---------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEE
T ss_pred             eEEEEeCCCCCCHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEE
Confidence            789999999999999996533         237888999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|||+++.................||+.|+|||.+.+..++.
T Consensus       170 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  211 (298)
T 3f66_A          170 ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT  211 (298)
T ss_dssp             CSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCH
T ss_pred             CcccccccccccchhccccccCCCCCccccChHHhcCCCCCh
Confidence            999999876543322222334456889999999998776653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.95  E-value=6.1e-29  Score=253.86  Aligned_cols=175  Identities=26%  Similarity=0.280  Sum_probs=141.4

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|+..+.||+|+||+||+|++..+|+.||||++....  ......+..|+..+.++ +|||||+++++|.     .+..
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~  131 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI  131 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence            46889999999999999999999999999999985432  23334566677666665 8999999999964     3457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+ +|+|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl  198 (311)
T 3p1a_A          132 LYLQTELC-GPSLQQHCEAWG---------ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKL  198 (311)
T ss_dssp             EEEEEECC-CCBHHHHHHHHC---------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEE
T ss_pred             EEEEEecc-CCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEE
Confidence            89999999 679988875432         238899999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|||+++......     ......||+.|+|||++.+ .++.
T Consensus       199 ~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~  234 (311)
T 3p1a_A          199 GDFGLLVELGTAG-----AGEVQEGDPRYMAPELLQG-SYGT  234 (311)
T ss_dssp             CCCTTCEECC-----------CCCCCGGGCCGGGGGT-CCST
T ss_pred             ccceeeeecccCC-----CCcccCCCccccCHhHhcC-CCCc
Confidence            9999998654321     1223459999999999876 5554

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.95  E-value=1.6e-28  Score=255.31  Aligned_cols=184  Identities=25%  Similarity=0.410  Sum_probs=147.8

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc---CC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDF---QG  514 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---~~  514 (640)
                      .++|++.+.||+|+||.||+|++..+|+.||||++....  ......+.+|+++++.++||||+++++++.....   ..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            356889999999999999999999999999999985433  2334678899999999999999999999755321   11


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                      ....++||||+++ ++.+.+.....         .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~---------~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~  162 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLV---------KFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGV  162 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTS---------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccC---------CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCC
Confidence            4468999999986 77766654322         37889999999999999999999   69999999999999999999


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      +||+|||+|+.+...............||+.|+|||++.+..
T Consensus       163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  204 (351)
T 3mi9_A          163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER  204 (351)
T ss_dssp             EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCC
T ss_pred             EEEccchhcccccccccccccccCCcccccCccCchhhcCCC
Confidence            999999999876533222222334457899999999997743

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.95  E-value=3.9e-29  Score=257.87  Aligned_cols=175  Identities=26%  Similarity=0.390  Sum_probs=148.4

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc--------hhHHHHHHHHHHHHhcCCCCCcceeEeeccCC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--------GALKSFMAECEALRNIRHRNLVKIITACSSSD  511 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  511 (640)
                      .++|++.+.||+|+||.||+|++..+++.||||++.....        ...+.+.+|+.++++++||||+++++++    
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~----   98 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF----   98 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE----
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence            4568899999999999999999999999999999964421        1234677899999999999999999995    


Q ss_pred             cCCCceeeEEeeccCCC-ChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC
Q 035691          512 FQGNDFKALVYEFMHHG-SLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD  590 (640)
Q Consensus       512 ~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~  590 (640)
                       ......++||||+.+| +|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+||+++
T Consensus        99 -~~~~~~~lv~e~~~~g~~l~~~~~~~~----------~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~  164 (335)
T 3dls_A           99 -ENQGFFQLVMEKHGSGLDLFAFIDRHP----------RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIA  164 (335)
T ss_dssp             -ECSSEEEEEEECCTTSCBHHHHHHTCC----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC
T ss_pred             -eeCCEEEEEEEeCCCCccHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEc
Confidence             3455789999999877 9999986543          27889999999999999999999   6999999999999999


Q ss_pred             CCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCC
Q 035691          591 NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV  637 (640)
Q Consensus       591 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  637 (640)
                      .++.+||+|||+++.......     .....||+.|+|||++.+..+
T Consensus       165 ~~~~~kL~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~  206 (335)
T 3dls_A          165 EDFTIKLIDFGSAAYLERGKL-----FYTFCGTIEYCAPEVLMGNPY  206 (335)
T ss_dssp             TTSCEEECCCTTCEECCTTCC-----BCEECSCGGGCCHHHHTTCCB
T ss_pred             CCCcEEEeecccceECCCCCc-----eeccCCCccccChhhhcCCCC
Confidence            999999999999987643211     123469999999999988776

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.95  E-value=1.8e-28  Score=246.08  Aligned_cols=176  Identities=24%  Similarity=0.288  Sum_probs=150.1

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .++|++.+.||+|+||.||+|++..++..||+|++........+.+.+|++++++++||||+++++++.     .....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   82 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDIY   82 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeEE
Confidence            345888999999999999999999999999999997665566788999999999999999999999964     445789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee---CCCCcEE
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL---DNDMIAH  596 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl---~~~~~~k  596 (640)
                      +||||+++++|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||++   +.++.+|
T Consensus        83 lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~  149 (277)
T 3f3z_A           83 LVMELCTGGELFERVVHKR----------VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLK  149 (277)
T ss_dssp             EEEECCCSCBHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEE
T ss_pred             EEEeccCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEE
Confidence            9999999999999886432          27889999999999999999999   699999999999999   7889999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|||+++.+....     ......||+.|+|||++.+. ++.
T Consensus       150 l~Dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~-~~~  186 (277)
T 3f3z_A          150 LIDFGLAARFKPGK-----MMRTKVGTPYYVSPQVLEGL-YGP  186 (277)
T ss_dssp             ECCCTTCEECCTTS-----CBCCCCSCTTTCCHHHHTTC-BCT
T ss_pred             EEecccceeccCcc-----chhccCCCCCccChHHhccc-CCc
Confidence            99999998654321     12234689999999998654 544

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.95  E-value=1.3e-28  Score=260.13  Aligned_cols=177  Identities=23%  Similarity=0.284  Sum_probs=139.3

Q ss_pred             CCCccc-CcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHh-cCCCCCcceeEeeccCCcCCCcee
Q 035691          441 GGFSSA-NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRN-IRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       441 ~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ++|.+. +.||+|+||+||+|+++.+|+.||||++...     ..+.+|+.++.+ .+||||+++++++... +.+..+.
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~~  134 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCL  134 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcEE
Confidence            345554 6899999999999999999999999998532     456788888754 5899999999986432 2235578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC---CCcE
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN---DMIA  595 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~---~~~~  595 (640)
                      ++|||||++|+|.+++.....        ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.   ++.+
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~  203 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGD--------QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAIL  203 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC-----------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCE
T ss_pred             EEEEEeCCCCcHHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccE
Confidence            999999999999999975432        238899999999999999999999   69999999999999997   7899


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+|||+++......     .....+||+.|+|||++.+..++.
T Consensus       204 kl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~  242 (400)
T 1nxk_A          204 KLTDFGFAKETTSHN-----SLTTPCYTPYYVAPEVLGPEKYDK  242 (400)
T ss_dssp             EECCCTTCEECC----------------CTTCCGGGSCCCCSSS
T ss_pred             EEEecccccccCCCC-----ccccCCCCCCccCHhhcCCCCCCC
Confidence            999999998653211     123456899999999998888765

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.95  E-value=4.1e-29  Score=271.30  Aligned_cols=180  Identities=28%  Similarity=0.466  Sum_probs=150.3

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .++|++.+.||+|+||.||+|+++.++..||||+++... ...+.|.+|+.+|++++|||||+++++|..     ....+
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~~~  292 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFY  292 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCcEE
Confidence            455788899999999999999999889999999996443 345789999999999999999999999643     34689


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +|||||++|+|.+++.....        ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|
T Consensus       293 lv~E~~~~g~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~D  361 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECNR--------QEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVAD  361 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSCT--------TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECC
T ss_pred             EEEEccCCCCHHHHHHhcCc--------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEee
Confidence            99999999999999964332        237889999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+++......   ........+|+.|+|||++.+..++.
T Consensus       362 FG~a~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~  398 (495)
T 1opk_A          362 FGLSRLMTGDT---YTAHAGAKFPIKWTAPESLAYNKFSI  398 (495)
T ss_dssp             TTCEECCTTCC---EECCTTCCCCGGGCCHHHHHHCEECH
T ss_pred             cccceeccCCc---eeecCCCcCCcceeCHhHHhcCCCCc
Confidence            99998764321   11222345678999999987766653

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.95  E-value=1.9e-28  Score=251.46  Aligned_cols=176  Identities=24%  Similarity=0.315  Sum_probs=150.0

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccch------hHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG------ALKSFMAECEALRNIRHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  514 (640)
                      ++|++.+.||+|+||.||+|++..+|+.||||++......      ..+.+.+|+.+++.++||||+++++++.     .
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~   86 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE-----N   86 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe-----c
Confidence            4588899999999999999999999999999999644321      3578999999999999999999999953     4


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC-
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-  593 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~-  593 (640)
                      ....++||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++ 
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~  153 (321)
T 2a2a_A           87 RTDVVLILELVSGGELFDFLAQKE----------SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNI  153 (321)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCS----------CEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTS
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCC
Confidence            457899999999999999996532          37889999999999999999999   6999999999999999888 


Q ss_pred             ---cEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          594 ---IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       594 ---~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                         .+||+|||+++......     ......||+.|+|||++.+..++.
T Consensus       154 ~~~~~kl~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~  197 (321)
T 2a2a_A          154 PIPHIKLIDFGLAHEIEDGV-----EFKNIFGTPEFVAPEIVNYEPLGL  197 (321)
T ss_dssp             SSCCEEECCCTTCEECCTTC-----CCCCCCSCGGGCCHHHHTTCCCCT
T ss_pred             CcCCEEEccCccceecCccc-----cccccCCCCCccCcccccCCCCCC
Confidence               79999999998664321     112346899999999998887764

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.95  E-value=8.4e-29  Score=247.16  Aligned_cols=178  Identities=30%  Similarity=0.422  Sum_probs=148.3

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .++|++.+.||+|+||.||+|.++ ++..||||++..... ..+.+.+|++++++++||||+++++++.     .....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   79 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCS-----KEYPIY   79 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSEE
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCceE
Confidence            456888999999999999999887 678899999964433 3467899999999999999999999953     445789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++|+|.+++....         ..+++..++.++.|++.|+.|||+   .+|+||||||+||+++.++.+||+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~D  147 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHG---------KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSD  147 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHG---------GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECC
T ss_pred             EEEEccCCCcHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEcc
Confidence            9999999999999986432         237889999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+++......   ........+|+.|+|||++.+..++.
T Consensus       148 fg~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~  184 (268)
T 3sxs_A          148 FGMTRYVLDDQ---YVSSVGTKFPVKWSAPEVFHYFKYSS  184 (268)
T ss_dssp             TTCEEECCTTC---EEECCSCCCCGGGCCHHHHHHSEEET
T ss_pred             Cccceecchhh---hhcccCCCcCcccCCHHHHhccCCch
Confidence            99998664321   12223345788899999987766654

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=3.4e-29  Score=261.89  Aligned_cols=181  Identities=27%  Similarity=0.433  Sum_probs=136.2

Q ss_pred             CcccCcccccccceEEEEEECCC---CeEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          443 FSSANLIGTGSFGSVYKGILDPD---QTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      |++.+.||+|+||.||+|++..+   +..||||.++.. .....+.|.+|+.++++++||||++++++|..    .+...
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~~~  166 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGSP  166 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC----CSSCC
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc----CCCCe
Confidence            55678999999999999987532   246899998543 33456789999999999999999999998733    33467


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||+++|+|.+++.....         .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~  234 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVA  234 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTTC---------CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEEC
T ss_pred             EEEEECCCCCCHHHHHhhccc---------CCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEe
Confidence            899999999999999965432         36788899999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |||+++.+...............+|+.|+|||++.+..++.
T Consensus       235 DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  275 (373)
T 3c1x_A          235 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT  275 (373)
T ss_dssp             CC---------------------CCGGGSCHHHHHHCCCCH
T ss_pred             eccccccccccccccccccCCCCCcccccChHHhcCCCCCc
Confidence            99999866432221122223345788999999998777654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.95  E-value=6.9e-29  Score=250.60  Aligned_cols=175  Identities=26%  Similarity=0.406  Sum_probs=142.2

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ++|++.+.||+|+||.||+|++ .+|+.||+|++....  ....+.+.+|++++++++||||+++++++.     .....
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc-----cCCeE
Confidence            4688899999999999999998 479999999995443  233477889999999999999999999954     34578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||+++ +|.+++.....         .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+
T Consensus        76 ~lv~e~~~~-~l~~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~  142 (288)
T 1ob3_A           76 VLVFEHLDQ-DLKKLLDVCEG---------GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIA  142 (288)
T ss_dssp             EEEEECCSE-EHHHHHHTSTT---------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             EEEEEecCC-CHHHHHHhccc---------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEe
Confidence            999999986 89888864322         37888999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCC-CC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ-VS  638 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s  638 (640)
                      |||+++......    .......||+.|+|||++.+.. ++
T Consensus       143 Dfg~~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~  179 (288)
T 1ob3_A          143 DFGLARAFGIPV----RKYTHEIVTLWYRAPDVLMGSKKYS  179 (288)
T ss_dssp             CTTHHHHHCC-------------CCCTTCCHHHHTTCCSCC
T ss_pred             ECccccccCccc----cccccccccccccCchheeCCCCCC
Confidence            999998653221    1122346899999999997643 44

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.95  E-value=1.4e-27  Score=239.45  Aligned_cols=210  Identities=23%  Similarity=0.240  Sum_probs=110.1

Q ss_pred             CCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCc
Q 035691           82 NIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYL  161 (640)
Q Consensus        82 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L  161 (640)
                      +|+.|+|++|++++..+..|.++++|++|+|++|+++++.+..|.++++|++|+|++|+++.+      .+..|.++++|
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~------~~~~~~~l~~L  102 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL------ALGAFSGLSSL  102 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEE------CTTTTTTCTTC
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCcc------ChhhhcCCccc
Confidence            445555555555555555555555555555555555555555555555555555555555443      12233334444


Q ss_pred             ceEecCCCCCCCcCc-CCCCCCCCCEEEccCCcCccc-CCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccC
Q 035691          162 EIVSLNVNSLRSIPI-SVGYLPKLQVLSLFENNISGE-IPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSK  239 (640)
Q Consensus       162 ~~L~L~~N~l~~ip~-~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~  239 (640)
                      ++|++++|.++.++. .+..+++|++|++++|.+++. +|..|..+++|++|+|++|++++..+..|..+++|+.+++  
T Consensus       103 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l--  180 (276)
T 2z62_A          103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL--  180 (276)
T ss_dssp             CEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCE--
T ss_pred             cEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccce--
Confidence            444444444443322 334444455555555544432 2444444444444444444444433333433333332100  


Q ss_pred             ccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCC
Q 035691          240 TIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKS  319 (640)
Q Consensus       240 n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  319 (640)
                                                        .|++++|++++..+..+.. .+|++|+|++|++++..+..|..+++
T Consensus       181 ----------------------------------~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~  225 (276)
T 2z62_A          181 ----------------------------------SLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTS  225 (276)
T ss_dssp             ----------------------------------EEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCS
T ss_pred             ----------------------------------eeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhccccc
Confidence                                              5666666666444444433 36777777777777666666777777


Q ss_pred             CCeEeCcCCcccccc
Q 035691          320 LEGLDLFQNTFQAKS  334 (640)
Q Consensus       320 L~~L~l~~N~l~~~~  334 (640)
                      |++|+|++|+|+|.|
T Consensus       226 L~~L~l~~N~~~c~c  240 (276)
T 2z62_A          226 LQKIWLHTNPWDCSC  240 (276)
T ss_dssp             CCEEECCSSCBCCCT
T ss_pred             ccEEEccCCcccccC
Confidence            777777777777655

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.95  E-value=1.6e-28  Score=246.60  Aligned_cols=179  Identities=25%  Similarity=0.392  Sum_probs=132.4

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      .++|++.+.||+|+||.||+|++..+|+.||||++....   ....+.+.+|+.++++++||||+++++++.     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   84 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DSN   84 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CSS
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cCC
Confidence            356888999999999999999998899999999995432   223477899999999999999999999953     445


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++|+|.+++....         ..+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.+|
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~k  152 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKNRV---------KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIK  152 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHTCS---------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEE
T ss_pred             eEEEEEecCCCCcHHHHHhhcc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEE
Confidence            7899999999999999987542         237889999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|||+++.......    ......||+.|+|||++.+..++.
T Consensus       153 l~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~  191 (278)
T 3cok_A          153 IADFGLATQLKMPHE----KHYTLCGTPNYISPEIATRSAHGL  191 (278)
T ss_dssp             ECCCTTCEECC--------------------------------
T ss_pred             EEeecceeeccCCCC----cceeccCCCCcCCcchhcCCCCCc
Confidence            999999986542211    112346899999999998877664

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.95  E-value=1.4e-28  Score=261.55  Aligned_cols=173  Identities=25%  Similarity=0.325  Sum_probs=137.7

Q ss_pred             HhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc--------hhHHHHHHHHHHHHhcCCCCCcceeEeecc
Q 035691          438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--------GALKSFMAECEALRNIRHRNLVKIITACSS  509 (640)
Q Consensus       438 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  509 (640)
                      ...++|.+.+.||+|+||.||+|+++.+++.||||++.....        .....+.+|++++++++|||||++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            345789999999999999999999999999999999964321        11235889999999999999999999853 


Q ss_pred             CCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee
Q 035691          510 SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL  589 (640)
Q Consensus       510 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl  589 (640)
                           .+..++||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+|||+
T Consensus       211 -----~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll  272 (419)
T 3i6u_A          211 -----AEDYYIVLELMEGGELFDKVVGNK----------RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLL  272 (419)
T ss_dssp             -----SSEEEEEEECCTTCBGGGGTSSSC----------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred             -----cCceEEEEEcCCCCcHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEE
Confidence                 234689999999999999886443          37899999999999999999999   699999999999999


Q ss_pred             CCC---CcEEEccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          590 DND---MIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       590 ~~~---~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      +.+   +.+||+|||+|+......     .....+||+.|+|||++.+
T Consensus       273 ~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~  315 (419)
T 3i6u_A          273 SSQEEDCLIKITDFGHSKILGETS-----LMRTLCGTPTYLAPEVLVS  315 (419)
T ss_dssp             SSSSSSCCEEECCSSTTTSCC----------------CTTCCTTTTC-
T ss_pred             ecCCCcceEEEeecccceecCCCc-----cccccCCCCCccCceeeec
Confidence            754   459999999998764321     2234569999999999864

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.95  E-value=3.3e-29  Score=261.78  Aligned_cols=186  Identities=27%  Similarity=0.390  Sum_probs=146.4

Q ss_pred             CCCcccCcccccccceEEEEEE-----CCCCeEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGIL-----DPDQTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  514 (640)
                      ++|++.+.||+|+||.||+|++     ..+++.||||+++.. .......+.+|+.++++++|||||++++++.     .
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~  145 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL-----Q  145 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe-----c
Confidence            4678889999999999999994     456789999999543 3344467899999999999999999999964     3


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC-
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-  593 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~-  593 (640)
                      ....++||||+++|+|.+++.......   .....+++..++.++.|++.||+|||+   .+|+||||||+|||++.++ 
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~  219 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRP---SQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGP  219 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCS---SSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSST
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhcccc---CccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCC
Confidence            446799999999999999996543211   112348899999999999999999999   6999999999999999555 


Q ss_pred             --cEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          594 --IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       594 --~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                        .+||+|||+|+.+......  .......||+.|+|||++.+..++.
T Consensus       220 ~~~~kL~DFG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~  265 (367)
T 3l9p_A          220 GRVAKIGDFGMARDIYRAGYY--RKGGCAMLPVKWMPPEAFMEGIFTS  265 (367)
T ss_dssp             TCCEEECCCHHHHHHHHHSSC--TTCCGGGSCGGGCCHHHHHHCCCCH
T ss_pred             CceEEECCCcccccccccccc--ccCCCcCCcccEECHHHhcCCCCCc
Confidence              5999999999855322111  1122345899999999998777654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.95  E-value=5.4e-28  Score=246.38  Aligned_cols=189  Identities=33%  Similarity=0.500  Sum_probs=156.7

Q ss_pred             cccccCHHHHHHhcCCCccc------CcccccccceEEEEEECCCCeEEEEEEeecc----cchhHHHHHHHHHHHHhcC
Q 035691          427 LLLNVSYESLLKATGGFSSA------NLIGTGSFGSVYKGILDPDQTVVAVKVLFLH----QRGALKSFMAECEALRNIR  496 (640)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~  496 (640)
                      ....+++.++..+++.|...      +.||+|+||.||+|++  +++.||||++...    .....+.+.+|+.+++.++
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~   88 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ   88 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence            34578899999999999877      8899999999999987  5889999998532    2334578999999999999


Q ss_pred             CCCCcceeEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 035691          497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQ  576 (640)
Q Consensus       497 H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~  576 (640)
                      ||||+++++++.     .....++||||+++|+|.+++......       ..+++..++.++.|++.||.|||+   .+
T Consensus        89 h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~---~~  153 (307)
T 2nru_A           89 HENLVELLGFSS-----DGDDLCLVYVYMPNGSLLDRLSCLDGT-------PPLSWHMRCKIAQGAANGINFLHE---NH  153 (307)
T ss_dssp             CTTBCCEEEEEC-----SSSSCEEEEECCTTCBHHHHHHTGGGC-------CCCCHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred             CCCeEEEEEEEe-----cCCceEEEEEecCCCcHHHHHHhccCC-------CCCCHHHHHHHHHHHHHHHHHHhc---CC
Confidence            999999999963     344689999999999999998643221       237899999999999999999999   69


Q ss_pred             eeeCCCCCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          577 IVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       577 ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      |+||||||+||+++.++.+||+|||+++.......  ........||+.|+|||++.+
T Consensus       154 i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~  209 (307)
T 2nru_A          154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ--TVMTSRIVGTTAYMAPEALRG  209 (307)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS--CEECSSCCSCGGGCCHHHHTT
T ss_pred             eecCCCCHHHEEEcCCCcEEEeecccccccccccc--cccccccCCCcCcCChHHhcC
Confidence            99999999999999999999999999986543221  112233569999999998865

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.95  E-value=1.9e-28  Score=246.76  Aligned_cols=178  Identities=22%  Similarity=0.370  Sum_probs=150.3

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ..++|++.+.||+|+||.||+|++..+|+.||+|++....  ....+.+.+|+.++++++||||+++++++.     ...
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   78 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EES   78 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-----cCC
Confidence            3578999999999999999999999999999999996443  334577889999999999999999999953     445


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc--
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI--  594 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~--  594 (640)
                      ..++||||+++|+|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.  
T Consensus        79 ~~~~v~e~~~~~~l~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~  145 (284)
T 3kk8_A           79 FHYLVFDLVTGGELFEDIVARE----------FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGA  145 (284)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTC
T ss_pred             EEEEEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCC
Confidence            7899999999999988875432          27888999999999999999999   69999999999999986655  


Q ss_pred             -EEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          595 -AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       595 -~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                       +||+|||++.......     ......||+.|+|||++.+..++.
T Consensus       146 ~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~  186 (284)
T 3kk8_A          146 AVKLADFGLAIEVNDSE-----AWHGFAGTPGYLSPEVLKKDPYSK  186 (284)
T ss_dssp             CEEECCCTTCEECCSSC-----BCCCSCSCGGGCCHHHHTTCCBCT
T ss_pred             cEEEeeceeeEEcccCc-----cccCCCCCcCCcCchhhcCCCCCc
Confidence             9999999998654321     112346899999999999887765

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.95  E-value=1.3e-28  Score=251.33  Aligned_cols=176  Identities=23%  Similarity=0.348  Sum_probs=143.1

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ++|++.+.||+|+||.||+|++..+|+.||||++.....  ...+.+.+|++++++++||||+++++++.     .....
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRRL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCeE
Confidence            578899999999999999999999999999999854332  23467889999999999999999999964     34578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||+++++|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+
T Consensus        78 ~lv~e~~~~~~l~~~~~~~~----------~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~  144 (311)
T 4agu_A           78 HLVFEYCDHTVLHELDRYQR----------GVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLC  144 (311)
T ss_dssp             EEEEECCSEEHHHHHHHTSS----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred             EEEEEeCCCchHHHHHhhhc----------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEe
Confidence            99999999999998875432          27889999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCC-CCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG-SQVS  638 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s  638 (640)
                      |||+++.......    ......||+.|+|||++.+ ..++
T Consensus       145 Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~  181 (311)
T 4agu_A          145 DFGFARLLTGPSD----YYDDEVATRWYRSPELLVGDTQYG  181 (311)
T ss_dssp             CCTTCEECC----------------GGGCCHHHHHTCSCCC
T ss_pred             eCCCchhccCccc----ccCCCcCCccccChHHHhcCCCCC
Confidence            9999986643211    1123468999999999876 3344

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.95  E-value=1.1e-28  Score=247.91  Aligned_cols=177  Identities=27%  Similarity=0.410  Sum_probs=147.7

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      .++|++.+.||+|+||.||+|++..+++.||||++....   ......+.+|+.+++.++||||+++++++.     ...
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   82 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DAT   82 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----cCC
Confidence            456888999999999999999999999999999985432   223467899999999999999999999953     345


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++|+|.+++....          .+++..+..++.|++.|++|||+   .+|+||||||+||+++.++.+|
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~  149 (279)
T 3fdn_A           83 RVYLILEYAPLGTVYRELQKLS----------KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELK  149 (279)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEE
T ss_pred             EEEEEEecCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEE
Confidence            7899999999999999886432          27888999999999999999998   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |+|||++.......      .....||+.|+|||++.+..++.+
T Consensus       150 l~Dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~  187 (279)
T 3fdn_A          150 IADFGWSVHAPSSR------RTDLCGTLDYLPPEMIEGRMHDEK  187 (279)
T ss_dssp             ECSCCEESCC--------------CCCCTTCCHHHHTTCCCCTT
T ss_pred             EEeccccccCCccc------ccccCCCCCccCHhHhccCCCCcc
Confidence            99999987543221      123468999999999988877653

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=2e-28  Score=255.73  Aligned_cols=178  Identities=24%  Similarity=0.336  Sum_probs=142.3

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc-CCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDF-QGND  516 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~~  516 (640)
                      .++|+..+.||+|+||.||+|++..+|+.||||++...  .....+.+.+|+++++.++||||+++++++..... ....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46788999999999999999999999999999998543  23345678999999999999999999999754421 1223


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+ +++|.+++...           .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+|
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~-----------~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~k  168 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE-----------KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELK  168 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEE
T ss_pred             eEEEEEecC-CCCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEE
Confidence            568999999 78999988642           27788999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCC-CCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG-SQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~  639 (640)
                      |+|||+++.....       ....+||++|+|||++.+ ..++.
T Consensus       169 l~Dfg~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~  205 (367)
T 1cm8_A          169 ILDFGLARQADSE-------MTGYVVTRWYRAPEVILNWMRYTQ  205 (367)
T ss_dssp             ECCCTTCEECCSS-------CCSSCSCGGGCCTHHHHTTTCCCT
T ss_pred             EEeeecccccccc-------cCcCcCCCCcCCHHHHhCCCCCCh
Confidence            9999999865321       123568999999999877 45554

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.95  E-value=9.4e-29  Score=258.32  Aligned_cols=187  Identities=19%  Similarity=0.264  Sum_probs=146.3

Q ss_pred             hcCCCcccCcccccccceEEEEEECCC-----CeEEEEEEeecccchh-----------HHHHHHHHHHHHhcCCCCCcc
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPD-----QTVVAVKVLFLHQRGA-----------LKSFMAECEALRNIRHRNLVK  502 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~  502 (640)
                      ..++|++.+.||+|+||.||+|++..+     ++.||||++.......           ...+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            356799999999999999999998754     5789999986443211           123455666777888999999


Q ss_pred             eeEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCC
Q 035691          503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDL  582 (640)
Q Consensus       503 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdl  582 (640)
                      +++++.... .+..+.++||||+ +|+|.+++....         ..+++..+..|+.|++.||+|||+   .+|+||||
T Consensus       113 ~~~~~~~~~-~~~~~~~lv~e~~-g~~L~~~~~~~~---------~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDl  178 (364)
T 3op5_A          113 YWGSGLHDK-NGKSYRFMIMDRF-GSDLQKIYEANA---------KRFSRKTVLQLSLRILDILEYIHE---HEYVHGDI  178 (364)
T ss_dssp             EEEEEEEEE-TTEEEEEEEEECE-EEEHHHHHHHTT---------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCC
T ss_pred             EEeeeeecc-CCcceEEEEEeCC-CCCHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecC
Confidence            999975432 2335689999999 999999986532         238899999999999999999999   69999999


Q ss_pred             CCCCeeeC--CCCcEEEccccccccCCCccCCC---ceeeccccccccccCcccCCCCCCCC
Q 035691          583 KPSNVLLD--NDMIAHVGDFGLTRFIPEVISSN---QCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       583 kp~NiLl~--~~~~~kl~DfGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+|||++  .++.+||+|||+|+.+.......   ........||+.|+|||++.+..++.
T Consensus       179 kp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  240 (364)
T 3op5_A          179 KASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSR  240 (364)
T ss_dssp             CGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCH
T ss_pred             CHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCc
Confidence            99999999  88999999999998764332111   11123456999999999999887764

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.95  E-value=9.4e-27  Score=232.52  Aligned_cols=205  Identities=23%  Similarity=0.308  Sum_probs=152.8

Q ss_pred             CCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcC-CCCCCCC
Q 035691          106 KLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPIS-VGYLPKL  184 (640)
Q Consensus       106 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~-~~~l~~L  184 (640)
                      +.+.+++++|+++. +|..+.  ++|++|+|++|+++.++      +..|.++++|++|++++|.++.+|.. +..+++|
T Consensus        17 ~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~------~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L   87 (270)
T 2o6q_A           17 NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLP------SKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNL   87 (270)
T ss_dssp             TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCC------TTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTC
T ss_pred             CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeC------HHHhcCCCCCCEEECCCCccCeeChhhhcCCCCC
Confidence            34555555555553 333222  34555666666555542      23455556666666666666665554 3557788


Q ss_pred             CEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCc
Q 035691          185 QVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPL  264 (640)
Q Consensus       185 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~  264 (640)
                      ++|+|++|.+++..+..|..+++|++|+|++|++++..+..|..+++|+.|                +|++|.+++..+.
T Consensus        88 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L----------------~Ls~n~l~~~~~~  151 (270)
T 2o6q_A           88 ETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYL----------------SLGYNELQSLPKG  151 (270)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEE----------------ECCSSCCCCCCTT
T ss_pred             CEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEE----------------ECCCCcCCccCHh
Confidence            888888888887777778888888888888888887777778888888887                7777888877777


Q ss_pred             cCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccC
Q 035691          265 AVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQ  335 (640)
Q Consensus       265 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  335 (640)
                      .|..+++|+.|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|+|.|.|.
T Consensus       152 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  222 (270)
T 2o6q_A          152 VFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN  222 (270)
T ss_dssp             TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred             HccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence            78889999999999999987777788889999999999999998777888999999999999999988764

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.95  E-value=4.1e-29  Score=252.34  Aligned_cols=174  Identities=24%  Similarity=0.396  Sum_probs=146.8

Q ss_pred             cCCCcccCcccccccceEEEEEECCCC-------eEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQ-------TVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDF  512 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  512 (640)
                      .++|.+.+.||+|+||.||+|++..++       ..||+|++........+.+.+|+.++++++||||+++++++..   
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---   83 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC---   83 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC---
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe---
Confidence            356888899999999999999987666       5799999976666667889999999999999999999999643   


Q ss_pred             CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC
Q 035691          513 QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND  592 (640)
Q Consensus       513 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~  592 (640)
                        ....++||||+++|+|.+++....         ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.+
T Consensus        84 --~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~  149 (289)
T 4fvq_A           84 --GDENILVQEFVKFGSLDTYLKKNK---------NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIRE  149 (289)
T ss_dssp             --TTCCEEEEECCTTCBHHHHHHHTG---------GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEEC
T ss_pred             --CCCCEEEEECCCCCCHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecC
Confidence              446789999999999999996532         237888999999999999999999   699999999999999888


Q ss_pred             Cc--------EEEccccccccCCCccCCCceeeccccccccccCcccCCC-CCCC
Q 035691          593 MI--------AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG-SQVS  638 (640)
Q Consensus       593 ~~--------~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s  638 (640)
                      +.        +||+|||+++.....        ....||+.|+|||++.+ ..++
T Consensus       150 ~~~~~~~~~~~kl~Dfg~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~  196 (289)
T 4fvq_A          150 EDRKTGNPPFIKLSDPGISITVLPK--------DILQERIPWVPPECIENPKNLN  196 (289)
T ss_dssp             CBGGGTBCCEEEECCCCSCTTTSCH--------HHHHHTTTTSCHHHHHCGGGCC
T ss_pred             CcccccccceeeeccCcccccccCc--------cccCCcCcccCHHHhCCCCCCC
Confidence            76        999999999754321        12347899999999876 4443

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.95  E-value=9.6e-29  Score=248.83  Aligned_cols=179  Identities=30%  Similarity=0.447  Sum_probs=145.7

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ..++|++.+.||+|+||.||+|.+. ++..||||++..... ..+.+.+|++++++++||||+++++++     ......
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   94 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPI   94 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCCCe
Confidence            3456888899999999999999987 788899999964433 346789999999999999999999995     344578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||+++|+|.+++....         ..+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~  162 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREMR---------HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVS  162 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCGG---------GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEEC
T ss_pred             EEEEeccCCCcHHHHHHHhc---------cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEc
Confidence            99999999999999996532         237889999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |||+++......   ........||+.|+|||++.+..++.
T Consensus       163 Dfg~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~  200 (283)
T 3gen_A          163 DFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSKFSS  200 (283)
T ss_dssp             STTGGGGBCCHH---HHSTTSTTSCGGGCCHHHHHHCCCSH
T ss_pred             cccccccccccc---cccccCCccCcccCCHHHhccCCCCc
Confidence            999998654321   11122345788999999998776653

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.95  E-value=2.8e-27  Score=237.24  Aligned_cols=220  Identities=21%  Similarity=0.232  Sum_probs=149.0

Q ss_pred             EEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCCEEE
Q 035691           32 IIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLD  111 (640)
Q Consensus        32 L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  111 (640)
                      .+..+..++ .+|..+.  ++|++|+|++|+|+.      +++..+..+++|+.|+|++|++++..+..|.++++|++|+
T Consensus        12 ~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~------~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~   82 (276)
T 2z62_A           12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRH------LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLI   82 (276)
T ss_dssp             EECTTSCCS-SCCSSSC--TTCCEEECTTCCCCE------ECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred             EEecCCCcc-ccCCCCC--CCccEEECCCCcccc------cCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEE
Confidence            444445554 3444333  356666666666654      5554455566666666666666666666777777777777


Q ss_pred             CcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCC--cCcCCCCCCCCCEEEc
Q 035691          112 FANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRS--IPISVGYLPKLQVLSL  189 (640)
Q Consensus       112 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~--ip~~~~~l~~L~~L~L  189 (640)
                      |++|++++..+..|.++++|++|++++|+++.++      ...+.++++|++|++++|.++.  +|..+..+++|++|+|
T Consensus        83 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~------~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~L  156 (276)
T 2z62_A           83 LTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE------NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL  156 (276)
T ss_dssp             CTTCCCCEECTTTTTTCTTCCEEECTTSCCCCST------TCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEEC
T ss_pred             CCCCccCccChhhhcCCccccEEECCCCCccccC------chhcccCCCCCEEECcCCccceecCchhhccCCCCCEEEC
Confidence            7777777766677777777777777777777652      2346677777777777777776  5677788888999999


Q ss_pred             cCCcCcccCCcCccCCCCCC----EEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCcc
Q 035691          190 FENNISGEIPSSLGNFTFLT----ELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLA  265 (640)
Q Consensus       190 ~~N~l~~~~p~~~~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~  265 (640)
                      ++|.+++..+..|..+++|+    .|++++|++++..+..+... +|+.|                +|++|++++..+..
T Consensus       157 s~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~-~L~~L----------------~L~~n~l~~~~~~~  219 (276)
T 2z62_A          157 SSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKEL----------------ALDTNQLKSVPDGI  219 (276)
T ss_dssp             CSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSC-CEEEE----------------ECCSSCCSCCCTTT
T ss_pred             CCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCC-cccEE----------------ECCCCceeecCHhH
Confidence            99999887777787777777    88888888886555544432 45555                66666666555555


Q ss_pred             CCCCCCCCEEECCCCccc
Q 035691          266 VGNLKSIPHLDLSKNKLS  283 (640)
Q Consensus       266 ~~~l~~L~~L~Ls~N~l~  283 (640)
                      |..+++|+.|+|++|+++
T Consensus       220 ~~~l~~L~~L~l~~N~~~  237 (276)
T 2z62_A          220 FDRLTSLQKIWLHTNPWD  237 (276)
T ss_dssp             TTTCCSCCEEECCSSCBC
T ss_pred             hcccccccEEEccCCccc
Confidence            666666666666666665

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.95  E-value=5.7e-27  Score=236.27  Aligned_cols=205  Identities=26%  Similarity=0.260  Sum_probs=125.0

Q ss_pred             CCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcCCCCCC
Q 035691          103 NASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLP  182 (640)
Q Consensus       103 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~  182 (640)
                      ++++|+++++++|.++. +|..+.  ++++.|+|++|+|+.+      .+..|.++++|+.|+|++|.|+.+|.. ..++
T Consensus         8 ~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~------~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~l~   77 (290)
T 1p9a_G            8 KVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTF------SLATLMPYTRLTQLNLDRAELTKLQVD-GTLP   77 (290)
T ss_dssp             CSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEE------EGGGGTTCTTCCEEECTTSCCCEEECC-SCCT
T ss_pred             ccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCcc------CHHHhhcCCCCCEEECCCCccCcccCC-CCCC
Confidence            34444444444444442 222221  3444444444444433      223344444444444444444444332 4455


Q ss_pred             CCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCC
Q 035691          183 KLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPI  262 (640)
Q Consensus       183 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~  262 (640)
                      +|++|+|++|.|+ .+|..+..+++|++|+|++|+|++..+..|.++++|+.|                +|++|+|++..
T Consensus        78 ~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L----------------~L~~N~l~~~~  140 (290)
T 1p9a_G           78 VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL----------------YLKGNELKTLP  140 (290)
T ss_dssp             TCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEE----------------ECTTSCCCCCC
T ss_pred             cCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEE----------------ECCCCCCCccC
Confidence            6666666666666 455566666667777777777766666666666666666                66666666666


Q ss_pred             CccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccC
Q 035691          263 PLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQ  335 (640)
Q Consensus       263 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  335 (640)
                      +..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|.|.|.
T Consensus       141 ~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~  212 (290)
T 1p9a_G          141 PGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE  212 (290)
T ss_dssp             TTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             hhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCc
Confidence            667777777777777777777665666677778888888888887 456666667788888888888887664

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.95  E-value=5.2e-29  Score=258.07  Aligned_cols=194  Identities=27%  Similarity=0.380  Sum_probs=151.6

Q ss_pred             HHHhcCCCcccCcccccccceEEEEEEC-----CCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeecc
Q 035691          436 LLKATGGFSSANLIGTGSFGSVYKGILD-----PDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSS  509 (640)
Q Consensus       436 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~  509 (640)
                      +....++|++.+.||+|+||.||+|++.     .+++.||||+++... ....+.+.+|+.++++++||||++++++|. 
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-  120 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA-  120 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc-
Confidence            3445678999999999999999999986     355899999996543 334578999999999999999999999964 


Q ss_pred             CCcCCCceeeEEeeccCCCChhhhcCCCCCCCC--------------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 035691          510 SDFQGNDFKALVYEFMHHGSLESWLHPESASDD--------------LNYSPSILSFLQRLNIAINVASALEYLHHHCKK  575 (640)
Q Consensus       510 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--------------~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~  575 (640)
                          .....++||||+++|+|.+++........              .......+++..++.++.|++.||.|||+   .
T Consensus       121 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~  193 (343)
T 1luf_A          121 ----VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---R  193 (343)
T ss_dssp             ----SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---T
T ss_pred             ----cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---C
Confidence                34578999999999999999865321100              00012458899999999999999999999   6


Q ss_pred             CeeeCCCCCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          576 QIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       576 ~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|+||||||+||+++.++.+||+|||+++........  .......||+.|+|||++.+..++.
T Consensus       194 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~  255 (343)
T 1luf_A          194 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY--KADGNDAIPIRWMPPESIFYNRYTT  255 (343)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB--C----CCBCGGGCCHHHHHHCCCCH
T ss_pred             CeecCCCCcceEEECCCCeEEEeecCCCcccccCccc--cccCCCcccceecChhhhccCCcCc
Confidence            9999999999999999999999999999865332111  1122345899999999988776653

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.95  E-value=6.2e-29  Score=255.74  Aligned_cols=182  Identities=24%  Similarity=0.328  Sum_probs=151.9

Q ss_pred             CCCcccCcccccccceEEEEE----ECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          441 GGFSSANLIGTGSFGSVYKGI----LDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ++|++.+.||+|+||.||+|+    ...+++.||||++........+.+.+|++++++++||||+++++++...   ...
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~   99 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP---GRQ   99 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS---SSC
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC---CCc
Confidence            468888999999999999999    4568899999999766666667899999999999999999999987532   345


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++|+|.+++....         ..+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.+|
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~k  167 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRHR---------ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVK  167 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHG---------GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEE
T ss_pred             eEEEEEeecCCCCHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEE
Confidence            7899999999999999986432         137899999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      |+|||+++....... .........||+.|+|||++.+..++
T Consensus       168 l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~  208 (327)
T 3lxl_A          168 IADFGLAKLLPLDKD-YYVVREPGQSPIFWYAPESLSDNIFS  208 (327)
T ss_dssp             ECCGGGCEECCTTCS-EEECSSCCCSCGGGSCHHHHHHCEEE
T ss_pred             EcccccceecccCCc-cceeeccCCccccccCHHHhccCCCC
Confidence            999999987643221 11122334588999999998776554

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.95  E-value=2.3e-28  Score=247.44  Aligned_cols=177  Identities=23%  Similarity=0.290  Sum_probs=150.1

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|.+.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.     ..+.
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~   89 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DNDF   89 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----cCCE
Confidence            46888899999999999999999999999999986442   334577899999999999999999999964     3457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++++|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||
T Consensus        90 ~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl  156 (294)
T 2rku_A           90 VFVVLELCRRRSLLELHKRRK----------ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKI  156 (294)
T ss_dssp             EEEEEECCTTCBHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEE
T ss_pred             EEEEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEE
Confidence            899999999999999885432          27889999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|||+++.......    ......||+.|+|||++.+..++.
T Consensus       157 ~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~  194 (294)
T 2rku_A          157 GDFGLATKVEYDGE----RKKVLCGTPNYIAPEVLSKKGHSF  194 (294)
T ss_dssp             CCCTTCEECCSTTC----CBCCCCSCCSSCCHHHHTTSCBCT
T ss_pred             EeccCceecccCcc----ccccccCCCCcCCcchhccCCCCc
Confidence            99999986542211    122346899999999998877664

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.95  E-value=4.6e-29  Score=251.79  Aligned_cols=183  Identities=28%  Similarity=0.454  Sum_probs=153.0

Q ss_pred             HHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          437 LKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       437 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ....++|++.+.||+|+||.||+|++..++..||+|++... ....+.+.+|++++++++||||+++++++.     ...
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~   82 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REP   82 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSS
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCC
Confidence            34456788899999999999999999989999999998643 334578999999999999999999999953     345


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++|+|.+++.....        ..+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.+|
T Consensus        83 ~~~~v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~  151 (288)
T 3kfa_A           83 PFYIITEFMTYGNLLDYLRECNR--------QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVK  151 (288)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCCT--------TTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEE
T ss_pred             CEEEEEEcCCCCcHHHHHHhccc--------CCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEE
Confidence            68999999999999999965332        237889999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|||+++......   ........+|+.|+|||++.+..++.
T Consensus       152 l~Dfg~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~  191 (288)
T 3kfa_A          152 VADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESLAYNKFSI  191 (288)
T ss_dssp             ECCCCGGGTSCSSS---SEEETTEEECGGGCCHHHHHHCCCCH
T ss_pred             EccCccceeccCCc---cccccCCccccCcCChhhhccCCCCc
Confidence            99999998764322   12223345788999999988776653

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.95  E-value=1.5e-28  Score=263.83  Aligned_cols=175  Identities=32%  Similarity=0.429  Sum_probs=145.4

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ..++|++.+.||+|+||.||+|.+.  |+.||||+++...  ..+.|.+|+.+|++++|||||+++++|..    .....
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~  262 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGL  262 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEEC----TTSCE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEc----CCCce
Confidence            3456788899999999999999985  7899999996433  45789999999999999999999999743    23468


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++|||||++|+|.+++.....        ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+
T Consensus       263 ~iv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~  331 (450)
T 1k9a_A          263 YIVTEYMAKGSLVDYLRSRGR--------SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVS  331 (450)
T ss_dssp             EEEEECCTTCBHHHHHHHHCT--------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEEC
T ss_pred             EEEEEecCCCcHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEe
Confidence            999999999999999975432        236888999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |||+++.....       .....+|+.|+|||++.+..++.
T Consensus       332 DfG~a~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~  365 (450)
T 1k9a_A          332 DFGLTKEASST-------QDTGKLPVKWTAPEALREKKFST  365 (450)
T ss_dssp             CCTTCEECC-------------CCCTTTSCHHHHHSSCCCH
T ss_pred             eCCCccccccc-------ccCCCCCcceeCHHHhcCCCCCc
Confidence            99999854221       11224788999999998887764

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.95  E-value=6.1e-28  Score=243.47  Aligned_cols=169  Identities=31%  Similarity=0.481  Sum_probs=141.2

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccch-------hHHHHHHHHHHHHhcCCCCCcceeEeeccCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG-------ALKSFMAECEALRNIRHRNLVKIITACSSSDF  512 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  512 (640)
                      .++|++.+.||+|+||.||+|++..+++.||||++......       ..+.+.+|++++++++||||+++++++...  
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--   95 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--   95 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--
Confidence            46788899999999999999999999999999998543321       126789999999999999999999996332  


Q ss_pred             CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeeCCCCCCCeeeC
Q 035691          513 QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQ--IVHCDLKPSNVLLD  590 (640)
Q Consensus       513 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~--ivHrdlkp~NiLl~  590 (640)
                           .++||||+++|+|.+++....         ..+++..++.++.|++.|++|||+   .+  |+||||||+||+++
T Consensus        96 -----~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~  158 (287)
T 4f0f_A           96 -----PRMVMEFVPCGDLYHRLLDKA---------HPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQ  158 (287)
T ss_dssp             -----TEEEEECCTTCBHHHHHHCTT---------SCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEES
T ss_pred             -----CeEEEEecCCCCHHHHHhccc---------CCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEe
Confidence                 269999999999998886443         238899999999999999999999   57  99999999999998


Q ss_pred             CCCc-----EEEccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          591 NDMI-----AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       591 ~~~~-----~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      .++.     +||+|||+++....       ......||+.|+|||++.+
T Consensus       159 ~~~~~~~~~~kl~Dfg~~~~~~~-------~~~~~~g~~~y~aPE~~~~  200 (287)
T 4f0f_A          159 SLDENAPVCAKVADFGLSQQSVH-------SVSGLLGNFQWMAPETIGA  200 (287)
T ss_dssp             CCCTTCSCCEEECCCTTCBCCSS-------CEECCCCCCTTSCGGGSSC
T ss_pred             ccCCCCceeEEeCCCCccccccc-------cccccCCCccccCchhhcc
Confidence            8776     99999999985432       1223569999999999843

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.95  E-value=6.4e-29  Score=255.60  Aligned_cols=179  Identities=24%  Similarity=0.413  Sum_probs=139.9

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeE----EEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTV----VAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      ++|+..+.||+|+||.||+|++..+++.    ||+|.+... .....+.+.+|+.++++++||||++++++|...     
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----   89 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   89 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-----
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----
Confidence            4588889999999999999998877765    477776432 234457899999999999999999999997532     


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                       ..++|+||+.+|+|.+++.....         .+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+
T Consensus        90 -~~~~v~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~  156 (327)
T 3poz_A           90 -TVQLITQLMPFGCLLDYVREHKD---------NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHV  156 (327)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHSTT---------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEE
T ss_pred             -CeEEEEEecCCCcHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCE
Confidence             36799999999999999865432         37889999999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+|||+|+.......  ........||+.|+|||++.+..++.
T Consensus       157 kl~Dfg~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~  198 (327)
T 3poz_A          157 KITDFGLAKLLGAEEK--EYHAEGGKVPIKWMALESILHRIYTH  198 (327)
T ss_dssp             EECCTTHHHHHTTTCC---------CCCGGGSCHHHHHHCCCCH
T ss_pred             EEccCcceeEccCCcc--cccccCCCccccccChHHhccCCCCc
Confidence            9999999987643222  11222345788999999998877764

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.95  E-value=7e-29  Score=256.45  Aligned_cols=172  Identities=24%  Similarity=0.340  Sum_probs=141.8

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCcee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      .++|++.+.||+|+||.||+|+++.+|+.||||+++.....    ..+|++++.++ +||||+++++++     .+....
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~   91 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVY-----DDGKYV   91 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEE
Confidence            45688999999999999999999999999999999654332    35688888887 799999999995     445688


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC----Cc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND----MI  594 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~----~~  594 (640)
                      ++||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||++.+.    +.
T Consensus        92 ~lv~E~~~gg~L~~~i~~~~----------~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~  158 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILRQK----------FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPES  158 (342)
T ss_dssp             EEEECCCCSCBHHHHHHTCT----------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGG
T ss_pred             EEEEeCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCe
Confidence            99999999999999986543          27889999999999999999999   699999999999998433    35


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV  637 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  637 (640)
                      +||+|||+++......    ......+||+.|+|||++.+..+
T Consensus       159 ~kl~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~  197 (342)
T 2qr7_A          159 IRICDFGFAKQLRAEN----GLLMTPCYTANFVAPEVLERQGY  197 (342)
T ss_dssp             EEECCCTTCEECBCTT----CCBCCSSCCSSCCCHHHHHHHHH
T ss_pred             EEEEECCCcccCcCCC----CceeccCCCccccCHHHhcCCCC
Confidence            9999999998664321    12234568999999999865433

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.95  E-value=2.3e-28  Score=252.36  Aligned_cols=177  Identities=23%  Similarity=0.296  Sum_probs=150.2

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|.+.+.||+|+||.||+|++..+++.||+|++...   .....+.+.+|+.+++.++||||+++++++.     ....
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~  115 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DNDF  115 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCCe
Confidence            4688889999999999999999999999999998643   2344578899999999999999999999954     3457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++++|.+++....          .+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.+||
T Consensus       116 ~~lv~e~~~~~~L~~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl  182 (335)
T 2owb_A          116 VFVVLELCRRRSLLELHKRRK----------ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKI  182 (335)
T ss_dssp             EEEEECCCTTCBHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEE
T ss_pred             EEEEEecCCCCCHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEE
Confidence            899999999999999886432          27889999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|||+++.......    ......||+.|+|||++.+..++.
T Consensus       183 ~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~  220 (335)
T 2owb_A          183 GDFGLATKVEYDGE----RKKVLCGTPNYIAPEVLSKKGHSF  220 (335)
T ss_dssp             CCCTTCEECCSTTC----CBCCCCSCCSSCCHHHHHTSCBCT
T ss_pred             eeccCceecccCcc----cccccCCCccccCHHHhccCCCCc
Confidence            99999986542211    122346899999999998877654

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.95  E-value=3.1e-28  Score=250.46  Aligned_cols=189  Identities=24%  Similarity=0.311  Sum_probs=152.7

Q ss_pred             ccCHHHHHHhcCCCccc-CcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhc-CCCCCcceeE
Q 035691          430 NVSYESLLKATGGFSSA-NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNI-RHRNLVKIIT  505 (640)
Q Consensus       430 ~~~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~  505 (640)
                      .+.+.......+.|.+. +.||+|+||.||+|++..+++.||+|++....  ......+.+|+.+++.+ +||||+++++
T Consensus        17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~   96 (327)
T 3lm5_A           17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE   96 (327)
T ss_dssp             CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            34444555556667776 88999999999999999999999999996433  33457899999999999 5699999999


Q ss_pred             eeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCC
Q 035691          506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPS  585 (640)
Q Consensus       506 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~  585 (640)
                      ++     ......++||||+++|+|.+++.....        ..+++..+..++.|++.||+|||+   .+|+||||||+
T Consensus        97 ~~-----~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~  160 (327)
T 3lm5_A           97 VY-----ENTSEIILILEYAAGGEIFSLCLPELA--------EMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQ  160 (327)
T ss_dssp             EE-----ECSSEEEEEEECCTTEEGGGGGSSCC---------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGG
T ss_pred             EE-----EeCCeEEEEEEecCCCcHHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChH
Confidence            95     345578999999999999999864322        348899999999999999999999   69999999999


Q ss_pred             CeeeCC---CCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          586 NVLLDN---DMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       586 NiLl~~---~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+++.   ++.+||+|||+++......     ......||+.|+|||++.+..++.
T Consensus       161 NIl~~~~~~~~~~kL~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~  212 (327)
T 3lm5_A          161 NILLSSIYPLGDIKIVDFGMSRKIGHAC-----ELREIMGTPEYLAPEILNYDPITT  212 (327)
T ss_dssp             GEEESCBTTBCCEEECCGGGCEEC--------------CCCGGGCCHHHHTTCCCCT
T ss_pred             HEEEecCCCCCcEEEeeCccccccCCcc-----ccccccCCcCccCCeeecCCCCCc
Confidence            999987   7899999999998664321     122356999999999999888765

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=3.2e-28  Score=246.83  Aligned_cols=181  Identities=25%  Similarity=0.365  Sum_probs=146.2

Q ss_pred             CcccCcccccccceEEEEEECCCCe---EEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQT---VVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      |...+.||+|+||.||+|++..++.   .||+|++.... ....+.+.+|+.++++++||||+++++++...    +...
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~   98 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP----EGLP   98 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----SSCC
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC----CCCc
Confidence            4556889999999999999754443   79999986433 34457899999999999999999999997432    2345


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||+.+|+|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~  166 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQ---------RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVA  166 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTT---------CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEecccCCCHHHHHhccc---------cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeC
Confidence            89999999999999996533         237888999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |||+++.................||+.|+|||.+.+..++.
T Consensus       167 Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  207 (298)
T 3pls_A          167 DFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTT  207 (298)
T ss_dssp             CTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCH
T ss_pred             cCCCcccccCCcccccccCcCCCCCccccChhhhccCCCCh
Confidence            99999866432211122223356899999999998887764

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.95  E-value=2.6e-28  Score=252.86  Aligned_cols=172  Identities=27%  Similarity=0.376  Sum_probs=143.6

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      .|+..+.||+|+||.||+|++..+|+.||||++....   ....+.+.+|++++++++|||||++++++.     .....
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~  129 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHTA  129 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred             heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCeE
Confidence            3778899999999999999998899999999996442   233467899999999999999999999964     34578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||+. |++.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+
T Consensus       130 ~lv~e~~~-g~l~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~  196 (348)
T 1u5q_A          130 WLVMEYCL-GSASDLLEVHK---------KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLG  196 (348)
T ss_dssp             EEEEECCS-EEHHHHHHHHT---------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEEC
T ss_pred             EEEEecCC-CCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEe
Confidence            99999997 57877774322         237889999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCC---CCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGM---GSQVST  639 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~  639 (640)
                      |||+++.....        ....||+.|+|||++.   ++.++.
T Consensus       197 DfG~a~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~  232 (348)
T 1u5q_A          197 DFGSASIMAPA--------NSFVGTPYWMAPEVILAMDEGQYDG  232 (348)
T ss_dssp             CCTTCBSSSSB--------CCCCSCGGGCCHHHHHTTSSCCBCT
T ss_pred             eccCceecCCC--------CcccCCcceeCHhhhccccCCCCCc
Confidence            99999865321        1246999999999985   344543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.95  E-value=3.7e-28  Score=247.85  Aligned_cols=180  Identities=22%  Similarity=0.250  Sum_probs=142.0

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.++++++||||+++++++.     .+.
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~  107 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE-----IDG  107 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETT
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe-----eCC
Confidence            467999999999999999999999899999999996442   223477899999999999999999999964     345


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++++|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+|
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~k  174 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQG----------PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAY  174 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEE
T ss_pred             eEEEEEEecCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEE
Confidence            7899999999999999986432          27888999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |+|||+++.......   .......||+.|+|||++.+..++.+
T Consensus       175 l~Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~  215 (309)
T 2h34_A          175 LVDFGIASATTDEKL---TQLGNTVGTLYYMAPERFSESHATYR  215 (309)
T ss_dssp             ECSCCC-------------------CCGGGCCGGGTCC----CC
T ss_pred             EecCccCcccccccc---ccccccCCCcCccCHHHHcCCCCCch
Confidence            999999986543211   11223468999999999988877653

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.95  E-value=2.1e-28  Score=250.42  Aligned_cols=177  Identities=28%  Similarity=0.324  Sum_probs=141.2

Q ss_pred             cCCCccc-CcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCce
Q 035691          440 TGGFSSA-NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       440 ~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      .+.|++. +.||+|+||.||+|++..+++.||||++........+.+.+|++++.++ +||||+++++++.     ..+.
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~-----~~~~   85 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE-----EEDR   85 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eCCE
Confidence            3457774 7899999999999999989999999999766555667899999999985 7999999999954     4457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc---
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI---  594 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~---  594 (640)
                      .++||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.   
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~  152 (316)
T 2ac3_A           86 FYLVFEKMRGGSILSHIHKRR----------HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSP  152 (316)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCS
T ss_pred             EEEEEEcCCCCcHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCc
Confidence            899999999999999986432          27888999999999999999999   69999999999999998775   


Q ss_pred             EEEccccccccCCCccCC---CceeeccccccccccCcccCCC
Q 035691          595 AHVGDFGLTRFIPEVISS---NQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      +||+|||+++........   ........+||+.|+|||++.+
T Consensus       153 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  195 (316)
T 2ac3_A          153 VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA  195 (316)
T ss_dssp             EEECCTTCCC-------------------CCSGGGCCHHHHHH
T ss_pred             eEEEEccCccccccCCccccccccccccccCCcCccChHHhhc
Confidence            999999999865321110   0111223469999999999864

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=4.4e-28  Score=250.43  Aligned_cols=185  Identities=26%  Similarity=0.342  Sum_probs=142.8

Q ss_pred             HhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhc--CCCCCcceeEeeccCCcCCC
Q 035691          438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI--RHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       438 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~~~~~~~  515 (640)
                      ...++|++.+.||+|+||.||+|++.  ++.||||++.....   ..+..|.+++...  +||||+++++++.... ...
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~  107 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGT-GSW  107 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGG
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCC
Confidence            34467999999999999999999985  89999999854332   3455566666554  8999999999975442 222


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeeeCCCCCCCeeeC
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHC-----KKQIVHCDLKPSNVLLD  590 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~-----~~~ivHrdlkp~NiLl~  590 (640)
                      ...++||||+++|+|.++++..           .+++..++.++.|++.||.|||+.+     .++|+||||||+||+++
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~-----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~  176 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST-----------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK  176 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC-----------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred             CceEEEEeccCCCcHHHHhhcc-----------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence            5789999999999999999532           2788999999999999999999821     12999999999999999


Q ss_pred             CCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          591 NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       591 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      .++.+||+|||+|+.+...............||+.|+|||++.+...+.
T Consensus       177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  225 (337)
T 3mdy_A          177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRN  225 (337)
T ss_dssp             TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTT
T ss_pred             CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCc
Confidence            9999999999999866433222222223457999999999998766543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.95  E-value=3.5e-28  Score=253.98  Aligned_cols=182  Identities=24%  Similarity=0.314  Sum_probs=150.8

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ..++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++..........
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            3567999999999999999999999999999999996433 334478899999999999999999999987655455567


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++ +|.+++...           .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||
T Consensus       105 ~~iv~e~~~~-~L~~~l~~~-----------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl  169 (364)
T 3qyz_A          105 VYIVQDLMET-DLYKLLKTQ-----------HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKI  169 (364)
T ss_dssp             EEEEEECCSE-EHHHHHHHC-----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEE
T ss_pred             EEEEEcccCc-CHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEE
Confidence            8999999984 899888532           27888999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      +|||+++........ .......+||+.|+|||++.+..
T Consensus       170 ~Dfg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~  207 (364)
T 3qyz_A          170 CDFGLARVADPDHDH-TGFLTEYVATRWYRAPEIMLNSK  207 (364)
T ss_dssp             CCCTTCEECCGGGCB-CCTTCCCCSCGGGCCHHHHHTBC
T ss_pred             EeCcceEecCCCCCc-cccccccccccCCCCCHHhcCCC
Confidence            999999876432211 11123357999999999876543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.95  E-value=4.1e-29  Score=256.65  Aligned_cols=197  Identities=26%  Similarity=0.418  Sum_probs=138.6

Q ss_pred             HHHHHhcCCCcccCcccccccceEEEEEECCCCe---EEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeec
Q 035691          434 ESLLKATGGFSSANLIGTGSFGSVYKGILDPDQT---VVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACS  508 (640)
Q Consensus       434 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~  508 (640)
                      +++....++|++.+.||+|+||.||+|++..++.   .||||++...  .....+.+.+|++++++++||||+++++++.
T Consensus        16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   95 (323)
T 3qup_A           16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL   95 (323)
T ss_dssp             CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred             hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence            3344556789999999999999999999876664   8999999644  3445678999999999999999999999975


Q ss_pred             cCCcCC-CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCe
Q 035691          509 SSDFQG-NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNV  587 (640)
Q Consensus       509 ~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~Ni  587 (640)
                      .....+ ....++||||+++|+|.+++.......    ....+++..++.++.|++.||+|||+   .+|+||||||+||
T Consensus        96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NI  168 (323)
T 3qup_A           96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE----NPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNC  168 (323)
T ss_dssp             CC-------CEEEEEECCTTCBHHHHHHHHHC-------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred             ccccccCCCccEEEEEeccCCcHHHHHHhhhccc----cccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceE
Confidence            443211 122489999999999999985432211    11248899999999999999999999   6999999999999


Q ss_pred             eeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          588 LLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       588 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +++.++.+||+|||+++........  .......+|+.|+|||++.+..++.
T Consensus       169 li~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~  218 (323)
T 3qup_A          169 MLAEDMTVCVADFGLSRKIYSGDYY--RQGCASKLPVKWLALESLADNLYTV  218 (323)
T ss_dssp             EECTTSCEEECCCCC-------------------CCGGGCCHHHHHHCCCCH
T ss_pred             EEcCCCCEEEeeccccccccccccc--cccccccCcccccCchhhcCCCCCC
Confidence            9999999999999999866432211  1122344788999999988776653

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.95  E-value=2e-28  Score=249.29  Aligned_cols=175  Identities=26%  Similarity=0.339  Sum_probs=146.1

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      ++|.+.+.||+|+||.||+|++..+|+.||+|++........+.+.+|+.+++.++||||+++++++.     .....++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   83 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHYYL   83 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEEE
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEEEE
Confidence            45888999999999999999999899999999997654444567899999999999999999999953     4457899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee---CCCCcEEE
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL---DNDMIAHV  597 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl---~~~~~~kl  597 (640)
                      ||||+++|+|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+||++   +.++.+||
T Consensus        84 v~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl  150 (304)
T 2jam_A           84 VMQLVSGGELFDRILERG----------VYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMI  150 (304)
T ss_dssp             EECCCCSCBHHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEB
T ss_pred             EEEcCCCccHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEE
Confidence            999999999999885432          27888999999999999999999   699999999999999   78899999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|||+++.....      ......||+.|+|||++.+..++.
T Consensus       151 ~Dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~  186 (304)
T 2jam_A          151 TDFGLSKMEQNG------IMSTACGTPGYVAPEVLAQKPYSK  186 (304)
T ss_dssp             CSCSTTCCCCCB------TTHHHHSCCCBCCTTTBSSCSCCH
T ss_pred             ccCCcceecCCC------ccccccCCCCccChHHhccCCCCc
Confidence            999999754321      112245899999999998887764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.95  E-value=8.2e-29  Score=254.60  Aligned_cols=179  Identities=23%  Similarity=0.371  Sum_probs=143.4

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeE----EEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTV----VAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      ++|++.+.||+|+||.||+|++..+++.    ||+|.+.... ....+.+.+|+.+++.++||||++++++|.      +
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~   86 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP------G   86 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC------B
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc------C
Confidence            5688889999999999999999877765    6777764322 233356788999999999999999999863      2


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      ...++||||+++|+|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~  154 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHR---------GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQV  154 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSG---------GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCE
T ss_pred             CccEEEEEeCCCCCHHHHHHHcc---------ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeE
Confidence            35789999999999999986542         136777899999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+|||+++.+......  .......||+.|+|||++.+..++.
T Consensus       155 kl~Dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~  196 (325)
T 3kex_A          155 QVADFGVADLLPPDDKQ--LLYSEAKTPIKWMALESIHFGKYTH  196 (325)
T ss_dssp             EECSCSGGGGSCCCTTC--CC-----CCTTTSCHHHHHHCCCCH
T ss_pred             EECCCCcccccCccccc--ccccCCCCcccccChHHhccCCCCh
Confidence            99999999976443221  1223345788999999998777664

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.95  E-value=3.6e-28  Score=244.81  Aligned_cols=176  Identities=26%  Similarity=0.428  Sum_probs=149.8

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+++++.++||||+++++++.     ....
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   88 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----DRKR   88 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----cCCE
Confidence            46888999999999999999999999999999995432   233467899999999999999999999954     3457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl  155 (284)
T 2vgo_A           89 IYLMLEFAPRGELYKELQKHG----------RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKI  155 (284)
T ss_dssp             EEEEECCCTTEEHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEE
T ss_pred             EEEEEEeCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEE
Confidence            899999999999999986432          27888999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||++.......      .....||+.|+|||++.+..++.+
T Consensus       156 ~Dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~  192 (284)
T 2vgo_A          156 ADFGWSVHAPSLR------RRTMCGTLDYLPPEMIEGKTHDEK  192 (284)
T ss_dssp             CCCTTCEECSSSC------BCCCCSCGGGCCHHHHTTCCBCTT
T ss_pred             ecccccccCcccc------cccccCCCCcCCHHHhccCCCCcc
Confidence            9999987553211      123468999999999998877653

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.95  E-value=3.3e-28  Score=257.04  Aligned_cols=177  Identities=25%  Similarity=0.365  Sum_probs=147.9

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      .++|.+.+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|++++++++||||+++++++....   ....
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~   84 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHK   84 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---CCee
Confidence            346888999999999999999999999999999996433 334577889999999999999999999975332   3467


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee----CCCCc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL----DNDMI  594 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl----~~~~~  594 (640)
                      ++||||+++|+|.+++......       ..+++..++.++.|++.||+|||+   .+|+||||||+||++    +.++.
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~  154 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNA-------YGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSV  154 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGT-------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEE
T ss_pred             EEEEecCCCCCHHHHHHhhhcc-------cCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCcee
Confidence            9999999999999999754321       238899999999999999999999   699999999999999    78889


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      +||+|||+++......     ......||+.|+|||++.+
T Consensus       155 ~kL~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~  189 (396)
T 4eut_A          155 YKLTDFGAARELEDDE-----QFVSLYGTEEYLHPDMYER  189 (396)
T ss_dssp             EEECCGGGCEECCCGG-----GSSCSSSCCTTCCHHHHHH
T ss_pred             EEEecCCCceEccCCC-----ccccccCCccccCHHHhhc
Confidence            9999999998764322     1123469999999998754

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.95  E-value=6.9e-28  Score=245.13  Aligned_cols=176  Identities=27%  Similarity=0.379  Sum_probs=150.7

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      +.|+..+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.     .....+
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   96 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLW   96 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEE
Confidence            45888899999999999999999899999999996543 345578999999999999999999999964     345789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++++|.+++...           .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|
T Consensus        97 lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~D  162 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLEPG-----------PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLAD  162 (303)
T ss_dssp             EEEECCTTEEHHHHHTTS-----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred             EEEEeCCCCcHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEee
Confidence            999999999999998532           27889999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+++......    .......||+.|+|||++.+..++.
T Consensus       163 fg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~  198 (303)
T 3a7i_A          163 FGVAGQLTDTQ----IKRNTFVGTPFWMAPEVIKQSAYDS  198 (303)
T ss_dssp             CTTCEECBTTB----CCBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred             cccceecCccc----cccCccCCCcCccCHHHHhcCCCCc
Confidence            99998664321    1122356899999999998887764

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=2.2e-28  Score=253.61  Aligned_cols=177  Identities=28%  Similarity=0.444  Sum_probs=140.1

Q ss_pred             HhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccch-----hHHHHHHHHHHHHhcCCCCCcceeEeeccCCc
Q 035691          438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG-----ALKSFMAECEALRNIRHRNLVKIITACSSSDF  512 (640)
Q Consensus       438 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  512 (640)
                      ...++|++.+.||+|+||.||+|++..+|+.||||++......     ..+.+.+|+++++.++||||+++++++.    
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----   82 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG----   82 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe----
Confidence            3457799999999999999999999989999999999643221     1246889999999999999999999953    


Q ss_pred             CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC
Q 035691          513 QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND  592 (640)
Q Consensus       513 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~  592 (640)
                       .....++||||+++ +|.+++.....         .+++..+..++.|++.||+|||+   .+|+||||||+||+++.+
T Consensus        83 -~~~~~~lv~e~~~~-~l~~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~  148 (346)
T 1ua2_A           83 -HKSNISLVFDFMET-DLEVIIKDNSL---------VLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDEN  148 (346)
T ss_dssp             -CTTCCEEEEECCSE-EHHHHHTTCCS---------SCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTT
T ss_pred             -eCCceEEEEEcCCC-CHHHHHHhcCc---------CCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCC
Confidence             44578999999986 88888865432         26677889999999999999999   699999999999999999


Q ss_pred             CcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          593 MIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       593 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      +.+||+|||+++.+.....    ......||+.|+|||++.+..
T Consensus       149 ~~~kl~Dfg~a~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~  188 (346)
T 1ua2_A          149 GVLKLADFGLAKSFGSPNR----AYTHQVVTRWYRAPELLFGAR  188 (346)
T ss_dssp             CCEEECCCGGGSTTTSCCC----CCCCSCCCCTTCCHHHHTTCS
T ss_pred             CCEEEEecccceeccCCcc----cCCcccccccccCchHhhCCC
Confidence            9999999999987643221    122346899999999997654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.95  E-value=1.4e-28  Score=251.50  Aligned_cols=199  Identities=25%  Similarity=0.399  Sum_probs=145.4

Q ss_pred             CHHHHHHhcCCCcccCcccccccceEEEEEECC---CCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEe
Q 035691          432 SYESLLKATGGFSSANLIGTGSFGSVYKGILDP---DQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITA  506 (640)
Q Consensus       432 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~  506 (640)
                      .++++....++|.+.+.||+|+||.||+|++..   ++..||||++....  ....+.+.+|+.++++++||||++++++
T Consensus        25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  104 (313)
T 3brb_A           25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV  104 (313)
T ss_dssp             CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence            344555566778889999999999999998764   45689999996442  3345779999999999999999999999


Q ss_pred             eccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCC
Q 035691          507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSN  586 (640)
Q Consensus       507 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~N  586 (640)
                      +...........++||||+++|+|.+++.......    ....+++..++.++.|++.||.|||+   .+|+||||||+|
T Consensus       105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~N  177 (313)
T 3brb_A          105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET----GPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARN  177 (313)
T ss_dssp             EEC-------CEEEEEECCTTCBHHHHHHHTTBTT----SCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGG
T ss_pred             EeeccccCCcccEEEEecccCCCHHHHHHHhhhhc----CCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcce
Confidence            86554333345699999999999999984332111    11348899999999999999999999   699999999999


Q ss_pred             eeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          587 VLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       587 iLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+++.++.+||+|||+++.......  ........+++.|+|||++.+..++.
T Consensus       178 Ili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~  228 (313)
T 3brb_A          178 CMLRDDMTVCVADFGLSKKIYSGDY--YRQGRIAKMPVKWIAIESLADRVYTS  228 (313)
T ss_dssp             EEECTTSCEEECSCSCC------------------CCGGGSCHHHHHSSCCCH
T ss_pred             EEEcCCCcEEEeecCcceecccccc--cCcccccCCCccccCchhhcCCCccc
Confidence            9999999999999999986543211  11122345788999999998877654

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.95  E-value=1.4e-28  Score=250.14  Aligned_cols=181  Identities=30%  Similarity=0.407  Sum_probs=146.3

Q ss_pred             CCcccCcccccccceEEEEE----ECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          442 GFSSANLIGTGSFGSVYKGI----LDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      .|+..+.||+|+||.||+|+    ...+++.||||++.... ....+.+.+|+++++.++||||+++++++....   ..
T Consensus        22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~   98 (302)
T 4e5w_A           22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG---GN   98 (302)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------C
T ss_pred             hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---Cc
Confidence            47788999999999999999    45689999999996443 334578999999999999999999999975432   34


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++|+|.+++....         ..+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.+|
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~k  166 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKNK---------NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVK  166 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHT---------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEE
T ss_pred             eEEEEEEeCCCCcHHHHHHhcc---------ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEE
Confidence            6789999999999999985432         237889999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      |+|||+++....... .........||..|+|||++.+..++
T Consensus       167 l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~  207 (302)
T 4e5w_A          167 IGDFGLTKAIETDKE-YYTVKDDRDSPVFWYAPECLMQSKFY  207 (302)
T ss_dssp             ECCCTTCEECCTTCC-EEECCCCTTCCGGGCCHHHHHHCEEE
T ss_pred             ECcccccccccCCCc-ceeccCCCCCCccccCCeeecCCCCC
Confidence            999999987643321 11222335688999999998776654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.95  E-value=1.1e-28  Score=253.95  Aligned_cols=180  Identities=26%  Similarity=0.435  Sum_probs=139.4

Q ss_pred             HHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCC
Q 035691          437 LKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--GALKSFMAECEALRNIRHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       437 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  514 (640)
                      ....++|++.+.||+|+||.||+|++..+++.||||++.....  ...+.+.+|++++++++||||+++++++.     .
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~  104 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-----H  104 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-----E
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-----c
Confidence            3445679999999999999999999999999999999964432  23457889999999999999999999954     4


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee-----
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL-----  589 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl-----  589 (640)
                      ....++||||+++ +|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||++     
T Consensus       105 ~~~~~lv~e~~~~-~L~~~~~~~~----------~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~  170 (329)
T 3gbz_A          105 NHRLHLIFEYAEN-DLKKYMDKNP----------DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDA  170 (329)
T ss_dssp             TTEEEEEEECCSE-EHHHHHHHCT----------TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC---
T ss_pred             CCEEEEEEecCCC-CHHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCC
Confidence            5578999999985 9999886443          27888999999999999999999   699999999999999     


Q ss_pred             CCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCC-CCC
Q 035691          590 DNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ-VST  639 (640)
Q Consensus       590 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~  639 (640)
                      +..+.+||+|||+++......    .......||+.|+|||++.+.. ++.
T Consensus       171 ~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~  217 (329)
T 3gbz_A          171 SETPVLKIGDFGLARAFGIPI----RQFTHEIITLWYRPPEILLGSRHYST  217 (329)
T ss_dssp             --CCEEEECCTTHHHHHC---------------CCTTCCHHHHTTCCCCCT
T ss_pred             CccceEEECcCCCccccCCcc----cccCCCcCCccccCHHHhcCCCCCCc
Confidence            455669999999998654221    1122346899999999998754 443

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.95  E-value=4.5e-28  Score=250.31  Aligned_cols=180  Identities=32%  Similarity=0.482  Sum_probs=140.4

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHH--HHhcCCCCCcceeEeeccCCcCCCce
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEA--LRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      .++|++.+.||+|+||.||+|++  +++.||||++.....   ..+..|.++  +..++||||+++++++......+...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            46788999999999999999987  689999999964432   344445444  44589999999998765444455567


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------CCCeeeCCCCCCCeeeCC
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHC------KKQIVHCDLKPSNVLLDN  591 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~------~~~ivHrdlkp~NiLl~~  591 (640)
                      .++||||+++|+|.+++....           .++..+..++.|++.||+|||+.+      .++|+||||||+|||++.
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~  155 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLHT-----------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN  155 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC-----------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECT
T ss_pred             EEEEEecCCCCcHHHHHhhcc-----------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcC
Confidence            889999999999999995432           478889999999999999999831      119999999999999999


Q ss_pred             CCcEEEccccccccCCCccCC----CceeeccccccccccCcccCCCC
Q 035691          592 DMIAHVGDFGLTRFIPEVISS----NQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       592 ~~~~kl~DfGla~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      ++.+||+|||+++.+......    .........||+.|+|||++.+.
T Consensus       156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  203 (336)
T 3g2f_A          156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGA  203 (336)
T ss_dssp             TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTC
T ss_pred             CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCC
Confidence            999999999999876432211    11122345699999999999873

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.95  E-value=4.2e-28  Score=253.12  Aligned_cols=178  Identities=24%  Similarity=0.340  Sum_probs=132.3

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCC-cCCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSD-FQGND  516 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~~  516 (640)
                      .++|+..+.||+|+||.||+|++..+|+.||||++...  .....+.+.+|+++++.++||||+++++++.... .....
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            47789999999999999999999999999999998543  2334578889999999999999999999975432 22334


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+ +++|.+++...           .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+|
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~-----------~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~k  172 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ-----------KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELK  172 (367)
T ss_dssp             CCEEEEECC-CEECC-----C-----------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEE
T ss_pred             eEEEEeccc-CCCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEE
Confidence            678999999 67998887531           27888999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCC-CCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG-SQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~  639 (640)
                      |+|||+++.....       ....+||++|+|||++.+ ..++.
T Consensus       173 L~DFG~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~  209 (367)
T 2fst_X          173 ILDFGLARHTADE-------MTGYVATRWYRAPEIMLNWMHYNQ  209 (367)
T ss_dssp             ECC----------------------CCCTTCCHHHHTTCCSCCT
T ss_pred             Eeecccccccccc-------CCCcCcCcCccChHHHcCCcCCCc
Confidence            9999999865321       223568999999999987 45554

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.95  E-value=9.2e-28  Score=240.63  Aligned_cols=177  Identities=23%  Similarity=0.318  Sum_probs=149.3

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.     .....+
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   81 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQY   81 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCEEE
Confidence            46888999999999999999999899999999996443 334578899999999999999999999954     345789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|
T Consensus        82 lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~d  148 (276)
T 2yex_A           82 LFLEYCSGGELFDRIEPDI----------GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISD  148 (276)
T ss_dssp             EEEECCTTEEGGGGSBTTT----------BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEEEecCCCcHHHHHhhcc----------CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEee
Confidence            9999999999999986432          37889999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV  637 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  637 (640)
                      ||.++.+.....  ........||+.|+|||++.+..+
T Consensus       149 fg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~  184 (276)
T 2yex_A          149 FGLATVFRYNNR--ERLLNKMCGTLPYVAPELLKRREF  184 (276)
T ss_dssp             CTTCEECEETTE--ECCBCCCCSCGGGCCGGGGTCSSB
T ss_pred             CCCccccCCCcc--hhcccCCccccCccChHHHhcCCC
Confidence            999986532211  111223568999999999987664

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.95  E-value=3.3e-28  Score=255.78  Aligned_cols=190  Identities=26%  Similarity=0.372  Sum_probs=150.9

Q ss_pred             cCCCcccCcccccccceEEEEEECC-------CCeEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCCcceeEeeccC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDP-------DQTVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRNLVKIITACSSS  510 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  510 (640)
                      .++|.+.+.||+|+||.||+|++..       .+..||||+++... ....+.+.+|+++++++ +|||||+++++|.  
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--  145 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--  145 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec--
Confidence            4568888999999999999999742       34689999996443 34457899999999999 9999999999964  


Q ss_pred             CcCCCceeeEEeeccCCCChhhhcCCCCCCCC------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCC
Q 035691          511 DFQGNDFKALVYEFMHHGSLESWLHPESASDD------LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKP  584 (640)
Q Consensus       511 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp  584 (640)
                         .....++||||+++|+|.+++........      .......+++..++.++.|++.||+|||+   .+|+||||||
T Consensus       146 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp  219 (382)
T 3tt0_A          146 ---QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAA  219 (382)
T ss_dssp             ---SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCG
T ss_pred             ---cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCc
Confidence               34468999999999999999965432110      00112358999999999999999999999   6999999999


Q ss_pred             CCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          585 SNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       585 ~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +||+++.++.+||+|||+|+.......  ........||+.|+|||++.+..++.
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~  272 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDY--YKKTTNGRLPVKWMAPEALFDRIYTH  272 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCT--TCCCTTCCCGGGGSCHHHHHSCCCCH
T ss_pred             ceEEEcCCCcEEEcccCcccccccccc--cccccCCCCCcceeCHHHhcCCCCCc
Confidence            999999999999999999986643221  11223345789999999998877664

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.95  E-value=4.2e-28  Score=250.01  Aligned_cols=176  Identities=26%  Similarity=0.398  Sum_probs=143.1

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ++|++.+.||+|+||.||+|++..+|+.||||++.....  ...+.+.+|+.+++.++||||+++++++.     .....
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   99 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KKKRW   99 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cCCEE
Confidence            468888999999999999999999999999999854432  23466889999999999999999999964     34578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||++++++.++.....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+
T Consensus       100 ~lv~e~~~~~~l~~~~~~~~----------~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~  166 (331)
T 4aaa_A          100 YLVFEFVDHTILDDLELFPN----------GLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLC  166 (331)
T ss_dssp             EEEEECCSEEHHHHHHHSTT----------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEEC
T ss_pred             EEEEecCCcchHHHHHhhcc----------CCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEE
Confidence            99999999999988765332          27889999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCC-CCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS-QVS  638 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s  638 (640)
                      |||+++.+.....    ......||+.|+|||++.+. .++
T Consensus       167 Dfg~~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~  203 (331)
T 4aaa_A          167 DFGFARTLAAPGE----VYDDEVATRWYRAPELLVGDVKYG  203 (331)
T ss_dssp             CCTTC----------------CCCCCTTCCHHHHTTCTTCC
T ss_pred             eCCCceeecCCcc----ccCCCcCCccccCcccccCCCCcc
Confidence            9999986543211    12234689999999999875 444

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.95  E-value=5.5e-28  Score=245.13  Aligned_cols=180  Identities=22%  Similarity=0.288  Sum_probs=149.0

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCcee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      .++|++.+.||+|+||.||+|++..+|+.||||++....  ..+.+.+|+.+++.+ +|++++++++++     ......
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~   81 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHN   81 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCcee
Confidence            467899999999999999999998899999999985332  234578899999999 799999999985     344578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc----
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI----  594 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~----  594 (640)
                      ++||||+ +|+|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.    
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~  148 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCG---------RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNAN  148 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTT---------TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTT
T ss_pred             EEEEEec-CCCHHHHHHHhc---------cCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCC
Confidence            9999999 999999996432         237899999999999999999999   69999999999999987776    


Q ss_pred             -EEEccccccccCCCccCCCc---eeeccccccccccCcccCCCCCCCC
Q 035691          595 -AHVGDFGLTRFIPEVISSNQ---CSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       595 -~kl~DfGla~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                       +||+|||+++..........   .......||+.|+|||++.+..++.
T Consensus       149 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  197 (298)
T 1csn_A          149 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSR  197 (298)
T ss_dssp             CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH
T ss_pred             eEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCCh
Confidence             99999999987654322111   1223457999999999998887764

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.95  E-value=6.4e-28  Score=251.90  Aligned_cols=188  Identities=23%  Similarity=0.280  Sum_probs=147.5

Q ss_pred             CHHHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc-----------hhHHHHHHHHHHHHhcCCCCC
Q 035691          432 SYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR-----------GALKSFMAECEALRNIRHRNL  500 (640)
Q Consensus       432 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~H~ni  500 (640)
                      ..+++....++|++.+.||+|+||.||+|++. +|+.||||++.....           ...+.+.+|++++++++||||
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            35677888999999999999999999999987 599999999843221           123789999999999999999


Q ss_pred             cceeEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeC
Q 035691          501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHC  580 (640)
Q Consensus       501 v~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHr  580 (640)
                      +++++++...+.......++||||++ |++.+++....         ..+++..+..++.|++.||.|||+   .+|+||
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~  158 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---------IVISPQHIQYFMYHILLGLHVLHE---AGVVHR  158 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCC
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHH---CcCEec
Confidence            99999976544344557899999998 58888776433         237889999999999999999999   699999


Q ss_pred             CCCCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCC-CCCC
Q 035691          581 DLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG-SQVS  638 (640)
Q Consensus       581 dlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s  638 (640)
                      ||||+||+++.++.+||+|||+++......     ......||+.|+|||++.+ ..++
T Consensus       159 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~  212 (362)
T 3pg1_A          159 DLHPGNILLADNNDITICDFNLAREDTADA-----NKTHYVTHRWYRAPELVMQFKGFT  212 (362)
T ss_dssp             CCCGGGEEECTTCCEEECCTTC--------------------CGGGCCHHHHTTCTTCC
T ss_pred             CCChHHEEEcCCCCEEEEecCccccccccc-----ccceecccceecCcHHhcCCCCCC
Confidence            999999999999999999999998543221     1223468999999999877 4444

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.95  E-value=4.6e-28  Score=243.80  Aligned_cols=176  Identities=23%  Similarity=0.304  Sum_probs=146.9

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc------hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR------GALKSFMAECEALRNIRHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  514 (640)
                      ++|++.+.||+|+||.||+|++..+|+.||+|++.....      ...+.+.+|+.++++++||||+++++++.     .
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~   79 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-----N   79 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----C
Confidence            358888999999999999999998999999999864321      13578999999999999999999999964     3


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC-
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-  593 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~-  593 (640)
                      ....++||||+++++|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++ 
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~  146 (283)
T 3bhy_A           80 KTDVVLILELVSGGELFDFLAEKE----------SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNV  146 (283)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSS
T ss_pred             CCeEEEEEeecCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCC
Confidence            457899999999999999986432          37889999999999999999999   6999999999999998877 


Q ss_pred             ---cEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          594 ---IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       594 ---~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                         .+||+|||+++......     ......||+.|+|||++.+..++.
T Consensus       147 ~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~  190 (283)
T 3bhy_A          147 PNPRIKLIDFGIAHKIEAGN-----EFKNIFGTPEFVAPEIVNYEPLGL  190 (283)
T ss_dssp             SSCCEEECCCTTCEECC-------------CCCGGGCCHHHHTTCCCCT
T ss_pred             CCCceEEEecccceeccCCC-----cccccCCCcCccCcceecCCCCCc
Confidence               89999999998654321     112345899999999998887764

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.95  E-value=7.9e-29  Score=249.21  Aligned_cols=180  Identities=26%  Similarity=0.385  Sum_probs=137.4

Q ss_pred             hcCCCcccCcccccccceEEEEEECC---CCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCC
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDP---DQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  514 (640)
                      ..++|++.+.||+|+||.||+|++..   .+..||+|++.... ....+.+.+|+.++++++||||+++++++.      
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------   86 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------   86 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc------
Confidence            34578889999999999999999864   35679999986433 334578999999999999999999999852      


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                      ++..++||||+++|+|.+++....         ..+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~  154 (281)
T 1mp8_A           87 ENPVWIIMELCTLGELRSFLQVRK---------YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDC  154 (281)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTT---------TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTE
T ss_pred             cCccEEEEecCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCC
Confidence            235789999999999999986433         237889999999999999999999   69999999999999999999


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +||+|||+++.......   .......+|+.|+|||++.+..++.
T Consensus       155 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~  196 (281)
T 1mp8_A          155 VKLGDFGLSRYMEDSTY---YKASKGKLPIKWMAPESINFRRFTS  196 (281)
T ss_dssp             EEECC----------------------CCGGGCCHHHHHHCCCSH
T ss_pred             EEECccccccccCcccc---cccccCCCcccccChhhcccCCCCC
Confidence            99999999987643221   1122234788999999987766653

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.95  E-value=1.9e-28  Score=246.66  Aligned_cols=180  Identities=26%  Similarity=0.438  Sum_probs=149.3

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc-------
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDF-------  512 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-------  512 (640)
                      .++|+..+.||+|+||.||+|++..+++.||+|++....    +.+.+|++++++++||||+++++++....+       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            345888999999999999999999899999999996543    346789999999999999999998743211       


Q ss_pred             ----CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCee
Q 035691          513 ----QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVL  588 (640)
Q Consensus       513 ----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiL  588 (640)
                          ......++||||+++|+|.+++.....        ..+++..++.++.|++.||.|||+   .+|+||||||+||+
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil  154 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--------EKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIF  154 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGG--------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccC--------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEE
Confidence                124457999999999999999964322        237889999999999999999999   69999999999999


Q ss_pred             eCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          589 LDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       589 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ++.++.+||+|||+++.......     .....||+.|+|||++.+..++.
T Consensus       155 ~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~  200 (284)
T 2a19_B          155 LVDTKQVKIGDFGLVTSLKNDGK-----RTRSKGTLRYMSPEQISSQDYGK  200 (284)
T ss_dssp             EEETTEEEECCCTTCEESSCCSC-----CCCCCSCCTTSCHHHHHCSCCCT
T ss_pred             EcCCCCEEECcchhheecccccc-----ccccCCcccccChhhhccCCCcc
Confidence            99999999999999986643221     12345899999999998877664

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.95  E-value=5.7e-28  Score=246.20  Aligned_cols=174  Identities=29%  Similarity=0.428  Sum_probs=139.4

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      ++|++.+.||+|+||.||+|++.  ++.||||++..  ....+.+.+|++++++++||||+++++++.       +..++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~~~~l   76 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL-------NPVCL   76 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-------TTTEE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------CCcEE
Confidence            45788899999999999999984  78999999853  334578999999999999999999999853       23689


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc-EEEcc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI-AHVGD  599 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~-~kl~D  599 (640)
                      ||||+++|+|.+++......       ..+++..++.++.|++.||+|||+....+|+||||||+||+++.++. +||+|
T Consensus        77 v~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~D  149 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEPL-------PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICD  149 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSSE-------ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECC
T ss_pred             EEEcCCCCCHHHHHhccCCC-------CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcc
Confidence            99999999999999754321       23678889999999999999999854458999999999999998886 79999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+++......       ....||+.|+|||++.+..++.
T Consensus       150 fg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~  182 (307)
T 2eva_A          150 FGTACDIQTHM-------TNNKGSAAWMAPEVFEGSNYSE  182 (307)
T ss_dssp             CCC-------------------CCTTSSCHHHHTCCCCCT
T ss_pred             ccccccccccc-------ccCCCCCceEChhhhCCCCCCc
Confidence            99997553211       1235899999999999887765

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.95  E-value=9.6e-28  Score=251.24  Aligned_cols=180  Identities=23%  Similarity=0.278  Sum_probs=141.5

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCC-cCCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSD-FQGND  516 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~~  516 (640)
                      .++|++.+.||+|+||.||+|++..+++.||||++...  .....+.+.+|+.+++.++||||+++++++.... .....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            46789999999999999999999999999999999643  2334567889999999999999999999975432 12334


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++ +|.+++..            .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+|
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~------------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~k  167 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM------------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLK  167 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS------------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEE
T ss_pred             ceEEEEEcCCC-CHHHHHhh------------ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEE
Confidence            68999999975 78777742            26788899999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |+|||+++......     ......||+.|+|||++.+..++.+
T Consensus       168 l~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~  206 (371)
T 2xrw_A          168 ILDFGLARTAGTSF-----MMTPYVVTRYYRAPEVILGMGYKEN  206 (371)
T ss_dssp             ECCCCC---------------------CTTCCHHHHTTCCCCTT
T ss_pred             EEEeeccccccccc-----ccCCceecCCccCHHHhcCCCCCch
Confidence            99999998653211     1223568999999999999887754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.95  E-value=1.1e-28  Score=257.39  Aligned_cols=176  Identities=25%  Similarity=0.359  Sum_probs=148.5

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.     .....+
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~  107 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEIS  107 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE-----ETTEEE
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE-----ECCEEE
Confidence            46888999999999999999999999999999996543 344578999999999999999999999964     345789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++|+|.+++....          .+++..+..++.|++.||.|||+.  .+|+||||||+||+++.++.+||+|
T Consensus       108 lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~D  175 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKAG----------RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCD  175 (360)
T ss_dssp             EEECCCTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEECCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEE
Confidence            9999999999999986432          278889999999999999999982  2899999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+++.....      ......||+.|+|||++.+..++.
T Consensus       176 fg~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~  209 (360)
T 3eqc_A          176 FGVSGQLIDS------MANSFVGTRSYMSPERLQGTHYSV  209 (360)
T ss_dssp             CCCCHHHHHH------C----CCCCTTCCHHHHTTCCCSH
T ss_pred             CCCCcccccc------cccCCCCCCCeECHHHHcCCCCCc
Confidence            9999754321      112346899999999999887764

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.95  E-value=3.7e-28  Score=263.77  Aligned_cols=174  Identities=29%  Similarity=0.367  Sum_probs=145.6

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ++|++.+.||+|+||.||+|+++.+++.||||++....  ......+.+|++++++++|||||++++++.     .....
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~   96 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSSF   96 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-----cCCEE
Confidence            45889999999999999999999999999999995432  334578999999999999999999999954     44578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC---CCCcE
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD---NDMIA  595 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~---~~~~~  595 (640)
                      ++||||+++|+|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+||+++   .++.+
T Consensus        97 ~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~  163 (486)
T 3mwu_A           97 YIVGELYTGGELFDEIIKRK----------RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDI  163 (486)
T ss_dssp             EEEECCCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCE
T ss_pred             EEEEEcCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCE
Confidence            99999999999998885432          27889999999999999999999   6999999999999995   45689


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      ||+|||+++.+....     .....+||+.|+|||++.+. ++
T Consensus       164 kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-~~  200 (486)
T 3mwu_A          164 KIIDFGLSTCFQQNT-----KMKDRIGTAYYIAPEVLRGT-YD  200 (486)
T ss_dssp             EECSCSCTTTBCCC---------CCTTGGGGCCGGGGGSC-CC
T ss_pred             EEEECCcCeECCCCC-----ccCCCcCCCCCCCHHHhCCC-CC
Confidence            999999998664321     12235699999999998763 44

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.95  E-value=1.2e-28  Score=253.20  Aligned_cols=176  Identities=24%  Similarity=0.402  Sum_probs=138.7

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccch-hHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG-ALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ++|.+.+.||+|+||.||+|++..+++.||||++...... ....+.+|+++++.++||||+++++++.     .....+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE-----CSSCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe-----eCCEEE
Confidence            4688899999999999999999999999999999644322 1224567999999999999999999954     345789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||++ |+|.+++....         ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|
T Consensus        77 lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~D  143 (324)
T 3mtl_A           77 LVFEYLD-KDLKQYLDDCG---------NIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLAD  143 (324)
T ss_dssp             EEEECCS-EEHHHHHHHTT---------TCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECS
T ss_pred             EEecccc-cCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEcc
Confidence            9999998 58888886433         237888999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCC-CCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS-QVS  638 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s  638 (640)
                      ||+++......    .......||+.|+|||++.+. .++
T Consensus       144 fg~a~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~  179 (324)
T 3mtl_A          144 FGLARAKSIPT----KTYDNEVVTLWYRPPDILLGSTDYS  179 (324)
T ss_dssp             SSEEECC----------------CGGGCCHHHHTTCCCCC
T ss_pred             CcccccccCCc----cccccccCcccccChhhhcCCCCCC
Confidence            99998653221    112234689999999998873 344

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.95  E-value=1.2e-28  Score=265.14  Aligned_cols=180  Identities=23%  Similarity=0.443  Sum_probs=148.4

Q ss_pred             HhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       438 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ...++|.+.+.||+|+||.||+|++. ++..||||+++... ...+.|.+|+.+|++++|||||++++++.      .+.
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~  256 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEP  256 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred             echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCc
Confidence            34566888899999999999999987 57889999996543 34578999999999999999999999963      235


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++|||||++|+|.+++.....        ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||
T Consensus       257 ~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl  325 (454)
T 1qcf_A          257 IYIITEFMAKGSLLDFLKSDEG--------SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKI  325 (454)
T ss_dssp             CEEEECCCTTCBHHHHHHSHHH--------HTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEE
T ss_pred             cEEEEeecCCCcHHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEE
Confidence            7899999999999999964321        137788899999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|||+++......   ........+|+.|+|||++.+..++.
T Consensus       326 ~DFG~a~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~  364 (454)
T 1qcf_A          326 ADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTI  364 (454)
T ss_dssp             CSTTGGGGBCCHH---HHTTCSSSSCGGGSCHHHHHHCCCCH
T ss_pred             eeCCCceEcCCCc---eeccCCCcccccccCHHHhccCCCCc
Confidence            9999998664321   11112234678999999998777664

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.95  E-value=1.4e-26  Score=233.46  Aligned_cols=201  Identities=24%  Similarity=0.253  Sum_probs=150.7

Q ss_pred             CCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCC
Q 035691           80 LPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCT  159 (640)
Q Consensus        80 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~  159 (640)
                      +++++.+++++|.++.+ |..+.  ++|++|+|++|+|++..+..|..+++|++|+|++|.|+.++.        ...++
T Consensus         9 l~~l~~l~~~~~~l~~i-p~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--------~~~l~   77 (290)
T 1p9a_G            9 VASHLEVNCDKRNLTAL-PPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--------DGTLP   77 (290)
T ss_dssp             STTCCEEECTTSCCSSC-CSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--------CSCCT
T ss_pred             cCCccEEECCCCCCCcC-CCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--------CCCCC
Confidence            34444444444444422 22221  456666666666666666666666666666666666665421        24566


Q ss_pred             CcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccC
Q 035691          160 YLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSK  239 (640)
Q Consensus       160 ~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~  239 (640)
                      +|++|++++|+++.+|..+..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|    
T Consensus        78 ~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L----  153 (290)
T 1p9a_G           78 VLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL----  153 (290)
T ss_dssp             TCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE----
T ss_pred             cCCEEECCCCcCCcCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEE----
Confidence            7777777777777777777788889999999999988777889999999999999999998888888888888888    


Q ss_pred             ccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCC
Q 035691          240 TIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHG  308 (640)
Q Consensus       240 n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  308 (640)
                                  +|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|++..
T Consensus       154 ------------~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C  209 (290)
T 1p9a_G          154 ------------SLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC  209 (290)
T ss_dssp             ------------ECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             ------------ECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence                        78888888777778889999999999999998 677778888899999999999874

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.95  E-value=9.3e-28  Score=242.54  Aligned_cols=177  Identities=26%  Similarity=0.391  Sum_probs=146.5

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .|.+.+.||+|+||.||+|.+..++..||+|++...  .....+.+.+|+.+++.++||||+++++++... .......+
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~~  105 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIV  105 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc-cCCCceEE
Confidence            366778899999999999999999999999998643  234557899999999999999999999987543 23456789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeeCCCCCCCeeeC-CCCcEE
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQ--IVHCDLKPSNVLLD-NDMIAH  596 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~--ivHrdlkp~NiLl~-~~~~~k  596 (640)
                      +||||+++|+|.+++....          .+++..+..++.|++.||.|||+   .+  |+||||||+||+++ +++.+|
T Consensus       106 lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~k  172 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFK----------VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVK  172 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEE
T ss_pred             EEEEecCCCCHHHHHHHcc----------CCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEE
Confidence            9999999999999986432          27888999999999999999999   46  99999999999997 789999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|||++......      ......||+.|+|||++.+ .++.
T Consensus       173 l~Dfg~~~~~~~~------~~~~~~~t~~y~aPE~~~~-~~~~  208 (290)
T 1t4h_A          173 IGDLGLATLKRAS------FAKAVIGTPEFMAPEMYEE-KYDE  208 (290)
T ss_dssp             ECCTTGGGGCCTT------SBEESCSSCCCCCGGGGGT-CCCT
T ss_pred             EeeCCCccccccc------ccccccCCcCcCCHHHHhc-cCCC
Confidence            9999999754322      1123468999999998864 3543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.95  E-value=2.8e-28  Score=250.73  Aligned_cols=188  Identities=25%  Similarity=0.354  Sum_probs=148.3

Q ss_pred             ccCHHHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCCcceeEeec
Q 035691          430 NVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-RHRNLVKIITACS  508 (640)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~  508 (640)
                      .++++++....++|++.+.||+|+||.||+|++..+|+.||||++..... ..+.+.+|+.+++++ +||||+++++++.
T Consensus        13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            34455556677889999999999999999999998999999999965433 346789999999999 8999999999975


Q ss_pred             cCCcC-CCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCe
Q 035691          509 SSDFQ-GNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNV  587 (640)
Q Consensus       509 ~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~Ni  587 (640)
                      ..... .....++||||+++|+|.+++.....        ..+++..+..++.|++.||.|||+   .+|+||||||+||
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NI  160 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--------NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNV  160 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHSGG--------GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGE
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhccc--------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHE
Confidence            43211 14578999999999999999865322        237888999999999999999999   6999999999999


Q ss_pred             eeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCC
Q 035691          588 LLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGM  633 (640)
Q Consensus       588 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  633 (640)
                      +++.++.+||+|||+++.......    ......||+.|+|||++.
T Consensus       161 l~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~  202 (326)
T 2x7f_A          161 LLTENAEVKLVDFGVSAQLDRTVG----RRNTFIGTPYWMAPEVIA  202 (326)
T ss_dssp             EECTTCCEEECCCTTTC-----------------CCGGGCCHHHHC
T ss_pred             EEcCCCCEEEeeCcCceecCcCcc----ccccccCCccccChhhhc
Confidence            999999999999999986543211    122346899999999987

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.95  E-value=6.8e-28  Score=250.77  Aligned_cols=185  Identities=26%  Similarity=0.394  Sum_probs=149.7

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ..++|++.+.||+|+||.||+|++..+|+.||||++.... ......+.+|+++++.++||||+++++++....+.....
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            3567899999999999999999999999999999996433 334567889999999999999999999986655555677


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+. |+|.+++...           .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||
T Consensus        89 ~~lv~e~~~-~~L~~~~~~~-----------~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl  153 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVISTQ-----------MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKV  153 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHHC-----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEE
T ss_pred             EEEEEeccC-ccHHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEE
Confidence            899999997 5898887532           27888999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCC------ceeeccccccccccCcccCCC-CCCC
Q 035691          598 GDFGLTRFIPEVISSN------QCSSVGLKGTVGYAAPEYGMG-SQVS  638 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-~~~s  638 (640)
                      +|||+++.........      ........||+.|+|||++.+ ..++
T Consensus       154 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  201 (353)
T 2b9h_A          154 CDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYS  201 (353)
T ss_dssp             CCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCC
T ss_pred             EecccccccccccccccCccccccchhhccccccccCCeeeccCCCcc
Confidence            9999998764322110      111223568999999998754 4443

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.95  E-value=5.8e-28  Score=252.18  Aligned_cols=176  Identities=27%  Similarity=0.413  Sum_probs=147.8

Q ss_pred             HHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc--------hhHHHHHHHHHHHHhc-CCCCCcceeEe
Q 035691          436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--------GALKSFMAECEALRNI-RHRNLVKIITA  506 (640)
Q Consensus       436 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l~~~  506 (640)
                      .....++|++.+.||+|+||.||+|+++.+|+.||||++.....        ...+.+.+|+.+++++ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            34445678999999999999999999988999999999864431        1245788999999999 89999999999


Q ss_pred             eccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCC
Q 035691          507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSN  586 (640)
Q Consensus       507 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~N  586 (640)
                      +.     .....++||||+++|+|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+|
T Consensus       169 ~~-----~~~~~~lv~e~~~g~~L~~~l~~~~----------~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~N  230 (365)
T 2y7j_A          169 YE-----SSSFMFLVFDLMRKGELFDYLTEKV----------ALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPEN  230 (365)
T ss_dssp             EE-----BSSEEEEEECCCTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGG
T ss_pred             Ee-----eCCEEEEEEEeCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHH
Confidence            53     3457899999999999999986432          37889999999999999999999   699999999999


Q ss_pred             eeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          587 VLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       587 iLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      |+++.++.+||+|||++..+....     ......||+.|+|||++.+
T Consensus       231 Il~~~~~~ikl~DfG~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~  273 (365)
T 2y7j_A          231 ILLDDNMQIRLSDFGFSCHLEPGE-----KLRELCGTPGYLAPEILKC  273 (365)
T ss_dssp             EEECTTCCEEECCCTTCEECCTTC-----CBCCCCSCGGGCCHHHHHH
T ss_pred             EEECCCCCEEEEecCcccccCCCc-----ccccCCCCCCccChhhccc
Confidence            999999999999999998664321     1223569999999999864

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=6.6e-28  Score=253.65  Aligned_cols=184  Identities=22%  Similarity=0.296  Sum_probs=142.4

Q ss_pred             HHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc----
Q 035691          437 LKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDF----  512 (640)
Q Consensus       437 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----  512 (640)
                      ....++|++.+.||+|+||.||+|++..+|+.||||++.....    ...+|+++++.++|||||++++++.....    
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            3456789999999999999999999999999999999854322    22479999999999999999999754321    


Q ss_pred             -----------------------------CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHH
Q 035691          513 -----------------------------QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA  563 (640)
Q Consensus       513 -----------------------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~  563 (640)
                                                   ....+.++||||+++ +|.+.+......      ...+++..+..++.|++
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~------~~~l~~~~~~~i~~qi~  151 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRS------GRSIPMNLISIYIYQLF  151 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHT------TCCCCHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhc------CCCCCHHHHHHHHHHHH
Confidence                                         234458899999984 777666421110      12388999999999999


Q ss_pred             HHHHHHhcCCCCCeeeCCCCCCCeeeC-CCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCC-CCC
Q 035691          564 SALEYLHHHCKKQIVHCDLKPSNVLLD-NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ-VST  639 (640)
Q Consensus       564 ~al~yLH~~~~~~ivHrdlkp~NiLl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~  639 (640)
                      .||+|||+   .+|+||||||+||+++ .++.+||+|||+|+.+....     ......||+.|+|||++.+.. ++.
T Consensus       152 ~aL~~LH~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~  221 (383)
T 3eb0_A          152 RAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-----PSVAYICSRFYRAPELMLGATEYTP  221 (383)
T ss_dssp             HHHHHHHT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-----CCCCCCCCSSCCCHHHHTTCSSCCT
T ss_pred             HHHHHHHH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-----CCcCcccCCCccCHHHhcCCCCCCc
Confidence            99999998   6999999999999997 68999999999998664321     122346899999999988754 553

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.95  E-value=3e-28  Score=249.04  Aligned_cols=189  Identities=24%  Similarity=0.354  Sum_probs=149.0

Q ss_pred             cCCCcccCcccccccceEEEEEE-----CCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQ  513 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  513 (640)
                      .++|.+.+.||+|+||.||+|++     +.+++.||||++.... ....+.+.+|+++++.++||||+++++++.     
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----   96 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS-----   96 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe-----
Confidence            45688889999999999999987     3456899999996433 344578999999999999999999999953     


Q ss_pred             CCceeeEEeeccCCCChhhhcCCCCCCCC--------------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 035691          514 GNDFKALVYEFMHHGSLESWLHPESASDD--------------LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVH  579 (640)
Q Consensus       514 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--------------~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivH  579 (640)
                      .....++||||+++|+|.+++........              .......+++..++.++.|++.||.|||+   .+|+|
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH  173 (314)
T 2ivs_A           97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVH  173 (314)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEEC
T ss_pred             cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcc
Confidence            34568999999999999999965432100              00011347889999999999999999999   69999


Q ss_pred             CCCCCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          580 CDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       580 rdlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      |||||+||+++.++.+||+|||+++.......  ........+|+.|+|||++.+..++
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~  230 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDS--YVKRSQGRIPVKWMAIESLFDHIYT  230 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSC--EECSSCCCSCGGGCCHHHHHHCEEC
T ss_pred             cccchheEEEcCCCCEEEcccccccccccccc--ceeccCCCCcccccChhhhcCCCcC
Confidence            99999999999999999999999986643221  1122234578899999998776554

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=4.6e-28  Score=251.07  Aligned_cols=193  Identities=25%  Similarity=0.361  Sum_probs=149.2

Q ss_pred             HHhcCCCcccCcccccccceEEEEEE-----CCCCeEEEEEEeecc-cchhHHHHHHHHHHHHhc-CCCCCcceeEeecc
Q 035691          437 LKATGGFSSANLIGTGSFGSVYKGIL-----DPDQTVVAVKVLFLH-QRGALKSFMAECEALRNI-RHRNLVKIITACSS  509 (640)
Q Consensus       437 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~  509 (640)
                      +...++|.+.+.||+|+||.||+|++     ..++..||||++... .....+.+.+|+.+++++ +||||+++++++..
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            34456788999999999999999997     346678999999643 233457899999999999 89999999999643


Q ss_pred             CCcCCCceeeEEeeccCCCChhhhcCCCCCCCC-------------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 035691          510 SDFQGNDFKALVYEFMHHGSLESWLHPESASDD-------------LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQ  576 (640)
Q Consensus       510 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------------~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~  576 (640)
                           ....++||||+++|+|.+++........             .......+++..++.++.|++.||+|||+   .+
T Consensus       121 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~  192 (344)
T 1rjb_A          121 -----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KS  192 (344)
T ss_dssp             -----SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred             -----CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CC
Confidence                 4468999999999999999975432100             00011347899999999999999999999   69


Q ss_pred             eeeCCCCCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          577 IVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       577 ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+||||||+||+++.++.+||+|||+++.......  ........||+.|+|||++.+..++.
T Consensus       193 ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~  253 (344)
T 1rjb_A          193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN--YVVRGNARLPVKWMAPESLFEGIYTI  253 (344)
T ss_dssp             EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTT--SEEETTEEECGGGCCHHHHHHCCCCH
T ss_pred             cccCCCChhhEEEcCCCcEEeCCCccCcccccCcc--ceeccCccCccCccCHHHhccCCCCh
Confidence            99999999999999999999999999986643221  12223345788999999987776653

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=4.7e-28  Score=249.71  Aligned_cols=182  Identities=26%  Similarity=0.469  Sum_probs=140.7

Q ss_pred             cCCCcccCcccccccceEEEEEECCC----CeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPD----QTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  514 (640)
                      .++|+..+.||+|+||.||+|++..+    +..||||++.... ......+.+|++++++++||||+++++++.     .
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~  117 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----K  117 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----S
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe-----c
Confidence            35677789999999999999987644    3469999996443 334567999999999999999999999953     3


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                      ....++||||+++|+|.+++....         ..+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~  185 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREKD---------GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLV  185 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTT---------TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCC
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCc
Confidence            457899999999999999986432         237889999999999999999999   69999999999999999999


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +||+|||+++........ ........+|+.|+|||++.+..++.
T Consensus       186 ~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~  229 (333)
T 1mqb_A          186 CKVSDFGLSRVLEDDPEA-TYTTSGGKIPIRWTAPEAISYRKFTS  229 (333)
T ss_dssp             EEECCCCC------------------CCCGGGSCHHHHHSCCCCH
T ss_pred             EEECCCCcchhhcccccc-ccccCCCCccccccCchhcccCCCCc
Confidence            999999999876432211 11122334688999999998777654

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.95  E-value=5.2e-29  Score=255.74  Aligned_cols=196  Identities=24%  Similarity=0.336  Sum_probs=152.2

Q ss_pred             HHHHHhcCCCcccCcccccccceEEEEEEC-----CCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEee
Q 035691          434 ESLLKATGGFSSANLIGTGSFGSVYKGILD-----PDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITAC  507 (640)
Q Consensus       434 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~  507 (640)
                      ++.....++|++.+.||+|+||.||+|++.     .+++.||||++.... ......+.+|+.+++.++||||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            344556678999999999999999999876     357889999996433 23446789999999999999999999996


Q ss_pred             ccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCe
Q 035691          508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNV  587 (640)
Q Consensus       508 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~Ni  587 (640)
                      .     .....++||||+++|+|.+++...............+++..++.++.|++.||+|||+   .+|+||||||+||
T Consensus        98 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NI  169 (322)
T 1p4o_A           98 S-----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNC  169 (322)
T ss_dssp             C-----SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGE
T ss_pred             c-----cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceE
Confidence            3     3456799999999999999986422100000001236888999999999999999999   6999999999999


Q ss_pred             eeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          588 LLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       588 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +++.++.+||+|||+++.......  ........||+.|+|||++.+..++.
T Consensus       170 li~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~  219 (322)
T 1p4o_A          170 MVAEDFTVKIGDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGVFTT  219 (322)
T ss_dssp             EECTTCCEEECCTTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHHHCCCCH
T ss_pred             EEcCCCeEEECcCccccccccccc--cccccCCCCCCCccChhhhccCCCCc
Confidence            999999999999999986543211  11122335789999999988776653

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.95  E-value=6.2e-28  Score=245.17  Aligned_cols=186  Identities=24%  Similarity=0.370  Sum_probs=145.1

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCC--------
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSD--------  511 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--------  511 (640)
                      .++|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.++++++||||+++++++....        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            35688899999999999999999989999999999543 334578899999999999999999999875421        


Q ss_pred             cCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC
Q 035691          512 FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN  591 (640)
Q Consensus       512 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~  591 (640)
                      .......++||||+++|+|.+++....         ..+++..++.++.|++.||+|||+   .+|+||||||+||+++.
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~  151 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSEN---------LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDE  151 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSC---------GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECT
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccc---------cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcC
Confidence            123457899999999999999996432         236778899999999999999999   69999999999999999


Q ss_pred             CCcEEEccccccccCCCccCC----------CceeeccccccccccCcccCCCC-CCC
Q 035691          592 DMIAHVGDFGLTRFIPEVISS----------NQCSSVGLKGTVGYAAPEYGMGS-QVS  638 (640)
Q Consensus       592 ~~~~kl~DfGla~~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~-~~s  638 (640)
                      ++.+||+|||+++........          .........||+.|+|||++.+. .++
T Consensus       152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  209 (303)
T 1zy4_A          152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYN  209 (303)
T ss_dssp             TSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCC
T ss_pred             CCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCc
Confidence            999999999999865422100          01112335689999999998764 444

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.95  E-value=3.7e-28  Score=249.82  Aligned_cols=182  Identities=29%  Similarity=0.429  Sum_probs=148.8

Q ss_pred             CCCcccCcccccccceEEEEEE----CCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          441 GGFSSANLIGTGSFGSVYKGIL----DPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ++|++.+.||+|+||.||+|++    ..+++.||||++........+.+.+|++++++++||||+++++++....   ..
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~  117 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---RR  117 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-------
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC---CC
Confidence            4578889999999999999984    5689999999997666666688999999999999999999999875322   34


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++|+|.+++....         ..+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.+|
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~k  185 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKHK---------ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVK  185 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHST---------TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEE
T ss_pred             ceEEEEECCCCCCHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEE
Confidence            6789999999999999996543         237889999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      |+|||+++........ ........+|..|+|||++.+..++
T Consensus       186 L~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~  226 (326)
T 2w1i_A          186 IGDFGLTKVLPQDKEY-YKVKEPGESPIFWYAPESLTESKFS  226 (326)
T ss_dssp             ECCCTTCEECCSSCSE-EECSSCCSCCGGGCCHHHHHHCEEE
T ss_pred             EecCcchhhccccccc-cccccCCCCceeEECchhhcCCCCC
Confidence            9999999876432211 1112224578889999998766554

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.95  E-value=6.1e-28  Score=243.37  Aligned_cols=174  Identities=24%  Similarity=0.345  Sum_probs=144.5

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~  516 (640)
                      .++|++.+.||+|+||.||+|++..+++.||||++....  ......+.+|+..+..+ +||||+++++++.     ..+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~-----~~~   84 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA-----EDD   84 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE-----ETT
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCC
Confidence            356888999999999999999999999999999996532  33456788999999999 9999999999964     345


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC-----
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN-----  591 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~-----  591 (640)
                      ..++||||+++|+|.+++......      ...+++..+..++.|++.||+|||+   .+|+||||||+||+++.     
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~  155 (289)
T 1x8b_A           85 HMLIQNEYCNGGSLADAISENYRI------MSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPN  155 (289)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHHH------TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC------
T ss_pred             eEEEEEEecCCCcHHHHHHhhccc------ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCc
Confidence            789999999999999998643210      0237889999999999999999999   69999999999999984     


Q ss_pred             --------------CCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          592 --------------DMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       592 --------------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                                    ...+||+|||.++......        ...||+.|+|||++.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--------~~~gt~~y~aPE~~~~~  205 (289)
T 1x8b_A          156 AASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ--------VEEGDSRFLANEVLQEN  205 (289)
T ss_dssp             --------------CCCEEECCCTTCEETTCSC--------CCCCCGGGCCHHHHTTC
T ss_pred             ccccccccccccCCceEEEEcccccccccCCcc--------ccCCCccccChhHhcCC
Confidence                          4479999999998654321        13489999999999875

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.95  E-value=4.4e-28  Score=251.33  Aligned_cols=185  Identities=20%  Similarity=0.299  Sum_probs=143.9

Q ss_pred             cCCCcccCcccccccceEEEEEECC---CCeEEEEEEeecccch-----------hHHHHHHHHHHHHhcCCCCCcceeE
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDP---DQTVVAVKVLFLHQRG-----------ALKSFMAECEALRNIRHRNLVKIIT  505 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~~  505 (640)
                      .++|.+.+.||+|+||.||+|++..   ++..||||++......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3578899999999999999999986   7889999998644321           1235778889999999999999999


Q ss_pred             eeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCC
Q 035691          506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPS  585 (640)
Q Consensus       506 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~  585 (640)
                      ++... +.+....++||||+ +|+|.+++....          .+++..++.++.|++.||+|||+   .+|+||||||+
T Consensus       116 ~~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~  180 (345)
T 2v62_A          116 SGLTE-FKGRSYRFMVMERL-GIDLQKISGQNG----------TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAA  180 (345)
T ss_dssp             EEEEE-SSSCEEEEEEEECE-EEEHHHHCBGGG----------BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGG
T ss_pred             ccccc-cCCCcEEEEEEecc-CCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHH
Confidence            97553 23456889999999 999999986543          38899999999999999999999   69999999999


Q ss_pred             CeeeCCCC--cEEEccccccccCCCccCC---CceeeccccccccccCcccCCCCCCCC
Q 035691          586 NVLLDNDM--IAHVGDFGLTRFIPEVISS---NQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       586 NiLl~~~~--~~kl~DfGla~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+++.++  .+||+|||+|+.+......   .........||+.|+|||++.+..++.
T Consensus       181 NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  239 (345)
T 2v62_A          181 NLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSR  239 (345)
T ss_dssp             GEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCH
T ss_pred             HEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCc
Confidence            99998877  9999999999876432211   111123457999999999998887664

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.95  E-value=4.8e-28  Score=262.91  Aligned_cols=175  Identities=29%  Similarity=0.379  Sum_probs=148.0

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||.||+|+++.+|+.||||++....   ....+.+.+|+.++++++|||||++++++.     ....
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~  100 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE-----DKGY  100 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCCE
Confidence            45888899999999999999999999999999995432   334578999999999999999999999953     4558


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee---CCCCc
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL---DNDMI  594 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl---~~~~~  594 (640)
                      .++||||+.+|+|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+||++   +.++.
T Consensus       101 ~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~  167 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIISRK----------RFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDAN  167 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHTCS----------CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCC
T ss_pred             EEEEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCc
Confidence            899999999999999886543          27889999999999999999999   699999999999999   56789


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +||+|||+++.+....     .....+||+.|+|||++.+ .++.
T Consensus       168 ~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~  206 (484)
T 3nyv_A          168 IRIIDFGLSTHFEASK-----KMKDKIGTAYYIAPEVLHG-TYDE  206 (484)
T ss_dssp             EEECCTTHHHHBCCCC-----SHHHHTTGGGTCCHHHHHT-CCCT
T ss_pred             EEEEeeeeeEEccccc-----ccccCCCCccccCceeecC-CCCC
Confidence            9999999998664321     1223469999999999876 4543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.95  E-value=7.6e-28  Score=261.79  Aligned_cols=175  Identities=24%  Similarity=0.318  Sum_probs=142.1

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ++|++.+.||+|+||.||+|+++.++..||||++....  ......+.+|+.+++.++|||||+++++|.     .....
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~  111 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKRNY  111 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCEE
Confidence            35888999999999999999999999999999996443  233577899999999999999999999964     44578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC---CcE
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND---MIA  595 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~---~~~  595 (640)
                      ++|||||++|+|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+||+++..   +.+
T Consensus       112 ~lv~e~~~~g~L~~~~~~~~----------~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~  178 (494)
T 3lij_A          112 YLVMECYKGGELFDEIIHRM----------KFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALI  178 (494)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCE
T ss_pred             EEEEecCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcE
Confidence            99999999999998885432          27888999999999999999999   699999999999999764   559


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+|||+|+.+....     .....+||+.|+|||++.+ .++.
T Consensus       179 kl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~-~~~~  216 (494)
T 3lij_A          179 KIVDFGLSAVFENQK-----KMKERLGTAYYIAPEVLRK-KYDE  216 (494)
T ss_dssp             EECCCTTCEECBTTB-----CBCCCCSCTTTCCHHHHTT-CBCT
T ss_pred             EEEECCCCeECCCCc-----cccccCCCcCeeCHHHHcc-cCCC
Confidence            999999998764321     1223569999999999864 4553

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.95  E-value=9.2e-28  Score=261.81  Aligned_cols=176  Identities=26%  Similarity=0.365  Sum_probs=145.4

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc-------------hhHHHHHHHHHHHHhcCCCCCcceeEe
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR-------------GALKSFMAECEALRNIRHRNLVKIITA  506 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~~~  506 (640)
                      .++|++.+.||+|+||+||+|+++.+++.||||++.....             ...+.+.+|+.++++++|||||+++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            4678999999999999999999999999999999964321             234678999999999999999999999


Q ss_pred             eccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCC
Q 035691          507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSN  586 (640)
Q Consensus       507 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~N  586 (640)
                      +.     .....++|||||++|+|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+|
T Consensus       115 ~~-----~~~~~~lv~e~~~gg~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~N  176 (504)
T 3q5i_A          115 FE-----DKKYFYLVTEFYEGGELFEQIINRH----------KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPEN  176 (504)
T ss_dssp             EE-----CSSEEEEEEECCTTCBHHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGG
T ss_pred             EE-----cCCEEEEEEecCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHH
Confidence            53     4557899999999999999885432          27899999999999999999999   699999999999


Q ss_pred             eeeCCCC---cEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          587 VLLDNDM---IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       587 iLl~~~~---~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+++.++   .+||+|||+++.+....     .....+||+.|+|||++.+ .++.
T Consensus       177 il~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~  226 (504)
T 3q5i_A          177 ILLENKNSLLNIKIVDFGLSSFFSKDY-----KLRDRLGTAYYIAPEVLKK-KYNE  226 (504)
T ss_dssp             EEESSTTCCSSEEECCCTTCEECCTTS-----CBCCCCSCTTTCCHHHHTT-CBCT
T ss_pred             EEEecCCCCccEEEEECCCCEEcCCCC-----ccccccCCcCCCCHHHhcc-CCCc
Confidence            9998776   69999999998764321     1223469999999999864 4553

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.95  E-value=4.2e-28  Score=248.35  Aligned_cols=187  Identities=21%  Similarity=0.245  Sum_probs=149.6

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .++|++.+.||+|+||.||+|++..+++.||||++........+.+.+|+++++.++||||+++++++.... ......+
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeE
Confidence            456889999999999999999998899999999997666666788999999999999999999999975321 2345788


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++|+|.+++......      ...+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~d  177 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDK------GNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMD  177 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTT------TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECC
T ss_pred             EEEEeCCCCcHHHHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEe
Confidence            999999999999988642111      1338899999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCC-----ceeeccccccccccCcccCCCCC
Q 035691          600 FGLTRFIPEVISSN-----QCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       600 fGla~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      ||+++.........     ........||+.|+|||++.+..
T Consensus       178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  219 (317)
T 2buj_A          178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQS  219 (317)
T ss_dssp             CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCS
T ss_pred             cCcchhcccccccccccccccccccccCCcccCCHhHhccCC
Confidence            99987653211110     00112245799999999987654

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.95  E-value=2.6e-26  Score=229.25  Aligned_cols=178  Identities=26%  Similarity=0.313  Sum_probs=91.3

Q ss_pred             CCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCC
Q 035691           52 ELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNL  131 (640)
Q Consensus        52 ~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  131 (640)
                      +|++|+|++|+|+.      +|+..+..+++|+.|+|++|+|+.+.+..|.++++|++|+|++|+++++.+..|..+++|
T Consensus        38 ~l~~L~l~~n~l~~------~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  111 (270)
T 2o6q_A           38 DTKKLDLQSNKLSS------LPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNL  111 (270)
T ss_dssp             TCSEEECCSSCCSC------CCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSC
T ss_pred             CCCEEECcCCCCCe------eCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCC
Confidence            34444444444432      333333344444444444444444444444445555555555555554444444555555


Q ss_pred             CEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcC-CCCCCCCCEEEccCCcCcccCCcCccCCCCCCE
Q 035691          132 TRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPIS-VGYLPKLQVLSLFENNISGEIPSSLGNFTFLTE  210 (640)
Q Consensus       132 ~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  210 (640)
                      ++|+|++|+++.++      +..|.++++|++|++++|.++.+|.. +..+++|++|+|++|.++++.+..|..+++|++
T Consensus       112 ~~L~l~~n~l~~~~------~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  185 (270)
T 2o6q_A          112 AELRLDRNQLKSLP------PRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKT  185 (270)
T ss_dssp             CEEECCSSCCCCCC------TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred             CEEECCCCccCeeC------HHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCE
Confidence            55555555554442      22344445555555555555554433 445566666666666666555555666666666


Q ss_pred             EEccCCCCCCCCCccccCCCCccEEeccCcc
Q 035691          211 LNLRGNSIRGSIPSALGNCHQLQSLDLSKTI  241 (640)
Q Consensus       211 L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~  241 (640)
                      |+|++|++++..+..|..+++|+.|++++|.
T Consensus       186 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  216 (270)
T 2o6q_A          186 LKLDNNQLKRVPEGAFDSLEKLKMLQLQENP  216 (270)
T ss_dssp             EECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EECCCCcCCcCCHHHhccccCCCEEEecCCC
Confidence            6666666665555556666666666444443

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=1.9e-28  Score=254.94  Aligned_cols=174  Identities=24%  Similarity=0.293  Sum_probs=144.7

Q ss_pred             CCCcccCcccccccceEEEEEEC---CCCeEEEEEEeeccc----chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCc
Q 035691          441 GGFSSANLIGTGSFGSVYKGILD---PDQTVVAVKVLFLHQ----RGALKSFMAECEALRNI-RHRNLVKIITACSSSDF  512 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  512 (640)
                      ++|++.+.||+|+||.||+|+..   .+++.||||+++...    ....+.+.+|+++++.+ +||||+++++++.    
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~----  129 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ----  129 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE----
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe----
Confidence            46888999999999999999984   588999999985432    23345677899999999 6999999999853    


Q ss_pred             CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC
Q 035691          513 QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND  592 (640)
Q Consensus       513 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~  592 (640)
                       .....++||||+++|+|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+||+++.+
T Consensus       130 -~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~  195 (355)
T 1vzo_A          130 -TETKLHLILDYINGGELFTHLSQRE----------RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSN  195 (355)
T ss_dssp             -ETTEEEEEECCCCSCBHHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTT
T ss_pred             -eCceEEEEeecCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCC
Confidence             3457899999999999999986432          27888999999999999999999   699999999999999999


Q ss_pred             CcEEEccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          593 MIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       593 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      +.+||+|||+++.+.....   ......+||+.|+|||++.+.
T Consensus       196 ~~~kl~DfG~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~  235 (355)
T 1vzo_A          196 GHVVLTDFGLSKEFVADET---ERAYDFCGTIEYMAPDIVRGG  235 (355)
T ss_dssp             SCEEESCSSEEEECCGGGG---GGGCGGGSCCTTCCHHHHTTC
T ss_pred             CcEEEeeCCCCeecccCCC---CcccCcccCcCccChhhhcCC
Confidence            9999999999986543211   122335699999999999864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.95  E-value=5.2e-28  Score=243.75  Aligned_cols=175  Identities=26%  Similarity=0.313  Sum_probs=141.6

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ++|.+.+.||+|+||.||+|+++.++..||+|++.... ....+.+.+|++++++++||||+++++++.     .....+
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~   96 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYHNMY   96 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCCeEE
Confidence            35788899999999999999999999999999996543 334578999999999999999999999963     445789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee---CCCCcEE
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL---DNDMIAH  596 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl---~~~~~~k  596 (640)
                      +||||+++|+|.+++......      ...+++..+..++.|++.||+|||+   .+|+||||||+||++   +.++.+|
T Consensus        97 lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~k  167 (285)
T 3is5_A           97 IVMETCEGGELLERIVSAQAR------GKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIK  167 (285)
T ss_dssp             EEECCCSCCBHHHHHHHHHHH------TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEE
T ss_pred             EEEEeCCCCcHHHHHHhhhhc------ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEE
Confidence            999999999999988532110      0237889999999999999999999   699999999999999   4567899


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      |+|||+++.+....     ......||+.|+|||++.+
T Consensus       168 l~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~  200 (285)
T 3is5_A          168 IIDFGLAELFKSDE-----HSTNAAGTALYMAPEVFKR  200 (285)
T ss_dssp             ECCCCCCCC---------------CTTGGGCCHHHHTT
T ss_pred             EEeeecceecCCcc-----cCcCcccccCcCChHHhcc
Confidence            99999998654321     1223468999999998754

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.95  E-value=2.6e-28  Score=262.14  Aligned_cols=179  Identities=28%  Similarity=0.489  Sum_probs=142.8

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ..++|++.+.||+|+||.||+|.+. .+..||||+++... ...+.|.+|+++|++++||||+++++++..      ...
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~  253 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI  253 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cce
Confidence            3456788899999999999999997 46779999996543 234789999999999999999999999632      357


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||+++|+|.+++.....        ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~~--------~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~  322 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGETG--------KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVA  322 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHHH--------TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEEC
T ss_pred             EEEehhhcCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEEC
Confidence            899999999999999964321        237888999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |||+++.......   .......+|+.|+|||++.+..++.
T Consensus       323 DfG~a~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~  360 (452)
T 1fmk_A          323 DFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTI  360 (452)
T ss_dssp             CCCTTC-----------------CCGGGSCHHHHHHCCCCH
T ss_pred             CCccceecCCCce---ecccCCcccccccCHhHHhcCCCCc
Confidence            9999987643211   1122345788999999998777664

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.95  E-value=1.8e-27  Score=243.81  Aligned_cols=183  Identities=23%  Similarity=0.366  Sum_probs=142.8

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCC--------
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSD--------  511 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--------  511 (640)
                      .++|++.+.||+|+||.||+|++..+++.||||++........+.+.+|++++++++||||+++++++....        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            467889999999999999999999899999999997766666788999999999999999999999874321        


Q ss_pred             -cCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC
Q 035691          512 -FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD  590 (640)
Q Consensus       512 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~  590 (640)
                       .......++||||++ |+|.+++...           .+++..+..++.|++.||+|||+   .+|+||||||+||+++
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~  154 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG-----------PLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFIN  154 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC-----------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC-----------CccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEc
Confidence             133467899999998 5999998532           27788899999999999999999   6999999999999997


Q ss_pred             -CCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCC-CCCC
Q 035691          591 -NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG-SQVS  638 (640)
Q Consensus       591 -~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s  638 (640)
                       +++.+||+|||+++........ ........||+.|+|||++.+ ..++
T Consensus       155 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~  203 (320)
T 2i6l_A          155 TEDLVLKIGDFGLARIMDPHYSH-KGHLSEGLVTKWYRSPRLLLSPNNYT  203 (320)
T ss_dssp             TTTTEEEECCCTTCBCC---------CCCGGGSCCTTCCHHHHHCTTCCC
T ss_pred             CCCCeEEEccCccccccCCCccc-ccccccccccccccCcHHhcCcccCC
Confidence             5679999999999876432111 112223457999999998865 4443

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.95  E-value=1.5e-27  Score=243.84  Aligned_cols=179  Identities=25%  Similarity=0.342  Sum_probs=146.0

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ..++|++.+.||+|+||.||+|++..+|+.||||++....  ..+.+.+|+.+++.++||||+++++++.     .....
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   99 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYF-----KNTDL   99 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEE
Confidence            4567889999999999999999999899999999986433  3467899999999999999999999964     34578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||+++|+|.+++....         ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+
T Consensus       100 ~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~  167 (314)
T 3com_A          100 WIVMEYCGAGSVSDIIRLRN---------KTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLA  167 (314)
T ss_dssp             EEEEECCTTEEHHHHHHHHT---------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEEC
T ss_pred             EEEeecCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEe
Confidence            99999999999999985322         237889999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |||+++.......    ......||+.|+|||++.+..++.+
T Consensus       168 dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~  205 (314)
T 3com_A          168 DFGVAGQLTDTMA----KRNTVIGTPFWMAPEVIQEIGYNCV  205 (314)
T ss_dssp             CCTTCEECBTTBS----CBCCCCSCGGGCCHHHHSSSCBCTT
T ss_pred             ecccchhhhhhcc----ccCccCCCCCccChhhcCCCCCCcc
Confidence            9999986543221    1223468999999999988877654

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.95  E-value=1.7e-27  Score=238.78  Aligned_cols=175  Identities=29%  Similarity=0.414  Sum_probs=141.8

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      .++|++.+.||+|+||.||+|++..+|+.||||++....   ....+.+.+|+.+++.++||||+++++++.     ...
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   84 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS-----TPT   84 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cCC
Confidence            467889999999999999999999899999999996432   234568899999999999999999999954     345


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++++|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+|
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~  151 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICKHG----------RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAK  151 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEE
T ss_pred             eEEEEEeccCCCcHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEE
Confidence            7899999999999999986432          27888999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV  637 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  637 (640)
                      |+|||+++......     ......||+.|+|||++.+..+
T Consensus       152 l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~  187 (276)
T 2h6d_A          152 IADFGLSNMMSDGE-----FLRTSCGSPNYAAPEVISGRLY  187 (276)
T ss_dssp             ECCCCGGGCCCC------------------CCTGGGTTSCC
T ss_pred             EeecccccccCCCc-----ceecccCCccccCHHHHcCCCC
Confidence            99999998654321     1123458999999999987654

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.95  E-value=1.1e-27  Score=242.50  Aligned_cols=174  Identities=25%  Similarity=0.363  Sum_probs=142.8

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      |....+||+|+||.||+|++..+++.||||++........+.+.+|+.+++.++||||+++++++.     .....++||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~   98 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS-----ENGFIKIFM   98 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEE-----eCCcEEEEE
Confidence            445568999999999999999899999999997666666678999999999999999999999964     345789999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC-CCcEEEcccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN-DMIAHVGDFG  601 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~-~~~~kl~DfG  601 (640)
                      ||+++|+|.+++......       ..+++..+..++.|++.||+|||+   .+|+||||||+||+++. ++.+||+|||
T Consensus        99 e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg  168 (295)
T 2clq_A           99 EQVPGGSLSALLRSKWGP-------LKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFG  168 (295)
T ss_dssp             ECCSEEEHHHHHHHTTCC-------CTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTT
T ss_pred             EeCCCCCHHHHHHhhccC-------CCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecc
Confidence            999999999998643221       236788899999999999999999   69999999999999987 8999999999


Q ss_pred             ccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          602 LTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       602 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      +++.......    ......||+.|+|||++.+.
T Consensus       169 ~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~  198 (295)
T 2clq_A          169 TSKRLAGINP----CTETFTGTLQYMAPEIIDKG  198 (295)
T ss_dssp             TCEESCC---------CCCCCCGGGCCHHHHHHG
T ss_pred             cccccCCCCC----cccccCCCccccChhhhcCC
Confidence            9986543211    12234689999999998654

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.95  E-value=3.6e-28  Score=247.06  Aligned_cols=173  Identities=26%  Similarity=0.352  Sum_probs=141.9

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .+.|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|+++++.++||||+++++++..     ....+
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   92 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-----DGKLW   92 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----C-CEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-----CCeEE
Confidence            4568899999999999999999998999999999976666667889999999999999999999999643     44789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++|+|.+++....         ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|
T Consensus        93 lv~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~D  160 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIMLELD---------RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLAD  160 (302)
T ss_dssp             EEEECCTTEEHHHHHHHHT---------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECC
T ss_pred             EEEEeCCCCcHHHHHHhhc---------cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEE
Confidence            9999999999999875422         237889999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGM  633 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  633 (640)
                      ||++.......    .......||+.|+|||++.
T Consensus       161 fg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~  190 (302)
T 2j7t_A          161 FGVSAKNLKTL----QKRDSFIGTPYWMAPEVVM  190 (302)
T ss_dssp             CHHHHHHHHHH----HC-----CCGGGCCHHHHH
T ss_pred             CCCCccccccc----cccccccCChhhcCCeeec
Confidence            99986432111    1112346899999999983

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.95  E-value=4.4e-28  Score=247.70  Aligned_cols=190  Identities=25%  Similarity=0.350  Sum_probs=150.3

Q ss_pred             cCCCcccCcccccccceEEEEEE-----CCCCeEEEEEEeecccc-hhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQR-GALKSFMAECEALRNI-RHRNLVKIITACSSSDF  512 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  512 (640)
                      .++|++.+.||+|+||.||+|++     ..+++.||||++..... ...+.+.+|+++++++ +||||+++++++..   
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~---   98 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI---   98 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec---
Confidence            45688899999999999999985     45778999999964432 3457899999999999 99999999999643   


Q ss_pred             CCCceeeEEeeccCCCChhhhcCCCCCCCC--------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCC
Q 035691          513 QGNDFKALVYEFMHHGSLESWLHPESASDD--------LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKP  584 (640)
Q Consensus       513 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--------~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp  584 (640)
                        ....++||||+++|+|.+++........        .......+++..++.++.|++.||.|||+   .+|+||||||
T Consensus        99 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp  173 (313)
T 1t46_A           99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAA  173 (313)
T ss_dssp             --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred             --CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCcc
Confidence              4467999999999999999865432100        00011248899999999999999999999   6999999999


Q ss_pred             CCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          585 SNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       585 ~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +||+++.++.+||+|||+++.......  ........||+.|+|||++.+..++.
T Consensus       174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~  226 (313)
T 1t46_A          174 RNILLTHGRITKICDFGLARDIKNDSN--YVVKGNARLPVKWMAPESIFNCVYTF  226 (313)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTT--SEECSSSEECGGGCCHHHHHHCCCCH
T ss_pred             ceEEEcCCCCEEEcccccccccccccc--ceeccCCCCcceeeChHHhcCCCCCh
Confidence            999999999999999999987654322  11222345788999999987776653

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.95  E-value=7.9e-28  Score=240.46  Aligned_cols=176  Identities=27%  Similarity=0.403  Sum_probs=135.3

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc----chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ----RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      .++|+..+.||+|+||.||+|++.  ++.||||++....    ....+.+.+|+++++.++||||+++++++.     ..
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   78 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-----KE   78 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CC
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----cC
Confidence            457888999999999999999984  8899999985432    223467899999999999999999999964     34


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC----
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN----  591 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~----  591 (640)
                      ...++||||+++|+|.+++...           .+++..++.++.|++.|++|||+....+|+||||||+||+++.    
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~  147 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLSGK-----------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN  147 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHTSS-----------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSS
T ss_pred             CceEEEEEcCCCCCHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccc
Confidence            4689999999999999998532           3788899999999999999999942123999999999999986    


Q ss_pred             ----CCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          592 ----DMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       592 ----~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                          ++.+||+|||+++.......      ....||+.|+|||++.+..++.
T Consensus       148 ~~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~  193 (271)
T 3dtc_A          148 GDLSNKILKITDFGLAREWHRTTK------MSAAGAYAWMAPEVIRASMFSK  193 (271)
T ss_dssp             SCCSSCCEEECCCCC-------------------CCGGGSCHHHHHHCCCSH
T ss_pred             ccccCcceEEccCCcccccccccc------cCCCCccceeCHHHhccCCCCc
Confidence                67899999999986543211      1345899999999988776654

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.95  E-value=4.1e-28  Score=248.25  Aligned_cols=200  Identities=22%  Similarity=0.322  Sum_probs=156.1

Q ss_pred             cCHHHHHHhcCCCcccCcccccccceEEEEEE-----CCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCCcce
Q 035691          431 VSYESLLKATGGFSSANLIGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRNLVKI  503 (640)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l  503 (640)
                      +...+.....++|++.+.||+|+||.||+|++     ..+++.||||++.... ....+.+.+|+++++++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            44555556677899999999999999999985     3567899999996543 23446799999999999 79999999


Q ss_pred             eEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCC------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 035691          504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDD------LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQI  577 (640)
Q Consensus       504 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~i  577 (640)
                      ++++...    +...++||||+++|+|.+++........      .......+++..++.++.|++.||.|||+   .+|
T Consensus        97 ~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i  169 (316)
T 2xir_A           97 LGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKC  169 (316)
T ss_dssp             EEEECCT----TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTC
T ss_pred             EEEEecC----CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCc
Confidence            9997432    3457899999999999999975443100      00001237889999999999999999999   699


Q ss_pred             eeCCCCCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          578 VHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       578 vHrdlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +||||||+||+++.++.+||+|||+++.......  ........||+.|+|||++.+..++.
T Consensus       170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~  229 (316)
T 2xir_A          170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRVYTI  229 (316)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTT--SEEETTEEECGGGCCHHHHHHCCCCH
T ss_pred             ccccCccceEEECCCCCEEECCCccccccccCcc--ceeccCCCcceeecCchhhccccccc
Confidence            9999999999999999999999999986643221  12223345789999999987776653

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.95  E-value=2e-28  Score=245.88  Aligned_cols=184  Identities=26%  Similarity=0.348  Sum_probs=148.8

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....  ....+.+.+|+.++++++||||+++++++...   ....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~   81 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT   81 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGTE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCce
Confidence            356888999999999999999999999999999996443  33457899999999999999999999986432   2457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eeeCCCCCCCeeeCCC
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQ-----IVHCDLKPSNVLLDND  592 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~-----ivHrdlkp~NiLl~~~  592 (640)
                      .++||||+++|+|.+++......      ...+++..++.++.|++.||+|||+   .+     |+||||||+||+++.+
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~  152 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKE------RQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGK  152 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSS
T ss_pred             EEEEEeCCCCCCHHHHHHhhccc------CCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCC
Confidence            89999999999999998643211      1237889999999999999999999   46     9999999999999999


Q ss_pred             CcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          593 MIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       593 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +.+||+|||+++......    .......||+.|+|||++.+..++.
T Consensus       153 ~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~  195 (279)
T 2w5a_A          153 QNVKLGDFGLARILNHDT----SFAKTFVGTPYYMSPEQMNRMSYNE  195 (279)
T ss_dssp             SCEEECCCCHHHHC---C----HHHHHHHSCCTTCCHHHHHCC-CCH
T ss_pred             CCEEEecCchheeecccc----ccccccCCCccccChHHhccCCCCc
Confidence            999999999998654311    1112345899999999998877653

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.94  E-value=1e-27  Score=247.42  Aligned_cols=189  Identities=23%  Similarity=0.386  Sum_probs=147.5

Q ss_pred             cCCCcccCcccccccceEEEEEEC-------CCCeEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCCcceeEeeccC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILD-------PDQTVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRNLVKIITACSSS  510 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  510 (640)
                      .++|++.+.||+|+||.||+|++.       .++..||||++.... ....+.+.+|+++++++ +||||++++++|.  
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--  111 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--  111 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc--
Confidence            457888999999999999999975       467789999996443 34457899999999999 8999999999964  


Q ss_pred             CcCCCceeeEEeeccCCCChhhhcCCCCCCCCC------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCC
Q 035691          511 DFQGNDFKALVYEFMHHGSLESWLHPESASDDL------NYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKP  584 (640)
Q Consensus       511 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp  584 (640)
                         .....++||||+++|+|.+++.........      ......+++..++.++.|++.||+|||+   .+|+||||||
T Consensus       112 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp  185 (334)
T 2pvf_A          112 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAA  185 (334)
T ss_dssp             ---SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSG
T ss_pred             ---cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCcc
Confidence               345789999999999999999754321100      0012348899999999999999999999   6999999999


Q ss_pred             CCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          585 SNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       585 ~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      +||+++.++.+||+|||+++.......  ........+|+.|+|||++.+..++
T Consensus       186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~  237 (334)
T 2pvf_A          186 RNVLVTENNVMKIADFGLARDINNIDY--YKKTTNGRLPVKWMAPEALFDRVYT  237 (334)
T ss_dssp             GGEEECTTCCEEECCCTTCEECTTTSS--EECCSCCCCCGGGCCHHHHHHCEEC
T ss_pred             ceEEEcCCCCEEEcccccccccccccc--ccccCCCCcccceeChHHhcCCCcC
Confidence            999999999999999999986643211  1122234578899999998766554

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.94  E-value=7e-28  Score=245.90  Aligned_cols=181  Identities=24%  Similarity=0.385  Sum_probs=139.4

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++...   .....+.+.+|+.++++++||||+++++++..     ...
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~  106 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE  106 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CCc
Confidence            4688899999999999999999889999999999643   33445789999999999999999999999643     457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++......      ...+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl  177 (310)
T 2wqm_A          107 LNIVLELADAGDLSRMIKHFKKQ------KRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKL  177 (310)
T ss_dssp             EEEEEECCCSCBHHHHHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEE
T ss_pred             EEEEEecCCCCCHHHHHHHhccc------ccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEE
Confidence            89999999999999988642111      1237888999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|||+++......    .......||+.|+|||++.+..++.
T Consensus       178 ~Dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~  215 (310)
T 2wqm_A          178 GDLGLGRFFSSKT----TAAHSLVGTPYYMSPERIHENGYNF  215 (310)
T ss_dssp             CCC----------------------CCSSCCHHHHTTCCCCH
T ss_pred             EeccceeeecCCC----ccccccCCCeeEeChHHhCCCCCCc
Confidence            9999998654321    1122346899999999998877653

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.94  E-value=2.8e-27  Score=243.65  Aligned_cols=171  Identities=22%  Similarity=0.316  Sum_probs=144.3

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcC-CCCCcceeEeeccCCcCCCceee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR-HRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ++|++.+.||+|+||.||+|++..+++.||||+++..   ..+.+.+|++++++++ ||||+++++++....   ....+
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~---~~~~~  109 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPV---SRTPA  109 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT---TCCEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCC---CCceE
Confidence            5688899999999999999999999999999998633   3367899999999997 999999999975422   45688


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC-cEEEc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVG  598 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~-~~kl~  598 (640)
                      +||||+++++|.+++.             .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++ .+||+
T Consensus       110 lv~e~~~~~~l~~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~  173 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQ-------------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLI  173 (330)
T ss_dssp             EEEECCCCCCHHHHGG-------------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EEEeccCchhHHHHHH-------------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEE
Confidence            9999999999999874             26778899999999999999999   6999999999999999776 89999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCC-CCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG-SQVS  638 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s  638 (640)
                      |||+|+.......     .....||+.|+|||++.+ ..++
T Consensus       174 Dfg~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~  209 (330)
T 3nsz_A          174 DWGLAEFYHPGQE-----YNVRVASRYFKGPELLVDYQMYD  209 (330)
T ss_dssp             CCTTCEECCTTCC-----CCSCCSCGGGCCHHHHTTCCCCC
T ss_pred             eCCCceEcCCCCc-----cccccccccccChhhhcCCCcCC
Confidence            9999986643221     123468999999999877 4444

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.94  E-value=5.8e-28  Score=240.83  Aligned_cols=178  Identities=29%  Similarity=0.462  Sum_probs=147.3

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .++|++.+.||+|+||.||+|++. +++.||+|++..... ..+.+.+|++++++++||||+++++++.     .....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   79 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPIC   79 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSCE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCeE
Confidence            356788899999999999999987 688999999965433 3367899999999999999999999964     344689


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++|+|.+++....         ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|
T Consensus        80 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~d  147 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQR---------GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSD  147 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTT---------TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECC
T ss_pred             EEEeCCCCCcHHHHHhhCc---------ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcc
Confidence            9999999999999986432         237888999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+++......   ........||+.|+|||++.+..++.
T Consensus       148 fg~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~  184 (267)
T 3t9t_A          148 FGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFSFSRYSS  184 (267)
T ss_dssp             TTGGGGBCCHH---HHSTTSTTCCGGGCCHHHHHHCCCCH
T ss_pred             ccccccccccc---ccccccccccccccChhhhcCCCccc
Confidence            99998653211   11122345788999999987766653

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.94  E-value=2e-27  Score=241.07  Aligned_cols=173  Identities=28%  Similarity=0.395  Sum_probs=146.1

Q ss_pred             HhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---------chhHHHHHHHHHHHHhcC-CCCCcceeEee
Q 035691          438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---------RGALKSFMAECEALRNIR-HRNLVKIITAC  507 (640)
Q Consensus       438 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~~~~  507 (640)
                      ...++|++.+.||+|+||.||+|+++.+|+.||||+++...         ....+.+.+|+++++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            34567899999999999999999999999999999996543         123467889999999995 99999999995


Q ss_pred             ccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCe
Q 035691          508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNV  587 (640)
Q Consensus       508 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~Ni  587 (640)
                      .     .....++||||+++|+|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+||
T Consensus        94 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Ni  155 (298)
T 1phk_A           94 E-----TNTFFFLVFDLMKKGELFDYLTEKV----------TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENI  155 (298)
T ss_dssp             E-----CSSEEEEEEECCTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGE
T ss_pred             c-----cCCeEEEEEeccCCCcHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceE
Confidence            3     4557899999999999999986432          37889999999999999999999   6999999999999


Q ss_pred             eeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCC
Q 035691          588 LLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGM  633 (640)
Q Consensus       588 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  633 (640)
                      +++.++.+||+|||+++......     ......||+.|+|||++.
T Consensus       156 l~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~  196 (298)
T 1phk_A          156 LLDDDMNIKLTDFGFSCQLDPGE-----KLREVCGTPSYLAPEIIE  196 (298)
T ss_dssp             EECTTCCEEECCCTTCEECCTTC-----CBCCCCSCGGGCCHHHHH
T ss_pred             EEcCCCcEEEecccchhhcCCCc-----ccccccCCccccCHHHhc
Confidence            99999999999999998654321     122346899999999875

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.94  E-value=4.8e-28  Score=248.97  Aligned_cols=180  Identities=24%  Similarity=0.411  Sum_probs=140.3

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEE----EEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVV----AVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v----avK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  514 (640)
                      .++|++.+.||+|+||.||+|++..+++.|    |+|.+... .....+.+.+|+.+++.++||||++++++|...    
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----   89 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----   89 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS----
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC----
Confidence            357889999999999999999998777655    66665322 334567899999999999999999999997432    


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                        ..++|+||+.+|+|.+++.....         .+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.
T Consensus        90 --~~~~v~~~~~~g~L~~~l~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~  155 (327)
T 3lzb_A           90 --TVQLITQLMPFGCLLDYVREHKD---------NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQH  155 (327)
T ss_dssp             --SEEEEECCCSSCBHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTE
T ss_pred             --CceEEEEecCCCcHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCC
Confidence              36799999999999999865432         37889999999999999999999   69999999999999999999


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +||+|||+++.+.....  ........||+.|+|||++.+..++.
T Consensus       156 ~kL~DfG~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~  198 (327)
T 3lzb_A          156 VKITDFGLAKLLGAEEK--EYHAEGGKVPIKWMALESILHRIYTH  198 (327)
T ss_dssp             EEECCTTC------------------CCCGGGSCHHHHHHCCCCH
T ss_pred             EEEccCcceeEccCccc--cccccCCCccccccCHHHHcCCCCCh
Confidence            99999999987643221  11222345788999999998877664

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.94  E-value=1.4e-27  Score=246.51  Aligned_cols=188  Identities=22%  Similarity=0.269  Sum_probs=136.8

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcC-CCCCcceeEeeccCC---cCCC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR-HRNLVKIITACSSSD---FQGN  515 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~---~~~~  515 (640)
                      ..+|++.+.||+|+||.||+|++..+++.||||++........+.+.+|+.+++++. ||||+++++++....   ....
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            446888999999999999999999999999999986666666678999999999996 999999999974321   1344


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeeCCCCCCCeeeCCCC
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQ--IVHCDLKPSNVLLDNDM  593 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~--ivHrdlkp~NiLl~~~~  593 (640)
                      ...++||||+. |+|.+++......       ..+++..++.++.|++.||.|||+   .+  |+||||||+||+++.++
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~-------~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~  175 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESR-------GPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQG  175 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTT-------CSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTS
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhcc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCC
Confidence            56899999996 6998887542111       238899999999999999999999   57  99999999999999999


Q ss_pred             cEEEccccccccCCCccCCC--------ceeeccccccccccCcccC---CCCCCC
Q 035691          594 IAHVGDFGLTRFIPEVISSN--------QCSSVGLKGTVGYAAPEYG---MGSQVS  638 (640)
Q Consensus       594 ~~kl~DfGla~~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~---~~~~~s  638 (640)
                      .+||+|||+++.........        ........||+.|+|||++   .+..++
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~  231 (337)
T 3ll6_A          176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIG  231 (337)
T ss_dssp             CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSS
T ss_pred             CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCC
Confidence            99999999998764322110        0111234589999999998   444444

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.94  E-value=1.2e-27  Score=266.12  Aligned_cols=178  Identities=27%  Similarity=0.381  Sum_probs=140.8

Q ss_pred             CcccC-cccccccceEEEEEEC--CCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          443 FSSAN-LIGTGSFGSVYKGILD--PDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       443 ~~~~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      +.+.+ .||+|+||.||+|.++  .++..||||+++... ....+.|.+|+++|++++|||||+++++|..      +..
T Consensus       337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~~  410 (613)
T 2ozo_A          337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EAL  410 (613)
T ss_dssp             EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SSE
T ss_pred             eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CCe
Confidence            33444 7999999999999875  356789999996543 3456789999999999999999999999742      247


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++|||||++|+|.+++....         ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+
T Consensus       411 ~lv~E~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~  478 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGKR---------EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKIS  478 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTCT---------TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEEC
T ss_pred             EEEEEeCCCCcHHHHHhhcc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEe
Confidence            89999999999999996543         238899999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |||+++.+...... ........+|+.|+|||++.+..++.
T Consensus       479 DFGla~~~~~~~~~-~~~~~~~~~~~~y~APE~~~~~~~~~  518 (613)
T 2ozo_A          479 DFGLSKALGADDSY-YTARSAGKWPLKWYAPECINFRKFSS  518 (613)
T ss_dssp             CCSTTTTCC---------------CCTTSCHHHHHHCCCCH
T ss_pred             eccCcccccCCCce-eeeccCCCCccceeCHhhhcCCCCCc
Confidence            99999876432211 11112234678999999998777764

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.94  E-value=6.1e-28  Score=242.43  Aligned_cols=178  Identities=25%  Similarity=0.462  Sum_probs=146.3

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ..++|++.+.||+|+||.||+|++. ++..||||++.... ...+.+.+|+++++.++||||+++++++.      .+..
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~   82 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPI   82 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc------CCCc
Confidence            3456888999999999999999986 67889999986433 24578999999999999999999999863      2347


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||+++|+|.+++.....        ..+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+
T Consensus        83 ~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~  151 (279)
T 1qpc_A           83 YIITEYMENGSLVDFLKTPSG--------IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIA  151 (279)
T ss_dssp             EEEEECCTTCBHHHHTTSHHH--------HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEEC
T ss_pred             EEEEecCCCCCHHHHHhcCCC--------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEEC
Confidence            899999999999999864321        137889999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      |||+++......   ........+|+.|+|||++.+..++
T Consensus       152 Dfg~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~  188 (279)
T 1qpc_A          152 DFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFT  188 (279)
T ss_dssp             CCTTCEECSSSC---EECCTTCCCCTTTSCHHHHHHCEEC
T ss_pred             CCcccccccCcc---cccccCCCCccCccChhhhccCCCC
Confidence            999998664321   1122234578899999998766554

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.94  E-value=1.6e-27  Score=254.09  Aligned_cols=175  Identities=23%  Similarity=0.333  Sum_probs=146.0

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhc------CCCCCcceeEeeccCCcC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI------RHRNLVKIITACSSSDFQ  513 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~~~~~~~~~~  513 (640)
                      ..+|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+++++.+      .|+||+++++++.     
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~-----  169 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT-----  169 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE-----
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc-----
Confidence            45789999999999999999999999999999999643 23346778888888887      5779999999954     


Q ss_pred             CCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC
Q 035691          514 GNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM  593 (640)
Q Consensus       514 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~  593 (640)
                      .....++||||+. |+|.+++.....        ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++
T Consensus       170 ~~~~~~lv~e~~~-~~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~  237 (429)
T 3kvw_A          170 FRNHICMTFELLS-MNLYELIKKNKF--------QGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQG  237 (429)
T ss_dssp             ETTEEEEEECCCC-CBHHHHHHHTTT--------CCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTT
T ss_pred             cCCeEEEEEeccC-CCHHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCC
Confidence            3457899999996 699988865432        237889999999999999999999   6999999999999999988


Q ss_pred             c--EEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          594 I--AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       594 ~--~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      .  +||+|||+|+.....       ....+||+.|+|||++.+..++.
T Consensus       238 ~~~vkL~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~  278 (429)
T 3kvw_A          238 RSGIKVIDFGSSCYEHQR-------VYTYIQSRFYRAPEVILGARYGM  278 (429)
T ss_dssp             SCCEEECCCTTCEETTCC-------CCSSCSCGGGCCHHHHHTBCCCT
T ss_pred             CcceEEeecccceecCCc-------ccccCCCCCccChHHHhCCCCCc
Confidence            7  999999999754321       12346899999999999888765

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.94  E-value=1.9e-27  Score=240.82  Aligned_cols=183  Identities=25%  Similarity=0.388  Sum_probs=145.9

Q ss_pred             HhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       438 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ...++|++.+.||+|+||.||+|++..+++.||||++.....  .+.+.+|+++++.++|++++..+++|.    .....
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~   79 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDY   79 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEE----EETTE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeec----CCCCc
Confidence            345789999999999999999999988999999998754332  235788999999999999888887763    34567


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee---CCCCc
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL---DNDMI  594 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl---~~~~~  594 (640)
                      .++||||+ +|+|.+++....         ..+++..+..++.|++.||.|||+   .+|+||||||+||++   ++++.
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~  146 (296)
T 4hgt_A           80 NVMVMELL-GPSLEDLFNFCS---------RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNL  146 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT---------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTC
T ss_pred             eEEEEEcc-CCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCe
Confidence            89999999 999999986432         238899999999999999999999   699999999999999   78899


Q ss_pred             EEEccccccccCCCccCCC---ceeeccccccccccCcccCCCCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSN---QCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +||+|||+++.........   ........||+.|+|||++.+..++.
T Consensus       147 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  194 (296)
T 4hgt_A          147 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSR  194 (296)
T ss_dssp             EEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCH
T ss_pred             EEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCc
Confidence            9999999998764432211   11223456999999999999887764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.94  E-value=7.4e-28  Score=248.38  Aligned_cols=195  Identities=25%  Similarity=0.336  Sum_probs=151.8

Q ss_pred             HHHHhcCCCcccCcccccccceEEEEEECCCCe-----EEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCCcceeEee
Q 035691          435 SLLKATGGFSSANLIGTGSFGSVYKGILDPDQT-----VVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRNLVKIITAC  507 (640)
Q Consensus       435 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~  507 (640)
                      +.....++|++.+.||+|+||.||+|++..+++     .||+|++.... ....+.+.+|+.+++.+ +||||++++++|
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            344556789999999999999999999876554     79999996543 33457899999999999 899999999996


Q ss_pred             ccCCcCCCceeeEEeeccCCCChhhhcCCCCCC----CCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCC
Q 035691          508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESAS----DDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLK  583 (640)
Q Consensus       508 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlk  583 (640)
                      .     .....++||||+++|+|.+++......    .........+++..++.++.|++.||+|||+   .+|+|||||
T Consensus       120 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlk  191 (333)
T 2i1m_A          120 T-----HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVA  191 (333)
T ss_dssp             C-----SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCS
T ss_pred             e-----cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcc
Confidence            4     344689999999999999998642110    0000011347889999999999999999999   699999999


Q ss_pred             CCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          584 PSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       584 p~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+||+++.++.+||+|||+++.......  ........||+.|+|||++.+..++.
T Consensus       192 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~  245 (333)
T 2i1m_A          192 ARNVLLTNGHVAKIGDFGLARDIMNDSN--YIVKGNARLPVKWMAPESIFDCVYTV  245 (333)
T ss_dssp             GGGCEEEGGGEEEBCCCGGGCCGGGCTT--SEECSSCEECGGGSCHHHHHHCCCCH
T ss_pred             cceEEECCCCeEEECccccccccccccc--eeecCCCCCCccccCHHHhccCCCCh
Confidence            9999999999999999999986543221  11222345788999999987766653

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.94  E-value=5.1e-27  Score=238.84  Aligned_cols=180  Identities=23%  Similarity=0.378  Sum_probs=145.8

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc----chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ----RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      .++|.+.+.||+|+||.||+|++..+++.||+|++....    ....+.+.+|++++++++||||+++++++..   ...
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   80 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK   80 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence            468999999999999999999999899999999996432    2345789999999999999999999999643   234


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      ...++||||+++| +.+++.....        ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+
T Consensus        81 ~~~~lv~e~~~~~-l~~~~~~~~~--------~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~  148 (305)
T 2wtk_C           81 QKMYMVMEYCVCG-MQEMLDSVPE--------KRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTL  148 (305)
T ss_dssp             -CEEEEEECCSEE-HHHHHHHSTT--------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCE
T ss_pred             CeEEEEehhccCC-HHHHHHhCcc--------cccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcE
Confidence            5689999999987 6666643322        238889999999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      ||+|||+++........  .......||+.|+|||++.+..
T Consensus       149 kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~  187 (305)
T 2wtk_C          149 KISALGVAEALHPFAAD--DTCRTSQGSPAFQPPEIANGLD  187 (305)
T ss_dssp             EECCCTTCEECCTTCSS--CEECCCCSCGGGCCHHHHTCCS
T ss_pred             EeeccccccccCccccc--cccccCCCCCCCcChhhccCcc
Confidence            99999999866432221  1223346899999999987643

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.94  E-value=1.6e-27  Score=238.01  Aligned_cols=173  Identities=23%  Similarity=0.348  Sum_probs=145.0

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ++|++.+.||+|+||.||+|++.  ++.||||++....  ....+.+.+|+.++++++||||+++++++....   ....
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~   84 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---APHP   84 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---SSSC
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---CCCe
Confidence            46888999999999999999984  8899999996543  334568999999999999999999999975432   3567


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeeCCCCCCCeeeCCCCcEE
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQ--IVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~--ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ++||||+++|+|.+++.....        ..+++..++.++.|++.||+|||+   .+  |+||||||+||+++.++.+|
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~  153 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTN--------FVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTAR  153 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSS--------CCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEE
T ss_pred             EeeecccCCCcHHHHHhhccc--------CCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCccee
Confidence            899999999999999975432        238899999999999999999998   57  99999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      |+|||++.....         ....||+.|+|||++.+..++
T Consensus       154 l~~~~~~~~~~~---------~~~~~t~~y~aPE~~~~~~~~  186 (271)
T 3kmu_A          154 ISMADVKFSFQS---------PGRMYAPAWVAPEALQKKPED  186 (271)
T ss_dssp             EEGGGSCCTTSC---------TTCBSCGGGSCHHHHHSCGGG
T ss_pred             EEeccceeeecc---------cCccCCccccChhhhccCCCC
Confidence            999988764321         123589999999999876544

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.94  E-value=8.3e-28  Score=241.72  Aligned_cols=179  Identities=24%  Similarity=0.393  Sum_probs=143.5

Q ss_pred             cCCCcccCcccccccceEEEEEECC---CCeEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDP---DQTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      .++|.+.+.||+|+||.||+|++..   ++..||+|++... .....+.+.+|+.+++.++||||+++++++..      
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------   84 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE------   84 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS------
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC------
Confidence            4568888999999999999998653   3456999998654 23445789999999999999999999998532      


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      ...++||||+++|+|.+++....         ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+
T Consensus        85 ~~~~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~  152 (281)
T 3cc6_A           85 EPTWIIMELYPYGELGHYLERNK---------NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECV  152 (281)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHT---------TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEE
T ss_pred             CCCEEEEecCCCCCHHHHHHhcc---------ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcE
Confidence            23589999999999999986432         237888999999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+|||+++.......   .......+|+.|+|||++.+..++.
T Consensus       153 kl~Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~  193 (281)
T 3cc6_A          153 KLGDFGLSRYIEDEDY---YKASVTRLPIKWMSPESINFRRFTT  193 (281)
T ss_dssp             EECCCCGGGCC------------CCCCCGGGCCHHHHHHCCCCH
T ss_pred             EeCccCCCcccccccc---cccccCCCCcceeCchhhccCCCCc
Confidence            9999999986643221   1122345788999999987776653

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.94  E-value=9.8e-28  Score=248.48  Aligned_cols=173  Identities=24%  Similarity=0.369  Sum_probs=138.9

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCC--CCCcceeEeeccCCcCC
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRH--RNLVKIITACSSSDFQG  514 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~  514 (640)
                      ..+.|++.+.||+|+||.||+|.+. +++.||||++....  ....+.+.+|+++++.++|  |||+++++++.     .
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~   80 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----T   80 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----C
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----e
Confidence            3456889999999999999999985 78999999996443  3345788999999999976  99999999954     4


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                      ....++||| +.+|+|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+|||++ ++.
T Consensus        81 ~~~~~lv~e-~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~  145 (343)
T 3dbq_A           81 DQYIYMVME-CGNIDLNSWLKKKK----------SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGM  145 (343)
T ss_dssp             SSEEEEEEC-CCSEEHHHHHHHSC----------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTE
T ss_pred             CCEEEEEEe-CCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCc
Confidence            457899999 56789999986532          27888999999999999999999   6999999999999997 678


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      +||+|||+++.+......  ......+||+.|+|||++.+
T Consensus       146 ~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~  183 (343)
T 3dbq_A          146 LKLIDFGIANQMQPDTTS--VVKDSQVGTVNYMPPEAIKD  183 (343)
T ss_dssp             EEECCCSSSCCC--------------CCCCSSCCHHHHHH
T ss_pred             EEEeecccccccCccccc--ccCCCCcCCcCcCCHHHHhh
Confidence            999999999876432211  11224569999999999864

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.94  E-value=1.9e-27  Score=240.10  Aligned_cols=173  Identities=32%  Similarity=0.475  Sum_probs=134.0

Q ss_pred             HhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       438 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      ...++|++.+.||+|+||.||+|++.   ..||||+++...  ....+.+.+|++++++++||||+++++++.      .
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~   91 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------A   91 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------S
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc------C
Confidence            34567999999999999999999864   359999996443  344578999999999999999999999742      2


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      ...++||||+++++|.+++....         ..+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~  159 (289)
T 3og7_A           92 PQLAIVTQWCEGSSLYHHLHASE---------TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTV  159 (289)
T ss_dssp             SSCEEEEECCCEEEHHHHHTTC------------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred             CccEEEEEecCCCcHHHHHhhcc---------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCE
Confidence            34789999999999999986443         238889999999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGM  633 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  633 (640)
                      ||+|||+++........  .......||+.|+|||++.
T Consensus       160 kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~  195 (289)
T 3og7_A          160 KIGDFGLATEKSRWSGS--HQFEQLSGSILWMAPEVIR  195 (289)
T ss_dssp             EECCCC--------------------CCCTTCCHHHHC
T ss_pred             EEccceecccccccccc--ccccccCCCccccCchhhc
Confidence            99999999865432111  1122346899999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.94  E-value=1.4e-27  Score=245.15  Aligned_cols=170  Identities=26%  Similarity=0.329  Sum_probs=138.9

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--------chhHHHHHHHHHHHHhcCCCCCcceeEeeccCC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--------RGALKSFMAECEALRNIRHRNLVKIITACSSSD  511 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  511 (640)
                      .++|.+.+.||+|+||.||+|++..+++.||||++....        ......+.+|++++++++||||+++++++..  
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--   86 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--   86 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence            346889999999999999999999999999999985432        1223458899999999999999999998632  


Q ss_pred             cCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC
Q 035691          512 FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN  591 (640)
Q Consensus       512 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~  591 (640)
                         + ..++||||+++|+|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+||+++.
T Consensus        87 ---~-~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~  149 (322)
T 2ycf_A           87 ---E-DYYIVLELMEGGELFDKVVGNK----------RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSS  149 (322)
T ss_dssp             ---S-SEEEEEECCTTEETHHHHSTTC----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESS
T ss_pred             ---C-ceEEEEecCCCCcHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEec
Confidence               2 3789999999999999886432          37888999999999999999999   69999999999999987


Q ss_pred             CCc---EEEccccccccCCCccCCCceeeccccccccccCcccCC
Q 035691          592 DMI---AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGM  633 (640)
Q Consensus       592 ~~~---~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  633 (640)
                      ++.   +||+|||+++.....     .......||+.|+|||++.
T Consensus       150 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~gt~~y~aPE~~~  189 (322)
T 2ycf_A          150 QEEDCLIKITDFGHSKILGET-----SLMRTLCGTPTYLAPEVLV  189 (322)
T ss_dssp             SSSSCCEEECCCTTCEECCCC-----HHHHHHHSCCTTCCHHHHH
T ss_pred             CCCCCeEEEccCccceecccc-----cccccccCCcCccCchhhc
Confidence            654   999999999865421     1112346899999999973

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.94  E-value=3.1e-27  Score=239.32  Aligned_cols=181  Identities=25%  Similarity=0.387  Sum_probs=148.6

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .++|++.+.||+|+||.||+|++..+|+.||||++.....  .+.+.+|+.+++.++|++++..++++.    ......+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~~   81 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNV   81 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEE----EETTEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCcccccc----CCCCceE
Confidence            5679999999999999999999988999999999864432  246889999999999998888777763    3345789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee---CCCCcEE
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL---DNDMIAH  596 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl---~~~~~~k  596 (640)
                      +||||+ +|+|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+||++   ++++.+|
T Consensus        82 lv~e~~-~~~L~~~~~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~k  148 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFCS---------RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVY  148 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTT---------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEE
T ss_pred             EEEEec-CCCHHHHHHhhc---------cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEE
Confidence            999999 899999986332         238899999999999999999999   699999999999999   4888999


Q ss_pred             EccccccccCCCccCCC---ceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSN---QCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|||+++.........   ........||+.|+|||++.+..++.
T Consensus       149 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  194 (296)
T 3uzp_A          149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSR  194 (296)
T ss_dssp             ECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCH
T ss_pred             EeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCc
Confidence            99999998765432211   01123456999999999999887764

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.94  E-value=5.2e-27  Score=244.77  Aligned_cols=190  Identities=21%  Similarity=0.268  Sum_probs=136.8

Q ss_pred             HHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc-
Q 035691          434 ESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDF-  512 (640)
Q Consensus       434 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-  512 (640)
                      ++.....++|++.+.||+|+||.||+|++..+|+.||||++.... .....+.+|++.++.++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            445667789999999999999999999999899999999985432 233466788888999999999999999754322 


Q ss_pred             -CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCCeeeCCCCCCCeee
Q 035691          513 -QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLH--HHCKKQIVHCDLKPSNVLL  589 (640)
Q Consensus       513 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH--~~~~~~ivHrdlkp~NiLl  589 (640)
                       ....+.++||||++++ +.+.+.....      ....+++..+..++.|++.|+.|||  +   .+|+||||||+||++
T Consensus        95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~------~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll  164 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDT-LHRCCRNYYR------RQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLV  164 (360)
T ss_dssp             CTTCEEEEEEEECCSCB-HHHHHHHHHT------TTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEE
T ss_pred             cccceeEEEEeeccccc-HHHHHHHHhh------cccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEE
Confidence             2233478999999874 4333321000      0123788899999999999999999  6   799999999999999


Q ss_pred             CC-CCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCC-CCC
Q 035691          590 DN-DMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ-VST  639 (640)
Q Consensus       590 ~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~  639 (640)
                      +. ++.+||+|||+++.+....     ......||+.|+|||++.+.. ++.
T Consensus       165 ~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~  211 (360)
T 3e3p_A          165 NEADGTLKLCDFGSAKKLSPSE-----PNVAYICSRYYRAPELIFGNQHYTT  211 (360)
T ss_dssp             ETTTTEEEECCCTTCBCCCTTS-----CCCSTTSCGGGCCHHHHTTCSSCCT
T ss_pred             eCCCCcEEEeeCCCceecCCCC-----CcccccCCcceeCHHHHcCCCCCCc
Confidence            96 8999999999998764322     122346899999999987655 443

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.94  E-value=1.1e-27  Score=254.67  Aligned_cols=179  Identities=26%  Similarity=0.382  Sum_probs=139.3

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc-CCCceeeE
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDF-QGNDFKAL  520 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~~~~~l  520 (640)
                      +|+..+.||+|+||.||+|++..+|+.||||++.....    .+.+|+++++.++|||||++++++..... .+..+.++
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            57888999999999999999998999999999854322    23479999999999999999998754321 22345779


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC-CcEEEcc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND-MIAHVGD  599 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~-~~~kl~D  599 (640)
                      ||||+++ ++.+.+......      ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.+ +.+||+|
T Consensus       131 v~e~~~~-~l~~~~~~~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~D  200 (420)
T 1j1b_A          131 VLDYVPE-TVYRVARHYSRA------KQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCD  200 (420)
T ss_dssp             EEECCCE-EHHHHHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECC
T ss_pred             ehhcccc-cHHHHHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEecc
Confidence            9999986 555554321100      1238889999999999999999999   699999999999999955 6789999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCC-CCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS-QVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~  639 (640)
                      ||+|+.+....     .....+||++|+|||++.+. .++.
T Consensus       201 FG~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~  236 (420)
T 1j1b_A          201 FGSAKQLVRGE-----PNVSYICSRYYRAPELIFGATDYTS  236 (420)
T ss_dssp             CTTCEECCTTC-----CCCSCCSCTTSCCHHHHTTCSSCCT
T ss_pred             chhhhhcccCC-----CceeeeeCCCcCCHHHHcCCCCCCc
Confidence            99998654321     12235689999999999775 4543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.94  E-value=1.4e-27  Score=244.53  Aligned_cols=178  Identities=29%  Similarity=0.420  Sum_probs=144.7

Q ss_pred             CcccCcccccccceEEEEEE----CCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          443 FSSANLIGTGSFGSVYKGIL----DPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      |++.+.||+|+||.||+|.+    ..+++.||||++.... ....+.+.+|++++++++||||+++++++...   +...
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~  109 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---GAAS  109 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TTTE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---CCce
Confidence            37889999999999988864    3578999999996543 34457899999999999999999999997543   2457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+++|+|.+++...           .+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.+||
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl  175 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRH-----------SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKI  175 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGS-----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEE
T ss_pred             EEEEEecccCCcHHHHHhhC-----------CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEE
Confidence            89999999999999998643           27888999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      +|||+++....... .........||+.|+|||++.+..++
T Consensus       176 ~Dfg~a~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~  215 (318)
T 3lxp_A          176 GDFGLAKAVPEGHE-YYRVREDGDSPVFWYAPECLKEYKFY  215 (318)
T ss_dssp             CCGGGCEECCTTCS-EEEC---CCCCGGGCCHHHHHHCEEE
T ss_pred             CCcccccccccccc-ccccccCCCCCceeeChHHhcCCCCC
Confidence            99999987643221 11122334588999999998776654

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.94  E-value=5.5e-27  Score=243.36  Aligned_cols=179  Identities=20%  Similarity=0.311  Sum_probs=145.6

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchh-----------------HHHHHHHHHHHHhcCCCCCcc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA-----------------LKSFMAECEALRNIRHRNLVK  502 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~H~niv~  502 (640)
                      .++|++.+.||+|+||.||+|++  +|+.||||++.......                 .+.+.+|++++++++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            46789999999999999999998  89999999996432211                 178999999999999999999


Q ss_pred             eeEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCC
Q 035691          503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDL  582 (640)
Q Consensus       503 l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdl  582 (640)
                      +++++.     ..+..++||||+++|+|.+++........  .....+++..++.++.|++.||.|||+.  .+|+||||
T Consensus       108 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dl  178 (348)
T 2pml_X          108 CEGIIT-----NYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDV  178 (348)
T ss_dssp             CSEEEE-----SSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHT--SCEECCCC
T ss_pred             EEEEEe-----eCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhcc--CCEeecCC
Confidence            999964     34578999999999999998331100000  0013488999999999999999999972  49999999


Q ss_pred             CCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          583 KPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       583 kp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      ||+||+++.++.+||+|||.++.....      ......||+.|+|||++.+.
T Consensus       179 ~p~Nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~  225 (348)
T 2pml_X          179 KPSNILMDKNGRVKLSDFGESEYMVDK------KIKGSRGTYEFMPPEFFSNE  225 (348)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECBTT------EECSSCSCGGGCCGGGGSSC
T ss_pred             ChHhEEEcCCCcEEEeccccccccccc------cccCCCCCcCccCchhhcCC
Confidence            999999999999999999999865332      22335689999999999877

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.94  E-value=1.1e-27  Score=266.96  Aligned_cols=173  Identities=26%  Similarity=0.373  Sum_probs=138.4

Q ss_pred             CcccccccceEEEEEE--CCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          447 NLIGTGSFGSVYKGIL--DPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      +.||+|+||.||+|.+  +.+++.||||+++...  ....+.+.+|+++|++++|||||+++++|..      +..++||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~  448 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM  448 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEE
Confidence            4799999999999965  4567899999996433  3345789999999999999999999999732      2468999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      |||++|+|.+++....          .+++..+..|+.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       449 E~~~~g~L~~~l~~~~----------~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGl  515 (635)
T 4fl3_A          449 EMAELGPLNKYLQQNR----------HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGL  515 (635)
T ss_dssp             ECCTTEEHHHHHHHCT----------TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTH
T ss_pred             EccCCCCHHHHHhhCC----------CCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCC
Confidence            9999999999996432          37889999999999999999999   6999999999999999999999999999


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+.+...... ........||+.|+|||++.+..++.
T Consensus       516 a~~~~~~~~~-~~~~~~~~~t~~y~APE~~~~~~~~~  551 (635)
T 4fl3_A          516 SKALRADENY-YKAQTHGKWPVKWYAPECINYYKFSS  551 (635)
T ss_dssp             HHHTTC--------------CGGGSCHHHHHHCCCCH
T ss_pred             ccccccCccc-cccccCCCCceeeeChhhhcCCCCCc
Confidence            9876432211 11122345788999999998877764

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.94  E-value=1.1e-27  Score=246.34  Aligned_cols=185  Identities=28%  Similarity=0.421  Sum_probs=143.6

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEE--EEEEeecc-cchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCc
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVV--AVKVLFLH-QRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ++|++.+.||+|+||.||+|++..++..+  |+|.+... .....+.+.+|+++++++ +||||+++++++.     ...
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~   99 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG   99 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ETT
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee-----eCC
Confidence            46888899999999999999998888765  89988643 233446789999999999 8999999999963     345


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCC------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDD------LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD  590 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~  590 (640)
                      ..++||||+++|+|.+++........      .......+++..++.++.|++.||+|||+   .+|+||||||+||+++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~  176 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVG  176 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEc
Confidence            78999999999999999975431000      00001348899999999999999999999   6999999999999999


Q ss_pred             CCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          591 NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       591 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      .++.+||+|||+++......     ......+|+.|+|||++.+..++
T Consensus       177 ~~~~~kL~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~  219 (327)
T 1fvr_A          177 ENYVAKIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYT  219 (327)
T ss_dssp             GGGCEEECCTTCEESSCEEC-----CC----CCTTTCCHHHHHHCEEC
T ss_pred             CCCeEEEcccCcCccccccc-----cccCCCCCccccChhhhccccCC
Confidence            99999999999998543211     11223478899999998766554

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=2.1e-27  Score=239.50  Aligned_cols=179  Identities=27%  Similarity=0.379  Sum_probs=144.5

Q ss_pred             CCCcccC-cccccccceEEEEEEC--CCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          441 GGFSSAN-LIGTGSFGSVYKGILD--PDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       441 ~~~~~~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ++|.+.+ .||+|+||.||+|.++  .++..||||+++... ....+.+.+|++++++++||||+++++++.      .+
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~   82 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------AE   82 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------SS
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec------CC
Confidence            4455555 8999999999999864  467889999996543 345578999999999999999999999962      23


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+++|+|.+++....         ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+|
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~k  150 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKR---------EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAK  150 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCT---------TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEE
T ss_pred             CcEEEEEeCCCCCHHHHHHhCC---------ccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEE
Confidence            5789999999999999986432         238899999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      |+|||+++........ ........||+.|+|||++.+..++
T Consensus       151 l~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~  191 (287)
T 1u59_A          151 ISDFGLSKALGADDSY-YTARSAGKWPLKWYAPECINFRKFS  191 (287)
T ss_dssp             ECCCTTCEECTTCSCE-ECCCCSSCCCGGGCCHHHHHHCEEC
T ss_pred             ECcccceeeeccCcce-eeccccccccccccCHHHhccCCCC
Confidence            9999999876432211 1112233578999999998766554

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.94  E-value=3.1e-27  Score=242.92  Aligned_cols=185  Identities=26%  Similarity=0.409  Sum_probs=148.9

Q ss_pred             HhcCCCcccCcccccccceEEEEEEC-CCCeEEEEEEeecccc--hhHHHHHHHHHHHHhc---CCCCCcceeEeeccCC
Q 035691          438 KATGGFSSANLIGTGSFGSVYKGILD-PDQTVVAVKVLFLHQR--GALKSFMAECEALRNI---RHRNLVKIITACSSSD  511 (640)
Q Consensus       438 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~  511 (640)
                      ...++|++.+.||+|+||.||+|++. .+|+.||||++.....  .....+.+|+.+++.+   +||||++++++|....
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            34577999999999999999999995 6789999999964332  2234566787777766   8999999999975433


Q ss_pred             cCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC
Q 035691          512 FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN  591 (640)
Q Consensus       512 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~  591 (640)
                      .......++||||++ |+|.+++.....        ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~  155 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPE--------PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTS  155 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCT--------TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECT
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhccc--------CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcC
Confidence            334567899999998 699998865432        237889999999999999999999   69999999999999999


Q ss_pred             CCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          592 DMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       592 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ++.+||+|||+++......     ......||+.|+|||++.+..++.
T Consensus       156 ~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~  198 (326)
T 1blx_A          156 SGQIKLADFGLARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYAT  198 (326)
T ss_dssp             TCCEEECSCCSCCCCCGGG-----GGCCCCCCCTTCCHHHHTTCCCCT
T ss_pred             CCCEEEecCcccccccCCC-----CccccccccceeCHHHHhcCCCCc
Confidence            9999999999998654221     122356899999999998887765

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.94  E-value=9.3e-29  Score=259.60  Aligned_cols=181  Identities=18%  Similarity=0.231  Sum_probs=137.2

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHH---HHHHhcCCCCCcceeE-------e
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAEC---EALRNIRHRNLVKIIT-------A  506 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~~-------~  506 (640)
                      .++|++.+.||+|+||.||+|++..+|+.||||++...   .....+.+.+|+   +++++++|||||++++       +
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            45688889999999999999999889999999999633   334557899999   4555568999999984       3


Q ss_pred             eccCC-------cCCCc-----eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 035691          507 CSSSD-------FQGND-----FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCK  574 (640)
Q Consensus       507 ~~~~~-------~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~  574 (640)
                      +....       +.++.     ..++||||+ +|+|.+++.......   .....+++..++.|+.|++.||+|||+   
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~---  224 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS---STHKSLVHHARLQLTLQVIRLLASLHH---  224 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTT---TTTHHHHHHHHHHHHHHHHHHHHHHHH---
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccc---cccccccHHHHHHHHHHHHHHHHHHHh---
Confidence            32211       00111     268999999 689999986432110   001234567888999999999999999   


Q ss_pred             CCeeeCCCCCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          575 KQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       575 ~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      .+|+||||||+|||++.++.+||+|||+|+....       .....+| +.|+|||++.+.
T Consensus       225 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-------~~~~~~g-~~y~aPE~~~~~  277 (377)
T 3byv_A          225 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-------RVVSSVS-RGFEPPELEARR  277 (377)
T ss_dssp             TTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-------EEECCCC-TTCCCHHHHHHH
T ss_pred             CCeecCCCCHHHEEEcCCCCEEEEechhheecCC-------cccCCCC-cCccChhhhccc
Confidence            6999999999999999999999999999985322       2223467 999999998766

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.94  E-value=5.2e-27  Score=245.68  Aligned_cols=177  Identities=25%  Similarity=0.310  Sum_probs=142.9

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcC-CCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQ-GND  516 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~-~~~  516 (640)
                      .++|...+.||+|+||.||+|++..+|+.||||++...  .....+.+.+|+.+++.++||||+++++++...... ...
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            46788899999999999999999999999999999643  233457889999999999999999999997544321 111


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+. |+|.+++..            .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+|
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~------------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~k  184 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM------------EFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELK  184 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS------------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEE
T ss_pred             eEEEEEcccc-ccHHHHhhc------------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEE
Confidence            3489999998 588887631            27889999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCC-CCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG-SQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~  639 (640)
                      |+|||+++.....       .....||+.|+|||++.+ ..++.
T Consensus       185 L~Dfg~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~  221 (371)
T 4exu_A          185 ILDFGLARHADAE-------MTGYVVTRWYRAPEVILSWMHYNQ  221 (371)
T ss_dssp             ECSTTCC---------------CTTCCCTTSCHHHHSCCSCCCT
T ss_pred             EEecCcccccccC-------cCCcccCccccCHHHhcCCCCCCc
Confidence            9999999865321       223468999999999987 55554

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.94  E-value=6.4e-28  Score=243.85  Aligned_cols=180  Identities=25%  Similarity=0.347  Sum_probs=143.3

Q ss_pred             hcCCCcccC-cccccccceEEEEEE--CCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcC
Q 035691          439 ATGGFSSAN-LIGTGSFGSVYKGIL--DPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQ  513 (640)
Q Consensus       439 ~~~~~~~~~-~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  513 (640)
                      ..++|.+.+ .||+|+||.||+|.+  ..+++.||||++....  ....+.+.+|+++++.++||||+++++++.     
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----   88 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----   88 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-----
Confidence            345677777 999999999999954  5667899999996443  233578999999999999999999999962     


Q ss_pred             CCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC
Q 035691          514 GNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM  593 (640)
Q Consensus       514 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~  593 (640)
                       .+..++||||+++|+|.+++....          .+++..++.++.|++.||+|||+   .+|+||||||+||+++.++
T Consensus        89 -~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~  154 (291)
T 1xbb_A           89 -AESWMLVMEMAELGPLNKYLQQNR----------HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQH  154 (291)
T ss_dssp             -SSSEEEEEECCTTEEHHHHHHHCT----------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETT
T ss_pred             -CCCcEEEEEeCCCCCHHHHHHhCc----------CCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCC
Confidence             235789999999999999996532          27888999999999999999999   6999999999999999999


Q ss_pred             cEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          594 IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       594 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      .+||+|||+++........ ........||+.|+|||++.+..++
T Consensus       155 ~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~  198 (291)
T 1xbb_A          155 YAKISDFGLSKALRADENY-YKAQTHGKWPVKWYAPECINYYKFS  198 (291)
T ss_dssp             EEEECCCTTCEECCTTCSE-EEC----CCCGGGCCHHHHHHCEEE
T ss_pred             cEEEccCCcceeeccCCCc-ccccccCCCCceeeChHHhccCCCC
Confidence            9999999999876432211 1112223467899999998766554

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.94  E-value=6.1e-28  Score=264.51  Aligned_cols=180  Identities=28%  Similarity=0.483  Sum_probs=147.7

Q ss_pred             HhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          438 KATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       438 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ...++|++.+.||+|+||.||+|++. .+..||||+++... ...+.|.+|+++|++++|||||+++++|..      ..
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~  335 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP  335 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred             cchhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee------cc
Confidence            34566788899999999999999997 46779999996543 234789999999999999999999999632      35


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++|||||++|+|.+++.....        ..+++..++.|+.||+.||+|||+   .+|+||||||+|||++.++.+||
T Consensus       336 ~~lv~e~~~~gsL~~~l~~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl  404 (535)
T 2h8h_A          336 IYIVTEYMSKGSLLDFLKGETG--------KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKV  404 (535)
T ss_dssp             CEEEECCCTTEEHHHHHSHHHH--------TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred             ceEeeehhcCCcHHHHHhhcCC--------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEE
Confidence            7899999999999999964321        237888999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|||+++.+....   ........++..|+|||++.+..++.
T Consensus       405 ~DFG~a~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~  443 (535)
T 2h8h_A          405 ADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTI  443 (535)
T ss_dssp             CCTTSTTTCCCHH---HHTTCSTTSCGGGSCHHHHHHCCCCH
T ss_pred             cccccceecCCCc---eecccCCcCcccccCHHHhccCCCCc
Confidence            9999998664321   11112234788999999998777664

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.94  E-value=2.1e-27  Score=250.13  Aligned_cols=171  Identities=23%  Similarity=0.365  Sum_probs=138.5

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcC--CCCCcceeEeeccCCcCCCc
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIR--HRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~~~  516 (640)
                      ..|++.+.||+|+||.||+|.+. +++.||||++....  ....+.+.+|++++++++  |||||++++++.     ...
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-----~~~  129 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ  129 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred             CceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----cCC
Confidence            35888999999999999999987 49999999996443  344578999999999996  599999999964     344


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||| +.+|+|.+++....          .+++..+..++.||+.||.|||+   .+|+||||||+|||++ ++.+|
T Consensus       130 ~~~lv~E-~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~k  194 (390)
T 2zmd_A          130 YIYMVME-CGNIDLNSWLKKKK----------SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLK  194 (390)
T ss_dssp             EEEEEEE-CCSEEHHHHHHHCS----------SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEE
T ss_pred             EEEEEEe-cCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEE
Confidence            7899999 56889999986543          27788899999999999999999   6999999999999995 58999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      |+|||+++.+.....  .......+||+.|+|||++.+
T Consensus       195 l~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~  230 (390)
T 2zmd_A          195 LIDFGIANQMQPDTT--SVVKDSQVGAVNYMPPEAIKD  230 (390)
T ss_dssp             ECCCSSSCCC-----------CCSCCCGGGCCHHHHHC
T ss_pred             EEecCccccccCCCc--cccCCCCCcCCCccChHHhhh
Confidence            999999987643221  111234569999999999875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.94  E-value=6.3e-27  Score=242.29  Aligned_cols=182  Identities=27%  Similarity=0.363  Sum_probs=145.5

Q ss_pred             HHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHh--cCCCCCcceeEeeccCCcCC
Q 035691          437 LKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRN--IRHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       437 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~~~~  514 (640)
                      ....++|++.+.||+|+||.||+|++  +|+.||||++...   ..+.+.+|++++..  ++||||+++++++.... ..
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~  111 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GT  111 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SS
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-Cc
Confidence            34456799999999999999999998  5899999998543   33567889998887  78999999999975432 11


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeeeCCCCCCCeee
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHC-----KKQIVHCDLKPSNVLL  589 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~-----~~~ivHrdlkp~NiLl  589 (640)
                      ....++||||+++|+|.+++...           .+++..++.++.|++.||.|||...     ..+|+||||||+||++
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~~-----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll  180 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNRY-----------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV  180 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHHC-----------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE
T ss_pred             cceeEEEEeecCCCcHHHHHhcc-----------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE
Confidence            23689999999999999999532           2788999999999999999999210     1699999999999999


Q ss_pred             CCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          590 DNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       590 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      +.++.+||+|||+++.................||+.|+|||++.+.
T Consensus       181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  226 (342)
T 1b6c_B          181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS  226 (342)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSC
T ss_pred             CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhccc
Confidence            9999999999999986543221111122345699999999999775

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.94  E-value=1.8e-27  Score=244.79  Aligned_cols=187  Identities=27%  Similarity=0.389  Sum_probs=142.8

Q ss_pred             cCCCcccCcccccccceEEEEE-----ECCCCeEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGI-----LDPDQTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQ  513 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~  513 (640)
                      .++|++.+.||+|+||.||+|+     ...+++.||||++... .......+.+|+.++++++||||+++++++.     
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----  103 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL-----  103 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc-----
Confidence            4568899999999999999998     4457889999999543 3344567899999999999999999999964     


Q ss_pred             CCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC--
Q 035691          514 GNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN--  591 (640)
Q Consensus       514 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~--  591 (640)
                      .....++||||+++|+|.+++.......   .....+++..++.++.|++.||.|||+   .+|+||||||+||+++.  
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~  177 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRP---SQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPG  177 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCS---SSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSS
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccc---cccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCC
Confidence            3446799999999999999997543211   112348899999999999999999999   69999999999999984  


Q ss_pred             -CCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          592 -DMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       592 -~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                       +..+||+|||+++.......  ........||+.|+|||++.+..++.
T Consensus       178 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~  224 (327)
T 2yfx_A          178 PGRVAKIGDFGMARDIYRASY--YRKGGCAMLPVKWMPPEAFMEGIFTS  224 (327)
T ss_dssp             TTCCEEECCCHHHHHHHC--------CCGGGSCGGGCCHHHHHHCCCCH
T ss_pred             CcceEEECccccccccccccc--cccCCCcCCCcceeCHhHhcCCCCCc
Confidence             44699999999975432211  11122345789999999987776653

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=1.3e-27  Score=262.48  Aligned_cols=163  Identities=15%  Similarity=0.041  Sum_probs=124.0

Q ss_pred             cccccccceEEEEEECCCCeEEEEEEeeccc----------chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCc
Q 035691          448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ----------RGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       448 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ..+.|++|.+..++....|+.||||++....          +...++|.+|+++|+++ .|+||++++++     ++++.
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~ed~~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAH-----GENAQ  315 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEE-----EECSS
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEE-----EEECC
Confidence            3566777777776666678999999995431          23346799999999999 79999999999     45566


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..||||||++||+|.+++.....          ++.   .+|+.||+.||+|+|+   .+||||||||+|||++++|.+|
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~~~~----------l~~---~~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vK  379 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAAGEE----------IDR---EKILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHAR  379 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHTTCC----------CCH---HHHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEE
T ss_pred             EEEEEEecCCCCcHHHHHHhCCC----------CCH---HHHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEE
Confidence            89999999999999999976543          343   3589999999999999   7999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      |+|||+|+......    ....+.+||+.|||||++.|.
T Consensus       380 L~DFGlAr~~~~~~----~~~~t~vGTp~YmAPE~l~g~  414 (569)
T 4azs_A          380 LIDFGSIVTTPQDC----SWPTNLVQSFFVFVNELFAEN  414 (569)
T ss_dssp             ECCCTTEESCC-------CCSHHHHHHHHHHHHHHC---
T ss_pred             EeecccCeeCCCCC----ccccCceechhhccHHHhCCC
Confidence            99999998764322    223456799999999999774

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.94  E-value=9e-28  Score=244.11  Aligned_cols=188  Identities=24%  Similarity=0.332  Sum_probs=128.6

Q ss_pred             HHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          437 LKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       437 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      ....++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.++++++||||+++++++..     .
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   85 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV-----K   85 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES-----S
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee-----c
Confidence            345678999999999999999999998889999999986443 3345678899999999999999999999643     4


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      +..++||||+++|+|.+++........  .....+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~  160 (303)
T 2vwi_A           86 DELWLVMKLLSGGSVLDIIKHIVAKGE--HKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSV  160 (303)
T ss_dssp             SCEEEEEECCTTCBHHHHHHHHHHTTT--TTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCE
T ss_pred             CCcEEEehhccCCchHHHHHHHhhccc--cccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCE
Confidence            468999999999999998853111000  011348899999999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCC-CceeeccccccccccCcccCCC
Q 035691          596 HVGDFGLTRFIPEVISS-NQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      ||+|||+++........ .........||+.|+|||++.+
T Consensus       161 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  200 (303)
T 2vwi_A          161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ  200 (303)
T ss_dssp             EECCCHHHHHCC---------------CCCTTCCHHHHHH
T ss_pred             EEEeccchheeccCCCccchhhhcccCCCccccCHHHhcc
Confidence            99999999865432111 1111223568999999998754

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.94  E-value=6.3e-27  Score=251.86  Aligned_cols=181  Identities=25%  Similarity=0.347  Sum_probs=145.5

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .++|++.+.||+|+||.||+|++..+++.||||++......  ..+..|+++++.++|++++..+.++    .......+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~----~~~~~~~~   79 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWF----GVEGDYNV   79 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEE----EEETTEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEE----EeeCCEEE
Confidence            46799999999999999999999989999999988644322  3578999999999875555444443    23345789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee---CCCCcEE
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL---DNDMIAH  596 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl---~~~~~~k  596 (640)
                      +||||+ +++|.+++....         ..+++..++.|+.||+.||+|||+   .+|+||||||+|||+   +.++.+|
T Consensus        80 lvme~~-g~sL~~ll~~~~---------~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vk  146 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVY  146 (483)
T ss_dssp             EEEECC-CCBHHHHHHHTT---------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEE
T ss_pred             EEEECC-CCCHHHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEE
Confidence            999999 999999986432         238899999999999999999999   699999999999999   6889999


Q ss_pred             EccccccccCCCccCCC---ceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSN---QCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|||+++.+.......   ........||+.|+|||++.+..++.
T Consensus       147 L~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~  192 (483)
T 3sv0_A          147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSR  192 (483)
T ss_dssp             ECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH
T ss_pred             EEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCCh
Confidence            99999998765432211   11223467999999999999887764

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.94  E-value=3.8e-27  Score=249.16  Aligned_cols=179  Identities=23%  Similarity=0.341  Sum_probs=145.7

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcC--------CCCCcceeEeeccCC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR--------HRNLVKIITACSSSD  511 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~~~~~~~~  511 (640)
                      .++|++.+.||+|+||+||+|++..+++.||||++... ....+.+.+|+++++.++        |+||+++++++....
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            46799999999999999999999999999999999643 334567899999999986        788999999864321


Q ss_pred             cCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeeCCCCCCCeeeC
Q 035691          512 FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKK-QIVHCDLKPSNVLLD  590 (640)
Q Consensus       512 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~-~ivHrdlkp~NiLl~  590 (640)
                       ......++||||+ +|++.+++.....        ..+++..+..++.|++.||+|||+   . +|+||||||+|||++
T Consensus       115 -~~~~~~~lv~e~~-~~~l~~~~~~~~~--------~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~  181 (397)
T 1wak_A          115 -VNGTHICMVFEVL-GHHLLKWIIKSNY--------QGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLS  181 (397)
T ss_dssp             -TTEEEEEEEECCC-CCBHHHHHHHTTT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEEC
T ss_pred             -CCCceEEEEEecc-CccHHHHHHhccc--------CCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEe
Confidence             2345789999999 5566665543221        238899999999999999999999   6 999999999999999


Q ss_pred             CCC-------------------------------------------------cEEEccccccccCCCccCCCceeecccc
Q 035691          591 NDM-------------------------------------------------IAHVGDFGLTRFIPEVISSNQCSSVGLK  621 (640)
Q Consensus       591 ~~~-------------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~  621 (640)
                      .++                                                 .+||+|||+|+.....       ....+
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-------~~~~~  254 (397)
T 1wak_A          182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-------FTEDI  254 (397)
T ss_dssp             CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-------SCSCC
T ss_pred             ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-------CccCC
Confidence            775                                                 7999999999866432       12246


Q ss_pred             ccccccCcccCCCCCCCC
Q 035691          622 GTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       622 gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+.|+|||++.+..++.
T Consensus       255 gt~~y~aPE~~~~~~~~~  272 (397)
T 1wak_A          255 QTRQYRSLEVLIGSGYNT  272 (397)
T ss_dssp             SCGGGCCHHHHHTSCCCT
T ss_pred             CCCcccCChhhcCCCCCc
Confidence            899999999999887765

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.94  E-value=6.2e-27  Score=257.42  Aligned_cols=186  Identities=24%  Similarity=0.343  Sum_probs=151.0

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCC-cCCCce
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSD-FQGNDF  517 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~~~  517 (640)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|++++++++||||+++++++.... +.....
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            36799999999999999999999989999999998643 3344578999999999999999999999975422 223567


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc---
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI---  594 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~---  594 (640)
                      .++||||+++|+|.+++......       ..+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.   
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~-------~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~  162 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENC-------CGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLI  162 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCT-------TCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCE
T ss_pred             EEEEEEeCCCCCHHHHHHhcccC-------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCcee
Confidence            89999999999999999754321       236777889999999999999999   69999999999999987664   


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +||+|||+++.......     .....||+.|+|||++.+..++.+
T Consensus       163 vKL~DFG~a~~~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~k  203 (676)
T 3qa8_A          163 HKIIDLGYAKELDQGEL-----CTEFVGTLQYLAPELLEQKKYTVT  203 (676)
T ss_dssp             EEECSCCCCCBTTSCCC-----CCCCCSCCTTCSSCSSCCSCCSTT
T ss_pred             EEEcccccccccccccc-----cccccCCcccCChHHhccCCCCch
Confidence            99999999987643221     123569999999999998888764

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.94  E-value=1.2e-27  Score=240.22  Aligned_cols=174  Identities=32%  Similarity=0.430  Sum_probs=137.5

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .++|++.+.||+|+||.||+|.+  +|+.||||+++..  ...+.+.+|++++++++||||+++++++..    .....+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~~   91 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLY   91 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCE
T ss_pred             hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCCceE
Confidence            35688889999999999999988  4889999998643  245789999999999999999999998632    234678


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++|+|.+++.....        ..+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|
T Consensus        92 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~D  160 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRGR--------SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSD  160 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHHH--------HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECC
T ss_pred             EEEecCCCCCHHHHHHhccc--------ccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEee
Confidence            99999999999999864321        126788899999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+++......       ....+++.|+|||++.+..++.
T Consensus       161 fg~~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~  193 (278)
T 1byg_A          161 FGLTKEASSTQ-------DTGKLPVKWTAPEALREKKFST  193 (278)
T ss_dssp             CCC-------------------CCTTTSCHHHHHHCCCCH
T ss_pred             ccccccccccc-------cCCCccccccCHHHhCCCCCCc
Confidence            99998543211       1234788999999987766653

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.94  E-value=1.3e-26  Score=241.14  Aligned_cols=177  Identities=25%  Similarity=0.312  Sum_probs=142.7

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcC-CCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQ-GND  516 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~-~~~  516 (640)
                      .++|...+.||+|+||.||+|+++.+|+.||||++...  .....+.+.+|+.+++.++||||+++++++...... ...
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            46788899999999999999999999999999999543  233456789999999999999999999997543311 112


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||++ |+|.+++..            .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+|
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~------------~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~k  166 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL------------KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELK  166 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS------------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEE
T ss_pred             eEEEEecccc-CCHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEE
Confidence            3589999998 588877631            27888999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCC-CCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG-SQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~  639 (640)
                      |+|||+++.....       .....||+.|+|||++.+ ..++.
T Consensus       167 l~Dfg~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~  203 (353)
T 3coi_A          167 ILDFGLARHADAE-------MTGYVVTRWYRAPEVILSWMHYNQ  203 (353)
T ss_dssp             ECSTTCTTC---------------CCSBCCSCHHHHSCCSCCCT
T ss_pred             EeecccccCCCCC-------ccccccCcCcCCHHHHhCcCCCCc
Confidence            9999999865321       123468999999999877 44443

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.94  E-value=1.1e-27  Score=250.96  Aligned_cols=178  Identities=14%  Similarity=0.081  Sum_probs=126.6

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc---hhHHHHHHHHHHHHhc--CCCCCcceeE-------eec
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR---GALKSFMAECEALRNI--RHRNLVKIIT-------ACS  508 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~H~niv~l~~-------~~~  508 (640)
                      ..|...+.||+|+||.||+|++..+|+.||||++.....   ...+.+.+|+.+++.+  +||||++++.       ++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            347888999999999999999999999999999976432   3346777885555444  6999887553       322


Q ss_pred             cCCc------------CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHH------HHHHHHHHHHHHHHh
Q 035691          509 SSDF------------QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQR------LNIAINVASALEYLH  570 (640)
Q Consensus       509 ~~~~------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~------~~i~~~i~~al~yLH  570 (640)
                      ....            ......++|||||+ |+|.+++.....         .+++..+      ..++.|++.||+|||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---------~~~~~~~~~~~vk~~i~~qi~~aL~~LH  211 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---------VYVFRGDEGILALHILTAQLIRLAANLQ  211 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---------SCCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---------ccchhhhhhhhhHHHHHHHHHHHHHHHH
Confidence            1110            00144799999999 899999965321         1233344      677899999999999


Q ss_pred             cCCCCCeeeCCCCCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCC--CCCC
Q 035691          571 HHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG--SQVS  638 (640)
Q Consensus       571 ~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s  638 (640)
                      +   .+|+||||||+|||++.++.+||+|||+|+.....       .....||+.|+|||++.+  ..++
T Consensus       212 ~---~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~  271 (371)
T 3q60_A          212 S---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-------GPASSVPVTYAPREFLNASTATFT  271 (371)
T ss_dssp             H---TTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-------EEGGGSCGGGCCHHHHTCSEEECC
T ss_pred             H---CCCccCcCCHHHEEECCCCCEEEEecceeeecCCC-------ccCccCCcCCcChhhccCCCCCcC
Confidence            9   69999999999999999999999999999865321       112347799999999987  4454

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.94  E-value=3.9e-27  Score=248.49  Aligned_cols=179  Identities=26%  Similarity=0.366  Sum_probs=137.5

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc-CCCceee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDF-QGNDFKA  519 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~~~~~  519 (640)
                      .+|+..+.||+|+||.||+|++..+++ ||+|++.....    ...+|+++++.++|||||++++++..... .+..+.+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            458888999999999999999986555 88887743322    12369999999999999999999754432 3344578


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC-CCCcEEEc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD-NDMIAHVG  598 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~-~~~~~kl~  598 (640)
                      +||||++++.+.........       ...+++..+..++.|++.||+|||+   .+|+||||||+||+++ .++.+||+
T Consensus       115 lv~e~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~  184 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKL-------KQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLI  184 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHT-------TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             EEeeccCccHHHHHHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEe
Confidence            99999987544433211110       0237888999999999999999999   6999999999999999 79999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCC-CCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ-VST  639 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~  639 (640)
                      |||+|+.+....     ......||+.|+|||++.+.. ++.
T Consensus       185 DFG~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~  221 (394)
T 4e7w_A          185 DFGSAKILIAGE-----PNVSYICSRYYRAPELIFGATNYTT  221 (394)
T ss_dssp             CCTTCEECCTTC-----CCCSSCSCGGGCCHHHHTTCSSCCT
T ss_pred             eCCCcccccCCC-----CCcccccCcCccCHHHHcCCCCCCc
Confidence            999998663321     122356899999999997754 543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.94  E-value=1.6e-27  Score=240.78  Aligned_cols=174  Identities=24%  Similarity=0.270  Sum_probs=129.7

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc--hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ..++|++.+.||+|+||.||+|++..+|+.||||++.....  ...+.+.++...++.++||||+++++++.     ...
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----~~~   79 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-----REG   79 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-----ccC
Confidence            34678899999999999999999999999999999964422  22234445555678889999999999964     344


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeeCCCCCCCeeeCCCCcE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKK-QIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~-~ivHrdlkp~NiLl~~~~~~  595 (640)
                      ..++||||+++ +|.+++......      ...+++..+..++.|++.||+|||+   . +|+||||||+||+++.++.+
T Consensus        80 ~~~lv~e~~~~-~l~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~  149 (290)
T 3fme_A           80 DVWICMELMDT-SLDKFYKQVIDK------GQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQV  149 (290)
T ss_dssp             SEEEEEECCSE-EHHHHHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCE
T ss_pred             CEEEEEehhcc-chHHHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCE
Confidence            78999999985 887776431110      0238899999999999999999998   5 99999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYG  632 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  632 (640)
                      ||+|||+++.......     .....||+.|+|||++
T Consensus       150 kl~Dfg~~~~~~~~~~-----~~~~~~t~~y~aPE~~  181 (290)
T 3fme_A          150 KMCDFGISGYLVDDVA-----KDIDAGCKPYMAPERI  181 (290)
T ss_dssp             EBCCC--------------------CCCCCCSCHHHH
T ss_pred             EEeecCCccccccccc-----ccccCCCccccChhhc
Confidence            9999999986643211     1223589999999996

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.94  E-value=1.4e-27  Score=248.30  Aligned_cols=179  Identities=16%  Similarity=0.201  Sum_probs=143.3

Q ss_pred             cCCCcccCcccccccceEEEEEECC--------CCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcc---------
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDP--------DQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK---------  502 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~---------  502 (640)
                      .++|++.+.||+|+||.||+|++..        .++.||||++...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3678999999999999999999986        4889999998643     35789999999999999988         


Q ss_pred             ------eeEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 035691          503 ------IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQ  576 (640)
Q Consensus       503 ------l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~  576 (640)
                            +++++.    ..+...++||||+ +|+|.+++.....        ..+++..++.++.|++.||+|||+   .+
T Consensus       116 ~~~i~~~~~~~~----~~~~~~~lv~e~~-~~~L~~~l~~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~---~~  179 (352)
T 2jii_A          116 LLAIPTCMGFGV----HQDKYRFLVLPSL-GRSLQSALDVSPK--------HVLSERSVLQVACRLLDALEFLHE---NE  179 (352)
T ss_dssp             TCSCCCCCEEEE----ETTTEEEEEEECC-CEEHHHHHHHSGG--------GCCCHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred             ccCccchhhccc----cCCcEEEEEecCC-CcCHHHHHHhCCc--------CCCCHHHHHHHHHHHHHHHHHHHh---CC
Confidence                  444432    1245789999999 9999999975421        238899999999999999999999   69


Q ss_pred             eeeCCCCCCCeeeCCCC--cEEEccccccccCCCccCCC---ceeeccccccccccCcccCCCCCCCC
Q 035691          577 IVHCDLKPSNVLLDNDM--IAHVGDFGLTRFIPEVISSN---QCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       577 ivHrdlkp~NiLl~~~~--~~kl~DfGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+||||||+||+++.++  .+||+|||+++.+.......   ........||+.|+|||++.+..++.
T Consensus       180 ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  247 (352)
T 2jii_A          180 YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSR  247 (352)
T ss_dssp             CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCH
T ss_pred             ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCc
Confidence            99999999999999998  99999999998765332111   11123346999999999998877764

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.94  E-value=9.3e-27  Score=240.46  Aligned_cols=175  Identities=22%  Similarity=0.317  Sum_probs=145.1

Q ss_pred             cCCCcccCcccccccceEEEEEE-CCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCC------CcceeEeeccCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGIL-DPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRN------LVKIITACSSSDF  512 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~  512 (640)
                      .++|++.+.||+|+||.||+|++ ..+++.||||+++.. ....+.+.+|+++++.++|++      ++++++++     
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~-----   86 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF-----   86 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE-----
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc-----
Confidence            46789999999999999999998 567899999998643 234567889999999887654      89999985     


Q ss_pred             CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC-
Q 035691          513 QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN-  591 (640)
Q Consensus       513 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~-  591 (640)
                      ......++||||+ +++|.+++.....        ..+++..+..++.|++.||+|||+   .+|+||||||+||+++. 
T Consensus        87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~  154 (339)
T 1z57_A           87 EHHGHICIVFELL-GLSTYDFIKENGF--------LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQS  154 (339)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTT--------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCC
T ss_pred             ccCCcEEEEEcCC-CCCHHHHHHhcCC--------CCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEecc
Confidence            3445889999999 8899998865432        237888999999999999999999   69999999999999987 


Q ss_pred             ------------------CCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          592 ------------------DMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       592 ------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                                        ++.+||+|||+++.....       .....||+.|+|||++.+..++.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~  213 (339)
T 1z57_A          155 DYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-------HSTLVSTRHYRAPEVILALGWSQ  213 (339)
T ss_dssp             CEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-------CCSSCSCGGGCCHHHHTTSCCCT
T ss_pred             ccccccCCccccccccccCCCceEeeCcccccCccc-------cccccCCccccChHHhhCCCCCc
Confidence                              668999999999865322       12346899999999999887765

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.94  E-value=6e-26  Score=226.91  Aligned_cols=221  Identities=22%  Similarity=0.244  Sum_probs=175.7

Q ss_pred             CCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCc
Q 035691           82 NIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYL  161 (640)
Q Consensus        82 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L  161 (640)
                      ++..+++..+.+...  ..+..+++|+.|++++|.++. + ..+..+++|++|+|++|.++.+        ..+.++++|
T Consensus        20 ~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--------~~l~~l~~L   87 (272)
T 3rfs_A           20 ETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--------SALKELTNL   87 (272)
T ss_dssp             HHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--------GGGTTCTTC
T ss_pred             HHHHHHhcCcccccc--cccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--------hhhcCCCCC
Confidence            444566666666543  335567788888888888874 3 3477888888888888888764        356778888


Q ss_pred             ceEecCCCCCCCcCcC-CCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCc
Q 035691          162 EIVSLNVNSLRSIPIS-VGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKT  240 (640)
Q Consensus       162 ~~L~L~~N~l~~ip~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n  240 (640)
                      ++|++++|.++.+|.. +..+++|++|+|++|.+++..+..|..+++|++|+|++|++++..+..|..+++|+.|     
T Consensus        88 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L-----  162 (272)
T 3rfs_A           88 TYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTEL-----  162 (272)
T ss_dssp             CEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE-----
T ss_pred             CEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEE-----
Confidence            8888888888886654 5778889999999999988777778888999999999999887777778888888888     


Q ss_pred             cccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCC
Q 035691          241 IFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSL  320 (640)
Q Consensus       241 ~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  320 (640)
                                 ++++|++++..+..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++.+.       +++|
T Consensus       163 -----------~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l  224 (272)
T 3rfs_A          163 -----------DLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGI  224 (272)
T ss_dssp             -----------ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTT
T ss_pred             -----------ECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHH
Confidence                       7778888877778888889999999999999887777788889999999999988743       4578


Q ss_pred             CeEeCcCCccccccCCcccCCC
Q 035691          321 EGLDLFQNTFQAKSQNGDVPRK  342 (640)
Q Consensus       321 ~~L~l~~N~l~~~~~~~~~p~~  342 (640)
                      +.|+++.|.++     |.+|..
T Consensus       225 ~~l~~~~n~~~-----g~ip~~  241 (272)
T 3rfs_A          225 RYLSEWINKHS-----GVVRNS  241 (272)
T ss_dssp             HHHHHHHHHTG-----GGBBCT
T ss_pred             HHHHHHHHhCC-----CcccCc
Confidence            88888888888     677754

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.93  E-value=7.8e-27  Score=263.53  Aligned_cols=172  Identities=26%  Similarity=0.357  Sum_probs=142.2

Q ss_pred             cCCCcccCcccccccceEEEEEECC-CCeEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDP-DQTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      .++|++.+.||+|+||.||+|++.. +|+.||||++... .....+.+.+|++++++++|||||++++++......+...
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            4679999999999999999999975 7899999998543 2344567899999999999999999999986554333334


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .|+||||+++++|.+++..            .+++..++.|+.||+.||.|||+   .+|+||||||+||+++.+ .+||
T Consensus       159 ~~lv~E~~~g~~L~~~~~~------------~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl  222 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ------------KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKL  222 (681)
T ss_dssp             EEEEEECCCCEECC----C------------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEE
T ss_pred             eEEEEEeCCCCcHHHHHhC------------CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEE
Confidence            6999999999999887642            27899999999999999999999   699999999999999875 8999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      +|||+++.....        ....||+.|+|||++.+.
T Consensus       223 ~DFG~a~~~~~~--------~~~~gt~~y~aPE~~~~~  252 (681)
T 2pzi_A          223 IDLGAVSRINSF--------GYLYGTPGFQAPEIVRTG  252 (681)
T ss_dssp             CCCTTCEETTCC--------SCCCCCTTTSCTTHHHHC
T ss_pred             EecccchhcccC--------CccCCCccccCHHHHcCC
Confidence            999999865432        234699999999988654

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.93  E-value=1.4e-26  Score=245.50  Aligned_cols=185  Identities=24%  Similarity=0.348  Sum_probs=129.8

Q ss_pred             Ccc-cCcccccccceEEEEEEC--CCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          443 FSS-ANLIGTGSFGSVYKGILD--PDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       443 ~~~-~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      |.+ .++||+|+||.||+|+++  .+++.||||++....  ....+.+|+.++++++|||||++++++..   ......+
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~~~   96 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLS---HADRKVW   96 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCeEE
Confidence            444 458999999999999976  468899999985432  23568899999999999999999999743   2345789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee----CCCCcE
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL----DNDMIA  595 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl----~~~~~~  595 (640)
                      +||||+++ +|.+++........ ......+++..+..++.|++.||.|||+   .+|+||||||+|||+    +.++.+
T Consensus        97 lv~e~~~~-~l~~~~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           97 LLFDYAEH-DLWHIIKFHRASKA-NKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             EEEECCSE-EHHHHHHHHHHHC--------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             EEEeCCCC-CHHHHHHHhccccc-cccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcE
Confidence            99999975 78777642211000 0011248899999999999999999999   699999999999999    778999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCC-CC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ-VS  638 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s  638 (640)
                      ||+|||+|+.+...... .......+||+.|+|||++.+.. ++
T Consensus       172 kl~Dfg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~  214 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYT  214 (405)
T ss_dssp             EECCTTCCC-----------------CCCTTCCHHHHTTCCSCC
T ss_pred             EEEECCCceecCCCCcc-cccCCCceecCcccCchhhcCCCccc
Confidence            99999999876432211 12223457999999999998754 44

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.93  E-value=1.2e-26  Score=244.05  Aligned_cols=183  Identities=25%  Similarity=0.310  Sum_probs=148.1

Q ss_pred             HHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcC-CCC-----CcceeEee
Q 035691          434 ESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR-HRN-----LVKIITAC  507 (640)
Q Consensus       434 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n-----iv~l~~~~  507 (640)
                      .......++|++.+.||+|+||+||+|++..+++.||||+++.. ......+..|+.+++.++ |++     |+++++++
T Consensus        47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~  125 (382)
T 2vx3_A           47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF  125 (382)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred             ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence            33345567899999999999999999999999999999999633 233467788999998885 553     89999985


Q ss_pred             ccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCe
Q 035691          508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNV  587 (640)
Q Consensus       508 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~Ni  587 (640)
                      .     .....++||||++ |+|.+++.....        ..+++..+..++.|++.||.|||++ ..+|+||||||+||
T Consensus       126 ~-----~~~~~~lv~e~~~-~~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NI  190 (382)
T 2vx3_A          126 M-----FRNHLCLVFEMLS-YNLYDLLRNTNF--------RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENI  190 (382)
T ss_dssp             E-----ETTEEEEEEECCC-CBHHHHHHHTTT--------SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGE
T ss_pred             c-----cCCceEEEEecCC-CCHHHHHhhcCc--------CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccE
Confidence            3     3458899999996 599998865432        2378899999999999999999952 26899999999999


Q ss_pred             eeC--CCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          588 LLD--NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       588 Ll~--~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |++  .++.+||+|||+|+.....       .....||+.|+|||++.+..++.
T Consensus       191 ll~~~~~~~~kL~DFG~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~  237 (382)
T 2vx3_A          191 LLCNPKRSAIKIVDFGSSCQLGQR-------IYQYIQSRFYRSPEVLLGMPYDL  237 (382)
T ss_dssp             EESSTTSCCEEECCCTTCEETTCC-------CCSSCSCGGGCCHHHHTTCCCCT
T ss_pred             EEecCCCCcEEEEeccCceecccc-------cccccCCccccChHHHcCCCCCc
Confidence            994  5788999999999866432       12346899999999999988775

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.93  E-value=1.2e-26  Score=234.01  Aligned_cols=173  Identities=28%  Similarity=0.363  Sum_probs=144.8

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      .++|++.+.||+|+||.||+|++..+++.||||++....  ....+.+.+|++++++++||||+++++++.     ....
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   95 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS   95 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----CCCe
Confidence            456899999999999999999999899999999996443  234578999999999999999999999964     3457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC---Cc
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND---MI  594 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~---~~  594 (640)
                      .++||||+++++|.+++....          .+++..++.++.|++.||.|||+   .+|+||||||+||+++.+   +.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~  162 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKRK----------RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCD  162 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCC
T ss_pred             EEEEEEccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCccc
Confidence            899999999999998875432          27889999999999999999999   699999999999999754   47


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      +||+|||+++.......     .....||+.|+|||++.+.
T Consensus       163 ~kL~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~  198 (287)
T 2wei_A          163 IKIIDFGLSTCFQQNTK-----MKDRIGTAYYIAPEVLRGT  198 (287)
T ss_dssp             EEECSTTGGGTBCCCSS-----CSCHHHHHTTCCHHHHTTC
T ss_pred             EEEeccCcceeecCCCc-----cccccCcccccChHHhcCC
Confidence            99999999986543211     1223589999999998764

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.93  E-value=1.3e-25  Score=224.44  Aligned_cols=227  Identities=22%  Similarity=0.258  Sum_probs=154.4

Q ss_pred             CCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCC
Q 035691           28 QLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKL  107 (640)
Q Consensus        28 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  107 (640)
                      ++..+++..+.+.....  +..+++|+.|++++|.++.      ++                          .+..+++|
T Consensus        20 ~l~~l~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~------~~--------------------------~l~~l~~L   65 (272)
T 3rfs_A           20 ETIKANLKKKSVTDAVT--QNELNSIDQIIANNSDIKS------VQ--------------------------GIQYLPNV   65 (272)
T ss_dssp             HHHHHHHTCSCTTSEEC--HHHHTTCCEEECTTSCCCC------CT--------------------------TGGGCTTC
T ss_pred             HHHHHHhcCcccccccc--cccccceeeeeeCCCCccc------cc--------------------------ccccCCCC
Confidence            34455566666554322  3456666666666666543      22                          23444555


Q ss_pred             CEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcC-CCCCCCCCE
Q 035691          108 EWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPIS-VGYLPKLQV  186 (640)
Q Consensus       108 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~-~~~l~~L~~  186 (640)
                      ++|+|++|++++.  ..+..+++|++|+|++|.++.+      .+..|.++++|++|++++|+++.+|.. +..+++|++
T Consensus        66 ~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~------~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  137 (272)
T 3rfs_A           66 RYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSL------PNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTY  137 (272)
T ss_dssp             CEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCC------CTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred             cEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCcc------ChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCE
Confidence            5555555555532  2445555555555555555544      223344555555555555555554443 566788888


Q ss_pred             EEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCccC
Q 035691          187 LSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAV  266 (640)
Q Consensus       187 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~  266 (640)
                      |+|++|.+++..+..|..+++|++|+|++|++++..+..|..+++|+.|                ++++|++++..+..|
T Consensus       138 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L----------------~L~~N~l~~~~~~~~  201 (272)
T 3rfs_A          138 LNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDL----------------RLYQNQLKSVPDGVF  201 (272)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE----------------ECCSSCCSCCCTTTT
T ss_pred             EECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEE----------------ECCCCcCCccCHHHH
Confidence            8888888887777778888888888888888887777778888888888                777888888888888


Q ss_pred             CCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCC
Q 035691          267 GNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKS  319 (640)
Q Consensus       267 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  319 (640)
                      ..+++|+.|+|++|.+.+.       +++|++|+++.|.++|.+|..++.+..
T Consensus       202 ~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~  247 (272)
T 3rfs_A          202 DRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAP  247 (272)
T ss_dssp             TTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred             hCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccCC
Confidence            9999999999999988743       557899999999999999988876543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.93  E-value=1.3e-26  Score=239.12  Aligned_cols=176  Identities=21%  Similarity=0.298  Sum_probs=123.8

Q ss_pred             cCCCccc-CcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHH-HHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          440 TGGFSSA-NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAEC-EALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       440 ~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      .++|.+. ++||+|+||.||+|+++.+|+.||||++....     ...+|+ ..++.++||||+++++++.... ..+..
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~  100 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMH-HGKRC  100 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCce
Confidence            4567774 46999999999999999999999999985432     122333 3456679999999999975421 22456


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC---CCc
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN---DMI  594 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~---~~~  594 (640)
                      .++||||+++|+|.+++.....        ..+++..++.++.|++.||.|||+   .+|+||||||+||+++.   ++.
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~~--------~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~  169 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERGD--------QAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAV  169 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC-C--------CCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCC
T ss_pred             EEEEEeccCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCce
Confidence            8999999999999999975432        248899999999999999999999   69999999999999976   456


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      +||+|||+++......      .....||+.|+|||++.+..++
T Consensus       170 ~kl~Dfg~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~  207 (336)
T 3fhr_A          170 LKLTDFGFAKETTQNA------LQTPCYTPYYVAPEVLGPEKYD  207 (336)
T ss_dssp             EEECCCTTCEEC----------------------------CHHH
T ss_pred             EEEeccccceeccccc------cccCCCCcCccChhhhCCCCCC
Confidence            9999999998653211      1234589999999999776554

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.93  E-value=7.1e-27  Score=261.43  Aligned_cols=182  Identities=25%  Similarity=0.371  Sum_probs=145.4

Q ss_pred             HHhcCCCcccCcccccccceEEEEEECC---CCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc
Q 035691          437 LKATGGFSSANLIGTGSFGSVYKGILDP---DQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDF  512 (640)
Q Consensus       437 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~  512 (640)
                      ....++|++.+.||+|+||.||+|++..   .+..||+|++.... ....+.+.+|+.++++++|||||++++++.    
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~----  461 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----  461 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe----
Confidence            3445668888999999999999999864   35679999986433 334578999999999999999999999863    


Q ss_pred             CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC
Q 035691          513 QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND  592 (640)
Q Consensus       513 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~  592 (640)
                        ++..++||||+++|+|.+++....         ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.+
T Consensus       462 --~~~~~lv~E~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~  527 (656)
T 2j0j_A          462 --ENPVWIIMELCTLGELRSFLQVRK---------FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSN  527 (656)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHTT---------TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEET
T ss_pred             --cCceEEEEEcCCCCcHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCC
Confidence              234789999999999999996432         237889999999999999999999   699999999999999999


Q ss_pred             CcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          593 MIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       593 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +.+||+|||+++.......   .......||+.|+|||++.+..++.
T Consensus       528 ~~vkL~DFG~a~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~  571 (656)
T 2j0j_A          528 DCVKLGDFGLSRYMEDSTY---YKASKGKLPIKWMAPESINFRRFTS  571 (656)
T ss_dssp             TEEEECCCCCCCSCCC-------------CCGGGCCHHHHHHCCCCH
T ss_pred             CCEEEEecCCCeecCCCcc---eeccCCCCCcceeCHHHhcCCCCCc
Confidence            9999999999987643221   1122345788999999987776653

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.93  E-value=7.9e-26  Score=221.53  Aligned_cols=197  Identities=18%  Similarity=0.198  Sum_probs=120.3

Q ss_pred             CCCCeeeccCCcccccCCccCcCCCCCCEEECcCCc-cCccCCccccCCCCCCEEEccc-CcCCCCCCCcccccccccCC
Q 035691           81 PNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNS-LTASIPEDLGRLRNLTRLNFAR-NDLGTRKVNDLRFLDSLVNC  158 (640)
Q Consensus        81 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~~~~l~~l  158 (640)
                      ++|+.|+|++|+|+++.+..|.++++|++|+|++|+ ++.+.+.+|.++++|++|+|++ |+++.++      +..|.++
T Consensus        31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~------~~~f~~l  104 (239)
T 2xwt_C           31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYID------PDALKEL  104 (239)
T ss_dssp             TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEEC------TTSEECC
T ss_pred             CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcC------HHHhCCC
Confidence            366666666666666666667777777777777775 6666666677777777777776 7776552      2345556


Q ss_pred             CCcceEecCCCCCCCcCcCCCCCCCCC---EEEccCC-cCcccCCcCccCCCCCC-EEEccCCCCCCCCCccccCCCCcc
Q 035691          159 TYLEIVSLNVNSLRSIPISVGYLPKLQ---VLSLFEN-NISGEIPSSLGNFTFLT-ELNLRGNSIRGSIPSALGNCHQLQ  233 (640)
Q Consensus       159 ~~L~~L~L~~N~l~~ip~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~  233 (640)
                      ++|++|++++|.++.+|. +..+++|+   +|++++| .++++.+..|.++++|+ +|++++|+++...+..|.. ++|+
T Consensus       105 ~~L~~L~l~~n~l~~lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~  182 (239)
T 2xwt_C          105 PLLKFLGIFNTGLKMFPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLD  182 (239)
T ss_dssp             TTCCEEEEEEECCCSCCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEE
T ss_pred             CCCCEEeCCCCCCccccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCC
Confidence            666666666666666665 55555665   7777777 66666566666666666 6666666666333333433 4555


Q ss_pred             EEeccCccccCCCCCceEEccCCc-CCCCCCccCCCC-CCCCEEECCCCcccCcCCccccCCCCCCeEEecCC
Q 035691          234 SLDLSKTIFLGQYPVRWLDLSHNH-LTGPIPLAVGNL-KSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSIN  304 (640)
Q Consensus       234 ~L~ls~n~~~~~~~l~~L~Ls~N~-l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  304 (640)
                      .|                ++++|+ +++..+..|.++ ++|+.|++++|+|++ +|..  .+++|+.|+++++
T Consensus       183 ~L----------------~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~  236 (239)
T 2xwt_C          183 AV----------------YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARNT  236 (239)
T ss_dssp             EE----------------ECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC
T ss_pred             EE----------------EcCCCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccCc
Confidence            55                555553 554555556666 666666666666653 2222  3445555555554

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.93  E-value=4.5e-27  Score=237.52  Aligned_cols=179  Identities=29%  Similarity=0.402  Sum_probs=135.5

Q ss_pred             CCCcccCcccccccceEEEEEECC-CC--eEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDP-DQ--TVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  514 (640)
                      ++|++.+.||+|+||.||+|++.. ++  ..||||+++..   .....+.+.+|++++++++||||+++++++...    
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----   93 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP----   93 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC----
Confidence            468889999999999999998642 33  36899998643   234457899999999999999999999996432    


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                        ..++||||+++|+|.+++....         ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.
T Consensus        94 --~~~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~  159 (291)
T 1u46_A           94 --PMKMVTELAPLGSLLDRLRKHQ---------GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDL  159 (291)
T ss_dssp             --SCEEEEECCTTCBHHHHHHHHG---------GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTE
T ss_pred             --CceeeEecccCCCHHHHHHhcc---------CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCC
Confidence              3689999999999999986432         237888999999999999999999   69999999999999999999


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      +||+|||+++........ ........+|+.|+|||++.+..++
T Consensus       160 ~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~  202 (291)
T 1u46_A          160 VKIGDFGLMRALPQNDDH-YVMQEHRKVPFAWCAPESLKTRTFS  202 (291)
T ss_dssp             EEECCCTTCEECCC-CCE-EEC-----CCGGGCCHHHHHHCEEE
T ss_pred             EEEccccccccccccccc-hhhhccCCCCceeeCchhhcCCCCC
Confidence            999999999876432211 1112234578899999998766554

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.93  E-value=4.9e-27  Score=239.88  Aligned_cols=178  Identities=22%  Similarity=0.288  Sum_probs=139.9

Q ss_pred             HHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc------hhHHHHHHHHHHHHhc----CCCCCcceeE
Q 035691          436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR------GALKSFMAECEALRNI----RHRNLVKIIT  505 (640)
Q Consensus       436 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~H~niv~l~~  505 (640)
                      .....++|++.+.||+|+||.||+|++..+++.||||++.....      .....+.+|+.++.++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            34556789999999999999999999988999999999954322      1223466799999988    8999999999


Q ss_pred             eeccCCcCCCceeeEEeec-cCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCC
Q 035691          506 ACSSSDFQGNDFKALVYEF-MHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKP  584 (640)
Q Consensus       506 ~~~~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp  584 (640)
                      ++     ...+..++|||| +.+++|.+++....          .+++..++.++.|++.||+|||+   .+|+||||||
T Consensus       106 ~~-----~~~~~~~~v~e~~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp  167 (312)
T 2iwi_A          106 WF-----ETQEGFMLVLERPLPAQDLFDYITEKG----------PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKD  167 (312)
T ss_dssp             EC----------CEEEEECCSSEEEHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSG
T ss_pred             EE-----ecCCeEEEEEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCh
Confidence            95     344578899999 78999999986432          27889999999999999999999   6999999999


Q ss_pred             CCeeeC-CCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCC
Q 035691          585 SNVLLD-NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV  637 (640)
Q Consensus       585 ~NiLl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  637 (640)
                      +||+++ .++.+||+|||+++......      .....||+.|+|||++.+..+
T Consensus       168 ~Nil~~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~  215 (312)
T 2iwi_A          168 ENILIDLRRGCAKLIDFGSGALLHDEP------YTDFDGTRVYSPPEWISRHQY  215 (312)
T ss_dssp             GGEEEETTTTEEEECCCSSCEECCSSC------BCCCCSCTTTSCHHHHHHSCB
T ss_pred             hhEEEeCCCCeEEEEEcchhhhcccCc------ccccCCcccccCceeeecCCC
Confidence            999999 88999999999998664321      123458999999998876554

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.93  E-value=1.4e-26  Score=242.70  Aligned_cols=179  Identities=20%  Similarity=0.310  Sum_probs=146.8

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcC-----------CCCCcceeEeec
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR-----------HRNLVKIITACS  508 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~  508 (640)
                      .++|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|++++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            35789999999999999999999989999999998633 234467889999999886           899999999975


Q ss_pred             cCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeeCCCCCCCe
Q 035691          509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKK-QIVHCDLKPSNV  587 (640)
Q Consensus       509 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~-~ivHrdlkp~Ni  587 (640)
                      ... ......++||||+ +++|.+++.....        ..+++..+..++.|++.||+|||+   . +|+||||||+||
T Consensus        97 ~~~-~~~~~~~lv~e~~-~~~L~~~~~~~~~--------~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NI  163 (373)
T 1q8y_A           97 HKG-PNGVHVVMVFEVL-GENLLALIKKYEH--------RGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENV  163 (373)
T ss_dssp             EEE-TTEEEEEEEECCC-CEEHHHHHHHTTT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGE
T ss_pred             ccC-CCCceEEEEEecC-CCCHHHHHHHhhc--------cCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHe
Confidence            432 2233689999999 8899999865332        237889999999999999999999   6 999999999999


Q ss_pred             eeC------CCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          588 LLD------NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       588 Ll~------~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +++      ..+.+||+|||+++......       ....||+.|+|||++.+..++.
T Consensus       164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~  214 (373)
T 1q8y_A          164 LMEIVDSPENLIQIKIADLGNACWYDEHY-------TNSIQTREYRSPEVLLGAPWGC  214 (373)
T ss_dssp             EEEEEETTTTEEEEEECCCTTCEETTBCC-------CSCCSCGGGCCHHHHHTCCCCT
T ss_pred             EEeccCCCcCcceEEEcccccccccCCCC-------CCCCCCccccCcHHHhCCCCCc
Confidence            994      44589999999998664321       2236899999999999887765

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.93  E-value=8.6e-26  Score=221.27  Aligned_cols=194  Identities=13%  Similarity=0.141  Sum_probs=116.7

Q ss_pred             CCCeEEcccCccCccCCcCCCCCCCCCEEEccCCC-cCCccccccCCchhhcCCCCCCeeeccC-CcccccCCccCcCCC
Q 035691           28 QLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNK-LEENQLVGELPPYIGFTLPNIRIPLLAG-NQFFGNIPHSISNAS  105 (640)
Q Consensus        28 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~lp~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~  105 (640)
                      +|++|++++|+|+++.+..|.++++|++|++++|+ ++.      +|+..|..+++|+.|+|++ |+++++.+..|.+++
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~------i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~  105 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQ------LESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELP  105 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCE------ECTTTEESCTTCCEEEEEEETTCCEECTTSEECCT
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcce------eCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCC
Confidence            66777777777766666566667777777777665 553      5655555666666666666 666666666666666


Q ss_pred             CCCEEECcCCccCccCCccccCCCCCC---EEEcccC-cCCCCCCCcccccccccCCCCcc-eEecCCCCCCCcCcCCCC
Q 035691          106 KLEWLDFANNSLTASIPEDLGRLRNLT---RLNFARN-DLGTRKVNDLRFLDSLVNCTYLE-IVSLNVNSLRSIPISVGY  180 (640)
Q Consensus       106 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~~~~l~~l~~L~-~L~L~~N~l~~ip~~~~~  180 (640)
                      +|++|+|++|++++ +|. |..+++|+   +|++++| +++.++      +..|.++++|+ .|++++|.++.+|.....
T Consensus       106 ~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~------~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~  177 (239)
T 2xwt_C          106 LLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIP------VNAFQGLCNETLTLKLYNNGFTSVQGYAFN  177 (239)
T ss_dssp             TCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEEC------TTTTTTTBSSEEEEECCSCCCCEECTTTTT
T ss_pred             CCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcC------cccccchhcceeEEEcCCCCCcccCHhhcC
Confidence            66666666666664 343 56666666   6666666 665542      23355566666 666666666665554433


Q ss_pred             CCCCCEEEccCCc-CcccCCcCccCC-CCCCEEEccCCCCCCCCCccccCCCCccEEecc
Q 035691          181 LPKLQVLSLFENN-ISGEIPSSLGNF-TFLTELNLRGNSIRGSIPSALGNCHQLQSLDLS  238 (640)
Q Consensus       181 l~~L~~L~L~~N~-l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls  238 (640)
                      .++|++|+|++|+ ++++.+..|.++ ++|+.|+|++|++++..+.   .+++|+.|+++
T Consensus       178 ~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~  234 (239)
T 2xwt_C          178 GTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIAR  234 (239)
T ss_dssp             TCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECT
T ss_pred             CCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeecc
Confidence            4556666666663 665555556666 6666666666666533332   34455555443

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.93  E-value=9.5e-27  Score=238.60  Aligned_cols=177  Identities=22%  Similarity=0.291  Sum_probs=145.9

Q ss_pred             HHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccch------hHHHHHHHHHHHHhcC--CCCCcceeEeec
Q 035691          437 LKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG------ALKSFMAECEALRNIR--HRNLVKIITACS  508 (640)
Q Consensus       437 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~~~~~  508 (640)
                      ....++|++.+.||+|+||.||+|++..+++.||||++......      ..+.+.+|+.++++++  ||||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            34467799999999999999999999999999999999644221      2245678999999996  599999999954


Q ss_pred             cCCcCCCceeeEEeeccCC-CChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCe
Q 035691          509 SSDFQGNDFKALVYEFMHH-GSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNV  587 (640)
Q Consensus       509 ~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~Ni  587 (640)
                           ..+..++||||+.+ ++|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||
T Consensus       119 -----~~~~~~lv~e~~~~~~~L~~~l~~~~----------~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NI  180 (320)
T 3a99_A          119 -----RPDSFVLILERPEPVQDLFDFITERG----------ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENI  180 (320)
T ss_dssp             -----CSSEEEEEEECCSSEEEHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGE
T ss_pred             -----cCCcEEEEEEcCCCCccHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHE
Confidence                 34578999999986 89999986432          27888999999999999999999   6999999999999


Q ss_pred             eeC-CCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCC
Q 035691          588 LLD-NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV  637 (640)
Q Consensus       588 Ll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  637 (640)
                      +++ +++.+||+|||+++......      .....||+.|+|||++.+..+
T Consensus       181 ll~~~~~~~kL~Dfg~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~  225 (320)
T 3a99_A          181 LIDLNRGELKLIDFGSGALLKDTV------YTDFDGTRVYSPPEWIRYHRY  225 (320)
T ss_dssp             EEETTTTEEEECCCTTCEECCSSC------BCCCCSCGGGSCHHHHHHSCB
T ss_pred             EEeCCCCCEEEeeCcccccccccc------ccCCCCCccCCChHHhccCCC
Confidence            999 78999999999998664321      123458999999999876554

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.93  E-value=3.6e-26  Score=235.04  Aligned_cols=175  Identities=23%  Similarity=0.308  Sum_probs=123.6

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHH-HHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECE-ALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      .++|+..+.||+|+||.||+|.+..+|+.||||++.... ......+..|+. +++.++||||+++++++.     ..+.
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~~~   95 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----REGD   95 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CSSE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eCCc
Confidence            367888899999999999999999899999999996543 233345666666 667789999999999964     3457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeeCCCCCCCeeeCCCCcEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKK-QIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~-~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      .++||||+++ +|.+++......     ....+++..+..++.|++.||.|||+   . +|+||||||+||+++.++.+|
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~k  166 (327)
T 3aln_A           96 CWICMELMST-SFDKFYKYVYSV-----LDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIK  166 (327)
T ss_dssp             EEEEECCCSE-EHHHHHHHHHHT-----TCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEE
T ss_pred             eEEEEeecCC-ChHHHHHHHHhh-----hcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEE
Confidence            8999999986 777766421000     01237888999999999999999999   6 999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGM  633 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  633 (640)
                      |+|||+++.......     .....||+.|+|||++.
T Consensus       167 l~Dfg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~  198 (327)
T 3aln_A          167 LCDFGISGQLVDSIA-----KTRDAGCRPYMAPERID  198 (327)
T ss_dssp             ECCCSSSCC----------------------------
T ss_pred             EccCCCceecccccc-----cccCCCCccccCceeec
Confidence            999999986643211     12235899999999983

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.93  E-value=2.3e-25  Score=231.17  Aligned_cols=211  Identities=17%  Similarity=0.138  Sum_probs=130.3

Q ss_pred             cEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCe
Q 035691            6 MLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRI   85 (640)
Q Consensus         6 ~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~   85 (640)
                      ++++.++++++ .+|..+  .+++++|+|++|+|+.+.+.+|.++++|++|||++|++.+     .+|...|.+++++..
T Consensus        12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~-----~i~~~~f~~L~~l~~   83 (350)
T 4ay9_X           12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE-----VIEADVFSNLPKLHE   83 (350)
T ss_dssp             TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCC-----EECTTSBCSCTTCCE
T ss_pred             CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCC-----ccChhHhhcchhhhh
Confidence            45666777777 556554  2467777777777776555667777777777777666532     466666666666553


Q ss_pred             -eeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEccc-CcCCCCCCCcccccccccCCC-Ccc
Q 035691           86 -PLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFAR-NDLGTRKVNDLRFLDSLVNCT-YLE  162 (640)
Q Consensus        86 -L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~~~~l~~l~-~L~  162 (640)
                       +.++.|+|+++.|+.|.++++|++|++++|+|+...+..+....++..|++.+ |++..++.      ..|..+. .++
T Consensus        84 ~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~------~~f~~~~~~l~  157 (350)
T 4ay9_X           84 IRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER------NSFVGLSFESV  157 (350)
T ss_dssp             EEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECT------TSSTTSBSSCE
T ss_pred             hhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccc------cchhhcchhhh
Confidence             55566777776677777777777777777777766555566666666666644 45555532      2233332 456


Q ss_pred             eEecCCCCCCCcCcCCCCCCCCCEEEccC-CcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCC
Q 035691          163 IVSLNVNSLRSIPISVGYLPKLQVLSLFE-NNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCH  230 (640)
Q Consensus       163 ~L~L~~N~l~~ip~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  230 (640)
                      .|+|++|+|+.+|...+...+|++|++++ |.++.+.++.|.++++|++|+|++|+|+...+..|.+++
T Consensus       158 ~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~  226 (350)
T 4ay9_X          158 ILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLK  226 (350)
T ss_dssp             EEECCSSCCCEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCC
T ss_pred             hhccccccccCCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccch
Confidence            66666666666666555555666666653 555544445566666666666666666644444444333

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.93  E-value=4.3e-26  Score=237.14  Aligned_cols=175  Identities=21%  Similarity=0.310  Sum_probs=142.7

Q ss_pred             cCCCcccCcccccccceEEEEEECCCC-eEEEEEEeecccchhHHHHHHHHHHHHhcCCCC------CcceeEeeccCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQ-TVVAVKVLFLHQRGALKSFMAECEALRNIRHRN------LVKIITACSSSDF  512 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~  512 (640)
                      .++|++.+.||+|+||.||+|++..++ +.||+|+++.. ....+.+.+|+.+++.++|++      ++.+++++     
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~-----   91 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF-----   91 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE-----
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee-----
Confidence            467899999999999999999997766 79999999643 234467889999999997766      88888884     


Q ss_pred             CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee---
Q 035691          513 QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL---  589 (640)
Q Consensus       513 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl---  589 (640)
                      ......++||||+ +|++.+++.....        ..+++..+..++.|++.||+|||+   .+|+||||||+||++   
T Consensus        92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~--------~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~  159 (355)
T 2eu9_A           92 NFHGHMCIAFELL-GKNTFEFLKENNF--------QPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNS  159 (355)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTT--------CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCC
T ss_pred             eeCCeEEEEEecc-CCChHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecc
Confidence            3445789999999 6677776654322        237889999999999999999999   699999999999999   


Q ss_pred             ----------------CCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          590 ----------------DNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       590 ----------------~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                                      +.++.+||+|||+++.....       .....||+.|+|||++.+..++.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~  218 (355)
T 2eu9_A          160 EFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-------HTTIVATRHYRPPEVILELGWAQ  218 (355)
T ss_dssp             CEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-------CCSSCSCGGGCCHHHHTTCCCCT
T ss_pred             cccccccccccccccccCCCcEEEeecCcccccccc-------ccCCcCCCcccCCeeeecCCCCC
Confidence                            56789999999999864322       12346999999999999887765

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.93  E-value=3e-26  Score=244.80  Aligned_cols=176  Identities=24%  Similarity=0.323  Sum_probs=126.5

Q ss_pred             CcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCceeeEE
Q 035691          443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDFKALV  521 (640)
Q Consensus       443 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~lv  521 (640)
                      |...+.||+|+||+||.+.. .+|+.||||++....   .+.+.+|+++++++ +|||||++++++     ......++|
T Consensus        17 ~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv   87 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIA   87 (434)
T ss_dssp             EEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEE
T ss_pred             eeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEE
Confidence            44568899999999987544 479999999985432   35678999999886 899999999984     445678999


Q ss_pred             eeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC---------
Q 035691          522 YEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND---------  592 (640)
Q Consensus       522 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~---------  592 (640)
                      ||||. |+|.+++.........   ....++..++.++.||+.||+|||+   .+|+||||||+||+++.+         
T Consensus        88 ~E~~~-gsL~~~l~~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~  160 (434)
T 2rio_A           88 LELCN-LNLQDLVESKNVSDEN---LKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQT  160 (434)
T ss_dssp             ECCCS-EEHHHHHHTC---------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred             EecCC-CCHHHHHhccCCCchh---hhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCccccccccc
Confidence            99996 6999999754432100   0111333467899999999999999   699999999999999754         


Q ss_pred             ----CcEEEccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          593 ----MIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       593 ----~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                          +.+||+|||+++.+..............+||+.|+|||++.+
T Consensus       161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  206 (434)
T 2rio_A          161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE  206 (434)
T ss_dssp             CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSC
T ss_pred             CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcc
Confidence                489999999998765432211112234569999999999976

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.93  E-value=2.2e-27  Score=247.57  Aligned_cols=207  Identities=17%  Similarity=0.168  Sum_probs=129.3

Q ss_pred             EEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCC----cCCCCCC-CCCEEEccCCCcCCccccccCCchhhcCC-
Q 035691            7 LINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIP----VNLTHCS-ELRTLDLVLNKLEENQLVGELPPYIGFTL-   80 (640)
Q Consensus         7 ~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~----~~~~~l~-~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l-   80 (640)
                      .++|++|++++.+|..+....+|++|+|++|.|++..+    ..|..++ +|++|+|++|+|+.      .....+..+ 
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~------~~~~~l~~~l   75 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGF------KNSDELVQIL   75 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGG------SCHHHHHHHH
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCH------HHHHHHHHHH
Confidence            56888999998888777777779999999999886666    6777888 89999998888764      322222222 


Q ss_pred             ----CCCCeeeccCCcccccCCccCc----CC-CCCCEEECcCCccCccCCcccc----C-CCCCCEEEcccCcCCCCCC
Q 035691           81 ----PNIRIPLLAGNQFFGNIPHSIS----NA-SKLEWLDFANNSLTASIPEDLG----R-LRNLTRLNFARNDLGTRKV  146 (640)
Q Consensus        81 ----~~L~~L~L~~N~l~~~~~~~~~----~l-~~L~~L~Ls~N~l~~~~~~~~~----~-l~~L~~L~L~~N~l~~~~~  146 (640)
                          ++|+.|+|++|++++..+..+.    .+ ++|++|+|++|+|++..+..+.    . .++|++|+|++|+++....
T Consensus        76 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~  155 (362)
T 3goz_A           76 AAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSS  155 (362)
T ss_dssp             HTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCH
T ss_pred             hccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHH
Confidence                7788888888888766665433    33 6788888888887765554433    3 2477777777777765422


Q ss_pred             CcccccccccCCC-CcceEecCCCCCCCcCc-----CCCCC-CCCCEEEccCCcCccc----CCcCccC-CCCCCEEEcc
Q 035691          147 NDLRFLDSLVNCT-YLEIVSLNVNSLRSIPI-----SVGYL-PKLQVLSLFENNISGE----IPSSLGN-FTFLTELNLR  214 (640)
Q Consensus       147 ~~~~~~~~l~~l~-~L~~L~L~~N~l~~ip~-----~~~~l-~~L~~L~L~~N~l~~~----~p~~~~~-l~~L~~L~L~  214 (640)
                      ..  ....+..++ +|++|+|++|+++..+.     .+... ++|++|+|++|.|++.    ++..+.. .++|++|+|+
T Consensus       156 ~~--l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls  233 (362)
T 3goz_A          156 DE--LIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLC  233 (362)
T ss_dssp             HH--HHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECC
T ss_pred             HH--HHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECc
Confidence            11  122333343 66666666666655322     12223 3566666666666542    2223333 2356666666


Q ss_pred             CCCCCCC
Q 035691          215 GNSIRGS  221 (640)
Q Consensus       215 ~N~l~~~  221 (640)
                      +|+|+..
T Consensus       234 ~N~l~~~  240 (362)
T 3goz_A          234 LNCLHGP  240 (362)
T ss_dssp             SSCCCCC
T ss_pred             CCCCCcH
Confidence            6665543

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.92  E-value=1.1e-25  Score=229.62  Aligned_cols=203  Identities=23%  Similarity=0.243  Sum_probs=134.7

Q ss_pred             CCCCEEECcCCccCccCCccc--cCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcC-cCCCCC
Q 035691          105 SKLEWLDFANNSLTASIPEDL--GRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIP-ISVGYL  181 (640)
Q Consensus       105 ~~L~~L~Ls~N~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip-~~~~~l  181 (640)
                      ++|++|+|++|.+++..|..+  ..+++|++|+|++|+++..... + ....+..+++|++|++++|.++.++ ..+..+
T Consensus        91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~-~-~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l  168 (310)
T 4glp_A           91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSW-L-AELQQWLKPGLKVLSIAQAHSPAFSCEQVRAF  168 (310)
T ss_dssp             SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSS-H-HHHHTTBCSCCCEEEEECCSSCCCCTTSCCCC
T ss_pred             CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhh-h-HHHHhhhccCCCEEEeeCCCcchhhHHHhccC
Confidence            456666666666666666555  5666666666666666542110 0 0012335666777777777776644 456667


Q ss_pred             CCCCEEEccCCcCcc---cC-CcCccCCCCCCEEEccCCCCCCCCCc----cccCCCCccEEeccCccccCCCCCceEEc
Q 035691          182 PKLQVLSLFENNISG---EI-PSSLGNFTFLTELNLRGNSIRGSIPS----ALGNCHQLQSLDLSKTIFLGQYPVRWLDL  253 (640)
Q Consensus       182 ~~L~~L~L~~N~l~~---~~-p~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~ls~n~~~~~~~l~~L~L  253 (640)
                      ++|++|+|++|++.+   .. +..+..+++|++|+|++|+++. ++.    .++.+++|+.|                +|
T Consensus       169 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L----------------~L  231 (310)
T 4glp_A          169 PALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSL----------------DL  231 (310)
T ss_dssp             TTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSE----------------EC
T ss_pred             CCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEE----------------EC
Confidence            777888888877654   22 2334677788888888888763 222    24566777666                77


Q ss_pred             cCCcCCCCCCccCCCC---CCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCcc
Q 035691          254 SHNHLTGPIPLAVGNL---KSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTF  330 (640)
Q Consensus       254 s~N~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  330 (640)
                      ++|++++..|..+..+   ++|++|+|++|+|+ .+|..+.  ++|++|+|++|+|++. |. +..+++|++|+|++|++
T Consensus       232 s~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l  306 (310)
T 4glp_A          232 SHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPF  306 (310)
T ss_dssp             TTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTT
T ss_pred             CCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCC
Confidence            7777777767666666   58888888888888 5666664  6888888888888864 32 67788888888888888


Q ss_pred             c
Q 035691          331 Q  331 (640)
Q Consensus       331 ~  331 (640)
                      +
T Consensus       307 ~  307 (310)
T 4glp_A          307 L  307 (310)
T ss_dssp             S
T ss_pred             C
Confidence            7

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.92  E-value=1.9e-26  Score=235.58  Aligned_cols=182  Identities=24%  Similarity=0.365  Sum_probs=141.3

Q ss_pred             ccCHHHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcC--CCCCcceeE
Q 035691          430 NVSYESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIR--HRNLVKIIT  505 (640)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--H~niv~l~~  505 (640)
                      .+.+.++....++|++.+.||+|+||.||+|++. +++.||||++....  ....+.+.+|++++++++  ||||+++++
T Consensus        17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~   95 (313)
T 3cek_A           17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD   95 (313)
T ss_dssp             ---CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred             CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence            3444455556677999999999999999999986 68999999996443  334578999999999997  599999999


Q ss_pred             eeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCC
Q 035691          506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPS  585 (640)
Q Consensus       506 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~  585 (640)
                      ++.     .....++||| +.+|+|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+
T Consensus        96 ~~~-----~~~~~~lv~e-~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~  156 (313)
T 3cek_A           96 YEI-----TDQYIYMVME-CGNIDLNSWLKKKK----------SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPA  156 (313)
T ss_dssp             EEE-----CSSEEEEEEC-CCSEEHHHHHHHCS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGG
T ss_pred             Eee-----cCCEEEEEEe-cCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcc
Confidence            954     3457899999 56789999986432          27888999999999999999999   69999999999


Q ss_pred             CeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          586 NVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       586 NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      ||++++ +.+||+|||+++.+......  .......||+.|+|||++.+
T Consensus       157 NIl~~~-~~~kL~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~  202 (313)
T 3cek_A          157 NFLIVD-GMLKLIDFGIANQMQPDTTS--VVKDSQVGTVNYMPPEAIKD  202 (313)
T ss_dssp             GEEEET-TEEEECCCSSSCC----------------CCGGGCCHHHHTT
T ss_pred             cEEEEC-CeEEEeeccccccccCcccc--ccccCCCCCCCcCCHHHHhh
Confidence            999964 89999999999876432211  11223468999999999876

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.92  E-value=9.5e-27  Score=242.82  Aligned_cols=255  Identities=17%  Similarity=0.222  Sum_probs=193.6

Q ss_pred             eEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCc----hhhcCCC-CCCeeeccCCcccccCCccCcCC-
Q 035691           31 YIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPP----YIGFTLP-NIRIPLLAGNQFFGNIPHSISNA-  104 (640)
Q Consensus        31 ~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~----~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l-  104 (640)
                      ++.+++|.+++.+|..+...++|++|||++|.|+.      .+.    ..+..++ +|+.|+|++|+|++..+..|..+ 
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~------~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l   75 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYS------ISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQIL   75 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGG------SCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHH
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCCh------HHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHH
Confidence            56899999999888877777789999999999875      554    4555687 89999999999998888888775 


Q ss_pred             ----CCCCEEECcCCccCccCCcc----ccCC-CCCCEEEcccCcCCCCCCCcccccccccC-CCCcceEecCCCCCCC-
Q 035691          105 ----SKLEWLDFANNSLTASIPED----LGRL-RNLTRLNFARNDLGTRKVNDLRFLDSLVN-CTYLEIVSLNVNSLRS-  173 (640)
Q Consensus       105 ----~~L~~L~Ls~N~l~~~~~~~----~~~l-~~L~~L~L~~N~l~~~~~~~~~~~~~l~~-l~~L~~L~L~~N~l~~-  173 (640)
                          ++|++|+|++|++++..+..    +..+ ++|++|+|++|+|+..+...+  ...+.. .++|++|+|++|.++. 
T Consensus        76 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l--~~~l~~~~~~L~~L~Ls~N~l~~~  153 (362)
T 3goz_A           76 AAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEF--KQAFSNLPASITSLNLRGNDLGIK  153 (362)
T ss_dssp             HTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHH--HHHHTTSCTTCCEEECTTSCGGGS
T ss_pred             hccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHH--HHHHHhCCCceeEEEccCCcCCHH
Confidence                99999999999999776664    4444 899999999999987643222  123444 3699999999999984 


Q ss_pred             ----cCcCCCCCC-CCCEEEccCCcCcccCCcCcc----CC-CCCCEEEccCCCCCCC----CCccccC-CCCccEEecc
Q 035691          174 ----IPISVGYLP-KLQVLSLFENNISGEIPSSLG----NF-TFLTELNLRGNSIRGS----IPSALGN-CHQLQSLDLS  238 (640)
Q Consensus       174 ----ip~~~~~l~-~L~~L~L~~N~l~~~~p~~~~----~l-~~L~~L~L~~N~l~~~----~~~~~~~-l~~L~~L~ls  238 (640)
                          ++..+..++ +|++|+|++|.|++..+..+.    .+ ++|++|+|++|.|+..    ++..+.. .++|+.|   
T Consensus       154 ~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L---  230 (362)
T 3goz_A          154 SSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSL---  230 (362)
T ss_dssp             CHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEE---
T ss_pred             HHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEE---
Confidence                344444555 899999999999877765444    44 6999999999999863    3444554 3478777   


Q ss_pred             CccccCCCCCceEEccCCcCCCCCC----ccCCCCCCCCEEECCCCcccCc-------CCccccCCCCCCeEEecCCccC
Q 035691          239 KTIFLGQYPVRWLDLSHNHLTGPIP----LAVGNLKSIPHLDLSKNKLSGE-------IPSSLGSCVGLEYLNLSINSFH  307 (640)
Q Consensus       239 ~n~~~~~~~l~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~-------~p~~~~~l~~L~~L~L~~N~l~  307 (640)
                                   +|++|.+++..+    ..+..+++|+.|+|++|.+.+.       ++..+..+++|++||+++|++.
T Consensus       231 -------------~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~  297 (362)
T 3goz_A          231 -------------NLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH  297 (362)
T ss_dssp             -------------ECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCC
T ss_pred             -------------ECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCC
Confidence                         666777765443    3456778888888888885433       2345677778888888888886


Q ss_pred             CC
Q 035691          308 GP  309 (640)
Q Consensus       308 ~~  309 (640)
                      ..
T Consensus       298 ~~  299 (362)
T 3goz_A          298 PS  299 (362)
T ss_dssp             GG
T ss_pred             Cc
Confidence            54

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.92  E-value=2.4e-26  Score=235.44  Aligned_cols=181  Identities=28%  Similarity=0.365  Sum_probs=140.3

Q ss_pred             HHHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccC
Q 035691          433 YESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSS  510 (640)
Q Consensus       433 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~  510 (640)
                      .++.....++|++.+.||+|+||.||+|++..   .||+|++....  ....+.+.+|+.++++++||||+++++++.. 
T Consensus        25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-  100 (319)
T 2y4i_B           25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-  100 (319)
T ss_dssp             GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC-
T ss_pred             cccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec-
Confidence            34444556789999999999999999999863   39999986432  2334567889999999999999999999643 


Q ss_pred             CcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC
Q 035691          511 DFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD  590 (640)
Q Consensus       511 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~  590 (640)
                          ....++||||+++++|.+++....         ..+++..++.++.|++.||+|||+   .+|+||||||+||+++
T Consensus       101 ----~~~~~iv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~  164 (319)
T 2y4i_B          101 ----PPHLAIITSLCKGRTLYSVVRDAK---------IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD  164 (319)
T ss_dssp             ----SSCEEEECBCCCSEEHHHHTTSSC---------CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC
T ss_pred             ----CCceEEEeecccCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe
Confidence                346899999999999999996543         237788999999999999999999   6999999999999998


Q ss_pred             CCCcEEEccccccccCCCccCC-CceeeccccccccccCcccCCC
Q 035691          591 NDMIAHVGDFGLTRFIPEVISS-NQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       591 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                       ++.+||+|||+++........ .........||+.|+|||++.+
T Consensus       165 -~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~  208 (319)
T 2y4i_B          165 -NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ  208 (319)
T ss_dssp             ---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSC
T ss_pred             -CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhh
Confidence             679999999998765321111 1111223458999999999875

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.92  E-value=4.1e-27  Score=247.99  Aligned_cols=249  Identities=18%  Similarity=0.207  Sum_probs=147.5

Q ss_pred             CCchhhhcCCCCCeEEcccCccCccC----CcCCCCCCCCCEEEccCCCcCCccccccCCchhh------cCCCCCCeee
Q 035691           18 NIPHEIGRLFQLRYIIFNSNTLQGQI----PVNLTHCSELRTLDLVLNKLEENQLVGELPPYIG------FTLPNIRIPL   87 (640)
Q Consensus        18 ~~p~~~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~------~~l~~L~~L~   87 (640)
                      .++..+..+++|++|+|++|.|+...    +..|..+++|++|+|++|.+.  .+.+.+|..+.      ..+++|+.|+
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~--~l~~~~~~~~~~l~~~l~~~~~L~~L~  100 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTG--RVKDEIPEALRLLLQALLKCPKLHTVR  100 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTT--SCGGGSHHHHHHHHHHHTTCTTCCEEE
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccC--ccccchhHHHHHHHHHHhhCCcccEEE
Confidence            56778889999999999999998753    345788999999999988753  34555665552      3355555555


Q ss_pred             ccCCcccc----cCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCC-----
Q 035691           88 LAGNQFFG----NIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNC-----  158 (640)
Q Consensus        88 L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l-----  158 (640)
                      |++|.|++    .+|..+..+++|++|+|++|.|+...+..+..                          .+..+     
T Consensus       101 Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~--------------------------~l~~l~~~~~  154 (386)
T 2ca6_A          101 LSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR--------------------------ALQELAVNKK  154 (386)
T ss_dssp             CCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH--------------------------HHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHH--------------------------HHHHHhhhhh
Confidence            55555554    24444455555555555555554322222221                          12222     


Q ss_pred             ----CCcceEecCCCCCCC--cC---cCCCCCCCCCEEEccCCcCcc-----cCCcCccCCCCCCEEEccCCCCC----C
Q 035691          159 ----TYLEIVSLNVNSLRS--IP---ISVGYLPKLQVLSLFENNISG-----EIPSSLGNFTFLTELNLRGNSIR----G  220 (640)
Q Consensus       159 ----~~L~~L~L~~N~l~~--ip---~~~~~l~~L~~L~L~~N~l~~-----~~p~~~~~l~~L~~L~L~~N~l~----~  220 (640)
                          ++|++|++++|+++.  +|   ..+..+++|++|+|++|.|+.     ..|..+..+++|+.|+|++|.|+    .
T Consensus       155 ~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~  234 (386)
T 2ca6_A          155 AKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS  234 (386)
T ss_dssp             HHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHH
T ss_pred             cccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHH
Confidence                444444444444431  22   233344556666666665551     23335566666666666666664    3


Q ss_pred             CCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCC----CCccC--CCCCCCCEEECCCCcccC----cCCccc
Q 035691          221 SIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGP----IPLAV--GNLKSIPHLDLSKNKLSG----EIPSSL  290 (640)
Q Consensus       221 ~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~----~~~~~--~~l~~L~~L~Ls~N~l~~----~~p~~~  290 (640)
                      .+|..+..+++|+.|                +|++|.+++.    ++..+  +.+++|+.|+|++|++++    .+|..+
T Consensus       235 ~l~~~l~~~~~L~~L----------------~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l  298 (386)
T 2ca6_A          235 ALAIALKSWPNLREL----------------GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI  298 (386)
T ss_dssp             HHHHHGGGCTTCCEE----------------ECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHH
T ss_pred             HHHHHHccCCCcCEE----------------ECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHH
Confidence            455556666666666                5555555433    34444  336777777777777775    366655


Q ss_pred             -cCCCCCCeEEecCCccCCCC
Q 035691          291 -GSCVGLEYLNLSINSFHGPI  310 (640)
Q Consensus       291 -~~l~~L~~L~L~~N~l~~~~  310 (640)
                       .++++|++|+|++|++++..
T Consensus       299 ~~~l~~L~~L~l~~N~l~~~~  319 (386)
T 2ca6_A          299 DEKMPDLLFLELNGNRFSEED  319 (386)
T ss_dssp             HHHCTTCCEEECTTSBSCTTS
T ss_pred             HhcCCCceEEEccCCcCCcch
Confidence             55677888888888877655

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.92  E-value=6.7e-26  Score=241.40  Aligned_cols=171  Identities=26%  Similarity=0.364  Sum_probs=127.9

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCceee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .+|...++||+|+||+||.... .+|+.||||++.....   ..+.+|+++++++ +|||||++++++     .+....+
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~~   94 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQY   94 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEEE
T ss_pred             EEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEEE
Confidence            4578889999999999654333 3789999999854332   2356899999999 899999999985     3455789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC-----CCc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN-----DMI  594 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~-----~~~  594 (640)
                      +|||||+ |+|.+++......         ..+..+..++.||+.||+|||+   .+|+||||||+||+++.     ...
T Consensus        95 lv~E~~~-g~L~~~l~~~~~~---------~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~  161 (432)
T 3p23_A           95 IAIELCA-ATLQEYVEQKDFA---------HLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIK  161 (432)
T ss_dssp             EEEECCS-EEHHHHHHSSSCC---------CCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCC
T ss_pred             EEEECCC-CCHHHHHHhcCCC---------ccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCcee
Confidence            9999997 5999998654321         2223456899999999999999   69999999999999953     336


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      +||+|||+|+........ .......+||+.|+|||++.+
T Consensus       162 ~kL~DFG~a~~~~~~~~~-~~~~~~~~gt~~y~APE~l~~  200 (432)
T 3p23_A          162 AMISDFGLCKKLAVGRHS-FSRRSGVPGTEGWIAPEMLSE  200 (432)
T ss_dssp             EEECCTTEEECC-------------CCSCTTSCCGGGTSC
T ss_pred             EEEecccceeeccCCCcc-eeeccccCCCcCccChhhhhc
Confidence            889999999876432211 122334679999999999974

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.92  E-value=3.2e-25  Score=226.14  Aligned_cols=226  Identities=15%  Similarity=0.154  Sum_probs=181.6

Q ss_pred             CCcEEeCCCCccccCCch---hhhcCCCCCeEEcccCccCccCCcCC--CCCCCCCEEEccCCCcCCccccccCC---ch
Q 035691            4 FLMLINLQQNNFSGNIPH---EIGRLFQLRYIIFNSNTLQGQIPVNL--THCSELRTLDLVLNKLEENQLVGELP---PY   75 (640)
Q Consensus         4 ~L~~L~L~~n~i~~~~p~---~~~~l~~L~~L~l~~N~l~~~~~~~~--~~l~~L~~L~Ls~N~l~~~~~~~~lp---~~   75 (640)
                      .++.|++.++.++...-.   .+..+++|++|++++|.+++..|..+  ..+++|++|+|++|+++.     ..+   ..
T Consensus        65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~-----~~~~~~~~  139 (310)
T 4glp_A           65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWAT-----GRSWLAEL  139 (310)
T ss_dssp             CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSS-----TTSSHHHH
T ss_pred             ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccc-----hhhhhHHH
Confidence            467888888887642211   23346789999999999999999988  999999999999999874     222   12


Q ss_pred             hhcCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCcc---C-CccccCCCCCCEEEcccCcCCCCCCCcccc
Q 035691           76 IGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS---I-PEDLGRLRNLTRLNFARNDLGTRKVNDLRF  151 (640)
Q Consensus        76 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  151 (640)
                      .+..+++|+.|+|++|++++..+..|.++++|++|||++|++.+.   . +..+..+++|++|+|++|+++.++.    .
T Consensus       140 ~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~----~  215 (310)
T 4glp_A          140 QQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTG----V  215 (310)
T ss_dssp             HTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHH----H
T ss_pred             HhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHH----H
Confidence            233699999999999999999999999999999999999998752   2 3345789999999999999976532    1


Q ss_pred             cc-cccCCCCcceEecCCCCCCCc-CcCCCCC---CCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccc
Q 035691          152 LD-SLVNCTYLEIVSLNVNSLRSI-PISVGYL---PKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSAL  226 (640)
Q Consensus       152 ~~-~l~~l~~L~~L~L~~N~l~~i-p~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~  226 (640)
                      +. .+.++++|++|+|++|+++.+ |..+..+   ++|++|+|++|+|+ .+|..+.  ++|++|+|++|+|++. |. +
T Consensus       216 ~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~  290 (310)
T 4glp_A          216 CAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-P  290 (310)
T ss_dssp             HHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-T
T ss_pred             HHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-h
Confidence            11 246889999999999999995 8777665   69999999999999 5677665  8999999999999965 33 6


Q ss_pred             cCCCCccEEeccCcccc
Q 035691          227 GNCHQLQSLDLSKTIFL  243 (640)
Q Consensus       227 ~~l~~L~~L~ls~n~~~  243 (640)
                      ..+++|+.|++++|.+.
T Consensus       291 ~~l~~L~~L~L~~N~l~  307 (310)
T 4glp_A          291 DELPEVDNLTLDGNPFL  307 (310)
T ss_dssp             TSCCCCSCEECSSTTTS
T ss_pred             hhCCCccEEECcCCCCC
Confidence            88899999955555443

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.92  E-value=1.3e-25  Score=229.87  Aligned_cols=171  Identities=22%  Similarity=0.259  Sum_probs=123.7

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccch--hHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG--ALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      .++|+..+.||+|+||.||+|+++.+|+.||||++......  ..+.+.++..+++.++||||+++++++.     ..+.
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~~~   98 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TNTD   98 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cCCc
Confidence            35678889999999999999999989999999999654322  2234445556788889999999999964     3457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeeeCCCCCCCeeeCCCCcEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKK-QIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~-~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      .++||||+ ++.+..+.....         ..+++..+..++.|++.||.|||+   . +|+||||||+||+++.++.+|
T Consensus        99 ~~lv~e~~-~~~~~~l~~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~k  165 (318)
T 2dyl_A           99 VFIAMELM-GTCAEKLKKRMQ---------GPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIK  165 (318)
T ss_dssp             EEEEECCC-SEEHHHHHHHHT---------SCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEE
T ss_pred             EEEEEecc-CCcHHHHHHHhc---------cCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEE
Confidence            89999999 445554443211         237889999999999999999998   4 899999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGM  633 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  633 (640)
                      |+|||+++......     ......||+.|+|||++.
T Consensus       166 l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~  197 (318)
T 2dyl_A          166 LCDFGISGRLVDDK-----AKDRSAGCAAYMAPERID  197 (318)
T ss_dssp             ECCCTTC-------------------CCTTCCHHHHC
T ss_pred             EEECCCchhccCCc-----cccccCCCccccChhhcc
Confidence            99999997654321     112345899999999985

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.92  E-value=2e-24  Score=219.75  Aligned_cols=171  Identities=23%  Similarity=0.339  Sum_probs=76.0

Q ss_pred             cCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcCCCCC
Q 035691          102 SNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYL  181 (640)
Q Consensus       102 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l  181 (640)
                      ..+++|++|+|++|++++..+  +..+++|++|+|++|+++.+        ..+..+++|+.|++++|+++.+|. +..+
T Consensus        60 ~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--------~~~~~l~~L~~L~l~~n~l~~~~~-l~~l  128 (308)
T 1h6u_A           60 QYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--------SAIAGLQSIKTLDLTSTQITDVTP-LAGL  128 (308)
T ss_dssp             GGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--------GGGTTCTTCCEEECTTSCCCCCGG-GTTC
T ss_pred             hccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--------hhhcCCCCCCEEECCCCCCCCchh-hcCC
Confidence            334444444444444443222  44444444444444444332        123334444444444444444332 3444


Q ss_pred             CCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCC
Q 035691          182 PKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGP  261 (640)
Q Consensus       182 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~  261 (640)
                      ++|++|++++|.+++..+  +..+++|++|+|++|++++..+  +..+++|+.|                ++++|++++.
T Consensus       129 ~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L----------------~l~~n~l~~~  188 (308)
T 1h6u_A          129 SNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTL----------------KADDNKISDI  188 (308)
T ss_dssp             TTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE----------------ECCSSCCCCC
T ss_pred             CCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEE----------------ECCCCccCcC
Confidence            445555555555443222  4444555555555555543222  4444444444                4444444432


Q ss_pred             CCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccC
Q 035691          262 IPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFH  307 (640)
Q Consensus       262 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  307 (640)
                      .+  +..+++|+.|+|++|++++..  .+..+++|++|+|++|+++
T Consensus       189 ~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~  230 (308)
T 1h6u_A          189 SP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTIT  230 (308)
T ss_dssp             GG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEE
T ss_pred             hh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeee
Confidence            22  444555555555555555332  2445555555555555554

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.92  E-value=3.6e-24  Score=217.87  Aligned_cols=198  Identities=23%  Similarity=0.290  Sum_probs=113.1

Q ss_pred             eCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeec
Q 035691            9 NLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLL   88 (640)
Q Consensus         9 ~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L   88 (640)
                      .+..+.+++..+  +..+++|++|++++|.++. +| .+..+++|++|+|++|++++      +++  +..+++|+.|+|
T Consensus        25 ~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~------~~~--~~~l~~L~~L~L   92 (308)
T 1h6u_A           25 AAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITD------LAP--LKNLTKITELEL   92 (308)
T ss_dssp             HTTCSSTTSEEC--HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC------CGG--GTTCCSCCEEEC
T ss_pred             HhCCCCcCceec--HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCC------Chh--HccCCCCCEEEc
Confidence            344444443322  4456666677777776663 33 46666667777776666654      443  344666666666


Q ss_pred             cCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCC
Q 035691           89 AGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNV  168 (640)
Q Consensus        89 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~  168 (640)
                      ++|++++.  ..|..+++|++|+|++|++++. +. +..+++|++|+|++|+++.++        .+..+++|+.|++++
T Consensus        93 ~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~--------~l~~l~~L~~L~l~~  160 (308)
T 1h6u_A           93 SGNPLKNV--SAIAGLQSIKTLDLTSTQITDV-TP-LAGLSNLQVLYLDLNQITNIS--------PLAGLTNLQYLSIGN  160 (308)
T ss_dssp             CSCCCSCC--GGGTTCTTCCEEECTTSCCCCC-GG-GTTCTTCCEEECCSSCCCCCG--------GGGGCTTCCEEECCS
T ss_pred             cCCcCCCc--hhhcCCCCCCEEECCCCCCCCc-hh-hcCCCCCCEEECCCCccCcCc--------cccCCCCccEEEccC
Confidence            66666643  2466666666666666666643 22 566666666666666665542        145556666666666


Q ss_pred             CCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEE
Q 035691          169 NSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSL  235 (640)
Q Consensus       169 N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  235 (640)
                      |.++.++. +..+++|++|++++|.+++..+  +..+++|++|+|++|++++..+  +..+++|+.|
T Consensus       161 n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L  222 (308)
T 1h6u_A          161 AQVSDLTP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIV  222 (308)
T ss_dssp             SCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEE
T ss_pred             CcCCCChh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEE
Confidence            66665544 5555666666666666654332  5555666666666666654332  4555555555

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.91  E-value=4.2e-27  Score=262.31  Aligned_cols=340  Identities=11%  Similarity=0.075  Sum_probs=202.6

Q ss_pred             CCcEEeCCCCc-ccc-CCchhhhcCCCCCeEEcccCccCcc----CCcCCCCCCCCCEEEccCCCcCCccccccCCchhh
Q 035691            4 FLMLINLQQNN-FSG-NIPHEIGRLFQLRYIIFNSNTLQGQ----IPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIG   77 (640)
Q Consensus         4 ~L~~L~L~~n~-i~~-~~p~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~   77 (640)
                      +|++|+|++|. ++. .++..+.++++|++|+|++|.+++.    ++..+..+++|++|+|++|.++.... +.++. ++
T Consensus       139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~-~~l~~-~~  216 (592)
T 3ogk_B          139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISP-KDLET-IA  216 (592)
T ss_dssp             GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCH-HHHHH-HH
T ss_pred             cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCH-HHHHH-HH
Confidence            38888888886 321 1223345788888888888887654    23344577888888888888763111 11222 23


Q ss_pred             cCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccC---ccCCccccCCCCCCEEEcccCcCCCCCCCccccccc
Q 035691           78 FTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLT---ASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDS  154 (640)
Q Consensus        78 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~---~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~  154 (640)
                      ..+++|+.|+|++|.+.+ +|..+.++++|++|+++.+...   ...+..+..+++|+.|+++++....       .+..
T Consensus       217 ~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~-------l~~~  288 (592)
T 3ogk_B          217 RNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-------MPIL  288 (592)
T ss_dssp             HHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTT-------GGGG
T ss_pred             hhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchhH-------HHHH
Confidence            357888888888888876 5577788888888888754332   2233456677777777777754333       2344


Q ss_pred             ccCCCCcceEecCCCCCCC--cCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEcc-----------CCCCCCC
Q 035691          155 LVNCTYLEIVSLNVNSLRS--IPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLR-----------GNSIRGS  221 (640)
Q Consensus       155 l~~l~~L~~L~L~~N~l~~--ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~-----------~N~l~~~  221 (640)
                      +..+++|++|++++|.++.  ++..+..+++|++|+++++-..+.++..+..+++|++|+|+           .|.++..
T Consensus       289 ~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~  368 (592)
T 3ogk_B          289 FPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQR  368 (592)
T ss_dssp             GGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHH
T ss_pred             HhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHH
Confidence            5567777777777777654  22234567777777777332222233334556777777777           2455432


Q ss_pred             C-CccccCCCCccEEeccCccccC---------CCCCceEEcc----CCcCCCC-----CCccCCCCCCCCEEECCCC--
Q 035691          222 I-PSALGNCHQLQSLDLSKTIFLG---------QYPVRWLDLS----HNHLTGP-----IPLAVGNLKSIPHLDLSKN--  280 (640)
Q Consensus       222 ~-~~~~~~l~~L~~L~ls~n~~~~---------~~~l~~L~Ls----~N~l~~~-----~~~~~~~l~~L~~L~Ls~N--  280 (640)
                      . +..+..+++|+.|+++.|.+.+         ...|+.|+++    .|.+++.     ++..+.++++|+.|+|+++  
T Consensus       369 ~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~  448 (592)
T 3ogk_B          369 GLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQG  448 (592)
T ss_dssp             HHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGG
T ss_pred             HHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCC
Confidence            1 1223456777777776555432         4457777775    5666643     2223555677777777643  


Q ss_pred             cccCcCCcccc-CCCCCCeEEecCCccCC-CCCccCCCCCCCCeEeCcCCccccccCCcccCCC-CCCCCCccccccCCC
Q 035691          281 KLSGEIPSSLG-SCVGLEYLNLSINSFHG-PIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRK-GIFKNASAISVAGNE  357 (640)
Q Consensus       281 ~l~~~~p~~~~-~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~p~~-~~~~~~~~~~~~~n~  357 (640)
                      .+++..+..+. .+++|++|+|++|.+++ .++..+.++++|++|+|++|+++..    .++.. ..+++++.+++++|.
T Consensus       449 ~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~----~~~~~~~~l~~L~~L~ls~n~  524 (592)
T 3ogk_B          449 GLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSER----AIAAAVTKLPSLRYLWVQGYR  524 (592)
T ss_dssp             GCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHH----HHHHHHHHCSSCCEEEEESCB
T ss_pred             CccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHH----HHHHHHHhcCccCeeECcCCc
Confidence            24444333333 35667777777777654 2334456667777777777765421    11111 224556666666665

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=1.5e-23  Score=206.77  Aligned_cols=158  Identities=23%  Similarity=0.278  Sum_probs=120.7

Q ss_pred             CcceEecCCCCCCCcC-cCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEecc
Q 035691          160 YLEIVSLNVNSLRSIP-ISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLS  238 (640)
Q Consensus       160 ~L~~L~L~~N~l~~ip-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls  238 (640)
                      .++.|++++|.++.++ ..+..+++|++|+|++|.|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|   
T Consensus        36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L---  112 (251)
T 3m19_A           36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKL---  112 (251)
T ss_dssp             TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE---
T ss_pred             CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEE---
Confidence            3445555555555533 245666777777777777777777777777888888888888877777777777777777   


Q ss_pred             CccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCC
Q 035691          239 KTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLK  318 (640)
Q Consensus       239 ~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  318 (640)
                                   +|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|++++..+..|..++
T Consensus       113 -------------~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  179 (251)
T 3m19_A          113 -------------YLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLG  179 (251)
T ss_dssp             -------------ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCT
T ss_pred             -------------EcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCC
Confidence                         7777777777777788888888888888888877666788888888888888888887777888888


Q ss_pred             CCCeEeCcCCccccc
Q 035691          319 SLEGLDLFQNTFQAK  333 (640)
Q Consensus       319 ~L~~L~l~~N~l~~~  333 (640)
                      +|++|+|++|+|.|.
T Consensus       180 ~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          180 KLQTITLFGNQFDCS  194 (251)
T ss_dssp             TCCEEECCSCCBCTT
T ss_pred             CCCEEEeeCCceeCC
Confidence            888888888888875

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.91  E-value=3.6e-24  Score=222.16  Aligned_cols=220  Identities=19%  Similarity=0.103  Sum_probs=120.1

Q ss_pred             CCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccC-CccccCCCCCCE-EEcccCcCCCCCCCcccccccccCCC
Q 035691           82 NIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASI-PEDLGRLRNLTR-LNFARNDLGTRKVNDLRFLDSLVNCT  159 (640)
Q Consensus        82 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~~~~l~~l~  159 (640)
                      +++.|+|++|+|+.+.+++|.++++|++|+|++|++.+.+ +.+|.++++|.+ +.+++|+|+.+      .++.|.+++
T Consensus        31 ~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l------~~~~f~~l~  104 (350)
T 4ay9_X           31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYI------NPEAFQNLP  104 (350)
T ss_dssp             TCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEE------CTTSBCCCT
T ss_pred             CCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCccccc------Cchhhhhcc
Confidence            3444444444444444444444444444444444443222 234444444432 33344444443      223344444


Q ss_pred             CcceEecCCCCCCCcCc-CCCCCCCCCEEEccC-CcCcccCCcCccCCC-CCCEEEccCCCCCCCCCccccCCCCccEEe
Q 035691          160 YLEIVSLNVNSLRSIPI-SVGYLPKLQVLSLFE-NNISGEIPSSLGNFT-FLTELNLRGNSIRGSIPSALGNCHQLQSLD  236 (640)
Q Consensus       160 ~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  236 (640)
                      +|++|++++|+++.+|. .+....++..|++.+ |.+..+.+..|..+. .++.|+|++|+|+.+.+..| ...+|+.| 
T Consensus       105 ~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f-~~~~L~~l-  182 (350)
T 4ay9_X          105 NLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAF-NGTQLDEL-  182 (350)
T ss_dssp             TCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSS-TTEEEEEE-
T ss_pred             ccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhc-cccchhHH-
Confidence            45555555555544433 223344566666644 566655566666654 57778888888875544444 34456666 


Q ss_pred             ccCccccCCCCCceEEcc-CCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCC
Q 035691          237 LSKTIFLGQYPVRWLDLS-HNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLS  315 (640)
Q Consensus       237 ls~n~~~~~~~l~~L~Ls-~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~  315 (640)
                                     +++ +|.++.+.+..|.++++|+.|||++|+|+...+..|.+   |+.|.+.++.--..+| .+.
T Consensus       183 ---------------~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~---L~~L~~l~~~~l~~lP-~l~  243 (350)
T 4ay9_X          183 ---------------NLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN---LKKLRARSTYNLKKLP-TLE  243 (350)
T ss_dssp             ---------------ECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTT---CCEEECTTCTTCCCCC-CTT
T ss_pred             ---------------hhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhcc---chHhhhccCCCcCcCC-Cch
Confidence                           554 36666555667888888888888888888554444444   4444444433223455 477


Q ss_pred             CCCCCCeEeCcCC
Q 035691          316 SLKSLEGLDLFQN  328 (640)
Q Consensus       316 ~l~~L~~L~l~~N  328 (640)
                      ++++|+.++++++
T Consensus       244 ~l~~L~~l~l~~~  256 (350)
T 4ay9_X          244 KLVALMEASLTYP  256 (350)
T ss_dssp             TCCSCCEEECSCH
T ss_pred             hCcChhhCcCCCC
Confidence            8888888888643

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.91  E-value=1.9e-25  Score=230.54  Aligned_cols=253  Identities=18%  Similarity=0.255  Sum_probs=136.6

Q ss_pred             CcEEeCCCCccccCCchhhhcC--CCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCC
Q 035691            5 LMLINLQQNNFSGNIPHEIGRL--FQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPN   82 (640)
Q Consensus         5 L~~L~L~~n~i~~~~p~~~~~l--~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~   82 (640)
                      ++.+|+++|.+.   |..+..+  ++++.|++++|.+.+..+. +..+++|++|+|++|.++                  
T Consensus        49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~------------------  106 (336)
T 2ast_B           49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIE------------------  106 (336)
T ss_dssp             SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEEC------------------
T ss_pred             heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcC------------------
Confidence            556666666655   4455555  5666666666666644443 345566666666655443                  


Q ss_pred             CCeeeccCCccccc-CCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccC-cCCCCCCCcccccccccCCCC
Q 035691           83 IRIPLLAGNQFFGN-IPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARN-DLGTRKVNDLRFLDSLVNCTY  160 (640)
Q Consensus        83 L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~~~l~~l~~  160 (640)
                                  +. ++..+..+++|++|+|++|++++..+..+..+++|++|+|++| .++...     .+..+.++++
T Consensus       107 ------------~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~-----l~~~~~~~~~  169 (336)
T 2ast_B          107 ------------VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA-----LQTLLSSCSR  169 (336)
T ss_dssp             ------------HHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHH-----HHHHHHHCTT
T ss_pred             ------------HHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHH-----HHHHHhcCCC
Confidence                        22 3333444444444444444444444444444444444444444 333210     1122344445


Q ss_pred             cceEecCCC-CCCC--cCcCCCCCC-CCCEEEccCC--cCc-ccCCcCccCCCCCCEEEccCCC-CCCCCCccccCCCCc
Q 035691          161 LEIVSLNVN-SLRS--IPISVGYLP-KLQVLSLFEN--NIS-GEIPSSLGNFTFLTELNLRGNS-IRGSIPSALGNCHQL  232 (640)
Q Consensus       161 L~~L~L~~N-~l~~--ip~~~~~l~-~L~~L~L~~N--~l~-~~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L  232 (640)
                      |++|++++| .++.  ++..+..++ +|++|++++|  .++ +.+|..+..+++|++|+|++|. +++..+..+..+++|
T Consensus       170 L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L  249 (336)
T 2ast_B          170 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL  249 (336)
T ss_dssp             CCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred             CCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCC
Confidence            555555555 4443  333444455 6666666666  333 2344555666677777777776 555555566666666


Q ss_pred             cEEeccCccccCCCCCceEEccCCc-CCCCCCccCCCCCCCCEEECCCCcccCcCCccccCC-CCCCeEEecCCccCCCC
Q 035691          233 QSLDLSKTIFLGQYPVRWLDLSHNH-LTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSC-VGLEYLNLSINSFHGPI  310 (640)
Q Consensus       233 ~~L~ls~n~~~~~~~l~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~  310 (640)
                      +.|                ++++|. ++......+..+++|+.|++++| ++.   ..+..+ ..|+.|++++|++++..
T Consensus       250 ~~L----------------~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~  309 (336)
T 2ast_B          250 QHL----------------SLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIA  309 (336)
T ss_dssp             CEE----------------ECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTT
T ss_pred             CEe----------------eCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCcccc
Confidence            666                444443 21111124667778888888877 332   233333 24677778888888887


Q ss_pred             CccCCC
Q 035691          311 HPGLSS  316 (640)
Q Consensus       311 ~~~~~~  316 (640)
                      |..+..
T Consensus       310 ~~~~~~  315 (336)
T 2ast_B          310 RPTIGN  315 (336)
T ss_dssp             CSSCSS
T ss_pred             CCcccc
Confidence            777664

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.91  E-value=1.6e-26  Score=243.46  Aligned_cols=235  Identities=23%  Similarity=0.358  Sum_probs=171.9

Q ss_pred             CCCCCeeeccCCcccccCC----ccCcCCCCCCEEECcCCc---cCccCCccc-------cCCCCCCEEEcccCcCCCCC
Q 035691           80 LPNIRIPLLAGNQFFGNIP----HSISNASKLEWLDFANNS---LTASIPEDL-------GRLRNLTRLNFARNDLGTRK  145 (640)
Q Consensus        80 l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~Ls~N~---l~~~~~~~~-------~~l~~L~~L~L~~N~l~~~~  145 (640)
                      +++|+.|+|++|+|+...+    ..|..+++|++|+|++|.   +++.+|..+       ..+++|++|+|++|.++...
T Consensus        31 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~  110 (386)
T 2ca6_A           31 DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTA  110 (386)
T ss_dssp             CSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTT
T ss_pred             CCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHH
Confidence            4555555555555554422    335567777777777753   334444443       57777888888888776531


Q ss_pred             CCcccccccccCCCCcceEecCCCCCCC-----cCcCCCCC---------CCCCEEEccCCcCc-ccCC---cCccCCCC
Q 035691          146 VNDLRFLDSLVNCTYLEIVSLNVNSLRS-----IPISVGYL---------PKLQVLSLFENNIS-GEIP---SSLGNFTF  207 (640)
Q Consensus       146 ~~~~~~~~~l~~l~~L~~L~L~~N~l~~-----ip~~~~~l---------~~L~~L~L~~N~l~-~~~p---~~~~~l~~  207 (640)
                      ..  ..+..+..+++|++|+|++|.++.     ++..+..+         ++|++|+|++|.|+ +.+|   ..+..+++
T Consensus       111 ~~--~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~  188 (386)
T 2ca6_A          111 QE--PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL  188 (386)
T ss_dssp             HH--HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTT
T ss_pred             HH--HHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCC
Confidence            11  133456677788888888888764     22223333         89999999999997 3444   46778899


Q ss_pred             CCEEEccCCCCCC-----CCCccccCCCCccEEeccCccccCCCCCceEEccCCcCC----CCCCccCCCCCCCCEEECC
Q 035691          208 LTELNLRGNSIRG-----SIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLT----GPIPLAVGNLKSIPHLDLS  278 (640)
Q Consensus       208 L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~----~~~~~~~~~l~~L~~L~Ls  278 (640)
                      |++|+|++|+|+.     ..|..+..+++|+.|                +|++|.++    +.+|..+..+++|+.|+|+
T Consensus       189 L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L----------------~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~  252 (386)
T 2ca6_A          189 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVL----------------DLQDNTFTHLGSSALAIALKSWPNLRELGLN  252 (386)
T ss_dssp             CCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEE----------------ECCSSCCHHHHHHHHHHHGGGCTTCCEEECT
T ss_pred             cCEEECcCCCCCHhHHHHHHHHHhhcCCCccEE----------------ECcCCCCCcHHHHHHHHHHccCCCcCEEECC
Confidence            9999999999982     345578888899888                77778875    4677889999999999999


Q ss_pred             CCcccCc----CCcccc--CCCCCCeEEecCCccCC----CCCccC-CCCCCCCeEeCcCCcccc
Q 035691          279 KNKLSGE----IPSSLG--SCVGLEYLNLSINSFHG----PIHPGL-SSLKSLEGLDLFQNTFQA  332 (640)
Q Consensus       279 ~N~l~~~----~p~~~~--~l~~L~~L~L~~N~l~~----~~~~~~-~~l~~L~~L~l~~N~l~~  332 (640)
                      +|+|++.    +|..+.  .+++|++|+|++|.+++    .+|..+ .++++|++|++++|+++.
T Consensus       253 ~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~  317 (386)
T 2ca6_A          253 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  317 (386)
T ss_dssp             TCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             CCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence            9999865    466663  48999999999999997    477766 678999999999999984

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=3.5e-23  Score=204.16  Aligned_cols=179  Identities=23%  Similarity=0.262  Sum_probs=111.7

Q ss_pred             CCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcc
Q 035691           83 IRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLE  162 (640)
Q Consensus        83 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~  162 (640)
                      .+.++++++.++. +|..+.  ++|+.|+|++|++++..+..|.++++|++|+|++|.|+.++                 
T Consensus        16 ~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-----------------   75 (251)
T 3m19_A           16 KKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLS-----------------   75 (251)
T ss_dssp             GTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCC-----------------
T ss_pred             CeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccC-----------------
Confidence            4455555555553 233332  35555555555555555555555555555555555554431                 


Q ss_pred             eEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccc
Q 035691          163 IVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIF  242 (640)
Q Consensus       163 ~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~  242 (640)
                                  |..+..+++|++|+|++|.|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|       
T Consensus        76 ------------~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L-------  136 (251)
T 3m19_A           76 ------------AGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKEL-------  136 (251)
T ss_dssp             ------------TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE-------
T ss_pred             ------------HhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEE-------
Confidence                        2234556666666666666666666666677777777777777776666666666666666       


Q ss_pred             cCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCC
Q 035691          243 LGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGP  309 (640)
Q Consensus       243 ~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  309 (640)
                               +|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|++++.
T Consensus       137 ---------~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          137 ---------RLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             ---------ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             ---------ECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence                     6666677666666777777777777777777766666777777777777777777653

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.91  E-value=1.2e-25  Score=232.14  Aligned_cols=245  Identities=19%  Similarity=0.222  Sum_probs=199.4

Q ss_pred             CCCCEEEccCCCcCCccccccCCchhhcCC--CCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCcc-CCccccC
Q 035691           51 SELRTLDLVLNKLEENQLVGELPPYIGFTL--PNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS-IPEDLGR  127 (640)
Q Consensus        51 ~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~  127 (640)
                      ..++.||+++|.+..         ..+..+  ++++.|++++|.+.+..+. +..+++|++|+|++|.+++. .+..+..
T Consensus        47 ~~~~~l~l~~~~~~~---------~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~  116 (336)
T 2ast_B           47 SLWQTLDLTGKNLHP---------DVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQ  116 (336)
T ss_dssp             TTSSEEECTTCBCCH---------HHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTT
T ss_pred             hhheeeccccccCCH---------HHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhh
Confidence            348899999887652         222334  8899999999999988776 45799999999999999876 7888999


Q ss_pred             CCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCC-CCCC--cCcCCCCCCCCCEEEccCC-cCccc-CCcCc
Q 035691          128 LRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVN-SLRS--IPISVGYLPKLQVLSLFEN-NISGE-IPSSL  202 (640)
Q Consensus       128 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N-~l~~--ip~~~~~l~~L~~L~L~~N-~l~~~-~p~~~  202 (640)
                      +++|++|+|++|.++..      .+..+..+++|++|++++| .++.  ++..+..+++|++|++++| .+++. ++..+
T Consensus       117 ~~~L~~L~L~~~~l~~~------~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~  190 (336)
T 2ast_B          117 CSKLQNLSLEGLRLSDP------IVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV  190 (336)
T ss_dssp             BCCCSEEECTTCBCCHH------HHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHH
T ss_pred             CCCCCEEeCcCcccCHH------HHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHH
Confidence            99999999999998764      5567888999999999999 7874  6766778899999999999 99864 57778


Q ss_pred             cCCC-CCCEEEccCC--CCC-CCCCccccCCCCccEEeccCccccCCCCCceEEccCCc-CCCCCCccCCCCCCCCEEEC
Q 035691          203 GNFT-FLTELNLRGN--SIR-GSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNH-LTGPIPLAVGNLKSIPHLDL  277 (640)
Q Consensus       203 ~~l~-~L~~L~L~~N--~l~-~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L  277 (640)
                      ..++ +|++|+|++|  .++ +.+|..+..+++|+.|                ++++|. +++..+..+..+++|+.|++
T Consensus       191 ~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L----------------~l~~~~~l~~~~~~~l~~l~~L~~L~l  254 (336)
T 2ast_B          191 AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL----------------DLSDSVMLKNDCFQEFFQLNYLQHLSL  254 (336)
T ss_dssp             HHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEE----------------ECTTCTTCCGGGGGGGGGCTTCCEEEC
T ss_pred             HhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEE----------------eCCCCCcCCHHHHHHHhCCCCCCEeeC
Confidence            8899 9999999999  455 4556677888899888                777777 67677788999999999999


Q ss_pred             CCCc-ccCcCCccccCCCCCCeEEecCCccCCCCCccCCCC-CCCCeEeCcCCccc
Q 035691          278 SKNK-LSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSL-KSLEGLDLFQNTFQ  331 (640)
Q Consensus       278 s~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~l~~N~l~  331 (640)
                      ++|. +.......+..+++|++|++++| ++   ...+..+ ..++.|++++|.++
T Consensus       255 ~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~  306 (336)
T 2ast_B          255 SRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFT  306 (336)
T ss_dssp             TTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSC
T ss_pred             CCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCc
Confidence            9995 33222236888999999999999 43   3344444 34788889999999

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.90  E-value=8.4e-25  Score=238.82  Aligned_cols=161  Identities=17%  Similarity=0.134  Sum_probs=118.3

Q ss_pred             cccCcccccccceEEEEEECCCCeEEEEEEeeccc--------chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          444 SSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--------RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       444 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      ...+.||+|+||.||+|..  .++.+|+|+.....        ....+.+.+|++++++++||||+++..++..     .
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-----~  411 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD-----L  411 (540)
T ss_dssp             ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE-----T
T ss_pred             CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe-----C
Confidence            3457899999999999954  57889999863321        1123568999999999999999955444322     2


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      +..++||||+++|+|.+++..                  +..++.|++.||+|||+   .+|+||||||+|||++.  .+
T Consensus       412 ~~~~lVmE~~~ggsL~~~l~~------------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~  468 (540)
T 3en9_A          412 DNKRIMMSYINGKLAKDVIED------------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DL  468 (540)
T ss_dssp             TTTEEEEECCCSEEHHHHSTT------------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SE
T ss_pred             CccEEEEECCCCCCHHHHHHH------------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eE
Confidence            345899999999999999864                  34689999999999999   69999999999999998  99


Q ss_pred             EEccccccccCCCccCCC---ceeeccccccccccCcccCCC
Q 035691          596 HVGDFGLTRFIPEVISSN---QCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      ||+|||+|+.........   .......+||+.|||||++.+
T Consensus       469 kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~  510 (540)
T 3en9_A          469 YIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWER  510 (540)
T ss_dssp             EECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHH
T ss_pred             EEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHH
Confidence            999999999764321100   001234679999999999854

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.90  E-value=6.9e-24  Score=213.40  Aligned_cols=145  Identities=14%  Similarity=0.098  Sum_probs=125.8

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      .++|++.+.||+|+||.||+|++..+++.||||++....   ....+.+.+|+.++++++||||+++++++.     ..+
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~  104 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH-----TRA  104 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETT
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE-----ECC
Confidence            367999999999999999999999899999999996543   233478999999999999999999999954     345


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..|+||||+++++|.+++...            .....+..|+.|++.||+|||+   .+|+||||||+||+++.++.+|
T Consensus       105 ~~~lv~e~~~g~~L~~~l~~~------------~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~k  169 (286)
T 3uqc_A          105 GGLVVAEWIRGGSLQEVADTS------------PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVV  169 (286)
T ss_dssp             EEEEEEECCCEEEHHHHHTTC------------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEE
T ss_pred             cEEEEEEecCCCCHHHHHhcC------------CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEE
Confidence            789999999999999998532            2344678899999999999999   6999999999999999999999


Q ss_pred             Eccccccc
Q 035691          597 VGDFGLTR  604 (640)
Q Consensus       597 l~DfGla~  604 (640)
                      |+++|...
T Consensus       170 l~~~~~~~  177 (286)
T 3uqc_A          170 LAYPATMP  177 (286)
T ss_dssp             ECSCCCCT
T ss_pred             EEeccccC
Confidence            99887654

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.90  E-value=2e-26  Score=256.94  Aligned_cols=270  Identities=13%  Similarity=0.094  Sum_probs=128.4

Q ss_pred             CCCCCeeeccCCccc----ccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccc
Q 035691           80 LPNIRIPLLAGNQFF----GNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSL  155 (640)
Q Consensus        80 l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l  155 (640)
                      +++|+.|+|++|.++    +.++..+.++++|++|+|++|.+.+ +|..+..+++|++|+++.+......   ......+
T Consensus       191 ~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~---~~~~~~l  266 (592)
T 3ogk_B          191 NTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGM---PEKYMNL  266 (592)
T ss_dssp             CCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTC---TTSSSCC
T ss_pred             CCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccch---HHHHHHh
Confidence            445555555555444    1222233344455555555555443 3344444555555555432211000   0012334


Q ss_pred             cCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCC-cCccCCCCCCEEEccCCCCCCCCCccccCCCCccE
Q 035691          156 VNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIP-SSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQS  234 (640)
Q Consensus       156 ~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  234 (640)
                      ..+++|+.|+++++....+|..+..+++|++|+|++|.+++... ..+..+++|++|+++++...+.++..+..+++|+.
T Consensus       267 ~~~~~L~~L~l~~~~~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~  346 (592)
T 3ogk_B          267 VFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKR  346 (592)
T ss_dssp             CCCTTCCEEEETTCCTTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCE
T ss_pred             hccccccccCccccchhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCE
Confidence            45555555555555444455555555566666666666543222 22455566666666622222222233345566666


Q ss_pred             EeccC-----------cccc---------CCCCCceEEccCCcCCCCCCccCCC-CCCCCEEECC----CCcccCc----
Q 035691          235 LDLSK-----------TIFL---------GQYPVRWLDLSHNHLTGPIPLAVGN-LKSIPHLDLS----KNKLSGE----  285 (640)
Q Consensus       235 L~ls~-----------n~~~---------~~~~l~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~Ls----~N~l~~~----  285 (640)
                      |++++           |.+.         +...|++|+++.|++++..+..+.. +++|+.|+++    .|.+++.    
T Consensus       347 L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~  426 (592)
T 3ogk_B          347 LRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDN  426 (592)
T ss_dssp             EEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHH
T ss_pred             EEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHH
Confidence            66662           2222         2345666666666665544444443 5666666664    5556542    


Q ss_pred             -CCccccCCCCCCeEEecCCc--cCCCCCccCC-CCCCCCeEeCcCCccccccCCcccCCC-CCCCCCccccccCCC
Q 035691          286 -IPSSLGSCVGLEYLNLSINS--FHGPIHPGLS-SLKSLEGLDLFQNTFQAKSQNGDVPRK-GIFKNASAISVAGNE  357 (640)
Q Consensus       286 -~p~~~~~l~~L~~L~L~~N~--l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~~~~~~p~~-~~~~~~~~~~~~~n~  357 (640)
                       ++..+.++++|++|+|++|.  +++..+..+. .+++|++|++++|.++..    .++.. ..+++++.+++.+|+
T Consensus       427 ~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~----~~~~~~~~~~~L~~L~l~~n~  499 (592)
T 3ogk_B          427 GVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDE----GLMEFSRGCPNLQKLEMRGCC  499 (592)
T ss_dssp             HHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHH----HHHHHHTCCTTCCEEEEESCC
T ss_pred             HHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHH----HHHHHHhcCcccCeeeccCCC
Confidence             22234456666666665332  4433222222 256666666666665521    11111 223455666666654

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.90  E-value=1.7e-24  Score=229.69  Aligned_cols=177  Identities=20%  Similarity=0.229  Sum_probs=126.8

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc---hhHHHHHHHHHHHHhcCC-CCCcce---------eEee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR---GALKSFMAECEALRNIRH-RNLVKI---------ITAC  507 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H-~niv~l---------~~~~  507 (640)
                      ..|...+.||+|+||.||+|++..+|+.||||++.....   ...+.+.+|+.+++.++| ++....         ...+
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            346677899999999999999999999999999863332   235789999999999987 221111         1111


Q ss_pred             c------------cCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 035691          508 S------------SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKK  575 (640)
Q Consensus       508 ~------------~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~  575 (640)
                      .            ..........+++|+++ +|+|.+++.......   .....+++..++.++.|++.||+|||+   .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~---~  230 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS---STHKSLVHHARLQLTLQVIRLLASLHH---Y  230 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHT---TTSHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhccc---ccCCCCCHHHHHHHHHHHHHHHHHHHh---C
Confidence            0            00000112356677755 679998884110000   001337788899999999999999999   6


Q ss_pred             CeeeCCCCCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccC
Q 035691          576 QIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYG  632 (640)
Q Consensus       576 ~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  632 (640)
                      +|+||||||+|||++.++.+||+|||+++.....       ....+| +.|+|||++
T Consensus       231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-------~~~~~g-~~y~aPE~~  279 (413)
T 3dzo_A          231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-------AVSPIG-RGFAPPETT  279 (413)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-------ECCCCC-TTTCCHHHH
T ss_pred             CcccCCcccceEEEecCCeEEEEeccceeecCCc-------cccCCC-CceeCchhh
Confidence            9999999999999999999999999999865322       233467 999999998

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.89  E-value=1.9e-23  Score=211.88  Aligned_cols=150  Identities=23%  Similarity=0.360  Sum_probs=126.7

Q ss_pred             CCCccc-CcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHH-HhcCCCCCcceeEeeccCCcCCCcee
Q 035691          441 GGFSSA-NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEAL-RNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       441 ~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ++|.+. +.||+|+||.||+|++..+++.||+|++...     ..+.+|+.++ +..+||||+++++++... +......
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~~   90 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCL   90 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCceE
Confidence            446665 7899999999999999999999999998532     4567888888 556999999999986432 1235578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC---CCcE
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN---DMIA  595 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~---~~~~  595 (640)
                      ++||||+++|+|.+++.....        ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.   ++.+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~  159 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGD--------QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAIL  159 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTT--------CCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCE
T ss_pred             EEEEeecCCCcHHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcE
Confidence            999999999999999975432        238899999999999999999999   69999999999999998   7899


Q ss_pred             EEccccccccCC
Q 035691          596 HVGDFGLTRFIP  607 (640)
Q Consensus       596 kl~DfGla~~~~  607 (640)
                      ||+|||+++...
T Consensus       160 kl~Dfg~a~~~~  171 (299)
T 3m2w_A          160 KLTDFGFAKETT  171 (299)
T ss_dssp             EECCCTTCEECT
T ss_pred             EEeccccccccc
Confidence            999999998654

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=3.3e-23  Score=207.41  Aligned_cols=142  Identities=19%  Similarity=0.194  Sum_probs=114.3

Q ss_pred             HHHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc------------------hhHHHHHHHHHHHHh
Q 035691          433 YESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR------------------GALKSFMAECEALRN  494 (640)
Q Consensus       433 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~  494 (640)
                      ...+......|++.+.||+|+||.||+|++ .+|+.||||+++....                  .....+.+|++++++
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~  160 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK  160 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence            445566667788889999999999999999 6899999999953221                  134678999999999


Q ss_pred             cCCCCCcceeEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 035691          495 IRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCK  574 (640)
Q Consensus       495 l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~  574 (640)
                      ++|   +++.+++.      .+..++||||+++|+|.+ +...                ....++.|++.||+|||+   
T Consensus       161 l~~---~~v~~~~~------~~~~~lvmE~~~g~~L~~-l~~~----------------~~~~i~~qi~~~l~~lH~---  211 (282)
T 1zar_A          161 LQG---LAVPKVYA------WEGNAVLMELIDAKELYR-VRVE----------------NPDEVLDMILEEVAKFYH---  211 (282)
T ss_dssp             TTT---SSSCCEEE------EETTEEEEECCCCEEGGG-CCCS----------------CHHHHHHHHHHHHHHHHH---
T ss_pred             ccC---CCcCeEEe------ccceEEEEEecCCCcHHH-cchh----------------hHHHHHHHHHHHHHHHHH---
Confidence            994   55555431      134689999999999998 4211                134699999999999999   


Q ss_pred             CCeeeCCCCCCCeeeCCCCcEEEcccccccc
Q 035691          575 KQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF  605 (640)
Q Consensus       575 ~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~  605 (640)
                      .+|+||||||+|||++ ++.+||+|||+|+.
T Consensus       212 ~giiHrDlkp~NILl~-~~~vkl~DFG~a~~  241 (282)
T 1zar_A          212 RGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE  241 (282)
T ss_dssp             TTEECSCCSTTSEEEE-TTEEEECCCTTCEE
T ss_pred             CCCEeCCCCHHHEEEE-CCcEEEEECCCCeE
Confidence            6999999999999999 99999999999973

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.89  E-value=2.5e-22  Score=193.70  Aligned_cols=159  Identities=23%  Similarity=0.253  Sum_probs=146.2

Q ss_pred             ceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCcc
Q 035691          162 EIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTI  241 (640)
Q Consensus       162 ~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~  241 (640)
                      +.+++++|.++.+|..+.  ++|++|+|++|.|+++.+..|..+++|++|+|++|+|++..|.+|.++++|+.|      
T Consensus        14 ~~v~c~~~~l~~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L------   85 (220)
T 2v9t_B           14 NIVDCRGKGLTEIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSL------   85 (220)
T ss_dssp             TEEECTTSCCSSCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEE------
T ss_pred             CEEEcCCCCcCcCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEE------
Confidence            578899999999998765  789999999999998888899999999999999999998889999999999988      


Q ss_pred             ccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCC
Q 035691          242 FLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLE  321 (640)
Q Consensus       242 ~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  321 (640)
                                +|++|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+
T Consensus        86 ----------~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  155 (220)
T 2v9t_B           86 ----------VLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQ  155 (220)
T ss_dssp             ----------ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCC
T ss_pred             ----------ECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCC
Confidence                      8888899977788899999999999999999998899999999999999999999998888999999999


Q ss_pred             eEeCcCCccccccCCcc
Q 035691          322 GLDLFQNTFQAKSQNGD  338 (640)
Q Consensus       322 ~L~l~~N~l~~~~~~~~  338 (640)
                      +|+|++|+|.|.|...+
T Consensus       156 ~L~L~~N~~~c~c~l~~  172 (220)
T 2v9t_B          156 TMHLAQNPFICDCHLKW  172 (220)
T ss_dssp             EEECCSSCEECSGGGHH
T ss_pred             EEEeCCCCcCCCCccHH
Confidence            99999999999876433

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.88  E-value=2e-22  Score=192.69  Aligned_cols=146  Identities=21%  Similarity=0.222  Sum_probs=73.8

Q ss_pred             CCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccc
Q 035691           72 LPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRF  151 (640)
Q Consensus        72 lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  151 (640)
                      +|+..+..+++|+.|+|++|++++..+..|.++++|++|+|++|+|+++.+..|..+++|++|+|++|+|+.++      
T Consensus        43 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~------  116 (208)
T 2o6s_A           43 LPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLP------  116 (208)
T ss_dssp             CCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC------
T ss_pred             CChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccC------
Confidence            33333333444444444444444444444444555555555555555444444455555555555555554432      


Q ss_pred             cccccCCCCcceEecCCCCCCCcCcC-CCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCC
Q 035691          152 LDSLVNCTYLEIVSLNVNSLRSIPIS-VGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCH  230 (640)
Q Consensus       152 ~~~l~~l~~L~~L~L~~N~l~~ip~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  230 (640)
                      +..|.++++|+.|++++|.++.+|.. +..+++|++|++++|.+.+       .+++|++|+++.|+++|.+|.+++.++
T Consensus       117 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~  189 (208)
T 2o6s_A          117 DGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVA  189 (208)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred             HhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCcccc
Confidence            12334445555555555555554443 4445666666666665542       234566666666666666666655554

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.88  E-value=3.7e-22  Score=192.44  Aligned_cols=161  Identities=19%  Similarity=0.182  Sum_probs=144.5

Q ss_pred             cceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCC-cCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccC
Q 035691          161 LEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIP-SSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSK  239 (640)
Q Consensus       161 L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~  239 (640)
                      -+.+++++|.++.+|..+.  +.+++|+|++|.|++..| ..|..+++|++|+|++|+|++..+.+|.++++|+.|    
T Consensus        13 ~~~l~~s~n~l~~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L----   86 (220)
T 2v70_A           13 GTTVDCSNQKLNKIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEI----   86 (220)
T ss_dssp             TTEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEE----
T ss_pred             CCEeEeCCCCcccCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEE----
Confidence            3578899999999987664  457899999999998755 568999999999999999998888899999999888    


Q ss_pred             ccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCC
Q 035691          240 TIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKS  319 (640)
Q Consensus       240 n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  319 (640)
                                  +|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++
T Consensus        87 ------------~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  154 (220)
T 2v70_A           87 ------------LLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHS  154 (220)
T ss_dssp             ------------ECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTT
T ss_pred             ------------ECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCC
Confidence                        88889999888889999999999999999999888999999999999999999999999999999999


Q ss_pred             CCeEeCcCCccccccCCccc
Q 035691          320 LEGLDLFQNTFQAKSQNGDV  339 (640)
Q Consensus       320 L~~L~l~~N~l~~~~~~~~~  339 (640)
                      |++|+|++|+|.|.+...++
T Consensus       155 L~~L~L~~N~l~c~c~l~~l  174 (220)
T 2v70_A          155 LSTLNLLANPFNCNCYLAWL  174 (220)
T ss_dssp             CCEEECCSCCEECSGGGHHH
T ss_pred             CCEEEecCcCCcCCCchHHH
Confidence            99999999999988764433

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.88  E-value=3.7e-22  Score=190.92  Aligned_cols=178  Identities=20%  Similarity=0.202  Sum_probs=98.3

Q ss_pred             CEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCE
Q 035691           54 RTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTR  133 (640)
Q Consensus        54 ~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  133 (640)
                      +.++.+.+.++.      +|..+   .++|+.|+|++|++++..+..|.++++|++|+|++|+|+++.+..|..+++|++
T Consensus        10 ~~v~c~~~~l~~------~p~~~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~   80 (208)
T 2o6s_A           10 TTVECYSQGRTS------VPTGI---PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTY   80 (208)
T ss_dssp             TEEECCSSCCSS------CCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             CEEEecCCCccC------CCCCC---CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCE
Confidence            455666665554      44433   245566666666666555555566666666666666666554455555555555


Q ss_pred             EEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcC-CCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEE
Q 035691          134 LNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPIS-VGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELN  212 (640)
Q Consensus       134 L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  212 (640)
                      |+|++|+++.+                              |.. +..+++|++|+|++|.|++..+..|..+++|++|+
T Consensus        81 L~Ls~n~l~~~------------------------------~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  130 (208)
T 2o6s_A           81 LNLSTNQLQSL------------------------------PNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLR  130 (208)
T ss_dssp             EECCSSCCCCC------------------------------CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             EECCCCcCCcc------------------------------CHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEE
Confidence            55555555543                              332 34455566666666666555555556666666666


Q ss_pred             ccCCCCCCCCCccccCCCCccEEeccCccccCCC-CCceEEccCCcCCCCCCccCCCCC
Q 035691          213 LRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQY-PVRWLDLSHNHLTGPIPLAVGNLK  270 (640)
Q Consensus       213 L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~-~l~~L~Ls~N~l~~~~~~~~~~l~  270 (640)
                      |++|++++..+..|..+++|+.|++++|.+.+.. .+++|+++.|+++|.+|..++.++
T Consensus       131 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~l~~L~~~~n~~~g~ip~~~~~l~  189 (208)
T 2o6s_A          131 LYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRYLSEWINKHSGVVRNSAGSVA  189 (208)
T ss_dssp             CCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred             CCCCccceeCHHHhccCCCccEEEecCCCeecCCCCHHHHHHHHHhCCceeeccCcccc
Confidence            6666666555555666666666644444333221 234445666666666666555544

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.87  E-value=3.5e-22  Score=218.12  Aligned_cols=195  Identities=26%  Similarity=0.372  Sum_probs=142.0

Q ss_pred             CCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCC
Q 035691           52 ELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNL  131 (640)
Q Consensus        52 ~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  131 (640)
                      +|+.|+|++|.|+.      +|..++   ++|+.|+|++|+|+. +|   ..+++|++|+|++|+|++ +|. |.+  +|
T Consensus        60 ~L~~L~Ls~n~L~~------lp~~l~---~~L~~L~Ls~N~l~~-ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L  122 (571)
T 3cvr_A           60 QFSELQLNRLNLSS------LPDNLP---PQITVLEITQNALIS-LP---ELPASLEYLDACDNRLST-LPE-LPA--SL  122 (571)
T ss_dssp             TCSEEECCSSCCSC------CCSCCC---TTCSEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC-CCT--TC
T ss_pred             CccEEEeCCCCCCc------cCHhHc---CCCCEEECcCCCCcc-cc---cccCCCCEEEccCCCCCC-cch-hhc--CC
Confidence            77788887777764      666553   677888888888773 44   346788888888888886 555 554  78


Q ss_pred             CEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEE
Q 035691          132 TRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTEL  211 (640)
Q Consensus       132 ~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  211 (640)
                      ++|+|++|+|+.++.          .+++|+.|++++|.|+.+|.   .+++|++|+|++|.|++ +|. |.  ++|+.|
T Consensus       123 ~~L~Ls~N~l~~lp~----------~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L  185 (571)
T 3cvr_A          123 KHLDVDNNQLTMLPE----------LPALLEYINADNNQLTMLPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEAL  185 (571)
T ss_dssp             CEEECCSSCCSCCCC----------CCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEE
T ss_pred             CEEECCCCcCCCCCC----------cCccccEEeCCCCccCcCCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEE
Confidence            888888888877532          46788888888888888876   46788899999998886 555 65  889999


Q ss_pred             EccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCcccc
Q 035691          212 NLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLG  291 (640)
Q Consensus       212 ~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  291 (640)
                      +|++|+|+ .+|. |..  +|         +.....++.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..|.
T Consensus       186 ~Ls~N~L~-~lp~-~~~--~L---------~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~  251 (571)
T 3cvr_A          186 DVSTNLLE-SLPA-VPV--RN---------HHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLS  251 (571)
T ss_dssp             ECCSSCCS-SCCC-CC-------------------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHH
T ss_pred             ECcCCCCC-chhh-HHH--hh---------hcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHH
Confidence            99999888 5554 443  44         111122344488888888 5777777799999999999999988888877


Q ss_pred             CCC
Q 035691          292 SCV  294 (640)
Q Consensus       292 ~l~  294 (640)
                      .++
T Consensus       252 ~l~  254 (571)
T 3cvr_A          252 QQT  254 (571)
T ss_dssp             HHH
T ss_pred             Hhh
Confidence            654

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.87  E-value=4.2e-22  Score=217.49  Aligned_cols=195  Identities=24%  Similarity=0.291  Sum_probs=156.3

Q ss_pred             hhhcCC-----CCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCccccc
Q 035691           22 EIGRLF-----QLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGN   96 (640)
Q Consensus        22 ~~~~l~-----~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~   96 (640)
                      .+.+++     +|+.|+|++|.|++ +|..+  +++|++|+|++|+|+.      +|    ..+++|+.|+|++|+|++ 
T Consensus        49 ~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~~------ip----~~l~~L~~L~Ls~N~l~~-  114 (571)
T 3cvr_A           49 AVSLLKECLINQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALIS------LP----ELPASLEYLDACDNRLST-  114 (571)
T ss_dssp             HHHHHHHHHHTTCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCSC------CC----CCCTTCCEEECCSSCCSC-
T ss_pred             hhhhccccccCCccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCcc------cc----cccCCCCEEEccCCCCCC-
Confidence            566665     89999999999986 66655  3789999999998875      77    237899999999999997 


Q ss_pred             CCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCc
Q 035691           97 IPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPI  176 (640)
Q Consensus        97 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~  176 (640)
                      +|. |.+  +|++|+|++|+|++ +|.   .+++|+.|+|++|+|+.++.          .+++|++|+|++|+|+.+|.
T Consensus       115 ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~----------~l~~L~~L~Ls~N~L~~lp~  177 (571)
T 3cvr_A          115 LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTMLPE----------LPTSLEVLSVRNNQLTFLPE  177 (571)
T ss_dssp             CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC----------CCTTCCEEECCSSCCSCCCC
T ss_pred             cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCcCCC----------cCCCcCEEECCCCCCCCcch
Confidence            555 665  89999999999997 555   67899999999999987632          46789999999999999988


Q ss_pred             CCCCCCCCCEEEccCCcCcccCCcCccCCCCC-------CEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCc
Q 035691          177 SVGYLPKLQVLSLFENNISGEIPSSLGNFTFL-------TELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVR  249 (640)
Q Consensus       177 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-------~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~  249 (640)
                       +.  ++|++|+|++|.|+ .+|. |..  +|       +.|+|++|+|+ .+|..+..+++|+.|              
T Consensus       178 -l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L--------------  235 (571)
T 3cvr_A          178 -LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTI--------------  235 (571)
T ss_dssp             -CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEE--------------
T ss_pred             -hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEE--------------
Confidence             65  89999999999999 5665 654  77       99999999998 567777779999888              


Q ss_pred             eEEccCCcCCCCCCccCCCCCC
Q 035691          250 WLDLSHNHLTGPIPLAVGNLKS  271 (640)
Q Consensus       250 ~L~Ls~N~l~~~~~~~~~~l~~  271 (640)
                        +|++|++++.+|..|..++.
T Consensus       236 --~L~~N~l~~~~p~~l~~l~~  255 (571)
T 3cvr_A          236 --ILEDNPLSSRIRESLSQQTA  255 (571)
T ss_dssp             --ECCSSSCCHHHHHHHHHHHH
T ss_pred             --EeeCCcCCCcCHHHHHHhhc
Confidence              77777777777777776654

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.87  E-value=2.3e-21  Score=188.13  Aligned_cols=157  Identities=25%  Similarity=0.305  Sum_probs=145.3

Q ss_pred             CcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccC
Q 035691          160 YLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSK  239 (640)
Q Consensus       160 ~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~  239 (640)
                      .-+.++++++.++.+|..+.  ++|++|+|++|.|+++.|..|.++++|++|+|++|+|....+..|..+++|+.|    
T Consensus        20 s~~~v~c~~~~l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L----   93 (229)
T 3e6j_A           20 SGTTVDCRSKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVL----   93 (229)
T ss_dssp             ETTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE----
T ss_pred             eCCEeEccCCCcCccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEE----
Confidence            46789999999999998665  899999999999999989999999999999999999998877888999999988    


Q ss_pred             ccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCC
Q 035691          240 TIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKS  319 (640)
Q Consensus       240 n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  319 (640)
                                  +|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++
T Consensus        94 ------------~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  160 (229)
T 3e6j_A           94 ------------DLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSS  160 (229)
T ss_dssp             ------------ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTT
T ss_pred             ------------ECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCC
Confidence                        88889999888888999999999999999999 78899999999999999999999888888999999


Q ss_pred             CCeEeCcCCccccccC
Q 035691          320 LEGLDLFQNTFQAKSQ  335 (640)
Q Consensus       320 L~~L~l~~N~l~~~~~  335 (640)
                      |+.|+|++|+|.|.+.
T Consensus       161 L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A          161 LTHAYLFGNPWDCECR  176 (229)
T ss_dssp             CCEEECTTSCBCTTBG
T ss_pred             CCEEEeeCCCccCCcc
Confidence            9999999999998774

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.87  E-value=1.2e-24  Score=242.53  Aligned_cols=196  Identities=17%  Similarity=0.183  Sum_probs=113.6

Q ss_pred             CCCCcceEecCCCCCCC--cCcCCCCCCCCCEEEccCCcCccc-CCcCccCCCCCCEEEcc---------CCCCCCCCCc
Q 035691          157 NCTYLEIVSLNVNSLRS--IPISVGYLPKLQVLSLFENNISGE-IPSSLGNFTFLTELNLR---------GNSIRGSIPS  224 (640)
Q Consensus       157 ~l~~L~~L~L~~N~l~~--ip~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~---------~N~l~~~~~~  224 (640)
                      .+++|+.|++++|.++.  ++..+..+++|++|++++| +... ++.....+++|++|+++         .+.++.....
T Consensus       287 ~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~  365 (594)
T 2p1m_B          287 VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLV  365 (594)
T ss_dssp             HHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHH
T ss_pred             hhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHH
Confidence            45667777777777554  2222445677777777766 3321 12222346777777773         2344432222


Q ss_pred             ccc-CCCCccEEeccCcccc---------CCCCCceEEcc--C----CcCCCCCC-----ccCCCCCCCCEEECCCCccc
Q 035691          225 ALG-NCHQLQSLDLSKTIFL---------GQYPVRWLDLS--H----NHLTGPIP-----LAVGNLKSIPHLDLSKNKLS  283 (640)
Q Consensus       225 ~~~-~l~~L~~L~ls~n~~~---------~~~~l~~L~Ls--~----N~l~~~~~-----~~~~~l~~L~~L~Ls~N~l~  283 (640)
                      .+. .+++|+.|+++.|.+.         ..+.|+.|+++  +    |.+++...     ..+..+++|+.|+|++ .++
T Consensus       366 ~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~  444 (594)
T 2p1m_B          366 SVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLT  444 (594)
T ss_dssp             HHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCC
T ss_pred             HHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-ccc
Confidence            222 3677777776666553         24567888887  3    45553221     1255677888888866 565


Q ss_pred             CcCCccccC-CCCCCeEEecCCccCCCCCccC-CCCCCCCeEeCcCCccccccCCcccCCCCCCCCCccccccCCC
Q 035691          284 GEIPSSLGS-CVGLEYLNLSINSFHGPIHPGL-SSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNE  357 (640)
Q Consensus       284 ~~~p~~~~~-l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~~~~~~p~~~~~~~~~~~~~~~n~  357 (640)
                      +..+..+.. +++|++|+|++|.+++..+..+ ..+++|++|+|++|+++.....   .-...+++++.+++.+|+
T Consensus       445 ~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~---~~~~~l~~L~~L~l~~~~  517 (594)
T 2p1m_B          445 DKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALL---ANASKLETMRSLWMSSCS  517 (594)
T ss_dssp             HHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHH---HTGGGGGGSSEEEEESSC
T ss_pred             HHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHH---HHHHhCCCCCEEeeeCCC
Confidence            544444544 6788888888888765444444 5578888888888887421110   011234567777777654

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.87  E-value=9.4e-25  Score=243.43  Aligned_cols=199  Identities=16%  Similarity=0.155  Sum_probs=144.9

Q ss_pred             cCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCC--cCcCCCCCCCCCEEEcc---------CCcC
Q 035691          126 GRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRS--IPISVGYLPKLQVLSLF---------ENNI  194 (640)
Q Consensus       126 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~--ip~~~~~l~~L~~L~L~---------~N~l  194 (640)
                      ..+++|++|+|++|.++...     ....+..+++|+.|++++| +..  ++.....+++|++|+++         .+.+
T Consensus       286 ~~~~~L~~L~L~~~~l~~~~-----l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l  359 (594)
T 2p1m_B          286 SVCSRLTTLNLSYATVQSYD-----LVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVAL  359 (594)
T ss_dssp             HHHTTCCEEECTTCCCCHHH-----HHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCC
T ss_pred             HhhCCCCEEEccCCCCCHHH-----HHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCC
Confidence            35688999999998865431     2223567899999999988 443  22222347899999994         3556


Q ss_pred             cccCCcCcc-CCCCCCEEEccCCCCCCCCCcccc-CCCCccEEecc--C----cccc-------------CCCCCceEEc
Q 035691          195 SGEIPSSLG-NFTFLTELNLRGNSIRGSIPSALG-NCHQLQSLDLS--K----TIFL-------------GQYPVRWLDL  253 (640)
Q Consensus       195 ~~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~ls--~----n~~~-------------~~~~l~~L~L  253 (640)
                      ++.....+. ++++|+.|.++.|.+++..+..+. .+++|+.|+++  +    +.+.             ....|+.|+|
T Consensus       360 ~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L  439 (594)
T 2p1m_B          360 TEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSL  439 (594)
T ss_dssp             CHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEEC
T ss_pred             CHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEee
Confidence            543333333 478999999999999866555554 58999999999  3    3333             3456999999


Q ss_pred             cCCcCCCCCCccCCC-CCCCCEEECCCCcccCcCCccc-cCCCCCCeEEecCCccCCCCCc-cCCCCCCCCeEeCcCCcc
Q 035691          254 SHNHLTGPIPLAVGN-LKSIPHLDLSKNKLSGEIPSSL-GSCVGLEYLNLSINSFHGPIHP-GLSSLKSLEGLDLFQNTF  330 (640)
Q Consensus       254 s~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~l~~N~l  330 (640)
                      ++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|++|+|++|++++.... ....+++|++|++++|++
T Consensus       440 ~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~  518 (594)
T 2p1m_B          440 SG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV  518 (594)
T ss_dssp             CS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred             cC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence            87 666555555554 8899999999999986655555 6689999999999999654333 445689999999999988


Q ss_pred             c
Q 035691          331 Q  331 (640)
Q Consensus       331 ~  331 (640)
                      +
T Consensus       519 ~  519 (594)
T 2p1m_B          519 S  519 (594)
T ss_dssp             B
T ss_pred             C
Confidence            5

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.86  E-value=3e-22  Score=201.89  Aligned_cols=184  Identities=25%  Similarity=0.282  Sum_probs=102.9

Q ss_pred             eCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeec
Q 035691            9 NLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLL   88 (640)
Q Consensus         9 ~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L   88 (640)
                      ++..+.+++..+  +..+++|++|++++|.++.. + .+..+++|++|+|++|+|+.      +++  +..+++|+.|+|
T Consensus        30 ~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~------~~~--l~~l~~L~~L~l   97 (291)
T 1h6t_A           30 NLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTD------IKP--LANLKNLGWLFL   97 (291)
T ss_dssp             HTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC------CGG--GTTCTTCCEEEC
T ss_pred             HhcCCCcccccc--hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCC------Ccc--cccCCCCCEEEC
Confidence            444455543322  34566666666666666633 2 25666666666666666654      333  334666666666


Q ss_pred             cCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCC
Q 035691           89 AGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNV  168 (640)
Q Consensus        89 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~  168 (640)
                      ++|++++.  ..+..+++|++|+|++|++++.  ..+..+++|++|+|++|+++.+        ..+..+++|+.|++++
T Consensus        98 ~~n~l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--------~~l~~l~~L~~L~L~~  165 (291)
T 1h6t_A           98 DENKVKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--------TVLSRLTKLDTLSLED  165 (291)
T ss_dssp             CSSCCCCG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--------GGGGGCTTCSEEECCS
T ss_pred             CCCcCCCC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--------hhhccCCCCCEEEccC
Confidence            66666542  2355666666666666666642  3455666666666666666543        2345555566666666


Q ss_pred             CCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCC
Q 035691          169 NSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIR  219 (640)
Q Consensus       169 N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  219 (640)
                      |+++.++. +..+++|++|+|++|.|++. | .+..+++|+.|++++|++.
T Consensus       166 N~l~~~~~-l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~  213 (291)
T 1h6t_A          166 NQISDIVP-LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECL  213 (291)
T ss_dssp             SCCCCCGG-GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEE
T ss_pred             Cccccchh-hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCccc
Confidence            66655544 55555666666666665532 2 2555555666666655555

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.86  E-value=6.3e-22  Score=218.50  Aligned_cols=193  Identities=24%  Similarity=0.265  Sum_probs=142.4

Q ss_pred             CcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCC
Q 035691            5 LMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIR   84 (640)
Q Consensus         5 L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~   84 (640)
                      +..++++.+.+.+..+  +..+.+|+.|++++|.|.. +| .|..+++|+.|+|++|+|+.      +|+  +..+++|+
T Consensus        23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~------~~~--l~~l~~L~   90 (605)
T 1m9s_A           23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD------IKP--LTNLKNLG   90 (605)
T ss_dssp             HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCC------CGG--GGGCTTCC
T ss_pred             HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCC------Chh--hccCCCCC
Confidence            3445667777775544  5677888888888888874 33 47888888888888888765      554  44688888


Q ss_pred             eeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceE
Q 035691           85 IPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIV  164 (640)
Q Consensus        85 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L  164 (640)
                      .|+|++|+|++.  ..|..+++|++|+|++|+|+++  ..+..+++|+.|+|++|+|+.+        ..+..+++|+.|
T Consensus        91 ~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--------~~l~~l~~L~~L  158 (605)
T 1m9s_A           91 WLFLDENKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--------TVLSRLTKLDTL  158 (605)
T ss_dssp             EEECCSSCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--------GGGGSCTTCSEE
T ss_pred             EEECcCCCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--------hhhcccCCCCEE
Confidence            888888888753  3677888888888888888853  3477888888888888888764        356677888888


Q ss_pred             ecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCc
Q 035691          165 SLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPS  224 (640)
Q Consensus       165 ~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~  224 (640)
                      +|++|.|+.+++ +..+++|+.|+|++|.|++.  ..+..+++|+.|+|++|++.+....
T Consensus       159 ~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~  215 (605)
T 1m9s_A          159 SLEDNQISDIVP-LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPIN  215 (605)
T ss_dssp             ECCSSCCCCCGG-GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCC
T ss_pred             ECcCCcCCCchh-hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCccc
Confidence            888888877655 77778888888888888754  3577788888888888887754433

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.86  E-value=1.1e-21  Score=204.28  Aligned_cols=159  Identities=21%  Similarity=0.208  Sum_probs=114.6

Q ss_pred             cceEecCCCCCCCcCcC-CC-CCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEecc
Q 035691          161 LEIVSLNVNSLRSIPIS-VG-YLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLS  238 (640)
Q Consensus       161 L~~L~L~~N~l~~ip~~-~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls  238 (640)
                      ++.|+|++|+|+.++.. +. .+++|++|+|++|.|+++.+..|.++++|++|+|++|+|++..+..|.++++|+.|   
T Consensus        41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L---  117 (361)
T 2xot_A           41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVL---  117 (361)
T ss_dssp             CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE---
T ss_pred             CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEE---
Confidence            44555555555554433 33 56777777777777776666777777777777777777776666677777777777   


Q ss_pred             CccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccc---cCCCCCCeEEecCCccCCCCCccCC
Q 035691          239 KTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSL---GSCVGLEYLNLSINSFHGPIHPGLS  315 (640)
Q Consensus       239 ~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~~~~~~~~~  315 (640)
                                   +|++|+|++..|..|.++++|+.|+|++|+|++..+..|   ..+++|+.|+|++|+|++..+..|.
T Consensus       118 -------------~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~  184 (361)
T 2xot_A          118 -------------LLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQ  184 (361)
T ss_dssp             -------------ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHH
T ss_pred             -------------ECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhh
Confidence                         666777776677788888888888888888885444445   5678888888888888877667777


Q ss_pred             CCCC--CCeEeCcCCccccccC
Q 035691          316 SLKS--LEGLDLFQNTFQAKSQ  335 (640)
Q Consensus       316 ~l~~--L~~L~l~~N~l~~~~~  335 (640)
                      .++.  ++.|+|++|+|.|.|.
T Consensus       185 ~l~~~~l~~l~l~~N~~~C~C~  206 (361)
T 2xot_A          185 KLPAWVKNGLYLHNNPLECDCK  206 (361)
T ss_dssp             HSCHHHHTTEECCSSCEECCHH
T ss_pred             hccHhhcceEEecCCCccCCcC
Confidence            7776  4889999999988774

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.86  E-value=1.4e-21  Score=197.04  Aligned_cols=189  Identities=24%  Similarity=0.308  Sum_probs=123.1

Q ss_pred             CCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcc
Q 035691           83 IRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLE  162 (640)
Q Consensus        83 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~  162 (640)
                      +..+.+..+.+++..  .+..+++|++|++++|.++.. + .+..+++|++|+|++|+++.++        .+.++++|+
T Consensus        26 ~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~--------~l~~l~~L~   93 (291)
T 1h6t_A           26 TIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--------PLANLKNLG   93 (291)
T ss_dssp             HHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--------GGTTCTTCC
T ss_pred             HHHHHhcCCCccccc--chhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCc--------ccccCCCCC
Confidence            334445555555332  234566777777777777753 3 3677777777777777776652        156667777


Q ss_pred             eEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccc
Q 035691          163 IVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIF  242 (640)
Q Consensus       163 ~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~  242 (640)
                      +|++++|.++.+|. +..+++|++|+|++|.+++.  ..+..+++|+.|+|++|++++.  ..+..+++|+.|       
T Consensus        94 ~L~l~~n~l~~~~~-l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L-------  161 (291)
T 1h6t_A           94 WLFLDENKVKDLSS-LKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTL-------  161 (291)
T ss_dssp             EEECCSSCCCCGGG-GTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEE-------
T ss_pred             EEECCCCcCCCChh-hccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEE-------
Confidence            77777777776554 66677777777777777743  3566777777777777777644  456666666666       


Q ss_pred             cCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCC
Q 035691          243 LGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHG  308 (640)
Q Consensus       243 ~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  308 (640)
                               ++++|++++..+  +..+++|+.|+|++|+|++ +| .+..+++|+.|++++|+++.
T Consensus       162 ---------~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          162 ---------SLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             ---------ECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred             ---------EccCCccccchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccC
Confidence                     666666665444  6677777777777777764 33 36667777777777777664

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.86  E-value=1.4e-21  Score=215.64  Aligned_cols=199  Identities=25%  Similarity=0.288  Sum_probs=139.1

Q ss_pred             CCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCc
Q 035691           82 NIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYL  161 (640)
Q Consensus        82 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L  161 (640)
                      ++..+.|+.+.+....+  +..+++|+.|+|++|.|+.+ + .|..+++|+.|+|++|+|+.++        .+..+++|
T Consensus        22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~--------~l~~l~~L   89 (605)
T 1m9s_A           22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--------PLTNLKNL   89 (605)
T ss_dssp             HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCG--------GGGGCTTC
T ss_pred             HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCCh--------hhccCCCC
Confidence            34455566666654433  44567777777777777743 3 4677777777777777776652        16667777


Q ss_pred             ceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCcc
Q 035691          162 EIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTI  241 (640)
Q Consensus       162 ~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~  241 (640)
                      +.|+|++|.|+.+| .+..+++|++|+|++|.|.+.  ..+..+++|+.|+|++|+|++.  ..|..+++|+.|      
T Consensus        90 ~~L~Ls~N~l~~l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L------  158 (605)
T 1m9s_A           90 GWLFLDENKIKDLS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTL------  158 (605)
T ss_dssp             CEEECCSSCCCCCT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEE------
T ss_pred             CEEECcCCCCCCCh-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEE------
Confidence            77777777777765 567778888888888888753  3577788888888888888754  457777777777      


Q ss_pred             ccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCC
Q 035691          242 FLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSL  317 (640)
Q Consensus       242 ~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  317 (640)
                                +|++|+|++..|  +..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|++.+.....+..+
T Consensus       159 ----------~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l  220 (605)
T 1m9s_A          159 ----------SLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNL  220 (605)
T ss_dssp             ----------ECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCSSC
T ss_pred             ----------ECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccccccE
Confidence                      677777776555  77888888888888888753  357788888888888888876544444433

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.85  E-value=2.5e-21  Score=201.52  Aligned_cols=174  Identities=20%  Similarity=0.145  Sum_probs=96.1

Q ss_pred             CEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCc-CCCCCCEEECcCCccCccCCccccCCCCCC
Q 035691           54 RTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSIS-NASKLEWLDFANNSLTASIPEDLGRLRNLT  132 (640)
Q Consensus        54 ~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  132 (640)
                      +++++++|.|+.      +|..++   +.++.|+|++|+|+++.+..|. ++++|++|+|++|+|+++.+..|.++++|+
T Consensus        21 ~~l~c~~~~l~~------iP~~~~---~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~   91 (361)
T 2xot_A           21 NILSCSKQQLPN------VPQSLP---SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLR   91 (361)
T ss_dssp             TEEECCSSCCSS------CCSSCC---TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred             CEEEeCCCCcCc------cCccCC---CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCC
Confidence            345555555443      444332   2345555555555555555554 555555555555555555555555555555


Q ss_pred             EEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCc-CcCCCCCCCCCEEEccCCcCcccCCcCc---cCCCCC
Q 035691          133 RLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSI-PISVGYLPKLQVLSLFENNISGEIPSSL---GNFTFL  208 (640)
Q Consensus       133 ~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L~L~~N~l~~~~p~~~---~~l~~L  208 (640)
                      +|+|++|+|+.+      .+..|.++++|+.|+|++|+|+.+ |..+..+++|++|+|++|.|+++.+..|   ..+++|
T Consensus        92 ~L~Ls~N~l~~~------~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L  165 (361)
T 2xot_A           92 YLDLSSNHLHTL------DEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKL  165 (361)
T ss_dssp             EEECCSSCCCEE------CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTC
T ss_pred             EEECCCCcCCcC------CHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcC
Confidence            555555555544      223344555555555555555554 3345556666666666666665444444   456777


Q ss_pred             CEEEccCCCCCCCCCccccCCCCc--cEEeccCccc
Q 035691          209 TELNLRGNSIRGSIPSALGNCHQL--QSLDLSKTIF  242 (640)
Q Consensus       209 ~~L~L~~N~l~~~~~~~~~~l~~L--~~L~ls~n~~  242 (640)
                      +.|+|++|+|+...+..|..++.+  +.|+|++|.+
T Consensus       166 ~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~  201 (361)
T 2xot_A          166 MLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL  201 (361)
T ss_dssp             CEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCE
T ss_pred             CEEECCCCCCCccCHHHhhhccHhhcceEEecCCCc
Confidence            777777777775555566666653  5665555544

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.85  E-value=1.1e-21  Score=201.55  Aligned_cols=226  Identities=11%  Similarity=0.052  Sum_probs=152.3

Q ss_pred             CCchhhcC--------CCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcC--
Q 035691           72 LPPYIGFT--------LPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDL--  141 (640)
Q Consensus        72 lp~~~~~~--------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l--  141 (640)
                      +|+..|.+        +++|+.++|.+ +++.+.+.+|.++++|+.|++++|.++.+.+.+|.++.++..+.+..+..  
T Consensus        84 I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~  162 (329)
T 3sb4_A           84 VPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYR  162 (329)
T ss_dssp             ECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHH
T ss_pred             cCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhh
Confidence            55555555        77777777777 67767777777777777777777777767777777766666666555321  


Q ss_pred             --CCCCCCcccccccccCCCCcc-eEecCCCCCCCcCcC----CCCCCCCCEEEccCCcCcccCCcCc-cCCCCCCEEEc
Q 035691          142 --GTRKVNDLRFLDSLVNCTYLE-IVSLNVNSLRSIPIS----VGYLPKLQVLSLFENNISGEIPSSL-GNFTFLTELNL  213 (640)
Q Consensus       142 --~~~~~~~~~~~~~l~~l~~L~-~L~L~~N~l~~ip~~----~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L  213 (640)
                        ..+      ....|.++..|+ .+.+...  ..++..    -....+++.+.+.++-.. .....+ ..+++|+.|+|
T Consensus       163 ~~~~i------~~~~f~~~~~L~~~i~~~~~--~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L  233 (329)
T 3sb4_A          163 FKNRW------EHFAFIEGEPLETTIQVGAM--GKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDI  233 (329)
T ss_dssp             TSTTT------TTSCEEESCCCEEEEEECTT--CCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEEC
T ss_pred             ccccc------cccccccccccceeEEecCC--CcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEEC
Confidence              111      112344555555 3333321  112221    112445666666655322 111111 23688899999


Q ss_pred             cCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCccCCCCCCCC-EEECCCCcccCcCCccccC
Q 035691          214 RGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIP-HLDLSKNKLSGEIPSSLGS  292 (640)
Q Consensus       214 ~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~  292 (640)
                      ++|+++.+.+.+|.+|.+|+.+                +|++| ++.+.+.+|.++++|+ .+++.+ .++.+.+.+|.+
T Consensus       234 ~~n~i~~I~~~aF~~~~~L~~l----------------~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~  295 (329)
T 3sb4_A          234 SKTNATTIPDFTFAQKKYLLKI----------------KLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMG  295 (329)
T ss_dssp             TTBCCCEECTTTTTTCTTCCEE----------------ECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTT
T ss_pred             CCCCcceecHhhhhCCCCCCEE----------------ECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhC
Confidence            9888887777888888888888                66666 6667778899999998 999988 777677788999


Q ss_pred             CCCCCeEEecCCccCCCCCccCCCCCCCCeEeC
Q 035691          293 CVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDL  325 (640)
Q Consensus       293 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  325 (640)
                      |++|+.|++++|.++.+.+.+|.++++|+.++.
T Consensus       296 c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          296 CDNLRYVLATGDKITTLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             CTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred             CccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence            999999999999998888889999999988874

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.84  E-value=2.5e-20  Score=180.79  Aligned_cols=155  Identities=23%  Similarity=0.202  Sum_probs=121.1

Q ss_pred             CCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCC
Q 035691           52 ELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNL  131 (640)
Q Consensus        52 ~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  131 (640)
                      ..+.++.+++.++.      +|..+   .++|+.|+|++|+|++..|..|.++++|++|+|++|+|+.+.+..|..+++|
T Consensus        20 s~~~v~c~~~~l~~------ip~~~---~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L   90 (229)
T 3e6j_A           20 SGTTVDCRSKRHAS------VPAGI---PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL   90 (229)
T ss_dssp             ETTEEECTTSCCSS------CCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred             eCCEeEccCCCcCc------cCCCC---CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCc
Confidence            35678888777765      77655   3678888888888888888888888888888888888887777778888888


Q ss_pred             CEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEE
Q 035691          132 TRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTEL  211 (640)
Q Consensus       132 ~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  211 (640)
                      ++|+|++|+|+.++      +..|..+++|++|+|++|+|+.+|..+..+++|++|+|++|.|++..+..|..+++|+.|
T Consensus        91 ~~L~Ls~N~l~~l~------~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  164 (229)
T 3e6j_A           91 TVLDLGTNQLTVLP------SAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHA  164 (229)
T ss_dssp             CEEECCSSCCCCCC------TTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             CEEECCCCcCCccC------hhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEE
Confidence            88888888888763      344667778888888888888888777778888888888888887666778888888888


Q ss_pred             EccCCCCCCC
Q 035691          212 NLRGNSIRGS  221 (640)
Q Consensus       212 ~L~~N~l~~~  221 (640)
                      +|++|++...
T Consensus       165 ~l~~N~~~c~  174 (229)
T 3e6j_A          165 YLFGNPWDCE  174 (229)
T ss_dssp             ECTTSCBCTT
T ss_pred             EeeCCCccCC
Confidence            8888887744

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.84  E-value=3.7e-20  Score=178.39  Aligned_cols=150  Identities=24%  Similarity=0.277  Sum_probs=85.6

Q ss_pred             CEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCE
Q 035691           54 RTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTR  133 (640)
Q Consensus        54 ~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  133 (640)
                      +.+++++|.++.      +|..+.   ++++.|+|++|+|+++.+..|.++++|++|+|++|+|+++.|.+|.++++|++
T Consensus        14 ~~v~c~~~~l~~------iP~~l~---~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~   84 (220)
T 2v9t_B           14 NIVDCRGKGLTE------IPTNLP---ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNS   84 (220)
T ss_dssp             TEEECTTSCCSS------CCSSCC---TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCE
T ss_pred             CEEEcCCCCcCc------CCCccC---cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCE
Confidence            455666666554      554432   45555555555555555555666666666666666666555555666666666


Q ss_pred             EEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcC-CCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEE
Q 035691          134 LNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPIS-VGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELN  212 (640)
Q Consensus       134 L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  212 (640)
                      |+|++|+|+.+                              |.. +..+++|++|+|++|.|+++.|..|..+++|++|+
T Consensus        85 L~Ls~N~l~~l------------------------------~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  134 (220)
T 2v9t_B           85 LVLYGNKITEL------------------------------PKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLS  134 (220)
T ss_dssp             EECCSSCCCCC------------------------------CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             EECCCCcCCcc------------------------------CHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEE
Confidence            65555555544                              332 23455556666666666555555666666666666


Q ss_pred             ccCCCCCCCCCccccCCCCccEEeccCccc
Q 035691          213 LRGNSIRGSIPSALGNCHQLQSLDLSKTIF  242 (640)
Q Consensus       213 L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~  242 (640)
                      |++|+|++..+..|..+++|+.|+|++|.|
T Consensus       135 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~  164 (220)
T 2v9t_B          135 LYDNKLQTIAKGTFSPLRAIQTMHLAQNPF  164 (220)
T ss_dssp             CCSSCCSCCCTTTTTTCTTCCEEECCSSCE
T ss_pred             CCCCcCCEECHHHHhCCCCCCEEEeCCCCc
Confidence            666666655555566666666664444443

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.84  E-value=3.9e-20  Score=178.27  Aligned_cols=151  Identities=21%  Similarity=0.250  Sum_probs=80.7

Q ss_pred             CEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCC-ccCcCCCCCCEEECcCCccCccCCccccCCCCCC
Q 035691           54 RTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIP-HSISNASKLEWLDFANNSLTASIPEDLGRLRNLT  132 (640)
Q Consensus        54 ~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  132 (640)
                      +++++++|.++.      +|..++   +.++.|+|++|+|++..+ ..|.++++|++|+|++|+|+++.+.+|.++++|+
T Consensus        14 ~~l~~s~n~l~~------iP~~~~---~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~   84 (220)
T 2v70_A           14 TTVDCSNQKLNK------IPEHIP---QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVN   84 (220)
T ss_dssp             TEEECCSSCCSS------CCSCCC---TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred             CEeEeCCCCccc------CccCCC---CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCC
Confidence            356666665554      554332   234556666666665533 3456666666666666666665555666666666


Q ss_pred             EEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCc-CcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEE
Q 035691          133 RLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSI-PISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTEL  211 (640)
Q Consensus       133 ~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~i-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  211 (640)
                      +|+|++|+|+.+      .+..|.++++|++|+|++|+|+.+ |..+..+++|++|+|++|.|++..|..|..+++|+.|
T Consensus        85 ~L~Ls~N~l~~~------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  158 (220)
T 2v70_A           85 EILLTSNRLENV------QHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTL  158 (220)
T ss_dssp             EEECCSSCCCCC------CGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEE
T ss_pred             EEECCCCccCcc------CHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEE
Confidence            666666666554      223344444444444444444443 3334444555555555555554445555555555555


Q ss_pred             EccCCCCC
Q 035691          212 NLRGNSIR  219 (640)
Q Consensus       212 ~L~~N~l~  219 (640)
                      +|++|++.
T Consensus       159 ~L~~N~l~  166 (220)
T 2v70_A          159 NLLANPFN  166 (220)
T ss_dssp             ECCSCCEE
T ss_pred             EecCcCCc
Confidence            55555544

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.83  E-value=2.5e-23  Score=228.33  Aligned_cols=200  Identities=22%  Similarity=0.217  Sum_probs=123.8

Q ss_pred             CCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCc-------------cCccCCcCCCCCCCCCEEE-ccCCCcCCccc
Q 035691            3 TFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNT-------------LQGQIPVNLTHCSELRTLD-LVLNKLEENQL   68 (640)
Q Consensus         3 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~-------------l~~~~~~~~~~l~~L~~L~-Ls~N~l~~~~~   68 (640)
                      ++|+.|+|++|+|+ .+|+.++.+++|+.|++++|.             +.+..|..++.+++|+.|| ++.|.+.    
T Consensus       349 ~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~----  423 (567)
T 1dce_A          349 EQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD----  423 (567)
T ss_dssp             TTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH----
T ss_pred             ccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc----
Confidence            45556666666665 456666666666666665553             3334444445555555555 3433221    


Q ss_pred             cccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCc
Q 035691           69 VGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVND  148 (640)
Q Consensus        69 ~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  148 (640)
                                   +|+.+.+++|.|+...+      ..|++|+|++|+|++ +|. |+.+++|+.|+|++|+|+.+    
T Consensus       424 -------------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~~l----  478 (567)
T 1dce_A          424 -------------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLRAL----  478 (567)
T ss_dssp             -------------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCCCC----
T ss_pred             -------------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccccc----
Confidence                         22333444555554322      247777777777775 454 77777777777777777743    


Q ss_pred             ccccccccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccC-CcCccCCCCCCEEEccCCCCCCCCCcc--
Q 035691          149 LRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEI-PSSLGNFTFLTELNLRGNSIRGSIPSA--  225 (640)
Q Consensus       149 ~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~~~--  225 (640)
                         |..+.++++|+.|+|++|+|+.+| .+..+++|++|+|++|.|++.. |..|..+++|+.|+|++|++++.+|..  
T Consensus       479 ---p~~~~~l~~L~~L~Ls~N~l~~lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~  554 (567)
T 1dce_A          479 ---PPALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQER  554 (567)
T ss_dssp             ---CGGGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTH
T ss_pred             ---chhhhcCCCCCEEECCCCCCCCCc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHH
Confidence               345667777777777777777776 6777777777777777777665 777777777777777777777554432  


Q ss_pred             -ccCCCCccEEe
Q 035691          226 -LGNCHQLQSLD  236 (640)
Q Consensus       226 -~~~l~~L~~L~  236 (640)
                       +..+++|+.|+
T Consensus       555 l~~~lp~L~~L~  566 (567)
T 1dce_A          555 LAEMLPSVSSIL  566 (567)
T ss_dssp             HHHHCTTCSEEE
T ss_pred             HHHHCcccCccC
Confidence             23356666663

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.83  E-value=6.4e-21  Score=189.08  Aligned_cols=166  Identities=25%  Similarity=0.315  Sum_probs=76.6

Q ss_pred             CCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCC
Q 035691           29 LRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLE  108 (640)
Q Consensus        29 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  108 (640)
                      ++.+++++|.+++..  .+..+++|++|++++|+|++      +| . +..+++|+.|+|++|+|++..+  |.++++|+
T Consensus        21 l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~------l~-~-l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~   88 (263)
T 1xeu_A           21 AVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS------LA-G-MQFFTNLKELHLSHNQISDLSP--LKDLTKLE   88 (263)
T ss_dssp             HHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC------CT-T-GGGCTTCCEEECCSSCCCCCGG--GTTCSSCC
T ss_pred             HHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc------ch-H-HhhCCCCCEEECCCCccCCChh--hccCCCCC
Confidence            334444444444222  23444444444444444433      33 1 1224444444444444444333  44455555


Q ss_pred             EEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEE
Q 035691          109 WLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLS  188 (640)
Q Consensus       109 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~  188 (640)
                      +|+|++|++++. |. +.. ++|++|+|++|+++.+        ..+..+++|+.|++++|+++.+| .+..+++|++|+
T Consensus        89 ~L~L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~--------~~l~~l~~L~~L~Ls~N~i~~~~-~l~~l~~L~~L~  156 (263)
T 1xeu_A           89 ELSVNRNRLKNL-NG-IPS-ACLSRLFLDNNELRDT--------DSLIHLKNLEILSIRNNKLKSIV-MLGFLSKLEVLD  156 (263)
T ss_dssp             EEECCSSCCSCC-TT-CCC-SSCCEEECCSSCCSBS--------GGGTTCTTCCEEECTTSCCCBCG-GGGGCTTCCEEE
T ss_pred             EEECCCCccCCc-Cc-ccc-CcccEEEccCCccCCC--------hhhcCcccccEEECCCCcCCCCh-HHccCCCCCEEE
Confidence            555555555532 21 111 4455555555555443        12444455555555555555543 344455555555


Q ss_pred             ccCCcCcccCCcCccCCCCCCEEEccCCCCCC
Q 035691          189 LFENNISGEIPSSLGNFTFLTELNLRGNSIRG  220 (640)
Q Consensus       189 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  220 (640)
                      |++|.|++.  ..+..+++|+.|++++|++..
T Consensus       157 L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~  186 (263)
T 1xeu_A          157 LHGNEITNT--GGLTRLKKVNWIDLTGQKCVN  186 (263)
T ss_dssp             CTTSCCCBC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred             CCCCcCcch--HHhccCCCCCEEeCCCCcccC
Confidence            555555543  345555555555555555543

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.83  E-value=4.8e-21  Score=189.96  Aligned_cols=164  Identities=20%  Similarity=0.221  Sum_probs=73.2

Q ss_pred             cEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCe
Q 035691            6 MLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRI   85 (640)
Q Consensus         6 ~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~   85 (640)
                      ..+++++|.+++..  .+..+++|++|++++|.|+. +| .+..+++|++|+|++|+|++      +|+  +..+++|+.
T Consensus        22 ~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~------~~~--l~~l~~L~~   89 (263)
T 1xeu_A           22 VKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISD------LSP--LKDLTKLEE   89 (263)
T ss_dssp             HHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC------CGG--GTTCSSCCE
T ss_pred             HHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCC------Chh--hccCCCCCE
Confidence            33444444444222  34444445555555554442 22 34444455555555444443      333  233444555


Q ss_pred             eeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEe
Q 035691           86 PLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVS  165 (640)
Q Consensus        86 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~  165 (640)
                      |+|++|++++..+  +.. ++|++|+|++|+|++. + .+..+++|++|+|++|+|+++        ..+..+++|+.|+
T Consensus        90 L~L~~N~l~~l~~--~~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~--------~~l~~l~~L~~L~  156 (263)
T 1xeu_A           90 LSVNRNRLKNLNG--IPS-ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKSI--------VMLGFLSKLEVLD  156 (263)
T ss_dssp             EECCSSCCSCCTT--CCC-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC--------GGGGGCTTCCEEE
T ss_pred             EECCCCccCCcCc--ccc-CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCCC--------hHHccCCCCCEEE
Confidence            5555555443221  111 4455555555554432 1 244444555555555544433        1234444455555


Q ss_pred             cCCCCCCCcCcCCCCCCCCCEEEccCCcCc
Q 035691          166 LNVNSLRSIPISVGYLPKLQVLSLFENNIS  195 (640)
Q Consensus       166 L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~  195 (640)
                      +++|+++.+ ..+..+++|+.|++++|.+.
T Consensus       157 L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~  185 (263)
T 1xeu_A          157 LHGNEITNT-GGLTRLKKVNWIDLTGQKCV  185 (263)
T ss_dssp             CTTSCCCBC-TTSTTCCCCCEEEEEEEEEE
T ss_pred             CCCCcCcch-HHhccCCCCCEEeCCCCccc
Confidence            555554444 33444444555555555444

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.82  E-value=2.7e-23  Score=228.04  Aligned_cols=202  Identities=23%  Similarity=0.229  Sum_probs=132.6

Q ss_pred             CCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCc-------------cCccCCccccCCCCCCEEE-cccCcCCCCC
Q 035691           80 LPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNS-------------LTASIPEDLGRLRNLTRLN-FARNDLGTRK  145 (640)
Q Consensus        80 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-------------l~~~~~~~~~~l~~L~~L~-L~~N~l~~~~  145 (640)
                      .++|+.|+|++|+++ .+|..++++++|+.|++++|.             +.+..|..++.+++|+.|+ ++.|.+.   
T Consensus       348 ~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~---  423 (567)
T 1dce_A          348 DEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD---  423 (567)
T ss_dssp             TTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH---
T ss_pred             CccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc---
Confidence            455555666666555 345555555556666655543             3334444455555555554 4444331   


Q ss_pred             CCcccccccccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCcc
Q 035691          146 VNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSA  225 (640)
Q Consensus       146 ~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~  225 (640)
                                    .|..+.+++|.++.+|.     ..|+.|+|++|.|++ +|. |+.+++|+.|+|++|+|+ .+|..
T Consensus       424 --------------~L~~l~l~~n~i~~l~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~  481 (567)
T 1dce_A          424 --------------DLRSKFLLENSVLKMEY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPA  481 (567)
T ss_dssp             --------------HHHHHHHHHHHHHHHHH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGG
T ss_pred             --------------hhhhhhhhcccccccCc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchh
Confidence                          23334445555555443     247888888888885 555 888888888888888888 66777


Q ss_pred             ccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcC-CccccCCCCCCeEEecCC
Q 035691          226 LGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEI-PSSLGSCVGLEYLNLSIN  304 (640)
Q Consensus       226 ~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N  304 (640)
                      |+++++|+.|                +|++|+|++ +| .|+.+++|+.|+|++|+|++.. |..|..+++|+.|+|++|
T Consensus       482 ~~~l~~L~~L----------------~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N  543 (567)
T 1dce_A          482 LAALRCLEVL----------------QASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN  543 (567)
T ss_dssp             GGGCTTCCEE----------------ECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTS
T ss_pred             hhcCCCCCEE----------------ECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCC
Confidence            8888888777                777777775 45 7888888888888888888766 788888888888888888


Q ss_pred             ccCCCCCcc---CCCCCCCCeEeC
Q 035691          305 SFHGPIHPG---LSSLKSLEGLDL  325 (640)
Q Consensus       305 ~l~~~~~~~---~~~l~~L~~L~l  325 (640)
                      +|++.+|..   +..+++|+.||+
T Consensus       544 ~l~~~~~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          544 SLCQEEGIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             GGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred             cCCCCccHHHHHHHHCcccCccCC
Confidence            887655432   233677777764

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.81  E-value=8.9e-20  Score=172.63  Aligned_cols=153  Identities=19%  Similarity=0.211  Sum_probs=83.8

Q ss_pred             CCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccC
Q 035691           48 THCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGR  127 (640)
Q Consensus        48 ~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  127 (640)
                      ..+++|++|++++|.|++      +| . +..+++|+.|++++|.++  .+..+..+++|++|++++|++++..+..|..
T Consensus        41 ~~l~~L~~L~l~~n~i~~------l~-~-l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~  110 (197)
T 4ezg_A           41 AQMNSLTYITLANINVTD------LT-G-IEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSG  110 (197)
T ss_dssp             HHHHTCCEEEEESSCCSC------CT-T-GGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTT
T ss_pred             hhcCCccEEeccCCCccC------hH-H-HhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcC
Confidence            344455555555555443      33 1 223455555555555443  2234555556666666666665555555566


Q ss_pred             CCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCC-CCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCC
Q 035691          128 LRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNS-LRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFT  206 (640)
Q Consensus       128 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~-l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  206 (640)
                      +++|++|+|++|+++..      .+..+..+++|++|++++|. ++.+| .+..+++|++|++++|.+++ ++ .+..++
T Consensus       111 l~~L~~L~Ls~n~i~~~------~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~  181 (197)
T 4ezg_A          111 LTSLTLLDISHSAHDDS------ILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFP  181 (197)
T ss_dssp             CTTCCEEECCSSBCBGG------GHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCS
T ss_pred             CCCCCEEEecCCccCcH------hHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCC
Confidence            66666666666665543      23445555666666666665 55555 45556667777777777664 23 566667


Q ss_pred             CCCEEEccCCCCC
Q 035691          207 FLTELNLRGNSIR  219 (640)
Q Consensus       207 ~L~~L~L~~N~l~  219 (640)
                      +|++|++++|+|.
T Consensus       182 ~L~~L~l~~N~i~  194 (197)
T 4ezg_A          182 KLNQLYAFSQTIG  194 (197)
T ss_dssp             SCCEEEECBC---
T ss_pred             CCCEEEeeCcccC
Confidence            7777777777664

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.80  E-value=1.8e-18  Score=181.57  Aligned_cols=266  Identities=10%  Similarity=0.112  Sum_probs=183.8

Q ss_pred             CCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCC
Q 035691           26 LFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNAS  105 (640)
Q Consensus        26 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  105 (640)
                      ...++.+.+.+ .++.+...+|.++ +|+.+++..| ++.      ++...|.. .+|+.+.|.+ .++.+.+.+|.+++
T Consensus       112 ~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~------I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~  180 (401)
T 4fdw_A          112 LKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKS------IGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCY  180 (401)
T ss_dssp             CSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCE------ECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCT
T ss_pred             cCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccE------ECHHhcCC-CCceEEEeCC-CccEehHHHhhCcc
Confidence            35666666653 4555666777774 6777777655 443      66777765 4677777775 66667777777788


Q ss_pred             CCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcCCCCCCCCC
Q 035691          106 KLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQ  185 (640)
Q Consensus       106 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~  185 (640)
                      +|+.++|++|+++.+...+|. ..+|+.+.|..| ++.+      ...+|.++++|+.+++..| ++.++...+.-.+|+
T Consensus       181 ~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I------~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~~~L~  251 (401)
T 4fdw_A          181 NLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEI------GSQAFLKTSQLKTIEIPEN-VSTIGQEAFRESGIT  251 (401)
T ss_dssp             TCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEE------CTTTTTTCTTCCCEECCTT-CCEECTTTTTTCCCS
T ss_pred             cCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hhee------hhhHhhCCCCCCEEecCCC-ccCccccccccCCcc
Confidence            888888887777776666776 477788877743 6665      3356677777777777764 566655433336777


Q ss_pred             EEEccCCcCcccCCcCccCCCCCCEEEccCCCCC-----CCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCC
Q 035691          186 VLSLFENNISGEIPSSLGNFTFLTELNLRGNSIR-----GSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTG  260 (640)
Q Consensus       186 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~  260 (640)
                      .+.+ .|.++.+.+.+|.++++|+.+++.+|.+.     .+.+.+|.+|++|+.+                +|. |.++.
T Consensus       252 ~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l----------------~l~-~~i~~  313 (401)
T 4fdw_A          252 TVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARF----------------EIP-ESIRI  313 (401)
T ss_dssp             EEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEE----------------CCC-TTCCE
T ss_pred             EEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeE----------------EeC-CceEE
Confidence            7777 45566566777777788888887777664     3555667777777766                555 34665


Q ss_pred             CCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCC-CCCeEeCcCCccc
Q 035691          261 PIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLK-SLEGLDLFQNTFQ  331 (640)
Q Consensus       261 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~  331 (640)
                      +...+|.++++|+.++|..| ++.+.+.+|.++ +|+.+++++|.+....+..|.+++ +++.|++..|.+.
T Consensus       314 I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          314 LGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             ECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             EhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            66777888888888888555 665667778888 888888888877766777777774 6777777777655

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.80  E-value=6.5e-20  Score=188.34  Aligned_cols=246  Identities=11%  Similarity=0.092  Sum_probs=180.8

Q ss_pred             CCCCCeEEcccCccC--------------------ccCCcCCCC--------CCCCCEEEccCCCcCCccccccCCchhh
Q 035691           26 LFQLRYIIFNSNTLQ--------------------GQIPVNLTH--------CSELRTLDLVLNKLEENQLVGELPPYIG   77 (640)
Q Consensus        26 l~~L~~L~l~~N~l~--------------------~~~~~~~~~--------l~~L~~L~Ls~N~l~~~~~~~~lp~~~~   77 (640)
                      +++|++|+|++|+|.                    .+.+.+|.+        +++|+.|+|.. .++.      +++..|
T Consensus        48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~------I~~~aF  120 (329)
T 3sb4_A           48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKN------IEDAAF  120 (329)
T ss_dssp             CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCE------ECTTTT
T ss_pred             hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccc------hhHHHh
Confidence            455666666666555                    345667888        99999999998 7765      999999


Q ss_pred             cCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCc----cCccCCccccCCCCCC-EEEcccCcCCCCCCCccccc
Q 035691           78 FTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNS----LTASIPEDLGRLRNLT-RLNFARNDLGTRKVNDLRFL  152 (640)
Q Consensus        78 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~----l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~~  152 (640)
                      .++++|+.+++++|.+..+.+.+|.++.++..+.+..+.    ...+...+|.++.+|+ .+.+....  .++..   ..
T Consensus       121 ~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~--~l~~~---~~  195 (329)
T 3sb4_A          121 KGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMG--KLEDE---IM  195 (329)
T ss_dssp             TTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTC--CHHHH---HH
T ss_pred             hcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCC--cHHHH---Hh
Confidence            999999999999999999999999998888888887743    3344566788888887 55554322  11100   00


Q ss_pred             ccccCCCCcceEecCCCCCCCcCcCC-CCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCC
Q 035691          153 DSLVNCTYLEIVSLNVNSLRSIPISV-GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQ  231 (640)
Q Consensus       153 ~~l~~l~~L~~L~L~~N~l~~ip~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  231 (640)
                      ..-....++..+.+.++-...-...+ ..+++|+.++|++|.++.+.+.+|.++++|+.|+|++| ++.+.+.+|.+|++
T Consensus       196 ~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~  274 (329)
T 3sb4_A          196 KAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGR  274 (329)
T ss_dssp             HTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTT
T ss_pred             hcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChh
Confidence            11112445566666554221111111 12678999999999998888888999999999999988 77777888999988


Q ss_pred             cc-EEeccCccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEe
Q 035691          232 LQ-SLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNL  301 (640)
Q Consensus       232 L~-~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  301 (640)
                      |+ .+                ++++ +++.+.+.+|.++++|+.|++++|+++.+.+.+|.++++|+.++.
T Consensus       275 L~~~l----------------~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          275 LAGTL----------------ELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             CCEEE----------------EECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred             ccEEE----------------EEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence            88 88                6665 676677889999999999999999998777789999999998874

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.80  E-value=7.9e-20  Score=173.00  Aligned_cols=153  Identities=16%  Similarity=0.234  Sum_probs=84.0

Q ss_pred             cCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCC
Q 035691          126 GRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNF  205 (640)
Q Consensus       126 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  205 (640)
                      ..+++|++|++++|.++.++        .+..+++|++|++++|.++.++ .+..+++|++|++++|.+++..|..|..+
T Consensus        41 ~~l~~L~~L~l~~n~i~~l~--------~l~~l~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~l~~n~l~~~~~~~l~~l  111 (197)
T 4ezg_A           41 AQMNSLTYITLANINVTDLT--------GIEYAHNIKDLTINNIHATNYN-PISGLSNLERLRIMGKDVTSDKIPNLSGL  111 (197)
T ss_dssp             HHHHTCCEEEEESSCCSCCT--------TGGGCTTCSEEEEESCCCSCCG-GGTTCTTCCEEEEECTTCBGGGSCCCTTC
T ss_pred             hhcCCccEEeccCCCccChH--------HHhcCCCCCEEEccCCCCCcch-hhhcCCCCCEEEeECCccCcccChhhcCC
Confidence            55666777777777766442        2445566666666666555443 45555666666666666665555556666


Q ss_pred             CCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCc-CCCCCCccCCCCCCCCEEECCCCcccC
Q 035691          206 TFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNH-LTGPIPLAVGNLKSIPHLDLSKNKLSG  284 (640)
Q Consensus       206 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~  284 (640)
                      ++|++|+|++|++++..|..+..+++|+.|                ++++|. ++ .+| .+..+++|+.|++++|++++
T Consensus       112 ~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L----------------~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~  173 (197)
T 4ezg_A          112 TSLTLLDISHSAHDDSILTKINTLPKVNSI----------------DLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD  173 (197)
T ss_dssp             TTCCEEECCSSBCBGGGHHHHTTCSSCCEE----------------ECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC
T ss_pred             CCCCEEEecCCccCcHhHHHHhhCCCCCEE----------------EccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC
Confidence            666666666666655455555555555555                444444 33 222 35555555555555555553


Q ss_pred             cCCccccCCCCCCeEEecCCccC
Q 035691          285 EIPSSLGSCVGLEYLNLSINSFH  307 (640)
Q Consensus       285 ~~p~~~~~l~~L~~L~L~~N~l~  307 (640)
                       ++ .+..+++|++|++++|++.
T Consensus       174 -~~-~l~~l~~L~~L~l~~N~i~  194 (197)
T 4ezg_A          174 -YR-GIEDFPKLNQLYAFSQTIG  194 (197)
T ss_dssp             -CT-TGGGCSSCCEEEECBC---
T ss_pred             -hH-HhccCCCCCEEEeeCcccC
Confidence             22 4555555555555555543

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.79  E-value=1.1e-19  Score=179.63  Aligned_cols=139  Identities=19%  Similarity=0.151  Sum_probs=106.4

Q ss_pred             CCcccCcccccccceEEEEEECCCCeE--EEEEEeecccch------------------------hHHHHHHHHHHHHhc
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTV--VAVKVLFLHQRG------------------------ALKSFMAECEALRNI  495 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l  495 (640)
                      -|++.+.||+|+||.||+|.+..+|+.  ||||+++.....                        ....+.+|++.+.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            356778999999999999998668989  999987432111                        113688999999999


Q ss_pred             CCCCC--cceeEeeccCCcCCCceeeEEeeccCC-C----ChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 035691          496 RHRNL--VKIITACSSSDFQGNDFKALVYEFMHH-G----SLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY  568 (640)
Q Consensus       496 ~H~ni--v~l~~~~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~y  568 (640)
                      +|+++  +..+++         ...++||||+.+ |    +|.++...             .++..+..++.|++.||.|
T Consensus       128 ~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~-------------~~~~~~~~i~~qi~~~l~~  185 (258)
T 1zth_A          128 KEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE-------------LKELDVEGIFNDVVENVKR  185 (258)
T ss_dssp             HHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG-------------GGGSCHHHHHHHHHHHHHH
T ss_pred             HhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc-------------cChHHHHHHHHHHHHHHHH
Confidence            88864  344332         235799999953 4    56655421             1123457899999999999


Q ss_pred             Hh-cCCCCCeeeCCCCCCCeeeCCCCcEEEccccccccCC
Q 035691          569 LH-HHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP  607 (640)
Q Consensus       569 LH-~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~  607 (640)
                      || +   .+|+||||||+|||+++  .++|+|||+|....
T Consensus       186 lH~~---~givHrDlkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          186 LYQE---AELVHADLSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             HHHT---SCEECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred             HHHH---CCEEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence            99 7   69999999999999998  99999999998653

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.79  E-value=2.1e-20  Score=211.53  Aligned_cols=222  Identities=20%  Similarity=0.220  Sum_probs=97.3

Q ss_pred             CCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCC
Q 035691           27 FQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASK  106 (640)
Q Consensus        27 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  106 (640)
                      +.++.|+|.+|.+.. .+.     ..|+.++|+.|.|..                    ++++.|.+. ..|+.|..+++
T Consensus       173 ~~~~~l~L~~n~~~~-~~~-----~~l~~l~Ls~~~i~~--------------------~~~~~n~~~-~~~~~~~~l~~  225 (727)
T 4b8c_D          173 PLTPKIELFANGKDE-ANQ-----ALLQHKKLSQYSIDE--------------------DDDIENRMV-MPKDSKYDDQL  225 (727)
T ss_dssp             ----------------------------------------------------------------------------CCCC
T ss_pred             CccceEEeeCCCCCc-chh-----hHhhcCccCcccccC--------------------cccccccee-cChhhhccCCC
Confidence            345566666666653 222     234455555554432                    233445544 45667777777


Q ss_pred             CCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcCCCCCCCCCE
Q 035691          107 LEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQV  186 (640)
Q Consensus       107 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~  186 (640)
                      |+.|+|++|.|. .+|..+..+++|++|+|++|.|+.+       +..|.++++|++|+|++|.|+.+|..+..+++|++
T Consensus       226 L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~~l-------p~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~  297 (727)
T 4b8c_D          226 WHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLTEL-------PAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKY  297 (727)
T ss_dssp             CCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCSCC-------CGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSE
T ss_pred             CcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCccc-------ChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCE
Confidence            777777777777 4555555777777777777777743       45567777777777777777777777777777777


Q ss_pred             EEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCc-cEEeccCccccCCCCCceEEccCCcCCCCCCcc
Q 035691          187 LSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQL-QSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLA  265 (640)
Q Consensus       187 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~  265 (640)
                      |+|++|.|+ .+|..|+.+++|++|+|++|+|++.+|..+..+... ..+                +|++|.+++.+|..
T Consensus       298 L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l----------------~l~~N~l~~~~p~~  360 (727)
T 4b8c_D          298 FYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIF----------------YLRDNRPEIPLPHE  360 (727)
T ss_dssp             EECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHH----------------HHHHCCCCCCCCCC
T ss_pred             EECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHH----------------hhccCcccCcCccc
Confidence            777777776 556667777777777777777777777666544221 123                56666666666543


Q ss_pred             CCCCCCCCEEECCCC--------cccCcCCccccCCCCCCeEEecCCcc
Q 035691          266 VGNLKSIPHLDLSKN--------KLSGEIPSSLGSCVGLEYLNLSINSF  306 (640)
Q Consensus       266 ~~~l~~L~~L~Ls~N--------~l~~~~p~~~~~l~~L~~L~L~~N~l  306 (640)
                            |+.|++++|        .|.+..+..+..+..+....++.|-+
T Consensus       361 ------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil  403 (727)
T 4b8c_D          361 ------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTL  403 (727)
T ss_dssp             -----------------------------------------------CC
T ss_pred             ------cceeEeecccccccccCCccccccchhhcccccceeeeecccc
Confidence                  344455555        23333333334444445555555544

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.79  E-value=2e-20  Score=211.63  Aligned_cols=222  Identities=21%  Similarity=0.208  Sum_probs=76.4

Q ss_pred             CCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCc---------cCCcCCCCCCCCCEEEccCCCcCCccccccCC
Q 035691            3 TFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQG---------QIPVNLTHCSELRTLDLVLNKLEENQLVGELP   73 (640)
Q Consensus         3 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~---------~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp   73 (640)
                      +.++.|+|.+|.+.. .+..+     |+.++|++|.|.+         ..|..|..++.|+.|||++|+|..      +|
T Consensus       173 ~~~~~l~L~~n~~~~-~~~~~-----l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~~------l~  240 (727)
T 4b8c_D          173 PLTPKIELFANGKDE-ANQAL-----LQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIFN------IS  240 (727)
T ss_dssp             -------------------------------------------------------CCCCCCEEECTTSCCSC------CC
T ss_pred             CccceEEeeCCCCCc-chhhH-----hhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCCC------CC
Confidence            347789999999985 34333     3444455554442         345555566666666666555543      55


Q ss_pred             chhhcCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccc
Q 035691           74 PYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLD  153 (640)
Q Consensus        74 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~  153 (640)
                      ..++ .+++|+.|+|++|.|+ .+|..|+++++|++|||++|+|+ .+|..|+                           
T Consensus       241 ~~~~-~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~---------------------------  290 (727)
T 4b8c_D          241 ANIF-KYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELG---------------------------  290 (727)
T ss_dssp             GGGG-GCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGG---------------------------
T ss_pred             hhhc-CCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhc---------------------------
Confidence            5444 2455555555555554 34444444455555555555544 2344444                           


Q ss_pred             cccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCC-CCEEEccCCCCCCCCCccccCCCCc
Q 035691          154 SLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTF-LTELNLRGNSIRGSIPSALGNCHQL  232 (640)
Q Consensus       154 ~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L  232 (640)
                         ++++|++|+|++|.|+.+|..+..+++|++|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|..+      
T Consensus       291 ---~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l------  361 (727)
T 4b8c_D          291 ---SCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHER------  361 (727)
T ss_dssp             ---GGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-------
T ss_pred             ---CCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcccc------
Confidence               445555555555555555555666666666666666666666665544321 2235666777666665432      


Q ss_pred             cEEeccCccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCccc
Q 035691          233 QSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLS  283 (640)
Q Consensus       233 ~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  283 (640)
                      ..|+++.|..        +....+.+.+..+..+..+..+....++.|-+.
T Consensus       362 ~~l~l~~n~~--------~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~  404 (727)
T 4b8c_D          362 RFIEINTDGE--------PQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC  404 (727)
T ss_dssp             ------------------------------------------------CCC
T ss_pred             ceeEeecccc--------cccccCCccccccchhhcccccceeeeeccccc
Confidence            3333333200        011123444555556666667777777777765

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.79  E-value=2.7e-19  Score=168.46  Aligned_cols=129  Identities=25%  Similarity=0.349  Sum_probs=67.5

Q ss_pred             ceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCc-CccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCc
Q 035691          162 EIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPS-SLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKT  240 (640)
Q Consensus       162 ~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n  240 (640)
                      +.+++++|.++.+|..+.  .+|++|+|++|.|+++.+. .|..+++|++|+|++|+|++..|.+|.++++|+.|     
T Consensus        11 ~~l~~s~~~l~~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L-----   83 (192)
T 1w8a_A           11 TTVDCTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQEL-----   83 (192)
T ss_dssp             TEEECTTSCCSSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE-----
T ss_pred             CEEEcCCCCcCcCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEE-----
Confidence            556666666666665443  2566666666666544443 35555555555555555555555555555555444     


Q ss_pred             cccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCC
Q 035691          241 IFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHG  308 (640)
Q Consensus       241 ~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  308 (640)
                                 +|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|++++
T Consensus        84 -----------~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  140 (192)
T 1w8a_A           84 -----------QLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC  140 (192)
T ss_dssp             -----------ECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred             -----------ECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence                       444444444444444445555555555555544444444444444444444444443

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.78  E-value=1.6e-18  Score=163.25  Aligned_cols=129  Identities=26%  Similarity=0.345  Sum_probs=76.3

Q ss_pred             CEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcC--CCCCCCCCEEEccCCcCcccCCcCccCCCCCC
Q 035691          132 TRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPIS--VGYLPKLQVLSLFENNISGEIPSSLGNFTFLT  209 (640)
Q Consensus       132 ~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~--~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  209 (640)
                      +.+++++|.++.+|.       .+.  .+|+.|++++|.|+.++..  +..+++|++|+|++|.|++..|..|.++++|+
T Consensus        11 ~~l~~s~~~l~~ip~-------~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   81 (192)
T 1w8a_A           11 TTVDCTGRGLKEIPR-------DIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQ   81 (192)
T ss_dssp             TEEECTTSCCSSCCS-------CCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCC
T ss_pred             CEEEcCCCCcCcCcc-------CCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCC
Confidence            556666666655432       111  1566666666666665442  45566666666666666665566666666666


Q ss_pred             EEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCc
Q 035691          210 ELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGE  285 (640)
Q Consensus       210 ~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  285 (640)
                      +|+|++|+|++..+..|.++++|+.|                +|++|+|++..|..|..+++|+.|+|++|.+++.
T Consensus        82 ~L~Ls~N~l~~~~~~~~~~l~~L~~L----------------~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~  141 (192)
T 1w8a_A           82 ELQLGENKIKEISNKMFLGLHQLKTL----------------NLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             EEECCSCCCCEECSSSSTTCTTCCEE----------------ECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred             EEECCCCcCCccCHHHhcCCCCCCEE----------------ECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence            66666666665555556666666555                5555566655566666666666666666666543

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.78  E-value=1.1e-17  Score=175.48  Aligned_cols=264  Identities=15%  Similarity=0.137  Sum_probs=220.1

Q ss_pred             CCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCC
Q 035691            3 TFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPN   82 (640)
Q Consensus         3 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~   82 (640)
                      +.++.+.+. |.++.+...+|.+. +|+.+.+..| ++.+...+|.++ +|+.+++.. .++.      ++...|..+++
T Consensus       113 ~~l~~i~ip-~~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~------I~~~aF~~c~~  181 (401)
T 4fdw_A          113 KGYNEIILP-NSVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQ------LKEDIFYYCYN  181 (401)
T ss_dssp             SSCSEEECC-TTCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCE------ECSSTTTTCTT
T ss_pred             CCccEEEEC-CccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccE------ehHHHhhCccc
Confidence            345566665 35666777889885 8999999877 887888899985 799999984 5554      88899999999


Q ss_pred             CCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcc
Q 035691           83 IRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLE  162 (640)
Q Consensus        83 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~  162 (640)
                      |+.++|++|+++.+...+|. .++|+.+.|..| ++.+...+|.++++|+.+++..| ++.++.      .+|.+ ++|+
T Consensus       182 L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~------~aF~~-~~L~  251 (401)
T 4fdw_A          182 LKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQ------EAFRE-SGIT  251 (401)
T ss_dssp             CCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECT------TTTTT-CCCS
T ss_pred             CCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCccc------ccccc-CCcc
Confidence            99999999999998888898 589999999855 88888999999999999999975 666643      45556 6899


Q ss_pred             eEecCCCCCCCcCc-CCCCCCCCCEEEccCCcCc-----ccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEe
Q 035691          163 IVSLNVNSLRSIPI-SVGYLPKLQVLSLFENNIS-----GEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLD  236 (640)
Q Consensus       163 ~L~L~~N~l~~ip~-~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  236 (640)
                      .+.+ .+.++.++. +|..+++|+.+++.+|.+.     .+.+.+|.++++|+.++|. +.++.+...+|.+|.+|+.+ 
T Consensus       252 ~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l-  328 (401)
T 4fdw_A          252 TVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQL-  328 (401)
T ss_dssp             EEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEE-
T ss_pred             EEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEE-
Confidence            9999 566888755 6778999999999998876     5778899999999999999 45887888899999999998 


Q ss_pred             ccCccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCC-CCCeEEecCCccC
Q 035691          237 LSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCV-GLEYLNLSINSFH  307 (640)
Q Consensus       237 ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~  307 (640)
                                     +|..| ++.+.+.+|.++ +|+.+++++|.+....+..|.+++ +++.|++..+.+.
T Consensus       329 ---------------~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          329 ---------------TIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             ---------------EECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             ---------------EECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence                           66443 666778899999 999999999999977788898884 7899999988764

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.76  E-value=5.7e-18  Score=159.37  Aligned_cols=134  Identities=23%  Similarity=0.282  Sum_probs=98.4

Q ss_pred             CEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCc
Q 035691          185 QVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPL  264 (640)
Q Consensus       185 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~  264 (640)
                      +.+++++|.++ .+|..+.  ++|++|+|++|+|+ .+|..|.++++|+.|                +|++|+|++..+.
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L----------------~Ls~N~i~~i~~~   72 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLI----------------DLSNNRISTLSNQ   72 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEE----------------ECCSSCCCCCCTT
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEE----------------ECCCCcCCEeCHh
Confidence            45555566555 3343332  45666667777666 455666666667666                6666777767777


Q ss_pred             cCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCcc
Q 035691          265 AVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGD  338 (640)
Q Consensus       265 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  338 (640)
                      .|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|+...+..|..+++|+.|+|++|+|.|.|...+
T Consensus        73 ~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~~  146 (193)
T 2wfh_A           73 SFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQW  146 (193)
T ss_dssp             TTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGGHH
T ss_pred             HccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcCHH
Confidence            78888888888888888887777788888888888888888887777788889999999999999998775433

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.74  E-value=6.3e-18  Score=155.46  Aligned_cols=140  Identities=18%  Similarity=0.164  Sum_probs=77.9

Q ss_pred             CCCCeEEcccCccC-ccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCC
Q 035691           27 FQLRYIIFNSNTLQ-GQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNAS  105 (640)
Q Consensus        27 ~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  105 (640)
                      ++|++|++++|.++ +.+|..+..+++|++|+|++|.|+.      +  ..+..+++|+.|+|++|++++.+|..+.+++
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~------~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~   95 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS------V--SNLPKLPKLKKLELSENRIFGGLDMLAEKLP   95 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCC------C--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCT
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCC------h--hhhccCCCCCEEECcCCcCchHHHHHHhhCC
Confidence            45555555555555 4445555555556666665555543      2  2223455566666666666555555555566


Q ss_pred             CCCEEECcCCccCccCC-ccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcC
Q 035691          106 KLEWLDFANNSLTASIP-EDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPIS  177 (640)
Q Consensus       106 ~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~  177 (640)
                      +|++|+|++|+|++..+ ..|..+++|++|++++|.++..+.-   ....+..+++|++|+++.|.+..+|.+
T Consensus        96 ~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~---~~~~~~~l~~L~~L~l~~n~~~~~~~~  165 (168)
T 2ell_A           96 NLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDY---RESVFKLLPQLTYLDGYDREDQEAPDS  165 (168)
T ss_dssp             TCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTH---HHHHHTTCSSCCEETTEETTSCBCCSS
T ss_pred             CCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHH---HHHHHHhCccCcEecCCCCChhhcccc
Confidence            66666666666664322 5566666666666666666554210   002455566666666666666665543

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.74  E-value=2.1e-17  Score=155.45  Aligned_cols=128  Identities=26%  Similarity=0.310  Sum_probs=113.6

Q ss_pred             ceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCcc
Q 035691          162 EIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTI  241 (640)
Q Consensus       162 ~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~  241 (640)
                      +.+++++|.++.+|..+.  ++|++|+|++|.|+ .+|..|.++++|++|+|++|+|++..+.+|.++++|+.|      
T Consensus        13 ~~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L------   83 (193)
T 2wfh_A           13 TVVRCSNKGLKVLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTL------   83 (193)
T ss_dssp             TEEECTTSCCSSCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE------
T ss_pred             CEEEcCCCCCCcCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEE------
Confidence            578888888888887664  68999999999998 677889999999999999999998888889999999888      


Q ss_pred             ccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCC
Q 035691          242 FLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHG  308 (640)
Q Consensus       242 ~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  308 (640)
                                +|++|+|++..|..|.++++|+.|+|++|+|+...+..|..+++|+.|+|++|++..
T Consensus        84 ----------~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A           84 ----------ILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             ----------ECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             ----------ECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence                      888888988888899999999999999999997777789999999999999999975

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.73  E-value=4.8e-17  Score=150.93  Aligned_cols=82  Identities=22%  Similarity=0.219  Sum_probs=46.4

Q ss_pred             EccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccc
Q 035691          252 DLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQ  331 (640)
Q Consensus       252 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  331 (640)
                      ++++|++++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++.
T Consensus        58 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  137 (177)
T 2o6r_A           58 SLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD  137 (177)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             ECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCee
Confidence            44444444444444555555555555555555444445555666666666666666555555566666666666666666


Q ss_pred             cc
Q 035691          332 AK  333 (640)
Q Consensus       332 ~~  333 (640)
                      +.
T Consensus       138 ~~  139 (177)
T 2o6r_A          138 CS  139 (177)
T ss_dssp             CC
T ss_pred             cc
Confidence            43

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.72  E-value=8.8e-17  Score=149.15  Aligned_cols=134  Identities=20%  Similarity=0.205  Sum_probs=120.7

Q ss_pred             CcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccC
Q 035691          160 YLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSK  239 (640)
Q Consensus       160 ~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~  239 (640)
                      ..+.+++++|.++.+|..+.  ++|++|++++|.+++..+..|..+++|++|+|++|+|++..+..|..+++|+.|    
T Consensus         8 ~~~~l~~~~~~l~~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L----   81 (177)
T 2o6r_A            8 SGTEIRCNSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTIL----   81 (177)
T ss_dssp             ETTEEECCSSCCSSCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE----
T ss_pred             CCCEEEecCCCCccCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEE----
Confidence            35789999999999997654  799999999999998888889999999999999999998888888999999988    


Q ss_pred             ccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCC
Q 035691          240 TIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIH  311 (640)
Q Consensus       240 n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~  311 (640)
                                  +|++|+|++..+..|..+++|+.|+|++|++++..+..|..+++|++|+|++|++++..|
T Consensus        82 ------------~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           82 ------------YLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             ------------ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             ------------ECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence                        888899998888889999999999999999997777778999999999999999987544

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.72  E-value=1.5e-17  Score=152.92  Aligned_cols=133  Identities=25%  Similarity=0.243  Sum_probs=89.8

Q ss_pred             CCCCCEEEccCCcCc-ccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCC
Q 035691          181 LPKLQVLSLFENNIS-GEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLT  259 (640)
Q Consensus       181 l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~  259 (640)
                      .++|++|++++|.++ +.+|..+..+++|++|+|++|.+++.  ..|..+++|+.|                +|++|+++
T Consensus        23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L----------------~Ls~N~l~   84 (168)
T 2ell_A           23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKL----------------ELSENRIF   84 (168)
T ss_dssp             TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEE----------------EEESCCCC
T ss_pred             cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEE----------------ECcCCcCc
Confidence            356677777777776 45566666677777777777777644  556666666666                66666666


Q ss_pred             CCCCccCCCCCCCCEEECCCCcccCcCC-ccccCCCCCCeEEecCCccCCCCC---ccCCCCCCCCeEeCcCCccc
Q 035691          260 GPIPLAVGNLKSIPHLDLSKNKLSGEIP-SSLGSCVGLEYLNLSINSFHGPIH---PGLSSLKSLEGLDLFQNTFQ  331 (640)
Q Consensus       260 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~l~~N~l~  331 (640)
                      +.+|..+..+++|+.|+|++|+|++..+ ..+..+++|++|++++|++++..+   ..+..+++|++|++++|.+.
T Consensus        85 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A           85 GGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             SCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             hHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            5566666667777777777777764322 567777777777777777775554   46777777777777777765

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.70  E-value=2.5e-17  Score=148.15  Aligned_cols=130  Identities=15%  Similarity=0.145  Sum_probs=72.6

Q ss_pred             CCCCeEEcccCccC-ccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCC
Q 035691           27 FQLRYIIFNSNTLQ-GQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNAS  105 (640)
Q Consensus        27 ~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  105 (640)
                      ++|+.|++++|.++ +.+|..+..+++|++|++++|+|+.      +  ..+..+++|+.|+|++|++++.+|..+.+++
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~------~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~   88 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS------I--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCP   88 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCC------C--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCT
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCC------c--hhhhcCCCCCEEECCCCcccchHHHHhhhCC
Confidence            45556666666655 4555555556666666666555543      2  2223455666666666666655555555566


Q ss_pred             CCCEEECcCCccCcc-CCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecC
Q 035691          106 KLEWLDFANNSLTAS-IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLN  167 (640)
Q Consensus       106 ~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~  167 (640)
                      +|++|++++|++++. .+..+..+++|++|++++|+++..+.-   ....+..+++|+.|+++
T Consensus        89 ~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~---~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           89 NLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDY---RENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             TCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTH---HHHHHHHCTTCCEETTB
T ss_pred             CCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHH---HHHHHHHCCCcccccCC
Confidence            666666666666653 235566666666666666666554210   00235556666666654

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.69  E-value=2e-17  Score=148.80  Aligned_cols=127  Identities=21%  Similarity=0.243  Sum_probs=72.6

Q ss_pred             CCCCEEEccCCcCc-ccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCC
Q 035691          182 PKLQVLSLFENNIS-GEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTG  260 (640)
Q Consensus       182 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~  260 (640)
                      ++|+.|++++|.++ +.+|..+..+++|++|++++|.+++.  ..+..+++|+.|                ++++|.+++
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L----------------~Ls~n~i~~   78 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKL----------------ELSDNRVSG   78 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEE----------------ECCSSCCCS
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEE----------------ECCCCcccc
Confidence            44555555555555 44555555555566666666655543  445555555555                555555554


Q ss_pred             CCCccCCCCCCCCEEECCCCcccCc-CCccccCCCCCCeEEecCCccCCCCC---ccCCCCCCCCeEeCc
Q 035691          261 PIPLAVGNLKSIPHLDLSKNKLSGE-IPSSLGSCVGLEYLNLSINSFHGPIH---PGLSSLKSLEGLDLF  326 (640)
Q Consensus       261 ~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~l~  326 (640)
                      .+|..+..+++|++|++++|++++. .+..+..+++|++|++++|++++..+   ..+..+++|++||++
T Consensus        79 ~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           79 GLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             CTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             hHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            4555555566666666666666542 23556666666666666666665444   356666666666654

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.69  E-value=1.3e-15  Score=160.34  Aligned_cols=292  Identities=13%  Similarity=0.086  Sum_probs=193.7

Q ss_pred             cccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCC---
Q 035691           15 FSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGN---   91 (640)
Q Consensus        15 i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N---   91 (640)
                      ++.+...+|.++.+|+.+.+.. .++.+...+|.++++|+.+++..+ ++.      ++...|....+|+.+.+..+   
T Consensus        59 VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~------I~~~aF~~c~~L~~i~~p~~l~~  130 (394)
T 4fs7_A           59 VVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKM------IGRCTFSGCYALKSILLPLMLKS  130 (394)
T ss_dssp             EEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCE------ECTTTTTTCTTCCCCCCCTTCCE
T ss_pred             EeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceE------ccchhhcccccchhhcccCceee
Confidence            4445556677777777777753 366566667777777777777543 332      55555555555555444332   


Q ss_pred             ------------------cccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccc
Q 035691           92 ------------------QFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLD  153 (640)
Q Consensus        92 ------------------~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~  153 (640)
                                        .+..+...+|.++++|+.+.+.++. ..+...+|.++.+|+.+++..| ++.+      ...
T Consensus       131 i~~~aF~~~~~~~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I------~~~  202 (394)
T 4fs7_A          131 IGVEAFKGCDFKEITIPEGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKII------RDY  202 (394)
T ss_dssp             ECTTTTTTCCCSEEECCTTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEE------CTT
T ss_pred             ecceeeecccccccccCccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEe------Cch
Confidence                              2222334567777777777776553 3356667777777777777665 4444      224


Q ss_pred             cccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCcc
Q 035691          154 SLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQ  233 (640)
Q Consensus       154 ~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  233 (640)
                      .|.++..|+.+.+..+.. .+........+|+.+.+..+ ++.+...+|.++.+|+.+.+..+... +...+|..+..++
T Consensus       203 ~F~~~~~L~~i~~~~~~~-~i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~  279 (394)
T 4fs7_A          203 CFAECILLENMEFPNSLY-YLGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLK  279 (394)
T ss_dssp             TTTTCTTCCBCCCCTTCC-EECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCC
T ss_pred             hhccccccceeecCCCce-EeehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccc
Confidence            566677777776665533 23334444567777777644 34366677888888888888777554 6667788888888


Q ss_pred             EEeccCc-----cccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCC
Q 035691          234 SLDLSKT-----IFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHG  308 (640)
Q Consensus       234 ~L~ls~n-----~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  308 (640)
                      .+....+     .|.+...|+.+.+..+ ++.+...+|.++++|+.++|.++ ++.+...+|.++.+|+.+++..| ++.
T Consensus       280 ~~~~~~~~i~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~  356 (394)
T 4fs7_A          280 KVIYGSVIVPEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRK  356 (394)
T ss_dssp             EEEECSSEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCE
T ss_pred             eeccCceeeccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccE
Confidence            7766543     4556667888888655 66566778888888888888754 66566778888888888888776 776


Q ss_pred             CCCccCCCCCCCCeEeCcCC
Q 035691          309 PIHPGLSSLKSLEGLDLFQN  328 (640)
Q Consensus       309 ~~~~~~~~l~~L~~L~l~~N  328 (640)
                      +...+|.++++|+.+++..+
T Consensus       357 I~~~aF~~C~~L~~i~lp~~  376 (394)
T 4fs7_A          357 IGANAFQGCINLKKVELPKR  376 (394)
T ss_dssp             ECTTTBTTCTTCCEEEEEGG
T ss_pred             ehHHHhhCCCCCCEEEECCC
Confidence            77788888888888888654

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.66  E-value=1.5e-16  Score=147.44  Aligned_cols=128  Identities=17%  Similarity=0.225  Sum_probs=56.1

Q ss_pred             CCCcEEeCCCCccccCCchhhhcCC-CCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCC
Q 035691            3 TFLMLINLQQNNFSGNIPHEIGRLF-QLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLP   81 (640)
Q Consensus         3 ~~L~~L~L~~n~i~~~~p~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~   81 (640)
                      ++|+.|+|++|+|+. +|. +..+. +|++|++++|.|++.  ..|..+++|++|+|++|+|+.      +|+.++..++
T Consensus        19 ~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~------~~~~~~~~l~   88 (176)
T 1a9n_A           19 VRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICR------IGEGLDQALP   88 (176)
T ss_dssp             TSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCE------ECSCHHHHCT
T ss_pred             CCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccc------cCcchhhcCC
Confidence            444555555555542 232 22222 455555555555433  334445555555555444442      4444433444


Q ss_pred             CCCeeeccCCcccccCC-ccCcCCCCCCEEECcCCccCccCCc----cccCCCCCCEEEcccCcC
Q 035691           82 NIRIPLLAGNQFFGNIP-HSISNASKLEWLDFANNSLTASIPE----DLGRLRNLTRLNFARNDL  141 (640)
Q Consensus        82 ~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~L~~N~l  141 (640)
                      +|+.|+|++|+|+...+ ..+..+++|++|++++|.++. .|.    .+..+++|+.|++++|.+
T Consensus        89 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~  152 (176)
T 1a9n_A           89 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKL  152 (176)
T ss_dssp             TCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCH
T ss_pred             CCCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCH
Confidence            44444444444432211 134444444444444444442 222    244444444444444443

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.66  E-value=6e-17  Score=166.04  Aligned_cols=146  Identities=10%  Similarity=0.094  Sum_probs=102.9

Q ss_pred             HHHHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc--------------hhHH--------HHHHHHH
Q 035691          433 YESLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR--------------GALK--------SFMAECE  490 (640)
Q Consensus       433 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~  490 (640)
                      +..+.....-|++...||+|+||.||+|... +|+.||||+++....              ....        ....|..
T Consensus        87 L~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~  165 (397)
T 4gyi_A           87 LHTHAARKDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA  165 (397)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHCCCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence            3455555556899999999999999999986 799999998743210              0111        2234566


Q ss_pred             HHHhcCCCCCcceeEeeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 035691          491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLH  570 (640)
Q Consensus       491 ~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH  570 (640)
                      .|.++.+.++.....+       .....++||||++|+.+..+....                ....++.|++.||.|||
T Consensus       166 nL~rL~~~gv~vp~p~-------~~~~~~LVME~i~G~~L~~l~~~~----------------~~~~l~~qll~~l~~lH  222 (397)
T 4gyi_A          166 FMKALYEEGFPVPEPI-------AQSRHTIVMSLVDALPMRQVSSVP----------------DPASLYADLIALILRLA  222 (397)
T ss_dssp             HHHHHHHTTCSCCCEE-------EEETTEEEEECCSCEEGGGCCCCS----------------CHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhcCCCCCeee-------eccCceEEEEecCCccHhhhcccH----------------HHHHHHHHHHHHHHHHH
Confidence            6666654443221111       011236999999998887654211                12467899999999999


Q ss_pred             cCCCCCeeeCCCCCCCeeeCCCC----------cEEEcccccccc
Q 035691          571 HHCKKQIVHCDLKPSNVLLDNDM----------IAHVGDFGLTRF  605 (640)
Q Consensus       571 ~~~~~~ivHrdlkp~NiLl~~~~----------~~kl~DfGla~~  605 (640)
                      .   .+||||||||.|||+++++          .+.|+||+-+-.
T Consensus       223 ~---~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          223 K---HGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             H---TTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             H---CCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            9   6999999999999998776          489999997653

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.64  E-value=3.1e-16  Score=145.25  Aligned_cols=79  Identities=15%  Similarity=0.057  Sum_probs=37.6

Q ss_pred             ccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccE
Q 035691          155 LVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQS  234 (640)
Q Consensus       155 l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  234 (640)
                      +.++++|+.|++++|.++.+|......++|++|+|++|.|++.  ..|..+++|++|+|++|+|++..+..|..+++|+.
T Consensus        15 ~~~~~~L~~L~l~~n~l~~i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~   92 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE   92 (176)
T ss_dssp             EECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred             cCCcCCceEEEeeCCCCchhHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCE
Confidence            3344445555555555554432111123555555555555543  34555555555555555555433333344444444


Q ss_pred             E
Q 035691          235 L  235 (640)
Q Consensus       235 L  235 (640)
                      |
T Consensus        93 L   93 (176)
T 1a9n_A           93 L   93 (176)
T ss_dssp             E
T ss_pred             E
Confidence            4

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.60  E-value=5.1e-15  Score=136.10  Aligned_cols=109  Identities=24%  Similarity=0.305  Sum_probs=76.8

Q ss_pred             CCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCC
Q 035691          208 LTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIP  287 (640)
Q Consensus       208 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  287 (640)
                      .+.+++++|.++. +|..+.  ++|+.|                +|++|+|++..|..|.++++|++|+|++|+|++..+
T Consensus        11 ~~~l~~s~n~l~~-ip~~~~--~~l~~L----------------~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~   71 (170)
T 3g39_A           11 GTTVDCSGKSLAS-VPTGIP--TTTQVL----------------YLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPA   71 (170)
T ss_dssp             TTEEECTTSCCSS-CCSCCC--TTCSEE----------------ECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCT
T ss_pred             CCEEEeCCCCcCc-cCccCC--CCCcEE----------------EcCCCcCCccChhhhcCcccCCEEECCCCCcCccCh
Confidence            3556666666663 333331  444444                666777776667777777777777777777776666


Q ss_pred             ccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccC
Q 035691          288 SSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQ  335 (640)
Q Consensus       288 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  335 (640)
                      ..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+|.+.
T Consensus        72 ~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           72 GVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             hhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            667777888888888888877777778888888888888888887663

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.59  E-value=1.6e-17  Score=157.19  Aligned_cols=127  Identities=21%  Similarity=0.262  Sum_probs=59.3

Q ss_pred             CCcEEeCCCCccccCCch------hhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhh
Q 035691            4 FLMLINLQQNNFSGNIPH------EIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIG   77 (640)
Q Consensus         4 ~L~~L~L~~n~i~~~~p~------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~   77 (640)
                      .++.++++.+.+++..|.      .|..+++|++|++++|.|++ +| .+..+++|++|+|++|+|+.      +|....
T Consensus        19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~------l~~~~~   90 (198)
T 1ds9_A           19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKK------IENLDA   90 (198)
T ss_dssp             CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECS------CSSHHH
T ss_pred             cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCccc------ccchhh
Confidence            444555555555554444      55555555555555555553 33 45555555555555555443      443222


Q ss_pred             cCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCC-ccccCCCCCCEEEcccCcC
Q 035691           78 FTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIP-EDLGRLRNLTRLNFARNDL  141 (640)
Q Consensus        78 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l  141 (640)
                       .+++|+.|+|++|+|++. | .+..+++|++|+|++|+|+...+ ..+..+++|++|++++|.+
T Consensus        91 -~~~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l  152 (198)
T 1ds9_A           91 -VADTLEELWISYNQIASL-S-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL  152 (198)
T ss_dssp             -HHHHCSEEEEEEEECCCH-H-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHH
T ss_pred             -cCCcCCEEECcCCcCCcC-C-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcc
Confidence             234444444444444432 1 34444444444444444443221 2344444444444444444

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.58  E-value=1.2e-14  Score=134.00  Aligned_cols=83  Identities=23%  Similarity=0.297  Sum_probs=57.1

Q ss_pred             EccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccc
Q 035691          252 DLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQ  331 (640)
Q Consensus       252 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  331 (640)
                      +|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|.
T Consensus        39 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           39 WLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             EeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCcc
Confidence            56666666666666666777777777777776555555667777777777777777666666777777777777777777


Q ss_pred             ccc
Q 035691          332 AKS  334 (640)
Q Consensus       332 ~~~  334 (640)
                      |.+
T Consensus       119 c~~  121 (174)
T 2r9u_A          119 CEC  121 (174)
T ss_dssp             TTB
T ss_pred             ccc
Confidence            655

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.58  E-value=7.5e-18  Score=159.46  Aligned_cols=147  Identities=22%  Similarity=0.282  Sum_probs=89.7

Q ss_pred             CCCCCeeeccCCcccccCCc------cCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccc
Q 035691           80 LPNIRIPLLAGNQFFGNIPH------SISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLD  153 (640)
Q Consensus        80 l~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~  153 (640)
                      ...++.++++.|.+++..|.      .|..+++|++|+|++|+|++ +| .+..+++|++|+|++|+++.++       .
T Consensus        17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~-------~   87 (198)
T 1ds9_A           17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIE-------N   87 (198)
T ss_dssp             TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCS-------S
T ss_pred             cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCccccc-------c
Confidence            44555555555555555554      66666667777777776665 44 6666666777777777666432       3


Q ss_pred             cccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCC-cCccCCCCCCEEEccCCCCCCCCCcc-------
Q 035691          154 SLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIP-SSLGNFTFLTELNLRGNSIRGSIPSA-------  225 (640)
Q Consensus       154 ~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~-------  225 (640)
                      .+..+++|+.|++++|+++.+| .+..+++|++|++++|.|++..+ ..+..+++|++|++++|++.+..|..       
T Consensus        88 ~~~~~~~L~~L~L~~N~l~~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~  166 (198)
T 1ds9_A           88 LDAVADTLEELWISYNQIASLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYR  166 (198)
T ss_dssp             HHHHHHHCSEEEEEEEECCCHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHH
T ss_pred             hhhcCCcCCEEECcCCcCCcCC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHH
Confidence            3444566666666666666665 35556667777777777664332 35666677777777777766554432       


Q ss_pred             ---ccCCCCccEEe
Q 035691          226 ---LGNCHQLQSLD  236 (640)
Q Consensus       226 ---~~~l~~L~~L~  236 (640)
                         +..+++|+.||
T Consensus       167 ~~~~~~l~~L~~Ld  180 (198)
T 1ds9_A          167 IEVVKRLPNLKKLD  180 (198)
T ss_dssp             HHHHHHCSSCSEEC
T ss_pred             HHHHHhCCCcEEEC
Confidence               56666666663

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.57  E-value=1.5e-14  Score=132.88  Aligned_cols=73  Identities=29%  Similarity=0.356  Sum_probs=38.7

Q ss_pred             cceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEE
Q 035691          161 LEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSL  235 (640)
Q Consensus       161 L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  235 (640)
                      .+.+++++|.++.+|..+.  ++|++|+|++|.|+++.|..|.++++|++|+|++|+|++..+..|.++++|+.|
T Consensus        11 ~~~l~~s~n~l~~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L   83 (170)
T 3g39_A           11 GTTVDCSGKSLASVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQL   83 (170)
T ss_dssp             TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             CCEEEeCCCCcCccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEE
Confidence            3455566666655555442  455555555555555555555555555555555555554444444444444444

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.55  E-value=1.5e-13  Score=144.43  Aligned_cols=302  Identities=12%  Similarity=0.056  Sum_probs=223.0

Q ss_pred             CCCCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCc--CCccc----------
Q 035691            1 NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKL--EENQL----------   68 (640)
Q Consensus         1 nl~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l--~~~~~----------   68 (640)
                      ++++|+.++|.. .++.+...+|.++.+|+.+++..+ ++.+...+|.++.+|+.+.+..+--  ....+          
T Consensus        69 ~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~~~~~~~~~~  146 (394)
T 4fs7_A           69 GCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEAFKGCDFKEITI  146 (394)
T ss_dssp             TCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTTTTTCCCSEEEC
T ss_pred             CCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeecceeeeccccccccc
Confidence            467899999974 588777889999999999999865 7767788999999999887764311  11111          


Q ss_pred             ---cccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCC
Q 035691           69 ---VGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRK  145 (640)
Q Consensus        69 ---~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  145 (640)
                         ...+....|....+|+.+.+.++. ..+...+|.++++|+.+++..| ++.+...+|.++..|+.+.+..+... + 
T Consensus       147 ~~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~-i-  222 (394)
T 4fs7_A          147 PEGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY-L-  222 (394)
T ss_dssp             CTTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE-E-
T ss_pred             CccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE-e-
Confidence               113456678888999999998664 5577889999999999999887 77678889999999999988776532 1 


Q ss_pred             CCcccccccccCCCCcceEecCCCCCCCcCc-CCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCc
Q 035691          146 VNDLRFLDSLVNCTYLEIVSLNVNSLRSIPI-SVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPS  224 (640)
Q Consensus       146 ~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~  224 (640)
                            .+.....+.|+.+.+..+ ++.++. .+..+..|+.+.+..+... +....|..+..++.+....+.+   ...
T Consensus       223 ------~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~~  291 (394)
T 4fs7_A          223 ------GDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV---PEK  291 (394)
T ss_dssp             ------CTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE---CTT
T ss_pred             ------ehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceee---ccc
Confidence                  122334466777776543 344433 4556777888887776554 6667777777777777766543   334


Q ss_pred             cccCCCCccEEeccCc-------cccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCC
Q 035691          225 ALGNCHQLQSLDLSKT-------IFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLE  297 (640)
Q Consensus       225 ~~~~l~~L~~L~ls~n-------~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  297 (640)
                      +|..+.+|+.+.+.++       .|.+...|+.+++.++ ++.+...+|.++++|+.+++..| ++.+...+|.++++|+
T Consensus       292 ~F~~~~~L~~i~l~~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~  369 (394)
T 4fs7_A          292 TFYGCSSLTEVKLLDSVKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLK  369 (394)
T ss_dssp             TTTTCTTCCEEEECTTCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCC
T ss_pred             cccccccccccccccccceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCC
Confidence            6777777777776543       4666677777788754 77677889999999999999887 7767788999999999


Q ss_pred             eEEecCCccCCCCCccCCCCCCCCeE
Q 035691          298 YLNLSINSFHGPIHPGLSSLKSLEGL  323 (640)
Q Consensus       298 ~L~L~~N~l~~~~~~~~~~l~~L~~L  323 (640)
                      .+++..+ ++ .+..+|.++++|+.+
T Consensus       370 ~i~lp~~-~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          370 KVELPKR-LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             EEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred             EEEECCC-CE-EhhheecCCCCCcEE
Confidence            9999876 33 345678888888765

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.55  E-value=2.9e-14  Score=131.51  Aligned_cols=72  Identities=22%  Similarity=0.274  Sum_probs=36.7

Q ss_pred             ceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEE
Q 035691          162 EIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSL  235 (640)
Q Consensus       162 ~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  235 (640)
                      +.+++++|.++.+|..+.  ++|++|+|++|.|+++.|..|.++++|++|+|++|+|++..+..|.++++|+.|
T Consensus        15 ~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L   86 (174)
T 2r9u_A           15 TLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQL   86 (174)
T ss_dssp             SEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             cEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEE
Confidence            455555555555555443  455555555555555545555555555555555555554433334444444444

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.52  E-value=8.5e-13  Score=138.72  Aligned_cols=294  Identities=10%  Similarity=0.113  Sum_probs=177.8

Q ss_pred             ccCCchhhhcCC-CCCeEEcccCccCccCCcCCCCCCCCCEEEccCCC---cCCccccccCCchhhcCCCCCCeeeccCC
Q 035691           16 SGNIPHEIGRLF-QLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNK---LEENQLVGELPPYIGFTLPNIRIPLLAGN   91 (640)
Q Consensus        16 ~~~~p~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~---l~~~~~~~~lp~~~~~~l~~L~~L~L~~N   91 (640)
                      +.+...+|.+.. .|+.+.+..+ ++.+...+|.++++|+.+.++.|.   ++.      ++...|....+|+.+.+..+
T Consensus        52 t~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~------Ig~~aF~~c~~L~~i~~~~~  124 (394)
T 4gt6_A           52 SKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKK------IGRQAFMFCSELTDIPILDS  124 (394)
T ss_dssp             EEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCE------ECTTTTTTCTTCCBCGGGTT
T ss_pred             eEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeE------echhhchhcccceeeccCCc
Confidence            334445676663 5888888644 676777888888888888887664   332      66777777777777776654


Q ss_pred             cccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCC
Q 035691           92 QFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSL  171 (640)
Q Consensus        92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l  171 (640)
                       ++.+...+|.++.+|+.+.+..+ ++.+...+|..+.+|+.+.+..+ ++.++..      +|.+ ..|+.+.+..+-.
T Consensus       125 -~~~I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~------aF~~-~~l~~i~ip~~~~  194 (394)
T 4gt6_A          125 -VTEIDSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEER------AFTG-TALTQIHIPAKVT  194 (394)
T ss_dssp             -CSEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTT------TTTT-CCCSEEEECTTCC
T ss_pred             -cceehhhhhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccc------cccc-cceeEEEECCccc
Confidence             55566677888888888888654 44466677888888888887654 4444322      2222 3455555544322


Q ss_pred             CCcCcCCCCCCCCCEEEccCCcCcccCCcCc--------------cCCCCCCEEEccCCCCCCCCCccccCCCCccEEec
Q 035691          172 RSIPISVGYLPKLQVLSLFENNISGEIPSSL--------------GNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDL  237 (640)
Q Consensus       172 ~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~--------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  237 (640)
                      .--...+....++.......+.... ....+              .....+..+.+.. .++.+...+|.++.+|+.+.+
T Consensus       195 ~i~~~af~~c~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~l  272 (394)
T 4gt6_A          195 RIGTNAFSECFALSTITSDSESYPA-IDNVLYEKSANGDYALIRYPSQREDPAFKIPN-GVARIETHAFDSCAYLASVKM  272 (394)
T ss_dssp             EECTTTTTTCTTCCEEEECCSSSCB-SSSCEEEECTTSCEEEEECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEEEC
T ss_pred             ccccchhhhccccceeccccccccc-ccceeecccccccccccccccccccceEEcCC-cceEcccceeeecccccEEec
Confidence            2222234444445544444333221 11100              0111222222211 122223344455555555444


Q ss_pred             cCc-------cccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCC
Q 035691          238 SKT-------IFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPI  310 (640)
Q Consensus       238 s~n-------~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  310 (640)
                      .++       .|.+...|+.+.+. +.++.+...+|.++.+|+.++|..+ ++.+...+|.+|.+|+.+.+..+ ++.+.
T Consensus       273 p~~~~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~  349 (394)
T 4gt6_A          273 PDSVVSIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIP  349 (394)
T ss_dssp             CTTCCEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCC
T ss_pred             ccccceecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEh
Confidence            322       23344445555664 4566566778899999999998765 66566778889999999999654 77677


Q ss_pred             CccCCCCCCCCeEeCcCCccc
Q 035691          311 HPGLSSLKSLEGLDLFQNTFQ  331 (640)
Q Consensus       311 ~~~~~~l~~L~~L~l~~N~l~  331 (640)
                      ..+|.++++|+.+++.+|...
T Consensus       350 ~~aF~~C~~L~~i~~~~~~~~  370 (394)
T 4gt6_A          350 ESAFSNCTALNNIEYSGSRSQ  370 (394)
T ss_dssp             GGGGTTCTTCCEEEESSCHHH
T ss_pred             HhHhhCCCCCCEEEECCceee
Confidence            788999999999999887644

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.45  E-value=4.6e-12  Score=133.08  Aligned_cols=294  Identities=9%  Similarity=0.074  Sum_probs=220.3

Q ss_pred             cCccCCcCCCCCC-CCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCc---ccccCCccCcCCCCCCEEECcC
Q 035691           39 LQGQIPVNLTHCS-ELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQ---FFGNIPHSISNASKLEWLDFAN  114 (640)
Q Consensus        39 l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~---l~~~~~~~~~~l~~L~~L~Ls~  114 (640)
                      ++.+...+|.++. .|+.+.+-.+ ++.      +....|.+..+|+.+.+..|.   ++.+...+|.++.+|+.+.+..
T Consensus        51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~------Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~  123 (394)
T 4gt6_A           51 VSKIGDRVFCNYKYVLTSVQIPDT-VTE------IGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILD  123 (394)
T ss_dssp             EEEECTTTTTTCCSCCCEEEECTT-CCE------ECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGT
T ss_pred             eeEcCHhhccCCCCcCEEEEECCC-eeE------EhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCC
Confidence            4556677888885 6999999743 543      888899999999999998774   7777788999999999998876


Q ss_pred             CccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcC
Q 035691          115 NSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNI  194 (640)
Q Consensus       115 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l  194 (640)
                      + ++.+...+|.++.+|+.+.+..+ +..+      ....|.++..|+.+.+..+ ++.++...+...+|+.+.+..+-.
T Consensus       124 ~-~~~I~~~aF~~c~~L~~i~lp~~-~~~I------~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~~~l~~i~ip~~~~  194 (394)
T 4gt6_A          124 S-VTEIDSEAFHHCEELDTVTIPEG-VTSV------ADGMFSYCYSLHTVTLPDS-VTAIEERAFTGTALTQIHIPAKVT  194 (394)
T ss_dssp             T-CSEECTTTTTTCTTCCEEECCTT-CCEE------CTTTTTTCTTCCEEECCTT-CCEECTTTTTTCCCSEEEECTTCC
T ss_pred             c-cceehhhhhhhhcccccccccce-eeee------cccceecccccccccccce-eeEeccccccccceeEEEECCccc
Confidence            6 66677889999999999999754 4444      3356788999999999765 666776555567899999987655


Q ss_pred             cccCCcCccCCCCCCEEEccCCCCCCCCCccc-------------cCCCCccEEec-------cCccccCCCCCceEEcc
Q 035691          195 SGEIPSSLGNFTFLTELNLRGNSIRGSIPSAL-------------GNCHQLQSLDL-------SKTIFLGQYPVRWLDLS  254 (640)
Q Consensus       195 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~-------------~~l~~L~~L~l-------s~n~~~~~~~l~~L~Ls  254 (640)
                      . +...+|.++.+++......+.........+             .....+..+.+       ....|.+...|+.+.+.
T Consensus       195 ~-i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp  273 (394)
T 4gt6_A          195 R-IGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMP  273 (394)
T ss_dssp             E-ECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECC
T ss_pred             c-cccchhhhccccceecccccccccccceeecccccccccccccccccccceEEcCCcceEcccceeeecccccEEecc
Confidence            4 777889999999998887766542211111             11223333333       34567788889999998


Q ss_pred             CCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCcccccc
Q 035691          255 HNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKS  334 (640)
Q Consensus       255 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  334 (640)
                      .+..+ +...+|.++++|+.+.+. +.++.+...+|.++.+|+.++|..+ ++.+...+|.++++|+.+.+..+ ++...
T Consensus       274 ~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~  349 (394)
T 4gt6_A          274 DSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIP  349 (394)
T ss_dssp             TTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCC
T ss_pred             cccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEh
Confidence            76554 678899999999999997 5566577789999999999999865 77777889999999999999755 55333


Q ss_pred             CCcccCCCCCCCCCccccccCCC
Q 035691          335 QNGDVPRKGIFKNASAISVAGNE  357 (640)
Q Consensus       335 ~~~~~p~~~~~~~~~~~~~~~n~  357 (640)
                      ...    .....+++.+.+.++.
T Consensus       350 ~~a----F~~C~~L~~i~~~~~~  368 (394)
T 4gt6_A          350 ESA----FSNCTALNNIEYSGSR  368 (394)
T ss_dssp             GGG----GTTCTTCCEEEESSCH
T ss_pred             HhH----hhCCCCCCEEEECCce
Confidence            221    1234567888888764

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.44  E-value=1.4e-13  Score=142.19  Aligned_cols=83  Identities=22%  Similarity=0.225  Sum_probs=46.4

Q ss_pred             EccC-CcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCcc
Q 035691          252 DLSH-NHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTF  330 (640)
Q Consensus       252 ~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  330 (640)
                      +|++ |+|++..+..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|+|++.++..|..++ |+.|+|++|+|
T Consensus        37 ~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~  115 (347)
T 2ifg_A           37 YIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL  115 (347)
T ss_dssp             ECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCC
T ss_pred             EccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCc
Confidence            4443 455544445555555555555555555555555555555566666666666555444555444 66666666666


Q ss_pred             ccccC
Q 035691          331 QAKSQ  335 (640)
Q Consensus       331 ~~~~~  335 (640)
                      .|.|.
T Consensus       116 ~c~c~  120 (347)
T 2ifg_A          116 HCSCA  120 (347)
T ss_dssp             CCCGG
T ss_pred             cCCCc
Confidence            66554

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.41  E-value=3.8e-13  Score=138.83  Aligned_cols=103  Identities=22%  Similarity=0.174  Sum_probs=74.8

Q ss_pred             eEecCCC-CCCCcCcCCCCCCCCCEEEccC-CcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCc
Q 035691          163 IVSLNVN-SLRSIPISVGYLPKLQVLSLFE-NNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKT  240 (640)
Q Consensus       163 ~L~L~~N-~l~~ip~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n  240 (640)
                      .++++++ .|+.+|. +..+++|++|+|++ |.|+++.+..|.++++|++|+|++|+|++.+|..|.++++|+.|     
T Consensus        12 ~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L-----   85 (347)
T 2ifg_A           12 GLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL-----   85 (347)
T ss_dssp             CEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE-----
T ss_pred             EEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEE-----
Confidence            4567776 7777777 77777778888875 77777766777777777777777777777777777777777777     


Q ss_pred             cccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCccc
Q 035691          241 IFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLS  283 (640)
Q Consensus       241 ~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  283 (640)
                                 +|++|+|++.++..|..++ |+.|+|++|.+.
T Consensus        86 -----------~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           86 -----------NLSFNALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             -----------ECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             -----------eCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence                       6666777766666666555 777777777765

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.40  E-value=1.8e-15  Score=157.21  Aligned_cols=144  Identities=19%  Similarity=0.119  Sum_probs=72.5

Q ss_pred             CCCCeeeccCCcccccCCccCc-CCCCCCEEECcCCccCccCCccc-----cCCCCCCEEEcccCcCCCCCCCccccccc
Q 035691           81 PNIRIPLLAGNQFFGNIPHSIS-NASKLEWLDFANNSLTASIPEDL-----GRLRNLTRLNFARNDLGTRKVNDLRFLDS  154 (640)
Q Consensus        81 ~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~~~~~~~~~  154 (640)
                      ++|+.|+|++|.|+......+. .+++|++|+|++|+|+......+     ...++|++|+|++|.|+......  ....
T Consensus       101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~--l~~~  178 (372)
T 3un9_A          101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAV--LMEG  178 (372)
T ss_dssp             SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHH--HHHH
T ss_pred             CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHH--HHHH
Confidence            4555555555555432222222 23455666666666554333322     23455666666666654421111  1223


Q ss_pred             ccCCCCcceEecCCCCCCC-----cCcCCCCCCCCCEEEccCCcCcccC----CcCccCCCCCCEEEccCCCCCCCCCcc
Q 035691          155 LVNCTYLEIVSLNVNSLRS-----IPISVGYLPKLQVLSLFENNISGEI----PSSLGNFTFLTELNLRGNSIRGSIPSA  225 (640)
Q Consensus       155 l~~l~~L~~L~L~~N~l~~-----ip~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~~~~  225 (640)
                      +..+++|++|+|++|.|+.     ++..+...++|++|+|++|.|+...    +..+...++|++|+|++|.|+......
T Consensus       179 L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~  258 (372)
T 3un9_A          179 LAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQV  258 (372)
T ss_dssp             HHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHH
T ss_pred             HhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHH
Confidence            3445556666666666553     1233444556777777777665432    223344566777777777766443333


Q ss_pred             c
Q 035691          226 L  226 (640)
Q Consensus       226 ~  226 (640)
                      +
T Consensus       259 L  259 (372)
T 3un9_A          259 L  259 (372)
T ss_dssp             H
T ss_pred             H
Confidence            3

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.40  E-value=9.3e-15  Score=151.78  Aligned_cols=170  Identities=18%  Similarity=0.161  Sum_probs=97.8

Q ss_pred             CCCCeEEcccCccCccCCcCCC-----CCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccC
Q 035691           27 FQLRYIIFNSNTLQGQIPVNLT-----HCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSI  101 (640)
Q Consensus        27 ~~L~~L~l~~N~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~  101 (640)
                      +.|+.|+|++|.|+......+.     ..++|++|||++|.|+...     ...+...+++|+.|+|++|.|+......+
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~-----~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L  146 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAG-----LRTLLPVFLRARKLGLQLNSLGPEACKDL  146 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHH-----HHHTHHHHHTEEEEECCSSCCCHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHH-----HHHHHHHHHhccHhhcCCCCCCHHHHHHH
Confidence            4566666666666543322222     2256667777766654311     11222234566777777777664433333


Q ss_pred             -----cCCCCCCEEECcCCccCcc----CCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCC
Q 035691          102 -----SNASKLEWLDFANNSLTAS----IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLR  172 (640)
Q Consensus       102 -----~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~  172 (640)
                           ...++|++|+|++|.|+..    ++..+..+++|++|+|++|.|+......  ..+.+...++|+.|+|++|.|+
T Consensus       147 ~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~--L~~~L~~~~~L~~L~Ls~N~i~  224 (372)
T 3un9_A          147 RDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLEL--LAAQLDRNRQLQELNVAYNGAG  224 (372)
T ss_dssp             HHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHH--HHHHGGGCSCCCEEECCSSCCC
T ss_pred             HHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHH--HHHHHhcCCCcCeEECCCCCCC
Confidence                 2356777777777777642    3334466777777777777776532111  1344556667777777777776


Q ss_pred             Cc-----CcCCCCCCCCCEEEccCCcCcccCCcCcc
Q 035691          173 SI-----PISVGYLPKLQVLSLFENNISGEIPSSLG  203 (640)
Q Consensus       173 ~i-----p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  203 (640)
                      ..     +..+...++|++|+|++|.|+......+.
T Consensus       225 ~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~  260 (372)
T 3un9_A          225 DTAALALARAAREHPSLELLHLYFNELSSEGRQVLR  260 (372)
T ss_dssp             HHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHH
Confidence            42     22344457788888888888755444443

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.33  E-value=1.6e-10  Score=120.59  Aligned_cols=283  Identities=10%  Similarity=0.032  Sum_probs=159.4

Q ss_pred             hhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccC
Q 035691           22 EIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSI  101 (640)
Q Consensus        22 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~  101 (640)
                      ++....+|+.+.+.. .++.+...+|.++.+|+.++|..+ ++.      ++...|... +|+.+.+..+ ++.+...+|
T Consensus        41 ~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~------Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF  110 (379)
T 4h09_A           41 WYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTS------IGDGAFADT-KLQSYTGMER-VKKFGDYVF  110 (379)
T ss_dssp             TGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCE------ECTTTTTTC-CCCEEEECTT-CCEECTTTT
T ss_pred             ccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceE------echhhhcCC-CCceEECCce-eeEecccee
Confidence            455566777777753 456566677777777777777533 433      666666543 5666655433 554555566


Q ss_pred             cCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCC--------
Q 035691          102 SNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRS--------  173 (640)
Q Consensus       102 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~--------  173 (640)
                      ... +|+.+++..+ ++.+...+|.+. +|+.+.+..+ ++.+      ....|.++..++...+..+....        
T Consensus       111 ~~~-~L~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i------~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~  180 (379)
T 4h09_A          111 QGT-DLDDFEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTI------KDGIGYKAENLEKIEVSSNNKNYVAENYVLY  180 (379)
T ss_dssp             TTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEE------CSCTTTTCTTCCEEEECTTCSSEEEETTEEE
T ss_pred             ccC-CcccccCCCc-cccccccccccc-eeeeeeccce-eecc------ccchhcccccccccccccccceeecccceec
Confidence            553 6777777654 333444455443 4555544432 2222      12234444555554444332211        


Q ss_pred             -----cCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCc-------c
Q 035691          174 -----IPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKT-------I  241 (640)
Q Consensus       174 -----ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n-------~  241 (640)
                           ....+.....+..+.+..+.-. .....+....+|+.+.+..+ +..+...+|.++.+|+.+.+.++       .
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~v~~I~~~a  258 (379)
T 4h09_A          181 NKNKTILESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKNVTSIGSFL  258 (379)
T ss_dssp             ETTSSEEEECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTTCCEECTTT
T ss_pred             ccccceeccccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCCccEeCccc
Confidence                 1111222333444443333222 33444444555555555433 22234444555555555544332       2


Q ss_pred             ccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCC
Q 035691          242 FLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLE  321 (640)
Q Consensus       242 ~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  321 (640)
                      |.+...++.+.+..+ ++.+...+|.++++|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++.+...+|.++++|+
T Consensus       259 F~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~  336 (379)
T 4h09_A          259 LQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALS  336 (379)
T ss_dssp             TTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCC
T ss_pred             cceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCC
Confidence            333334444466543 55456678888888999988888888677788888888998888755 6666778888888888


Q ss_pred             eEeCcCC
Q 035691          322 GLDLFQN  328 (640)
Q Consensus       322 ~L~l~~N  328 (640)
                      .+.+..+
T Consensus       337 ~i~ip~~  343 (379)
T 4h09_A          337 TISYPKS  343 (379)
T ss_dssp             CCCCCTT
T ss_pred             EEEECCc
Confidence            8887654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.27  E-value=1.5e-11  Score=121.45  Aligned_cols=147  Identities=14%  Similarity=0.082  Sum_probs=111.3

Q ss_pred             HHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcC-CCCCcceeEeeccCCcCCC
Q 035691          437 LKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR-HRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       437 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~  515 (640)
                      .....+|+.....+.|+.+.||++..  .++.+++|+...........+.+|+++++.+. |..++++++++.     ..
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~   82 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HD   82 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ET
T ss_pred             HHHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cC
Confidence            34445688888889899999999875  36789999986432233346889999999884 677888998853     33


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHC----------------------  573 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~----------------------  573 (640)
                      ...++||||++|.++.+.....               .....++.+++.++..||+..                      
T Consensus        83 ~~~~lv~e~i~G~~l~~~~~~~---------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~  147 (263)
T 3tm0_A           83 GWSNLLMSEADGVLCSEEYEDE---------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLN  147 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHCCTT---------------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHH
T ss_pred             CceEEEEEecCCeehhhccCCc---------------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHh
Confidence            4679999999999998763211               112467889999999999821                      


Q ss_pred             ----------------------------------CCCeeeCCCCCCCeeeCCCCcEEEcccccccc
Q 035691          574 ----------------------------------KKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF  605 (640)
Q Consensus       574 ----------------------------------~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~  605 (640)
                                                        +..++|+|++|.||++++++.+.|+||+.+..
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          148 NDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                              14589999999999998766678999998764

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.22  E-value=1.3e-09  Score=113.65  Aligned_cols=300  Identities=9%  Similarity=0.069  Sum_probs=217.2

Q ss_pred             CCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCC
Q 035691            3 TFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPN   82 (640)
Q Consensus         3 ~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~   82 (640)
                      .+|+.+.+. ..++.+...+|.++.+|+.+.|..+ ++.+...+|.++ +|+.+.+..+ ++.      ++...|. ..+
T Consensus        46 ~~i~~v~ip-~~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~------I~~~aF~-~~~  114 (379)
T 4h09_A           46 DRISEVRVN-SGITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKK------FGDYVFQ-GTD  114 (379)
T ss_dssp             GGCSEEEEC-TTEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCE------ECTTTTT-TCC
T ss_pred             cCCEEEEeC-CCccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeE------eccceec-cCC
Confidence            346666665 4577677789999999999999754 777888899987 6888887643 443      7777886 458


Q ss_pred             CCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcc------ccccccc
Q 035691           83 IRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDL------RFLDSLV  156 (640)
Q Consensus        83 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~------~~~~~l~  156 (640)
                      |+.+.+..+ +..+...+|.+. +|+.+.+..+ ++.+...+|..+.+++.+.+..+..........      .....+.
T Consensus       115 L~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (379)
T 4h09_A          115 LDDFEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYP  191 (379)
T ss_dssp             CSEEECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECC
T ss_pred             cccccCCCc-cccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceecccc
Confidence            999999876 444666677665 6777777654 565778889999999999888765433211100      0112344


Q ss_pred             CCCCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEe
Q 035691          157 NCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLD  236 (640)
Q Consensus       157 ~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  236 (640)
                      .+..+..+.+..+.-......+....+|+.+.+..+ +..+...+|.++..|+.+.+..+ ++.+...+|.++.+|+.+.
T Consensus       192 ~~~~~~~~~~~~~~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~  269 (379)
T 4h09_A          192 AAKTGTEFTIPSTVKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLN  269 (379)
T ss_dssp             TTCCCSEEECCTTCCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEE
T ss_pred             ccccccccccccceeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccc
Confidence            455555555554433323345566777888888655 44466778888888888888766 5556677888888888887


Q ss_pred             ccC-------ccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCC
Q 035691          237 LSK-------TIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGP  309 (640)
Q Consensus       237 ls~-------n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  309 (640)
                      +..       ..|.+...|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.+..+ ++.+
T Consensus       270 l~~~i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I  347 (379)
T 4h09_A          270 FYAKVKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLI  347 (379)
T ss_dssp             ECCCCSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEE
T ss_pred             ccccceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEE
Confidence            754       35677778888899999998778899999999999999865 77577789999999999999765 7767


Q ss_pred             CCccCCCCCCC
Q 035691          310 IHPGLSSLKSL  320 (640)
Q Consensus       310 ~~~~~~~l~~L  320 (640)
                      ...+|.+.+.+
T Consensus       348 ~~~aF~~c~~~  358 (379)
T 4h09_A          348 ESGAFEGSSIT  358 (379)
T ss_dssp             CTTTTTTSSCC
T ss_pred             chhHhhCCCCC
Confidence            77788776433

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.09  E-value=2e-10  Score=113.13  Aligned_cols=139  Identities=17%  Similarity=0.116  Sum_probs=97.0

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCC--CcceeEeeccCCcCCCcee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRN--LVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~~~~~  518 (640)
                      .++....+.+.|..+.||++... +|..+++|+....   ....+..|+++++.+.+.+  +++++++..     .....
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~~~~   90 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRD   90 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCE
T ss_pred             CCCceEecccCCCCceEEEEecC-CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEecc-----CCCCC
Confidence            34444444446667999999753 6778999987433   2245778999999886544  456777743     23457


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHC-------------------------  573 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~-------------------------  573 (640)
                      ++||||++|.++.  ...             ..   ...++.+++.++..||+..                         
T Consensus        91 ~~v~e~i~G~~l~--~~~-------------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (264)
T 1nd4_A           91 WLLLGEVPGQDLL--SSH-------------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGL  152 (264)
T ss_dssp             EEEEECCSSEETT--TSC-------------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTC
T ss_pred             EEEEEecCCcccC--cCc-------------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCC
Confidence            8999999998874  211             11   1246777777888887632                         


Q ss_pred             ------------------------------CCCeeeCCCCCCCeeeCCCCcEEEccccccccC
Q 035691          574 ------------------------------KKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI  606 (640)
Q Consensus       574 ------------------------------~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~  606 (640)
                                                    +..++|+|++|.||++++++.+.|+|||.+...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          153 VDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             CCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             ccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence                                          123999999999999988777789999998643

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.99  E-value=1.3e-10  Score=119.42  Aligned_cols=156  Identities=18%  Similarity=0.255  Sum_probs=81.1

Q ss_pred             CCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCcccc--CCCCCCEEEccc--CcCC-CCCCCcccccc
Q 035691           79 TLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLG--RLRNLTRLNFAR--NDLG-TRKVNDLRFLD  153 (640)
Q Consensus        79 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~L~~--N~l~-~~~~~~~~~~~  153 (640)
                      .+|+|+.|.|++|.-.. ++. +. +++|+.|+|..+.++......+.  .+++|++|+|+.  |... .....++.  .
T Consensus       170 ~~P~L~~L~L~g~~~l~-l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~--~  244 (362)
T 2ra8_A          170 AMPLLNNLKIKGTNNLS-IGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFR--P  244 (362)
T ss_dssp             TCTTCCEEEEECCBTCB-CCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTG--G
T ss_pred             cCCCCcEEEEeCCCCce-ecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHH--H
Confidence            35666666666652111 122 32 56677777776666543333333  567777777643  2211 10010110  1


Q ss_pred             cc--cCCCCcceEecCCCCCCC-cCcCC---CCCCCCCEEEccCCcCcccC----CcCccCCCCCCEEEccCCCCCCCCC
Q 035691          154 SL--VNCTYLEIVSLNVNSLRS-IPISV---GYLPKLQVLSLFENNISGEI----PSSLGNFTFLTELNLRGNSIRGSIP  223 (640)
Q Consensus       154 ~l--~~l~~L~~L~L~~N~l~~-ip~~~---~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~~  223 (640)
                      .+  ..+++|+.|+|.+|.+.. .+..+   ..+++|++|+|+.|.|.+..    +..+..+++|+.|+|++|.|+...-
T Consensus       245 ~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~  324 (362)
T 2ra8_A          245 LFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMK  324 (362)
T ss_dssp             GSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHH
T ss_pred             HHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHH
Confidence            11  235677777777777653 21111   24677888888888777532    3333456778888888887764322


Q ss_pred             ccccC-CCCccEEeccCcc
Q 035691          224 SALGN-CHQLQSLDLSKTI  241 (640)
Q Consensus       224 ~~~~~-l~~L~~L~ls~n~  241 (640)
                      ..+.. +  ...++++++.
T Consensus       325 ~~l~~al--g~~~~~~~~~  341 (362)
T 2ra8_A          325 KELQKSL--PMKIDVSDSQ  341 (362)
T ss_dssp             HHHHHHC--CSEEECCSBC
T ss_pred             HHHHHHc--CCEEEecCCc
Confidence            22322 1  2446555543

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.97  E-value=1.4e-10  Score=119.37  Aligned_cols=135  Identities=13%  Similarity=0.219  Sum_probs=80.3

Q ss_pred             ccCcCCCCCCEEECcCCc-cCccCCccccCCCCCCEEEcccCcCCCCCCCccccccccc--CCCCcceEecCC--CC---
Q 035691           99 HSISNASKLEWLDFANNS-LTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLV--NCTYLEIVSLNV--NS---  170 (640)
Q Consensus        99 ~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~--~l~~L~~L~L~~--N~---  170 (640)
                      ..+..+++|+.|+|++|. ++  .+. +. +++|++|+|..+.+...      ....+.  .+++|+.|+|+.  |.   
T Consensus       166 ~ll~~~P~L~~L~L~g~~~l~--l~~-~~-~~~L~~L~L~~~~l~~~------~l~~l~~~~lp~L~~L~L~~~~~~~~~  235 (362)
T 2ra8_A          166 PVLDAMPLLNNLKIKGTNNLS--IGK-KP-RPNLKSLEIISGGLPDS------VVEDILGSDLPNLEKLVLYVGVEDYGF  235 (362)
T ss_dssp             HHHHTCTTCCEEEEECCBTCB--CCS-CB-CTTCSEEEEECSBCCHH------HHHHHHHSBCTTCCEEEEECBCGGGTC
T ss_pred             HHHhcCCCCcEEEEeCCCCce--ecc-cc-CCCCcEEEEecCCCChH------HHHHHHHccCCCCcEEEEecccccccc
Confidence            445667788888887773 32  222 33 67888888887776543      112232  567788887743  21   


Q ss_pred             ---CCCcCcCC--CCCCCCCEEEccCCcCcccCCcCc---cCCCCCCEEEccCCCCCCC----CCccccCCCCccEEecc
Q 035691          171 ---LRSIPISV--GYLPKLQVLSLFENNISGEIPSSL---GNFTFLTELNLRGNSIRGS----IPSALGNCHQLQSLDLS  238 (640)
Q Consensus       171 ---l~~ip~~~--~~l~~L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~ls  238 (640)
                         +..+...+  ..+++|++|+|++|.+....+..+   ..+++|++|+|+.|.|...    ++..+..+++|+.|+++
T Consensus       236 ~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~  315 (362)
T 2ra8_A          236 DGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMK  315 (362)
T ss_dssp             CSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECC
T ss_pred             chhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECC
Confidence               11121222  236788888888887764332222   2467788888888887653    23334556778888777


Q ss_pred             Ccccc
Q 035691          239 KTIFL  243 (640)
Q Consensus       239 ~n~~~  243 (640)
                      .|.+.
T Consensus       316 ~n~i~  320 (362)
T 2ra8_A          316 YNYLS  320 (362)
T ss_dssp             SBBCC
T ss_pred             CCcCC
Confidence            66543

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.92  E-value=5.4e-09  Score=108.09  Aligned_cols=145  Identities=14%  Similarity=0.141  Sum_probs=104.1

Q ss_pred             ccCcccccccceEEEEEECCCCeEEEEEEee--cccc-hhHHHHHHHHHHHHhcC--CCCCcceeEeeccCCcCCCceee
Q 035691          445 SANLIGTGSFGSVYKGILDPDQTVVAVKVLF--LHQR-GALKSFMAECEALRNIR--HRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       445 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ..+.++.|.++.||+....  +..+++|+..  .... .....+.+|+.+++.+.  +..+++++.++.....  ....+
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~--~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV--IGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT--TSSCE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc--cCCeE
Confidence            3467899999999998764  4678888765  2221 22356788999999986  4568888888754421  13468


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHC--------------------------  573 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~--------------------------  573 (640)
                      +||||++|..+.+...            ..++...+..++.+++.+|..||...                          
T Consensus       118 ~vme~v~G~~l~~~~~------------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQSL------------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQ  185 (359)
T ss_dssp             EEEECCCCBCCCCTTC------------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHH
T ss_pred             EEEEecCCeecCCCcc------------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHH
Confidence            9999999877643111            12566778889999999999999731                          


Q ss_pred             -----------------------------CCCeeeCCCCCCCeeeCCCCc--EEEcccccccc
Q 035691          574 -----------------------------KKQIVHCDLKPSNVLLDNDMI--AHVGDFGLTRF  605 (640)
Q Consensus       574 -----------------------------~~~ivHrdlkp~NiLl~~~~~--~kl~DfGla~~  605 (640)
                                                   ...++|+|++|.||++++++.  +.|+||+.+..
T Consensus       186 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          186 YKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                         257999999999999987753  68999999874

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.58  E-value=5.2e-09  Score=97.07  Aligned_cols=118  Identities=12%  Similarity=0.102  Sum_probs=58.1

Q ss_pred             cCcCCCCCCEEECcCC-ccCcc----CCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCC-
Q 035691          100 SISNASKLEWLDFANN-SLTAS----IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRS-  173 (640)
Q Consensus       100 ~~~~l~~L~~L~Ls~N-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~-  173 (640)
                      .+...++|++|+|++| .|...    +...+...++|++|+|++|.|.......  ..+.+...+.|++|+|++|.|.. 
T Consensus        31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~--l~~~L~~n~~L~~L~L~~N~i~~~  108 (185)
T 1io0_A           31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFA--LAEMLKVNNTLKSLNVESNFISGS  108 (185)
T ss_dssp             HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHH--HHHHHHHCSSCCEEECCSSCCCHH
T ss_pred             HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHH--HHHHHHhCCCcCEEECcCCcCCHH
Confidence            3445556666666666 55532    2233444556666666666665421111  11233344455555555555543 


Q ss_pred             ----cCcCCCCCCCCCEEEc--cCCcCcccC----CcCccCCCCCCEEEccCCCCC
Q 035691          174 ----IPISVGYLPKLQVLSL--FENNISGEI----PSSLGNFTFLTELNLRGNSIR  219 (640)
Q Consensus       174 ----ip~~~~~l~~L~~L~L--~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~  219 (640)
                          +...+...++|++|+|  ++|.|....    ...+...+.|++|+|++|.+.
T Consensus       109 g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          109 GILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence                2233444455666666  556655322    122333455666666665553

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.57  E-value=8.2e-09  Score=100.66  Aligned_cols=129  Identities=18%  Similarity=0.257  Sum_probs=76.0

Q ss_pred             EEcccCccCccCCc-CCCCCCCCCE--EEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccc--cCCccCcCCCC
Q 035691           32 IIFNSNTLQGQIPV-NLTHCSELRT--LDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFG--NIPHSISNASK  106 (640)
Q Consensus        32 L~l~~N~l~~~~~~-~~~~l~~L~~--L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~  106 (640)
                      |...+|.-++.++- .|...+.|+.  ++++.|+...  +.+.+ ..+...+++|+.|+|++|+|++  .+|..+..+++
T Consensus       121 l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~~--~~~~l-~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~  197 (267)
T 3rw6_A          121 MSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSC--MAATL-RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPN  197 (267)
T ss_dssp             HHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHHH--HHHHH-HHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTT
T ss_pred             HHhccchhccccCHHHcCCCcchhhcCccccCCHHHH--HHHHH-HHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCC
Confidence            34444444332222 2444455555  6677775432  22211 1223457888888888888887  34566778888


Q ss_pred             CCEEECcCCccCccCCccccCCC--CCCEEEcccCcCCCCCCC-cccccccccCCCCcceEe
Q 035691          107 LEWLDFANNSLTASIPEDLGRLR--NLTRLNFARNDLGTRKVN-DLRFLDSLVNCTYLEIVS  165 (640)
Q Consensus       107 L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~-~~~~~~~l~~l~~L~~L~  165 (640)
                      |+.|+|++|+|++.  ..+..+.  +|++|+|++|.+...-.. .-.....+..+++|+.||
T Consensus       198 L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          198 LKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             CCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             CCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence            99999999988865  3344444  888999999988652100 000112356677787775

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.56  E-value=1.5e-08  Score=94.04  Aligned_cols=43  Identities=9%  Similarity=0.029  Sum_probs=22.5

Q ss_pred             hhhcCCCCCeEEcccC-ccCcc----CCcCCCCCCCCCEEEccCCCcC
Q 035691           22 EIGRLFQLRYIIFNSN-TLQGQ----IPVNLTHCSELRTLDLVLNKLE   64 (640)
Q Consensus        22 ~~~~l~~L~~L~l~~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~   64 (640)
                      .+...+.|++|+|++| .|...    +...+...++|++|||++|.|.
T Consensus        31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~   78 (185)
T 1io0_A           31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN   78 (185)
T ss_dssp             HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred             HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCC
Confidence            3444555666666666 55421    2233444555666666655554

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.50  E-value=1.3e-08  Score=99.16  Aligned_cols=43  Identities=28%  Similarity=0.359  Sum_probs=25.5

Q ss_pred             cCCCCCCEEECcCCccCcc--CCccccCCCCCCEEEcccCcCCCC
Q 035691          102 SNASKLEWLDFANNSLTAS--IPEDLGRLRNLTRLNFARNDLGTR  144 (640)
Q Consensus       102 ~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~  144 (640)
                      .++++|++|+|++|+|+++  +|..+..+++|+.|+|++|+|+++
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~  211 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE  211 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc
Confidence            3456666666666666652  234455666666666666666554

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.43  E-value=4.2e-07  Score=91.42  Aligned_cols=139  Identities=17%  Similarity=0.191  Sum_probs=93.3

Q ss_pred             cCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcC-CCC--CcceeEeeccCCcCCCceeeEEe
Q 035691          446 ANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR-HRN--LVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       446 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      .+.++.|....||+..     ..+++|+....  .....+.+|.++++.+. +..  +++++..+....  .....|+||
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~--~~~~~~~vm   95 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSE--TYQMSFAGF   95 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCS--SCSCSCEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCC--CCCcceEEE
Confidence            3568899999999863     35888885322  33467889999998873 333  445555432211  112357899


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHH------------------------------  572 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~------------------------------  572 (640)
                      ||++|..+.+...            ..++..++..++.+++..+..||+.                              
T Consensus        96 ~~i~G~~l~~~~~------------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (304)
T 3sg8_A           96 TKIKGVPLTPLLL------------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSR  163 (304)
T ss_dssp             ECCCCEECCHHHH------------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTT
T ss_pred             cccCCeECCcccc------------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcc
Confidence            9999987754221            1144455566677777777777641                              


Q ss_pred             -------------------------CCCCeeeCCCCCCCeeeCC--CCcEEEcccccccc
Q 035691          573 -------------------------CKKQIVHCDLKPSNVLLDN--DMIAHVGDFGLTRF  605 (640)
Q Consensus       573 -------------------------~~~~ivHrdlkp~NiLl~~--~~~~kl~DfGla~~  605 (640)
                                               ....++|+|++|.||++++  ...+.|+||+.+..
T Consensus       164 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~  223 (304)
T 3sg8_A          164 ELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI  223 (304)
T ss_dssp             TSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred             cCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence                                     1235899999999999998  56689999998864

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.31  E-value=2.4e-06  Score=84.14  Aligned_cols=135  Identities=18%  Similarity=0.102  Sum_probs=91.6

Q ss_pred             ccccccc-eEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcC-CCCCcceeEeeccCCcCCCceeeEEeeccC
Q 035691          449 IGTGSFG-SVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR-HRNLVKIITACSSSDFQGNDFKALVYEFMH  526 (640)
Q Consensus       449 lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~~lv~e~~~  526 (640)
                      +..|..| .||+.....++..+++|+-..   +....+.+|..+|+.+. +--+.++++++..     .+..++|||+++
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~~lvme~l~  103 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDAWLLTTAIP  103 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEECCC
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeEEEEEEeeC
Confidence            4455555 699988776778899998643   33466888999998874 4446778877543     346789999999


Q ss_pred             CCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 035691          527 HGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHH----------------------------------  572 (640)
Q Consensus       527 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~----------------------------------  572 (640)
                      |.++.+......              .....++.+++..+.-||..                                  
T Consensus       104 G~~~~~~~~~~~--------------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (272)
T 4gkh_A          104 GKTAFQVLEEYP--------------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDD  169 (272)
T ss_dssp             SEEHHHHHHHCG--------------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCG
T ss_pred             CccccccccCCH--------------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccc
Confidence            987765432110              01223444555555555531                                  


Q ss_pred             ---------------------CCCCeeeCCCCCCCeeeCCCCcEEEcccccccc
Q 035691          573 ---------------------CKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF  605 (640)
Q Consensus       573 ---------------------~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~  605 (640)
                                           ....++|+|+.+.||++++++.+-|+||+.+..
T Consensus       170 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          170 ERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             GGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                 012378999999999999888788999998864

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.29  E-value=3.7e-06  Score=84.48  Aligned_cols=138  Identities=14%  Similarity=0.100  Sum_probs=89.2

Q ss_pred             cCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCC---CCcceeEeeccCCcCCCceeeEEe
Q 035691          446 ANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHR---NLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       446 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      .+.++.|....||+.     |..+++|+-.  .......+..|.++|+.+.+.   .+.+.+.++..    .....++||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~----~~g~~~~v~   92 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR----SDGNPFVGY   92 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC----TTSCEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc----CCCceEEEE
Confidence            345788888899987     4557888742  223346789999999999653   35666666531    233567999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHH------------------------------  572 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~------------------------------  572 (640)
                      ||++|..+.+....            .++......++.+++..|..||+.                              
T Consensus        93 e~i~G~~l~~~~~~------------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~  160 (306)
T 3tdw_A           93 RKVQGQILGEDGMA------------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQV  160 (306)
T ss_dssp             ECCCSEECHHHHHT------------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHT
T ss_pred             eccCCeECchhhhh------------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhc
Confidence            99999877652110            022233333444444444444432                              


Q ss_pred             ---------------------------CCCCeeeCCCCCCCeeeCC---CCc-EEEccccccccC
Q 035691          573 ---------------------------CKKQIVHCDLKPSNVLLDN---DMI-AHVGDFGLTRFI  606 (640)
Q Consensus       573 ---------------------------~~~~ivHrdlkp~NiLl~~---~~~-~kl~DfGla~~~  606 (640)
                                                 .+..++|+|++|.||++++   ++. +.|+||+.+...
T Consensus       161 ~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          161 FPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             GGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             ccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                       1245799999999999987   355 589999988643

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.94  E-value=2.3e-05  Score=80.47  Aligned_cols=85  Identities=8%  Similarity=-0.030  Sum_probs=55.2

Q ss_pred             cCcc-cccccceEEEEEEC--C----CCeEEEEEEeeccc---chhHHHHHHHHHHHHhcC-C--CCCcceeEeeccCCc
Q 035691          446 ANLI-GTGSFGSVYKGILD--P----DQTVVAVKVLFLHQ---RGALKSFMAECEALRNIR-H--RNLVKIITACSSSDF  512 (640)
Q Consensus       446 ~~~l-g~G~~g~Vy~~~~~--~----~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~~~  512 (640)
                      .+.| +.|....+|+....  .    ++..+++|+.....   ......+..|+.+++.+. +  -.+.+++.++.....
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 78888999988653  1    16678889764322   101245678888888874 3  357788887643321


Q ss_pred             CCCceeeEEeeccCCCChhh
Q 035691          513 QGNDFKALVYEFMHHGSLES  532 (640)
Q Consensus       513 ~~~~~~~lv~e~~~~g~L~~  532 (640)
                        ....++||||++|..+.+
T Consensus       105 --~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 --LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             --TSSCEEEEECCCCBCCCB
T ss_pred             --cCCceEEEEecCCCChhh
Confidence              124579999999877654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.92  E-value=3.7e-05  Score=80.25  Aligned_cols=76  Identities=14%  Similarity=0.134  Sum_probs=48.5

Q ss_pred             cCcccccccceEEEEEECCCCeEEEEEEeecccc-------hhHHHHHHHHHHHHhcCC--C-CCcceeEeeccCCcCCC
Q 035691          446 ANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR-------GALKSFMAECEALRNIRH--R-NLVKIITACSSSDFQGN  515 (640)
Q Consensus       446 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~-niv~l~~~~~~~~~~~~  515 (640)
                      .+.+|.|.++.||+++...+++.|+||......+       .....+..|.++++.+..  + .+++++.+.       .
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-------~  107 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T  107 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-------C
Confidence            4578999999999997765678899998643211       123456788888887742  3 345666542       1


Q ss_pred             ceeeEEeeccCCC
Q 035691          516 DFKALVYEFMHHG  528 (640)
Q Consensus       516 ~~~~lv~e~~~~g  528 (640)
                      +..++||||+++.
T Consensus       108 ~~~~lvmE~l~g~  120 (397)
T 2olc_A          108 EMAVTVMEDLSHL  120 (397)
T ss_dssp             TTTEEEECCCTTS
T ss_pred             CccEEEEEeCCCc
Confidence            2347999999764

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.87  E-value=2.2e-05  Score=67.55  Aligned_cols=65  Identities=18%  Similarity=0.206  Sum_probs=53.1

Q ss_pred             CEEECCCCccc-CcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCccc
Q 035691          273 PHLDLSKNKLS-GEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDV  339 (640)
Q Consensus       273 ~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  339 (640)
                      ..++.+++.|+ ..+|..+.  ++|++|+|++|+|+.+.+..|..+++|+.|+|++|+|.|.+...++
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l~~l   76 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLVPL   76 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGGHHH
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCccHHH
Confidence            47888888886 35665554  3689999999999988888899999999999999999998875433

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.81  E-value=0.00018  Score=73.06  Aligned_cols=32  Identities=25%  Similarity=0.329  Sum_probs=28.5

Q ss_pred             CCCeeeCCCCCCCeeeCCCCcEEEcccccccc
Q 035691          574 KKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF  605 (640)
Q Consensus       574 ~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~  605 (640)
                      +..++|+|+++.||+++.++.+.|+||+.+..
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            36899999999999998888999999998753

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.57  E-value=1.7e-05  Score=71.65  Aligned_cols=12  Identities=25%  Similarity=0.235  Sum_probs=5.3

Q ss_pred             CCCCCEEEccCC
Q 035691          181 LPKLQVLSLFEN  192 (640)
Q Consensus       181 l~~L~~L~L~~N  192 (640)
                      +++|++|+|+++
T Consensus       138 ~~~L~~L~L~~c  149 (176)
T 3e4g_A          138 FRNLKYLFLSDL  149 (176)
T ss_dssp             CTTCCEEEEESC
T ss_pred             CCCCCEEECCCC
Confidence            344444444443

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.56  E-value=0.0003  Score=69.66  Aligned_cols=78  Identities=18%  Similarity=0.096  Sum_probs=56.2

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCC---CCCcceeEeeccCCcCCCcee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRH---RNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~~~~~~~~~~~~~~~  518 (640)
                      .+...+.+|.|..+.||+.+.. +|+.|.||+-..........|..|++.|+.+.-   -.+++++++.         ..
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~~   85 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------DR   85 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------TT
T ss_pred             CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---------Cc
Confidence            3455677899999999999886 789999998754433334568899999988742   2455666542         13


Q ss_pred             eEEeeccCCCC
Q 035691          519 ALVYEFMHHGS  529 (640)
Q Consensus       519 ~lv~e~~~~g~  529 (640)
                      ++||||++++.
T Consensus        86 ~lv~e~l~~~~   96 (288)
T 3f7w_A           86 TLAMEWVDERP   96 (288)
T ss_dssp             EEEEECCCCCC
T ss_pred             eEEEEeecccC
Confidence            68999998764

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.53  E-value=1.3e-05  Score=72.38  Aligned_cols=34  Identities=12%  Similarity=0.171  Sum_probs=15.8

Q ss_pred             CCCEEEccCCcCcccCCcCccCCCCCCEEEccCC
Q 035691          183 KLQVLSLFENNISGEIPSSLGNFTFLTELNLRGN  216 (640)
Q Consensus       183 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  216 (640)
                      +|+.||++++.|+...-..+.++++|++|+|++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C   95 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC   95 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence            3555555555544333333444444444444444

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.53  E-value=1.8e-05  Score=72.83  Aligned_cols=115  Identities=10%  Similarity=0.159  Sum_probs=60.1

Q ss_pred             cCCCCCCEEECcCC-ccCcc----CCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCC---
Q 035691          102 SNASKLEWLDFANN-SLTAS----IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRS---  173 (640)
Q Consensus       102 ~~l~~L~~L~Ls~N-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~---  173 (640)
                      .+-+.|++|+|++| +|...    +..++..-+.|+.|+|++|+|.......+  .+.+..-+.|+.|+|+.|.|..   
T Consensus        38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~al--A~aL~~N~tL~~L~L~~N~Ig~~Ga  115 (197)
T 1pgv_A           38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGL--IELIETSPSLRVLNVESNFLTPELL  115 (197)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTH--HHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred             hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHH--HHHHhcCCccCeEecCCCcCCHHHH
Confidence            34456666666664 55421    23345555666777777776654422221  2334445566666666666653   


Q ss_pred             --cCcCCCCCCCCCEEEccCCcC---ccc----CCcCccCCCCCCEEEccCCCC
Q 035691          174 --IPISVGYLPKLQVLSLFENNI---SGE----IPSSLGNFTFLTELNLRGNSI  218 (640)
Q Consensus       174 --ip~~~~~l~~L~~L~L~~N~l---~~~----~p~~~~~l~~L~~L~L~~N~l  218 (640)
                        +-..+..-+.|++|+|++|..   ...    +...+..-+.|+.|+++.|.+
T Consensus       116 ~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A          116 ARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  169 (197)
T ss_dssp             HHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence              222344445577777765432   211    122344445666666665543

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.43  E-value=0.00023  Score=61.10  Aligned_cols=56  Identities=25%  Similarity=0.299  Sum_probs=39.8

Q ss_pred             ceEecCCCCCC--CcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCC
Q 035691          162 EIVSLNVNSLR--SIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIR  219 (640)
Q Consensus       162 ~~L~L~~N~l~--~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  219 (640)
                      ..++.+++.|+  .+|..+.  ++|++|+|++|+|+.+.++.|..+++|+.|+|++|.+.
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            36677777777  6775543  46777788888777666667777777777777777664

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.42  E-value=2.1e-05  Score=72.45  Aligned_cols=94  Identities=16%  Similarity=0.144  Sum_probs=49.3

Q ss_pred             cCcCCCCCCEEECcCCccCccC----CccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCC---CC
Q 035691          100 SISNASKLEWLDFANNSLTASI----PEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNS---LR  172 (640)
Q Consensus       100 ~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~---l~  172 (640)
                      ++..-+.|+.|+|++|+|....    ..++..-+.|++|+|++|.|+......  +.+.+..-+.|+.|+|++|.   +.
T Consensus        65 aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a--la~aL~~N~tL~~L~L~n~~~~~ig  142 (197)
T 1pgv_A           65 AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR--LLRSTLVTQSIVEFKADNQRQSVLG  142 (197)
T ss_dssp             HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH--HHHHTTTTCCCSEEECCCCSSCCCC
T ss_pred             HHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH--HHHHHhhCCceeEEECCCCcCcCcC
Confidence            3444556666666666665322    223334566677777777665432211  12344445557777776542   22


Q ss_pred             C-----cCcCCCCCCCCCEEEccCCcCc
Q 035691          173 S-----IPISVGYLPKLQVLSLFENNIS  195 (640)
Q Consensus       173 ~-----ip~~~~~l~~L~~L~L~~N~l~  195 (640)
                      .     +-..+..-++|+.|+++.|.+.
T Consensus       143 ~~g~~~ia~aL~~N~tL~~L~l~~~~~g  170 (197)
T 1pgv_A          143 NQVEMDMMMAIEENESLLRVGISFASME  170 (197)
T ss_dssp             HHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             HHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence            1     1122333456777777766543

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.41  E-value=0.00097  Score=66.62  Aligned_cols=76  Identities=16%  Similarity=0.106  Sum_probs=57.0

Q ss_pred             ccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcC---CCCCcceeEeeccCCcCCCceeeEE
Q 035691          445 SANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR---HRNLVKIITACSSSDFQGNDFKALV  521 (640)
Q Consensus       445 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~~~~~~lv  521 (640)
                      ..+.|+.|.+..+|+...  ++..++||+....   ....+..|.+.|+.+.   ...+++++.++..     ....++|
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lv  109 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLL  109 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEE
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEE
Confidence            346789999999999875  4677889987532   3467889999888873   3567888887532     2467999


Q ss_pred             eeccCCCCh
Q 035691          522 YEFMHHGSL  530 (640)
Q Consensus       522 ~e~~~~g~L  530 (640)
                      |||+++..+
T Consensus       110 me~l~G~~~  118 (312)
T 3jr1_A          110 LEALNKSKN  118 (312)
T ss_dssp             EECCCCCCC
T ss_pred             EEeccCCCC
Confidence            999998764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.23  E-value=0.001  Score=69.76  Aligned_cols=31  Identities=23%  Similarity=0.384  Sum_probs=27.6

Q ss_pred             CCeeeCCCCCCCeeeCCCCcEEEccccccccC
Q 035691          575 KQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI  606 (640)
Q Consensus       575 ~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~  606 (640)
                      ..++|+|++|.||++++++ ++++||+.+...
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            6899999999999998776 999999988743

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.85  E-value=0.0034  Score=62.40  Aligned_cols=71  Identities=8%  Similarity=0.039  Sum_probs=41.7

Q ss_pred             cCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCC-cceeEeeccCCcCCCceeeEEeec
Q 035691          446 ANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNL-VKIITACSSSDFQGNDFKALVYEF  524 (640)
Q Consensus       446 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~~~~~~lv~e~  524 (640)
                      .+.|+.|....+|+.      ..+++|+........ .....|+.+++.+...++ .++++++.       +.-++|+||
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~~-------~~~~~v~e~   88 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVDP-------ATGVMVTRY   88 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEECT-------TTCCEEEEC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEEC-------CCCEEEEee
Confidence            567888989999998      347888774321111 122467777776642222 46665521       123689999


Q ss_pred             c-CCCCh
Q 035691          525 M-HHGSL  530 (640)
Q Consensus       525 ~-~~g~L  530 (640)
                      + ++.++
T Consensus        89 i~~g~~l   95 (301)
T 3dxq_A           89 IAGAQTM   95 (301)
T ss_dssp             CTTCEEC
T ss_pred             cCCCccC
Confidence            9 55433

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.79  E-value=0.0036  Score=62.87  Aligned_cols=171  Identities=12%  Similarity=0.089  Sum_probs=85.1

Q ss_pred             cCHHHHHHhcCCCcc-----cCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCC--Ccce
Q 035691          431 VSYESLLKATGGFSS-----ANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRN--LVKI  503 (640)
Q Consensus       431 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l  503 (640)
                      ++.+++......|..     .+.++.|....+|+.... +| .+++|+.....  ..+.+..|+.++..+...+  ++++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            344444444444433     245677888899998764 34 68899885421  1234556777777664222  3444


Q ss_pred             eEeeccCCc-CCCceeeEEeeccCCCChhh-----------h---cCC--CCCCCCCCCCCCCCCHHHHHH---------
Q 035691          504 ITACSSSDF-QGNDFKALVYEFMHHGSLES-----------W---LHP--ESASDDLNYSPSILSFLQRLN---------  557 (640)
Q Consensus       504 ~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~-----------~---l~~--~~~~~~~~~~~~~~~~~~~~~---------  557 (640)
                      +.......+ ......+++|+|++|..+..           .   ++.  ...............|.....         
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            332111000 11234689999999865321           0   110  000000000000011211100         


Q ss_pred             ---HHHHHHHHHHHHhcC----CCCCeeeCCCCCCCeeeCCCCcEEEcccccccc
Q 035691          558 ---IAINVASALEYLHHH----CKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF  605 (640)
Q Consensus       558 ---i~~~i~~al~yLH~~----~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~  605 (640)
                         +...+...++++...    .+..++|+|+.+.||++++++.+.|+||+.+..
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence               011234445555432    235789999999999999876678999988753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.67  E-value=0.0032  Score=66.06  Aligned_cols=73  Identities=19%  Similarity=0.251  Sum_probs=47.8

Q ss_pred             CcccccccceEEEEEECC-------CCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCC-cceeEeeccCCcCCCcee
Q 035691          447 NLIGTGSFGSVYKGILDP-------DQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNL-VKIITACSSSDFQGNDFK  518 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~~~~~  518 (640)
                      +.|+.|-...||++....       ++..|++|+....  +....+..|..+++.+...++ +++++.+     .+    
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----  147 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----  147 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----
Confidence            457778888999998753       2578889987321  112456689998888743333 6676653     11    


Q ss_pred             eEEeeccCCCCh
Q 035691          519 ALVYEFMHHGSL  530 (640)
Q Consensus       519 ~lv~e~~~~g~L  530 (640)
                      .+||||++|..+
T Consensus       148 g~v~e~l~G~~l  159 (429)
T 1nw1_A          148 GRLEEYIPSRPL  159 (429)
T ss_dssp             EEEECCCCEEEC
T ss_pred             CEEEEEeCCccc
Confidence            278999986443

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.54  E-value=0.013  Score=58.98  Aligned_cols=32  Identities=25%  Similarity=0.281  Sum_probs=27.7

Q ss_pred             CCCeeeCCCCCCCeeeCCC----CcEEEcccccccc
Q 035691          574 KKQIVHCDLKPSNVLLDND----MIAHVGDFGLTRF  605 (640)
Q Consensus       574 ~~~ivHrdlkp~NiLl~~~----~~~kl~DfGla~~  605 (640)
                      +..++|+|+.+.||+++.+    +.+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            3579999999999999874    6899999998864

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.53  E-value=0.0041  Score=63.84  Aligned_cols=146  Identities=12%  Similarity=0.108  Sum_probs=81.7

Q ss_pred             CcccccccceEEEEEECC-------CCeEEEEEEeecccchhHHHHHHHHHHHHhcC-CCCCcceeEeeccCCcCCCcee
Q 035691          447 NLIGTGSFGSVYKGILDP-------DQTVVAVKVLFLHQRGALKSFMAECEALRNIR-HRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      +.+..|-...+|++....       +++.|++|+... .........+|.++++.+. +.-..++++++.     +    
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~-----~----  125 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFP-----E----  125 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET-----T----
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC-----C----
Confidence            456677788999988742       357888988622 1123456678999988874 333356666632     1    


Q ss_pred             eEEeeccCCCChhhh-c----------------CCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-----------------
Q 035691          519 ALVYEFMHHGSLESW-L----------------HPESASDDLNYSPSILSFLQRLNIAINVAS-----------------  564 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~-l----------------~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~-----------------  564 (640)
                      .+||||++|..+..- +                +....  . ...+...-+.++.++..++..                 
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~--~-~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l  202 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEM--P-FTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL  202 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCC--S-SCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCC--C-CCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence            289999998554310 0                11100  0 000111123444555544322                 


Q ss_pred             --HHHHHh----c-CCCCCeeeCCCCCCCeeeCCC----CcEEEcccccccc
Q 035691          565 --ALEYLH----H-HCKKQIVHCDLKPSNVLLDND----MIAHVGDFGLTRF  605 (640)
Q Consensus       565 --al~yLH----~-~~~~~ivHrdlkp~NiLl~~~----~~~kl~DfGla~~  605 (640)
                        .+.+|.    . ..+..++|+|+.+.||+++.+    +.+.++||..|..
T Consensus       203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence              233332    1 123468999999999999876    7899999998763

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.41  E-value=0.012  Score=62.09  Aligned_cols=74  Identities=16%  Similarity=0.070  Sum_probs=46.3

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCC-cceeEeeccCCcCCCceeeEEeecc
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNL-VKIITACSSSDFQGNDFKALVYEFM  525 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~~~~~~lv~e~~  525 (640)
                      +.|+.|-...+|++....++..+++|+........ -....|..+++.+...++ +++++++     .  +  ..||||+
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~-----~--~--G~v~e~I  183 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFF-----T--N--GRIEEFM  183 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEE-----T--T--EEEEECC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEe-----C--C--eEEEEee
Confidence            56777888999999886445788899873322111 112578888888864444 5666663     1  1  2599999


Q ss_pred             CCCCh
Q 035691          526 HHGSL  530 (640)
Q Consensus       526 ~~g~L  530 (640)
                      +|..+
T Consensus       184 ~G~~l  188 (458)
T 2qg7_A          184 DGYAL  188 (458)
T ss_dssp             CSEEC
T ss_pred             CCccC
Confidence            87444

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.41  E-value=0.027  Score=56.46  Aligned_cols=78  Identities=10%  Similarity=0.076  Sum_probs=46.6

Q ss_pred             cccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCC--CcceeEeeccCC-cCCCceeeEEeec
Q 035691          448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRN--LVKIITACSSSD-FQGNDFKALVYEF  524 (640)
Q Consensus       448 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~-~~~~~~~~lv~e~  524 (640)
                      .++ |....||+.... +|+.+++|+..... .....+..|..++..+....  +++++.. .... .......++||||
T Consensus        33 ~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEEEC
T ss_pred             eec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEEEEe
Confidence            455 777899987654 56678999985321 12356677888887774222  3444433 1110 1113356789999


Q ss_pred             cCCCC
Q 035691          525 MHHGS  529 (640)
Q Consensus       525 ~~~g~  529 (640)
                      ++|..
T Consensus       109 i~G~~  113 (328)
T 1zyl_A          109 VGGRQ  113 (328)
T ss_dssp             CCCEE
T ss_pred             cCCCC
Confidence            98754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.11  E-value=0.018  Score=58.18  Aligned_cols=31  Identities=23%  Similarity=0.340  Sum_probs=27.7

Q ss_pred             CCeeeCCCCCCCeeeCCCCcEEEcccccccc
Q 035691          575 KQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF  605 (640)
Q Consensus       575 ~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~  605 (640)
                      ..++|+|+.+.||++++++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            5789999999999999888899999987764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=95.97  E-value=0.012  Score=60.36  Aligned_cols=74  Identities=15%  Similarity=0.182  Sum_probs=42.4

Q ss_pred             CcccccccceEEEEEECC--------CCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCC-CcceeEeeccCCcCCCce
Q 035691          447 NLIGTGSFGSVYKGILDP--------DQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRN-LVKIITACSSSDFQGNDF  517 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~~~~  517 (640)
                      ..++.|....+|+.....        .+..+++|+...... .......|.++++.+...+ .+++++..     .    
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~----  108 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF-----N----  108 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec-----C----
Confidence            456778788999988652        136788888643221 1112357888888774333 44666542     1    


Q ss_pred             eeEEeeccCCCCh
Q 035691          518 KALVYEFMHHGSL  530 (640)
Q Consensus       518 ~~lv~e~~~~g~L  530 (640)
                      -++||||++|..+
T Consensus       109 ~~~v~e~i~G~~l  121 (369)
T 3c5i_A          109 GGRIEEWLYGDPL  121 (369)
T ss_dssp             TEEEEECCCSEEC
T ss_pred             CcEEEEEecCCcC
Confidence            2589999987543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.19  E-value=0.11  Score=53.99  Aligned_cols=74  Identities=14%  Similarity=0.147  Sum_probs=45.3

Q ss_pred             CcccccccceEEEEEECCC-------CeEEEEEEeecccchhHHHHHHHHHHHHhcC-CCCCcceeEeeccCCcCCCcee
Q 035691          447 NLIGTGSFGSVYKGILDPD-------QTVVAVKVLFLHQRGALKSFMAECEALRNIR-HRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      +.+..|-...+|+......       +..|++|+...... ..-...+|.++++.+. +.-..++++.+     .    -
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~----~  145 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF-----P----E  145 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T----T
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C----C
Confidence            4566677888999887521       57788888633221 1112357888887774 32245555542     1    2


Q ss_pred             eEEeeccCCCCh
Q 035691          519 ALVYEFMHHGSL  530 (640)
Q Consensus       519 ~lv~e~~~~g~L  530 (640)
                      +.||||++|..+
T Consensus       146 ~~I~efI~G~~l  157 (424)
T 3mes_A          146 GRIEEFIDGEPL  157 (424)
T ss_dssp             EEEEECCCSEEC
T ss_pred             CEEEEEeCCccC
Confidence            589999998653

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=87.81  E-value=0.066  Score=56.46  Aligned_cols=61  Identities=11%  Similarity=0.007  Sum_probs=18.0

Q ss_pred             ccCcccccccceEEEEEECCCCeEEEE------EEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeec
Q 035691          445 SANLIGTGSFGSVYKGILDPDQTVVAV------KVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACS  508 (640)
Q Consensus       445 ~~~~lg~G~~g~Vy~~~~~~~~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~  508 (640)
                      ..+.+|   ||.||+|.+.....+|||      |..+..  .+.....|.+|..+++..+|||+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            446676   999999999755568888      665322  2223457889999999999999999988753

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=87.20  E-value=0.12  Score=53.42  Aligned_cols=30  Identities=23%  Similarity=0.380  Sum_probs=25.1

Q ss_pred             CeeeCCCCCCCeee------CCCCcEEEcccccccc
Q 035691          576 QIVHCDLKPSNVLL------DNDMIAHVGDFGLTRF  605 (640)
Q Consensus       576 ~ivHrdlkp~NiLl------~~~~~~kl~DfGla~~  605 (640)
                      .++|+|+.+.||++      +++..++++||-.|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            35799999999999      4567899999998763

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=83.56  E-value=0.58  Score=30.81  Aligned_cols=30  Identities=17%  Similarity=0.052  Sum_probs=15.1

Q ss_pred             CeeeehhhhhhHHHHHHHHHh-hhheeeccc
Q 035691          384 GFKLMIPLLSGLVGLVLVMSL-LIIDRLRRK  413 (640)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~~-~~~~r~rr~  413 (640)
                      ...|+.+++.+++++++++.. ++++|+|+.
T Consensus        10 ~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~   40 (44)
T 2ks1_B           10 IPSIATGMVGALLLLLVVALGIGLFMRRRHI   40 (44)
T ss_dssp             SSSSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred             cceEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence            344666666666655544433 344444433

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	640
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-43
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-42
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-41
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-40
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	7e-39
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-38
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-38
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-38
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-38
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-38
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-38
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-37
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-37
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-37
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-37
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-37
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-37
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-36
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-36
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-36
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-35
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-35
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-35
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-35
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-34
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-34
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-34
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-34
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-34
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-34
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-32
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-31
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-31
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	9e-31
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-30
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-30
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-29
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-29
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-29
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-29
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-28
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-28
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-28
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-27
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-27
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-27
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-27
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-27
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-27
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-25
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-25
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-25
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-25
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-25
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-24
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-24
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-24
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-24
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-23
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-23
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-22
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-22
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-21
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-18
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-04
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-04
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-04
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-13
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	8e-13
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-18
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-13
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-12
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	6e-11
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	8e-06
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	0.002
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	0.004
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-11
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	8e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-05
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-11
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	7e-11
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-10
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-09
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-09
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	7e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	1e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	6e-04
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	7e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	7e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	8e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-06
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	1e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	8e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.001
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.002
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.003
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	9e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.002
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	9e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.003

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 3e-43
 Identities = 55/192 (28%), Positives = 84/192 (43%), Gaps = 25/192 (13%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGA--LKSFMAECEALRNIRHRNLVKII 504
             IG+GSFG+VYKG    D   VAVK+L +       L++F  E   LR  RH N++  +
Sbjct: 14  QRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
              +          A+V ++    SL   LH                 ++ ++IA   A 
Sbjct: 71  GYST------APQLAIVTQWCEGSSLYHHLHIIETK---------FEMIKLIDIARQTAQ 115

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            ++YLH      I+H DLK +N+ L  D+   +GDFGL         S+Q   +   G++
Sbjct: 116 GMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL--SGSI 170

Query: 625 GYAAPEYGMGSQ 636
            + APE      
Sbjct: 171 LWMAPEVIRMQD 182

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  152 bits (385), Expect = 3e-42
 Identities = 51/223 (22%), Positives = 98/223 (43%), Gaps = 31/223 (13%)

Query: 432 SYESLLKATGGFSSA---------NLIGTGSFGSVYKGILDPD---QTVVAVKVLFL-HQ 478
           ++E   +A   F+            +IG G FG V  G L      +  VA+K L   + 
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 479 RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPES 538
               + F++E   +    H N++ +    +      +    ++ EFM +GSL+S+L    
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-----STPVMIITEFMENGSLDSFLRQND 122

Query: 539 ASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG 598
               +         +Q + +   +A+ ++YL        VH DL   N+L++++++  V 
Sbjct: 123 GQFTV---------IQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVS 170

Query: 599 DFGLTRFIPEVIS-SNQCSSVGLKGTVGYAAPEYGMGSQVSTN 640
           DFGL+RF+ +  S     S++G K  + + APE     + ++ 
Sbjct: 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA 213

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (381), Expect = 2e-41
 Identities = 46/198 (23%), Positives = 81/198 (40%), Gaps = 24/198 (12%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR-GALKSFMAECEALRNIRHRNLV 501
           F   + +G G+ G V+K    P   V+A K++ L  +       + E + L       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
               A  S     +   ++  E M  GSL+  L               +       ++I 
Sbjct: 68  GFYGAFYS-----DGEISICMEHMDGGSLDQVLK----------KAGRIPEQILGKVSIA 112

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           V   L YL    K  I+H D+KPSN+L+++     + DFG++  + + ++++        
Sbjct: 113 VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------ 164

Query: 622 GTVGYAAPEYGMGSQVST 639
           GT  Y +PE   G+  S 
Sbjct: 165 GTRSYMSPERLQGTHYSV 182

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 3e-40
 Identities = 45/193 (23%), Positives = 84/193 (43%), Gaps = 22/193 (11%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITA 506
             +G G FG V+ G      T VAVK L         +F+AE   ++ ++H+ LV++   
Sbjct: 19  ERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV 76

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            +           ++ E+M +GSL  +L   S           L+  + L++A  +A  +
Sbjct: 77  VTQEPI------YIITEYMENGSLVDFLKTPSGIK--------LTINKLLDMAAQIAEGM 122

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            ++        +H DL+ +N+L+ + +   + DFGL R I +   +   +  G K  + +
Sbjct: 123 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED---NEYTAREGAKFPIKW 176

Query: 627 AAPEYGMGSQVST 639
            APE       + 
Sbjct: 177 TAPEAINYGTFTI 189

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 7e-39
 Identities = 49/194 (25%), Positives = 80/194 (41%), Gaps = 22/194 (11%)

Query: 449 IGTGSFGSVYKGIL--DPDQTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIIT 505
           +G G+FGSV +G+      Q  VA+KVL    ++   +  M E + +  + +  +V++I 
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
            C +          LV E    G L  +L  +            +       +   V+  
Sbjct: 77  VCQAEAL------MLVMEMAGGGPLHKFLVGKREE---------IPVSNVAELLHQVSMG 121

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG 625
           ++YL        VH DL   NVLL N   A + DFGL++ +    S     S G K  + 
Sbjct: 122 MKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG-KWPLK 177

Query: 626 YAAPEYGMGSQVST 639
           + APE     + S+
Sbjct: 178 WYAPECINFRKFSS 191

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 2e-38
 Identities = 47/197 (23%), Positives = 74/197 (37%), Gaps = 17/197 (8%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKII 504
             IGTGS+G   K     D  ++  K L          +  ++E   LR ++H N+V+  
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
                   + N    +V E+   G L S +               L     L +   +  
Sbjct: 70  DRIID---RTNTTLYIVMEYCEGGDLASVIT------KGTKERQYLDEEFVLRVMTQLTL 120

Query: 565 ALEYLHHH--CKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
           AL+  H        ++H DLKP+NV LD      +GDFGL R     ++ +   +    G
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI----LNHDTSFAKAFVG 176

Query: 623 TVGYAAPEYGMGSQVST 639
           T  Y +PE       + 
Sbjct: 177 TPYYMSPEQMNRMSYNE 193

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 2e-38
 Identities = 49/192 (25%), Positives = 77/192 (40%), Gaps = 20/192 (10%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACS 508
           IG G FG V++G        VAVK+    +  +     AE      +RH N++  I A +
Sbjct: 11  IGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADN 67

Query: 509 SSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEY 568
             +        LV ++  HGSL  +L+  + + +             + +A++ AS L +
Sbjct: 68  KDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVE-----------GMIKLALSTASGLAH 115

Query: 569 LHHHC-----KKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
           LH        K  I H DLK  N+L+  +    + D GL         +   +     GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

Query: 624 VGYAAPEYGMGS 635
             Y APE    S
Sbjct: 176 KRYMAPEVLDDS 187

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 3e-38
 Identities = 46/186 (24%), Positives = 74/186 (39%), Gaps = 21/186 (11%)

Query: 449 IGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITA 506
           IG GSF +VYKG+       VA   L   +  +   + F  E E L+ ++H N+V+   +
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
              S  +G     LV E M  G+L+++L              ++      +    +   L
Sbjct: 77  W-ESTVKGKKCIVLVTELMTSGTLKTYLK----------RFKVMKIKVLRSWCRQILKGL 125

Query: 567 EYLHHHCKKQIVHCDLKPSNVLL-DNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG 625
           ++LH      I+H DLK  N+ +        +GD GL        +          GT  
Sbjct: 126 QFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI------GTPE 178

Query: 626 YAAPEY 631
           + APE 
Sbjct: 179 FMAPEM 184

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  141 bits (356), Expect = 4e-38
 Identities = 44/197 (22%), Positives = 70/197 (35%), Gaps = 29/197 (14%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRN 499
           FS    IG GSFG+VY      +  VVA+K +           +  + E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
            ++                 LV E+    + +     +            L  ++   + 
Sbjct: 77  TIQYRGCY-----LREHTAWLVMEYCLGSASDLLEVHKKP----------LQEVEIAAVT 121

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
                 L YLH H    ++H D+K  N+LL    +  +GDFG    +    S        
Sbjct: 122 HGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-------- 170

Query: 620 LKGTVGYAAPEYGMGSQ 636
             GT  + APE  +   
Sbjct: 171 FVGTPYWMAPEVILAMD 187

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 5e-38
 Identities = 55/193 (28%), Positives = 82/193 (42%), Gaps = 26/193 (13%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITA 506
             IG G FG V  G        VAVK +        ++F+AE   +  +RH NLV+++  
Sbjct: 13  QTIGKGEFGDVMLGDYR--GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 68

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
                 +      +V E+M  GSL  +L         +   S+L     L  +++V  A+
Sbjct: 69  I----VEEKGGLYIVTEYMAKGSLVDYLR--------SRGRSVLGGDCLLKFSLDVCEAM 116

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
           EYL  +     VH DL   NVL+  D +A V DFGLT+       + +         V +
Sbjct: 117 EYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-------LPVKW 166

Query: 627 AAPEYGMGSQVST 639
            APE     + ST
Sbjct: 167 TAPEALREKKFST 179

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 6e-38
 Identities = 47/212 (22%), Positives = 83/212 (39%), Gaps = 30/212 (14%)

Query: 448 LIGTGSFGSVYKGIL-----DPDQTVVAVKVLFL-HQRGALKSFMAECEALRNI-RHRNL 500
           ++G+G+FG V                VAVK+L         ++ M+E + +  +  H N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH-------------PESASDDLNYSP 547
           V ++ AC+      +    L++E+  +G L ++L                    +     
Sbjct: 104 VNLLGACTL-----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158

Query: 548 SILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIP 607
           ++L+F   L  A  VA  +E+L        VH DL   NVL+ +  +  + DFGL R I 
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 608 EVISSNQCSSVGLKGTVGYAAPEYGMGSQVST 639
              +     +      V + APE       + 
Sbjct: 216 SDSNYVVRGNAR--LPVKWMAPESLFEGIYTI 245

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 1e-37
 Identities = 46/197 (23%), Positives = 79/197 (40%), Gaps = 24/197 (12%)

Query: 447 NLIGTGSFGSVYKGILDPDQT--VVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVK 502
             +G+G+FG+V KG     +    VAVK+L             +AE   ++ + +  +V+
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +I  C +  +       LV E    G L  +L               +     + +   V
Sbjct: 73  MIGICEAESW------MLVMEMAELGPLNKYLQQNRH----------VKDKNIIELVHQV 116

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
           +  ++YL        VH DL   NVLL     A + DFGL++ +    +  +  + G K 
Sbjct: 117 SMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KW 172

Query: 623 TVGYAAPEYGMGSQVST 639
            V + APE     + S+
Sbjct: 173 PVKWYAPECINYYKFSS 189

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 1e-37
 Identities = 52/193 (26%), Positives = 85/193 (44%), Gaps = 22/193 (11%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITA 506
             +GTG FG V  G     Q  VA+K++          F+ E + + N+ H  LV++   
Sbjct: 10  KELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGV 67

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
           C+           ++ E+M +G L ++L                   Q L +  +V  A+
Sbjct: 68  CTK-----QRPIFIITEYMANGCLLNYLR---------EMRHRFQTQQLLEMCKDVCEAM 113

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
           EYL        +H DL   N L+++  +  V DFGL+R++ +       SSVG K  V +
Sbjct: 114 EYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---DEYTSSVGSKFPVRW 167

Query: 627 AAPEYGMGSQVST 639
           + PE  M S+ S+
Sbjct: 168 SPPEVLMYSKFSS 180

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 1e-37
 Identities = 45/196 (22%), Positives = 75/196 (38%), Gaps = 27/196 (13%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKI 503
             +G G FG+VY       + ++A+KVL    L + G       E E   ++RH N++++
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
                           L+ E+   G++   L             S     +       +A
Sbjct: 72  YGYFHD-----ATRVYLILEYAPLGTVYRELQ----------KLSKFDEQRTATYITELA 116

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
           +AL Y H     +++H D+KP N+LL +     + DFG +   P    +  C      GT
Sbjct: 117 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC------GT 167

Query: 624 VGYAAPEYGMGSQVST 639
           + Y  PE   G     
Sbjct: 168 LDYLPPEMIEGRMHDE 183

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 2e-37
 Identities = 47/190 (24%), Positives = 76/190 (40%), Gaps = 21/190 (11%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITA 506
             +G G+FG VYK        + A KV+       L+ +M E + L +  H N+VK++ A
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
                    +   ++ EF   G++++ +               L+  Q   +      AL
Sbjct: 78  FYY-----ENNLWILIEFCAGGAVDAVMLELERP---------LTESQIQVVCKQTLDAL 123

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            YLH +   +I+H DLK  N+L   D    + DFG++      I           GT  +
Sbjct: 124 NYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS----FIGTPYW 176

Query: 627 AAPEYGMGSQ 636
            APE  M   
Sbjct: 177 MAPEVVMCET 186

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 4e-37
 Identities = 50/193 (25%), Positives = 87/193 (45%), Gaps = 22/193 (11%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITA 506
             +G G FG V+ G      T VA+K L        ++F+ E + ++ +RH  LV++   
Sbjct: 23  VKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV 80

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
            S           +V E+M  GSL  +L  E+           L   Q +++A  +AS +
Sbjct: 81  VSEEPI------YIVTEYMSKGSLLDFLKGET--------GKYLRLPQLVDMAAQIASGM 126

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            Y+        VH DL+ +N+L+  +++  V DFGL R I +   +   +  G K  + +
Sbjct: 127 AYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKW 180

Query: 627 AAPEYGMGSQVST 639
            APE  +  + + 
Sbjct: 181 TAPEAALYGRFTI 193

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 5e-37
 Identities = 51/193 (26%), Positives = 84/193 (43%), Gaps = 22/193 (11%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITA 506
             IG+G FG V+ G    ++  VA+K +        + F+ E E +  + H  LV++   
Sbjct: 11  QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGV 68

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
           C            LV+EFM HG L  +L  +                  L + ++V   +
Sbjct: 69  CLE-----QAPICLVFEFMEHGCLSDYLRTQRGLFAAE---------TLLGMCLDVCEGM 114

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
            YL   C   ++H DL   N L+  + +  V DFG+TRF+ +   ++     G K  V +
Sbjct: 115 AYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST---GTKFPVKW 168

Query: 627 AAPEYGMGSQVST 639
           A+PE    S+ S+
Sbjct: 169 ASPEVFSFSRYSS 181

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 3e-36
 Identities = 40/194 (20%), Positives = 70/194 (36%), Gaps = 21/194 (10%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVKIIT 505
             +G G++G V   +    +  VAVK++ +       ++   E    + + H N+VK   
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
                  +  + + L  E+   G L   + P+            +           + + 
Sbjct: 71  HR-----REGNIQYLFLEYCSGGELFDRIEPDIG----------MPEPDAQRFFHQLMAG 115

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG 625
           + YLH      I H D+KP N+LLD      + DFGL             + +   GT+ 
Sbjct: 116 VVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLP 170

Query: 626 YAAPEYGMGSQVST 639
           Y APE     +   
Sbjct: 171 YVAPELLKRREFHA 184

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 5e-36
 Identities = 48/197 (24%), Positives = 81/197 (41%), Gaps = 20/197 (10%)

Query: 447 NLIGTGSFGSVYKGIL---DPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVK 502
            +IG G FG VY G L   D  +   AVK L  +   G +  F+ E   +++  H N++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           ++  C     +      +V  +M HG L +++  E+ +  +            +   + V
Sbjct: 93  LLGIC----LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK---------DLIGFGLQV 139

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
           A  +        K+ VH DL   N +LD      V DFGL R + +    +  +  G K 
Sbjct: 140 AKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196

Query: 623 TVGYAAPEYGMGSQVST 639
            V + A E     + +T
Sbjct: 197 PVKWMALESLQTQKFTT 213

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  134 bits (339), Expect = 7e-36
 Identities = 52/213 (24%), Positives = 84/213 (39%), Gaps = 30/213 (14%)

Query: 447 NLIGTGSFGSVYKGIL-----DPDQTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNL 500
             IG G+FG V++            T+VAVK+L           F  E   +    + N+
Sbjct: 19  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78

Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYS-------------- 546
           VK++  C+           L++E+M +G L  +L   S     + S              
Sbjct: 79  VKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133

Query: 547 PSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
           P  LS  ++L IA  VA+ + YL        VH DL   N L+  +M+  + DFGL+R I
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNI 190

Query: 607 PEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST 639
                     +      + +  PE    ++ +T
Sbjct: 191 YSADYYKADGNDA--IPIRWMPPESIFYNRYTT 221

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  134 bits (337), Expect = 1e-35
 Identities = 50/193 (25%), Positives = 88/193 (45%), Gaps = 20/193 (10%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITA 506
           + +G G +G VY+G+       VAVK L       ++ F+ E   ++ I+H NLV+++  
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
           C+           ++ EFM +G+L  +L           +   +S +  L +A  ++SA+
Sbjct: 82  CTR-----EPPFYIITEFMTYGNLLDYLR--------ECNRQEVSAVVLLYMATQISSAM 128

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
           EYL        +H DL   N L+  + +  V DFGL+R +         +  G K  + +
Sbjct: 129 EYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKW 182

Query: 627 AAPEYGMGSQVST 639
            APE    ++ S 
Sbjct: 183 TAPESLAYNKFSI 195

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 2e-35
 Identities = 44/193 (22%), Positives = 75/193 (38%), Gaps = 23/193 (11%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITA 506
             IG G+ G+VY  +       VA++ + L Q+   +  + E   +R  ++ N+V  + +
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
                    D   +V E++  GSL   +      +            Q   +      AL
Sbjct: 86  Y-----LVGDELWVVMEYLAGGSLTDVVTETCMDEG-----------QIAAVCRECLQAL 129

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGY 626
           E+LH +   Q++H D+K  N+LL  D    + DFG        I+  Q     + GT  +
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ----ITPEQSKRSTMVGTPYW 182

Query: 627 AAPEYGMGSQVST 639
            APE         
Sbjct: 183 MAPEVVTRKAYGP 195

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 2e-35
 Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 23/207 (11%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNI-RHR 498
               ++IG G+FG V K  +  D   +   +  + +   +   + F  E E L  +  H 
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 499 NLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH------PESASDDLNYSPSILSF 552
           N++ ++ AC     +   +  L  E+  HG+L  +L        + A    N + S LS 
Sbjct: 72  NIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126

Query: 553 LQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISS 612
            Q L+ A +VA  +    +  +KQ +H DL   N+L+  + +A + DFGL+R     +  
Sbjct: 127 QQLLHFAADVARGM---DYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183

Query: 613 NQCSSVGLKGTVGYAAPEYGMGSQVST 639
                   +  V + A E    S  +T
Sbjct: 184 TMG-----RLPVRWMAIESLNYSVYTT 205

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 2e-35
 Identities = 45/209 (21%), Positives = 85/209 (40%), Gaps = 26/209 (12%)

Query: 436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVL-----FLHQRGALKSFMAECE 490
           +LK T  F    ++G+G+FG+VYKG+  P+   V + V            A K  + E  
Sbjct: 5   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63

Query: 491 ALRNIRHRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSIL 550
            + ++ + ++ +++  C +S  Q      L+ + M  G L  ++     +          
Sbjct: 64  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQ------ 111

Query: 551 SFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVI 610
                LN  + +A  + YL      ++VH DL   NVL+       + DFGL + +    
Sbjct: 112 ---YLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA-- 163

Query: 611 SSNQCSSVGLKGTVGYAAPEYGMGSQVST 639
              +  + G K  + + A E  +    + 
Sbjct: 164 EEKEYHAEGGKVPIKWMALESILHRIYTH 192

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 1e-34
 Identities = 53/197 (26%), Positives = 76/197 (38%), Gaps = 25/197 (12%)

Query: 449 IGTGSFGSVYKGILDPD---QTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVK 502
           +G GSFG V +G  D        VAVK L    L Q  A+  F+ E  A+ ++ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +     +   +      +V E    GSL   L        L               A+ V
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLG---------TLSRYAVQV 120

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
           A  + YL        +H DL   N+LL    +  +GDFGL R +P+    +       K 
Sbjct: 121 AEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ-NDDHYVMQEHRKV 176

Query: 623 TVGYAAPEYGMGSQVST 639
              + APE       S 
Sbjct: 177 PFAWCAPESLKTRTFSH 193

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 2e-34
 Identities = 45/199 (22%), Positives = 86/199 (43%), Gaps = 23/199 (11%)

Query: 443 FSSANLIGTGSFGSVYKGILDPD----QTVVAVKVLFL-HQRGALKSFMAECEALRNIRH 497
            +   +IG G FG VYKG+L       +  VA+K L   +       F+ E   +    H
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 498 RNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLN 557
            N++++    S           ++ E+M +G+L+ +L  +             S LQ + 
Sbjct: 69  HNIIRLEGVISK-----YKPMMIITEYMENGALDKFLREK---------DGEFSVLQLVG 114

Query: 558 IAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSS 617
           +   +A+ +    +      VH DL   N+L++++++  V DFGL+R + +       ++
Sbjct: 115 MLRGIAAGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED-DPEATYTT 170

Query: 618 VGLKGTVGYAAPEYGMGSQ 636
            G K  + + APE     +
Sbjct: 171 SGGKIPIRWTAPEAISYRK 189

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 2e-34
 Identities = 46/199 (23%), Positives = 82/199 (41%), Gaps = 16/199 (8%)

Query: 447 NLIGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNL 500
             +G GSFG VY+G+      D  +T VA+K +           F+ E   ++     ++
Sbjct: 26  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85

Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           V+++               ++ E M  G L+S+L     +   N   +  S  + + +A 
Sbjct: 86  VRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +A  + YL+ +   + VH DL   N ++  D    +GDFG+TR I E     +      
Sbjct: 141 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG-- 195

Query: 621 KGTVGYAAPEYGMGSQVST 639
              V + +PE       +T
Sbjct: 196 LLPVRWMSPESLKDGVFTT 214

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 4e-34
 Identities = 43/196 (21%), Positives = 72/196 (36%), Gaps = 23/196 (11%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKI 503
            ++G GSF +V            A+K+L    + +   +     E + +  + H   VK+
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
                   FQ ++       +  +G L  ++    +                      + 
Sbjct: 74  YFT-----FQDDEKLYFGLSYAKNGELLKYIRKIGS----------FDETCTRFYTAEIV 118

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
           SALEYLH      I+H DLKP N+LL+ DM   + DFG  + +       + +S    GT
Sbjct: 119 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF--VGT 173

Query: 624 VGYAAPEYGMGSQVST 639
             Y +PE         
Sbjct: 174 AQYVSPELLTEKSACK 189

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 6e-34
 Identities = 46/208 (22%), Positives = 80/208 (38%), Gaps = 25/208 (12%)

Query: 447 NLIGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQR-GALKSFMAECEALRNI-RHRN 499
             +G G+FG V +              VAVK+L         ++ M+E + L  +  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH--------PESASDDLNYSPSILS 551
           +V ++ AC+           ++ E+  +G L ++L          +++   +      L 
Sbjct: 89  IVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 552 FLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVIS 611
               L+ +  VA  + +L        +H DL   N+LL +  I  + DFGL R I     
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKN--D 198

Query: 612 SNQCSSVGLKGTVGYAAPEYGMGSQVST 639
           SN       +  V + APE       + 
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTF 226

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  130 bits (328), Expect = 6e-34
 Identities = 47/194 (24%), Positives = 77/194 (39%), Gaps = 24/194 (12%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITAC 507
            +GTG+FG V++          A K +        ++   E + +  +RH  LV +  A 
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA- 91

Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F+ ++   ++YEFM  G L   +  E          + +S  + +     V   L 
Sbjct: 92  ----FEDDNEMVMIYEFMSGGELFEKVADE---------HNKMSEDEAVEYMRQVCKGLC 138

Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHV--GDFGLTRFIPEVISSNQCSSVGLKGTVG 625
           ++H +     VH DLKP N++        +   DFGLT  +       + S     GT  
Sbjct: 139 HMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-----DPKQSVKVTTGTAE 190

Query: 626 YAAPEYGMGSQVST 639
           +AAPE   G  V  
Sbjct: 191 FAAPEVAEGKPVGY 204

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  124 bits (312), Expect = 2e-32
 Identities = 41/195 (21%), Positives = 76/195 (38%), Gaps = 18/195 (9%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKII 504
           ++G G    V+          VAVKVL             F  E +    + H  +V + 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
               +    G     +V E++   +L   +H          +   ++  + + +  +   
Sbjct: 74  DTGEAETPAGPLP-YIVMEYVDGVTLRDIVH----------TEGPMTPKRAIEVIADACQ 122

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
           AL + H +    I+H D+KP+N+++       V DFG+ R I +  +S   ++  + GT 
Sbjct: 123 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA-AVIGTA 178

Query: 625 GYAAPEYGMGSQVST 639
            Y +PE   G  V  
Sbjct: 179 QYLSPEQARGDSVDA 193

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  123 bits (309), Expect = 2e-31
 Identities = 41/195 (21%), Positives = 71/195 (36%), Gaps = 24/195 (12%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITAC 507
            +G+G+FG V++ +      V   K +         +   E   +  + H  L+ +  A 
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA- 94

Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F+      L+ EF+  G L   +  E            +S  + +N        L+
Sbjct: 95  ----FEDKYEMVLILEFLSGGELFDRIAAEDYK---------MSEAEVINYMRQACEGLK 141

Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHV--GDFGLTRFIPEVISSNQCSSVGLKGTVG 625
           ++H H    IVH D+KP N++ +    + V   DFGL   +     +          T  
Sbjct: 142 HMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL-----NPDEIVKVTTATAE 193

Query: 626 YAAPEYGMGSQVSTN 640
           +AAPE      V   
Sbjct: 194 FAAPEIVDREPVGFY 208

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 4e-31
 Identities = 47/194 (24%), Positives = 79/194 (40%), Gaps = 25/194 (12%)

Query: 448 LIGTGSFGSVYKGILDPDQ---TVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVKI 503
            IG G FG V++GI    +     VA+K           + F+ E   +R   H ++VK+
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
           I   +       +   ++ E    G L S+L     S         L     +  A  ++
Sbjct: 74  IGVIT------ENPVWIIMELCTLGELRSFLQVRKYS---------LDLASLILYAYQLS 118

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
           +AL YL        VH D+   NVL+ ++    +GDFGL+R++ +   S    +   K  
Sbjct: 119 TALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED---STYYKASKGKLP 172

Query: 624 VGYAAPEYGMGSQV 637
           + + APE     + 
Sbjct: 173 IKWMAPESINFRRF 186

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 9e-31
 Identities = 47/195 (24%), Positives = 81/195 (41%), Gaps = 18/195 (9%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKII 504
             IG G+FG V+K         VA+K + +   + G   + + E + L+ ++H N+V +I
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 505 TACSSSDFQGNDFKA---LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
             C +     N  K    LV++F  H       +             +L       I   
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-------------VLVKFTLSEIKRV 122

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
           +   L  L++  + +I+H D+K +NVL+  D +  + DFGL R      +S         
Sbjct: 123 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

Query: 622 GTVGYAAPEYGMGSQ 636
            T+ Y  PE  +G +
Sbjct: 183 VTLWYRPPELLLGER 197

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 2e-30
 Identities = 45/194 (23%), Positives = 73/194 (37%), Gaps = 17/194 (8%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVL-FLHQRGALKSFMAECEALRNIRHRNLVKIIT 505
           + IG G++G V     + ++  VA+K +     +   +  + E + L   RH N++ I  
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
              +   +      LV   M    L   L  +            LS          +   
Sbjct: 74  IIRAPTIEQMKDVYLVTHLMG-ADLYKLLKTQH-----------LSNDHICYFLYQILRG 121

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG 625
           L+Y+H      ++H DLKPSN+LL+      + DFGL R        +         T  
Sbjct: 122 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP-DHDHTGFLTEYVATRW 177

Query: 626 YAAPEYGMGSQVST 639
           Y APE  + S+  T
Sbjct: 178 YRAPEIMLNSKGYT 191

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 2e-30
 Identities = 41/205 (20%), Positives = 74/205 (36%), Gaps = 20/205 (9%)

Query: 447 NLIGTGSFGSVYKGIL-----DPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNL 500
             +G G+FG V +              VAVK+L         ++ M+E + L +I H   
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLH------PESASDDLNYSPSILSFLQ 554
           V  +    +          ++ EF   G+L ++L               +     L+   
Sbjct: 79  VVNLLGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135

Query: 555 RLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQ 614
            +  +  VA  +E+L      + +H DL   N+LL    +  + DFGL R I +     +
Sbjct: 136 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192

Query: 615 CSSVGLKGTVGYAAPEYGMGSQVST 639
                 +  + + APE       + 
Sbjct: 193 KGDA--RLPLKWMAPETIFDRVYTI 215

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  117 bits (293), Expect = 2e-29
 Identities = 43/196 (21%), Positives = 74/196 (37%), Gaps = 28/196 (14%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKI 503
             +GTGSFG V+      +    A+KVL    + +   ++    E   L  + H  ++++
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
                    Q      ++ +++  G L S L       +                    A
Sbjct: 70  WGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV-------------AKFYAA 111

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
                L +   K I++ DLKP N+LLD +    + DFG  +++P+V  +       L GT
Sbjct: 112 EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-------LCGT 164

Query: 624 VGYAAPEYGMGSQVST 639
             Y APE       + 
Sbjct: 165 PDYIAPEVVSTKPYNK 180

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  114 bits (287), Expect = 4e-29
 Identities = 49/204 (24%), Positives = 80/204 (39%), Gaps = 33/204 (16%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---------RGALKSFMAECEALRNIR- 496
            ++G G    V + I  P     AVK++ +           +   ++ + E + LR +  
Sbjct: 9   EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68

Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
           H N++++        ++ N F  LV++ M  G L  +L               LS  +  
Sbjct: 69  HPNIIQLK-----DTYETNTFFFLVFDLMKKGELFDYLT----------EKVTLSEKETR 113

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
            I   +   +  LH      IVH DLKP N+LLD+DM   + DFG +  +       +  
Sbjct: 114 KIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV- 169

Query: 617 SVGLKGTVGYAAPEYGMGSQVSTN 640
                GT  Y APE    S    +
Sbjct: 170 ----CGTPSYLAPEIIECSMNDNH 189

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 6e-29
 Identities = 47/199 (23%), Positives = 82/199 (41%), Gaps = 21/199 (10%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVK 502
           ++   +IG GSFG VY+  L     +VA+K +   +R        E + +R + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVR 77

Query: 503 IITAC-SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
           +     SS + +   +  LV +++         H        + +   L  +        
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-------YSRAKQTLPVIYVKLYMYQ 130

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDND-MIAHVGDFGLTRFIPEVISSNQCSSVGL 620
           +  +L Y+H      I H D+KP N+LLD D  +  + DFG  + +         S +  
Sbjct: 131 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYI-- 183

Query: 621 KGTVGYAAPEYGMGSQVST 639
             +  Y APE   G+   T
Sbjct: 184 -CSRYYRAPELIFGATDYT 201

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 7e-29
 Identities = 49/208 (23%), Positives = 84/208 (40%), Gaps = 25/208 (12%)

Query: 447 NLIGTGSFGSVYKGIL-------DPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNI-RH 497
             +G G+FG V                T VAVK+L        L   ++E E ++ I +H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 498 RNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHP------ESASDDLNYSPSILS 551
           +N++ ++ AC+      +    ++ E+   G+L  +L        E + +  +     LS
Sbjct: 79  KNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 552 FLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVIS 611
               ++ A  VA  +EYL      + +H DL   NVL+  D +  + DFGL R I     
Sbjct: 134 SKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHH--I 188

Query: 612 SNQCSSVGLKGTVGYAAPEYGMGSQVST 639
                +   +  V + APE       + 
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTH 216

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  115 bits (289), Expect = 1e-28
 Identities = 43/200 (21%), Positives = 65/200 (32%), Gaps = 30/200 (15%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFL------HQRGALKSFMAECEALRNIR 496
           FS   +IG G FG VY         + A+K L               +       +    
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
              +V +  A     F   D  + + + M+ G L   L       +              
Sbjct: 66  CPFIVCMSYA-----FHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----------DMR 110

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCS 616
             A  +   LE++H+     +V+ DLKP+N+LLD      + D GL     +        
Sbjct: 111 FYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV- 166

Query: 617 SVGLKGTVGYAAPEYGMGSQ 636
                GT GY APE      
Sbjct: 167 -----GTHGYMAPEVLQKGV 181

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  112 bits (280), Expect = 5e-28
 Identities = 41/197 (20%), Positives = 72/197 (36%), Gaps = 25/197 (12%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITAC 507
            IG+GSFG +Y G        VA+K+     +        E +  + ++    +  I  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
                   D+  +V E +     + +                 S    L +A  + S +E
Sbjct: 72  ----GAEGDYNVMVMELLGPSLEDLFNFCS----------RKFSLKTVLLLADQMISRIE 117

Query: 568 YLHHHCKKQIVHCDLKPSNVL---LDNDMIAHVGDFGLTRFIPEVISSNQ---CSSVGLK 621
           Y+H       +H D+KP N L        + ++ DFGL +   +  +        +  L 
Sbjct: 118 YIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174

Query: 622 GTVGYAAPEYGMGSQVS 638
           GT  YA+    +G + S
Sbjct: 175 GTARYASINTHLGIEQS 191

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 8e-28
 Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 27/198 (13%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR-----GALKSFMAECEALRNIRHRNLV 501
           + +G G F +VYK        +VA+K + L  R     G  ++ + E + L+ + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
            ++ A            +LV++FM                       +L+        + 
Sbjct: 64  GLLDAF-----GHKSNISLVFDFMETDLEVIIKDNSL----------VLTPSHIKAYMLM 108

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLK 621
               LEYLH H    I+H DLKP+N+LLD + +  + DFGL +       +         
Sbjct: 109 TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ----V 161

Query: 622 GTVGYAAPEYGMGSQVST 639
            T  Y APE   G+++  
Sbjct: 162 VTRWYRAPELLFGARMYG 179

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 1e-27
 Identities = 47/199 (23%), Positives = 79/199 (39%), Gaps = 23/199 (11%)

Query: 447 NLIGTGSFGSVYKGI-LDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNI---RHRNL 500
             IG G++G V+K   L      VA+K + +   + G   S + E   LR++    H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           V++   C+ S         LV+E +                        +      ++  
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---------VPEPGVPTETIKDMMF 123

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L++LH H    +VH DLKP N+L+ +     + DFGL R     ++         
Sbjct: 124 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV----- 175

Query: 621 KGTVGYAAPEYGMGSQVST 639
             T+ Y APE  + S  +T
Sbjct: 176 VVTLWYRAPEVLLQSSYAT 194

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 2e-27
 Identities = 41/196 (20%), Positives = 70/196 (35%), Gaps = 26/196 (13%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEAL-RNIRHRNLVKIITA 506
           ++G G  G V +      Q   A+K+L    +        E E   R  +  ++V+I+  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73

Query: 507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASAL 566
             +  + G     +V E +  G L S +         +      +  +   I  ++  A+
Sbjct: 74  YENL-YAGRKCLLIVMECLDGGELFSRIQ--------DRGDQAFTEREASEIMKSIGEAI 124

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLD---NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
           +YLH      I H D+KP N+L      + I  + DFG  +           S      T
Sbjct: 125 QYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS-----HNSLTTPCYT 176

Query: 624 VGYAAPEYGMGSQVST 639
             Y APE     +   
Sbjct: 177 PYYVAPEVLGPEKYDK 192

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 2e-27
 Identities = 43/197 (21%), Positives = 69/197 (35%), Gaps = 26/197 (13%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEAL-RNIRHRNLVK 502
            ++G GSFG V+           A+K L    +     ++  M E   L     H  L  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 503 IITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINV 562
           +         Q  +    V E+++ G L   +                   +    A  +
Sbjct: 68  MFCTF-----QTKENLFFVMEYLNGGDLMYHIQSCHK----------FDLSRATFYAAEI 112

Query: 563 ASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKG 622
              L++LH      IV+ DLK  N+LLD D    + DFG+ +      +          G
Sbjct: 113 ILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT----FCG 165

Query: 623 TVGYAAPEYGMGSQVST 639
           T  Y APE  +G + + 
Sbjct: 166 TPDYIAPEILLGQKYNH 182

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  110 bits (275), Expect = 2e-27
 Identities = 36/199 (18%), Positives = 67/199 (33%), Gaps = 27/199 (13%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITAC 507
            IG GSFG +++G    +   VA+K     +R        E    + +     +  +   
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
                Q      LV + +               D L+      S       A  + + ++
Sbjct: 70  ----GQEGLHNVLVIDLLGPSLE----------DLLDLCGRKFSVKTVAMAAKQMLARVQ 115

Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG-----DFGLTRFIPEVISSNQ---CSSVG 619
            +H      +V+ D+KP N L+      +       DFG+ +F  + ++           
Sbjct: 116 SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 172

Query: 620 LKGTVGYAAPEYGMGSQVS 638
           L GT  Y +    +G + S
Sbjct: 173 LSGTARYMSINTHLGREQS 191

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 3e-27
 Identities = 39/194 (20%), Positives = 74/194 (38%), Gaps = 25/194 (12%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITAC 507
            +G G FG V++ +    +     K + +           E   L   RHRN++ +  + 
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHES- 69

Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALE 567
               F+  +   +++EF+    +   ++          S   L+  + ++    V  AL+
Sbjct: 70  ----FESMEELVMIFEFISGLDIFERIN---------TSAFELNEREIVSYVHQVCEALQ 116

Query: 568 YLHHHCKKQIVHCDLKPSNVLLDNDMIAHV--GDFGLTRFIPEVISSNQCSSVGLKGTVG 625
           +LH H    I H D++P N++      + +   +FG  R +         +   L     
Sbjct: 117 FLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-----KPGDNFRLLFTAPE 168

Query: 626 YAAPEYGMGSQVST 639
           Y APE      VST
Sbjct: 169 YYAPEVHQHDVVST 182

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  109 bits (274), Expect = 4e-27
 Identities = 41/194 (21%), Positives = 66/194 (34%), Gaps = 21/194 (10%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIIT 505
           +++GTG+F  V        Q +VA+K +      G   S   E   L  I+H N+V +  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
                 ++      L+ + +  G L   +                +      +   V  A
Sbjct: 75  I-----YESGGHLYLIMQLVSGGELFDRIV----------EKGFYTERDASRLIFQVLDA 119

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG 625
           ++YLH                  LD D    + DFGL++       S   ++    GT G
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTAC---GTPG 174

Query: 626 YAAPEYGMGSQVST 639
           Y APE       S 
Sbjct: 175 YVAPEVLAQKPYSK 188

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  105 bits (263), Expect = 3e-25
 Identities = 50/235 (21%), Positives = 80/235 (34%), Gaps = 37/235 (15%)

Query: 417 TSSESSSRKDLLLNVSYESLLKATGGFSSA---------NLIGTGSFGSVYKGILDPDQT 467
             SE  S K+ L     + L K      +            +GTGSFG V          
Sbjct: 8   KGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGN 67

Query: 468 VVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVYEF 524
             A+K+L    + +   ++  + E   L+ +    LVK+  +   +          V E+
Sbjct: 68  HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM-----VMEY 122

Query: 525 MHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKP 584
           +  G + S L                S       A  +    EYLH      +++ DLKP
Sbjct: 123 VAGGEMFSHLR----------RIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKP 169

Query: 585 SNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST 639
            N+L+D      V DFG  + +     +       L GT    APE  +    + 
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRTWT-------LCGTPEALAPEIILSKGYNK 217

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 4e-25
 Identities = 38/201 (18%), Positives = 69/201 (34%), Gaps = 32/201 (15%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLH------QRGALKSFMAECEALRNIR--HRN 499
           L+G+G FGSVY GI   D   VA+K +         +         E   L+ +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
           +++++           D   L+ E             E  +         L      +  
Sbjct: 71  VIRLLDWFER-----PDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFF 116

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLD-NDMIAHVGDFGLTRFIPEVISSNQCSSV 618
             V  A+ +        ++H D+K  N+L+D N     + DFG    + + + ++     
Sbjct: 117 WQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD--- 170

Query: 619 GLKGTVGYAAPEYGMGSQVST 639
              GT  Y+ PE+    +   
Sbjct: 171 ---GTRVYSPPEWIRYHRYHG 188

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 4e-25
 Identities = 44/196 (22%), Positives = 73/196 (37%), Gaps = 25/196 (12%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVL---FLHQRGALKSFMAECEALRNIRHRNLVKI 503
            L+G G+FG V            A+K+L    +  +  +   + E   L+N RH  L  +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 504 ITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVA 563
             A      Q +D    V E+ + G L   L              + +  +       + 
Sbjct: 71  KYAF-----QTHDRLCFVMEYANGGELFFHLS----------RERVFTEERARFYGAEIV 115

Query: 564 SALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGT 623
           SAL    +   + +V+ D+K  N++LD D    + DFGL +       S+  +     GT
Sbjct: 116 SAL---EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI----SDGATMKTFCGT 168

Query: 624 VGYAAPEYGMGSQVST 639
             Y APE    +    
Sbjct: 169 PEYLAPEVLEDNDYGR 184

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  103 bits (257), Expect = 4e-25
 Identities = 42/192 (21%), Positives = 76/192 (39%), Gaps = 25/192 (13%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKII 504
             IG G++G VYK   +      A+K + L +   G   + + E   L+ ++H N+VK+ 
Sbjct: 8   EKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
               +          LV+E +     +     E               L+ +     +  
Sbjct: 67  DVIHT-----KKRLVLVFEHLDQDLKKLLDVCEG-------------GLESVTAKSFLLQ 108

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            L  + +   ++++H DLKP N+L++ +    + DFGL R                  T+
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARA----FGIPVRKYTHEIVTL 164

Query: 625 GYAAPEYGMGSQ 636
            Y AP+  MGS+
Sbjct: 165 WYRAPDVLMGSK 176

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 5e-25
 Identities = 46/196 (23%), Positives = 78/196 (39%), Gaps = 23/196 (11%)

Query: 443 FSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNL 500
           F     IG G++G VYK        VVA+K + L     G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 501 VKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAI 560
           VK++           +   LV+EF+H    +              + + +      +   
Sbjct: 64  VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDA---------SALTGIPLPLIKSYLF 109

Query: 561 NVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGL 620
            +   L + H H    ++H DLKP N+L++ +    + DFGL R           +    
Sbjct: 110 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA----FGVPVRTYTHE 162

Query: 621 KGTVGYAAPEYGMGSQ 636
             T+ Y APE  +G +
Sbjct: 163 VVTLWYRAPEILLGCK 178

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 1e-24
 Identities = 41/195 (21%), Positives = 78/195 (40%), Gaps = 24/195 (12%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKII 504
             IG G++G+V+K        +VA+K + L     G   S + E   L+ ++H+N+V++ 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
               S     +    LV+EF      + +       D               +    +  
Sbjct: 68  DVLHS-----DKKLTLVFEFCDQDLKKYFDSCNGDLDPE----------IVKSFLFQLLK 112

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            L + H      ++H DLKP N+L++ +    + +FGL R     +       V    T+
Sbjct: 113 GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV----TL 165

Query: 625 GYAAPEYGMGSQVST 639
            Y  P+   G+++ +
Sbjct: 166 WYRPPDVLFGAKLYS 180

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 1e-24
 Identities = 40/192 (20%), Positives = 71/192 (36%), Gaps = 25/192 (13%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIIT 505
            +G+G++G+V   +       VA+K L+         K    E   L+++RH N++ ++ 
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 506 ACSSSDFQGNDFK-ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             +  +   +     LV  FM     +   H +            L   +   +   +  
Sbjct: 85  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK------------LGEDRIQFLVYQMLK 132

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            L Y+H        H DLKP N+ ++ D    + DFGL R     ++           T 
Sbjct: 133 GLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY-------VVTR 182

Query: 625 GYAAPEYGMGSQ 636
            Y APE  +   
Sbjct: 183 WYRAPEVILNWM 194

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 2e-24
 Identities = 36/203 (17%), Positives = 66/203 (32%), Gaps = 33/203 (16%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLH------QRGALKSFMAECEALRNIRHRNLV 501
            +G+G F  V K          A K +         +  + +    E   L+ I+H N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 502 KIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAIN 561
            +        ++      L+ E +  G L  +                L+  +       
Sbjct: 77  TLHEV-----YENKTDVILILELVAGGELFDF----------LAEKESLTEEEATEFLKQ 121

Query: 562 VASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA----HVGDFGLTRFIPEVISSNQCSS 617
           + +    +++    QI H DLKP N++L +  +      + DFGL   I           
Sbjct: 122 ILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI-- 176

Query: 618 VGLKGTVGYAAPEYGMGSQVSTN 640
               GT  + APE      +   
Sbjct: 177 ---FGTPEFVAPEIVNYEPLGLE 196

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  101 bits (253), Expect = 3e-24
 Identities = 39/192 (20%), Positives = 71/192 (36%), Gaps = 29/192 (15%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR-HRNLVKIIT 505
             +G G +  V++ I   +   V VK+L   +    K    E + L N+R   N++ +  
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLAD 97

Query: 506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASA 565
                    +   ALV+E +++   +                  L+          +  A
Sbjct: 98  IVKDPV---SRTPALVFEHVNNTDFKQLYQT-------------LTDYDIRFYMYEILKA 141

Query: 566 LEYLHHHCKKQIVHCDLKPSNVLLDND-MIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
           L+Y H      I+H D+KP NV++D++     + D+GL  F       N         + 
Sbjct: 142 LDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-----VASR 193

Query: 625 GYAAPEYGMGSQ 636
            +  PE  +  Q
Sbjct: 194 YFKGPELLVDYQ 205

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.6 bits (247), Expect = 2e-23
 Identities = 39/195 (20%), Positives = 67/195 (34%), Gaps = 24/195 (12%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLF--LHQRGALKSFMAECEALRNIRHRNLVKIIT 505
            IG+G+ G V           VA+K L      +   K    E   ++ + H+N++ ++ 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 506 ACSSSD-FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
             +     +      LV E M     +                      +   +   +  
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE-------------RMSYLLYQMLC 130

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            +++LH      I+H DLKPSN+++ +D    + DFGL R                  T 
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-----VVTR 182

Query: 625 GYAAPEYGMGSQVST 639
            Y APE  +G     
Sbjct: 183 YYRAPEVILGMGYKE 197

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.4 bits (244), Expect = 5e-23
 Identities = 38/192 (19%), Positives = 71/192 (36%), Gaps = 23/192 (11%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLF--LHQRGALKSFMAECEALRNIRHRNLVKII 504
           + +G+G++GSV           VAVK L          K    E   L++++H N++ ++
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 505 TACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVAS 564
              + +          +   +    L + +  +            L+      +   +  
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-----------LTDDHVQFLIYQILR 132

Query: 565 ALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTV 624
            L+Y+H        H DLKPSN+ ++ D    + DFGL R   + ++           T 
Sbjct: 133 GLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-------TR 182

Query: 625 GYAAPEYGMGSQ 636
            Y APE  +   
Sbjct: 183 WYRAPEIMLNWM 194

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.1 bits (238), Expect = 2e-22
 Identities = 41/197 (20%), Positives = 75/197 (38%), Gaps = 27/197 (13%)

Query: 447 NLIGTGSFGSVYKG---ILDPDQTVVAVKVL----FLHQRGALKSFMAECEALRNIRHRN 499
            ++GTG++G V+            + A+KVL     + +    +    E + L +IR   
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 500 LVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIA 559
            +  +       FQ      L+ ++++ G L + L                       + 
Sbjct: 90  FLVTLHYA----FQTETKLHLILDYINGGELFTHLSQRER-------------FTEHEVQ 132

Query: 560 INVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVG 619
           I V   +  L H  K  I++ D+K  N+LLD++    + DFGL++      +        
Sbjct: 133 IYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF-- 190

Query: 620 LKGTVGYAAPEYGMGSQ 636
             GT+ Y AP+   G  
Sbjct: 191 -CGTIEYMAPDIVRGGD 206

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 95.9 bits (237), Expect = 5e-22
 Identities = 34/194 (17%), Positives = 73/194 (37%), Gaps = 7/194 (3%)

Query: 448 LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITAC 507
            +G G F +V+      + T VA+K++   +    ++   E + L+ +   +  K  +  
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASD-DLNYSPSILSFLQRLNIAINVASAL 566
           ++   +  D          H  +   +  E+       Y    +  +    I+  +   L
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 567 EYLHHHCKKQIVHCDLKPSNVLLD-NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVG 625
           +Y+H  C   I+H D+KP NVL++  D   ++    +             ++     T  
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS--IQTRE 194

Query: 626 YAAPEYGMGSQVST 639
           Y +PE  +G+    
Sbjct: 195 YRSPEVLLGAPWGC 208

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 95.1 bits (235), Expect = 1e-21
 Identities = 68/332 (20%), Positives = 112/332 (33%), Gaps = 16/332 (4%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
            L  L  IN   N  +   P  +  L +L  I+ N+N +    P+         TL    
Sbjct: 64  YLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQ 121

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
               +          +  +   I                  +  + L+ L          
Sbjct: 122 ITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLD 181

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGY 180
           I  +     ++         L     N +  +  L   T L+ +SLN N L+ I  ++  
Sbjct: 182 ISSNKVSDISVLAKLTNLESLIATN-NQISDITPLGILTNLDELSLNGNQLKDIG-TLAS 239

Query: 181 LPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIP----SALGNCHQLQSLD 236
           L  L  L L  N IS   P  L   T LTEL L  N I    P    +AL N    ++  
Sbjct: 240 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQL 297

Query: 237 LSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGL 296
              +       + +L L  N+++   P+   +L  +  L  + NK+S    SSL +   +
Sbjct: 298 EDISPISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFANNKVSD--VSSLANLTNI 353

Query: 297 EYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN 328
            +L+   N         L++L  +  L L   
Sbjct: 354 NWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 84.7 bits (208), Expect = 4e-18
 Identities = 70/336 (20%), Positives = 123/336 (36%), Gaps = 21/336 (6%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
            +T L    L   +  G     +  L  L  I F++N L    P  L + ++L  + +  
Sbjct: 45  QVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNN 97

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
           N++ +   +  L    G TL N +I  +   +   N+     +++ +  +   +   +  
Sbjct: 98  NQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQ 157

Query: 121 IPEDLGRLRNLTRL-NFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVG 179
                 ++ +L  L N    +      N +  +  L   T LE +    N +  I   +G
Sbjct: 158 QLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDI-TPLG 216

Query: 180 YLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSK 239
            L  L  LSL  N +      +L + T LT+L+L  N I    P  L    +L  L L  
Sbjct: 217 ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGA 272

Query: 240 TIFLGQYPVRWLDL----SHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVG 295
                  P+  L        N         + NLK++ +L L  N +S   P  + S   
Sbjct: 273 NQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTK 330

Query: 296 LEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQ 331
           L+ L  + N         L++L ++  L    N   
Sbjct: 331 LQRLFFANNKVSDV--SSLANLTNINWLSAGHNQIS 364

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.7 bits (99), Expect = 1e-04
 Identities = 42/246 (17%), Positives = 86/246 (34%), Gaps = 22/246 (8%)

Query: 100 SISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDL-GTRKVNDLRFLDSLVNC 158
           S ++  ++  L      +  SI + +  L NLT++NF+ N L     + +L  L  ++  
Sbjct: 39  SQTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMN 96

Query: 159 TYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGN-------------F 205
                    + +L ++     +  ++  +   +N  +        N              
Sbjct: 97  NNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSL 156

Query: 206 TFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLA 265
             L+  N   +    +  + L       +     ++      +  L  ++N ++   P  
Sbjct: 157 QQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP-- 214

Query: 266 VGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDL 325
           +G L ++  L L+ N+L      +L S   L  L+L+ N         LS L  L  L L
Sbjct: 215 LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 270

Query: 326 FQNTFQ 331
             N   
Sbjct: 271 GANQIS 276

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.3 bits (98), Expect = 1e-04
 Identities = 18/75 (24%), Positives = 29/75 (38%), Gaps = 6/75 (8%)

Query: 138 RNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGE 197
           +  LG   V D      L   T L+   L + S+  +     YL  L  ++   N ++  
Sbjct: 26  KTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGV----EYLNNLTQINFSNNQLTDI 81

Query: 198 IPSSLGNFTFLTELN 212
            P  L N T L ++ 
Sbjct: 82  TP--LKNLTKLVDIL 94

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 8e-04
 Identities = 14/83 (16%), Positives = 26/83 (31%), Gaps = 4/83 (4%)

Query: 175 PISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQS 234
            +S   L ++  L      I       +     LT++N   N +    P  L N  +L  
Sbjct: 37  TVSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVD 92

Query: 235 LDLSKTIFLGQYPVRWLDLSHNH 257
           + ++        P+  L      
Sbjct: 93  ILMNNNQIADITPLANLTNLTGL 115

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 85.9 bits (211), Expect = 6e-19
 Identities = 58/299 (19%), Positives = 100/299 (33%), Gaps = 32/299 (10%)

Query: 42  QIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSI 101
           ++P +L    +   LDL  NK+ E      +       L N+   +L  N+     P + 
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITE------IKDGDFKNLKNLHTLILINNKISKISPGAF 75

Query: 102 SNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYL 161
           +   KLE L  + N L     +    L+ L         +           + L     +
Sbjct: 76  APLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKS------VFNGLNQMIVV 129

Query: 162 EIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGS 221
           E+ +  + S      +   + KL  + + + NI+  IP  L     LTEL+L GN I   
Sbjct: 130 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKV 186

Query: 222 IPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSH-------NHLTGPIPLAVGNLKSIPH 274
             ++L   + L  L LS             +  H       N+    +P  + + K I  
Sbjct: 187 DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQV 246

Query: 275 LDLSKNKLSG------EIPSSLGSCVGLEYLNLSINSF-HGPIHPG-LSSLKSLEGLDL 325
           + L  N +S         P           ++L  N   +  I P     +     + L
Sbjct: 247 VYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 68.1 bits (165), Expect = 5e-13
 Identities = 40/179 (22%), Positives = 62/179 (34%), Gaps = 12/179 (6%)

Query: 160 YLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIR 219
           +L +V  +   L  +P  +   P   +L L  N I+        N   L  L L  N I 
Sbjct: 11  HLRVVQCSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68

Query: 220 GSIPSALGNCHQLQSLDLSKTIFLG-----QYPVRWLDLSHNHLTGPIPLAVGNLKSIPH 274
              P A     +L+ L LSK             ++ L +  N +T         L  +  
Sbjct: 69  KISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIV 128

Query: 275 LDL--SKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQ 331
           ++L  +  K SG    +      L Y+ ++  +    I  GL    SL  L L  N   
Sbjct: 129 VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT 184

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 67.4 bits (163), Expect = 8e-13
 Identities = 53/263 (20%), Positives = 92/263 (34%), Gaps = 36/263 (13%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           NL  L  + L  N  S   P     L +L  +  + N L+           ELR  +  +
Sbjct: 53  NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEI 112

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
            K+ ++     L   I   L           +  G    +     KL ++  A+ ++T +
Sbjct: 113 TKVRKSVF-NGLNQMIVVELGTNP------LKSSGIENGAFQGMKKLSYIRIADTNIT-T 164

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSL------------------VNCTYLE 162
           IP+ L    +LT L+   N +       L+ L++L                   N  +L 
Sbjct: 165 IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLR 222

Query: 163 IVSLNVNSLRSIPISVGYLPKLQVLSLFENNISG------EIPSSLGNFTFLTELNLRGN 216
            + LN N L  +P  +     +QV+ L  NNIS         P         + ++L  N
Sbjct: 223 ELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 282

Query: 217 SIRGS--IPSALGNCHQLQSLDL 237
            ++     PS     +   ++ L
Sbjct: 283 PVQYWEIQPSTFRCVYVRAAVQL 305

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 82.5 bits (203), Expect = 1e-18
 Identities = 25/170 (14%), Positives = 44/170 (25%), Gaps = 33/170 (19%)

Query: 447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFL----------HQRGALKSFMAECEALRNIR 496
            L+G G   +V+            VK   +           +      F           
Sbjct: 6   KLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 497 HRNLVKIITACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRL 556
            R L K+        +      A++ E +    L                          
Sbjct: 65  FRALQKLQGLAVPKVYAWEGN-AVLMELIDAKELYRVRVE-----------------NPD 106

Query: 557 NIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFI 606
            +   +   +   +H     IVH DL   NVL+  + I  + DF  +  +
Sbjct: 107 EVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEGI-WIIDFPQSVEV 152

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 69.4 bits (168), Expect = 2e-13
 Identities = 56/308 (18%), Positives = 94/308 (30%), Gaps = 72/308 (23%)

Query: 99  HSISNASKLEWLDFANNSLT--ASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLV 156
            + +   ++  LD +  +L     IP  L  L  L  L     +     +       ++ 
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP-----AIA 98

Query: 157 NCTYLEIVSLNVNSLRSIPIS-VGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRG 215
             T L  + +   ++       +  +  L  L    N +SG +P S+ +   L  +   G
Sbjct: 99  KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158

Query: 216 NSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVR-------------------------- 249
           N I G+IP + G+  +L +        L                                
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFG 218

Query: 250 -----WLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSIN 304
                       +        VG  K++  LDL  N++ G +P  L     L  LN+S N
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278

Query: 305 SFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGIS 364
           +  G I P   +L+  +                                A N+ LCG   
Sbjct: 279 NLCGEI-PQGGNLQRFDVSAY----------------------------ANNKCLCGSP- 308

Query: 365 ELKLPPCT 372
              LP CT
Sbjct: 309 ---LPACT 313

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 66.3 bits (160), Expect = 2e-12
 Identities = 53/261 (20%), Positives = 85/261 (32%), Gaps = 28/261 (10%)

Query: 8   INLQQNNFSGN--IPHEIGRLFQLRYIIFNSNT-LQGQIPVNLTHCSELRTLDLVLNKLE 64
           ++L   N      IP  +  L  L ++       L G IP  +   ++L  L +    + 
Sbjct: 55  LDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS 114

Query: 65  ENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPED 124
                    P     +  +     + N   G +P SIS+   L  + F  N ++ +IP+ 
Sbjct: 115 GAI------PDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS 168

Query: 125 LGRLRNLTRLNFARN------------------DLGTRKVNDLRFLDSLVNCTYLEIVSL 166
            G    L                             +R + +        +    + + L
Sbjct: 169 YGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHL 228

Query: 167 NVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSAL 226
             NSL      VG    L  L L  N I G +P  L    FL  LN+  N++ G IP   
Sbjct: 229 AKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-G 287

Query: 227 GNCHQLQSLDLSKTIFLGQYP 247
           GN  +      +    L   P
Sbjct: 288 GNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 61.7 bits (148), Expect = 6e-11
 Identities = 55/253 (21%), Positives = 90/253 (35%), Gaps = 40/253 (15%)

Query: 88  LAGNQFFGN--IPHSISNASKLEWLDFANN-SLTASIPEDLGRLRNLTRLNFARNDLGTR 144
           L+G        IP S++N   L +L      +L   IP  + +L  L  L     ++   
Sbjct: 57  LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116

Query: 145 KVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGN 204
             + L  + +LV   +            ++P S+  LP L  ++   N ISG IP S G+
Sbjct: 117 IPDFLSQIKTLVTLDFS-----YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171

Query: 205 FTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWL------------- 251
           F+ L        +              L  +DLS+ +  G   V +              
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231

Query: 252 ------------------DLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSC 293
                             DL +N + G +P  +  LK +  L++S N L GEIP   G+ 
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNL 290

Query: 294 VGLEYLNLSINSF 306
              +    + N  
Sbjct: 291 QRFDVSAYANNKC 303

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 45.9 bits (107), Expect = 8e-06
 Identities = 14/61 (22%), Positives = 24/61 (39%), Gaps = 1/61 (1%)

Query: 3   TFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNK 62
             L  ++L+ N   G +P  + +L  L  +  + N L G+IP    +           NK
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302

Query: 63  L 63
            
Sbjct: 303 C 303

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 38.6 bits (88), Expect = 0.002
 Identities = 15/51 (29%), Positives = 22/51 (43%), Gaps = 3/51 (5%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCS 51
            L FL  +N+  NN  G IP + G L +     + +N      P  L  C+
Sbjct: 266 QLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP--LPACT 313

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 37.4 bits (85), Expect = 0.004
 Identities = 37/199 (18%), Positives = 61/199 (30%), Gaps = 37/199 (18%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
           +L  L+ I    N  SG IP   G   +L   +  S          LT        +L L
Sbjct: 147 SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN-------RLTGKIPPTFANLNL 199

Query: 61  NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS 120
             ++ ++ + E    + F        +             +  +  L  LD  NN +  +
Sbjct: 200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGT 259

Query: 121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGY 180
           +P+ L +L+ L  LN + N+L                                IP   G 
Sbjct: 260 LPQGLTQLKFLHSLNVSFNNL-----------------------------CGEIP-QGGN 289

Query: 181 LPKLQVLSLFENNISGEIP 199
           L +  V +   N      P
Sbjct: 290 LQRFDVSAYANNKCLCGSP 308

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.4 bits (150), Expect = 2e-11
 Identities = 36/204 (17%), Positives = 60/204 (29%), Gaps = 32/204 (15%)

Query: 157 NCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGN 216
                  V+ +  +L ++P  +       +L L EN +     ++L  +T LT+LNL   
Sbjct: 8   KVASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65

Query: 217 SIRGSIPSAL-----------------------------GNCHQLQSLDLSKTIFLGQYP 247
            +                                      +    +   L      G   
Sbjct: 66  ELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGE 125

Query: 248 VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFH 307
           ++ L L  N L    P  +     +  L L+ N L+      L     L+ L L  NS +
Sbjct: 126 LQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY 185

Query: 308 GPIHPGLSSLKSLEGLDLFQNTFQ 331
             I  G      L    L  N + 
Sbjct: 186 -TIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.9 bits (120), Expect = 1e-07
 Identities = 30/186 (16%), Positives = 58/186 (31%), Gaps = 3/186 (1%)

Query: 97  IPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLV 156
           +P  +        L  + N L       L     LT+LN  R +L   +V+    +   +
Sbjct: 25  LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTL 82

Query: 157 NCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGN 216
           + ++ ++ SL +       ++V  +   ++ SL    + G                L   
Sbjct: 83  DLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPG 142

Query: 217 SIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLD 276
            +  +      +       +L   +  G   +  L L  N L   IP        +P   
Sbjct: 143 LLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAF 201

Query: 277 LSKNKL 282
           L  N  
Sbjct: 202 LHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.5 bits (106), Expect = 8e-06
 Identities = 35/199 (17%), Positives = 64/199 (32%), Gaps = 24/199 (12%)

Query: 71  ELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRN 130
            LPP +     +  I  L+ N  +     ++   ++L  L+     LT    +    L  
Sbjct: 24  ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG--TLPV 78

Query: 131 LTRLNFARNDLGTRKVNDLRFLD-----------------SLVNCTYLEIVSLNVNSLRS 173
           L  L+ + N L +  +                        +L     L+ + L  N L++
Sbjct: 79  LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138

Query: 174 IPISVGYLPKLQVLSLFE-NNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQL 232
           +P  +              NN++      L     L  L L+ NS+  +IP      H L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197

Query: 233 QSLDLSKTIFLGQYPVRWL 251
               L    +L    + + 
Sbjct: 198 PFAFLHGNPWLCNCEILYF 216

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.2 bits (100), Expect = 4e-05
 Identities = 36/181 (19%), Positives = 61/181 (33%), Gaps = 32/181 (17%)

Query: 177 SVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLD 236
            V  +     ++  + N++  +P  L      T L+L  N +     + L    +L  L+
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 237 LSKTIFLGQYPVRWLDL-----------------------------SHNHLTGPIPLAVG 267
           L +           L +                             S N LT     A+ 
Sbjct: 62  LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121

Query: 268 NLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQ 327
            L  +  L L  N+L    P  L     LE L+L+ N+        L+ L++L+ L L +
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181

Query: 328 N 328
           N
Sbjct: 182 N 182

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.5 bits (150), Expect = 3e-11
 Identities = 42/235 (17%), Positives = 73/235 (31%), Gaps = 22/235 (9%)

Query: 97  IPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLV 156
           +P  I   +  + +    N ++          RNLT L    N              + +
Sbjct: 26  VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSN----VLARIDAAAFTGL 79

Query: 157 NCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGN 216
                  +S N       P +   L +L  L L    +    P        L  L L+ N
Sbjct: 80  ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDN 139

Query: 217 SIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLD 276
           +++        +   L                  L L  N ++     A   L S+  L 
Sbjct: 140 ALQALPDDTFRDLGNLT----------------HLFLHGNRISSVPERAFRGLHSLDRLL 183

Query: 277 LSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQ 331
           L +N+++   P +      L  L L  N+        L+ L++L+ L L  N + 
Sbjct: 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.4 bits (147), Expect = 7e-11
 Identities = 41/176 (23%), Positives = 58/176 (32%), Gaps = 11/176 (6%)

Query: 164 VSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIP 223
            S     L+++P+ +      Q + L  N IS    +S      LT L L  N +     
Sbjct: 16  TSCPQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA 73

Query: 224 SALGNCHQLQSLDLSKTIFLGQ---------YPVRWLDLSHNHLTGPIPLAVGNLKSIPH 274
           +A      L+ LDLS    L             +  L L    L    P     L ++ +
Sbjct: 74  AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQY 133

Query: 275 LDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTF 330
           L L  N L      +      L +L L  N            L SL+ L L QN  
Sbjct: 134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.8 bits (143), Expect = 2e-10
 Identities = 52/274 (18%), Positives = 82/274 (29%), Gaps = 24/274 (8%)

Query: 19  IPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGF 78
           +P  I      + I  + N +      +   C  L      +  L  N L          
Sbjct: 26  VPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLT-----ILWLHSNVLARIDAAAFTG 78

Query: 79  TLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFAR 138
                ++ L    Q     P +     +L  L      L    P     L  L  L    
Sbjct: 79  LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQD 138

Query: 139 NDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGY-LPKLQVLSLFENNISGE 197
           N L           D+  +   L  + L+ N + S+P      L  L  L L +N ++  
Sbjct: 139 NALQAL------PDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192

Query: 198 IPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWL------ 251
            P +  +   L  L L  N++      AL     LQ L L+   ++     R L      
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQK 252

Query: 252 -DLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSG 284
              S + +   +P     L       L+ N L G
Sbjct: 253 FRGSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.4 bits (134), Expect = 2e-09
 Identities = 41/253 (16%), Positives = 66/253 (26%), Gaps = 51/253 (20%)

Query: 8   INLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQI------------------------ 43
           I L  N  S            L  +  +SN L                            
Sbjct: 37  IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 96

Query: 44  -PVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSIS 102
            P        L TL L      +   + EL P +   L  ++   L  N        +  
Sbjct: 97  DPATFHGLGRLHTLHL------DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150

Query: 103 NASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLV------ 156
           +   L  L    N +++        L +L RL   +N +     +  R L  L+      
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210

Query: 157 ------------NCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGN 204
                           L+ + LN N       +      LQ      + +   +P  L  
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAG 270

Query: 205 FTF--LTELNLRG 215
                L   +L+G
Sbjct: 271 RDLKRLAANDLQG 283

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 54.3 bits (130), Expect = 1e-09
 Identities = 23/108 (21%), Positives = 40/108 (37%), Gaps = 10/108 (9%)

Query: 185 QVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTI--- 241
           +VL L   +++  +   L     +T L+L  N +R   P+ L     L+ L  S      
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN 57

Query: 242 ---FLGQYPVRWLDLSHNHLTG-PIPLAVGNLKSIPHLDLSKNKLSGE 285
                    ++ L L +N L        + +   +  L+L  N L  E
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.3 bits (104), Expect = 4e-06
 Identities = 32/130 (24%), Positives = 51/130 (39%), Gaps = 14/130 (10%)

Query: 110 LDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVN 169
           L  A+  LT  +   L +L  +T L+ + N L            +L     LE++  + N
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALP-------PALAALRCLEVLQASDN 53

Query: 170 SLRSIPISVGYLPKLQVLSLFENNI-SGEIPSSLGNFTFLTELNLRGN---SIRGSIPSA 225
           +L ++   V  LP+LQ L L  N +        L +   L  LNL+GN      G     
Sbjct: 54  ALENVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERL 112

Query: 226 LGNCHQLQSL 235
                 + S+
Sbjct: 113 AEMLPSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.0 bits (98), Expect = 2e-05
 Identities = 26/102 (25%), Positives = 34/102 (33%), Gaps = 24/102 (23%)

Query: 249 RWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPS-------------------- 288
           R L L+H  LT    L    L  + HLDLS N+L    P+                    
Sbjct: 1   RVLHLAHKDLTVLCHL--EQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58

Query: 289 -SLGSCVGLEYLNLSINSF-HGPIHPGLSSLKSLEGLDLFQN 328
             + +   L+ L L  N          L S   L  L+L  N
Sbjct: 59  DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 100

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.5 bits (94), Expect = 7e-05
 Identities = 26/93 (27%), Positives = 43/93 (46%), Gaps = 3/93 (3%)

Query: 147 NDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFT 206
            DL  L  L     +  + L+ N LR++P ++  L  L+VL   +N +  E    + N  
Sbjct: 8   KDLTVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNAL--ENVDGVANLP 65

Query: 207 FLTELNLRGNSIRG-SIPSALGNCHQLQSLDLS 238
            L EL L  N ++  +    L +C +L  L+L 
Sbjct: 66  RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQ 98

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.7 bits (124), Expect = 9e-08
 Identities = 19/101 (18%), Positives = 35/101 (34%), Gaps = 11/101 (10%)

Query: 161 LEIVSLNVNSLRSIPIS--VGYLPKLQVLSLFENNISGE----IPSSLGNFTFLTELNLR 214
           ++ + +    L     +  +  L + QV+ L +  ++      I S+L     L ELNLR
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 215 GNSIRGSIPSALG-----NCHQLQSLDLSKTIFLGQYPVRW 250
            N +       +         ++Q L L      G      
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVL 104

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.0 bits (117), Expect = 6e-07
 Identities = 17/89 (19%), Positives = 33/89 (37%), Gaps = 11/89 (12%)

Query: 182 PKLQVLSLFENNISGE----IPSSLGNFTFLTELNLRGNSIRGSIPSALG-----NCHQL 232
             L+VL L + ++S      + ++L     L EL+L  N +  +    L          L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 233 QSLDLSKTIFLGQYP--VRWLDLSHNHLT 259
           + L L    +  +    ++ L+     L 
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLR 457

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (112), Expect = 2e-06
 Identities = 18/89 (20%), Positives = 31/89 (34%), Gaps = 9/89 (10%)

Query: 239 KTIFLGQYPVRWLDLSHNHLTG----PIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCV 294
           + +      +R L L+   ++      +   +    S+  LDLS N L       L   V
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 295 -----GLEYLNLSINSFHGPIHPGLSSLK 318
                 LE L L    +   +   L +L+
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.7 bits (111), Expect = 3e-06
 Identities = 16/113 (14%), Positives = 34/113 (30%), Gaps = 24/113 (21%)

Query: 208 LTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTG----PIP 263
           +  L+++   +  +  + L     LQ               + + L    LT      I 
Sbjct: 4   IQSLDIQCEELSDARWAEL--LPLLQQC-------------QVVRLDDCGLTEARCKDIS 48

Query: 264 LAVGNLKSIPHLDLSKNKLSGEIPSSLGS-----CVGLEYLNLSINSFHGPIH 311
            A+    ++  L+L  N+L       +          ++ L+L      G   
Sbjct: 49  SALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC 101

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.7 bits (111), Expect = 3e-06
 Identities = 16/85 (18%), Positives = 26/85 (30%), Gaps = 10/85 (11%)

Query: 251 LDLSHNHLT-GPIPLAVGNLKSIPHLDLSKNKLSGE----IPSSLGSCVGLEYLNLSINS 305
           LD+    L+       +  L+    + L    L+      I S+L     L  LNL  N 
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 306 FHGPIHPGLSSL-----KSLEGLDL 325
                   +          ++ L L
Sbjct: 67  LGDVGVHCVLQGLQTPSCKIQKLSL 91

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 5e-06
 Identities = 19/98 (19%), Positives = 29/98 (29%), Gaps = 25/98 (25%)

Query: 204 NFTFLTELNLRGNSIRG----SIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLT 259
             + L  L L    +      S+ + L   H L+                 LDLS+N L 
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE----------------LDLSNNCLG 410

Query: 260 GPIPLAVG-----NLKSIPHLDLSKNKLSGEIPSSLGS 292
               L +          +  L L     S E+   L +
Sbjct: 411 DAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQA 448

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.3 bits (97), Expect = 2e-04
 Identities = 16/116 (13%), Positives = 31/116 (26%), Gaps = 31/116 (26%)

Query: 107 LEWLDFANNSLT-ASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVS 165
           ++ LD     L+ A   E L  L+    +      L                        
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEA--------------------- 42

Query: 166 LNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLG-----NFTFLTELNLRGN 216
                 + I  ++   P L  L+L  N +       +          + +L+L+  
Sbjct: 43  ----RCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 2e-04
 Identities = 12/80 (15%), Positives = 23/80 (28%), Gaps = 10/80 (12%)

Query: 157 NCTYLEIVSLNVNSL-----RSIPISVGYLPKLQVLSLFENNISGEIPSSLG-----NFT 206
             + L ++ L    +      S+  ++     L+ L L  N +       L         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 207 FLTELNLRGNSIRGSIPSAL 226
            L +L L        +   L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 7e-04
 Identities = 13/69 (18%), Positives = 24/69 (34%), Gaps = 8/69 (11%)

Query: 268 NLKSIPHLDLSKNKLSGEIPSSLGSCV-GLEYLNLSINSFHG----PIHPGLSSLKSLEG 322
           +++S   LD+   +LS    + L   +   + + L            I   L    +L  
Sbjct: 3   DIQS---LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59

Query: 323 LDLFQNTFQ 331
           L+L  N   
Sbjct: 60  LNLRSNELG 68

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 7e-04
 Identities = 13/94 (13%), Positives = 33/94 (35%), Gaps = 14/94 (14%)

Query: 52  ELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQF----FGNIPHSISNASKL 107
           ++++LD+   +L + +    LP      L   ++  L           +I  ++     L
Sbjct: 3   DIQSLDIQCEELSDARWAELLP-----LLQQCQVVRLDDCGLTEARCKDISSALRVNPAL 57

Query: 108 EWLDFANNSLTASIPEDLGRL-----RNLTRLNF 136
             L+  +N L       + +        + +L+ 
Sbjct: 58  AELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSL 91

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 50.2 bits (118), Expect = 1e-07
 Identities = 34/189 (17%), Positives = 56/189 (29%), Gaps = 17/189 (8%)

Query: 110 LDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVN 169
           +D     L   IP D+    + T L    N                     +++      
Sbjct: 13  VDCTGRGLK-EIPRDIPL--HTTELLLNDN----ELGRISSDGLFGRLPHLVKLELKRNQ 65

Query: 170 SLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNC 229
                P +      +Q L L EN I             L  LNL  N I   +P +  + 
Sbjct: 66  LTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHL 125

Query: 230 HQLQSLDLSKTIFLGQYPVRWL-------DLSHNHLTGPIPLAVGNLKSIPHLDLSKNKL 282
           + L SL+L+   F     + W         L+        P     ++ +   DL  ++ 
Sbjct: 126 NSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP---SKVRDVQIKDLPHSEF 182

Query: 283 SGEIPSSLG 291
                +S G
Sbjct: 183 KCSSENSEG 191

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.8 bits (117), Expect = 5e-07
 Identities = 18/77 (23%), Positives = 35/77 (45%), Gaps = 8/77 (10%)

Query: 157 NCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGN 216
               LE ++++ N L  +P      P+L+ L    N+++ E+P    N   L +L++  N
Sbjct: 282 LPPSLEELNVSNNKLIELPAL---PPRLERLIASFNHLA-EVPELPQN---LKQLHVEYN 334

Query: 217 SIRGSIPSALGNCHQLQ 233
            +R   P    +   L+
Sbjct: 335 PLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 48.3 bits (113), Expect = 2e-06
 Identities = 29/119 (24%), Positives = 41/119 (34%), Gaps = 34/119 (28%)

Query: 189 LFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPV 248
            + N  S EI S       L ELN+  N +   +P+                       +
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR-------------------L 306

Query: 249 RWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSG--EIPSSLGSCVGLEYLNLSINS 305
             L  S NHL   +P    NLK    L +  N L    +IP S+         +L +NS
Sbjct: 307 ERLIASFNHLAE-VPELPQNLK---QLHVEYNPLREFPDIPESVE--------DLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 45.2 bits (105), Expect = 2e-05
 Identities = 22/105 (20%), Positives = 36/105 (34%), Gaps = 16/105 (15%)

Query: 31  YIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAG 90
             ++  N    +I         L  L++  NKL       ELP       P +   + + 
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI------ELPA----LPPRLERLIASF 313

Query: 91  NQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLN 135
           N     +P    N   L+ L    N L    P+    + +L R+N
Sbjct: 314 NH-LAEVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDL-RMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.5 bits (98), Expect = 1e-04
 Identities = 22/96 (22%), Positives = 33/96 (34%), Gaps = 14/96 (14%)

Query: 91  NQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLR 150
           N     I         LE L+ +NN L   +P    RL  L   +F          N L 
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL-IASF----------NHLA 317

Query: 151 FLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQV 186
            +  L     L+ + +  N LR  P     +  L++
Sbjct: 318 EVPEL--PQNLKQLHVEYNPLREFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.0 bits (94), Expect = 4e-04
 Identities = 15/61 (24%), Positives = 27/61 (44%), Gaps = 8/61 (13%)

Query: 251 LDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPI 310
           L+L++  L+  +P    +L+    L  S N L+ E+P    S   L+ L +  N+     
Sbjct: 43  LELNNLGLSS-LPELPPHLE---SLVASCNSLT-ELPELPQS---LKSLLVDNNNLKALS 94

Query: 311 H 311
            
Sbjct: 95  D 95

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 40.2 bits (92), Expect = 6e-04
 Identities = 18/76 (23%), Positives = 27/76 (35%), Gaps = 5/76 (6%)

Query: 245 QYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSIN 304
              +       N  +  I        S+  L++S NKL  E+P+       LE L  S N
Sbjct: 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFN 314

Query: 305 SFHGPIHPGLSSLKSL 320
                +     +LK L
Sbjct: 315 HLAE-VPELPQNLKQL 329

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.9 bits (115), Expect = 7e-07
 Identities = 45/271 (16%), Positives = 81/271 (29%), Gaps = 24/271 (8%)

Query: 54  RTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFA 113
           +TLDL    L         P   G  L    I       F         +  +++ +D +
Sbjct: 3   QTLDLTGKNL--------HPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLS 54

Query: 114 NNSLT-ASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLR 172
           N+ +  +++   L +   L  L+     L          +++L   + L    LN++   
Sbjct: 55  NSVIEVSTLHGILSQCSKLQNLSLEGLRLSDP------IVNTLAKNSNLV--RLNLSGCS 106

Query: 173 SIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQL 232
                           L E N+S        +FT         +         L    + 
Sbjct: 107 GFSEFALQTLLSSCSRLDELNLSWCF-----DFTEKHVQVAVAHVSETITQLNLSGYRKN 161

Query: 233 QSLDLSKTIFLGQYPVRWLDLSHNHL-TGPIPLAVGNLKSIPHLDLSK-NKLSGEIPSSL 290
                  T+      +  LDLS + +           L  + HL LS+   +  E    L
Sbjct: 162 LQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLEL 221

Query: 291 GSCVGLEYLNLSINSFHGPIHPGLSSLKSLE 321
           G    L+ L +      G +     +L  L+
Sbjct: 222 GEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ 252

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.9 bits (107), Expect = 7e-06
 Identities = 46/256 (17%), Positives = 77/256 (30%), Gaps = 38/256 (14%)

Query: 8   INLQQNNFSGNIPHEIGRLFQLRYIIFN-SNTLQGQIPVNLTHCSELRTLDLVLNKLEEN 66
           ++L   N   ++    GRL     I F    +   Q          ++ +DL  + +E +
Sbjct: 5   LDLTGKNLHPDV---TGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61

Query: 67  QLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFAN--NSLTASIPED 124
            L G L          ++   L G +    I ++++  S L  L+ +        ++   
Sbjct: 62  TLHGILSQ-----CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTL 116

Query: 125 LGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPIS------- 177
           L     L  LN +     T K   +         T L +     N  +S   +       
Sbjct: 117 LSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPN 176

Query: 178 -------------------VGYLPKLQVLSLFE-NNISGEIPSSLGNFTFLTELNLRGNS 217
                                 L  LQ LSL    +I  E    LG    L  L + G  
Sbjct: 177 LVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIV 236

Query: 218 IRGSIPSALGNCHQLQ 233
             G++         LQ
Sbjct: 237 PDGTLQLLKEALPHLQ 252

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.7 bits (112), Expect = 1e-06
 Identities = 26/203 (12%), Positives = 59/203 (29%), Gaps = 13/203 (6%)

Query: 100 SISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCT 159
           + ++   +  L      +T +I E +  L NL  L    N +            + +  +
Sbjct: 36  TQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELS 93

Query: 160 YLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIR 219
              + +++  +      ++               +S      L          L G +  
Sbjct: 94  GNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNL 153

Query: 220 GSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSK 279
                         +     T       +  L    N ++   PL   +L ++  + L  
Sbjct: 154 Q-------YLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPL--ASLPNLIEVHLKN 204

Query: 280 NKLSGEIPSSLGSCVGLEYLNLS 302
           N++S   P  L +   L  + L+
Sbjct: 205 NQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.9 bits (110), Expect = 2e-06
 Identities = 30/216 (13%), Positives = 63/216 (29%), Gaps = 9/216 (4%)

Query: 1   NLTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVL 60
            L   + I   ++N +  +      L  +  +      +   I   + + + L  L+L  
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72

Query: 61  NKLEENQLVGELP--PYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLT 118
           N++ +   +  L     +  +   ++                 S            ++L 
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 119 ASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISV 178
               +                   +     +  L  L N + L  +  + N +  I   +
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDIS-PL 191

Query: 179 GYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLR 214
             LP L  + L  N IS   P  L N + L  + L 
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 8e-05
 Identities = 33/223 (14%), Positives = 67/223 (30%), Gaps = 15/223 (6%)

Query: 103 NASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLE 162
             +    +    +++T ++      L  +T L+     + T        ++ +     L 
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--------IEGVQYLNNLI 66

Query: 163 IVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSI 222
            + L  N +  +   +  L K+  L L  N +      +        +L     +    +
Sbjct: 67  GLELKDNQITDLAP-LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPL 125

Query: 223 PSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKL 282
                       L+    I           LS  +        + NL  +  L    NK+
Sbjct: 126 AGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKI 185

Query: 283 SGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDL 325
           S   P  L S   L  ++L  N         L++  +L  + L
Sbjct: 186 SDISP--LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTL 224

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.3 bits (111), Expect = 1e-06
 Identities = 38/210 (18%), Positives = 76/210 (36%), Gaps = 9/210 (4%)

Query: 118 TASIPEDLGRLRNLTRL-NFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPI 176
           T ++P  + ++ +        +++L  + V D    + L +   +   + ++ S++ I  
Sbjct: 7   TITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGI-- 64

Query: 177 SVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLD 236
              YLP +  L L  N ++   P +         L+        S+             +
Sbjct: 65  --QYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHN 122

Query: 237 LSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGL 296
               I    +  +   L   +        +  L  +  L L  N++S  +P  L     L
Sbjct: 123 GISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKL 180

Query: 297 EYLNLSINSFHGPIHPGLSSLKSLEGLDLF 326
           + L LS N         L+ LK+L+ L+LF
Sbjct: 181 QNLYLSKNHISDL--RALAGLKNLDVLELF 208

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.7 bits (104), Expect = 1e-05
 Identities = 40/207 (19%), Positives = 70/207 (33%), Gaps = 11/207 (5%)

Query: 120 SIPEDLGRLRNLTRLNFA---RNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPI 176
           +I +D    +  T    A   +  LG   V D      L   T L+   L + S+  +  
Sbjct: 1   TITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGV-- 58

Query: 177 SVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLD 236
              YL  L  ++   N ++   P           +N    +    + +           +
Sbjct: 59  --EYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNN 116

Query: 237 LSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGL 296
               I   +       L  +  T     A+  L S+  L+ S N+++   P  L +   L
Sbjct: 117 QITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTL 174

Query: 297 EYLNLSINSFHGPIHPGLSSLKSLEGL 323
           E L++S N         L+ L +LE L
Sbjct: 175 ERLDISSNKVSDI--SVLAKLTNLESL 199

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 42.9 bits (99), Expect = 8e-05
 Identities = 9/60 (15%), Positives = 24/60 (40%), Gaps = 5/60 (8%)

Query: 183 KLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRG----SIPSALGNCHQLQSLDLS 238
            L++ ++   +    + + L     + E+ L GN+I       +   + +   L+  + S
Sbjct: 9   SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.1 bits (89), Expect = 0.001
 Identities = 15/93 (16%), Positives = 31/93 (33%), Gaps = 13/93 (13%)

Query: 245 QYPVRWLDLSHNHLTGPIP------LAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVG--- 295
              +R L L+   L+           +      +  L L  N++  +   +L + +    
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301

Query: 296 --LEYLNLSINSFH--GPIHPGLSSLKSLEGLD 324
             L +L L+ N F     +   +  + S  G  
Sbjct: 302 PDLLFLELNGNRFSEEDDVVDEIREVFSTRGRG 334

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.3 bits (87), Expect = 0.002
 Identities = 9/63 (14%), Positives = 20/63 (31%), Gaps = 5/63 (7%)

Query: 249 RWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGE----IPSSLGSCVGLEYLNLSIN 304
           +   ++       +   +    S+  + LS N +  E    +  ++ S   LE    S  
Sbjct: 11  KLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDI 69

Query: 305 SFH 307
              
Sbjct: 70  FTG 72

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 37.9 bits (86), Expect = 0.003
 Identities = 8/79 (10%), Positives = 22/79 (27%), Gaps = 4/79 (5%)

Query: 161 LEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGE----IPSSLGNFTFLTELNLRGN 216
           L++ ++     +S+   +     ++ + L  N I  E    +  ++ +   L        
Sbjct: 10  LKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDI 69

Query: 217 SIRGSIPSALGNCHQLQSL 235
                          L   
Sbjct: 70  FTGRVKDEIPEALRLLLQA 88

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.0 bits (95), Expect = 9e-05
 Identities = 23/133 (17%), Positives = 37/133 (27%), Gaps = 13/133 (9%)

Query: 166 LNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSA 225
           L    +  + + +         +L    +       L        LN R +    ++   
Sbjct: 4   LKPEQVEQLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRII 60

Query: 226 LGNCHQLQSLDLSKTIFLGQYPVRW----------LDLSHNHLTGPIPLAVGNLKSIPHL 275
             N  +L SL+LS         +            L+LS N L     L       +  L
Sbjct: 61  EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEEL 120

Query: 276 DLSKNKLSGEIPS 288
            L  N LS     
Sbjct: 121 WLDGNSLSDTFRD 133

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.1 bits (85), Expect = 0.002
 Identities = 25/135 (18%), Positives = 46/135 (34%), Gaps = 9/135 (6%)

Query: 221 SIPSALGNCH--QLQSLDLSK----TIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPH 274
            +   +   +    Q+LDL         + Q     L+   +     + +   N+  +  
Sbjct: 11  QLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSSMAAT-LRIIEENIPELLS 69

Query: 275 LDLSKNKLSG--EIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQA 332
           L+LS N+L    ++ S +     L+ LNLS N               LE L L  N+   
Sbjct: 70  LNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129

Query: 333 KSQNGDVPRKGIFKN 347
             ++       I + 
Sbjct: 130 TFRDQSTYISAIRER 144

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.1 bits (89), Expect = 9e-04
 Identities = 5/41 (12%), Positives = 11/41 (26%)

Query: 198 IPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLS 238
                   +    L++    I       L N  +L++    
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.7 bits (88), Expect = 0.001
 Identities = 35/235 (14%), Positives = 63/235 (26%), Gaps = 25/235 (10%)

Query: 97  IPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLV 156
           IP  +        L F    L            +L ++  ++ND+      D+      +
Sbjct: 23  IPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80

Query: 157 NCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGN 216
           +   +E      N L   P +   LP LQ L +    I         +      L+++ N
Sbjct: 81  HEIRIEK---ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN 137

Query: 217 SIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHL---------TGPIPL-AV 266
               +I          +S+ L       Q                         +P    
Sbjct: 138 INIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVF 197

Query: 267 GNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLE 321
                   LD+S+ ++       L +   L   +             L  L +LE
Sbjct: 198 HGASGPVILDISRTRIHSLPSYGLENLKKLRARST----------YNLKKLPTLE 242

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (85), Expect = 0.003
 Identities = 35/239 (14%), Positives = 59/239 (24%), Gaps = 11/239 (4%)

Query: 98  PHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSL-- 155
            H I + S         + +T  IP DL   RN   L F    L   +         L  
Sbjct: 2   HHRICHCSNRV-FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 57

Query: 156 -----VNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTE 210
                 +   +    +  N  +   I +     L  ++         +   L + T +  
Sbjct: 58  IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117

Query: 211 LNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLK 270
           L                  +         +     +    L L+ N +      A    +
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ 177

Query: 271 SIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNT 329
                    N L            G   L++S    H     GL +LK L     +   
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	640
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.98
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.98
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.98
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.97
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.97
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.97
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.97
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.97
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.97
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.97
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.97
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.97
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.97
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.97
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.97
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.97
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.97
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.97
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.97
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.96
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.96
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.96
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.96
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.95
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.95
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.95
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.94
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.92
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.89
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.86
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.85
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.85
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.84
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.84
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.83
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.82
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.82
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.81
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.81
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.81
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.8
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.8
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.69
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.66
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.64
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.64
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.63
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.59
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.58
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.55
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.55
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.52
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.47
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.46
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.43
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.78
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.66
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.39
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.88
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.75
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.67
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.51
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.29
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.15
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.98
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.47
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.34

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-37  Score=311.24  Aligned_cols=177  Identities=24%  Similarity=0.325  Sum_probs=154.7

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      ++|+..+.||+|+||+||+|+++.+|+.||||++........+.+.+|++++++++|||||++++++     ...+..|+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEE-----EECCEEEE
Confidence            4699999999999999999999999999999999776666668899999999999999999999995     44558899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      |||||++|+|.+++...           .+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+||
T Consensus        95 vmEy~~gg~L~~~~~~~-----------~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DF  160 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTET-----------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDF  160 (293)
T ss_dssp             EEECCTTCBHHHHHHHS-----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCC
T ss_pred             EEEecCCCcHHHHhhcc-----------CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccc
Confidence            99999999999987532           27889999999999999999999   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |+|+.+....    ......+||+.|||||++.+..++.+
T Consensus       161 G~a~~~~~~~----~~~~~~~gt~~Y~aPE~~~~~~~~~~  196 (293)
T d1yhwa1         161 GFCAQITPEQ----SKRSTMVGTPYWMAPEVVTRKAYGPK  196 (293)
T ss_dssp             TTCEECCSTT----CCBCCCCSCGGGCCHHHHSSSCBCTH
T ss_pred             hhheeecccc----ccccccccCCCccChhhhcCCCCCch
Confidence            9998764321    12234579999999999999888753

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-38  Score=309.21  Aligned_cols=179  Identities=22%  Similarity=0.321  Sum_probs=150.2

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR-GALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++..... ...+.+.+|++++++++|||||++++++     .+++..
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~-----~~~~~~   78 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ   78 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEE-----EETTEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeee-----ccCcee
Confidence            3578899999999999999999999999999999965432 3346789999999999999999999995     445688


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      |+|||||++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+
T Consensus        79 ~ivmEy~~gg~L~~~l~~~~----------~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~  145 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEPDI----------GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKIS  145 (271)
T ss_dssp             EEEEECCTTEEGGGGSBTTT----------BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEEC
T ss_pred             EEEEeccCCCcHHHHHhcCC----------CCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEc
Confidence            99999999999999996543          38899999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVS  638 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s  638 (640)
                      |||+|+......  ........+||+.|||||++.+..++
T Consensus       146 DFG~a~~~~~~~--~~~~~~~~~GT~~Y~APE~~~~~~~~  183 (271)
T d1nvra_         146 DFGLATVFRYNN--RERLLNKMCGTLPYVAPELLKRREFH  183 (271)
T ss_dssp             CCTTCEECEETT--EECCBCCCCSCGGGSCTHHHHCSSBC
T ss_pred             cchhheeeccCC--ccccccceeeCcCccCHhHhcCCCCC
Confidence            999998764321  11223346799999999999887753

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-37  Score=304.47  Aligned_cols=176  Identities=27%  Similarity=0.417  Sum_probs=152.7

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||+||+|+++.+++.||+|++...   +....+.+.+|+++++.++|||||++++++     .+++.
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~   80 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDATR   80 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECCE
Confidence            4588899999999999999999999999999998643   234457889999999999999999999995     44568


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++|||||++|+|.+++....          .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||
T Consensus        81 ~~ivmEy~~~g~L~~~l~~~~----------~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl  147 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQKLS----------KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKI  147 (263)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEE
T ss_pred             EEEEEeecCCCcHHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEee
Confidence            899999999999999986433          27899999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||+|+.....      .....+||+.|||||++.+..++.|
T Consensus       148 ~DFG~a~~~~~~------~~~~~~Gt~~Y~APE~~~~~~~~~~  184 (263)
T d2j4za1         148 ADFGWSVHAPSS------RRTTLCGTLDYLPPEMIEGRMHDEK  184 (263)
T ss_dssp             CCCCSCSCCCCC------CCEETTEEGGGCCHHHHTTCCCCTT
T ss_pred             cccceeeecCCC------cccccCCCCcccCHHHHcCCCCCch
Confidence            999999865432      1223579999999999999888764

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-38  Score=319.47  Aligned_cols=179  Identities=25%  Similarity=0.360  Sum_probs=153.2

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ..++|++.+.||+|+||+||+|+++.+|+.||+|+++.. +....+.+.+|+++|++++|||||+++++|.     +...
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~   78 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGE   78 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-----CSSE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCE
Confidence            356799999999999999999999999999999999654 3344578999999999999999999999954     4457


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++|||||++|+|.+++....          .+++..+..++.|++.||.|||+.  .+|+||||||+|||+++++.+||
T Consensus        79 ~~iVmEy~~gg~L~~~l~~~~----------~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl  146 (322)
T d1s9ja_          79 ISICMEHMDGGSLDQVLKKAG----------RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKL  146 (322)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEE
T ss_pred             EEEEEEcCCCCcHHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEE
Confidence            899999999999999986432          378999999999999999999972  38999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||+|+.+.+.      ...+.+||++|||||++.+.+++.+
T Consensus       147 ~DFGla~~~~~~------~~~~~~GT~~Y~APEvl~~~~y~~~  183 (322)
T d1s9ja_         147 CDFGVSGQLIDS------MANSFVGTRSYMSPERLQGTHYSVQ  183 (322)
T ss_dssp             CCCCCCHHHHHH------TC---CCSSCCCCHHHHHCSCCCTT
T ss_pred             eeCCCccccCCC------ccccccCCccccCchHHcCCCCCcH
Confidence            999999865332      1224579999999999999988864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-37  Score=310.67  Aligned_cols=185  Identities=28%  Similarity=0.449  Sum_probs=155.7

Q ss_pred             HHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          436 LLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       436 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      ++...++|++.+.||+|+||+||+|+++.+++.||||+++.. ....++|.+|+++|++++|||||+++++|.     ++
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~   85 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----RE   85 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEe-----eC
Confidence            334456788889999999999999999989999999998643 334578999999999999999999999964     34


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      +..++|||||++|+|.+++.....        ..+++..+..|+.||+.||+|||+   .+|+||||||+|||+++++.+
T Consensus        86 ~~~~iv~E~~~~g~l~~~l~~~~~--------~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~  154 (287)
T d1opja_          86 PPFYIITEFMTYGNLLDYLRECNR--------QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLV  154 (287)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCT--------TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCE
T ss_pred             CeeEEEeecccCcchHHHhhhccc--------cchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcE
Confidence            578999999999999999864332        348899999999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ||+|||+|+......   .....+..||+.|||||++.++.++.|
T Consensus       155 Kl~DFG~a~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~k  196 (287)
T d1opja_         155 KVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESLAYNKFSIK  196 (287)
T ss_dssp             EECCCCCTTTCCSSS---SEEETTEEECGGGCCHHHHHHCCCSHH
T ss_pred             EEccccceeecCCCC---ceeeccccccccccChHHHcCCCCCch
Confidence            999999999764322   222334458999999999998888753

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-37  Score=307.47  Aligned_cols=186  Identities=25%  Similarity=0.341  Sum_probs=142.4

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++....  +...+.+.+|++++++++|||||++++++.+.   .....
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~~   80 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTTL   80 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCEE
Confidence            56889999999999999999999999999999996543  34457799999999999999999999986432   23467


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeeCCCCCCCeeeCCCCcEE
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHC--KKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~--~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      |+|||||++|+|.+++......      ...+++..++.++.|++.||+|||+..  ..+|+||||||+|||++.++.+|
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~------~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk  154 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKE------RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK  154 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHH------TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred             EEEEecCCCCcHHHHHHhcccc------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence            9999999999999998542211      023889999999999999999999831  12499999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|||+|+.+....    ....+.+||+.|||||++.+..++.
T Consensus       155 l~DFG~a~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~  193 (269)
T d2java1         155 LGDFGLARILNHDT----SFAKAFVGTPYYMSPEQMNRMSYNE  193 (269)
T ss_dssp             ECCHHHHHHC---------------CCCSCCCHHHHTTCCCCH
T ss_pred             EeeccceeecccCC----CccccCCCCcccCCHHHHcCCCCCh
Confidence            99999999764321    1223467999999999999988875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-37  Score=305.65  Aligned_cols=179  Identities=25%  Similarity=0.367  Sum_probs=150.8

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++...   .....+.+.+|++++++++|||||++++++     .+++.
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~   82 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK   82 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSSE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECCE
Confidence            4689999999999999999999999999999999643   234457899999999999999999999994     44568


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .|+|||||++|+|.+++...+          .+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+||
T Consensus        83 ~~ivmEy~~gg~L~~~~~~~~----------~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl  149 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRKIG----------SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQI  149 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEE
T ss_pred             EEEEEEccCCCCHHHhhhccC----------CCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEe
Confidence            899999999999999886443          38899999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|||+|+.+.....  .......+||+.|||||++.+..++.
T Consensus       150 ~DFG~a~~~~~~~~--~~~~~~~~GT~~Y~APE~~~~~~~~~  189 (288)
T d1uu3a_         150 TDFGTAKVLSPESK--QARANSFVGTAQYVSPELLTEKSACK  189 (288)
T ss_dssp             CCCTTCEECC------------CCCCGGGCCHHHHHTCCCCH
T ss_pred             cccccceecccCCc--ccccccccCCccccCceeeccCCCCc
Confidence            99999987643211  12223457999999999999888764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-37  Score=306.74  Aligned_cols=173  Identities=27%  Similarity=0.350  Sum_probs=149.3

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      +.|++.+.||+|+||+||+|+++.+|+.||||+++.......+.+.+|+++|++++|||||++++++.     +.+..++
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCeEEE
Confidence            35788899999999999999999999999999997766666788999999999999999999999954     4557899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      |||||++|+|.+++....         ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+||
T Consensus        87 vmEy~~~g~L~~~~~~~~---------~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DF  154 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELE---------RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADF  154 (288)
T ss_dssp             EEECCTTEEHHHHHHHHT---------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEecCCCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEec
Confidence            999999999999875432         238899999999999999999999   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      |+|+.....    .......+||+.|||||++.+
T Consensus       155 G~a~~~~~~----~~~~~~~~Gt~~y~APE~l~~  184 (288)
T d2jfla1         155 GVSAKNTRT----IQRRDSFIGTPYWMAPEVVMC  184 (288)
T ss_dssp             TTCEECHHH----HHHHTCCCSCCTTCCHHHHTT
T ss_pred             hhhhccCCC----cccccccccccccCCHHHHhh
Confidence            999865321    112234579999999999854

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-36  Score=307.20  Aligned_cols=178  Identities=28%  Similarity=0.348  Sum_probs=154.7

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++..   .....+.+.+|+.+|++++|||||+++++     +.+.+.
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~-----~~~~~~   79 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA-----FQTHDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEE-----EECSSE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEee-----eccccc
Confidence            4688999999999999999999999999999999643   23456788999999999999999999999     455668


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .|+|||||++|+|.+++....          .+++..+..++.|++.||+|||+   ++|+||||||+|||++.+|.+||
T Consensus        80 ~~iv~ey~~gg~L~~~~~~~~----------~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl  146 (337)
T d1o6la_          80 LCFVMEYANGGELFFHLSRER----------VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKI  146 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEE
T ss_pred             cccceeccCCCchhhhhhccc----------CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEE
Confidence            999999999999999987543          27888999999999999999999   79999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||+|+......    ......+||+.|||||++.+..++.+
T Consensus       147 ~DFG~a~~~~~~~----~~~~~~~GT~~Y~aPE~~~~~~y~~~  185 (337)
T d1o6la_         147 TDFGLCKEGISDG----ATMKTFCGTPEYLAPEVLEDNDYGRA  185 (337)
T ss_dssp             CCCTTCBCSCCTT----CCBCCCEECGGGCCGGGGSSSCBCTT
T ss_pred             eecccccccccCC----cccccceeCHHHhhhhhccCCCCChh
Confidence            9999998654321    12234679999999999999988764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-36  Score=297.79  Aligned_cols=179  Identities=29%  Similarity=0.472  Sum_probs=142.4

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .++|++.+.||+|+||+||+|+++ +++.||||+++... ...++|.+|++++++++|||||+++|+|..     ++..+
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~~~~   76 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPIC   76 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCE
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceecc-----CCceE
Confidence            357888999999999999999987 67889999996433 334789999999999999999999999743     34689


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +|||||++|+|.+++.....         .+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|
T Consensus        77 lv~E~~~~g~L~~~l~~~~~---------~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~D  144 (263)
T d1sm2a_          77 LVFEFMEHGCLSDYLRTQRG---------LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSD  144 (263)
T ss_dssp             EEEECCTTCBHHHHHHTTTT---------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECS
T ss_pred             EEEEecCCCcHHHHhhcccc---------CCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecc
Confidence            99999999999999865432         37889999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ||+|+.......   .......||+.|||||++.+..++.|
T Consensus       145 FGla~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~k  182 (263)
T d1sm2a_         145 FGMTRFVLDDQY---TSSTGTKFPVKWASPEVFSFSRYSSK  182 (263)
T ss_dssp             CC---------------------CTTSCCHHHHTTCCCCHH
T ss_pred             cchheeccCCCc---eeecceecCcccCChHHhcCCCCCch
Confidence            999987643221   12233568999999999999988753

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-36  Score=295.51  Aligned_cols=177  Identities=26%  Similarity=0.392  Sum_probs=145.9

Q ss_pred             cccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEE
Q 035691          444 SSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALV  521 (640)
Q Consensus       444 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv  521 (640)
                      +..+.||+|+||+||+|+++.+++.||+|++...  .+...+.|.+|+++|++++|||||++++++... ...+...++|
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~~iv   90 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec-cccCCEEEEE
Confidence            5567899999999999999999999999998644  334457899999999999999999999997543 2335578999


Q ss_pred             eeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC-CCCcEEEccc
Q 035691          522 YEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD-NDMIAHVGDF  600 (640)
Q Consensus       522 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~-~~~~~kl~Df  600 (640)
                      ||||++|+|.+++....          .+++..+..++.||+.||+|||+. ..+|+||||||+|||++ +++.+||+||
T Consensus        91 mE~~~~g~L~~~l~~~~----------~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DF  159 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFK----------VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDL  159 (270)
T ss_dssp             EECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             EeCCCCCcHHHHHhccc----------cccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeec
Confidence            99999999999986432          378899999999999999999983 12399999999999996 5799999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|+.....      ...+.+||+.|||||++.+ +++.
T Consensus       160 Gla~~~~~~------~~~~~~GT~~Y~aPE~~~~-~~~~  191 (270)
T d1t4ha_         160 GLATLKRAS------FAKAVIGTPEFMAPEMYEE-KYDE  191 (270)
T ss_dssp             TGGGGCCTT------SBEESCSSCCCCCGGGGGT-CCCT
T ss_pred             CcceeccCC------ccCCcccCccccCHHHhCC-CCCC
Confidence            999854321      1234579999999999865 4654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.9e-36  Score=306.81  Aligned_cols=177  Identities=26%  Similarity=0.363  Sum_probs=153.4

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++........+.+.+|+++|++++|||||++++++     .+++..++
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~i  100 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMVM  100 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----EETTEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEE
Confidence            4689999999999999999999999999999999766666667899999999999999999999995     44568999


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC--CCCcEEEc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD--NDMIAHVG  598 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~--~~~~~kl~  598 (640)
                      |||||++|+|.+++....         ..+++..+..++.||+.||+|||+   .+|+||||||+|||++  .++.+||+
T Consensus       101 vmE~~~gg~L~~~l~~~~---------~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~  168 (350)
T d1koaa2         101 IYEFMSGGELFEKVADEH---------NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLI  168 (350)
T ss_dssp             EECCCCSCBHHHHHTCTT---------SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEEC
T ss_pred             EEEcCCCCCHHHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEe
Confidence            999999999999986433         238999999999999999999999   6999999999999996  45789999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |||+|+.+....     ......||+.|||||++.+..++.
T Consensus       169 DFG~a~~~~~~~-----~~~~~~gT~~Y~aPEv~~~~~~~~  204 (350)
T d1koaa2         169 DFGLTAHLDPKQ-----SVKVTTGTAEFAAPEVAEGKPVGY  204 (350)
T ss_dssp             CCTTCEECCTTS-----CEEEECSCTTTCCHHHHHTCCBCH
T ss_pred             ecchheeccccc-----ccceecCcccccCHHHHcCCCCCh
Confidence            999998764321     123356999999999999887764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-36  Score=301.36  Aligned_cols=178  Identities=25%  Similarity=0.466  Sum_probs=149.5

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .++|++.+.||+|+||+||+|+++ +++.||||+++... ...+.|.+|++++++++|||||+++|+|..      +..+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~~~   83 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIY   83 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc------CCeE
Confidence            456788899999999999999987 68899999996433 344789999999999999999999998632      2468


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +|||||++|+|.+++.....        ..+++..++.|+.||+.||.|||+   .+|+||||||+|||+++++.+||+|
T Consensus        84 iv~Ey~~~g~L~~~~~~~~~--------~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~D  152 (272)
T d1qpca_          84 IITEYMENGSLVDFLKTPSG--------IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIAD  152 (272)
T ss_dssp             EEEECCTTCBHHHHTTSHHH--------HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECC
T ss_pred             EEEEeCCCCcHHHHHhhcCC--------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeecc
Confidence            99999999999998764332        238899999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+|+.+...   .........||+.|||||++.++.++.
T Consensus       153 FGla~~~~~~---~~~~~~~~~gt~~y~APE~~~~~~~~~  189 (272)
T d1qpca_         153 FGLARLIEDN---EYTAREGAKFPIKWTAPEAINYGTFTI  189 (272)
T ss_dssp             CTTCEECSSS---CEECCTTCCCCTTTSCHHHHHHCEECH
T ss_pred             ccceEEccCC---ccccccccCCcccccChHHHhCCCCCc
Confidence            9999976432   122233456899999999998877764

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-36  Score=298.29  Aligned_cols=174  Identities=32%  Similarity=0.484  Sum_probs=141.7

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ..++|++.+.||+|+||+||+|+++   ..||||+++..  +....+.|.+|++++++++|||||++++++..      +
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~   76 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------P   76 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------S
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------c
Confidence            4577899999999999999999864   35999999644  34456789999999999999999999998632      3


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++|||||++|+|.+++.....         .+++..+..|+.||+.||+|||+   ++|+||||||+|||++.++.+|
T Consensus        77 ~~~lv~Ey~~~g~L~~~l~~~~~---------~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~K  144 (276)
T d1uwha_          77 QLAIVTQWCEGSSLYHHLHIIET---------KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVK  144 (276)
T ss_dssp             SCEEEEECCCEEEHHHHHHTSCC---------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEE
T ss_pred             EEEEEEecCCCCCHHHHHhhccC---------CCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEE
Confidence            46899999999999999965432         38899999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      |+|||+|+.......  ........||+.|||||++.+.
T Consensus       145 l~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~  181 (276)
T d1uwha_         145 IGDFGLATVKSRWSG--SHQFEQLSGSILWMAPEVIRMQ  181 (276)
T ss_dssp             ECCCCCSCC--------------CCCCGGGCCHHHHTTC
T ss_pred             EccccceeeccccCC--cccccccccCcccCCHHHHhcc
Confidence            999999987643221  1122345799999999999754

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.8e-36  Score=302.42  Aligned_cols=178  Identities=26%  Similarity=0.353  Sum_probs=137.1

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      .+.|++.+.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+++|++++|||||++++++     .+++..
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~   82 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHL   82 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence            456889999999999999999999999999999996443 23346788999999999999999999995     445689


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC---CCCcE
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD---NDMIA  595 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~---~~~~~  595 (640)
                      |+|||||+||+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||++.   +++.+
T Consensus        83 ~lvmE~~~gg~L~~~l~~~~----------~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~v  149 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVEKG----------FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKI  149 (307)
T ss_dssp             EEEECCCCSCBHHHHHHTCS----------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCE
T ss_pred             EEEEeccCCCcHHHhhhccc----------CCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceE
Confidence            99999999999999996543          38899999999999999999999   6999999999999994   57899


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ||+|||+|+......     ...+.+||+.|||||++.+..++.|
T Consensus       150 kl~DFG~a~~~~~~~-----~~~~~~GT~~y~APE~~~~~~~~~~  189 (307)
T d1a06a_         150 MISDFGLSKMEDPGS-----VLSTACGTPGYVAPEVLAQKPYSKA  189 (307)
T ss_dssp             EECCC-----------------------CTTSCHHHHTTCCCCTH
T ss_pred             EEeccceeEEccCCC-----eeeeeeeCccccCcHHHcCCCCCcH
Confidence            999999998653221     1234579999999999999888753

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.5e-36  Score=301.46  Aligned_cols=175  Identities=29%  Similarity=0.376  Sum_probs=152.5

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++..   .....+.+.+|+.+++.++|||||++++++     .+...
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCCe
Confidence            4588899999999999999999999999999999643   234457899999999999999999999995     44568


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++|||||+||++..++.....          +++..+..++.||+.||+|||+   ++|+||||||+|||++.+|.+||
T Consensus        79 ~~ivmE~~~gg~l~~~~~~~~~----------~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL  145 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLRKSQR----------FPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKI  145 (316)
T ss_dssp             EEEEECCCCSCBHHHHHHHTSS----------CCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEE
T ss_pred             eeeEeeecCCcccccccccccc----------ccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEE
Confidence            9999999999999998865433          6778888999999999999999   79999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||+|+......       .+.+||+.|||||++.+..++.+
T Consensus       146 ~DFG~a~~~~~~~-------~~~~Gt~~Y~APE~l~~~~y~~~  181 (316)
T d1fota_         146 TDFGFAKYVPDVT-------YTLCGTPDYIAPEVVSTKPYNKS  181 (316)
T ss_dssp             CCCSSCEECSSCB-------CCCCSCTTTCCHHHHTTCCBCTT
T ss_pred             ecCccceEecccc-------ccccCcccccCHHHHcCCCCCch
Confidence            9999998764321       23579999999999999888764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.9e-36  Score=301.54  Aligned_cols=182  Identities=26%  Similarity=0.462  Sum_probs=137.5

Q ss_pred             CCCcccCcccccccceEEEEEECCCCe---EEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQT---VVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ++|++.+.||+|+||+||+|+++.+++   .||||.+... .....+.|.+|+++|++++|||||+++|+|..     .+
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-----~~  100 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-----ST  100 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----SS
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----CC
Confidence            346677899999999999999976654   6889988543 34456789999999999999999999999643     34


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++|||||++|+|.+++.....         .+++.++..++.||+.||+|||+   ++|+||||||+|||++.++.+|
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~---------~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~K  168 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDG---------QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCK  168 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTT---------CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEE
T ss_pred             EEEEEEEecCCCcceeeeccccC---------CCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEE
Confidence            68999999999999998865432         38999999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCC-ceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSN-QCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|||+|+.+....... .....+..||+.|||||++.+..++.
T Consensus       169 l~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  212 (299)
T d1jpaa_         169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTS  212 (299)
T ss_dssp             ECCC-----------------------CGGGSCHHHHHSCCCCH
T ss_pred             ECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCc
Confidence            99999999765432211 22223356899999999998888764

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.4e-36  Score=301.32  Aligned_cols=168  Identities=25%  Similarity=0.348  Sum_probs=144.7

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      .|+..+.||+|+||+||+|++..+|+.||||++....   ....+.+.+|+++|++++|||||++++++.     +.+..
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~   90 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHTA   90 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE-----ECCEE
Confidence            3888899999999999999999999999999996543   234467999999999999999999999953     44578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++|||||++|++..++....          .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+
T Consensus        91 ~iv~E~~~~g~l~~~~~~~~----------~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~  157 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLEVHKK----------PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLG  157 (309)
T ss_dssp             EEEEECCSEEHHHHHHHHTS----------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEEC
T ss_pred             EEEEEecCCCchHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEe
Confidence            99999999999977664332          38899999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      |||+|+.....        ...+||+.|||||++.+.
T Consensus       158 DFG~a~~~~~~--------~~~~GT~~Y~APE~~~~~  186 (309)
T d1u5ra_         158 DFGSASIMAPA--------NSFVGTPYWMAPEVILAM  186 (309)
T ss_dssp             CCTTCBSSSSB--------CCCCSCGGGCCHHHHTTT
T ss_pred             ecccccccCCC--------CccccCccccCHHHHhcc
Confidence            99999865321        234699999999999753

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.5e-35  Score=303.47  Aligned_cols=177  Identities=21%  Similarity=0.280  Sum_probs=153.3

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++........+.+.+|+++|++++|||||++++++     .++...|+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~i  103 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMVL  103 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEE
Confidence            4688999999999999999999999999999999766655567889999999999999999999994     45568899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC--CCCcEEEc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD--NDMIAHVG  598 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~--~~~~~kl~  598 (640)
                      |||||++|+|.+++....         ..+++..+..|+.||+.||+|||+   .+|+||||||+|||++  .++.+||+
T Consensus       104 vmE~~~gg~L~~~~~~~~---------~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~  171 (352)
T d1koba_         104 ILEFLSGGELFDRIAAED---------YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKII  171 (352)
T ss_dssp             EEECCCCCBHHHHTTCTT---------CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEEC
T ss_pred             EEEcCCCChHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEe
Confidence            999999999998875443         238999999999999999999999   6999999999999998  57899999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |||+|+.+....     ......||+.|||||++.+..++.
T Consensus       172 DFGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~  207 (352)
T d1koba_         172 DFGLATKLNPDE-----IVKVTTATAEFAAPEIVDREPVGF  207 (352)
T ss_dssp             CCTTCEECCTTS-----CEEEECSSGGGCCHHHHTTCCBCH
T ss_pred             ecccceecCCCC-----ceeeccCcccccCHHHHcCCCCCC
Confidence            999998764321     122356999999999999988764

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-35  Score=294.70  Aligned_cols=180  Identities=27%  Similarity=0.393  Sum_probs=147.0

Q ss_pred             CCCcccCc-ccccccceEEEEEECC--CCeEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          441 GGFSSANL-IGTGSFGSVYKGILDP--DQTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       441 ~~~~~~~~-lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ++|.+.+. ||+|+||+||+|+++.  ++..||||+++.. .....++|.+|+++|++++|||||+++|+|..      +
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~   81 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E   81 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------C
Confidence            34556664 9999999999998753  4568999999644 34456789999999999999999999999742      2


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++|||||++|+|.+++...+.         .+++..+..++.|++.||+|||+   ++|+||||||+||+++.++.+|
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~~~---------~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~K  149 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGKRE---------EIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAK  149 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTT---------TSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEE
T ss_pred             eEEEEEEeCCCCcHHHHhhcccc---------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCcee
Confidence            47899999999999998864432         38999999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|||+|+.+..... .........||+.|||||++.++.++.
T Consensus       150 l~DFGla~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~  191 (285)
T d1u59a_         150 ISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFRKFSS  191 (285)
T ss_dssp             ECCCTTCEECTTCSC-EECCCCSSCCCGGGCCHHHHHHCEECH
T ss_pred             eccchhhhccccccc-ccccccccccCccccChHHHhCCCCCc
Confidence            999999997653221 112223456899999999998777664

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-35  Score=286.39  Aligned_cols=178  Identities=30%  Similarity=0.451  Sum_probs=151.6

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      .++|++.+.||+|+||+||+|+++ +++.||||+++.... ..++|.+|+.++++++|||||+++|+|.     .+...+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~-----~~~~~~   75 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIF   75 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----CSSSEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEe-----eCCceE
Confidence            467899999999999999999996 788999999975433 3478999999999999999999999964     345789


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGD  599 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~D  599 (640)
                      +||||+++|++.+++.....         .+++..+.+++.|+++||+|||+   .+|+||||||+||++++++.+||+|
T Consensus        76 iv~Ey~~~g~l~~~~~~~~~---------~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~D  143 (258)
T d1k2pa_          76 IITEYMANGCLLNYLREMRH---------RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSD  143 (258)
T ss_dssp             EEEECCTTEEHHHHHHSGGG---------CCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEEccCCCcHHHhhhcccc---------CCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECc
Confidence            99999999999998754432         37888999999999999999999   6999999999999999999999999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+|+.+.+...   .......||+.|+|||++.+..++.
T Consensus       144 fG~a~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~  180 (258)
T d1k2pa_         144 FGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSS  180 (258)
T ss_dssp             CSSCCBCSSSSC---CCCCCSCCCGGGCCHHHHHHCCCCH
T ss_pred             chhheeccCCCc---eeecccCCCCCcCCcHHhcCCCCCc
Confidence            999987654322   1223456899999999998888764

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-35  Score=294.71  Aligned_cols=182  Identities=26%  Similarity=0.472  Sum_probs=142.2

Q ss_pred             cCCCcccCcccccccceEEEEEECCCC----eEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQ----TVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  514 (640)
                      .+.|+..++||+|+||+||+|.++.++    ..||||++... .......|.+|++++++++|||||+++|+|..     
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~-----   80 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-----   80 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec-----
Confidence            456788899999999999999987554    47999998643 33445679999999999999999999999643     


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                      .+..++|||||.+|++.+++.....         .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.
T Consensus        81 ~~~~~~v~e~~~~~~l~~~~~~~~~---------~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~  148 (283)
T d1mqba_          81 YKPMMIITEYMENGALDKFLREKDG---------EFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLV  148 (283)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTTT---------CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCC
T ss_pred             CCceEEEEEecccCcchhhhhcccc---------cccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCe
Confidence            3468999999999999987754432         38899999999999999999999   69999999999999999999


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +||+|||+|+.+...... ........||+.|||||++.+..++.
T Consensus       149 ~Kl~DFGla~~~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~  192 (283)
T d1mqba_         149 CKVSDFGLSRVLEDDPEA-TYTTSGGKIPIRWTAPEAISYRKFTS  192 (283)
T ss_dssp             EEECCCCC------------------CCCGGGSCHHHHHSCCCCH
T ss_pred             EEEcccchhhcccCCCcc-ceEeccCCCCccccCHHHHccCCCCC
Confidence            999999999976443221 22233456899999999999888765

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-35  Score=292.24  Aligned_cols=177  Identities=23%  Similarity=0.283  Sum_probs=151.3

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc------chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ------RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  514 (640)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++...      ....+.+.+|+++|++++|||||++++++     .+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~   84 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----EN   84 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EE
Confidence            56899999999999999999999999999999995432      12357899999999999999999999995     44


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC-
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-  593 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~-  593 (640)
                      ....++|||||++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++ 
T Consensus        85 ~~~~~iv~E~~~gg~L~~~i~~~~----------~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~  151 (293)
T d1jksa_          85 KTDVILILELVAGGELFDFLAEKE----------SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNV  151 (293)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSS
T ss_pred             CCEEEEEEEcCCCccccchhcccc----------ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCC
Confidence            568899999999999999986432          38899999999999999999999   6999999999999998776 


Q ss_pred             ---cEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          594 ---IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       594 ---~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                         .+|++|||+|+......     ...+..||+.|||||++.+..++.|
T Consensus       152 ~~~~vkl~DfG~a~~~~~~~-----~~~~~~~t~~y~APE~~~~~~~~~~  196 (293)
T d1jksa_         152 PKPRIKIIDFGLAHKIDFGN-----EFKNIFGTPEFVAPEIVNYEPLGLE  196 (293)
T ss_dssp             SSCCEEECCCTTCEECTTSC-----BCSCCCCCGGGCCHHHHTTCCBCTH
T ss_pred             cccceEecchhhhhhcCCCc-----cccccCCCCcccCHHHHcCCCCCCc
Confidence               59999999998764321     1223568999999999998888753

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.5e-35  Score=299.90  Aligned_cols=175  Identities=26%  Similarity=0.312  Sum_probs=152.2

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~  517 (640)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++...   +....+.+.+|+++|+.++|||||++++++     .....
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~  115 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----ccccc
Confidence            3688999999999999999999999999999999643   234457899999999999999999999994     44567


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .++||||+.+|+|.+++....          .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||
T Consensus       116 ~~~v~e~~~~g~l~~~l~~~~----------~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL  182 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRRIG----------RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV  182 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEE
T ss_pred             cccccccccccchhhhHhhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEe
Confidence            899999999999999886443          27889999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||+|+.+...       ....+||+.|||||++.+..++.+
T Consensus       183 ~DFG~a~~~~~~-------~~~~~Gt~~Y~APE~~~~~~~~~~  218 (350)
T d1rdqe_         183 TDFGFAKRVKGR-------TWTLCGTPEALAPEIILSKGYNKA  218 (350)
T ss_dssp             CCCTTCEECSSC-------BCCCEECGGGCCHHHHTTCCBCTH
T ss_pred             eeceeeeecccc-------cccccCccccCCHHHHcCCCCCcc
Confidence            999999976432       123569999999999999888753

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-35  Score=289.99  Aligned_cols=173  Identities=26%  Similarity=0.376  Sum_probs=140.4

Q ss_pred             CcccccccceEEEEEEC--CCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEEe
Q 035691          447 NLIGTGSFGSVYKGILD--PDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALVY  522 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv~  522 (640)
                      +.||+|+||+||+|.++  .+++.||||+++..  +....+.|.+|+++|++++|||||+++|+|..      +..++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence            46999999999999864  34578999999543  33345789999999999999999999999742      2468999


Q ss_pred             eccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccccc
Q 035691          523 EFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFGL  602 (640)
Q Consensus       523 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfGl  602 (640)
                      |||++|+|.+++....          .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus        87 E~~~~g~L~~~l~~~~----------~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGl  153 (277)
T d1xbba_          87 EMAELGPLNKYLQQNR----------HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGL  153 (277)
T ss_dssp             ECCTTEEHHHHHHHCT----------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             EcCCCCcHHHHHhhcc----------CCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhh
Confidence            9999999999986543          38899999999999999999999   6999999999999999999999999999


Q ss_pred             cccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          603 TRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       603 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+.+..... .........||+.|||||++.+..+|.
T Consensus       154 a~~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~  189 (277)
T d1xbba_         154 SKALRADEN-YYKAQTHGKWPVKWYAPECINYYKFSS  189 (277)
T ss_dssp             CEECCTTCS-EEEC----CCCGGGCCHHHHHHCEEEH
T ss_pred             hhhcccccc-ccccccccCCCceecCchhhcCCCCCc
Confidence            987643222 122233456899999999998777654

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-34  Score=295.15  Aligned_cols=190  Identities=25%  Similarity=0.366  Sum_probs=148.5

Q ss_pred             cCCCcccCcccccccceEEEEEECCCC-----eEEEEEEeecc-cchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQ-----TVVAVKVLFLH-QRGALKSFMAECEALRNI-RHRNLVKIITACSSSDF  512 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  512 (640)
                      .++|++.+.||+|+||+||+|++..++     ..||||.+... .......+.+|+.++.++ +|||||+++++|.    
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~----  111 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT----  111 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe----
Confidence            456888999999999999999986444     36999988533 334457899999999998 8999999999964    


Q ss_pred             CCCceeeEEeeccCCCChhhhcCCCCCCCC-------------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeee
Q 035691          513 QGNDFKALVYEFMHHGSLESWLHPESASDD-------------LNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVH  579 (640)
Q Consensus       513 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------------~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivH  579 (640)
                       ..+..++|||||++|+|.++++.......             .......+++..++.++.||+.||+|||+   ++|+|
T Consensus       112 -~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiH  187 (325)
T d1rjba_         112 -LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVH  187 (325)
T ss_dssp             -SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred             -eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeee
Confidence             34578999999999999999975432110             00012348899999999999999999999   69999


Q ss_pred             CCCCCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          580 CDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       580 rdlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |||||+||+++.++.+||+|||+|+.......  .....+..||+.|||||++.++.++.
T Consensus       188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~  245 (325)
T d1rjba_         188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSN--YVVRGNARLPVKWMAPESLFEGIYTI  245 (325)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTT--SEEETTEEECGGGCCHHHHHHCCCCH
T ss_pred             ccCchhccccccCCeEEEeeccccccccCCCc--eeeeccccCCCccCChHHHcCCCCCc
Confidence            99999999999999999999999987643222  22223456899999999998888775

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-34  Score=290.96  Aligned_cols=178  Identities=25%  Similarity=0.348  Sum_probs=150.9

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecc---cchhHHHHHHHHHHHH-hcCCCCCcceeEeeccCCcCCCc
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH---QRGALKSFMAECEALR-NIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ++|.+.+.||+|+||+||+|+++.+|+.||||+++..   .....+.+..|..++. .++|||||++++++     .+++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence            5788999999999999999999999999999999643   2334566777877765 68999999999994     4456


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..|+|||||++|+|.+++....          .+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+|
T Consensus        77 ~~yivmEy~~~g~L~~~i~~~~----------~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~k  143 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQSCH----------KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIK  143 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEE
T ss_pred             ceeEEEeecCCCcHHHHhhccC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCcee
Confidence            8999999999999999996543          27888999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      |+|||+|+......    .......||+.|+|||++.+..++.|
T Consensus       144 l~DFG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~  183 (320)
T d1xjda_         144 IADFGMCKENMLGD----AKTNTFCGTPDYIAPEILLGQKYNHS  183 (320)
T ss_dssp             ECCCTTCBCCCCTT----CCBCCCCSCGGGCCHHHHTTCCBCTH
T ss_pred             ccccchhhhccccc----ccccccCCCCCcCCHHHHcCCCCCch
Confidence            99999998654221    12233579999999999999988763

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-35  Score=290.85  Aligned_cols=177  Identities=28%  Similarity=0.495  Sum_probs=143.1

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      ++|++.+.||+|+||+||+|+++ +++.||||+++... ...+.|.+|+.++++++|||||+++++|..      +..++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~~~l   88 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYI   88 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEE
T ss_pred             HHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec------CCeEE
Confidence            56889999999999999999997 45679999996443 344789999999999999999999999632      24689


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      |||||++|++.+++.....        ..++|..++.++.||+.||+|||+   .+|+||||||+|||+|+++.+||+||
T Consensus        89 v~Ey~~~g~l~~~~~~~~~--------~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~Df  157 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGETG--------KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADF  157 (285)
T ss_dssp             EECCCTTCBHHHHHSHHHH--------TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             EEEecCCCchhhhhhhccc--------ccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEccc
Confidence            9999999999988864322        238999999999999999999999   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+|+.......   .......||+.|+|||++.++.++.
T Consensus       158 Gla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~  193 (285)
T d1fmka3         158 GLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTI  193 (285)
T ss_dssp             CTTC-----------------CCGGGSCHHHHHHCCCCH
T ss_pred             chhhhccCCCc---eeeccccccccccChHHHhCCCCCc
Confidence            99987643221   1223346899999999998888764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.6e-34  Score=285.79  Aligned_cols=185  Identities=22%  Similarity=0.349  Sum_probs=147.4

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++...   ....+.|.+|+++++.++|||||++++++.... ....
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence            467999999999999999999999999999999996432   334567999999999999999999999975432 2234


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..|+||||++||+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+||+++.++..+
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~----------~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~  151 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEG----------PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVK  151 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEE
T ss_pred             eEEEEEECCCCCEehhhhcccC----------CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccce
Confidence            5889999999999999886443          28899999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ++|||.++....... ........+||+.|||||++.+..++.
T Consensus       152 l~d~~~~~~~~~~~~-~~~~~~~~~Gt~~Y~aPE~~~~~~~~~  193 (277)
T d1o6ya_         152 VMDFGIARAIADSGN-SVTQTAAVIGTAQYLSPEQARGDSVDA  193 (277)
T ss_dssp             ECCCTTCEECC-----------------TTCCHHHHTTCCCCH
T ss_pred             eehhhhhhhhccccc-cccccccccCcccccCHHHHcCCCCCc
Confidence            999999876533221 122233467999999999999988774

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4e-34  Score=294.41  Aligned_cols=175  Identities=25%  Similarity=0.298  Sum_probs=144.5

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc---chhHHHHHH---HHHHHHhcCCCCCcceeEeeccCCcCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ---RGALKSFMA---ECEALRNIRHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~H~niv~l~~~~~~~~~~~  514 (640)
                      ++|++.+.||+|+||.||+|+++.+|+.||||++....   ......+.+   |+++++.++|||||++++++     .+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~~   78 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HT   78 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----EC
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----EE
Confidence            57899999999999999999999999999999985332   222233444   46667777899999999995     44


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                      .+..|+|||||++|+|.+++....          .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.
T Consensus        79 ~~~~~ivmE~~~gg~L~~~l~~~~----------~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~  145 (364)
T d1omwa3          79 PDKLSFILDLMNGGDLHYHLSQHG----------VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGH  145 (364)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSC
T ss_pred             CCEEEEEEEecCCCcHHHHHHhcc----------cccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCc
Confidence            568899999999999999986543          27888999999999999999999   79999999999999999999


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCC-CCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS-QVST  639 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~  639 (640)
                      +||+|||+|+.+....      ....+||+.|||||++.++ .++.
T Consensus       146 iKl~DFGla~~~~~~~------~~~~~GT~~y~APE~~~~~~~~~~  185 (364)
T d1omwa3         146 VRISDLGLACDFSKKK------PHASVGTHGYMAPEVLQKGVAYDS  185 (364)
T ss_dssp             EEECCCTTCEECSSSC------CCSCCSCGGGCCHHHHSTTCCCCT
T ss_pred             EEEeeeceeeecCCCc------ccccccccccchhHHhhcCCCCCc
Confidence            9999999998664321      2235699999999999754 4554

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.7e-34  Score=282.63  Aligned_cols=172  Identities=28%  Similarity=0.398  Sum_probs=147.9

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc---------hhHHHHHHHHHHHHhcC-CCCCcceeEeecc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR---------GALKSFMAECEALRNIR-HRNLVKIITACSS  509 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~  509 (640)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++....         ...+.+.+|+.++++++ |||||++++++  
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--   79 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--   79 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec--
Confidence            3678999999999999999999999999999999964421         12356889999999997 99999999995  


Q ss_pred             CCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeee
Q 035691          510 SDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLL  589 (640)
Q Consensus       510 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl  589 (640)
                         .+++..|+|||||++|+|.+++....          .+++..+..++.||+.||+|||+   .+|+||||||+||++
T Consensus        80 ---~~~~~~~ivmE~~~~g~L~~~l~~~~----------~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill  143 (277)
T d1phka_          80 ---ETNTFFFLVFDLMKKGELFDYLTEKV----------TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILL  143 (277)
T ss_dssp             ---ECSSEEEEEEECCTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred             ---ccCcceEEEEEcCCCchHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEE
Confidence               45568999999999999999996432          38999999999999999999999   699999999999999


Q ss_pred             CCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCC
Q 035691          590 DNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMG  634 (640)
Q Consensus       590 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  634 (640)
                      +.++.+||+|||+|+......     .....+||+.|+|||++.+
T Consensus       144 ~~~~~~kl~DFG~a~~~~~~~-----~~~~~~gt~~y~~PE~~~~  183 (277)
T d1phka_         144 DDDMNIKLTDFGFSCQLDPGE-----KLREVCGTPSYLAPEIIEC  183 (277)
T ss_dssp             CTTCCEEECCCTTCEECCTTC-----CBCCCCSCGGGCCHHHHHH
T ss_pred             cCCCCeEEccchheeEccCCC-----ceeeeeccCCCCCHHHhhc
Confidence            999999999999998764321     1233569999999999864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-34  Score=287.14  Aligned_cols=177  Identities=21%  Similarity=0.277  Sum_probs=150.1

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      -++|++.+.||+|+||+||+|+++.+|+.||||+++.... ....+.+|+++|+.++|||||++++++     .++...|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~   77 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESF-----ESMEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence            3678999999999999999999999999999999965433 335688999999999999999999994     4556899


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC--CcEEE
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND--MIAHV  597 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~--~~~kl  597 (640)
                      +|||||+||+|.+++.....         .+++..+..++.||+.||+|||+   .+|+||||||+|||++.+  ..+||
T Consensus        78 lvmE~~~gg~L~~~i~~~~~---------~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl  145 (321)
T d1tkia_          78 MIFEFISGLDIFERINTSAF---------ELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKI  145 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSSC---------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEE
T ss_pred             EEEecCCCCcHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEE
Confidence            99999999999999965432         38899999999999999999999   699999999999999854  58999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|||+++.....     .......||+.|+|||...+..++.
T Consensus       146 ~DFG~~~~~~~~-----~~~~~~~~t~~y~ape~~~~~~~~~  182 (321)
T d1tkia_         146 IEFGQARQLKPG-----DNFRLLFTAPEYYAPEVHQHDVVST  182 (321)
T ss_dssp             CCCTTCEECCTT-----CEEEEEESCGGGSCHHHHTTCEECH
T ss_pred             cccchhhccccC-----CcccccccccccccchhccCCCCCc
Confidence            999999865321     1122346899999999998877654

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-34  Score=290.17  Aligned_cols=179  Identities=24%  Similarity=0.414  Sum_probs=143.4

Q ss_pred             CCCcccCcccccccceEEEEEECCCCe----EEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQT----VVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      ++|++.++||+|+||+||+|++..+|+    +||+|.++.. .....+.|.+|++++++++|||||+++|+|...     
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence            468999999999999999999987776    5888887533 334567899999999999999999999997532     


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                       ..+++|||+.+|+|.+++....         ..+++..++.++.||+.||+|||+   ++|+||||||+||+++.++.+
T Consensus        84 -~~~~v~e~~~~~~l~~~~~~~~---------~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~  150 (317)
T d1xkka_          84 -TVQLITQLMPFGCLLDYVREHK---------DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHV  150 (317)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHTS---------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEE
T ss_pred             -CeeEEEEeccCCcccccccccc---------cCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCe
Confidence             3578899999999998876543         238899999999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+|||+|+.......  ........||+.|||||++.++.+|.
T Consensus       151 kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~  192 (317)
T d1xkka_         151 KITDFGLAKLLGAEEK--EYHAEGGKVPIKWMALESILHRIYTH  192 (317)
T ss_dssp             EECCCSHHHHTTTTCC----------CCTTTSCHHHHHHCCCCH
T ss_pred             Eeeccccceecccccc--cccccccccCccccChHHHhcCCCCh
Confidence            9999999997643222  12223346899999999999888875

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=2.8e-33  Score=283.92  Aligned_cols=257  Identities=30%  Similarity=0.473  Sum_probs=211.0

Q ss_pred             CCCeeeccCCcccc--cCCccCcCCCCCCEEECcC-CccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCC
Q 035691           82 NIRIPLLAGNQFFG--NIPHSISNASKLEWLDFAN-NSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNC  158 (640)
Q Consensus        82 ~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l  158 (640)
                      +++.|+|++|.+++  .+|..++++++|++|||++ |+++|.+|..|++|++|++|+|++|++.+.      .+..+..+
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~------~~~~~~~~  124 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA------IPDFLSQI  124 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEE------CCGGGGGC
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhcccccccc------ccccccch
Confidence            56677777777776  3677788888888888875 778777788888888888888888888765      33456677


Q ss_pred             CCcceEecCCCCCCC-cCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCC-CEEEccCCCCCCCCCccccCCCCccEEe
Q 035691          159 TYLEIVSLNVNSLRS-IPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFL-TELNLRGNSIRGSIPSALGNCHQLQSLD  236 (640)
Q Consensus       159 ~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~  236 (640)
                      ..|+.++++.|.+.. +|..+..++.|+.+++++|.+.+.+|..+..+..+ +.+++++|++++..|..+..+..+ .+ 
T Consensus       125 ~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l-  202 (313)
T d1ogqa_         125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FV-  202 (313)
T ss_dssp             TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EE-
T ss_pred             hhhcccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cc-
Confidence            778888888887766 77788888889999999999888888888888776 888889999988888777766544 45 


Q ss_pred             ccCccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCC
Q 035691          237 LSKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSS  316 (640)
Q Consensus       237 ls~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  316 (640)
                                     ++++|...+.+|..+..+++|+.+++++|.+++.+| .+..+++|++|+|++|++++.+|..|.+
T Consensus       203 ---------------~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~  266 (313)
T d1ogqa_         203 ---------------DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQ  266 (313)
T ss_dssp             ---------------ECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGG
T ss_pred             ---------------cccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhC
Confidence                           777888888889999999999999999999986654 6888899999999999999999999999


Q ss_pred             CCCCCeEeCcCCccccccCCcccCCCCCCCCCccccccCCCCCcCCCcCCCCCCC
Q 035691          317 LKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGISELKLPPC  371 (640)
Q Consensus       317 l~~L~~L~l~~N~l~~~~~~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~~~~p~~  371 (640)
                      +++|++|||++|+++     |.+|..+.+++++.+++.+|+.+||.|.    |+|
T Consensus       267 L~~L~~L~Ls~N~l~-----g~iP~~~~L~~L~~l~l~~N~~l~g~pl----p~c  312 (313)
T d1ogqa_         267 LKFLHSLNVSFNNLC-----GEIPQGGNLQRFDVSAYANNKCLCGSPL----PAC  312 (313)
T ss_dssp             CTTCCEEECCSSEEE-----EECCCSTTGGGSCGGGTCSSSEEESTTS----SCC
T ss_pred             CCCCCEEECcCCccc-----ccCCCcccCCCCCHHHhCCCccccCCCC----CCC
Confidence            999999999999998     7888877888999999999999999764    566

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-33  Score=287.60  Aligned_cols=177  Identities=23%  Similarity=0.286  Sum_probs=145.9

Q ss_pred             CCCcccC-cccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCcee
Q 035691          441 GGFSSAN-LIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       441 ~~~~~~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ++|.+.. +||+|+||+||+|++..+++.||||+++..     ..+.+|++++.++ +|||||++++++... +..+...
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~~   84 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCL   84 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCEE
Confidence            4677764 699999999999999999999999998532     4567899987655 899999999986432 2334678


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC---CCcE
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN---DMIA  595 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~---~~~~  595 (640)
                      |+|||||+||+|.+++.....        ..+++..+..|+.|++.||+|||+   .+|+||||||+|||+++   .+.+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~--------~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~  153 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGD--------QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAIL  153 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSC--------CCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCE
T ss_pred             EEEEECCCCCcHHHHHHhcCC--------CCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccc
Confidence            999999999999999965432        348999999999999999999999   69999999999999985   5679


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+|||+|+......     .....+||+.|||||++.+..++.
T Consensus       154 Kl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~y~~  192 (335)
T d2ozaa1         154 KLTDFGFAKETTSHN-----SLTTPCYTPYYVAPEVLGPEKYDK  192 (335)
T ss_dssp             EECCCTTCEECCCCC-----CCCCCSCCCSSCCCCCCCGGGGSH
T ss_pred             cccccceeeeccCCC-----ccccccCCcccCCcHHHcCCCCCH
Confidence            999999998764322     122356999999999998887764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-33  Score=283.46  Aligned_cols=169  Identities=27%  Similarity=0.407  Sum_probs=138.6

Q ss_pred             cCcccccccceEEEEEECCCCeEEEEEEeecccch-----hHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          446 ANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRG-----ALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       446 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      .++||+|+||+||+|+++.+|+.||||+++.....     ..+.+.+|+.++++++|||||++++++     ..++..++
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~i   77 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNISL   77 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCEE
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCceee
Confidence            47899999999999999999999999999644321     135688999999999999999999995     44557899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||+.++++..+.....          .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+||
T Consensus        78 vmE~~~~~~~~~~~~~~~----------~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DF  144 (299)
T d1ua2a_          78 VFDFMETDLEVIIKDNSL----------VLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADF  144 (299)
T ss_dssp             EEECCSEEHHHHHTTCCS----------SCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             hhhhhcchHHhhhhhccc----------CCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccC
Confidence            999999988877664332          26777889999999999999999   79999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      |+|+.......    .....+||+.|||||++.+..
T Consensus       145 G~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~  176 (299)
T d1ua2a_         145 GLAKSFGSPNR----AYTHQVVTRWYRAPELLFGAR  176 (299)
T ss_dssp             GGGSTTTSCCC----CCCCSCCCCTTCCHHHHTTCS
T ss_pred             ccccccCCCcc----cccceecChhhccHHHHccCC
Confidence            99986643221    223357999999999987654

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-34  Score=285.75  Aligned_cols=197  Identities=22%  Similarity=0.321  Sum_probs=145.1

Q ss_pred             HHHHHhcCCCcccCcccccccceEEEEEECC-----CCeEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCCcceeEe
Q 035691          434 ESLLKATGGFSSANLIGTGSFGSVYKGILDP-----DQTVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRNLVKIITA  506 (640)
Q Consensus       434 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~  506 (640)
                      .+++...++|++.+.||+|+||+||+|++..     +++.||||+++... ....+.+.+|...+.++ +|+|||.++++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            3344445678999999999999999999753     45789999996433 34456788888888877 68999999998


Q ss_pred             eccCCcCCCceeeEEeeccCCCChhhhcCCCCCCC------CCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeC
Q 035691          507 CSSSDFQGNDFKALVYEFMHHGSLESWLHPESASD------DLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHC  580 (640)
Q Consensus       507 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHr  580 (640)
                      +..    .+...++|||||++|+|.+++.......      ........+++..+..++.||+.||.|||+   ++|+||
T Consensus        86 ~~~----~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHr  158 (299)
T d1ywna1          86 CTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHR  158 (299)
T ss_dssp             ECS----TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred             ecc----CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCC
Confidence            743    3456799999999999999986432210      000112348899999999999999999999   699999


Q ss_pred             CCCCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          581 DLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       581 dlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||||+|||+++++.+||+|||+|+.......  ........||+.|||||++.+..++.
T Consensus       159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~  215 (299)
T d1ywna1         159 DLAARNILLSEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRVYTI  215 (299)
T ss_dssp             CCCGGGEEECGGGCEEECC------CCSCTT--SCCTTSCCCGGGGCCHHHHHHCCCCH
T ss_pred             cCCccceeECCCCcEEEccCcchhhcccccc--ccccCceeeCccccchhHhhcCCCCc
Confidence            9999999999999999999999987643222  12223457999999999998888764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-33  Score=282.41  Aligned_cols=178  Identities=28%  Similarity=0.452  Sum_probs=146.5

Q ss_pred             cCcccccccceEEEEEECCCC---eEEEEEEeec-ccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEE
Q 035691          446 ANLIGTGSFGSVYKGILDPDQ---TVVAVKVLFL-HQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALV  521 (640)
Q Consensus       446 ~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv  521 (640)
                      .++||+|+||+||+|++..++   ..||||+++. .+....++|.+|+++|++++|||||+++|+|...    +...++|
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~lv  107 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGSPLVV  107 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCceEEE
Confidence            468999999999999986543   4699999863 3455668899999999999999999999997432    3468899


Q ss_pred             eeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEcccc
Q 035691          522 YEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDFG  601 (640)
Q Consensus       522 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~DfG  601 (640)
                      ||||++|+|.+++.....         ..++..++.++.|++.||.|+|+   ++|+||||||+|||+++++.+||+|||
T Consensus       108 ~E~~~~g~l~~~~~~~~~---------~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG  175 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFG  175 (311)
T ss_dssp             EECCTTCBHHHHHHCTTC---------CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSG
T ss_pred             EEEeecCchhhhhccccc---------cchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEeccc
Confidence            999999999998875432         36778899999999999999999   799999999999999999999999999


Q ss_pred             ccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          602 LTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       602 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +++.................||+.|+|||++.+..++.
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  213 (311)
T d1r0pa_         176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT  213 (311)
T ss_dssp             GGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCH
T ss_pred             chhhccccccccceecccccccccccChHHHhcCCCCC
Confidence            99976543322222333456899999999998887764

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.8e-34  Score=286.57  Aligned_cols=197  Identities=27%  Similarity=0.380  Sum_probs=154.8

Q ss_pred             HHHHHhcCCCcccCcccccccceEEEEEEC-----CCCeEEEEEEeecccc-hhHHHHHHHHHHHHhcCCCCCcceeEee
Q 035691          434 ESLLKATGGFSSANLIGTGSFGSVYKGILD-----PDQTVVAVKVLFLHQR-GALKSFMAECEALRNIRHRNLVKIITAC  507 (640)
Q Consensus       434 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~  507 (640)
                      .+++...++|++.+.||+|+||+||+|+++     .+++.||||+++.... ...++|.+|++++++++||||++++++|
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            344555678999999999999999999975     3568999999965433 3457899999999999999999999996


Q ss_pred             ccCCcCCCceeeEEeeccCCCChhhhcCCCCCCC--------------CCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 035691          508 SSSDFQGNDFKALVYEFMHHGSLESWLHPESASD--------------DLNYSPSILSFLQRLNIAINVASALEYLHHHC  573 (640)
Q Consensus       508 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~--------------~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~  573 (640)
                      ..     ....++||||+++|+|.+++.......              ........+++..++.|+.|++.||+|||+  
T Consensus        86 ~~-----~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~--  158 (301)
T d1lufa_          86 AV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--  158 (301)
T ss_dssp             CS-----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--
T ss_pred             cc-----CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc--
Confidence            43     346889999999999999986432110              001112348899999999999999999999  


Q ss_pred             CCCeeeCCCCCCCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          574 KKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       574 ~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                       .+|+||||||+|||+|.++.+||+|||+|+.+......  ....+..||+.|||||++.+..+|.|
T Consensus       159 -~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~t~k  222 (301)
T d1lufa_         159 -RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY--KADGNDAIPIRWMPPESIFYNRYTTE  222 (301)
T ss_dssp             -TTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB--C----CCBCGGGCCHHHHHHCCCCHH
T ss_pred             -CCeEeeEEcccceEECCCCcEEEccchhheeccCCccc--cccCCCCcCcCcCCHHHHccCCCChh
Confidence             69999999999999999999999999999866433221  22234568999999999998888753

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=2.8e-33  Score=281.31  Aligned_cols=179  Identities=27%  Similarity=0.315  Sum_probs=139.7

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeEE
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKALV  521 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~lv  521 (640)
                      +|.+.+.||+|+||.||+|++  +|+.||||+++.... ....++.|+..+..++|||||+++++|.... ......++|
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv   79 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV   79 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEE
Confidence            456778999999999999997  689999999854332 1122334555556789999999999986543 233468999


Q ss_pred             eeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          522 YEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHH-----CKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       522 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~-----~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ||||++|+|.++++..           .++|..++.++.|++.||.|+|+.     ..++|+||||||+|||+++++.+|
T Consensus        80 ~Ey~~~g~L~~~l~~~-----------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~K  148 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRY-----------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  148 (303)
T ss_dssp             EECCTTCBHHHHHHHC-----------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred             EecccCCCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeE
Confidence            9999999999999643           278999999999999999999973     236999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS  635 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  635 (640)
                      |+|||+++.+...............||+.|||||++.+.
T Consensus       149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  187 (303)
T d1vjya_         149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS  187 (303)
T ss_dssp             ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTC
T ss_pred             EEecCccccccCCCcceeccccceecccCcCChhhcccc
Confidence            999999987644322222233446799999999998764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=4.6e-33  Score=279.65  Aligned_cols=176  Identities=26%  Similarity=0.387  Sum_probs=143.9

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++...  +...+.+.+|++++++++|||||++++++     .+....
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-----~~~~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc-----ccccce
Confidence            57889999999999999999999999999999996443  22357899999999999999999999995     445689


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++||||+.++.+........         ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+
T Consensus        77 ~iv~e~~~~~~~~~~~~~~~---------~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~  144 (298)
T d1gz8a_          77 YLVFEFLHQDLKKFMDASAL---------TGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLA  144 (298)
T ss_dssp             EEEEECCSEEHHHHHHHTTT---------TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             eEEEeecCCchhhhhhhhcc---------cCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceec
Confidence            99999998654443332222         238999999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV  637 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  637 (640)
                      |||+|+.....    .......+||+.|+|||++....+
T Consensus       145 DFG~a~~~~~~----~~~~~~~~gt~~y~apE~~~~~~~  179 (298)
T d1gz8a_         145 DFGLARAFGVP----VRTYTHEVVTLWYRAPEILLGCKY  179 (298)
T ss_dssp             STTHHHHHCCC----SBCTTCCBCCCTTCCHHHHTTCSS
T ss_pred             cCCcceeccCC----cccceeecccceeeehhhhccccC
Confidence            99999865322    122233569999999999877664

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1e-33  Score=280.66  Aligned_cols=179  Identities=26%  Similarity=0.387  Sum_probs=138.0

Q ss_pred             cCCCcccCcccccccceEEEEEECCC---CeEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPD---QTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGN  515 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~  515 (640)
                      .++|++.+.||+|+||.||+|++..+   +..||||.++.. .....+.|.+|++++++++|||||+++++|.      +
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~   79 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E   79 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------S
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------c
Confidence            45688899999999999999998644   457899988543 3344578999999999999999999999963      2


Q ss_pred             ceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcE
Q 035691          516 DFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIA  595 (640)
Q Consensus       516 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~  595 (640)
                      +..++||||+++|++.+++.....         .+++..++.++.||+.||.|||+   .+|+||||||+||+++.++.+
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~~~---------~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~  147 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVRKY---------SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCV  147 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTT---------TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEE
T ss_pred             CeEEEEEEeccCCcHHhhhhccCC---------CCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcE
Confidence            357899999999999988754332         37899999999999999999999   699999999999999999999


Q ss_pred             EEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          596 HVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       596 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ||+|||+|+.......   .......||+.|+|||++.+..++.
T Consensus       148 Kl~DfG~a~~~~~~~~---~~~~~~~gt~~y~apE~l~~~~~~~  188 (273)
T d1mp8a_         148 KLGDFGLSRYMEDSTY---YKASKGKLPIKWMAPESINFRRFTS  188 (273)
T ss_dssp             EECC----------------------CCGGGCCHHHHHHCCCSH
T ss_pred             EEccchhheeccCCcc---eeccceecCcccchhhHhccCCCCC
Confidence            9999999987643221   1223346899999999998887764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-33  Score=277.25  Aligned_cols=173  Identities=32%  Similarity=0.437  Sum_probs=139.2

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      ++|++.+.||+|+||.||+|+++  |+.||||+++..  ...++|.+|++++++++|||||+++|+|..    ..+..++
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~l   78 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYI   78 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEe----cCCcEEE
Confidence            45678899999999999999984  789999999543  344789999999999999999999999743    2345799


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEccc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVGDF  600 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~Df  600 (640)
                      ||||+++|+|.+++.....        ..+++..++.|+.||+.||.|||+   .+|+||||||+||+++.++.+|++||
T Consensus        79 v~ey~~~g~L~~~l~~~~~--------~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~df  147 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRGR--------SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDF  147 (262)
T ss_dssp             EECCCTTEEHHHHHHHHHH--------HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred             EEeccCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeeccc
Confidence            9999999999999864321        237899999999999999999999   69999999999999999999999999


Q ss_pred             cccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          601 GLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       601 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      |+++.....       .....+|+.|+|||++.+..+|+
T Consensus       148 g~s~~~~~~-------~~~~~~~~~y~aPE~l~~~~~t~  179 (262)
T d1byga_         148 GLTKEASST-------QDTGKLPVKWTAPEALREKKFST  179 (262)
T ss_dssp             CC-------------------CCTTTSCHHHHHHCCCCH
T ss_pred             ccceecCCC-------CccccccccCCChHHHhCCCCCh
Confidence            999865321       11235789999999998888775

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.4e-32  Score=277.54  Aligned_cols=184  Identities=24%  Similarity=0.362  Sum_probs=148.2

Q ss_pred             cCCCcccCcccccccceEEEEEECCC-CeEEEEEEeeccc--chhHHHHHHHHHHHHhc---CCCCCcceeEeeccCCcC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPD-QTVVAVKVLFLHQ--RGALKSFMAECEALRNI---RHRNLVKIITACSSSDFQ  513 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~  513 (640)
                      .++|++.+.||+|+||+||+|++..+ ++.||||+++...  ......+.+|+.+++.+   +|||||+++++|......
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46799999999999999999999655 6789999996432  22234566777777665   799999999998655445


Q ss_pred             CCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC
Q 035691          514 GNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM  593 (640)
Q Consensus       514 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~  593 (640)
                      .....+++|||+++|++........         ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~  153 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPE---------PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSG  153 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCT---------TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTC
T ss_pred             cCceEEEEEEeccCCchhhhhhccC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCC
Confidence            5667899999999887765443322         237888999999999999999999   6999999999999999999


Q ss_pred             cEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          594 IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       594 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      .+||+|||+++.....     ......+||+.|||||++.+.+++.|
T Consensus       154 ~~kl~dfg~~~~~~~~-----~~~~~~~gT~~Y~APE~~~~~~y~~~  195 (305)
T d1blxa_         154 QIKLADFGLARIYSFQ-----MALTSVVVTLWYRAPEVLLQSSYATP  195 (305)
T ss_dssp             CEEECSCCSCCCCCGG-----GGGCCCCCCCTTCCHHHHTTCCCCTH
T ss_pred             Ceeecchhhhhhhccc-----ccCCCcccChhhcCcchhcCCCCChh
Confidence            9999999999865322     12234579999999999999988764

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-33  Score=284.87  Aligned_cols=192  Identities=24%  Similarity=0.345  Sum_probs=151.9

Q ss_pred             HhcCCCcccCcccccccceEEEEEEC-----CCCeEEEEEEeecc-cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCC
Q 035691          438 KATGGFSSANLIGTGSFGSVYKGILD-----PDQTVVAVKVLFLH-QRGALKSFMAECEALRNIRHRNLVKIITACSSSD  511 (640)
Q Consensus       438 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~  511 (640)
                      ...++|++.+.||+|+||+||+|.+.     .+++.||||+++.. .......|.+|++++++++|||||+++++|.   
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~---   93 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS---   93 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC---
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe---
Confidence            33467788899999999999999874     24578999999643 3344567999999999999999999999964   


Q ss_pred             cCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC
Q 035691          512 FQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN  591 (640)
Q Consensus       512 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~  591 (640)
                        .++..++|||||++|+|.+++...+...........+++..+.+++.|++.||.|||+   .+|+||||||+|||+++
T Consensus        94 --~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~  168 (308)
T d1p4oa_          94 --QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAE  168 (308)
T ss_dssp             --SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECT
T ss_pred             --cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecC
Confidence              3446899999999999999886322110000111236888999999999999999999   69999999999999999


Q ss_pred             CCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          592 DMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       592 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      ++++||+|||+|+.+.....  ........||+.|+|||.+.++.++.
T Consensus       169 ~~~~Kl~DFGla~~~~~~~~--~~~~~~~~~t~~y~aPe~l~~~~~~~  214 (308)
T d1p4oa_         169 DFTVKIGDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGVFTT  214 (308)
T ss_dssp             TCCEEECCTTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHHHCCCCH
T ss_pred             CceEEEeecccceeccCCcc--eeeccceecccccCCHHHHccCCCCc
Confidence            99999999999987644321  22233446899999999998887764

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7.3e-33  Score=279.42  Aligned_cols=186  Identities=28%  Similarity=0.414  Sum_probs=145.9

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeE--EEEEEeecc-cchhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCcCCCc
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTV--VAVKVLFLH-QRGALKSFMAECEALRNI-RHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ++|++.+.||+|+||+||+|+++.+|..  ||||++... .....+.|.+|+++|+++ +|||||+++++|.     .++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~~~   84 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG   84 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ETT
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe-----cCC
Confidence            4678889999999999999999888764  667776432 334556899999999998 7999999999964     345


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCC------CCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC
Q 035691          517 FKALVYEFMHHGSLESWLHPESASD------DLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD  590 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~  590 (640)
                      ..++||||+++|+|.++++......      ........+++..+.+++.||+.||.|+|+   ++|+||||||+|||++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~  161 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVG  161 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEc
Confidence            7899999999999999997542100      000112458999999999999999999999   6999999999999999


Q ss_pred             CCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          591 NDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       591 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      .++.+||+|||+|+.......     .....||+.|+|||.+.++.++.
T Consensus       162 ~~~~~kl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~  205 (309)
T d1fvra_         162 ENYVAKIADFGLSRGQEVYVK-----KTMGRLPVRWMAIESLNYSVYTT  205 (309)
T ss_dssp             GGGCEEECCTTCEESSCEECC-----C----CCTTTCCHHHHHHCEECH
T ss_pred             CCCceEEcccccccccccccc-----ccceecCCcccchHHhccCCCCc
Confidence            999999999999986543221     12345899999999998887764

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=1.9e-30  Score=270.52  Aligned_cols=185  Identities=25%  Similarity=0.327  Sum_probs=109.0

Q ss_pred             ccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccE
Q 035691          155 LVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQS  234 (640)
Q Consensus       155 l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  234 (640)
                      +..+++++.+++++|.++.++. ....++|++|++++|.++. + +.+..+++|+.|++++|++++..+  +..+++|+.
T Consensus       193 ~~~l~~~~~l~l~~n~i~~~~~-~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~  267 (384)
T d2omza2         193 LAKLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTE  267 (384)
T ss_dssp             GGGCTTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSE
T ss_pred             cccccccceeeccCCccCCCCc-ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccCCE
Confidence            4455666666666666666543 3334566666666666663 2 245666666666666666664432  556666666


Q ss_pred             EeccCccccCC------CCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCC
Q 035691          235 LDLSKTIFLGQ------YPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHG  308 (640)
Q Consensus       235 L~ls~n~~~~~------~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  308 (640)
                      |++++|.+.+.      ..++.+++++|.+++  ...+..+++++.|++++|++++..  .+..+++|++|++++|+|++
T Consensus       268 L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~  343 (384)
T d2omza2         268 LKLGANQISNISPLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD  343 (384)
T ss_dssp             EECCSSCCCCCGGGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC
T ss_pred             eeccCcccCCCCcccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC
Confidence            66666654432      235566666666664  234566666667777777666432  25666667777777776664


Q ss_pred             CCCccCCCCCCCCeEeCcCCccccccCCcccCCCCCCCCCccccccCC
Q 035691          309 PIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGN  356 (640)
Q Consensus       309 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~p~~~~~~~~~~~~~~~n  356 (640)
                       ++ .+.++++|++|++++|+++...     | ...++.++.+++++|
T Consensus       344 -l~-~l~~l~~L~~L~l~~N~l~~l~-----~-l~~l~~L~~L~L~~N  383 (384)
T d2omza2         344 -VS-SLANLTNINWLSAGHNQISDLT-----P-LANLTRITQLGLNDQ  383 (384)
T ss_dssp             -CG-GGGGCTTCCEEECCSSCCCBCG-----G-GTTCTTCSEEECCCE
T ss_pred             -Ch-hHcCCCCCCEEECCCCcCCCCh-----h-hccCCCCCEeeCCCC
Confidence             22 4666666777777766666321     1 233455666666555

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4e-33  Score=276.12  Aligned_cols=174  Identities=22%  Similarity=0.283  Sum_probs=143.9

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccc------hhHHHHHHHHHHHHhcC--CCCCcceeEeeccCC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR------GALKSFMAECEALRNIR--HRNLVKIITACSSSD  511 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~  511 (640)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++....      .....+.+|+.++++++  |||||++++++    
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~----   78 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF----   78 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE----
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE----
Confidence            3579999999999999999999999999999999964321      11234678999999986  89999999994    


Q ss_pred             cCCCceeeEEeeccCC-CChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC
Q 035691          512 FQGNDFKALVYEFMHH-GSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD  590 (640)
Q Consensus       512 ~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~  590 (640)
                       .+.+..++||||+.+ +++.+++....          .+++..+..++.|++.||+|||+   ++|+||||||+|||++
T Consensus        79 -~~~~~~~lv~e~~~~~~~l~~~~~~~~----------~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~  144 (273)
T d1xwsa_          79 -ERPDSFVLILERPEPVQDLFDFITERG----------ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILID  144 (273)
T ss_dssp             -ECSSEEEEEEECCSSEEEHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEE
T ss_pred             -eeCCeEEEEEEeccCcchHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEe
Confidence             445688999999976 67888775432          38899999999999999999999   7999999999999998


Q ss_pred             C-CCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCC
Q 035691          591 N-DMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV  637 (640)
Q Consensus       591 ~-~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  637 (640)
                      . ++.+||+|||+|+.....      ...+.+||+.|||||++.+.++
T Consensus       145 ~~~~~vkl~DFG~a~~~~~~------~~~~~~GT~~y~aPE~~~~~~~  186 (273)
T d1xwsa_         145 LNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPEWIRYHRY  186 (273)
T ss_dssp             TTTTEEEECCCTTCEECCSS------CBCCCCSCGGGSCHHHHHHSCB
T ss_pred             cCCCeEEECccccceecccc------cccccccCCCcCCHHHHcCCCC
Confidence            5 579999999999865332      1224579999999999987665

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7.1e-32  Score=276.65  Aligned_cols=181  Identities=24%  Similarity=0.306  Sum_probs=146.3

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc-chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ-RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      +++|++.+.||+|+||+||+|++..+|+.||||+++... ....+.+++|+++|++++|||||++++++....+......
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            457999999999999999999999999999999996443 3445789999999999999999999999876655444445


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      +++ +|+.+|+|.+++...           .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+
T Consensus        87 ~l~-~~~~~g~L~~~l~~~-----------~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~  151 (345)
T d1pmea_          87 YLV-THLMGADLYKLLKTQ-----------HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKIC  151 (345)
T ss_dssp             EEE-EECCCEEHHHHHHHC-----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEEC
T ss_pred             EEE-EeecCCchhhhhhcC-----------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEc
Confidence            555 566789999998532           27899999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      |||+|+........ .......+||+.|+|||++....
T Consensus       152 DfG~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~  188 (345)
T d1pmea_         152 DFGLARVADPDHDH-TGFLTEYVATRWYRAPEIMLNSK  188 (345)
T ss_dssp             CCTTCEECCGGGCB-CCTTCCCCSCGGGCCGGGTTTBC
T ss_pred             ccCceeeccCCCcc-ceeeccccccceechHHHhhcCC
Confidence            99999876433221 11223456999999999986543

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=5.3e-32  Score=274.47  Aligned_cols=250  Identities=27%  Similarity=0.406  Sum_probs=153.5

Q ss_pred             CCeEEcccCccCc--cCCcCCCCCCCCCEEEccC-CCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCC
Q 035691           29 LRYIIFNSNTLQG--QIPVNLTHCSELRTLDLVL-NKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNAS  105 (640)
Q Consensus        29 L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  105 (640)
                      ++.|+|++|.+++  .+|.++.+|++|++|||++ |.     +.|.+|+.+.. +++|++|+|++|+|.+..+..+..+.
T Consensus        52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~-----l~g~iP~~i~~-L~~L~~L~Ls~N~l~~~~~~~~~~~~  125 (313)
T d1ogqa_          52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINN-----LVGPIPPAIAK-LTQLHYLYITHTNVSGAIPDFLSQIK  125 (313)
T ss_dssp             EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETT-----EESCCCGGGGG-CTTCSEEEEEEECCEEECCGGGGGCT
T ss_pred             EEEEECCCCCCCCCCCCChHHhcCccccccccccccc-----ccccccccccc-ccccchhhhccccccccccccccchh
Confidence            4444444444443  2344444444555555442 22     22334444332 44555555555555555555555555


Q ss_pred             CCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCc-ceEecCCCCCCC-cCcCCCCCCC
Q 035691          106 KLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYL-EIVSLNVNSLRS-IPISVGYLPK  183 (640)
Q Consensus       106 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L-~~L~L~~N~l~~-ip~~~~~l~~  183 (640)
                      +|+++++++|++.+.+|..|..+++|+.+++++|.+++.      .++.+..+..+ +.++++.|+++. .|..+..+ .
T Consensus       126 ~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~------ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l-~  198 (313)
T d1ogqa_         126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA------IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-N  198 (313)
T ss_dssp             TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEE------CCGGGGCCCTTCCEEECCSSEEEEECCGGGGGC-C
T ss_pred             hhcccccccccccccCchhhccCcccceeeccccccccc------ccccccccccccccccccccccccccccccccc-c
Confidence            555555555555555555555555555555555555432      23333333333 455555555554 33344444 3


Q ss_pred             CCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCC
Q 035691          184 LQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIP  263 (640)
Q Consensus       184 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~  263 (640)
                      +..+++++|.+.+.+|..+..+++|+.+++++|.+.+.+| .+..+++|+.|                +|++|+++|.+|
T Consensus       199 ~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L----------------~Ls~N~l~g~iP  261 (313)
T d1ogqa_         199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGL----------------DLRNNRIYGTLP  261 (313)
T ss_dssp             CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEE----------------ECCSSCCEECCC
T ss_pred             cccccccccccccccccccccccccccccccccccccccc-ccccccccccc----------------cCccCeecccCC
Confidence            4578888888888888888888888888888888876554 57777777777                777888888888


Q ss_pred             ccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCc-cCCC
Q 035691          264 LAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINS-FHGP  309 (640)
Q Consensus       264 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~  309 (640)
                      ..|+++++|++|+|++|+|+|.+|. ++++++|+.+++++|+ +.|.
T Consensus       262 ~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~  307 (313)
T d1ogqa_         262 QGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGS  307 (313)
T ss_dssp             GGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEEST
T ss_pred             hHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCC
Confidence            8888888888888888888888874 6778888888888887 4553

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.9e-32  Score=275.89  Aligned_cols=187  Identities=24%  Similarity=0.373  Sum_probs=146.6

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCC---cCC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSD---FQG  514 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---~~~  514 (640)
                      .++|++.+.||+|+||+||+|++..+|+.||||++...  .+...+++.+|+++|++++||||+++++++....   ...
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            36789999999999999999999999999999998543  2334577899999999999999999999975432   122


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                      ....++||||++++.+..+....          ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~----------~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~  155 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVL----------VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGV  155 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTT----------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSC
T ss_pred             CceEEEEEeccCCCccchhhhcc----------cccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCc
Confidence            45689999999988776654332          237888899999999999999999   69999999999999999999


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCC-CCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS-QVST  639 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~  639 (640)
                      +||+|||+|+................+||+.|+|||++.+. .++.
T Consensus       156 ~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~  201 (318)
T d3blha1         156 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGP  201 (318)
T ss_dssp             EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCT
T ss_pred             EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCc
Confidence            99999999987654332222233345799999999999876 3444

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.4e-33  Score=274.18  Aligned_cols=180  Identities=29%  Similarity=0.399  Sum_probs=137.8

Q ss_pred             CCCcccCcccccccceEEEEEECC-CC--eEEEEEEeecc---cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCC
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDP-DQ--TVVAVKVLFLH---QRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQG  514 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~  514 (640)
                      ++|++.+.||+|+||+||+|++.. ++  ..||||+++..   .....+.|.+|+.+|++++|||||+++|+|..     
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-----   82 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-----   82 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence            468889999999999999998642 22  47899998543   33445789999999999999999999999742     


Q ss_pred             CceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCc
Q 035691          515 NDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMI  594 (640)
Q Consensus       515 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~  594 (640)
                       +..++|||||++|++.+++....         ..+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.
T Consensus        83 -~~~~lv~e~~~~~~l~~~~~~~~---------~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~  149 (273)
T d1u46a_          83 -PPMKMVTELAPLGSLLDRLRKHQ---------GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDL  149 (273)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHG---------GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTE
T ss_pred             -cchheeeeeecCcchhhhhhccc---------CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccc
Confidence             24689999999999998875432         238899999999999999999999   69999999999999999999


Q ss_pred             EEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          595 AHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       595 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +||+|||+++....... .........||+.|+|||++.+..+|.
T Consensus       150 vkl~DfGl~~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~  193 (273)
T d1u46a_         150 VKIGDFGLMRALPQNDD-HYVMQEHRKVPFAWCAPESLKTRTFSH  193 (273)
T ss_dssp             EEECCCTTCEECCC-CC-EEEC-----CCGGGCCHHHHHHCEEEH
T ss_pred             eeeccchhhhhcccCCC-cceecCccccCcccCCHHHHhCCCCCc
Confidence            99999999997644322 122223345788999999998877654

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.97  E-value=1.7e-29  Score=254.77  Aligned_cols=246  Identities=21%  Similarity=0.249  Sum_probs=148.4

Q ss_pred             CcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCC
Q 035691            5 LMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIR   84 (640)
Q Consensus         5 L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~   84 (640)
                      ++.+|-++++++ .+|..+.  +++++|+|++|+|+.+.+.+|.++++|++||+++|.+..      +++..|..+++|+
T Consensus        12 ~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~------i~~~~f~~l~~L~   82 (305)
T d1xkua_          12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK------ISPGAFAPLVKLE   82 (305)
T ss_dssp             TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCC------BCTTTTTTCTTCC
T ss_pred             CCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccc------cchhhhhCCCccC
Confidence            455666666666 4555543  467777777777775555567777777777777776664      5555566667777


Q ss_pred             eeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceE
Q 035691           85 IPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIV  164 (640)
Q Consensus        85 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L  164 (640)
                      .|++++|+|+.+....   ...|+.|++++|.+..+.+..+.....+..++...|.......    ....+..+++|+.+
T Consensus        83 ~L~l~~n~l~~l~~~~---~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~----~~~~~~~l~~L~~l  155 (305)
T d1xkua_          83 RLYLSKNQLKELPEKM---PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI----ENGAFQGMKKLSYI  155 (305)
T ss_dssp             EEECCSSCCSBCCSSC---CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGB----CTTGGGGCTTCCEE
T ss_pred             EecccCCccCcCccch---hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCC----CccccccccccCcc
Confidence            7777777766443322   2456667777777766555566666666666666665443321    22345556666666


Q ss_pred             ecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccC
Q 035691          165 SLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLG  244 (640)
Q Consensus       165 ~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~  244 (640)
                      +++.|.++.+|..+  +++|+.|++++|.+.+..+..|.+++.++.|++++|.+.+..+.+|.++++|++|         
T Consensus       156 ~l~~n~l~~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L---------  224 (305)
T d1xkua_         156 RIADTNITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLREL---------  224 (305)
T ss_dssp             ECCSSCCCSCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEE---------
T ss_pred             ccccCCccccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceee---------
Confidence            66666666655433  3566666666666665666666666666666666666665555555555555555         


Q ss_pred             CCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCc
Q 035691          245 QYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGE  285 (640)
Q Consensus       245 ~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  285 (640)
                             +|++|+|+ .+|.+|..+++|++|+|++|+|+..
T Consensus       225 -------~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i  257 (305)
T d1xkua_         225 -------HLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI  257 (305)
T ss_dssp             -------ECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCC
T ss_pred             -------eccccccc-ccccccccccCCCEEECCCCccCcc
Confidence                   55555555 3345555556666666666665533

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.4e-32  Score=273.26  Aligned_cols=190  Identities=25%  Similarity=0.332  Sum_probs=152.7

Q ss_pred             cCCCcccCcccccccceEEEEEEC-----CCCeEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCCcceeEeeccCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILD-----PDQTVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRNLVKIITACSSSDF  512 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~  512 (640)
                      .++|++.+.||+|+||.||+|++.     .+++.||||+++... .....+|.+|+.+++++ +|||||+++++|..   
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~---   98 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI---   98 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee---
Confidence            456788899999999999999863     467899999996543 34556899999999999 69999999999643   


Q ss_pred             CCCceeeEEeeccCCCChhhhcCCCCCCCCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCC
Q 035691          513 QGNDFKALVYEFMHHGSLESWLHPESASDDL--------NYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKP  584 (640)
Q Consensus       513 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~--------~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp  584 (640)
                        ....++|||||++|+|.++++........        ......+++..+..++.||+.||+|||+   ++|+||||||
T Consensus        99 --~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp  173 (311)
T d1t46a_          99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAA  173 (311)
T ss_dssp             --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred             --CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccc
Confidence              34689999999999999998654321110        0112358899999999999999999999   6999999999


Q ss_pred             CCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCC
Q 035691          585 SNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       585 ~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +||+++.++.+|++|||+++.......  .......+||+.|+|||++.++.++.
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~  226 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSN--YVVKGNARLPVKWMAPESIFNCVYTF  226 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTT--SEECSSSEECGGGCCHHHHHHCCCCH
T ss_pred             ccccccccCcccccccchheeccCCCc--ceEeeecccChHHcCHHHhcCCCCCC
Confidence            999999999999999999997754322  22333467899999999998887764

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7.5e-32  Score=270.62  Aligned_cols=191  Identities=26%  Similarity=0.377  Sum_probs=146.8

Q ss_pred             cCCCcccCcccccccceEEEEEECCCC-------eEEEEEEeeccc-chhHHHHHHHHHHHHhc-CCCCCcceeEeeccC
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQ-------TVVAVKVLFLHQ-RGALKSFMAECEALRNI-RHRNLVKIITACSSS  510 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~  510 (640)
                      .++|.+.+.||+|+||.||+|+...++       ..||||+++... ......+.+|...+.++ +|||||+++++|.. 
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~-   90 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-   90 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence            356788899999999999999875433       579999996543 34457889999999888 89999999999743 


Q ss_pred             CcCCCceeeEEeeccCCCChhhhcCCCCCCC------CCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCC
Q 035691          511 DFQGNDFKALVYEFMHHGSLESWLHPESASD------DLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKP  584 (640)
Q Consensus       511 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp  584 (640)
                          +...++|||||++|+|.+++.......      ........+++.+++.++.|++.||+|||+   .+|+||||||
T Consensus        91 ----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp  163 (299)
T d1fgka_          91 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAA  163 (299)
T ss_dssp             ----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred             ----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecc
Confidence                457899999999999999996543211      011122458999999999999999999999   6999999999


Q ss_pred             CCeeeCCCCcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          585 SNVLLDNDMIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       585 ~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||++.++.+||+|||+++........  .......||+.|+|||.+.++.+++|
T Consensus       164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~y~~k  217 (299)
T d1fgka_         164 RNVLVTEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFDRIYTHQ  217 (299)
T ss_dssp             GGEEECTTCCEEECSTTCCCCGGGCCTT--CCCTTSCCGGGGSCHHHHHHCCCCHH
T ss_pred             cceeecCCCCeEeccchhhccccccccc--cccccCCCChhhhhhhHhcCCCCCch
Confidence            9999999999999999999976543222  12334568999999999998888753

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.97  E-value=1.2e-31  Score=267.74  Aligned_cols=174  Identities=25%  Similarity=0.381  Sum_probs=143.1

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++....  +...+.+.+|+.+|++++|||||++++++     ...+..
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeec-----ccCCce
Confidence            57889999999999999999997 78999999995442  33357899999999999999999999995     445578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      +++|||+.++.+..+.....          .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+|++
T Consensus        76 ~i~~e~~~~~~~~~~~~~~~----------~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~  142 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDVCEG----------GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIA  142 (286)
T ss_dssp             EEEEECCSEEHHHHHHTSTT----------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             eEEEEeehhhhHHHHHhhcC----------CcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEec
Confidence            99999999887777765332          38999999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV  637 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  637 (640)
                      |||.|.......    .......|++.|+|||.+.+..+
T Consensus       143 DfG~a~~~~~~~----~~~~~~~~~~~y~~pE~~~~~~~  177 (286)
T d1ob3a_         143 DFGLARAFGIPV----RKYTHEIVTLWYRAPDVLMGSKK  177 (286)
T ss_dssp             CTTHHHHHCC-------------CCCTTCCHHHHTTCCS
T ss_pred             ccccceecccCc----cccceecccchhhhHHHHhCCCC
Confidence            999998653321    12233468999999999976543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.97  E-value=2.5e-31  Score=265.92  Aligned_cols=180  Identities=22%  Similarity=0.292  Sum_probs=147.3

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCC-CCCcceeEeeccCCcCCCcee
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRH-RNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~~~~~  518 (640)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.....  .+.+.+|+++++.++| +|++.+++++     ..+...
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~   76 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHN   76 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCCcc
Confidence            4679999999999999999999999999999998854322  2456788999999965 8999999884     345578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCC-----CC
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDN-----DM  593 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~-----~~  593 (640)
                      ++||||+ +|+|.+++.....         .+++.++..++.|++.||+|||+   .+|+||||||+||+++.     ++
T Consensus        77 ~~vme~~-~~~l~~~~~~~~~---------~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~  143 (293)
T d1csna_          77 VLVIDLL-GPSLEDLLDLCGR---------KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNAN  143 (293)
T ss_dssp             EEEEECC-CCBHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTT
T ss_pred             EEEEEec-CCCHHHHHHhhcc---------chhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCC
Confidence            9999999 6899988764432         37889999999999999999999   79999999999999974     57


Q ss_pred             cEEEccccccccCCCccCCC---ceeeccccccccccCcccCCCCCCCC
Q 035691          594 IAHVGDFGLTRFIPEVISSN---QCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       594 ~~kl~DfGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      .+||+|||+|+.+.+.....   .......+||+.|||||++.+..++.
T Consensus       144 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~  192 (293)
T d1csna_         144 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSR  192 (293)
T ss_dssp             CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH
T ss_pred             ceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCCh
Confidence            89999999999765432211   12234567999999999999988774

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.97  E-value=5.8e-31  Score=268.29  Aligned_cols=169  Identities=22%  Similarity=0.323  Sum_probs=142.7

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcC-CCCCcceeEeeccCCcCCCceee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR-HRNLVKIITACSSSDFQGNDFKA  519 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~~  519 (640)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++..   ..+.+.+|+++|++++ ||||+++++++...   .....+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCcee
Confidence            4689999999999999999999999999999998643   3467889999999995 99999999996532   345689


Q ss_pred             EEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC-cEEEc
Q 035691          520 LVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVG  598 (640)
Q Consensus       520 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~-~~kl~  598 (640)
                      +|||||++|+|..+.+             .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++ .+||+
T Consensus       109 ~v~e~~~~~~L~~~~~-------------~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~  172 (328)
T d3bqca1         109 LVFEHVNNTDFKQLYQ-------------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLI  172 (328)
T ss_dssp             EEEECCCSCBGGGTTT-------------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EEEeecCCCcHHHHhc-------------CCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeec
Confidence            9999999999987642             27888999999999999999999   6999999999999998654 69999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      |||+|+......     .....+||+.|+|||.+.+..
T Consensus       173 DFG~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~  205 (328)
T d3bqca1         173 DWGLAEFYHPGQ-----EYNVRVASRYFKGPELLVDYQ  205 (328)
T ss_dssp             CGGGCEECCTTC-----CCCSCCSCGGGCCHHHHTTCC
T ss_pred             ccccceeccCCC-----cccccccCccccCcccccCCC
Confidence            999998664321     122356899999999988765

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.6e-31  Score=271.79  Aligned_cols=175  Identities=25%  Similarity=0.340  Sum_probs=141.1

Q ss_pred             cCCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc-CCCc
Q 035691          440 TGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDF-QGND  516 (640)
Q Consensus       440 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~~  516 (640)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++..  .+...+.+.+|+++|+.++|||||+++++|...+. ....
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            56799999999999999999999999999999999643  33445788999999999999999999999865432 2334


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..++||||+ ++++..+.+..           .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+|
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~-----------~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~k  161 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE-----------KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELK  161 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEE
T ss_pred             eEEEEEecc-cccHHHHHHhc-----------cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccc
Confidence            578999999 55777766422           38899999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      ++|||+|+......       ...+||+.|+|||++.+..
T Consensus       162 l~Dfg~a~~~~~~~-------~~~~~t~~y~aPE~~~~~~  194 (346)
T d1cm8a_         162 ILDFGLARQADSEM-------TGYVVTRWYRAPEVILNWM  194 (346)
T ss_dssp             ECCCTTCEECCSSC-------CSSCSCGGGCCTHHHHTTT
T ss_pred             cccccceeccCCcc-------ccccccccccCHHHHcCCC
Confidence            99999998664322       2356999999999987754

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.5e-31  Score=271.97  Aligned_cols=179  Identities=26%  Similarity=0.385  Sum_probs=140.5

Q ss_pred             CCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCC-cCCCceeeE
Q 035691          442 GFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSD-FQGNDFKAL  520 (640)
Q Consensus       442 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~~~~~~l  520 (640)
                      +|+..++||+|+||+||+|+++.+|+.||||++.....    .+.+|+++|++++|||||++++++.... ..+..+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            46777899999999999999999999999999965432    2347999999999999999999975443 234456889


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCC-cEEEcc
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDM-IAHVGD  599 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~-~~kl~D  599 (640)
                      |||||++|.+..+......       ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++ .+||+|
T Consensus        97 v~Ey~~~~~~~~l~~~~~~-------~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~D  166 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRA-------KQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCD  166 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHT-------TCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECC
T ss_pred             EEeccCCccHHHHHhhhhc-------cCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEec
Confidence            9999987654433321111       1248999999999999999999999   6999999999999999775 899999


Q ss_pred             ccccccCCCccCCCceeeccccccccccCcccCCCC-CCCC
Q 035691          600 FGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGS-QVST  639 (640)
Q Consensus       600 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~  639 (640)
                      ||+|+......     ...+.+||+.|+|||.+.+. .++.
T Consensus       167 FG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~  202 (350)
T d1q5ka_         167 FGSAKQLVRGE-----PNVSYICSRYYRAPELIFGATDYTS  202 (350)
T ss_dssp             CTTCEECCTTS-----CCCSCCSCTTSCCHHHHTTCSSCCT
T ss_pred             ccchhhccCCc-----ccccccccccccChHHhhcccCCCc
Confidence            99998664321     12235699999999998765 3443

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=7.6e-31  Score=263.76  Aligned_cols=180  Identities=26%  Similarity=0.380  Sum_probs=143.3

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCceeeE
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFKAL  520 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~~l  520 (640)
                      ++|++.+.||+|+||+||+|++..+|+.||||++.....  .+++..|+++++.++|+++|..++.|    ....+..++
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~----~~~~~~~~i   80 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC----GAEGDYNVM   80 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEE----EEETTEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEE----EecCCEEEE
Confidence            569999999999999999999999999999999865432  24578999999999988877776665    334567899


Q ss_pred             EeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeC---CCCcEEE
Q 035691          521 VYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLD---NDMIAHV  597 (640)
Q Consensus       521 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~---~~~~~kl  597 (640)
                      ||||++ |++.+.+....         ..+++..+..++.|++.||+|||+   .+|+||||||+||+++   .+..+|+
T Consensus        81 vme~~~-~~l~~~~~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl  147 (299)
T d1ckia_          81 VMELLG-PSLEDLFNFCS---------RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYI  147 (299)
T ss_dssp             EEECCC-CBHHHHHHHTT---------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEE
T ss_pred             EEEEcC-Cchhhhhhhcc---------CCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeee
Confidence            999995 46655543322         238899999999999999999999   6999999999999975   4557999


Q ss_pred             ccccccccCCCccCCC---ceeeccccccccccCcccCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSN---QCSSVGLKGTVGYAAPEYGMGSQVST  639 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~s~  639 (640)
                      +|||+|+.+.......   .......+||+.|||||++.+..++.
T Consensus       148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  192 (299)
T d1ckia_         148 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSR  192 (299)
T ss_dssp             CCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCH
T ss_pred             eccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCC
Confidence            9999999775432211   12234567999999999999988764

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2e-30  Score=266.90  Aligned_cols=179  Identities=23%  Similarity=0.268  Sum_probs=140.6

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecc--cchhHHHHHHHHHHHHhcCCCCCcceeEeeccCCc-CCCce
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLH--QRGALKSFMAECEALRNIRHRNLVKIITACSSSDF-QGNDF  517 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~~~~  517 (640)
                      ++|++.++||+|+||+||+|+++.+|+.||||++...  .....+.+.+|+.++++++|||||++++++..... +....
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            5789999999999999999999999999999999643  23445678999999999999999999999854432 34568


Q ss_pred             eeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEE
Q 035691          518 KALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHV  597 (640)
Q Consensus       518 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl  597 (640)
                      .|+|||||.++.+..+ .            ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+|+
T Consensus        97 ~~iv~Ey~~~~l~~~~-~------------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl  160 (355)
T d2b1pa1          97 VYLVMELMDANLCQVI-Q------------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKI  160 (355)
T ss_dssp             EEEEEECCSEEHHHHH-T------------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEE
T ss_pred             eEEEEeccchHHHHhh-h------------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceee
Confidence            8999999987655544 2            227888999999999999999999   69999999999999999999999


Q ss_pred             ccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          598 GDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       598 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      +|||+++......     .....+||+.|+|||++.+..++++
T Consensus       161 ~df~~~~~~~~~~-----~~~~~~~t~~y~aPE~l~~~~~~~~  198 (355)
T d2b1pa1         161 LDFGLARTAGTSF-----MMTPYVVTRYYRAPEVILGMGYKEN  198 (355)
T ss_dssp             CCCCC--------------------CCTTCCHHHHTTCCCCTT
T ss_pred             echhhhhcccccc-----ccccccccccccChhhhcCCCCCCC
Confidence            9999988654321     2233568999999999999888764

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.5e-30  Score=258.22  Aligned_cols=175  Identities=22%  Similarity=0.371  Sum_probs=148.7

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCcee
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++...  ....+.+.+|+.+++.++|||||++++++.     +....
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-----~~~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc-----cccce
Confidence            46889999999999999999999999999999996543  344578999999999999999999999954     44578


Q ss_pred             eEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEEEc
Q 035691          519 ALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAHVG  598 (640)
Q Consensus       519 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~kl~  598 (640)
                      ++|||++.++++..++...+          .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+
T Consensus        77 ~iv~~~~~~~~l~~~~~~~~----------~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~  143 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSCNG----------DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLA  143 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTTT----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEEC
T ss_pred             eEEeeecccccccccccccc----------ccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeee
Confidence            99999999999988876443          37888999999999999999999   699999999999999999999999


Q ss_pred             cccccccCCCccCCCceeeccccccccccCcccCCCCCC
Q 035691          599 DFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV  637 (640)
Q Consensus       599 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  637 (640)
                      |||.|+.......    ......+++.|+|||++.+..+
T Consensus       144 DFG~a~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~  178 (292)
T d1unla_         144 NFGLARAFGIPVR----CYSAEVVTLWYRPPDVLFGAKL  178 (292)
T ss_dssp             CCTTCEECCSCCS----CCCSCCSCGGGCCHHHHTTCSC
T ss_pred             ecchhhcccCCCc----cceeeccccchhhhhHhccCCC
Confidence            9999987643222    1222357889999999887653

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.7e-30  Score=265.71  Aligned_cols=178  Identities=22%  Similarity=0.294  Sum_probs=145.5

Q ss_pred             hcCCCcccCcccccccceEEEEEECCCCeEEEEEEeeccc--chhHHHHHHHHHHHHhcCCCCCcceeEeeccCCcCCCc
Q 035691          439 ATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQ--RGALKSFMAECEALRNIRHRNLVKIITACSSSDFQGND  516 (640)
Q Consensus       439 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~~~  516 (640)
                      ..++|++.+.||+|+||+||+|++..+|+.||||+++...  ....+.+.+|+++|++++|||||++++++.........
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            3567999999999999999999999999999999996443  33446789999999999999999999997554433334


Q ss_pred             eeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCCCcEE
Q 035691          517 FKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDNDMIAH  596 (640)
Q Consensus       517 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~~~~k  596 (640)
                      ..+++|+|+.+|+|.+++...           .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+|
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~~-----------~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~k  161 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKCQ-----------KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELK  161 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTTC-----------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEE
T ss_pred             ceEEEEEeecCCchhhhcccc-----------cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCcccccccccccc
Confidence            456778888999999998532           28889999999999999999999   6999999999999999999999


Q ss_pred             EccccccccCCCccCCCceeeccccccccccCcccCCCCCC
Q 035691          597 VGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQV  637 (640)
Q Consensus       597 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  637 (640)
                      ++|||+|......       ..+..||+.|+|||+..+..+
T Consensus       162 l~dfg~a~~~~~~-------~~~~~g~~~y~apE~~~~~~~  195 (348)
T d2gfsa1         162 ILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMH  195 (348)
T ss_dssp             ECCC----CCTGG-------GSSSCHHHHTSCHHHHTTCSC
T ss_pred             ccccchhcccCcc-------cccccccccccCchhhcCCcc
Confidence            9999999765322       223468999999999877654

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.96  E-value=3.3e-28  Score=245.34  Aligned_cols=267  Identities=26%  Similarity=0.335  Sum_probs=200.4

Q ss_pred             CCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCC
Q 035691           28 QLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKL  107 (640)
Q Consensus        28 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  107 (640)
                      .++.++.++++++ .+|..+.  +++++|||++|+|++      +|+..|..+++|+.|++++|.+..+.|..|.++++|
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~------l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L   81 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITE------IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL   81 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCC------BCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTC
T ss_pred             cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCC------cChhHhhccccccccccccccccccchhhhhCCCcc
Confidence            4667888888888 5566664  578888888888876      887777778888888888888888888888888888


Q ss_pred             CEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCc---CcCCCCCCCC
Q 035691          108 EWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSI---PISVGYLPKL  184 (640)
Q Consensus       108 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~i---p~~~~~l~~L  184 (640)
                      ++|++++|+|+. +|..+  ...|..|++++|.+..++      ...+.....+..++...|.....   +..+..+++|
T Consensus        82 ~~L~l~~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~------~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L  152 (305)
T d1xkua_          82 ERLYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVR------KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKL  152 (305)
T ss_dssp             CEEECCSSCCSB-CCSSC--CTTCCEEECCSSCCCBBC------HHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTC
T ss_pred             CEecccCCccCc-Cccch--hhhhhhhhccccchhhhh------hhhhhccccccccccccccccccCCCcccccccccc
Confidence            888888888885 44332  356888888888887763      23455566677777777765542   3345667788


Q ss_pred             CEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCc
Q 035691          185 QVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPL  264 (640)
Q Consensus       185 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~  264 (640)
                      +.+++++|.+.. +|..+  +++|+.|++++|.+....+..|.+++.++.|                ++++|.+++..+.
T Consensus       153 ~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L----------------~~s~n~l~~~~~~  213 (305)
T d1xkua_         153 SYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKL----------------GLSFNSISAVDNG  213 (305)
T ss_dssp             CEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEE----------------ECCSSCCCEECTT
T ss_pred             CccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhcccccccc----------------ccccccccccccc
Confidence            888888888873 44433  4678888888888887777778777777777                7777778777778


Q ss_pred             cCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccC------CCCCCCCeEeCcCCcccc
Q 035691          265 AVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGL------SSLKSLEGLDLFQNTFQA  332 (640)
Q Consensus       265 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~------~~l~~L~~L~l~~N~l~~  332 (640)
                      .|.++++|++|+|++|+|+ .+|.+|..+++|++|+|++|+|+.+....|      ..+.+|+.|+|++|+++.
T Consensus       214 ~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~  286 (305)
T d1xkua_         214 SLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY  286 (305)
T ss_dssp             TGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred             cccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence            8888888888888888887 567788888888888888888886544443      346777888888887763

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=2.6e-28  Score=254.17  Aligned_cols=294  Identities=26%  Similarity=0.323  Sum_probs=239.2

Q ss_pred             CCCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCC
Q 035691            2 LTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLP   81 (640)
Q Consensus         2 l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~   81 (640)
                      |.+|++|++++|+|+..  +.++.+++|++|+|++|+|++..|  |+++++|++|++++|+|++      +++  +..++
T Consensus        43 l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~------i~~--l~~l~  110 (384)
T d2omza2          43 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD------ITP--LANLT  110 (384)
T ss_dssp             HTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC------CGG--GTTCT
T ss_pred             hCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCcc--ccCCccccccccccccccc------ccc--ccccc
Confidence            46788999999988853  358888899999999999885443  8888999999999888875      443  34588


Q ss_pred             CCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCcc-----------------------------------------
Q 035691           82 NIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTAS-----------------------------------------  120 (640)
Q Consensus        82 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-----------------------------------------  120 (640)
                      +|+.|++++|.+++..+  ......+..+....|.+...                                         
T Consensus       111 ~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (384)
T d2omza2         111 NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS  188 (384)
T ss_dssp             TCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred             ccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccc
Confidence            89999999888886544  33455677777666654321                                         


Q ss_pred             CCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCc
Q 035691          121 IPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPS  200 (640)
Q Consensus       121 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~  200 (640)
                      ....+..+++++.+++++|.++.+.        .+..+++|+.|++++|+++.+| .+..+++|+.|++++|.+++..+ 
T Consensus       189 ~~~~~~~l~~~~~l~l~~n~i~~~~--------~~~~~~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~l~~n~l~~~~~-  258 (384)
T d2omza2         189 DISVLAKLTNLESLIATNNQISDIT--------PLGILTNLDELSLNGNQLKDIG-TLASLTNLTDLDLANNQISNLAP-  258 (384)
T ss_dssp             CCGGGGGCTTCSEEECCSSCCCCCG--------GGGGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCCGG-
T ss_pred             cccccccccccceeeccCCccCCCC--------cccccCCCCEEECCCCCCCCcc-hhhcccccchhccccCccCCCCc-
Confidence            2234667899999999999998762        2456789999999999999876 56778999999999999996543 


Q ss_pred             CccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCC------CCCceEEccCCcCCCCCCccCCCCCCCCE
Q 035691          201 SLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQ------YPVRWLDLSHNHLTGPIPLAVGNLKSIPH  274 (640)
Q Consensus       201 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~------~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~  274 (640)
                       +..+++|++|++++|++++..  .+..++.++.++++.|.+.+.      ..++.|++++|++++..  .+..+++|+.
T Consensus       259 -~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~  333 (384)
T d2omza2         259 -LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQR  333 (384)
T ss_dssp             -GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCE
T ss_pred             -ccccccCCEeeccCcccCCCC--ccccccccccccccccccccccccchhcccCeEECCCCCCCCCc--ccccCCCCCE
Confidence             888999999999999998654  478899999999999986543      45899999999999764  3889999999


Q ss_pred             EECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCC
Q 035691          275 LDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQN  328 (640)
Q Consensus       275 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  328 (640)
                      |++++|+|++ ++ .|.++++|++|++++|+|++..|  +.++++|+.|+|++|
T Consensus       334 L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         334 LFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             EECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             EECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            9999999984 44 69999999999999999997655  899999999999998

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.4e-30  Score=263.41  Aligned_cols=175  Identities=25%  Similarity=0.327  Sum_probs=145.5

Q ss_pred             CCCcccCcccccccceEEEEEE---CCCCeEEEEEEeecc----cchhHHHHHHHHHHHHhcCC-CCCcceeEeeccCCc
Q 035691          441 GGFSSANLIGTGSFGSVYKGIL---DPDQTVVAVKVLFLH----QRGALKSFMAECEALRNIRH-RNLVKIITACSSSDF  512 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~  512 (640)
                      ++|++.+.||+|+||+||+|+.   +.+|+.||||+++..    +....+.+.+|++++++++| |||+++++++     
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~-----   98 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----   98 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE-----
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee-----
Confidence            4588999999999999999987   447899999998532    22334678899999999976 8999999984     


Q ss_pred             CCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCeeeCCC
Q 035691          513 QGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVLLDND  592 (640)
Q Consensus       513 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiLl~~~  592 (640)
                      .+....++||||+.+|+|.+++.....          +++..+..++.|++.|++|+|+   .+|+||||||+||+++.+
T Consensus        99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~----------~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~  165 (322)
T d1vzoa_          99 QTETKLHLILDYINGGELFTHLSQRER----------FTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSN  165 (322)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTT
T ss_pred             ccCCceeeeeecccccHHHHHHHhccc----------ccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCC
Confidence            445588999999999999999865432          6778889999999999999999   699999999999999999


Q ss_pred             CcEEEccccccccCCCccCCCceeeccccccccccCcccCCCCC
Q 035691          593 MIAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQ  636 (640)
Q Consensus       593 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  636 (640)
                      +.+||+|||+|+.+......   ......||+.|+|||.+.+..
T Consensus       166 ~~vkL~DFG~a~~~~~~~~~---~~~~~~g~~~~~~pe~~~~~~  206 (322)
T d1vzoa_         166 GHVVLTDFGLSKEFVADETE---RAYDFCGTIEYMAPDIVRGGD  206 (322)
T ss_dssp             SCEEESCSSEEEECCGGGGG---GGCGGGSCCTTCCHHHHTTCC
T ss_pred             CCEEEeeccchhhhcccccc---cccccccccccchhHHhhcCC
Confidence            99999999999876432221   123356999999999998754

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=5.2e-27  Score=233.82  Aligned_cols=211  Identities=21%  Similarity=0.222  Sum_probs=148.6

Q ss_pred             CCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCc
Q 035691           82 NIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYL  161 (640)
Q Consensus        82 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L  161 (640)
                      +++.|+|++|+|+++.+.+|.++++|++||+++|+|..+.+..+..++.++.++..                        
T Consensus        33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~------------------------   88 (284)
T d1ozna_          33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS------------------------   88 (284)
T ss_dssp             TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC------------------------
T ss_pred             CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccc------------------------
Confidence            44555555555555555555556666666666666655555555555555554433                        


Q ss_pred             ceEecCCCCCCCc-CcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCc
Q 035691          162 EIVSLNVNSLRSI-PISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKT  240 (640)
Q Consensus       162 ~~L~L~~N~l~~i-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n  240 (640)
                           ..|.++.+ |..+..+++|++|++++|.+....+..+...++|+.+++++|+|+++.+.+|..+++|+.|     
T Consensus        89 -----~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L-----  158 (284)
T d1ozna_          89 -----DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHL-----  158 (284)
T ss_dssp             -----SCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE-----
T ss_pred             -----cccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhc-----
Confidence                 23333333 3345566777777777777776666677777777777777777776666777777777777     


Q ss_pred             cccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCC
Q 035691          241 IFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSL  320 (640)
Q Consensus       241 ~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  320 (640)
                                 ++++|++++..+.+|.++++|+.+++++|++++..|..|.++++|++||+++|++.+..+..|..+++|
T Consensus       159 -----------~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L  227 (284)
T d1ozna_         159 -----------FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRAL  227 (284)
T ss_dssp             -----------ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTC
T ss_pred             -----------ccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccccccccccccccccccc
Confidence                       677777777777888888888888888888888888888888888888888888888888888888888


Q ss_pred             CeEeCcCCccccccCCc
Q 035691          321 EGLDLFQNTFQAKSQNG  337 (640)
Q Consensus       321 ~~L~l~~N~l~~~~~~~  337 (640)
                      ++|+|++|+|.|.|...
T Consensus       228 ~~L~l~~N~l~C~C~~~  244 (284)
T d1ozna_         228 QYLRLNDNPWVCDCRAR  244 (284)
T ss_dssp             CEEECCSSCEECSGGGH
T ss_pred             CEEEecCCCCCCCccch
Confidence            88888888888877543

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.4e-27  Score=236.28  Aligned_cols=224  Identities=21%  Similarity=0.199  Sum_probs=192.7

Q ss_pred             cEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCe
Q 035691            6 MLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRI   85 (640)
Q Consensus         6 ~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~   85 (640)
                      ..++.++++++ .+|..+.  +++++|+|++|+|+.+.+.+|.++++|++||+++|+|..      ++...+..+..++.
T Consensus        14 ~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~------i~~~~~~~~~~~~~   84 (284)
T d1ozna_          14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR------IDAAAFTGLALLEQ   84 (284)
T ss_dssp             CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCE------ECTTTTTTCTTCCE
T ss_pred             eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccc------cccccccccccccc
Confidence            35678888888 6676554  578999999999998888889999999999999999875      77778777888888


Q ss_pred             eec-cCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceE
Q 035691           86 PLL-AGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIV  164 (640)
Q Consensus        86 L~L-~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L  164 (640)
                      ++. ..|.++.+.+..|.++++|++|++++|.+....+..+....+|+.+++++|+|+.++      +..|..+++|+.|
T Consensus        85 l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~------~~~f~~~~~L~~L  158 (284)
T d1ozna_          85 LDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALP------DDTFRDLGNLTHL  158 (284)
T ss_dssp             EECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC------TTTTTTCTTCCEE
T ss_pred             cccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccC------hhHhccccchhhc
Confidence            765 577888888899999999999999999999888888999999999999999999874      3567788899999


Q ss_pred             ecCCCCCCCcCc-CCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCcccc
Q 035691          165 SLNVNSLRSIPI-SVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFL  243 (640)
Q Consensus       165 ~L~~N~l~~ip~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~  243 (640)
                      ++++|+++.+|. .+..+++|+++++++|+++++.|..|.++++|++|++++|++.+..+.+|.++++|+.|++++|.+.
T Consensus       159 ~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~  238 (284)
T d1ozna_         159 FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV  238 (284)
T ss_dssp             ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred             ccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence            999999998754 5677999999999999999999999999999999999999999888889999999999977666554


Q ss_pred             C
Q 035691          244 G  244 (640)
Q Consensus       244 ~  244 (640)
                      .
T Consensus       239 C  239 (284)
T d1ozna_         239 C  239 (284)
T ss_dssp             C
T ss_pred             C
Confidence            3

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.7e-26  Score=227.67  Aligned_cols=205  Identities=26%  Similarity=0.242  Sum_probs=141.1

Q ss_pred             CCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcCCCCCCCC
Q 035691          105 SKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKL  184 (640)
Q Consensus       105 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L  184 (640)
                      ..+.++|.+++.|+. +|..+.  ++|++|+|++|+|+.+      .+..|.++++|++|+|++|+|+.+|. +..+++|
T Consensus        10 ~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l------~~~~f~~l~~L~~L~L~~N~l~~l~~-~~~l~~L   79 (266)
T d1p9ag_          10 ASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTF------SLATLMPYTRLTQLNLDRAELTKLQV-DGTLPVL   79 (266)
T ss_dssp             TTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEE------EGGGGTTCTTCCEEECTTSCCCEEEC-CSCCTTC
T ss_pred             CCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCc------CHHHhhcccccccccccccccccccc-ccccccc
Confidence            344444555555553 333222  3455555555555444      22334455555555555555555543 3456677


Q ss_pred             CEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCc
Q 035691          185 QVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPL  264 (640)
Q Consensus       185 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~  264 (640)
                      ++|+|++|+++ ..+..+..+++|+.|++++|.+.+..+..+..+.+++.|                ++++|.++...+.
T Consensus        80 ~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L----------------~l~~n~l~~l~~~  142 (266)
T d1p9ag_          80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL----------------YLKGNELKTLPPG  142 (266)
T ss_dssp             CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEE----------------ECTTSCCCCCCTT
T ss_pred             ccccccccccc-ccccccccccccccccccccccceeeccccccccccccc----------------cccccccceeccc
Confidence            77777777776 345567777777777777777777677777777777777                7777777777777


Q ss_pred             cCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCc
Q 035691          265 AVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNG  337 (640)
Q Consensus       265 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  337 (640)
                      .+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|.|.|...
T Consensus       143 ~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~~~  214 (266)
T d1p9ag_         143 LLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEIL  214 (266)
T ss_dssp             TTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGGH
T ss_pred             cccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcchH
Confidence            8888888888888888888777788888888999999999988 56777778889999999999999887643

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=7e-26  Score=223.15  Aligned_cols=200  Identities=24%  Similarity=0.254  Sum_probs=155.9

Q ss_pred             CCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCC
Q 035691           81 PNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTY  160 (640)
Q Consensus        81 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~  160 (640)
                      ..+...+.+++.++. +|..+.  ++|++|||++|+|+++.+.+|.++++|++|+|++|+|+.++        .+..+++
T Consensus        10 ~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--------~~~~l~~   78 (266)
T d1p9ag_          10 ASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--------VDGTLPV   78 (266)
T ss_dssp             TTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--------CCSCCTT
T ss_pred             CCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--------ccccccc
Confidence            334444555555553 343332  45677777777777666667777777777777777776542        2445677


Q ss_pred             cceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCc
Q 035691          161 LEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKT  240 (640)
Q Consensus       161 L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n  240 (640)
                      |++|+|++|+++.++..+..+++|++|++++|.+.+..+..+..+.++++|++++|.+....+..+..+++|+.+     
T Consensus        79 L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l-----  153 (266)
T d1p9ag_          79 LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL-----  153 (266)
T ss_dssp             CCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE-----
T ss_pred             ccccccccccccccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhc-----
Confidence            777777777777777777888889999999999988888888889999999999999998888888888888888     


Q ss_pred             cccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCC
Q 035691          241 IFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHG  308 (640)
Q Consensus       241 ~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  308 (640)
                                 ++++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++..
T Consensus       154 -----------~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C  209 (266)
T d1p9ag_         154 -----------SLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC  209 (266)
T ss_dssp             -----------ECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             -----------ccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence                       88888888888888999999999999999998 788888889999999999999874

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.92  E-value=5.2e-26  Score=234.88  Aligned_cols=179  Identities=20%  Similarity=0.252  Sum_probs=137.1

Q ss_pred             CCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcC-----------CCCCcceeEeecc
Q 035691          441 GGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR-----------HRNLVKIITACSS  509 (640)
Q Consensus       441 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~  509 (640)
                      ++|++.++||+|+||+||+|+++.+|+.||||+++... ...+.+.+|+++++.++           |+|||++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            45899999999999999999999999999999996432 33467788999888875           5789999888642


Q ss_pred             CCcCCCceeeEEeeccCCCChhhh-cCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCCee
Q 035691          510 SDFQGNDFKALVYEFMHHGSLESW-LHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPSNVL  588 (640)
Q Consensus       510 ~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~NiL  588 (640)
                         ......+++|+++..+..... ......        ..+++..+..++.||+.|++|||+.  .+|+||||||+|||
T Consensus        92 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIl  158 (362)
T d1q8ya_          92 ---KGPNGVHVVMVFEVLGENLLALIKKYEH--------RGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVL  158 (362)
T ss_dssp             ---EETTEEEEEEEECCCCEEHHHHHHHTTT--------SCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEE
T ss_pred             ---ccccceeeeeeecccccccccccccccc--------cCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHee
Confidence               223456677777665543222 211111        3478889999999999999999974  68999999999999


Q ss_pred             eCCCC------cEEEccccccccCCCccCCCceeeccccccccccCcccCCCCCCCCC
Q 035691          589 LDNDM------IAHVGDFGLTRFIPEVISSNQCSSVGLKGTVGYAAPEYGMGSQVSTN  640 (640)
Q Consensus       589 l~~~~------~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k  640 (640)
                      ++.++      .+|++|||.|+.....       ....+||+.|+|||++.+..++.|
T Consensus       159 l~~~~~~~~~~~~kl~dfg~s~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~  209 (362)
T d1q8ya_         159 MEIVDSPENLIQIKIADLGNACWYDEH-------YTNSIQTREYRSPEVLLGAPWGCG  209 (362)
T ss_dssp             EEEEETTTTEEEEEECCCTTCEETTBC-------CCSCCSCGGGCCHHHHHTCCCCTH
T ss_pred             eeccCcccccceeeEeecccccccccc-------cccccccccccChhhccccCCCcc
Confidence            97654      4999999999855322       123469999999999998887653

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.89  E-value=5.8e-21  Score=195.30  Aligned_cols=280  Identities=26%  Similarity=0.313  Sum_probs=181.7

Q ss_pred             CCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCC
Q 035691            4 FLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNI   83 (640)
Q Consensus         4 ~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L   83 (640)
                      +|+.|||++|+|+ .+|+.   .++|++|+|++|+|+ .+|..   +.+|++|++++|+++.      ++..    .+.|
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~------l~~l----p~~L  100 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKA------LSDL----PPLL  100 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC------CCSC----CTTC
T ss_pred             CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccch------hhhh----cccc
Confidence            5889999999998 57753   578999999999999 66764   4589999999999875      4421    3569


Q ss_pred             CeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcce
Q 035691           84 RIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEI  163 (640)
Q Consensus        84 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~  163 (640)
                      +.|+|++|.+... | .++.+++|++|++++|.++.. +.   ....+..+.+..+.....        ..+..++.++.
T Consensus       101 ~~L~L~~n~l~~l-p-~~~~l~~L~~L~l~~~~~~~~-~~---~~~~l~~l~~~~~~~~~~--------~~l~~l~~l~~  166 (353)
T d1jl5a_         101 EYLGVSNNQLEKL-P-ELQNSSFLKIIDVDNNSLKKL-PD---LPPSLEFIAAGNNQLEEL--------PELQNLPFLTA  166 (353)
T ss_dssp             CEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSSC--------CCCTTCTTCCE
T ss_pred             ccccccccccccc-c-chhhhccceeecccccccccc-cc---ccccccchhhcccccccc--------cccccccccee
Confidence            9999999999854 4 367899999999999998853 32   235566777766665432        33556677777


Q ss_pred             EecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCcccc----------------
Q 035691          164 VSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALG----------------  227 (640)
Q Consensus       164 L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~----------------  227 (640)
                      ++++.|.+..++...   ...+.+...++.+. ..+ .+..++.|+.+++++|.... .+....                
T Consensus       167 L~l~~n~~~~~~~~~---~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~~~~~~~l~~~~~~~~~~~~~~  240 (353)
T d1jl5a_         167 IYADNNSLKKLPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRDNYLTDLP  240 (353)
T ss_dssp             EECCSSCCSSCCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSCCTTCCEEECCSSCCSCCC
T ss_pred             ccccccccccccccc---cccccccccccccc-ccc-cccccccccccccccccccc-cccccccccccccccccccccc
Confidence            777777766654322   22344454444444 222 24455555666655555442 221111                


Q ss_pred             -CCCCccEEeccCccccCCCC----CceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEec
Q 035691          228 -NCHQLQSLDLSKTIFLGQYP----VRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLS  302 (640)
Q Consensus       228 -~l~~L~~L~ls~n~~~~~~~----l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  302 (640)
                       ....+...++..+.+.+...    ....+++.|.+.+    ....+++|++|+|++|+|+ .+|..   +++|+.|+|+
T Consensus       241 ~~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~----~~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~  312 (353)
T d1jl5a_         241 ELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRS----LCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIAS  312 (353)
T ss_dssp             CCCTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSE----ECCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECC
T ss_pred             cccccccccccccccccccccccchhcccccccCcccc----ccccCCCCCEEECCCCccC-ccccc---cCCCCEEECC
Confidence             12233334444433332222    2344555555542    2334678999999999998 56654   4678899999


Q ss_pred             CCccCCCCCccCCCCCCCCeEeCcCCccccc
Q 035691          303 INSFHGPIHPGLSSLKSLEGLDLFQNTFQAK  333 (640)
Q Consensus       303 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  333 (640)
                      +|+|+. +|..   +++|++|++++|+++..
T Consensus       313 ~N~L~~-l~~~---~~~L~~L~L~~N~L~~l  339 (353)
T d1jl5a_         313 FNHLAE-VPEL---PQNLKQLHVEYNPLREF  339 (353)
T ss_dssp             SSCCSC-CCCC---CTTCCEEECCSSCCSSC
T ss_pred             CCcCCc-cccc---cCCCCEEECcCCcCCCC
Confidence            999984 5543   46789999999998854

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=1.8e-21  Score=188.45  Aligned_cols=216  Identities=16%  Similarity=0.121  Sum_probs=149.7

Q ss_pred             cEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCe
Q 035691            6 MLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRI   85 (640)
Q Consensus         6 ~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~   85 (640)
                      +.++.++++++ .+|+.+.  +++++|++++|+|+.+.+.+|.++++|++|+|++|.+..     .+|+..|..+++++.
T Consensus        11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~-----~i~~~~f~~l~~l~~   82 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE-----VIEADVFSNLPKLHE   82 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCC-----EECSSSEESCTTCCE
T ss_pred             CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccc-----eeecccccccccccc
Confidence            56777777777 5665443  478888888888886666678888888888888776643     466666777788887


Q ss_pred             eecc-CCcccccCCccCcCCCCCCEEECcCCccCccCCc-cccCCCCCCEEEcccCcCCCCCCCcccccccccCC-CCcc
Q 035691           86 PLLA-GNQFFGNIPHSISNASKLEWLDFANNSLTASIPE-DLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNC-TYLE  162 (640)
Q Consensus        86 L~L~-~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l-~~L~  162 (640)
                      +.+. .|++....+..|.++++|++|++++|+++...+. .+..+..+..+..+++.+..++.      ..|.++ ..++
T Consensus        83 l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~------~~~~~~~~~l~  156 (242)
T d1xwdc1          83 IRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER------NSFVGLSFESV  156 (242)
T ss_dssp             EEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECT------TSSTTSBSSCE
T ss_pred             ccccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccc------cccccccccce
Confidence            7765 4677777777788888888888888887754332 23445556666667777766533      233343 3677


Q ss_pred             eEecCCCCCCCcCcCCCCCCCCCEE-EccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEE
Q 035691          163 IVSLNVNSLRSIPISVGYLPKLQVL-SLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSL  235 (640)
Q Consensus       163 ~L~L~~N~l~~ip~~~~~l~~L~~L-~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  235 (640)
                      .|++++|+++.++......++++.+ ++++|.|+.+.+..|.++++|++|+|++|+|+...+..|.++++|+.+
T Consensus       157 ~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l  230 (242)
T d1xwdc1         157 ILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR  230 (242)
T ss_dssp             EEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESS
T ss_pred             eeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccC
Confidence            7788888887777666666665554 456677776556667778888888888888876666667777666665

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.85  E-value=7.4e-22  Score=183.64  Aligned_cols=133  Identities=20%  Similarity=0.193  Sum_probs=104.3

Q ss_pred             cccCcccccccceEEEEEECCCCeEEEEEEeecccc------------------hhHHHHHHHHHHHHhcCCCCCcceeE
Q 035691          444 SSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQR------------------GALKSFMAECEALRNIRHRNLVKIIT  505 (640)
Q Consensus       444 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~~  505 (640)
                      .+.+.||+|+||+||+|++. +|+.||||+++....                  .....+..|...+.++.|++++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            45689999999999999986 799999998742110                  01234567889999999999999876


Q ss_pred             eeccCCcCCCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCC
Q 035691          506 ACSSSDFQGNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHHCKKQIVHCDLKPS  585 (640)
Q Consensus       506 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~~~ivHrdlkp~  585 (640)
                      +.         ..+++|||++++.+.++                 +......++.|++.|+.|||+   .+|+||||||+
T Consensus        82 ~~---------~~~lvme~~~~~~~~~l-----------------~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~  132 (191)
T d1zara2          82 WE---------GNAVLMELIDAKELYRV-----------------RVENPDEVLDMILEEVAKFYH---RGIVHGDLSQY  132 (191)
T ss_dssp             EE---------TTEEEEECCCCEEGGGC-----------------CCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTT
T ss_pred             ec---------CCEEEEEeeccccccch-----------------hhHHHHHHHHHHHHHHHHHhh---CCEEEccCChh
Confidence            62         13699999988665442                 112345789999999999999   69999999999


Q ss_pred             CeeeCCCCcEEEccccccccCC
Q 035691          586 NVLLDNDMIAHVGDFGLTRFIP  607 (640)
Q Consensus       586 NiLl~~~~~~kl~DfGla~~~~  607 (640)
                      |||+++++ ++++|||.|+...
T Consensus       133 NILv~~~~-~~liDFG~a~~~~  153 (191)
T d1zara2         133 NVLVSEEG-IWIIDFPQSVEVG  153 (191)
T ss_dssp             SEEEETTE-EEECCCTTCEETT
T ss_pred             heeeeCCC-EEEEECCCcccCC
Confidence            99999655 8899999997653

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=3e-21  Score=186.91  Aligned_cols=218  Identities=20%  Similarity=0.144  Sum_probs=111.6

Q ss_pred             CeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCccccc-CCccCcCCCCCC
Q 035691           30 RYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGN-IPHSISNASKLE  108 (640)
Q Consensus        30 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~  108 (640)
                      +.++.+++.++ .+|..+.  +++++|||++|+|+.      +|...|.++++|+.|+|++|.+... .+.+|.++++++
T Consensus        11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~------l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~   81 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRV------IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLH   81 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCE------ECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCC
T ss_pred             CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCc------cChhHhhccchhhhhhhccccccceeeccccccccccc
Confidence            34555555555 3443332  345555555555543      4444444455555555555544432 233444455555


Q ss_pred             EEECc-CCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCc--CCCCCCCCC
Q 035691          109 WLDFA-NNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPI--SVGYLPKLQ  185 (640)
Q Consensus       109 ~L~Ls-~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~--~~~~l~~L~  185 (640)
                      +|++. .|++....+..|.++++|++|++++|.+.                              ..+.  .+..+..+.
T Consensus        82 ~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~------------------------------~~~~~~~~~~l~~l~  131 (242)
T d1xwdc1          82 EIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK------------------------------HLPDVHKIHSLQKVL  131 (242)
T ss_dssp             EEEEECCTTCCEECTTSEECCTTCCEEEEESCCCC------------------------------SCCCCTTTCBSSCEE
T ss_pred             cccccccccccccccccccccccccccccchhhhc------------------------------ccccccccccccccc
Confidence            55443 24444444444555555555555555443                              3222  122234444


Q ss_pred             EEEccCCcCcccCCcCccCCC-CCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCCcCCCCCCc
Q 035691          186 VLSLFENNISGEIPSSLGNFT-FLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGPIPL  264 (640)
Q Consensus       186 ~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~~~~  264 (640)
                      .+...++.+..+.+..|.+++ .++.|++++|+++...+..|. ..+++.+               +++++|+|+.+.+.
T Consensus       132 ~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~-~~~l~~~---------------~~l~~n~l~~l~~~  195 (242)
T d1xwdc1         132 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFN-GTQLDEL---------------NLSDNNNLEELPND  195 (242)
T ss_dssp             EEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTT-TCCEEEE---------------ECTTCTTCCCCCTT
T ss_pred             cccccccccccccccccccccccceeeeccccccccccccccc-chhhhcc---------------ccccccccccccHH
Confidence            555555556555555555543 566666666666644443332 3333333               14555666655555


Q ss_pred             cCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEec
Q 035691          265 AVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLS  302 (640)
Q Consensus       265 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  302 (640)
                      .|.++++|++|+|++|+|+...+..|.++++|+.|++.
T Consensus       196 ~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~  233 (242)
T d1xwdc1         196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY  233 (242)
T ss_dssp             TTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred             HhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence            66777777777777777765445556666666665553

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.84  E-value=8.5e-21  Score=181.69  Aligned_cols=205  Identities=20%  Similarity=0.220  Sum_probs=135.0

Q ss_pred             CCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcc
Q 035691           83 IRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLE  162 (640)
Q Consensus        83 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~  162 (640)
                      +..++++.+++++..  .++.+.+|++|++++|.|+.+ + .+..+++|++|++++|+++.+        ..+..+++|+
T Consensus        21 ~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~ls~n~i~~~--------~~l~~l~~l~   88 (227)
T d1h6ua2          21 AIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDL--------APLKNLTKIT   88 (227)
T ss_dssp             HHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCC--------GGGTTCCSCC
T ss_pred             HHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc-h-hHhcCCCCcEeecCCceeecc--------cccccccccc
Confidence            344455566665432  345566777777777777743 3 366777777777777777654        2356667777


Q ss_pred             eEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccc
Q 035691          163 IVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIF  242 (640)
Q Consensus       163 ~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~  242 (640)
                      ++++++|.++.++ .+..+++|++++++++.+.+.  ..+...+.++.+.++++.+....  .+.++++|+.|       
T Consensus        89 ~l~~~~n~~~~i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L-------  156 (227)
T d1h6ua2          89 ELELSGNPLKNVS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYL-------  156 (227)
T ss_dssp             EEECCSCCCSCCG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEE-------
T ss_pred             ccccccccccccc-ccccccccccccccccccccc--chhccccchhhhhchhhhhchhh--hhccccccccc-------
Confidence            7777777776665 356677777777777776643  23556677777777777776332  35566666666       


Q ss_pred             cCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCe
Q 035691          243 LGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEG  322 (640)
Q Consensus       243 ~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  322 (640)
                               ++++|.+++.  ..|.++++|+.|+|++|++++. + .++++++|++|+|++|+++++.|  +.++++|++
T Consensus       157 ---------~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~  221 (227)
T d1h6ua2         157 ---------SIGNAQVSDL--TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFI  221 (227)
T ss_dssp             ---------ECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCE
T ss_pred             ---------cccccccccc--hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCE
Confidence                     6666666532  2367778888888888888743 2 37777888888888888875432  777888888


Q ss_pred             EeCc
Q 035691          323 LDLF  326 (640)
Q Consensus       323 L~l~  326 (640)
                      |+++
T Consensus       222 L~ls  225 (227)
T d1h6ua2         222 VTLT  225 (227)
T ss_dssp             EEEE
T ss_pred             EEee
Confidence            8876

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.84  E-value=1e-20  Score=181.12  Aligned_cols=201  Identities=23%  Similarity=0.280  Sum_probs=109.5

Q ss_pred             EeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeee
Q 035691            8 INLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPL   87 (640)
Q Consensus         8 L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~   87 (640)
                      ++++.+.+++..  .+..+.+|+.|++++|.|+.. + .+..+++|++|++++|+|++      +++  +..+++++.++
T Consensus        24 ~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~ls~n~i~~------~~~--l~~l~~l~~l~   91 (227)
T d1h6ua2          24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITD------LAP--LKNLTKITELE   91 (227)
T ss_dssp             HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC------CGG--GTTCCSCCEEE
T ss_pred             HHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc-h-hHhcCCCCcEeecCCceeec------ccc--ccccccccccc
Confidence            455555555433  345556666666666666633 2 36666666666666666653      222  23456666666


Q ss_pred             ccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecC
Q 035691           88 LAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLN  167 (640)
Q Consensus        88 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~  167 (640)
                      +++|.++.+  ..|.++++|+.+++++|...+.  ..+...+.+..+.++++.+...        ..+.++++|+.|+++
T Consensus        92 ~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--------~~~~~~~~L~~L~l~  159 (227)
T d1h6ua2          92 LSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--------SPLAGLTNLQYLSIG  159 (227)
T ss_dssp             CCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--------GGGGGCTTCCEEECC
T ss_pred             ccccccccc--cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--------hhhcccccccccccc
Confidence            666665532  2455566666666666655532  2244555566666666555432        224445556666666


Q ss_pred             CCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEec
Q 035691          168 VNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDL  237 (640)
Q Consensus       168 ~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  237 (640)
                      +|.++..+. +..+++|++|+|++|+++++ + .+.++++|++|+|++|+|++..|  ++++++|+.|++
T Consensus       160 ~n~~~~~~~-l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~l  224 (227)
T d1h6ua2         160 NAQVSDLTP-LANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL  224 (227)
T ss_dssp             SSCCCCCGG-GTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEE
T ss_pred             ccccccchh-hcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEe
Confidence            665554432 45555666666666665532 2 25555666666666666553322  555555555544

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.83  E-value=1e-18  Score=178.30  Aligned_cols=279  Identities=23%  Similarity=0.257  Sum_probs=182.7

Q ss_pred             CCCCcEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCC
Q 035691            2 LTFLMLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLP   81 (640)
Q Consensus         2 l~~L~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~   81 (640)
                      +++|++|+|++|+|+ .+|+.   ..+|+.|++++|+++. ++. +  .+.|++||+++|.|+.      +|..  ..++
T Consensus        57 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~-l~~-l--p~~L~~L~L~~n~l~~------lp~~--~~l~  120 (353)
T d1jl5a_          57 PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKA-LSD-L--PPLLEYLGVSNNQLEK------LPEL--QNSS  120 (353)
T ss_dssp             CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CCS-C--CTTCCEEECCSSCCSS------CCCC--TTCT
T ss_pred             CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccch-hhh-h--cccccccccccccccc------ccch--hhhc
Confidence            468999999999999 66765   4589999999999984 443 1  2469999999999986      7753  3589


Q ss_pred             CCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcc------------
Q 035691           82 NIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDL------------  149 (640)
Q Consensus        82 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~------------  149 (640)
                      +|+.|++++|.+....+    ....+..+++..+...  .+..+..++.++.|++++|.+...+....            
T Consensus       121 ~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~~  194 (353)
T d1jl5a_         121 FLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNIL  194 (353)
T ss_dssp             TCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCC
T ss_pred             cceeecccccccccccc----ccccccchhhcccccc--ccccccccccceecccccccccccccccccccccccccccc
Confidence            99999999999875432    2467888888887776  34567888899999999998876532110            


Q ss_pred             cccccccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCC
Q 035691          150 RFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNC  229 (640)
Q Consensus       150 ~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  229 (640)
                      .....+..++.|+.+++++|....+|..   ..++..+.+.+|.+.. .+.   ....+...++..|.+.+.     ..+
T Consensus       195 ~~~~~~~~l~~L~~l~l~~n~~~~~~~~---~~~l~~~~~~~~~~~~-~~~---~~~~l~~~~~~~~~~~~l-----~~l  262 (353)
T d1jl5a_         195 EELPELQNLPFLTTIYADNNLLKTLPDL---PPSLEALNVRDNYLTD-LPE---LPQSLTFLDVSENIFSGL-----SEL  262 (353)
T ss_dssp             SSCCCCTTCTTCCEEECCSSCCSSCCSC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSEE-----SCC
T ss_pred             cccccccccccccccccccccccccccc---cccccccccccccccc-ccc---cccccccccccccccccc-----ccc
Confidence            0011223344455555555544444322   2334444555544442 111   123344444444443311     111


Q ss_pred             -CCccEEeccCccccC----CCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCC
Q 035691          230 -HQLQSLDLSKTIFLG----QYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSIN  304 (640)
Q Consensus       230 -~~L~~L~ls~n~~~~----~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  304 (640)
                       ......++..+.+.+    ...|++|+|++|+|+ .+|..   +++|+.|+|++|+|+ .+|..   +.+|++|+|++|
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N  334 (353)
T d1jl5a_         263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYN  334 (353)
T ss_dssp             CTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSS
T ss_pred             cchhcccccccCccccccccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCC
Confidence             233455566655433    346999999999999 45643   578999999999999 56653   468999999999


Q ss_pred             ccCCCCCccCCCCCCCCeEeCc
Q 035691          305 SFHGPIHPGLSSLKSLEGLDLF  326 (640)
Q Consensus       305 ~l~~~~~~~~~~l~~L~~L~l~  326 (640)
                      +|+ .+|...   .+|+.|.+.
T Consensus       335 ~L~-~lp~~~---~~L~~L~~~  352 (353)
T d1jl5a_         335 PLR-EFPDIP---ESVEDLRMN  352 (353)
T ss_dssp             CCS-SCCCCC---TTCCEEECC
T ss_pred             cCC-CCCccc---cccCeeECc
Confidence            998 456543   356666653

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.82  E-value=9.3e-20  Score=171.91  Aligned_cols=180  Identities=26%  Similarity=0.345  Sum_probs=103.0

Q ss_pred             eeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEe
Q 035691           86 PLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVS  165 (640)
Q Consensus        86 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~  165 (640)
                      ..++.+.+++.++.  ..+.+|++|++++|.++...  .+..+++|++|+|++|+|+.++        .+..+++|+.|+
T Consensus        29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--------~~~~l~~L~~L~   96 (210)
T d1h6ta2          29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--------PLANLKNLGWLF   96 (210)
T ss_dssp             HHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--------GGTTCTTCCEEE
T ss_pred             HHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--------ccccCccccccc
Confidence            34555555544432  23556777777777776432  2566777777777777776542        244566666666


Q ss_pred             cCCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCC
Q 035691          166 LNVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQ  245 (640)
Q Consensus       166 L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~  245 (640)
                      +++|+++.+| .+..+++|+.|++++|.+.. + ..+..+++++.+++++|.++..  ..+..+++|+.+          
T Consensus        97 l~~n~i~~l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l----------  161 (210)
T d1h6ta2          97 LDENKVKDLS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTL----------  161 (210)
T ss_dssp             CCSSCCCCGG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEE----------
T ss_pred             cccccccccc-cccccccccccccccccccc-c-cccccccccccccccccccccc--cccccccccccc----------
Confidence            6666666665 35556666666666666652 2 2455666666666666666532  234445555555          


Q ss_pred             CCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEec
Q 035691          246 YPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLS  302 (640)
Q Consensus       246 ~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  302 (640)
                            ++++|++++..  .+.++++|+.|+|++|+|+. +| .|.++++|++|+|+
T Consensus       162 ------~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         162 ------SLEDNQISDIV--PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF  208 (210)
T ss_dssp             ------ECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred             ------ccccccccccc--cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence                  55555555322  25556666666666666652 33 35556666666654

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.82  E-value=2.3e-20  Score=173.60  Aligned_cols=177  Identities=21%  Similarity=0.277  Sum_probs=123.7

Q ss_pred             cceEecCCCCCCCcCcCCCCCCCCCEEEccCCcCcc-cCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEeccC
Q 035691          161 LEIVSLNVNSLRSIPISVGYLPKLQVLSLFENNISG-EIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSK  239 (640)
Q Consensus       161 L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~  239 (640)
                      .+.+++++++++.+|..+.  +++++|+|++|+|++ ..+..|.++++|++|+|++|++....+..|..+++|+.|    
T Consensus        10 ~~~v~Cs~~~L~~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L----   83 (192)
T d1w8aa_          10 GTTVDCTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQEL----   83 (192)
T ss_dssp             TTEEECTTSCCSSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE----
T ss_pred             CCEEEEeCCCcCccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccccccccccee----
Confidence            4567777888888877664  578888888888865 345667788888888888888887777778877777777    


Q ss_pred             ccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCcccCcCCccccCCCCCCeEEecCCccCCCCCccCCCCCC
Q 035691          240 TIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLSGEIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKS  319 (640)
Q Consensus       240 n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  319 (640)
                                  +|++|+|+++.|.+|.++++|++|+|++|+|++..|.+|..+++|++|+|++|++....+..+ -...
T Consensus        84 ------------~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~-~~~~  150 (192)
T d1w8aa_          84 ------------QLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEW  150 (192)
T ss_dssp             ------------ECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHH
T ss_pred             ------------eeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHH-Hhhh
Confidence                        777777777777778888888888888888887777778888888888888888765332211 1123


Q ss_pred             CCeEeCcCCccccccCCcccCCCCCCCCCccccccCCCCCcCCC
Q 035691          320 LEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGI  363 (640)
Q Consensus       320 L~~L~l~~N~l~~~~~~~~~p~~~~~~~~~~~~~~~n~~~c~~~  363 (640)
                      ++.+.+..|.++|.     .|.  .+......++..|...|..+
T Consensus       151 l~~~~l~~~~~~c~-----~p~--~l~~~~l~~L~~n~l~C~~~  187 (192)
T d1w8aa_         151 LRKKSLNGGAARCG-----APS--KVRDVQIKDLPHSEFKCSSE  187 (192)
T ss_dssp             HHHHCCSGGGCBBC-----SST--TTTTSBGGGSCTTTCCCCCC
T ss_pred             hhhhcccCCCeEeC-----CCh--hhcCCEeeecCHhhCcCCCC
Confidence            55556666666642     222  24455566777777666543

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.81  E-value=1.3e-19  Score=170.92  Aligned_cols=181  Identities=25%  Similarity=0.358  Sum_probs=124.0

Q ss_pred             eEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCCEE
Q 035691           31 YIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWL  110 (640)
Q Consensus        31 ~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  110 (640)
                      ...++.+.+++.++.  ..+.+|++|++++|.|+.      ++. + ..+++|+.|+|++|+|++..  .++.+++|++|
T Consensus        28 ~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~------l~~-l-~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L   95 (210)
T d1h6ta2          28 KDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS------VQG-I-QYLPNVTKLFLNGNKLTDIK--PLANLKNLGWL   95 (210)
T ss_dssp             HHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCC------CTT-G-GGCTTCCEEECCSSCCCCCG--GGTTCTTCCEE
T ss_pred             HHHhCcCccCCccCH--HHhcCccEEECcCCCCCC------chh-H-hhCCCCCEEeCCCccccCcc--ccccCcccccc
Confidence            345666666654443  345667777777777654      331 2 23677777777777777543  35677788888


Q ss_pred             ECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEEcc
Q 035691          111 DFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLSLF  190 (640)
Q Consensus       111 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~  190 (640)
                      ++++|+|++ +| .+..+++|+.|++++|.+..+        ..+.+++.++.++++.|.++..+ .+..+++|++++++
T Consensus        96 ~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~~--------~~l~~l~~l~~l~~~~n~l~~~~-~~~~l~~L~~l~l~  164 (210)
T d1h6ta2          96 FLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--------NGLVHLPQLESLYLGNNKITDIT-VLSRLTKLDTLSLE  164 (210)
T ss_dssp             ECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--------GGGGGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECC
T ss_pred             ccccccccc-cc-ccccccccccccccccccccc--------ccccccccccccccccccccccc-cccccccccccccc
Confidence            888888775 33 477778888888888877654        34667777888888888877644 35557788888888


Q ss_pred             CCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEecc
Q 035691          191 ENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDLS  238 (640)
Q Consensus       191 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls  238 (640)
                      +|.++++.  .+.++++|++|+|++|+|+. +| .|.++++|+.|+|+
T Consensus       165 ~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         165 DNQISDIV--PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF  208 (210)
T ss_dssp             SSCCCCCG--GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred             cccccccc--cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence            88887533  37788888888888888874 34 47788888888654

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.81  E-value=3.4e-20  Score=173.42  Aligned_cols=180  Identities=24%  Similarity=0.297  Sum_probs=127.1

Q ss_pred             CCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCC
Q 035691           29 LRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLE  108 (640)
Q Consensus        29 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  108 (640)
                      +..+.++.+.+++.++.  ..+.+|++|++++|.|++      ++ ++ ..+++|+.|+|++|+|++..|  |+++++|+
T Consensus        20 ~i~~~l~~~~~~~~~~~--~~l~~l~~L~l~~~~i~~------l~-~l-~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~   87 (199)
T d2omxa2          20 KMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKS------ID-GV-EYLNNLTQINFSNNQLTDITP--LKNLTKLV   87 (199)
T ss_dssp             HHHHHTTCSSTTSEECH--HHHTTCCEEECTTSCCCC------CT-TG-GGCTTCCEEECCSSCCCCCGG--GTTCTTCC
T ss_pred             HHHHHhCCCCCCCccCH--HHhcCCCEEECCCCCCCC------cc-cc-ccCCCcCcCccccccccCccc--ccCCcccc
Confidence            34456667777654432  456777788887777765      32 12 237777777777777776543  77888888


Q ss_pred             EEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcCCCCCCCCCEEE
Q 035691          109 WLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPISVGYLPKLQVLS  188 (640)
Q Consensus       109 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~  188 (640)
                      +|++++|.+..+ + .+.++++|+.|++++|.+...        +.+..+++|+.|++++|++..+| .+..+++|++|+
T Consensus        88 ~L~l~~n~~~~~-~-~l~~l~~L~~L~l~~~~~~~~--------~~~~~l~~L~~L~l~~n~l~~~~-~l~~~~~L~~L~  156 (199)
T d2omxa2          88 DILMNNNQIADI-T-PLANLTNLTGLTLFNNQITDI--------DPLKNLTNLNRLELSSNTISDIS-ALSGLTSLQQLN  156 (199)
T ss_dssp             EEECCSSCCCCC-G-GGTTCTTCSEEECCSSCCCCC--------GGGTTCTTCSEEECCSSCCCCCG-GGTTCTTCSEEE
T ss_pred             cccccccccccc-c-ccccccccccccccccccccc--------cccchhhhhHHhhhhhhhhcccc-cccccccccccc
Confidence            888888887743 3 377888888888888877654        34667778888888888887765 466778888888


Q ss_pred             ccCCcCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEE
Q 035691          189 LFENNISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSL  235 (640)
Q Consensus       189 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  235 (640)
                      +++|++++..  .+.++++|++|++++|+|+.. + .++++++|+.|
T Consensus       157 l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~i-~-~l~~L~~L~~L  199 (199)
T d2omxa2         157 FSSNQVTDLK--PLANLTTLERLDISSNKVSDI-S-VLAKLTNLESL  199 (199)
T ss_dssp             CCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEE
T ss_pred             cccccccCCc--cccCCCCCCEEECCCCCCCCC-c-cccCCCCCCcC
Confidence            8888887542  377888888888888888743 3 46777777765

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.81  E-value=7.5e-20  Score=171.06  Aligned_cols=178  Identities=21%  Similarity=0.280  Sum_probs=148.7

Q ss_pred             EEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCee
Q 035691            7 LINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIP   86 (640)
Q Consensus         7 ~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L   86 (640)
                      .++++.+.+++..+  ...+.++++|++++|.|+.. + .+..+++|++|+|++|+|++      +++  +..+++|+.|
T Consensus        22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l-~-~l~~l~nL~~L~Ls~N~l~~------~~~--l~~l~~L~~L   89 (199)
T d2omxa2          22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI-D-GVEYLNNLTQINFSNNQLTD------ITP--LKNLTKLVDI   89 (199)
T ss_dssp             HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC------CGG--GTTCTTCCEE
T ss_pred             HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc-c-ccccCCCcCcCccccccccC------ccc--ccCCcccccc
Confidence            34677788886554  35678999999999999853 3 47889999999999999876      543  4569999999


Q ss_pred             eccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEec
Q 035691           87 LLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSL  166 (640)
Q Consensus        87 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L  166 (640)
                      ++++|.+....  .+.++++|+.|++++|.+...  ..+..+++|+.|++++|++..+        +.+..+++|+.|++
T Consensus        90 ~l~~n~~~~~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--------~~l~~~~~L~~L~l  157 (199)
T d2omxa2          90 LMNNNQIADIT--PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--------SALSGLTSLQQLNF  157 (199)
T ss_dssp             ECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--------GGGTTCTTCSEEEC
T ss_pred             ccccccccccc--ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--------cccccccccccccc
Confidence            99999998543  488999999999999999854  3478999999999999999765        35778899999999


Q ss_pred             CCCCCCCcCcCCCCCCCCCEEEccCCcCcccCCcCccCCCCCCEE
Q 035691          167 NVNSLRSIPISVGYLPKLQVLSLFENNISGEIPSSLGNFTFLTEL  211 (640)
Q Consensus       167 ~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  211 (640)
                      ++|+++.++. +..+++|++|++++|+|+++ + .++.+++|++|
T Consensus       158 ~~n~l~~l~~-l~~l~~L~~L~ls~N~i~~i-~-~l~~L~~L~~L  199 (199)
T d2omxa2         158 SSNQVTDLKP-LANLTTLERLDISSNKVSDI-S-VLAKLTNLESL  199 (199)
T ss_dssp             CSSCCCCCGG-GTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEE
T ss_pred             ccccccCCcc-ccCCCCCCEEECCCCCCCCC-c-cccCCCCCCcC
Confidence            9999999864 78899999999999999853 3 58889999876

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.80  E-value=2.6e-20  Score=173.14  Aligned_cols=129  Identities=20%  Similarity=0.264  Sum_probs=83.8

Q ss_pred             cEEeCCCCccccCCchhhhcCCCCCeEEcccCccCc-cCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCC
Q 035691            6 MLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQG-QIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIR   84 (640)
Q Consensus         6 ~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~   84 (640)
                      +.++.++++++ .+|+.+.  +++++|+|++|+|+. ..+..|.++++|++|+|++|++..      +++..|..+++|+
T Consensus        11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~------~~~~~~~~~~~L~   81 (192)
T d1w8aa_          11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG------IEPNAFEGASHIQ   81 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCC------BCTTTTTTCTTCC
T ss_pred             CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccc------ccccccccccccc
Confidence            45666777766 4555442  466677777777754 334556666777777777666654      5556666666666


Q ss_pred             eeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCC
Q 035691           85 IPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGT  143 (640)
Q Consensus        85 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  143 (640)
                      .|+|++|+|+++.|++|.++++|++|+|++|+|+++.+++|..+++|++|+|++|.+..
T Consensus        82 ~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~  140 (192)
T d1w8aa_          82 ELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC  140 (192)
T ss_dssp             EEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred             eeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccc
Confidence            66666666666666666666666666666666666666666666666666666666654

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.80  E-value=5.1e-22  Score=210.80  Aligned_cols=352  Identities=18%  Similarity=0.105  Sum_probs=217.7

Q ss_pred             CCCcEEeCCCCccccCC-chhhhcCCCCCeEEcccCccCc----cCCcCCCCCCCCCEEEccCCCcCCccccccCCchhh
Q 035691            3 TFLMLINLQQNNFSGNI-PHEIGRLFQLRYIIFNSNTLQG----QIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIG   77 (640)
Q Consensus         3 ~~L~~L~L~~n~i~~~~-p~~~~~l~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~   77 (640)
                      .+|+.||+++|+|++.. .+.+..++++++|+|++|.|+.    .++.++..+++|++|||++|+|++.... .+...+.
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~-~l~~~l~   80 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVH-CVLQGLQ   80 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHH-HHHHTTC
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHH-HHHHHHh
Confidence            36899999999998643 4557889999999999999984    3455678899999999999998641111 1222222


Q ss_pred             cCCCCCCeeeccCCccccc----CCccCcCCCCCCEEECcCCccCccCCcc-----------------------------
Q 035691           78 FTLPNIRIPLLAGNQFFGN----IPHSISNASKLEWLDFANNSLTASIPED-----------------------------  124 (640)
Q Consensus        78 ~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-----------------------------  124 (640)
                      ....+|+.|+|++|+++..    ++..+..+++|++|+|++|.|+......                             
T Consensus        81 ~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~  160 (460)
T d1z7xw1          81 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP  160 (460)
T ss_dssp             STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred             cCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcc
Confidence            3346899999999999754    4567888999999999999986421111                             


Q ss_pred             ----ccCCCCCCEEEcccCcCCCCCCCcccccccc-cCCCCcceEecCCCCCCCcC-----cCCCCCCCCCEEEccCCcC
Q 035691          125 ----LGRLRNLTRLNFARNDLGTRKVNDLRFLDSL-VNCTYLEIVSLNVNSLRSIP-----ISVGYLPKLQVLSLFENNI  194 (640)
Q Consensus       125 ----~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l-~~l~~L~~L~L~~N~l~~ip-----~~~~~l~~L~~L~L~~N~l  194 (640)
                          +.....++.++++++.+.......  ....+ ........+++..+.+....     ..+...+.++.+++++|.+
T Consensus       161 ~~~~l~~~~~~~~~~ls~~~~~~~~~~~--~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~  238 (460)
T d1z7xw1         161 LASVLRAKPDFKELTVSNNDINEAGVRV--LCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL  238 (460)
T ss_dssp             HHHHHHHCTTCCEEECCSSBCHHHHHHH--HHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBC
T ss_pred             cccccccccccccccccccccccccccc--cccccccccccccccccccccccchhhhcccccccccccccccchhhccc
Confidence                122345666666665543211000  00001 11234556677666654321     1233456777888887766


Q ss_pred             cc-----cCCcCccCCCCCCEEEccCCCCCCCC----CccccCCCCccEEeccCcccc-------------CCCCCceEE
Q 035691          195 SG-----EIPSSLGNFTFLTELNLRGNSIRGSI----PSALGNCHQLQSLDLSKTIFL-------------GQYPVRWLD  252 (640)
Q Consensus       195 ~~-----~~p~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~ls~n~~~-------------~~~~l~~L~  252 (640)
                      ..     ..+..+.....++.+++++|.+....    ...+...+.++.+++++|.+.             ....++.++
T Consensus       239 ~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~  318 (460)
T d1z7xw1         239 GDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLW  318 (460)
T ss_dssp             HHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEE
T ss_pred             cccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccc
Confidence            42     12233445567888888887775332    223455677777888777653             123477788


Q ss_pred             ccCCcCCCCCCc----cCCCCCCCCEEECCCCcccCc----CCcccc-CCCCCCeEEecCCccCCC----CCccCCCCCC
Q 035691          253 LSHNHLTGPIPL----AVGNLKSIPHLDLSKNKLSGE----IPSSLG-SCVGLEYLNLSINSFHGP----IHPGLSSLKS  319 (640)
Q Consensus       253 Ls~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~L~~N~l~~~----~~~~~~~l~~  319 (640)
                      +++|.++.....    .+...++|++|+|++|+|++.    ++..+. ..+.|++|+|++|.|+..    ++..+..+++
T Consensus       319 l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~  398 (460)
T d1z7xw1         319 VKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHS  398 (460)
T ss_dssp             CTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCC
T ss_pred             ccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCC
Confidence            888877643322    334556788888888887643    222232 356688888888888642    3344556788


Q ss_pred             CCeEeCcCCccccccCCc---ccCCCCCCCCCccccccCCCCC
Q 035691          320 LEGLDLFQNTFQAKSQNG---DVPRKGIFKNASAISVAGNEKL  359 (640)
Q Consensus       320 L~~L~l~~N~l~~~~~~~---~~p~~~~~~~~~~~~~~~n~~~  359 (640)
                      |++|||++|+++......   .+..  .-..++.+.+.+|.+.
T Consensus       399 L~~L~Ls~N~i~~~g~~~l~~~l~~--~~~~L~~l~l~~~~~~  439 (460)
T d1z7xw1         399 LRELDLSNNCLGDAGILQLVESVRQ--PGCLLEQLVLYDIYWS  439 (460)
T ss_dssp             CCEEECCSSSCCHHHHHHHHHHHTS--TTCCCCEEECTTCCCC
T ss_pred             CCEEECCCCcCCHHHHHHHHHHHHh--CCCccCEEECCCCCCC
Confidence            888888888876321100   0111  1124666777776553

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.69  E-value=5.9e-20  Score=194.64  Aligned_cols=329  Identities=16%  Similarity=0.130  Sum_probs=218.7

Q ss_pred             CCCCeEEcccCccCccC-CcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCccccc----CCccC
Q 035691           27 FQLRYIIFNSNTLQGQI-PVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGN----IPHSI  101 (640)
Q Consensus        27 ~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~----~~~~~  101 (640)
                      .+|+.|++++|++++.. ...+..+++|++|+|++|.|++..+. .+...+ ...++|+.|+|++|.|+..    +...+
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~-~l~~~L-~~~~~L~~LdLs~N~i~~~~~~~l~~~l   79 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCK-DISSAL-RVNPALAELNLRSNELGDVGVHCVLQGL   79 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHH-HHHHHH-HTCTTCCEEECTTCCCHHHHHHHHHHTT
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHH-HHHHHH-hcCCCCCEEECcCCcCChHHHHHHHHHH
Confidence            36899999999998632 34456789999999999988642211 233333 3589999999999999732    22333


Q ss_pred             c-CCCCCCEEECcCCccCcc----CCccccCCCCCCEEEcccCcCCCCCCCccc--------------------------
Q 035691          102 S-NASKLEWLDFANNSLTAS----IPEDLGRLRNLTRLNFARNDLGTRKVNDLR--------------------------  150 (640)
Q Consensus       102 ~-~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--------------------------  150 (640)
                      . ...+|++|+|++|+|+..    ++..+..+++|++|+|++|.++..+...+.                          
T Consensus        80 ~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~  159 (460)
T d1z7xw1          80 QTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE  159 (460)
T ss_dssp             CSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH
T ss_pred             hcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhc
Confidence            3 235899999999999854    356678899999999999998643111000                          


Q ss_pred             -ccccccCCCCcceEecCCCCCCCc--C---cCC-CCCCCCCEEEccCCcCcccC----CcCccCCCCCCEEEccCCCCC
Q 035691          151 -FLDSLVNCTYLEIVSLNVNSLRSI--P---ISV-GYLPKLQVLSLFENNISGEI----PSSLGNFTFLTELNLRGNSIR  219 (640)
Q Consensus       151 -~~~~l~~l~~L~~L~L~~N~l~~i--p---~~~-~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~  219 (640)
                       ....+.....++.++++.+.+...  .   ..+ ........+++..+.+....    ...+...+.++.+++++|++.
T Consensus       160 ~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~  239 (460)
T d1z7xw1         160 PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG  239 (460)
T ss_dssp             HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccc
Confidence             001123345677777777765431  0   111 11235667888887765221    123455788999999999875


Q ss_pred             C-----CCCccccCCCCccEEeccCcccc------------CCCCCceEEccCCcCCCCCCcc-----CCCCCCCCEEEC
Q 035691          220 G-----SIPSALGNCHQLQSLDLSKTIFL------------GQYPVRWLDLSHNHLTGPIPLA-----VGNLKSIPHLDL  277 (640)
Q Consensus       220 ~-----~~~~~~~~l~~L~~L~ls~n~~~------------~~~~l~~L~Ls~N~l~~~~~~~-----~~~l~~L~~L~L  277 (640)
                      .     ..+..+.....++.+++++|.+.            ....++.+++++|.++......     ......|+.+++
T Consensus       240 ~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l  319 (460)
T d1z7xw1         240 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWV  319 (460)
T ss_dssp             HHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred             ccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccc
Confidence            2     22334556789999999998653            3456899999999986322211     234568999999


Q ss_pred             CCCcccCcCCcc----ccCCCCCCeEEecCCccCCC----CCccC-CCCCCCCeEeCcCCccccccCCcccCCC-CCCCC
Q 035691          278 SKNKLSGEIPSS----LGSCVGLEYLNLSINSFHGP----IHPGL-SSLKSLEGLDLFQNTFQAKSQNGDVPRK-GIFKN  347 (640)
Q Consensus       278 s~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~~~----~~~~~-~~l~~L~~L~l~~N~l~~~~~~~~~p~~-~~~~~  347 (640)
                      ++|.++......    +...++|++|+|++|++++.    ++..+ ...+.|++|+|++|.++..+.. .++.. ...++
T Consensus       320 ~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~-~l~~~l~~~~~  398 (460)
T d1z7xw1         320 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCS-SLAATLLANHS  398 (460)
T ss_dssp             TTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHH-HHHHHHHHCCC
T ss_pred             cccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHH-HHHHHHhcCCC
Confidence            999998554333    34567899999999998642    22333 3567899999999999742211 11110 12367


Q ss_pred             CccccccCCCC
Q 035691          348 ASAISVAGNEK  358 (640)
Q Consensus       348 ~~~~~~~~n~~  358 (640)
                      +..+++++|+.
T Consensus       399 L~~L~Ls~N~i  409 (460)
T d1z7xw1         399 LRELDLSNNCL  409 (460)
T ss_dssp             CCEEECCSSSC
T ss_pred             CCEEECCCCcC
Confidence            88999999864

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.66  E-value=8.2e-17  Score=144.24  Aligned_cols=131  Identities=18%  Similarity=0.124  Sum_probs=85.0

Q ss_pred             hhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCc
Q 035691           23 IGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSIS  102 (640)
Q Consensus        23 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  102 (640)
                      |.+..+|++|+|++|+|+. ++..+..+++|++|||++|+|++      ++.  +..+++|+.|+|++|+|+.+.+..+.
T Consensus        14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~------l~~--~~~l~~L~~L~ls~N~i~~l~~~~~~   84 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK------LDG--FPLLRRLKTLLVNNNRICRIGEGLDQ   84 (162)
T ss_dssp             EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCE------ECC--CCCCSSCCEEECCSSCCCEECSCHHH
T ss_pred             ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCc------cCC--cccCcchhhhhcccccccCCCccccc
Confidence            5566667777777777773 35555667777777777777764      332  33467777777777777766666666


Q ss_pred             CCCCCCEEECcCCccCccCC-ccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEe
Q 035691          103 NASKLEWLDFANNSLTASIP-EDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVS  165 (640)
Q Consensus       103 ~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~  165 (640)
                      .+++|++|+|++|+|+.... ..+..+++|++|++++|.++..+.  + -...+..+++|++||
T Consensus        85 ~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~--~-r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          85 ALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH--Y-RLYVIYKVPQVRVLD  145 (162)
T ss_dssp             HCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTT--H-HHHHHHHCTTCSEET
T ss_pred             cccccccceeccccccccccccccccccccchhhcCCCccccccc--h-HHHHHHHCCCcCeeC
Confidence            77777777777777775322 456777777777777777765421  0 012355667777765

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.64  E-value=1.4e-16  Score=142.76  Aligned_cols=128  Identities=22%  Similarity=0.168  Sum_probs=88.8

Q ss_pred             CCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCcccc
Q 035691           47 LTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLG  126 (640)
Q Consensus        47 ~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  126 (640)
                      |.++.+|++|||++|+|+.      +| .++..+++|+.|+|++|+|+.+  +.|..+++|++|++++|+|+.+.+..+.
T Consensus        14 ~~n~~~lr~L~L~~n~I~~------i~-~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~   84 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIPV------IE-NLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQ   84 (162)
T ss_dssp             EECTTSCEEEECTTSCCCS------CC-CGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHH
T ss_pred             ccCcCcCcEEECCCCCCCc------cC-ccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccc
Confidence            5677788888888888876      65 3445678888888888888755  3477788888888888888876666667


Q ss_pred             CCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCc----CCCCCCCCCEEE
Q 035691          127 RLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPI----SVGYLPKLQVLS  188 (640)
Q Consensus       127 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~----~~~~l~~L~~L~  188 (640)
                      .+++|++|+|++|+|+.++     ....+..+++|++|++++|.++..|.    .+..+++|++||
T Consensus        85 ~l~~L~~L~L~~N~i~~~~-----~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          85 ALPDLTELILTNNSLVELG-----DLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             HCTTCCEEECCSCCCCCGG-----GGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             cccccccceeccccccccc-----cccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            7888888888888877652     12345566666666666666665553    234455566554

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.64  E-value=8.2e-17  Score=158.87  Aligned_cols=221  Identities=16%  Similarity=0.196  Sum_probs=159.8

Q ss_pred             cEEeCCCCccccCCchhhhcCC--CCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCC
Q 035691            6 MLINLQQNNFSGNIPHEIGRLF--QLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNI   83 (640)
Q Consensus         6 ~~L~L~~n~i~~~~p~~~~~l~--~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L   83 (640)
                      +.|||+++.+.   |+.+..+.  .+..+.+++..+..... ......+|++|||+++.+...     ....++..+++|
T Consensus         3 ~~lDLs~~~l~---~~~l~~l~~~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~-----~l~~l~~~c~~L   73 (284)
T d2astb2           3 QTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVS-----TLHGILSQCSKL   73 (284)
T ss_dssp             SEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHH-----HHHHHHTTBCCC
T ss_pred             CEEECCCCCCC---chHHHHHHhccceEeeccccccccchh-hhccCCCCCEEECCCCccCHH-----HHHHHHHhCCCc
Confidence            58999999886   33333322  35667777777663333 334567999999998877542     223456678999


Q ss_pred             CeeeccCCcccccCCccCcCCCCCCEEECcC-CccCcc-CCccccCCCCCCEEEcccC-cCCCCCCCccccccccc-CCC
Q 035691           84 RIPLLAGNQFFGNIPHSISNASKLEWLDFAN-NSLTAS-IPEDLGRLRNLTRLNFARN-DLGTRKVNDLRFLDSLV-NCT  159 (640)
Q Consensus        84 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~~~l~-~l~  159 (640)
                      +.|+|+++.++...+..++.+++|++|+|++ +.++.. ....+.++++|++|+++++ .++...     ....+. .++
T Consensus        74 ~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~-----~~~~~~~~~~  148 (284)
T d2astb2          74 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKH-----VQVAVAHVSE  148 (284)
T ss_dssp             SEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHH-----HHHHHHHSCT
T ss_pred             ccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccccccccccccccc-----chhhhccccc
Confidence            9999999999988888899999999999999 467642 2233467899999999985 444321     112222 347


Q ss_pred             CcceEecCCC--CCCC--cCcCCCCCCCCCEEEccCC-cCcccCCcCccCCCCCCEEEccCC-CCCCCCCccccCCCCcc
Q 035691          160 YLEIVSLNVN--SLRS--IPISVGYLPKLQVLSLFEN-NISGEIPSSLGNFTFLTELNLRGN-SIRGSIPSALGNCHQLQ  233 (640)
Q Consensus       160 ~L~~L~L~~N--~l~~--ip~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~  233 (640)
                      .|+.|++++.  .++.  +......+++|++|++++| .+++.....+..+++|++|+|+++ .++......++++++|+
T Consensus       149 ~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~  228 (284)
T d2astb2         149 TITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLK  228 (284)
T ss_dssp             TCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCC
T ss_pred             ccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCC
Confidence            8999999875  3443  3333355789999999986 577777788999999999999994 67766666788889999


Q ss_pred             EEeccCc
Q 035691          234 SLDLSKT  240 (640)
Q Consensus       234 ~L~ls~n  240 (640)
                      .|+++++
T Consensus       229 ~L~l~~~  235 (284)
T d2astb2         229 TLQVFGI  235 (284)
T ss_dssp             EEECTTS
T ss_pred             EEeeeCC
Confidence            9955543

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.63  E-value=6.2e-16  Score=131.62  Aligned_cols=103  Identities=23%  Similarity=0.319  Sum_probs=58.2

Q ss_pred             cEEeCCCCccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCe
Q 035691            6 MLINLQQNNFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRI   85 (640)
Q Consensus         6 ~~L~L~~n~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~   85 (640)
                      ++|||++|+|+ .++ .++.+++|++|++++|+|+ .+|..|..+++|++|++++|+|+.      +|            
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~------l~------------   59 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN------VD------------   59 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC------CG------------
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc------cC------------
Confidence            45666666666 333 3666666666666666666 445556666666666666666654      32            


Q ss_pred             eeccCCcccccCCccCcCCCCCCEEECcCCccCccCC-ccccCCCCCCEEEcccCcCCC
Q 035691           86 PLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIP-EDLGRLRNLTRLNFARNDLGT  143 (640)
Q Consensus        86 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~  143 (640)
                                    .|+++++|++|++++|+|+...+ ..+..+++|+.|++++|+++.
T Consensus        60 --------------~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~~  104 (124)
T d1dcea3          60 --------------GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ  104 (124)
T ss_dssp             --------------GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             --------------ccccccccCeEECCCCccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence                          24445555555555555553321 345555555555555555544

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.59  E-value=2.4e-15  Score=127.93  Aligned_cols=118  Identities=25%  Similarity=0.301  Sum_probs=88.9

Q ss_pred             CEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCE
Q 035691           54 RTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTR  133 (640)
Q Consensus        54 ~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  133 (640)
                      ++|||++|+|+.      ++. + ..+++|+.|++++|+|+. +|..|+.+++|++|++++|+|+.. | .+..+++|++
T Consensus         1 R~L~Ls~n~l~~------l~~-l-~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~   69 (124)
T d1dcea3           1 RVLHLAHKDLTV------LCH-L-EQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV-D-GVANLPRLQE   69 (124)
T ss_dssp             SEEECTTSCCSS------CCC-G-GGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCE
T ss_pred             CEEEcCCCCCCC------Ccc-c-ccCCCCCEEECCCCccCc-chhhhhhhhccccccccccccccc-C-ccccccccCe
Confidence            356666666654      432 2 346667777777777764 466788899999999999999964 4 4899999999


Q ss_pred             EEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCCCcCcC---C-CCCCCCCEE
Q 035691          134 LNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLRSIPIS---V-GYLPKLQVL  187 (640)
Q Consensus       134 L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ip~~---~-~~l~~L~~L  187 (640)
                      |++++|+|+.++     ....+..+++|+.|++++|.++.++..   + ..+|+|+.|
T Consensus        70 L~l~~N~i~~~~-----~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          70 LLLCNNRLQQSA-----AIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             EECCSSCCCSSS-----TTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             EECCCCccCCCC-----CchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence            999999999874     235678899999999999999876532   2 336777766

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.58  E-value=1.7e-16  Score=156.52  Aligned_cols=59  Identities=24%  Similarity=0.232  Sum_probs=32.1

Q ss_pred             CCCCCeeeccCCccccc-CCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEccc
Q 035691           80 LPNIRIPLLAGNQFFGN-IPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFAR  138 (640)
Q Consensus        80 l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  138 (640)
                      ..+|++|+|+++.++.. ++..+.++++|++|+|+++.++...+..+..+++|++|+|++
T Consensus        45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~  104 (284)
T d2astb2          45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG  104 (284)
T ss_dssp             CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred             CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence            44556666665555432 223345555666666666655554555555555666666655

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.55  E-value=2.3e-16  Score=160.43  Aligned_cols=248  Identities=19%  Similarity=0.254  Sum_probs=163.3

Q ss_pred             CCchhhhcCCCCCeEEcccCccCc----cCCcCCCCCCCCCEEEccCCCcCCccccccCCchh------hcCCCCCCeee
Q 035691           18 NIPHEIGRLFQLRYIIFNSNTLQG----QIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYI------GFTLPNIRIPL   87 (640)
Q Consensus        18 ~~p~~~~~l~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~------~~~l~~L~~L~   87 (640)
                      .+...+.....|+.|+|++|.|..    .+...+...++|+.|+++++.+....  ...|...      ....++|+.|+
T Consensus        22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~--~~~~~~~~~l~~~l~~~~~L~~L~   99 (344)
T d2ca6a1          22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVK--DEIPEALRLLLQALLKCPKLHTVR   99 (344)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCG--GGSHHHHHHHHHHHTTCTTCCEEE
T ss_pred             HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccc--cccchHHHHHHHHHhhCCCccccc
Confidence            345667778889999999998864    23445677889999999877653211  1111111      23467899999


Q ss_pred             ccCCccccc----CCccCcCCCCCCEEECcCCccCccCCcc-------------ccCCCCCCEEEcccCcCCCCCCCccc
Q 035691           88 LAGNQFFGN----IPHSISNASKLEWLDFANNSLTASIPED-------------LGRLRNLTRLNFARNDLGTRKVNDLR  150 (640)
Q Consensus        88 L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-------------~~~l~~L~~L~L~~N~l~~~~~~~~~  150 (640)
                      |++|.+...    +...+...++|++|++++|.++......             ....+.|+.|++++|+++......  
T Consensus       100 L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~--  177 (344)
T d2ca6a1         100 LSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE--  177 (344)
T ss_dssp             CCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHH--
T ss_pred             ccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccccccccccccc--
Confidence            999988754    2334456789999999999876321111             235678999999999887542211  


Q ss_pred             ccccccCCCCcceEecCCCCCCC------cCcCCCCCCCCCEEEccCCcCccc----CCcCccCCCCCCEEEccCCCCCC
Q 035691          151 FLDSLVNCTYLEIVSLNVNSLRS------IPISVGYLPKLQVLSLFENNISGE----IPSSLGNFTFLTELNLRGNSIRG  220 (640)
Q Consensus       151 ~~~~l~~l~~L~~L~L~~N~l~~------ip~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~  220 (640)
                      +...+..++.|++|++++|+++.      +...+...++|+.|+|++|.++..    +...+...++|++|+|++|.|+.
T Consensus       178 l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~  257 (344)
T d2ca6a1         178 WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA  257 (344)
T ss_dssp             HHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred             ccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCc
Confidence            22345667889999999999874      223456678899999999988643    33456788999999999999875


Q ss_pred             CCCccc----cC--CCCccEEeccCccccCCCCCceEEccCCcCCCC----CCccC-CCCCCCCEEECCCCcccCc
Q 035691          221 SIPSAL----GN--CHQLQSLDLSKTIFLGQYPVRWLDLSHNHLTGP----IPLAV-GNLKSIPHLDLSKNKLSGE  285 (640)
Q Consensus       221 ~~~~~~----~~--l~~L~~L~ls~n~~~~~~~l~~L~Ls~N~l~~~----~~~~~-~~l~~L~~L~Ls~N~l~~~  285 (640)
                      .....+    ..  ...|+.|                ++++|+|+..    +...+ .++++|+.|+|++|++...
T Consensus       258 ~g~~~l~~~l~~~~~~~L~~L----------------~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~  317 (344)
T d2ca6a1         258 RGAAAVVDAFSKLENIGLQTL----------------RLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE  317 (344)
T ss_dssp             HHHHHHHHHHHTCSSCCCCEE----------------ECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred             hhhHHHHHHhhhccCCCCCEE----------------ECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCc
Confidence            422222    22  2456677                5555555432    22223 2556677777777777554

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.55  E-value=3.7e-16  Score=158.89  Aligned_cols=247  Identities=17%  Similarity=0.160  Sum_probs=168.4

Q ss_pred             CcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCccccc----------CCccCcCCCCCCEEECc
Q 035691           44 PVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGN----------IPHSISNASKLEWLDFA  113 (640)
Q Consensus        44 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~----------~~~~~~~l~~L~~L~Ls  113 (640)
                      ...+.....|++|+|++|.|...... .+... ....++|+.++++++.+...          +...+...++|+.|+|+
T Consensus        24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~-~l~~~-l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~  101 (344)
T d2ca6a1          24 FAVLLEDDSVKEIVLSGNTIGTEAAR-WLSEN-IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  101 (344)
T ss_dssp             SHHHHHCSCCCEEECTTSEECHHHHH-HHHHT-TTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHhhCCCCCEEECcCCcCCHHHHH-HHHHH-HHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence            34566788999999999988542211 12112 23478999999998765422          12335567899999999


Q ss_pred             CCccCcc----CCccccCCCCCCEEEcccCcCCCCCCCccc-------ccccccCCCCcceEecCCCCCCC-----cCcC
Q 035691          114 NNSLTAS----IPEDLGRLRNLTRLNFARNDLGTRKVNDLR-------FLDSLVNCTYLEIVSLNVNSLRS-----IPIS  177 (640)
Q Consensus       114 ~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-------~~~~l~~l~~L~~L~L~~N~l~~-----ip~~  177 (640)
                      +|.++..    +...+...++|++|++++|.+.......+.       ........+.|+.+++++|.++.     +...
T Consensus       102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~  181 (344)
T d2ca6a1         102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT  181 (344)
T ss_dssp             SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred             ccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccch
Confidence            9999864    233456789999999999987542111100       00112356789999999999874     2233


Q ss_pred             CCCCCCCCEEEccCCcCccc-----CCcCccCCCCCCEEEccCCCCCCC----CCccccCCCCccEEeccCccccCCCCC
Q 035691          178 VGYLPKLQVLSLFENNISGE-----IPSSLGNFTFLTELNLRGNSIRGS----IPSALGNCHQLQSLDLSKTIFLGQYPV  248 (640)
Q Consensus       178 ~~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~ls~n~~~~~~~l  248 (640)
                      +...+.|++|+|++|.|...     +...+...++|+.|+|++|.++..    +...+..+++|++|             
T Consensus       182 l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L-------------  248 (344)
T d2ca6a1         182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL-------------  248 (344)
T ss_dssp             HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEE-------------
T ss_pred             hhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhh-------------
Confidence            45578899999999998742     344577889999999999998632    33456777888888             


Q ss_pred             ceEEccCCcCCCCCC----ccCC--CCCCCCEEECCCCcccCcC----Ccccc-CCCCCCeEEecCCccCC
Q 035691          249 RWLDLSHNHLTGPIP----LAVG--NLKSIPHLDLSKNKLSGEI----PSSLG-SCVGLEYLNLSINSFHG  308 (640)
Q Consensus       249 ~~L~Ls~N~l~~~~~----~~~~--~l~~L~~L~Ls~N~l~~~~----p~~~~-~l~~L~~L~L~~N~l~~  308 (640)
                         +|++|.|++...    ..+.  ..+.|++|++++|+|+...    ...+. ++++|++|+|++|++..
T Consensus       249 ---~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         249 ---GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             ---ECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             ---hhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence               666666653222    2222  2467999999999987432    23332 56789999999999964

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.52  E-value=1.9e-14  Score=127.67  Aligned_cols=138  Identities=20%  Similarity=0.159  Sum_probs=98.4

Q ss_pred             CCCCEEEccCCCCCCCCCccccCCCCccEEeccCccccCCCCCceEEccCC-cCCCCCCccCCCCCCCCEEECCCCcccC
Q 035691          206 TFLTELNLRGNSIRGSIPSALGNCHQLQSLDLSKTIFLGQYPVRWLDLSHN-HLTGPIPLAVGNLKSIPHLDLSKNKLSG  284 (640)
Q Consensus       206 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~n~~~~~~~l~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  284 (640)
                      ...+.++.+++.+. ..|..+..+++|+.|                ++++| .|+.+.+.+|.++++|+.|+|++|+|+.
T Consensus         8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L----------------~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~   70 (156)
T d2ifga3           8 HGSSGLRCTRDGAL-DSLHHLPGAENLTEL----------------YIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF   70 (156)
T ss_dssp             SSSSCEECCSSCCC-TTTTTSCSCSCCSEE----------------ECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCE
T ss_pred             CCCCeEEecCCCCc-cCcccccCccccCee----------------ecCCCccccccCchhhccccccCcceeeccccCC
Confidence            44556677777766 445566666777766                56544 4776667788889999999999999987


Q ss_pred             cCCccccCCCCCCeEEecCCccCCCCCccCCCCCCCCeEeCcCCccccccCCcccCCCCCCCCCccccccCCCCCcCCCc
Q 035691          285 EIPSSLGSCVGLEYLNLSINSFHGPIHPGLSSLKSLEGLDLFQNTFQAKSQNGDVPRKGIFKNASAISVAGNEKLCGGIS  364 (640)
Q Consensus       285 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~p~~~~~~~~~~~~~~~n~~~c~~~~  364 (640)
                      +.|.+|..+++|++|+|++|+|+...+..|..+ +|+.|+|++|+|.|.|...++..+.   ......+..+...|..|.
T Consensus        71 i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~C~C~~~~l~~~~---~~~~~~~~~~~~~C~~p~  146 (156)
T d2ifga3          71 VAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLHCSCALRWLQRWE---EEGLGGVPEQKLQCHGQG  146 (156)
T ss_dssp             ECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSC-CCCEEECCSSCCCCCGGGHHHHHHH---HTTCSSCGGGCCCCSSSS
T ss_pred             cccccccccccccceeccCCCCcccChhhhccc-cccccccCCCcccCCchHHHHHHHH---HhccCccCcCCcEECcCh
Confidence            778889999999999999999987666666655 6999999999999888665554321   111223334556676654

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.47  E-value=9.6e-14  Score=123.01  Aligned_cols=108  Identities=20%  Similarity=0.106  Sum_probs=70.6

Q ss_pred             CCcceEecCCCCCCCcCcCCCCCCCCCEEEccCC-cCcccCCcCccCCCCCCEEEccCCCCCCCCCccccCCCCccEEec
Q 035691          159 TYLEIVSLNVNSLRSIPISVGYLPKLQVLSLFEN-NISGEIPSSLGNFTFLTELNLRGNSIRGSIPSALGNCHQLQSLDL  237 (640)
Q Consensus       159 ~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  237 (640)
                      ...+.++++++.+..+|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.+.+|..+++|+.|  
T Consensus         8 ~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L--   85 (156)
T d2ifga3           8 HGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL--   85 (156)
T ss_dssp             SSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE--
T ss_pred             CCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce--
Confidence            3445567777777777776766777777777654 4766666667777777777777777776666667666666666  


Q ss_pred             cCccccCCCCCceEEccCCcCCCCCCccCCCCCCCCEEECCCCccc
Q 035691          238 SKTIFLGQYPVRWLDLSHNHLTGPIPLAVGNLKSIPHLDLSKNKLS  283 (640)
Q Consensus       238 s~n~~~~~~~l~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  283 (640)
                                    +|++|+|+...+..|..+ +|+.|+|++|.+.
T Consensus        86 --------------~Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~  116 (156)
T d2ifga3          86 --------------NLSFNALESLSWKTVQGL-SLQELVLSGNPLH  116 (156)
T ss_dssp             --------------ECCSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred             --------------eccCCCCcccChhhhccc-cccccccCCCccc
Confidence                          666666664444445443 4666666666653

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.46  E-value=7.7e-16  Score=142.76  Aligned_cols=128  Identities=20%  Similarity=0.204  Sum_probs=81.2

Q ss_pred             CcEEeCCCC--ccccCCchhhhcCCCCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCC
Q 035691            5 LMLINLQQN--NFSGNIPHEIGRLFQLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPN   82 (640)
Q Consensus         5 L~~L~L~~n--~i~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~   82 (640)
                      ++.++++++  .|. .+|..+..+++|++|+|++|+|+. ++ .|..+++|++|+|++|+|++      +|... ..+++
T Consensus        25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~~------i~~~~-~~~~~   94 (198)
T d1m9la_          25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKK------IENLD-AVADT   94 (198)
T ss_dssp             CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEECS------CSSHH-HHHHH
T ss_pred             cceeeeecccCchh-hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhccccccc------ccccc-ccccc
Confidence            344555543  233 455677788888888888888874 33 37777788888888777765      55322 22456


Q ss_pred             CCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCC-ccccCCCCCCEEEcccCcCCCC
Q 035691           83 IRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIP-EDLGRLRNLTRLNFARNDLGTR  144 (640)
Q Consensus        83 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~  144 (640)
                      |+.|++++|+|+.+  ..+..+++|++|+|++|+|+.... ..|..+++|++|+|++|++...
T Consensus        95 L~~L~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~  155 (198)
T d1m9la_          95 LEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND  155 (198)
T ss_dssp             CCEEECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHH
T ss_pred             cccccccccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCccccC
Confidence            77777777777643  235666677777777777764322 3566667777777777766543

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.43  E-value=1.6e-15  Score=140.52  Aligned_cols=105  Identities=19%  Similarity=0.177  Sum_probs=43.4

Q ss_pred             CCCCCeeeccCCcccccCCccCcCCCCCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCcccccccccCCC
Q 035691           80 LPNIRIPLLAGNQFFGNIPHSISNASKLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCT  159 (640)
Q Consensus        80 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~  159 (640)
                      +++|+.|+|++|+|+.+ + .|.++++|++|+|++|+|+. +|..+..+++|++|++++|+|+.+        +.+..++
T Consensus        47 L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~l--------~~~~~l~  115 (198)
T d1m9la_          47 LKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASL--------SGIEKLV  115 (198)
T ss_dssp             TTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCCH--------HHHHHHH
T ss_pred             ccccceeECcccCCCCc-c-cccCCccccChhhccccccc-cccccccccccccccccccccccc--------ccccccc
Confidence            34444444444444322 1 24444444444444444442 233333333444444444444432        1233334


Q ss_pred             CcceEecCCCCCCCcCc--CCCCCCCCCEEEccCCcCc
Q 035691          160 YLEIVSLNVNSLRSIPI--SVGYLPKLQVLSLFENNIS  195 (640)
Q Consensus       160 ~L~~L~L~~N~l~~ip~--~~~~l~~L~~L~L~~N~l~  195 (640)
                      +|+.|++++|+|+.++.  .+..+++|++|+|++|.+.
T Consensus       116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_         116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             cccccccccchhccccccccccCCCccceeecCCCccc
Confidence            44444444444444331  2334444444444444443

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.78  E-value=2.1e-10  Score=101.86  Aligned_cols=127  Identities=13%  Similarity=0.043  Sum_probs=80.9

Q ss_pred             CCCeEEcccCccCccCCcCCCCCCCCCEEEccCCCcCCccccccCCchhhcCCCCCCeeeccCCcccccC--CccCcCCC
Q 035691           28 QLRYIIFNSNTLQGQIPVNLTHCSELRTLDLVLNKLEENQLVGELPPYIGFTLPNIRIPLLAGNQFFGNI--PHSISNAS  105 (640)
Q Consensus        28 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~lp~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~  105 (640)
                      ..+.|++++++..    ..+..+..+..|+...|.+.       ....++..+++|+.|+|++|+|+...  +..+..++
T Consensus        23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-------~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~   91 (162)
T d1koha1          23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-------TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAP   91 (162)
T ss_dssp             SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-------HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHST
T ss_pred             hhCeeecccCCCC----chhhhccchhhcchhhhHhh-------hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCC
Confidence            3455666655432    12444444444444433322       22345556889999999999998653  35577889


Q ss_pred             CCCEEECcCCccCccCCccccCCCCCCEEEcccCcCCCCCCCccc-ccccccCCCCcceEe
Q 035691          106 KLEWLDFANNSLTASIPEDLGRLRNLTRLNFARNDLGTRKVNDLR-FLDSLVNCTYLEIVS  165 (640)
Q Consensus       106 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~~~~l~~l~~L~~L~  165 (640)
                      +|+.|||++|+|+...+-.+....+|+.|+|++|.+......... ....+..+++|+.||
T Consensus        92 ~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1          92 NLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD  152 (162)
T ss_dssp             TCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred             cccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence            999999999999976554555566799999999998765322111 112355678888775

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.66  E-value=7.6e-10  Score=98.09  Aligned_cols=42  Identities=29%  Similarity=0.315  Sum_probs=18.5

Q ss_pred             cCCCCCCEEECcCCccCccC--CccccCCCCCCEEEcccCcCCC
Q 035691          102 SNASKLEWLDFANNSLTASI--PEDLGRLRNLTRLNFARNDLGT  143 (640)
Q Consensus       102 ~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~  143 (640)
                      .++++|++|+|++|+|+.+.  +..+..+++|+.|+|++|+|+.
T Consensus        62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~  105 (162)
T d1koha1          62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS  105 (162)
T ss_dssp             HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC
T ss_pred             HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc
Confidence            34444555555555544321  1223344444444444444443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.39  E-value=1.3e-06  Score=83.39  Aligned_cols=149  Identities=15%  Similarity=0.094  Sum_probs=96.7

Q ss_pred             HHHHhcCCCcccCcccccccceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcC-CCCCcceeEeeccCCcC
Q 035691          435 SLLKATGGFSSANLIGTGSFGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR-HRNLVKIITACSSSDFQ  513 (640)
Q Consensus       435 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~  513 (640)
                      ++...-+.|+..+..+.++.+.||+...  +++.+++|+...........+.+|...+..+. +--+.+++.++.     
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~-----   80 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----   80 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEe-----
Confidence            4555556677666555555678998763  56667888875544444455778888887763 434567776632     


Q ss_pred             CCceeeEEeeccCCCChhhhcCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC---------------------
Q 035691          514 GNDFKALVYEFMHHGSLESWLHPESASDDLNYSPSILSFLQRLNIAINVASALEYLHHH---------------------  572 (640)
Q Consensus       514 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~---------------------  572 (640)
                      .+...++||++++|..+.+......               ....++.+++..+..||+.                     
T Consensus        81 ~~~~~~lv~~~l~G~~~~~~~~~~~---------------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~  145 (263)
T d1j7la_          81 HDGWSNLLMSEADGVLCSEEYEDEQ---------------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYL  145 (263)
T ss_dssp             ETTEEEEEEECCSSEEHHHHTTTCS---------------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHH
T ss_pred             cCCceEEEEEecccccccccccccc---------------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHH
Confidence            2346789999999988765432111               1122344444455555531                     


Q ss_pred             -----------------------------------CCCCeeeCCCCCCCeeeCCCCcEEEcccccccc
Q 035691          573 -----------------------------------CKKQIVHCDLKPSNVLLDNDMIAHVGDFGLTRF  605 (640)
Q Consensus       573 -----------------------------------~~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~~  605 (640)
                                                         ....++|+|+.|.||++++++.+-|+||+.+..
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         146 LNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                               012378999999999999877778999998864

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.88  E-value=2e-06  Score=75.78  Aligned_cols=18  Identities=6%  Similarity=-0.162  Sum_probs=9.0

Q ss_pred             CCCCCCCCEEEccCCcCc
Q 035691          178 VGYLPKLQVLSLFENNIS  195 (640)
Q Consensus       178 ~~~l~~L~~L~L~~N~l~  195 (640)
                      +...++|++|++++|.+.
T Consensus        96 L~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          96 TLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             TTTTCCCSEEECCCCSSC
T ss_pred             HHhCCcCCEEECCCCcCC
Confidence            333445555555555443

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.75  E-value=2.7e-06  Score=74.90  Aligned_cols=69  Identities=19%  Similarity=0.157  Sum_probs=30.9

Q ss_pred             cCCCCCCEEECcCCccCccC----CccccCCCCCCEEEcccCcCCCCCCCcccccccccCCCCcceEecCCCCCC
Q 035691          102 SNASKLEWLDFANNSLTASI----PEDLGRLRNLTRLNFARNDLGTRKVNDLRFLDSLVNCTYLEIVSLNVNSLR  172 (640)
Q Consensus       102 ~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L~~N~l~  172 (640)
                      ...++|++|+|++|.++...    ...+...+.|++|+|++|.|+......  ..+.+...+.|++|++++|.+.
T Consensus        41 ~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~--l~~aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          41 CNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR--LLRSTLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             TTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH--HHHHTTTTCCCSEEECCCCSSC
T ss_pred             hhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH--HHHHHHhCCcCCEEECCCCcCC
Confidence            33444555555555554211    122333455555555555554322111  1233444455555555555443

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.67  E-value=9.1e-05  Score=69.56  Aligned_cols=74  Identities=12%  Similarity=0.055  Sum_probs=47.6

Q ss_pred             ccccc-cceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcC--CCCCcceeEeeccCCcCCCceeeEEeecc
Q 035691          449 IGTGS-FGSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIR--HRNLVKIITACSSSDFQGNDFKALVYEFM  525 (640)
Q Consensus       449 lg~G~-~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~~~~~~lv~e~~  525 (640)
                      +..|. -+.||+.... ++..+++|.-.....   ..+..|+..++.+.  .-.+.+++.++..     ....++||+|+
T Consensus        18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-----~~~~~~v~~~i   88 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLLGEV   88 (255)
T ss_dssp             CSCTTSSCEEEEEECT-TSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEEECC
T ss_pred             cCCcccCCeEEEEEeC-CCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeeccc-----ccceEEEEEee
Confidence            34444 3678998764 566788897643332   34667787777663  3335667766432     34678999999


Q ss_pred             CCCChh
Q 035691          526 HHGSLE  531 (640)
Q Consensus       526 ~~g~L~  531 (640)
                      +|.++.
T Consensus        89 ~G~~~~   94 (255)
T d1nd4a_          89 PGQDLL   94 (255)
T ss_dssp             SSEETT
T ss_pred             eccccc
Confidence            886653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.51  E-value=0.00013  Score=73.36  Aligned_cols=76  Identities=16%  Similarity=0.148  Sum_probs=47.3

Q ss_pred             CcccccccceEEEEEECCCCeEEEEEEeecc----c---chhHHHHHHHHHHHHhcC-C--CCCcceeEeeccCCcCCCc
Q 035691          447 NLIGTGSFGSVYKGILDPDQTVVAVKVLFLH----Q---RGALKSFMAECEALRNIR-H--RNLVKIITACSSSDFQGND  516 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~~~~~~~  516 (640)
                      +.||.|....||+.+...+++.|+||.-...    .   .....+...|.+.++.+. +  ..+++++.+..       +
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~-------~  104 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT-------E  104 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET-------T
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC-------C
Confidence            4689999999999988777888999975321    1   112234456777777652 2  45667776532       2


Q ss_pred             eeeEEeeccCCCC
Q 035691          517 FKALVYEFMHHGS  529 (640)
Q Consensus       517 ~~~lv~e~~~~g~  529 (640)
                      ..++|||++++..
T Consensus       105 ~~~lvmE~L~~~~  117 (392)
T d2pula1         105 MAVTVMEDLSHLK  117 (392)
T ss_dssp             TTEEEECCCTTSE
T ss_pred             CCEEEEeccCCcc
Confidence            3468999997643

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.29  E-value=7.7e-06  Score=71.83  Aligned_cols=17  Identities=0%  Similarity=0.006  Sum_probs=8.4

Q ss_pred             cCCCCCCEEEcccCcCC
Q 035691          126 GRLRNLTRLNFARNDLG  142 (640)
Q Consensus       126 ~~l~~L~~L~L~~N~l~  142 (640)
                      ...++|++|+|++|.++
T Consensus        43 ~~n~~L~~L~Ls~n~l~   59 (166)
T d1io0a_          43 KTNTYVKKFSIVGTRSN   59 (166)
T ss_dssp             TTCCSCCEEECTTSCCC
T ss_pred             hcCCccCeeeccCCccc
Confidence            34445555555555443

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.15  E-value=2.8e-05  Score=68.04  Aligned_cols=43  Identities=14%  Similarity=0.161  Sum_probs=23.8

Q ss_pred             CcCCCCCCEEECcCCccCccC----CccccCCCCCCEEEcccCcCCC
Q 035691          101 ISNASKLEWLDFANNSLTASI----PEDLGRLRNLTRLNFARNDLGT  143 (640)
Q Consensus       101 ~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~  143 (640)
                      +...++|++|+|++|.++...    ...+...++++.|++++|.+..
T Consensus        42 l~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~   88 (166)
T d1io0a_          42 LKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG   88 (166)
T ss_dssp             HTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred             HhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccc
Confidence            345566666666666665321    2234445666666666666543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.98  E-value=0.0011  Score=64.49  Aligned_cols=73  Identities=11%  Similarity=0.089  Sum_probs=45.6

Q ss_pred             ceEEEEEECCCCeEEEEEEeecccchhHHHHHHHHHHHHhcCCCCC--cceeEeeccCCcCCCceeeEEeeccCCCC
Q 035691          455 GSVYKGILDPDQTVVAVKVLFLHQRGALKSFMAECEALRNIRHRNL--VKIITACSSSDFQGNDFKALVYEFMHHGS  529 (640)
Q Consensus       455 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~~~~~~~~~~lv~e~~~~g~  529 (640)
                      -.||+++.. +|+.|++|+.+.... ..+++..|.+.+..+....+  +..+.......+..+...+.++++++|..
T Consensus        36 N~vy~v~~~-dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          36 NRVYQFQDE-DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SEEEEECCT-TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             ceeEEEEcC-CCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            479999875 788899999854322 34667888888887743322  22222211222334556788999987643

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.47  E-value=0.055  Score=51.44  Aligned_cols=31  Identities=26%  Similarity=0.373  Sum_probs=27.9

Q ss_pred             CCCeeeCCCCCCCeeeCCCCcEEEccccccc
Q 035691          574 KKQIVHCDLKPSNVLLDNDMIAHVGDFGLTR  604 (640)
Q Consensus       574 ~~~ivHrdlkp~NiLl~~~~~~kl~DfGla~  604 (640)
                      +.++||+|+.++||+++++...-|.||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            4689999999999999998888899999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.34  E-value=0.023  Score=56.26  Aligned_cols=73  Identities=18%  Similarity=0.213  Sum_probs=46.7

Q ss_pred             CcccccccceEEEEEECC-------CCeEEEEEEeecccchhHHHHHHHHHHHHhcC-CCCCcceeEeeccCCcCCCcee
Q 035691          447 NLIGTGSFGSVYKGILDP-------DQTVVAVKVLFLHQRGALKSFMAECEALRNIR-HRNLVKIITACSSSDFQGNDFK  518 (640)
Q Consensus       447 ~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~~~~~  518 (640)
                      +.|+.|-.=.+|++....       .+..|.+++.- ... ......+|..+++.+. +.-.+++++++.     +    
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~-----~----  116 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFS-----G----  116 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEET-----T----
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcC-----C----
Confidence            457777778899998752       33567777653 222 2234567888888874 433457777742     1    


Q ss_pred             eEEeeccCCCCh
Q 035691          519 ALVYEFMHHGSL  530 (640)
Q Consensus       519 ~lv~e~~~~g~L  530 (640)
                      .+||||++|..+
T Consensus       117 g~I~efi~g~~l  128 (395)
T d1nw1a_         117 GRLEEYIPSRPL  128 (395)
T ss_dssp             EEEECCCCEEEC
T ss_pred             ceEEEEeccccC
Confidence            478999987544